PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Firuzi, O; Zhuo, JM; Chinnici, CM; Wisniewski, T; Pratio, D				Firuzi, Omidreza; Zhuo, Jiamin; Chinnici, Cinzia M.; Wisniewski, Thomas; Pratio, Domenico			5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer's disease	FASEB JOURNAL			English	Article						gamma-secretase; Tg2576; A beta; amyloid-beta precursor protein; leukotrienes	LIPID-PEROXIDATION; PLAQUE-FORMATION; TRANSGENIC MICE; GAMMA-SECRETASE; UP-REGULATION; IN-VIVO; PROTEIN; BRAIN; EXPRESSION; A-BETA-42	5-Lipoxygenase (5LO), by producing leukotrienes, is a proinflammatory enzyme, and there is evidence suggesting that it is up-regulated with aging and may be involved in Alzheimer's disease (AD). In this paper, we studied the effect of 5LO-targeted gene disruption on the amyloid phenotype of a transgenic mouse model of AD, the Tg2576. Amyloid-beta (A beta) deposition in the brains of Tg2576 mice lacking 5LO was reduced by 64-80% compared with Tg2576 controls. This reduction was associated with a similar significant decrease in A beta levels measured by sandwich ELISA. Absence of 5LO did not induce any significant change in amyloid-beta precursor protein (APP) levels and processing, or A beta catabolic pathways. Furthermore, in vitro studies showed that 5LO activation or 5LO metabolites increase, whereas 5LO inhibition decreases, A beta formation, secondary to correspondent changes in gamma-secretase activity. These data establish for the first time a novel functional role for 5LO in the pathogenesis of AD-like amyloidosis, thereby modulating gamma-secretase activity. Our work suggests that pharmacological inhibition of 5LO could provide a novel therapeutic tool for AD.	[Firuzi, Omidreza; Zhuo, Jiamin; Chinnici, Cinzia M.; Pratio, Domenico] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Wisniewski, Thomas] NYU, Sch Med, Dept Neurol Psychiat & Pathol, New York, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; New York University	Wisniewski, T (corresponding author), Temple Univ, Sch Med, Dept Pharmacol, 3420 N Broad St,Med Res Bldg,Room 706A, Philadelphia, PA 19140 USA.	praticod@temple.edu	Firuzi, Omidreza/A-1025-2012; Zhuo, Jia-Min/M-7546-2014; Wisniewski, Thomas/Q-6525-2019	Zhuo, Jia-Min/0000-0001-9199-5485; Wisniewski, Thomas/0000-0002-3379-8966; Firuzi, Omidreza/0000-0002-2248-5198; chinnici, cinzia/0000-0001-9318-6606	NATIONAL INSTITUTE ON AGING [R01AG022203, R01AG015408, P30AG008051] Funding Source: NIH RePORTER; NIA NIH HHS [AG15408, R01 AG022203, AG22203, R01 AG022203-05, AG008051, P30 AG008051, P30 AG008051-14, R01 AG015408-09, R01 AG015408] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Burkert E, 2003, J LEUKOCYTE BIOL, V73, P191, DOI 10.1189/jlb.0702354; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; Chinnici CM, 2007, NEUROBIOL AGING, V28, P1457, DOI 10.1016/j.neurobiolaging.2006.06.007; Drazen JM, 1999, NAT GENET, V22, P168, DOI 10.1038/9680; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Firuzi O, 2006, ANN NEUROL, V59, P219, DOI 10.1002/ana.20774; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Golde TE, 2003, J CLIN INVEST, V111, P11, DOI 10.1172/JCI200317527; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Lammers CH, 1996, J NEUROCHEM, V66, P147; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Liang XB, 2005, J NEUROSCI, V25, P10180, DOI 10.1523/JNEUROSCI.3591-05.2005; Manev H, 1998, RESTOR NEUROL NEUROS, V12, P81; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Mhatre M, 2006, DRUG FUTURE, V31, P83, DOI 10.1358/dof.2006.031.01.963590; Morris AAM, 1998, LANCET, V352, P1487, DOI 10.1016/S0140-6736(05)60322-4; PIOMELLI D, 1994, CRIT REV NEUROBIOL, V8, P65; Pratico D, 2004, AM J PATHOL, V164, P1655, DOI 10.1016/S0002-9440(10)63724-8; Pratico D, 1998, FASEB J, V12, P1777, DOI 10.1096/fasebj.12.15.1777; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Qu TY, 2000, NEUROBIOL AGING, V21, P647, DOI 10.1016/S0197-4580(00)00167-6; Qu TY, 2001, J NEUROPSYCH CLIN N, V13, P304, DOI 10.1176/appi.neuropsych.13.2.304; Selkoe DJ, 2002, J CLIN INVEST, V110, P1375, DOI 10.1172/JCI200216783; SIMMET T, 1990, BRAIN RES, V515, P79, DOI 10.1016/0006-8993(90)90579-Z; Sung S, 2004, AM J PATHOL, V165, P2197, DOI 10.1016/S0002-9440(10)63269-5; Sung S, 2003, FASEB J, V17, P323, DOI 10.1096/fj.03-0961fje; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Uz T, 1998, FASEB J, V12, P439, DOI 10.1096/fasebj.12.6.439; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Yermakova AV, 2001, NEUROBIOL AGING, V22, P823, DOI 10.1016/S0197-4580(01)00303-7; Zhou Y, 2006, LIFE SCI, V79, P1645, DOI 10.1016/j.lfs.2006.05.022	37	142	146	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2008	22	4					1169	1178		10.1096/fj.07-9131.com	http://dx.doi.org/10.1096/fj.07-9131.com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	17998412	Green Accepted			2022-12-25	WOS:000254581000022
J	Surinya, KH; Forbes, BE; Occhiodoro, F; Booker, GW; Francis, GL; Siddle, K; Wallace, JC; Cosgrove, LJ				Surinya, Katharina Helen; Forbes, Briony E.; Occhiodoro, Filomena; Booker, Grant W.; Francis, Geoffrey Leonard; Siddle, Kenneth; Wallace, John C.; Cosgrove, Leah J.			An investigation of the ligand binding properties and negative cooperativity of soluble insulin-like growth factor receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I RECEPTOR; ALANINE-SCANNING MUTAGENESIS; HIGH-AFFINITY BINDING; STRUCTURAL BASIS; ALPHA-SUBUNIT; IGF-II; MONOCLONAL-ANTIBODIES; FACTOR (IGF)-II; DOMAIN; SPECIFICITY	To investigate the interaction of the insulin-like growth factor (IGF) ligands with the insulin-like growth factor type 1 receptor (IGF-1R), we have generated two soluble variants of the IGF-1R. We have recombinantly expressed the ectodomain of IGF-1R or fused this domain to the constant domain from the Fc fragment of mouse immunoglobulin. The ligand binding properties of these soluble IGF-1Rs for IGF-I and IGF-II were investigated using conventional ligand competition assays and BIAcore biosensor technology. In ligand competition assays, the soluble IGF-1Rs both bound IGF-I with similar affinities and a 5-fold lower affinity than that seen for the wild type receptor. In addition, both soluble receptors bound IGF-II with similar affinities to the wild type receptor. BIAcore analyses showed that both soluble IGF-1Rs exhibited similar ligand-specific association and dissociation rates for IGF-I and for IGF-II. The soluble IGF-1R proteins both exhibited negative cooperativity for IGF-I, IGF-II, and the 24-60 antibody, which binds to the IGF-1R cysteine-rich domain. We conclude that the addition of the self-associating Fc domain to the IGF-1R ectodomain does not affect ligand binding affinity, which is in contrast to the soluble ectodomain of the IR. This study highlights some significant differences in ligand binding modes between the IGF-1R and the insulin receptor, which may ultimately contribute to the different biological activities conferred by the two receptors.	[Occhiodoro, Filomena; Cosgrove, Leah J.] CSIRO Mol & Hlth Technol, Adelaide, SA 5000, Australia; [Surinya, Katharina Helen; Forbes, Briony E.; Booker, Grant W.; Wallace, John C.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Francis, Geoffrey Leonard] Novozymes GroPep Ltd, Adelaide, SA 5000, Australia; [Siddle, Kenneth] Univ Cambridge, Dept Clin Biochem, Cambridge CB2 2QR, England	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Adelaide; Novozymes; University of Cambridge	Cosgrove, LJ (corresponding author), CSIRO Mol & Hlth Technol, PO Box 10041 BC, Adelaide, SA 5000, Australia.	leah.cosgrove@csiro.au	, John/AAP-5150-2020; Cosgrove, Leah J/A-7764-2010; Forbes, Briony/R-1838-2019	Cosgrove, Leah J/0000-0002-8340-4291; Surinya, Kathy/0000-0003-0507-2962; Forbes, Briony/0000-0003-4360-9927				Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; ANDERSEN AS, 1990, BIOCHEMISTRY-US, V29, P7363, DOI 10.1021/bi00484a002; ANDERSEN AS, 1992, J BIOL CHEM, V267, P13681; Bass J, 1996, J BIOL CHEM, V271, P19367, DOI 10.1074/jbc.271.32.19367; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; BONISCHNETZLER M, 1987, J BIOL CHEM, V262, P8395; Brandt J, 2001, J BIOL CHEM, V276, P12378, DOI 10.1074/jbc.M009402200; Chakravarty A, 2005, BIOCHEM BIOPH RES CO, V331, P74, DOI 10.1016/j.bbrc.2005.03.122; Chan SJ, 2007, J BIOL CHEM, V282, P13754, DOI 10.1074/jbc.M700724200; CHRISTOFFERSEN CT, 1994, ENDOCRINOLOGY, V135, P472, DOI 10.1210/en.135.1.472; Cosgrove L, 1995, PROTEIN EXPRES PURIF, V6, P789, DOI 10.1006/prep.1995.0010; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; De Meyts P, 2002, GROWTH HORM IGF RES, V12, P81, DOI 10.1054/ghir.2002.0264; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; DEMEYTS P, 1994, HORM RES, V42, P152, DOI 10.1159/000184188; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Denley A, 2005, MOL ENDOCRINOL, V19, P711, DOI 10.1210/me.2004-0409; Denley A, 2005, CYTOKINE GROWTH F R, V16, P421, DOI 10.1016/j.cytogfr.2005.04.004; FABRY M, 1992, J BIOL CHEM, V267, P8950; FELTZ SM, 1988, BIOCHEMISTRY-US, V27, P3234, DOI 10.1021/bi00409a017; Forbes BE, 2002, EUR J BIOCHEM, V269, P961, DOI 10.1046/j.0014-2956.2001.02735.x; FRANCIS GL, 1993, BIOCHEM J, V293, P713, DOI 10.1042/bj2930713; GICQUEL C, 1994, J CLIN ENDOCR METAB, V78, P1444, DOI 10.1210/jc.78.6.1444; GUSTAFSON TA, 1990, J BIOL CHEM, V265, P18663; Hao CL, 2006, BIOCHEM BIOPH RES CO, V347, P334, DOI 10.1016/j.bbrc.2006.06.089; Hoyne PA, 2000, FEBS LETT, V479, P15, DOI 10.1016/S0014-5793(00)01872-X; Jansson M, 1997, J BIOL CHEM, V272, P8189, DOI 10.1074/jbc.272.13.8189; Keyhanfar M, 2007, BIOCHEM J, V401, P269, DOI 10.1042/BJ20060890; KING R, 1992, J MOL ENDOCRINOL, V8, P29, DOI 10.1677/jme.0.0080029; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; KJELDSEN T, 1994, J BIOL CHEM, V269, P32942; Kristensen C, 1998, J BIOL CHEM, V273, P17780, DOI 10.1074/jbc.273.28.17780; Kristensen C, 1999, J BIOL CHEM, V274, P37351, DOI 10.1074/jbc.274.52.37351; KUROSE T, 1994, J BIOL CHEM, V269, P29190; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; LOETSCHER H, 1991, J BIOL CHEM, V266, P18324; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Molina L, 2000, FEBS LETT, V467, P226, DOI 10.1016/S0014-5793(00)01161-3; Mynarcik DC, 1996, J BIOL CHEM, V271, P2439, DOI 10.1074/jbc.271.5.2439; Mynarcik DC, 1997, J BIOL CHEM, V272, P18650, DOI 10.1074/jbc.272.30.18650; PIETRZKOWSKI Z, 1992, CELL GROWTH DIFFER, V3, P199; Quinn KA, 1996, J BIOL CHEM, V271, P11477, DOI 10.1074/jbc.271.19.11477; Renehan AG, 2000, BRIT J CANCER, V83, P1344, DOI 10.1054/bjoc.2000.1462; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; SCHUMACHER R, 1993, J BIOL CHEM, V268, P1087; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; SOOS MA, 1992, J BIOL CHEM, V267, P12955; Surinya HH, 2002, J BIOL CHEM, V277, P16718, DOI 10.1074/bjc.M112014200; SWEET LJ, 1987, J BIOL CHEM, V262, P6939; TOLLEFSEN SE, 1988, J BIOL CHEM, V263, P16267; TOLLEFSEN SE, 1991, BIOCHEMISTRY-US, V30, P48, DOI 10.1021/bi00215a008; Vella V, 2002, J CLIN ENDOCR METAB, V87, P245, DOI 10.1210/jc.87.1.245; Walenkamp MJE, 2005, J CLIN ENDOCR METAB, V90, P2855, DOI 10.1210/jc.2004-1254; Ward CW, 2007, TRENDS BIOCHEM SCI, V32, P129, DOI 10.1016/j.tibs.2007.01.001; WHITTAKER J, 1994, MOL ENDOCRINOL, V8, P1521, DOI 10.1210/me.8.11.1521; WILLIAMS PF, 1995, J BIOL CHEM, V270, P3012, DOI 10.1074/jbc.270.7.3012; Woods KA, 1997, ACTA PAEDIATR, V86, P39; ZHANG B, 1991, P NATL ACAD SCI USA, V88, P9858, DOI 10.1073/pnas.88.21.9858; ZHANG B, 1991, BIOCHEMISTRY-US, V30, P5113, DOI 10.1021/bi00235a001	62	31	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5355	5363		10.1074/jbc.M707054200	http://dx.doi.org/10.1074/jbc.M707054200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18056713	hybrid			2022-12-25	WOS:000253426700015
J	Xie, Y; Xu, K; Linn, DE; Yang, X; Guo, Z; Shimelis, H; Nakanishi, T; Ross, DD; Chen, H; Fazli, L; Gleave, ME; Qiu, Y				Xie, Yingqiu; Xu, Kexin; Linn, Douglas E.; Yang, Xi; Guo, Zhiyong; Shimelis, Hermela; Nakanishi, Takeo; Ross, Douglas D.; Chen, Hegang; Fazli, Ladan; Gleave, Martin E.; Qiu, Yun			The 44-kDa pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE; PROTEIN; TRANSPORTER; ANDROGEN; ABCG2; PHOSPHATASE; ACTIVATION; EXPRESSION; RECEPTOR; ETK/BMX	We previously showed that the 44-kDa serine/threonine kinase Pim-1 (Pim-1L) can protect prostate cancer cells from apoptosis induced by chemotherapeutic drugs (Xie, Y., Xu, K., Dai, B., Guo, Z., Jiang, T., Chen, H., and Qiu, Y. (2006) Oncogene 25, 70-78). To further explore the mechanisms of Pim-1L-mediated resistance to chemotherapeutic drugs in prostate cancer cells, we employed a yeast two-hybrid screening to identify cellular proteins that were associated with Pim-1L, and we found the ABC transporter BCRP/ABCG2 as one of the potential interacting partners of Pim-1L. We also showed that the expression level of Pim-1L and BCRP was up-regulated in mitoxantrone and docetaxel-resistant prostate cancer cell lines. Pim-1L was co-localized with BCRP on the plasma membrane and induced phosphorylation of BCRP at threonine 362. Knocking-down Pim-1L expression in the drug-resistant prostate cancer cells abolished multimer formation of endogenous BCRP and resensitized the resistant cells to chemotherapeutic drugs suggesting that BCRP phosphorylation induced by Pim-1L was essential for its functionality. This is further corroborated by our finding that the plasma membrane localization and drug-resistant activity of BCRP were compromised by T362A mutation. Our data suggest that Pim-1L may protect prostate cancer cells from apoptosis, at least in part, through regulation of transmembrane drug efflux pump. These findings may provide a potential therapeutic approach by disrupting Pim-1 signaling to reverse BCRP-mediated multidrug resistance.	[Xie, Yingqiu; Xu, Kexin; Linn, Douglas E.; Yang, Xi; Guo, Zhiyong; Shimelis, Hermela; Ross, Douglas D.; Qiu, Yun] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA; [Nakanishi, Takeo; Ross, Douglas D.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Ross, Douglas D.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Chen, Hegang] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; [Ross, Douglas D.] Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Nakanishi, Takeo; Ross, Douglas D.; Qiu, Yun] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Ross, Douglas D.; Fazli, Ladan; Gleave, Martin E.] Vancouver Gen Hosp, Prostate Ctr, Vancouver, BC V6H 3Z6, Canada	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; University System of Maryland; University of Maryland Baltimore; University of British Columbia	Qiu, Y (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, 655 W Baltimore St,BRB Rm 4-002, Baltimore, MD 21201 USA.	yqiu@som.umaryland.edu	Nakanishi, Takeo/C-3891-2015	Nakanishi, Takeo/0000-0002-6561-7138; Shimelis, Hermela/0000-0003-1284-8909	NATIONAL CANCER INSTITUTE [R01CA106504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007263] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA106504, CA106504] Funding Source: Medline; NIEHS NIH HHS [T32ES07263] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Allen JD, 2002, MOL CANCER THER, V1, P427; Bachmann M, 2006, INT J BIOCHEM CELL B, V38, P430, DOI 10.1016/j.biocel.2005.10.010; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Gregory CW, 2001, CANCER RES, V61, P2892; Henriksen U, 2005, J CELL SCI, V118, P1417, DOI 10.1242/jcs.01729; Huss WJ, 2005, CANCER RES, V65, P6640, DOI 10.1158/0008-5472.CAN-04-2548; Janvilisri T, 2003, J BIOL CHEM, V278, P20645, DOI 10.1074/jbc.M301358200; Jiang TY, 2004, J BIOL CHEM, V279, P50181, DOI 10.1074/jbc.M409108200; Kage K, 2002, INT J CANCER, V97, P626, DOI 10.1002/ijc.10100; Kim O, 2004, ONCOGENE, V23, P1838, DOI 10.1038/sj.onc.1207304; Koike N, 2000, FEBS LETT, V467, P17, DOI 10.1016/S0014-5793(00)01105-4; Leverson JD, 1998, MOL CELL, V2, P417, DOI 10.1016/S1097-2765(00)80141-0; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Wakabayashi K, 2006, J EXP THER ONCOL, V5, P205; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Xie XM, 2001, CANCER RES, V61, P6795; Xie Y, 2006, ONCOGENE, V25, P70, DOI 10.1038/sj.onc.1209058; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Yang HB, 2002, J BIOL CHEM, V277, P30219, DOI 10.1074/jbc.M111933200; Zalcberg J, 2000, PROSTATE CANCER P D, V3, P66, DOI 10.1038/sj.pcan.4500394	26	146	151	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3349	3356		10.1074/jbc.M707773200	http://dx.doi.org/10.1074/jbc.M707773200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056989	hybrid			2022-12-25	WOS:000253083000039
J	Mallorqui-Fernandez, N; Manandhar, SP; Mallorqui-Fernandez, G; Uson, I; Wawrzonek, K; Kantyka, T; Sola, M; Thogersen, IB; Enghild, JJ; Potempa, J; Gomis-Ruth, FX				Mallorqui-Fernandez, Noemi; Manandhar, Surya P.; Mallorqui-Fernandez, Goretti; Uson, Isabel; Wawrzonek, Katarzyna; Kantyka, Tomasz; Sola, Maria; Thogersen, Ida B.; Enghild, Jan J.; Potempa, Jan; Gomis-Ruth, F. Xavier			A new autocatalytic activation mechanism for cysteine proteases revealed by Prevotella intermedia interpain A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORPHYROMONAS-GINGIVALIS; CRYSTAL-STRUCTURE; PEPTIDASE; BINDING; PURIFICATION; PROTEINASE; MATURATION; RESOLUTION; SEQUENCE; MODEL	Prevotella intermedia is a major periodontopathogen contributing to human gingivitis and periodontitis. Such pathogens release proteases as virulence factors that cause deterrence of host defenses and tissue destruction. A new cysteine protease from the cysteine-histidine-dyad class, interpain A, was studied in its zymogenic and self-processed mature forms. The latter consists of a bivalved moiety made up by two subdomains. In the structure of a catalytic cysteine-to-alanine zymogen variant, the right subdomain interacts with an unusual prodomain, thus contributing to latency. Unlike the catalytic cysteine residue, already in its competent conformation in the zymogen, the catalytic histidine is swung out from its active conformation and trapped in a cage shaped by a backing helix, a zymogenic hairpin, and a latency flap in the zymogen. Dramatic rearrangement of up to 20 A of these elements triggered by a tryptophan switch occurs during activation and accounts for a new activation mechanism for proteolytic enzymes. These findings can be extrapolated to related potentially pathogenic cysteine proteases such as Streprococcus pyogenes SpeB and Porphyromonas gingivalis periodontain.	[Manandhar, Surya P.; Potempa, Jan] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Mallorqui-Fernandez, Noemi; Mallorqui-Fernandez, Goretti; Sola, Maria; Gomis-Ruth, F. Xavier] Consejo Superior Investigac Cient, Dept Biol Struct, Barcelona 08034, Spain; [Uson, Isabel] Consejo Superior Investigac Cient, Inst Catalana Recerca & Estudis Avancats, Inst Mol Biol, Barcelona 08034, Spain; [Wawrzonek, Katarzyna; Kantyka, Tomasz; Potempa, Jan] Jagiellonian Univ, Fac Biotechnol, Dept Microbiol, PL-30387 Krakow, Poland; [Thogersen, Ida B.; Enghild, Jan J.] Univ Aarhus, Dept Mol Biol, DK-8000 Aarhus C, Denmark	University System of Georgia; University of Georgia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); ICREA; Jagiellonian University; Aarhus University	Potempa, J (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	potempa@mol.uj.edu.pl; xgrcri@ibmb.csic.es	Potempa, Jan/AAA-6850-2021	Kantyka, Tomasz/0000-0003-3023-2382; Enghild, Jan Johannes/0000-0001-9292-9172; Sola, Maria/0000-0002-0838-9706; Gomis-Ruth, F. Xavier/0000-0002-6848-6874	NIDCR NIH HHS [DE 09761, R01 DE009761-16A2, R01 DE009761] Funding Source: Medline; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE009761] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); ICREA(ICREA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AIYAR A, 1997, METHOD MOL BIOL, V57, P177; *AM ASS PUBL HLTH, 1983, J PUBLIC HTLH DENT, V43, P106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caliandro R, 2005, ACTA CRYSTALLOGR D, V61, P556, DOI 10.1107/S090744490500404X; Chen CY, 2003, J BIOL CHEM, V278, P17336, DOI 10.1074/jbc.M209038200; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Cygler M, 1996, STRUCTURE, V4, P405, DOI 10.1016/S0969-2126(96)00046-9; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deschner J, 2003, ARCH MICROBIOL, V179, P430, DOI 10.1007/s00203-003-0548-1; DRENTH J, 1976, BIOCHEMISTRY-US, V15, P3731, DOI 10.1021/bi00662a014; Eley BM, 2003, PERIODONTOL 2000, V31, P105, DOI 10.1034/j.1600-0757.2003.03107.x; ELLIOTT SD, 1945, J EXP MED, V81, P573, DOI 10.1084/jem.81.6.573; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Filipek R, 2004, BIOCHEMISTRY-US, V43, P14306, DOI 10.1021/bi048661m; Fine DH, 2006, PERIODONTOL 2000, V42, P114, DOI 10.1111/j.1600-0757.2006.00189.x; Fujimura S, 2003, FEMS MICROBIOL LETT, V219, P305, DOI 10.1016/S0378-1097(03)00048-X; Guan SM, 2006, ANAEROBE, V12, P279, DOI 10.1016/j.anaerobe.2006.09.001; Haffajee Anne D, 2003, Ann Periodontol, V8, P115, DOI 10.1902/annals.2003.8.1.115; HOFMANN B, 1993, ACTA CRYSTALLOGR A S, V49, pC102; Jordan RCK, 2004, PERIODONTOL 2000, V34, P217, DOI 10.1046/j.0906-6713.2002.003433.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kagawa TF, 2000, P NATL ACAD SCI USA, V97, P2235, DOI 10.1073/pnas.040549997; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LOESCHE WJ, 1982, J PERIODONTOL, V53, P223, DOI 10.1902/jop.1982.53.4.223; MADDEN TE, 1995, INFECT IMMUN, V63, P238, DOI 10.1128/IAI.63.1.238-247.1995; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nelson D, 1999, J BIOL CHEM, V274, P12245, DOI 10.1074/jbc.274.18.12245; Nguyen KA, 2007, J BACTERIOL, V189, P833, DOI 10.1128/JB.01530-06; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; PIKE R, 1994, J BIOL CHEM, V269, P406; POLGAR L, 2004, HDB PROTEOLYTIC ENZY, V3, P1072; Potempa J, 2005, MOL MICROBIOL, V57, P605, DOI 10.1111/j.1365-2958.2005.04714.x; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; SHELDRICK GM, 2001, INT TABLES CRYSTALLO, VF, P734; Shibata Y, 2003, ORAL MICROBIOL IMMUN, V18, P196, DOI 10.1034/j.1399-302X.2003.00057.x; Sivaraman J, 1999, PROTEIN SCI, V8, P283; Tanner ACR, 2006, PERIODONTOL 2000, V42, P88, DOI 10.1111/j.1600-0757.2006.00184.x; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; Walker CB, 1996, PERIODONTOL 2000, V10, P79, DOI 10.1111/j.1600-0757.1996.tb00069.x; Wenig K, 2004, P NATL ACAD SCI USA, V101, P17371, DOI 10.1073/pnas.0407965101; Zhu MF, 2004, P NATL ACAD SCI USA, V101, P302, DOI 10.1073/pnas.2036536100	47	36	37	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2871	2882		10.1074/jbc.M708481200	http://dx.doi.org/10.1074/jbc.M708481200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	17993455	hybrid, Green Accepted, Green Submitted			2022-12-25	WOS:000252622300044
J	Solheim, SA; Torgersen, KM; Tasken, K; Berge, T				Solheim, Silje Anette; Torgersen, Knut Martin; Tasken, Kjetil; Berge, Torunn			Regulation of FynT function by dual domain docking on PAG/Cbp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC-FAMILY KINASES; PROTEIN-TYROSINE KINASE; T-CELL-ACTIVATION; GLYCOSPHINGOLIPID-ENRICHED MICRODOMAINS; SH3 DOMAINS; BINDING-PROTEIN; PHAGE DISPLAY; LIPID RAFTS; PROCESSIVE PHOSPHORYLATION; TRANSMEMBRANE ADAPTER	In resting T-cells, the transmembrane adaptor protein PAG ( phosphoprotein associated with glycosphingolipid-enriched microdomains) is constitutively tyrosine-phosphorylated, a state maintained by the Src family kinase FynT. PAG has a role in negative regulation of Src family kinases in T-cells by recruitment of Csk (C-terminal Src kinase) to the membrane via binding to PAG phosphotyrosine 317. The interaction between FynT and PAG is essential for PAG function; however, so far the FynT binding mode has been unknown. Here, we demonstrate that the FynT-PAG complex formation is a dual domain docking process, involving SH2 domain binding to PAG phosphotyrosines as well as an SH3 domain interaction with the first proline-rich region of PAG. This binding mode affects FynT kinase activity, PAG phosphorylation, and recruitment of FynT and Csk, demonstrated in Jurkat TAg cells after antibody stimulation of the T cell receptor. Furthermore, we show that TCR-induced tyrosine phosphorylation is regulated by SH3 domain modulation of the FynT-PAG interaction in human primary T-cells. Although FynT SH3 domain association is shown to be crucial for efficiently initiating PAG phosphorylation, we suggest that engagement of the SH2 domain on PAG renders FynT insensitive to Csk negative regulation. Thus, in T-cells, PAG is involved in positive as well as negative regulation of FynT activity.	[Solheim, Silje Anette; Torgersen, Knut Martin; Tasken, Kjetil; Berge, Torunn] Biotechnol Ctr Oslo, NO-0349 Oslo, Norway; [Solheim, Silje Anette; Torgersen, Knut Martin; Tasken, Kjetil; Berge, Torunn] Univ Oslo, Ctr Mol Med Norway, Nord EMBL Partnership, Oslo, Norway	University of Oslo	Solheim, SA (corresponding author), Biotechnol Ctr Oslo, Gaustadalleen 21, NO-0349 Oslo, Norway.	Torunn.Berge@biotek.uio.no		Tasken, Kjetil/0000-0003-2841-4697				Alexandropoulos K, 1996, GENE DEV, V10, P1341, DOI 10.1101/gad.10.11.1341; Arold ST, 2001, J BIOL CHEM, V276, P17199, DOI 10.1074/jbc.M011185200; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brdickova N, 2003, J EXP MED, V198, P1453, DOI 10.1084/jem.20031484; Brdickova N, 2001, FEBS LETT, V507, P133, DOI 10.1016/S0014-5793(01)02955-6; Burack WR, 1997, BIOCHEMISTRY-US, V36, P5929, DOI 10.1021/bi970535d; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; Davidson D, 2007, MOL CELL BIOL, V27, P1960, DOI 10.1128/MCB.01983-06; Durrheim GA, 2001, CELL BIOL INT, V25, P33, DOI 10.1006/cbir.2000.0675; Feng SB, 1995, P NATL ACAD SCI USA, V92, P12408, DOI 10.1073/pnas.92.26.12408; Guappone AC, 1997, MOL CELL BIOCHEM, V175, P243, DOI 10.1023/A:1006840104666; HIRAI H, 1990, MOL CELL BIOL, V10, P1307, DOI 10.1128/MCB.10.4.1307; Ingley E, 2006, J BIOL CHEM, V281, P31920, DOI 10.1074/jbc.M602637200; Itoh K, 2002, J IMMUNOL, V168, P541, DOI 10.4049/jimmunol.168.2.541; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kitaura J, 2007, J IMMUNOL, V178, P455, DOI 10.4049/jimmunol.178.1.455; Kramer A, 1998, METH MOL B, V87, P25; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; MarieCardine A, 1997, J BIOL CHEM, V272, P16077, DOI 10.1074/jbc.272.26.16077; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Ohtake H, 2002, J IMMUNOL, V168, P2087, DOI 10.4049/jimmunol.168.5.2087; OKAMURA H, 1995, J BIOL CHEM, V270, P26613, DOI 10.1074/jbc.270.44.26613; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Pellicena P, 2001, J BIOL CHEM, V276, P28190, DOI 10.1074/jbc.M100055200; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RICHARD S, 1995, MOL CELL BIOL, V15, P186, DOI 10.1128/MCB.15.1.186; RICKLES RJ, 1995, P NATL ACAD SCI USA, V92, P10909, DOI 10.1073/pnas.92.24.10909; RICKLES RJ, 1994, EMBO J, V13, P5598, DOI 10.1002/j.1460-2075.1994.tb06897.x; Schmedt C, 1998, NATURE, V394, P901, DOI 10.1038/29802; Scott MP, 2000, BIOCHEMISTRY-US, V39, P14531, DOI 10.1021/bi001850u; Shima T, 2003, P NATL ACAD SCI USA, V100, P14897, DOI 10.1073/pnas.2432139100; Smida M, 2007, BLOOD, V110, P596, DOI 10.1182/blood-2006-07-038752; Takeuchi S, 2000, J BIOL CHEM, V275, P29183, DOI 10.1074/jbc.C000326200; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Torgersen KM, 2001, J BIOL CHEM, V276, P29313, DOI 10.1074/jbc.C100014200; Ulmer TS, 2002, STRUCTURE, V10, P901, DOI 10.1016/S0969-2126(02)00781-5; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; WENG ZG, 1995, MOL CELL BIOL, V15, P5627; Yasuda K, 2002, J IMMUNOL, V169, P2813, DOI 10.4049/jimmunol.169.6.2813; Zozulya S, 1999, NAT BIOTECHNOL, V17, P1193, DOI 10.1038/70736	46	27	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2773	2783		10.1074/jbc.M705215200	http://dx.doi.org/10.1074/jbc.M705215200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18056706	hybrid			2022-12-25	WOS:000252622300035
J	Violin, JD; DiPilato, LM; Yildirim, N; Elston, TC; Zhang, J; Lefkowitz, RJ				Violin, Jonathan D.; DiPilato, Lisa M.; Yildirim, Necmettin; Elston, Timothy C.; Zhang, Jin; Lefkowitz, Robert J.			beta(2)-adrenergic receptor signaling and desensitization elucidated by quantitative modeling of real time cAMP dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; BETA-ADRENERGIC-RECEPTOR; DEPENDENT PROTEIN-KINASE; EPAC ACTIVATION; ARRESTIN; PHOSPHORYLATION; INTERNALIZATION; LOCALIZATION; NETWORK; SITES	G protein-coupled receptor signaling is dynamically regulated by multiple feedback mechanisms, which rapidly attenuate signals elicited by ligand stimulation, causing desensitization. The individual contributions of these mechanisms, however, are poorly understood. Here, we use an improved fluorescent biosensor for cAMP to measure second messenger dynamics stimulated by endogenous beta(2)-adrenergic receptor (beta(2)AR) in living cells. beta(2)AR stimulation with isoproterenol results in a transient pulse of cAMP, reaching a maximal concentration of similar to 10 mu M and persisting for less than 5 min. We investigated the contributions of cAMP-dependent kinase, G protein-coupled receptor kinases, and beta-arrestin to the regulation of beta(2)AR signal kinetics by using small molecule inhibitors, small interfering RNAs, and mouse embryonic fibroblasts. We found that the cAMP response is restricted in duration by two distinct mechanisms in HEK-293 cells: G protein-coupled receptor kinase (GRK6)-mediated receptor phosphorylation leading to beta-arrestin mediated receptor inactivation and cAMP-dependent kinase-mediated induction of cAMP metabolism by phosphodiesterases. A mathematical model of beta(2)AR signal kinetics, fit to these data, revealed that direct receptor inactivation by cAMP-dependent kinase is insignificant but that GRK6/beta-arrestin-mediated inactivation is rapid and profound, occurring with a half-time of 70 s. This quantitative system analysis represents an important advance toward quantifying mechanisms contributing to the physiological regulation of receptor signaling.	[Elston, Timothy C.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Violin, Jonathan D.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27706 USA; [DiPilato, Lisa M.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21218 USA; [Zhang, Jin] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21218 USA; [Zhang, Jin] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Zhang, Jin] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21218 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem, Durham, NC 27710 USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute	Elston, TC (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	telston@amath.unc.edu; jzhang32@jhmi.edu; lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070631, R01HL016037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079271] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL 70631, R01 HL 16037] Funding Source: Medline; NIDDK NIH HHS [F31 DK 074831, DK 073368] Funding Source: Medline; NIGMS NIH HHS [GM 079271] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Brown KS, 2004, PHYS BIOL, V1, P184, DOI 10.1088/1478-3967/1/3/006; Cong M, 2001, J BIOL CHEM, V276, P15192, DOI 10.1074/jbc.M009130200; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DECHAMPLAIN J, 1976, CIRC RES, V38, P109, DOI 10.1161/01.RES.38.2.109; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Lemon G, 2003, J THEOR BIOL, V223, P93, DOI 10.1016/S0022-5193(03)00079-1; Lemon G, 2003, J THEOR BIOL, V223, P113, DOI 10.1016/S0022-5193(03)00080-8; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Penn RB, 1999, J PHARMACOL EXP THER, V288, P428; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; Saucerman JJ, 2003, J BIOL CHEM, V278, P47997, DOI 10.1074/jbc.M308362200; Seibold A, 2000, MOL PHARMACOL, V58, P1162, DOI 10.1124/mol.58.5.1162; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Tran TM, 2007, MOL PHARMACOL, V71, P47, DOI 10.1124/mol.106.028456; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Violin JD, 2006, J BIOL CHEM, V281, P36411, DOI 10.1074/jbc.M607956200; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Xu C, 2003, J CELL BIOL, V161, P779, DOI 10.1083/jcb.200301070; Yu YH, 2007, P NATL ACAD SCI USA, V104, P2809, DOI 10.1073/pnas.0611005104; Zaccolo M, 2002, CURR OPIN CELL BIOL, V14, P160, DOI 10.1016/S0955-0674(02)00316-2; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	38	185	189	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2949	2961		10.1074/jbc.M707009200	http://dx.doi.org/10.1074/jbc.M707009200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18045878	hybrid, Green Published			2022-12-25	WOS:000252622300051
J	Reixach, N; Foss, TR; Santelli, E; Pascual, J; Kelly, JW; Buxbaum, JN				Reixach, Natalia; Foss, Ted R.; Santelli, Eugenio; Pascual, Jaime; Kelly, Jeffery W.; Buxbaum, Joel N.			Human-murine transthyretin heterotetramers are kinetically stable and non-amyloidogenic - A lesson in the generation of transgenic models of diseases involving oligomeric proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVE CONFORMATIONS; FIBRIL FORMATION; MICE; DENATURATION; GENE; POLYNEUROPATHY; STABILIZATION; REFINEMENT; EXPRESSION; DEPOSITION	The transthyretin amyloidoses appear to be caused by rate-limiting tetramer dissociation and partial monomer unfolding of the human serum protein transthyretin, resulting in aggregation and extracellular deposition of amorphous aggregates and amyloid fibrils. Mice transgenic for few copies of amyloid-prone human transthyretin variants, including the aggressive L55P mutant, failed to develop deposits. Silencing the murine transthyretin gene in the presence of the L55P human gene resulted in enhanced tissue deposition. To test the hypothesis that the murine protein interacted with human transthyretin, preventing the dissociation and partial unfolding required for amyloidogenesis, we produced recombinant murine transthyretin and human/murine transthyretin heterotetramers and compared their structures and biophysical properties to recombinant human transthyretin. We found no significant differences between the crystal structures of murine and human homotetramers. Murine transthyretin is not amyloidogenic because the native homotetramer is kinetically stable under physiologic conditions and cannot dissociate into partially unfolded monomers, the misfolding and aggregation precursor. Heterotetramers composed of murine and human subunits are also kinetically stable. These observations explain the lack of transthyretin deposition in transgenics carrying a low copy number of human transthyretin genes. The incorporation of mouse subunits into tetramers otherwise composed of human amyloidprone transthyretin subunits imposes kinetic stability, preventing dissociation and subsequent amyloidogenesis.	[Reixach, Natalia; Buxbaum, Joel N.] Wm Keck Autoimmune Dis Ctr, Div Rheumatol Res, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Foss, Ted R.; Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Foss, Ted R.; Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Santelli, Eugenio; Pascual, Jaime] Burnham Inst Med Res, Inflammat & Infect Dis Ctr, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Sanford Burnham Prebys Medical Discovery Institute	Reixach, N (corresponding author), 10550 N Torrey Pines Rd,MEM-230, La Jolla, CA 92037 USA.	natalia@scripps.edu	pascual, jaime/D-4566-2009	pascual, jaime/0000-0001-8992-7475; Reixach, Natalia/0000-0002-7877-0908	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK046335, R01DK046335, R29DK046335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015916] Funding Source: NIH RePORTER; NIA NIH HHS [AG15916] Funding Source: Medline; NIDDK NIH HHS [DK46335] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexander PA, 2007, P NATL ACAD SCI USA, V104, P11963, DOI 10.1073/pnas.0700922104; ARAKI S, 1994, MOL NEUROBIOL, V8, P15, DOI 10.1007/BF02778004; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUXBAUM JN, 2005, RHEUMATOLOGY, P1669; Coelho Teresa, 1993, Journal of Rheumatology, V20, P179; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; CORNWELL GG, 1983, AM J MED, V75, P618, DOI 10.1016/0002-9343(83)90443-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Fung J, 2004, J NEUROCHEM, V91, P1398, DOI 10.1111/j.1471-4159.2004.02828.x; Garzuly F, 1996, NEUROLOGY, V47, P1562, DOI 10.1212/WNL.47.6.1562; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hammarstrom P, 2001, SCIENCE, V293, P2459, DOI 10.1126/science.1062245; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Hammarstrom P, 2001, BIOCHEMISTRY-US, V40, P11453, DOI 10.1021/bi010673+; Hornberg A, 2000, J MOL BIOL, V302, P649, DOI 10.1006/jmbi.2000.4078; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; JACOBSON DR, 1992, HUM GENET, V89, P353; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Johnson SM, 2005, ACCOUNTS CHEM RES, V38, P911, DOI 10.1021/ar020073i; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaplan B, 1997, CLIN EXP IMMUNOL, V110, P472, DOI 10.1046/j.1365-2249.1997.4421454.x; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Kohno K, 1997, AM J PATHOL, V150, P1497; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; LIPMAN RD, 1993, LAB ANIM SCI, V43, P439; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGATA Y, 1995, J BIOCHEM-TOKYO, V117, P169, DOI 10.1093/oxfordjournals.jbchem.a124705; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRZEDBORSKI S, 1992, J NEUROSCI, V12, P1658; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Schneider F, 2001, PROTEIN SCI, V10, P1606, DOI 10.1110/ps.8901; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; SIPE JD, 1992, ANNU REV BIOCHEM, V61, P947, DOI 10.1146/annurev.bi.61.070192.004503; Sousa JC, 2004, J NEUROCHEM, V88, P1052, DOI 10.1046/j.1471-4159.2003.02309.x; Sousa MM, 2001, AM J PATHOL, V159, P1993; Sousa MM, 2002, AM J PATHOL, V161, P1935, DOI 10.1016/S0002-9440(10)64469-0; Tagoe CE, 2007, AMYLOID, V14, P227, DOI 10.1080/13506120701464396; Teng MH, 2001, LAB INVEST, V81, P385, DOI 10.1038/labinvest.3780246; Teng MH, 1996, AMYLOID, V3, P187, DOI 10.3109/13506129609045521; Ueda M, 2007, BIOCHEM BIOPH RES CO, V352, P299, DOI 10.1016/j.bbrc.2006.11.045; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; YAMAMURA K, 1987, DEV GENET, V8, P195, DOI 10.1002/dvg.1020080404; Zeldenrust S, 1999, AMYLOID AND AMYLOIDOSIS 1998, P255	52	43	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2098	2107		10.1074/jbc.M708028200	http://dx.doi.org/10.1074/jbc.M708028200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18006495	hybrid			2022-12-25	WOS:000252501000037
J	Yoshikane, Y; Yokochi, N; Yamasaki, M; Mizutani, K; Ohnishi, K; Mikami, B; Hayashi, H; Yagi, T				Yoshikane, Yu; Yokochi, Nana; Yamasaki, Masayuki; Mizutani, Kimihiko; Ohnishi, Kouhei; Mikami, Bunzo; Hayashi, Hideyuki; Yagi, Toshiharu			Crystal structure of pyridoxamine-pyruvate aminotransferase from Mesorhizobium loti MAFF303099	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANINE-GLYOXYLATE AMINOTRANSFERASE; ASPARTATE-AMINOTRANSFERASE; ESCHERICHIA-COLI; PHOSPHOSERINE AMINOTRANSFERASE; TRANSAMINASE; ENZYME; RESOLUTION; SITE; CRYSTALLOGRAPHY; STEREOCHEMISTRY	Pyridoxamine-pyruvate aminotransferase (PPAT; EC 2.6.1.30) is a pyridoxal 5'-phosphate-independent aminotransferase and catalyzes reversible transamination between pyridoxamine and pyruvate to form pyridoxal and L-alanine. The crystal structure of PPAT from Mesorhizobium loti has been solved in space group P4(3)2(1)2 and was refined to an R factor of 15.6% (R-free = 20.6%) at 2.0 angstrom resolution. In addition, the structures of PPAT in complexes with pyridoxamine, pyridoxal, and pyridoxyl-L-alanine have been refined to R factors of 15.6, 15.4, and 14.5% (R-free = 18.6, 18.1, and 18.4%) at 1.7, 1.7, and 2.0 angstrom resolution, respectively. PPAT is a homotetramer and each subunit is composed of a large N-terminal domain, consisting of seven beta-sheets and eight alpha-helices, and a smaller C-terminal domain, consisting of three beta-sheets and four alpha-helices. The substrate pyridoxal is bound through an aldimine linkage to Lys-197 in the active site. The alpha-carboxylate group of the substrate amino/keto acid is hydrogen-bonded to Arg-336 and Arg-345. The structures revealed that the bulky side chain of Glu-68 interfered with the binding of the phosphate moiety of pyridoxal 5'-phosphate and made PPAT specific to pyridoxal. The reaction mechanism of the enzyme is discussed based on the structures and kinetics results.	[Yoshikane, Yu; Yokochi, Nana; Yagi, Toshiharu] Kochi Univ, Fac Agr, Dept Bioresource Sci, Nanko Ku, Kochi 7838502, Japan; [Yamasaki, Masayuki; Mizutani, Kimihiko; Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 7838502, Japan; [Ohnishi, Kouhei] Kochi Univ, Res Inst Mol Genet, Nanko Ku, Kochi 7838502, Japan; [Yagi, Toshiharu] Osaka Med Coll, Dept Biochem, Osaka 5698686, Japan	Kochi University; Kyoto University; Kochi University; Osaka Medical College	Yagi, T (corresponding author), Kochi Univ, Fac Agr, Dept Bioresource Sci, Nanko Ku, Monobe Otsu 200, Kochi 7838502, Japan.	yagito@cc.kochi-u.ac.jp	Ohnishi, Kouhei/AAN-9527-2020					AYLING JE, 1968, BIOCHEMISTRY-US, V7, P1626, DOI 10.1021/bi00845a003; AYLING JE, 1968, BIOCHEMISTRY-US, V7, P4537, DOI 10.1021/bi00852a050; AYLING JE, 1968, BIOCHEMISTRY-US, V7, P1616, DOI 10.1021/bi00845a002; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen CCH, 2002, BIOCHEMISTRY-US, V41, P13162, DOI 10.1021/bi026231v; DEMPSEY WB, 1963, BIOCHEMISTRY-US, V2, P1414, DOI 10.1021/bi00906a037; Dubnovitsky AP, 2005, PROTEIN SCI, V14, P97, DOI 10.1110/ps.041029805; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FUJIOKA M, 1965, J BIOL CHEM, V240, P3044; FUJIOKA M, 1965, J BIOL CHEM, V240, P3050; GILMER PJ, 1977, BIOCHEMISTRY-US, V16, P5241, DOI 10.1021/bi00643a013; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Han GW, 2005, PROTEINS, V58, P971; Han Q, 2006, J BIOL CHEM, V281, P37175, DOI 10.1074/jbc.M607032200; Hayashi H, 1998, BIOCHEMISTRY-US, V37, P15076, DOI 10.1021/bi981517e; Hester G, 1999, J MOL BIOL, V286, P829, DOI 10.1006/jmbi.1998.2506; HODSDON J, 1978, BIOCHEM J, V169, P429, DOI 10.1042/bj1690429; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Katsura Y, 2004, PROTEINS, V55, P487, DOI 10.1002/prot.20020; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; KOLB H, 1968, BIOCHEMISTRY-US, V7, P2946, DOI 10.1021/bi00848a035; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Meyer P, 2005, BIOCHIMIE, V87, P1041, DOI 10.1016/j.biochi.2005.09.001; MILES EW, 1982, J BIOL CHEM, V257, P4203; Mizuguchi H, 2001, BIOCHEMISTRY-US, V40, P353, DOI 10.1021/bi001403e; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSON MJK, 1986, J BIOL CHEM, V261, P5115; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; TONEY MD, 1987, J BIOL CHEM, V262, P12403; WADA H, 1962, J BIOL CHEM, V237, P133; YANO T, 1992, BIOCHEMISTRY-US, V31, P5878, DOI 10.1021/bi00140a025; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Yoshikane Y, 2006, BIOCHEM J, V396, P499, DOI 10.1042/BJ20060078; Zhang XX, 2003, J MOL BIOL, V331, P643, DOI 10.1016/S0022-2836(03)00791-5	39	15	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1120	1127		10.1074/jbc.M708061200	http://dx.doi.org/10.1074/jbc.M708061200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17989071	Green Published, hybrid			2022-12-25	WOS:000252128100052
J	Achour, A; Biquard, JM; Krsmanovic, V; M'Bika, JP; Ficheux, D; Sikorska, M; Cozzone, AJ				Achour, Ammar; Biquard, Jean-Michel; Krsmanovic, Velibor; M'Bika, Jean-Pierre; Ficheux, Damien; Sikorska, Marianna; Cozzone, Alain J.			Induction of Human Immunodeficiency Virus (HIV-1) Envelope Specific Cell-Mediated Immunity by a Non-Homologous Synthetic Peptide	PLOS ONE			English	Article								Background. Cell mediated immunity, including efficient CTL response, is required to prevent HIV-1 from cell-to-cell transmission. In previous investigations, we have shown that B1 peptide derived by Fourier transformation of HIV-1 primary structures and sharing no sequence homology with the parent proteins was able to generate antiserum which recognizes envelope and Tat proteins. Here we have investigated cellular immune response towards a novel non-homologous peptide, referred to as cA1 peptide. Methodology/Principal Findings. The 20 amino acid sequence of cA1 peptide was predicted using the notion of peptide hydropathic properties; the peptide is encoded by the complementary anti-sense DNA strand to the sense strand of previously described non-homologous A1 peptide. In this report we demonstrate that the cA1 peptide can be a target for major histocompatibility complex (MHC) class I-restricted cytotoxic T lymphocytes in HIV-1-infected or envelope-immunized individuals. The cA1 peptide is recognized in association with different MHC class I allotypes and could prime in vitro CTLs, derived from gp160-immunized individuals capable to recognize virus variants. Conclusions/Significance. For the first time a theoretically designed immunogen involved in broad-based cell-immune memory activation is described. Our findings may thus contribute to the advance in vaccine research by describing a novel strategy to develop a synthetic AIDS vaccine.	[Achour, Ammar; Biquard, Jean-Michel; M'Bika, Jean-Pierre] Univ Paris 05, Ctr Univ St Peres, Lab Interferons, Paris, France; [Krsmanovic, Velibor] Univ Lyon 1, Mol Biol Lab, F-69365 Lyon, France; [Ficheux, Damien] IFR 128 Biosci Lyon Gerland, Lyon, France; [Sikorska, Marianna] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Cozzone, Alain J.] UCBL, CNRS, UMR 5086, Inst Biol & Chim Prot, Lyon, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; National Research Council Canada; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Achour, A (corresponding author), Univ Paris 05, Ctr Univ St Peres, Lab Interferons, Paris, France.	ammar.achour@univ-paris5.fr			Centre National de la Recherche Scientifique, (CNRS, France); National Research Council (NRC, Canada); Association pour le Developpement des Biotherapies experimentales ADBEA (Paris, France)	Centre National de la Recherche Scientifique, (CNRS, France)(Centre National de la Recherche Scientifique (CNRS)); National Research Council (NRC, Canada); Association pour le Developpement des Biotherapies experimentales ADBEA (Paris, France)	This research was supported by Centre National de la Recherche Scientifique, (CNRS, France), National Research Council (NRC, Canada) and Association pour le Developpement des Biotherapies experimentales ADBEA (Paris, France).	Achour A, 2003, VIROLOGY, V315, P245, DOI 10.1016/S0042-6822(03)00535-X; ACHOUR A, 1993, VACCINE, V11, P699, DOI 10.1016/0264-410X(93)90251-R; ACHOUR A, 1990, P NATL ACAD SCI USA, V87, P7045, DOI 10.1073/pnas.87.18.7045; Achour A, 1996, J VIROL, V70, P6741, DOI 10.1128/JVI.70.10.6741-6750.1996; ACHOUR A, 1994, AIDS RES HUM RETROV, V10, P19, DOI 10.1089/aid.1994.10.19; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; BEX F, 1994, BLOOD, V84, P3317; Biquard JM, 2003, AIDS, V17, P2001, DOI 10.1097/00002030-200309050-00026; BIRO J, 1981, MED HYPOTHESES, V7, P981, DOI 10.1016/0306-9877(81)90094-3; BIRO J, 1981, MED HYPOTHESES, V7, P995, DOI 10.1016/0306-9877(81)90095-5; BLALOCK JE, 1990, TRENDS BIOTECHNOL, V8, P140, DOI 10.1016/0167-7799(90)90159-U; BLALOCK JE, 1984, BIOCHEM BIOPH RES CO, V121, P203, DOI 10.1016/0006-291X(84)90707-1; BLALOCK JE, 1986, BIOCHEM J, V234, P679, DOI 10.1042/bj2340679; BOHR H, 1988, FEBS LETT, V241, P223, DOI 10.1016/0014-5793(88)81066-4; BORK P, 1990, EUR J BIOCHEM, V191, P347, DOI 10.1111/j.1432-1033.1990.tb19129.x; BOST KL, 1985, BIOCHEM BIOPH RES CO, V128, P1373, DOI 10.1016/0006-291X(85)91092-7; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; CLARKE BL, 1991, ANTISENSE NUCLEIC AC, P169; CORNETTE JL, 1987, J MOL BIOL, V195, P659, DOI 10.1016/0022-2836(87)90189-6; COSIC I, 1986, BIOCHEM BIOPH RES CO, V141, P831, DOI 10.1016/S0006-291X(86)80248-0; COSIC I, 1992, EUR J BIOCHEM, V205, P613, DOI 10.1111/j.1432-1033.1992.tb16819.x; COSIC I, 1994, MOL CELL BIOCHEM, V130, P1, DOI 10.1007/BF01084262; COSIC I, 1991, EUR J BIOCHEM, V198, P113, DOI 10.1111/j.1432-1033.1991.tb15993.x; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; FINERMOORE J, 1984, P NATL ACAD SCI-BIOL, V81, P155, DOI 10.1073/pnas.81.1.155; FORSDYKE DR, 1995, J MOL EVOL, V41, P582; GOTCH FM, 1986, J EXP MED, V165, P408; HEINE V, 1973, THEORY PSEUDOPOTENTI; HERTZ GZ, 1990, COMPUT APPL BIOSCI, V6, P81; Ivanovic V, 2004, MED HYPOTHESES, V62, P727, DOI 10.1016/j.mehy.2003.11.027; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; KENNETH C, 1992, J IMMUNOL, V149, P2560; Krsmanovic V, 1998, J PEPT RES, V52, P410; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; MCLACHLAN AD, 1983, J MOL BIOL, V164, P605, DOI 10.1016/0022-2836(83)90053-0; Meckler L.B., 1969, BIOFIZIKA, V14, P581; MERINO E, 1994, NUCLEIC ACIDS RES, V22, P1903, DOI 10.1093/nar/22.10.1903; NAKAI K, 1988, PROTEIN ENG, V2, P93, DOI 10.1093/protein/2.2.93; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; PICARD O, 1992, J ACQ IMMUN DEF SYND, V5, P539; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; RICHARDS FM, 1988, PROTEINS, V3, P71, DOI 10.1002/prot.340030202; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; SUNNARBORG A, 1990, J BACTERIOL, V172, P2642, DOI 10.1128/jb.172.5.2642-2649.1990; TAKAHASHI H, 1989, J EXP MED, V170, P2023, DOI 10.1084/jem.170.6.2023; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Tropsha Alexander, 1992, Journal of Molecular Recognition, V5, P43, DOI 10.1002/jmr.300050202; VELJKOVIC V, 1987, CANCER BIOCHEM BIOPH, V9, P139; VELJKOVIC V, 1972, PHYS REV LETT, V29, P105, DOI 10.1103/PhysRevLett.29.105; Veljkovic V., 1980, THEORETICAL APPROACH	55	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1214	10.1371/journal.pone.0001214	http://dx.doi.org/10.1371/journal.pone.0001214			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043730	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459300004
J	Mao, L; Zabel, C; Herrmann, M; Nolden, T; Mertes, F; Magnol, L; Chabert, C; Hartl, D; Herault, Y; Delabar, JM; Manke, T; Himmelbauer, H; Klose, J				Mao, Lei; Zabel, Claus; Herrmann, Marion; Nolden, Tobias; Mertes, Florian; Magnol, Laetitia; Chabert, Caroline; Hartl, Daniela; Herault, Yann; Delabar, Jean Maurice; Manke, Thomas; Himmelbauer, Heinz; Klose, Joachim			Proteomic Shifts in Embryonic Stem Cells with Gene Dose Modifications Suggest the Presence of Balancer Proteins in Protein Regulatory Networks	PLOS ONE			English	Article								Large numbers of protein expression changes are usually observed in mouse models for neurodegenerative diseases, even when only a single gene was mutated in each case. To study the effect of gene dose alterations on the cellular proteome, we carried out a proteomic investigation on murine embryonic stem cells that either overexpressed individual genes or displayed aneuploidy over a genomic region encompassing 14 genes. The number of variant proteins detected per cell line ranged between 70 and 110, and did not correlate with the number of modified genes. In cell lines with single gene mutations, up and down-regulated proteins were always in balance in comparison to parental cell lines regarding number as well as concentration of differentially expressed proteins. In contrast, dose alteration of 14 genes resulted in an unequal number of up and down-regulated proteins, though the balance was kept at the level of protein concentration. We propose that the observed protein changes might partially be explained by a proteomic network response. Hence, we hypothesize the existence of a class of "balancer'' proteins within the proteomic network, defined as proteins that buffer or cushion a system, and thus oppose multiple system disturbances. Through database queries and resilience analysis of the protein interaction network, we found that potential balancer proteins are of high cellular abundance, possess a low number of direct interaction partners, and show great allelic variation. Moreover, balancer proteins contribute more heavily to the network entropy, and thus are of high importance in terms of system resilience. We propose that the "elasticity'' of the proteomic regulatory network mediated by balancer proteins may compensate for changes that occur under diseased conditions.	[Mao, Lei; Zabel, Claus; Herrmann, Marion; Hartl, Daniela; Klose, Joachim] Charite Univ Med Berlin, Inst Human Genet, Berlin, Germany; [Mao, Lei; Nolden, Tobias; Mertes, Florian; Manke, Thomas; Himmelbauer, Heinz] Max Planck Inst Mol Genet, Berlin, Germany; [Magnol, Laetitia; Herault, Yann] CNRS Uni Orleans, UMR6218, IEM, Inst Transgenose, Orleans, France; [Chabert, Caroline; Delabar, Jean Maurice] Univ Paris 07, EA 3508, Paris, France	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; UDICE-French Research Universities; Universite Paris Cite	Mao, L (corresponding author), Charite Univ Med Berlin, Inst Human Genet, Berlin, Germany.	lei.mao@charite.de	Manke, Thomas/L-9075-2019; Herault, Yann/B-5500-2012	Herault, Yann/0000-0001-7049-6900; Manke, Thomas/0000-0003-3702-0868; Nolden, Tobias/0000-0002-8996-5612	German National Genome Research Network (NGFN); EU [37627]; Lejeune foundation; Volkswagen Foundation	German National Genome Research Network (NGFN); EU(European Commission); Lejeune foundation; Volkswagen Foundation(Volkswagen)	This work was co-supported by the German National Genome Research Network (NGFN) program established by the German Ministry for Education and Research (BMBF), and by the EU grant 37627 "AnEUploidy''. C. Chabert and L. Magnol were supported by a Lejeune foundation grant. T. Manke was supported by a grant from the Volkswagen Foundation.	Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balazsi G, 2005, P NATL ACAD SCI USA, V102, P7841, DOI 10.1073/pnas.0500365102; Branchi I, 2004, J NEUROPATH EXP NEUR, V63, P429, DOI 10.1093/jnen/63.5.429; Brault V, 2006, PLOS GENET, V2, P911, DOI 10.1371/journal.pgen.0020086; BROWN GC, 1991, J THEOR BIOL, V153, P195, DOI 10.1016/S0022-5193(05)80422-9; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chan SK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-227; Chung SM, 2002, STEM CELLS, V20, P139, DOI 10.1634/stemcells.20-2-139; Demetrius L, 2004, THEOR POPUL BIOL, V65, P211, DOI 10.1016/j.tpb.2003.12.002; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; Huang JF, 2006, LIVER INT, V26, P54; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Klose J, 1999, METH MOL B, V112, P147; KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175; Lopes C, 2003, BIOCHEM BIOPH RES CO, V305, P915, DOI 10.1016/S0006-291X(03)00867-2; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Manke T, 2006, J R SOC INTERFACE, V3, P843, DOI 10.1098/rsif.2006.0140; Mao L, 2006, EXP GERONTOL, V41, P11, DOI 10.1016/j.exger.2005.09.012; MILLER RM, 2007, EXP NEUROL, V23, P23; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; NEBRICH G, 2007, ELECTROPHORESIS, V19, P19; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Periquet M, 2005, J NEUROCHEM, V95, P1259, DOI 10.1111/j.1471-4159.2005.03442.x; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Testa Giuseppe, 2004, Methods Mol Biol, V256, P123; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wiles MV, 2000, NAT GENET, V24, P13, DOI 10.1038/71622; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Zabel C, 2004, INT REV NEUROBIOL, V61, P241; Zabel C, 2006, J PROTEOME RES, V5, P1948, DOI 10.1021/pr0601077; Zhang HL, 2007, BIOCHEM BIOPH RES CO, V352, P456, DOI 10.1016/j.bbrc.2006.11.031	44	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1218	10.1371/journal.pone.0001218	http://dx.doi.org/10.1371/journal.pone.0001218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043732	gold, Green Submitted, Green Published			2022-12-25	WOS:000207459300006
J	Vandewalle, G; Schmidt, C; Albouy, G; Sterpenich, V; Darsaud, A; Rauchs, G; Berken, PY; Balteau, E; Degueldre, C; Luxen, A; Maquet, P; Dijk, DJ				Vandewalle, Gilles; Schmidt, Christina; Albouy, Genevieve; Sterpenich, Virginie; Darsaud, Annabelle; Rauchs, Geraldine; Berken, Pierre-Yves; Balteau, Evelyne; Degueldre, Christian; Luxen, Andre; Maquet, Pierre; Dijk, Derk-Jan			Brain Responses to Violet, Blue, and Green Monochromatic Light Exposures in Humans: Prominent Role of Blue Light and the Brainstem	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; SUPRACHIASMATIC NUCLEUS; HIGH-SENSITIVITY; ACTION SPECTRUM; MELANOPSIN; MELATONIN; SLEEP; ILLUMINATION; PROJECTIONS; EXPRESSION	Background. Relatively long duration retinal light exposure elicits nonvisual responses in humans, including modulation of alertness and cognition. These responses are thought to be mediated in part by melanopsin-expressing retinal ganglion cells which are more sensitive to blue light than violet or green light. The contribution of the melanopsin system and the brain mechanisms involved in the establishment of such responses to light remain to be established. Methodology/Principal Findings. We exposed 15 participants to short duration (50 s) monochromatic violet (430 nm), blue (473 nm), and green (527 nm) light exposures of equal photon flux (10(13) ph/cm(2)/s) while they were performing a working memory task in fMRI. At light onset, blue light, as compared to green light, increased activity in the left hippocampus, left thalamus, and right amygdala. During the task, blue light, as compared to violet light, increased activity in the left middle frontal gyrus, left thalamus and a bilateral area of the brainstem consistent with activation of the locus coeruleus. Conclusion/Significance. These results support a prominent contribution of melanopsin-expressing retinal ganglion cells to brain responses to light within the very first seconds of an exposure. The results also demonstrate the implication of the brainstem in mediating these responses in humans and speak for a broad involvement of light in the regulation of brain function.	[Vandewalle, Gilles; Schmidt, Christina; Albouy, Genevieve; Sterpenich, Virginie; Darsaud, Annabelle; Rauchs, Geraldine; Balteau, Evelyne; Degueldre, Christian; Luxen, Andre; Maquet, Pierre] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Berken, Pierre-Yves] Univ Liege, Dept Phys, Hololab, Liege, Belgium; [Maquet, Pierre] Ctr Hosp Univ Liege, Dept Neurol, Liege, Belgium; [Dijk, Derk-Jan] Univ Surrey, Surrey Sleep Res Ctr, Guildford GU2 5XH, Surrey, England	University of Liege; University of Liege; University of Liege; University of Surrey	Maquet, P (corresponding author), Univ Liege, Cyclotron Res Ctr, Liege, Belgium.	pmaquet@ulg.ac.be	ALBOUY, Genevieve/K-5350-2015; ALBOUY, Genevieve/P-4723-2019; RAUCHS, Géraldine/L-7921-2015; Dijk, Derk-Jan/D-8387-2011	ALBOUY, Genevieve/0000-0002-5437-023X; ALBOUY, Genevieve/0000-0002-5437-023X; RAUCHS, Géraldine/0000-0001-7128-2189; Sterpenich, Virginie/0000-0002-2125-833X; Vandewalle, Gilles/0000-0003-2483-2752; , Pierre/0000-0003-3106-3357	Belgian Fond National de la Recherche Scientifique (F.N.R.S.), La Fondation Medicale Reine Elisabeth; University of Liege, Interuniversity Attraction Pole [P5/04]; Wellcome Trust [GR069714MA]	Belgian Fond National de la Recherche Scientifique (F.N.R.S.), La Fondation Medicale Reine Elisabeth(Fonds de la Recherche Scientifique - FNRS); University of Liege, Interuniversity Attraction Pole(University of LiegeBelgian Federal Science Policy Office); Wellcome Trust(Wellcome TrustEuropean Commission)	Funding: This study was supported by the Belgian Fond National de la Recherche Scientifique (F.N.R.S.), La Fondation Medicale Reine Elisabeth, the University of Liege, Interuniversity Attraction Pole P5/04, and by the Wellcome Trust-GR069714MA (DJD). GV, CS, VS, AD, GR and PM are supported by the F.N.R.S.	Aggelopoulos NC, 2000, J PHYSIOL-LONDON, V523, P211, DOI 10.1111/j.1469-7793.2000.t01-1-00211.x; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Amaral DG, 1992, AMYGDALA NEUROBIOLOG, P465; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brainard GC, 2001, J NEUROSCI, V21, P6405; Braver TS, 2001, NEUROIMAGE, V14, P48, DOI 10.1006/nimg.2001.0791; BUCK SL, 2003, VISUAL NEUROSCIENCES, P863; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cajochen C, 2006, CHRONOBIOL INT, V23, P461, DOI 10.1080/07420520500545813; Cajochen C, 2006, EUR J NEUROSCI, V23, P1082, DOI 10.1111/j.1460-9568.2006.04613.x; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Castle M, 2005, NEUROSCIENCE, V134, P657, DOI 10.1016/j.neuroscience.2005.04.031; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Dijk DJ, 2002, J APPL PHYSIOL, V92, P852, DOI 10.1152/japplphysiol.00924.2001; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Foucher JR, 2004, NEUROIMAGE, V22, P688, DOI 10.1016/j.neuroimage.2004.01.048; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; GREENWOOD KM, 1994, ERGONOMICS, V37, P377, DOI 10.1080/00140139408963653; Hankins MW, 2002, CURR BIOL, V12, P191, DOI 10.1016/S0960-9822(02)00659-0; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Horne JA, 1976, INT J CHRONOBIOL, V4, P97; International Commission of Non-Ionizing Radiation Protection (ICNIRP), 1997, HEALTH PHYS, V73, P539; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; JONES BE, 2003, FRONT BIOSCI, pS438; Kastner S, 2004, J NEUROPHYSIOL, V91, P438, DOI 10.1152/jn.00553.2003; Lockley SW, 2006, SLEEP, V29, P161; Lockley SW, 2003, J CLIN ENDOCR METAB, V88, P4502, DOI 10.1210/jc.2003-030570; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Meijer JH, 1998, J NEUROSCI, V18, P9078; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Morin LP, 2005, J COMP NEUROL, V487, P204, DOI 10.1002/cne.20546; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Munch M, 2006, AM J PHYSIOL-REG I, V290, pR1421, DOI 10.1152/ajpregu.00478.2005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Perrin F, 2004, CURR BIOL, V14, P1842, DOI 10.1016/j.cub.2004.09.082; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Revell VL, 2006, NEUROSCI LETT, V399, P96, DOI 10.1016/j.neulet.2006.01.032; Sander D, 2005, NEUROIMAGE, V28, P848, DOI 10.1016/j.neuroimage.2005.06.023; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; Sollars PJ, 2003, VISUAL NEUROSCI, V20, P601, DOI 10.1017/S0952523803206027; Solomon SG, 2007, NAT REV NEUROSCI, V8, P276, DOI 10.1038/nrn2094; Steer RA, 1997, PSYCHOL REP, V80, P443, DOI 10.2466/pr0.1997.80.2.443; Sterpenich V, 2006, J NEUROSCI, V26, P7416, DOI 10.1523/JNEUROSCI.1001-06.2006; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; VANDEWALLE G, 2007, CEREBRAL CORTEX; Vandewalle G, 2006, CURR BIOL, V16, P1616, DOI 10.1016/j.cub.2006.06.031; Wirz-Justice A, 2004, SCIENCE, V303, P467	61	159	161	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1247	10.1371/journal.pone.0001247	http://dx.doi.org/10.1371/journal.pone.0001247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043754	Green Published, gold			2022-12-25	WOS:000207459300028
J	An, XP; Lu, J; Huang, JD; Zhang, BZ; Liu, DB; Zhang, X; Chen, JH; Zhou, YS; Tong, YG				An, Xiaoping; Lu, Jun; Huang, Jian-dong; Zhang, Baozhong; Liu, Dabin; Zhang, Xin; Chen, Jinhui; Zhou, Yusen; Tong, Yigang			Rapid Assembly of Multiple-Exon cDNA Directly from Genomic DNA	PLOS ONE			English	Article								Background. Polymerase chain reaction (PCR) is extensively applied in gene cloning. But due to the existence of introns, low copy number of particular genes and high complexity of the eukaryotic genome, it is usually impossible to amplify and clone a gene as a full-length sequence directly from the genome by ordinary PCR based techniques. Cloning of cDNA instead of genomic DNA involves multiple steps: harvest of tissues that express the gene of interest, RNA isolation, cDNA synthesis (reverse transcription), and PCR amplification. To simplify the cloning procedures and avoid the problems caused by ubiquitously distributed durable RNases, we have developed a novel strategy allowing the cloning of any cDNA or open reading frame (ORF) with wild type sequence in any spliced form from a single genomic DNA preparation. Methodology. Our "Genomic DNA Splicing'' technique contains the following steps: first, all exons of the gene are amplified from a genomic DNA preparation, using software-optimized, highly efficient primers residing in flanking introns. Next, the tissue-specific exon sequences are assembled into one full-length sequence by overlapping PCR with deliberately designed primers located at the splicing sites. Finally, software-optimized outmost primers are exploited for efficient amplification of the assembled full-length products. Conclusions. The "Genomic DNA Splicing'' protocol avoids RNA preparation and reverse transcription steps, and the entire assembly process can be finished within hours. Since genomic DNA is more stable than RNA, it may be a more practical cloning strategy for many genes, especially the ones that are very large and difficult to generate a full length cDNA using oligo-dT primed reverse transcription. With this technique, we successfully cloned the full-length wild type coding sequence of human polymeric immunoglobulin receptor, which is 2295 bp in length and composed of 10 exons.	[Huang, Jian-dong] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [An, Xiaoping; Zhang, Baozhong; Liu, Dabin; Zhang, Xin; Chen, Jinhui; Zhou, Yusen; Tong, Yigang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Lu, Jun] Capital Med Univ, Beijing YouAn Hosp, Beijing, Peoples R China	University of Hong Kong; Beijing Institute of Microbiology & Epidemiology; Capital Medical University	Huang, JD (corresponding author), Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.	jdhuang@hkucc.hku.hk; tongyg@nic.bmi.ac.cn	Liu, Dabin/GNH-2648-2022; /C-4277-2009	/0000-0001-7531-2816; Tong, Yigang/0000-0002-8503-8045; Liu, Dabin/0000-0002-3811-8317	National High Technology Research and Development Program of China [2001AA215361]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work is supported by National High Technology Research and Development Program of China (2001AA215361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHISTYAKOV D A, 1991, Molekulyarnaya Biologiya (Moscow), V25, P1273; DILLON PJ, 1990, BIOTECHNIQUES, V9, P298; Gao WT, 2004, BIOTECHNOL PROGR, V20, P443, DOI 10.1021/bp0300467; GOEDDEL DV, 1979, P NATL ACAD SCI USA, V76, P106, DOI 10.1073/pnas.76.1.106; HAYASHI N, 1994, BIOTECHNIQUES, V17, P310; HEYNEKER HL, 1976, NATURE, V263, P748, DOI 10.1038/263748a0; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; ITAKURA K, 1977, SCIENCE, V198, P1056, DOI 10.1126/science.412251; LEBEDENKO EN, 1991, NUCLEIC ACIDS RES, V19, P6757, DOI 10.1093/nar/19.24.6757; MANDECKI W, 1990, GENE, V94, P103, DOI 10.1016/0378-1119(90)90474-6; MANDECKI W, 1988, GENE, V68, P101, DOI 10.1016/0378-1119(88)90603-8; PRODROMOU C, 1992, PROTEIN ENG, V5, P827, DOI 10.1093/protein/5.8.827; SANDHU GS, 1992, BIOTECHNIQUES, V12, P14; Sandhu KS, 2005, BIOINFORMATICS, V21, P2091, DOI 10.1093/bioinformatics/bti304; Schageman JJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r36; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; VANDENBROECK K, 1991, BIOCHEM BIOPH RES CO, V180, P1408, DOI 10.1016/S0006-291X(05)81353-1; Withers-Martinez C, 1999, PROTEIN ENG, V12, P1113, DOI 10.1093/protein/12.12.1113; Wu Xiaolin, 2006, Appl Bioinformatics, V5, P119, DOI 10.2165/00822942-200605020-00007; Xiong AS, 2006, NAT PROTOC, V1, P791, DOI 10.1038/nprot.2006.103; Xiong AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh094; Xiong AS, 2005, J APPL MICROBIOL, V98, P418, DOI 10.1111/j.1365-2672.2004.02476.x; Xiong AS, 2004, J BIOCHEM MOL BIOL, V37, P282; Young L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh058; [朱晓峰 ZHU Xiaofeng], 2007, [中国生物工程杂志, Journal of Chinese Biotechnology], V27, P86	27	13	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1179	10.1371/journal.pone.0001179	http://dx.doi.org/10.1371/journal.pone.0001179			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000550	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459100021
J	Makunin, IV; Pheasant, M; Simons, C; Mattick, JS				Makunin, Igor V.; Pheasant, Michael; Simons, Cas; Mattick, John S.			Orthologous MicroRNA Genes Are Located in Cancer-Associated Genomic Regions in Human and Mouse	PLOS ONE			English	Article							RETROVIRAL INSERTIONAL MUTAGENESIS; C-MYC; IDENTIFICATION; BIOGENESIS; ACTIVATION; ONCOGENES; CISTRON; MIRNAS	Background. MicroRNAs (miRNAs) are short non-coding RNAs that regulate differentiation and development in many organisms and play an important role in cancer. Methodology/Principal Findings. Using a public database of mapped retroviral insertion sites from various mouse models of cancer we demonstrate that MLV-derived retroviral inserts are enriched in close proximity to mouse miRNA loci. Clustered inserts from cancer-associated regions (Common Integration Sites, CIS) have a higher association with miRNAs than non-clustered inserts. Ten CIS-associated miRNA loci containing 22 miRNAs are located within 10 kb of known CIS insertions. Only one CIS-associated miRNA locus overlaps a RefSeq protein-coding gene and six loci are located more than 10 kb from any RefSeq gene. CIS-associated miRNAs on average are more conserved in vertebrates than miRNAs associated with non-CIS inserts and their human homologs are also located in regions perturbed in cancer. In addition we show that miRNA genes are enriched around promoter and/or terminator regions of RefSeq genes in both mouse and human. Conclusions/Significance. We provide a list of ten miRNA loci potentially involved in the development of blood cancer or brain tumors. There is independent experimental support from other studies for the involvement of miRNAs from at least three CIS-associated miRNA loci in cancer development.	[Makunin, Igor V.; Pheasant, Michael; Simons, Cas; Mattick, John S.] Univ Queensland, Inst Mol Biosci, Special Res Ctr Funct & Appl Genom, Australian Res Council ARC, Brisbane, Qld, Australia	University of Queensland	Mattick, JS (corresponding author), Univ Queensland, Inst Mol Biosci, Special Res Ctr Funct & Appl Genom, Australian Res Council ARC, Brisbane, Qld, Australia.	j.mattick@imb.uq.edu.au	Mattick, John/ABH-6130-2020; Pheasant, Michael/A-7564-2008; Simons, Cas/A-7905-2011; Mattick, John S/I-7789-2012	Mattick, John/0000-0002-7680-7527; Pheasant, Michael/0000-0001-9781-7655; Simons, Cas/0000-0003-3147-8042; Mattick, John S/0000-0002-7680-7527	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bijl J, 2005, GENE DEV, V19, P224, DOI 10.1101/gad.1268505; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; Johansson FK, 2004, P NATL ACAD SCI USA, V101, P11334, DOI 10.1073/pnas.0402716101; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim R, 2003, J VIROL, V77, P2056, DOI 10.1128/JVI.77.3.2056-2062.2003; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lum AM, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-5; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Sevignani C, 2007, P NATL ACAD SCI USA, V104, P8017, DOI 10.1073/pnas.0702177104; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simons C, 2006, GENOME RES, V16, P164, DOI 10.1101/gr4624306; Slape C, 2007, CANCER RES, V67, P5148, DOI 10.1158/0008-5472.CAN-07-0075; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Suzuki T, 2006, EMBO J, V25, P3422, DOI 10.1038/sj.emboj.7601215; Wang CL, 2006, P NATL ACAD SCI USA, V103, P18680, DOI 10.1073/pnas.0609030103; Xi YG, 2007, CANCER INFORM, V3, P245; Yamashita N, 2005, BRIT J HAEMATOL, V131, P495, DOI 10.1111/j.1365-2141.2005.05793.x; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	29	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1133	10.1371/journal.pone.0001133	http://dx.doi.org/10.1371/journal.pone.0001133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17989771	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459000017
J	Korupolu, RV; Muenster, U; Read, JD; Vale, W; Fischer, WH				Korupolu, Radhika V.; Muenster, Uwe; Read, Jessica D.; Vale, Wylie; Fischer, Wolfgang H.			Activin A/Bone Morphogenetic Protein (BMP) chimeras exhibit BMP-like activity and antagonize activin and myostatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II RECEPTORS; SIGNALING PATHWAYS; CELL-MEMBRANE; BINDING; COMPLEX; CLONING; IDENTIFICATION; PROLIFERATION; ACTIVATION; REGULATORS	Activins and bone morphogenetic proteins (BMPs) are members of the transforming growth factor-beta family of growth and differentiation factors that induce signaling in target cells by assembling type II and type I receptors at the cell surface. Ligand residues involved in type II binding are located predominantly in the C-terminal region that forms an extended beta-sheet, whereas residues involved in type I binding are located in the beta-helical and preceding loop central portion of the molecule. To test whether the central residues are sufficient to determine specificity toward type I receptors, activin A/BMP chimeras were constructed in which the central residues (45-79) of activin A were replaced with corresponding residues of BMP2 and BMP7. The chimeras were assessed for activin type II receptor (Act RII) binding, activin-like bioactivity, and BMP-like activity as well as antagonistic properties toward activin A and myostatin. ActA/BMP7 chimera retained Act RII binding affinity comparable with wild type activin A, whereas ActA/BMP2 chimera showed a slightly reduced affinity toward Act RII. Both the chimeras were devoid of significant activin bioactivity in 293T cells in the A3 Lux reporter assay up to concentrations 10-fold higher than the minimal effective activin A concentration (similar to 4 nM). In contrast, these chimeras showed BMP-like activity in a BRE-Luc assay in HepG2 cells as well as induced osteoblast-like phenotype in C2C12 cells expressing alkaline phosphatase. Furthermore, both the chimeras activated Smad1 but not Smad2 in C2C12 cells. Also, both the chimeras antagonized ligands that signal via activin type II receptor, such as activin A and myostatin. These data indicate that activin residues in the central region determine its specificity toward type I receptors. ActA/BMP chimeras can be useful in the study of receptor specificities and modulation of transforming growth factor-beta members, activins, and BMPs.	[Korupolu, Radhika V.; Muenster, Uwe; Read, Jessica D.; Vale, Wylie; Fischer, Wolfgang H.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	Salk Institute	Fischer, WH (corresponding author), 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	fischer@salk.edu			NICHD NIH HHS [HD-13527] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD013527] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Attisano L, 1996, MOL CELL BIOL, V16, P1066; Candia AF, 1997, DEVELOPMENT, V124, P4467; Chen YG, 2002, EXP BIOL MED, V227, P75, DOI 10.1177/153537020222700201; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Duncan SA, 2001, GENE DEV, V15, P1879, DOI 10.1101/gad.920601; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Fischer WH, 2003, J ENDOCRINOL, V176, P61, DOI 10.1677/joe.0.1760061; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Gray PC, 2000, J BIOL CHEM, V275, P3206, DOI 10.1074/jbc.275.5.3206; Greenwald J, 2004, MOL CELL, V15, P485, DOI 10.1016/j.molcel.2004.07.011; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Harrison CA, 2004, J BIOL CHEM, V279, P28036, DOI 10.1074/jbc.M402782200; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; Keller R, 2004, NATURE, V430, P305, DOI 10.1038/430305a; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; Lebrun JJ, 1997, MOL CELL BIOL, V17, P1682, DOI 10.1128/MCB.17.3.1682; Lee WS, 2001, BIOL REPROD, V65, P994, DOI 10.1095/biolreprod65.4.994; LIU VF, 1995, STEM CELLS, V13, P117; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Matzuk MM, 1996, RECENT PROG HORM RES, V51, P123; MATZUK MM, 1996, RECENT PROG HORM RES, V51, P155; Muenster U, 2005, J BIOL CHEM, V280, P36626, DOI 10.1074/jbc.M507236200; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Phillips DJ, 2000, BIOESSAYS, V22, P689, DOI 10.1002/1521-1878(200008)22:8<689::AID-BIES2>3.0.CO;2-5; Risbridger GP, 2001, ENDOCR REV, V22, P836, DOI 10.1210/er.22.6.836; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SONG JJ, 1995, ENDOCRINOLOGY, V136, P4293, DOI 10.1210/en.136.10.4293; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; VALE W, 1988, RECENT PROG HORM RES, V44, P1; VALE W, 1983, METHOD ENZYMOL, V103, P565; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Wankell M, 2003, ANN NY ACAD SCI, V995, P48, DOI 10.1111/j.1749-6632.2003.tb03209.x; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wuytens G, 1999, J BIOL CHEM, V274, P9821, DOI 10.1074/jbc.274.14.9821; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; Zhao GQ, 2001, DEV BIOL, V240, P212, DOI 10.1006/dbio.2001.0448	46	15	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3782	3790		10.1074/jbc.M704530200	http://dx.doi.org/10.1074/jbc.M704530200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18056265	hybrid			2022-12-25	WOS:000253083500012
J	Desmots, F; Russell, HR; Michel, D; McKinnon, PJ				Desmots, Fabienne; Russell, Helen R.; Michel, Denis; McKinnon, Peter J.			Scythe regulates apoptosis-inducing factor stability during endoplasmic reticulum stress-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITS PROTEIN-SYNTHESIS; MAMMALIAN-CELLS; FACTOR AIF; UBIQUITIN; REAPER; DEATH; DEGRADATION; CASPASE-3; PATHWAY; ROLES	Scythe (BAT3; HLA-(B) under bar (a) under bar ssociated (t) under bar ranscript (3) under bar, Bag 6) is a protein that has been implicated in apoptosis because it can modulate the Drosophila melanogaster apoptotic regulator, Reaper. Mice lacking Scythe show pronounced defects in organogenesis and in the regulation of apoptosis and proliferation during mammalian development. However, the biochemical pathways important for Scythe function are unknown. We report here multiple levels of interaction between Scythe and the apoptogenic mitochondrial intermembrane protein AIF ((a) under bar poptosis-(i) under bar nducing (f) under bar actor). Scythe physically interacts with AIF and regulates its stability. AIF stability is markedly reduced in Scythe(-/-) cells, which are more resistant to endoplasmic reticulum stress induced by thapsigargin. Reintroduction of Scythe or overexpression of AIF in Scythe(-/-) cells restores their sensitivity to apoptosis. Together, these data implicate Scythe as a regulator of AIF.	[Desmots, Fabienne; Russell, Helen R.; McKinnon, Peter J.] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Russell, Helen R.; Michel, Denis] Univ Rennes 1, CNRS, UMR 6026, F-35042 Rennes, France	St Jude Children's Research Hospital; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Desmots, F (corresponding author), St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA.	fabienne.desmots@univ-rennes1.fr		Michel, Denis/0000-0002-0643-8025				Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Garrido C, 2004, CURR OPIN CELL BIOL, V16, P639, DOI 10.1016/j.ceb.2004.09.008; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Haining WN, 1999, P NATL ACAD SCI USA, V96, P4936, DOI 10.1073/pnas.96.9.4936; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kikukawa Y, 2005, FEBS J, V272, P6373, DOI 10.1111/j.1742-4658.2005.05032.x; Kim JT, 2006, FEBS LETT, V580, P6375, DOI 10.1016/j.febslet.2006.10.049; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Kumar R, 2004, BIOCHEM BIOPH RES CO, V323, P1293, DOI 10.1016/j.bbrc.2004.09.006; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Miller J, 2005, FEBS LETT, V579, P3224, DOI 10.1016/j.febslet.2005.03.042; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Porter AG, 2006, BIOESSAYS, V28, P834, DOI 10.1002/bies.20444; Sanges D, 2006, APOPTOSIS, V11, P1629, DOI 10.1007/s10495-006-9006-2; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Seth R, 2005, J BIOL CHEM, V280, P31230, DOI 10.1074/jbc.M503305200; Spierings D, 2005, SCIENCE, V310, P66, DOI 10.1126/science.1117105; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tait SWG, 2004, CELL DEATH DIFFER, V11, P800, DOI 10.1038/sj.cdd.4401410; Thress K, 1999, EMBO J, V18, P5486, DOI 10.1093/emboj/18.20.5486; Thress K, 1998, EMBO J, V17, P6135, DOI 10.1093/emboj/17.21.6135; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200	28	63	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3264	3271		10.1074/jbc.M706419200	http://dx.doi.org/10.1074/jbc.M706419200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056262	hybrid			2022-12-25	WOS:000253083000030
J	Dou, H; Theriot, CA; Das, A; Hegde, ML; Matsumoto, Y; Boldogh, I; Hazra, TK; Bhakat, KK; Mitra, S				Dou, Hong; Theriot, Corey A.; Das, Aditi; Hegde, Muralidhar L.; Matsumoto, Yoshihiro; Boldogh, Istvan; Hazra, Tapas K.; Bhakat, Kishor K.; Mitra, Sankar			Interaction of the human DNA glycosylase NEIL1 with proliferating cell nuclear antigen - The potential for replication-associated repair of oxidized bases in mammaliangenomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURIFIED HUMAN PROTEINS; EXCISION-REPAIR; ESCHERICHIA-COLI; POLYMERASE-BETA; FLAP ENDONUCLEASE-1; HUMAN NTH1; DAMAGE; PCNA; IDENTIFICATION; COMPLEX	NEIL1 and NEIL2 compose a family of DNA glycosylases that is distinct from that of the other two DNA glycosylases, OGG1 and NTH1, all of which are involved in repair of oxidized bases in mammalian genomes. That the NEIL proteins, unlike OGG1 and NTH1, are able to excise base lesions from single-stranded DNA regions suggests their preferential involvement in repair during replication and/or transcription. Previous studies showing S phase-specific activation of NEIL1, but not NEIL2, suggested NEIL1 involvement in the repair of replicating DNA. Here, we show that human NEIL1 stably interacts both in vivo and in vitro with proliferating cell nuclear antigen ( PCNA), the sliding clamp for DNA replication. PCNA stimulates NEIL1 activity in excising the oxidized base 5-hydroxyuracil from single-stranded DNA sequences including fork structures. PCNA enhances NEIL1 loading on the substrate. In contrast, although present in the NEIL2 immunocomplex, PCNA does not stimulate NEIL2. NEIL1 interacts with PCNA via a domain that is located in a region near the C terminus, dispensable for base excision activity. The interacting sequence in NEIL1, which lacks the canonical PCNA-binding motif, includes a sequence conserved in DNA polymerase delta and implicated in its PCNA binding. Mammalian two-hybrid analysis confirmed PCNA interaction with NEIL1. The G127A mutation in PCNA reduces its stimulatory activity, suggesting that the interdomain connector loop, a common binding interface of PCNA, is involved in NEIL1 binding. These results strongly support in vivo function of NEIL1 in preferential repair of oxidized bases in DNA prior to replication.	[Dou, Hong; Theriot, Corey A.; Das, Aditi; Hegde, Muralidhar L.; Hazra, Tapas K.; Bhakat, Kishor K.; Mitra, Sankar] Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Boldogh, Istvan] Univ Texas Galveston, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Matsumoto, Yoshihiro] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Fox Chase Cancer Center	Mitra, S (corresponding author), Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, 6-136 Med Res Bldg, Galveston, TX 77555 USA.	samitra@utmb.edu	Bhakat, Kishor/C-8072-2012; Classen, Scott/AAY-8176-2020	Hegde, Muralidhar/0000-0001-7333-8123; Matsumoto, Yoshihiro/0000-0001-6580-7188	NATIONAL CANCER INSTITUTE [P01CA092584, R01CA102271, R01CA063154, R01CA081063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG021830] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA063154, R01 CA081063, P01 CA092584, R01 CA102271] Funding Source: Medline; NIAID NIH HHS [P01 AI062885] Funding Source: Medline; NIA NIH HHS [P01 AG021830, P01 AG021830-040003] Funding Source: Medline; NIEHS NIH HHS [P30 ES006676-129007, P30 ES006676, P30 ES06676] Funding Source: Medline; PHS HHS [T32-07254] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Boldogh I, 2001, NUCLEIC ACIDS RES, V29, P2802, DOI 10.1093/nar/29.13.2802; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Cadet JL, 1998, NEUROCHEM INT, V32, P117, DOI 10.1016/S0197-0186(97)00031-4; Das A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703343200; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Dianova II, 2001, BIOCHEMISTRY-US, V40, P12639, DOI 10.1021/bi011117i; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1; GRISHAM MB, 1986, AM J PHYSIOL, V251, pG567, DOI 10.1152/ajpgi.1986.251.4.G567; Guan X, 2007, NUCLEIC ACIDS RES, V35, P2463, DOI 10.1093/nar/gkm075; GUSCHLBAUER W, 1991, NUCLEIC ACIDS RES, V19, P1753, DOI 10.1093/nar/19.8.1753; Harrigan JA, 2006, NUCLEIC ACIDS RES, V34, P745, DOI 10.1093/nar/gkj475; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; Hazra IK, 1998, NUCLEIC ACIDS RES, V26, P5116, DOI 10.1093/nar/26.22.5116; Hazra TK, 2007, DNA REPAIR, V6, P470, DOI 10.1016/j.dnarep.2006.10.011; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Helt CE, 2005, CELL CYCLE, V4, P529, DOI 10.4161/cc.4.4.1598; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Ikeda S, 1998, J BIOL CHEM, V273, P21585, DOI 10.1074/jbc.273.34.21585; Izumi T, 2003, TOXICOLOGY, V193, P43, DOI 10.1016/S0300-483X(03)00289-0; Kathe SD, 2004, J BIOL CHEM, V279, P18511, DOI 10.1074/jbc.M313598200; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Lehmann AR, 2006, EXP CELL RES, V312, P2673, DOI 10.1016/j.yexcr.2006.06.010; Liu YA, 2007, J BIOL CHEM, V282, P13532, DOI 10.1074/jbc.M611295200; Lu AL, 2006, FRONT BIOSCI-LANDMRK, V11, P3062, DOI 10.2741/2033; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; Matsumoto Y, 1999, J BIOL CHEM, V274, P33703, DOI 10.1074/jbc.274.47.33703; Matsumoto Y, 2001, PROG NUCLEIC ACID RE, V68, P129; Mitra S, 1997, MOL CELLS, V7, P305; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; Naryzhny SN, 2004, J BIOL CHEM, V279, P20194, DOI 10.1074/jbc.M312850200; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Oyama M, 2004, BIOCHEM BIOPH RES CO, V321, P183, DOI 10.1016/j.bbrc.2004.06.136; Parlanti E, 2007, NUCLEIC ACIDS RES, V35, P1569, DOI 10.1093/nar/gkl1159; Pascucci B, 1999, J BIOL CHEM, V274, P33696, DOI 10.1074/jbc.274.47.33696; Podlutsky AJ, 2001, EMBO J, V20, P1477, DOI 10.1093/emboj/20.6.1477; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Shimazaki N, 2002, GENES CELLS, V7, P639, DOI 10.1046/j.1365-2443.2002.00547.x; Silvia TA, 2004, DNA REPAIR, V3, P483, DOI 10.1016/j.dnarep.2004.01.003; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; Takao M, 2002, J BIOL CHEM, V277, P42205, DOI 10.1074/jbc.M206884200; Tomkinson AE, 2001, PROG NUCLEIC ACID RE, V68, P151; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Zhang P, 1998, J BIOL CHEM, V273, P713, DOI 10.1074/jbc.273.2.713; ZHANG SJ, 1995, J BIOL CHEM, V270, P7988, DOI 10.1074/jbc.270.14.7988; Zharkov DO, 2003, DNA REPAIR, V2, P839, DOI 10.1016/S1568-7864(03)00084-3	58	119	123	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3130	3140		10.1074/jbc.M709186200	http://dx.doi.org/10.1074/jbc.M709186200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18032376	hybrid			2022-12-25	WOS:000253083000016
J	Skinner, SJ; Deleault, KM; Fecteau, R; Brooks, SA				Skinner, Stephen J.; Deleault, Kristen M.; Fecteau, Ryan; Brooks, Seth A.			Extracellular signal-regulated kinase regulation of tumor necrosis factor-alpha mRNA nucleocytoplasmic transport requires TAP-NxT1 binding and the AU-rich element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; EXON JUNCTION COMPLEX; HUMAN MONOCYTIC CELLS; ZINC-FINGER PROTEINS; TNF-ALPHA; GENE-EXPRESSION; LIPOPOLYSACCHARIDE STIMULATION; POSTTRANSCRIPTIONAL REGULATION; TRISTETRAPROLIN TTP	Tumor necrosis factor-alpha(TNF-alpha) production is regulated by transcriptional and posttranscriptional mechanisms. Lipopolysaccharide activates the NF kappa B pathway increasing TNF-alpha transcription. Lipopolysaccharide also activates the mitogen-activated protein kinase pathways, resulting in stabilization and enhanced translation of the TNF-alpha message. In addition, nuclear export of the TNF-alpha mRNA is a posttranscriptionally regulated process involving the Tpl2-ERK pathway and requiring the presence of the TNF-alpha AU-rich element (ARE). We demonstrate that nuclear export of the TNF-alpha message requires not only the TNF-alpha ARE but also the interaction of the proteins TAP and NxT1, both of which are involved in nucleocytoplasmic transport of mRNA. Through the use of dominant negative ERK1 and ERK2, we establish that control of TNF-alpha mRNA nuclear export operates specifically through ERK1. Finally, we examined the role of two established TNF-alpha ARE-binding proteins, HuR and tristetraprolin, that shuttle between the nucleus and cytoplasm. These data demonstrate that neither tristetraprolin nor HuR is required for TNF-alpha mRNA export. It is unclear at this time if ARE-binding protein(s) directly interact with the TAP-NxT1 complex, if each complex is independently targeted by ERK1, or if only one complex is targeted.	[Skinner, Stephen J.; Brooks, Seth A.] Vet Adm Med Ctr, White River Jct, VT 05009 USA; [Deleault, Kristen M.; Fecteau, Ryan] Dartmouth Coll, Dartmouth Med Sch, Dept Med, Lebanon, NH 03756 USA; [Brooks, Seth A.] Dartmouth Coll, Dept Microbiol & Immunol, Lebanon, NH 03756 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Dartmouth College; Dartmouth College	Brooks, SA (corresponding author), Vet Adm Med Ctr, Res 151,215 N Main St, White River Jct, VT 05009 USA.	seth.brooks@dartmouth.edu	Fecteau, Ryan/GXI-0446-2022	Fecteau, Ryan/0000-0002-3744-2924				Aguilera A, 2005, CURR OPIN CELL BIOL, V17, P242, DOI 10.1016/j.ceb.2005.03.001; Anderson P, 2000, ANN RHEUM DIS, V59, P3; Babu GR, 2006, BBA-MOL CELL RES, V1763, P174, DOI 10.1016/j.bbamcr.2005.12.010; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; Baseggio L, 2002, EUR CYTOKINE NETW, V13, P92; Behm-Ansmant I, 2006, GENE DEV, V20, P391, DOI 10.1101/gad.1407606; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; Brooks SA, 2004, J IMMUNOL, V172, P7263, DOI 10.4049/jimmunol.172.12.7263; Brooks SA, 2002, ARTHRITIS RHEUM, V46, P1362, DOI 10.1002/art.10235; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; CATLING AD, 1995, MOL CELL BIOL, V15, P5214; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Chen YL, 2006, BIOCHEM BIOPH RES CO, V346, P160, DOI 10.1016/j.bbrc.2006.05.093; Cho J, 2005, J BIOL CHEM, V280, P20442, DOI 10.1074/jbc.M413554200; Cho JH, 2005, P NATL ACAD SCI USA, V102, P2350, DOI 10.1073/pnas.0409856102; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Custodio N, 2004, RNA, V10, P622, DOI 10.1261/rna.5258504; DELEAULT KM, 2007, IN PRESS MOL IMMUNOL; Deleault KM, 2008, MOL IMMUNOL, V45, P13, DOI 10.1016/j.molimm.2007.05.017; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eliopoulos AG, 2003, EMBO J, V22, P3855, DOI 10.1093/emboj/cdg386; FROST JA, 1994, P NATL ACAD SCI USA, V91, P3844, DOI 10.1073/pnas.91.9.3844; GEPPERT TD, 1994, MOL MED, V1, P93; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; HACKER H, 2006, SCI STKE OCT    1017, P2006; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kontoyiannis D, 2001, EMBO J, V20, P3760, DOI 10.1093/emboj/20.14.3760; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kotlyarov A, 2002, BIOCHEM SOC T, V30, P959, DOI 10.1042/BST0300959; KRAMER B, 1994, BBA-GENE STRUCT EXPR, V1219, P413, DOI 10.1016/0167-4781(94)90066-3; KRAMER B, 1995, J BIOL CHEM, V270, P6577; KRUYS V, 1993, J EXP MED, V177, P1383, DOI 10.1084/jem.177.5.1383; Lai WS, 2001, J BIOL CHEM, V276, P23144, DOI 10.1074/jbc.M100680200; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Means TK, 2000, J LEUKOCYTE BIOL, V67, P885, DOI 10.1002/jlb.67.6.885; Medzhitov R, 2000, SEMIN IMMUNOL, V12, P185, DOI 10.1006/smim.2000.0230; Myokai F, 1999, P NATL ACAD SCI USA, V96, P4518, DOI 10.1073/pnas.96.8.4518; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Rigby WFC, 2005, J IMMUNOL, V174, P7883, DOI 10.4049/jimmunol.174.12.7883; Rutault K, 2001, J BIOL CHEM, V276, P6666, DOI 10.1074/jbc.M005486200; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; Silverman ES, 2001, AM J RESP CRIT CARE, V163, P778, DOI 10.1164/ajrccm.163.3.2003123; Steer JH, 2000, J BIOL CHEM, V275, P18432, DOI 10.1074/jbc.M906304199; Stoecklin G, 2003, MOL CELL BIOL, V23, P3506, DOI 10.1128/MCB.23.10.3506-3515.2003; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; Tang XR, 2003, P NATL ACAD SCI USA, V100, P4096, DOI 10.1073/pnas.0630562100; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; TANNENBAUM CS, 1988, J IMMUNOL, V140, P3640; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; TREDE NS, 1995, J IMMUNOL, V155, P902; Tsai EY, 1996, MOL CELL BIOL, V16, P5232; Tsai EY, 1996, MOL CELL BIOL, V16, P459; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Waterfield M, 2004, MOL CELL BIOL, V24, P6040, DOI 10.1128/MCB.24.13.6040-6048.2004; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; West MA, 2000, J TRAUMA, V49, P298, DOI 10.1097/00005373-200008000-00018; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952; ZUCKERMAN SH, 1989, J IMMUNOL, V143, P1223	70	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3191	3199		10.1074/jbc.M705575200	http://dx.doi.org/10.1074/jbc.M705575200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18048358	hybrid			2022-12-25	WOS:000253083000022
J	Diaz, AR; Stephenson, S; Green, JM; Levdikov, VM; Wilkinson, AJ; Perego, M				Diaz, Alejandra R.; Stephenson, Sophie; Green, J. Michael; Levdikov, Vladimir M.; Wilkinson, Anthony J.; Perego, Marta			Functional role for a conserved aspartate in the Spo0E signature motif involved in the dephosphorylation of the Bacillus subtilis sporulation regulator Spo0A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; RESPONSE REGULATOR; CRYSTAL-STRUCTURE; NEGATIVE REGULATION; PHOSPHATASE; MECHANISM; PROTEINS; INITIATION; CHEY; INHIBITION	Sporulation is a complex developmental system characterizing Gram-positive bacteria of the genus Bacillus and Clostridium. In Bacillus subtilis the phosphorelay signal transduction system regulates the initiation of sporulation by integrating a myriad of positive and negative signals through the action of histidine sensor kinases and aspartyl phosphate phosphatases. The Spo0E family of phosphatases dephosphorylates the Spo0A response regulator and transcription factor of the phosphorelay. In this study we analyzed the role of the Spo0E signature motif in protein activity. This family is characterized by a conserved signature motif centered around the sequence "SQELD." Alanine scanning mutagenesis was carried out on the T-35 IXXSQ ELDCLI46 residues of B. subtilis Spo0E and in vivo and in vitro activities were analyzed. The ability of the mutant proteins to interact with Spo0A similar to P was assayed by fluorescence resonance energy transfer spectroscopy. The results suggested that aspartate 43 has a critical role in Spo0E catalytic activity, whereas the other residues have a role in protein conformation and/or interaction with Spo0A. Residues Thr(35) and Cys(44) did not seem to have any critical functional or structural role. We propose that Asp(43) of Spo0E may function in a manner similar to the one proposed for the catalytic mechanisms of nucleotidase members of the haloacid dehalogenase family. These proteins use an aspartyl nucleophile as their common catalytic strategy and the active site of haloacid dehalogenase proteins shares a common geometry and identity of conserved amino acids with the active site of response regulators (Ridder, I. S., and Dijkstra, B. W. (1999) Biochem. J. 339, 223-226).	[Diaz, Alejandra R.; Stephenson, Sophie; Green, J. Michael; Perego, Marta] Scripps Res Inst, Dept Mol & Expt Med, Div Cellular Biol, La Jolla, CA 92037 USA; [Levdikov, Vladimir M.; Wilkinson, Anthony J.] Univ York, Dept Chem, Struct Biol Lab, York YO10 5YW, N Yorkshire, England	Scripps Research Institute; University of York - UK	Perego, M (corresponding author), 10050 N Torrey Pines Rd,MEM-116, La Jolla, CA 92037 USA.	mperego@scripps.edu	Levdikov, Vladimir/AAA-6139-2022	Wilkinson, Anthony/0000-0003-4577-9479; Levdikov, Vladimir/0000-0003-3041-1049	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055594] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 55594] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Bailey MF, 2004, J MOL BIOL, V336, P673, DOI 10.1016/j.jmb.2003.11.023; Bitto E, 2006, J BIOL CHEM, V281, P20521, DOI 10.1074/jbc.M602000200; Bongiorni C, 2005, J BACTERIOL, V187, P4353, DOI 10.1128/JB.187.13.4353-4361.2005; Bongiorni C, 2007, J BACTERIOL, V189, P2637, DOI 10.1128/JB.01798-06; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; Burkholder WF, 2001, CELL, V104, P269, DOI 10.1016/S0092-8674(01)00211-2; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Grenha R, 2006, J BIOL CHEM, V281, P37993, DOI 10.1074/jbc.M607617200; Grimshaw CE, 1998, BIOCHEMISTRY-US, V37, P1365, DOI 10.1021/bi971917m; Guhaniyogi J, 2006, J MOL BIOL, V359, P624, DOI 10.1016/j.jmb.2006.03.050; Ishikawa S, 2002, J BIOL CHEM, V277, P20483, DOI 10.1074/jbc.M201086200; Jiang M, 2000, MOL MICROBIOL, V38, P535, DOI 10.1046/j.1365-2958.2000.02148.x; KOBAYASHI K, 1995, J BACTERIOL, V177, P176, DOI 10.1128/jb.177.1.176-182.1995; Kumar S, 1998, BIOPHYS J, V75, P1935, DOI 10.1016/S0006-3495(98)77634-9; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lahiri SD, 2002, BIOCHEMISTRY-US, V41, P8351, DOI 10.1021/bi0202373; LEDEAUX JR, 1995, J BACTERIOL, V177, P861, DOI 10.1128/jb.177.3.861-863.1995; Lee SY, 2001, NAT STRUCT BIOL, V8, P52; Lewis RJ, 2000, J MOL BIOL, V297, P757, DOI 10.1006/jmbi.2000.3598; Lewis RJ, 1999, J MOL BIOL, V294, P9, DOI 10.1006/jmbi.1999.3261; Paredes CJ, 2005, NAT REV MICROBIOL, V3, P969, DOI 10.1038/nrmicro1288; PEREGO M, 1994, CELL, V79, P1047, DOI 10.1016/0092-8674(94)90035-3; Perego M, 2001, MOL MICROBIOL, V42, P133, DOI 10.1046/j.1365-2958.2001.02611.x; PEREGO M, 1991, J BACTERIOL, V173, P2514, DOI 10.1128/jb.173.8.2514-2520.1991; PEREGO M, 2002, BACILLUS SUBTILIS IT, P473; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Ridder IS, 1999, BIOCHEM J, V339, P223, DOI 10.1042/0264-6021:3390223; Rinaldo-Matthis A, 2002, NAT STRUCT BIOL, V9, P779, DOI 10.1038/nsb846; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Smits WK, 2007, MOL MICROBIOL, V65, P103, DOI 10.1111/j.1365-2958.2007.05776.x; Stephenson K, 2002, MOL MICROBIOL, V46, P297, DOI 10.1046/j.1365-2958.2002.03186.x; Stephenson SJ, 2002, MOL MICROBIOL, V44, P1455, DOI 10.1046/j.1365-2958.2002.02974.x; STOCK AM, 1989, NATURE, V337, P745, DOI 10.1038/337745a0; Szurmant H, 2004, J BIOL CHEM, V279, P21787, DOI 10.1074/jbc.M311497200; Wang L, 1997, GENE DEV, V11, P2569, DOI 10.1101/gad.11.19.2569; Wang WR, 2001, STRUCTURE, V9, P65, DOI 10.1016/S0969-2126(00)00558-X; Zapf J, 2000, STRUCTURE, V8, P851, DOI 10.1016/S0969-2126(00)00174-X; Zhao R, 2002, NAT STRUCT BIOL, V9, P570	44	24	25	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2962	2972		10.1074/jbc.M709032200	http://dx.doi.org/10.1074/jbc.M709032200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18045868	hybrid			2022-12-25	WOS:000252622300052
J	Pedersen, M; Carmosino, M; Forbush, B				Pedersen, Meike; Carmosino, Monica; Forbush, Biff			Intramolecular and intermolecular fluorescence resonance energy transfer in fluorescent protein-tagged na-k-cl cotransporter (NKCC1) - Sensitivity to regulatory conformational change and cell volume	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-K+-2CL(-) COTRANSPORTER; NA-K-2CL COTRANSPORTER; CHLORIDE; KINASE; PHOSPHORYLATION; MODULATION; ACTIVATION; TERMINUS; STRESS; ION	To examine the structure and function of the Na-K-Cl cotransporter, NKCC1, we tagged the transporter with cyan (CFP) and yellow (YFP) fluorescent proteins and measured fluorescence resonance energy transfer ( FRET) in stably expressing human embryonic kidney cell lines. Fluorescent protein tags were added at the N-terminal residue between the regulatory domain and the membrane domain and within a poorly conserved region of the C terminus. Both singly and doubly tagged NKCC1s were appropriately trafficked to the cell membrane and were fully functional; regulation was normal except when YFP was inserted near the regulatory domain, in which case activation occurred only upon incubation with calyculin A. Quenching of YFP fluorescence by Cl- provided a ratiometric indicator of intracellular [Cl-]. All of the CFP/YFP NKCC pairs exhibited some level of FRET, demonstrating the presence of dimers or higher multimers in functioning NKCC1. With YFP near the regulatory domain and CFP in the C terminus, we recorded a 6% FRET change signaling the regulatory phosphorylation event. On the other hand, when the probe was placed at the extreme N terminus, such changes were not seen, presumably due to the length and predicted flexibility of the N terminus. Substantial FRET changes were observed cotemporaneous with cell volume changes, possibly reflective of an increase in molecular crowding upon cell shrinkage.	[Pedersen, Meike; Carmosino, Monica; Forbush, Biff] Yale Univ, Dept Cellular & Mol Physiol, Sch Med, New Haven, CT 06520 USA	Yale University	Forbush, B (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, Sch Med, PO 208026, New Haven, CT 06520 USA.	biff.forbush@yale.edu	Carmosino, Monica/O-2594-2014	Carmosino, Monica/0000-0001-7600-8816	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047661] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 47661] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Anselmo AN, 2006, P NATL ACAD SCI USA, V103, P10883, DOI 10.1073/pnas.0604607103; Baker BJ, 2007, J NEUROSCI METH, V161, P32, DOI 10.1016/j.jneumeth.2006.10.005; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Casula S, 2001, J BIOL CHEM, V276, P41870, DOI 10.1074/jbc.M107155200; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Darman RB, 2001, J BIOL CHEM, V276, P34359, DOI 10.1074/jbc.C100368200; Dempski RE, 2006, J BIOL CHEM, V281, P36338, DOI 10.1074/jbc.M604788200; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Efendiev R, 2006, FEBS LETT, V580, P5067, DOI 10.1016/j.febslet.2006.08.035; Ellis RJ, 2006, BIOL CHEM, V387, P485, DOI 10.1515/BC.2006.064; Elsliger MA, 1999, BIOCHEMISTRY-US, V38, P5296, DOI 10.1021/bi9902182; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Gimenez I, 2005, AM J PHYSIOL-RENAL, V289, pF1341, DOI 10.1152/ajprenal.00214.2005; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Gimenez I, 2007, J BIOL CHEM, V282, P6540, DOI 10.1074/jbc.M610780200; Giraldez T, 2005, J GEN PHYSIOL, V126, P429, DOI 10.1085/jgp.200509368; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Iakoucheva LM, 2003, STRUCTURE, V11, P1316, DOI 10.1016/j.str.2003.10.009; Isenring P, 1997, J BIOL CHEM, V272, P24556, DOI 10.1074/jbc.272.39.24556; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kim KH, 2005, J BIOL CHEM, V280, P6463, DOI 10.1074/jbc.M409162200; KRAPF R, 1988, BIOPHYS J, V53, P955, DOI 10.1016/S0006-3495(88)83176-X; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Lytle C, 1998, AM J PHYSIOL-CELL PH, V274, pC1002, DOI 10.1152/ajpcell.1998.274.4.C1002; LYTLE C, 1992, AM J PHYSIOL, V262, pC1009, DOI 10.1152/ajpcell.1992.262.4.C1009; LYTLE C, 1992, J BIOL CHEM, V267, P25428; Lytle C, 1996, AM J PHYSIOL-CELL PH, V270, pC437, DOI 10.1152/ajpcell.1996.270.2.C437; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; Minton AP, 2005, BIOPHYS J, V88, P971, DOI 10.1529/biophysj.104.050351; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Moore-Hoon ML, 2000, BIOCHEMISTRY-US, V39, P3718, DOI 10.1021/bi992301v; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; PARKER JC, 1995, J GEN PHYSIOL, V105, P677, DOI 10.1085/jgp.105.6.677; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Plata C, 1999, AM J PHYSIOL-RENAL, V276, pF359, DOI 10.1152/ajprenal.1999.276.3.F359; Salahpour A, 2007, NAT METHODS, V4, P599, DOI 10.1038/nmeth0807-599; Salvi A, 2002, AAPS PHARMSCI, V4, DOI 10.1208/ps040421; Simard CF, 2004, J BIOL CHEM, V279, P40769, DOI 10.1074/jbc.M406458200; Simard CF, 2007, J BIOL CHEM, V282, P18083, DOI 10.1074/jbc.M607811200; Starremans PGJF, 2003, J AM SOC NEPHROL, V14, P3039, DOI 10.1097/01.ASN.0000097370.29737.5B; Summers JC, 1997, AM J PHYSIOL-CELL PH, V273, pC360, DOI 10.1152/ajpcell.1997.273.2.C360; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Wachter RM, 2000, J MOL BIOL, V301, P157, DOI 10.1006/jmbi.2000.3905; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zheng J, 2003, J NEUROSCI, V23, P8167; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1; Zimmermann B, 2005, EMBO J, V24, P2053, DOI 10.1038/sj.emboj.7600682	54	30	30	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2663	2674		10.1074/jbc.M708194200	http://dx.doi.org/10.1074/jbc.M708194200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18045874	hybrid			2022-12-25	WOS:000252622300023
J	Pan, H; Luo, C; Li, R; Qiao, A; Zhang, L; Mines, M; Nyanda, AM; Zhang, J; Fan, GH				Pan, Heng; Luo, Cherry; Li, Runsheng; Qiao, Aimin; Zhang, Li; Mines, Marjelo; Nyanda, Alfred M.; Zhang, Jingwu; Fan, Guo-Huang			Cyclophilin a is required for CXCR4-mediated nuclear export of heterogeneous nuclear ribonucleoprotein a2, activation and nuclear translocation of ERK1/2, and chemotactic cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYL-PROLYL ISOMERASE; CHEMOKINE RECEPTOR CXCR4; DEPENDENT MACROPHAGE PROLIFERATION; HEMATOPOIETIC PROGENITOR CELLS; REGULATED KINASE ACTIVATION; CYCLOSPORINE-A; EXTRACELLULAR SIGNAL; BINDING-PROTEIN; LUNG-CANCER; MAP KINASE	The chemokine receptor CXCR4-mediated signaling cascades play an important role in cell proliferation and migration, but the underlying mechanisms by which the receptor signaling is regulated remain incompletely understood. Here, we demonstrate that CXCR4 was co-immunoprecipitated with cyclophilin A (CyPA) from the lysate of HEK293 cells stably expressing CXCR4. Although both the glutathione S-transferase-CXCR4N- and C-terminal fusion proteins were associated with the purified CyPA, truncation of the C-terminal domain of CXCR4 robustly inhibited the receptor co-immunoprecipitation with CyPA in intact cells, thereby suggesting a critical role of the receptor C terminus in this interaction. Ligand stimulation of CXCR4 induced CyPA phosphorylation and nuclear translocation, both of which were inhibited by truncation of the C-terminal domain of CXCR4. CyPA was associated with transportin 1, and knockdown of transportin 1 by RNA interference(RNAi) blocked CXCL12-induced nuclear translocation of CyPA, thereby suggesting a transportin 1-mediated nuclear import of CyPA. CyPA formed a complex with heterogeneous nuclear ribonucleoprotein ( hnRNP) A2, which underwent nuclear export in response to activation of CXCR4. Interestingly, the CXCR4-mediated nuclear export of hnRNP A2 was blocked by RNAi of CyPA. Moreover, CXCR4-evoked activation of extracellular signal-regulated kinase 1/2 (ERK1/2) was attenuated by CyPA RNAi, by overexpression of a PPIase-deficient mutant of CyPA (CyPA-R55A), and by pretreatment of the immunosuppressive drugs, cyclosporine A and sanglifehrin A. Finally, CXCL12-induced chemotaxis of HEK293 cells stably expressing CXCR4 or Jurkat T cells was inhibited by CyPA RNAi or CsA treatment.	[Luo, Cherry; Qiao, Aimin; Mines, Marjelo; Nyanda, Alfred M.; Fan, Guo-Huang] Meharry Med Coll, Dept Vet Affairs, Dept Neurobiol & Neurotoxicol, Nashville, TN 37208 USA; [Pan, Heng; Li, Runsheng; Zhang, Jingwu] Shanghai Jiao Tong Univ, Chinese Acad Sci, Sch Med, Inst Hlth Sci,Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China; [Zhang, Li] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA	Meharry Medical College; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Vanderbilt University	Fan, GH (corresponding author), Meharry Med Coll, Dept Vet Affairs, Dept Neurobiol & Neurotoxicol, Nashville, TN 37208 USA.	gfan@mmc.edu			NCRR NIH HHS [RR 03032-19] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Ansari H, 2002, MOL CELL BIOL, V22, P6993, DOI 10.1128/MCB.22.20.6993-7003.2002; Arai A, 2006, CELL SIGNAL, V18, P2162, DOI 10.1016/j.cellsig.2006.05.001; Bodner A, 2003, J NEUROIMMUNOL, V140, P1, DOI 10.1016/S0165-5728(03)00162-0; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Burger M, 2003, ONCOGENE, V22, P8093, DOI 10.1038/sj.onc.1207097; Chen TY, 2004, BLOOD, V103, P413, DOI 10.1182/blood-2003-07-2412; Colgan J, 2004, IMMUNITY, V21, P189, DOI 10.1016/j.immuni.2004.07.005; Comalada M, 2003, EUR J IMMUNOL, V33, P3091, DOI 10.1002/eji.200324074; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; de Parseval A, 2001, J VIROL, V75, P4528, DOI 10.1128/JVI.75.10.4528-4539.2001; Ding Y, 2006, MOL PHARMACOL, V69, P1269, DOI 10.1124/mol.105.020271; Dornan J, 2003, CURR TOP MED CHEM, V3, P1392, DOI 10.2174/1568026033451899; Dragic T, 2001, J GEN VIROL, V82, P1807, DOI 10.1099/0022-1317-82-8-1807; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Floridi F, 2003, J NEUROIMMUNOL, V135, P38, DOI 10.1016/S0165-5728(02)00432-0; Fridell RA, 1997, J CELL SCI, V110, P1325; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; Galigniana MD, 2004, J BIOL CHEM, V279, P55754, DOI 10.1074/jbc.M406259200; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Golding H, 2005, J BIOL CHEM, V280, P29570, DOI 10.1074/jbc.M500236200; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hartmann TN, 2004, J BIOL REG HOMEOS AG, V18, P126; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Inoue A, 2005, J CELL SCI, V118, P2303, DOI 10.1242/jcs.02345; Inoue A, 2007, P NATL ACAD SCI USA, V104, P8983, DOI 10.1073/pnas.0607595104; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lenormand P, 1998, J CELL BIOL, V142, P625, DOI 10.1083/jcb.142.3.625; Leopold PL, 2000, HUM GENE THER, V11, P151, DOI 10.1089/10430340050016238; Leverson JD, 1998, MOL CELL, V2, P417, DOI 10.1016/S1097-2765(00)80141-0; Li RS, 2006, J BIOL CHEM, V281, P37616, DOI 10.1074/jbc.M607266200; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Luo C, 2006, J BIOL CHEM, V281, P30081, DOI 10.1074/jbc.M605837200; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Majka M, 2000, EUR J HAEMATOL, V64, P164, DOI 10.1034/j.1600-0609.2000.90112.x; Munro TP, 1999, J BIOL CHEM, V274, P34389, DOI 10.1074/jbc.274.48.34389; Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982; Neuhaus T, 2003, CELL PROLIFERAT, V36, P75, DOI 10.1046/j.1365-2184.2003.00262.x; Pan JD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-56; Peng SB, 2005, MOL CANCER RES, V3, P227; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; Rycyzyn MA, 2000, MOL ENDOCRINOL, V14, P1175, DOI 10.1210/me.14.8.1175; Sanchez-Tillo E, 2006, EUR J IMMUNOL, V36, P2515, DOI 10.1002/eji.200535270; Sanglier JJ, 1999, J ANTIBIOT, V52, P466, DOI 10.7164/antibiotics.52.466; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Stamnes MA, 1990, CURR OPIN CELL BIOL, V2, P1104, DOI 10.1016/0955-0674(90)90163-9; Suikkanen S, 2003, J VIROL, V77, P10270, DOI 10.1128/JVI.77.19.10270-10279.2003; Syed F, 2003, ENDOCRINE, V20, P83, DOI 10.1385/ENDO:20:1-2:83; Tsai HR, 2004, EUR J PHARMACOL, V498, P45, DOI 10.1016/j.ejphar.2004.07.077; Uchida D, 2003, EXP CELL RES, V290, P289, DOI 10.1016/S0014-4827(03)00344-6; Weber KSC, 2001, MOL BIOL CELL, V12, P3074, DOI 10.1091/mbc.12.10.3074; Wedlich-Soldner R, 2000, EMBO J, V19, P1974, DOI 10.1093/emboj/19.9.1974; Wu MQ, 2006, INT J MOL MED, V17, P749; Wysoczynski M, 2005, BLOOD, V105, P40, DOI 10.1182/blood-2004-04-1430; YANG WM, 1995, J BIOL CHEM, V270, P15187, DOI 10.1074/jbc.270.25.15187; Yoo SH, 1997, J MOL BIOL, V269, P780, DOI 10.1006/jmbi.1997.1051; Yoo YD, 2006, J BIOL CHEM, V281, P15352, DOI 10.1074/jbc.M511825200; Zagar Y, 2004, J BIOL CHEM, V279, P2403, DOI 10.1074/jbc.M309132200; Zenke G, 2001, J IMMUNOL, V166, P7165, DOI 10.4049/jimmunol.166.12.7165; Zhang YY, 2004, STEM CELLS, V22, P1015, DOI 10.1634/stemcells.22-6-1015; Zhao M, 2006, MOL PHARMACOL, V69, P66, DOI 10.1124/mol.105.016923; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	70	85	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					623	637		10.1074/jbc.M704934200	http://dx.doi.org/10.1074/jbc.M704934200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17991743	hybrid			2022-12-25	WOS:000251940300067
J	Cohen, R; Marom, M; Atlas, D				Cohen, Roy; Marom, Merav; Atlas, Daphne			Depolarization-Evoked Secretion Requires Two Vicinal Transmembrane Cysteines of Syntaxin 1A	PLOS ONE			English	Article								Background. The interactions of the voltage-gated Ca2+ channel (VGCC) with syntaxin 1A (Sx 1A), Synaptosome-associated protein of 25 kD (SNAP-25), and synaptotagmin, couple electrical excitation to evoked secretion. Two vicinal Cys residues, Cys 271 and Cys 272 in the Sx 1A transmembrane domain, are highly conserved and participate in modulating channel kinetics. Each of the Sx1A Cys mutants, differently modify the kinetics of Cav1.2, and neuronal Cav2.2 calcium channel. Methodology/Principle Findings. We examined the effects of various Sx1A Cys mutants and the syntaxin isoforms 2, 3, and 4 each of which lack vicinal Cys residues, on evoked secretion, monitoring capacitance transients in a functional release assay. Membrane capacitance in Xenopus oocytes co-expressing Cav1.2, Sx1A, SNAP-25 and synaptotagmin, which is Bot C- and Bot A-sensitive, was elicited by a double 500 ms depolarizing pulse to 0 mV. The evoked-release was obliterated when a single Cys Sx1A mutant or either one of the Sx isoforms were substituted for Sx 1A, demonstrating the essential role of vicinal Cys residues in the depolarization mediated process. Protein expression and confocal imaging established the level of the mutated proteins in the cell and their targeting to the plasma membrane. Conclusions/Significance. We propose a model whereby the two adjacent transmembranal Cys residues of Sx 1A, lash two calcium channels. Consistent with the necessity of a minimal fusion complex termed the excitosome, each Sx1A is in a complex with SNAP-25, Syt1, and the Ca2+ channel. A Hill coefficient >2 imply that at least three excitosome complexes are required for generating a secreting hetero-oligomer protein complex. This working model suggests that a fusion pore that opens during membrane depolarization could be lined by alternating transmembrane segments of Sx1A and VGCC. The functional coupling of distinct amino acids of Sx 1A with VGCC appears to be essential for depolarization-evoked secretion.	[Cohen, Roy; Marom, Merav; Atlas, Daphne] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Atlas, D (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	datlas@vms.huji.ac.il			Lili Safra Foundation; Mrs. Betty Pfeffer and G.H. Gerson Fund	Lili Safra Foundation; Mrs. Betty Pfeffer and G.H. Gerson Fund	We acknowledge the Lili Safra Foundation, Mrs. Betty Pfeffer and G.H. Gerson Fund for (DA). Funding only.	Arien H, 2003, J BIOL CHEM, V278, P29231, DOI 10.1074/jbc.M301401200; Atlas D, 2001, CELL MOL NEUROBIOL, V21, P717, DOI 10.1023/A:1015104105262; Atlas D, 2001, J NEUROCHEM, V77, P972, DOI 10.1046/j.1471-4159.2001.00347.x; Bement WM, 2000, J EXP ZOOL, V286, P767, DOI 10.1002/(SICI)1097-010X(20000601)286:7<767::AID-JEZ11>3.0.CO;2-L; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Bonanno G, 2000, BRIT J PHARMACOL, V129, P1780, DOI 10.1038/sj.bjp.0703251; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Chen XC, 2006, BIOPHYS J, V90, P2062, DOI 10.1529/biophysj.105.071415; Cohen R, 2005, BIOPHYS J, V89, P4364, DOI 10.1529/biophysj.105.064642; Cohen R, 2004, NEUROSCIENCE, V128, P831, DOI 10.1016/j.neuroscience.2004.07.027; COHEN R, 2007, METHODS MOL IN PRESS; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fisher TE, 2001, PROG BIOPHYS MOL BIO, V77, P269, DOI 10.1016/S0079-6107(01)00017-7; FROST SC, 1985, J BIOL CHEM, V260, P2646; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; Jarvis SE, 2005, CELL CALCIUM, V37, P483, DOI 10.1016/j.ceca.2005.01.017; Jarvis SE, 2002, J BIOL CHEM, V277, P44399, DOI 10.1074/jbc.M206902200; Kang Y, 2002, DIABETOLOGIA, V45, P231, DOI 10.1007/s00125-001-0718-0; Lerner I, 2006, J NEUROCHEM, V97, P116, DOI 10.1111/j.1471-4159.2006.03709.x; Melia TJ, 2007, FEBS LETT, V581, P2131, DOI 10.1016/j.febslet.2007.02.066; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Morgans CW, 1996, J NEUROSCI, V16, P6713; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Pickett JA, 2007, BIOCHEM BIOPH RES CO, V359, P599, DOI 10.1016/j.bbrc.2007.05.128; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; SCHIAVO G, 1993, J BIOL CHEM, V268, P11516; Schmitt BM, 2002, BIOPHYS J, V82, P1345, DOI 10.1016/S0006-3495(02)75490-8; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Sherry DM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-54; SMITH SJ, 1993, J PHYSIOL-LONDON, V472, P573, DOI 10.1113/jphysiol.1993.sp019963; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Song HT, 2003, J NEUROPHYSIOL, V89, P1143, DOI 10.1152/jn.00482.2002; Spurlin BA, 2004, DIABETES, V53, P2223, DOI 10.2337/diabetes.53.9.2223; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; Stigliani S, 2003, J NEUROCHEM, V85, P409, DOI 10.1046/j.1471-4159.2003.01689.x; Sun L, 2006, EUR J NEUROSCI, V23, P1391, DOI 10.1111/j.1460-9568.2006.04653.x; Szule JA, 2004, SCIENCE, V306; Tobi D, 1998, RECEPTOR CHANNEL, V6, P89; TOONEN RF, 2007, TRENDS NEUROSCI; Trus M, 2001, NEUROSCIENCE, V104, P599, DOI 10.1016/S0306-4522(01)00083-5; TRUS M, 2007, BIOCHEMISTR IN PRESS; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Volchuk A, 1996, MOL BIOL CELL, V7, P1075, DOI 10.1091/mbc.7.7.1075; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wiser O, 1997, FEBS LETT, V404, P203, DOI 10.1016/S0014-5793(97)00130-0; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; Wiser O, 2002, P NATL ACAD SCI USA, V99, P3968, DOI 10.1073/pnas.052017299; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Xia FZ, 2004, J BIOL CHEM, V279, P24685, DOI 10.1074/jbc.M314314200; Yang SN, 1999, P NATL ACAD SCI USA, V96, P10164, DOI 10.1073/pnas.96.18.10164; YOSHIDA S, 1992, J PHYSIOL-LONDON, V458, P307, DOI 10.1113/jphysiol.1992.sp019419; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0	58	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1273	10.1371/journal.pone.0001273	http://dx.doi.org/10.1371/journal.pone.0001273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060067	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459400020
J	Iser, WB; Wolkow, CA				Iser, Wendy B.; Wolkow, Catherine A.			DAF-2/Insulin-Like Signaling in C. elegans Modifies Effects of Dietary Restriction and Nutrient Stress on Aging, Stress and Growth	PLOS ONE			English	Article								Background. Dietary restriction (DR) and reduced insulin/IGF-I-like signaling (IIS) are two regimens that promote longevity in a variety of organisms. Genetic analysis in C. elegans nematodes has shown that DR and IIS couple to distinct cellular signaling pathways. However, it is not known whether these pathways ultimately converge on overlapping or distinct targets to extend lifespan. Principal Findings. We investigated this question by examining additional effects of DR in wildtype animals and in daf-2 mutants with either moderate or severe IIS deficits. Surprisingly, DR and IIS had opposing effects on these physiological processes. First, DR induced a stress-related change in intestinal vesicle trafficking, termed the FIRE response, which was suppressed in daf-2 mutants. Second, DR did not strongly affect expression of a daf-2- and stress-responsive transcriptional reporter. Finally, DR-related growth impairment was suppressed in daf-2 mutants. Conclusions. These findings reveal that an important biological function of DAF-2/IIS is to enhance growth and survival under nutrient-limited conditions. However, we also discovered that levels of DAF-2 pathway activity modified the effects of DR on longevity. Thus, while DR and IIS clearly affect lifespan through independent targets, there may also be some prolongevity targets that are convergently regulated by these pathways.	[Iser, Wendy B.; Wolkow, Catherine A.] NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Wolkow, CA (corresponding author), NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	wolkowca@grc.nia.nih.gov			NIA Intramural Research Program; New Scholar in Aging Award from the Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [Z01AG000320] Funding Source: NIH RePORTER	NIA Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); New Scholar in Aging Award from the Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the NIA Intramural Research Program and by a New Scholar in Aging Award from the Ellison Medical Foundation (CAW). Funding sources were not involved in any aspect of the study or manuscript preparation and submission.	BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Cypser JR, 2002, J GERONTOL A-BIOL, V57, pB109, DOI 10.1093/gerona/57.3.B109; Gami MS, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-45; Gems D, 1998, GENETICS, V150, P129; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Iser WB, 2007, DEV BIOL, V303, P434, DOI 10.1016/j.ydbio.2006.04.467; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kodama E, 2006, GENE DEV, V20, P2955, DOI 10.1101/gad.1479906; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Leiers BR, 2003, FREE RADICAL BIO MED, V34, P1405, DOI 10.1016/S0891-5849(03)00102-3; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Masoro EJ, 1998, EXP GERONTOL, V33, P61, DOI 10.1016/S0531-5565(97)00071-5; McCulloch D, 2003, EXP GERONTOL, V38, P129, DOI 10.1016/S0531-5565(02)00147-X; Morck C, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-39; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Olsen A, 2006, BIOGERONTOLOGY, V7, P221, DOI 10.1007/s10522-006-9018-x; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; SWANSON MM, 1981, DEV BIOL, V84, P27, DOI 10.1016/0012-1606(81)90367-5; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2003, MOL BIOL CELL, V14, P2972, DOI 10.1091/mbc.E03-01-0858; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Walker G, 2005, MECH AGEING DEV, V126, P929, DOI 10.1016/j.mad.2005.03.014; Walker GA, 2001, J GERONTOL A-BIOL, V56, pB281, DOI 10.1093/gerona/56.7.B281; Weinkove D, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-1	44	25	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1240	10.1371/journal.pone.0001240	http://dx.doi.org/10.1371/journal.pone.0001240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043747	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459300021
J	Satoh, K; Doi, K; Nagata, T; Kishimoto, N; Suzuki, K; Otomo, Y; Kawai, J; Nakamura, M; Hirozane-Kishikawa, T; Kanagawa, S; Arakawa, T; Takahashi-Iida, J; Murata, M; Ninomiya, N; Sasaki, D; Fukuda, S; Tagami, M; Yamagata, H; Kurita, K; Kamiya, K; Yamamoto, M; Kikuta, A; Bito, T; Fujitsuka, N; Ito, K; Kanamori, H; Choi, IR; Nagamura, Y; Matsumoto, T; Murakami, K; Matsubara, K; Carninci, P; Hayashizaki, Y; Kikuchi, S				Satoh, Kouji; Doi, Koji; Nagata, Toshifumi; Kishimoto, Naoki; Suzuki, Kohji; Otomo, Yasuhiro; Kawai, Jun; Nakamura, Mari; Hirozane-Kishikawa, Tomoko; Kanagawa, Saeko; Arakawa, Takahiro; Takahashi-Iida, Juri; Murata, Mitsuyoshi; Ninomiya, Noriko; Sasaki, Daisuke; Fukuda, Shiro; Tagami, Michihira; Yamagata, Harumi; Kurita, Kanako; Kamiya, Kozue; Yamamoto, Mayu; Kikuta, Ari; Bito, Takahito; Fujitsuka, Nahoko; Ito, Kazue; Kanamori, Hiroyuki; Choi, Il-Ryong; Nagamura, Yoshiaki; Matsumoto, Takashi; Murakami, Kazuo; Matsubara, Ken-ichi; Carninci, Piero; Hayashizaki, Yoshihide; Kikuchi, Shoshi			Gene Organization in Rice Revealed by Full-Length cDNA Mapping and Gene Expression Analysis through Microarray	PLOS ONE			English	Article							IN-VITRO TRANSCRIPTS; INFORMATION RESOURCE; DRAFT SEQUENCE; NONCODING RNAS; GENOME; ANNOTATION; DATABASE; MODEL; CENTROMERE; REGIONS	Rice (Oryza sativa L.) is a model organism for the functional genomics of monocotyledonous plants since the genome size is considerably smaller than those of other monocotyledonous plants. Although highly accurate genome sequences of indica and japonica rice are available, additional resources such as full-length complementary DNA (FL-cDNA) sequences are also indispensable for comprehensive analyses of gene structure and function. We cross-referenced 28.5K individual loci in the rice genome defined by mapping of 578K FL-cDNA clones with the 56K loci predicted in the TIGR genome assembly. Based on the annotation status and the presence of corresponding cDNA clones, genes were classified into 23K annotated expressed (AE) genes, 33K annotated non-expressed (ANE) genes, and 5.5K non-annotated expressed (NAE) genes. We developed a 60mer oligo-array for analysis of gene expression from each locus. Analysis of gene structures and expression levels revealed that the general features of gene structure and expression of NAE and ANE genes were considerably different from those of AE genes. The results also suggested that the cloning efficiency of rice FL-cDNA is associated with the transcription activity of the corresponding genetic locus, although other factors may also have an effect. Comparison of the coverage of FL-cDNA among gene families suggested that FL-cDNA from genes encoding rice- or eukaryote-specific domains, and those involved in regulatory functions were difficult to produce in bacterial cells. Collectively, these results indicate that rice genes can be divided into distinct groups based on transcription activity and gene structure, and that the coverage bias of FL-cDNA clones exists due to the incompatibility of certain eukaryotic genes in bacteria.	[Satoh, Kouji; Doi, Koji; Nagata, Toshifumi; Kishimoto, Naoki; Nagamura, Yoshiaki; Matsumoto, Takashi; Kikuchi, Shoshi] Natl Inst Agrobiol Sci, Div Genome & Biodivers Res, Tsukuba, Ibaraki, Japan; [Suzuki, Kohji] Hitachi Software Engn, Shinagawa Ku, Tokyo, Japan; [Otomo, Yasuhiro; Murakami, Kazuo; Matsubara, Ken-ichi] FAIS, Lab Genome Sequencing & Anal Grp, Tsukuba, Ibaraki, Japan; [Matsubara, Ken-ichi] Nara Inst Sci & Technol, Nara, Japan; [Kawai, Jun; Nakamura, Mari; Hirozane-Kishikawa, Tomoko; Kanagawa, Saeko; Arakawa, Takahiro; Takahashi-Iida, Juri; Murata, Mitsuyoshi; Ninomiya, Noriko; Sasaki, Daisuke; Fukuda, Shiro; Tagami, Michihira; Carninci, Piero; Hayashizaki, Yoshihide] RIKEN Yokohama Inst, Genom Sci Ctr, Genome Explorat Res Grp, Kanagawa, Japan; [Kawai, Jun; Carninci, Piero; Hayashizaki, Yoshihide] RIKEN Wako Inst, Genome Sci Lab, Wako, Saitama, Japan; [Yamagata, Harumi; Kurita, Kanako; Kamiya, Kozue; Yamamoto, Mayu; Kikuta, Ari; Bito, Takahito; Fujitsuka, Nahoko; Ito, Kazue; Kanamori, Hiroyuki] Inst Soc Technoinnovat Agr Forestry & Fisheries, Tsukuba, Ibaraki, Japan; [Choi, Il-Ryong] DAPO, Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Manila, Philippines	National Institute of Agrobiological Sciences - Japan; Hitachi Limited; Nara Institute of Science & Technology; RIKEN; RIKEN; CGIAR; International Rice Research Institute (IRRI)	Kikuchi, S (corresponding author), Natl Inst Agrobiol Sci, Div Genome & Biodivers Res, Tsukuba, Ibaraki, Japan.	skikuchi@nias.affrc.go.jp	Doi, Koji/D-1298-2009; Kawai, Jun/A-6451-2016; Carninci, Piero/K-1568-2014; Hayashizaki, Yoshihide/N-6590-2015	Doi, Koji/0000-0002-6027-1799; Carninci, Piero/0000-0001-7202-7243; Fukuda, Shiro/0000-0002-0065-662X	BRAIN; Ministry of Agriculture, Forestry and Fisheries (MAFF); MAFF; Consultative Group for International Agricultural Research (CGIAR)	BRAIN; Ministry of Agriculture, Forestry and Fisheries (MAFF)(Ministry of Agriculture Forestry & Fisheries - Japan); MAFF(Ministry of Agriculture Forestry & Fisheries - Japan); Consultative Group for International Agricultural Research (CGIAR)	This study was supported by a Rice Genome Full-Length cDNA Library Construction Project grant from BRAIN and by the Rice Genome Simulator Project from the Ministry of Agriculture, Forestry and Fisheries (MAFF), Japan; additional funding was received through a QTL project on Green Techno from MAFF and the Generation Challenge program funded by several international donors of the Consultative Group for International Agricultural Research (CGIAR).	Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Choi IR, 1999, PHYTOPATHOLOGY, V89, P1182, DOI 10.1094/PHYTO.1999.89.12.1182; Costa FF, 2007, GENE, V386, P1, DOI 10.1016/j.gene.2006.09.028; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gibbings JG, 2003, PLANT BIOTECHNOL J, V1, P271, DOI 10.1046/j.1467-7652.2003.00026.x; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gojobori T, 2007, GENOME RES, V17, P175, DOI 10.1101/gr.5509507; Hashimoto S, 2004, NAT BIOTECHNOL, V22, P1146, DOI 10.1038/nbt998; Imanishi T., 2004, PLOS BIOL, V2; Jaiswal P, 2006, NUCLEIC ACIDS RES, V34, pD717, DOI 10.1093/nar/gkj154; Jakab G, 1997, J GEN VIROL, V78, P3141, DOI 10.1099/0022-1317-78-12-3141; Johansen IE, 1996, P NATL ACAD SCI USA, V93, P12400, DOI 10.1073/pnas.93.22.12400; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Li L, 2006, NAT GENET, V38, P124, DOI 10.1038/ng1704; Lin HN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r41; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mizuno H, 2006, PLANT J, V46, P206, DOI 10.1111/j.1365-313X.2006.02684.X; Mizuno H, 2006, DNA RES, V13, P267, DOI 10.1093/dnares/dsm001; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NADEAU K, 1993, J BIOL CHEM, V268, P1479; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Nakano M, 2006, NUCLEIC ACIDS RES, V34, pD731, DOI 10.1093/nar/gkj077; Ohyanagi H, 2006, NUCLEIC ACIDS RES, V34, pD741, DOI 10.1093/nar/gkj094; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Ren XY, 2006, TRENDS GENET, V22, P528, DOI 10.1016/j.tig.2006.08.008; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P224, DOI 10.1093/nar/gkg076; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Sugawara H, 2007, NUCLEIC ACIDS RES, V35, pD13, DOI 10.1093/nar/gkl908; Wu JZ, 2002, PLANT CELL, V14, P525, DOI 10.1105/tpc.010274; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yan HH, 2007, CHROMOSOME RES, V15, P77, DOI 10.1007/s10577-006-1104-z; Yan HH, 2006, PLANT CELL, V18, P2123, DOI 10.1105/tpc.106.043794; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang JW, 2005, PLANT J, V42, P772, DOI 10.1111/j.1365-313X.2005.02408.x; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhao WM, 2004, NUCLEIC ACIDS RES, V32, pD377, DOI 10.1093/nar/gkh085; Zhou Yan, 2003, Genomics Proteomics & Bioinformatics, V1, P26	45	42	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1235	10.1371/journal.pone.0001235	http://dx.doi.org/10.1371/journal.pone.0001235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043742	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459300016
J	Zhu, XF; Cooper, RS				Zhu, Xiaofeng; Cooper, Richard S.			Admixture Mapping Provides Evidence of Association of the VNN1 Gene with Hypertension	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ETHNIC-DIFFERENCES; PROSTATE-CANCER; COMMON VARIANT; BLOOD-PRESSURE; DISEASE; LINKAGE; DISCOVERY; LOCUS; SUSCEPTIBILITY	Migration patterns in modern societies have created the opportunity to use population admixture as a strategy to identify susceptibility genes. To implement this strategy, we genotyped a highly informative ancestry marker panel of 2270 single nucleotide polymorphisms in a random population sample of African Americans (N = 1743), European Americans (N = 1000) and Mexican Americans (N = 581). We then examined the evidence for over-transmission of specific loci to cases from one of the two ancestral populations. Hypertension cases and controls were defined based on standard clinical criteria. Both case-only and case-control analyses were performed among African Americans. With the genome-wide markers we replicated the findings identified in our previous admixture mapping study on chromosomes 6 and 21 [1]. For case-control analysis we then genotyped 51 missense SNPs in 36 genes spaced across an 18.3 Mb region. Further analyses demonstrated that the missense SNP rs2272996 (or N131S) in the VNN1 gene was significantly associated with hypertension in African Americans and the association was replicated in Mexican Americans; a non-significant opposite association was observed in European Americans. This SNP also accounted for most of the evidence observed in the admixture analysis on chromosome 6. Despite these encouraging results, susceptibility loci for hypertension have been exceptionally difficult to localize and confirmation by independent studies will be necessary to establish these findings.	[Zhu, Xiaofeng] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Cooper, Richard S.] Loyola Univ, Stritch Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA	Case Western Reserve University; Loyola University Chicago	Zhu, XF (corresponding author), Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	xzhu1@darwin.case.edu	Zhu, Xiaofeng/O-6874-2019	Zhu, Xiaofeng/0000-0003-0037-411X	National Human Genome Research Institute [HG003054]; National Heart, Lung, and Blood Institute [HL074166]; Donald W. Reynolds Clinical Cardiovascular Center at UT Southwestern, Dallas, TX; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074166] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003054] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Donald W. Reynolds Clinical Cardiovascular Center at UT Southwestern, Dallas, TX; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants (HG003054) from the National Human Genome Research Institute, (HL074166) from the National Heart, Lung, and Blood Institute, the Donald W. Reynolds Clinical Cardiovascular Center at UT Southwestern, Dallas, TX.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Bouzekri N, 2004, EUR J HUM GENET, V12, P460, DOI 10.1038/sj.ejhg.5201166; Cooper RS, 1996, ANN EPIDEMIOL, V6, P173, DOI 10.1016/1047-2797(96)00009-9; CURRAN JE, 2007, AM J HUM GENET, P62; Darvasi A, 2005, NAT GENET, V37, P118, DOI 10.1038/ng0205-118; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Falush D, 2003, GENETICS, V164, P1567; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Halder Indrani, 2003, Human Genomics, V1, P52; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; Montana G, 2004, AM J HUM GENET, V75, P771, DOI 10.1086/425281; Nakajima T, 2004, AM J HUM GENET, V74, P898, DOI 10.1086/420793; Nievergelt CM, 2005, CURR HYPERTENS REP, V7, P31, DOI 10.1007/s11906-005-0052-x; Oparil S, 2003, ANN INTERN MED, V139, P761, DOI 10.7326/0003-4819-139-9-200311040-00011; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pitari G, 2000, FEBS LETT, V483, P149, DOI 10.1016/S0014-5793(00)02110-4; Pritchard JK, 2000, GENETICS, V155, P945; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Samani NJ, 2003, AM J HYPERTENS, V16, P167, DOI 10.1016/S0895-7061(02)03244-2; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Smith MW, 2005, NAT REV GENET, V6, P623, DOI 10.1038/nrg1657; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Tang H, 2006, NAT GENET, V38, P13, DOI 10.1038/ng0106-13; Tang H, 2006, AM J HUM GENET, V79, P1, DOI 10.1086/504302; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; Tian C, 2006, AM J HUM GENET, V79, P640, DOI 10.1086/507954; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WARD R, 1990, HYPERTENSION PATHOPH, P81; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhang C, 2004, GENET EPIDEMIOL, V27, P225, DOI 10.1002/gepi.20021; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510; Zhu XF, 2004, AM J HUM GENET, V74, P1136, DOI 10.1086/421329; Zhu XF, 2001, AM J HUM GENET, V68, P1139, DOI 10.1086/320104; Zhu XF, 2006, HUM GENET, V120, P431, DOI 10.1007/s00439-006-0224-z	51	44	48	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1244	10.1371/journal.pone.0001244	http://dx.doi.org/10.1371/journal.pone.0001244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043751	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459300025
J	Lehnert, S; Gotz, C; Kartarius, S; Schafer, B; Montenarh, M				Lehnert, S.; Goetz, C.; Kartarius, S.; Schaefer, B.; Montenarh, M.			Protein kinase CK2 interacts with the splicing factor hPrp3p	ONCOGENE			English	Article						protein kinase CK2; hPrp3p; splicing factor; phosphorylation; protein -protein interaction	CARBOXYL-TERMINAL DOMAIN; RNA-POLYMERASE-II; DOMINANT RETINITIS-PIGMENTOSA; BETA-SUBUNIT; CASEIN KINASE-2; CYCLIN-H; PHOSPHORYLATION; EXPRESSION; SUBSTRATE; BINDING	Numerous signalling pathways in cells are influenced by the ubiquitous Ser/ Thr protein kinase CK2. Protein kinase CK2 is composed of two regulatory beta-subunits and two catalytic alpha- or alpha'- subunits. Several of the known CK2 substrates are proteins known to regulate transcriptional events. Here, we describe that protein kinase CK2 interacts with the splicing factor hPrp3p, which is important for the assembly of the spliceosome. In a two-hybrid screen hPrp3p is exclusively bound to the catalytic alpha- or alpha'- subunits of CK2 but not to the regulatory beta-subunit. The interaction was confirmed by coimmunoprecipitation experiments in vitro and in vivo. Moreover, both proteins colocalized in nuclear speckles which is typical for splicing factor compartments within the nucleus. Phosphorylation experiments revealed that hPrp3p is also a substrate of protein kinase CK2. The main phosphorylation site was mapped to C- terminal residues. In vitro and in vivo splicing assays showed that the splicing activity is significantly influenced by the CK2 - hPrp3p interaction. Thus, these data showed that CK2 is involved in the regulation of RNA processing.	[Lehnert, S.; Goetz, C.; Kartarius, S.; Schaefer, B.; Montenarh, M.] Univ Saarland, D-66421 Homburg, Germany	Saarland University	Montenarh, M (corresponding author), Univ Saarland, Gebaude 44, D-66421 Homburg, Germany.	Montenarh@uks.eu	Montenarh, Mathias/AAB-6689-2020					Bosc DG, 2000, J BIOL CHEM, V275, P14295, DOI 10.1074/jbc.275.19.14295; BURNETT G, 1954, J BIOL CHEM, V211, P969; Cabrejos ME, 2004, J CELL BIOCHEM, V93, P2, DOI 10.1002/jcb.20209; Chakarova CF, 2002, HUM MOL GENET, V11, P87, DOI 10.1093/hmg/11.1.87; Faust M, 1999, FEBS LETT, V462, P51, DOI 10.1016/S0014-5793(99)01492-1; Faust M, 2002, BIOCHEM BIOPH RES CO, V269, P6; Gonzalez-Santos JM, 2002, J BIOL CHEM, V277, P23764, DOI 10.1074/jbc.M111461200; Gotz C, 2005, MOL CELL BIOCHEM, V274, P181, DOI 10.1007/s11010-005-2950-2; GRANKOWSKI N, 1991, EUR J BIOCHEM, V198, P25, DOI 10.1111/j.1432-1033.1991.tb15982.x; Guerra B, 1998, ACTA CRYSTALLOGR D, V54, P143, DOI 10.1107/S0907444997010184; Guerra B, 1999, FEBS LETT, V462, P353, DOI 10.1016/S0014-5793(99)01553-7; Guerra B, 1997, ONCOGENE, V14, P2683, DOI 10.1038/sj.onc.1201112; Jain N, 1996, J BIOL CHEM, V271, P13530, DOI 10.1074/jbc.271.23.13530; Krempler A, 2005, CELL MOL LIFE SCI, V62, P1379, DOI 10.1007/s00018-005-5023-5; KUENZEL EA, 1985, P NATL ACAD SCI USA, V82, P737, DOI 10.1073/pnas.82.3.737; Li MF, 1999, J MOL BIOL, V293, P1067, DOI 10.1006/jmbi.1999.3207; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Maita H, 2004, EXP CELL RES, V300, P283, DOI 10.1016/j.yexcr.2004.07.029; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1994, BIOCHEMISTRY-US, V33, P4336, DOI 10.1021/bi00180a030; Messenger MM, 2002, J BIOL CHEM, V277, P23054, DOI 10.1074/jbc.M200111200; Palancade B, 2002, J BIOL CHEM, V277, P36061, DOI 10.1074/jbc.M205192200; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; Penner CG, 1997, J CELL BIOCHEM, V64, P525; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Schneider E, 2002, ONCOGENE, V21, P5031, DOI 10.1038/sj.onc.1205690; SCHNEIDER HR, 1988, BIOCHEM BIOPH RES CO, V156, P1390, DOI 10.1016/S0006-291X(88)80786-1; Schuster N, 1999, FEBS LETT, V447, P160, DOI 10.1016/S0014-5793(99)00273-2; SHI Y, 1994, P NATL ACAD SCI USA, V91, P2767, DOI 10.1073/pnas.91.7.2767; STALTER G, 1994, BIOCHEM BIOPH RES CO, V202, P141, DOI 10.1006/bbrc.1994.1904; Trembley JH, 2005, MOL CELL BIOL, V25, P1446, DOI 10.1128/MCB.25.4.1446-1457.2005; Trembley JH, 2003, J BIOL CHEM, V278, P2265, DOI 10.1074/jbc.M207518200	35	18	19	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2008	27	17					2390	2400		10.1038/sj.onc.1210882	http://dx.doi.org/10.1038/sj.onc.1210882			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286KN	18026141				2022-12-25	WOS:000254844900004
J	Etxeberria, A; Aivar, P; Rodriguez-Alfaro, JA; Alaimo, A; Villace, P; Gomez-Posada, JC; Areso, P; Villarroel, A				Etxeberria, Ainhoa; Aivar, Paloma; Rodriguez-Alfaro, Jose Angel; Alaimo, Alessandro; Villace, Patricia; Gomez-Posada, Juan Camilo; Areso, Pilar; Villarroel, Alvaro			Calmodulin regulates the trafficking of KCNQ2 potassium channels	FASEB JOURNAL			English	Article						channelolpathies; epilepsy; BFNC; Kv7; benign; familial neonatal convulsions	SURFACE EXPRESSION; K+ CHANNELS; I-KS; MECHANISM; SUBUNIT; DETERMINANTS; EXCITABILITY; KCNQ2/KCNQ3; SUPPRESSION; NEUROGRANIN	Voltage-dependent potassium KCNQ2 (Kv7.2) channels play a prominent role in the control of neuronal excitability. These channels must associate with calmodulin to function correctly and, indeed, a mutation (R353G) that impairs this association provokes the onset of a form of human neonatal epilepsy known as benign familial neonatal convulsions (BFNC). We show here that perturbation of calmodulin binding leads to endoplasmic reticulum (ER) retention of KCNQ2, reducing the number of channels that reach the plasma membrane. Interestingly, elevating the expression of calmodulin in the BFNC mutant partially restores the intracellular distribution of the KCNQ channel. In contrast, overexpression of a Ca2+-binding incompetent calmodulin or sequestering of calmodulin promotes the retention of wild-type channels in the ER. Thus, a direct interaction with Ca2+-calmodulin appears to be critical for the correct activity of KCNQ2 potassium channels as it controls the channels' exit from the ER.	[Etxeberria, Ainhoa; Aivar, Paloma; Rodriguez-Alfaro, Jose Angel; Alaimo, Alessandro; Villace, Patricia; Gomez-Posada, Juan Camilo; Villarroel, Alvaro] Univ Basque Country, CSIC, EHU, Unidad Biofis, Leioa 48940, Spain; [Areso, Pilar] Univ Basque Country, UPV EHU, Dept Farmacol, Leioa 48940, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country	Villarroel, A (corresponding author), Univ Basque Country, CSIC, EHU, Unidad Biofis, Barrio Sarriena S-N, Leioa 48940, Spain.	gbxvimua@lg.ehu.es	Messier, Claude/A-2322-2008; Alaimo, Alessandro/C-6334-2016; Villarroel, Alvaro/H-5580-2015	Messier, Claude/0000-0002-4791-1763; Alaimo, Alessandro/0000-0002-5888-6268; 				BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; Chung HJ, 2006, P NATL ACAD SCI USA, V103, P8870, DOI 10.1073/pnas.0603376103; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Etxeberria A, 2004, J NEUROSCI, V24, P9146, DOI 10.1523/JNEUROSCI.3194-04.2004; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Heusser K, 2005, CURR OPIN NEUROBIOL, V15, P364, DOI 10.1016/j.conb.2005.04.001; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Lee WS, 2003, J BIOL CHEM, V278, P25940, DOI 10.1074/jbc.M302091200; MANDERS EMM, 1992, J CELL SCI, V103, P857; Martire M, 2004, J NEUROSCI, V24, P592, DOI 10.1523/JNEUROSCI.3143-03.2004; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; NeunerJehle M, 1996, BRAIN RES, V733, P149, DOI 10.1016/0006-8993(96)00786-X; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Peretz A, 2005, MOL PHARMACOL, V67, P1053, DOI 10.1124/mol.104.007112; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Richards MC, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013938; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Schwake M, 2006, J NEUROSCI, V26, P3757, DOI 10.1523/JNEUROSCI.5017-05.2006; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Schwarz JR, 2006, J PHYSIOL-LONDON, V573, P17, DOI 10.1113/jphysiol.2006.106815; Shahidullah M, 2005, P NATL ACAD SCI USA, V102, P16454, DOI 10.1073/pnas.0503966102; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Soldovieri MV, 2006, J BIOL CHEM, V281, P418, DOI 10.1074/jbc.M510980200; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Tran QK, 2003, J BIOL CHEM, V278, P24247, DOI 10.1074/jbc.C300165200; Villace P, 2004, NUCLEIC ACIDS RES, V32, P2411, DOI 10.1093/nar/gkh552; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200; Zhabotinsky AM, 2006, J NEUROSCI, V26, P7337, DOI 10.1523/JNEUROSCI.0729-06.2006	40	83	84	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2008	22	4					1135	1143		10.1096/fj.07-9712com	http://dx.doi.org/10.1096/fj.07-9712com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	17993630				2022-12-25	WOS:000254581000019
J	Loveridge, CJ; MacDonald, ADH; Thoms, HC; Dunlop, MG; Stark, LA				Loveridge, C. J.; MacDonald, A. D. H.; Thoms, H. C.; Dunlop, M. G.; Stark, L. A.			The proapoptotic effects of sulindac, sulindac sulfone and indomethacin are mediated by nucleolar translocation of the RelA(p65) subunit of NF-kappa B	ONCOGENE			English	Article						chemoprevention; colon cancer; aspirin; cell adhesion; nucleolus; cell death	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TRANSCRIPTIONAL REGULATION; EXPRESSION; APOPTOSIS; CHEMOPREVENTION; ICAM-1; CELLS; GENE; RELA	Understanding the mechanisms that underlie the antitumour activity of non-steroidal anti-inflammatory drugs (NSAIDs) against colorectal cancer will allow the development of more effective and specific chemopreventative agents. Modulation of the NF-kappa B pathway has been implicated as a key effector of the antitumour effect of aspirin, but the effects of non-aspirin NSAIDs on this pathway have yet to be fully defined. Here, we demonstrate that sulindac, sulindac sulfone and indomethacin activate the NF-kappa B pathway in colorectal cancer cells, as determined by western blot analysis of cytoplasmic levels of I kappa B alpha and immunocytochemical analysis of nuclear NF-kappa B/RelA. Furthermore, we show that all of these NSAIDs induce nucleolar translocation of the RelA subunit of NF-kappa B. Using RelA deleted for the previously described nucleolar localization signal, we demonstrate that this response is causally involved in the apoptotic effects of these agents. Finally, we demonstrate that NSAID-mediated nucleolar translocation of RelA is associated with downregulation of NF-kappa B-driven transcription and of the NF-kappa B target gene, ICAM-1. These data identify nucleolar translocation of RelA and the associated repression of the NF-kappa B-driven transcription as a central molecular mechanism of NSAID-mediated growth inhibition and apoptosis. As well as providing new understanding of the molecular determinants of RelA function, these findings also have relevance to the development of novel chemotherapeutic and chemopreventative agents.	Univ Edinburgh, Canc Res Ctr, Colon Canc Genet Grp, Sch Clin & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Stark, LA (corresponding author), Univ Edinburgh, Edinburgh Canc Res Ctr, Colon Canc Genet Grp, MRC,Human Genet Unit,Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland.	lesley.stark@hgu.mrc.ac.uk	Dunlop, Malcolm G/F-1973-2011	Dunlop, Malcolm G/0000-0002-3033-5851; Loveridge, Carolyn/0000-0002-6237-8661	Cancer Research UK [C48/A6361, C20658/A6656, C348/A3758] Funding Source: Medline; Medical Research Council [MC_U127527198] Funding Source: Medline; MRC [MC_U127527198] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BRANDLI DW, 1991, CLIN PHARMACOL THER, V50, P650, DOI 10.1038/clpt.1991.203; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Din FVN, 2004, BRIT J CANCER, V91, P381, DOI 10.1038/sj.bjc.6601913; DIPPOLD W, 1993, GUT, V34, P1593, DOI 10.1136/gut.34.11.1593; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Gardner SH, 2004, BRIT J CANCER, V91, P153, DOI 10.1038/sj.bjc.6601901; Grau MV, 2006, BASIC CLIN PHARMACOL, V98, P281, DOI 10.1111/j.1742-7843.2006.pto_294.x; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; Perkins ND, 2004, TRENDS CELL BIOL, V14, P64, DOI 10.1016/j.tcb.2003.12.004; Smith ML, 2000, EUR J CANCER, V36, P664, DOI 10.1016/S0959-8049(99)00333-0; Stark LA, 2005, MOL CELL BIOL, V25, P5985, DOI 10.1128/MCB.25.14.5985-6004.2005; Stark LA, 2001, FASEB J, V15, P1273, DOI 10.1096/fj.00-0529fje; Stark LA, 2007, CARCINOGENESIS, V28, P968, DOI 10.1093/carcin/bgl220; Sun YJ, 2005, MOL CANCER THER, V4, P51; Thoms HC, 2007, CANCER RES, V67, P1660, DOI 10.1158/0008-5472.CAN-06-1038; Vainer B, 2006, SCAND J GASTROENTERO, V41, P318, DOI 10.1080/00365520510024241; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407	19	48	48	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2008	27	18					2648	2655		10.1038/sj.onc.1210891	http://dx.doi.org/10.1038/sj.onc.1210891			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	289LW	18059344				2022-12-25	WOS:000255057000014
J	Roze, E; Betuing, S; Deyts, C; Marcon, E; Brami-Cherrier, K; Pages, C; Humbert, S; Merienne, K; Caboche, J				Roze, Emmanuel; Betuing, Sandrine; Deyts, Carole; Marcon, Estelle; Brami-Cherrier, Karen; Pages, Christiane; Humbert, Sandrine; Merienne, Karine; Caboche, Jocelyne			Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death	FASEB JOURNAL			English	Article						Huntington's disease; polyglutamine; histone modifications; nucleosomal response; c-Fos	SIGNAL-REGULATED KINASE; EARLY GENE INDUCTION; HISTONE H3 PHOSPHORYLATION; DISEASE TRANSGENIC MICE; MOUSE MODEL; STATUS EPILEPTICUS; BRAIN; MSK1; EXPRESSION; NEURONS	Huntington's disease (HD) is a neurodegenerative disorder due to an abnormal polyglutamine expansion in the N-terminal region of huntingtin protein (Exp-Htt). This expansion causes protein aggregation. and neuronal dysfunction and death. Transcriptional dysregulation due to Exp-Htt participates in neuronal death in HD. Here, using the R6/2 transgenic mouse model of HD, we identified a new molecular alteration that could account for gene dysregulation in these mice. Despite a nuclear activation of the mitogen activated protein ldnase/extracellular regulated kinase (ERK) along with Elk-1 and cAMP responsive element binding, two transcription factors involved in c-Fos transcription, we failed to detect any histone H3 phosphorylation, which is expected after nuclear ERK activation. Accordingly, we found in the striatum of these mice a deficiency of mitogen- and stress-activated kinase-1 (MSK-1), a kinase downstream ERR, critically involved in H3 phosphorylation and c-Fos induction. We extended this observation to Exp-Htt-expressing striatal neurons and postmortem brains of HD patients. In vitro, knocking out MSK 1 expression potentiated Exp-Htt induced striatal death. Its overexpression induced H3 phosphorylation and c-Fos expression and totally protected against striatal neurodegeneration induced by Exp-Htt. We propose that MSK 1 deficiency is involved in transcriptional dysregulation and striatal degeneration. Restoration of its expression and activity may be a new therapeutic target in HD.	[Roze, Emmanuel; Betuing, Sandrine; Deyts, Carole; Marcon, Estelle; Pages, Christiane; Caboche, Jocelyne] Univ Paris 06, CNRS, UMR 7102, F-75005 Paris, France; [Roze, Emmanuel] Hop St Antoine, Assitance Publ Hop Paris, Serv Neurol, F-75571 Paris, France; [Brami-Cherrier, Karen] Univ Paris 06, INSERM, UMRS 839, F-75005 Paris, France; [Merienne, Karine] CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, Dept Mol Pathol,U596,UMR 7104, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Caboche, J (corresponding author), Univ Paris 06, CNRS, UMR 7102, 9 Quai St, F-75005 Paris, France.	jocelyne.caboche@snv.jussieu.fr	Betuing, Sandrine/X-2179-2018; brami-cherrier, karen/I-9263-2014; Humbert, Sandrine/S-2981-2016; Longo, Kenneth A/A-5631-2010; Betuing, Sandrine/F-2967-2013; Betuing, Sandrine/X-1957-2019	brami-cherrier, karen/0000-0002-3009-3821; Merienne, Karine/0000-0003-2549-2315; Humbert, Sandrine/0000-0002-9501-2658				ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Apostol BL, 2006, HUM MOL GENET, V15, P273, DOI 10.1093/hmg/ddi443; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; Benchoua A, 2006, MOL BIOL CELL, V17, P1652, DOI 10.1091/mbc.E05-07-0607; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; Brami-Cherrier K, 2005, J NEUROSCI, V25, P11444, DOI 10.1523/JNEUROSCI.1711-05.2005; Brami-Cherrier K, 2007, J NEUROCHEM, V101, P697, DOI 10.1111/j.1471-4159.2006.04352.x; Charvin D, 2005, P NATL ACAD SCI USA, V102, P12218, DOI 10.1073/pnas.0502698102; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Crosio C, 2003, J CELL SCI, V116, P4905, DOI 10.1242/jcs.00804; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Drobic B, 2004, CANCER RES, V64, P9076, DOI 10.1158/0008-5472.CAN-04-2369; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Garcia M, 2002, J NEUROSCI, V22, P2174, DOI 10.1523/JNEUROSCI.22-06-02174.2002; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Heffron D, 2005, MOL BRAIN RES, V136, P134, DOI 10.1016/j.molbrainres.2005.01.014; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Huang YF, 2002, J NEUROSCI, V22, P8422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Lievens JC, 2002, MOL CELL NEUROSCI, V20, P638, DOI 10.1006/mcne.2002.1152; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Markou T, 2002, BIOCHEM J, V365, P757, DOI 10.1042/BJ20011828; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Obrietan K, 2004, J NEUROSCI, V24, P791, DOI 10.1523/JNEUROSCI.3493-03.2004; Putignano E, 2007, NEURON, V53, P747, DOI 10.1016/j.neuron.2007.02.007; Quinn N, 1998, J NEUROL, V245, P709, DOI 10.1007/s004150050272; Rakhit S, 2005, MOL PHARMACOL, V67, P1158, DOI 10.1124/mol.104.005447; ROBERTSON LM, 1995, NEURON, V14, P241, DOI 10.1016/0896-6273(95)90282-1; Ryu H, 2006, P NATL ACAD SCI USA, V103, P19176, DOI 10.1073/pnas.0606373103; Sadri-Vakili G, 2007, HUM MOL GENET, V16, P1293, DOI 10.1093/hmg/ddm078; Sgambato V, 1998, J NEUROSCI, V18, P214; Sgambato V, 1998, J NEUROSCI, V18, P8814; Sng JCG, 2006, EUR J NEUROSCI, V23, P1269, DOI 10.1111/j.1460-9568.2006.04641.x; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Spektor BS, 2002, MOL BRAIN RES, V102, P118, DOI 10.1016/S0169-328X(02)00216-4; Stack EC, 2007, HUM MOL GENET, V16, P1164, DOI 10.1093/hmg/ddm064; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Valjent E, 2000, J NEUROSCI, V20, P8701; Vanhoutte P, 1999, MOL CELL BIOL, V19, P136; Vanhoutte P, 2001, J BIOL CHEM, V276, P5189, DOI 10.1074/jbc.M006678200; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Yu M, 2003, J PHYSIOL-LONDON, V546, P327, DOI 10.1113/jphysiol.2002.034223; Zhang JH, 2002, NAT GENET, V30, P416, DOI 10.1038/ng859; Zhong SP, 2000, J BIOL CHEM, V275, P20980, DOI 10.1074/jbc.M909934199	51	71	77	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2008	22	4					1083	1093		10.1096/fj.07-9814	http://dx.doi.org/10.1096/fj.07-9814			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	18029446				2022-12-25	WOS:000254581000014
J	Grubina, R; Basu, S; Tiso, M; Kim-Shapiro, DB; Gladwin, MT				Grubina, Rozalina; Basu, Swati; Tiso, Mauro; Kim-Shapiro, Daniel B.; Gladwin, Mark T.			Nitrite reductase activity of hemoglobin S (sickle) provides insight into contributions of heme redox potential versus ligand affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION; CELL HEMOGLOBIN; OXYGEN-BINDING; OXIDE; DEOXYHEMOGLOBIN; NO; OXIDATION; BLOOD; POLYMERIZATION; KINETICS	Hemoglobin A (HbA) is an allosterically regulated nitrite reductase that reduces nitrite to NO under physiological hypoxia. The efficiency of this reaction is modulated by two intrinsic and opposing properties: availability of unliganded ferrous hemes and R-state character of the hemoglobin tetramer. Nitrite is reduced by deoxygenated ferrous hemes, such that heme deoxygenation increases the rate of NO generation. However, heme reactivity with nitrite, represented by its bimolecular rate constant, is greatest when the tetramer is in the R quaternary state. The mechanism underlying the higher reactivity of R-state hemes remains elusive. It can be due to the lower heme redox potential of R-state ferrous hemes or could reflect the high ligand affinity geometry of R-state tetramers that facilitates nitrite binding. We evaluated the nitrite reductase activity of unpolymerized sickle hemoglobin (HbS), whose oxygen affinity and cooperativity profile are equal to those of HbA, but whose heme iron has a lower redox potential. We now report that HbS exhibits allosteric nitrite reductase activity with competing proton and redox Bohr effects. In addition, we found that solution phase HbS reduces nitrite to NO significantly faster than HbA, supporting the thesis that heme electronics (i.e. redox potential) contributes to the high reactivity of R-state deoxy-hemes with nitrite. From a pathophysiological standpoint, under conditions where HbS polymers form, the rate of nitrite reduction is reduced compared with HbA and solution-phase HbS, indicating that HbS polymers reduce nitrite more slowly.	[Grubina, Rozalina; Tiso, Mauro; Gladwin, Mark T.] NHLBI, Vasc Med Branch, Bethesda, MD 20892 USA; [Gladwin, Mark T.] Natl Inst Hlth, Ctr Clin, Dept Crit Care Med, Bethesda, MD 20892 USA; [Grubina, Rozalina] Howard Hughes Med Inst, Natl Inst Res Scholars Program, Bethesda, MD 20814 USA; [Basu, Swati; Kim-Shapiro, Daniel B.] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Howard Hughes Medical Institute; Wake Forest University	Gladwin, MT (corresponding author), CRC, Bldg 10,Rm 5-5140,10 Ctr Dr, Bethesda, MD 20892 USA.	mgladwin@nih.gov	Kim-Shapiro, Daniel/HGA-2682-2022		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058091, R37HL058091, K02HL078706, R29HL058091] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NHLBI NIH HHS [HL078706, HL58091, R37 HL058091] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLEN D W, 1954, Rev Hematol, V9, P155; ANTONINI E, 1964, J BIOL CHEM, V239, P907; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; Blankman JI, 2000, BIOCHEMISTRY-US, V39, P14806, DOI 10.1021/bi000731b; Bohr C, 1904, SKAND ARCH PHYSIOL, V16, P402, DOI 10.1111/j.1748-1716.1904.tb01382.x; Bonaventura C, 2002, J BIOL CHEM, V277, P14557, DOI 10.1074/jbc.M107658200; Bonaventura C, 2007, IUBMB LIFE, V59, P498, DOI 10.1080/15216540601188546; Brooks J, 1937, PROC R SOC SER B-BIO, V123, P368, DOI 10.1098/rspb.1937.0057; BRUNORI M, 1965, J BIOL CHEM, V240, P3317; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; DeYoung A, 1981, Methods Enzymol, V76, P792; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Eaton W A, 1990, Adv Protein Chem, V40, P63, DOI 10.1016/S0065-3233(08)60287-9; EATON WA, 1987, BLOOD, V70, P1245; FAULKNER KM, 1995, J BIOL CHEM, V270, P13604, DOI 10.1074/jbc.270.23.13604; Gamgee A, 1868, PHILOS T ROY SOC LON, V158, P589, DOI DOI 10.1098/RSTL.1868.0025; GILL SJ, 1979, J MOL BIOL, V130, P175, DOI 10.1016/0022-2836(79)90425-X; Gladwin MT, 2006, AM J PHYSIOL-HEART C, V291, pH2026, DOI 10.1152/ajpheart.00407.2006; Gladwin MT, 2005, NAT CHEM BIOL, V1, P308, DOI 10.1038/nchembio1105-308; Grubina R, 2007, J BIOL CHEM, V282, P12916, DOI 10.1074/jbc.M700546200; Haldane J, 1901, J Hyg (Lond), V1, P115; Harrington JP, 1998, COMP BIOCHEM PHYS B, V119, P305, DOI 10.1016/S0305-0491(97)00330-1; Hataishi R, 2006, AM J PHYSIOL-HEART C, V291, pH379, DOI 10.1152/ajpheart.01172.2005; HEBBEL RP, 1988, P NATL ACAD SCI USA, V85, P237, DOI 10.1073/pnas.85.1.237; HOFFMAN BM, 1976, P NATL ACAD SCI USA, V73, P800, DOI 10.1073/pnas.73.3.800; HOFRICHTER J, 1976, P NATL ACAD SCI USA, V73, P3035, DOI 10.1073/pnas.73.9.3035; Hsu LL, 2007, BLOOD, V109, P3088, DOI 10.1182/blood-2006-08-039438; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; Hunter CJ, 2004, NAT MED, V10, P1122, DOI 10.1038/nm1109; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; Kim-Shapiro DB, 2004, FREE RADICAL BIO MED, V36, P402, DOI 10.1016/j.freeradbiomed.2003.10.030; Kozlov AV, 2005, ANTIOXID REDOX SIGN, V7, P515, DOI 10.1089/ars.2005.7.515; MIZUKAMI H, 1977, P SOC EXP BIOL MED, V154, P304, DOI 10.3181/00379727-154-39659; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; NOGUCHI CT, 1983, J CLIN INVEST, V72, P846, DOI 10.1172/JCI111055; NOGUCHI CT, 1985, ANNU REV BIOPHYS BIO, V14, P239, DOI 10.1146/annurev.biophys.14.1.239; NOGUCHI CT, 1984, BIOPHYS J, V45, P1153, DOI 10.1016/S0006-3495(84)84263-0; PAPA S, 1986, METHOD ENZYMOL, V126, P331; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; PENNELLY RR, 1978, BIOCH CLIN ASPECTS H, P401; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; Rassaf T, 2007, CIRC RES, V100, P1749, DOI 10.1161/CIRCRESAHA.107.152488; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Roche CJ, 2006, J BIOL CHEM, V281, P36874, DOI 10.1074/jbc.M603914200; ROSSIBERNARDI L, 1975, CLIN CHEM, V21, P1747; SEAKINS M, 1973, J CLIN INVEST, V52, P422, DOI 10.1172/JCI107199; SHAPIRO DB, 1994, BIOCHEM BIOPH RES CO, V205, P154, DOI 10.1006/bbrc.1994.2643; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; SINGER K, 1953, BLOOD, V8, P1008, DOI 10.1182/blood.V8.11.1008.1008; SUNSHINE HR, 1979, J MOL BIOL, V133, P435, DOI 10.1016/0022-2836(79)90402-9; SUNSHINE HR, 1982, J MOL BIOL, V158, P251, DOI 10.1016/0022-2836(82)90432-6; Taboy CH, 2000, J BIOL CHEM, V275, P39048, DOI 10.1074/jbc.M004547200; TAYLOR JOHN FULLER, 1939, JOUR BIOL CHEM, V131, P649; Tsuchiya K, 2005, AM J PHYSIOL-HEART C, V288, pH2163, DOI 10.1152/ajpheart.00525.2004; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; WINSLOW RM, 1978, P S CLIN BIOCH ASP H	60	45	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3628	3638		10.1074/jbc.M705222200	http://dx.doi.org/10.1074/jbc.M705222200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056715	hybrid			2022-12-25	WOS:000253083000068
J	Lee, J; Seo, SR; Wonum, J; Park, J; Oh, Y; Chung, KC				Lee, Jung; Seo, Su Ryeon; Wonum, Ji; Park, Joongkyu; Oh, Yohan; Chung, Kwang Chul			NF-kappa B-inducing kinase phosphorylates and blocks the degradation of down syndrome candidate region 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCINEURIN-INTERACTING PROTEIN-1; NEURONAL CELL-DEATH; ALZHEIMERS-DISEASE; DSCR1 ADAPT78; SIGNALING PATHWAYS; ENDOTHELIAL-CELLS; GENE-EXPRESSION; BETA; INHIBITOR; ALPHA	Down syndrome, the most frequent genetic disorder, is characterized by an extra copy of all or part of chromosome 21. Down syndrome candidate region 1 (DSCR1) gene, which is located on chromosome 21, is highly expressed in the brain of Down syndrome patients. Although its cellular function remains unknown, DSCR1 expression is linked to inflammation, angiogenesis, and cardiac development. To explore the functional role of DSCR1 and the regulation of its expression, we searched for novel DSCR1-interacting proteins using a yeast two-hybrid assay. Using a human fetal brain library, we found that DSCR1 interacts with NF-kappa B-inducing kinase (NIK). Furthermore, we demonstrate that NIK specifically interacts with and phosphorylates the C-terminal region of DSCR1 in immortalized hippocampal cells as well as in primary cortical neurons. This NIK-mediated phosphorylation of DSCR1 increases its protein stability and blocks its proteasomal degradation, the effects of which lead to an increase in soluble and insoluble DSCR1 levels. We show that an increase in insoluble DSCR1 levels results in the formation of cytosolic aggregates. Interestingly, we found that whereas the formation of these inclusions does not significantly alter the viability of neuronal cells, the overexpression of DSCR1 without the formation of aggregates is cytotoxic.	[Lee, Jung; Wonum, Ji; Park, Joongkyu; Oh, Yohan; Chung, Kwang Chul] Yonsei Univ, Coll Sci, Dept Biol, Seoul 120749, South Korea; [Seo, Su Ryeon] Kangwon Natl Univ, Sch Biosci & Biotechnol, Dept Mol Biosci, Chunchon 200701, South Korea	Yonsei University; Kangwon National University	Chung, KC (corresponding author), Yonsei Univ, Coll Sci, Dept Biol, Shinchon Dong 134, Seoul 120749, South Korea.	kchung@yonsei.ac.kr	Oh, Yohan/C-9107-2013; Park, Joongkyu/ADZ-1994-2022	Oh, Yohan/0000-0002-9249-8664; Park, Joongkyu/0000-0002-5675-2872				Abbasi S, 2006, J BIOL CHEM, V281, P7717, DOI 10.1074/jbc.M510775200; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Birbach A, 2004, J CELL SCI, V117, P3615, DOI 10.1242/jcs.01224; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cho YJ, 2005, ARCH BIOCHEM BIOPHYS, V439, P121, DOI 10.1016/j.abb.2005.05.002; Cook CN, 2005, J ALZHEIMERS DIS, V8, P63; COYLE JT, 1986, BRAIN RES BULL, V16, P773, DOI 10.1016/0361-9230(86)90074-2; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Davies KJA, 2001, BIOFACTORS, V15, P91, DOI 10.1002/biof.5520150208; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Epstein C J, 1995, Prog Clin Biol Res, V393, P241; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; FRANTZ B, 1994, EMBO J, V13, P861, DOI 10.1002/j.1460-2075.1994.tb06329.x; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Harris CD, 2005, CELL MOL LIFE SCI, V62, P2477, DOI 10.1007/s00018-005-5085-4; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Kim YS, 2006, J BIOL CHEM, V281, P39051, DOI 10.1074/jbc.M604659200; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lee EJ, 2007, MOL CELL NEUROSCI, V35, P585, DOI 10.1016/j.mcn.2007.05.003; Lilienbaum A, 2003, MOL CELL BIOL, V23, P2680, DOI 10.1128/MCB.23.8.2680-2698.2003; Lin HY, 2003, FREE RADICAL BIO MED, V35, P528, DOI 10.1016/S0891-5849(03)00358-7; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Lukiw WJ, 2000, NEUROCHEM RES, V25, P1173, DOI 10.1023/A:1007627725251; Luo C, 1996, P NATL ACAD SCI USA, V93, P8907, DOI 10.1073/pnas.93.17.8907; MANN DMA, 1987, J NEUROL SCI, V80, P79, DOI 10.1016/0022-510X(87)90223-1; Min YK, 2003, J NEUROSCI RES, V71, P689, DOI 10.1002/jnr.10520; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Pfister SC, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-24; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Ryeom S, 2003, NAT IMMUNOL, V4, P874, DOI 10.1038/ni966; STEFFAN NM, 1995, J IMMUNOL, V155, P4685; Suzuki K, 2001, BIOCHEM BIOPH RES CO, V285, P991, DOI 10.1006/bbrc.2001.5263; Tanzi RE, 1996, NAT MED, V2, P31, DOI 10.1038/nm0196-31; Toyoda A, 2002, GENOME RES, V12, P1323, DOI 10.1101/gr.153702; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WISNIEWSKI KE, 1984, NEW ENGL J MED, V311, P1187; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yao YG, 2004, BIOCHEM BIOPH RES CO, V321, P648, DOI 10.1016/j.bbrc.2004.06.176; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zhu J, 2000, CELL MOL LIFE SCI, V57, P411, DOI 10.1007/PL00000703	49	35	35	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3392	3400		10.1074/jbc.M706707200	http://dx.doi.org/10.1074/jbc.M706707200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056702	hybrid			2022-12-25	WOS:000253083000044
J	Ma, J; Yan, RL; Zu, X; Cheng, JM; Rao, K; Liao, DF; Cao, DL				Ma, Jun; Yan, Ruilan; Zu, Xuyu; Cheng, Ji-Ming; Rao, Krishna; Liao, Duan-Fang; Cao, Deliang			Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN ALDOSE REDUCTASE; PROSTATE-CANCER; SIGNAL-TRANSDUCTION; GROWTH-INHIBITION; SYNTHASE; OVEREXPRESSION; EXPRESSION; CARCINOMA; GENE	Recent studies have demonstrated that aldo-keto reductase family 1 B10 (AKR1B10), a novel protein overexpressed in human hepatocellular carcinoma and non-small cell lung carcinoma, may facilitate cancer cell growth by detoxifying intracellular reactive carbonyls. This study presents a novel function of AKR1B10 in tumorigenic mammary epithelial cells (RAO-3), regulating fatty acid synthesis. In RAO-3 cells, Sephacryl-S 300 gel filtration and DEAE-Sepharose ion exchange chromatography demonstrated that AKR1B10 exists in two distinct forms, monomers (similar to 40 kDa) bound to DEAE-Sepharose column and protein complexes (similar to 300 kDa) remaining in flow-through. Co-immunoprecipitation with AKR1B10 antibody and protein mass spectrometry analysis identified that AKR1B10 associates with acetyl-CoA carboxylase-alpha (ACCA), arate-limiting enzyme of denovo fatty acid synthesis. This association between AKR1B10 and ACCA proteins was further confirmed by co-immunoprecipitation with ACCA antibody and pulldown assays with recombinant AKR1B10 protein. Intracellular fluorescent studies showed that AKR1B10 and ACCA proteins co-localize in the cytoplasm of RAO-3 cells. More interestingly, small interfering RNA-mediated AKR1B10 knock down increased ACCA degradation through ubiquitination-proteasome pathway and resulted in > 50% decrease of fatty acid synthesis in RAO-3 cells. These data suggest that AKR1B10 is a novel regulator of the biosynthesis of fatty acid, an essential component of the cell membrane, in breast cancer cells.	[Ma, Jun; Yan, Ruilan; Zu, Xuyu; Rao, Krishna] So Illinois Univ, Sch Med, SimmonsCooper Canc Inst, Dept Med Microbiol, Springfield, IL 62702 USA; [Cheng, Ji-Ming] So Illinois Univ, Sch Med, Div Hematol & Oncol, Springfield, IL 62702 USA; [Zu, Xuyu; Liao, Duan-Fang] Nanhua Univ, Sch Life Sci & Technol, Inst Pharm & Pharmacol, Div Pharmacoproteom, Hengyang 421001, Hunan, Peoples R China	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; University of South China	Cao, DL (corresponding author), So Illinois Univ, Sch Med, SimmonsCooper Canc Inst, Dept Med Microbiol, 913 N Rutledge St, Springfield, IL 62702 USA.	dcao@siumed.edu	高, 雨莉/HGU-8187-2022		NATIONAL CANCER INSTITUTE [R21CA122327] Funding Source: NIH RePORTER; NCI NIH HHS [CA122327] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Cao DL, 1998, J BIOL CHEM, V273, P11429, DOI 10.1074/jbc.273.19.11429; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Cheng JM, 2006, INT J CANCER, V118, P2957, DOI 10.1002/ijc.21739; Crosas B, 2003, BIOCHEM J, V373, P973, DOI 10.1042/BJ20021818; Dragnev K H, 2000, Oncologist, V5, P361, DOI 10.1634/theoncologist.5-5-361; Dyck JRB, 1999, EUR J BIOCHEM, V262, P184, DOI 10.1046/j.1432-1327.1999.00371.x; Fediuc S, 2006, J LIPID RES, V47, P412, DOI 10.1194/jlr.M500438-JLR200; Fukumoto S, 2005, CLIN CANCER RES, V11, P1776, DOI 10.1158/1078-0432.CCR-04-1238; Hyndman D, 2003, CHEM-BIOL INTERACT, V143, P621, DOI 10.1016/S0009-2797(02)00193-X; Jin J, 2006, FRONT BIOSCI-LANDMRK, V11, P2767, DOI 10.2741/2006; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Lee KWY, 2001, ANTI-CANCER DRUG, V12, P129, DOI 10.1097/00001813-200102000-00005; Magnard C, 2002, ONCOGENE, V21, P6729, DOI 10.1038/sj.onc.1205915; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; Milgraum LZ, 1997, CLIN CANCER RES, V3, P2115; Moreau K, 2006, J BIOL CHEM, V281, P3172, DOI 10.1074/jbc.M504652200; Neels JG, 2006, SCIENCE, V312, P1756, DOI 10.1126/science.1130476; Penning TM, 2005, CLIN CANCER RES, V11, P1687, DOI 10.1158/1078-0432.CCR-05-0071; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Rossi S, 2003, MOL CANCER RES, V1, P707; Rouquette-Jazdanian AK, 2002, BIOCHEM J, V363, P645, DOI 10.1042/0264-6021:3630645; Shurbaji MS, 1996, HUM PATHOL, V27, P917, DOI 10.1016/S0046-8177(96)90218-X; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Swinnen JV, 2004, J STEROID BIOCHEM, V92, P273, DOI 10.1016/j.jsbmb.2004.10.013; Swinnen JV, 2002, INT J CANCER, V98, P19, DOI 10.1002/ijc.10127; Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077; WITTERS LA, 1994, INT J BIOCHEM, V26, P589, DOI 10.1016/0020-711X(94)90018-3; Yahagi N, 2005, EUR J CANCER, V41, P1316, DOI 10.1016/j.ejca.2004.12.037; Yan RL, 2007, INT J CANCER, V121, P2301, DOI 10.1002/ijc.22933; Zang Y, 2005, OBES RES, V13, P1530, DOI 10.1038/oby.2005.188; Zu XY, 2007, TOXICOL SCI, V97, P562, DOI 10.1093/toxsci/kfm033	35	125	130	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3418	3423		10.1074/jbc.M707650200	http://dx.doi.org/10.1074/jbc.M707650200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056116	hybrid			2022-12-25	WOS:000253083000047
J	Ochi, H; Hans, S; Westerfield, M				Ochi, Haruki; Hans, Stefan; Westerfield, Monte			Smarcd3 regulates the timing of zebrafish myogenesis onset	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-BOX GENES; CHROMATIN REMODELING COMPLEX; MAMMALIAN SWI/SNF COMPLEXES; NO-TAIL; MUSCLE SPECIFICATION; GLI REGULATION; FLOOR PLATE; HEDGEHOG; EMBRYOS; MYF5	A cascade of signaling events triggers myogenesis in vertebrates. Although studies of zebrafish indicate that fibroblast growth factor (Fgf), Hedgehog (Hh), and the T-box transcription factors, No tail (Ntl) and T-box gene 16 (Tbx16), regulate myogenesis, the hierarchy of these factors has not been determined. Recently, another transcriptional cofactor, Smarcd3, a subunit of the SWI/SNF chromatin-remodeling complex, has been shown to be required for heart muscle formation in mouse. In zebrafish, fgf8 and ntl expression commences during blastula stages, whereas myogenesis, as indicated by myod expression, does not begin until much later during mid-gastrula stages. smarcd3b expression, on the other hand, becomes enriched in the marginal zone just prior to the beginning of myod expression. Overexpression of smarcd3 shifts the onset of myod and myf5 expression earlier, and myod and myf5 expression in adaxial cells, the earliest muscle precursors, requires Smarcd3, indicating that Smarcd3 is the limiting factor that regulates the onset of myogenesis. Smarcd3 physically interacts with Ntl, and Smarcd3 overexpression fails to rescue myod expression in ntl mutants, demonstrating that function of Smarcd3 depends on Ntl activity. We propose a model in which cooperative activity of Fgf, Ntl, and Smarcd3 is required for the onset of myogenesis, with Smarcd3b serving as the primary regulator of the timing of myogenesis onset.	[Ochi, Haruki; Hans, Stefan; Westerfield, Monte] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Ochi, H (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	monte@uoneuro.uoregon.edu	Ochi, Haruki/AAR-7235-2020	Ochi, Haruki/0000-0002-0088-581X	NIAMS NIH HHS [AR45575] Funding Source: Medline; NICHD NIH HHS [HD22486] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045575] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Amacher SL, 2002, DEVELOPMENT, V129, P3311; Borycki AG, 1999, DEVELOPMENT, V126, P4053; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Coutelle O, 2001, DEV BIOL, V236, P136, DOI 10.1006/dbio.2001.0193; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Draper BW, 2003, DEVELOPMENT, V130, P4639, DOI 10.1242/dev.00671; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; Eroglu B, 2006, DEV DYNAM, V235, P2722, DOI 10.1002/dvdy.20911; Furthauer M, 2004, DEVELOPMENT, V131, P2853, DOI 10.1242/dev.01156; Goering LM, 2003, P NATL ACAD SCI USA, V100, P9410, DOI 10.1073/pnas.1633548100; Gregg RG, 2003, P NATL ACAD SCI USA, V100, P6535, DOI 10.1073/pnas.0631813100; GRIFFIN K, 1995, DEVELOPMENT, V121, P2983; Griffin KJP, 2003, DEV BIOL, V264, P456, DOI 10.1016/j.ydbio.2003.09.008; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Groves JA, 2005, DEVELOPMENT, V132, P4211, DOI 10.1242/dev.01958; Gustafsson MK, 2002, GENE DEV, V16, P114, DOI 10.1101/gad.940702; HALPERN ME, 1993, CELL, V75, P99, DOI 10.1016/0092-8674(93)90682-G; Hans S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-5; Hirsinger E, 2004, DEV BIOL, V275, P143, DOI 10.1016/j.ydbio.2004.07.030; Hong WY, 2004, CANCER RES, V64, P7256, DOI 10.1158/0008-5472.CAN-04-0931; Indra AK, 2005, DEVELOPMENT, V132, P4533, DOI 10.1242/dev.02019; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Ochi H, 2007, DEV GROWTH DIFFER, V49, P1, DOI 10.1111/j.1440-169x.2007.00905.x; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Reifers F, 1998, DEVELOPMENT, V125, P2381; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Seo S, 2005, DEVELOPMENT, V132, P105, DOI 10.1242/dev.01548; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Teboul L, 2003, GENE DEV, V17, P2870, DOI 10.1101/gad.1117603; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5	38	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3529	3536		10.1074/jbc.M708594200	http://dx.doi.org/10.1074/jbc.M708594200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056260	hybrid			2022-12-25	WOS:000253083000058
J	Huang, YH; Lin, Y; Brown, TE; Han, MH; Saal, DB; Neve, RL; Zukin, RS; Sorg, BA; Nestler, EJ; Malenka, RC; Dong, Y				Huang, Yanhua H.; Lin, Ying; Brown, Travis E.; Han, Ming-Hu; Saal, Daniel B.; Neve, Rachael L.; Zukin, R. Suzanne; Sorg, Barbara A.; Nestler, Eric J.; Malenka, Robert C.; Dong, Yan			CREB modulates the functional output of nucleus accumbens neurons - A critical role of N-methyl-D-aspartate glutamate receptor (NMDAR) receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTEX PYRAMIDAL NEURONS; LONG-TERM DEPRESSION; BEHAVIORAL SENSITIZATION; PREFRONTAL CORTEX; IN-VIVO; PROJECTION NEURONS; EMOTIONAL STIMULI; DOPAMINE NEURONS; COCAINE REWARD; EXPRESSION	Nucleusaccumbens(NAc) medium spiny neurons cycle between two states, a functionally inactive downstate and a functionally active upstate. Here, we show that activation of the transcription factor cAMP-response element- binding protein (CREB), a common molecular response to several drugs of abuse, increases both duration of the upstate and action potential firing during the upstate. This effect of CREB is mediated by enhanced N-methyl-D-aspartate glutamate receptor (NMDAR) function: increased CREB activity increases both NMDAR-mediated synaptic currents and surface level of NMDARs, while inhibition of NMDARs abolishes the effect of CREB on upstate duration. Furthermore, mimicking the effect of CREB by pharmacological enhancement of NMDAR function in the NAc in vivo suppressed novelty-and cocaine-elicited locomotor activity. These findings suggest that by enhancing NMDAR-mediated synaptic transmission, CREB activation promotes the proportion of time NAc neurons spend in the upstate. This effect, along with the CREB enhancement of NAc membrane excitability ( Dong, Y.,Green, T., Saal, D., Marie, H., Neve, R., Nestler, E. J., and Malenka, R. C.( 2006) Nat. Neurosci. 9,475 - 477), may counteract drug-induced maladaptations in the NAc and thus ameliorate the addictive state.	[Huang, Yanhua H.; Brown, Travis E.; Saal, Daniel B.; Sorg, Barbara A.; Dong, Yan] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA; [Lin, Ying; Zukin, R. Suzanne] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Neve, Rachael L.] Harvard Univ, Sch Med, McLean Hosp, Dept Psychiat, Belmont, MA 02478 USA; [Han, Ming-Hu] Univ Texas SW Med Ctr Dallas, Dept Psychiat & Basic Neurosci, Dallas, TX 75390 USA; [Malenka, Robert C.; Dong, Yan] Stanford Univ, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA	Washington State University; Yeshiva University; Albert Einstein College of Medicine; Harvard University; McLean Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University	Dong, Y (corresponding author), Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, POB 646520-VCAPP,Wegner 205, Pullman, WA 99164 USA.	yandong@vetmed.wsu.edu	Dong, Yan/A-4154-2016; Han, Ming-Hu/G-8836-2012; Huang, Yanhua/P-1583-2015	Dong, Yan/0000-0003-0016-9028; Huang, Yanhua/0000-0003-1770-0196; Sorg, Barbara/0000-0002-4913-4910	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023206] Funding Source: NIH RePORTER; NIDA NIH HHS [R37 DA023206, R01 DA023206-01A2, R01 DA023206] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Atlason PT, 2007, J BIOL CHEM, V282, P25299, DOI 10.1074/jbc.M702778200; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Brady AM, 2005, J NEUROSCI, V25, P6687, DOI 10.1523/JNEUROSCI.0643-05.2005; Brady AM, 2003, ANN NY ACAD SCI, V1003, P358, DOI 10.1196/annals.1300.026; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; Cain ME, 2005, EXP CLIN PSYCHOPHARM, V13, P367, DOI 10.1037/1064-1297.13.4.367; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Chen BS, 2006, J BIOL CHEM, V281, P16583, DOI 10.1074/jbc.M513029200; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong Y, 2005, J NEUROSCI, V25, P936, DOI 10.1523/JNEUROSCI.4715-04.2005; Dong Y, 2006, NAT NEUROSCI, V9, P475, DOI 10.1038/nn1661; Dong Y, 2004, P NATL ACAD SCI USA, V101, P14282, DOI 10.1073/pnas.0401553101; Dong Y, 2003, J NEUROSCI, V23, P2686; Green TA, 2006, J NEUROSCI, V26, P8235, DOI 10.1523/JNEUROSCI.0880-06.2006; Lee JLC, 2006, J NEUROSCI, V26, P10051, DOI 10.1523/JNEUROSCI.2466-06.2006; LORIAUX MM, 1994, J BIOL CHEM, V269, P28839; Mahon S, 2006, J NEUROSCI, V26, P12587, DOI 10.1523/JNEUROSCI.3987-06.2006; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Mattson BJ, 2005, J NEUROCHEM, V95, P1481, DOI 10.1111/j.1471-4159.2005.03500.x; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Neve RL, 2005, BIOTECHNIQUES, V39, P381, DOI 10.2144/05393PS01; O'Donnell P, 1999, ANN NY ACAD SCI, V877, P157, DOI 10.1111/j.1749-6632.1999.tb09267.x; ODONNELL P, 1995, J NEUROSCI, V15, P3622; ONN SP, 1994, SYNAPSE, V16, P231, DOI 10.1002/syn.890160308; Onn SP, 2000, J NEUROSCI, V20, P2332; Papadakis M, 2004, J BIOL CHEM, V279, P14703, DOI 10.1074/jbc.M313446200; Plenz D, 1998, J NEUROSCI, V18, P266; Prybylowski K, 2004, J BIOL CHEM, V279, P9673, DOI 10.1074/jbc.R300029200; Rouaud E, 2003, BRIT J PHARMACOL, V140, P1051, DOI 10.1038/sj.bjp.0705541; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sakai N, 2002, MOL PHARMACOL, V61, P1453, DOI 10.1124/mol.61.6.1453; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Vergara R, 2003, J PHYSIOL-LONDON, V553, P169, DOI 10.1113/jphysiol.2003.050799; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; WILSON CJ, 1986, BRAIN RES, V367, P201, DOI 10.1016/0006-8993(86)91593-3; Wolf JA, 2005, J NEUROSCI, V25, P9080, DOI 10.1523/JNEUROSCI.2220-05.2005	39	54	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2751	2760		10.1074/jbc.M706578200	http://dx.doi.org/10.1074/jbc.M706578200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18055458	Green Accepted, hybrid			2022-12-25	WOS:000252622300033
J	Mayer, G; Hamelin, J; Asselin, MC; Pasquato, A; Marcinkiewicz, E; Tang, M; Tabibzadeh, S; Seidah, NG				Mayer, Gaetan; Hamelin, Josee; Asselin, Marie-Claude; Pasquato, Antonella; Marcinkiewicz, Edwidge; Tang, Meiyi; Tabibzadeh, Siamak; Seidah, Nabil G.			The regulated cell surface zymogen activation of the proprotein convertase PC5A directs the processing of its secretory substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL LIPASE; HEPARAN-SULFATE; PROTEOLYTIC ACTIVATION; ENZYME ACTIVATION; GOLGI-APPARATUS; FURIN; CLEAVAGE; ENDOPROTEASE; PROTEINS; MATRIX	The proprotein convertases are synthesized as zymogens that acquire activity upon autocatalytic removal of their NH2-terminal prosegment. Based on the convertase furin, to fold properly and gain activity, the convertases PC5A, PACE4, and PC7 are presumed to undergo two sequential prosegment cleavages in the endoplasmic reticulum and then in the trans-Golgi network. However, biochemical and immunocytochemical experiments revealed that mouse PC5A is complexed to its prosegment at the plasma membrane. This labeling is lost upon treatment with heparin and is increased by overexpressing members of the syndecan family and CD44, suggesting attachment of secreted PC5A-prosegment complex to heparan sulfate proteoglycans. Following stimulation of Y1 cells with adrenocorticotropic hormone or 8-bromo-cyclic AMP, the cell surface labeling of the prosegment of PC5A is greatly diminished, whereas the signal for mature PC5A is increased. Moreover, after stimulation, the protease activity of PC5A is enhanced, as evidenced by the cleavage of the PC5A substrates Lefty, ADAMTS-4, endothelial lipase, and PCSK9. Our data suggest a novel mechanism for PC5A activation and substrate cleavage at the cell surface, through a regulated removal of its prosegment. A similar mechanism may also apply to the convertase PACE4, thereby extending our knowledge of the molecular details of the zymogen activation and functions of these heparan sulfate proteoglycan-bound convertases.	[Mayer, Gaetan; Hamelin, Josee; Asselin, Marie-Claude; Pasquato, Antonella; Marcinkiewicz, Edwidge; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Tang, Meiyi; Tabibzadeh, Siamak] SUNY Stony Brook, Stony Brook, NY 11794 USA	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Seidah, NG (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342; Pasquato, Antonella/0000-0002-9428-0722				Allard Delphine, 2005, Hum Mutat, V26, P497, DOI 10.1002/humu.9383; Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; APTE SS, 1995, J BIOL CHEM, V270, P14313, DOI 10.1074/jbc.270.24.14313; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Bergeron E, 2005, BIOCHEM BIOPH RES CO, V326, P554, DOI 10.1016/j.bbrc.2004.11.063; Bergeron E, 2003, BIOCHEM J, V373, P475, DOI 10.1042/BJ20021630; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Broedl UC, 2004, TRENDS CARDIOVAS MED, V14, P202, DOI 10.1016/j.tcm.2004.03.003; Constam DB, 1996, J CELL BIOL, V134, P181, DOI 10.1083/jcb.134.1.181; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; Cui YZ, 2001, GENE DEV, V15, P2797; DeBie I, 1996, J CELL BIOL, V135, P1261, DOI 10.1083/jcb.135.5.1261; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; Feliciangeli SF, 2006, J BIOL CHEM, V281, P16108, DOI 10.1074/jbc.M600760200; GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X; Gauster M, 2005, J LIPID RES, V46, P977, DOI 10.1194/jlr.M400500-JLR200; Goldman DC, 2006, DEVELOPMENT, V133, P1933, DOI 10.1242/dev.02368; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; Jin WJ, 2005, J BIOL CHEM, V280, P36551, DOI 10.1074/jbc.M502264200; Jin WJ, 2003, J CLIN INVEST, V111, P357, DOI [10.1172/JCI16146, 10.1172/JCI200316146]; Kalus I, 2003, J BIOL CHEM, V278, P10381, DOI 10.1074/jbc.M208351200; Koo BK, 2006, J MOL BIOL, V355, P651, DOI 10.1016/j.jmb.2005.09.087; Kramer KL, 2003, ANNU REV GENET, V37, P461, DOI 10.1146/annurev.genet.37.061103.090226; Lander AD, 1998, MATRIX BIOL, V17, P465, DOI 10.1016/S0945-053X(98)90093-2; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; LUSSON J, 1993, P NATL ACAD SCI USA, V90, P6691, DOI 10.1073/pnas.90.14.6691; Marcinkiewicz M, 1999, J COMP NEUROL, V403, P471, DOI 10.1002/(SICI)1096-9861(19990125)403:4<471::AID-CNE4>3.0.CO;2-S; Mayer G, 2004, CELL TISSUE RES, V316, P55, DOI 10.1007/s00441-004-0866-x; Mayer G, 2004, J HISTOCHEM CYTOCHEM, V52, P567, DOI 10.1177/002215540405200502; Mayer G, 2003, J CELL SCI, V116, P1763, DOI 10.1242/jcs.00394; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; Nagase H, 2003, ARTHRITIS RES THER, V5, P94, DOI 10.1186/ar630; NAKAGAWA T, 1993, FEBS LETT, V327, P165, DOI 10.1016/0014-5793(93)80163-O; Nour N, 2005, MOL BIOL CELL, V16, P5215, DOI 10.1091/mbc.E05-06-0504; Nour N, 2003, J BIOL CHEM, V278, P2886, DOI 10.1074/jbc.M208009200; Pisciotta L, 2006, ATHEROSCLEROSIS, V186, P433, DOI 10.1016/j.atherosclerosis.2005.08.015; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; Schimmer BP, 2006, ENDOCRINOLOGY, V147, P2357, DOI 10.1210/en.2005-1526; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Somerville RPT, 2004, J BIOL CHEM, V279, P35159, DOI 10.1074/jbc.M402380200; Sopory S, 2006, J BIOL CHEM, V281, P34021, DOI 10.1074/jbc.M605330200; Stawowy P, 2005, CIRCULATION, V111, P2820, DOI 10.1161/CIRCULATIONAHA.104.502617; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sucic JF, 1999, BIOCHEM J, V339, P639, DOI 10.1042/0264-6021:3390639; Tang MY, 2005, ENDOCRINOLOGY, V146, P5313, DOI 10.1210/en.2005-0684; Taylor NA, 2003, FASEB J, V17, P1215, DOI 10.1096/fj.02-0831rev; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tortorella MD, 2005, ARCH BIOCHEM BIOPHYS, V444, P34, DOI 10.1016/j.abb.2005.09.018; Tsuji A, 1999, J BIOCHEM, V126, P591, DOI 10.1093/oxfordjournals.jbchem.a022491; Tsuji A, 2003, BBA-PROTEINS PROTEOM, V1645, P95, DOI 10.1016/S1570-9639(02)00532-0; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Ulloa L, 2001, J BIOL CHEM, V276, P21387, DOI 10.1074/jbc.M006933200; VEY M, 1994, J CELL BIOL, V127, P1829, DOI 10.1083/jcb.127.6.1829; Xiang Y, 2000, MOL BIOL CELL, V11, P1257, DOI 10.1091/mbc.11.4.1257; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	63	68	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2373	2384		10.1074/jbc.M708763200	http://dx.doi.org/10.1074/jbc.M708763200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039650	hybrid			2022-12-25	WOS:000252501000064
J	Fu, QH; Figuera-Losada, M; Ploplis, VA; Cnudde, S; Geiger, JH; Prorok, M; Castellino, FJ				Fu, Qihua; Figuera-Losada, Mariana; Ploplis, Victoria A.; Cnudde, Sara; Geiger, James H.; Prorok, Mary; Castellino, Francis J.			The lack of binding of VEK-30, an internal peptide from the group a streptococcal m-like protein, PAM, to murine plasminogen is due to two amino acid replacements in the plasminogen kringle-2 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL SURFACE PROTEIN; RECOMBINANT KRINGLE-1; S2 CELLS; ACTIVATION; LIGANDS; FIBRIN; GENE; IDENTIFICATION; STREPTOKINASE; ACQUISITION	VEK-30, a 30-amino acid internal peptide present within a streptococcal M-like plasminogen (Pg)-binding protein (PAM) from Gram-positive group-A streptococci (GAS), represents an epitope within PAM that shows high affinity for the lysine binding site (LBS) of the kringle-2 (K2) domain of human (h) Pg. VEK-30 does not interact with this same region of mouse (m) Pg, despite the high conservation of the mK2- and hK2-LBS. To identify the molecular basis for the species specificity of this interaction, hPg and mPg variants were generated, including an hPg chimera with the mK2 sequence and an mPg chimera containing the hK2 sequence. The binding of synthetic VEK-30 to these variants was studied by surface plasmon resonance. The data revealed that, in otherwise intact Pg, the species specificity of VEK-30 binding in these two cases is entirely dictated by two K2 residues that are different between hPg and mPg, namely, Arg-220 of hPg, which is a Gly in mPg, and Leu-222 of hPg, which is a Pro in mPg, neither of which are members of the canonical K2-LBS. Neither the activation of hPg, nor the enzymatic activity of its activated product, plasmin (hPm), are compromised by replacing these two amino acids by their murine counterparts. It is also demonstrated that hPg is more susceptible to activation to hPm after complexation with VEK-30 and that this property is greatly reduced as a result of the R220G and L222P replacements in hPg. These mechanisms for accumulation of protease activity on GAS likely contribute to the virulence of PAM(+)-GAS strains and identify targets for new therapeutic interventions.	[Fu, Qihua; Figuera-Losada, Mariana; Ploplis, Victoria A.; Prorok, Mary; Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Fu, Qihua; Figuera-Losada, Mariana; Ploplis, Victoria A.; Prorok, Mary; Castellino, Francis J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Cnudde, Sara; Geiger, James H.] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	University of Notre Dame; University of Notre Dame; Michigan State University	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, 230 Raclin Carmichael Hall, Notre Dame, IN 46556 USA.	fcastell@nd.edu	Fu, Qihua/AAW-9989-2020	Geiger, James/0000-0002-9443-4488	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013423, P01HL073750, R37HL013423] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 073750, HL 013423] Funding Source: Medline; NIGMS NIH HHS [GM 0638947] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERGE A, 1993, J BIOL CHEM, V268, P25417; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; CHIBBER BAK, 1986, P NATL ACAD SCI USA, V83, P1237, DOI 10.1073/pnas.83.5.1237; Cnudde SE, 2006, BIOCHEMISTRY-US, V45, P11052, DOI 10.1021/bi060914j; DEVRIES C, 1990, J BIOL CHEM, V265, P13547; FLEURY V, 1993, EUR J BIOCHEM, V216, P549, DOI 10.1111/j.1432-1033.1993.tb18173.x; FLEURY V, 1993, FIBRINOLYSIS, V7, P87, DOI 10.1016/0268-9499(93)90028-T; HOOVER GJ, 1993, BIOCHEMISTRY-US, V32, P10936, DOI 10.1021/bi00092a002; Iwaki T, 2003, BIOTECHNIQUES, V35, P482, DOI 10.2144/03353bm08; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; LOTTENBERG R, 1987, INFECT IMMUN, V55, P1914, DOI 10.1128/IAI.55.8.1914-1918.1987; Mathews II, 1996, BIOCHEMISTRY-US, V35, P2567, DOI 10.1021/bi9521351; MCCANCE SG, 1994, J BIOL CHEM, V269, P32405; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; MENHART N, 1991, BIOCHEMISTRY-US, V30, P1948, DOI 10.1021/bi00221a031; MENHART N, 1995, BIOCHEMISTRY-US, V34, P1482, DOI 10.1021/bi00005a003; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; MILES LA, 1988, J BIOL CHEM, V263, P11928; Monroy V, 2000, INFECT IMMUN, V68, P4327, DOI 10.1128/IAI.68.7.4327-4330.2000; Nilsen SL, 1999, J BIOL CHEM, V274, P22380, DOI 10.1074/jbc.274.32.22380; Nilsen SL, 1999, PROTEIN EXPRES PURIF, V16, P136, DOI 10.1006/prep.1999.1045; Ploplis VA, 2002, THROMB HAEMOSTASIS, V87, P22, DOI 10.1055/s-0037-1612938; Ploplis VA, 2001, FRONT BIOSCI-LANDMRK, V6, pD555, DOI 10.2741/Ploplis; Ploplis VA, 2000, METHODS, V21, P103, DOI 10.1006/meth.2000.0981; Ringdahl U, 1998, J BIOL CHEM, V273, P6424, DOI 10.1074/jbc.273.11.6424; Rios-Steiner JL, 2001, J MOL BIOL, V308, P705, DOI 10.1006/jmbi.2001.4646; Schenone MM, 2000, J PEPT RES, V56, P438, DOI 10.1034/j.1399-3011.2000.00810.x; Schroeder B, 1999, INFECT IMMUN, V67, P6487; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; SOTTRUPJENSEN L, 1978, PROGR CHEM FIBRINOLY, V3, P191; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; URANO T, 1987, P NATL ACAD SCI USA, V84, P4031, DOI 10.1073/pnas.84.12.4031; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; WISTEDT AC, 1995, MOL MICROBIOL, V18, P569, DOI 10.1111/j.1365-2958.1995.mmi_18030569.x; Wistedt AC, 1998, J BIOL CHEM, V273, P24420, DOI 10.1074/jbc.273.38.24420	36	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1580	1587		10.1074/jbc.M705063200	http://dx.doi.org/10.1074/jbc.M705063200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18039665	hybrid			2022-12-25	WOS:000252282700043
J	Woo, CWH; Siow, YL; Karmin, O				Woo, Connie W. H.; Siow, Yaw L.; Karmin, O.			Homocysteine induces monocyte chemoattractant protein-1 expression in hepatocytes mediated via activator protein-1 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; FATTY LIVER-DISEASE; ENDOPLASMIC-RETICULUM STRESS; ACUTE CORONARY SYNDROMES; ENDOTHELIAL-CELLS; SYSTEMIC INFLAMMATION; TRANSCRIPTION FACTORS; SIGNALING PATHWAY; VASCULAR-DISEASE; MCP-1 EXPRESSION	Hyperhomocysteinemia is characterized by abnormally high concentrations of homocysteine (Hcy) in the plasma. It is a metabolic disorder associated with dysfunction of several organs such as atherosclerosis, altered lipid metabolism, and liver injury. In this study we investigated the effect of Hcy on transcriptional regulation of monocyte chemoattractant protein-1 (MCP-1), a potent chemokine, expression in hepatocytes. Hyperhomocysteinemia was induced in rats by a high-methionine diet for 4 weeks. MCP-1 mRNA and protein levels were significantly elevated in the liver tissue homogenate and in hepatocytes of hyperhomocysteinemic rats. The role of transcription factors in MCP-1 expression was examined by electrophoretic mobility shift assay. Activation of activator protein (AP)-1 but not nuclear factor kappa B was detected in the liver tissue of those rats. Incubation of rat hepatocytes with Hcy ( 50-200 mu M) caused a significant increase in AP-1 activation followed by an increase in intracellular MCP-1 mRNA expression and an elevation of MCP-1 protein secreted into the culture medium. Hcy markedly increased the DNA binding activity of human recombinant AP-1 (c-Fos and c-Jun proteins). The presence of a sulfhydryl group in Hcy was essential for Hcy-induced AP-1 activation. When hepatocytes were transfected with decoy AP-1 oligodeoxynucleotide to inhibit AP-1 activation, Hcy-induced MCP-1 mRNA expression was abolished. Further analysis revealed that increased hepatic MCP-1 expression was positively correlated with the serum MCP-1 level. These results suggest that Hcy-induced MCP-1 expression in the liver is mediated via AP-1 activation, which may contribute to chronic inflammation associated with hyperhomocysteinemia.	[Woo, Connie W. H.; Siow, Yaw L.; Karmin, O.] Univ Manitoba, Canadian Ctr Agrifood Res Hlth & Med, St Boniface Gen Hosp, Res Ctr,Dept Anim Sci & Physiol, Winnipeg, MB R2H 2A6, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba	Karmin, O (corresponding author), Univ Manitoba, Canadian Ctr Agrifood Res Hlth & Med, St Boniface Gen Hosp, Res Ctr,Dept Anim Sci & Physiol, 351 Tache Ave, Winnipeg, MB R2H 2A6, Canada.	karmino@sbrc.ca	Woo, Connie/AAX-2588-2020	Woo, Connie Wai Hong/0000-0002-9574-9828; O, Karmin/0000-0002-2163-9458; Siow, Yaw/0000-0001-6623-2881				ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; ABATE C, 1990, P NATL ACAD SCI USA, V87, P1032, DOI 10.1073/pnas.87.3.1032; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Au-Yeung KKW, 2004, CIRC RES, V94, P28, DOI 10.1161/01.RES.0000108264.67601.2C; Beauchamp MC, 2002, DIABETES, V51, P1180, DOI 10.2337/diabetes.51.4.1180; Brea A, 2005, ARTERIOSCL THROM VAS, V25, P1045, DOI 10.1161/01.ATV.0000160613.57985.18; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Bukara M, 2000, ALCOHOL, V20, P193, DOI 10.1016/S0741-8329(99)00100-7; CARSON NAJ, 1965, J PEDIATR-US, V66, P565, DOI 10.1016/S0022-3476(65)80121-4; Choudhury JA, 2003, MOL BIOL CELL, V14, P1334, DOI 10.1091/mbc.E02-07-0378; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; de Lemos JA, 2003, CIRCULATION, V107, P690, DOI 10.1161/01.CIR.0000049742.68848.99; Drunat S, 2002, FREE RADICAL BIO MED, V33, P659, DOI 10.1016/S0891-5849(02)00957-7; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Gao CH, 1999, HEPATOLOGY, V30, P1405, DOI 10.1002/hep.510300602; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Hung MJ, 2006, AM J CARDIOL, V97, P1429, DOI 10.1016/j.amjcard.2005.12.035; JACOBSEN DW, 2000, HOMOCYSTEINE VASCULA; Ji C, 2003, GASTROENTEROLOGY, V124, P1488, DOI 10.1016/S0016-5085(03)00276-2; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; Kanno K, 2005, DIGEST DIS SCI, V50, P942, DOI 10.1007/s10620-005-2669-7; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kerner A, 2005, ARTERIOSCL THROM VAS, V25, P193, DOI 10.1161/01.ATV.0000148324.63685.6a; Kuboki S, 2007, AM J PHYSIOL-GASTR L, V292, pG201, DOI 10.1152/ajpgi.00186.2006; Marumo T, 1999, DIABETES, V48, P1131, DOI 10.2337/diabetes.48.5.1131; MCCULLY KS, 1969, AM J PATHOL, V56, P111; Mikael LG, 2006, CIRC RES, V98, P564, DOI 10.1161/01.RES.0000204825.66410.0b; Muhlbauer M, 2003, GASTROENTEROLOGY, V125, P1085, DOI 10.1016/S0016-5085(03)01213-7; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Paxian M, 2002, ANTIOXID REDOX SIGN, V4, P711, DOI 10.1089/152308602760598855; Polytarchou C, 2005, J BIOL CHEM, V280, P40428, DOI 10.1074/jbc.M505120200; RACKER E, 1955, J BIOL CHEM, V217, P867; Robert K, 2005, GASTROENTEROLOGY, V128, P1405, DOI 10.1053/j.gastro.2005.02.034; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Siendones E, 2004, HEPATOLOGY, V40, P1295, DOI 10.1002/hep.20448; Sung FL, 2001, MOL CELL BIOCHEM, V216, P121, DOI 10.1023/A:1017383916068; Suzuki F, 1998, J BIOL CHEM, V273, P29302, DOI 10.1074/jbc.273.45.29302; Suzuki YJ, 2000, FREE RADICAL BIO MED, V28, P39, DOI 10.1016/S0891-5849(99)00200-2; Targher G, 2007, ATHEROSCLEROSIS, V190, P18, DOI 10.1016/j.atherosclerosis.2006.06.004; Wang GP, 2002, ARTERIOSCL THROM VAS, V22, P1777, DOI 10.1161/01.ATV.0000035404.18281.37; Wang GP, 2000, BIOCHEM J, V352, P817, DOI 10.1042/0264-6021:3520817; Wang GP, 2001, AM J PHYSIOL-HEART C, V280, pH2840, DOI 10.1152/ajpheart.2001.280.6.H2840; Wang NP, 1999, ARTERIOSCL THROM VAS, V19, P2078, DOI 10.1161/01.ATV.19.9.2078; Wang YP, 2000, KIDNEY INT, V57, P2011, DOI 10.1046/j.1523-1755.2000.00051.x; WEINSTEIN CL, 1988, J BIOL CHEM, V263, P16568; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Woo CWH, 2006, BBA-MOL BASIS DIS, V1762, P656, DOI 10.1016/j.bbadis.2006.05.012; Woo CWH, 2006, ARTERIOSCL THROM VAS, V26, P1043, DOI 10.1161/01.ATV.0000214981.58499.32; Woo CWH, 2005, AM J PHYSIOL-ENDOC M, V288, pE1002, DOI 10.1152/ajpendo.00518.2004; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P5252, DOI 10.1073/pnas.88.12.5252; YOSHIMURA T, 1989, FEBS LETT, V244, P487, DOI 10.1016/0014-5793(89)80590-3	54	28	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1282	1292		10.1074/jbc.M707886200	http://dx.doi.org/10.1074/jbc.M707886200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024959	hybrid			2022-12-25	WOS:000252282700011
J	Baumgartner, BG; Orpinell, M; Duran, J; Ribas, V; Burghardt, HE; Bach, D; Villar, AV; Paz, JC; Gonzalez, M; Camps, M; Oriola, J; Rivera, F; Palacin, M; Zorzano, A				Baumgartner, Bernhard G.; Orpinell, Meritxell; Duran, Jordi; Ribas, Vicent; Burghardt, Hans E.; Bach, Daniel; Victoria Villar, Ana; Paz, Jose C.; Gonzalez, Meritxell; Camps, Marta; Oriola, Josep; Rivera, Francisca; Palacin, Manuel; Zorzano, Antonio			Identification of a Novel Modulator of Thyroid Hormone Receptor-Mediated Action	PLOS ONE			English	Article								Background. Diabetes is characterized by reduced thyroid function and altered myogenesis after muscle injury. Here we identify a novel component of thyroid hormone action that is repressed in diabetic rat muscle. Methodology/Principal Findings. We have identified a gene, named DOR, abundantly expressed in insulin-sensitive tissues such as skeletal muscle and heart, whose expression is highly repressed in muscle from obese diabetic rats. DOR expression is up-regulated during muscle differentiation and its loss-of-function has a negative impact on gene expression programmes linked to myogenesis or driven by thyroid hormones. In agreement with this, DOR enhances the transcriptional activity of the thyroid hormone receptor TR alpha 1. This function is driven by the N-terminal part of the protein. Moreover, DOR physically interacts with TR alpha 1 and to T-3-responsive promoters, as shown by ChIP assays. T-3 stimulation also promotes the mobilization of DOR from its localization in nuclear PML bodies, thereby indicating that its nuclear localization and cellular function may be related. Conclusions/Significance. Our data indicate that DOR modulates thyroid hormone function and controls myogenesis. DOR expression is down-regulated in skeletal muscle in diabetes. This finding may be of relevance for the alterations in muscle function associated with this disease.	[Baumgartner, Bernhard G.; Orpinell, Meritxell; Duran, Jordi; Ribas, Vicent; Burghardt, Hans E.; Bach, Daniel; Victoria Villar, Ana; Paz, Jose C.; Gonzalez, Meritxell; Camps, Marta; Palacin, Manuel; Zorzano, Antonio] Univ Barcelona, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Baumgartner, Bernhard G.; Orpinell, Meritxell; Duran, Jordi; Ribas, Vicent; Burghardt, Hans E.; Bach, Daniel; Victoria Villar, Ana; Paz, Jose C.; Gonzalez, Meritxell; Camps, Marta; Palacin, Manuel; Zorzano, Antonio] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain; [Oriola, Josep; Rivera, Francisca] Hosp Clin Barcelona, Serv Hormonal, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Zorzano, A (corresponding author), Univ Barcelona, Inst Res Biomed IRB Barcelona, Barcelona, Spain.	azorzano@pcb.ub.es	Duran, Jordi/J-7298-2017; Duran, Jordi/AGP-2068-2022; Zorzano, Antonio/R-5479-2018; Paz, Jose Carlos/I-5783-2015; Ribas, Vicent/K-1390-2014; Villar, Ana/I-5190-2015; Camps, Marta/F-6557-2016	Duran, Jordi/0000-0002-8342-4882; Paz, Jose Carlos/0000-0001-9684-9735; Ribas, Vicent/0000-0003-3380-2256; Villar, Ana/0000-0003-4588-9598; Camps, Marta/0000-0001-5392-1792; Palacin, Manuel/0000-0002-8670-293X	Ministerio de Educacion y Ciencia ( MEC) [SAF2005-00445]; Generalitat de Catalunya [2005SGR00947]; Instituto de Salud Carlos III [ISCIII-RETIC RD06]	Ministerio de Educacion y Ciencia ( MEC)(Spanish GovernmentEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This study was supported by research grants from the Ministerio de Educacion y Ciencia ( MEC) ( SAF2005-00445), the Generalitat de Catalunya ( 2005SGR00947), and the Instituto de Salud Carlos III ( ISCIII-RETIC RD06, REDIMET).	ALBAGLICURIEL O, 1993, DIFFERENTIATION, V52, P201, DOI 10.1111/j.1432-0436.1993.tb00632.x; Aughsteen AA, 2006, J PANCREAS, V7, P382; Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; CARNAC G, 1992, MOL ENDOCRINOL, V6, P1185, DOI 10.1210/me.6.8.1185; CHAO TT, 1976, CELL TISSUE RES, V168, P239, DOI 10.1007/BF00215880; Chubb SAP, 2005, CLIN ENDOCRINOL, V62, P480, DOI 10.1111/j.1365-2265.2005.02246.x; COLLIE ESR, 1992, CELL GROWTH DIFFER, V3, P31; Dong CH, 2003, AM J HUM GENET, V72, P115, DOI 10.1086/345648; DOWNES M, 1993, CELL GROWTH DIFFER, V4, P901; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Enrique-Tarancon G, 2000, BIOCHEM J, V350, P171, DOI 10.1042/0264-6021:3500171; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; FOWDEN AL, 1995, REPROD FERT DEVELOP, V7, P351, DOI 10.1071/RD9950351; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P2198, DOI 10.1073/pnas.96.5.2198; Greenman RL, 2005, DIABETES CARE, V28, P1425, DOI 10.2337/diacare.28.6.1425; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Isogai Y, 2003, CURR OPIN CELL BIOL, V15, P296, DOI 10.1016/S0955-0674(03)00052-8; Iwasaki N, 2003, DIABETES, V52, P209, DOI 10.2337/diabetes.52.1.209; IZUMO S, 1986, SCIENCE, V231, P597, DOI 10.1126/science.3945800; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; KABADI UM, 1984, J AM GERIATR SOC, V32, P375, DOI 10.1111/j.1532-5415.1984.tb02043.x; KLUEBER KM, 1994, ANAT REC, V239, P18, DOI 10.1002/ar.1092390104; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; MARCHAL S, 1995, EXP CELL RES, V220, P1, DOI 10.1006/excr.1995.1285; MCINTOSH LM, 1994, MUSCLE NERVE, V17, P444, DOI 10.1002/mus.880170413; Moreno H, 2003, J BIOL CHEM, V278, P40557, DOI 10.1074/jbc.M306609200; MUSCAT GEO, 1995, BIOESSAYS, V17, P211, DOI 10.1002/bies.950170307; MUSCAT GEO, 1994, NUCLEIC ACIDS RES, V22, P583, DOI 10.1093/nar/22.4.583; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; OPPENHEIMER JH, 1987, ENDOCR REV, V8, P288, DOI 10.1210/edrv-8-3-288; Pernitsky AN, 1996, BIOCHEM CELL BIOL, V74, P315, DOI 10.1139/o96-034; Ros-Baro A, 2001, P NATL ACAD SCI USA, V98, P12050, DOI 10.1073/pnas.211341698; Santalucia T, 2001, J MOL BIOL, V314, P195, DOI 10.1006/jmbi.2001.5091; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Sharma D, 2000, MOL ENDOCRINOL, V14, P2001, DOI 10.1210/me.14.12.2001; Sharma D, 2002, P NATL ACAD SCI USA, V99, P7934, DOI 10.1073/pnas.122004799; Smithson MJ, 1998, DIABETIC MED, V15, P148, DOI 10.1002/(SICI)1096-9136(199802)15:2<148::AID-DIA540>3.0.CO;2-H; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vinals F, 1997, J BIOL CHEM, V272, P12913, DOI 10.1074/jbc.272.20.12913; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; Watada H, 2000, P NATL ACAD SCI USA, V97, P9443, DOI 10.1073/pnas.97.17.9443; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wu WS, 2001, MOL CELL BIOL, V21, P2259, DOI 10.1128/MCB.21.7.2259-2268.2001; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zaidi SK, 2005, EMBO REP, V6, P128, DOI 10.1038/sj.embor.7400337	52	38	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1183	10.1371/journal.pone.0001183	http://dx.doi.org/10.1371/journal.pone.0001183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030323	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459200002
J	Gaume, L; Forterre, Y				Gaume, Laurence; Forterre, Yoel			A Viscoelastic Deadly Fluid in Carnivorous Pitcher Plants	PLOS ONE			English	Article								Background. The carnivorous plants of the genus Nepenthes, widely distributed in the Asian tropics, rely mostly on nutrients derived from arthropods trapped in their pitcher-shaped leaves and digested by their enzymatic fluid. The genus exhibits a great diversity of prey and pitcher forms and its mechanism of trapping has long intrigued scientists. The slippery inner surfaces of the pitchers, which can be waxy or highly wettable, have so far been considered as the key trapping devices. However, the occurrence of species lacking such epidermal specializations but still effective at trapping insects suggests the possible implication of other mechanisms. Methodology/Principal Findings. Using a combination of insect bioassays, highspeed video and rheological measurements, we show that the digestive fluid of Nepenthes rafflesiana is highly viscoelastic and that this physical property is crucial for the retention of insects in its traps. Trapping efficiency is shown to remain strong even when the fluid is highly diluted by water, as long as the elastic relaxation time of the fluid is higher than the typical time scale of insect movements. Conclusions/Significance. This finding challenges the common classification of Nepenthes pitchers as simple passive traps and is of great adaptive significance for these tropical plants, which are often submitted to high rainfalls and variations in fluid concentration. The viscoelastic trap constitutes a cryptic but potentially widespread adaptation of Nepenthes species and could be a homologous trait shared through common ancestry with the sundew (Drosera) flypaper plants. Such large production of a highly viscoelastic biopolymer fluid in permanent pools is nevertheless unique in the plant kingdom and suggests novel applications for pest control.	[Gaume, Laurence] CNRS, UMR AMAP 5120, Montpellier, France; [Forterre, Yoel] Univ Aix Marseille 1, CNRS, IUSTI, UMR 6595, Marseille, France	CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Gaume, L (corresponding author), CNRS, UMR AMAP 5120, Montpellier, France.	lgaume@cirad.fr; Yoel.Forterre@polytech.univ-mrs.fr			University Montpellier II and by the French national agency of research (ANR)	University Montpellier II and by the French national agency of research (ANR)(French National Research Agency (ANR))	The work was supported by a grant "Young researcher and innovative project'' from the University Montpellier II and by the French national agency of research (ANR) "Young researcher program: Interaction fluide-structure chez les plantes''. The study funders played no role in designing the study, data collection/analysis or preparation of the manuscript.	ALBERT VA, 1992, SCIENCE, V257, P1491, DOI 10.1126/science.1523408; Balland M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021911; Bergeron V, 2000, NATURE, V405, P772, DOI 10.1038/35015525; Bird RB, 1987, DYNAMICS POLYMERIC L, V1; Bohn HF, 2004, P NATL ACAD SCI USA, V101, P14138, DOI 10.1073/pnas.0405885101; Bush JWM, 2006, ANNU REV FLUID MECH, V38, P339, DOI 10.1146/annurev.fluid.38.050304.092157; CHEEK M, 2001, PUBLICATION DEP NATL, V15, P1; Clarke C., 1997, NEPENTHES OF BORNEO; Clarke C.M., 2001, NEPENTHES SUMATRA PE; Darwin C., 1875, INSECTIVOROUS PLANTS; DENNY M, 1980, NATURE, V285, P160, DOI 10.1038/285160a0; DIGIUSTO B, FUNCTIONAL IN PRESS; Drelich J., 2006, MEASUREMENT INTERFAC, V2nd; Ellison AM, 2003, ADV ECOL RES, V33, P1, DOI 10.1016/S0065-2504(03)33009-0; Entov VM, 1997, J NON-NEWTON FLUID, V72, P31, DOI 10.1016/S0377-0257(97)00022-0; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Gaume L, 2004, ARTHROPOD STRUCT DEV, V33, P103, DOI 10.1016/j.asd.2003.11.005; Gaume L, 2002, NEW PHYTOL, V156, P479, DOI 10.1046/j.1469-8137.2002.00530.x; Gaume L, 2006, J TROP ECOL, V22, P341, DOI 10.1017/S0266467405003111; Gorb E, 2005, J EXP BIOL, V208, P4651, DOI 10.1242/jeb.01939; Gorb SN, 2000, ARTHROPOD STRUCT DEV, V29, P129, DOI 10.1016/S1467-8039(00)00020-7; GOWDA DC, 1982, PHYTOCHEMISTRY, V21, P2297, DOI 10.1016/0031-9422(82)85194-7; Grotberg JB, 2001, ANNU REV BIOMED ENG, V3, P421, DOI 10.1146/annurev.bioeng.3.1.421; GU YP, 2006, ENCY SURFACE COLLOID; HEPBURN JS, 1927, WAGNER FREE I SCI, V11, P35; HOLDGATE MW, 1955, J EXP BIOL, V32, P591; Juniper B.E., 1989, CARNIVOROUS PLANTS; Juniper BE., 1962, NEW SCI, V13, P75; Kato M., 1993, Tropical Zoology, V6, P11; Larson R. G., 1999, STRUCTURE RHEOLOGY C, P443; Lauga E, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2751388; Lide D., 2004, HDB CHEM PHYS; Lloyd F.E., 1942, CARNIVOROUS PLANTS; Moran JA, 1996, J ECOL, V84, P515, DOI 10.2307/2261474; MORTON JF, 1990, J ETHNOPHARMACOL, V29, P245, DOI 10.1016/0378-8741(90)90036-S; Read DB, 2003, NEW PHYTOL, V157, P315, DOI 10.1046/j.1469-8137.2003.00665.x; Riedel M, 2007, PLANTA, V225, P1517, DOI 10.1007/s00425-006-0437-3; Rodd LE, 2005, APPL RHEOL, V15, P12, DOI 10.1515/arh-2005-0001; Salmon B., 1993, CARNIVOROUS PLANT NE, V23, P101; Vogel S., 1994, LIFE MOVING FLUIDS P	40	85	88	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1185	10.1371/journal.pone.0001185	http://dx.doi.org/10.1371/journal.pone.0001185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030325	Green Submitted, gold, Green Published			2022-12-25	WOS:000207459200004
J	Schneider, BS; Mcgee, CE; Jordan, JM; Stevenson, HL; Soong, L; Higgs, S				Schneider, Bradley S.; McGee, Charles E.; Jordan, Jeffrey M.; Stevenson, Heather L.; Soong, Lynn; Higgs, Stephen			Prior Exposure to Uninfected Mosquitoes Enhances Mortality in Naturally-Transmitted West Nile Virus Infection	PLOS ONE			English	Article								Background. The global emergence of West Nile virus (WNV) has highlighted the importance of mosquito-borne viruses. These are inoculated in vector saliva into the vertebrate skin and circulatory system. Arthropod-borne (arbo) viruses such as WNV are transmitted to vertebrates as an infectious mosquito probes the skin for blood, depositing the virus and saliva into the skin and circulation. Growing evidence has demonstrated that arthropod, and recently mosquito, saliva can have a profound effect on pathogen transmission efficiency, pathogenesis, and disease course. A potentially important aspect of natural infections that has been ignored is that in nature vertebrates are typically exposed to the feeding of uninfected mosquitoes prior to the mosquito that transmits WNV. The possibility that pre-exposure to mosquito saliva might modulate WNV infection was explored. Principal Findings. Here we report that sensitization to mosquito saliva exacerbates viral infection. Prior exposure of mice to mosquito feeding resulted in increased mortality following WNV infection. This aggravated disease course was associated with enhanced early viral replication, increased interleukin-10 expression, and elevated influx of WNV-susceptible cell types to the inoculation site. This exacerbated disease course was mimicked by passive transfer of mosquito-sensitized serum. Significance. This is the first report that sensitization to arthropod saliva can exacerbate arthropod-borne infection, contrary to previous studies with parasite and bacteria infections. This research suggests that in addition to the seroreactivity of the host to virus, it is important to take into account the immune response to vector feeding.	[Schneider, Bradley S.; McGee, Charles E.; Jordan, Jeffrey M.; Stevenson, Heather L.; Soong, Lynn; Higgs, Stephen] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Galveston, TX USA; [Soong, Lynn] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Schneider, Bradley S.] Inst Pasteur, Paris, France	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Higgs, S (corresponding author), Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Galveston, TX USA.	sthiggs@utmb.edu		Stevenson, Heather/0000-0002-0645-7621; Schneider, Bradley S/0000-0001-7642-0018	Centers for Disease Control Fellowship Training Program in Vector-Borne Infectious Diseases [T01/CCT622892]; Zelda Zinn Casper Scholarship; Arthur V. Simmang Scholarship; Pasteur Foundation, New York, NY; National Institutes of Health [R01AI47246, AI47246]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047246] Funding Source: NIH RePORTER	Centers for Disease Control Fellowship Training Program in Vector-Borne Infectious Diseases; Zelda Zinn Casper Scholarship; Arthur V. Simmang Scholarship; Pasteur Foundation, New York, NY; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	B. S. Schneider, C. E. McGee, and H. L. Stevenson were supported by the Centers for Disease Control Fellowship Training Program in Vector-Borne Infectious Diseases T01/CCT622892. B. S. Schneider was also aided by the generous support of the Zelda Zinn Casper Scholarship and the Arthur V. Simmang Scholarship, and is currently funded by the Pasteur Foundation, New York, NY. This research was supported by the National Institutes of Health grant number R01AI47246 and, in part, by the National Institutes of Health grant number AI47246 to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley DWC, 2003, VIROLOGY, V309, P190, DOI 10.1016/S0042-6822(03)00150-8; Belkaid Y, 1998, J EXP MED, V188, P1941, DOI 10.1084/jem.188.10.1941; Belkaid Y, 1996, J IMMUNOL METHODS, V199, P5, DOI 10.1016/S0022-1759(96)00117-2; Brady MT, 2003, EUR J IMMUNOL, V33, P3448, DOI 10.1002/eji.200324251; Busch MP, 2006, EMERG INFECT DIS, V12, P395, DOI 10.3201/eid1203.051287; Byrne SN, 2001, J INVEST DERMATOL, V117, P702, DOI 10.1046/j.0022-202x.2001.01454.x; Chambers TJ, 2003, ADV VIRUS RES, V60, P273, DOI 10.1016/S0065-3527(03)60008-4; CHAMBERS TJ, 2003, FLAVIVIRUSES PATHOGE, P486; Chen YL, 1998, INT ARCH ALLERGY IMM, V116, P269, DOI 10.1159/000023955; Donovan MJ, 2007, INFECT IMMUN, V75, P2523, DOI 10.1128/IAI.01928-06; Edwards JF, 1998, J MED ENTOMOL, V35, P261, DOI 10.1093/jmedent/35.3.261; Ejrnaes M, 2006, J EXP MED; ENK AH, 1993, J IMMUNOL, V151, P2390; Griffiths PD, 2002, REV MED VIROL, V12, P197, DOI 10.1002/rmv.364; Higgs S, 2005, P NATL ACAD SCI USA, V102, P8871, DOI 10.1073/pnas.0503835102; Johnston LJ, 2000, J INVEST DERMATOL, V114, P560, DOI 10.1046/j.1523-1747.2000.00904.x; Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351; Limesand KH, 2000, PARASITE IMMUNOL, V22, P461, DOI 10.1046/j.1365-3024.2000.00326.x; MACATONIA SE, 1993, J IMMUNOL, V150, P3755; Peng ZK, 2004, ANN ALLERG ASTHMA IM, V93, P553, DOI 10.1016/S1081-1206(10)61262-8; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; ROSSIGNOL PA, 1984, AM J TROP MED HYG, V33, P17, DOI 10.4269/ajtmh.1984.33.17; Salek-Ardakani S, 2002, VIROLOGY, V304, P342, DOI 10.1006/viro.2002.1716; Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74; Schneider BS, 2004, VIRAL IMMUNOL, V17, P565, DOI 10.1089/vim.2004.17.565; SCHNEIDER BS, TO1CCT622892; Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; SITATI EM, 2006, J VIROL; TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436; TURELL MJ, 1995, J MED ENTOMOL, V32, P563, DOI 10.1093/jmedent/32.4.563; Vanlandingham DL, 2004, AM J TROP MED HYG, V71, P120, DOI 10.4269/ajtmh.2004.71.120; Wasserman HA, 2004, PARASITE IMMUNOL, V26, P295, DOI 10.1111/j.0141-9838.2004.00712.x; Wikel SK, 1997, INFECT IMMUN, V65, P335, DOI 10.1128/IAI.65.1.335-338.1997	34	55	58	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1171	10.1371/journal.pone.0001171	http://dx.doi.org/10.1371/journal.pone.0001171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000543	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459100013
J	Reinbold, M; Luo, JL; Nedelko, T; Jerchow, B; Murphy, ME; Whibley, C; Wei, Q; Hollstein, M				Reinbold, M.; Luo, J-L; Nedelko, T.; Jerchow, B.; Murphy, M. E.; Whibley, C.; Wei, Q.; Hollstein, M.			Common tumour p53 mutations in immortalized cells from Hupki mice heterozygous at codon 72	ONCOGENE			English	Article						lung cancer; mutation hotspot; embryonic broblasts; senescence; polymorphism	LUNG-CANCER; POLYMORPHIC VARIANTS; MURINE FIBROBLASTS; GENE-MUTATIONS; DNA-DAMAGE; HOT-SPOTS; TRANSVERSIONS; INHIBITION; HOTSPOTS; ADDUCTS	Codon 72 of human p53 gene is polymorphic, encoding arginine or proline. Here we report construction of a human p53 knock-in (Hupki) mouse encoding the codon 72(pro) variant. The new strain was crossed with the original Hupki mice (codon 72(arg/arg)) to obtain primary embryonic fibroblasts polymorphic at codon 72 or homozygous for codon 72(pro). The fibroblasts, cultured under standard conditions, immortalized within 12 weeks and acquired p53 mutations similarly to Hupki codon 72(arg/arg) cells investigated previously. Sequencing of human p53 exons 4-9 in immortalized cultures revealed missense mutations found repeatedly in human tumours. In cell lines ensuing from benzo(a) pyrene-treated cultures the combined p53 mutation pattern from experiments with the 3 codon 72 genotypes showed a predominance of strand-biased G to T transversions (18 of 36 mutations), and mutations recurring at smokers' lung tumour hotspot codons 157 and 273, supporting involvement of tobacco carcinogens in shaping the mutation signature in lung cancers of smokers. Mutations in cell lines from unexposed cultures did not cluster at these codons and G to T transversions were uncommon (2 of 52 mutations) (Fisher's exact test P < 0.0001). Most mutations (13/16) in cell lines derived from cells polymorphic at codon 72 were found on the proline allele, with loss of the arginine allele.	[Whibley, C.; Hollstein, M.] Univ Leeds, Fac Med & Hlth, LIGHT Labs, Leeds LS2 9JT, W Yorkshire, England; [Reinbold, M.; Nedelko, T.; Wei, Q.; Hollstein, M.] German Canc Res Ctr, Dept Genet Alternat Carcinogenesis, D-6900 Heidelberg, Germany; [Luo, J-L] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Jerchow, B.] Max Delbruck Ctr, Berlin, Germany; [Murphy, M. E.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	University of Leeds; Helmholtz Association; German Cancer Research Center (DKFZ); University of California System; University of California San Diego; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Fox Chase Cancer Center	Hollstein, M (corresponding author), Univ Leeds, Fac Med & Hlth, LIGHT Labs, Clarendon Way, Leeds LS2 9JT, W Yorkshire, England.	m.hollstein@leeds.ac.uk		Jerchow, Boris-Alexander/0000-0002-7031-8730; Murphy, Maureen/0000-0001-7644-7296	NATIONAL CANCER INSTITUTE [R01CA102184] Funding Source: NIH RePORTER; Cancer Research UK Funding Source: Medline; NCI NIH HHS [R01 CA102184] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Chen JX, 1998, CANCER RES, V58, P2070; Dearth LR, 2007, CARCINOGENESIS, V28, P289, DOI 10.1093/carcin/bgl132; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Denissenko MF, 1998, ONCOGENE, V16, P1241, DOI 10.1038/sj.onc.1201647; Denissenko MF, 1997, P NATL ACAD SCI USA, V94, P3893, DOI 10.1073/pnas.94.8.3893; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; Hu YC, 2005, CLIN CANCER RES, V11, P2502, DOI 10.1158/1078-0432.CCR-04-1913; Liu Zhipei, 2007, Genet Eng (N Y), V28, P45, DOI 10.1007/978-0-387-34504-8_3; Liu ZP, 2005, CANCER RES, V65, P2583, DOI 10.1158/0008-5472.CAN-04-3675; Liu ZP, 2004, P NATL ACAD SCI USA, V101, P2963, DOI 10.1073/pnas.0308607101; Luo JL, 2001, ONCOGENE, V20, P320, DOI 10.1038/sj.onc.1204080; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; Nelson HH, 2005, CARCINOGENESIS, V26, P1770, DOI 10.1093/carcin/bgi125; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Pfeifer GP, 2003, MUTAT RES-FUND MOL M, V526, P39, DOI 10.1016/S0027-5107(03)00013-7; Pietsch EC, 2006, ONCOGENE, V25, P1602, DOI 10.1038/sj.onc.1209367; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Storey A, 1998, NATURE, V393, P229, DOI 10.1038/30400; Szymanowska A, 2006, LUNG CANCER, V52, P9, DOI 10.1016/j.lungcan.2005.12.007; Thomas M, 1999, MOL CELL BIOL, V19, P1092; vom Brocke J, 2006, CARCINOGENESIS, V27, P2141, DOI 10.1093/carcin/bg1101; Zienolddiny S, 2001, BRIT J CANCER, V84, P226, DOI 10.1054/bjoc.2000.1528	29	33	33	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 24	2008	27	19					2788	2794		10.1038/sj.onc.1210932	http://dx.doi.org/10.1038/sj.onc.1210932			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	292IK	17998932	Green Accepted			2022-12-25	WOS:000255259500014
J	Connell, CM; Colnaghi, R; Wheatley, SP				Connell, Claire M.; Colnaghi, Rita; Wheatley, Sally P.			Nuclear survivin has reduced stability and is not cytoprotective	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICE VARIANTS; SUBCELLULAR-LOCALIZATION; AURORA-B; DEGRADATION; PROTEIN; APOPTOSIS; MITOSIS; EXPORT; PHOSPHORYLATION; EXPRESSION	Survivin is an essential mitotic protein that is overexpressed in many cancers, and its presence is correlated with increased resistance to radiation and chemotherapy. Here we demonstrate that sending survivin into the nucleus accelerates its degradation in a cdh1-dependent manner, abolishes the radio resistance normally conferred to cells by its overexpression, and prevents survivin from inhibiting apoptosis without affecting its mitotic localization. Our data suggest that targeting survivin to the nucleus provides an efficient means of eliminating it from the cell and may prove a novel strategy in cancer treatment, particularly in combination with radiotherapy.	[Connell, Claire M.; Colnaghi, Rita; Wheatley, Sally P.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sussex	Wheatley, SP (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	s.p.wheatley@sussex.ac.uk			Medical Research Council [G0300662B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Arora V, 2007, J BIOL CHEM, V282, P26202, DOI 10.1074/jbc.M700776200; Caldas H, 2005, ONCOGENE, V24, P1994, DOI 10.1038/sj.onc.1208350; Colnaghi R, 2006, J BIOL CHEM, V281, P33450, DOI 10.1074/jbc.C600164200; Joseph TW, 2003, FASEB J, V17, P1622, DOI 10.1096/fj.02-0931com; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Knauer SK, 2007, CELL CYCLE, V6, P518, DOI 10.4161/cc.6.5.3902; Knauer SK, 2007, FASEB J, V21, P207, DOI 10.1096/fj.06-5741com; Li FZ, 2005, INT J CANCER, V114, P509, DOI 10.1002/ijc.20768; Mahotka C, 1999, CANCER RES, V59, P6097; Mahotka C, 2002, CELL DEATH DIFFER, V9, P1334, DOI 10.1038/sj.cdd.4401091; Mollinari C, 2003, DEV CELL, V5, P295, DOI 10.1016/S1534-5807(03)00205-3; Munoz-Fontela C, 2003, BIOCHEM J, V374, P545, DOI 10.1042/BJ20021890; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Noton EA, 2006, J BIOL CHEM, V281, P1286, DOI 10.1074/jbc.M508773200; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Rodriguez JA, 2006, ONCOGENE, V25, P4867, DOI 10.1038/sj.onc.1209499; Rodriguez JA, 2002, EXP CELL RES, V275, P44, DOI 10.1006/excr.2002.5492; Stauber RH, 2006, TRAFFIC, V7, P1461, DOI 10.1111/j.1600-0854.2006.00486.x; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Temme A, 2007, CANCER LETT, V250, P177, DOI 10.1016/j.canlet.2006.09.020; Weinstein J, 1997, J BIOL CHEM, V272, P28501, DOI 10.1074/jbc.272.45.28501; Wheatley SP, 2001, CURR BIOL, V11, P886, DOI 10.1016/S0960-9822(01)00238-X; Zhao J, 2000, J CELL SCI, V113, P4363; Zhou Y, 2003, J BIOL CHEM, V278, P12530, DOI 10.1074/jbc.M212853200	24	61	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3289	3296		10.1074/jbc.M704461200	http://dx.doi.org/10.1074/jbc.M704461200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18057009	hybrid, Green Accepted			2022-12-25	WOS:000253083000033
J	Lehner, I; Basting, D; Meyer, B; Haase, W; Manolikas, T; Kaiser, C; Karas, M; Glaubitz, C				Lehner, Ines; Basting, Daniel; Meyer, Bjoern; Haase, Winfried; Manolikas, Theofanis; Kaiser, Christoph; Karas, Michael; Glaubitz, Clemens			The key residue for substrate transport (Glu(14)) in the EmrE dimer is asymmetric	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL MULTIDRUG TRANSPORTER; CARBON-CARBON CONNECTIVITIES; ANTISEPTIC-RESISTANCE GENES; CELL-FREE EXPRESSION; ESCHERICHIA-COLI; MEMBRANE-PROTEIN; SECONDARY STRUCTURE; LIGAND-BINDING; EFFLUX PUMP; ANTIPORTER	Transport proteins exhibiting broad substrate specificities are major determinants for the phenomenon of multidrug resistance. The Escherichia coli multidrug transporter EmrE, a 4-transmembrane, helical 12-kDa membrane protein, forms a functional dimer to transport a diverse array of aromatic, positively charged substrates in a proton/drug antiport fashion. Here, we report C-13 chemical shifts of the essential residue Glu(14) within the binding pocket. To ensure a native environment, EmrE was reconstituted into E. coli lipids. Experiments were carried out using one- and two-dimensional double quantum filtered C-13 solid state NMR. For an unambiguous assignment of Glu(14), an E25A mutation was introduced to create a single glutamate mutant. Glu(14) was C-13-labeled using cell-free expression. Purity, labeling, homogeneity, and functionality were probed by mass spectrometry, NMR spectroscopy, freeze fracture electron microscopy, and transport assays. For Glu(14), two distinct sets of chemical shifts were observed that indicates structural asymmetry in the binding pocket of homodimeric EmrE. Upon addition of ethidium bromide, chemical shift changes and altered line shapes were observed, demonstrating substrate coordination by both Glu(14) in the dimer.	[Lehner, Ines; Basting, Daniel; Manolikas, Theofanis; Kaiser, Christoph; Glaubitz, Clemens] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Lehner, Ines; Manolikas, Theofanis; Kaiser, Christoph; Glaubitz, Clemens] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany; [Haase, Winfried] Max Planck Inst Biophys, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Max Planck Society	Glaubitz, C (corresponding author), Max Von Laue Str 9, D-60438 Frankfurt, Germany.	glaubitz@em.uni-frankfurt.de	Glaubitz, Clemens/D-5714-2011	Glaubitz, Clemens/0000-0002-3554-6586				Alam MM, 2003, MICROB DRUG RESIST, V9, P109, DOI 10.1089/107662903765826697; Arkin IT, 1996, BIOCHEMISTRY-US, V35, P7233, DOI 10.1021/bi960094i; Basting D, 2008, FASEB J, V22, P365, DOI 10.1096/fj.07-9162com; Betz M, 2004, BIOCHEMISTRY-US, V43, P5820, DOI 10.1021/bi049948m; Bockmann A, 2003, J BIOMOL NMR, V27, P323, DOI 10.1023/A:1025820611009; Butler PJG, 2004, J MOL BIOL, V340, P797, DOI 10.1016/j.jmb.2004.05.014; Carravetta M, 2001, J AM CHEM SOC, V123, P10628, DOI 10.1021/ja016027f; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DROBNY G, 1979, FARADAY DIV CHEM SOC, V13, P49; Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; GRINIUS LL, 1994, J BIOL CHEM, V269, P29998; Gutman N, 2003, J BIOL CHEM, V278, P16082, DOI 10.1074/jbc.M213120200; Hong M, 2003, BIOPOLYMERS, V70, P158, DOI 10.1002/bip.10431; Jack DL, 2000, J BACTERIOL, V182, P2311, DOI 10.1128/JB.182.8.2311-2313.2000; Kikukawa T, 2006, BBA-BIOMEMBRANES, V1758, P673, DOI 10.1016/j.bbamem.2006.04.004; Klammt C, 2005, FEBS J, V272, P6024, DOI 10.1111/j.1742-4658.2005.05002.x; Klammt C, 2004, EUR J BIOCHEM, V271, P568, DOI 10.1111/j.1432-1033.2003.03959.x; Kobayashi M, 2006, J BIOMOL NMR, V36, P279, DOI 10.1007/s10858-006-9094-x; Koteiche HA, 2003, BIOCHEMISTRY-US, V42, P6099, DOI 10.1021/bi0342867; Krupka RM, 1999, J MEMBRANE BIOL, V167, P35, DOI 10.1007/s002329900469; Kunishima N, 2005, J MOL BIOL, V352, P212, DOI 10.1016/j.jmb.2005.07.008; le Coutre J, 1998, P NATL ACAD SCI USA, V95, P6114, DOI 10.1073/pnas.95.11.6114; Lesage A, 1999, J AM CHEM SOC, V121, P10987, DOI 10.1021/ja992272b; Lesage A, 1997, J AM CHEM SOC, V119, P7867, DOI 10.1021/ja971089k; Masaoka Y, 2000, J BACTERIOL, V182, P2307, DOI 10.1128/JB.182.8.2307-2310.2000; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; Ninio S, 2004, FEBS LETT, V562, P193, DOI 10.1016/S0014-5793(04)00240-6; Ninio S, 2003, J BIOL CHEM, V278, P12000, DOI 10.1074/jbc.M213119200; Noguchi N, 1999, FEMS MICROBIOL LETT, V172, P247, DOI 10.1111/j.1574-6968.1999.tb13475.x; PAULSEN IT, 1995, J BACTERIOL, V177, P2827, DOI 10.1128/jb.177.10.2827-2833.1995; PEROZO E, 1993, BIOCHEMISTRY-US, V32, P10471, DOI 10.1021/bi00090a025; Poget SF, 2007, J AM CHEM SOC, V129, P2432, DOI 10.1021/ja0679836; Poget SF, 2006, J BIOMOL NMR, V36, P10, DOI 10.1007/s10858-005-5346-4; Poole K, 2002, J APPL MICROBIOL, V92, p55S, DOI 10.1046/j.1365-2672.92.5s1.8.x; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Ratnala VRP, 2007, J AM CHEM SOC, V129, P867, DOI 10.1021/ja0652262; Rotem D, 2004, J BIOL CHEM, V279, P48787, DOI 10.1074/jbc.M408187200; Sachs RK, 2003, J BIOL CHEM, V278, P44222, DOI 10.1074/jbc.M307148200; Schuldiner S, 2001, NEWS PHYSIOL SCI, V16, P130; Schumacher MA, 2004, EMBO J, V23, P2923, DOI 10.1038/sj.emboj.7600288; Schwaiger M, 1998, EUR J BIOCHEM, V254, P610, DOI 10.1046/j.1432-1327.1998.2540610.x; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sikora CW, 2005, BIOPHYS J, V88, P475, DOI 10.1529/biophysj.104.049247; Soskine M, 2004, J BIOL CHEM, V279, P9951, DOI 10.1074/jbc.M312853200; Soskine M, 2002, P NATL ACAD SCI USA, V99, P12043, DOI 10.1073/pnas.192392899; Soskine M, 2006, J BIOL CHEM, V281, P36205, DOI 10.1074/jbc.M607186200; Straus SK, 1998, J BIOMOL NMR, V12, P39, DOI 10.1023/A:1008280716360; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tate CG, 2001, EMBO J, V20, P77, DOI 10.1093/emboj/20.1.77; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Van Bambeke F, 2000, BIOCHEM PHARMACOL, V60, P457, DOI 10.1016/S0006-2952(00)00291-4; VANIWAARDEN PR, 1993, BIOCHEMISTRY-US, V32, P5419, DOI 10.1021/bi00071a017; WANG J, 1994, P NATL ACAD SCI USA, V91, P7242, DOI 10.1073/pnas.91.15.7242; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Yerushalmi H, 2001, J BIOL CHEM, V276, P12744, DOI 10.1074/jbc.M010979200; Yerushalmi H, 1996, J BIOL CHEM, V271, P31044, DOI 10.1074/jbc.271.49.31044; Zhang FL, 2005, J MAGN RESON, V174, P219, DOI 10.1016/j.jmr.2005.02.013; Zhang ZG, 2007, BIOCHEMISTRY-US, V46, P5218, DOI 10.1021/bi7001604	65	43	43	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3281	3288		10.1074/jbc.M707899200	http://dx.doi.org/10.1074/jbc.M707899200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18042544	hybrid			2022-12-25	WOS:000253083000032
J	Watanabe, N; Lam, E				Watanabe, Naohide; Lam, Eric			BAX inhibitor-1 modulates endoplasmic reticulum stress-mediated programmed cell death in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; SYSTEMIC ACQUIRED-RESISTANCE; CHEMICAL CHAPERONES; MOLECULAR CHARACTERIZATION; PLANT HOMOLOG; ORYZA-SATIVA; BARLEY ROOTS; SALT STRESS; APOPTOSIS; YEAST	The components and pathways that regulate programmed cell death (PCD) in plants remain poorly understood. Here we describe the impact of drug-induced endoplasmic reticulum ( ER) stress on Arabidopsis seedlings and present evidence for the role of Arabidopsis BAX inhibitor-1 (AtBI1) as a modulator of ER stress-mediated PCD. We found that treatment of Arabidopsis seedlings with tunicamycin (TM), an inhibitor of N-linked glycosylation and an inducer of ER stress by triggering accumulation of unfolded proteins in the ER, results in strong inhibition of root growth and loss of survival accompanied by typical hallmarks of PCD such as accumulation of H2O2, chromatin condensation, and oligonucleosomal fragmentation of nuclear DNA. These phenotypes are alleviated by co-treatment with either of two different chemical chaperones, sodium 4-phenylbutyrate and tauroursodeoxycholic acid, both with chaperone properties that can reduce the load of misfolded protein in the ER. Expression of AtBI1 mRNA and its promoter activity are increased dramatically prior to initiation of TM-induced PCD. Compared with wild-type plants, two AtBI1 mutants (atbi1-1 and atbi1-2) exhibit hypersensitivity to TM with accelerated PCD progression. Conversely, overexpressing AtBI1 markedly reduces the sensitivity of Arabidopsis seedlings to TM. However, alterations in AtBI1 gene expression levels do not cause a significant effect on the expression patterns of typical ER stress-inducible genes (AtBip2, AtPDI, AtCRT1, and AtCNX1). We propose that AtBI1 plays a pivotal role as a highly conserved survival factor during ER stress that acts in parallel to the unfolded protein response pathway.	[Watanabe, Naohide; Lam, Eric] Rutgers State Univ, Biotechnol Ctr Agr & Environm, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Lam, E (corresponding author), Rutgers State Univ, Biotechnol Ctr Agr & Environm, 59 Dudley Rd, New Brunswick, NJ 08901 USA.	lam@aesop.rutgers.edu						Baek D, 2004, PLANT MOL BIOL, V56, P15, DOI 10.1007/s11103-004-3096-4; Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Bolduc N, 2003, PLANTA, V216, P377, DOI 10.1007/s00425-002-0879-1; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; Chae HJ, 2003, GENE, V323, P101, DOI 10.1016/j.gene.2003.09.011; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crosti P, 2001, PROTOPLASMA, V216, P31, DOI 10.1007/BF02680128; Danon A, 2004, J BIOL CHEM, V279, P779, DOI 10.1074/jbc.M304468200; de Almeida SF, 2007, J BIOL CHEM, V282, P27905, DOI 10.1074/jbc.M702672200; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; Deshmukh S, 2006, P NATL ACAD SCI USA, V103, P18450, DOI 10.1073/pnas.0605697103; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Gallois P, 1997, PLANT J, V11, P1325, DOI 10.1046/j.1365-313X.1997.11061325.x; Hofius D, 2007, SEMIN CANCER BIOL, V17, P166, DOI 10.1016/j.semcancer.2006.12.001; Huckelhoven R, 2004, APOPTOSIS, V9, P299, DOI 10.1023/B:APPT.0000025806.71000.1c; Huckelhoven R, 2003, P NATL ACAD SCI USA, V100, P5555, DOI 10.1073/pnas.0931464100; Huh GH, 2002, PLANT J, V29, P649, DOI 10.1046/j.0960-7412.2001.01247.x; Ihara-Ohori Y, 2007, PLANT PHYSIOL, V143, P650, DOI 10.1104/pp.106.090878; Iwata Y, 2005, P NATL ACAD SCI USA, V102, P5280, DOI 10.1073/pnas.0408941102; Iwata Y, 2005, PLANTA, V220, P804, DOI 10.1007/s00425-004-1479-z; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jelitto-Van Dooren EPWM, 1999, PLANT CELL, V11, P1935, DOI 10.2307/3871088; Jin C, 2002, NAT REV MOL CELL BIO, V3, P453, DOI 10.1038/nrm832; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Katsuhara M, 1997, PLANT CELL PHYSIOL, V38, P1091, DOI 10.1093/oxfordjournals.pcp.a029277; Katsuhara M, 1996, PLANT CELL PHYSIOL, V37, P169, DOI 10.1093/oxfordjournals.pcp.a028928; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kawai M, 1999, FEBS LETT, V464, P143, DOI 10.1016/S0014-5793(99)01695-6; Kawai-Yamada M, 2005, J BIOL CHEM, V280, P39468, DOI 10.1074/jbc.M509632200; Kawai-Yamada M, 2004, PLANT CELL, V16, P21, DOI 10.1105/tpc.014613; Kawai-Yamada M, 2001, P NATL ACAD SCI USA, V98, P12295, DOI 10.1073/pnas.211423998; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; Koizumi N, 2001, PLANT PHYSIOL, V127, P949, DOI 10.1104/pp.010636; Kubota K, 2006, J NEUROCHEM, V97, P1259, DOI 10.1111/j.1471-4159.2006.03782.x; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lawen A, 2003, BIOESSAYS, V25, P888, DOI 10.1002/bies.10329; Lee GH, 2007, J BIOL CHEM, V282, P21618, DOI 10.1074/jbc.M700053200; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Matsumura H, 2003, PLANT J, V33, P425, DOI 10.1046/j.1365-313X.2003.01639.x; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Okushima Y, 2002, PLANT CELL PHYSIOL, V43, P532, DOI 10.1093/pcp/pcf063; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; PULLEN GR, 1981, J IMMUNOL METHODS, V43, P87, DOI 10.1016/0022-1759(81)90039-9; Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339; Ryerson DE, 1996, PLANT CELL, V8, P393, DOI 10.1105/tpc.8.3.393; Sanchez P, 2000, PLANT J, V21, P393, DOI 10.1046/j.1365-313x.2000.00690.x; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; Watanabe N, 2004, MOL PLANT PATHOL, V5, P65, DOI 10.1111/j.1364-3703.2004.00206.x; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; Westphalen BC, 2005, CELL DEATH DIFFER, V12, P304, DOI 10.1038/sj.cdd.4401547; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Zuppini A, 2004, J CELL SCI, V117, P2591, DOI 10.1242/jcs.01126	60	162	170	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3200	3210		10.1074/jbc.M706659200	http://dx.doi.org/10.1074/jbc.M706659200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18039663	hybrid			2022-12-25	WOS:000253083000023
J	Osborne, SL; Wen, PJ; Boucheron, C; Nguyen, HN; Hayakawa, M; Kaizawa, H; Parker, PJ; Vitale, N; Meunier, FA				Osborne, Shona L.; Wen, Peter J.; Boucheron, Christine; Nguyen, Hao N.; Hayakawa, Masahiko; Kaizawa, Hiroyuki; Parker, Peter J.; Vitale, Nicolas; Meunier, Frederic A.			PIKfyve negatively regulates exocytosis in neurosecretory cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-PHOSPHATE 5-KINASE; PROTEIN-KINASE; PLASMA-MEMBRANE; LOCALIZATION; PHOSPHOINOSITIDES; PHOSPHORYLATION; IDENTIFICATION; METABOLISM; GRANULES; KINETICS	Regulated secretion depends upon a highly coordinated series of protein-protein and protein-lipid interactions. Two phosphoinositides, phosphatidylinositol 4,5- bisphosphate and phosphatidylinositol 3-phosphate, are important for the ATP-dependent priming of the secretory apparatus prior to Ca2+-dependent exocytosis. Mechanisms that control phosphoinositide levels are likely to play an important role in priming fine tuning. Here we have investigated the involvement of PIKfyve, a phosphoinositide 5- kinase that can phosphorylate phosphatidylinositol 3-phosphate to produce phosphatidylinositol 3,5- bisphosphate on large dense core vesicle exocytosis from neuroendocrine cells. PIKfyve localizes to a subpopulation of secretory granules in chromaffin and PC12 cells. Nicotine stimulation promoted recruitment of PIKfyve-EGFP onto secretory vesicles in PC12 cells. YM-201636, a selective inhibitor of PIKfyve activity, and PIKfyve knockdown by small interfering RNA potentiated secretory granule exocytosis. Overexpression of PIKfyve or its yeast orthologue Fab1p inhibited regulated secretion in PC12 cells, whereas a catalytically inactive PIKfyve mutant had no effect. These results demonstrate a novel inhibitory role for PIKfyve catalytic activity in regulated secretion and provide further evidence for a fine tuning of exocytosis by 3-phosphorylated phosphoinositides.	[Osborne, Shona L.; Wen, Peter J.; Nguyen, Hao N.; Meunier, Frederic A.] Univ Queensland, Queensland Brain Inst, Mol Dynam Synapt Funct Lab, Brisbane, Qld 4072, Australia; [Osborne, Shona L.; Wen, Peter J.; Nguyen, Hao N.; Meunier, Frederic A.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Boucheron, Christine; Parker, Peter J.] Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, London WC2A 3PX, England; [Hayakawa, Masahiko; Kaizawa, Hiroyuki] Astellas Pharma Inc, Tsukuba, Ibaraki 3058585, Japan; [Vitale, Nicolas] CNRS, UMR 7168 LC2, Inst Neurosci Cellulaires & Integrat, Dept Neurotransmiss & Secret Neuroendocrine, F-67084 Strasbourg, France	University of Queensland; University of Queensland; Cancer Research UK; Astellas Pharmaceuticals; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Meunier, FA (corresponding author), Univ Queensland, Queensland Brain Inst, Mol Dynam Synapt Funct Lab, Brisbane, Qld 4072, Australia.	f.meunier@uq.edu.au	Meunier, Frederic A/C-8161-2009; Osborne, Shona/C-8290-2009; Parker, Peter j/D-5192-2013; Vitale, Nicolas/G-5967-2014	Meunier, Frederic A/0000-0001-6400-1107; Vitale, Nicolas/0000-0002-4752-4907; parker, peter/0000-0002-6218-2933; Osborne, Shona/0000-0002-7012-9278				Berwick DC, 2004, J CELL SCI, V117, P5985, DOI 10.1242/jcs.01517; BON S, 1990, EUR J BIOCHEM, V190, P221, DOI 10.1111/j.1432-1033.1990.tb15567.x; BURGOYNE RD, 1992, INVESTIGATION INTRAC; Cabezas A, 2006, GENE, V371, P34, DOI 10.1016/j.gene.2005.11.009; Clague MJ, 2005, TRAFFIC, V6, P1063, DOI 10.1111/j.1600-0854.2005.00338.x; Cockcroft S, 2001, SEMIN CELL DEV BIOL, V12, P183, DOI 10.1006/scdb.2000.0235; Cooke FT, 2002, ARCH BIOCHEM BIOPHYS, V407, P143, DOI 10.1016/S0003-9861(02)00487-3; Cooke FT, 1998, CURR BIOL, V8, P1219, DOI 10.1016/S0960-9822(07)00513-1; Cremona O, 2001, J CELL SCI, V114, P1041; DITTIE AS, 1995, BIOCHEM J, V310, P777, DOI 10.1042/bj3100777; Evans GJO, 2006, J BIOL CHEM, V281, P1564, DOI 10.1074/jbc.M503628200; Friant S, 2003, DEV CELL, V5, P499, DOI 10.1016/S1534-5807(03)00238-7; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Ikonomov NC, 2007, EXP CELL RES, V313, P2404, DOI 10.1016/j.yexcr.2007.03.024; Ikonomov OC, 2002, ENDOCRINOLOGY, V143, P4742, DOI 10.1210/en.2002-220615; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Ishiki M, 2005, J BIOL CHEM, V280, P28792, DOI 10.1074/jbc.M500501200; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Kong AM, 2006, MOL CELL BIOL, V26, P6065, DOI 10.1128/MCB.00203-06; Latham CF, 2007, INT J BIOCHEM CELL B, V39, P1576, DOI 10.1016/j.biocel.2006.11.015; Latham CF, 2007, J NEUROCHEM, V100, P1543, DOI 10.1111/j.1471-4159.2006.04286.x; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; McEwen RK, 1999, J BIOL CHEM, V274, P33905, DOI 10.1074/jbc.274.48.33905; McGuinness L, 2003, ENDOCRINOLOGY, V144, P720, DOI 10.1210/en.2002-220847; Meunier FA, 2005, MOL BIOL CELL, V16, P4841, DOI 10.1091/mbc.E05-02-0171; Meunier FA, 2002, EMBO J, V21, P6733, DOI 10.1093/emboj/cdf677; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Osborne SL, 2007, MOL CELL PROTEOMICS, V6, P1158, DOI 10.1074/mcp.M600430-MCP200; Osborne SL, 2006, J NEUROCHEM, V98, P336, DOI 10.1111/j.1471-4159.2006.03892.x; Osborne SL, 2001, NEURON, V32, P9, DOI 10.1016/S0896-6273(01)00455-X; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sbrissa D, 2000, BIOCHEMISTRY-US, V39, P15980, DOI 10.1021/bi001897f; Shisheva A, 2001, J BIOL CHEM, V276, P11859, DOI 10.1074/jbc.M008437200; Shisheva A, 2001, CELL BIOL INT, V25, P1201, DOI 10.1006/cbir.2001.0803; Shisheva A, 1999, MOL CELL BIOL, V19, P623; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sugita S, 2004, METHODS, V33, P267, DOI 10.1016/j.ymeth.2004.01.005; Tooze SA, 2001, TRENDS CELL BIOL, V11, P116, DOI 10.1016/S0962-8924(00)01907-3; Tsuboi T, 2007, GENES CELLS, V12, P511, DOI 10.1111/j.1365-2443.2007.01070.x; Vitale N, 2005, J BIOL CHEM, V280, P29921, DOI 10.1074/jbc.M413748200; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101	50	41	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2804	2813		10.1074/jbc.M704856200	http://dx.doi.org/10.1074/jbc.M704856200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18039667	hybrid			2022-12-25	WOS:000252622300038
J	Taylor, PL; Blakely, KM; De Leon, GP; Walker, JR; McArthur, F; Evdokimova, E; Zhang, K; Valvano, MA; Wright, GD; Junop, MS				Taylor, Patricia L.; Blakely, Kim M.; De Leon, Gladys P.; Walker, John R.; McArthur, Fiona; Evdokimova, Elena; Zhang, Kun; Valvano, Miguel A.; Wright, Gerard D.; Junop, Murray S.			Structure and function of sedoheptulose-7-phosphate isomerase, a critical enzyme for lipopolysaccharide biosynthesis and a target for antibiotic adjuvants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-MANNO-HEPTOSE; OUTER-MEMBRANE PERMEABILITY; ESCHERICHIA-COLI; PHOSPHOHEPTOSE ISOMERASE; SALMONELLA-TYPHIMURIUM; PHOSPHOGLUCOSE ISOMERASE; MOLECULAR-BASIS; IN-VIVO; CORE; GENE	The barrier imposed by lipopolysaccharide (LPS) in the outer membrane of Gram-negative bacteria presents a significant challenge in treatment of these organisms with otherwise effective hydrophobic antibiotics. The absence of L-glycero-D-manno-heptose in the LPS molecule is associated with a dramatically increased bacterial susceptibility to hydrophobic antibiotics and thus enzymes in the ADP-heptose biosynthesis pathway are of significant interest. GmhA catalyzes the isomerization of D-sedoheptulose 7-phosphate into D-glycero-Dmannoheptose 7-phosphate, the first committed step in the formation of ADP-heptose. Here we report structures of GmhA from Escherichia coli and Pseudomonas aeruginosa in apo,substrate, and product-bound forms, which together suggest that GmhA adopts two distinct conformations during isomerization through reorganization of quaternary structure. Biochemical characterization of GmhA mutants, combined with in vivo analysis of LPS biosynthesis and novobiocin susceptibility, identifies key catalytic residues. We postulate GmhA acts through an enediol-intermediate isomerase mechanism.	[Taylor, Patricia L.; Blakely, Kim M.; De Leon, Gladys P.; Zhang, Kun; Wright, Gerard D.; Junop, Murray S.] McMaster Univ, Hlth Sci Ctr, Dept Biomed Chem & Biomed Sci, DeGroote Sch Med, Hamilton, ON L8N 3Z5, Canada; [Walker, John R.; Evdokimova, Elena] Ontario Ctr Struct Proteom, Best Inst, Toronto, ON M5G 1L6, Canada; [McArthur, Fiona] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada; [McArthur, Fiona; Valvano, Miguel A.] Univ Western Ontario, Dept Microbiol & Immunol, Siebens Drake Res Inst, Infect Dis Res Grp, London, ON N6A 5C1, Canada	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Structural Genomics Consortium; Western University (University of Western Ontario)	Junop, MS (corresponding author), McMaster Univ, Hlth Sci Ctr, Dept Biomed Chem & Biomed Sci, DeGroote Sch Med, 1200 Main St W,Rm 4N20A, Hamilton, ON L8N 3Z5, Canada.	junopm@mcmaster.ca	Junop, Murray S/E-4160-2015; Wright, G/ABB-7666-2021; Valvano, Miguel A/G-8759-2012; Perez-Ponce de Leon, Gerardo/U-3869-2017	Junop, Murray S/0000-0001-6676-5717; Valvano, Miguel A/0000-0001-8229-3641; Wright, Gerard/0000-0002-9129-7131; /0000-0002-5255-895X; Perez-Ponce de Leon, Gerardo/0000-0001-6472-5113				Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Berrisford JM, 2006, J MOL BIOL, V358, P1353, DOI 10.1016/j.jmb.2006.03.015; Brooke JS, 1996, J BIOL CHEM, V271, P3608; Brooke JS, 1996, J BACTERIOL, V178, P3339, DOI 10.1128/jb.178.11.3339-3341.1996; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; De Leon GP, 2006, CHEM BIOL, V13, P437, DOI 10.1016/j.chembiol.2006.02.010; EIDELS L, 1971, P NATL ACAD SCI USA, V68, P1673, DOI 10.1073/pnas.68.8.1673; EIDELS L, 1974, J BIOL CHEM, V249, P5642; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraternali F, 2002, NUCLEIC ACIDS RES, V30, P2950, DOI 10.1093/nar/gkf373; FUKUI K, 1988, BIOCHEMISTRY-US, V27, P6693, DOI 10.1021/bi00418a008; Grossman TH, 1998, GENE, V209, P95, DOI 10.1016/S0378-1119(98)00020-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kneidinger B, 2002, J BACTERIOL, V184, P363, DOI 10.1128/JB.184.2.363-369.2002; Kneidinger B, 2001, J BIOL CHEM, V276, P20935, DOI 10.1074/jbc.M100378200; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee S, 1999, J MOL CATAL B-ENZYM, V6, P369, DOI 10.1016/S1381-1177(98)00131-3; Loutet SA, 2006, J BACTERIOL, V188, P2073, DOI 10.1128/JB.188.6.2073-2080.2006; Marolda Cristina L., 2006, V347, P237; McArthur F, 2005, J BACTERIOL, V187, P5292, DOI 10.1128/JB.187.15.5292-5300.2005; Milewski S, 2006, ARCH BIOCHEM BIOPHYS, V450, P39, DOI 10.1016/j.abb.2006.03.019; Morrison JP, 2007, BIOCHEMISTRY-US, V46, P3916, DOI 10.1021/bi602641m; Murshudov GN, 1996, P CCP4 STUDY WEEKEND, P93; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; OGara M, 1997, EUR J BIOCHEM, V247, P1009, DOI 10.1111/j.1432-1033.1997.01009.x; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; QORONFLEH MW, 1995, J BIOTECHNOL, V39, P119, DOI 10.1016/0168-1656(94)00149-7; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Seetharaman J, 2006, PROTEINS, V63, P1092, DOI 10.1002/prot.20908; SIRISENA DM, 1994, J BACTERIOL, V176, P2379, DOI 10.1128/JB.176.8.2379-2385.1994; TAMAKI S, 1971, J BACTERIOL, V105, P968, DOI 10.1128/JB.105.3.968-975.1971; Teplyakov A, 1998, STRUCTURE, V6, P1047, DOI 10.1016/S0969-2126(98)00105-1; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valvano MA, 2000, J BACTERIOL, V182, P488, DOI 10.1128/JB.182.2.488-497.2000; Valvano MA, 2002, MICROBIOL-SGM, V148, P1979, DOI 10.1099/00221287-148-7-1979; Wright GD, 2007, TRENDS MOL MED, V13, P260, DOI 10.1016/j.molmed.2007.04.004; Yethon J. A., 2001, Current Drug Targets - Infectious Disorders, V1, P91, DOI 10.2174/1568005014606143	44	56	60	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2835	2845		10.1074/jbc.M706163200	http://dx.doi.org/10.1074/jbc.M706163200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18056714	hybrid			2022-12-25	WOS:000252622300041
J	Johmura, Y; Osada, S; Nishizuka, M; Imagawa, M				Johmura, Yoshikazu; Osada, Shigehiro; Nishizuka, Makoto; Imagawa, Masayoshi			FAD24 acts in concert with histone acetyltransferase HBO1 to promote adipogenesis by controlling DNA replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CLONAL EXPANSION; STIMULATES ADIPOCYTE DIFFERENTIATION; ORIGIN RECOGNITION COMPLEX; PREADIPOCYTE DIFFERENTIATION; TRANSCRIPTIONAL REGULATION; CHROMATIN ASSOCIATION; GENE-EXPRESSION; BUDDING YEAST; 3T3-L1 CELLS; EARLY-STAGE	Preadipocytes differentiate into adipocytes through approximately two rounds of mitosis, referred to as mitotic clonal expansion (MCE), but the events early in the differentiation process are not fully understood. Previously, we identified and characterized a novel gene, fad24 (factor for adipocyte differentiation 24), induced to express at the early stages of adipocyte differentiation. Although fad24 clearly has crucial roles in adipogenesis, its precise functions remain unknown. Here we show that the knockdown of fad24 by RNAi in 3T3-L1 preadipocytes repressed MCE. Moreover, FAD24 interacts with HBO1, a histone acetyltransferase and positive regulator of DNA replication initiation. The knockdown of hbo1 repressed MCE and adipogenesis, indicating that FAD24 acts in concert with HBO1 to promote adipogenesis by controlling DNA replication. Regarding the molecular mechanisms behind the regulation of DNA replication by fad24, we revealed that FAD24 co- localizes with HBO1 to chromatin during late mitosis, which is when the pre-replication initiation complex is assembled. Furthermore, chromatin immunoprecipitation experiments indicated that FAD24 localizes to origins of DNA replication with HBO1. When fad24 expression was inhibited during adipocyte differentiation, the recruitment of HBO1 to origins of DNA replication was reduced. Thus, FAD24 controls DNA replication by recruiting HBO1 to origins of DNA replication and is required for MCE during adipocyte differentiation.	[Johmura, Yoshikazu; Osada, Shigehiro; Nishizuka, Makoto; Imagawa, Masayoshi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Mizuho Ku, Aichi 4678603, Japan	Nagoya City University	Imagawa, M (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Mizuho Ku, 3-1 Tanabe Dori, Aichi 4678603, Japan.	imagawa@phar.nagoya-cu.ac.jp						Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bjorntorp P, 1974, Horm Metab Res, VSuppl 4, P77; Burke TW, 2001, J BIOL CHEM, V276, P15397, DOI 10.1074/jbc.M011556200; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Du YCN, 2002, CELL, V109, P835, DOI 10.1016/S0092-8674(02)00773-0; Fajas L, 2002, DEV CELL, V3, P903, DOI 10.1016/S1534-5807(02)00360-X; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Hwang CS, 1997, ANNU REV CELL DEV BI, V13, P231, DOI 10.1146/annurev.cellbio.13.1.231; Iizuka M, 2006, MOL CELL BIOL, V26, P1098, DOI 10.1128/MCB.26.3.1098-1108.2006; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Imagawa M, 1999, BIOCHEM BIOPH RES CO, V254, P299, DOI 10.1006/bbrc.1998.9937; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Ladenburger EM, 2002, MOL CELL BIOL, V22, P1036, DOI 10.1128/MCB.22.4.1036-1048.2002; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishizuka M, 2002, BIOCHEM J, V361, P629, DOI 10.1042/0264-6021:3610629; Nishizuka M, 2003, J BIOL CHEM, V278, P15279, DOI 10.1074/jbc.M211479200; Nishizuka M, 2001, J BIOL CHEM, V276, P29625, DOI 10.1074/jbc.C100272200; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Okuno Y, 2001, EMBO J, V20, P4263, DOI 10.1093/emboj/20.15.4263; Patel YM, 2000, J BIOL CHEM, V275, P17653, DOI 10.1074/jbc.M910445199; REBECCA KR, 2006, MOL CELL BIOL, V26, P3707; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2002, ANN NY ACAD SCI, V979, P143, DOI 10.1111/j.1749-6632.2002.tb04875.x; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Stedman W, 2004, J VIROL, V78, P12566, DOI 10.1128/JVI.78.22.12566-12575.2004; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tominaga K, 2004, J CELL SCI, V117, P6217, DOI 10.1242/jcs.01546; Tominaga K, 2004, FEBS LETT, V577, P49, DOI 10.1016/j.febslet.2004.09.062; Tominaga K, 2004, J BIOL CHEM, V279, P34840, DOI 10.1074/jbc.M312927200; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; Wiper-Bergeron N, 2003, EMBO J, V22, P2135, DOI 10.1093/emboj/cdg218; Yoo EJ, 2006, J BIOL CHEM, V281, P6608, DOI 10.1074/jbc.M508982200; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101; Zhang YX, 2002, CELL, V109, P849, DOI 10.1016/S0092-8674(02)00805-X	54	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2265	2274		10.1074/jbc.M707880200	http://dx.doi.org/10.1074/jbc.M707880200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18029353	hybrid			2022-12-25	WOS:000252501000054
J	Soundararajan, R; Wishart, AD; Rupasinghe, HPV; Arcellana-Panlilio, M; Nelson, CM; Mayne, M; Robertson, GS				Soundararajan, Ramani; Wishart, Alexander D.; Rupasinghe, H. P. Vasantha; Arcellana-Panlilio, Mayi; Nelson, Carolanne M.; Mayne, Michael; Robertson, George S.			Quercetin 3-glucoside protects neuroblastoma (SH-SY5Y) cells in vitro against oxidative damage by inducing sterol regulatory element-binding protein-2-mediated cholesterol biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; LIPID-PEROXIDATION; LDL-RECEPTOR; ANTIOXIDANT ACTIVITY; INDUCED APOPTOSIS; GENE-EXPRESSION; OXYGEN RADICALS; HEPG2 CELLS; FLAVONOIDS; MEMBRANE	The flavonoid quercetin 3-glucoside (Q3G) protected SH-SY5Y, HEK293, and MCF-7 cells against hydrogen peroxide-induced oxidative stress. cDNA microarray studies suggested that Q3G-pretreated cells subjected to oxidative stress up-regulate the expression of genes associated with lipid and cholesterol biosynthesis. Q3G pretreatment elevated both the expression and activation of sterol regulatory element-binding protein-2 (SREBP-2) only in SH-SY5Y cells subjected to oxidative stress. Inhibition of SREBP-2 expression by small interfering RNA or small molecule inhibitors of 2,3-oxidosqualene: lanosterol cyclase or HMG-CoA reductase blocked Q3G-mediated cytoprotection in SH-SY5Y cells. By contrast, Q3G did not protect either HEK293 or MCF-7 cells via this signaling pathway. Moreover, the addition of isopentenyl pyrophosphate rescued SH-SY5Y cells from the inhibitory effect of HMG-CoA reductase inhibition. Last, Q3G pretreatment enhanced the incorporation of [C-14] acetate into [C-14] cholesterol in SH-SY5Y cells under oxidative stress. Taken together, these studies suggest a novel mechanism for flavonoid-induced cytoprotection in SH-SY5Y cells involving SREBP-2-mediated sterol synthesis that decreases lipid peroxidation by maintaining membrane integrity in the presence of oxidative stress.	[Robertson, George S.] Dalhousie Univ, Dept Pharmacol & Psychiat, Halifax, NS B3H 1X5, Canada; [Soundararajan, Ramani; Wishart, Alexander D.; Robertson, George S.] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 1X5, Canada; [Rupasinghe, H. P. Vasantha] Nova Scotia Agr Coll, Dept Environm Sci, Truro, NS B2N 5E3, Canada; [Arcellana-Panlilio, Mayi] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Nelson, Carolanne M.] Univ Prince Edward Isl, Dept Family & Nutr Sci, Charlottetown, PE C1A 4P3, Canada; [Mayne, Michael] Natl Res Council Canada, Inst Nutrisci & Hlth, Charlottetown, PE C1A 5T1, Canada	Dalhousie University; Dalhousie University; Dalhousie University; University of Calgary; University of Prince Edward Island; National Research Council Canada	Robertson, GS (corresponding author), Dalhousie Univ, Dept Pharmacol & Psychiat, Sir Charles Tupper Med Bldg,5850 Coll St, Halifax, NS B3H 1X5, Canada.	George.Robertson@dal.ca	Rupasinghe, H.P. Vasantha/B-6049-2013; Arcellana-Panlilio, Mayi/AGZ-0728-2022	Rupasinghe, H.P. Vasantha/0000-0003-3435-0052; Arcellana-Panlilio, Mayi/0000-0003-4829-8873; Robertson, George/0000-0001-8411-7721				AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; Angeloni C, 2007, BIOCHIMIE, V89, P73, DOI 10.1016/j.biochi.2006.09.006; Ayala-Grosso C, 2002, BRAIN PATHOL, V12, P430; Beyea MM, 2007, J BIOL CHEM, V282, P5207, DOI 10.1074/jbc.M611063200; Boyer J, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-5; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Bursill CA, 2006, J AGR FOOD CHEM, V54, P1621, DOI 10.1021/jf051736o; CATTEL L, 1986, LIPIDS, V21, P31, DOI 10.1007/BF02534300; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Choi YJ, 2005, J NUTR, V135, P707, DOI 10.1093/jn/135.4.707; Chow JM, 2005, BIOCHEM PHARMACOL, V69, P1839, DOI 10.1016/j.bcp.2005.03.017; Dajas F, 2003, BRAZ J MED BIOL RES, V36, P1613, DOI 10.1590/S0100-879X2003001200002; Davalos A, 2006, J NUTR, V136, P1766, DOI 10.1093/jn/136.7.1766; Dhakshinamoorthy S, 2000, CURR TOP CELL REGUL, V36, P201; Endo A, 2004, ATHEROSCLEROSIS SUPP, V5, P67, DOI 10.1016/j.atherosclerosissup.2004.08.026; Fan CL, 2006, PHARMACOL REP, V58, P577; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Girotti AW, 1998, J LIPID RES, V39, P1529; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Grand-Perret T, 2001, NAT MED, V7, P1332, DOI 10.1038/nm1201-1332; Gutteridge JMC, 2000, ANN NY ACAD SCI, V899, P136, DOI 10.1111/j.1749-6632.2000.tb06182.x; HALLIWELL B, 1993, HAEMOSTASIS, V23, P118; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Higashi Y, 2003, J BIOL CHEM, V278, P21450, DOI 10.1074/jbc.M301376200; Incardona JP, 2000, CURR OPIN CELL BIOL, V12, P193, DOI 10.1016/S0955-0674(99)00076-9; Ishige K, 2001, FREE RADICAL BIO MED, V30, P433, DOI 10.1016/S0891-5849(00)00498-6; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jacob RF, 2005, J BIOL CHEM, V280, P39380, DOI 10.1074/jbc.M507587200; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jeong YJ, 2005, BRIT J NUTR, V93, P581, DOI 10.1079/BJN20041397; Kang SS, 2004, BIOORG MED CHEM LETT, V14, P2261, DOI 10.1016/j.bmcl.2004.02.003; Kuhn DJ, 2004, BBA-MOL CELL BIOL L, V1682, P1, DOI 10.1016/j.bbalip.2003.12.006; Lopez-Revuelta A, 2006, CHEM-BIOL INTERACT, V161, P79, DOI 10.1016/j.cbi.2006.03.004; Mandel S, 2006, MOL NUTR FOOD RES, V50, P229, DOI 10.1002/mnfr.200500156; Molina MF, 2003, BIOL PHARM BULL, V26, P1398, DOI 10.1248/bpb.26.1398; Montine KS, 2004, CHEM PHYS LIPIDS, V128, P117, DOI 10.1016/j.chemphyslip.2003.10.010; Morand OH, 1997, J LIPID RES, V38, P373; Mullen E, 2004, J NUTR, V134, P2942, DOI 10.1093/jn/134.11.2942; Peng IW, 2003, J NUTR, V133, P2184, DOI 10.1093/jn/133.7.2184; Robichon C, 2007, BIOCHIMIE, V89, P260, DOI 10.1016/j.biochi.2006.09.015; Russo VC, 2004, BRAIN RES, V1009, P40, DOI 10.1016/j.brainres.2004.02.042; Sagun KC, 2005, FASEB J, V19, P1657, DOI 10.1096/fj.05-4107com; SAIJA A, 1995, FREE RADICAL BIO MED, V19, P481, DOI 10.1016/0891-5849(94)00240-K; Shin DH, 2006, J NEUROCHEM, V96, P561, DOI 10.1111/j.1471-4159.2005.03582.x; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; Singh DK, 2006, J NUTR, V136, p759S, DOI 10.1093/jn/136.3.759S; Skarits C, 2003, CLIN CHIM ACTA, V336, P27, DOI 10.1016/S0009-8981(03)00295-X; Spencer JPE, 2004, ARCH BIOCHEM BIOPHYS, V423, P148, DOI 10.1016/j.abb.2003.11.010; Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017; Wang H, 1999, FREE RADICAL BIO MED, V27, P683, DOI 10.1016/S0891-5849(99)00119-7; Wang J, 2005, BIOCHEM BIOPH RES CO, V332, P735, DOI 10.1016/j.bbrc.2005.05.013; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Williamson G, 1996, CARCINOGENESIS, V17, P2385, DOI 10.1093/carcin/17.11.2385; Wolffram S, 2002, J NUTR, V132, P630, DOI 10.1093/jn/132.4.630; Xia M, 2005, J BIOL CHEM, V280, P36792, DOI 10.1074/jbc.M505047200; YAGI K, 1987, CHEM PHYS LIPIDS, V45, P337, DOI 10.1016/0009-3084(87)90071-5; YANG B, FASEB 4, V20, P1501; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; YEAGLE PL, 1991, BIOCHIMIE, V73, P1303, DOI 10.1016/0300-9084(91)90093-G; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; Youdim KA, 2002, BIOL CHEM, V383, P503, DOI 10.1515/BC.2002.052; Youdim KA, 2004, FREE RADICAL BIO MED, V37, P1683, DOI 10.1016/j.freeradbiomed.2004.08.002; Zhuang LY, 2005, J CLIN INVEST, V115, P959	67	58	63	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2231	2245		10.1074/jbc.M703583200	http://dx.doi.org/10.1074/jbc.M703583200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18032389	hybrid			2022-12-25	WOS:000252501000051
J	Yamashita, T; Bouzhir-Sima, L; Lambry, JC; Liebl, U; Vos, MH				Yamashita, Taku; Bouzhir-Sima, Latifa; Lambry, Jean-Christophe; Liebl, Ursula; Vos, Marten H.			Ligand dynamics and early signaling events in the heme domain of the sensor protein Dos from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLVED RESONANCE RAMAN; DIRECT OXYGEN SENSOR; GEMINATE-RECOMBINATION; REGULATED PHOSPHODIESTERASE; TRANSCRIPTIONAL ACTIVATOR; CRYSTAL-STRUCTURE; NO RECOMBINATION; EC DOS; BINDING; ABSORPTION	In the heme-based sensor Dos from Escherichia coli, the ferrous heme is coordinated by His-77 and Met-95. The latter residue is replaced upon oxygen binding or oxidation of the heme. Here we investigate the early signaling processes upon dissociation of the distal ligand using ultrafast spectroscopy and site-directed mutagenesis. Geminate CO rebinding to the heme domain DosH appears insensitive to replacement of Met-95, in agreement with the notion that this residue is oriented out of the heme pocket in the presence of external ligands. A uniquely slow 35-ps phase in rebinding of the flexible methionine side chain after dissociation from ferrous DosH is completely abolished in rebinding of the more rigid histidine side chain in the M95H mutant protein, where only the 7-ps phase, common to all 6-coordinate heme proteins, is observed. Temperature-dependence studies indicate that all rebinding of internal and external ligands is essentially barrierless, but that CfigsO escape from the heme pocket is an activated process. Solvent viscosity studies combined with molecular dynamics simulations show that there are two configurations in the ferrous 6-coordinate protein, involving two isomers of the Met-95 side chain, of which the structural changes extend to the solvent-exposed backbone, which is part of the flexible FG loop. One of these configurations has considerable motional freedom in the Met-95-dissociated state. We suggest that this configuration corresponds to an early signaling intermediate state, is responsible for the slow rebinding, and allows small ligands in the protein to efficiently compete for binding with the heme.	[Yamashita, Taku; Bouzhir-Sima, Latifa; Lambry, Jean-Christophe; Liebl, Ursula; Vos, Marten H.] Ecole Polytech, CNRS, Lab Opt & Biosci, F-91128 Palaiseau, France; [Yamashita, Taku; Bouzhir-Sima, Latifa; Lambry, Jean-Christophe; Liebl, Ursula; Vos, Marten H.] INSERM, U696, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Vos, MH (corresponding author), Ecole Polytech, CNRS, Lab Opt & Biosci, F-91128 Palaiseau, France.	marten.vos@polytechnique.edu		Lambry, Jean-Christophe/0000-0001-8264-0391; Vos, Marten/0000-0003-0493-4831; LIEBL, Ursula/0000-0003-0869-4388				Aono S, 1996, BIOCHEM BIOPH RES CO, V228, P752, DOI 10.1006/bbrc.1996.1727; Autenrieth F, 2004, J COMPUT CHEM, V25, P1613, DOI 10.1002/jcc.20079; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cianetti S, 2004, J AM CHEM SOC, V126, P13932, DOI 10.1021/ja046442i; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; DOSTER W, 1982, BIOCHEMISTRY-US, V21, P4831, DOI 10.1021/bi00263a001; Franzen S, 2001, BIOPHYS J, V80, P2372, DOI 10.1016/S0006-3495(01)76207-8; Franzen S, 2006, J PHYS CHEM B, V110, P14483, DOI 10.1021/jp056790m; Gonzalez G, 2002, BIOCHEMISTRY-US, V41, P8414, DOI 10.1021/bi025845x; Hao B, 2002, BIOCHEMISTRY-US, V41, P12952, DOI 10.1021/bi020144l; Hirata S, 2003, EUR J BIOCHEM, V270, P4771, DOI 10.1046/j.1432-1033.2003.03879.x; Ionascu D, 2005, J AM CHEM SOC, V127, P16921, DOI 10.1021/ja054249y; Jasaitis A, 2006, BIOCHEMISTRY-US, V45, P6018, DOI 10.1021/bi060012i; JONGEWARD KA, 1988, J BIOL CHEM, V263, P6027; Key J, 2005, BIOCHEMISTRY-US, V44, P4627, DOI 10.1021/bi047942r; Kriegl JM, 2002, P NATL ACAD SCI USA, V99, P7992, DOI 10.1073/pnas.082244399; Kruglik SG, 2007, P NATL ACAD SCI USA, V104, P7408, DOI 10.1073/pnas.0700445104; Kumazaki S, 2000, J BIOL CHEM, V275, P38378, DOI 10.1074/jbc.M005533200; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; LAMBRIGHT DG, 1991, CHEM PHYS, V158, P249, DOI 10.1016/0301-0104(91)87069-8; Liebl U, 2003, BIOCHEMISTRY-US, V42, P6527, DOI 10.1021/bi027359f; Liebl U, 2002, P NATL ACAD SCI USA, V99, P12771, DOI 10.1073/pnas.192311699; MARDEN MC, 1986, BIOCHEMISTRY-US, V25, P2786, DOI 10.1021/bi00358a008; MARTIN JL, 1994, METHOD ENZYMOL, V232, P416; Negrerie M, 2006, J PHYS CHEM B, V110, P12766, DOI 10.1021/jp0559377; Park HJ, 2004, BIOCHEMISTRY-US, V43, P2738, DOI 10.1021/bi035980p; PETRICH JW, 1988, BIOCHEMISTRY-US, V27, P4049, DOI 10.1021/bi00411a022; Sasakura Y, 2006, ACCOUNTS CHEM RES, V39, P37, DOI 10.1021/ar0501525; Sasakura Y, 2002, J BIOL CHEM, V277, P23821, DOI 10.1074/jbc.M202738200; Sato A, 2002, J BIOL CHEM, V277, P32650, DOI 10.1074/jbc.M204559200; Shelver D, 1997, P NATL ACAD SCI USA, V94, P11216, DOI 10.1073/pnas.94.21.11216; Shreve AP, 1999, J PHYS CHEM B, V103, P7969, DOI 10.1021/jp991163g; Silkstone G, 2002, BIOPHYS CHEM, V98, P65, DOI 10.1016/S0301-4622(02)00085-6; Silkstone G, 2007, J BIOL CHEM, V282, P1638, DOI 10.1074/jbc.M605760200; SRAJER V, 1988, J AM CHEM SOC, V110, P6656, DOI 10.1021/ja00228a009; STEINBACH PJ, 1991, BIOCHEMISTRY-US, V30, P3988, DOI 10.1021/bi00230a026; Takahashi H, 2006, CHEM LETT, V35, P970, DOI 10.1246/cl.2006.970; Tanaka A, 2007, J BIOL CHEM, V282, P21301, DOI 10.1074/jbc.M701920200; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Vos MH, 2008, BBA-BIOENERGETICS, V1777, P15, DOI 10.1016/j.bbabio.2007.10.004; Vos MH, 2000, P NATL ACAD SCI USA, V97, P1554, DOI 10.1073/pnas.030528197; Vos MH, 2000, J CHIN CHEM SOC-TAIP, V47, P765; Wang W, 2000, J PHYS CHEM B, V104, P10789, DOI 10.1021/jp0008602; Ye X, 2005, J AM CHEM SOC, V127, P5854, DOI 10.1021/ja042365f; Ye X, 2002, J AM CHEM SOC, V124, P5914, DOI 10.1021/ja017359n; YOUNG RD, 1984, J CHEM PHYS, V81, P3730, DOI 10.1063/1.448124	47	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2344	2352		10.1074/jbc.M708123200	http://dx.doi.org/10.1074/jbc.M708123200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039668	hybrid			2022-12-25	WOS:000252501000061
J	Amutha, B; Gordon, DM; Gu, YJ; Lyver, ER; Dancis, A; Pain, D				Amutha, Boominathan; Gordon, Donna M.; Gu, Yajuan; Lyver, Elise R.; Dancis, Andrew; Pain, Debkumar			GTP is required for iron-sulfur cluster biogenesis in mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-S CLUSTER; SACCHAROMYCES-CEREVISIAE; PROTEIN IMPORT; YEAST FRATAXIN; MATURATION; HOMOLOG; ACTIVATION; NFS1P; TRANSLOCATION; TRANSCRIPTION	Iron-sulfur (Fe-S) cluster biogenesis in mitochondria is an essential process and is conserved from yeast to humans. Several proteins with Fe-S cluster cofactors reside in mitochondria, including aconitase [4Fe-4S] and ferredoxin [2Fe-2S]. We found that mitochondria isolated from wild-type yeast contain a pool of apoaconitase and machinery capable of forming new clusters and inserting them into this endogenous apoprotein pool. These observations allowed us to develop assays to assess the role of nucleotides (GTP and ATP) in cluster biogenesis in mitochondria. We show that Fe-S cluster biogenesis in isolated mitochondria is enhanced by the addition of GTP and ATP. Hydrolysis of both GTP and ATP is necessary, and the addition of ATP cannot circumvent processes that require GTP hydrolysis. Both in vivo and in vitro experiments suggest that GTP must enter into the matrix to exert its effects on cluster biogenesis. Upon import into isolated mitochondria, purified apoferredoxin can also be used as a substrate by the Fe-S cluster machinery in a GTP-dependent manner. GTP is likely required for a common step involved in the cluster biogenesis of aconitase and ferredoxin. To our knowledge this is the first report demonstrating a role of GTP in mitochondrial Fe-S cluster biogenesis.	[Amutha, Boominathan; Gordon, Donna M.; Gu, Yajuan; Pain, Debkumar] Univ Med & Dent New Jersey, Dept Physiol & Pharmacol, NJ Med Sch, Newark, NJ 07101 USA; [Lyver, Elise R.; Dancis, Andrew] Univ Penn, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania	Pain, D (corresponding author), Univ Med & Dent New Jersey, Dept Physiol & Pharmacol, NJ Med Sch, 185 S Orange Ave,MSBI-669, Newark, NJ 07101 USA.	painde@umdnj.edu			NIDDK NIH HHS [DK 53953] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK053953, R01DK053953] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Amutha B, 2003, BIOCHEM J, V370, P805, DOI 10.1042/BJ20021415; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Blokesch M, 2002, BIOCHEM SOC T, V30, P674, DOI 10.1042/BST0300674; Brazzolotto X, 2006, J BIOL CHEM, V281, P769, DOI 10.1074/jbc.M510310200; Chaudhuri TK, 2001, CELL, V107, P235, DOI 10.1016/S0092-8674(01)00523-2; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; FUKUCHI T, 1993, GENE, V129, P141; Garland SA, 1999, J MOL BIOL, V294, P897, DOI 10.1006/jmbi.1999.3294; Gordon DM, 2006, BIOCHEM J, V400, P163, DOI 10.1042/BJ20060904; Kaut A, 2000, J BIOL CHEM, V275, P15955, DOI 10.1074/jbc.M909502199; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; KENNEDY MC, 1984, J BIOL CHEM, V259, P3145; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kim R, 2001, J BIOL CHEM, V276, P17524, DOI 10.1074/jbc.M010695200; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Knight SAB, 1998, J BIOL CHEM, V273, P18389, DOI 10.1074/jbc.273.29.18389; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; Lange H, 1999, J BIOL CHEM, V274, P18989, DOI 10.1074/jbc.274.27.18989; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P237, DOI 10.1023/A:1005532912212; Lesuisse E, 2004, BIOCHEM J, V378, P599, DOI 10.1042/BJ20031387; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; Li J, 2001, J BIOL CHEM, V276, P1503, DOI 10.1074/jbc.M007198200; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Lutz T, 2001, J MOL BIOL, V307, P815, DOI 10.1006/jmbi.2001.4527; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Muhlenhoff U, 2002, J BIOL CHEM, V277, P29810, DOI 10.1074/jbc.M204675200; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Przybyla-Zawislak B, 1999, GENETICS, V152, P153; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Schulke N, 1999, J BIOL CHEM, V274, P22847, DOI 10.1074/jbc.274.32.22847; Sepuri NBV, 1998, J BIOL CHEM, V273, P20941, DOI 10.1074/jbc.273.33.20941; Sepuri NBV, 1998, J BIOL CHEM, V273, P1420, DOI 10.1074/jbc.273.3.1420; Seznec H, 2004, HUM MOL GENET, V13, P1017, DOI 10.1093/hmg/ddh114; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; STUART RA, 1994, EUR J BIOCHEM, V220, P9, DOI 10.1111/j.1432-1033.1994.tb18593.x; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Unciuleac MC, 2007, BIOCHEMISTRY-US, V46, P6812, DOI 10.1021/bi6026665; Vozza A, 2004, J BIOL CHEM, V279, P20850, DOI 10.1074/jbc.M313610200; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Zhang Y, 2006, J BIOL CHEM, V281, P22493, DOI 10.1074/jbc.M604246200	51	32	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1362	1371		10.1074/jbc.M706808200	http://dx.doi.org/10.1074/jbc.M706808200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18029354	hybrid			2022-12-25	WOS:000252282700019
J	Lange, Y; Ory, DS; Ye, J; Lanier, MH; Hsu, FF; Steck, TL				Lange, Yvonne; Ory, Daniel S.; Ye, Jin; Lanier, Michael H.; Hsu, Fong-Fu; Steck, Theodore L.			Effectors of rapid homeostatic responses of endoplasmic reticulum cholesterol and 3-hydroxy-3-methylglutaryl-CoA reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; STEROL TRANSPORT; MOVEMENT; LANOSTEROL; COENZYME; 25-HYDROXYCHOLESTEROL; DEGRADATION; BINDING; UBIQUITINATION; BIOSYNTHESIS	The cholesterol content of the endoplasmic reticulum (ER) and the activity of 3-hydroxy- 3-methylglutaryl-CoA reductase (HMGR) imbedded therein respond homeostatically within minutes to changes in the level of plasma membrane cholesterol. We have now examined the roles of sterol regulatory element-binding protein (SREBP)-dependent gene expression, side chain oxysterol biosynthesis, and cholesterol precursors in the short term regulation of ER cholesterol levels and HMGR activity. We found that SREBP-dependent gene expression is not required for the response to changes in cell cholesterol of either the pool of ER cholesterol or the rate of cholesterol esterification. It was also found that the acute proteolytic inactivation of HMGR triggered by cholesterol loading required the conversion of cholesterol to 27-hydroxycholesterol. High levels of exogenous 24,25-dihydrolanosterol drove the inactivation of HMGR; lanosterol did not. However, purging endogenous 24,25-dihydrolanosterol, lanosterol, and other biosynthetic sterol intermediates by treating cells with NB- 598 did not greatly affect either the setting of their ER cholesterol pool or the inactivation of their HMGR. In summary, neither SREBP-regulated genes nor 27-hydroxycholesterol is involved in setting the ER cholesterol pool. On the other hand, 27-hydroxycholesterol, rather than cholesterol itself or biosynthetic precursors of cholesterol, stimulates the rapid inactivation of HMGR in response to high levels of cholesterol.	[Lange, Yvonne; Ye, Jin] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA; [Ory, Daniel S.; Lanier, Michael H.; Hsu, Fong-Fu] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Steck, Theodore L.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Rush University; Washington University (WUSTL); University of Chicago	Lange, Y (corresponding author), Rush Univ, Med Ctr, Dept Pathol, 1653 W Congress Pkwy, Chicago, IL 60612 USA.	ylange@rush.edu	Lange, Yvonne/A-7794-2009; Steck, Theodore/GWM-4373-2022	Steck, Theodore/0000-0002-8391-9244; Hsu, Fong-Fu/0000-0001-5368-0183	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067773, R55HL028448, R01HL028448] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR 00954] Funding Source: Medline; NHLBI NIH HHS [HL 28448, HL 67773] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRESLOW JL, 1975, BIOCHIM BIOPHYS ACTA, V398, P10, DOI 10.1016/0005-2760(75)90165-4; BROWN MS, 1974, J BIOL CHEM, V249, P7306; BUTTKE TM, 1992, J BIOL CHEM, V267, P8819; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; CHANG TY, 1979, J BIOL CHEM, V254, P1258; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Du XM, 2004, J BIOL CHEM, V279, P47010, DOI 10.1074/jbc.M408690200; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; HASAN MT, 1994, SOMAT CELL MOLEC GEN, V20, P183, DOI 10.1007/BF02254759; HIDAKA Y, 1991, J BIOL CHEM, V266, P13171; HORIE M, 1990, J BIOL CHEM, V265, P18075; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Javitt NB, 2000, BBA-MOL CELL BIOL L, V1529, P136, DOI 10.1016/S1388-1981(00)00143-8; JAVITT NB, 1990, J LIPID RES, V31, P1527; KRUEGER KE, 1990, J BIOL CHEM, V265, P15015; Lange Y, 2005, J BIOL CHEM, V280, P36126, DOI 10.1074/jbc.M507149200; LANGE Y, 1995, J LIPID RES, V36, P1092; Lange Y, 2004, P NATL ACAD SCI USA, V101, P11664, DOI 10.1073/pnas.0404766101; Lange Y, 2002, BIOCHEM BIOPH RES CO, V290, P488, DOI 10.1006/bbrc.2001.6156; LANGE Y, 1991, J BIOL CHEM, V266, P21439; Lange Y, 1996, TRENDS CELL BIOL, V6, P205, DOI 10.1016/0962-8924(96)20016-9; Lange Y, 1997, J BIOL CHEM, V272, P13103, DOI 10.1074/jbc.272.20.13103; Lange Y, 1999, J LIPID RES, V40, P2264; LEITERSDORF E, 1994, AM J HUM GENET, V55, P907; Li YF, 2004, J BIOL CHEM, V279, P45226, DOI 10.1074/jbc.M407600200; Maxfield FR, 2006, CURR OPIN CELL BIOL, V18, P379, DOI 10.1016/j.ceb.2006.06.012; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Ory DS, 2004, CIRC RES, V95, P660, DOI 10.1161/01.RES.0000143422.83209.be; PARISH EJ, 1995, LIPIDS, V30, P247, DOI 10.1007/BF02537828; Plemenitas A, 1999, EUR J BIOCHEM, V266, P317, DOI 10.1046/j.1432-1327.1999.00829.x; Prinz WA, 2007, PROG LIPID RES, V46, P297, DOI 10.1016/j.plipres.2007.06.002; Radhakrishnan A, 2000, BIOCHEMISTRY-US, V39, P8119, DOI 10.1021/bi0005097; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; REISS AB, 1994, J LIPID RES, V35, P1026; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2004, J BIOL CHEM, V279, P28798, DOI 10.1074/jbc.M402442200; Steck TL, 2002, BIOPHYS J, V83, P2118, DOI 10.1016/S0006-3495(02)73972-6; Sullivan DP, 2006, BIOCHEM SOC T, V34, P356, DOI 10.1042/BST0340356; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; TINT GS, 1982, J LIPID RES, V23, P597	45	87	90	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1445	1455		10.1074/jbc.M706967200	http://dx.doi.org/10.1074/jbc.M706967200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024962	hybrid			2022-12-25	WOS:000252282700028
J	Sakai, H; Sato, A; Masuda, K; Takeoka, S; Tsuchida, E				Sakai, Hiromi; Sato, Atsushi; Masuda, Kaoru; Takeoka, Shinji; Tsuchida, Eishun			Encapsulation of concentrated hemoglobin solution in phospholipid vesicles retards the reaction with NO, but not CO, by intracellular diffusion barrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACILITATED OXYGEN-TRANSPORT; HUMAN SERUM-ALBUMIN; NITRIC-OXIDE; CARBON-MONOXIDE; HEMORRHAGIC-SHOCK; HB-VESICLES; BLOOD; ERYTHROCYTES; DERIVATIVES; MEMBRANE	One physiological significance of the red blood cell (RBC) structure is that NO binding of Hb is retarded by encapsulation with the cell membrane. To clarify the mechanism, we analyzed Hb-vesicles (HbVs) with different intracellular Hb concentrations, [Hb] in, and different particle sizes using stopped-flow spectrophotometry. The apparent NO binding rate constant, k(on)'((NO)), of HbV at [Hb](in) = 1 g/dl was 2.6 x 10(7) M-1 s(-1), which was almost equal to k(on)((NO)) of molecular Hb, indicating that the lipid membrane presents no obstacle for NO binding. With increasing [Hb] in to 35 g/dl, k(on)'((NO)) decreased to 0.9 x 10(7) M-1 s(-1), which was further decreased to 0.5 x 10(7) M-1 s(-1) with enlarging particle diameter from 265 to 452 nm. For CO binding, which is intrinsically much slower than NO binding, k(on)'((CO)) did not change greatly with [Hb] in and the particle diameter. Results obtained using diffusion simulations coupled with elementary binding reactions concur with these tendencies and clarify that NO is trapped rapidly by Hb from the interior surface region to the core of HbV at a high [Hb] in, retarding NO diffusion toward the core of HbV. In contrast, slow CO binding allows time for further CO- diffusion to the core. Simulations extrapolated to larger particles (8 mu m) showing retardation even for CO binding. The obtained k(on)'((NO)) and k(on)'((CO)) yield values similar to those reported for RBCs. In summary, the intracellular, not extracellular, diffusion barrier is predominant due to the rapid NO binding that induces a rapid sink of NO from the interior surface to the core, retarding further NO diffusion and binding.	[Sakai, Hiromi; Tsuchida, Eishun] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Sato, Atsushi; Takeoka, Shinji] Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo 1698555, Japan; [Masuda, Kaoru] Kobelco Res Inst Inc, Kobe, Hyogo 6512271, Japan	Waseda University; Waseda University; Kobelco Research Institute Inc.	Tsuchida, E (corresponding author), Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	eishun@waseda.jp	Sakai, Hiromi/J-2529-2019	Sakai, Hiromi/0000-0002-0681-3032				Azarov I, 2005, J BIOL CHEM, V280, P39024, DOI 10.1074/jbc.M509045200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Bouwer ST, 1997, BBA-PROTEIN STRUCT M, V1338, P127, DOI 10.1016/S0167-4838(96)00197-5; Bunn HF, 1995, TRANSFUS CLIN BIOL, V2, P433, DOI 10.1016/S1246-7820(05)80068-0; CARLSEN E, 1958, J GEN PHYSIOL, V42, P83, DOI 10.1085/jgp.42.1.83; Chang TMS, 2006, ARTIF CELL BLOOD SUB, V34, P551, DOI 10.1080/10731190600973808; Chen XS, 1996, B CHEM SOC JPN, V69, P255, DOI 10.1246/bcsj.69.255; COIN JT, 1979, J BIOL CHEM, V254, P1178; DJORDJEVICH L, 1980, EXP HEMATOL, V8, P584; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; Goda N, 1998, J CLIN INVEST, V101, P604, DOI 10.1172/JCI1324; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; Gulati A, 1999, J LAB CLIN MED, V133, P112, DOI 10.1016/S0022-2143(99)90003-3; Han TH, 2005, BBA-GEN SUBJECTS, V1723, P135, DOI 10.1016/j.bbagen.2005.01.013; Hartridge H, 1927, J PHYSIOL-LONDON, V52, P232, DOI 10.1113/jphysiol.1927.sp002354; Herold S, 2001, BIOCHEMISTRY-US, V40, P3385, DOI 10.1021/bi002407m; HESS JR, 1993, J APPL PHYSIOL, V74, P1769, DOI 10.1152/jappl.1993.74.4.1769; Huang KT, 2007, NITRIC OXIDE-BIOL CH, V16, P209, DOI 10.1016/j.niox.2006.11.002; Huang KT, 2001, P NATL ACAD SCI USA, V98, P11771, DOI 10.1073/pnas.201276698; Jeffers A, 2006, FREE RADICAL BIO MED, V41, P1557, DOI 10.1016/j.freeradbiomed.2006.08.017; Kavdia M, 2002, AM J PHYSIOL-HEART C, V282, pH2245, DOI 10.1152/ajpheart.00972.2001; Kim-Shapiro DB, 2006, ARTERIOSCL THROM VAS, V26, P697, DOI 10.1161/01.ATV.0000204350.44226.9a; Liu XP, 1998, J BIOL CHEM, V273, P18709, DOI 10.1074/jbc.273.30.18709; Liu XP, 2002, J BIOL CHEM, V277, P26194, DOI 10.1074/jbc.M201939200; Matheson B, 2002, J APPL PHYSIOL, V93, P1479, DOI 10.1152/japplphysiol.00191.2002; Minneci PC, 2005, J CLIN INVEST, V115, P3409, DOI 10.1172/JCI25040; MINTON AP, 1978, J PHYS CHEM-US, V82, P1934, DOI 10.1021/j100506a016; Nakai K, 1998, J LAB CLIN MED, V132, P313, DOI 10.1016/S0022-2143(98)90045-2; Nakai K, 1996, J CARDIOVASC PHARM, V28, P115, DOI 10.1097/00005344-199607000-00018; Nishide H, 1997, ARTIF CELL BLOOD SUB, V25, P335, DOI 10.3109/10731199709118924; Olson J S, 1981, Methods Enzymol, V76, P631; Olson JS, 2003, METH MOLEC MED, V82, P65; Olson JS, 2004, FREE RADICAL BIO MED, V36, P685, DOI 10.1016/j.freeradbiomed.2003.11.030; Page TC, 1998, MICROVASC RES, V55, P54, DOI 10.1006/mvre.1997.2055; Rochon G, 2004, HYPERTENSION, V43, P1110, DOI 10.1161/01.HYP.0000123075.48420.e8; Rohlfs RJ, 1998, J BIOL CHEM, V273, P12128, DOI 10.1074/jbc.273.20.12128; ROSE EJ, 1983, J AM CHEM SOC, V105, P2866, DOI 10.1021/ja00347a056; Rudolph AS, 1997, J APPL PHYSIOL, V82, P1826, DOI 10.1152/jappl.1997.82.6.1826; SAKAI H, 1993, PROTEIN EXPRES PURIF, V4, P563, DOI 10.1006/prep.1993.1074; Sakai H, 1999, AM J PHYSIOL-HEART C, V276, pH553, DOI 10.1152/ajpheart.1999.276.2.H553; Sakai H, 1996, POLYM ADVAN TECHNOL, V7, P639, DOI 10.1002/(SICI)1099-1581(199608)7:8<639::AID-PAT572>3.0.CO;2-2; Sakai H, 2000, AM J PHYSIOL-HEART C, V279, pH908, DOI 10.1152/ajpheart.2000.279.3.H908; Sakai H, 2006, TRANSFUSION, V46, P339, DOI 10.1111/j.1537-2995.2006.00727.x; Sakai H, 1996, BIOTECHNOL PROGR, V12, P119, DOI 10.1021/bp950068w; Sakai H, 2000, BIOCONJUGATE CHEM, V11, P425, DOI 10.1021/bc990173h; Sakai H, 2004, CRIT CARE MED, V32, P539, DOI 10.1097/01.CCM.0000109774.99665.22; Sakai H, 2003, AM J PHYSIOL-HEART C, V285, pH2543, DOI 10.1152/ajpheart.00537.2003; Sakai H, 2003, CLIN CHEM LAB MED, V41, P222, DOI 10.1515/CCLM.2003.036; Sakai H, 2002, J BIOCHEM, V131, P611, DOI 10.1093/oxfordjournals.jbchem.a003141; Sloan EP, 1999, JAMA-J AM MED ASSOC, V282, P1857, DOI 10.1001/jama.282.19.1857; Sou K, 2003, BIOTECHNOL PROGR, V19, P1547, DOI 10.1021/bp0201004; SUEMATSU M, 1995, J CLIN INVEST, V96, P2431, DOI 10.1172/JCI118300; SZEBENI J, 1985, BIOCHEMISTRY-US, V24, P2827, DOI 10.1021/bi00333a003; SZEBENI J, 1984, BIOCHIM BIOPHYS ACTA, V798, P60, DOI 10.1016/0304-4165(84)90010-2; TAKEOKA S, 1994, J MACROMOL SCI PURE, VA31, P97; Takeoka S, 1996, LANGMUIR, V12, P1755, DOI 10.1021/la940936j; Tsai AG, 2006, BLOOD, V108, P3603, DOI 10.1182/blood-2006-02-005272; Vandegriff KD, 1997, BIOPHYS CHEM, V69, P23, DOI 10.1016/S0301-4622(97)00079-3; VANDEGRIFF KD, 1984, J BIOL CHEM, V259, P2619; Vaughn MW, 2000, J BIOL CHEM, V275, P2342, DOI 10.1074/jbc.275.4.2342; WANG L, 1992, POLYM ADVAN TECHNOL, V3, P17; YOKOHAMA H, 1994, ARTIF ORGANS TODAY, V4, P107	62	61	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1508	1517		10.1074/jbc.M707660200	http://dx.doi.org/10.1074/jbc.M707660200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18003613	hybrid			2022-12-25	WOS:000252282700035
J	Chen, Y; Cai, T; Yang, CJ; Turner, DA; Giovannucci, DR; Xie, ZJ				Chen, Ying; Cai, Ting; Yang, Changjun; Turner, David A.; Giovannucci, David R.; Xie, Zijian			Regulation of inositol 1,4,5-trisphosphate receptor-mediated calcium release by the Na/K-ATPase in cultured renal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/K+-ATPASE; SIGNALING MICRODOMAINS; ENDOPLASMIC-RETICULUM; LLC-PK1 CELLS; IP3 RECEPTORS; KIDNEY-CELLS; HOMER BINDS; CAVEOLAE; NA,K-ATPASE; COMPLEX	It is known that the Na/K-ATPase alpha 1 subunit interacts directly with inositol 1,4,5-triphosphate (IP3) receptors. In this study we tested whether this interaction is required for extracellular stimuli to efficiently regulate endoplasmic reticulum ( ER) Ca2+ release. Using cultured pig kidney LLC-PK1 cells as a model, we demonstrated that graded knockdown of the cellular Na/K-ATPase alpha 1 subunit resulted in a parallel attenuation of ATP-induced ER Ca2+ release. When the knockdown cells were rescued by knocking in a rat alpha 1, the expression of rat alpha 1 restored not only the cellular Na/K-ATPase but also ATP-induced ER Ca2+ release. Mechanistically, this defect in ATP-induced ER Ca2+ release was neither due to the changes in the amount or the function of cellular IP3 and P2Y receptors nor the ER Ca2+ content. However, the alpha 1 knockdown did redistribute cellular IP3 receptors. The pool of IP3 receptors that resided close to the plasma membrane was abolished. Because changes in the plasma membrane proximity could reduce the efficiency of signal transmission from P2Y receptors to the ER, we further determined the dose-dependent effects of ATP on protein kinase C is an element of activation and ER Ca2+ release. The data showed that the alpha 1 knockdown de-sensitized the ATP-induced ER Ca2+ release but not PKC is an element of activation. Moreover, expression of the N terminus of Na/K-ATPase alpha 1 subunit not only disrupted the formation of the Na/K-ATPase-IP3 receptor complex but also abolished the ATP-induced Ca2+ release. Finally, we observed that the alpha 1 knockdown was also effective in attenuating ER Ca2+ release provoked by angiotensin II and epidermal growth factor.	[Chen, Ying; Cai, Ting; Yang, Changjun; Xie, Zijian] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Turner, David A.; Giovannucci, David R.] Univ Toledo, Coll Med, Dept Neurosci, Toledo, OH 43614 USA	University of Toledo; University of Toledo	Xie, ZJ (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, 3035 Arlington Ave, Toledo, OH 43614 USA.	Zi-Jian.Xie@utoledo.edu	Yang, Changjun/N-3767-2014; Giovannucci, David R/A-5657-2018	Yang, Changjun/0000-0002-4354-4943; Chen, Ying/0000-0002-6862-5678	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078565] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-67936, HL-36573] Funding Source: Medline; NIGMS NIH HHS [GM-78565] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Blaustein MR, 2001, TRENDS NEUROSCI, V24, P602, DOI 10.1016/S0166-2236(00)01891-9; Bosanac I, 2004, BBA-MOL CELL RES, V1742, P89, DOI 10.1016/j.bbamcr.2004.09.016; BUSH KT, 1994, J BIOL CHEM, V269, P23694; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Cui J, 2004, J BIOL CHEM, V279, P16311, DOI 10.1074/jbc.M400206200; Delmas P, 2002, NEURON, V36, P787, DOI 10.1016/S0896-6273(02)01097-8; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; Filipovic DM, 1998, AM J PHYSIOL-RENAL, V274, pF1070, DOI 10.1152/ajprenal.1998.274.6.F1070; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; HARADA H, 1993, AM J PHYSIOL, V264, pC956, DOI 10.1152/ajpcell.1993.264.4.C956; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Hur EM, 2005, J CELL BIOL, V169, P657, DOI 10.1083/jcb.200411034; Isshiki M, 2002, J CELL SCI, V115, P475; Jacob SN, 2005, J NEUROSCI, V25, P2853, DOI 10.1523/JNEUROSCI.4313-04.2005; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kogo H, 1997, ACTA HISTOCHEM CYTOC, V30, P593, DOI 10.1267/ahc.30.593; Lea JP, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022029.50356.2C; Lencesova L, 2004, J BIOL CHEM, V279, P2885, DOI 10.1074/jbc.M310365200; Li CL, 2003, AM J PHYSIOL-RENAL, V285, pF889, DOI 10.1152/ajprenal.00170.2003; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Michikawa T, 1999, NEURON, V23, P799, DOI 10.1016/S0896-6273(01)80037-4; Missiaen L, 2000, MOL PHARMACOL, V57, P564, DOI 10.1124/mol.57.3.564; Miyakawa-Naito A, 2003, J BIOL CHEM, V278, P50355, DOI 10.1074/jbc.M305378200; Mobasheri Ali, 2003, Cancer Cell Int, V3, P8, DOI 10.1186/1475-2867-3-8; Mohammadi K, 2001, J BIOL CHEM, V276, P42050, DOI 10.1074/jbc.M107892200; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Nguyen ANT, 2007, J AM SOC NEPHROL, V18, P46, DOI 10.1681/ASN.2006010086; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Piepenhagen PA, 1998, MOL BIOL CELL, V9, P3161, DOI 10.1091/mbc.9.11.3161; Ralevic V, 1998, PHARMACOL REV, V50, P413; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Tanimura A, 2000, J BIOL CHEM, V275, P27488; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Vermassen E, 2004, BIOL CELL, V96, P3, DOI 10.1016/j.biolcel.2003.11.004; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; WODOPIA R, 2000, AM J PSYSL, V278, pL1110; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Yuan ZK, 2005, MOL BIOL CELL, V16, P4034, DOI 10.1091/mbc.E05-04-0295; Zhang SB, 2003, J BIOL CHEM, V278, P4048, DOI 10.1074/jbc.M209960200; Zhang SB, 2006, J BIOL CHEM, V281, P21954, DOI 10.1074/jbc.M601578200; Zhang ZS, 1998, J BIOL CHEM, V273, P18681, DOI 10.1074/jbc.273.30.18681	47	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1128	1136		10.1074/jbc.M708025200	http://dx.doi.org/10.1074/jbc.M708025200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17993456	hybrid			2022-12-25	WOS:000252128100053
J	Gumbiner-Russo, LM; Rosenberg, SM				Gumbiner-Russo, Laura M.; Rosenberg, Susan M.			Physical Analyses of E. coli Heteroduplex Recombination Products In Vivo: On the Prevalence of 5 ' and 3 ' Patches	PLOS ONE			English	Article							DOUBLE-STRAND-BREAK; HOT-SPOT CHI; STRUCTURE-SPECIFIC ENDONUCLEASE; LAMBDA RAP PROTEIN; ESCHERICHIA-COLI; PHAGE-LAMBDA; HOMOLOGOUS RECOMBINATION; BACTERIOPHAGE-LAMBDA; RECBC ENZYME; SINGLE-STRAND	Background. Homologous recombination in Escherichia coli creates patches (non-crossovers) or splices ( half crossovers), each of which may have associated heteroduplex DNA. Heteroduplex patches have recombinant DNA in one strand of the duplex, with parental flanking markers. Which DNA strand is exchanged in heteroduplex patches reflects the molecular mechanism of recombination. Several models for the mechanism of E. coli RecBCD-mediated recombinational double-strand-end (DSE) repair specify that only the 3'-ending strand invades the homologous DNA, forming heteroduplex in that strand. There is, however, in vivo evidence that patches are found in both strands. Methodology/Principle Findings. This paper re-examines heteroduplex-patch-strand polarity using phage lambda and the lambda dv plasmid as DNA substrates recombined via the E. coli RecBCD system in vivo. These DNAs are mutant for lambda recombination functions, including orf and rap, which were functional in previous studies. Heteroduplexes are isolated, separated on polyacrylamide gels, and quantified using Southern blots for heteroduplex analysis. This method reveals that heteroduplexes are still found in either 5' or 3' DNA strands in approximately equal amounts, even in the absence of orf and rap. Also observed is an independence of the RuvC Holliday-junction endonuclease on patch formation, and a slight but statistically significant alteration of patch polarity by recD mutation. Conclusions/Significance. These results indicate that orf and rap did not contribute to the presence of patches, and imply that patches occurring in both DNA strands reflects the molecular mechanism of recombination in E. coli. Most importantly, the lack of a requirement for RuvC implies that endonucleolytic resolution of Holliday junctions is not necessary for heteroduplex-patch formation, contrary to predictions of all of the major previous models. This implies that patches are not an alternative resolution of the same intermediate that produces splices, and do not bear on models for splice formation. We consider two mechanisms that use DNA replication instead of endonucleolytic resolution for formation of heteroduplex patches in either DNA strand: synthesis-dependent-strand annealing and a strand-assimilation mechanism.	[Gumbiner-Russo, Laura M.; Rosenberg, Susan M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Rosenberg, SM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	smr@bcm.tmc.edu		Rosenberg, Susan M./0000-0003-1444-473X	National Cancer Institute [R01-CA85777]; NATIONAL CANCER INSTITUTE [R01CA085777] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute grant R01-CA85777.	Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Anderson DG, 1997, GENES CELLS, V2, P117, DOI 10.1046/j.1365-2443.1997.1130311.x; ARBER W, 1983, COLD SPRING HARBOR M, P433; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BACHMANN BJ, 1996, ESCHERICHIA COLI SAL, P2460; BIEK DP, 1986, J BACTERIOL, V167, P594, DOI 10.1128/jb.167.2.594-603.1986; Bolt EL, 2002, MOL CELL, V10, P187, DOI 10.1016/S1097-2765(02)00560-9; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; CAMPBELL A, 1971, BACTERIOPHAGE LAMBDA, P13; CARRAWAY M, 1993, J BACTERIOL, V175, P3972, DOI 10.1128/JB.175.13.3972-3980.1993; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COHEN A, 1986, J BACTERIOL, V167, P327, DOI 10.1128/jb.167.1.327-335.1986; Court DL, 2002, ANNU REV GENET, V36, P361, DOI 10.1146/annurev.genet.36.061102.093104; DABERT P, 1992, P NATL ACAD SCI USA, V89, P12073, DOI 10.1073/pnas.89.24.12073; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Diamonti AJ, 2002, P NATL ACAD SCI USA, V99, P2866, DOI 10.1073/pnas.052709799; DIXON DA, 1993, CELL, V73, P87, DOI 10.1016/0092-8674(93)90162-J; Doe CL, 2004, NUCLEIC ACIDS RES, V32, P1480, DOI 10.1093/nar/gkh317; DOWER NA, 1981, P NATL ACAD SCI-BIOL, V78, P7033, DOI 10.1073/pnas.78.11.7033; DUTREIX M, 1991, J MOL BIOL, V219, P645, DOI 10.1016/0022-2836(91)90661-O; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; FEISS M, 1983, LAMBDA, V2, P305; Friedman-Ohana R, 1998, P NATL ACAD SCI USA, V95, P6909, DOI 10.1073/pnas.95.12.6909; GANESAN S, 1993, J MOL BIOL, V229, P67, DOI 10.1006/jmbi.1993.1008; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Goldberg A R, 1969, Virology, V38, P200, DOI 10.1016/0042-6822(69)90148-2; Gumbiner-Russo LM, 2001, GENE, V273, P97, DOI 10.1016/S0378-1119(01)00565-0; HAGEMANN AT, 1991, GENETICS, V129, P611; Harris RS, 1996, GENETICS, V142, P681; HARRIS RS, 1994, SCIENCE, V264, P258, DOI 10.1126/science.8146657; HOLBECK SL, 1992, GENETICS, V132, P879; HOLLIFIELD WC, 1987, MOL GEN GENET, V210, P248, DOI 10.1007/BF00325690; JORDAN H, 1997, FOCUS, V19, P60; KONFORTI BB, 1987, P NATL ACAD SCI USA, V84, P690, DOI 10.1073/pnas.84.3.690; KONFORTI BB, 1990, J BIOL CHEM, V265, P6916; KOPPEN A, 1995, P NATL ACAD SCI USA, V92, P6249, DOI 10.1073/pnas.92.14.6249; KORANGY F, 1994, BIOCHEMISTRY-US, V33, P9552, DOI 10.1021/bi00198a022; KORANGY F, 1993, BIOCHEMISTRY-US, V32, P4873, DOI 10.1021/bi00069a024; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Leung WY, 1997, P NATL ACAD SCI USA, V94, P6851, DOI 10.1073/pnas.94.13.6851; LICHTEN M, 1990, P NATL ACAD SCI USA, V87, P7653, DOI 10.1073/pnas.87.19.7653; LLOYD RG, 1991, J BACTERIOL, V173, P5414, DOI 10.1128/jb.173.17.5414-5418.1991; LLOYD RG, 1993, NUCLEIC ACIDS RES, V21, P1719, DOI 10.1093/nar/21.8.1719; LLOYD RG, 1996, ESCHERICHIA COLI SAL, V2, P2236; Lopez CR, 2005, MOL MICROBIOL, V58, P80, DOI 10.1111/j.1365-2958.2005.04812.x; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; MAGNER DB, 2006, THESIS; Martinez-Morales F, 1999, J BACTERIOL, V181, P7143, DOI 10.1128/JB.181.22.7143-7148.1999; Mason JC, 2004, J BIOL CHEM, V279, P41611, DOI 10.1074/jbc.M407981200; Maxwell KL, 2005, P NATL ACAD SCI USA, V102, P11260, DOI 10.1073/pnas.0503399102; McGlynn P, 1999, NUCLEIC ACIDS RES, V27, P3049, DOI 10.1093/nar/27.15.3049; McIlwraith MJ, 2001, J MOL BIOL, V305, P23, DOI 10.1006/jmbi.2000.4268; Miesel L, 1996, J BACTERIOL, V178, P3146, DOI 10.1128/jb.178.11.3146-3155.1996; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Motamedi MR, 1999, GENE DEV, V13, P2889, DOI 10.1101/gad.13.21.2889; MURPHY KC, 1991, J BACTERIOL, V173, P5808, DOI 10.1128/jb.173.18.5808-5821.1991; MURRAY NE, 1974, NATURE, V251, P476, DOI 10.1038/251476a0; MYERS RS, 1995, P NATL ACAD SCI USA, V92, P6244, DOI 10.1073/pnas.92.14.6244; MYERS RS, 1994, ANNU REV GENET, V28, P49, DOI 10.1146/annurev.ge.28.120194.000405; NAG DK, 1990, GENETICS, V125, P753; NAGAMINE CM, 1989, AM J HUM GENET, V45, P337; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; PALAS KM, 1990, J BIOL CHEM, V265, P3447; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; PARKER BO, 1992, P NATL ACAD SCI USA, V89, P1730, DOI 10.1073/pnas.89.5.1730; PEARSON RK, 1988, GENETICS, V118, P13; Poteete AR, 2002, J BACTERIOL, V184, P4626, DOI 10.1128/JB.184.16.4626-4629.2002; Razavy H, 1996, GENETICS, V142, P333; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; RINKEN R, 1992, J BACTERIOL, V174, P5424, DOI 10.1128/JB.174.16.5424-5429.1992; ROSENBERG SM, 1991, BIOCHIMIE, V73, P385, DOI 10.1016/0300-9084(91)90105-A; ROSENBERG SM, 1985, GENE, V38, P165, DOI 10.1016/0378-1119(85)90215-X; ROSENBERG SM, 1987, CELL, V48, P855, DOI 10.1016/0092-8674(87)90082-1; ROSENBERG SM, 1988, GENETICS, V120, P7; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; Sambrook J, 2001, MOL CLONING LAB MANU; SAWITZKE JA, 1992, GENETICS, V130, P7; Sawitzke JA, 1997, GENETICS, V147, P357; SAWITZKE JA, 1994, J BACTERIOL, V176, P6730, DOI 10.1128/JB.176.21.6730-6737.1994; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Sharples GJ, 2004, J MOL BIOL, V340, P739, DOI 10.1016/j.jmb.2004.05.030; Sharples GJ, 1998, P NATL ACAD SCI USA, V95, P13507, DOI 10.1073/pnas.95.23.13507; Shiao T, 2004, HUM MOL GENET, V13, P1873, DOI 10.1093/hmg/ddh204; SIDDIQI I, 1991, GENETICS, V128, P7; SIGNER ER, 1968, J MOL BIOL, V34, P261, DOI 10.1016/0022-2836(68)90251-9; SILBERSTEIN Z, 1993, GENETICS, V133, P439; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Smith G. R., 1981, STADLER GENET S, V13, P25; SMITH GR, 1985, BIOESSAYS, V2, P244, DOI 10.1002/bies.950020603; SMITH GR, 1984, COLD SPRING HARB SYM, V49, P485, DOI 10.1101/SQB.1984.049.01.055; STAHL FW, 1975, J MOL BIOL, V94, P203, DOI 10.1016/0022-2836(75)90078-9; STAHL FW, 1995, GENETICS, V139, P1107; STITT BL, 1989, J BACTERIOL, V171, P3872, DOI 10.1128/jb.171.7.3872-3880.1989; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Storici F, 2006, MOL CELL BIOL, V26, P7645, DOI 10.1128/MCB.00672-06; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TAYLOR AF, 1985, J MOL BIOL, V185, P431, DOI 10.1016/0022-2836(85)90414-0; TAYLOR AF, 1988, GENETIC RECOMBINATIO, P231; THALER DS, 1989, GENOME, V31, P53, DOI 10.1139/g89-013; THALER DS, 1988, ANNU REV GENET, V22, P169, DOI 10.1146/annurev.ge.22.120188.001125; THALER DS, 1987, GENETICS, V116, P501; Wang JD, 2000, J BIOL CHEM, V275, P507, DOI 10.1074/jbc.275.1.507; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; WHITBY MC, 1993, CELL, V75, P341, DOI 10.1016/0092-8674(93)80075-P; WHITE RL, 1974, P NATL ACAD SCI USA, V71, P1544, DOI 10.1073/pnas.71.4.1544; WOLD MS, 1982, P NATL ACAD SCI-BIOL, V79, P6176, DOI 10.1073/pnas.79.20.6176; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; Zissler J, 1971, BACTERIOPHAGE LAMBDA, P455	113	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1242	10.1371/journal.pone.0001242	http://dx.doi.org/10.1371/journal.pone.0001242			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043749	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459300023
J	Lee, S; Horn, V; Julien, E; Liu, Y; Wysocka, J; Bowerman, B; Hengartner, MO; Herr, W				Lee, Soyoung; Horn, Virginie; Julien, Eric; Liu, Yi; Wysocka, Joanna; Bowerman, Bruce; Hengartner, Michael O.; Herr, Winship			Epigenetic Regulation of Histone H3 Serine 10 Phosphorylation Status by HCF-1 Proteins in C. elegans and Mammalian Cells	PLOS ONE			English	Article							VIRUS VP16-INDUCED COMPLEX; CAENORHABDITIS-ELEGANS; REVERSE GENETICS; FAMILY; ASSOCIATION; DROSOPHILA; VP16; DEFECTS; RB; METHYLTRANSFERASE	Background. The human herpes simplex virus (HSV) host cell factor HCF-1 is a transcriptional coregulator that associates with both histone methyl-and acetyltransferases, and a histone deacetylase and regulates cell proliferation and division. In HSV-infected cells, HCF-1 associates with the viral protein VP16 to promote formation of a multiprotein-DNA transcriptional activator complex. The ability of HCF proteins to stabilize this VP16-induced complex has been conserved in diverse animal species including Drosophila melanogaster and Caenorhabditis elegans suggesting that VP16 targets a conserved cellular function of HCF-1. Methodology/Principal Findings. To investigate the role of HCF proteins in animal development, we have characterized the effects of loss of the HCF-1 homolog in C. elegans, called Ce HCF-1. Two large hcf-1 deletion mutants (pk924 and ok559) are viable but display reduced fertility. Loss of Ce HCF-1 protein at reduced temperatures (e.g., 12uC), however, leads to a high incidence of embryonic lethality and early embryonic mitotic and cytokinetic defects reminiscent of mammalian cell-division defects upon loss of HCF-1 function. Even when viable, however, at normal temperature, mutant embryos display reduced levels of phospho-histone H3 serine 10 (H3S10P), a modification implicated in both transcriptional and mitotic regulation. Mammalian cells with defective HCF-1 also display defects inmitotic H3S10P status. Conclusions/Significance. These results suggest that HCF-1 proteins possess conserved roles in the regulation of cell division and mitotic histone phosphorylation.	[Horn, Virginie; Herr, Winship] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Lee, Soyoung; Julien, Eric; Liu, Yi; Wysocka, Joanna; Hengartner, Michael O.; Herr, Winship] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Lee, Soyoung] SUNY Stony Brook, Mol & Cellular Biol Program, Stony Brook, NY 11794 USA; [Bowerman, Bruce] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Lausanne; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Oregon	Herr, W (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	Winship.Herr@unil.ch	JULIEN, ERIC/Y-5873-2019; Hengartner, Michael O/E-6235-2011; Herr, Winship/E-6491-2012; Lee, Soyoung/T-6669-2019; Lee, Soyoung/AHC-5032-2022	JULIEN, ERIC/0000-0003-2976-666X; Herr, Winship/0000-0002-3606-4546; Lee, Soyoung/0000-0002-4614-2931; Hengartner, Michael/0000-0002-7584-596X	NIGMS [GM 45498]; Swiss National Science Foundation; University of Lausanne; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S15GM045498] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Lausanne; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIGMS grant GM 45498, the Swiss National Science Foundation, and the University of Lausanne. The sponsors or funders were not involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Ajuh PM, 2000, NUCLEIC ACIDS RES, V28, P678, DOI 10.1093/nar/28.3.678; Beltran S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r67; BORK P, 1994, J MOL BIOL, V236, P1277, DOI 10.1016/0022-2836(94)90056-6; BRENNER S, 1974, GENETICS, V77, P71; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Cui MX, 2006, PLOS GENET, V2, P719, DOI 10.1371/journal.pgen.0020074; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; FERGUSON EL, 1989, GENETICS, V123, P109; Freiman RN, 1997, GENE DEV, V11, P3122, DOI 10.1101/gad.11.23.3122; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; Guelman S, 2006, MOL CELL BIOL, V26, P871, DOI 10.1128/MCB.26.3.871-882.2006; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Izeta A, 2003, EUR J CELL BIOL, V82, P495, DOI 10.1078/0171-9335-00341; Izeta A, 2003, GENE, V305, P175, DOI 10.1016/S0378-1119(03)00380-9; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Johnson KM, 1999, J VIROL, V73, P3930, DOI 10.1128/JVI.73.5.3930-3940.1999; Julien E, 2004, MOL CELL, V14, P713, DOI 10.1016/j.molcel.2004.06.008; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; KRISTIE TM, 1989, EMBO J, V8, P4229, DOI 10.1002/j.1460-2075.1989.tb08608.x; KRISTIE TM, 1995, J BIOL CHEM, V270, P4387, DOI 10.1074/jbc.270.9.4387; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Lee S, 2001, J VIROL, V75, P12402, DOI 10.1128/JVI.75.24.12402-12411.2001; Liu Y, 1999, MOL CELL BIOL, V19, P909; Lu R, 1998, J VIROL, V72, P6291, DOI 10.1128/JVI.72.8.6291-6297.1998; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Mahajan SS, 2003, J CELL PHYSIOL, V194, P117, DOI 10.1002/jcp.10193; Miller DM, 1995, METHOD CELL BIOL, V48, P365; OEGEMA K, 2006, C ELEGANS, DOI DOI 10.1895/WORMBOOK.1.72.1; Plasterk RHA, 1995, METHOD CELL BIOL, V48, P59; Reilly PT, 2002, EXP CELL RES, V277, P119, DOI 10.1006/excr.2002.5551; Reilly PT, 2002, MOL CELL BIOL, V22, P6767, DOI 10.1128/MCB.22.19.6767-6778.2002; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; SPECTOR DL, 1986, EXP CELL RES, V163, P87, DOI 10.1016/0014-4827(86)90560-4; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; WILSON AC, 1993, COLD SPRING HARB SYM, V58, P167, DOI 10.1101/SQB.1993.058.01.021; WILSON AC, 1995, GENE DEV, V9, P2445, DOI 10.1101/gad.9.20.2445; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2001, BIOCHEMISTRY-US, V40, P5786, DOI 10.1021/bi010086o; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	44	19	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1213	10.1371/journal.pone.0001213	http://dx.doi.org/10.1371/journal.pone.0001213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043729	Green Published, Green Accepted, gold			2022-12-25	WOS:000207459300003
J	Lang, KS; Hegazy, AN; Lang, PA; Eschli, B; Lohning, M; Hengartner, H; Zinkernagel, RM; Recher, M				Lang, Karl S.; Hegazy, Ahmed N.; Lang, Philipp A.; Eschli, Bruno; Loehning, Max; Hengartner, Hans; Zinkernagel, Rolf M.; Recher, Mike			"Negative Vaccination'' by Specific CD4(+) T Cell Tolerisation Enhances Virus-Specific Protective Antibody Responses	PLOS ONE			English	Article							NEUTRALIZING ANTIBODY; MEMORY; INFECTION; PERSISTENCE; EXHAUSTION; EFFECTOR; IMMUNITY; MICE; HYPERGAMMAGLOBULINEMIA; LYMPHOCYTES	Background. Cooperation of CD4(+) T helper cells with specific B cells is crucial for protective vaccination against pathogens by inducing long-lived neutralizing antibody responses. During infection with persistence-prone viruses, prolonged virus replication correlates with low neutralizing antibody responses. We recently described that a viral mutant of lymphocytic choriomeningitis virus (LCMV), which lacks a T helper epitope, counterintuitively induced an enhanced protective antibody response. Likewise, partial depletion of the CD4(+) T cell compartment by using anti-CD4 antibodies enhanced protective antibodies. Principal Findings. Here we have developed a protocol to selectively reduce the CD4(+) T cell response against viral CD4(+) T cell epitopes. We demonstrate that in vivo treatment with LCMV-derived MHC-II peptides induced non-responsiveness of specific CD4(+) T cells without affecting CD4(+) T cell reactivity towards other antigens. This was associated with accelerated virus-specific neutralizing IgG-antibody responses. In contrast to a complete absence of CD4(+) T cell help, tolerisation did not impair CD8(+) T cell responses. Conclusions. This result reveals a novel "negative vaccination'' strategy where specific CD4(+) T cell unresponsiveness may be used to enhance the delayed protective antibody responses in chronic virus infections.	[Lang, Karl S.; Hegazy, Ahmed N.; Lang, Philipp A.; Eschli, Bruno; Loehning, Max; Hengartner, Hans; Zinkernagel, Rolf M.; Recher, Mike] Univ Zurich Hosp, Inst Expt Immunol, Dept Pathol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Lang, KS (corresponding author), Univ Zurich Hosp, Inst Expt Immunol, Dept Pathol, CH-8091 Zurich, Switzerland.	karlslang@gmail.com	Löhning, Max/AAL-2967-2021; Lang, Karl S/R-2505-2016	Löhning, Max/0000-0001-6382-7281; Hegazy, Ahmed N./0000-0002-2946-8251; Recher, Mike/0000-0002-9121-6936; Lang, Karl/0000-0001-9783-7605	Swiss National Science Foundation [3100A0-100779, 3100A0-100068]; Deutsche Forschungsgemeinschaft (DFG) [LA1419/1-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the Swiss National Science Foundation grants to Hans Hengartner N degrees 3100A0-100779 and Rolf Zinkernagel N degrees 3100A0-100068, and the Deutsche Forschungsgemeinschaft (DFG) LA1419/1-1 to Karl Lang.	Ada G, 2001, NEW ENGL J MED, V345, P1042, DOI 10.1056/NEJMra011223; AICHELE P, 1995, J EXP MED, V182, P261, DOI 10.1084/jem.182.1.261; Brundler MA, 1996, EUR J IMMUNOL, V26, P2257, DOI 10.1002/eji.1830260943; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; Ciurea A, 2000, P NATL ACAD SCI USA, V97, P2749, DOI 10.1073/pnas.040558797; COHEN J, 1993, SCIENCE, V262, P980, DOI 10.1126/science.8235635; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; ESCHLI B, 2007, J VIROL; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hunziker L, 2003, NAT IMMUNOL, V4, P343, DOI 10.1038/ni911; Inchauspe Genevieve, 2003, Clin Liver Dis, V7, P243, DOI 10.1016/S1089-3261(02)00067-3; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kaplan DE, 2007, GASTROENTEROLOGY, V132, P654, DOI 10.1053/j.gastro.2006.11.044; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Lang KS, 2005, EUR J IMMUNOL, V35, P738, DOI 10.1002/eji.200425828; LEHMANNGRUBE F, 1993, J VIROL, V67, P332, DOI 10.1128/JVI.67.1.332-339.1993; Marusic S, 1997, J EXP MED, V186, P507, DOI 10.1084/jem.186.4.507; Matter M, 2006, J EXP MED, V203, P2145, DOI 10.1084/jem.20060651; Meyer MF, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-58; MOSKOPHIDIS D, 1992, J VIROL, V66, P3661, DOI 10.1128/JVI.66.6.3661-3668.1992; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Mullen GED, 2006, VACCINE, V24, P2497, DOI 10.1016/j.vaccine.2005.12.034; Pinschewer DD, 2004, J CLIN INVEST, V114, P988, DOI 10.1172/JCI200422374; Recher M, 2004, NAT IMMUNOL, V5, P934, DOI 10.1038/ni1102; Rosa D, 2005, P NATL ACAD SCI USA, V102, P18544, DOI 10.1073/pnas.0509402102; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Staprans SI, 2004, P NATL ACAD SCI USA, V101, P13026, DOI 10.1073/pnas.0404739101; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Thomson M, 2003, J VIROL, V77, P862, DOI 10.1128/JVI.77.2.862-870.2003; Unsoeld H, 2002, J IMMUNOL, V169, P638, DOI 10.4049/jimmunol.169.2.638; von Reyn CF, 2005, LANCET INFECT DIS, V5, P132; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394	36	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1162	10.1371/journal.pone.0001162	http://dx.doi.org/10.1371/journal.pone.0001162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000535	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459100005
J	Al-Sakere, B; Andre, F; Bernat, C; Connault, E; Opolon, P; Davalos, RV; Rubinsky, B; Mir, LM				Al-Sakere, Bassim; Andre, Franck; Bernat, Claire; Connault, Elisabeth; Opolon, Paule; Davalos, Rafael V.; Rubinsky, Boris; Mir, Lluis M.			Tumor Ablation with Irreversible Electroporation	PLOS ONE			English	Article								We report the first successful use of irreversible electroporation for the minimally invasive treatment of aggressive cutaneous tumors implanted in mice. Irreversible electroporation is a newly developed non-thermal tissue ablation technique in which certain short duration electrical fields are used to permanently permeabilize the cell membrane, presumably through the formation of nanoscale defects in the cell membrane. Mathematical models of the electrical and thermal fields that develop during the application of the pulses were used to design an efficient treatment protocol with minimal heating of the tissue. Tumor regression was confirmed by histological studies which also revealed that it occurred as a direct result of irreversible cell membrane permeabilization. Parametric studies show that the successful outcome of the procedure is related to the applied electric field strength, the total pulse duration as well as the temporal mode of delivery of the pulses. Our best results were obtained using plate electrodes to deliver across the tumor 80 pulses of 100 mu s at 0.3 Hz with an electrical field magnitude of 2500 V/cm. These conditions induced complete regression in 12 out of 13 treated tumors, (92%), in the absence of tissue heating. Irreversible electroporation is thus a new effective modality for non-thermal tumor ablation.	[Al-Sakere, Bassim; Andre, Franck; Bernat, Claire; Connault, Elisabeth; Opolon, Paule; Mir, Lluis M.] Inst Gustave Roussy, CNRS, UMR 8121, Villejuif, France; [Al-Sakere, Bassim; Andre, Franck; Bernat, Claire; Connault, Elisabeth; Opolon, Paule; Mir, Lluis M.] Univ Paris Sud, UMR 8121, Villejuif, France; [Davalos, Rafael V.] Virginia Tech Wake Forest Univ, Sch Biomed Engn & Sci, Blacksburg, VA USA; [Rubinsky, Boris] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Rubinsky, Boris] Univ Calif Berkeley, Grad Program Biophys, Berkeley, CA 94720 USA; [Rubinsky, Boris] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Rubinsky, Boris] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, Ctr Bioengn Serv Humanity & Soc, Jerusalem, Israel	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Virginia Polytechnic Institute & State University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Hebrew University of Jerusalem	Mir, LM (corresponding author), Inst Gustave Roussy, CNRS, UMR 8121, Villejuif, France.	luismir@igr.fr	Davalos, Rafael/F-9012-2011; Rubinsky, Boris/B-4439-2010; MIR, Lluis M/AAJ-9110-2020; Sano, Michael/E-1715-2011	Rubinsky, Boris/0000-0002-2794-1543; , Lluis/0000-0002-8671-9467	CNRS; IGR; U. S. National Institutes of Health (NIH) [NIH R01 RR018961]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR018961] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); IGR; U. S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants of CNRS and IGR. BR was supported in part by the U. S. National Institutes of Health (NIH) under Grant NIH R01 RR018961. The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sakere B, 2007, TECHNOL CANCER RES T, V6, P301, DOI 10.1177/153303460700600406; Andre F, 2004, GENE THER, V11, pS33, DOI 10.1038/sj.gt.3302367; BECKER SM, 2006, ASME, V128, P76; Beebe SJ, 2003, DNA CELL BIOL, V22, P785, DOI 10.1089/104454903322624993; BELEHRAD.J, 1972, INT J CANCER, V27, P461, DOI 10.1002/ijc.2910090302; BELEHRADEK M, 1993, CANCER-AM CANCER SOC, V72, P3694, DOI 10.1002/1097-0142(19931215)72:12<3694::AID-CNCR2820721222>3.0.CO;2-2; DAMIANOU CA, 1995, IEEE T ULTRASON FERR, V42, P182, DOI 10.1109/58.365232; Davalos R, 2000, MICROSCALE THERM ENG, V4, P147; Davalos RV, 2003, BIOELECTROCHEMISTRY, V61, P99, DOI 10.1016/j.bioelechem.2003.07.001; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; de Baere T, 2006, CARDIOVASC INTER RAD, V29, P650, DOI 10.1007/s00270-005-0187-9; Deng JD, 2003, BIOPHYS J, V84, P2709, DOI 10.1016/S0006-3495(03)75076-0; Deng ZS, 2001, PHYSICA A, V300, P521, DOI 10.1016/S0378-4371(01)00373-9; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; Gothelf A, 2003, CANCER TREAT REV, V29, P371, DOI 10.1016/S0305-7372(03)00073-2; Gowrishankar TR, 2006, BIOCHEM BIOPH RES CO, V349, P643, DOI 10.1016/j.bbrc.2006.08.097; HALM EW, 1978, CANCER, V42, P2591; Huang Y, 1999, BIOMED MICRODEVICES, V2, P145, DOI 10.1023/A:1009901821588; INCROPERA FP, 2002, INTRO HEAT TRANSFER, pCH5; Martin RCG, 2006, AM SURGEON, V72, P391; Marty M, 2006, EJC SUPPL, V4, P3, DOI 10.1016/j.ejcsup.2006.08.002; Miklavcic D, 2000, BBA-GEN SUBJECTS, V1523, P73, DOI 10.1016/S0304-4165(00)00101-X; Miklavcic D, 1998, BIOPHYS J, V74, P2152, DOI 10.1016/S0006-3495(98)77924-X; Miklavcic D, 2006, EJC SUPPL, V4, P45, DOI 10.1016/j.ejcsup.2006.08.006; Miller L, 2005, TECHNOL CANCER RES T, V4, P699, DOI 10.1177/153303460500400615; Mir LM, 2006, EJC SUPPL, V4, P14, DOI 10.1016/j.ejcsup.2006.08.003; Mir LM, 2005, ADV GENET, V54, P83, DOI 10.1016/S0065-2660(05)54005-7; MIR LM, 1991, EUR J CANCER, V27, P68, DOI 10.1016/0277-5379(91)90064-K; Mir LM, 2001, BIOELECTROCHEMISTRY, V53, P1, DOI 10.1016/S0302-4598(00)00112-4; Mir LM, 1998, BRIT J CANCER, V77, P2336, DOI 10.1038/bjc.1998.388; Mohamed F, 2004, J SURG ONCOL, V88, P14, DOI 10.1002/jso.20117; Mouraviev V, 2006, CURR OPIN UROL, V16, P152, DOI 10.1097/01.mou.0000193393.54598.9f; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; ONIK G, 1991, CANCER, V67, P901, DOI 10.1002/1097-0142(19910215)67:4<901::AID-CNCR2820670408>3.0.CO;2-Z; ONIK GM, 1993, CANCER, V72, P1291, DOI 10.1002/1097-0142(19930815)72:4<1291::AID-CNCR2820720423>3.0.CO;2-I; ORLOWSKI S, 1993, BIOCHIM BIOPHYS ACTA, V1154, P51, DOI 10.1016/0304-4157(93)90016-H; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; SAPARETO SA, 1984, INT J RADIAT ONCOL, V10, P787, DOI 10.1016/0360-3016(84)90379-1; Sersa G, 2003, CANC THER, V1, P133; Sersa G, 2006, EJC SUPPL, V4, P52, DOI 10.1016/j.ejcsup.2006.08.007; SWARUP A, 1991, BIOELECTROMAGNETICS, V12, P1, DOI 10.1002/bem.2250120102; *UKCCCR, BR J CANC, V77, P1; WHITE FM, 1988, APPENDIX C PROPERTIE, P672; WHITFIELD W, 1988, J ROYAL SOC HLTH, V1, P1	44	329	366	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1135	10.1371/journal.pone.0001135	http://dx.doi.org/10.1371/journal.pone.0001135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17989772	Green Published, gold			2022-12-25	WOS:000207459000019
J	Chang, CL; Hong, E; Lao-Sirieix, P; Fitzgerald, RC				Chang, C-L; Hong, E.; Lao-Sirieix, P.; Fitzgerald, R. C.			A novel role for the retinoic acid-catabolizing enzyme CYP26A1 in Barrett's associated adenocarcinoma	ONCOGENE			English	Article						vitamin A; oesophageal adenocarcinoma; proliferation; invasion; bile acids	VITAMIN-A; RECEPTOR-GAMMA; HUMAN BREAST; IN-VITRO; EXPRESSION; CANCER; METABOLISM; GROWTH; DIFFERENTIATION; INHIBITION	Vitamin A deficiency is associated with carcinogenesis, and upregulation of CYP26A1, a major retinoic acid (RA)-catabolizing enzyme, has recently been shown in cancer. We have previously demonstrated alterations of RA biosynthesis in Barrett's oesophagus, the precursor lesion to oesophageal adenocarcinoma. The aims of this study were to determine CYP26A1 expression levels and functional effects in Barrett's associated carcinogenesis. Retinoic acid response element reporter cells were used to determine RA levels in non-dysplastic and dysplastic Barrett's cell lines and endoscopic biopsies. CYP26A1 expression levels, with or without induction by RA and lithocholic acid, were determined by quantitative reverse transcriptase-PCR (RT-PCR) and immunohistochemistry. CYP26A1 promoter activity was determined by a luciferase reporter construct. CYP26A1 was stably over-expressed in GihTERT cells, which were evaluated for gene-expression changes (pathway array and quantitative RT-PCR), cellular proliferation (cytometric DNA pro. le and colorimetric assay) and invasion (in vitro matrigel assay) with or without the CYP inhibitor ketaconazole. RA levels decreased progressively with the degree of dysplasia (P < 0.05) and were inversely correlated with CYP26A1 gene levels and activity (P < 0.01). CYP26A1 expression was increased synergistically by RA and lithocholic acid (P < 0.05). Overexpression of CYP26A1 led to induction of c-Myc, epidermal growth factor receptor and matrix metalloproteinase 3 as well as downregulation of tissue inhibitor metalloproteinase 1 and 3. Functional effects of CYP26A1 overexpression were increased proliferation (P < 0.01) and invasion in vitro (P < 0.01), which were inhibited by ketaconazole. Overexpression of CYP26A1 causes intracellular RA depletion and drives the cell into a highly proliferative and invasive state with induction of other known oncogenes.	[Chang, C-L; Hong, E.; Lao-Sirieix, P.; Fitzgerald, R. C.] MRC, Hutchison Res Ctr, Canc Cell Unit, Cambridge CB2 2XZ, England; [Chang, C-L] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan	Mackay Memorial Hospital	Fitzgerald, RC (corresponding author), MRC, Hutchison Res Ctr, Canc Cell Unit, Cambridge CB2 2XZ, England.	rcf@hutchison-mrc.cam.ac.uk	Chang, Chih-Long/AAJ-8784-2020	Chang, Chih-Long/0000-0003-3981-9366; Fitzgerald, Rebecca/0000-0002-3434-3568	Medical Research Council [MC_U105365007] Funding Source: Medline; MRC [MC_U105365007] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abu-Abed SS, 1998, J BIOL CHEM, V273, P2409, DOI 10.1074/jbc.273.4.2409; Avidan B, 2002, AM J GASTROENTEROL, V97, P1930, DOI 10.1111/j.1572-0241.2002.05902.x; Bancewicz J, 2002, LANCET, V359, P1727; Bax DA, 2005, J SURG ONCOL, V92, P89, DOI 10.1002/jso.20353; BERTRAM JS, 1993, ANN NY ACAD SCI, V686, P161, DOI 10.1111/j.1749-6632.1993.tb39170.x; Bigg HF, 2000, EUR J BIOCHEM, V267, P4150, DOI 10.1046/j.1432-1327.2000.01459.x; Brabender J, 2004, ONCOGENE, V23, P4780, DOI 10.1038/sj.onc.1207663; Chang CL, 2007, GUT, V56, P906, DOI 10.1136/gut.2006.097915; Downie D, 2005, CLIN CANCER RES, V11, P7369, DOI 10.1158/1078-0432.CCR-05-0466; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; Hormi-Carver K, 2007, AM J PHYSIOL-GASTR L, V292, pG18, DOI 10.1152/ajpgi.00237.2006; Klamt F, 2003, MUTAT RES-GEN TOX EN, V539, P117, DOI 10.1016/S1383-5718(03)00155-4; Liu T, 2005, BRIT J CANCER, V93, P310, DOI 10.1038/sj.bjc.6602700; Lord RVN, 2001, SURGERY, V129, P267, DOI 10.1067/msy.2001.110856; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Niederreither K, 2002, NAT GENET, V31, P84, DOI 10.1038/ng876; Osanai M, 2005, MOL PHARMACOL, V67, P1808, DOI 10.1124/mol.104.005769; Palanca-Wessels MCA, 2003, CARCINOGENESIS, V24, P1183, DOI 10.1093/carcin/bgg076; Patel JB, 2004, J MED CHEM, V47, P6716, DOI 10.1021/jm0401457; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Radominska-Pandya A, 2002, BIOCHEMISTRY-US, V41, P4883, DOI 10.1021/bi0121151; Reifen R, 1998, INT J MOL MED, V1, P579; SAFFIOTTI U, 1967, CANCER-AM CANCER SOC, V20, P857, DOI 10.1002/1097-0142(1967)20:5&lt;857::AID-CNCR2820200545&gt;3.0.CO;2-3; Sah JF, 2002, J BIOL CHEM, V277, P9728, DOI 10.1074/jbc.M110897200; Schoenermark MP, 1999, ANN NY ACAD SCI, V878, P466, DOI 10.1111/j.1749-6632.1999.tb07703.x; Shelton DN, 2006, CANCER RES, V66, P7571, DOI 10.1158/0008-5472.CAN-06-1067; SMITH AH, 1991, AM J EPIDEMIOL, V133, P661, DOI 10.1093/oxfordjournals.aje.a115941; Van Heusden J, 2002, BRIT J CANCER, V86, P605, DOI 10.1038/sj.bjc.6600056; WALD N, 1980, LANCET, V2, P813; Webster RP, 1996, IN VIVO, V10, P113; Winters C, 1987, GASTROENTEROLOGY, V92, P118, DOI 10.1016/0016-5085(87)90847-X; Wolbach SB, 1925, J EXP MED, V42, P753, DOI 10.1084/jem.42.6.753; WOUTERS W, 1992, CANCER RES, V52, P2841; Yung BYM, 2004, FEBS LETT, V578, P211, DOI 10.1016/j.febslet.2004.08.089	34	26	27	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 8	2008	27	21					2951	2960		10.1038/sj.onc.1210969	http://dx.doi.org/10.1038/sj.onc.1210969			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	298IP	18059332				2022-12-25	WOS:000255681700002
J	Bae, B; Ohene-Adjei, S; Kocherginskaya, S; Mackie, RI; Spies, MA; Cann, IKO; Nair, SK				Bae, Brian; Ohene-Adjei, Samuel; Kocherginskaya, Svetlana; Mackie, Roderick I.; Spies, M. Ashley; Cann, Isaac K. O.; Nair, Satish K.			Molecular basis for the selectivity and specificity of ligand recognition by the family 16 carbohydrate-binding modules from Thermoanaerobacterium polysaccharolyticum ManA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOMATED STRUCTURE SOLUTION; HELIX CONFORMATION; CELLULOMONAS-FIMI; EXPRESSION; DOMAINS; COMPLEX; CLONING; HYDROLYSIS; COMPONENT; CHECKING	Enzymes that hydrolyze complex polysaccharides into simple sugars are modular in architecture and consist of single or multiple catalytic domains fused to targeting modules called carbohydratebinding modules (CBMs). CBMs bind to their ligands with high affinity and increase the efficiency of the catalytic components by targeting the enzymes to its substrate. Here we utilized a multidisciplinary approach to characterize each of the two family 16 carbohydrate-binding domain components of the highly active mannanase from the thermophile Thermoanaerobacterium polysaccharolyticum. These represent the first crystal structures of family 16 CBMs. Calorimetric analysis showed that although these CBMs demonstrate high specificity toward beta-1,4-linked sugars, they can engage both cello- and manno-polysaccharides. To elucidate the molecular basis for this specificity and selectivity, we have determined high resolution crystal structures of each of the two CBMs, as well as of binary complexes of CBM16-1 bound to either mannopentaose or cellopentaose. These results provide detailed molecular insights into ligand recognition and yield a framework for rational engineering experiments designed to expand the natural repertoire of these targeting modules.	[Bae, Brian; Spies, M. Ashley; Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Cann, Isaac K. O.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Ohene-Adjei, Samuel; Kocherginskaya, Svetlana; Mackie, Roderick I.; Cann, Isaac K. O.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Mackie, Roderick I.; Spies, M. Ashley; Cann, Isaac K. O.; Nair, Satish K.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nair, SK (corresponding author), Univ Illinois, Dept Biochem, 600 S Mathews Ave, Urbana, IL 61801 USA.	snair@uiuc.edu	Nair, Satish/AAY-2510-2021					Ahsan MM, 1996, J BACTERIOL, V178, P5732, DOI 10.1128/jb.178.19.5732-5740.1996; Black GW, 1996, BIOCHEM J, V319, P515, DOI 10.1042/bj3190515; Bolam DN, 2001, BIOCHEMISTRY-US, V40, P2468, DOI 10.1021/bi002564l; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2003, J BIOL CHEM, V278, P6120, DOI 10.1074/jbc.M209554200; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Cann IKO, 1999, J BACTERIOL, V181, P1643, DOI 10.1128/JB.181.5.1643-1651.1999; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P14077, DOI 10.1073/pnas.212516199; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; COUGHLAN MP, 1985, BIOCHEM SOC T, V13, P405, DOI 10.1042/bst0130405; DIN N, 1994, MOL MICROBIOL, V11, P747, DOI 10.1111/j.1365-2958.1994.tb00352.x; Flint J, 2005, J BIOL CHEM, V280, P23718, DOI 10.1074/jbc.M501551200; Freelove ACJ, 2001, J BIOL CHEM, V276, P43010, DOI 10.1074/jbc.M107143200; Ito Y, 2003, APPL ENVIRON MICROB, V69, P6969, DOI 10.1128/AEM.69.12.6969-6978.2003; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Linder M, 1996, J BIOL CHEM, V271, P21268, DOI 10.1074/jbc.271.35.21268; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mizushima T, 2004, NAT STRUCT MOL BIOL, V11, P365, DOI 10.1038/nsmb732; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; SAITO H, 1991, CARBOHYD RES, V217, P181, DOI 10.1016/0008-6215(91)84128-2; Southall SM, 1999, FEBS LETT, V447, P58, DOI 10.1016/S0014-5793(99)00263-X; Sunna A, 2001, BIOCHEM J, V356, P791, DOI 10.1042/0264-6021:3560791; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; TOMME P, 1991, BIOCHEMISTRY-US, V35, P13885; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Walden H, 2004, J MOL BIOL, V342, P861, DOI 10.1016/j.jmb.2004.07.067; Young SH, 2000, J BIOL CHEM, V275, P11874, DOI 10.1074/jbc.275.16.11874	36	39	42	1	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12415	12425		10.1074/jbc.M706513200	http://dx.doi.org/10.1074/jbc.M706513200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18025086	hybrid			2022-12-25	WOS:000255340000058
J	Bousquet, M; Saint-Pierre, M; Julien, C; Salem, N; Cicchetti, F; Calon, F				Bousquet, M.; Saint-Pierre, M.; Julien, C.; Salem, N., Jr.; Cicchetti, F.; Calon, F.			Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease	FASEB JOURNAL			English	Article						MPTP; neuroprotection; DHA; dopamine	DOCOSAHEXAENOIC ACID; DOPAMINE TRANSPORTER; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; MOUSE MODEL; TYROSINE-HYDROXYLASE; MONOAMINERGIC NEUROTRANSMISSION; INDUCED DYSKINESIAS; SUBSTANTIA-NIGRA; LEARNING-ABILITY	In this study, we examined whether omega-3 (n-3) polyunsaturated fatty acids (PUFAs) may exert neuroprotective action in Parkinson's disease, as previously shown in Alzheimer's disease. We exposed mice to either a control or a high n-3 PUFA diet from 2 to 12 months of age and then treated them with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP; 140 mg/kg in 5 days). High n-3 PUFA dietary consumption completely prevented the MPTP-induced decrease of tyrosine hydroxylase (TH)-labeled nigral cells (P<0.01 vs. MPTP mice on control diet), Nurr1 mRNA (P<0.01 vs. MPTP mice on control diet), and dopamine transporter mRNA levels (P<0.05 vs. MPTP mice on control diet) in the substantia nigra. Although n-3 PUFA dietary treatment had no effect on striatal dopaminergic terminals, the high n-3 PUFA diet protected against the MPTP-induced decrease in dopamine (P<0.05 vs. MPTP mice on control diet) and its metabolite dihydroxyphenylacetic acid (P<0.05 vs. MPTP mice on control diet) in the striatum. Taken together, these data suggest that a high n-3 PUFA dietary intake exerts neuroprotective actions in an animal model of Parkinsonism.	[Bousquet, M.; Julien, C.; Calon, F.] CHUQ, CHU Laval, Ctr Res Endocrinol Mol & Oncol, Quebec City, PQ G1V 4G2, Canada; [Saint-Pierre, M.; Cicchetti, F.] CHUQ, CHU Laval, Ctr Res Neurosci, Quebec City, PQ, Canada; [Bousquet, M.; Julien, C.; Calon, F.] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Cicchetti, F.] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Salem, N., Jr.] NIAAA, Sect Nutr Neurosci, Lab Membrane Biochem & Biophys, Div Intramural Clin & Biol Res, Rockville, MD 20852 USA	Laval University; Laval University; McGill University; Laval University; Laval University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Calon, F (corresponding author), CHUQ, CHU Laval, Res Ctr, T2-05,2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.	francesca.cicchetti@crchul.ulaval.ca; frederic.calon@crchul.ulaval.ca	Julien, Carl/AAU-5309-2021; Calon, Frederic/AAF-4390-2020; soler, martha maricel m gomez/L-6025-2014	soler, martha maricel m gomez/0000-0002-4412-8108; Calon, Frederic/0000-0002-4203-0887; Cicchetti, Francesca/0000-0001-5490-1961				Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; Akbar M, 2002, J NEUROCHEM, V82, P655, DOI 10.1046/j.1471-4159.2002.01015.x; [Anonymous], [No title captured]; Bazan NG, 2005, BRAIN PATHOL, V15, P159; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; Bezard E, 1997, EXP NEUROL, V148, P288, DOI 10.1006/exnr.1997.6648; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; BRECKENRIDGE WC, 1973, BIOCHIM BIOPHYS ACTA, V320, P681, DOI 10.1016/0304-4165(73)90148-7; Calon F, 2006, CAN MED ASSOC J, V174, P483, DOI 10.1503/cmaj.050663; Calon F, 2005, EUR J NEUROSCI, V22, P617, DOI 10.1111/j.1460-9568.2005.04253.x; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Calon F, 2003, MOVEMENT DISORD, V18, P241, DOI 10.1002/mds.10343; Calon F, 2001, SYNAPSE, V40, P225, DOI 10.1002/syn.1045; Chalon S, 1998, J NUTR, V128, P2512, DOI 10.1093/jn/128.12.2512; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chen H, 2003, AM J EPIDEMIOL, V157, P1007, DOI 10.1093/aje/kwg073; CHRISTENSEN O, 1988, ACTA PSYCHIAT SCAND, V78, P587, DOI 10.1111/j.1600-0447.1988.tb06388.x; Costantini LC, 2001, EUR J NEUROSCI, V13, P1085, DOI 10.1046/j.0953-816x.2001.01473.x; Danthi SJ, 2005, BIOCHEM BIOPH RES CO, V327, P485, DOI 10.1016/j.bbrc.2004.12.033; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2002, NEURON, V35, P219, DOI 10.1016/S0896-6273(02)00780-8; de Lau LML, 2005, NEUROLOGY, V64, P2040, DOI 10.1212/01.WNL.0000166038.67153.9F; Delion S, 1997, J LIPID RES, V38, P680; Di Monte DA, 2002, NEUROTOXICOLOGY, V23, P487, DOI 10.1016/S0161-813X(02)00099-2; Ethier I, 2004, BIOL PSYCHIAT, V56, P522, DOI 10.1016/j.biopsych.2004.06.036; Fedorova I, 2006, PROSTAG LEUKOTR ESS, V75, P271, DOI 10.1016/j.plefa.2006.07.006; FOLCH J, 1957, J BIOL CHEM, V226, P497; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Gainetdinov RR, 1997, J NEUROCHEM, V69, P1322; Glaser JR, 2000, J CHEM NEUROANAT, V20, P115, DOI 10.1016/S0891-0618(00)00073-9; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hashimoto M, 2005, J NUTR, V135, P549, DOI 10.1093/jn/135.3.549; Hashimoto M, 2002, J NEUROCHEM, V81, P1084, DOI 10.1046/j.1471-4159.2002.00905.x; Hogan SA, 2003, J MICROENCAPSUL, V20, P675, DOI 10.1080/0265204031000151974; Horrocks LA, 2004, PROSTAG LEUKOTR ESS, V70, P361, DOI 10.1016/j.plefa.2003.12.011; Huot P, 2007, J NEUROCHEM, V101, P1441, DOI 10.1111/j.1471-4159.2006.04430.x; Jaber M, 1999, EUR J NEUROSCI, V11, P3499, DOI 10.1046/j.1460-9568.1999.00764.x; Jourdain S, 2005, J NEUROENDOCRINOL, V17, P509, DOI 10.1111/j.1365-2826.2005.01337.x; Joyce JN, 1997, MOVEMENT DISORD, V12, P885, DOI 10.1002/mds.870120609; Julien C, 2006, NEUROCHEM INT, V48, P404, DOI 10.1016/j.neuint.2005.12.002; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Jump DB, 2002, CURR OPIN LIPIDOL, V13, P155, DOI 10.1097/00041433-200204000-00007; Kaul S, 2003, EUR J NEUROSCI, V18, P1387, DOI 10.1046/j.1460-9568.2003.02864.x; Kim HY, 2007, J BIOL CHEM, V282, P18661, DOI 10.1074/jbc.R700015200; Kolanowski W, 2004, INT J FOOD SCI NUTR, V55, P333, DOI 10.1080/09637480410001725157; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; Le W, 1999, J NEUROCHEM, V73, P2218; Lee MA, 2002, NEUROSCI LETT, V333, P74, DOI 10.1016/S0304-3940(02)00981-3; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Maclean C H, 2005, Evid Rep Technol Assess (Summ), P1; Maes M, 1996, J AFFECT DISORDERS, V38, P35, DOI 10.1016/0165-0327(95)00092-5; Mandavilli BS, 2000, BRAIN RES, V885, P45, DOI 10.1016/S0006-8993(00)02926-7; Mao LM, 2001, DEV BRAIN RES, V131, P57, DOI 10.1016/S0165-3806(01)00260-7; Masood A, 2005, J LIPID RES, V46, P2299, DOI 10.1194/jlr.D500022-JLR200; McGeer PL, 2001, ADV NEUROL, V86, P83; McNamara RK, 2006, PROSTAG LEUKOTR ESS, V75, P237, DOI 10.1016/j.plefa.2006.07.009; Miller GW, 1999, TRENDS PHARMACOL SCI, V20, P424, DOI 10.1016/S0165-6147(99)01379-6; Mizuno Y, 2001, ADV NEUROL, V86, P13; Moriguchi T, 2004, J LIPID RES, V45, P1437, DOI 10.1194/jlr.M400087-JLR200; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; MURRAY AM, 1995, ANN NEUROL, V37, P300, DOI 10.1002/ana.410370306; Nakahara T, 2001, NEUROSCIENCE, V108, P601, DOI 10.1016/S0306-4522(01)00441-9; *NEW ALZH CLIN TRI, 2006, AM J ALZHEIMERS DIS, V21, P460; Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013; Pawlosky RJ, 2001, ALCOHOL CLIN EXP RES, V25, P1758, DOI 10.1097/00000374-200112000-00011; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Przedborski S, 1996, P NATL ACAD SCI USA, V93, P4565, DOI 10.1073/pnas.93.10.4565; Przedborski S, 2003, ANN NY ACAD SCI, V991, P189; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Samadi P, 2006, ANN NEUROL, V59, P282, DOI 10.1002/ana.20738; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; SCHAPIRA AHV, 1994, MOVEMENT DISORD, V9, P125, DOI 10.1002/mds.870090202; Seebungkert B, 2002, EUR J NEUROSCI, V16, P2085, DOI 10.1046/j.1460-9568.2002.02288.x; Soderstrom K, 2006, CELL TRANSPLANT, V15, P251, DOI 10.3727/000000006783982025; Su KP, 2003, EUR NEUROPSYCHOPHARM, V13, P267, DOI 10.1016/S0924-977X(03)00032-4; SUNDSTROM E, 1987, BRAIN RES, V405, P26; Suzuki H, 1997, INT J VITAM NUTR RES, V67, P272; Tanner CM, 1996, NEUROL CLIN, V14, P317, DOI 10.1016/S0733-8619(05)70259-0; Tanner CM, 2003, ADV NEUROL, V91, P133; TREEN M, 1992, ARCH BIOCHEM BIOPHYS, V294, P564, DOI 10.1016/0003-9861(92)90726-D; Tremblay ME, 2006, NEUROBIOL AGING, V27, P862, DOI 10.1016/j.neurobiolaging.2005.04.004; Vreugdenhil M, 1996, P NATL ACAD SCI USA, V93, P12559, DOI 10.1073/pnas.93.22.12559; Wheaton DH, 2003, ARCH OPHTHALMOL-CHIC, V121, P1269, DOI 10.1001/archopht.121.9.1269; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Yavin E, 2002, NUTR NEUROSCI, V5, P149, DOI 10.1080/10284150290003159; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	89	173	182	0	31	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2008	22	4					1213	1225		10.1096/fj.07-9677com	http://dx.doi.org/10.1096/fj.07-9677com			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	18032633				2022-12-25	WOS:000254581000026
J	Wang, N; Yvan-Charvet, L; Lutjohann, D; Mulder, M; Vanmierlo, T; Kim, TW; Tall, AR				Wang, Nan; Yvan-Charvet, Laurent; Luetjohann, Dieter; Mulder, Monique; Vanmierlo, Tim; Kim, Tae-Wan; Tall, Alan R.			ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain	FASEB JOURNAL			English	Article						Abcg1; Abcg4; astrocyte; neuron; apolipoprotein E; efflux	NEWLY SYNTHESIZED CHOLESTEROL; CENTRAL-NERVOUS-SYSTEM; CARDIOVASCULAR-DISEASE; ABCA1; ABCG1; MICE; ATHEROSCLEROSIS; EXPRESSION; CELLS; MOUSE	Transporters in the ABCG family appear to be involved in the cellular excretion of cholesterol and other sterols in a cell- and tissue-specific fashion. Overexpression of ATP-binding cassette transporters G1 (Abcg1) and G4 (Abcg4) can promote cellular cholesterol efflux to high-density lipoprotein (HDL), but the in vivo functions of Abcg4 are poorly understood. We used mice with knockouts of Abcg1 or Abcg4 singly or together to further elucidate the function of these transporters. Abcg1 and Abcg4 are highly expressed in the brain and are found in both astrocytes and neurons. Whereas Abcg2(-/-) or Abcg4(-/-) mice showed essentially normal levels of brain sterols, in Abcg1(-/-)/Abcg4(-/-) mice, levels of several sterol intermediates in the cholesterol biosynthetic pathway, namely desmosterol, lathosterol, and lanosterol, as well as 27-OH cholesterol, were increased 2- to 3-fold. Overexpression of Abcg1 or Abcg4 promoted efflux of desmosterol and cholesterol from cells to HDL, and combined deficiency of these transporters led to defective efflux and accumulation of these sterols in primary astrocytes. Consistent with defective efflux and sterol accumulation, cholesterol biosynthesis was reduced in Abcg1(-/-)/Abcg4(-/-) astrocytes. The accumulation of desmosterol, a known liver-X receptor (LXR) activator, was associated with increased expression of LXR target genes, including ATP-binding cassette transporter Al, and increased apolipoprotein E secretion in Abcg1(-/-)/ Abcg4-/- astrocytes. Our findings provide the first in vivo demonstration of a role for Abcg4 in sterol efflux in the brain and show that Abcg1 and Abcg4 have overlapping functions in astrocytes, promoting efflux of cholesterol, desmosterol, and possibly other sterol biosynthetic intermediates to HDL.	[Wang, Nan; Yvan-Charvet, Laurent; Tall, Alan R.] Columbia Univ, Dept Med, Div Mol Med, New York, NY 10032 USA; [Kim, Tae-Wan] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Luetjohann, Dieter] Univ Bonn, Inst Clin Biochem & Pharmacol, D-5300 Bonn, Germany; [Mulder, Monique] Maastricht Univ, Dept Basic Neurosci, Maastricht, Netherlands	Columbia University; Columbia University; University of Bonn; Maastricht University	Wang, N (corresponding author), Columbia Univ, Dept Med, Div Mol Med, PS 8-401,630 W 168th St, New York, NY 10032 USA.	nw30@columbia.edu	Vanmierlo, Tim/C-7773-2013; Tall, Alan/AAT-8528-2021	Vanmierlo, Tim/0000-0003-2912-0578; Yvan-Charvet, Laurent/0000-0002-7748-4942				Abildayeva K, 2006, J BIOL CHEM, V281, P12799, DOI 10.1074/jbc.M601019200; Aiello RJ, 2003, ARTERIOSCL THROM VAS, V23, P972, DOI 10.1161/01.ATV.0000054661.21499.FB; Baldan A, 2006, CURR OPIN LIPIDOL, V17, P227, DOI 10.1097/01.mol.0000226113.89812.bb; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Brunham LR, 2006, ANNU REV NUTR, V26, P105, DOI 10.1146/annurev.nutr.26.061505.111214; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Cserepes J, 2004, BIOCHEM BIOPH RES CO, V320, P860, DOI 10.1016/j.bbrc.2004.06.037; DIETSCHY JM, 1967, J LIPID RES, V8, P97; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Engelking LJ, 2006, J CLIN INVEST, V116, P2356, DOI 10.1172/JCI28988; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Heverin M, 2007, ARTERIOSCL THROM VAS, V27, P2191, DOI 10.1161/ATVBAHA.107.149823; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; Hirsch-Reinshagen V, 2004, J BIOL CHEM, V279, P41197, DOI 10.1074/jbc.M407962200; Hobbs HH, 2002, COLD SPRING HARB SYM, V67, P499, DOI 10.1101/sqb.2002.67.499; IGNATIUS MJ, 1987, SCIENCE, V236, P959, DOI 10.1126/science.3576212; JOHNSON WJ, 1995, J BIOL CHEM, V270, P25037, DOI 10.1074/jbc.270.42.25037; Karten B, 2006, J BIOL CHEM, V281, P4049, DOI 10.1074/jbc.M508915200; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Kim WS, 2007, J BIOL CHEM, V282, P2851, DOI 10.1074/jbc.M607831200; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; Lusa S, 2003, J BIOL CHEM, V278, P19844, DOI 10.1074/jbc.M212503200; Mutka AL, 2004, J BIOL CHEM, V279, P48654, DOI 10.1074/jbc.M405345200; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Ranalletta M, 2006, ARTERIOSCL THROM VAS, V26, P2308, DOI 10.1161/01.ATV.0000242275.92915.43; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; Savary S, 1996, MAMM GENOME, V7, P673, DOI 10.1007/s003359900203; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; Tachikawa M, 2005, J NEUROCHEM, V95, P294, DOI 10.1111/j.1471-4159.2005.03369.x; Tall AR, 2002, J CLIN INVEST, V110, P899, DOI 10.1172/JCI200216391; Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104; Thelen KM, 2006, J PHARMACOL EXP THER, V316, P1146, DOI 10.1124/jpet.105.094136; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Wang N, 2006, ARTERIOSCL THROM VAS, V26, P1310, DOI 10.1161/01.ATV.0000218998.75963.02; Wechsler A, 2003, SCIENCE, V302, P2087, DOI 10.1126/science.1090776; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/pnas.192276999	44	130	137	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2008	22	4					1073	1082		10.1096/fj.07-9944com	http://dx.doi.org/10.1096/fj.07-9944com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	18039927				2022-12-25	WOS:000254581000013
J	Metcalfe, C; Macdonald, IK; Murphy, EJ; Brown, KA; Raven, EL; Moody, PCE				Metcalfe, Clive; Macdonald, Isabel K.; Murphy, Emma J.; Brown, Katherine A.; Raven, Emma Lloyd; Moody, Peter C. E.			The tuberculosis prodrug isoniazid bound to activating peroxidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ARTHROMYCES-RAMOSUS PEROXIDASE; CYTOCHROME-C PEROXIDASE; MYCOBACTERIUM-TUBERCULOSIS; CATALASE-PEROXIDASE; CRYSTAL-STRUCTURE; ASCORBATE PEROXIDASE; SALICYLHYDROXAMIC ACID; BENZHYDROXAMIC ACID; ACTIVE-SITE	Isoniazid (INH, isonicotinic acid hydrazine) is one of only two therapeutic agents effective in treating tuberculosis. This prodrug is activated by the heme enzyme catalase peroxidase (KatG) endogenous to Mycobacterium tuberculosis but the mechanism of activation is poorly understood, in part because the binding interaction has not been properly established. The class I peroxidases ascorbate peroxidase (APX) and cytochrome c peroxidase (CcP) have active site structures very similar to KatG and are also capable of activating isoniazid. We report here the first crystal structures of complexes of isoniazid bound to APX and CcP. These are the first structures of isoniazid bound to any activating enzymes. The structures show that isoniazid binds close to the delta-heme edge in both APX and CcP, although the precise binding orientation varies slightly in the two cases. A second binding site for INH is found in APX at the gamma-heme edge close to the established ascorbate binding site, indicating that the gamma-heme edge can also support the binding of aromatic substrates. We also show that in an active site mutant of soybean APX (W41A) INH can bind directly to the heme iron to become an inhibitor and in a different mode when the distal histidine is replaced by alanine (H42A). These structures provide the first unambiguous evidence for the location of the isoniazid binding site in the class I peroxidases and provide rationalization of isoniazid resistance in naturally occurring KatG mutant strains of M. tuberculosis.	[Moody, Peter C. E.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Metcalfe, Clive; Macdonald, Isabel K.; Murphy, Emma J.; Raven, Emma Lloyd] Univ Leicester, Dept Chem, Leicester LE1 9HN, Leics, England; [Brown, Katherine A.] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, Div Cell & Mol Biol, Dept Life Sci, London SW7 2AZ, England	University of Leicester; University of Leicester; Imperial College London	Moody, PCE (corresponding author), Univ Leicester, Dept Biochem, Lancaster Rd, Leicester LE1 9HN, Leics, England.	peter.moody@le.ac.uk	Moody, Peter/A-6832-2008	Moody, Peter/0000-0003-1762-9238; Murphy, Emma/0000-0003-4551-8068; Raven, Emma/0000-0002-1643-8694; Metcalfe, Clive/0000-0002-7856-8574	Biotechnology and Biological Sciences Research Council [BB/C001184/1, B19083] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Badyal SK, 2006, J BIOL CHEM, V281, P24512, DOI 10.1074/jbc.M602602200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bertrand T, 2004, J BIOL CHEM, V279, P38991, DOI 10.1074/jbc.M402382200; Bodiguel J, 2001, J AM CHEM SOC, V123, P3832, DOI 10.1021/ja002674f; COCKERILL FR, 1995, J INFECT DIS, V171, P240, DOI 10.1093/infdis/171.1.240; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FINZEL BC, 1984, J BIOL CHEM, V259, P3027; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; FISHEL LA, 1987, BIOCHEMISTRY-US, V26, P351, DOI 10.1021/bi00376a004; Haas WH, 1997, ANTIMICROB AGENTS CH, V41, P1601, DOI 10.1128/AAC.41.7.1601; Henriksen A, 1998, BIOCHEMISTRY-US, V37, P8054, DOI 10.1021/bi980234j; HEYM B, 1995, MOL MICROBIOL, V15, P235, DOI 10.1111/j.1365-2958.1995.tb02238.x; Itakura H, 1997, FEBS LETT, V412, P107, DOI 10.1016/S0014-5793(97)00751-5; Johnsson K, 1997, J BIOL CHEM, V272, P2834, DOI 10.1074/jbc.272.5.2834; Kapetanaki S, 2003, BIOCHEMISTRY-US, V42, P3835, DOI 10.1021/bi026992y; Lad L, 2002, EUR J BIOCHEM, V269, P3182, DOI 10.1046/j.1432-1033.2002.02998.x; Lad L, 2002, BIOCHEMISTRY-US, V41, P13774, DOI 10.1021/bi0261591; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Marttila HJ, 1998, ANTIMICROB AGENTS CH, V42, P2443, DOI 10.1128/AAC.42.9.2443; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musser JM, 1996, J INFECT DIS, V173, P196, DOI 10.1093/infdis/173.1.196; Nagy JM, 1997, J BIOL CHEM, V272, P31265, DOI 10.1074/jbc.272.50.31265; Pierattelli R, 2004, J BIOL CHEM, V279, P39000, DOI 10.1074/jbc.M402384200; Poulos TL, 2007, NAT PROD REP, V24, P504, DOI 10.1039/b604195g; POULOS TL, 1980, J BIOL CHEM, V255, P575; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; ROUSE DA, 1995, ANTIMICROB AGENTS CH, V39, P2472, DOI 10.1128/AAC.39.11.2472; ROUSE DA, 1995, INFECT IMMUN, V63, P1427, DOI 10.1128/IAI.63.4.1427-1433.1995; Sharp KH, 2004, BIOCHEMISTRY-US, V43, P8644, DOI 10.1021/bi049343q; Sharp KH, 2003, NAT STRUCT BIOL, V10, P303, DOI 10.1038/nsb913; SUNDARAMOORTHY M, 1994, J BIOL CHEM, V269, P32759; Tsukamoto K, 1999, BIOCHEMISTRY-US, V38, P12558, DOI 10.1021/bi982925l; Welinder KG, 1992, CURR OPIN STRUC BIOL, V2, P388, DOI [DOI 10.1016/0959-440X(92)90230-5, 10.1016/0959-440x(92)90230-5]; *WHO, 2002, REP INF DIS; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	38	67	70	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6193	6200		10.1074/jbc.M707412200	http://dx.doi.org/10.1074/jbc.M707412200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18056997	Green Published, hybrid			2022-12-25	WOS:000253779500026
J	Kiss, AZ; Ruban, AV; Horton, P				Kiss, Anett Z.; Ruban, Alexander V.; Horton, Peter			The PsbS protein controls the organization of the photosystem II antenna in higher plant thylakoid membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; GREEN PLANTS; CHLOROPHYLL FLUORESCENCE; ARABIDOPSIS-THALIANA; CIRCULAR-DICHROISM; EXCITATION-ENERGY; CHLOROPLASTS; PHOTOPROTECTION; SUBUNIT; PHOTOSYNTHESIS	The PsbS subunit of photosystem II (PSII) plays a key role in nonphotochemical quenching (NPQ), the major photoprotective regulatory mechanism in higher plant thylakoid membranes, but its mechanism of action is unknown. Here we describe direct evidence that PsbS controls the organization of PSII and its light harvesting system (LHCII). The changes in chlorophyll fluorescence amplitude associated with the Mg2+-dependent restacking of thylakoid membranes were measured in thylakoids prepared from wild-type plants, a PsbS-deficient mutant and a PsbS overexpresser. The Mg2+ requirement and sigmoidicity of the titration curves for the fluorescence rise were negatively correlated with the level of PsbS. Using a range of PsbS mutants, this effect of PsbS was shown not to depend upon its efficacy in controlling NPQ, but to be related only to protein concentration. Electron microscopy and fluorescence spectroscopy showed that this effect was because of enhancement of the Mg2+-dependent re-association of PSII and LHCII by PsbS, rather than an effect on stacking per se. In the presence of PsbS the LHCII.PSII complex was also more readily removed from thylakoid membranes by detergent, and the level of PsbS protein correlated with the amplitude of the psi-type CD signal originating from features of LHCII.PSII organization. It is proposed that PsbS regulates the interaction between LHCII and PSII in the grana membranes, explaining how it acts as a pH-dependent trigger of the conformational changes within the PSII light harvesting system that result in NPQ.	[Ruban, Alexander V.] Univ London Queen Mary Coll, Sch Biol & Chem Sci, London E1 4NS, England; [Kiss, Anett Z.; Horton, Peter] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of London; Queen Mary University London; University of Sheffield	Kiss, AZ (corresponding author), Univ London Queen Mary Coll, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	a.ruban@qmul.ac.uk; p.horton@sheffield.ac.uk	Horton, Peter/A-3958-2012	Horton, Peter/0000-0002-6095-1460; Kiss, Anett/0000-0001-5720-3325	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ARNTZEN CJ, 1976, BIOCHIM BIOPHYS ACTA, V449, P259, DOI 10.1016/0005-2728(76)90138-9; BARBER J, 1982, ANNU REV PLANT PHYS, V33, P261, DOI 10.1146/annurev.pp.33.060182.001401; BARZDA V, 1994, BIOCHEMISTRY-US, V33, P10837, DOI 10.1021/bi00201a034; Bergantino E, 2003, P NATL ACAD SCI USA, V100, P15265, DOI 10.1073/pnas.2533072100; BOEKEMA EJ, 1995, P NATL ACAD SCI USA, V92, P175, DOI 10.1073/pnas.92.1.175; BRIANTAIS JM, 1979, BIOCHIM BIOPHYS ACTA, V548, P128, DOI 10.1016/0005-2728(79)90193-2; BUTLER WL, 1975, BIOCHIM BIOPHYS ACTA, V396, P72, DOI 10.1016/0005-2728(75)90190-5; Crouchman S, 2006, FEBS LETT, V580, P2053, DOI 10.1016/j.febslet.2006.03.005; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; GARAB G, 1988, BIOCHEMISTRY-US, V27, P2425, DOI 10.1021/bi00407a027; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Horton P, 2000, PHILOS T R SOC B, V355, P1361, DOI 10.1098/rstb.2000.0698; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Jansson S, 1997, BBA-BIOENERGETICS, V1320, P297, DOI 10.1016/S0005-2728(97)00033-9; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; JANSSON S, 1994, BBA-BIOENERGETICS, V1184, P1, DOI 10.1016/0005-2728(94)90148-1; KELLER D, 1986, J CHEM PHYS, V84, P2972, DOI 10.1063/1.450278; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, FUNCT PLANT BIOL, V29, P1131, DOI 10.1071/FP02065; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Lokstein H, 2002, BBA-BIOENERGETICS, V1553, P309, DOI 10.1016/S0005-2728(02)00184-6; MURATA N, 1969, BIOCHIM BIOPHYS ACTA, V189, P171, DOI 10.1016/0005-2728(69)90045-0; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Peterson RB, 2001, PLANTA, V214, P142, DOI 10.1007/s004250100601; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2006, J BIOL CHEM, V281, P14981, DOI 10.1074/jbc.M511415200; Ruban AV, 2000, FEBS LETT, V477, P181, DOI 10.1016/S0014-5793(00)01799-3; RUBIN BT, 1981, BIOCHIM BIOPHYS ACTA, V634, P174, DOI 10.1016/0005-2728(81)90137-7; Teardo E, 2007, BBA-BIOENERGETICS, V1767, P703, DOI 10.1016/j.bbabio.2006.12.002; van Amerongen H, 2001, J PHYS CHEM B, V105, P604, DOI 10.1021/jp0028406; Yakushevska AE, 2003, BIOCHEMISTRY-US, V42, P608, DOI 10.1021/bi027109z	37	144	151	2	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3972	3978		10.1074/jbc.M707410200	http://dx.doi.org/10.1074/jbc.M707410200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18055452	hybrid			2022-12-25	WOS:000253083500031
J	Liu, LB; Pilch, PF				Liu, Libin; Pilch, Paul F.			A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; ADIPOCYTE CAVEOLAE; SIGNAL-TRANSDUCTION; ACTIN CYTOSKELETON; TRANSPORT VESICLES; INSULIN-RESISTANCE; RAT ADIPOCYTES; GOLGI-COMPLEX; ADIPOSE-CELLS; KNOCKOUT MICE	Cavin (PTRF) has been shown to be a highly abundant protein component of caveolae, but its functional role there is unknown. Here, we confirm that cavin co-localizes with caveolin-1 in adipocytes by confocal microscopy and co-distributes with caveolin-1 in lipid raft fractions by sucrose gradient flotation. However, cavin does not directly associate with caveolin-1 as solubilization of caveolae disrupts their interaction. Cholesterol depletion with beta-cyclodextrin causes a significant down-regulation of cavin from plasma membrane lipid raft fractions. Overexpression of cavin in HEK293-Cav-1 cells and knockdown of cavin in 3T3-L1 adipocytes enhances and diminishes caveolin-1 levels, respectively, indicating an important role for cavin in maintaining the level of caveolin-1. A truncated form of cavin, eGFP-cavin-1-322, which lacks 74 amino acids from the C-terminal, reveals a microtubular network localization by confocal microscopy. Disruption of cytoskeletal elements with latrunculin B or nocodazole diminishes cavin expression without affecting the caveolin-1 amount. We propose that the presence of cavin on the inside surface of caveolae stabilizes these structures, probably through interaction with the cytoskeleton, and cavin therefore plays an important role in caveolae formation and organization.	[Liu, Libin; Pilch, Paul F.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Pilch, PF (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St,K402, Boston, MA 02118 USA.	ppilch@bu.edu	Liu, Libin/ABH-6019-2020	Liu, Libin/0000-0001-5056-1517; Pilch, Paul/0000-0003-1997-0499	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030425] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-30425, R01 DK097708] Funding Source: Medline; PHS HHS [56935] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; CARPENTIER JL, 1976, J LIPID RES, V17, P335; Chamberlain LH, 2002, J BIOL CHEM, V277, P49750, DOI 10.1074/jbc.M206936200; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; CONRAD PA, 1995, J CELL BIOL, V131, P1421, DOI 10.1083/jcb.131.6.1421; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; FAN JY, 1983, J CELL SCI, V61, P219; Fernandez I, 2002, P NATL ACAD SCI USA, V99, P11193, DOI 10.1073/pnas.172196599; Fielding CJ, 2000, BBA-MOL CELL BIOL L, V1529, P210, DOI 10.1016/S1388-1981(00)00150-5; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Hagiwara Y, 2000, HUM MOL GENET, V9, P3047, DOI 10.1093/hmg/9.20.3047; Hailstones D, 1998, J LIPID RES, V39, P369; Hasegawa T, 2000, BIOCHEM J, V347, P55, DOI 10.1042/0264-6021:3470055; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hommelgaard AM, 2005, TRAFFIC, V6, P720, DOI 10.1111/j.1600-0854.2005.00314.x; IZUMI T, 1988, ANAT REC, V220, P225, DOI 10.1002/ar.1092200302; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; KANDROR KV, 1995, J CELL BIOL, V129, P999, DOI 10.1083/jcb.129.4.999; Kanzaki M, 2002, J BIOL CHEM, V277, P25867, DOI 10.1074/jbc.C200292200; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; Lipardi C, 1998, J CELL BIOL, V140, P617, DOI 10.1083/jcb.140.3.617; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Liu LB, 2003, J BIOL CHEM, V278, P30157, DOI 10.1074/jbc.M301511200; Liu LB, 2006, MOL BIOL CELL, V17, P4249, DOI 10.1091/mbc.E06-04-0278; MAKITA T, 1978, ARCH HISTOL JAPON, V41, P167, DOI 10.1679/aohc1950.41.167; Meshulam T, 2006, BIOCHEMISTRY-US, V45, P2882, DOI 10.1021/bi051999b; Mineo C, 1998, J CELL BIOL, V141, P601, DOI 10.1083/jcb.141.3.601; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; PALADE GE, 1953, J APPL PHYS, V24, P1424; Park DS, 2002, AM J PATHOL, V160, P2207, DOI 10.1016/S0002-9440(10)61168-6; Parolini I, 1999, J BIOL CHEM, V274, P25718, DOI 10.1074/jbc.274.36.25718; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pilch PF, 2007, J LIPID RES, V48, P2103, DOI 10.1194/jlr.R700009-JLR200; Pohl J, 2004, BIOCHEMISTRY-US, V43, P4179, DOI 10.1021/bi035743m; Razani B, 2001, J BIOL CHEM, V276, P38121; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Shogomori H, 2003, BIOL CHEM, V384, P1259, DOI 10.1515/BC.2003.139; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Souto RP, 2003, J BIOL CHEM, V278, P18321, DOI 10.1074/jbc.M211541200; Sowa G, 2003, P NATL ACAD SCI USA, V100, P6511, DOI 10.1073/pnas.1031672100; Stahlhut M, 2000, MOL BIOL CELL, V11, P325, DOI 10.1091/mbc.11.1.325; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; STREMMEL W, 1986, P NATL ACAD SCI USA, V83, P3584, DOI 10.1073/pnas.83.11.3584; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Thorn H, 2003, MOL BIOL CELL, V14, P3967, DOI 10.1091/mbc.E03-01-0050; Vinten J, 2001, CELL TISSUE RES, V305, P99, DOI 10.1007/s004410100389; Vinten J, 2005, BBA-BIOMEMBRANES, V1717, P34, DOI 10.1016/j.bbamem.2005.09.013; Voldstedlund M, 2003, ACTA PHYSIOL SCAND, V179, P179, DOI 10.1046/j.1365-201X.2003.01183.x; VOLDSTEDLUND M, 1993, J MEMBRANE BIOL, V136, P63; WAY M, 1995, FEBS LETT, V376, P108, DOI 10.1016/0014-5793(95)01256-7; Westermann M, 2005, HISTOCHEM CELL BIOL, V123, P613, DOI 10.1007/s00418-004-0750-5; Wharton J, 2005, J BIOL CHEM, V280, P13483, DOI 10.1074/jbc.M413891200; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799	63	208	216	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4314	4322		10.1074/jbc.M707890200	http://dx.doi.org/10.1074/jbc.M707890200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18056712	hybrid			2022-12-25	WOS:000253083500066
J	Anelli, V; Gault, CR; Cheng, AB; Obeid, LM				Anelli, Viviana; Gault, Christopher R.; Cheng, Amy B.; Obeid, Lina M.			Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR-INDUCED ACTIVATION; INDUCIBLE FACTOR-ALPHA; SPHINGOSINE-1-PHOSPHATE RECEPTOR; FUNCTIONAL-CHARACTERIZATION; EXTRACELLULAR RELEASE; MOLECULAR-CLONING; KINASE EXPRESSION; GRANULE CELLS; PROTEIN	Sphingosine 1-phosphate (S1P), a sphingolipid metabolite that plays an important role in the regulation of cell survival, growth, migration, and angiogenesis, acts both inside the cells and as an extracellular mediator through binding to five G protein-coupled receptors (S1P(1-5)). Sphingosine kinase 1 (SK1), the enzyme responsible for S1P production, is overexpressed in many solid tumors, including gliomas. One common feature of these tumors is the presence of "hypoxic regions," characterized by cells expressing high levels of hypoxia-inducible factors HIF-1 alpha and HIF-2 alpha, two transcription regulators that modulate the levels of proteins with crucial roles in tumor progression. So far, nothing is known about the role and the regulation of SK1 during tumor-induced hypoxia or about SK1 regulation and HIFs. Here we investigated the role of HIF-1 alpha and HIF-2 alpha in the regulation of SK1 during hypoxic stress in glioma-derived U87MG cells. We report that hypoxia increases SK1 mRNA levels, protein expression, and enzyme activity, followed by intracellular S1P production and S1P release. Interestingly, knockdown of HIF-2 alpha by small interfering RNA abolished the induction of SK1 and the production of extracellular S1P after CoCl2 treatment, whereas HIF-1 alpha small interfering RNA resulted in an increase of HIF-2 alpha and of SK1 protein levels. Moreover, using chromatin immunoprecipitation analysis, we demonstrate that HIF-2 alpha binds the SK1 promoter. Functionally, we demonstrate that conditioned medium from hypoxia-treated tumor cells results in neoangiogenesis in human umbilical vein endothelial cells in a S1P receptor-dependent manner. These studies provide evidence of a link between S1P production as a potent angiogenic agent and the hypoxic phenotype observed in many tumors.	[Obeid, Lina M.] Ralph H Johnson Affairs Med Ctr, Charleston, SC 29401 USA; [Gault, Christopher R.; Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Anelli, Viviana; Cheng, Amy B.; Obeid, Lina M.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Anelli, Viviana] Univ Milan, Dept Med Chem Biochem & Biotechnol, I-20090 Milan, Italy	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Medical University of South Carolina; University of Milan	Obeid, LM (corresponding author), Med Univ S Carolina, Dept Med, Div Gen Internal Med Geriatr, POB 250779, Charleston, SC 29403 USA.	obeid@musc.edu		obeid, lina/0000-0002-0734-0847; ANELLI, Viviana Vittoria/0000-0003-1964-3252	NCI NIH HHS [P01 CA097132] Funding Source: Medline; NIGMS NIH HHS [R01 GM062887] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad M, 2006, PROSTAG OTH LIPID M, V79, P278, DOI 10.1016/j.prostaglandins.2006.03.001; Anelli V, 2005, J NEUROCHEM, V92, P1204, DOI 10.1111/j.1471-4159.2004.02955.x; Bassi R, 2006, GLIA, V53, P621, DOI 10.1002/glia.20324; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Billich A, 2005, CELL SIGNAL, V17, P1203, DOI 10.1016/j.cellsig.2004.12.005; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Fieber CB, 2006, EXP CELL RES, V312, P1164, DOI 10.1016/j.yexcr.2006.01.022; French KJ, 2006, J PHARMACOL EXP THER, V318, P596, DOI 10.1124/jpet.106.101345; French KJ, 2003, CANCER RES, V63, P5962; Gunaratnam L, 2003, J BIOL CHEM, V278, P44966, DOI 10.1074/jbc.M305502200; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Heringdorf DM, 1999, FEBS LETT, V461, P217, DOI 10.1016/S0014-5793(99)01463-5; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Igarashi J, 2003, P NATL ACAD SCI USA, V100, P10664, DOI 10.1073/pnas.1934494100; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; Johnson KR, 2005, J HISTOCHEM CYTOCHEM, V53, P1159, DOI 10.1369/jhc.4A6606.2005; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Khatua S, 2003, CANCER RES, V63, P1865; Leclercq TM, 2006, IUBMB LIFE, V58, P467, DOI 10.1080/15216540600871126; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Leek RD, 2002, CANCER RES, V62, P1326; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nava VE, 2000, FEBS LETT, V473, P81, DOI 10.1016/S0014-5793(00)01510-6; O'Rourke JF, 1997, ONCOL RES, V9, P327; Okada T, 2005, J BIOL CHEM, V280, P36318, DOI 10.1074/jbc.M504507200; Olivera A, 1999, FASEB J, V13, P1593, DOI 10.1096/fasebj.13.12.1593; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Olivera A, 2003, J BIOL CHEM, V278, P46452, DOI 10.1074/jbc.M308749200; Olivera A, 1996, J CELL BIOCHEM, V60, P529, DOI 10.1002/(SICI)1097-4644(19960315)60:4<529::AID-JCB9>3.0.CO;2-U; Payne SG, 2002, FEBS LETT, V531, P54, DOI 10.1016/S0014-5793(02)03480-4; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; PLATE KH, 1994, INT J CANCER, V59, P520, DOI 10.1002/ijc.2910590415; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Riboni L, 2000, J NEUROCHEM, V75, P503, DOI 10.1046/j.1471-4159.2000.0750503.x; Rius RA, 1997, FEBS LETT, V417, P173, DOI 10.1016/S0014-5793(97)01277-5; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; Shu XD, 2002, MOL CELL BIOL, V22, P7758, DOI 10.1128/MCB.22.22.7758-7768.2002; Spiegel S, 2002, TRENDS CELL BIOL, V12, P236, DOI 10.1016/S0962-8924(02)02277-8; Srinivas V, 1999, BIOCHEM BIOPH RES CO, V260, P557, DOI 10.1006/bbrc.1999.0878; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Taha TA, 2004, BBA-MOL CELL BIOL L, V1682, P48, DOI 10.1016/S1388-1981(04)00023-X; Tanimoto T, 2002, J BIOL CHEM, V277, P42997, DOI 10.1074/jbc.M204764200; Tao R, 2007, CARDIOVASC RES, V74, P56, DOI 10.1016/j.cardiores.2007.01.015; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Van Brocklyn JR, 2002, CANCER LETT, V181, P195, DOI 10.1016/S0304-3835(02)00050-2; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Wykoff CC, 2004, BRIT J CANCER, V90, P1235, DOI 10.1038/sj.bjc.6601657; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Young N, 2006, THESCIENTIFICWORLDJO, V6, P946, DOI 10.1100/tsw.2006.182; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Yun JK, 2002, ARCH BIOCHEM BIOPHYS, V408, P78, DOI 10.1016/S0003-9861(02)00526-X	62	108	119	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3365	3375		10.1074/jbc.M708241200	http://dx.doi.org/10.1074/jbc.M708241200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18055454	hybrid			2022-12-25	WOS:000253083000041
J	Connors, EC; Ballif, BA; Morielli, AD				Connors, Emilee C.; Ballif, Bryan A.; Morielli, Anthony D.			Homeostatic regulation of kv1.2 potassium channel trafficking by cyclic AMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-DEPENDENT SUPPRESSION; ROOT GANGLION NEURONS; GENE-EXPRESSION; MESSENGER-RNA; CELL LINE; PHOSPHORYLATION; ENDOCYTOSIS; CAMP; CORTACTIN; STIMULATION	The Shaker family potassium channel, Kv1.2, is a key determinant of membrane excitability in neurons and cardiovascular tissue. Kv1.2 is subject to multiple forms of regulation and therefore integrates cellular signals involved in the homeostasis of excitability. The cyclic AMP/protein kinase A (PKA) pathway enhances Kv1.2 ionic current; however, the mechanisms for this are not fully known. Here we show that cAMP maintains Kv1.2 homeostasis through opposing effects on channel trafficking. We found that Kv1.2 is regulated by two distinct cAMP pathways, one PKA-dependent and the other PKA-independent. PKA inhibitors elevate Kv1.2 surface levels, suggesting that basal levels of cAMP control steady-state turnover of the channel. Elevation of cAMP above basal levels also increases the amount of Kv1.2 at the cell surface. This effect is not blocked by PKA inhibitors, but is blocked by inhibition of Kv1.2 endocytosis. We conclude that Kv1.2 levels at the cell surface are kept in dynamic balance by opposing effects of cAMP.	[Connors, Emilee C.; Morielli, Anthony D.] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; [Ballif, Bryan A.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Morielli, AD (corresponding author), Univ Vermont, Coll Med, Dept Pharmacol, Rm E-317,89 Beamout Ave, Burlington, VT 05405 USA.	anthony.morielli@uvm.edu			NCRR NIH HHS [5 P20 RR016435-07, P20 RR16462] Funding Source: Medline; NINDS NIH HHS [R0NS050623] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435, P20RR016462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050623] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Brew HM, 2007, J NEUROPHYSIOL, V98, P1501, DOI 10.1152/jn.00640.2006; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Campomanes CR, 2002, J BIOL CHEM, V277, P8298, DOI 10.1074/jbc.M110276200; Chang SY, 2002, J CELL SCI, V115, P783; Chen L, 2006, ACTA BIOCH BIOPH SIN, V38, P95, DOI 10.1111/j.1745-7270.2006.00141.x; Chen ZX, 2007, INT J PARASITOL, V37, P743, DOI 10.1016/j.ijpara.2006.12.018; Cox RH, 2002, VASC PHARMACOL, V38, P13, DOI 10.1016/S1537-1891(02)00122-2; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Hattan D, 2002, J BIOL CHEM, V277, P38596, DOI 10.1074/jbc.M205005200; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Hong ZG, 2004, AM J RESP CELL MOL, V31, P337, DOI 10.1165/rcmb.2003-0386OC; HOSODA K, 1994, J NEUROCHEM, V63, P1635; Howard M, 2000, AM J PHYSIOL-CELL PH, V279, pC375, DOI 10.1152/ajpcell.2000.279.2.C375; HUANG XY, 1993, CELL, V75, P1145, DOI 10.1016/0092-8674(93)90324-J; HUANG XY, 1994, P NATL ACAD SCI USA, V91, P624, DOI 10.1073/pnas.91.2.624; Ishikawa K, 1999, MUSCLE NERVE, V22, P502, DOI 10.1002/(SICI)1097-4598(199904)22:4<502::AID-MUS12>3.0.CO;2-K; Kim DS, 2002, MOL BRAIN RES, V105, P146, DOI 10.1016/S0169-328X(02)00388-1; KUWAHARA M, 1995, J BIOL CHEM, V270, P10384, DOI 10.1074/jbc.270.18.10384; Lambe EK, 2001, J NEUROSCI, V21, P9955, DOI 10.1523/JNEUROSCI.21-24-09955.2001; Lu H, 2004, AM J PHYSIOL-RENAL, V286, pF233, DOI 10.1152/ajprenal.00179.2003; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Nesti E, 2004, MOL BIOL CELL, V15, P4073, DOI 10.1091/mbc.E03-11-0788; Pereira MMC, 2007, BIOCHEM J, V405, P181, DOI 10.1042/BJ20061879; PRINCE LS, 1994, P NATL ACAD SCI USA, V91, P5192, DOI 10.1073/pnas.91.11.5192; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Valenti G, 2000, J CELL SCI, V113, P1985; Wang J, 1997, J CLIN INVEST, V100, P2347, DOI 10.1172/JCI119774; Williams MR, 2007, P NATL ACAD SCI USA, V104, P17412, DOI 10.1073/pnas.0703865104; Yang EK, 2004, NEUROSCIENCE, V123, P867, DOI 10.1016/j.neuroscience.2003.11.014; Yang SM, 2004, MOL ENDOCRINOL, V18, P2312, DOI 10.1210/me.2004-0148; Yoo D, 2005, J BIOL CHEM, V280, P35281, DOI 10.1074/jbc.M504836200	32	25	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3445	3453		10.1074/jbc.M708875200	http://dx.doi.org/10.1074/jbc.M708875200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18003609	hybrid			2022-12-25	WOS:000253083000050
J	Fei, Q; McCormack, AL; Di Monte, DA; Ethell, DW				Fei, Qingyan; McCormack, Alison L.; Di Monte, Donato A.; Ethell, Douglas W.			Paraquat neurotoxicity is mediated by a Bak-dependent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVIRONMENTAL RISK-FACTORS; PARKINSONS-DISEASE; CELL-DEATH; OXIDATIVE STRESS; PROAPOPTOTIC BAX; APOPTOSIS; EXPOSURE; BCL-2; PESTICIDES; RESISTANCE	Paraquat (PQ) causes selective degeneration of dopaminergic neurons in the substantia nigra pars compacta, reproducing an important pathological feature of Parkinson disease. Oxidative stress, c-Jun N-terminal kinase activation, and alpha-synuclein aggregation are each induced by PQ, but details of the cell death mechanisms involved remain unclear. We have identified a Bak-dependent cell death mechanism that is required for PQ-induced neurotoxicity. PQ induced morphological and biochemical features that were consistent with apoptosis, including dose-dependent cytochrome c release, with subsequent caspase-3 and poly(ADP-ribose) polymerase cleavage. Changes in nuclear morphology and loss of viability were blocked by cycloheximide, caspase inhibitor, and Bcl-2 overexpression. Evaluation of Bcl-2 family members showed that PQ induced high levels of Bak, Bid, BNip3, and Noxa. Small interfering RNA-mediated knockdown of BNip3, Noxa, and Bak each protected cells from PQ, but Bax knockdown did not. Finally, we tested the sensitivity of Bak-deficient mice and found them to be resistant to PQ treatments that depleted tyrosine hydroxylase immuno-positive neurons in the substantia nigra pars compacta of wild-type mice.	[Fei, Qingyan; Ethell, Douglas W.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [McCormack, Alison L.; Di Monte, Donato A.] Parkinsons Inst, Sunnyvale, CA 94085 USA	University of California System; University of California Riverside	Ethell, DW (corresponding author), B1621 Comp Stats Bldg,UC Riverside,900 Univ Ave, Riverside, CA 92521 USA.	doug.ethell@ucr.edu		Di Monte, Donato/0000-0002-8296-836X				Bharath S, 2002, BIOCHEM PHARMACOL, V64, P1037, DOI 10.1016/S0006-2952(02)01174-7; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Casciano I, 2004, ANN NY ACAD SCI, V1028, P157, DOI 10.1196/annals.1322.017; Di Monte DA, 2003, LANCET NEUROL, V2, P531, DOI 10.1016/S1474-4422(03)00501-5; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Eggert A, 2001, CANCER RES, V61, P1314; ETHELL DW, 2001, APOPTOSIS TECHNIQUES, P21; Filomeni G, 2006, ANTIOXID REDOX SIGN, V8, P2187, DOI 10.1089/ars.2006.8.2187; Gainetdinov RR, 1997, J NEUROCHEM, V69, P1322; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Gorell JM, 1998, NEUROLOGY, V50, P1346, DOI 10.1212/WNL.50.5.1346; Green DR, 2007, CANCER CELL, V12, P97, DOI 10.1016/j.ccr.2007.07.011; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; HERTZMAN C, 1990, AM J IND MED, V17, P349, DOI 10.1002/ajim.4700170307; HUBBLE JP, 1993, NEUROLOGY, V43, P1693, DOI 10.1212/WNL.43.9.1693; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; JIMENEZJIMENEZ FJ, 1992, J NEUROL SCI, V112, P30; Kim DH, 2004, J KOREAN MED SCI, V19, P113, DOI 10.3346/jkms.2004.19.1.113; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Liou HH, 1997, NEUROLOGY, V48, P1583, DOI 10.1212/WNL.48.6.1583; Manning-Bog AB, 2003, J NEUROSCI, V23, P3095; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; McCormack AL, 2006, NEUROSCIENCE, V141, P929, DOI 10.1016/j.neuroscience.2006.03.069; McCormack AL, 2005, J NEUROCHEM, V93, P1030, DOI 10.1111/j.1471-4159.2005.03088.x; McCormack AL, 2003, J NEUROCHEM, V85, P82, DOI 10.1046/j.1471-4159.2003.01621.x; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; Nakamura T, 2007, CELL MOL LIFE SCI, V64, P1609, DOI 10.1007/s00018-007-6525-0; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; Peng J, 2005, J BIOL CHEM, V280, P29194, DOI 10.1074/jbc.M500984200; Peng J, 2004, J BIOL CHEM, V279, P32626, DOI 10.1074/jbc.M404596200; Peng J, 2007, J NEUROSCI, V27, P6914, DOI 10.1523/JNEUROSCI.1569-07.2007; Ramachandiran S, 2007, TOXICOL SCI, V95, P163, DOI 10.1093/toxsci/kfl125; Richardson JR, 2005, TOXICOL SCI, V88, P193, DOI 10.1093/toxsci/kfi304; Ruiz-Vela A, 2005, EMBO REP, V6, P379, DOI 10.1038/sj.embor.7400375; SEMCHUK KM, 1992, NEUROLOGY, V42, P1328, DOI 10.1212/WNL.42.7.1328; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Shimizu K, 2001, BRAIN RES, V906, P135, DOI 10.1016/S0006-8993(01)02577-X; Sowter HM, 2001, CANCER RES, V61, P6669; Stephenson J, 2000, JAMA-J AM MED ASSOC, V283, P3055, DOI 10.1001/jama.283.23.3055; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; Vila M, 2001, P NATL ACAD SCI USA, V98, P2837, DOI 10.1073/pnas.051633998; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366	49	76	78	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3357	3364		10.1074/jbc.M708451200	http://dx.doi.org/10.1074/jbc.M708451200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056701	hybrid			2022-12-25	WOS:000253083000040
J	Suzuki, T; Seth, A; Rao, R				Suzuki, Takuya; Seth, Ankur; Rao, Radhakrishna			Role of phospholipase C gamma-induced activation of protein kinase C epsilon (PKC epsilon) and PKC beta I in epidermal growth factor-mediated protection of tight junctions from acetaldehyde in caco-2 cell monolayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARACELLULAR PERMEABILITY; TYROSINE PHOSPHORYLATION; OXIDATIVE STRESS; POSSIBLE INVOLVEMENT; INDUCED DISRUPTION; HYDROGEN-PEROXIDE; EPITHELIAL-CELLS; INDUCED INCREASE; OCCLUDIN; BARRIER	Epidermal growth factor (EGF) protects the intestinal epithelial tight junctions from acetaldehyde-induced insult. The role of phospholipase C gamma (PLC gamma) and protein kinase C (PKC) iso-forms in the mechanism of EGF-mediated protection of tight junction from acetaldehyde was evaluated in Caco-2 cell monolayers. EGF-mediated prevention of acetaldehyde-induced decrease in transepithelial electrical resistance and an increase in inulin permeability, and subcellular redistribution of occludin and ZO-1 was attenuated by reduced expression of PLC gamma 1 by short hairpin RNA. EGF induced a rapid activation of PLC gamma 1 and PLC-dependent membrane translocation of PKC epsilon and PKC alpha I. Inhibition of PKC activity or selective interference of membrane translocation of PKC epsilon andPKC beta I by RACK interference peptides attenuated EGF-mediated prevention of acetaldehyde-induced increase in inulin permeability and redistribution of occludin and ZO-1. BAPTA-AM and thapsigargin blocked EGF-induced membrane translocation of PKC beta I and attenuated EGF-mediated prevention of acetaldehyde-induced disruption of tight junctions. EGF-induced translocation of PKC epsilon and PKC beta I was associated with organization of F-actin near the perijunctional region. This study shows that PLC gamma-mediated activation of PKC epsilon and PKC beta I and intracellular calcium is involved in EGF-mediated protection of tight junctions from acetaldehyde-induced insult.	[Suzuki, Takuya; Seth, Ankur; Rao, Radhakrishna] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Rao, R (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	rkrao@physio1.utmem.edu	Seth, Ankur/AAE-1800-2020; Suzuki, Takuya/H-3750-2019	Suzuki, Takuya/0000-0003-3709-543X; Seth, Ankur/0000-0003-0140-4691	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012307] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01-AA12307, R01 AA012307] Funding Source: Medline; NIDDK NIH HHS [R01 DK055532, R01-DK55532] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; Atkinson KJ, 2001, AM J PHYSIOL-GASTR L, V280, pG1280, DOI 10.1152/ajpgi.2001.280.6.G1280; Banan A, 2001, AM J PHYSIOL-GASTR L, V281, pG412, DOI 10.1152/ajpgi.2001.281.2.G412; Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Basuroy S, 2003, J BIOL CHEM, V278, P11916, DOI 10.1074/jbc.M211710200; Chen ML, 2002, J BIOL CHEM, V277, P4247, DOI 10.1074/jbc.M109254200; Chen YH, 2002, MOL BIOL CELL, V13, P1227, DOI 10.1091/mbc.01-08-0423; Clarke H, 2000, J CELL SCI, V113, P3187; Clayburgh DR, 2006, J CLIN INVEST, V116, P2682, DOI 10.1172/JCI29218; FLEMING TP, 1993, DEVELOPMENT, V117, P1135; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Hirase T, 2001, J BIOL CHEM, V276, P10423, DOI 10.1074/jbc.M007136200; HOLLANDER D, 1994, GUT, V26, P1621; Homann N, 2000, CARCINOGENESIS, V21, P663, DOI 10.1093/carcin/21.4.663; ISHIKAWA S, 1994, AM J PHYSIOL-GASTR L, V267, pG1067, DOI 10.1152/ajpgi.1994.267.6.G1067; Kale G, 2003, BIOCHEM BIOPH RES CO, V302, P324, DOI 10.1016/S0006-291X(03)00167-0; Koivisto T, 1996, ALCOHOL CLIN EXP RES, V20, P551, DOI 10.1111/j.1530-0277.1996.tb01091.x; KONTUREK PK, 1990, GASTROENTEROLOGY, V99, P1607, DOI 10.1016/0016-5085(90)90464-C; Lee DBN, 2006, AM J PHYSIOL-RENAL, V290, pF20, DOI 10.1152/ajprenal.00052.2005; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Matthay MA, 2002, CHEST, V122, p340S, DOI 10.1378/chest.122.6_suppl.340S; Nunbhakdi-Craig V, 2002, J CELL BIOL, V158, P967, DOI 10.1083/jcb.200206114; NUSRAT A, 1995, P NATL ACAD SCI USA, V92, P10629, DOI 10.1073/pnas.92.23.10629; Poschl G, 2004, ALCOHOL ALCOHOLISM, V39, P155, DOI 10.1093/alcalc/agh057; Rao R, 1996, EUR J PHARMACOL, V303, P209, DOI 10.1016/0014-2999(96)00186-0; Rao R, 1999, BIOCHEM PHARMACOL, V57, P685, DOI 10.1016/S0006-2952(98)00333-5; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; RAO RK, 1991, LIFE SCI, V48, P1685, DOI 10.1016/0024-3205(91)90205-P; Rao RK, 1998, ALCOHOL CLIN EXP RES, V22, P1724, DOI 10.1097/00000374-199811000-00015; Rao RK, 2000, AM J PHYSIOL-GASTR L, V279, pG332, DOI 10.1152/ajpgi.2000.279.2.G332; Ries J, 1997, AM J PHYSIOL-CELL PH, V272, pC794, DOI 10.1152/ajpcell.1997.272.3.C794; RYEOM SV, 1998, P NATL ACAD SCI USA, V96, P319; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Seth A, 2004, AM J PHYSIOL-GASTR L, V287, pG510, DOI 10.1152/ajpgi.00058.2004; Seth A, 2007, J BIOL CHEM, V282, P11487, DOI 10.1074/jbc.M610597200; Sheth P, 2004, ALCOHOL CLIN EXP RES, V28, P797, DOI 10.1097/01.ALC.0000125358.92335.90; Sheth P, 2003, J BIOL CHEM, V278, P49239, DOI 10.1074/jbc.M305654200; Sheth P, 2007, BIOCHEM J, V402, P291, DOI 10.1042/BJ20060665; Shifflett DE, 2005, LAB INVEST, V85, P1308, DOI 10.1038/labinvest.3700330; Simonovic I, 2000, CELL MICROBIOL, V2, P305, DOI 10.1046/j.1462-5822.2000.00055.x; STUART RO, 1995, P NATL ACAD SCI USA, V92, P6072, DOI 10.1073/pnas.92.13.6072; Tillonen J, 2000, ALCOHOL CLIN EXP RES, V24, P570, DOI 10.1111/j.1530-0277.2000.tb02026.x; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; Utech M, 2005, MOL BIOL CELL, V16, P5040, DOI 10.1091/mbc.E05-03-0193; WAHL MI, 1989, CANCER CELL-MON REV, V1, P101; Walsh SV, 2001, GASTROENTEROLOGY, V121, P566, DOI 10.1053/gast.2001.27060; Ward PD, 2003, J PHARMACOL EXP THER, V304, P689, DOI 10.1124/jpet.102.043638; Ward PD, 2002, J BIOL CHEM, V277, P35760, DOI 10.1074/jbc.M203134200; ZHANG Y, 1993, J CELL BIOL, V120, P477	52	64	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3574	3583		10.1074/jbc.M709141200	http://dx.doi.org/10.1074/jbc.M709141200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	17991733	hybrid			2022-12-25	WOS:000253083000063
J	Zhang, DW; Lu, C; Whiteman, M; Chance, B; Armstrong, JS				Zhang, Dawei; Lu, Chao; Whiteman, Matthew; Chance, Britton; Armstrong, Jeffrey S.			The mitochondrial permeability transition regulates cytochrome c release for apoptosis during endoplasmic reticulum stress by remodeling the cristae junction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSLOCASE; CELL-DEATH; CYCLOPHILIN-D; OXIDATIVE STRESS; PORE; DNA; BAX; COOPERATE; BCL-2; LIFE	The role of the mitochondrial permeability transition (MPT) in apoptosis and necrosis is controversial. Here we show that the MPT regulates the release of cytochrome c for apoptosis during endoplasmic reticulum (ER) stress by remodeling the cristae junction (CJ). CEM cells, HCT116 colon cancer cells, and murine embryo fibroblast cells were treated with the ER stressor thapsigargin (THG), which led to cyclophilin D-dependent mitochondrial release of the profusion GTPase optic atrophy 1 (OPA1), which controls CJ integrity, and cytochrome c, leading to apoptosis. Interference RNA knockdown of Bax blocked OPA1 and cytochrome c release after THG treatment but did not prevent the MPT, showing that Bax was essential for the release of cytochrome c by MPT. In isolated mitochondria, MPT led to OPA1 and cytochrome c release independently of voltage-dependent anion channel and the outer membrane, indicating that the MPT is an inner membrane phenomenon. Last, the MPT was regulated by the electron transport chain but not mitochondrial reactive oxygen species, since THG-induced cell death was not blocked by antioxidants and did not occur in cells lacking mitochondrial DNA. Our results show that the MPT regulates CJ remodeling for cytochrome c-dependent apoptosis induced by ER stress and that mitochondrial electron transport is indispensable for this process.	[Zhang, Dawei; Lu, Chao; Armstrong, Jeffrey S.] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Zhang, Dawei] Inst Biomed Engn & Nanotechnol, Singapore 138669, Singapore; [Whiteman, Matthew] Univ Exeter, Penn Sch Med, Exeter EX1 2LU, Devon, England; [Whiteman, Matthew] Univ Plymouth, Penn Sch Med, Exeter EX1 2LU, Devon, England; [Chance, Britton] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	National University of Singapore; University of Exeter; University of Exeter; University of Plymouth; University of Pennsylvania	Zhang, DW (corresponding author), Natl Univ Singapore, Dept Biochem, 8 Med Dr, Singapore 117597, Singapore.	bchjsa@nus.edu.sg	Whiteman, Matthew/C-6079-2009; Lu, Chao/E-8047-2012	Whiteman, Matthew/0000-0002-6583-6779; Lu, Chao/0000-0003-0982-8122; Zhang, Dawei/0000-0001-6613-945X				Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x; Armstrong JS, 2006, MITOCHONDRION, V6, P225, DOI 10.1016/j.mito.2006.07.006; Armstrong JS, 2002, FASEB J, V16, P1263, DOI 10.1096/fj.02-0097fje; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Chua YL, 2005, BIOCHEM BIOPH RES CO, V337, P375, DOI 10.1016/j.bbrc.2005.09.059; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; DENIAUD A, 2008, IN PRESS ONCOGENE; Fontaine E, 1999, J BIOENERG BIOMEMBR, V31, P335, DOI 10.1023/A:1005475802350; Forte M, 2005, J BIOENERG BIOMEMBR, V37, P121, DOI 10.1007/s10863-005-6565-9; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gao WH, 2001, J CELL SCI, V114, P2855; Gil J, 2003, FREE RADICAL BIO MED, V35, P1500, DOI 10.1016/j.freeradbiomed.2003.08.022; Gogvadze V, 2004, BIOCHEM J, V378, P213, DOI 10.1042/BJ20031193; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; JACOBSON MD, 1993, NATURE, V361, P365, DOI 10.1038/361365a0; Jiang DM, 2001, J BIOL CHEM, V276, P47524, DOI 10.1074/jbc.M108834200; Jiang SN, 1999, J BIOL CHEM, V274, P29905, DOI 10.1074/jbc.274.42.29905; Kim JS, 2006, AM J PHYSIOL-HEART C, V290, pH2024, DOI 10.1152/ajpheart.00683.2005; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Park SY, 2004, J BIOL CHEM, V279, P7512, DOI 10.1074/jbc.M307677200; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Petit PX, 1996, FEBS LETT, V396, P7, DOI 10.1016/0014-5793(96)00988-X; PON LA, 2001, METHODS CELL BIOL MI, P75; PON LA, 2007, METHODS CELL BIOL MI, P355; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; SCHNEIDER MD, 2005, SCI STKE, V287, P26; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Skulachev VP, 2000, IUBMB LIFE, V49, P365, DOI 10.1080/152165400410209; Tan KO, 2005, P NATL ACAD SCI USA, V102, P14623, DOI 10.1073/pnas.0503524102; Vergani L, 2004, EUR J BIOCHEM, V271, P3646, DOI 10.1111/j.1432-1033.2004.04298.x; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yamaguchi H, 2003, CANCER RES, V63, P1483; Zhang D, 2007, CELL DEATH DIFFER, V14, P703, DOI 10.1038/sj.cdd.4402072	45	51	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3476	3486		10.1074/jbc.M707528200	http://dx.doi.org/10.1074/jbc.M707528200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056990	hybrid			2022-12-25	WOS:000253083000053
J	Shi, Y; Cui, NR; Shi, WW; Jiang, C				Shi, Yun; Cui, Ningren; Shi, Weiwei; Jiang, Chun			A short motif in Kir6.1 consisting of four phosphorylation repeats underlies the vascular K-ATP channel inhibition by protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; RECTIFYING POTASSIUM CHANNELS; SUBUNIT STOICHIOMETRY; INTRACELLULAR PROTONS; INDUCED ACTIVATION; MESENTERIC-ARTERY; N-TERMINUS; TRAFFICKING; MODULATION; RECEPTOR	Vascular ATP-sensitiveK(+) channels are inhibited by multiple vasoconstricting hormones via the protein kinase C (PKC) pathway. However, the molecular substrates for PKC phosphorylation remain unknown. To identify the PKC sites, Kir6.1/SUR2B and Kir6.2/SUR2B were expressed in HEK293 cells. Following channel activation by pinacidil, the catalytic fragment of PKC inhibited the Kir6.1/SUR2B currents but not the Kir6.2/SUR2B currents. Phorbol 12-myristate 13-acetate (a PKCactivator) had similar effects. Using Kir6.1-Kir6.2 chimeras, two critical protein domains for the PKC-dependent channel inhibition were identified. The proximal N terminus of Kir6.1 was necessary for channel inhibition. Because there was no PKC phosphorylation site in the N-terminal region, our results suggest its potential involvement in channel gating. The distal C terminus of Kir6.1 was crucial where there are several consensus PKC sites. Mutation of Ser-354, Ser-379, Ser-385, Ser-391, or Ser-397 to non-phosphorylatable alanine reduced PKC inhibition moderately but significantly. Combined mutations of these residues had greater effects. The channel inhibition was almost completely abolished when 5 of them were jointly mutated. In vitro phosphorylation assay showed that 4 of the serine residues were necessary for the PKC-dependent P-32 incorporation into the distal C-terminal peptides. Thus, a motif containing four phosphorylation repeats is identified in the Kir6.1 subunit underlying the PKC-dependent inhibition of the Kir6.1/SUR2B channel. The presence of the phosphorylation motif in Kir6.1, but not in its close relative Kir6.2, suggests that the vascular K-ATP channel may have undergone evolutionary optimization, allowing it to be regulated by a variety of vasoconstricting hormones and neurotransmitters.	[Shi, Yun; Cui, Ningren; Shi, Weiwei; Jiang, Chun] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University	Jiang, C (corresponding author), Georgia State Univ, Dept Biol, 33 Gilmer St, Atlanta, GA 30302 USA.	cjiang@gsu.edu	SHI, WEIWEI/B-3477-2008; Shi, Yun S/T-8845-2018; Shi, Yun/B-5623-2009	SHI, WEIWEI/0000-0001-6216-712X; Shi, Yun/0000-0002-8842-9818	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067890] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL067890, HL 067890] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Babenko AP, 2001, J BIOL CHEM, V276, P49083, DOI 10.1074/jbc.M108763200; Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672; Cole WC, 2000, CIRC RES, V87, P112, DOI 10.1161/01.RES.87.2.112; Cui Y, 2002, AM J RESP CELL MOL, V26, P135, DOI 10.1165/ajrcmb.26.1.4622; Cukras CA, 2002, J GEN PHYSIOL, V120, P437, DOI 10.1085/jgp.20028621; Grishin A, 2006, J BIOL CHEM, V281, P30104, DOI 10.1074/jbc.M602439200; Hayabuchi Y, 2001, J PHYSIOL-LONDON, V530, P193, DOI 10.1111/j.1469-7793.2001.0193l.x; Hu KL, 2003, NEURON, V38, P417, DOI 10.1016/S0896-6273(03)00256-3; Jackson WF, 2005, MICROCIRCULATION, V12, P113, DOI 10.1080/10739680590896072; Kondo C, 1998, RECEPTOR CHANNEL, V6, P129; Kubo M, 1997, J PHYSIOL-LONDON, V503, P489, DOI 10.1111/j.1469-7793.1997.489bg.x; Li L, 2003, J MEMBRANE BIOL, V196, P61, DOI 10.1007/s00232-003-0625-z; Light PE, 2000, P NATL ACAD SCI USA, V97, P9058, DOI 10.1073/pnas.160068997; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; Minami K, 2004, DIABETES, V53, pS176, DOI 10.2337/diabetes.53.suppl_3.S176; Morrissey Alison, 2005, BMC Physiol, V5, P1, DOI 10.1186/1472-6793-5-1; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Park WS, 2005, J CARDIOVASC PHARM, V45, P99, DOI 10.1097/01.fjc.0000150442.49051.f7; Pearson WL, 2006, J MEMBRANE BIOL, V213, P187, DOI 10.1007/s00232-006-0058-6; Piao HL, 2001, J BIOL CHEM, V276, P36673, DOI 10.1074/jbc.M106123200; Proks P, 1999, J PHYSIOL-LONDON, V514, P19, DOI 10.1111/j.1469-7793.1999.019af.x; Qu ZQ, 1999, J BIOL CHEM, V274, P13783, DOI 10.1074/jbc.274.20.13783; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; Quinn KV, 2003, CIRC RES, V93, P646, DOI 10.1161/01.RES.0000095247.81449.8E; Sampson LJ, 2007, CARDIOVASC RES, V76, P61, DOI 10.1016/j.cardiores.2007.05.020; Schulze D, 2003, J BIOL CHEM, V278, P10500, DOI 10.1074/jbc.M208413200; Shi WW, 2007, AM J PHYSIOL-REG I, V293, pR191, DOI 10.1152/ajpregu.00047.2007; Shi Y, 2007, AM J PHYSIOL-REG I, V293, pR1205, DOI 10.1152/ajpregu.00337.2007; STANDEN NB, 1989, SCIENCE, V245, P177, DOI 10.1126/science.2501869; Thorneloe KS, 2002, J PHYSIOL-LONDON, V541, P65, DOI 10.1113/jphysiol.2002.018101; Wang RP, 2007, MOL PHARMACOL, V71, P1646, DOI 10.1124/mol.106.030528; Wang RP, 2006, J MEMBRANE BIOL, V213, P155, DOI 10.1007/s00232-006-0038-x; Xu HX, 2001, J BIOL CHEM, V276, P38690, DOI 10.1074/jbc.M106595200; Xu HX, 2001, J BIOL CHEM, V276, P12898, DOI 10.1074/jbc.M009631200; Yamada M, 1997, J PHYSIOL-LONDON, V499, P715, DOI 10.1113/jphysiol.1997.sp021963; Yoo D, 2004, J BIOL CHEM, V279, P6863, DOI 10.1074/jbc.M311599200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; ZHANG H, 1995, BRIT J PHARMACOL, V114, P662, DOI 10.1111/j.1476-5381.1995.tb17190.x	40	25	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2488	2494		10.1074/jbc.M708769200	http://dx.doi.org/10.1074/jbc.M708769200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18048350	hybrid, Green Accepted			2022-12-25	WOS:000252622300005
J	Cocolakis, E; Dai, M; Drevet, L; Ho, J; Haines, E; Ali, S; Lebrun, JJ				Cocolakis, Eftihia; Dai, Meiou; Drevet, Loren; Ho, Joanne; Haines, Eric; Ali, Suhad; Lebrun, Jean-Jacques			Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; CASEIN GENE; PROLACTIN RECEPTOR; FUNCTIONAL-DIFFERENTIATION; TYROSINE PHOSPHORYLATION; TARGETED DISRUPTION; STAT5-LIKE FACTOR; INTERFERON-GAMMA; PROLINE-RICH	Both the transforming growth factor-beta(TGF beta)/Smad and the prolactin/JAK/STAT pathway are critical to the proper development, maintenance, and function of the mammary epithelial tissue. Interestingly, opposing physiological effects between these two signaling pathways are prominent in the regulation of mammary gland development. However, the exact nature of the biological network existing between the Smad and STAT signal transduction pathways has remained elusive. We identified a novel regulatory cross-talk mechanism by which TGF beta-induced Smad signaling acts to antagonize prolactin-mediated JAK/STAT signaling and expression of target genes. Furthermore, we found activin, another member of the TGF beta family, to also efficiently block STAT5 signaling and beta-casein expression in mammary epithelial cells. Our results indicate that ligand-induced activation of Smad2, -3, and -4 by activin and TGF beta leads to a direct inhibition of STAT5 transactivation and STAT5-mediated transcription of the downstream target genes, beta-casein and cyclin D1, thereby blocking vital processes for mammary gland growth and differentiation. Finally, we unveiled the mechanism by which these two signaling cascades antagonize their effects, and we found that activated Smads inhibit STAT5 association with its co-activator CREB-binding protein, thus blocking STAT5 transactivation of its target genes and leading to inhibition of mammary gland differentiation and lactation.	[Cocolakis, Eftihia; Dai, Meiou; Drevet, Loren; Ho, Joanne; Haines, Eric; Ali, Suhad; Lebrun, Jean-Jacques] McGill Univ, Royal Victoria Hosp, Dept Med, Hormones & Canc Res Unit, Montreal, PQ H3A 1A1, Canada	McGill University; Royal Victoria Hospital	Lebrun, JJ (corresponding author), McGill Univ, Royal Victoria Hosp, Dept Med, Hormones & Canc Res Unit, 687 Pine Ave, Montreal, PQ H3A 1A1, Canada.	JJ.Lebrun@mcgill.ca	Lebrun, Jean-Jacques/GNP-5222-2022					Bailey JP, 2004, MOL ENDOCRINOL, V18, P1171, DOI 10.1210/me.2003-0345; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Bright JJ, 1998, J IMMUNOL, V161, P1772; Bright JJ, 1997, J IMMUNOL, V159, P175; Brockman JL, 2005, MOL CELL ENDOCRINOL, V239, P45, DOI 10.1016/j.mce.2005.04.006; Callus BA, 2000, J BIOL CHEM, V275, P16954, DOI 10.1074/jbc.M909976199; Cella N, 1998, MOL CELL BIOL, V18, P1783, DOI 10.1128/MCB.18.4.1783; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chacko BM, 2001, NAT STRUCT BIOL, V8, P248, DOI 10.1038/84995; Choi KM, 2004, MOL ENDOCRINOL, V18, P1670, DOI 10.1210/me.2003-0483; Cocolakis E, 2001, J BIOL CHEM, V276, P18430, DOI 10.1074/jbc.M010768200; Daniel CW, 2001, ADV EXP MED BIOL, V501, P61; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; de Caestecker MP, 2000, J BIOL CHEM, V275, P2115, DOI 10.1074/jbc.275.3.2115; de Guise C, 2006, ENDOCRINOLOGY, V147, P4351, DOI 10.1210/en.2006-0444; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DOPPLER W, 1990, MOL ENDOCRINOL, V4, P912, DOI 10.1210/mend-4-6-912; DOPPLER W, 1995, J BIOL CHEM, V270, P17962, DOI 10.1074/jbc.270.30.17962; DOPPLER W, 1989, P NATL ACAD SCI USA, V86, P104, DOI 10.1073/pnas.86.1.104; DUSANTERFOURT I, 1994, EMBO J, V13, P2583, DOI 10.1002/j.1460-2075.1994.tb06548.x; EBERT KM, 1991, BIO-TECHNOL, V9, P835, DOI 10.1038/nbt0991-835; Faure E, 2000, CELL TISSUE RES, V300, P89, DOI 10.1007/s004410000183; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Ghosh AK, 2001, J BIOL CHEM, V276, P11041, DOI 10.1074/jbc.M004709200; GUYETTE WA, 1979, CELL, V17, P1013, DOI 10.1016/0092-8674(79)90340-4; Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Iavnilovitch E, 2002, MOL CANCER RES, V1, P32; Inman CK, 2005, MOL CELL BIOL, V25, P3182, DOI 10.1128/MCB.25.8.3182-3193.2005; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Jayaraman L, 2000, J BIOL CHEM, V275, P40710, DOI 10.1074/jbc.M005799200; JHAPPAN C, 1993, EMBO J, V12, P1835, DOI 10.1002/j.1460-2075.1993.tb05832.x; Kabotyanski EB, 2006, MOL ENDOCRINOL, V20, P2355, DOI 10.1210/me.2006-0160; Kirch HC, 1997, EUR J BIOCHEM, V246, P736, DOI 10.1111/j.1432-1033.1997.00736.x; LEBRUN JJ, 1995, P NATL ACAD SCI USA, V92, P4031, DOI 10.1073/pnas.92.9.4031; LEBRUN JJ, 1995, J BIOL CHEM, V270, P10664, DOI 10.1074/jbc.270.18.10664; LEBRUN JJ, 1997, INHIBIN ACTIVIN FOLL, P1; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Mieth M, 1990, GROWTH FACTORS, V4, DOI 10.3109/08977199009011005; Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065; Nguyen AV, 2000, DEVELOPMENT, V127, P3107; Nouhi Z, 2006, CANCER RES, V66, P1824, DOI 10.1158/0008-5472.CAN-05-2292; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; PALLARD C, 1995, J BIOL CHEM, V270, P15942, DOI 10.1074/jbc.270.27.15942; PALLARD C, 1995, EMBO J, V14, P2847, DOI 10.1002/j.1460-2075.1995.tb07284.x; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; PIERCE DF, 1993, GENE DEV, V7, P2308, DOI 10.1101/gad.7.12a.2308; Ripperger JA, 1995, ANN NY ACAD SCI, V762, P459; RIPPERGER JA, 1995, J BIOL CHEM, V270, P29998, DOI 10.1074/jbc.270.50.29998; Robinson GW, 1997, DEVELOPMENT, V124, P2701; ROBINSON SD, 1991, DEVELOPMENT, V113, P867; ROBINSON SD, 1993, J CELL BIOL, V120, P245, DOI 10.1083/jcb.120.1.245; RUFFJAMISON S, 1995, P NATL ACAD SCI USA, V92, P4215, DOI 10.1073/pnas.92.10.4215; RUI H, 1994, J BIOL CHEM, V269, P5364; RUI H, 1994, ENDOCRINOLOGY, V135, P1299, DOI 10.1210/en.135.4.1299; SCHMITT-NEY M, 1991, MOL CELL BIOL, V11, P3745, DOI 10.1128/MCB.11.7.3745; Senyuk V, 2002, ONCOGENE, V21, P3232, DOI 10.1038/sj.onc.1205436; Sicinski P, 1997, J MAMMARY GLAND BIOL, V2, P335, DOI 10.1023/A:1026391128117; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; Sovak MA, 1999, CELL GROWTH DIFFER, V10, P537; STRANGE R, 1992, DEVELOPMENT, V115, P49; Sudarshan C, 1999, J IMMUNOL, V162, P2974; SUDLOW AW, 1994, BIOCHEM J, V304, P333, DOI 10.1042/bj3040333; TOPPER YJ, 1980, PHYSIOL REV, V60, P1049, DOI 10.1152/physrev.1980.60.4.1049; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Valderrama-Carvajal H, 2002, NAT CELL BIOL, V4, P963, DOI 10.1038/ncb885; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; Wang GN, 2005, BIOCHEM J, V386, P29, DOI 10.1042/BJ20041820; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092	72	49	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1293	1307		10.1074/jbc.M707492200	http://dx.doi.org/10.1074/jbc.M707492200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024957	hybrid			2022-12-25	WOS:000252282700012
J	Fan, YX; Wong, LL; Ding, JH; Spiridonov, NA; Johnson, RC; Johnson, GR				Fan, Ying-Xin; Wong, Lily; Ding, Jinhui; Spiridonov, Nikolay A.; Johnson, Richard C.; Johnson, Gibbes R.			Mutational activation of ErbB2 reveals a new protein kinase autoinhibition mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; EXTRACELLULAR REGION; CRYSTAL-STRUCTURE; SIGNAL-TRANSDUCTION; CATALYTIC-ACTIVITY; LUNG-CANCER; DOMAIN; EGF; PHOSPHORYLATION	Autoinhibition plays a key role in the control of protein kinase activity. ErbB2 is a unique receptor-tyrosine kinase that does not bind ligand but possesses an extracellular domain poised to engage other ErbBs. Little is known about the molecular mechanism for ErbB2 catalytic regulation. Here we show that ErbB2 kinase is strongly autoinhibited, and a loop connecting the alpha C helix and beta 4 sheet within the kinase domain plays a major role in the control of kinase activity. Mutations of two Gly residues at positions 776 and 778 in this loop dramatically increase ErbB2 catalytic activity. Kinetic analysis demonstrates that mutational activation is due to similar to 10- and similar to 7-fold increases in ATP binding affinity and turnover number, respectively. Expression of the activated ErbB2 mutants in cells resulted in elevated ligand- independent ErbB2 autophosphorylation, ErbB3 phosphorylation, and stimulation of mitogen-activated protein kinase. Molecular modeling suggests that the ErbB2 kinase domain is stabilized in an inactive state via a hydrophobic interaction between the alpha C-beta 4 and activation loops. Importantly, many ErbB2 human cancer mutations have been identified in the alpha C-beta 4 loop, including the activating G776S mutation studied here. Our findings reveal a new kinase regulatory mechanism in which the alpha C-beta 4 loop functions as an intramolecular switch that controls ErbB2 activity and suggests that loss of alpha C-beta 4 loop-mediated autoinhibition is involved in oncogenic activation of ErbB2.	[Fan, Ying-Xin; Wong, Lily; Spiridonov, Nikolay A.; Johnson, Gibbes R.] US FDA, Ctr Drug Evaluat & Res, Div Therapeut Prot, Bethesda, MD 20892 USA; [Ding, Jinhui] NIH, NIA, Neurogenet Lab, Bioinformat Sect, Bethesda, MD 20892 USA; [Johnson, Richard C.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University	Fan, YX (corresponding author), US FDA, Ctr Drug Evaluat & Res, Div Therapeut Prot, Bldg 29A,Rm 3B-20,8800 Rockville Pike, Bethesda, MD 20892 USA.	ying-xin.fan@fda.hhs.gov; gibbes.johnson@fda.hhs.gov	Spiridonov, Nikolay/B-6287-2014					Adams JA, 2003, BIOCHEMISTRY-US, V42, P601, DOI 10.1021/bi020617o; Alimandi M, 1997, EMBO J, V16, P5608, DOI 10.1093/emboj/16.18.5608; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Brignola PS, 2002, J BIOL CHEM, V277, P1576, DOI 10.1074/jbc.M105907200; Chan R, 2002, MOL CELL BIOL, V22, P1073, DOI 10.1128/MCB.22.4.1073-1078.2002; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Citri A, 2004, EMBO REP, V5, P1165, DOI 10.1038/sj.embor.7400300; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cohen BM, 1996, J BIOL CHEM, V271, P4813; Deb TB, 1998, J BIOL CHEM, V273, P16643, DOI 10.1074/jbc.273.27.16643; Deb TB, 2001, J BIOL CHEM, V276, P15554, DOI 10.1074/jbc.M100928200; Fan YX, 2005, BIOCHEM J, V392, P417, DOI 10.1042/BJ20051122; Fan YX, 2004, J BIOL CHEM, V279, P38143, DOI 10.1074/jbc.M405760200; Fan YX, 1996, BIOCHEM J, V315, P97, DOI 10.1042/bj3150097; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; GUY PM, 1992, J BIOL CHEM, V267, P13851; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ishizawar RC, 2007, ONCOGENE, V26, P3503, DOI 10.1038/sj.onc.1210138; Jan AY, 2000, BIOCHEMISTRY-US, V39, P9786, DOI 10.1021/bi9924922; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Lee JW, 2006, CLIN CANCER RES, V12, P57, DOI 10.1158/1078-0432.CCR-05-0976; LENTERINK AE, 1998, EMBO J, V17, P3385; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MOHAMMADI M, 1993, BIOCHEMISTRY-US, V32, P8742, DOI 10.1021/bi00085a004; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; PIERCE JH, 1988, SCIENCE, V239, P628, DOI 10.1126/science.3257584; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SEGATTO O, 1990, New Biologist, V2, P187; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tikhomirov O, 2003, CANCER RES, V63, P39; WADA T, 1990, CELL, V61, P1339, DOI 10.1016/0092-8674(90)90697-D; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	49	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1588	1596		10.1074/jbc.M708116200	http://dx.doi.org/10.1074/jbc.M708116200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18039657	hybrid			2022-12-25	WOS:000252282700044
J	Hifumi, E; Morihara, F; Hatiuchi, K; Okuda, T; Nishizono, A; Uda, T				Hifumi, Emi; Morihara, Fumiko; Hatiuchi, Kenji; Okuda, Takuro; Nishizono, Akira; Uda, Taizo			Catalytic features and eradication ability of antibody light-chain UA15-L against Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; ORAL VACCINATION; UREASE; INFECTION; IMMUNIZATION; HYDROLYSIS; SUBUNITS; PEPTIDE	We have successfully developed a catalytic antibody capable of degrading the active site of the urease of Helicobacter pylori and eradicating the bacterial infection in a mouse stomach. This monoclonal antibody UA15 was generated using a designed recombinant protein UreB, which contained the crucial region of the H. pylori urease beta-subunit active site, for immunization. The light chain of this antibody (UA15-L) by itself showed a proteolytic activity to substantially degrade both UreB and the intact urease. Oral administration of UA15-L also significantly reduced the number of H. pylori in a mouse stomach. This is the first example of a monoclonal catalytic antibody capable of functioning in vivo, and such an antibody may have a therapeutic utility in the future.	[Hifumi, Emi; Hatiuchi, Kenji; Okuda, Takuro; Uda, Taizo] Japan Sci & Technol Corp, CREST, JST, Kawaguchi, Saitama 3320012, Japan; [Hifumi, Emi] Oita Univ, Res Ctr Appl Med Engn, Oita 8701192, Japan; [Uda, Taizo] Oita Univ, Fac Engn, Dept Appl Biochem, Oita 8701192, Japan; [Morihara, Fumiko] Fukuyama Med Lab Co, Fukuyama, Hiroshima 7208510, Japan; [Nishizono, Akira] Oita Univ, Dept Infect Dis, Fac Med, Oita 8795593, Japan	Japan Science & Technology Agency (JST); Oita University; Oita University; Oita University	Uda, T (corresponding author), Japan Sci & Technol Corp, CREST, JST, Kawaguchi, Saitama 3320012, Japan.	uda@cc.oita-u.ac.jp		Uda, Taizo/0000-0001-8146-7902				ANCHIN JM, 1994, J MOL GRAPHICS, V12, P257, DOI 10.1016/0263-7855(94)80102-9; CORTHESYTHEULAZ I, 1995, GASTROENTEROLOGY, V109, P115, DOI 10.1016/0016-5085(95)90275-9; ERHAN S, 1974, NATURE, V251, P353, DOI 10.1038/251353a0; Fujii R, 2004, BIOTECHNOL BIOENG, V86, P737, DOI 10.1002/bit.20047; GAO QS, 1994, J BIOL CHEM, V269, P32389; GOODWIN CS, 1986, J ANTIMICROB CHEMOTH, V17, P309, DOI 10.1093/jac/17.3.309; GRAHAM DY, 1991, GASTROENTEROLOGY, V100, P1495, DOI 10.1016/0016-5085(91)90644-Z; Ha NC, 2001, NAT STRUCT BIOL, V8, P505, DOI 10.1038/88563; Hatiuchi K, 2003, IMMUNOL LETT, V86, P249, DOI 10.1016/S0165-2478(03)00030-0; Hifumi E, 2005, FEBS J, V272, P4497, DOI 10.1111/j.1742-4658.2005.04869.x; Hifumi E, 2003, BIOTECHNOL BIOENG, V84, P485, DOI 10.1002/bit.10806; Hifumi E, 2002, J IMMUNOL METHODS, V269, P283, DOI 10.1016/S0022-1759(02)00242-9; HU LT, 1990, INFECT IMMUN, V58, P992, DOI 10.1128/IAI.58.4.992-998.1990; Huo XH, 2006, WORLD J GASTROENTERO, V12, P3105, DOI 10.3748/wjg.v12.i19.3105; Ikeda Y, 1998, J FERMENT BIOENG, V86, P271, DOI 10.1016/S0922-338X(98)80129-3; Ikewaki J, 2000, MICROBIOL IMMUNOL, V44, P29, DOI 10.1111/j.1348-0421.2000.tb01243.x; Kolesnikov AV, 2000, P NATL ACAD SCI USA, V97, P13526, DOI 10.1073/pnas.200360497; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; MARSHALL BJ, 1988, LANCET, V2, P1437; MEI S, 1991, J BIOL CHEM, V266, P15571; Mitsuda Y, 2005, IMMUNOL LETT, V96, P63, DOI 10.1016/j.imlet.2004.07.018; Mitsuda Y, 2004, BIOTECHNOL BIOENG, V86, P217, DOI 10.1002/bit.20031; NAGATA K, 1993, ANTIMICROB AGENTS CH, V37, P769, DOI 10.1128/AAC.37.4.769; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; Raghavan S, 2002, INFECT IMMUN, V70, P6383, DOI 10.1128/IAI.70.11.6383-6388.2002; Raghavan S, 2002, INFECT IMMUN, V70, P4621, DOI 10.1128/IAI.70.8.4621-4627.2002; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; Uda T, 2004, J BIOSCI BIOENG, V97, P143, DOI 10.1016/S1389-1723(04)70183-8	28	48	52	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					899	907		10.1074/jbc.M705674200	http://dx.doi.org/10.1074/jbc.M705674200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17991752	hybrid			2022-12-25	WOS:000252128100030
J	Jung, YS; Kim, HY; Kim, J; Lee, MG; Pouyssegur, J; Kim, E				Jung, Yong-Sam; Kim, Hye-Young; Kim, Juno; Lee, Min-Goo; Pouyssegur, Jacques; Kim, Eunhee			Physical interactions and functional coupling between Daxx and sodium hydrogen exchanger 1 in ischemic cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA-H EXCHANGE; PML ONCOGENIC DOMAINS; NHE1 NA+/H+ EXCHANGER; FAS-INDUCED APOPTOSIS; ADAPTER PROTEIN DAXX; BINDING-PROTEIN; GROWTH-FACTOR; TRANSCRIPTIONAL ACTIVATION; INTRACELLULAR PH; ERM PROTEINS	Daxx, a death domain-associated protein, is implicated in ischemic cell death. To clarify the mechanism of cell death mediated by Daxx, a yeast two-hybrid assay was performed. Sodium hydrogen exchanger isoform 1 (NHE1) was identified as a Daxx-interacting protein. During ischemic stress, Daxx translocates from the nucleus to the cytoplasm, where it colocalizes with NHE1. Daxx binds to the ezrin/radixin/moesin-interacting domain of NHE1, in competition with ezrin. Consistent with this finding, transfection of the constitutively cytoplasmic mutant, Daxx(W621A), inhibited ezrin-mediated Akt-1 activation. Moreover, transfection of Daxx(W621A), but not the Daxx(S667A) mutant that is confined to the nucleus, accelerated pH(i) recovery from an acid load, indicating that the cytoplasmic protein activates NHE1. Based on the results, we propose that ischemic insult triggers the nucleocytoplasmic translocation of Daxx, following which cytoplasmic Daxx stimulates the NHE1 transporter activity and suppresses activation of the NHE1-ezrin-Akt-1 pathway. Our data support a novel molecular function of Daxx as an upstream regulator of NHE1 in ischemic cell death.	[Jung, Yong-Sam; Kim, Hye-Young; Kim, Eunhee] Chungnam Natl Univ, Sch Biosci & Biotechnol, Taejon 305764, South Korea; [Kim, Juno; Lee, Min-Goo] Yonsei Univ, Coll Med, Dept Pharmacol, Seoul 120752, South Korea; [Kim, Juno; Lee, Min-Goo] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea; [Pouyssegur, Jacques] Univ Nice, Inst Signaling Dev Biol & Canc Res, CNRS, UMR 6543,Ctr A Lacassagne, F-06189 Nice, France	Chungnam National University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Kim, E (corresponding author), Chungnam Natl Univ, Sch Biosci & Biotechnol, 220 Gung Dong, Taejon 305764, South Korea.	eunhee@cnu.ac.kr	Lee, Min Goo/D-5635-2012; Lee, Min Goo/AAS-4636-2020	Lee, Min Goo/0000-0001-7436-012X; Lee, Min Goo/0000-0001-7436-012X				Barriere H, 2001, AM J PHYSIOL-CELL PH, V281, pC810, DOI 10.1152/ajpcell.2001.281.3.C810; Bianchini L, 1997, J BIOL CHEM, V272, P271; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Charette SJ, 2000, ANN NY ACAD SCI, V926, P126; Chen LY, 2003, MOL CELL BIOL, V23, P7108, DOI 10.1128/MCB.23.20.7108-7121.2003; COUNILLON L, 1993, MOL PHARMACOL, V44, P1041; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Ding D, 2000, EXP NEUROL, V162, P1, DOI 10.1006/exnr.2000.7226; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; FLIEGEL L, 1993, BIOCHEM J, V296, P273, DOI 10.1042/bj2960273; Garnovskaya MN, 2003, J BIOL CHEM, V278, P16908, DOI 10.1074/jbc.M209883200; Gautreau A, 1999, P NATL ACAD SCI USA, V96, P7300, DOI 10.1073/pnas.96.13.7300; Gottlieb RA, 1996, J CLIN INVEST, V97, P2391, DOI 10.1172/JCI118683; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; Han W, 2006, J BIOL CHEM, V281, P1461, DOI 10.1074/jbc.M509786200; Hollenbach AD, 1999, EMBO J, V18, P3702, DOI 10.1093/emboj/18.13.3702; Hooley R, 1996, J BIOL CHEM, V271, P6152, DOI 10.1074/jbc.271.11.6152; Inoue H, 2003, BIOL PHARM BULL, V26, P148, DOI 10.1248/bpb.26.148; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jang MS, 2002, BIOCHEM BIOPH RES CO, V295, P495, DOI 10.1016/S0006-291X(02)00699-X; Jorgensen NK, 1999, J NEUROSCI RES, V56, P358; Jung YS, 2007, FEBS LETT, V581, P843, DOI 10.1016/j.febslet.2007.01.055; Karmazyn M, 2001, EXPERT OPIN INV DRUG, V10, P835, DOI 10.1517/13543784.10.5.835; Kawai T, 2003, MOL CELL BIOL, V23, P6174, DOI 10.1128/MCB.23.17.6174-6186.2003; Khaled AR, 2001, MOL CELL BIOL, V21, P7545, DOI 10.1128/MCB.21.22.7545-7557.2001; Kim EJ, 2003, NUCLEIC ACIDS RES, V31, P5356, DOI 10.1093/nar/gkg741; Kim J, 2007, EUR J PHARMACOL, V567, P131, DOI 10.1016/j.ejphar.2007.03.056; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Li RZ, 2000, ONCOGENE, V19, P745, DOI 10.1038/sj.onc.1203385; Li XJ, 2002, J BIOL CHEM, V277, P36085, DOI 10.1074/jbc.M111952200; Li XJ, 2006, BIOCHEMISTRY-US, V45, P2414, DOI 10.1021/bi051132d; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; Liu H, 1997, J MOL CELL CARDIOL, V29, P2077, DOI 10.1006/jmcc.1997.0442; Luo J, 2005, J NEUROSCI, V25, P11256, DOI 10.1523/JNEUROSCI.3271-05.2005; Mentzer RM, 2003, ANN THORAC SURG, V75, pS700, DOI 10.1016/S0003-4975(02)04700-8; Michaelson JS, 2003, J CELL SCI, V116, P345, DOI 10.1242/jcs.00234; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Muromoto R, 2006, ONCOGENE, V25, P2131, DOI 10.1038/sj.onc.1209235; MURPHY E, 1991, CIRC RES, V68, P1250, DOI 10.1161/01.RES.68.5.1250; Nefkens I, 2003, J CELL SCI, V116, P513, DOI 10.1242/jcs.00253; ORLOWSKI J, 2003, THE NA PLUS H PLUS E, P17; Perez OD, 2002, IMMUNITY, V16, P51, DOI 10.1016/S1074-7613(02)00266-2; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Piper HM, 1996, BASIC RES CARDIOL, V91, P191, DOI 10.1007/BF00788905; POLLENZ RS, 1992, CELL, V69, P951, DOI 10.1016/0092-8674(92)90614-I; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Ryu SW, 2000, BIOCHEM BIOPH RES CO, V279, P6, DOI 10.1006/bbrc.2000.3882; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; SARDET C, 1990, SCIENCE, V247, P723, DOI 10.1126/science.2154036; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; SIESJO BK, 1993, PROG BRAIN RES, V96, P23; Song JJ, 2003, J BIOL CHEM, V278, P47245, DOI 10.1074/jbc.M213201200; Song JJ, 2003, J CELL BIOCHEM, V90, P304, DOI 10.1002/jcb.10619; Song JJ, 2004, J BIOL CHEM, V279, P30573, DOI 10.1074/jbc.M404512200; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; TAKEUCHI K, 1994, J CELL BIOL, V125, P1371, DOI 10.1083/jcb.125.6.1371; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; Torii S, 1999, EMBO J, V18, P6037, DOI 10.1093/emboj/18.21.6037; Wakabayashi S, 1997, BIOCHEMISTRY-US, V36, P12854, DOI 10.1021/bi9715472; Wang YG, 2003, CIRC RES, V93, P776, DOI 10.1161/01.RES.0000094746.24774.DC; Wu KL, 2003, AM J PHYSIOL-RENAL, V284, pF829, DOI 10.1152/ajprenal.00314.2002; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yan WH, 2001, J BIOL CHEM, V276, P31349, DOI 10.1074/jbc.M102679200; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zhong S, 2000, J EXP MED, V191, P631, DOI 10.1084/jem.191.4.631	70	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1018	1025		10.1074/jbc.M707722200	http://dx.doi.org/10.1074/jbc.M707722200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18003619	hybrid			2022-12-25	WOS:000252128100041
J	Ma, XL; Sayed, N; Baskaran, P; Beuve, A; van den Akker, F				Ma, Xiaolei; Sayed, Nazish; Baskaran, Padmamalini; Beuve, Annie; van den Akker, Focco			PAS-mediated dimerization of soluble guanylyl cyclase revealed by signal transduction histidine kinase domain crystal structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; NITRIC-OXIDE; FUNCTIONAL-CHARACTERIZATION; MOLECULAR GRAPHICS; CATALYTIC DOMAINS; ADENYLYL-CYCLASE; VASCULAR SYSTEM; HEME DOMAIN; NO; SENSOR	Signal transduction histidine kinases (STHK) are key for sensing environmental stresses, crucial for cell survival, and attain their sensing ability using small molecule binding domains. The N-terminal domain in an STHK from Nostoc punctiforme is of unknown function yet is homologous to the central region in soluble guanylyl cyclase (sGC), the main receptor for nitric oxide (NO). This domain is termed H-NOXA (or H-NOBA) because it is often associated with the heme-nitric oxide/oxygen binding (H-NOX) domain. A structure-function approach was taken to investigate the role of H-NOXA in STHK and sGC. We report the 2.1 angstrom resolution crystal structure of the dimerized H-NOXA domain of STHK, which reveals a Per-Arnt-Sim (PAS) fold. The H-NOXA monomers dimerize in a parallel arrangement juxtaposing their N-terminal helices and preceding residues. Such PAS dimerization is similar to that previously observed for EcDOS, AvNifL, and RmFixL. Deletion of 7 N-terminal residues affected dimer organization. Alanine scanning mutagenesis in sGC indicates that the H-NOXA domains of sGC could adopt a similar dimer organization. Although most putative interface mutations did decrease sGC beta 1 H-NOXA homodimerization, heterodimerization of full-length heterodimeric sGC was mostly unaffected, likely due to the additional dimerization contacts of sGC in the coiled-coil and catalytic domains. Exceptions are mutations sGC alpha 1 F285A and sGC beta 1 F217A, which each caused a drastic drop in NO stimulated activity, and mutations sGC alpha 1 Q368A and sGC beta 1 Q309A, which resulted in both a complete lack of activity and heterodimerization. Our structural and mutational results provide new insights into sGC and STHK dimerization and overall architecture.	[Ma, Xiaolei; van den Akker, Focco] Case Western Reserve Univ, Dept Biochem RT500, Cleveland, OH 44106 USA; [Sayed, Nazish; Baskaran, Padmamalini; Beuve, Annie] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pharmacol & Physiol, Newark, NJ 07103 USA	Case Western Reserve University; Rutgers State University New Brunswick; Rutgers State University Medical Center	van den Akker, F (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	focco.vandenakker@case.edu	Ma, Xiaolei/G-2058-2010	Sayed, Nazish/0000-0002-8229-721X; Ma, Xiaolei/0000-0002-5307-827X	NHLBI NIH HHS [R01 HL075329, R01 HL075329-02] Funding Source: Medline; NIGMS NIH HHS [R01 GM067640] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067640] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; Anantharaman V, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-25; Behrends S, 2003, CURR MED CHEM, V10, P291, DOI 10.2174/0929867033368286; BIRKTOFT JJ, 1989, BIOCHEMISTRY-US, V28, P6065, DOI 10.1021/bi00440a051; Cary SPL, 2006, TRENDS BIOCHEM SCI, V31, P231, DOI 10.1016/j.tibs.2006.02.003; Chang FJ, 2005, J BIOL CHEM, V280, P11513, DOI 10.1074/jbc.M412203200; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friebe A, 1999, BIOCHEMISTRY-US, V38, P15253, DOI 10.1021/bi9908944; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; Galperin MY, 2004, ENVIRON MICROBIOL, V6, P552, DOI 10.1111/j.1462-2920.2004.00633.x; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Hefti MH, 2004, EUR J BIOCHEM, V271, P1198, DOI 10.1111/j.1432-1033.2004.04023.x; Hering KW, 2006, BIOORG MED CHEM LETT, V16, P618, DOI 10.1016/j.bmcl.2005.10.093; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Iyer LM, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-5; John B, 2003, NUCLEIC ACIDS RES, V31, P3982, DOI 10.1093/nar/gkg460; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; Koesling D, 2004, NEUROCHEM INT, V45, P813, DOI 10.1016/j.neuint.2004.03.011; Koglin M, 2001, J BIOL CHEM, V276, P30737, DOI 10.1074/jbc.M102549200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; Lamothe M, 2004, BIOCHEMISTRY-US, V43, P3039, DOI 10.1021/bi0360051; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li ZQ, 2005, BIOCHEMISTRY-US, V44, P939, DOI 10.1021/bi0489208; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mergia E, 2006, J CLIN INVEST, V116, P1731, DOI 10.1172/JCI27657; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miyatake H, 2000, J MOL BIOL, V301, P415, DOI 10.1006/jmbi.2000.3954; Morton DB, 2003, J EXP BIOL, V206, P937, DOI 10.1242/jeb.00160; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narikawa R, 2004, DNA RES, V11, P69, DOI 10.1093/dnares/11.2.69; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Ohmori M, 2001, DNA RES, V8, P271, DOI 10.1093/dnares/8.6.271; Padayatti PS, 2004, PHARMACOL THERAPEUT, V104, P83, DOI 10.1016/j.pharmthera.2004.08.003; Pandini A, 2007, BIOCHEMISTRY-US, V46, P696, DOI 10.1021/bi061460t; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Ponstingl H, 2003, J APPL CRYSTALLOGR, V36, P1116, DOI 10.1107/S0021889803012421; Pyriochou A, 2005, CELL SIGNAL, V17, P407, DOI 10.1016/j.cellsig.2004.09.008; Reinelt S, 2003, J BIOL CHEM, V278, P39189, DOI 10.1074/jbc.M305864200; Rothkegel C, 2007, MOL PHARMACOL, V72, P1181, DOI 10.1124/mol.107.036368; Rothkegel C, 2006, FEBS LETT, V580, P4205, DOI 10.1016/j.febslet.2006.06.079; Satyshur KA, 2007, STRUCTURE, V15, P363, DOI 10.1016/j.str.2007.01.018; Shiga T, 2005, ZOOL SCI, V22, P735, DOI 10.2108/zsj.22.735; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tews I, 2005, SCIENCE, V308, P1020, DOI 10.1126/science.1107642; Wagner C, 2005, J BIOL CHEM, V280, P17687, DOI 10.1074/jbc.M412099200; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Yildiz O, 2005, MOL CELL, V17, P69, DOI 10.1016/j.molcel.2004.11.022; YUEN PST, 1994, J BIOL CHEM, V269, P791; Zabel U, 1999, J BIOL CHEM, V274, P18149, DOI 10.1074/jbc.274.26.18149; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0; Zhao JM, 2006, P NATL ACAD SCI USA, V103, P11561, DOI 10.1073/pnas.0601567103; Zhou ZM, 2004, J BIOL CHEM, V279, P24935, DOI 10.1074/jbc.M402105200; Zhulin IB, 1997, TRENDS BIOCHEM SCI, V22, P331, DOI 10.1016/S0968-0004(97)01110-9	62	78	81	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1167	1178		10.1074/jbc.M706218200	http://dx.doi.org/10.1074/jbc.M706218200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18006497	Green Accepted, hybrid			2022-12-25	WOS:000252128100057
J	Shen, MQ; Reitman, ZJ; Zhao, Y; Moustafa, I; Wang, QX; Arnold, JJ; Pathak, HB; Cameron, CE				Shen, Miaoqing; Reitman, Zachary J.; Zhao, Yan; Moustafa, Ibrahim; Wang, Qixin; Arnold, Jamie J.; Pathak, Harsh B.; Cameron, Craig E.			Picornavirus genome replication - Identification of the surface of the poliovirus (PV) 3C dimer that interacts with PV 3Dpol during VPg uridylylation and construction of a structural model for the PV3C(2)-3Dpol complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; POSITIVE-STRAND; NEGATIVE-STRAND; IN-VITRO; CLOVERLEAF RNA; PROTEINASE 3C; VIRAL-RNA; PROTEOLYTIC ACTIVITIES; MOLECULAR-DYNAMICS; 5-NONCODING REGION	Picornaviruses have a peptide termed VPg covalently linked to the 5 '-end of the genome. Attachment of VPg to the genome occurs in at least two steps. First, Tyr-3 of VPg, or some precursor thereof, is used as a primer by the viral RNA-dependent RNA polymerase, 3Dpol, to produce VPg-pUpU. Second, VPg-pUpU is used as a primer to produce full-length genomic RNA. Production of VPg-pUpU is templated by a single adenylate residue located in the loop of an RNA stem-loop structure termed oriI by using a slide-back mechanism. Recruitment of 3Dpol to and its stability on oriI have been suggested to require an interaction between the back of the thumb subdomain of 3Dpol and an undefined region of the 3C domain of viral protein 3CD. We have performed surface acidic-to-alanine-scanning mutagenesis of 3C to identify the surface of 3C with which 3Dpol interacts. This analysis identified numerous viable poliovirus mutants with reduced growth kinetics that correlated to reduced kinetics of RNA synthesis that was attributable to a change in VPg-pUpU production. Importantly, these 3C derivatives were all capable of binding to oriI as well as wild-type 3C. Synthetic lethality was observed for these mutants when placed in the context of a poliovirus mutant containing 3Dpol-R455A, a residue on the back of the thumb required for VPg uridylylation. These data were used to guide molecular docking of the structures for a poliovirus 3C dimer and 3Dpol, leading to a structural model for the 3C2-3Dpol complex that extrapolates well to all picornaviruses.	[Shen, Miaoqing; Reitman, Zachary J.; Zhao, Yan; Moustafa, Ibrahim; Wang, Qixin; Arnold, Jamie J.; Pathak, Harsh B.; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 201, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cameron, CE (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 201, University Pk, PA 16802 USA.	cec9@psu.edu		Reitman, Zachary/0000-0002-9122-9550	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053531, R56AI053531] Funding Source: NIH RePORTER; NIAID NIH HHS [AI053531, R01 AI053531, R56 AI053531, R37 AI053531, R01 AI053531-05] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDINO R, 1993, EMBO J, V12, P3587, DOI 10.1002/j.1460-2075.1993.tb06032.x; Barton DJ, 1996, METHOD ENZYMOL, V275, P35; Belov GA, 2005, J VIROL, V79, P7207, DOI 10.1128/JVI.79.11.7207-7216.2005; Belov GA, 2007, J VIROL, V81, P9259, DOI 10.1128/JVI.00840-07; Belov GA, 2007, J VIROL, V81, P558, DOI 10.1128/JVI.01820-06; Belov GA, 2007, CELL CYCLE, V6, P36, DOI 10.4161/cc.6.1.3683; Bergmann EM, 1997, J VIROL, V71, P2436, DOI 10.1128/JVI.71.3.2436-2448.1997; Blair WS, 1998, RNA, V4, P215; Blair WS, 1996, VIROLOGY, V218, P1, DOI 10.1006/viro.1996.0160; CALIGUIRI LA, 1968, VIROLOGY, V35, P408, DOI 10.1016/0042-6822(68)90219-5; Cuconati A, 1998, J VIROL, V72, P6456, DOI 10.1128/JVI.72.8.6456-6464.1998; DIAMOND SE, 1994, J VIROL, V68, P863, DOI 10.1128/JVI.68.2.863-876.1994; Dmitrieva TM, 2007, VIROLOGY, V365, P79, DOI 10.1016/j.virol.2007.02.038; DOEDENS J, 1994, ARCH VIROL, P159; Ferrer-Orta C, 2006, EMBO J, V25, P880, DOI 10.1038/sj.emboj.7600971; Franco D, 2005, J VIROL, V79, P6358, DOI 10.1128/JVI.79.10.6358-6367.2005; Franco D, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-86; Gamarnik AV, 2000, J VIROL, V74, P2219, DOI 10.1128/JVI.74.5.2219-2226.2000; Gerber K, 2001, J VIROL, V75, P10979, DOI 10.1128/JVI.75.22.10979-10990.2001; Gohara DW, 2000, J BIOL CHEM, V275, P25523, DOI 10.1074/jbc.M002671200; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Goodfellow I, 2000, J VIROL, V74, P4590, DOI 10.1128/JVI.74.10.4590-4600.2000; HAMMERLE T, 1992, J VIROL, V66, P6028; HAMMERLE T, 1991, J BIOL CHEM, V266, P5412; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; HARRIS KS, 1992, J VIROL, V66, P7481, DOI 10.1128/JVI.66.12.7481-7489.1992; HARRIS KS, 1994, J BIOL CHEM, V269, P27004; Herold J, 2000, J VIROL, V74, P6394, DOI 10.1128/JVI.74.14.6394-6400.2000; Hobson SD, 2001, EMBO J, V20, P1153, DOI 10.1093/emboj/20.5.1153; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kistler AL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-40; Kusov YY, 1997, RNA, V3, P291; LEONG LEC, 1993, J BIOL CHEM, V268, P25735; Lyle JM, 2002, SCIENCE, V296, P2218, DOI 10.1126/science.1070585; Lyons T, 2001, J VIROL, V75, P10696, DOI 10.1128/JVI.75.22.10696-10708.2001; Marcotte LL, 2007, J VIROL, V81, P3583, DOI 10.1128/JVI.02306-06; MAYNELL LA, 1992, J VIROL, V66, P1985, DOI 10.1128/JVI.66.4.1985-1994.1992; Morasco BJ, 2003, J VIROL, V77, P5136, DOI 10.1128/JVI.77.9.5136-5144.2003; Mosimann SC, 1997, J MOL BIOL, V273, P1032, DOI 10.1006/jmbi.1997.1306; Murray KE, 2003, J VIROL, V77, P4739, DOI 10.1128/JVI.77.8.4739-4750.2003; Nayak A, 2005, J VIROL, V79, P7698, DOI 10.1128/JVI.79.12.7698-7706.2005; NOBLE J, 1970, VIROLOGY, V40, P634, DOI 10.1016/0042-6822(70)90208-4; Ohlenschlager O, 2004, STRUCTURE, V12, P237, DOI 10.1016/j.str.2004.01.014; Parsley TB, 1997, RNA, V3, P1124; PATA JD, 1995, RNA, V1, P466; Pathak HB, 2007, J BIOL CHEM, V282, P16202, DOI 10.1074/jbc.M610608200; Pathak HB, 2002, J BIOL CHEM, V277, P31551, DOI 10.1074/jbc.M204408200; PATHAK HB, 2006, UNIFIED MODEL INITIA; Paul Aniko V., 2002, P227; Paul AV, 2000, J VIROL, V74, P10359, DOI 10.1128/JVI.74.22.10359-10370.2000; Paul AV, 2003, J BIOL CHEM, V278, P43951, DOI 10.1074/jbc.M307441200; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; Peters H, 2005, BIOCHEM J, V385, P363, DOI 10.1042/BJ20041153; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Racaniello V.R., 2001, FIELDS VIROLOGY, P455; Rieder E, 2000, J VIROL, V74, P10371, DOI 10.1128/JVI.74.22.10371-10380.2000; Semler BL, 2002, MOL BIOL PICORNAVIRU; Shen M, 2007, J VIROL, V81, P12485, DOI 10.1128/JVI.00972-07; Shih SR, 2004, J BIOMED SCI, V11, P239, DOI 10.1159/000076036; Tellez AB, 2006, J MOL BIOL, V357, P665, DOI 10.1016/j.jmb.2005.12.044; TERSHAK DR, 1982, J VIROL, V41, P313, DOI 10.1128/JVI.41.1.313-318.1982; Thiviyanathan V, 2004, P NATL ACAD SCI USA, V101, P12688, DOI 10.1073/pnas.0403079101; Thompson AA, 2004, EMBO J, V23, P3462, DOI 10.1038/sj.emboj.7600357; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; van Ooij MJM, 2006, J GEN VIROL, V87, P103, DOI 10.1099/vir.0.81297-0; WALKER PK, 1995, J BIOL CHEM, V270, P14510, DOI 10.1074/jbc.270.24.14510; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; XIANG WK, 1995, J VIROL, V69, P3658, DOI 10.1128/JVI.69.6.3658-3667.1995; Yang Y, 2004, J BIOL CHEM, V279, P12659, DOI 10.1074/jbc.M312992200; Yin J, 2003, J VIROL, V77, P5152, DOI 10.1128/JVI.77.9.5152-5166.2003; Zell R, 2002, RNA, V8, P188, DOI 10.1017/S1355838202012785	72	33	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					875	888		10.1074/jbc.M707907200	http://dx.doi.org/10.1074/jbc.M707907200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17993457	Green Accepted, hybrid			2022-12-25	WOS:000252128100028
J	Song, WL; Wang, M; Ricciotti, E; Fries, S; Yu, Y; Grosser, T; Reilly, M; Lawson, JA; FitzGerald, GA				Song, Wen-Liang; Wang, Miao; Ricciotti, Emanuela; Fries, Susanne; Yu, Ying; Grosser, Tilo; Reilly, Muredach; Lawson, John A.; FitzGerald, Garret A.			Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D-2 in mice and humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATOGRAPHY-MASS-SPECTROMETRY; NICOTINIC-ACID; D SYNTHASE; INDUCIBLE CYCLOOXYGENASE; PLATELET ACTIVATION; ASPIRIN CHALLENGE; BRONCHIAL-ASTHMA; CELL ACTIVATION; PPAR-GAMMA; EXPRESSION	Prostaglandin D-2 (PGD(2)) is a cyclooxygenase (COX) product of arachidonic acid that activates D prostanoid receptors to modulate vascular, platelet, and leukocyte function in vitro. However, little is known about its enzymatic origin or its formation in vivo in cardiovascular or inflammatory disease.11,15-Dioxo-9 alpha-hydroxy-2,3,4,5-tetranorprostan-1,20-dioic acid (tetranor PGDM) was identified by mass spectrometry as a metabolite of infused PGD2 that is detectable in mouse and human urine. Using liquid chromatography-tandem mass spectrometry, tetranor PGDM was much more abundant than the PGD(2) metabolites, 11 beta-PGF(2 alpha) and 2,3-dinor-11 beta-PGF(2 alpha), in human urine and was the only endogenous metabolite detectable in mouse urine. Infusion of PGD2 dose dependently increased urinary tetranor PGDM > 2,3-dinor-11 beta-PGF(2 alpha) > 11 beta-PGF(2 alpha) in mice. Deletion of either lipocalin-type or hemopoietic PGD synthase enzymes decreased urinary tetranor PGDM. Deletion or knockdown of COX-1, but not deletion of COX-2, decreased urinary tetranor PGDM in mice. Correspondingly, both PGDM and 2,3-dinor-11 beta-PGF(2 alpha) were suppressed by inhibition of COX-1 and COX-2, but not by selective inhibition of COX-2 in humans. PGD2 has been implicated in both the development and resolution of inflammation. Administration of bacterial lipopolysaccharide coordinately elevated tetranor PGDM and 2,3-dinor-11 beta-PGF(2 alpha) in volunteers, coincident with a pyrexial and systemic inflammatory response, but both metabolites fell during the resolution phase. Niacin increased tetranor PGDM and 2,3-dinor-11 beta-PGF(2 alpha), in humans coincident with facial flushing. Tetranor PGDM is an abundant metabolite in urine that reflects modulated biosynthesis of PGD(2) in humans and mice.	[Song, Wen-Liang; Wang, Miao; Ricciotti, Emanuela; Fries, Susanne; Yu, Ying; Grosser, Tilo; Reilly, Muredach; Lawson, John A.; FitzGerald, Garret A.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	FitzGerald, GA (corresponding author), Univ Penn, Sch Med, Inst Translat Med & Therapeut, 153 Johnson Pavilion,Hamilton Walk, Philadelphia, PA 19104 USA.	garret@spirit.gcrc.upenn.edu	Ricciotti, Emanuela/AAH-2729-2019; Grosser, Tilo/A-1057-2007; FitzGerald, Garret A/A-4222-2010	Grosser, Tilo/0000-0001-8569-8396; Song, Wenliang/0000-0002-1866-0635; Reilly, Muredach/0000-0002-3035-9386; Wang, Miao/0000-0002-0532-6312	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL083799, R01HL073278] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-023567] Funding Source: Medline; NHLBI NIH HHS [HL R01 073278, HL 83799] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BANDERLAAN PA, 2005, J LIPID RES, V46, P829; Barr RG, 2007, AM J RESP CRIT CARE, V175, P120, DOI 10.1164/rccm.200603-411OC; BEASLEY CRW, 1987, J CLIN INVEST, V79, P978, DOI 10.1172/JCI112909; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Bochenek G, 2004, THORAX, V59, P459, DOI 10.1136/thx.2003.013573; Bochenek G, 2003, J ALLERGY CLIN IMMUN, V111, P743, DOI 10.1067/mai.2003.1387; BUSHFIELD M, 1985, BIOCHEM J, V232, P267, DOI 10.1042/bj2320267; Carlson LA, 2005, J INTERN MED, V258, P94, DOI 10.1111/j.1365-2796.2005.01528.x; CATELLA F, 1986, P NATL ACAD SCI USA, V83, P5861, DOI 10.1073/pnas.83.16.5861; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Cheng K, 2006, P NATL ACAD SCI USA, V103, P6682, DOI 10.1073/pnas.0601574103; Cheng Y, 2006, J CLIN INVEST, V116, P1391, DOI 10.1172/JCI27540; Dieter P, 2000, BIOCHEM BIOPH RES CO, V276, P488, DOI 10.1006/bbrc.2000.3496; Eguchi Y, 1997, P NATL ACAD SCI USA, V94, P14689, DOI 10.1073/pnas.94.26.14689; FITZGERALD GA, 1984, NEW ENGL J MED, V310, P1065, DOI 10.1056/NEJM198404263101701; FITZGERALD GA, 1983, J CLIN INVEST, V71, P676, DOI 10.1172/JCI110814; Flower DR, 1996, BIOCHEM J, V318, P1; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fries S, 2006, GASTROENTEROLOGY, V130, P55, DOI 10.1053/j.gastro.2005.10.002; GILES H, 1989, BRIT J PHARMACOL, V96, P291, DOI 10.1111/j.1476-5381.1989.tb11816.x; Gilroy DW, 2003, FASEB J, V17, P2269, DOI 10.1096/fj.02-1162fje; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; HAMBERG M, 1976, BIOCHIM BIOPHYS ACTA, V431, P189, DOI 10.1016/0005-2760(76)90273-3; Inoue T, 2001, THROMB HAEMOSTASIS, V85, P165; LISTON TE, 1985, J BIOL CHEM, V260, P3172; MACDERMOT J, 1984, PROSTAGLANDINS, V27, P163, DOI 10.1016/0090-6980(84)90071-6; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; McAdam BF, 2000, J CLIN INVEST, V105, P1473, DOI 10.1172/JCI9523; Misso NLA, 2004, CLIN EXP ALLERGY, V34, P624, DOI 10.1111/j.1365-2222.2004.1912.x; MORROW JD, 1989, PROSTAGLANDINS, V38, P263, DOI 10.1016/0090-6980(89)90088-9; MORROW JD, 1995, J INVEST DERMATOL, V104, P937, DOI 10.1111/1523-1747.ep12606209; Nagata K, 1999, FEBS LETT, V459, P195, DOI 10.1016/S0014-5793(99)01251-X; Nagata K, 1999, J IMMUNOL, V162, P1278; O'Sullivan S, 1999, PROSTAG OTH LIPID M, V57, P149, DOI 10.1016/S0090-6980(98)00076-8; OELZ O, 1977, PROSTAGLANDINS, V13, P225, DOI 10.1016/0090-6980(77)90004-1; OSullivan S, 1996, J ALLERGY CLIN IMMUN, V98, P421, DOI 10.1016/S0091-6749(96)70167-7; PARSONS WG, 1988, J IMMUNOL, V141, P2413; PICKETT WC, 1981, ANAL BIOCHEM, V111, P115, DOI 10.1016/0003-2697(81)90237-2; Reddy ST, 1997, J BIOL CHEM, V272, P3231, DOI 10.1074/jbc.272.6.3231; ROBERTS LJ, 1980, NEW ENGL J MED, V303, P1400, DOI 10.1056/NEJM198012113032405; Song WL, 2007, METHOD ENZYMOL, V433, P51, DOI 10.1016/S0076-6879(07)33003-6; Sun J, 2007, J CLIN INVEST, V117, P3359, DOI 10.1172/JCI31311; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Taba Y, 2000, CIRC RES, V86, P967, DOI 10.1161/01.RES.86.9.967; Trivedi SG, 2006, P NATL ACAD SCI USA, V103, P5179, DOI 10.1073/pnas.0507175103; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; WATANABE K, 1986, P NATL ACAD SCI USA, V83, P1583, DOI 10.1073/pnas.83.6.1583; WILLIAMS TJ, 1977, NATURE, V270, P530, DOI 10.1038/270530a0; Yu Y, 2005, J CLIN INVEST, V115, P986, DOI 10.1172/JCI23683	50	68	72	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1179	1188		10.1074/jbc.M706839200	http://dx.doi.org/10.1074/jbc.M706839200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17993463	hybrid			2022-12-25	WOS:000252128100058
J	Yun, S; Moller, A; Chae, SK; Hong, WP; Bae, YJ; Bowtell, DDL; Ryu, SH; Suh, PG				Yun, Sanguk; Moeller, Andreas; Chae, Suhn-Kee; Hong, Won-Pyo; Bae, Young Ju; Bowtell, David D. L.; Ryu, Sung Ho; Suh, Pann-Ghill			Siah proteins induce the epidermal growth factor-dependent degradation of phospholipase C epsilon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME PATHWAY; PRIMARY-CELLS; CYCLIC-AMP; GENE; ABSENTIA; RECEPTOR; ACTIVATION; APOPTOSIS; P53; HOMOLOGS	Phospholipase C epsilon (PLC epsilon) is activated by various growth factors or G-protein-coupled receptor ligands via different activation mechanisms. The Ras association ( RA) domain of PLC epsilon is known to be important for its ability to bind with Ras-family GTPase upon growth factor stimulation. In the present study, we identified Siah1 and Siah2 as novel binding partners of the PLC epsilon RA domain. Both Siah1 and Siah2 interacted with the RA2 domain of PLC epsilon, and the mutation of Lys-2186 of the PLC epsilon RA2 domain abolished this association. Moreover, Siah induced the ubiquitination and degradation of PLC epsilon upon epidermal growth factor (EGF) stimulation, and Siah proteins were phosphorylated on multiple tyrosine residues via an Src-dependent pathway upon EGF treatment. The Src inhibitor abolished the EGF-dependent ubiquitination of PLC epsilon, and the Siah1 phosphorylation-deficient mutant could not increase the EGF-dependent ubiquitination and degradation of PLC epsilon. The EGF-dependent degradation of PLC epsilon was blocked in mouse embryonic fibroblast (MEF) cells derived from Siah1a/Siah2 double knockout mice, and the extrinsic expression of wild-type Siah1 restored the degradation of PLC epsilon, whereas the phosphorylation-deficient mutant did not. Siah1 expression abolished PLC epsilon-dependent potentiation of EGF-dependent cell growth. In addition, the expression of wild-type Siah1 in Siah1a/Siah2-double knockout MEF cells inhibited EGF-dependent cell growth, and this inhibition was abolished by PLC epsilon knockdown. Our results suggest that the Siah-dependent degradation of PLC epsilon plays a role in the regulation of growth factor-dependent cell growth.	[Yun, Sanguk; Hong, Won-Pyo; Bae, Young Ju; Ryu, Sung Ho; Suh, Pann-Ghill] Pohang Univ Sci & Technol, Div Mol & Life Sci, Dept Life Sci, Pohang 790784, Kyung Buk, South Korea; [Moeller, Andreas; Bowtell, David D. L.] Peter MacCallum Canc Ctr, Canc Genom & Biochem Lab, Dept Res, Melbourne, Vic 3002, Australia; [Moeller, Andreas; Bowtell, David D. L.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Chae, Suhn-Kee] Paichai Univ, Dept Biochem, Taejon 302735, South Korea; [Chae, Suhn-Kee] Paichai Univ, Biomed Res Ctr, Taejon 302735, South Korea	Pohang University of Science & Technology (POSTECH); Peter Maccallum Cancer Center; University of Melbourne; Pai Chai University; Pai Chai University	Suh, PG (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Dept Life Sci, Pohang 790784, Kyung Buk, South Korea.	pgs@postech.ac.kr	Suh, Pann-Ghill/F-3610-2010; Bowtell, David/H-1007-2016; Möller, Andreas/O-1063-2015	Bowtell, David/0000-0001-9089-7525; Möller, Andreas/0000-0002-8618-6998; Chae, Suhn-Kee/0000-0003-2164-1053; Ryu, Sung Ho/0000-0003-0913-3048				Amson RB, 1996, P NATL ACAD SCI USA, V93, P3953, DOI 10.1073/pnas.93.9.3953; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Boehm J, 2001, EMBO J, V20, P4153, DOI 10.1093/emboj/20.15.4153; Bruzzoni-Giovanelli H, 1999, ONCOGENE, V18, P7101, DOI 10.1038/sj.onc.1203187; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; Cockcroft S, 2006, TRENDS BIOCHEM SCI, V31, P4, DOI 10.1016/j.tibs.2005.11.003; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; DELLA NG, 1993, DEVELOPMENT, V117, P1333; Evellin S, 2002, J BIOL CHEM, V277, P16805, DOI 10.1074/jbc.M112024200; Frew IJ, 2002, MOL CELL BIOL, V22, P8155, DOI 10.1128/MCB.22.23.8155-8164.2002; Germani A, 2000, ONCOGENE, V19, P5997, DOI 10.1038/sj.onc.1204002; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Hains MD, 2006, MOL PHARMACOL, V69, P2068, DOI 10.1124/mol.105.017921; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Hu G, 1997, GENOMICS, V46, P103, DOI 10.1006/geno.1997.4997; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; Khurana A, 2006, J BIOL CHEM, V281, P35316, DOI 10.1074/jbc.M606568200; Kim CJ, 2004, ONCOGENE, V23, P8591, DOI 10.1038/sj.onc.1208113; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Moriyoshi K, 2004, P NATL ACAD SCI USA, V101, P8614, DOI 10.1073/pnas.0403042101; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Roperch JP, 1999, P NATL ACAD SCI USA, V96, P8070, DOI 10.1073/pnas.96.14.8070; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Seifert JP, 2004, J BIOL CHEM, V279, P47992, DOI 10.1074/jbc.M407111200; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Song CH, 2002, ONCOGENE, V21, P8105, DOI 10.1038/sj.onc.1206003; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tadano M, 2005, MOL CELL BIOL, V25, P2191, DOI 10.1128/MCB.25.6.2191-2199.2005; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Xu ZH, 2006, J BIOL CHEM, V281, P303, DOI 10.1074/jbc.M509060200; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775	38	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1034	1042		10.1074/jbc.M705874200	http://dx.doi.org/10.1074/jbc.M705874200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17998205	hybrid			2022-12-25	WOS:000252128100043
J	Bibert, S; Roy, S; Schaer, D; Horisberger, JD; Geering, K				Bibert, Stephanie; Roy, Sophie; Schaer, Daniele; Horisberger, Jean-Daniel; Geering, Kaethi			Phosphorylation of phospholemman (FXYD1) by protein kinases A and C modulates distinct Na,K-ATPase isozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT CARDIAC MYOCYTES; NA-K-ATPASE; BETA-SUBUNIT; VENTRICULAR MYOCYTES; FUNCTIONAL INTERACTIONS; ALPHA-SUBUNIT; ION-TRANSPORT; PUMP FUNCTION; HIGH-AFFINITY; SODIUM-PUMP	Phospholemman (FXYD1), mainly expressed in heart and skeletal muscle, is a member of the FXYD protein family, which has been shown to decrease the apparent K+ and Na+ affinity of Na,K-ATPase (Crambert, G., Fuzesi, M., Garty, H., Karlish, S., and Geering, K. ( 2002) Proc. Natl. Acad. Sci. U. S. A. 99, 11476 11481). In this study, we use the Xenopus oocyte expression system to study the role of phospholemman phosphorylation by protein kinases A and C in the modulation of different Na, K-ATPase isozymes present in the heart. Phosphorylation of phospholemman by protein kinase A has no effect on the maximal transport activity or on the apparent K+ affinity of Na, K-ATPase alpha 1/beta 1 and alpha 2/beta 1 isozymes but increases their apparent Na+ affinity, dependent on phospholemman phosphorylation at Ser(68). Phosphorylation of phospholemman by protein kinase C affects neither the maximal transport activity of alpha 1/beta 1 isozymes nor the K+ affinity of alpha 1/beta 1 and alpha 2/beta 1 isozymes. However, protein kinase C phosphorylation of phospholemman increases the maximal Na, K-pump current of alpha 2/beta 1 isozymes by an increase in their turnover number. Thus, our results indicate that protein kinase A phosphorylation of phospholemman has similar functional effects on Na, K-ATPase alpha 1/beta and alpha 2/beta isozymes and increases their apparent Na+ affinity, whereas protein kinase C phosphorylation of phospholemman modulates the transport activity of Na, K-ATPase alpha 2/beta but not of alpha 1/beta isozymes. The complex and distinct regulation of Na, K-ATPase isozymes by phosphorylation of phospholemman may be important for the efficient control of heart contractility and excitability.	Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland	University of Lausanne	Geering, K (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, 27 Rue du Bugnon, CH-1005 Lausanne, Switzerland.	Kaethi.Geering@unil.ch	Horisberger, Jean-Daniel/A-2538-2009	Bibert, Stephanie/0000-0001-5170-7506				Asahi M, 2000, J BIOL CHEM, V275, P15034, DOI 10.1074/jbc.275.20.15034; Beguin P, 2001, EMBO J, V20, P3993, DOI 10.1093/emboj/20.15.3993; BERLIN JR, 1992, ANN NY ACAD SCI, V671, P440, DOI 10.1111/j.1749-6632.1992.tb43823.x; Bossuyt J, 2005, CIRC RES, V97, P558, DOI 10.1161/01.RES.0000181172.27931.c3; Bossuyt J, 2006, J BIOL CHEM, V281, P32765, DOI 10.1074/jbc.M606254200; Chen LSK, 1997, GENOMICS, V41, P435, DOI 10.1006/geno.1997.4665; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Despa S, 2007, AM J PHYSIOL-CELL PH, V293, pC321, DOI 10.1152/ajpcell.00597.2006; Feschenko MS, 2003, J NEUROSCI, V23, P2161; Fuller W, 2004, FASEB J, V18, P197, DOI 10.1096/fj.03-0213fje; Fuller W, 2006, CIRC RES, V99, P1290, DOI 10.1161/01.RES.0000253090.54488.81; GAO J, 1995, J GEN PHYSIOL, V106, P995, DOI 10.1085/jgp.106.5.995; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 1996, J CELL BIOL, V133, P1193, DOI 10.1083/jcb.133.6.1193; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; GIRARDET M, 1981, BIOCHEMISTRY-US, V20, P6684, DOI 10.1021/bi00526a025; Han F, 2006, CIRC RES, V99, P1376, DOI 10.1161/01.RES.0000251667.73461.fb; Hasler U, 1998, J BIOL CHEM, V273, P30826, DOI 10.1074/jbc.273.46.30826; JAISSER F, 1994, J GEN PHYSIOL, V103, P605, DOI 10.1085/jgp.103.4.605; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; Jia LG, 2005, AM J PHYSIOL-HEART C, V288, pH1982, DOI 10.1152/ajpheart.00142.2004; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; Li CM, 2005, J BIOL CHEM, V280, P42738, DOI 10.1074/jbc.M508451200; Li CM, 2004, J BIOL CHEM, V279, P38895, DOI 10.1074/jbc.M406697200; Lifshitz Y, 2006, J BIOL CHEM, V281, P15790, DOI 10.1074/jbc.M601993200; Mahmmoud YA, 2000, J BIOL CHEM, V275, P35969, DOI 10.1074/jbc.M005168200; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MOGUL DJ, 1989, CIRC RES, V64, P1063, DOI 10.1161/01.RES.64.6.1063; MOORMAN JR, 1995, NATURE, V377, P737, DOI 10.1038/377737a0; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; Pavlovic D, 2007, FASEB J, V21, P1539, DOI 10.1096/fj.06-7269com; Rembold CM, 2005, J VASC RES, V42, P483, DOI 10.1159/000088102; SHULL GE, 1986, NATURE, V321, P429, DOI 10.1038/321429a0; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; Silverman BD, 2005, CARDIOVASC RES, V65, P93, DOI 10.1016/j.cardiores.2004.09.005; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Swift F, 2007, CARDIOVASC RES, V75, P109, DOI 10.1016/j.cardiores.2007.03.017; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; VASILETS LA, 1991, J BIOL CHEM, V266, P16285; WALAAS SI, 1994, BIOCHEM J, V304, P635, DOI 10.1042/bj3040635; Zhang XQ, 2006, J APPL PHYSIOL, V100, P212, DOI 10.1152/japplphysiol.00757.2005	44	87	88	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					476	486		10.1074/jbc.M705830200	http://dx.doi.org/10.1074/jbc.M705830200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17991751	hybrid			2022-12-25	WOS:000251940300053
J	Agca, C; Donkin, SS				Agca, Cansu; Donkin, Shawn S.			Expression of Pyruvate Carboxylase mRNA Variants in Liver of Dairy Cattle at Calving	PLOS ONE			English	Article								Background. Bovine liver expresses six pyruvate carboxylase (PC) transcript variants, bPC5'A, bPC5'B, bPC5'C, bPC5'D, bPC5'E, and bPC5'F, which only differ at the 5' untranslated region (UTR) and contain a common coding region. The objective of this experiment was to determine the profile and abundance of PC transcripts in bovine liver at calving. Methodology/Principal Findings. A ribonuclease protection assay (RPA) protocol was developed to simplify analysis of these variants and investigate the changes in abundance of each 5' UTR transcript relative to total PC mRNA. Liver biopsy samples collected from seven cows on +1 d relative to calving were analyzed by RPA to determine the profile in PC 5' UTR variants. Results show that all six bovine PC 5' UTR variants are detected at calving. Data indicate that bovine PC 5' UTR variant A is the most abundant, variants C and E are least abundant and expression of variants B, D and F is intermediate at calving. Conclusions. This manuscript describes a simplified RPA method that quantifies the abundance of six PC transcripts by using two riboprobes. The lack of uniformity in the pattern of PC 5' UTR variants at calving suggests an additional complexity for control of bovine PC mRNA expression at calving that may be the result of transcriptional controls, variation in mRNA processing, or a combination of these processes.	[Agca, Cansu; Donkin, Shawn S.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Donkin, SS (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	sdonkin@purdue.edu		Donkin, Shawn/0000-0003-3571-4946	Purdue University Agricultural Research Programs [17,457]; USDA Cooperative State Research, Education, and Extension Service [2001-35206-11265];  [NC-1009]	Purdue University Agricultural Research Programs; USDA Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); 	This project was supported in part through funds from the Purdue University Agricultural Research Programs (paper no. 17,457) as a contribution to North Central Regional project NC-1009 and was supported by National Research Initiative Competitive Grant no. 2001-35206-11265 from the USDA Cooperative State Research, Education, and Extension Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agca C, 2004, ANIM BIOTECHNOL, V15, P47, DOI 10.1081/ABIO-120037897; Bradford BJ, 2005, J NUTR, V135, P2206, DOI 10.1093/jn/135.9.2206; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Greenfield RB, 2000, J DAIRY SCI, V83, P1228, DOI 10.3168/jds.S0022-0302(00)74989-7; Hartwell JR, 2001, J DAIRY SCI, V84, P490, DOI 10.3168/jds.S0022-0302(01)74499-2; Jiang HL, 2001, GENE, V265, P45, DOI 10.1016/S0378-1119(01)00356-0; Jitrapakdee S, 2006, CELL MOL LIFE SCI, V63, P843, DOI 10.1007/s00018-005-5410-y; Jitrapakdee S, 1996, BIOCHEM BIOPH RES CO, V223, P695, DOI 10.1006/bbrc.1996.0958; Jitrapakdee S, 2001, BIOCHEM BIOPH RES CO, V287, P411, DOI 10.1006/bbrc.2001.5599; Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001; Jitrapakdee S, 1997, J BIOL CHEM, V272, P20522, DOI 10.1074/jbc.272.33.20522; Jitrapakdee S, 1998, J BIOL CHEM, V273, P34422, DOI 10.1074/jbc.273.51.34422; KrausFriedmann N, 1996, METABOLISM, V45, P389, DOI 10.1016/S0026-0495(96)90296-6; LOPEZCASILLAS F, 1992, METABOLISM, V41, P201, DOI 10.1016/0026-0495(92)90154-3; Parker EM, 1999, J NEUROCHEM, V73, P913, DOI 10.1046/j.1471-4159.1999.0730913.x; PEKHLETSKY RI, 1992, MOL CELL ENDOCRINOL, V90, P103, DOI 10.1016/0303-7207(92)90107-H; REYNOLDS CK, 1988, J DAIRY SCI, V71, P1803, DOI 10.3168/jds.S0022-0302(88)79749-0; She P, 1999, J DAIRY SCI, V82, P1118, DOI 10.3168/jds.S0022-0302(99)75335-X; Velez JC, 2005, J DAIRY SCI, V88, P2938, DOI 10.3168/jds.S0022-0302(05)72974-X; WEINBERG MB, 1979, J BIOL CHEM, V254, P9492	20	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1270	10.1371/journal.pone.0001270	http://dx.doi.org/10.1371/journal.pone.0001270			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060064	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459400017
J	Dong, CZ; Qian, ZL; Jia, PL; Wang, Y; Huang, W; Li, YX				Dong, Changzheng; Qian, Ziliang; Jia, Peilin; Wang, Ying; Huang, Wei; Li, Yixue			Gene-Centric Characteristics of Genome-Wide Association Studies	PLOS ONE			English	Article							CONSERVED ELEMENTS; SNPS; PORTABILITY; SELECTION; COVERAGE; MUTATION; DISEASE; VARIANT; RISK; LOCI	Background. The high-throughput genotyping chips have contributed greatly to genome-wide association (GWA) studies to identify novel disease susceptibility single nucleotide polymorphisms ( SNPs). The high-density chips are designed using two different SNP selection approaches, the direct gene-centric approach, and the indirect quasi-random SNPs or linkage disequilibrium (LD)-based tagSNPs approaches. Although all these approaches can provide high genome coverage and ascertain variants in genes, it is not clear to which extent these approaches could capture the common genic variants. It is also important to characterize and compare the differences between these approaches. Methodology/Principal Findings. In our study, by using both the Phase II HapMap data and the disease variants extracted from OMIM, a gene-centric evaluation was first performed to evaluate the ability of the approaches in capturing the disease variants in Caucasian population. Then the distribution patterns of SNPs were also characterized in genic regions, evolutionarily conserved introns and nongenic regions, ontologies and pathways. The results show that, no mater which SNP selection approach is used, the current high-density SNP chips provide very high coverage in genic regions and can capture most of known common disease variants under HapMap frame. The results also show that the differences between the direct and the indirect approaches are relatively small. Both have similar SNP distribution patterns in these gene-centric characteristics. Conclusions/Significance. This study suggests that the indirect approaches not only have the advantage of high coverage but also are useful for studies focusing on various functional SNPs either in genes or in the conserved regions that the direct approach supports. The study and the annotation of characteristics will be helpful for designing and analyzing GWA studies that aim to identify genetic risk factors involved in common diseases, especially variants in genes and conserved regions.	[Dong, Changzheng; Wang, Ying; Huang, Wei] Chinese Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China; [Dong, Changzheng; Qian, Ziliang; Jia, Peilin; Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Bioinformat Ctr, Shanghai, Peoples R China; [Dong, Changzheng; Qian, Ziliang; Jia, Peilin] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Huang, Wei] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai 200030, Peoples R China; [Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences	Huang, W (corresponding author), Chinese Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China.	huangwei@chgc.sh.cn; yxli@sibs.ac.cn	Jia, Peilin/B-4519-2013		National Basic Research Program of China [2006CB910700, 2004CB720103, 2004CB518606, 2003CB715901, 2004CB518605]; National High-Tech RD Program (863) [2006AA02Z334]; National Science Fund for Distinguished Young Scholars [30625019]; Chinese High-Tech Program [2006AA020706]; Shanghai Science and Technology Committee [06XD14015]	National Basic Research Program of China(National Basic Research Program of China); National High-Tech RD Program (863)(National High Technology Research and Development Program of China); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Chinese High-Tech Program; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	YL was supported by grants from National Basic Research Program of China (2006CB910700, 2004CB720103, 2004CB518606, 2003CB715901) and National High-Tech R&D Program (863)(2006AA02Z334). WH was supported by National Science Fund for Distinguished Young Scholars ( 30625019), the National Basic Research Program (2004CB518605), Chinese High-Tech Program (2006AA020706), and Shanghai Science and Technology Committee (06XD14015). None of these institutions play any direct or indirect role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Akey JM, 2001, HUM GENET, V108, P516, DOI 10.1007/s004390100524; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; [Anonymous], ONLINE MENDELIAN INH; [Anonymous], DBSNP; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auro K, 2007, PLOS GENET, V3, P1244, DOI 10.1371/journal.pgen.0030120; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Bielinsky AK, 2001, CURR BIOL, V11, P1427, DOI 10.1016/S0960-9822(01)00444-4; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; Fredman D, 2002, NUCLEIC ACIDS RES, V30, P387, DOI 10.1093/nar/30.1.387; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gonzalez-Neira A, 2006, GENOME RES, V16, P323, DOI 10.1101/gr.4138406; Grice EA, 2005, HUM MOL GENET, V14, P3837, DOI 10.1093/hmg/ddi408; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Huang W, 2006, P NATL ACAD SCI USA, V103, P1418, DOI 10.1073/pnas.0510360103; Hughes JR, 2005, P NATL ACAD SCI USA, V102, P9830, DOI 10.1073/pnas.0503401102; JARUZELSKA J, 1995, J BIOL CHEM, V270, P20370, DOI 10.1074/jbc.270.35.20370; Jorgenson E, 2006, NAT REV GENET, V7, P885, DOI 10.1038/nrg1962; Kanchisa M., 2006, NUCLEIC ACIDS RES, V34, pD354; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; Nicolae DL, 2006, PLOS GENET, V2, P665, DOI 10.1371/journal.pgen.0020067; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; PROIA RL, 1982, P NATL ACAD SCI-BIOL, V79, P6360, DOI 10.1073/pnas.79.20.6360; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shin JT, 2005, NUCLEIC ACIDS RES, V33, P5437, DOI 10.1093/nar/gki853; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Tantoso E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-238; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Willer CJ, 2006, GENET EPIDEMIOL, V30, P180, DOI 10.1002/gepi.20131; Wiltshire S, 2006, EUR J HUM GENET, V14, P1209, DOI 10.1038/sj.ejhg.5201678; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; YOSHIDA A, 1984, P NATL ACAD SCI-BIOL, V81, P258, DOI 10.1073/pnas.81.1.258; NHLBI PROGRAM GENOMI; ENTREZ GENE	47	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1262	10.1371/journal.pone.0001262	http://dx.doi.org/10.1371/journal.pone.0001262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060058	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459400011
J	Dong, T; Moran, E; Nguyen, VC; Simmons, C; Luhn, K; Peng, YC; Wills, B; Nguyen, PD; Le, TTT; Tran, TH; McMichael, A; Farrar, J; Rowland-Jones, S				Dong, Tao; Moran, Edward; Nguyen Vinh Chau; Simmons, Cameron; Luhn, Kerstin; Peng, Yanchun; Wills, Bridget; Nguyen Phuong Dung; Le Thi Thu Thao; Tran Tinh Hien; McMichael, Andrew; Farrar, Jeremy; Rowland-Jones, Sarah			High Pro-Inflammatory Cytokine Secretion and Loss of High Avidity Cross-Reactive Cytotoxic T-Cells during the Course of Secondary Dengue Virus Infection	PLOS ONE			English	Article							ORIGINAL ANTIGENIC SIN; FACTOR-ALPHA LEVELS; ANTIBODY-RESPONSE; LYMPHOCYTES; ACTIVATION; CTL; PATHOGENESIS; APOPTOSIS; DELETION; IMMUNOPATHOGENESIS	Background. Dengue is one of the most important human diseases transmitted by an arthropod vector and the incidence of dengue virus infection has been increasing - over half the world's population now live in areas at risk of infection. Most infections are asymptomatic, but a subset of patients experience a potentially fatal shock syndrome characterised by plasma leakage. Severe forms of dengue are epidemiologically associated with repeated infection by more than one of the four dengue virus serotypes. Generally attributed to the phenomenon of antibody-dependent enhancement, recent observations indicate that T-cells may also influence disease phenotype. Methods and Findings. Virus-specific cytotoxic T lymphocytes (CTL) showing high level cross reactivity between dengue serotypes could be expanded from blood samples taken during the acute phase of secondary dengue infection. These could not be detected in convalescence when only CTL populations demonstrating significant serotype specificity were identified. Dengue cross-reactive CTL clones derived from these patients were of higher avidity than serotype-specific clones and produced much higher levels of both type 1 and certain type 2 cytokines, many previously implicated in dengue pathogenesis. Conclusion. Dengue serotype cross-reactive CTL clones showing high avidity for antigen produce higher levels of inflammatory cytokines than serotype-specific clones. That such cells cannot be expanded from convalescent samples suggests that they may be depleted, perhaps as a consequence of activation-induced cell death. Such high avidity cross-reactive memory CTL may produce inflammatory cytokines during the course of secondary infection, contributing to the pathogenesis of vascular leak. These cells appear to be subsequently deleted leaving a more serotype-specific memory CTL pool. Further studies are needed to relate these cellular observations to disease phenotype in a large group of patients. If confirmed they have significant implications for understanding the role of virus-specific CTL in pathogenesis of dengue disease.	[Dong, Tao; Moran, Edward; Luhn, Kerstin; Peng, Yanchun; McMichael, Andrew; Rowland-Jones, Sarah] John Radcliffe Hosp, Weatherall Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DU, England; [Simmons, Cameron; Wills, Bridget; Nguyen Phuong Dung; Farrar, Jeremy] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam; [Nguyen Vinh Chau; Le Thi Thu Thao; Tran Tinh Hien] Hosp Trop Dis, Ho Chi Minh City, Vietnam	University of Oxford; University of Oxford	Dong, T (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DU, England.	tao.dong@imm.ox.ac.uk; edward.moran@imm.ox.ac.uk	Simmons, Cameron P/ABA-3896-2021; Farrar, Jeremy J./HGA-7610-2022	Simmons, Cameron P/0000-0002-9039-7392; Wills, Bridget/0000-0001-9086-8804; Farrar, Jeremy/0000-0002-2700-623X; Dong, Tao/0000-0003-3545-3758	Medical Research Council, UK; Wellcome Trust; European Molecular Biology Organisation; Medical Research Council [MC_U137884180, G0600520] Funding Source: researchfish; MRC [MC_U137884180, G0600520] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Molecular Biology Organisation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council, UK ( T. D., Y. C. P., A. M., S. R. J.) and the Wellcome Trust (N. V. C, C. S., B. W., N. P. D., J. F.). K. L. has a long-term fellowship from the European Molecular Biology Organisation. E. M. is a Wellcome Trust Clinical Research Training fellow.	Alexander-Miller MA, 1998, J EXP MED, V188, P1391, DOI 10.1084/jem.188.8.1391; AlexanderMiller MA, 1996, P NATL ACAD SCI USA, V93, P4102, DOI 10.1073/pnas.93.9.4102; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Bashyam HS, 2006, J IMMUNOL, V176, P2817, DOI 10.4049/jimmunol.176.5.2817; Brehm MA, 2004, CELL MICROBIOL, V6, P411, DOI 10.1111/j.1462-5822.2004.00390.x; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Choi EML, 2003, J IMMUNOL, V171, P5116, DOI 10.4049/jimmunol.171.10.5116; Dong T, 1996, EUR J IMMUNOL, V26, P335, DOI 10.1002/eji.1830260210; Dong T, 2004, J EXP MED, V200, P1547, DOI 10.1084/jem.20032044; Drake DR, 2005, J IMMUNOL, V175, P1507, DOI 10.4049/jimmunol.175.3.1507; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311; HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830; HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324; Hober D, 1998, J MED VIROL, V54, P210, DOI 10.1002/(SICI)1096-9071(199803)54:3&lt;210::AID-JMV12&gt;3.0.CO;2-L; KANMITCHELL JBB, 2004, J IMMUNOL       0401, P5249; Kittigul L, 2000, J VIROL METHODS, V90, P51, DOI 10.1016/S0166-0934(00)00215-9; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; KURANE I, 1991, J CLIN INVEST, V88, P1473, DOI 10.1172/JCI115457; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; MA H, 2000, J IMMUNOL       0601, P5698; Ma HL, 2001, CELL IMMUNOL, V214, P89, DOI 10.1006/cimm.2001.1884; McKee MD, 2005, J TRANSL MED, V3, P1, DOI 10.1186/1479-5876-3-35; Molldrem JJ, 2003, J CLIN INVEST, V111, P639, DOI 10.1172/JCI200316398; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500; Mustafa AS, 2001, FEMS IMMUNOL MED MIC, V30, P229, DOI 10.1111/j.1574-695X.2001.tb01575.x; Perez AB, 2004, J MED VIROL, V73, P230, DOI 10.1002/jmv.20080; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Price DA, 1998, CURR BIOL, V8, P355, DOI 10.1016/S0960-9822(98)70138-1; Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]; Rothman AL, 2003, ADV VIRUS RES, V60, P397, DOI 10.1016/S0065-3527(03)60010-2; Rothman AL, 1999, VIROLOGY, V257, P1, DOI 10.1006/viro.1999.9656; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005; Snyder JT, 2003, CURR HIV RES, V1, P287, DOI 10.2174/1570162033485230; Speiser DE, 1996, EUR J IMMUNOL, V26, P3055, DOI 10.1002/eji.1830261235; Sytwu HK, 1996, IMMUNITY, V5, P17, DOI 10.1016/S1074-7613(00)80306-4; Tanchot C, 1998, IMMUNITY, V8, P581, DOI 10.1016/S1074-7613(00)80563-4; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vaughn DW, 1999, AM J TROP MED HYG, V60, P693, DOI 10.4269/ajtmh.1999.60.693; Vazquez S, 2003, CLIN DIAGN LAB IMMUN, V10, P1074, DOI 10.1128/CDLI.10.6.1074-1077.2003; WHO, 1997, DENG HAEM FEV DIAGN; Xu XN, 2001, IMMUNITY, V14, P591, DOI 10.1016/S1074-7613(01)00133-9; Zeh HJ, 1999, J IMMUNOL, V162, P989; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0; Zivny J, 1999, J IMMUNOL, V163, P2754	51	76	76	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1192	10.1371/journal.pone.0001192	http://dx.doi.org/10.1371/journal.pone.0001192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060049	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459400001
J	von Ahlfen, S; Missel, A; Bendrat, K; Schlumpberger, M				von Ahlfen, Silke; Missel, Andreas; Bendrat, Klaus; Schlumpberger, Martin			Determinants of RNA Quality from FFPE Samples	PLOS ONE			English	Article								The large archives of formalin-fixed paraffin-embedded (FFPE) tissue specimens that exist are a highly valuable source of sample material for molecular biological analysis, including gene expression profiling. However, current data on adverse effects of standard pathological practice on the usefulness of biomolecular analytes obtained from such archived specimens is largely anecdotal. Here, we present a systematic examination of the most relevant parameters for integrity and useability of RNA obtained from FFPE samples, including storage time and conditions, fixation time, and specimen size. The results are particularly relevant for any application relying on cDNA synthesis as an initial step of the procedure, such as RT-PCR, and microarray analysis.	[von Ahlfen, Silke; Missel, Andreas; Schlumpberger, Martin] QIAGEN GmbH, Hilden, Germany	QIAGEN GmbH	Schlumpberger, M (corresponding author), QIAGEN GmbH, Hilden, Germany.	martin.schlumpberger@qiagen.com			QIAGEN GmbH	QIAGEN GmbH	SvA, AM, and MS are employees of QIAGEN GmbH.	Bhudevi B, 2003, J VIROL METHODS, V109, P25, DOI 10.1016/S0166-0934(03)00040-5; BRESTERS D, 1994, J VIROL METHODS, V48, P267, DOI 10.1016/0166-0934(94)90125-2; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; DEMPSTER WT, 1960, AM J ANAT, V107, P59, DOI 10.1002/aja.1001070105; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Krafft AE, 1997, MOL DIAGN, V2, P217, DOI 10.1016/S1084-8592(97)80032-X; KRAUS E, 1976, H-S Z PHYSIOL CHEM, V357, P233; Lewis F, 2001, J PATHOL, V195, P66, DOI 10.1002/1096-9896(200109)195:1<66::AID-PATH921>3.0.CO;2-F; Macabeo-Ong M, 2002, MODERN PATHOL, V15, P979, DOI 10.1097/01.MP.0000026054.62220.FC; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Werner M, 2000, AM J SURG PATHOL, V24, P1016, DOI 10.1097/00000478-200007000-00014	12	257	267	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1261	10.1371/journal.pone.0001261	http://dx.doi.org/10.1371/journal.pone.0001261			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060057	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459400010
J	Koo, BK; Yoon, MJ; Yoon, KJ; Im, SK; Kim, YY; Kim, CH; Suh, PG; Jan, YN; Kong, YY				Koo, Bon-Kyoung; Yoon, Mi-Jeong; Yoon, Ki-Jun; Im, Sun-Kyoung; Kim, Yoon-Young; Kim, Cheol-Hee; Suh, Pann-Ghill; Jan, Yuh Nung; Kong, Young-Yun			An Obligatory Role of Mind Bomb-1 in Notch Signaling of Mammalian Development	PLOS ONE			English	Article								Background. The Notch signaling pathway is an evolutionarily conserved intercellular signaling module essential for cell fate specification that requires endocytosis of Notch ligands. Structurally distinct E3 ubiquitin ligases, Neuralized (Neur) and Mind bomb (Mib), cooperatively regulate the endocytosis of Notch ligands in Drosophila. However, the respective roles of the mammalian E3 ubiquitin ligases, Neur1, Neur2, Mib1, and Mib2, in mammalian development are poorly understood. Methodology/Principal Findings. Through extensive use of mammalian genetics, here we show that Neur1 and Neur2 double mutants and Mib2 2/2 mice were viable and grossly normal. In contrast, conditional inactivation of Mib1 in various tissues revealed the representative Notch phenotypes: defects of arterial specification as deltalike4 mutants, abnormal cerebellum and skin development as jagged1 conditional mutants, and syndactylism as jagged2 mutants. Conclusions/Significance. Our data provide the first evidence that Mib1 is essential for Jagged as well as Deltalike ligand-mediated Notch signaling in mammalian development, while Neur1, Neur2, and Mib2 are dispensable.	[Koo, Bon-Kyoung; Yoon, Mi-Jeong; Yoon, Ki-Jun; Im, Sun-Kyoung; Kim, Yoon-Young; Suh, Pann-Ghill; Kong, Young-Yun] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, Kyungbuk, South Korea; [Kim, Cheol-Hee] Chungnam Natl Univ, Dept Biol, Taejon, South Korea; [Jan, Yuh Nung] Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA USA; [Jan, Yuh Nung] Univ Calif San Francisco, Dept Biochem, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Pohang University of Science & Technology (POSTECH); Chungnam National University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Kong, YY (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, Kyungbuk, South Korea.	ykong@postech.ac.kr	Yoon, Ki-Jun/S-8170-2018; Koo, Bon-Kyoung/V-5219-2017; Suh, Pann-Ghill/F-3610-2010	Koo, Bon-Kyoung/0000-0002-4134-8033; Jan, Yuh Nung/0000-0003-1367-6299; Yoon, Ki-Jun/0000-0003-2985-2541; Kim, Cheol-Hee/0000-0002-3019-0699	Ministry of Science and Technology, the Republic of Korea [M103KV010021-06K220102110]; Ministry of Science & Technology in Korea [FG06-42-1]; Korea Science and Engineering Foundation	Ministry of Science and Technology, the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of KoreaMinistry of Science & Technology (MOST), Republic of Korea); Ministry of Science & Technology in Korea(Ministry of Science & Technology (MOST), Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This research was supported by a grant (M103KV010021-06K220102110) from Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Science and Technology, the Republic of Korea. This work was also supported by (FG06-42-1) of the 21C Frontier Functional Human Genome Project from the Ministry of Science & Technology in Korea and the Vascular System Research center grant from the Korea Science and Engineering Foundation	Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Barsi JC, 2005, MECH DEVELOP, V122, P1106, DOI 10.1016/j.mod.2005.06.005; BOULIANNE GL, 1991, EMBO J, V10, P2975, DOI 10.1002/j.1460-2075.1991.tb07848.x; Commisso C, 2007, MOL BIOL CELL, V18, P1, DOI 10.1091/mbc.E06-08-0753; Deblandre GA, 2001, DEV CELL, V1, P795, DOI 10.1016/S1534-5807(01)00091-0; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Fitzgerald K, 1995, DEVELOPMENT, V121, P4275; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Klein AL, 2004, DEV BIOL, V266, P161, DOI 10.1016/j.ydbio.2003.10.017; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Lai EC, 2005, DEVELOPMENT, V132, P2319, DOI 10.1242/dev.01825; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Le Borgne R, 2005, PLOS BIOL, V3, P688, DOI 10.1371/journal.pbio.0030096; Lind D, 2005, J NEUROSCI RES, V79, P295, DOI 10.1002/jnr.20354; Lutolf S, 2002, DEVELOPMENT, V129, P373; Macias D, 1997, DEVELOPMENT, V124, P1109; Pan YH, 2005, DEV BIOL, V286, P472, DOI 10.1016/j.ydbio.2005.08.037; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Parks AL, 2000, DEVELOPMENT, V127, P1373; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Pitsouli C, 2005, DEVELOPMENT, V132, P4041, DOI 10.1242/dev.01979; Ruan YL, 2001, P NATL ACAD SCI USA, V98, P9907, DOI 10.1073/pnas.171321098; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Sidow A, 1997, NATURE, V389, P722, DOI 10.1038/39587; Song R, 2006, J BIOL CHEM, V281, P36391, DOI 10.1074/jbc.M606601200; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Sun X, 1996, DEVELOPMENT, V122, P2465; Sun X, 1997, DEVELOPMENT, V124, P3439; Vollrath B, 2001, MOL CELL BIOL, V21, P7481, DOI 10.1128/MCB.21.21.7481-7494.2001; Weller M, 2006, DEV NEUROSCI-BASEL, V28, P70, DOI 10.1159/000090754; WHEATLEY SC, 1993, DEVELOPMENT, V119, P295; Yamamoto N, 2003, CURR BIOL, V13, P333, DOI 10.1016/S0960-9822(03)00081-2; Yeh E, 2001, CURR BIOL, V11, P1675, DOI 10.1016/S0960-9822(01)00527-9; Zhang CJ, 2007, DEV BIOL, V305, P14, DOI 10.1016/j.ydbio.2007.01.034; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738	47	95	96	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1221	10.1371/journal.pone.0001221	http://dx.doi.org/10.1371/journal.pone.0001221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043734	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459300008
J	Mutschelknauss, M; Kummer, M; Muser, J; Feinstein, SB; Meyer, PM; Biedermann, BC				Mutschelknauss, Marcus; Kummer, Marco; Muser, Juergen; Feinstein, Steve B.; Meyer, Peter M.; Biedermann, Barbara C.			Individual Assessment of Arteriosclerosis by Empiric Clinical Profiling	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; RISK-ASSESSMENT STRATEGIES; CORONARY-HEART-DISEASE; CARDIOVASCULAR EVENTS; VULNERABLE PATIENT; BIOMARKERS; PREDICTION; OBESITY; ATHEROSCLEROSIS; DEFINITIONS	Background. Arteriosclerosis is a common cause of chronic morbidity and mortality. Myocardial infarction, stroke or other cardiovascular events identify vulnerable patients who suffer from symptomatic arteriosclerosis. Biomarkers to identify vulnerable patients before cardiovascular events occur are warranted to improve care for affected individuals. We tested how accurately basic clinical data can describe and assess the activity of arteriosclerosis in the individual patient. Methodology/Principal Findings. 269 in-patients who were treated for various conditions at the department of general medicine of an academic tertiary care center were included in a cross-sectional study. Personal history and clinical examination were obtained. When paraclinical tests were performed, the results were added to the dataset. The numerical variables in the clinical examination were statistically compared between patients with proven symptomatic arteriosclerosis (n = 100) and patients who had never experienced cardiovascular events in the past (n = 110). 25 variables were different between these two patient groups and contributed to the disease activity score. The percentile distribution of these variables defined the empiric clinical profile. Anthropometric data, signs of arterial, cardiac and renal disease, systemic inflammation and health economics formed the major categories of the empiric clinical profile that described an individual patient's disease activity. The area under the curve of the receiver operating curve for symptomatic arteriosclerosis was 0.891 (95% CI 0.799-0.983) for the novel disease activity score compared to 0.684 (95% CI 0.600-0.769) for the 10-year risk calculated according to the Framingham score. In patients suffering from symptomatic arteriosclerosis, the disease activity score deteriorated more rapidly after two years of follow-up (from 1.25 to 1.48, P = 0.005) compared to age- and sex-matched individuals free of cardiovascular events (from 1.09 to 1.19, P = 0.125). Conclusions/Significance. Empiric clinical profiling and the disease activity score that are based on accessible, available and affordable clinical data are valid markers for symptomatic arteriosclerosis.	[Biedermann, Barbara C.] Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland; [Mutschelknauss, Marcus; Kummer, Marco; Muser, Juergen] Kantonsspital Bruderholz, Univ Dept Med, Bruderholz, Switzerland; [Feinstein, Steve B.; Meyer, Peter M.] Rush Univ, Med Ctr, Dept Prevent Med, Chicago, IL 60612 USA	University of Basel; Kantonsspital Baselland; Rush University	Biedermann, BC (corresponding author), Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland.	barbara.biedermann@ksbh.ch			Swiss National Science Foundation [3200-664121]; SCORE-Fellowship; European Union [LSHM-CT-2004-005206]; Stiftung fur Medizinische Forschung, Basel, Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SCORE-Fellowship; European Union(European Commission); Stiftung fur Medizinische Forschung, Basel, Switzerland	This work was supported by the Swiss National Science Foundation (Grant-Nr. 3200-664121, SCORE-Fellowship to BCB), by the European Union MOLSTROKE (Molecular basis of vascular events leading to thrombotic stroke) project, LSHM-CT-2004-005206, and by the Stiftung fur Medizinische Forschung, Basel, Switzerland. The funding source had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Burke AP, 2003, J AM COLL CARDIOL, V41, p240A; Carr MC, 2004, J CLIN ENDOCR METAB, V89, P2601, DOI 10.1210/jc.2004-0432; Chade AR, 2005, HYPERTENSION, V45, P1042, DOI 10.1161/01.HYP.0000167121.14254.a0; Clement DL, 2003, NEW ENGL J MED, V348, P2407, DOI 10.1056/NEJMoa022273; Doobay AV, 2005, ARTERIOSCL THROM VAS, V25, P1463, DOI 10.1161/01.ATV.0000168911.78624.b7; Einstein AJ, 2007, CIRCULATION, V116, P1290, DOI 10.1161/CIRCULATIONAHA.107.688101; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Fleming C, 2005, ANN INTERN MED, V142, P203, DOI 10.7326/0003-4819-142-3-200502010-00012; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hayoz D, 2005, J INTERN MED, V258, P238, DOI 10.1111/j.1365-2796.2005.01536.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Mark Daniel B., 2003, Journal of the American College of Cardiology, V41, P1906, DOI 10.1016/S0735-1097(03)00362-0; McDermott MM, 2001, J GEN INTERN MED, V16, P384, DOI 10.1046/j.1525-1497.2001.016006384.x; Naghavi M, 2003, CIRCULATION, V108, P1772, DOI 10.1161/01.CIR.0000087481.55887.C9; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; NAGHAVI M, 2006, AM J CARDIOL, V98, P2, DOI DOI 10.1016/J.AMJCARD.2006.03.002; Ohman EM, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.11.004; Pasternak Richard C., 2003, Journal of the American College of Cardiology, V41, P1863, DOI 10.1016/S0735-1097(03)00358-9; Pradhan AD, 2002, JAMA-J AM MED ASSOC, V288, P980, DOI 10.1001/jama.288.8.980; Redberg Rita F., 2003, Journal of the American College of Cardiology, V41, P1886, DOI 10.1016/S0735-1097(03)00360-7; Revkin JH, 2007, PHARMACOL REV, V59, P40, DOI 10.1124/pr.59.1.1; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Stoll M, 2001, SCIENCE, V294, P1723, DOI 10.1126/science.1062117; Sukhija R, 2005, AM J CARDIOL, V96, P825, DOI 10.1016/j.amjcard.2005.05.029; VANGAAL LF, 1989, J AM COLL NUTR, V8, P504; Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Wilson PW, 2003, J AM COLL CARDIOL, V41, p267A; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	36	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1215	10.1371/journal.pone.0001215	http://dx.doi.org/10.1371/journal.pone.0001215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043731	gold, Green Submitted, Green Published			2022-12-25	WOS:000207459300005
J	Pinto, J; Lynd, A; Vicente, JL; Santolamazza, F; Randle, NP; Gentile, G; Moreno, M; Simard, F; Charlwood, JD; do Rosario, VE; Caccone, A; della Torre, A; Donnelly, MJ				Pinto, Joaeo; Lynd, Amy; Vicente, Jose L.; Santolamazza, Federica; Randle, Nadine P.; Gentile, Gabriele; Moreno, Marta; Simard, Frederic; Charlwood, Jacques Derek; do Rosario, Virgilio E.; Caccone, Adalgisa; della Torre, Alessandra; Donnelly, Martin J.			Multiple Origins of Knockdown Resistance Mutations in the Afrotropical Mosquito Vector Anopheles gambiae	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; INSECTICIDE RESISTANCE; STATISTICAL-METHOD; MOLECULAR-FORMS; KDR MUTATION; DIFFERENTIATION; S.S.; POPULATIONS; IDENTIFICATION; COALESCENT	How often insecticide resistance mutations arise in natural insect populations is a fundamental question for understanding the evolution of resistance and also for modeling its spread. Moreover, the development of resistance is regarded as a favored model to study the molecular evolution of adaptive traits. In the malaria vector Anopheles gambiae two point mutations (L1014F and L1014S) in the voltage-gated sodium channel gene, that confer knockdown resistance (kdr) to DDT and pyrethroid insecticides, have been described. In order to determine whether resistance alleles result from single or multiple mutation events, genotyping of the kdr locus and partial sequencing of the upstream intron-1 was performed on a total of 288 A. gambiae S-form collected from 28 localities in 15 countries. Knockdown resistance alleles were found to be widespread in West Africa with co-occurrence of both 1014S and 1014F in West-Central localities. Differences in intron-1 haplotype composition suggest that kdr alleles may have arisen from at least four independent mutation events. Neutrality tests provided evidence for a selective sweep acting on this genomic region, particularly in West Africa. The frequency and distribution of these kdr haplotypes varied geographically, being influenced by an interplay between different mutational occurrences, gene flow and local selection. This has important practical implications for the management and sustainability of malaria vector control programs.	[Pinto, Joaeo; Vicente, Jose L.; do Rosario, Virgilio E.] Inst Higiene & Med Trop, Ctr Malaria & Outras Doencas Tropicais, Lisbon, Portugal; [Pinto, Joaeo; Lynd, Amy; Randle, Nadine P.; Donnelly, Martin J.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [Santolamazza, Federica; della Torre, Alessandra] Univ Roma La Sapienza, Dipartimento Sci Sanita Pubbl, Sez Parassitol, Ist Pasteur,Fdn Cecni Bolognetti, Rome, Italy; [Gentile, Gabriele] Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy; [Moreno, Marta] Inst Salud Carlos III, Ctr Nacl Med Trop, Madrid, Spain; [Simard, Frederic] Org Coordinat Lutte Endemies Afr Cent, Yaounde, Cameroon; [Simard, Frederic] Inst Rech Dev, Yaounde, Cameroon; [Charlwood, Jacques Derek] DBL Inst Hlth Res & Dev, Charlottenlund, Denmark; [Caccone, Adalgisa] Yale Univ, Yale Inst Biospher Studies, New Haven, CT USA; [Caccone, Adalgisa] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Liverpool School of Tropical Medicine; University of Liverpool; Sapienza University Rome; University of Rome Tor Vergata; Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); Institut de Recherche pour le Developpement (IRD); Yale University; Yale University	Pinto, J (corresponding author), Inst Higiene & Med Trop, Ctr Malaria & Outras Doencas Tropicais, Lisbon, Portugal.	jpinto@ihmt.unl.pt	Lynd, Amy/C-8938-2013; SIMARD, Frederic/J-9489-2016; Moreno, Marta/AAW-8848-2020; Caccone, Adalgisa/AAE-4238-2021; Lynd, Amy/AAE-9640-2020; Frederic, SIMARD/AFV-5001-2022; Pinto, Joao/C-2208-2012; Vicente, José/I-2126-2012; Gentile, Gabriele/E-8945-2013; J., Pinto/H-6177-2019	SIMARD, Frederic/0000-0002-2871-5329; Moreno, Marta/0000-0002-9091-5612; Caccone, Adalgisa/0000-0002-8949-9260; Lynd, Amy/0000-0001-6054-0525; Frederic, SIMARD/0000-0002-2871-5329; Pinto, Joao/0000-0001-8572-7708; Gentile, Gabriele/0000-0002-1045-6816; J., Pinto/0000-0001-8572-7708; Donnelly, Martin/0000-0001-5218-1497; Santolamazza, Federica/0000-0001-5029-6733	Foundation of Science and Technology-FEDER, Portugal [POCTI/ESP/44837/2002, SFRH/BPD/10086/2002]; UNICEF/UNDP/World Bank/WHO; YIBS-Ecosave; NIH [NIH RO1AI046018]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046018] Funding Source: NIH RePORTER	Foundation of Science and Technology-FEDER, Portugal; UNICEF/UNDP/World Bank/WHO(World Health Organization); YIBS-Ecosave; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work received financial support by the Foundation of Science and Technology-FEDER, Portugal (POCTI/ESP/44837/2002) and by the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. JP was funded by Foundation of Science and Technology-FEDER, Portugal (SFRH/BPD/10086/2002). AC was also supported by YIBS-Ecosave funds and by the NIH grant NIH RO1AI046018.	Alon M, 2006, INSECT BIOCHEM MOLEC, V36, P71, DOI 10.1016/j.ibmb.2005.10.007; Andreev D, 1999, J MOL EVOL, V48, P615, DOI 10.1007/PL00006504; Anstead JA, 2005, INSECT BIOCHEM MOLEC, V35, P249, DOI 10.1016/j.ibmb.2004.12.004; Chandre F, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P319; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CRANDALL KA, 1993, GENETICS, V134, P959; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Etang J, 2006, AM J TROP MED HYG, V74, P795, DOI 10.4269/ajtmh.2006.74.795; Fanello C, 2003, INSECT MOL BIOL, V12, P241, DOI 10.1046/j.1365-2583.2003.00407.x; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Gentile G, 2004, INSECT MOL BIOL, V13, P371, DOI 10.1111/j.0962-1075.2004.00494.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HUDSON RR, 1985, GENETICS, V111, P147; Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809; Lehmann T, 1998, MOL BIOL EVOL, V15, P264, DOI 10.1093/oxfordjournals.molbev.a025923; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Li N, 2003, GENETICS, V165, P2213; Lynd A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-16; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Newcomb RD, 2005, J MOL EVOL, V60, P207, DOI 10.1007/s00239-004-0104-x; PERRET C, 2006, ATLAS REGIONAL INTEG; Pinto J, 2006, MED VET ENTOMOL, V20, P27, DOI 10.1111/j.1365-2915.2006.00611.x; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; RAYMOND M, 1991, NATURE, V350, P151, DOI 10.1038/350151a0; Reimer LJ, 2005, INSECT MOL BIOL, V14, P683, DOI 10.1111/j.1365-2583.2005.00599.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Slotman MA, 2007, MOL ECOL, V16, P639, DOI 10.1111/j.1365-294X.2006.03172.x; Slotman MA, 2006, AM J TROP MED HYG, V74, P641, DOI 10.4269/ajtmh.2006.74.641; STEPHAN W, 1989, GENETICS, V121, P89, DOI 10.1093/genetics/121.1.89; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591; TAJIMA F, 1989, GENETICS, V123, P585; TEMPLETON AR, 1992, GENETICS, V132, P619; Verhaeghen K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-16; Wandiga SO, 2001, PURE APPL CHEM, V73, P1147, DOI 10.1351/pac200173071147; Weill M, 2000, INSECT MOL BIOL, V9, P451, DOI 10.1046/j.1365-2583.2000.00206.x; Weissmann G, 2006, FASEB J, V20, P2427, DOI 10.1096/fj.06-1201ufm; Yawson AE, 2007, GENETICS, V175, P751, DOI 10.1534/genetics.106.065888	43	93	95	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1243	10.1371/journal.pone.0001243	http://dx.doi.org/10.1371/journal.pone.0001243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043750	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459300024
J	Tsukamoto-Yasui, M; Sasaki, T; Matsumoto, W; Hasegawa, A; Toyoda, T; Usami, A; Kubota, Y; Ochiai, T; Hori, T; Matsuki, N; Ikegaya, Y				Tsukamoto-Yasui, Masako; Sasaki, Takuya; Matsumoto, Wataru; Hasegawa, Ayako; Toyoda, Takeshi; Usami, Atsushi; Kubota, Yuichi; Ochiai, Taku; Hori, Tomokatsu; Matsuki, Norio; Ikegaya, Yuji			Active Hippocampal Networks Undergo Spontaneous Synaptic Modification	PLOS ONE			English	Article								The brain is self-writable; as the brain voluntarily adapts itself to a changing environment, the neural circuitry rearranges its functional connectivity by referring to its own activity. How the internal activity modifies synaptic weights is largely unknown, however. Here we report that spontaneous activity causes complex reorganization of synaptic connectivity without any external (or artificial) stimuli. Under physiologically relevant ionic conditions, CA3 pyramidal cells in hippocampal slices displayed spontaneous spikes with bistable slow oscillations of membrane potential, alternating between the so-called UP and DOWN states. The generation of slow oscillations did not require fast synaptic transmission, but their patterns were coordinated by local circuit activity. In the course of generating spontaneous activity, individual neurons acquired bidirectional long-lasting synaptic modification. The spontaneous synaptic plasticity depended on a rise in intracellular calcium concentrations of postsynaptic cells, but not on NMDA receptor activity. The direction and amount of the plasticity varied depending on slow oscillation patterns and synapse locations, and thus, they were diverse in a network. Once this global synaptic refinement occurred, the same neurons now displayed different patterns of spontaneous activity, which in turn exhibited different levels of synaptic plasticity. Thus, active networks continuously update their internal states through ongoing synaptic plasticity. With computational simulations, we suggest that with this slow oscillation-induced plasticity, a recurrent network converges on a more specific state, compared to that with spike timing-dependent plasticity alone.	[Tsukamoto-Yasui, Masako; Sasaki, Takuya; Matsumoto, Wataru; Hasegawa, Ayako; Toyoda, Takeshi; Usami, Atsushi; Matsuki, Norio; Ikegaya, Yuji] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo, Japan; [Kubota, Yuichi; Ochiai, Taku; Hori, Tomokatsu] Tokyo Womens Med Univ, Dept Neurosurg, Shinjuku Ku, Tokyo, Japan; [Ikegaya, Yuji] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan	University of Tokyo; Tokyo Women's Medical University; Japan Science & Technology Agency (JST)	Ikegaya, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo, Japan.	ikegaya@mol.f.u-tokyo.ac.jp	Sasaki, Takuya/J-3283-2015	Hori, Tomokatsu/0000-0001-7611-896X; Ikegaya, Yuji/0000-0003-2260-8191	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18021008, 17023015, 17650090, 17689004, 19659013]; Sumitomo Foundation [050038]; Takeda Science Foundation; Asahi Glass Foundation; Research Foundation for Pharmaceutical Sciences	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Asahi Glass Foundation; Research Foundation for Pharmaceutical Sciences	Funding: This work was supported in part by a Grant-in-Aid for Science Research on Priority Areas (Elucidation of neural network function in the brain: No. 18021008, No. 17023015), a Grant-in-Aid for Science Research (No. 17650090, No. 17689004, No. 19659013) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Sumitomo Foundation (No. 050038), the Takeda Science Foundation, the Asahi Glass Foundation, and the Research Foundation for Pharmaceutical Sciences.	Amaral David G., 1995, P443; ANIKSZTEJN L, 1991, NATURE, V349, P67, DOI 10.1038/349067a0; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Bains JS, 1999, NAT NEUROSCI, V2, P720, DOI 10.1038/11184; Behrens CJ, 2005, NAT NEUROSCI, V8, P1560, DOI 10.1038/nn1571; BENARI Y, 1988, J PHYSIOL-LONDON, V404, P365, DOI 10.1113/jphysiol.1988.sp017294; Best PJ, 2001, ANNU REV NEUROSCI, V24, P459, DOI 10.1146/annurev.neuro.24.1.459; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bland BH, 2005, EXP NEUROL, V195, P458, DOI 10.1016/j.expneurol.2005.06.007; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; COLOM LV, 1987, BRAIN RES, V422, P277, DOI 10.1016/0006-8993(87)90934-6; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Debanne D, 1999, J NEUROSCI, V19, P10664, DOI 10.1523/JNEUROSCI.19-24-10664.1999; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; EVARTS EV, 1964, J NEUROPHYSIOL, V27, P152, DOI 10.1152/jn.1964.27.2.152; Hahn TTG, 2007, P NATL ACAD SCI USA, V104, P5169, DOI 10.1073/pnas.0700222104; Hahn TTG, 2006, NAT NEUROSCI, V9, P1359, DOI 10.1038/nn1788; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; HOPFIELD JJ, 1982, P NATL ACAD SCI USA, V79, P2558; Hu B, 2005, J NEUROPHYSIOL, V93, P316, DOI 10.1152/jn.00172.2004; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Ivenshitz M, 2006, J NEUROSCI, V26, P1199, DOI 10.1523/JNEUROSCI.2964-05.2006; JONES HC, 1987, J PHYSIOL-LONDON, V383, P441; Kamme F, 2003, J NEUROSCI, V23, P3607; Kirov SA, 1999, J NEUROSCI, V19, P2876; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Le Be JV, 2006, P NATL ACAD SCI USA, V103, P13214, DOI 10.1073/pnas.0604691103; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; McNay EC, 2004, J NEUROSCI METH, V132, P35, DOI 10.1016/j.jneumeth.2003.08.014; Mehta MR, 2007, NAT NEUROSCI, V10, P13, DOI 10.1038/nn0107-13; MOGHADDAM B, 1987, BRAIN RES, V406, P337, DOI 10.1016/0006-8993(87)90803-1; MOGHADDAM B, 1989, J NEUROCHEM, V53, P652, DOI 10.1111/j.1471-4159.1989.tb07383.x; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; NICHOLSON C, 1977, P NATL ACAD SCI USA, V74, P1287, DOI 10.1073/pnas.74.3.1287; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; PSARROPOULOU C, 1990, BRAIN RES, V508, P70, DOI 10.1016/0006-8993(90)91119-2; Raman IM, 1999, ANN NY ACAD SCI, V868, P93, DOI 10.1111/j.1749-6632.1999.tb11279.x; ROBINSON HPC, 1991, BIOPHYS J, V59, P295, DOI 10.1016/S0006-3495(91)82223-8; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; SANSEVERINO E R, 1973, Brain Research, V54, P225; Sasaki T, 2007, J NEUROSCI, V27, P517, DOI 10.1523/JNEUROSCI.4514-06.2007; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SOMJEN GG, 1985, J NEUROPHYSIOL, V53, P1098, DOI 10.1152/jn.1985.53.4.1098; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; Takahashi N, 2007, NEUROSCI RES, V58, P219, DOI 10.1016/j.neures.2007.03.001; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; WILSON CJ, 1981, BRAIN RES, V220, P67, DOI 10.1016/0006-8993(81)90211-0; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; YAMAGUCHI T, 1986, Bulletin of Tokyo Medical and Dental University, V33, P1; Yuste R, 2005, NAT REV NEUROSCI, V6, P477, DOI 10.1038/nrn1686; ZHANG ET, 1990, J CEREBR BLOOD F MET, V10, P136, DOI 10.1038/jcbfm.1990.18; Zhang Y, 1998, J NEUROSCI, V18, P9256	75	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1250	10.1371/journal.pone.0001250	http://dx.doi.org/10.1371/journal.pone.0001250			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043757	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459300031
J	Ohgaki, R; Fukura, N; Matsushita, M; Mitsui, K; Kanazawa, H				Ohgaki, Ryuichi; Fukura, Naomi; Matsushita, Masafumi; Mitsui, Keiji; Kanazawa, Hiroshi			Cell surface levels of organellar Na+/H+ exchanger isoform 6 are regulated by interaction with RACK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; MOLECULAR-CLONING; FUNCTIONAL EXPRESSION; SECRETORY PATHWAY; TOPOLOGY MODEL; PH REGULATION; RECEPTOR; MEMBRANE; GOLGI; TRANSPORT	In mammalian cells, four Na+/H+ exchangers (NHE6-NHE9) are localized to intracellular compartments. NHE6 and NHE9 are predominantly localized to sorting and recycling endosomes, NHE7 to the trans-Golgi network, and NHE8 to the mid-trans-Golgi stacks. The unique localization of NHEs may contribute to establishing organelle-specific pH values and ion homeostasis in cells. Mechanisms underlying the regulation and targeting of organellar NHEs are largely unknown. We identified an interaction between NHE9 and RACK1 (receptor for activated C kinase 1), a cytoplasmic scaffold protein, by yeast two-hybrid screening using the NHE9 C terminus as bait. The NHE9 C terminus is exposed to the cytoplasm, verifying that the interaction is topologically possible. The binding region was further delineated to the central region of the NHE9 C terminus. RACK1 also bound NHE6 and NHE7, but not NHE8, in vitro. Endogenous association between NHE6 and RACK1 was confirmed by co-immunoprecipitation and co-localization in HeLa cells. The luminal pH of the recycling endosome was elevated in RACK1 knockdown cells, accompanied by a decrease in the amount of NHE6 on the cell surface, although the total level of NHE6 was not significantly altered. These results indicate that RACK1 plays a role in regulating the distribution of NHE6 between endosomes and the plasma membrane and contributes to maintaining luminal pH of the endocytic recycling compartments.	[Ohgaki, Ryuichi; Fukura, Naomi; Matsushita, Masafumi; Mitsui, Keiji; Kanazawa, Hiroshi] Osaka Univ, Grad Sch Med, Dept Biol Sci, Osaka 5600043, Japan	Osaka University	Kanazawa, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Biol Sci, Osaka 5600043, Japan.	kanazawa@bio.sci.osaka-u.ac.jp		Ohgaki, Ryuichi/0000-0002-6894-7239				Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Attaphitaya S, 1999, J BIOL CHEM, V274, P4383, DOI 10.1074/jbc.274.7.4383; Baird NR, 1999, J BIOL CHEM, V274, P4377, DOI 10.1074/jbc.274.7.4377; Bajno L, 2000, J CELL BIOL, V149, P697, DOI 10.1083/jcb.149.3.697; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2002, AM J PHYSIOL-CELL PH, V282, pC1031, DOI 10.1152/ajpcell.00420.2001; CARNELL L, 1994, J CELL BIOL, V127, P693, DOI 10.1083/jcb.127.3.693; COSSON P, 1989, J CELL BIOL, V108, P377, DOI 10.1083/jcb.108.2.377; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Futai M, 2000, J EXP BIOL, V203, P107; Gallina A, 2001, VIROLOGY, V283, P7, DOI 10.1006/viro.2001.0855; Kim JH, 1996, J CELL BIOL, V134, P1387, DOI 10.1083/jcb.134.6.1387; Lehoux S, 2001, J BIOL CHEM, V276, P15794, DOI 10.1074/jbc.M100410200; Liedtke CM, 2002, J BIOL CHEM, V277, P22925, DOI 10.1074/jbc.M201917200; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Lin PJC, 2007, CELL SIGNAL, V19, P978, DOI 10.1016/j.cellsig.2006.11.006; Lin PJC, 2005, J CELL SCI, V118, P1885, DOI 10.1242/jcs.02315; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; Miyazaki E, 2001, J BIOL CHEM, V276, P49221, DOI 10.1074/jbc.M106267200; Mourton T, 2001, J BIOL CHEM, V276, P14896, DOI 10.1074/jbc.M010823200; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Nieland TJF, 2004, TRAFFIC, V5, P478, DOI 10.1111/j.1398-9219.2004.00193.x; Numata M, 2001, J BIOL CHEM, V276, P17387, DOI 10.1074/jbc.M101319200; Onishi I, 2007, CELL SIGNAL, V19, P194, DOI 10.1016/j.cellsig.2006.06.011; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Presley JF, 1997, J BIOL CHEM, V272, P13929, DOI 10.1074/jbc.272.21.13929; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; Sato Y, 2005, J BIOCHEM, V138, P425, DOI 10.1093/jb/mvi132; Smith PR, 2000, J VIROL, V74, P3082, DOI 10.1128/JVI.74.7.3082-3092.2000; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; TSE CM, 1993, J BIOL CHEM, V268, P11917; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; Wells KM, 2001, J BIOL CHEM, V276, P3401, DOI 10.1074/jbc.M001688200; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Yamaguchi T, 2003, P NATL ACAD SCI USA, V100, P12510, DOI 10.1073/pnas.2034966100; Yan WH, 2001, J BIOL CHEM, V276, P31349, DOI 10.1074/jbc.M102679200; Yedovitzky M, 1997, J BIOL CHEM, V272, P1417, DOI 10.1074/jbc.272.3.1417; ZEN K, 1992, J CELL BIOL, V119, P99, DOI 10.1083/jcb.119.1.99	45	53	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4417	4429		10.1074/jbc.M705146200	http://dx.doi.org/10.1074/jbc.M705146200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18057008	hybrid			2022-12-25	WOS:000253083500076
J	Aguiar, RS; Lovsin, N; Tanuri, A; Peterlin, BM				Aguiar, Renato S.; Lovsin, Nika; Tanuri, Amilcar; Peterlin, B. Matija			Vpr.A3A chimera inhibits HIV replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RETROVIRAL RESTRICTION; POTENT INHIBITORS; ENZYME APOBEC3G; PROTEINS; VPR; RETROTRANSPOSITION; INFECTION; DNA; HYPERMUTATION	Several APOBEC3 proteins (A3F and A3G), that are cytidine deaminases restrict human immunodeficiency virus (HIV) replication in the absence of the viral infectivity factor (Vif) protein. However, Vif leads to their degradation and counteracts their effects. Another member, A3A, restricts some retrotransposons and another virus but not HIV. Wereasoned that this failure was due to the lack of appropriate targeting. Thus, we fused A3A to another viral protein, Vpr, which binds p6 in Gag and is incorporated into viral cores. Indeed, the Vpr. A3A chimera but not A3A was found abundantly in the viral core. It also restricted potently the replication of HIV and simian immunodeficiency virus in the presence and absence of Vif. Because we identified a high frequency of G to Amutations in viral cDNAs, this antiviral activity was mediated by DNA editing. Interestingly, our fusion protein did not restrict murine leukemia virus, which does not incorporate Vpr. Thus, by targeting appropriately a potent single domain cytidine deaminase, we rendered HIV and simian immunodeficiency virus restriction resistant to Vif.	[Aguiar, Renato S.; Peterlin, B. Matija] Univ Calif San Francisco, Dept Med Microbiol & Immunol, San Francisco, CA 94143 USA; [Lovsin, Nika] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia; [Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, BR-21944970 Rio De Janeiro, Brazil	University of California System; University of California San Francisco; University of Ljubljana; Universidade Federal do Rio de Janeiro	Peterlin, BM (corresponding author), Univ Calif San Francisco, Dept Med Microbiol & Immunol, 533 Parnassus Ave,U422, San Francisco, CA 94143 USA.	matija.peterlin@ucsf.edu	Aguiar, Renato S/G-3542-2015; Tanuri, Amilcar/AAM-8601-2021	Aguiar, Renato S/0000-0001-5180-3717; 	NIGMS NIH HHS [P50 GM082250, P50 GM082250-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chiu YL, 2006, TRENDS IMMUNOL, V27, P291, DOI 10.1016/j.it.2006.04.003; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Costa LJ, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-33; Doehle BP, 2005, J VIROL, V79, P8201, DOI 10.1128/JVI.79.13.8201-8207.2005; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Fletcher TM, 1997, EMBO J, V16, P5123, DOI 10.1093/emboj/16.16.5123; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Goila-Gaur R, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-61; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Kieffer TL, 2005, J VIROL, V79, P1975, DOI 10.1128/JVI.79.3.1975-1980.2005; KONDO E, 1995, J VIROL, V69, P2759, DOI 10.1128/JVI.69.5.2759-2764.1995; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Le Rouzic E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-11; Lee YN, 2007, PLOS PATHOG, V3, P119, DOI 10.1371/journal.ppat.0030010; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Miyagij E, 2007, J VIROL, V81, P13346, DOI 10.1128/JVI.01361-07; Morner A, 1999, J VIROL, V73, P2343; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; Okeoma CM, 2007, NATURE, V445, P927, DOI 10.1038/nature05540; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Schumacher AJ, 2005, P NATL ACAD SCI USA, V102, P9854, DOI 10.1073/pnas.0501694102; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Towers G, 2000, P NATL ACAD SCI USA, V97, P12295, DOI 10.1073/pnas.200286297; Wu XY, 1997, EMBO J, V16, P5113, DOI 10.1093/emboj/16.16.5113; WU XY, 1995, J VIROL, V69, P3389, DOI 10.1128/JVI.69.6.3389-3398.1995; Yao XJ, 1999, GENE THER, V6, P1590, DOI 10.1038/sj.gt.3300988; Yap MW, 2004, P NATL ACAD SCI USA, V101, P10786, DOI 10.1073/pnas.0402876101; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zennou V, 2006, VIROLOGY, V349, P31, DOI 10.1016/j.virol.2005.12.035; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	47	54	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2518	2525		10.1074/jbc.M706436200	http://dx.doi.org/10.1074/jbc.M706436200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18057006	hybrid			2022-12-25	WOS:000252622300008
J	Harwood, FC; Shu, L; Houghton, PJ				Harwood, Franklin C.; Shu, Lili; Houghton, Peter J.			mTORC1 signaling can regulate growth factor activation of p44/42 mitogen-activated protein kinases through protein phosphatase 2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS COMPLEX-1; SARCOMA-CELL-LINES; P70 S6 KINASE; MAP KINASE; MAMMALIAN TARGET; GENE-PRODUCTS; CATALYTIC SUBUNIT; MULTIPLE ROLES; MESSENGER-RNA; OKADAIC ACID	The mTORC1 complex ( mammalian target of rapamycin (mTOR)-raptor) is modulated by mitogen-activated protein (p44/42 MAP) kinases (p44/42) through phosphorylation and inactivation of the tuberous sclerosis complex. However, a role for mTORC1 signaling in modulating activation of p44/42 has not been reported. We show that in two cancer cell lines regulation of the p44/42 MAPKs is mTORC1-dependent. In Rh1 cells rapamycin inhibited insulin-like growth factor-I (IGF-I)-stimulated phosphorylation of Thr(202) but not Tyr(204) and suppressed activation of p44/42 kinase activity. Down-regulation of raptor, which inhibits mTORC1 signaling, had a similar effect to rapamycin in blocking IGF-I- stimulated Tyr204 phosphorylation. Rapamycin did not block maximal phosphorylation of Tyr204 but retarded the rate of dephosphorylation of Tyr204 following IGF-I stimulation. IGF-I stimulation of MEK1 phosphorylation (Ser(217/221)) was not inhibited by rapamycin. Higher concentrations of rapamycin (>= 100 ng/ml) were required to inhibit epidermal growth factor (EGF)induced phosphorylation of p44/42 ( Thr202). Rapamycin-induced inhibition of p44/42 ( Thr202) phosphorylation by IGF-I was reversed by low concentrations of okadaic acid, suggesting involvement of protein phosphatase 2A(PP2A). Both IGF-I and EGF caused dissociation of PP2A catalytic subunit (PP2Ac) from p42. Whereas low concentrations of rapamycin ( 1 ng/ml) inhibited dissociation of PP2Ac after IGF-I stimulation, it required higher concentrations (> 100 ng/ ml) to block EGF-induced dissociation, consistent with the ability for rapamycin to attenuate growth factor-induced activation of p44/42. The effect of rapamycin on IGF-I or insulin activation of p44/42 was recapitulated by amino acid deprivation. Rapamycin effects altering the kinetics of p44/42 phosphorylation were completely abrogated in Rh1mTORrr cells that express a rapamycin-resistant mTOR, whereas the effects of amino acid deprivation were similar in Rh1 and Rh1mTORrr cells. These results indicate complex regulation of p44/42 by phosphatases downstream of mTORC1. This suggests a model in which mTORC1 modulates the phosphorylation of Thr202 on p44/42 MAPKs through direct or indirect regulation of PP2Ac.	[Harwood, Franklin C.; Shu, Lili; Houghton, Peter J.] St Jude Childrens Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Houghton, PJ (corresponding author), St Jude Childrens Hosp, Dept Mol Pharmacol, 332 N Lauderdale St, Memphis, TN 38105 USA.	peter.houghton@stjude.org	Houghton, Peter/E-3265-2011		NATIONAL CANCER INSTITUTE [P01CA023099, R01CA077776] Funding Source: NIH RePORTER; NCI NIH HHS [CA 21675, CA 77776, CA 23099] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Begum N, 1996, J BIOL CHEM, V271, P31166, DOI 10.1074/jbc.271.49.31166; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Braczkowski R, 2002, CANCER-AM CANCER SOC, V95, P1735, DOI 10.1002/cncr.10865; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; CHOU MM, 1995, CURR OPIN CELL BIOL, V7, P806, DOI 10.1016/0955-0674(95)80064-6; Chung HY, 1999, CELL SIGNAL, V11, P575, DOI 10.1016/S0898-6568(99)00033-9; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; DILLING MB, 1994, CANCER RES, V54, P903; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; ELBADRY OM, 1990, CELL GROWTH DIFFER, V1, P325; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Goldberg Y, 1999, BIOCHEM PHARMACOL, V57, P321, DOI 10.1016/S0006-2952(98)00245-7; GOTOH Y, 1990, EUR J BIOCHEM, V193, P671, DOI 10.1111/j.1432-1033.1990.tb19385.x; GRESSNER AM, 1974, BIOCHEM BIOPH RES CO, V60, P1482, DOI 10.1016/0006-291X(74)90365-9; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Hosoi H, 1998, MOL PHARMACOL, V54, P815, DOI 10.1124/mol.54.5.815; Huang SL, 2004, J BIOL CHEM, V279, P36490, DOI 10.1074/jbc.M401208200; Iiboshi Y, 1999, J BIOL CHEM, V274, P1092, DOI 10.1074/jbc.274.2.1092; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Khaleghpour K, 1999, MOL CELL BIOL, V19, P4302; Kloeker S, 2003, PROTEIN EXPRES PURIF, V31, P19, DOI 10.1016/S1046-5928(03)00141-4; Knauf U, 2001, MOL CELL BIOL, V21, P5500, DOI 10.1128/MCB.21.16.5500-5511.2001; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Molhoek KR, 2005, J TRANSL MED, V3, P1, DOI 10.1186/1479-5876-3-39; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; NIELSEN FC, 1995, NATURE, V377, P358, DOI 10.1038/377358a0; Parra JL, 2005, J BIOL CHEM, V280, P37623, DOI 10.1074/jbc.M508356200; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Prickett TD, 2004, J BIOL CHEM, V279, P38912, DOI 10.1074/jbc.M401444200; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Remmelink M, 1998, J CANCER RES CLIN, V124, P155, DOI 10.1007/s004320050149; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Sekulic A, 2000, CANCER RES, V60, P3504; SHAPIRO DN, 1994, J CLIN INVEST, V94, P1235, DOI 10.1172/JCI117441; SMITH MA, 2007, IN PRESS PEDIAT BLOO; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Thimmaiah KN, 2003, CANCER RES, V63, P364; Toretsky JA, 2001, CANCER-AM CANCER SOC, V92, P2941, DOI 10.1002/1097-0142(20011201)92:11<2941::AID-CNCR10072>3.0.CO;2-C; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200	66	22	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2575	2585		10.1074/jbc.M706173200	http://dx.doi.org/10.1074/jbc.M706173200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18056704	hybrid			2022-12-25	WOS:000252622300014
J	Freeman, SN; Ma, YH; Cress, WD				Freeman, Scott N.; Ma, Yihong; Cress, W. Douglas			RhoBTB2 (DBC2) is a mitotic E2F1 target gene with a novel role in apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; TUMOR-SUPPRESSOR GENES; DNA-BINDING DOMAINS; CHROMOSOME ARM 8P; S-PHASE ENTRY; FAMILY-MEMBER; TRANSCRIPTION FACTORS; UBIQUITIN-LIGASE; MICROARRAY ANALYSIS; RB/E2F PATHWAY	We have identified the RhoBTB2 putative tumor suppressor gene as a direct target of the E2F1 transcription factor. Overexpression of E2F1 led to up- regulation of RhoBTB2 at the level of mRNA and protein. This also occurred during the induction of E2F1 activity in the presence of cycloheximide, thus indicating that RhoBTB2 is a direct target. RNAi- mediated knockdown of E2F1 resulted in decreased RhoBTB2 protein expression, demonstrating that RhoBTB2 is a physiological target of E2F1. Because E2F1 primarily serves to transcribe genes involved in cell cycle progression and apoptosis, we explored whether RhoBTB2 played roles in either of these processes. We found RhoBTB2 expression highly up- regulated during mitosis, which was partially dependent on the presence of E2F1. Furthermore, overexpression of RhoBTB2 induced a short term increase in cell cycle progression and proliferation, while long term expression had a negative effect on these processes. We similarly found RhoBTB2 up- regulated during drug- induced apoptosis, with this being primarily dependent on E2F1. Finally, we observed that knockdown of RhoBTB2 levels via siRNA delayed the onset of drug- induced apoptosis. Collectively, we describe RhoBTB2 as a novel direct target of E2F1 with roles in cell cycle and apoptosis.	[Freeman, Scott N.; Ma, Yihong; Cress, W. Douglas] Univ S Florida, Mol Oncol Program, H Lee Moffit Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Freeman, Scott N.; Ma, Yihong; Cress, W. Douglas] Univ S Florida, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA; [Freeman, Scott N.] Univ S Florida, Canc Biol PhD Program, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Cress, WD (corresponding author), 12902 Magnolia Dr, Tampa, FL 33612 USA.	douglas.cress@moffitt.org			NATIONAL CANCER INSTITUTE [R01CA090489] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA090489-05, R01 CA090489] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEIJERSBERGEN RL, 1994, GENE DEV, V8, P2680, DOI 10.1101/gad.8.22.2680; BOVA GS, 1993, CANCER RES, V53, P3869; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Brown MR, 1999, GYNECOL ONCOL, V74, P98, DOI 10.1006/gyno.1999.5439; BUCK V, 1995, ONCOGENE, V11, P31; Cam H, 2003, CANCER CELL, V3, P311, DOI 10.1016/S1535-6108(03)00080-1; Carrassa L, 2003, CELL CYCLE, V2, P604, DOI 10.4161/cc.2.6.503; Cartwright P, 1998, ONCOGENE, V17, P611, DOI 10.1038/sj.onc.1201975; Christensen J, 2005, NUCLEIC ACIDS RES, V33, P5458, DOI 10.1093/nar/gki855; CRESS WD, 1994, J VIROL, V68, P4212, DOI 10.1128/JVI.68.7.4213-4219.1994; de Bruin A, 2003, J BIOL CHEM, V278, P42041, DOI 10.1074/jbc.M308105200; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; DeGregori J, 2006, CURR MOL MED, V6, P739; Di Stefano L, 2003, EMBO J, V22, P6289, DOI 10.1093/emboj/cdg613; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; EMI M, 1992, CANCER RES, V52, P5368; Frame FM, 2006, ONCOGENE, V25, P3258, DOI 10.1038/sj.onc.1209352; FUJIWARA Y, 1993, CANCER RES, V53, P1172; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Gaubatz S, 1998, P NATL ACAD SCI USA, V95, P9190, DOI 10.1073/pnas.95.16.9190; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; GINSBERG D, 1994, GENE DEV, V8, P2665, DOI 10.1101/gad.8.22.2665; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; He YW, 2000, ONCOGENE, V19, P3422, DOI 10.1038/sj.onc.1203682; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; ITOH A, 1995, CELL MOL BIOL RES, V41, P147; IVEYHOYLE M, 1993, MOL CELL BIOL, V13, P7802, DOI 10.1128/MCB.13.12.7802; Johnson DG, 2006, CURR MOL MED, V6, P731; Kalejta RF, 1997, CYTOMETRY, V29, P286, DOI 10.1002/(SICI)1097-0320(19971201)29:4<286::AID-CYTO4>3.0.CO;2-8; KOWALIK TF, 1995, J VIROL, V69, P2491, DOI 10.1128/JVI.69.4.2491-2500.1995; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Logan N, 2005, ONCOGENE, V24, P5000, DOI 10.1038/sj.onc.1208703; Logan N, 2004, ONCOGENE, V23, P5138, DOI 10.1038/sj.onc.1207649; LUNDGREN R, 1992, GENE CHROMOSOME CANC, V4, P16, DOI 10.1002/gcc.2870040103; Ma Y, 2007, ONCOGENE, V26, P3532, DOI 10.1038/sj.onc.1210143; Ma YH, 2003, MOL CANCER THER, V2, P73; Maiti B, 2005, J BIOL CHEM, V280, P18211, DOI 10.1074/jbc.M501410200; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; SHAN B, 1994, MOL CELL BIOL, V14, P8166, DOI 10.1128/MCB.14.12.8166; Siripurapu V, 2005, J MOL BIOL, V346, P83, DOI 10.1016/j.jmb.2004.11.043; Stevens C, 2004, DNA REPAIR, V3, P1071, DOI 10.1016/j.dnarep.2004.03.034; Sunwoo JB, 1996, GENE CHROMOSOME CANC, V16, P164, DOI 10.1002/(SICI)1098-2264(199607)16:3<164::AID-GCC2>3.0.CO;2-X; Trimarchi JM, 1998, P NATL ACAD SCI USA, V95, P2850, DOI 10.1073/pnas.95.6.2850; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Wilkins A, 2004, GENE DEV, V18, P856, DOI 10.1101/gad.1177904; Wistuba II, 1999, CANCER RES, V59, P1973; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; YEE AS, 1987, EMBO J, V6, P2061, DOI 10.1002/j.1460-2075.1987.tb02471.x; Yoshihara T, 2007, BIOCHEM BIOPH RES CO, V358, P1076, DOI 10.1016/j.bbrc.2007.05.037; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	61	24	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2353	2362		10.1074/jbc.M705986200	http://dx.doi.org/10.1074/jbc.M705986200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039672	Green Accepted, hybrid			2022-12-25	WOS:000252501000062
J	Zhao, W; Liu, M; Kirkwood, KL				Zhao, Wenpu; Liu, Min; Kirkwood, Keith L.			p38 alpha stabilizes interleukin-6 mRNA via multiple AU-rich elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; POSTTRANSCRIPTIONAL REGULATION; SECONDARY STRUCTURES; BINDING PROTEINS; GROWTH; CLONING; PATHWAY; BIOSYNTHESIS; DEGRADATION	AU-rich elements (AREs) in the 3'- untranslated region (UTR) of unstable mRNA dictate their degradation or mediate translational repression. Cell signaling through p38 alpha MAPK is necessary for post-transcriptional regulation of many pro-inflammatory cytokines. Here, the cis-acting elements of interleukin-6 (IL-6) 3'-UTR mRNA that required p38 alpha signaling for mRNA stability and translation were identified. Using mouse embryonic fibroblasts (MEFs) derived from p38 alpha(+/+) and p38 alpha(-/-) mice, we observed that p38 alpha is obligatory for the IL-1-induced IL-6 biosynthesis. IL-6 mRNA stability is promoted by p38 alpha via 3'-UTR. To understand the mechanism of cis-elements regulated by p38 alpha at post-transcriptional level, truncation of 3'-UTR and the full-length 3'-UTR with individual AUUUA motif mutation placed in gene reporter system was employed. Mutation-based screen performed in p38 alpha(+/+) and p38 alpha(-/-) mouse embryonic fibroblast cells revealed that ARE1, ARE2, and ARE5 in IL-6 3'-UTR were targeted by p38 alpha, and truncation-based screen showed that IL-6 3'- UTR-(56-173) was targeted by p38 alpha to stable mRNA. RNA secondary structure analysis indicated that modulated reporter gene expression was consistent with predicted secondary structure changes.	[Zhao, Wenpu; Liu, Min; Kirkwood, Keith L.] Univ Michigan, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kirkwood, KL (corresponding author), Univ Michigan, Dept Periodont & Oral Med, 1011 N Univ Ave, Ann Arbor, MI 48109 USA.	klkirk@umich.edu	Kirkwood, Keith L/L-4728-2018	Kirkwood, Keith/0000-0003-4519-8973	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018290] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE018290, R01 DE018290-01] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Antic D, 1997, AM J HUM GENET, V61, P273, DOI 10.1086/514866; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Clark A, 2000, ARTHRITIS RES, V2, P172, DOI 10.1186/ar83; Derrigo M, 2000, INT J MOL MED, V5, P111; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fu J, 1998, CHINESE MED J-PEKING, V111, P265; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Hackermuller J, 2005, GENE, V345, P3, DOI 10.1016/j.gene.2004.11.043; Hiller M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl544; HIRANO T, 1988, EUR J IMMUNOL, V18, P1797, DOI 10.1002/eji.1830181122; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; ISSHIKI H, 1990, MOL CELL BIOL, V10, P2757, DOI 10.1128/MCB.10.6.2757; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li XL, 2007, J BIOL CHEM, V282, P7950, DOI 10.1074/jbc.M607939200; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; Meisner NC, 2004, CHEMBIOCHEM, V5, P1432, DOI 10.1002/cbic.200400219; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Miyazawa K, 1998, J BIOL CHEM, V273, P24832, DOI 10.1074/jbc.273.38.24832; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Okamoto M, 1997, CANCER RES, V57, P141; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Patil C, 2004, IMMUNOL INVEST, V33, P213, DOI 10.1081/IMM-120034231; Pietersma A, 1997, BIOCHEM BIOPH RES CO, V230, P44, DOI 10.1006/bbrc.1996.5886; RAY A, 1989, ANN NY ACAD SCI, V557, P353; Ray A, 1989, ANN NY ACAD SCI, V557, P361; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Stoecklin G, 2001, RNA, V7, P1578; Tachibana M, 2000, CELL TISSUE RES, V301, P353, DOI 10.1007/s004410000235; Wang XS, 1997, J BIOL CHEM, V272, P23668, DOI 10.1074/jbc.272.38.23668; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; ZUKER M, 1989, METHOD ENZYMOL, V180, P262	44	59	61	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1778	1785		10.1074/jbc.M707573200	http://dx.doi.org/10.1074/jbc.M707573200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18042545	Green Accepted, hybrid			2022-12-25	WOS:000252501000003
J	Haince, JF; McDonald, D; Rodrigue, A; Dery, U; Masson, JY; Hendzel, MJ; Poirier, GG				Haince, Jean-Francois; McDonald, Darin; Rodrigue, Amelie; Dery, Ugo; Masson, Jean-Yves; Hendzel, Michael J.; Poirier, Guy G.			PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; POSTTRANSLATIONAL MODIFICATION; HOMOLOGOUS RECOMBINATION; CHROMATIN-STRUCTURE; ATM ACTIVATION; EARLY RESPONSE; POLY(ADP-RIBOSE); REPAIR; PARP-1; CELLS	Poly(ADP-ribose) polymerase 1 (PARP1) is a nuclear enzyme that is rapidly activated by DNA strand breaks and signals the presence of DNA lesions by attaching ADP-ribose units to chromatin-associated proteins. The therapeutic applications of PARP inhibitors in potentiating the killing action of ionizing radiation have been well documented and are attracting increasing interest as a cancer treatment. However, the initial kinetics underlying the recognition of multiple DNA lesions by PARP1 and how inhibition of PARP potentiates the activity of DNA-damaging agents are unknown. Here we report the spatiotemporal dynamics of PARP1 recruitment to DNA damage induced by laser microirradiation in single living cells. We provide direct evidence that PARP1 is able to accumulate at a locally induced DNA double strand break. Most importantly, we observed that the rapid accumulation of MRE11 and NBS1 at sites of DNA damage requires PARP1. By determining the kinetics of protein assembly following DNA damage, our study reveals the cooperation between PARP1 and the double strand break sensors MRE11 and NBS1 in the close vicinity of a DNA lesion. This may explain the sensitivity of cancer cells to PARP inhibitors.	[Haince, Jean-Francois; Poirier, Guy G.] Univ Laval, Ctr Hosp Univ Quebec, Fac Med, Hlth & Environm Unit,Laval Univ Hosp Res Ctr, Quebec City, PQ G1V 4G2, Canada; [McDonald, Darin; Hendzel, Michael J.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [McDonald, Darin; Hendzel, Michael J.] Univ Alberta, Fac Med, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; [Rodrigue, Amelie; Dery, Ugo; Masson, Jean-Yves] CHUQ, Hotel Dieu, Genome Stabil Lab, Laval Univ Canc Res Ctr, Quebec City, PQ G1R 2J6, Canada	Laval University; University of Alberta; University of Alberta; Laval University	Poirier, GG (corresponding author), CHUL Rm RC-9700,2705 Laurier Blvd, Quebec City, PQ G1V 4G2, Canada.	guy.poirier@crchul.ulaval.ca	Hendzel, Michael/C-3391-2009	Hendzel, Michael/0000-0002-9603-7945; Masson, Jean Yves/0000-0002-4403-7169; Rodrigue, Amelie/0000-0001-9883-7084; Poirier, Guy/0000-0002-4869-1424				Aguilar-Quesada R, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-29; Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Boisvert FM, 2005, GENE DEV, V19, P671, DOI 10.1101/gad.1279805; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Bradshaw PS, 2005, NAT GENET, V37, P193, DOI 10.1038/ng1506; Brown ML, 2002, P NATL ACAD SCI USA, V99, P4532, DOI 10.1073/pnas.072495299; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Dong ZW, 1999, J BIOL CHEM, V274, P19513, DOI 10.1074/jbc.274.28.19513; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Goodarzi AA, 2004, DNA REPAIR, V3, P753, DOI 10.1016/j.dnarep.2004.03.041; Haince JF, 2007, J BIOL CHEM, V282, P16441, DOI 10.1074/jbc.M608406200; Hochegger H, 2006, EMBO J, V25, P1305, DOI 10.1038/sj.emboj.7601015; Huber A, 2004, DNA REPAIR, V3, P1103, DOI 10.1016/j.dnarep.2004.06.002; Kang J, 2002, EMBO J, V21, P1447, DOI 10.1093/emboj/21.6.1447; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; McDonald D, 2006, J CELL BIOL, V172, P541, DOI 10.1083/jcb.200507101; Meldrum RA, 2003, EMBO REP, V4, P1144, DOI 10.1038/sj.embor.7400028; Mortusewicz O, 2006, NUCLEIC ACIDS RES, V34, P3523, DOI 10.1093/nar/gkl492; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Tartier L, 2003, MUTAGENESIS, V18, P411, DOI 10.1093/mutage/geg015; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Yung TMC, 2004, J BIOL CHEM, V279, P39686, DOI 10.1074/jbc.M402729200	39	396	412	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1197	1208		10.1074/jbc.M706734200	http://dx.doi.org/10.1074/jbc.M706734200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18025084	hybrid			2022-12-25	WOS:000252128100060
J	Kim, H; Han, JR; Park, J; Oh, M; James, SE; Chang, S; Lu, Q; Lee, KY; Ki, H; Song, WJ; Kim, K				Kim, Hangun; Han, Jeong-Ran; Park, Jaejun; Oh, Minsoo; James, Sarah E.; Chang, Sunghoe; Lu, Qun; Lee, Kwang Youl; Ki, Hyunkyoung; Song, Woo-Joo; Kim, Kwonseop			delta-catenin-induced dendritic morphogenesis - An essential role of p190RhoGEF interaction through Akt1-mediated phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPEAT PROTEIN/DELTA-CATENIN; RHO-FAMILY GTPASES; BINDING PROTEIN; SPINE MORPHOLOGY; P120 CATENIN; SYNAPTIC PLASTICITY; ACTIN CYTOSKELETON; EXCHANGE FACTOR; IDENTIFICATION; KINASE	delta-Catenin was first identified through its interaction with Presenilin-1 and has been implicated in the regulation of dendrogenesis and cognitive function. However, the molecular mechanisms by which delta-catenin promotes dendritic morphogenesis were unclear. In this study, we demonstrated delta-catenin interaction with p190RhoGEF, and the importance of Akt1-mediated phosphorylation at Thr-454 residue of delta-catenin in this interaction. We have also found that delta-catenin overexpression decreased the binding between p190RhoGEF and RhoA, and significantly lowered the levels of GTP-RhoA but not those of GTP-Rac1 and -Cdc42. delta-Catenin T454A, a defective form in p190RhoGEF binding, did not decrease the binding between p190RhoGEF and RhoA. delta-Catenin T454A also did not lower GTP-RhoA levels and failed to induce dendrite-like process formation in NIH 3T3 fibroblasts. Furthermore, delta-catenin T454A significantly reduced the length and number of mature mushroom shaped spines in primary hippocampal neurons. These results highlight signaling events in the regulation of delta-catenin-induced dendrogenesis and spine morphogenesis.	[Kim, Hangun; Han, Jeong-Ran; Oh, Minsoo; Lee, Kwang Youl; Ki, Hyunkyoung; Kim, Kwonseop] Chonnam Natl Univ, Coll Pharm, Kwangju 500757, South Korea; [Kim, Hangun; Han, Jeong-Ran; Oh, Minsoo; Lee, Kwang Youl; Ki, Hyunkyoung; Kim, Kwonseop] Chonnam Natl Univ, Res Inst Drug Dev, Kwangju 500757, South Korea; [Park, Jaejun; Chang, Sunghoe] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; [James, Sarah E.; Lu, Qun] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27834 USA; [Song, Woo-Joo] Inje Univ, Grad Program Neurosci, Taejon 614735, South Korea; [Song, Woo-Joo] Inje Univ, Inst Brain Sci & Technol, Taejon 614735, South Korea	Chonnam National University; Chonnam National University; Gwangju Institute of Science & Technology (GIST); University of North Carolina; East Carolina University; Inje University; Inje University	Kim, K (corresponding author), Chonnam Natl Univ, Coll Pharm, Bldg 1-1211,300 Yongbong Dong, Kwangju 500757, South Korea.	koskim@chonnam.ac.kr	Chang, Sunghoe/J-2784-2012	chang, sunghoe/0000-0002-3446-7288	NCI NIH HHS [R01 CA111891-02, CA11891, R01 CA111891-03, R01 CA111891-01A1, R01 CA111891] Funding Source: Medline; NIA NIH HHS [R03 AG026630, R03 AG026630-02, R03 AG026630-01, AG026630] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA111891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG026630] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; BONDESON J, 1990, BIOCHIM BIOPHYS ACTA, V1026, P186, DOI 10.1016/0005-2736(90)90063-T; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Canete-Soler R, 2001, J BIOL CHEM, V276, P32046, DOI 10.1074/jbc.M104104200; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; Deguchi M, 2000, J BIOL CHEM, V275, P29875, DOI 10.1074/jbc.M005384200; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fujita T, 2004, BIOCHEM J, V382, P717, DOI 10.1042/BJ20040141; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; Goswami A, 2005, MOL CELL, V20, P33, DOI 10.1016/j.molcel.2005.08.016; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Henle F, 2006, J BIOL CHEM, V281, P24955, DOI 10.1074/jbc.M604114200; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Ide N, 1999, BIOCHEM BIOPH RES CO, V256, P456, DOI 10.1006/bbrc.1999.0364; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Izawa I, 2002, J BIOL CHEM, V277, P5345, DOI 10.1074/jbc.M110052200; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Jones SB, 2002, NEUROSCIENCE, V115, P1009, DOI 10.1016/S0306-4522(02)00532-8; Kim H, 2005, J BIOL CHEM, V280, P22462, DOI 10.1074/jbc.M502769200; Kim K, 2002, EXP CELL RES, V275, P171, DOI 10.1006/excr.2002.5503; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Li WJ, 2005, DEV DYNAM, V234, P512, DOI 10.1002/dvdy.20496; Lu Q, 2002, J NEUROSCI RES, V67, P618, DOI 10.1002/jnr.10151; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Mackie S, 2005, FEBS J, V272, P4202, DOI 10.1111/j.1742-4658.2005.04832.x; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Martinez MC, 2003, J CELL BIOL, V162, P99, DOI 10.1083/jcb.200211025; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Meng YH, 2003, REV NEUROSCIENCE, V14, P233; Meyer D, 1999, J BIOL CHEM, V274, P35113, DOI 10.1074/jbc.274.49.35113; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; Paffenholz R, 1997, DIFFERENTIATION, V61, P293, DOI 10.1046/j.1432-0436.1997.6150293.x; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Powell DW, 2002, J BIOL CHEM, V277, P21639, DOI 10.1074/jbc.M203167200; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Reynolds AB, 1996, EXP CELL RES, V225, P328, DOI 10.1006/excr.1996.0183; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schubert V, 2006, J CELL BIOL, V172, P453, DOI 10.1083/jcb.200506136; Silverman JB, 2007, J NEUROSCI, V27, P8505, DOI 10.1523/JNEUROSCI.1395-07.2007; Tanahashi H, 1999, NEUROREPORT, V10, P563, DOI 10.1097/00001756-199902250-00022; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Tigyi G, 1996, J NEUROCHEM, V66, P537; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang QH, 2003, NEURON, V38, P915, DOI 10.1016/S0896-6273(03)00356-8; Zhai JB, 2003, J BIOL CHEM, V278, P24865, DOI 10.1074/jbc.M302381200; Zhai JB, 2001, J BIOL CHEM, V276, P41318, DOI 10.1074/jbc.M107709200; Zhou JH, 1997, NEUROREPORT, V8, P2085, DOI 10.1097/00001756-199705260-00054; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	64	56	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					977	987		10.1074/jbc.M707158200	http://dx.doi.org/10.1074/jbc.M707158200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17993462	hybrid, Green Submitted, Green Accepted			2022-12-25	WOS:000252128100037
J	Ferquel, E; de Haro, L; Jan, V; Guillemin, I; Jourdain, S; Teynie, A; d'Alayer, J; Choumet, V				Ferquel, Elisabeth; de Haro, Luc; Jan, Virginie; Guillemin, Isabelle; Jourdain, Sabine; Teynie, Alexandre; d'Alayer, Jacques; Choumet, Valerie			Reappraisal of Vipera aspis Venom Neurotoxicity	PLOS ONE			English	Article								Background. The variation of venom composition with geography is an important aspect of intraspecific variability in the Vipera genus, although causes of this variability remain unclear. The diversity of snake venom is important both for our understanding of venomous snake evolution and for the preparation of relevant antivenoms to treat envenomations. A geographic intraspecific variation in snake venom composition was recently reported for Vipera aspis aspis venom in France. Since 1992, cases of human envenomation after Vipera aspis aspis bites in south-east France involving unexpected neurological signs were regularly reported. The presence of genes encoding PLA(2) neurotoxins in the Vaa snake genome led us to investigate any neurological symptom associated with snake bites in other regions of France and in neighboring countries. In parallel, we used several approaches to characterize the venom PLA(2) composition of the snakes captured in the same areas. Methodology/Principal Findings. We conducted an epidemiological survey of snake bites in various regions of France. In parallel, we carried out the analysis of the genes and the transcripts encoding venom PLA(2)s. We used SELDI technology to study the diversity of PLA(2) in various venom samples. Neurological signs (mainly cranial nerve disturbances) were reported after snake bites in three regions of France: Languedoc-Roussillon, Midi-Pyrenees and Provence-Alpes-Cote d'Azur. Genomes of Vipera aspis snakes from south-east France were shown to contain ammodytoxin isoforms never described in the genome of Vipera aspis from other French regions. Surprisingly, transcripts encoding venom neurotoxic PLA(2)s were found in snakes of Massif Central region. Accordingly, SELDI analysis of PLA(2) venom composition confirmed the existence of population of neurotoxic Vipera aspis snakes in the west part of the Massif Central mountains. Conclusions/Significance. The association of epidemiological studies to genetic, biochemical and immunochemical analyses of snake venoms allowed a good evaluation of the potential neurotoxicity of snake bites. A correlation was found between the expression of neurological symptoms in humans and the intensity of the cross-reaction of venoms with anti-ammodytoxin antibodies, which is correlated with the level of neurotoxin (vaspin and/or ammodytoxin) expression in the venom. The origin of the two recently identified neurotoxic snake populations is discussed according to venom PLA(2) genome and transcriptome data.	[Ferquel, Elisabeth; Jan, Virginie; Guillemin, Isabelle; Choumet, Valerie] Inst Pasteur, Unite Venins, Paris, France; [de Haro, Luc] Hop Salvator, Ctr Antipoison, Marseille, France; [Jourdain, Sabine] Ciphergen, Paris, France; [Teynie, Alexandre] Ctr Rech Theix, UENC INRA, St Genes Champanelle, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Aix-Marseille Universite; INRAE	Choumet, V (corresponding author), Unite Biochim & Biol Mol Insectes, Paris, France.	vchoumet@pasteur.fr	de Haro, Luc/AAT-2911-2020	de Haro, Luc/0000-0003-2250-6312	Institut Pasteur ( Programmes Transversaux de Recherche)	Institut Pasteur ( Programmes Transversaux de Recherche)	Financial support was provided by Institut Pasteur ( Programmes Transversaux de Recherche).	AUDEBERT F, 1992, TOXICON, V30, P599, DOI 10.1016/0041-0101(92)90854-X; Banumathi S, 2001, ACTA CRYSTALLOGR D, V57, P1552, DOI 10.1107/S0907444901013543; BEAR PM, 1990, PROPOS MORSURES VIPE; Beer E, 1998, TOXICON, V36, P697, DOI 10.1016/S0041-0101(97)00168-2; Beer E, 1998, TOXICON, V36, P729, DOI 10.1016/S0041-0101(97)00138-4; Carlsson M, 2004, MOL ECOL, V13, P3147, DOI 10.1111/j.1365-294X.2004.02315.x; CHABERT JM, 1977, LYON MEDITERRANCE ME, V4, P259; CHIPPAUX JP, 1991, TOXICON, V29, P1279, DOI 10.1016/0041-0101(91)90116-9; Chippaux JP, 1998, TOXICON, V36, P823, DOI 10.1016/S0041-0101(97)00160-8; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; CHOUMET V, 1991, TOXICON, V29, P441, DOI 10.1016/0041-0101(91)90018-M; Creer S, 2003, J MOL EVOL, V56, P317, DOI 10.1007/s00239-002-2403-4; Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0; Daltry JC, 1996, TOXICON, V34, P67, DOI 10.1016/0041-0101(95)00122-0; de Haro L, 2002, HUM EXP TOXICOL, V21, P137, DOI 10.1191/0960327102ht226oa; de Haro L., 1994, REV PRATICIEN MED GE, V265, P20; DUGUY R, 1979, Bulletin de la Societe d'Histoire Naturelle de Toulouse, V115, P359; DUPUY F, 1975, ENVENIMATION VIPERIN; Fry BG, 2006, NATURE, V439, P584, DOI 10.1038/nature04328; FRY BG, 2007, MOL CELL PROTEOMICS; Garrigues T, 2005, MOL PHYLOGENET EVOL, V35, P35, DOI 10.1016/j.ympev.2004.11.004; GLENN J L, 1978, Toxicon, V16, P81, DOI 10.1016/0041-0101(78)90065-X; Guillemin I, 2003, EUR J BIOCHEM, V270, P2697, DOI 10.1046/j.1432-1033.2003.03629.x; Ivanovski G, 2002, TOXICON, V40, P543, DOI 10.1016/S0041-0101(01)00250-1; Jakubowski JA, 2005, J EXP BIOL, V208, P2873, DOI 10.1242/jeb.01713; Jan V, 2002, FEBS LETT, V527, P263, DOI 10.1016/S0014-5793(02)03205-2; JAN VM, 2007, PHOSPHOLIPASE A2 DIV, DOI DOI 10.1016/J.TOXICON.2007.07.024; JOUGLARD J, 1970, J MED STRASBOURG ERE; Komori Y, 1996, ARCH BIOCHEM BIOPHYS, V327, P303, DOI 10.1006/abbi.1996.0126; Kordis D, 1997, EUR J BIOCHEM, V246, P772, DOI 10.1111/j.1432-1033.1997.00772.x; MANCHEVA I, 1984, H-S Z PHYSIOL CHEM, V365, P885, DOI 10.1515/bchm2.1984.365.2.885; MEBS D, 1984, TOXICON, V22, P831, DOI 10.1016/0041-0101(84)90170-3; Mukherjee AK, 1998, COMP BIOCHEM PHYS A, V119, P621, DOI 10.1016/S1095-6433(97)00475-3; Orsini P, 1998, PRESSE MED, V27, P1277; Perbandt M, 1997, FEBS LETT, V412, P573, DOI 10.1016/S0014-5793(97)00853-3; POZIO E, 1988, TROP MED PARASITOL, V39, P62; PUIG J, 1995, J SMALL ANIM PRACT, V36, P333, DOI 10.1111/j.1748-5827.1995.tb02942.x; Radonic V, 1997, MIL MED, V162, P179, DOI 10.1093/milmed/162.3.179; RADVANYI F, 1989, ANAL BIOCHEM, V177, P103, DOI 10.1016/0003-2697(89)90022-5; RIOUL P, 2001, EVALUATION UTILISATI; RITONJA A, 1985, BIOCHIM BIOPHYS ACTA, V828, P306, DOI 10.1016/0167-4838(85)90312-7; Saint Girons H., 1984, Bulletin de la Societe d'Histoire Naturelle de Toulouse, V119, P81; Sasa M, 1999, TOXICON, V37, P249, DOI 10.1016/S0041-0101(98)00121-4; Seiberras S, 2002, PRESSE MED, V31, P262; Shashidharamurthy R, 2002, MOL CELL BIOCHEM, V229, P93, DOI 10.1023/A:1017972511272; Stoebner PE, 2001, PRESSE MED, V30, P220; Thomas L, 2006, TOXICON, V48, P23, DOI 10.1016/j.toxicon.2006.04.007; Ursenbacher S, 2006, MOL PHYLOGENET EVOL, V38, P546, DOI 10.1016/j.ympev.2005.08.004; VORDERWU L, 2005, NATURE METHODS, V2, P393; WATT G, 1986, NEW ENGL J MED, V315, P1444, DOI 10.1056/NEJM198612043152303; ZECCHINI B, 1992, SERPENTS FRANCE SYST	51	54	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1194	10.1371/journal.pone.0001194	http://dx.doi.org/10.1371/journal.pone.0001194			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030329	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459200008
J	Shamaei-Tousi, A; D'Aiuto, F; Nibali, L; Steptoe, A; Coates, ARM; Parkar, M; Donos, N; Henderson, B				Shamaei-Tousi, Alireza; D'Aiuto, Francesco; Nibali, Luigi; Steptoe, Andrew; Coates, Anthony R. M.; Parkar, Mohamed; Donos, Nikos; Henderson, Brian			Differential Regulation of Circulating Levels of Molecular Chaperones in Patients Undergoing Treatment for Periodontal Disease	PLOS ONE			English	Article								Background. Evidence is emerging that molecular chaperones, in addition to their intracellular protein folding actions, can act as intercellular signaling proteins with an ability to modulate leukocyte function. Recent evidence has also shown that these proteins can exist in the circulation and may be involved in disease pathogenesis. We have used periodontitis and its treatment as a model of inflammation in the human to determine its effects on levels of circulating HSP10, HSP60 and BiP. Methodology/Principal Findings. A group of periodontal patients and matched controls were examined at the beginning of the study and then at 1 day and 6 months following periodontal or control therapy. Plasma levels of HSP10, HSP60 and BiP were measured by immunoassay and related to other plasma measures of inflammation. Periodontal patients had significantly less circulating levels of HSP10 or BiP compared with the controls. In contrast, more periodontal patients had intermediate levels of HSP60. Treatment of the periodontitis caused an increase in plasma levels of HSP10 although it had no effect on BiP. Treatment had no influence of HSP60 levels. Plasma HSP10 levels after therapy correlated with markers of periodontal clinical improvement. Conclusions/Significance. Circulating levels of molecular chaperones are influenced by local inflammation. HSP10 is known to be an anti-inflammatory factor. The marked decrease of this circulating protein in active inflammation and its recovery post-treatment suggests that it may have a role in controlling periodontal inflammation.	[Shamaei-Tousi, Alireza; Henderson, Brian] UCL, UCL Eastman Dent Inst, Div Microbial Dis, London, England; [Shamaei-Tousi, Alireza; Coates, Anthony R. M.] Univ London St Georges Hosp, Sch Med, London SW17 0RE, England; [D'Aiuto, Francesco; Nibali, Luigi; Parkar, Mohamed; Donos, Nikos] UCL, UCL Eastman Dent Inst & Hosp, Periodontol Unit, London, England; [Steptoe, Andrew] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; University College London; St Georges University London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	Shamaei-Tousi, A (corresponding author), UCL, UCL Eastman Dent Inst, Div Microbial Dis, London, England.	ashamaei@sgul.ac.uk	Steptoe, Andrew/Y-2440-2019	Coates, Anthony/0000-0001-8052-3175; Steptoe, Andrew/0000-0001-7808-4943	British Heart Foundation [PG/03/029]; ARMC	British Heart Foundation(British Heart Foundation); ARMC	We are grateful to the British Heart Foundation ( grant PG/03/029) for support to BH, AS, ARMC and for financial support for AS-T.	Athanasas-Platsis S, 2003, J NEUROL SCI, V214, P27, DOI 10.1016/S0022-510X(03)00170-9; Brownlie RJ, 2006, ARTHRITIS RHEUM-US, V54, P854, DOI 10.1002/art.21654; CAVANAGH AC, 1994, EUR J BIOCHEM, V222, P551, DOI 10.1111/j.1432-1033.1994.tb18897.x; Corrigall VM, 2004, ARTHRITIS RHEUM-US, V50, P1164, DOI 10.1002/art.20134; D'Aiuto F, 2005, INFLAMM RES, V54, P412, DOI 10.1007/s00011-005-1375-4; D'Aiuto F, 2004, J PERIODONTAL RES, V39, P294, DOI 10.1111/j.1600-0765.2004.00741.x; D'Aiuto F, 2004, J DENT RES, V83, P156, DOI 10.1177/154405910408300214; D'Aiuto F, 2006, AM HEART J, V151, P977, DOI 10.1016/j.ahj.2005.06.018; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; Ellis RJ, 2006, TRENDS BIOCHEM SCI, V31, P395, DOI 10.1016/j.tibs.2006.05.001; Feng ZM, 2006, PERIODONTOL 2000, V40, P50, DOI 10.1111/j.1600-0757.2005.00148.x; Frostegard Johan, 2005, P195, DOI 10.1017/CBO9780511546310.013; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Halcox JPJ, 2005, ARTERIOSCL THROM VAS, V25, pE141, DOI 10.1161/01.ATV.0000185832.34992.ff; Hansen JJ, 2003, HUM GENET, V112, P71, DOI 10.1007/s00439-002-0837-9; Henderson B, 2005, MOL CHAPERONES CELL; Henderson Brian, 2005, P78, DOI 10.1017/CBO9780511546310.006; Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200; Leppa S, 1997, ANN MED, V29, P73, DOI 10.3109/07853899708998745; Lewthwaite J, 2002, CIRCULATION, V106, P196, DOI 10.1161/01.CIR.0000021121.26290.2C; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; Maguire M, 2002, CELL STRESS CHAPERON, V7, P317, DOI 10.1379/1466-1268(2002)007<0317:CUISOC>2.0.CO;2; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; MORTON H, 1977, LANCET, V1, P394; Nibali L, 2006, J CLIN PERIODONTOL, V33, P529, DOI 10.1111/j.1600-051X.2006.00952.x; Pockley AG, 1999, CELL STRESS CHAPERON, V4, P29, DOI 10.1054/csac.1998.0121; Pockley AG, 2003, HYPERTENSION, V42, P235, DOI 10.1161/01.HYP.0000086522.13672.23; Pockley AG, 2000, HYPERTENSION, V36, P303, DOI 10.1161/01.HYP.36.2.303; SHAMAEITOUSI A, 2006, EUR HEART J; SHAMAEITOUSI A, 2007, CELL STRESS IN PRESS; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; Vanags D, 2006, LANCET, V368, P855, DOI 10.1016/S0140-6736(06)69210-6; Xu QB, 2000, CIRCULATION, V102, P14, DOI 10.1161/01.CIR.102.1.14; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zanin-Zhorov A, 2006, J CLIN INVEST, V116, P2022, DOI 10.1172/JCI28423; Zhu JH, 2003, ARTERIOSCL THROM VAS, V23, P1055, DOI 10.1161/01.ATV.0000074899.60898.FD; Zugel U, 1999, IMMUNOBIOLOGY, V201, P22	38	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1198	10.1371/journal.pone.0001198	http://dx.doi.org/10.1371/journal.pone.0001198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030332	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000207459200011
J	Lee, DY; Sugden, B				Lee, D. Y.; Sugden, B.			The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy	ONCOGENE			English	Article						autophagy; EBV; LMP1	EPSTEIN-BARR-VIRUS; MEMBRANE-PROTEIN 1; LATENT MEMBRANE-PROTEIN-1; GROWTH TRANSFORMATION; NUCLEAR ANTIGEN; LMP1; PROLIFERATION; ASSOCIATION; RECEPTOR; CD40	Epstein-Barr virus (EBV) is a herpes virus that is associated with several human cancers. Infection of B cells by EBV leads to their induction and maintenance of proliferation and requires the oncogene, latent membrane protein 1 (LMP1). LMP1 signals in a ligand-independent manner and is expressed at widely different levels in cells of a single clone. It is this unusual distribution that allows LMP1 to stimulate multiple, distinct pathways. Average levels of LMP1 induce proliferation while high levels induce cytostasis and inhibition of protein synthesis. These inhibitory pathways are induced by the six transmembrane domains of LMP1. We uncovered a novel function encoded by transmembrane domains 3-6 of LMP1; they induce autophagy in a dose-dependent manner and thus, modify the physiology of their host. Cells that express low levels of LMP1 display early stages of autophagy, autophagosomes; those that express high levels of this oncogene display late stages of autophagy, autolysosomes. Inhibition of autophagy in EBV-positive cells leads to an accumulation of LMP1 and a decreased ability to form colonies. These results indicate that LMP1's induction of autophagy contributes to its own regulation and that of its host cell.	[Lee, D. Y.; Sugden, B.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Sugden, B (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	sugden@oncology.wisc.edu			NCI NIH HHS [P30 CA014520, CA070723] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; BAICHWAL VR, 1987, J VIROL, V61, P866, DOI 10.1128/JVI.61.3.866-875.1987; Bornkamm GW, 2001, PHILOS T R SOC B, V356, P437, DOI 10.1098/rstb.2000.0781; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Devergne O, 1996, MOL CELL BIOL, V16, P7098; Dirmeier U, 2005, ONCOGENE, V24, P1711, DOI 10.1038/sj.onc.1208367; Dirmeier U, 2003, CANCER RES, V63, P2982; Gires O, 1999, EMBO J, V18, P3064, DOI 10.1093/emboj/18.11.3064; Gires O, 1997, EMBO J, V16, P6131, DOI 10.1093/emboj/16.20.6131; GREGORY CD, 1990, J GEN VIROL, V71, P1481, DOI 10.1099/0022-1317-71-7-1481; Humme S, 2003, P NATL ACAD SCI USA, V100, P10989, DOI 10.1073/pnas.1832776100; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; Kaykas A, 2000, ONCOGENE, V19, P1400, DOI 10.1038/sj.onc.1203365; Kaykas A, 2002, J VIROL, V76, P11551, DOI 10.1128/JVI.76.22.11551-11560.2002; Kieser A, 1997, EMBO J, V16, P6478, DOI 10.1093/emboj/16.21.6478; Kilger E, 1998, EMBO J, V17, P1700, DOI 10.1093/emboj/17.6.1700; KNUTSON JC, 1987, ANAL BIOCHEM, V164, P44, DOI 10.1016/0003-2697(87)90365-4; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lam N, 2004, J VIROL, V78, P1657, DOI 10.1128/JVI.78.4.1657-1664.2004; Lam N, 2003, CELL SIGNAL, V15, P9, DOI 10.1016/S0898-6568(02)00083-9; Lee J, 2007, J VIROL, V81, P9121, DOI 10.1128/JVI.00136-07; MARTIN J, 1991, J VIROL, V65, P3246, DOI 10.1128/JVI.65.6.3246-3258.1991; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; Neuhierl B, 2002, P NATL ACAD SCI USA, V99, P15036, DOI 10.1073/pnas.232381299; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Sandberg M, 1997, J VIROL, V71, P4649, DOI 10.1128/JVI.71.6.4649-4656.1997; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Taylor GS, 2006, J IMMUNOL, V177, P3746, DOI 10.4049/jimmunol.177.6.3746; Uchida J, 1999, SCIENCE, V286, P300, DOI 10.1126/science.286.5438.300; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023	36	114	116	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 1	2008	27	20					2833	2842		10.1038/sj.onc.1210946	http://dx.doi.org/10.1038/sj.onc.1210946			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	295VR	18037963				2022-12-25	WOS:000255502500004
J	Menges, CW; McCance, DJ				Menges, C. W.; McCance, D. J.			Constitutive activation of the Raf-MAPK pathway causes negative feedback inhibition of Ras-PI3K-AKT and cellular arrest through the EphA(2) receptor	ONCOGENE			English	Article						Raf-MEK1; Ras; PI3; AKT; kinase; EphA(2) receptor	TYROSINE KINASE; PROTEIN-KINASE; CYCLE ARREST; AKT; DIFFERENTIATION; CELLS; P21(CIP1); GROWTH; PROLIFERATION; ANGIOGENESIS	The Raf-mitogen-activated protein kinase (MAPK) and phosphatidylinositide 3-kinase (PI3K)-AKT pathways are two downstream effectors of the small GTPase Ras. Although both pathways are positively regulated by Ras, the Raf-MAPK and PI3K-AKT pathways have been shown to control opposing functions within the cell, suggesting a need for cross-talk regulation. The PI3K -AKT pathway can inhibit the Raf-MAPK pathway directly during processes such as muscle differentiation. Here we describe the ability of the Raf-MAPK pathway to negatively regulate the PI3K-AKT pathway during cellular arrest. Constitutive activation of Raf or methyl ethyl ketone 1 (MEK1) leads to inhibition of AKT and cellular arrest. Furthermore, we show that activation of Raf-MEK1 signaling causes negative feedback inhibition of Ras through the ephrin receptor EphA(2). EphA(2)-mediated negative feedback inhibition is required for Raf-induced AKT inhibition and cell cycle arrest, therefore establishing the inhibition of the Ras-PI3K-AKT pathway as a necessary event for the Raf-MEK1-regulated cellular arrest.	[Menges, C. W.; McCance, D. J.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland; [Menges, C. W.] Univ Rochester, Sch Med, Dept Biochem, Rochester, NY USA; [Menges, C. W.] Univ Rochester, Sch Med, Dept Biophys, Rochester, NY USA; [McCance, D. J.] Univ Rochester, Sch Med, Dept Microbiol, Rochester, NY USA; [McCance, D. J.] Univ Rochester, Sch Med, Dept Immunol, Rochester, NY USA; [McCance, D. J.] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY USA	Queens University Belfast; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	McCance, DJ (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, MBC Bldg, Belfast BT9 7BL, Antrim, North Ireland.	d.mccance@qub.ac.uk			NIAID NIH HHS [R01 AI 30798] Funding Source: Medline; NIDCR NIH HHS [R01 DE015935] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015935] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Brantley DM, 2002, ONCOGENE, V21, P7011, DOI 10.1038/sj.onc.1205679; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Cheng N, 2002, MOL CANCER RES, V1, P2; Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; Cichowski K, 2003, GENE DEV, V17, P449, DOI 10.1101/gad.1054703; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Hobbs RM, 2004, J INVEST DERMATOL, V123, P503, DOI 10.1111/j.0022-202X.2004.23225.x; Holt KH, 1996, MOL CELL BIOL, V16, P577; Kinch MS, 2003, CLIN EXP METASTAS, V20, P59, DOI 10.1023/A:1022546620495; Laprise P, 2004, J CELL PHYSIOL, V199, P32, DOI 10.1002/jcp.10432; Lawlor MA, 2001, J CELL SCI, V114, P2903; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Mirza AM, 2004, MOL CELL BIOL, V24, P10868, DOI 10.1128/MCB.24.24.10868-10881.2004; Reusch HP, 2001, J BIOL CHEM, V276, P33630, DOI 10.1074/jbc.M105322200; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Scholl FA, 2004, CANCER RES, V64, P6035, DOI 10.1158/0008-5472.CAN-04-0017; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Thrash BR, 2006, J BIOL CHEM, V281, P12155, DOI 10.1074/jbc.M512116200; Walker-Daniels J, 2003, AM J PATHOL, V162, P1037, DOI 10.1016/S0002-9440(10)63899-0; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; Westbrook TF, 2002, MOL CELL BIOL, V22, P7041, DOI 10.1128/MCB.22.20.7041-7052.2002; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	28	72	73	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 1	2008	27	20					2934	2940		10.1038/sj.onc.1210957	http://dx.doi.org/10.1038/sj.onc.1210957			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	295VR	18059341				2022-12-25	WOS:000255502500015
J	Bennett, HL; Brummer, T; Jeanes, A; Yap, AS; Daly, RJ				Bennett, H. L.; Brummer, T.; Jeanes, A.; Yap, A. S.; Daly, R. J.			Gab2 and Src co-operate in human mammary epithelial cells to promote growth factor independence and disruption of acinar morphogenesis	ONCOGENE			English	Article						tyrosine kinase; signal transduction; E-cadherin; cell-cell adhesion; cell invasion	DOCKING PROTEIN GAB2; E-CADHERIN; SIGNALING PATHWAY; ACTIVATION; PHOSPHORYLATION; PROLIFERATION; ADHESION; ROLES; AKT; DEPHOSPHORYLATION	The Gab2 docking protein is a target of several oncogenic protein tyrosine kinases and potentiates activation of the Ras/extracellular signal regulated kinase and phosphatidylinositol 3-kinase (PI3-kinase) pathways. Since Gab2 is phosphorylated by c-Src, and both proteins are over-expressed in breast cancers, we have determined the biological consequences of their co-expression in the immortalized human mammary epithelial cell line MCF-10A. While overexpression of c-Src did not affect acinar morphogenesis or growth factor dependence in three-dimensional culture, c-Src co-operated with Gab2 to promote epidermal growth factor (EGF)-independent acinar growth. In contrast, expression of v-Src or the activated mutant c-SrcY527F led to a spectrum of aberrant phenotypes ranging from spheroids with incomplete luminal clearance to highly disrupted, dispersed structures. Gab2 co-expression shifted the phenotypic distribution towards the dispersed phenotype, an effect not observed with a Gab2 mutant unable to bind the p85 subunit of PI3-kinase (Gab2 Delta p85). In v-Src-expressing cells, Gab2, but not Gab2 Delta p85, significantly decreased E-cadherin adhesive strength without altering its surface expression. Gab2 associated with E-cadherin in the presence and absence of v-Src, indicating that the ability of Gab2 to weaken the strength of cell-cell contacts may reflect enhanced activation of PI3-kinase at adherens junctions. Gab2 also increased migration and invasion of these cells in transwell assays, but these effects were p85-independent. Overall, these findings demonstrate a novel mechanism whereby Gab2 may promote metastatic spread and indicate that Gab2 may play several roles during breast cancer progression.	[Bennett, H. L.; Brummer, T.; Daly, R. J.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW 2010, Australia; [Jeanes, A.; Yap, A. S.] Univ Queensland, Inst Mol Biosci, Queensland, Australia	Garvan Institute of Medical Research; University of Queensland	Daly, RJ (corresponding author), Garvan Inst Med Res, Canc Res Program, 384 Victoria St, Sydney, NSW 2010, Australia.	r.daly@garvan.org.au	Daly, Roger J/C-8179-2009; Jeanes, Angela/D-9770-2011; Brummer, Tilman/B-6218-2016; Brummer, Tilman/AAA-9428-2020; Yap, Alpha S./J-1554-2014	Jeanes, Angela/0000-0003-0717-6298; Brummer, Tilman/0000-0003-4387-7905; Brummer, Tilman/0000-0003-4387-7905; Yap, Alpha S./0000-0002-1038-8956; Daly, Roger/0000-0002-5739-8027				Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; BRIEHER WM, 1994, J CELL BIOL, V126, P519, DOI 10.1083/jcb.126.2.519; Brummer T, 2006, J BIOL CHEM, V281, P626, DOI 10.1074/jbc.M509567200; Clevenger CV, 2004, AM J PATHOL, V165, P1449, DOI 10.1016/S0002-9440(10)63403-7; Daly RJ, 2002, ONCOGENE, V21, P5175, DOI 10.1038/sj.onc.1205522; Debnath J, 2003, J CELL BIOL, V163, P315, DOI 10.1083/jcb.200304159; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Grille SJ, 2003, CANCER RES, V63, P2172; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Guan KL, 2000, J BIOL CHEM, V275, P27354; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Ischenko I, 2003, ONCOGENE, V22, P6311, DOI 10.1038/sj.onc.1206742; JANES PW, 1994, ONCOGENE, V9, P3601; Kassenbrock CK, 2002, J BIOL CHEM, V277, P24967, DOI 10.1074/jbc.M201026200; Ke Y, 2007, ONCOGENE, V26, P4951, DOI 10.1038/sj.onc.1210315; Kong M, 2003, J BIOL CHEM, V278, P5837, DOI 10.1074/jbc.M208286200; Kotelevets L, 2004, FASEB J, V18, P115, DOI 10.1096/fj.04-1942fje; Kotelevets L, 2001, J CELL BIOL, V155, P1129, DOI 10.1083/jcb.200105109; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Lu YL, 2003, J BIOL CHEM, V278, P40057, DOI 10.1074/jbc.M303621200; Lynch DK, 2002, EMBO J, V21, P72, DOI 10.1093/emboj/21.1.72; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Nishida K, 1999, BLOOD, V93, P1809, DOI 10.1182/blood.V93.6.1809.406k35_1809_1816; Nyga R, 2005, BIOCHEM J, V390, P359, DOI 10.1042/BJ20041523; Pang JH, 2005, J BIOL CHEM, V280, P3043, DOI 10.1074/jbc.M412148200; Podar K, 2004, J BIOL CHEM, V279, P21658, DOI 10.1074/jbc.M305783200; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; REYNOLDS AB, 1987, EMBO J, V6, P2359, DOI 10.1002/j.1460-2075.1987.tb02512.x; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; SHORE EM, 1991, J BIOL CHEM, V266, P19672; Verma S, 2004, J BIOL CHEM, V279, P34062, DOI 10.1074/jbc.M404814200; Vogelmann R, 2005, J CELL SCI, V118, P4901, DOI 10.1242/jcs.02594; Wada T, 2005, NAT MED, V11, P394, DOI 10.1038/nm1203; Wang FM, 2005, BREAST CANCER RES TR, V89, P5, DOI 10.1007/s10549-004-1002-z; Wrobel CN, 2004, J CELL BIOL, V165, P263, DOI 10.1083/jcb.200309102; Yamasaki S, 2001, J BIOL CHEM, V276, P45175, DOI 10.1074/jbc.M105384200; Yu M, 2006, J IMMUNOL, V176, P2421, DOI 10.4049/jimmunol.176.4.2421; Yu WM, 2002, BLOOD, V99, P2351, DOI 10.1182/blood.V99.7.2351	44	33	33	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 24	2008	27	19					2693	2704		10.1038/sj.onc.1210928	http://dx.doi.org/10.1038/sj.onc.1210928			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	292IK	17998934				2022-12-25	WOS:000255259500004
J	Macoritto, M; Nguyen-Yamamoto, L; Huang, DC; Samuel, S; Yang, XF; Wang, TT; White, JH; Kremer, R				Macoritto, Michael; Nguyen-Yamamoto, Loan; Huang, Dao Chao; Samuel, Sara; Yang, Xian Fang; Wang, Tian Tian; White, John H.; Kremer, Richard			Phosphorylation of the human retinoid X receptor alpha at serine 260 impairs coactivator(s) recruitment and induces hormone resistance to multiple ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; HUMAN-PAPILLOMAVIRUS TYPE-16; GENE PROMOTER; ACTIVATION; PROTEIN; EXPRESSION; BINDING; TRANSACTIVATION; IDENTIFICATION; KERATINOCYTES	The retinoid X receptor alpha(RXR alpha) is a member of the nuclear receptor superfamily that regulates transcription of target genes through heterodimerization with several partners, including peroxisome proliferator-activated receptor, retinoic acid receptor, thyroid receptor, and vitamin D receptor (VDR). We have shown previously that signaling through VDR center dot RXR alpha heterodimers was attenuated in ras-transformed keratinocytes due to phosphorylation of serine 260 of the RXR alpha via the activated Ras-Raf-MAPK cascade in these cells. In this study we demonstrate that phosphorylation at serine 260, a site located in the omega loop-AF-2 interacting domain of RXR alpha, inhibits signaling through several heterodimeric partners of the RXR alpha. The inhibition of signaling results in reduced transactivational response to ligand presentation and the reduced physiological response of growth inhibition not only of 1,25-dihydroxyvitamin D-3 but also of retinoic acid receptor alpha ligands and LG1069 (an RXR alpha ligand). This partial resistance to ligands could be reversed by inhibition of MAPK activity or by overexpression of a non-phosphorylable RXR alpha mutant at serine 260 (RXR alpha Ser-260 -> Ala). Importantly, phosphorylation of RXR alpha at serine 260 impaired the recruitment of DRIP205 and other coactivators to the VDR center dot RXR alpha complex. Chromatin immunoprecipitation and pulldown assays further demonstrated that coactivator recruitment to the VDR center dot RXR complex could be restored by treatment with a MAPK inhibitor. Our data suggest that phosphorylation at serine 260 plays a critical role in inducing hormone resistance of RXR alpha-mediated signaling likely through structural changes in the H-1-H-3 omega loop-AF2 coactivator(s) interacting domain.	[Macoritto, Michael; Nguyen-Yamamoto, Loan; Huang, Dao Chao; Samuel, Sara; Yang, Xian Fang; Wang, Tian Tian; White, John H.; Kremer, Richard] McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A1, Canada	McGill University	Kremer, R (corresponding author), McGill Univ, Ctr Hlth, 687 Pine Ave W,Rm H4-67, Montreal, PQ H3A 1A1, Canada.	Richard.kremer@mcgill.ca	white, john h/N-9782-2013	white, john h/0000-0002-4785-2687; Kremer, Richard/0000-0002-7053-2139				BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Bruck N, 2005, CELL SIGNAL, V17, P1229, DOI 10.1016/j.cellsig.2004.12.006; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Deng WG, 2003, ANAL BIOCHEM, V323, P12, DOI 10.1016/j.ab.2003.08.007; DURST M, 1987, ONCOGENE, V1, P251; DURST M, 1989, VIROLOGY, V173, P767, DOI 10.1016/0042-6822(89)90595-3; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Horiuchi H, 2004, J EXP CLIN CANC RES, V23, P599; JIANG HP, 1994, ONCOGENE, V9, P3397; Li D, 2002, J BIOL CHEM, V277, P31416, DOI 10.1074/jbc.M204818200; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Masuyama H, 1997, MOL ENDOCRINOL, V11, P1507, DOI 10.1210/me.11.10.1507; Matsushima-Nishiwaki R, 2001, CANCER RES, V61, P7675; MCKENNA NJ, 1995, NATURE, V375, P359; MEYER ME, 1989, CELL, V57, P433, DOI 10.1016/0092-8674(89)90918-5; MULLER R, 1982, NATURE, V299, P640, DOI 10.1038/299640a0; Narayanan R, 2004, J BIOL CHEM, V279, P47298, DOI 10.1074/jbc.M404101200; Narvaez CJ, 1996, ENDOCRINOLOGY, V137, P400, DOI 10.1210/en.137.2.400; Oda Y, 2003, MOL ENDOCRINOL, V17, P2329, DOI 10.1210/me.2003-0063; ONATE SA, 1995, SCIENCE, V270, P1354; Pandey PK, 2005, MOL CELL BIOL, V25, P10695, DOI 10.1128/MCB.25.24.10695-10710.2005; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rowan BG, 2000, J BIOL CHEM, V275, P4475, DOI 10.1074/jbc.275.6.4475; Saramaki A, 2006, NUCLEIC ACIDS RES, V34, P543, DOI 10.1093/nar/gkj460; SEBAG M, 1992, J BIOL CHEM, V267, P12162; Sinkkonen L, 2005, NUCLEIC ACIDS RES, V33, P2440, DOI 10.1093/nar/gki502; Solomon C, 1999, J CLIN INVEST, V103, P1729, DOI 10.1172/JCI6871; Solomon C, 2001, RADIAT RES, V155, P156, DOI 10.1667/0033-7587(2001)155[0156:VDRIRT]2.0.CO;2; Solomon C, 1998, J BIOL CHEM, V273, P17573, DOI 10.1074/jbc.273.28.17573; Takeshita A, 1997, J BIOL CHEM, V272, P27629, DOI 10.1074/jbc.272.44.27629; TASSET D, 1990, CELL, V62, P1177, DOI 10.1016/0092-8674(90)90394-T; Thompson PD, 2001, J MOL ENDOCRINOL, V27, P211, DOI 10.1677/jme.0.0270211; TRAMONTANO D, 1986, J BIOL CHEM, V261, P3919; Tran NQ, 2004, BIOCHEM J, V381, P267, DOI 10.1042/BJ20031653; Treuter E, 1998, MOL ENDOCRINOL, V12, P864, DOI 10.1210/me.12.6.864; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wang TT, 2005, MOL ENDOCRINOL, V19, P2685, DOI 10.1210/me.2005-0106; WEIGEL NL, 1995, J STEROID BIOCHEM, V53, P509, DOI 10.1016/0960-0760(95)00098-K; Westin S, 1998, NATURE, V395, P199, DOI 10.1038/26040; WHITFIELD GK, 2005, VITAMIN D, P220; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P206; Zachos G, 1997, CRIT REV ONCOL HEMAT, V26, P65, DOI 10.1016/S1040-8428(97)00013-9; Zilliacus J, 2001, MOL ENDOCRINOL, V15, P501, DOI 10.1210/me.15.4.501; Zugmaier G, 1996, BRIT J CANCER, V73, P1341, DOI 10.1038/bjc.1996.256	47	43	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4943	4956		10.1074/jbc.M707517200	http://dx.doi.org/10.1074/jbc.M707517200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18003614	hybrid			2022-12-25	WOS:000253426500052
J	Lajoie-Mazenc, I; Tovar, D; Penary, M; Lortal, B; Allart, S; Favard, C; Brihoum, M; Pradines, A; Favre, G				Lajoie-Mazenc, Isabelle; Tovar, Daniel; Penary, Marie; Lortal, Barbara; Allart, Sophie; Favard, Cyril; Brihoum, Meryem; Pradines, Anne; Favre, Gilles			MAP1A light chain-2 interacts with GTP-RhoB to control epidermal growth factor (EGF)-dependent EGF receptor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-1A; BINDING-PROTEIN; RAS TRANSFORMATION; FACTOR-BETA; EXPRESSION; CELLS; ACTIN; GTPASES; FAMILY; LOCALIZATION	Rho GTPases have been implicated in the control of several cellular functions, including regulation of the actin cytoskeleton, cell proliferation, and oncogenesis. Unlike RhoA and RhoC, RhoB localizes in part to endosomes and controls endocytic trafficking. Using a yeast two-hybrid screen and a glutathione S-transferase pulldown assay, we identified LC2, the light chain of the microtubule-associated protein MAP1A, as a novel binding partner for RhoB. GTP binding and the 18-amino acid C-terminal hypervariable domain of RhoB are critical for its binding to MAP1A/LC2. Coimmunoprecipitation and immunofluorescence experiments showed that this interaction occurs in U87 cells. Down-regulation of MAP1A/LC2 expression decreased epidermal growth factor (EGF) receptor expression and modified the signaling response to EGF treatment. We concluded that MAP1A/LC2 is critical for RhoB function in EGF-induced EGF receptor regulation. Because MAP1A/LC2 is thought to function as an adaptor between microtubules and other molecules, we postulate that the RhoB and MAP1A/LC2 interactions facilitate endocytic vesicle trafficking and regulate the trafficking of signaling molecules.	[Lajoie-Mazenc, Isabelle; Tovar, Daniel; Penary, Marie; Lortal, Barbara; Pradines, Anne] Inst Claudius Regaud, INSERM, U 563, F-31052 Toulouse, France; [Lajoie-Mazenc, Isabelle; Tovar, Daniel; Penary, Marie; Lortal, Barbara; Pradines, Anne; Favre, Gilles] Dept Oncogenese Signalisat & Innovat Therapeut, INSERM, U 563, F-31059 Toulouse, France; [Lajoie-Mazenc, Isabelle; Tovar, Daniel; Penary, Marie; Lortal, Barbara; Brihoum, Meryem; Pradines, Anne; Favre, Gilles] Univ Toulouse 3, Fac Pharmaceut Sci, F-31059 Toulouse, France; [Allart, Sophie] INSERM, IFR 30, F-31024 Toulouse, France; [Favard, Cyril] IPBS, CNRS, UMR 5089, F-31077 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Claudius Regaud; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Lajoie-Mazenc, I (corresponding author), Inst Claudius Regaud, INSERM, U 563, F-31052 Toulouse, France.	lajoie.isabelle@claudiusregaud.fr	Lajoie-Mazenc, Isabelle/M-4636-2014; Pradines, Anne/M-3935-2014; Favard, Cyril/P-6392-2016; FAVRE, Gilles/K-9189-2014	Pradines, Anne/0000-0002-2449-678X; Favard, Cyril/0000-0002-8304-2980; FAVRE, Gilles/0000-0002-2344-1883				ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Ader I, 2002, ONCOGENE, V21, P5998, DOI 10.1038/sj.onc.1205746; Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Adnane J, 2002, J BIOL CHEM, V277, P8500, DOI 10.1074/jbc.M104367200; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Baron R, 2000, P NATL ACAD SCI USA, V97, P11626, DOI 10.1073/pnas.97.21.11626; BLOOM GS, 1984, J CELL BIOL, V98, P331, DOI 10.1083/jcb.98.1.331; Brenman JE, 1998, J NEUROSCI, V18, P8805; Canguilhem B, 2005, J BIOL CHEM, V280, P43257, DOI 10.1074/jbc.M508650200; Chien CL, 2005, EXP CELL RES, V308, P446, DOI 10.1016/j.yexcr.2005.05.007; DeFranco C, 1998, MOL BIOL CELL, V9, P1695, DOI 10.1091/mbc.9.7.1695; Ellis S, 2000, TRENDS CELL BIOL, V10, P85, DOI 10.1016/S0962-8924(99)01710-9; Engel ME, 1998, J BIOL CHEM, V273, P9921, DOI 10.1074/jbc.273.16.9921; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; Forget MA, 2002, CLIN EXP METASTAS, V19, P9, DOI 10.1023/A:1013884426692; Fritz G, 1997, J BIOL CHEM, V272, P30637, DOI 10.1074/jbc.272.49.30637; Fritz G, 2000, BIOCHEM BIOPH RES CO, V268, P784, DOI 10.1006/bbrc.2000.2211; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; FRITZ G, 1995, J BIOL CHEM, V270, P25172, DOI 10.1074/jbc.270.42.25172; Gampel A, 2002, BIOCHEM J, V366, P393, DOI 10.1042/BJ20020844; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Huang M, 2006, HISTOL HISTOPATHOL, V21, P213, DOI 10.14670/HH-21.213; Ives JH, 2004, J BIOL CHEM, V279, P31002, DOI 10.1074/jbc.M402214200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JAHNER D, 1991, MOL CELL BIOL, V11, P3682; Jiang K, 2004, ONCOGENE, V23, P1136, DOI 10.1038/sj.onc.1207236; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; LANGKOPF A, 1992, J BIOL CHEM, V267, P16561; LEBOWITZ PF, 1995, MOL CELL BIOL, V15, P6613; Lebowitz PF, 1998, CELL ADHES COMMUN, V6, P277, DOI 10.3109/15419069809010787; Liu AX, 2001, P NATL ACAD SCI USA, V98, P6192, DOI 10.1073/pnas.111137198; Liu AX, 2000, MOL CELL BIOL, V20, P6105, DOI 10.1128/MCB.20.16.6105-6113.2000; Longhurst DM, 2006, J BIOL CHEM, V281, P12030, DOI 10.1074/jbc.M513756200; Magiera MM, 2004, BIOCHEM J, V382, P803, DOI 10.1042/BJ20040122; Malcolm T, 2003, ONCOGENE, V22, P6142, DOI 10.1038/sj.onc.1206638; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; Mazieres J, 2005, EXP CELL RES, V304, P354, DOI 10.1016/j.yexcr.2004.10.019; Mellor H, 1998, J BIOL CHEM, V273, P4811, DOI 10.1074/jbc.273.9.4811; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Milia J, 2005, CELL DEATH DIFFER, V12, P492, DOI 10.1038/sj.cdd.4401586; Mircescu H, 2002, EUR J BIOCHEM, V269, P6241, DOI 10.1046/j.1432-1033.2002.03343.x; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Neel NF, 2007, J CELL SCI, V120, P1559, DOI 10.1242/jcs.03437; Noiges R, 2002, J NEUROSCI, V22, P2106, DOI 10.1523/JNEUROSCI.22-06-02106.2002; Park SM, 2004, FEBS LETT, V570, P143, DOI 10.1016/j.febslet.2004.06.037; PEDROTTI B, 1994, CELL MOTIL CYTOSKEL, V29, P110, DOI 10.1002/cm.970290203; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2001, TRAFFIC, V2, P303, DOI 10.1034/j.1600-0854.2001.002005303.x; Rondanino C, 2007, TRAFFIC, V8, P932, DOI 10.1111/j.1600-0854.2007.00575.x; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; SCHOENFELD TA, 1994, INT REV CYTOL, V151, P67, DOI 10.1016/S0074-7696(08)62631-5; SCHOENFELD TA, 1989, J NEUROSCI, V9, P1712; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Skuli N, 2006, CANCER RES, V66, P482, DOI 10.1158/0008-5472.CAN-05-2299; Stamatakis K, 2002, J BIOL CHEM, V277, P49389, DOI 10.1074/jbc.M204049200; Steuve S, 2006, EXP CELL RES, V312, P3981, DOI 10.1016/j.yexcr.2006.08.028; Togel M, 1999, FEBS LETT, V451, P15, DOI 10.1016/S0014-5793(99)00523-2; Togel M, 1998, J CELL BIOL, V143, P695, DOI 10.1083/jcb.143.3.695; WANG S, 2004, NOVART FDN SYMP, V259, P285; Wang Shaowen, 2004, Novartis Found Symp, V259, P238; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Westmark CJ, 2005, ONCOGENE, V24, P502, DOI 10.1038/sj.onc.1208224; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Wherlock M, 2004, J CELL SCI, V117, P3221, DOI 10.1242/jcs.01193; ZALCMAN G, 1995, ONCOGENE, V10, P1935	69	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4155	4164		10.1074/jbc.M709639200	http://dx.doi.org/10.1074/jbc.M709639200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18056259	hybrid			2022-12-25	WOS:000253083500051
J	Tibrewal, N; Wu, Y; D'mello, V; Akakura, R; George, TC; Varnum, B; Birge, RB				Tibrewal, Nitu; Wu, Yi; D'mello, Veera; Akakura, Reiko; George, Thaddeus C.; Varnum, Brian; Birge, Raymond B.			Autophosphorylation docking site tyr-867 in mer receptor tyrosine kinase allows for dissociation of multiple signaling pathways for phagocytosis of apoptotic cells and down-modulation of lipopolysaccharide-inducible NF-kappa B transcriptional activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER SEGMENT PHAGOCYTOSIS; PIGMENT EPITHELIAL-CELLS; C-MER; PROTEIN-S; PHOSPHATIDYLSERINE RECEPTOR; EXPRESSION ANALYSIS; RETINAL DYSTROPHY; DENDRITIC CELLS; KNOCKOUT MICE; V-RYK	Efficient clearance of apoptotic cells is essential for tissue homeostasis, allowing for cellular turnover without inflammatory consequences. The Mer (Nyk and c-Eyk) receptor tyrosine kinase (Mertk) is involved in two aspects of apoptotic cell clearance by acting as a receptor for Gas6, a gamma-carboxylated phosphatidylserine-binding protein that bridges apoptotic and viable cells. First, Mertk acts in a bona fide engulfment pathway in concert with alpha v beta 5 integrin by regulating cytoskeletal assemblages, and second, it acts as a negative regulator for inflammation by down-modulating pro-inflammatory signals mediated from bacterial lipopolysaccharide-Toll-like receptor 4 (TLR4) signaling, and hence recapitulating anti-inflammatory immune modulation by apoptotic cells. Here we describe Mertk postreceptor events that govern phagocytosis and cytoskeletal signaling are principally mediated by autophosphorylation site Tyr-867. Using the Mertk Y867F mutant and pharmacological inhibitors, we show that Tyr-867 is required for phosphatidylinositol 3-kinase and phospholipase C gamma 2 activation; their activation in turn elicits protein kinase C-dependent signals that act on the actin cytoskeleton. Although Mertk(Y867F) blocked the tyrosine phosphorylation of FAK on Tyr-861 and p130(cas) and also abrogated the phagocytosis of apoptotic cells, this mutant did not suppress lipopolysaccharide-inducible NF-kappa B transcription, nor was NF-kappa B activation dependent on the protein kinase C inhibitor, calphostin C. Finally, unlike the cytoskeletal events associated with Tyr-867 autophosphorylation, the trans-inhibition of NF kappa B occurred in a postnuclear-dependent fashion independent of cytosolic I kappa B phosphorylation and p65/RelA sequestration. Taken together, these data suggest that Mertk has distinct and separable effects for phagocytosis and for resolving inflammation, providing a molecular rationale for how immune licensing and inflammation can be dissociated from phagocytosis in a single phagocytic receptor.	[Tibrewal, Nitu; Wu, Yi; D'mello, Veera; Akakura, Reiko; Birge, Raymond B.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [George, Thaddeus C.] Amnis Corp, Seattle, WA 98121 USA; [Varnum, Brian] Amgen Inc, Amgen Pharmaceut, Inflammat Dept, Newbury Pk, CA 91320 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Amgen	Birge, RB (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, 185 S Orange Ave, Newark, NJ 07103 USA.	birgera@umdnj.edu	D'Mello, Veera/GNM-5247-2022					Camenisch TD, 1999, J IMMUNOL, V162, P3498; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; Duncan JL, 2003, ADV EXP MED BIOL, V533, P165; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Ek S, 2002, CANCER RES, V62, P4398; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Finnemann SC, 1999, J EXP MED, V190, P861, DOI 10.1084/jem.190.6.861; Fraser DA, 2007, J BIOL CHEM, V282, P7360, DOI 10.1074/jbc.M605741200; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; Georgescu MM, 1999, MOL CELL BIOL, V19, P1171; Graham DK, 2006, CLIN CANCER RES, V12, P2662, DOI 10.1158/1078-0432.CCR-05-2208; GRAHAM DK, 1994, CELL GROWTH DIFFER, V5, P647; GRAHAM DK, 1995, ONCOGENE, V10, P2349; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Hall MO, 2005, EXP EYE RES, V81, P581, DOI 10.1016/j.exer.2005.03.017; Hall MO, 2003, ADV EXP MED BIOL, V533, P331; Hall MO, 2001, EXP EYE RES, V73, P509, DOI 10.1006/exer.2001.1062; JIA R, 1992, J VIROL, V66, P5975, DOI 10.1128/JVI.66.10.5975-5987.1992; JIA R, 1994, J BIOL CHEM, V269, P1839; Keating AK, 2006, ONCOGENE, V25, P6092, DOI 10.1038/sj.onc.1209633; Khaled AR, 1998, CELL IMMUNOL, V185, P49, DOI 10.1006/cimm.1998.1272; Leverrier Y, 2001, CURR BIOL, V11, P195, DOI 10.1016/S0960-9822(01)00047-1; Ling L, 1996, J BIOL CHEM, V271, P18355, DOI 10.1074/jbc.271.31.18355; LING L, 1995, MOL CELL BIOL, V15, P6582; Liu YQ, 2005, J PHARMACOL SCI, V98, P361, DOI 10.1254/jphs.FPJ05005X; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Lucas M, 2003, J IMMUNOL, V171, P2610, DOI 10.4049/jimmunol.171.5.2610; Lucas M, 2006, J IMMUNOL, V177, P4047, DOI 10.4049/jimmunol.177.6.4047; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Mitchell JE, 2006, J BIOL CHEM, V281, P5718, DOI 10.1074/jbc.M509775200; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Nandrot EF, 2006, AM J PHYSIOL-CELL PH, V290, pC1256, DOI 10.1152/ajpcell.00480.2005; Neznanov N, 2004, DNA CELL BIOL, V23, P175, DOI 10.1089/104454904322964779; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; RESCIGNO J, 1991, ONCOGENE, V6, P1909; Sasaki T, 2002, J BIOL CHEM, V277, P44164, DOI 10.1074/jbc.M207340200; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; Shankar SL, 2006, J NEUROSCI, V26, P5638, DOI 10.1523/JNEUROSCI.5063-05.2006; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Todt JC, 2004, J LEUKOCYTE BIOL, V75, P705, DOI 10.1189/jlb.0903439; Todt JC, 2002, J BIOL CHEM, V277, P35906, DOI 10.1074/jbc.M202967200; Unkeless JC, 1997, CURR OPIN IMMUNOL, V9, P338, DOI 10.1016/S0952-7915(97)80079-9; Vanden Berghe W, 2003, ADV EXP MED BIOL, V544, P181; VARNUM BC, 1995, NATURE, V373, P623, DOI 10.1038/373623a0; Vely F, 1997, J IMMUNOL, V159, P2075; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632	52	99	106	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3618	3627		10.1074/jbc.M706906200	http://dx.doi.org/10.1074/jbc.M706906200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18039660	hybrid			2022-12-25	WOS:000253083000067
J	Ashish; Juncadella, IJ; Garg, R; Boone, CD; Anguita, J; Krueger, JK				Ashish; Juncadella, Ignacio J.; Garg, Renu; Boone, Christopher D.; Anguita, Juan; Krueger, Joanna K.			Conformational rearrangement within the soluble domains of the CD4 receptor is ligand-specific	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; CRYSTAL-STRUCTURE; HIV; ANTIBODIES; RESOLUTION; FRAGMENT; TYPE-1	Ligand binding induces shape changes within the four modular ectodomains (D1-D4) of the CD4 receptor, an important receptor in immune signaling. Small angle x-ray scattering (SAXS) on both a two-domain and a four-domain construct of the soluble CD4 (sCD4) is consistent with known crystal structures demonstrating a bilobal and a semi-extended tetralobal Z conformation in solution, respectively. Detection of conformational changes within sCD4 as a result of ligand binding was followed by SAXS on sCD4 bound to two different glycoprotein ligands: the tick saliva immunosuppressor Salp15 and the HIV-1 envelope protein gp120. Ab initio modeling of these data showed that both Salp15 and gp120 bind to the D1 domain of sCD4 and yet induce drastically different structural rearrangements. Upon binding, Salp15 primarily distorts the characteristic lobal architecture of the sCD4 without significantly altering the semi-extended shape of the sCD4 receptor. In sharp contrast, the interaction of gp120 with sCD4 induces a shape change within sCD4 that can be described as a Z-to-U bi-fold closure of the four domains across its flexible D2-D3 linker. Placement of known crystal structures within the boundaries of the SAXS-derived models suggests that the ligand induced shape changes could be a result of conformational changes within this D2 - D3 linker. Functionally, the observed shape changes in CD4 receptor causes dissociation of lymphocyte kinase from the cytoplasmic domain of Salp15-bound CD4 and facilitates an interaction between the exposed V3 loops of CD4-bound gp120 molecule to the extracellular loops of its co-receptor, a step essential for HIV-1 viral entry.	[Ashish; Boone, Christopher D.; Krueger, Joanna K.] Univ N Carolina, Dept Chem, Charlotte, NC 28223 USA; [Garg, Renu] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA; [Juncadella, Ignacio J.; Anguita, Juan] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte; University of Massachusetts System; University of Massachusetts Amherst	Krueger, JK (corresponding author), Univ N Carolina, Dept Chem, Charlotte, NC 28223 USA.	jkkruege@uncc.edu	Anguita, Juan/D-5432-2011; Krueger, Joanna/A-3110-2011	Anguita, Juan/0000-0003-2061-7182; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053064] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 053064, R01 AI053064-05, R01 AI053064] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anguita J, 2002, IMMUNITY, V16, P849, DOI 10.1016/S1074-7613(02)00325-4; Ashish, 2006, BIOPHYS J, V91, pL69, DOI 10.1529/biophysj.106.090381; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADY RL, 1993, SCIENCE, V260, P979, DOI 10.1126/science.8493535; Garg R, 2006, J IMMUNOL, V177, P6579, DOI 10.4049/jimmunol.177.10.6579; GARLICK RL, 1990, AIDS RES HUM RETROV, V6, P465, DOI 10.1089/aid.1990.6.465; Glatter O., 1982, SMALL ANGLE X RAY SC; Hager-Braun C, 2002, BIOCHEMISTRY-US, V41, P1759, DOI 10.1021/bi011626k; HARRISON SC, 1992, COLD SPRING HARB SYM, V57, P541, DOI 10.1101/SQB.1992.057.01.059; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; HEALEY D, 1990, J EXP MED, V172, P1233, DOI 10.1084/jem.172.4.1233; Huang B, 1997, J IMMUNOL, V158, P216; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Kim PW, 2003, SCIENCE, V301, P1725, DOI 10.1126/science.1085643; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KWONG PD, 1990, P NATL ACAD SCI USA, V87, P6423, DOI 10.1073/pnas.87.16.6423; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LIFSON JD, 1989, IMMUNOL REV, V109, P93, DOI 10.1111/j.1600-065X.1989.tb00021.x; Moir S, 1996, J VIROL, V70, P8019, DOI 10.1128/JVI.70.11.8019-8028.1996; Popik W, 2004, J BIOL CHEM, V279, P704, DOI 10.1074/jbc.M306380200; RYU SE, 1994, STRUCTURE, V2, P59, DOI 10.1016/S0969-2126(00)00008-3; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; SWEET RW, 1991, CURR OPIN BIOTECH, V2, P622, DOI 10.1016/0958-1669(91)90089-N; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; Wang JH, 2001, P NATL ACAD SCI USA, V98, P10799, DOI 10.1073/pnas.191124098; Wu H, 1996, P NATL ACAD SCI USA, V93, P15030, DOI 10.1073/pnas.93.26.15030; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; Zhou TQ, 2005, P NATL ACAD SCI USA, V102, P14575, DOI 10.1073/pnas.0507267102	34	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2761	2772		10.1074/jbc.M708325200	http://dx.doi.org/10.1074/jbc.M708325200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18045872	hybrid			2022-12-25	WOS:000252622300034
J	Li, J; Chen, LA; Townsend, CM; Evers, BM				Li, Jing; Chen, L. Andy; Townsend, Courtney M., Jr.; Evers, B. Mark			PKD1, PKD2, and their substrate Kidins220 regulate neurotensin secretion in the BON human endocrine cell line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-D; ENDOPLASMIC-RETICULUM STRESS; MEMBRANE-SPANNING PROTEIN; GOLGI COMPARTMENT; D ACTIVATION; PKC-ALPHA; C-MU; GROWTH; PHOSPHORYLATION; NEUROTROPHIN	Neurotensin (NT) is a gut peptide that plays an important role in gastrointestinal secretion, motility, and growth as well as the proliferation of NT receptor-positive cancers. Protein kinase D (PKD) family members (PKD1, 2, and 3) have been identified as important regulators of secretory transport at the trans-Golgi network. Previously, we showed that PKD1 contributes to stimulated NT secretion; however, the mechanisms are not entirely clear. Here, we show that Kidins220, which is a substrate of PKD proteins in neuroendocrine cells, is localized in the ends of the processes of BON cells, similar to the expression pattern of NT vesicles, and translocates to the membrane and large vesicle-like structures formed in response to phorbol 12-myristate 13-acetate treatment. The short hairpin RNA targeting Kidins220 inhibits NT secretion in parental BON cells or BON cells stably expressing the gastrin-releasing peptide receptor treated with either phorbol 12-myristate 13-acetate or bombesin, respectively. Furthermore, we demonstrate that endogenous PKD1, PKD2, and Kidins220 co-exist with NT-containing vesicles. Overexpression of the kinase-dead PKD1 abrogates Kidins220 expression and NT vesicle formation. Our data establish a physiological link between the PKD/Kidins220 pathway and NT-containing vesicles and suggest the role of this pathway in the regulation of hormone secretion. Because NT is an important gut hormone that affects secretion, inflammation, and both normal and tumor cell growth, our findings identify a novel signaling pathway that may be amenable to drug targeting for clinical applications.	[Li, Jing; Chen, L. Andy; Townsend, Courtney M., Jr.; Evers, B. Mark] Univ Texas Galveston, Med Branch, Dept Surg, Galveston, TX 77555 USA; [Li, Jing; Chen, L. Andy; Evers, B. Mark] Univ Texas Galveston, Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Evers, BM (corresponding author), Univ Texas Galveston, Med Branch, Dept Surg, 301 Univ Blvd, Galveston, TX 77555 USA.	mevers@utmb.edu	Li, Jing/B-7206-2011		NIA NIH HHS [R37 AG010885-16, R37 AG010885, R37 AG 10885] Funding Source: Medline; NIDDK NIH HHS [P01 DK035608-220001, R01 DK048498, P01 DK 35608, P01 DK035608, R01 DK 48489, P01 DK035608-22, U01 DK048489, R01 DK048498-13] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK035608, U01DK048489, R01DK048498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG010885] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arevalo JC, 2004, EMBO J, V23, P2358, DOI 10.1038/sj.emboj.7600253; Arevolo JC, 2006, J BIOL CHEM, V281, P1001, DOI 10.1074/jbc.M504163200; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bracale A, 2007, MOL BIOL CELL, V18, P142, DOI 10.1091/mbc.E06-05-0453; Cabrera-Poch N, 2004, J BIOL CHEM, V279, P28592, DOI 10.1074/jbc.M312242200; CARRAWAY R, 1975, J BIOL CHEM, V250, P1907; Carraway RE, 2006, PEPTIDES, V27, P2445, DOI 10.1016/j.peptides.2006.04.030; CARY N, 2004, SAS STAT 9 1 USERS G; Castagliuolo I, 1999, J CLIN INVEST, V103, P843, DOI 10.1172/JCI4217; Chang HW, 2007, J CLIN ENDOCR METAB, V92, P1863, DOI 10.1210/jc.2006-2338; Chang MS, 2004, J NEUROSCI RES, V78, P186, DOI 10.1002/jnr.20262; Evers BM, 2006, PEPTIDES, V27, P2424, DOI 10.1016/j.peptides.2006.01.028; EVERS BM, 1991, GASTROENTEROLOGY, V101, P303, DOI 10.1016/0016-5085(91)90004-5; EVERS BM, 1994, ANN NY ACAD SCI, V733, P393, DOI 10.1111/j.1749-6632.1994.tb17289.x; Iglesias T, 2000, J BIOL CHEM, V275, P40048, DOI 10.1074/jbc.M005261200; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Kong HY, 2001, J NEUROSCI, V21, P176, DOI 10.1523/JNEUROSCI.21-01-00176.2001; Li J, 2005, J BIOL CHEM, V280, P8351, DOI 10.1074/jbc.M409431200; Li J, 2002, AM J PHYSIOL-GASTR L, V283, pG1197, DOI 10.1152/ajpgi.00177.2002; Li J, 2004, J BIOL CHEM, V279, P28466, DOI 10.1074/jbc.M314307200; Li J, 2007, MOL ENDOCRINOL, V21, P159, DOI 10.1210/me.2006-0340; Maier D, 2006, GENE EXPR PATTERNS, V6, P849, DOI 10.1016/j.modgep.2006.03.007; MARGIORIS AN, 1992, ENDOCRINOLOGY, V131, P703, DOI 10.1210/en.131.2.703; Moore EDW, 1999, J BIOL CHEM, V274, P22493, DOI 10.1074/jbc.274.32.22493; Pothoulakis C, 2000, CURR OPIN GASTROEN, V16, P536, DOI 10.1097/00001574-200011000-00013; Prestle J, 1996, J CELL BIOL, V134, P1401, DOI 10.1083/jcb.134.6.1401; Renna M, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703778200; Riol-Blanco L, 2004, EUR J IMMUNOL, V34, P108, DOI 10.1002/eji.200324640; Romero DG, 2006, ENDOCRINOLOGY, V147, P6046, DOI 10.1210/en.2006-0794; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sanchez-Ruiloba L, 2006, J BIOL CHEM, V281, P18888, DOI 10.1074/jbc.M603044200; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; Yaney GC, 2002, AM J PHYSIOL-ENDOC M, V283, pE880, DOI 10.1152/ajpendo.00474.2001; Yang GD, 2007, J BIOL CHEM, V282, P16567, DOI 10.1074/jbc.M700605200; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090	36	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2614	2621		10.1074/jbc.M707513200	http://dx.doi.org/10.1074/jbc.M707513200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18048355	hybrid, Green Accepted			2022-12-25	WOS:000252622300018
J	Lv, CX; Chen, MR; Gan, GL; Wang, LF; Xu, T; Ding, JP				Lv, Caixia; Chen, Maorong; Gan, Geliang; Wang, Lifen; Xu, Tao; Ding, Jiuping			Four-turn alpha-helical segment prevents surface expression of the auxiliary h beta 2 subunit of BK-type channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNEL; ACTIVATED POTASSIUM CHANNEL; ENDOCYTIC TRAFFICKING SIGNALS; BETA-SUBUNIT; LARGE-CONDUCTANCE; CRYSTAL-STRUCTURE; CHROMAFFIN CELLS; MOLECULAR-BASIS; SPLICE VARIANT; VOLTAGE	Large conductance, voltage- and Ca2+- activated K+ (BK) channels encoded by the mslo alpha and beta 2 subunits exist abundantly in rat chromaffin cells, pancreatic beta cells, and DRG neurons. The extracellular loop of h beta 2 acting as the channel regulator influences the rectification and toxin sensitivity of BK channels, and the inactivation domain at its N terminus induces rapid inactivation. However, the regulatory mechanism, especially the trafficking mechanism of h beta 2, is still unknown. With the help of immunofluorescence and patch clamp techniques, we determine that the h beta 2 subunit alone resides in the endoplasmic reticulum, suggesting that trafficking mechanism of h beta 2 differs from that of h beta 1 opposite to what we predicted previously. We further demonstrate that a four-turn alpha helical segment at the N terminus of h beta 2 prevents the surface expression of h beta 2, that is, the helical segment itself is a retention signal. Using the c-Myc epitope-tagged extracellular loop of h beta 2, we reveal that the most accessible site by antibody is located at the middle of the extracellular loop, which might provide clues to understand how the auxiliary beta subunits regulates the toxin sensitivity and the rectification of BK-type channels.	[Lv, Caixia; Chen, Maorong; Gan, Geliang; Wang, Lifen; Xu, Tao; Ding, Jiuping] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Hubei, Peoples R China; [Xu, Tao] Chinese Acad Sci, Inst Biophys, Natl lab Biomacromol, Beijing 100101, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Institute of Biophysics, CAS	Ding, JP (corresponding author), Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Hubei, Peoples R China.	xutao@ibp.ac.cn; jpding@mail.hust.edu.cn	Chen, Maorong/AAF-4006-2019; Xu, Tao/G-5474-2010	Chen, Maorong/0000-0003-3744-8864; 				Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Bentrop D, 2001, J BIOL CHEM, V276, P42116, DOI 10.1074/jbc.M107118200; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Bright JN, 2002, BIOPOLYMERS, V64, P303, DOI 10.1002/bip.10197; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Ding JP, 1998, BIOPHYS J, V74, P268, DOI 10.1016/S0006-3495(98)77785-9; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; Hanner M, 1998, J BIOL CHEM, V273, P16289, DOI 10.1074/jbc.273.26.16289; Hu S, 2003, PHYSIOL GENOMICS, V15, P191, DOI 10.1152/physiolgenomics.00110.2003; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jin P, 2002, J BIOL CHEM, V277, P43724, DOI 10.1074/jbc.M205795200; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Li W, 2007, J CELL PHYSIOL, V212, P348, DOI 10.1002/jcp.21007; Li ZW, 1999, J NEUROPHYSIOL, V81, P611, DOI 10.1152/jn.1999.81.2.611; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Nimigean CM, 1999, J GEN PHYSIOL, V113, P425, DOI 10.1085/jgp.113.3.425; Qian X, 2002, J GEN PHYSIOL, V120, P829, DOI 10.1085/jgp.20028692; Savalli N, 2007, J GEN PHYSIOL, V130, P117, DOI 10.1085/jgp.200709803; Toro B, 2006, NEUROSCIENCE, V142, P661, DOI 10.1016/j.neuroscience.2006.06.061; TsengCrank J, 1996, P NATL ACAD SCI USA, V93, P9200, DOI 10.1073/pnas.93.17.9200; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Xia XM, 2003, J GEN PHYSIOL, V121, P125, DOI 10.1085/jgp.20028667; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Xia XM, 2000, J NEUROSCI, V20, P4890; Zarei MM, 2007, NEUROSCIENCE, V147, P80, DOI 10.1016/j.neuroscience.2007.04.019; Zarei MM, 2004, P NATL ACAD SCI USA, V101, P10072, DOI 10.1073/pnas.0302919101; Zarei MM, 2001, J BIOL CHEM, V276, P16232, DOI 10.1074/jbc.M008852200; Zeng XH, 2003, NAT STRUCT BIOL, V10, P448, DOI 10.1038/nsb932; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang Z, 2006, J NEUROSCI, V26, P11833, DOI 10.1523/JNEUROSCI.3812-06.2006	32	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2709	2715		10.1074/jbc.M704440200	http://dx.doi.org/10.1074/jbc.M704440200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	17991741	hybrid			2022-12-25	WOS:000252622300028
J	Girard, C; Verheggen, C; Neel, H; Cammas, A; Vagner, S; Soret, J; Bertrand, E; Bordonne, R				Girard, Cyrille; Verheggen, Celine; Neel, Henry; Cammas, Anne; Vagner, Stephan; Soret, Johann; Bertrand, Edouard; Bordonne, Remy			Characterization of a short isoform of human Tgs1 hypermethylase associating with small nucleolar ribonucleoprotein core proteins and produced by limited proteolytic processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME ENTRY SITE; NF-KAPPA-B; SMALL-NUCLEAR; ALTERNATIVE TRANSLATION; CAP HYPERMETHYLASE; BINDING-SITE; RNASE III; PROTEASOME; YEAST; METHYLTRANSFERASE	Tgs1 is the hypermethylase responsible for m(3)G cap formation of U small nuclear RNAs (U snRNAs) and small nucleolar RNAs (snoRNAs). In vertebrates, hypermethylation of snRNAs occurs in the cytoplasm, whereas this process takes place in the nucleus for snoRNAs. Accordingly, the hypermethylase is found in both compartments with a diffuse localization in the cytoplasm and a concentration in Cajal bodies in the nucleoplasm. In this study, we report that the Tgs1 hypermethylase exists as two species, a full-length cytoplasmic isoform and a shorter nuclear isoform of 65-70 kDa. The short isoform exhibits methyltransferase activity and associates with components of box C/D and H/ACA snoRNPs, pointing to a role of this isoform in hypermethylation of snoRNAs. We also show that production of the short Tgs1 isoform is inhibited by MG132, suggesting that it results from proteasomal limited processing of the full-length Tgs1 protein. Together, our results suggest that proteasome maturation constitutes a mechanism regulating Tgs1 function by generating Tgs1 species with different substrate specificities, subcellular localizations, and functions.	[Girard, Cyrille; Verheggen, Celine; Neel, Henry; Soret, Johann; Bertrand, Edouard; Bordonne, Remy] Univ Montpellier, CNRS, IFR 122, Inst Genet Mol,UMR 5535, Montpellier 5, France; [Cammas, Anne; Vagner, Stephan] Univ Toulouse 2, INSERM U653, F-31052 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite de Toulouse - Jean Jaures	Bordonne, R (corresponding author), Univ Montpellier, CNRS, IFR 122, Inst Genet Mol,UMR 5535, 1919 Route Mende, Montpellier 5, France.	remy.bordonne@igmm.cnrs.fr	Vagner, Stephan/G-3664-2013; CAMMAS, Anne/M-7238-2014; Girard, Cyrille/ABA-2180-2020	CAMMAS, Anne/0000-0002-3240-9172; Verheggen, Celine/0000-0003-2459-9700; bertrand, edouard/0000-0002-9642-7994; vagner, stephan/0000-0003-1452-7164				AUSUBEL FM, 1997, CURRENT PROTOCOLS MO, P491; Baker SP, 2005, CELL, V123, P361, DOI 10.1016/j.cell.2005.10.013; Bertrand E, 2004, PROG MOL SUBCELL BIO, V35, P79; Bharti AK, 1996, J BIOL CHEM, V271, P1993, DOI 10.1074/jbc.271.4.1993; Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; Bonnal S, 2003, J BIOL CHEM, V278, P39330, DOI 10.1074/jbc.M305580200; Chanfreau G, 1998, J MOL BIOL, V284, P975, DOI 10.1006/jmbi.1998.2237; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Enunlu I, 2003, BIOCHEM BIOPH RES CO, V309, P44, DOI 10.1016/S0006-291X(03)01514-6; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Hausmann S, 2005, J BIOL CHEM, V280, P4021, DOI 10.1074/jbc.C400554200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kiss T, 2004, J CELL SCI, V117, P5949, DOI 10.1242/jcs.01487; Komonyi O, 2005, J BIOL CHEM, V280, P12397, DOI 10.1074/jbc.M409251200; Kufel J, 2000, MOL CELL BIOL, V20, P5415, DOI 10.1128/MCB.20.15.5415-5424.2000; Lemm I, 2006, MOL BIOL CELL, V17, P3221, DOI 10.1091/mbc.E06-03-0247; Maraia RJ, 2002, GENE EXPRESSION, V10, P41; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; Mouaikel J, 2003, NUCLEIC ACIDS RES, V31, P4899, DOI 10.1093/nar/gkg656; Mouaikel J, 2003, EMBO REP, V4, P616, DOI 10.1038/sj.embor.embor863; Mouaikel J, 2002, MOL CELL, V9, P891, DOI 10.1016/S1097-2765(02)00484-7; Nanbru C, 1997, J BIOL CHEM, V272, P32061, DOI 10.1074/jbc.272.51.32061; ORIAN A, 1995, J BIOL CHEM, V270, P21707, DOI 10.1074/jbc.270.37.21707; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; PLESSEL G, 1994, MOL CELL BIOL, V14, P4160, DOI 10.1128/MCB.14.6.4160; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Ruan JP, 2007, MOL BIOCHEM PARASIT, V155, P66, DOI 10.1016/j.molbiopara.2007.05.008; Seipelt RL, 1999, NUCLEIC ACIDS RES, V27, P587, DOI 10.1093/nar/27.2.587; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Stavreva DA, 2006, MOL CELL BIOL, V26, P5131, DOI 10.1128/MCB.02227-05; TERNS MP, 1994, SCIENCE, V264, P959, DOI 10.1126/science.8178154; Terns MP, 2001, CURR BIOL, V11, pR862, DOI 10.1016/S0960-9822(01)00517-6; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; Verheggen C, 2002, EMBO J, V21, P2736, DOI 10.1093/emboj/21.11.2736; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Xue DH, 2000, EMBO J, V19, P1650, DOI 10.1093/emboj/19.7.1650	42	35	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2060	2069		10.1074/jbc.M704209200	http://dx.doi.org/10.1074/jbc.M704209200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039666	hybrid			2022-12-25	WOS:000252501000033
J	Suzuki, T; Kelly, VP; Motohashi, H; Nakajima, O; Takahashi, S; Nishimura, S; Yamamoto, M				Suzuki, Takafumi; Kelly, Vincent P.; Motohashi, Hozumi; Nakajima, Osamu; Takahashi, Satoru; Nishimura, Susumu; Yamamoto, Masayuki			Deletion of the selenocysteine tRNA gene in macrophages and liver results in compensatory gene induction of cytoprotective enzymes by Nrf2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NRF2; SELENOPROTEIN SYNTHESIS; SELENIUM DEFICIENCY; SELECTIVE-INHIBITION; NRF2-KEAP1 PATHWAY; HEME OXYGENASE-1; EXPRESSION; MICE; PROTECTION; GROWTH	The selenocysteine tRNA (tRNA(Sec)) molecule is the sight of synthesis for the amino acid selenocysteine and the adaptor for its translational insertion into selenoprotein enzymes, the majority of which contribute to cellular redox homeostasis. To examine the consequences of selenoprotein depletion on the oxidative environment of the cell, we generated a conditional knock-out mouse for the tRNASec gene (Trsp). Deletion of Trsp in either macrophages or liver elevated oxidative stress and activated the transcriptional induction of cytoprotective antioxidant and detoxification enzyme genes, including glutathione S-transferase P1 and NAD( P)H:quinone oxidoreductase 1, and other well known target genes of the transcription factor Nrf2 ((N) under barF-E2-(r) under bar elated (f) under bar actor 2). Simultaneous disruption of Trsp and Nrf2 severely compromised the cytoprotective response. Double knock-out macrophages displayed reduced viability, elevated oxidative stress, and increased susceptible to hydrogen peroxide treatment compared with deletion of either gene alone. Mice carrying a liver-specific deletion of Trsp on an Nrf2-null background experienced hepatocellular apoptosis and displayed a severely reduced survival rate compared with loss of Trsp alone. Our results thus demonstrate that reduced selenoprotein activity is counterbalanced by an Nrf2-mediated cytoprotective response, which is essential for maintaining cellular redox homeostasis and viability.	[Motohashi, Hozumi; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Suzuki, Takafumi; Kelly, Vincent P.; Nishimura, Susumu; Yamamoto, Masayuki] Univ Tsukuba, Exploratory Res Adv Technol Environm Response Pro, Tsukuba, Ibaraki 3058577, Japan; [Suzuki, Takafumi; Kelly, Vincent P.; Nishimura, Susumu; Yamamoto, Masayuki] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; [Motohashi, Hozumi; Yamamoto, Masayuki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; [Nakajima, Osamu] Yamagata Univ, Res Lab Mol Genet, Yamagata 9909585, Japan	Tohoku University; University of Tsukuba; University of Tsukuba; University of Tsukuba; Yamagata University	Yamamoto, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	masi@mail.tains.tohoku.ac.jp	Suzuki, Takafumi/ABC-6582-2020; Yamamoto, Masayuki/A-4873-2010; Motohashi, Hozumi/AAZ-2628-2020; Kelly, Vincent P/I-2151-2017	Suzuki, Takafumi/0000-0002-3425-8208; Yamamoto, Masayuki/0000-0002-9073-9436; Kelly, Vincent P/0000-0001-7067-5407				Aoki Y, 2001, TOXICOL APPL PHARM, V173, P154, DOI 10.1006/taap.2001.9176; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Behne D, 2001, ANNU REV NUTR, V21, P453, DOI 10.1146/annurev.nutr.21.1.453; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; BOYNE R, 1986, J COMP PATHOL, V96, P379, DOI 10.1016/0021-9975(86)90033-2; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; CHANG M, 1990, J BIOL CHEM, V265, P5418; Cho HY, 2005, FREE RADICAL BIO MED, V38, P325, DOI 10.1016/j.freeradbiomed.2004.10.013; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; CHRISTENSEN MJ, 1994, BIOCHEM BIOPH RES CO, V202, P271, DOI 10.1006/bbrc.1994.1923; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; CROSS M, 1988, P NATL ACAD SCI USA, V85, P6232, DOI 10.1073/pnas.85.17.6232; Dinkova-Kostova AT, 2001, P NATL ACAD SCI USA, V98, P3404, DOI 10.1073/pnas.051632198; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Faust N, 2000, BLOOD, V96, P719; Fuhrman B, 2004, FREE RADICAL BIO MED, V37, P259, DOI 10.1016/j.freeradbiomed.2004.04.026; GAIROLA C, 1985, BIOCHEM BIOPH RES CO, V132, P397, DOI 10.1016/0006-291X(85)91035-6; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 2001, CANCER LETT, V174, P103, DOI 10.1016/S0304-3835(01)00695-4; Immenschuh S, 2000, BIOCHEM PHARMACOL, V60, P1121, DOI 10.1016/S0006-2952(00)00443-3; Ishii T, 1999, FREE RADICAL RES, V31, P351, DOI 10.1080/10715769900300921; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jameson RR, 2002, J NUTR, V132, P1830, DOI 10.1093/jn/132.7.1830; Jeong DW, 2002, J BIOL CHEM, V277, P17871, DOI 10.1074/jbc.M200808200; Katsuoka F, 2005, J BIOL CHEM, V280, P4483, DOI 10.1074/jbc.M411451200; Kelly VP, 2005, MOL CELL BIOL, V25, P3658, DOI 10.1128/MCB.25.9.3658-3669.2005; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; Lee JS, 2005, CANCER LETT, V224, P171, DOI 10.1016/j.canlet.2004.09.042; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; MCKEEHAN WL, 1976, P NATL ACAD SCI USA, V73, P2023, DOI 10.1073/pnas.73.6.2023; McMahon M, 2001, CANCER RES, V61, P3299; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; McWalter GK, 2004, J NUTR, V134, p3499S, DOI 10.1093/jn/134.12.3499S; Moosmann B, 2004, LANCET, V363, P892, DOI 10.1016/S0140-6736(04)15739-5; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mostert V, 2003, BIOL CHEM, V384, P681, DOI 10.1515/BC.2003.076; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Moustafa ME, 2001, MOL CELL BIOL, V21, P3840, DOI 10.1128/MCB.21.11.3840-3852.2001; OLSSON U, 1993, INT J VITAM NUTR RES, V63, P31; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Saito Y, 1999, J BIOL CHEM, V274, P2866, DOI 10.1074/jbc.274.5.2866; Saito Y, 2003, J BIOL CHEM, V278, P39428, DOI 10.1074/jbc.M305542200; Sakurai A, 2005, J CELL PHYSIOL, V203, P529, DOI 10.1002/jcp.20246; Sawa T, 2007, NAT CHEM BIOL, V3, P727, DOI 10.1038/nchembio.2007.33; Shibahara S, 2002, ANTIOXID REDOX SIGN, V4, P593, DOI 10.1089/15230860260220094; Sinzinger H, 2001, J CLIN PHARM THER, V26, P303, DOI 10.1046/j.1365-2710.2001.00360.x; Suzuki T, 2005, BIOCHEM J, V388, P65, DOI 10.1042/BJ20041860; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Warner GJ, 2000, J BIOL CHEM, V275, P28110; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324	60	70	72	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2021	2030		10.1074/jbc.M708352200	http://dx.doi.org/10.1074/jbc.M708352200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039655	hybrid			2022-12-25	WOS:000252501000029
J	Kondo, A; Hirayama, N; Sugito, Y; Shono, M; Tanaka, T; Kitamura, N				Kondo, Asuka; Hirayama, Naoki; Sugito, Yasuko; Shono, Michihiro; Tanaka, Toshiaki; Kitamura, Naomi			Coupling of Grb2 to Gab1 mediates hepatocyte growth factor-induced high intensity ERK signal required for inhibition of HepG2 hepatoma cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; MET RECEPTOR; SCATTER FACTOR; CYCLE ARREST; TRANSCRIPTION FACTORS; REGULATED KINASE; BINDING-SITE; MAP-KINASE; LINE HEPG2; C-MET	Activation of the extracellular signal-regulated kinase (ERK) pathway is a key factor in the regulation of cell proliferation by growth factors. Hepatocyte growth factor (HGF)-induced cell cycle arrest in the human hepatocellular carcinoma cell line HepG2 requires strong activation of the ERK pathway. In this study, we investigated the molecular mechanism of the activation. We constructed a chimeric receptor composed of the extracellular domain of the NGF receptor and the cytoplasmic domain of the HGF receptor (c-Met) and introduced a point mutation (N1358H) into the chimeric receptor, which specifically abrogates the direct binding of Grb2 to c-Met. The mutant chimeric receptor failed to mediate the strong activation of ERK, up-regulation of the expression of a Cdk inhibitor p16(INK4a) and inhibition of HepG2 cell proliferation by ligand stimulation. Moreover, the mutant receptor did not induce tyrosine phosphorylation of the docking protein Gab1. Knockdown of Gab1 using siRNA suppressed the HGF-induced strong activation of ERK and inhibition of HepG2 cell proliferation. These results suggest that coupling of Grb2 to Gab1 mediates the HGF-induced strong activation of the ERK pathway, which is required for the inhibition of HepG2 cell proliferation.	[Kondo, Asuka; Hirayama, Naoki; Sugito, Yasuko; Shono, Michihiro; Tanaka, Toshiaki; Kitamura, Naomi] Tokyo Inst Technol, Dept Biol Sci, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Kitamura, N (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Grad Sch Biosci & Biotechnol, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	nkitamur@bio.titech.ac.jp	Tanaka, Toshiaki/C-5567-2013	Tanaka, Toshiaki/0000-0002-9448-1452				BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; FATEUR V, 1997, CELL GROWTH DIFFER, V8, P655; Fenig E, 1997, CLIN CANCER RES, V3, P135; Fourier TM, 1996, J BIOL CHEM, V271, P22211, DOI 10.1074/jbc.271.36.22211; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Han JH, 2005, J BIOL CHEM, V280, P31548, DOI 10.1074/jbc.M503431200; Kimura A, 1999, CANCER RES, V59, P5133; KOMADA M, 1992, EUR J BIOCHEM, V204, P857, DOI 10.1111/j.1432-1033.1992.tb16705.x; Lahlou H, 2003, J BIOL CHEM, V278, P39356, DOI 10.1074/jbc.M304524200; Maroun CR, 2000, MOL CELL BIOL, V20, P8513, DOI 10.1128/MCB.20.22.8513-8525.2000; Montagner A, 2005, J BIOL CHEM, V280, P5350, DOI 10.1074/jbc.M410012200; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; Nguyen L, 1997, J BIOL CHEM, V272, P20811, DOI 10.1074/jbc.272.33.20811; PELICCI G, 1995, ONCOGENE, V10, P1631; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Ponzetto C, 1996, J BIOL CHEM, V271, P14119, DOI 10.1074/jbc.271.24.14119; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Potempa S, 1998, MOL BIOL CELL, V9, P2185, DOI 10.1091/mbc.9.8.2185; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Terauchi R, 2000, EXP CELL RES, V256, P411, DOI 10.1006/excr.2000.4850; Tsukada Y, 2004, J BIOCHEM, V136, P701, DOI 10.1093/jb/mvh177; Tsukada Y, 2001, J BIOL CHEM, V276, P40968, DOI 10.1074/jbc.M010890200; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; WEIDNER KM, 1993, J CELL BIOL, V121, P145, DOI 10.1083/jcb.121.1.145	30	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1428	1436		10.1074/jbc.M704999200	http://dx.doi.org/10.1074/jbc.M704999200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18003605	hybrid			2022-12-25	WOS:000252282700026
J	Putkey, JA; Waxham, MN; Gaertner, TR; Brewer, KJ; Goldsmith, M; Kubota, Y; Kleerekoper, QK				Putkey, John A.; Waxham, M. Neal; Gaertner, Tara R.; Brewer, Kari J.; Goldsmith, Michael; Kubota, Yoshihisa; Kleerekoper, Quinn K.			Acidic/IQ motif regulator of calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; CALCIUM-BINDING; CA2+ BINDING; IQ MOTIF; NEUROGRANIN; DYNAMICS; DOMAIN; SITES; DISSOCIATION; RECOGNITION	The small IQ motif proteins PEP-19 (62 amino acids) and RC3 (78 amino acids) greatly accelerate the rates of Ca2+ binding to sites III and IV in the C-domain of calmodulin (CaM). We show here that PEP-19 decreases the degree of cooperativity of Ca2+ binding to sites III and IV, and we present a model showing that this could increase Ca2+ binding rate constants. Comparative sequence analysis showed that residues 28 to 58 from PEP-19 are conserved in other proteins. This region includes the IQ motif (amino acids 39-62), and an adjacent acidic cluster of amino acids (amino acids 28-40). A synthetic peptide spanning residues 28-62 faithfully mimics intact PEP-19 with respect to increasing the rates of Ca2+ association and dissociation, as well as binding preferentially to the C-domain of CaM. In contrast, a peptide encoding only the core IQ motif does not modulate Ca2+ binding, and binds to multiple sites on CaM. A peptide that includes only the acidic region does not bind to CaM. These results show that PEP-19 has a novel acidic/IQ CaM regulatory motif in which the IQ sequence provides a targeting function that allows binding of PEP-19 to CaM, whereas the acidic residues modify the nature of this interaction, and are essential for modulating Ca2+ binding to the C-domain of CaM.	[Putkey, John A.; Brewer, Kari J.; Goldsmith, Michael; Kleerekoper, Quinn K.] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Waxham, M. Neal; Gaertner, Tara R.; Kubota, Yoshihisa] Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Putkey, JA (corresponding author), 6431 Fannin St, Houston, TX 77030 USA.	john.putkey@uth.tmc.edu		Brewer Savannah, Kari/0000-0002-8908-7004; Waxham, M. Neal/0000-0003-4801-1190	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038310] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM069611, GM 069611] Funding Source: Medline; NINDS NIH HHS [P01 NS038310, NS 038310] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bayley PM, 1996, PROTEIN SCI, V5, P1215, DOI 10.1002/pro.5560050701; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Biekofsky RR, 1998, BIOCHEMISTRY-US, V37, P7617, DOI 10.1021/bi9800449; Bootman MD, 2001, J CELL SCI, V114, P2213; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cui YF, 2003, ANAL BIOCHEM, V315, P175, DOI 10.1016/S0003-2697(03)00007-1; Evenas J, 2001, STRUCTURE, V9, P185, DOI 10.1016/S0969-2126(01)00575-5; Evenas J, 1997, BIOCHEMISTRY-US, V36, P3448, DOI 10.1021/bi9628275; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Gaertner TR, 2004, J BIOL CHEM, V279, P39374, DOI 10.1074/jbc.M405352200; HAIECH J, 2002, CALCIUM BINDING PROT, V2, P25; Johnson JD, 1996, J BIOL CHEM, V271, P761, DOI 10.1074/jbc.271.2.761; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; LINSE S, 1991, J BIOL CHEM, V266, P8050; MARTIN SR, 1992, EUR J BIOCHEM, V205, P1107, DOI 10.1111/j.1432-1033.1992.tb16879.x; MAUNE JF, 1992, J BIOL CHEM, V267, P5286; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Pak JH, 2000, P NATL ACAD SCI USA, V97, P11232, DOI 10.1073/pnas.210184697; PEDIGO S, 1995, BIOCHEMISTRY-US, V34, P10676, DOI 10.1021/bi00033a044; Peersen OB, 1997, PROTEIN SCI, V6, P794; PENG JW, 2004, BIOCHEMISTRY-US, V34, P16733; Persechini A, 1996, J BIOL CHEM, V271, P62, DOI 10.1074/jbc.271.1.62; PUTKEY JA, 1987, METHOD ENZYMOL, V139, P303; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Putkey JA, 2003, J BIOL CHEM, V278, P49667, DOI 10.1074/jbc.C300372200; Rakhilin SV, 2004, SCIENCE, V306, P698, DOI 10.1126/science.1099961; Slemmon JR, 2000, MOL NEUROBIOL, V22, P99, DOI 10.1385/MN:22:1-3:099; Slemmon JR, 1996, J BIOL CHEM, V271, P15911, DOI 10.1074/jbc.271.27.15911; Sorensen BR, 1998, BIOCHEMISTRY-US, V37, P4244, DOI 10.1021/bi9718200; Torok K, 2001, BIOCHEMISTRY-US, V40, P14878, DOI 10.1021/bi010920+; Trybus KM, 2007, J BIOL CHEM, V282, P23316, DOI 10.1074/jbc.M701636200; Ulmer TS, 2003, J BIOL CHEM, V278, P29261, DOI 10.1074/jbc.M302837200; van Dalen JJW, 2003, EUR J NEUROSCI, V18, P13, DOI 10.1046/j.1460-9568.2003.02720.x; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; VanScyoc WS, 2002, BIOPHYS J, V83, P2767, DOI 10.1016/S0006-3495(02)75286-7; Waxham MN, 1998, J BIOL CHEM, V273, P17579, DOI 10.1074/jbc.273.28.17579; Wu JF, 2002, J BIOL CHEM, V277, P19498, DOI 10.1074/jbc.M109082200; Xiong LW, 2005, J BIOL CHEM, V280, P7070, DOI 10.1074/jbc.M410558200	39	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1401	1410		10.1074/jbc.M703831200	http://dx.doi.org/10.1074/jbc.M703831200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17991744	hybrid, Green Accepted			2022-12-25	WOS:000252282700023
J	Gagarina, V; Carlberg, AL; Pereira-Mouries, L; Hall, DJ				Gagarina, Viktoria; Carlberg, Alyssa L.; Pereira-Mouries, Lucilia; Hall, David J.			Cartilage oligomeric matrix protein protects cells against death by elevating members of the IAP family of survival proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; 5-STRANDED COILED-COIL; SYNOVIAL-FLUID; IX COLLAGEN; COMP; MUTATIONS; APOPTOSIS; PSEUDOACHONDROPLASIA; THROMBOSPONDIN-5; ACTIVATION	Cartilage oligomeric matrix protein (COMP) is a component of cartilage, synovium, ligament, and tendon, yet its normal function is largely unknown. To identify its function we have expressed it in 293 and HeLa cell lines and in primary human chondrocytes. We find that COMP protects these cells against death, either in the presence or absence of tumor necrosis factor alpha and is able to block activation of caspase 3, a critical effector caspase. This effect appears to be mediated by the IAP (inhibitor of apoptosis protein) family of anti-apoptotic proteins because the levels of XIAP, survivin, cIAP1 and cIAP2 are significantly elevated in the COMP-expressing cells and down-regulation of survivin and XIAP protein levels by small interfering RNAs blocks the ability of COMP to enhance survival. The mRNAs for most of the IAP family members were not increased by COMP, indicating that a translational/post-translational mechanism was involved in their induction. However, in both HeLa cells and chondrocytes, COMP induced survivin mRNA by 5-fold. Thus survivin is the first gene identified to be up-regulated transcriptionally by COMP. The carboxyl-terminal half of the protein comprising the type 3 repeats and the RGD sequence (CaCTD domain) was sufficient to promote survival and to elevate the IAPs. Further, an RGD peptide was able to block the prosurvival effect of COMP and the induction of XIAP and survivin, indicating that survival is likely mediated through integrin signaling. These data point to a new role for COMP in protecting cells against death.	NIH, NIAMS, Cartilage Mol Genet Grp, Cartilage Biol & Orthoped Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Hall, DJ (corresponding author), NIH, NIAMS, Cartilage Mol Genet Grp, Cartilage Biol & Orthoped Branch, Bldg 13 Rm 3W17,9000 Rockville Pike, Bethesda, MD 20892 USA.	halld@mail.nih.gov		Pereira Mouries, Lucilia/0000-0001-5836-6011	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041141, ZIAAR041141] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Briggs MD, 1998, AM J HUM GENET, V62, P311, DOI 10.1086/301713; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; CARVALHOBITTENC.M, 2002, J GENE MED, V4, P14; Chen FH, 2007, J BIOL CHEM, V282, P24591, DOI 10.1074/jbc.M611390200; Chen FH, 2005, J BIOL CHEM, V280, P32655, DOI 10.1074/jbc.M504778200; Clark AG, 1999, ARTHRITIS RHEUM, V42, P2356, DOI 10.1002/1529-0131(199911)42:11<2356::AID-ANR14>3.0.CO;2-R; Deere M, 1998, AM J MED GENET, V80, P510, DOI 10.1002/(SICI)1096-8628(19981228)80:5<510::AID-AJMG14>3.0.CO;2-F; Di Cesare PE, 2002, MATRIX BIOL, V21, P461, DOI 10.1016/S0945-053X(02)00015-X; DICESARE PE, 1995, J ORTHOPAED RES, V13, P422, DOI 10.1002/jor.1100130316; Dickinson SC, 2003, MATRIX BIOL, V22, P267, DOI 10.1016/S0945-053X(03)00034-9; Dodge GR, 1998, OSTEOARTHR CARTILAGE, V6, P435, DOI 10.1053/joca.1998.0147; Ebert O, 1999, CYTOKINES CELL MOL T, V5, P165; EFIMOV VP, 1994, FEBS LETT, V341, P54, DOI 10.1016/0014-5793(94)80239-4; Farina G, 2006, MATRIX BIOL, V25, P213, DOI 10.1016/j.matbio.2006.01.007; Fotin-Mleczek M, 2004, J BIOL CHEM, V279, P677, DOI 10.1074/jbc.M310969200; Friess H, 2001, ANN SURG, V234, P769, DOI 10.1097/00000658-200112000-00008; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Guo Y, 1998, EMBO J, V17, P5265, DOI 10.1093/emboj/17.18.5265; Hammes HP, 1996, NAT MED, V2, P529, DOI 10.1038/nm0596-529; Hashimoto Y, 2003, AM J PATHOL, V163, P101, DOI 10.1016/S0002-9440(10)63634-6; He LS, 2006, J BIOL CHEM, V281, P11235, DOI 10.1074/jbc.M508779200; Hecht JT, 2004, J ORTHOP RES, V22, P759, DOI 10.1016/j.orthres.2003.11.010; Hecht JT, 1998, MATRIX BIOL, V17, P625, DOI 10.1016/S0945-053X(98)90113-5; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; Holcik M, 2001, APOPTOSIS, V6, P253, DOI 10.1023/A:1011379307472; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Ishii Y, 2006, SPINE, V31, P1539, DOI 10.1097/01.brs.0000221994.61882.4a; Jones JL, 1999, J CLIN PATHOL-MOL PA, V52, P208, DOI 10.1136/mp.52.4.208; JordanSciutto KL, 1997, EXP CELL RES, V236, P527, DOI 10.1006/excr.1997.3762; Kipnes J, 2003, OSTEOARTHR CARTILAGE, V11, P442, DOI 10.1016/S1063-4584(03)00055-4; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; LAWLER J, 2002, ENCY MOL MED, P481; Lohmander LS, 1999, ARTHRITIS RHEUM, V42, P534, DOI 10.1002/1529-0131(199904)42:3<534::AID-ANR19>3.0.CO;2-J; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; MORGELIN M, 1992, J BIOL CHEM, V267, P6137; Murphy JM, 1999, MATRIX BIOL, V18, P487, DOI 10.1016/S0945-053X(99)00042-6; Neidhart M, 1997, BRIT J RHEUMATOL, V36, P1151; Petersson IF, 1998, BRIT J RHEUMATOL, V37, P46; RENZING J, 1995, ONCOGENE, V10, P1865; Riessen R, 2001, ARTERIOSCL THROM VAS, V21, P47, DOI 10.1161/01.ATV.21.1.47; Rodriguez A, 1999, ANAL BIOCHEM, V272, P171, DOI 10.1006/abio.1999.4156; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; SAXNE T, 1992, BRIT J RHEUMATOL, V31, P583; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Stennicke HR, 2002, TRENDS BIOCHEM SCI, V27, P94, DOI 10.1016/S0968-0004(01)02045-X; Vilim V, 1997, ARCH BIOCHEM BIOPHYS, V341, P8, DOI 10.1006/abbi.1997.9941; Lipinski KV, 2006, CIRC RES, V98, P1490, DOI 10.1161/01.RES.0000229267.77982.0d; Xiao Y, 2004, J GASTROEN HEPATOL, V19, P296, DOI 10.1111/j.1440-1746.2003.03268.x; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874	53	34	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					648	659		10.1074/jbc.M704035200	http://dx.doi.org/10.1074/jbc.M704035200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17993464	hybrid			2022-12-25	WOS:000251940300069
J	Nagai, A; Kim, WK; Lee, HJ; Jeong, HS; Kim, KS; Hong, SH; Park, IH; Kim, SU				Nagai, Atsushi; Kim, Woo K.; Lee, Hong J.; Jeong, Han S.; Kim, Kwang S.; Hong, Seok H.; Park, In H.; Kim, Seung U.			Multilineage Potential of Stable Human Mesenchymal Stem Cell Line Derived from Fetal Marrow	PLOS ONE			English	Article							PROMOTES FUNCTIONAL RECOVERY; CEREBRAL-ARTERY OCCLUSION; IN-VITRO DIFFERENTIATION; BONE-MARROW; STROMAL CELLS; INTRACEREBRAL HEMORRHAGE; RAT MODEL; BRAIN TRANSPLANTATION; PROGENITOR CELLS; ADULT-RAT	Human bone marrow contains two major cell types, hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs). MSCs possess self-renewal capacity and pluripotency defined by their ability to differentiate into osteoblasts, chondrocytes, adipocytes and muscle cells. MSCs are also known to differentiate into neurons and glial cells in vitro, and in vivo following transplantation into the brain of animal models of neurological disorders including ischemia and intracerebral hemorrhage (ICH) stroke. In order to obtain sufficient number and homogeneous population of human MSCs, we have clonally isolated permanent and stable human MSC lines by transfecting primary cell cultures of fetal human bone marrow MSCs with a retroviral vector encoding v-myc gene. One of the cell lines, HM3.B10 (B10), was found to differentiate into neural cell types including neural stem cells, neurons, astrocytes and oligodendrocytes in vitro as shown by expression of genetic markers for neural stem cells ( nestin and Musashi1), neurons ( neurofilament protein, synapsin and MAP2), astrocytes ( glial fibrillary acidic protein, GFAP) and oligodendrocytes ( myelin basic protein, MBP) as determined by RT-PCR assay. In addition, B10 cells were found to differentiate into neural cell types as shown by immunocytochical demonstration of nestin ( for neural stem cells), neurofilament protein and beta-tubulin III ( neurons) GFAP ( astrocytes), and galactocerebroside ( oligodendrocytes). Following brain transplantation in mouse ICH stroke model, B10 human MSCs integrate into host brain, survive, differentiate into neurons and astrocytes and induce behavioral improvement in the ICH animals. B10 human MSC cell line is not only a useful tool for the studies of organogenesis and specifically for the neurogenesis, but also provides a valuable source of cells for cell therapy studies in animal models of stroke and other neurological disorders.	[Nagai, Atsushi; Kim, Woo K.; Lee, Hong J.; Jeong, Han S.; Kim, Kwang S.; Hong, Seok H.; Kim, Seung U.] Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC V6T 1W5, Canada; [Nagai, Atsushi] Shimane Univ, Sch Med, Dept Lab Med, Izumo, Shimane, Japan; [Kim, Woo K.; Lee, Hong J.; Park, In H.; Kim, Seung U.] Gachon Univ, Gil Hosp, Inst Regnerat Med, Inchon, South Korea; [Jeong, Han S.] Chonnam Natl Univ, Sch Med, Dept Physiol, Kwangju, South Korea	University of British Columbia; Shimane University; Gachon University; Chonnam National University	Kim, SU (corresponding author), Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC V6T 1W5, Canada.	sukim@interchange.ubc.ca		Jeong, Han-Seong/0000-0001-6921-6625; Nagai, Atsushi/0000-0002-9280-8044	Korean Government (MOST) [M10641050001-06N4105-00110]; Canadian Myelin Research Initiative	Korean Government (MOST)(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government); Canadian Myelin Research Initiative	This study was supported by the Korean Government (MOST M10641050001-06N4105-00110) and the Canadian Myelin Research Initiative.	Acampora D, 2001, PROG NEUROBIOL, V64, P69, DOI 10.1016/S0301-0082(00)00042-3; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; Borlongan CV, 2005, LIFE SCI, V76, P1503, DOI 10.1016/j.lfs.2004.09.022; Borlongan CV, 2004, STROKE, V35, P2206, DOI 10.1161/01.STR.0000138954.25825.0b; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Cau E, 1997, DEVELOPMENT, V124, P1611; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Cho T, 2002, NEUROREPORT, V13, P1447, DOI 10.1097/00001756-200208070-00020; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Ehtesham M, 2004, NEOPLASIA, V6, P287, DOI 10.1593/neo.03427; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Gajovic S, 1997, DIFFERENTIATION, V62, P187; Gebel JM, 2000, NEUROL CLIN, V18, P419, DOI 10.1016/S0733-8619(05)70200-0; Good P, 1998, GENOMICS, V52, P382, DOI 10.1006/geno.1998.5456; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Inagawa T, 2002, NEUROSURG REV, V25, P237, DOI 10.1007/s10143-002-0222-0; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Jiang YH, 2003, P NATL ACAD SCI USA, V100, P11854, DOI 10.1073/pnas.1834196100; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kim BJ, 2002, NEUROREPORT, V13, P1185, DOI 10.1097/00001756-200207020-00023; Kim Seung U, 2002, Methods Mol Biol, V198, P55; Kim SU, 2006, NEUROPATHOLOGY, V26, P129, DOI 10.1111/j.1440-1789.2006.00688.x; KIM SU, 1986, J NEUROSCI RES, V15, P303, DOI 10.1002/jnr.490150303; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; KIM SU, 1983, BRAIN RES, V274, P79, DOI 10.1016/0006-8993(83)90522-X; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Krause DS, 2002, GENE THER, V9, P754, DOI 10.1038/sj.gt.3301760; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Lee HJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000156; Lee HJ, 2007, STEM CELLS, V25, P1204, DOI 10.1634/stemcells.2006-0409; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lee ST, 2005, NEUROSCI RES, V52, P243, DOI 10.1016/j.neures.2005.03.016; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Meng XL, 2003, J NEUROSCI RES, V74, P266, DOI 10.1002/jnr.10764; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Modo M, 2002, BRAIN RES, V958, P70, DOI 10.1016/S0006-8993(02)03463-7; Morgenstern LB, 2005, STROKE, V36, pE23, DOI 10.1161/01.STR.0000155685.77775.4c; Nagai A, 2001, NEUROBIOL DIS, V8, P1057, DOI 10.1006/nbdi.2001.0437; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Ourednik V, 2001, SCIENCE, V293, P1820, DOI 10.1126/science.1060580; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Ryu JK, 2004, NEUROBIOL DIS, V16, P68, DOI 10.1016/j.nbd.2004.01.016; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Schmidt NO, 2005, NEOPLASIA, V7, P623, DOI 10.1593/neo.04781; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; Snyder SH, 1998, NEURON, V21, P283, DOI 10.1016/S0896-6273(00)80538-3; Sommer L, 1995, NEURON, V15, P1245, DOI 10.1016/0896-6273(95)90005-5; Steiner JP, 1997, P NATL ACAD SCI USA, V94, P2019, DOI 10.1073/pnas.94.5.2019; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Sun LX, 2004, J CLIN INVEST, V113, P1364, DOI 10.1172/JCI200420001; Terzic J, 1999, INT J DEV BIOL, V43, P501; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tondreau T, 2004, DIFFERENTIATION, V72, P319, DOI 10.1111/j.1432-0436.2004.07207003.x; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wieczorek G, 2003, CELL TISSUE RES, V311, P227, DOI 10.1007/s00441-002-0671-3; Woitge Henning W., 1999, Current Opinion in Rheumatology, V11, P218, DOI 10.1097/00002281-199905000-00011; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Zhang RL, 2004, J NEUROSCI, V24, P5810, DOI 10.1523/JNEUROSCI.1109-04.2004; Zhang WR, 1999, NEUROSCI LETT, V276, P161, DOI 10.1016/S0304-3940(99)00848-4; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	83	104	114	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1272	10.1371/journal.pone.0001272	http://dx.doi.org/10.1371/journal.pone.0001272			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060066	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459400019
J	Bull, TJ; Gilbert, SC; Sridhar, S; Linedale, R; Dierkes, N; Sidi-Boumedine, K; Hermon-Taylor, J				Bull, Tim J.; Gilbert, Sarah C.; Sridhar, Saranya; Linedale, Richard; Dierkes, Nicola; Sidi-Boumedine, Karim; Hermon-Taylor, John			A Novel Multi-Antigen Virally Vectored Vaccine against Mycobacterium avium Subspecies paratuberculosis	PLOS ONE			English	Article								Background. Mycobacterium avium subspecies paratuberculosis causes systemic infection and chronic intestinal inflammation in many species including primates. Humans are exposed through milk and from sources of environmental contamination. Hitherto, the only vaccines available against Mycobacterium avium subspecies paratuberculosis have been limited to veterinary use and comprised attenuated or killed organisms. Methods. We developed a vaccine comprising a fusion construct designated HAV, containing components of two secreted and two cell surface Mycobacterium avium subspecies paratuberculosis proteins. HAV was transformed into DNA, human Adenovirus 5 (Ad5) and Modified Vaccinia Ankara (MVA) delivery vectors. Full length expression of the predicted 95 kDa fusion protein was confirmed. Principal Findings. Vaccination of naive and Mycobacterium avium subspecies paratuberculosis infected C57BL/6 mice using DNA-prime/MVA-boost or Ad5-prime/MVA-boost protocols was highly immunogenic resulting in significant IFN-gamma ELISPOT responses by splenocytes against recombinant vaccine antigens and a range of HAV specific peptides. This included strong recognition of a T-cell epitope GFAEINPIA located near the C-terminus of the fusion protein. Antibody responses to recombinant vaccine antigens and HAV specific peptides but not GFAEINPIA, also occurred. No immune recognition of vaccine antigens occurred in any sham vaccinated Mycobacterium avium subspecies paratuberculosis infected mice. Vaccination using either protocol significantly attenuated pre-existing Mycobacterium avium subspecies paratuberculosis infection measured by qPCR in spleen and liver and the Ad5-prime/MVA-boost protocol also conferred some protection against subsequent challenge. No adverse effects of vaccination occurred in any of the mice. Conclusions/Significance. A range of modern veterinary and clinical vaccines for the treatment and prevention of disease caused by Mycobacterium avium subspecies paratuberculosis are needed. The present vaccine proved to be highly immunogenic without adverse effect in mice and both attenuated pre-existing Mycobacterium avium subspecies paratuberculosis infection and conferred protection against subsequent challenge. Further studies of the present vaccine in naturally infected animals and humans are indicated.	[Bull, Tim J.; Linedale, Richard; Dierkes, Nicola; Sidi-Boumedine, Karim; Hermon-Taylor, John] St Georges Univ London, Dept Cardiovasc Sci Surg, London, England; [Gilbert, Sarah C.; Sridhar, Saranya] Univ Oxford, Nuffield Dept Med, Wellcome Trust Ctr Human Genet, Oxford, England	St Georges University London; University of Oxford; Wellcome Centre for Human Genetics	Hermon-Taylor, J (corresponding author), St Georges Univ London, Dept Cardiovasc Sci Surg, London, England.	jhermon@sgul.ac.uk	Gilbert, Sarah C./H-2857-2019	Gilbert, Sarah C./0000-0002-6823-9750; Sidi-Boumedine, Karim/0000-0003-2746-9629; Sridhar, Saranya/0000-0002-4267-3102	MRC/NERC; National Association of Crohn's and Colitis; Action Medical Research	MRC/NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)Medical Research Council UK (MRC)); National Association of Crohn's and Colitis; Action Medical Research	Support for this work was contributed by grants from the MRC/NERC, National Association of Crohn's and Colitis, Action Medical Research and multiple trusts and private donors. The funders had no role in the study design and conduct, data collection and analysis, decision to publish, or in the preparation of the manuscript.	Autschbach F, 2005, GUT, V54, P944, DOI 10.1136/gut.2004.045526; Basagoudanavar SH, 2006, VET RES COMMUN, V30, P357, DOI 10.1007/s11259-006-3253-0; Begg DJ, 2005, VACCINE, V23, P4999, DOI 10.1016/j.vaccine.2005.05.031; BUERGELT CD, 1978, VET PATHOL, V15, P196, DOI 10.1177/030098587801500206; Bull TJ, 2003, J CLIN MICROBIOL, V41, P2915, DOI 10.1128/JCM.41.7.2915-2923.2003; Bull TJ, 2000, VET MICROBIOL, V77, P453, DOI 10.1016/S0378-1135(00)00330-8; Chacon O, 2004, ANNU REV MICROBIOL, V58, P329, DOI 10.1146/annurev.micro.58.030603.123726; CHIODINI RJ, 1993, J COMP PATHOL, V109, P309, DOI 10.1016/S0021-9975(08)80295-2; Clarke CJ, 1997, J COMP PATHOL, V116, P217, DOI 10.1016/S0021-9975(97)80001-1; Clarke CJ, 1996, J COMP PATHOL, V114, P419, DOI 10.1016/S0021-9975(96)80017-X; Corn JL, 2005, APPL ENVIRON MICROB, V71, P6963, DOI 10.1128/AEM.71.11.6963-6967.2005; Corpa JM, 2000, VET REC, V146, P195, DOI 10.1136/vr.146.7.195; Dupont C, 2005, J MED MICROBIOL, V54, P1083, DOI 10.1099/jmm.0.46163-0; Eckstein TM, 2003, MICROBIOL-SGM, V149, P2797, DOI 10.1099/mic.0.26528-0; Ellingson JLE, 2005, J FOOD PROTECT, V68, P966, DOI 10.4315/0362-028X-68.5.966; Estcourt MJ, 2005, EUR J IMMUNOL, V35, P2532, DOI 10.1002/eji.200535184; Feller M, 2007, LANCET INFECT DIS, V7, P607, DOI 10.1016/S1473-3099(07)70211-6; Gearry RB, 2006, INFLAMM BOWEL DIS, V12, P936, DOI 10.1097/01.mib.0000231572.88806.b9; Greig A, 1999, J CLIN MICROBIOL, V37, P1746, DOI 10.1128/JCM.37.6.1746-1751.1999; Gwozdz JM, 2000, AUST VET J, V78, P560, DOI 10.1111/j.1751-0813.2000.tb11902.x; Hanke T, 1998, VACCINE, V16, P426, DOI 10.1016/S0264-410X(97)00296-X; Hanke T, 1998, VACCINE, V16, P439, DOI 10.1016/S0264-410X(97)00226-0; Hermon-Taylor J, 2000, CAN J GASTROENTEROL, V14, P521, DOI 10.1155/2000/798305; Hildebrand H, 2003, GUT, V52, P1432, DOI 10.1136/gut.52.10.1432; Huntley JF, 2005, INFECT IMMUN, V73, P6877, DOI 10.1128/IAI.73.10.6877-6884.2005; Kalis CHJ, 2001, AM J VET RES, V62, P270, DOI 10.2460/ajvr.2001.62.270; Koets A, 2006, VACCINE, V24, P2550, DOI 10.1016/j.vaccine.2005.12.019; KORMENDY B, 1994, VET MICROBIOL, V41, P117, DOI 10.1016/0378-1135(94)90141-4; LARSEN AB, 1978, AM J VET RES, V39, P65; Mackintosh CG, 2005, NEW ZEAL VET J, V53, P216, DOI 10.1080/00480169.2005.36549; Manning EJB, 2001, REV SCI TECH OIE, V20, P133, DOI 10.20506/rst.20.1.1275; Marri PR, 2006, FEMS MICROBIOL REV, V30, P906, DOI 10.1111/j.1574-6976.2006.00041.x; McShane H, 2001, INFECT IMMUN, V69, P681, DOI 10.1128/IAI.69.2.681-686.2001; Mullerad J, 2002, MED MICROBIOL IMMUN, V190, P179, DOI 10.1007/s00430-001-0104-z; Mullerad J, 2003, MICROB PATHOGENESIS, V34, P81, DOI 10.1016/S0882-4010(02)00209-7; Mura M, 2006, APPL ENVIRON MICROB, V72, P854, DOI 10.1128/AEM.72.1.854-859.2006; Muskens J, 2002, VET MICROBIOL, V86, P269, DOI 10.1016/S0378-1135(02)00006-8; Naser SA, 1998, CURR MICROBIOL, V37, P373, DOI 10.1007/s002849900396; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Olsen I, 2000, INFECT IMMUN, V68, P801, DOI 10.1128/IAI.68.2.801-808.2000; Pickup RW, 2006, APPL ENVIRON MICROB, V72, P4067, DOI 10.1128/AEM.02490-05; Pickup RW, 2005, APPL ENVIRON MICROB, V71, P2130, DOI 10.1128/AEM.71.4.2130-2139.2005; Raizman EA, 2005, CAN J VET RES, V69, P32; Reddacliff L, 2006, VET MICROBIOL, V115, P77, DOI 10.1016/j.vetmic.2005.12.021; RIEMANN HP, 1983, ADV VET SCI COMP MED, V27, P481; Rigden RC, 2006, J MED MICROBIOL, V55, P1735, DOI 10.1099/jmm.0.46785-0; Romero C, 2005, INFLAMM BOWEL DIS, V11, P116, DOI 10.1097/00054725-200502000-00004; SANDERSON JD, 1992, GUT, V33, P145, DOI 10.1136/gut.33.2.145; SAXEGAARD F, 1985, VET REC, V116, P439, DOI 10.1136/vr.116.16.439; SCANU AM, 2007, J CLIN MICR IN PRESS, V45; Sechi LA, 2006, VACCINE, V24, P229, DOI 10.1016/j.vaccine.2005.08.086; Sechi LA, 2005, AM J GASTROENTEROL, V100, P1529, DOI 10.1111/j.1572-0241.2005.41415.x; Sheridan JM, 2003, J MOL MICROB BIOTECH, V5, P57, DOI 10.1159/000068723; Shin SJ, 2005, INFECT IMMUN, V73, P5074, DOI 10.1128/IAI.73.8.5074-5085.2005; SIGURDSSON B, 1960, AM J VET RES, V21, P54; Singh SV, 2007, VACCINE, V25, P7102, DOI 10.1016/j.vaccine.2007.07.054; STUART P, 1965, BRIT VET J, V121, P289, DOI 10.1016/S0007-1935(17)41102-X; SWEENEY RW, 1992, J CLIN MICROBIOL, V30, P166, DOI 10.1128/JCM.30.1.166-171.1992; Tizard M, 1998, MICROBIOL-SGM, V144, P3413, DOI 10.1099/00221287-144-12-3413; TIZARD MLV, 1992, J GEN MICROBIOL, V138, P1729, DOI 10.1099/00221287-138-8-1729; Turunen P, 2006, INFLAMM BOWEL DIS, V12, P677, DOI 10.1097/00054725-200608000-00002; vanSchaik G, 1996, VET REC, V139, P624; Vind I, 2006, AM J GASTROENTEROL, V101, P1274, DOI 10.1111/j.1572-0241.2006.00552.x; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; WENTINK GH, 1994, J VET MED B, V41, P517, DOI 10.1111/j.1439-0450.1994.tb00258.x; Whittington RJ, 2005, APPL ENVIRON MICROB, V71, P5304, DOI 10.1128/AEM.71.9.5304-5308.2005; Whittington RJ, 2004, APPL ENVIRON MICROB, V70, P2989, DOI 10.1128/AEM.70.5.2989-3004.2004; WILESMITH JW, 1982, BRIT VET J, V138, P321, DOI 10.1016/S0007-1935(17)31037-0; Withers-Martinez C, 1999, PROTEIN ENG, V12, P1113, DOI 10.1093/protein/12.12.1113	69	26	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1229	10.1371/journal.pone.0001229	http://dx.doi.org/10.1371/journal.pone.0001229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043737	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000207459300011
J	Choi, K; Creighton, CJ; Stivers, D; Fujimoto, N; Kurie, JM				Choi, Kuicheon; Creighton, Chad J.; Stivers, David; Fujimoto, Nobukazu; Kurie, Jonathan M.			Transcriptional Profiling of Non-Small Cell Lung Cancer Cells with Activating EGFR Somatic Mutations	PLOS ONE			English	Article								Background. Activating somatic mutations in epidermal growth factor receptor (EGFR) confer unique biologic features to non-small cell lung cancer (NSCLC) cells, but the transcriptional mediators of EGFR in this subgroup of NSCLC have not been fully elucidated. Methodology/Principal Findings. Here we used genetic and pharmacologic approaches to elucidate the transcriptomes of NSCLC cell lines. We transcriptionally profiled a panel of EGFR-mutant and -wild-type NSCLC cell lines cultured in the presence or absence of an EGFR tyrosine kinase inhibitor. Hierarchical analysis revealed that the cell lines segregated on the basis of EGFR mutational status (mutant versus wild-type), and expression signatures were identified by supervised analysis that distinguished the cell lines based on mutational status (wild-type versus mutant) and type of mutation (L858R versus D746-750). Using an EGFR mutation-specific expression signature as a probe, we mined the gene expression profiles of two independent cohorts of NSCLC patients and found the signature in a subset. EGFR tyrosine kinase inhibitor treatment regulated the expression of multiple genes, and pharmacologic inhibition of the protein products of two of them (PTGS2 and EphA2) inhibited anchorage-independent growth in EGFR-mutant NSCLC cells. Conclusions/Significance. We have elucidated genes not previously associated with EGFR-mutant NSCLC, two of which enhanced the clonogenicity of these cells, distinguishing these mediators from others previously shown to maintain cell survival. These findings have potential clinical relevance given the availability of pharmacologic tools to inhibit the protein products of these genes.	[Choi, Kuicheon; Fujimoto, Nobukazu; Kurie, Jonathan M.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Stivers, David] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Kurie, JM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA.	jkurie@mdanderson.org	Fujimoto, Nobukazu/U-8488-2019	Fujimoto, Nobukazu/0000-0002-4516-0433	National Cancer Institute [P50 CA70907, P30 CA125123, R01 CA117965]; NATIONAL CANCER INSTITUTE [R01CA117965, P50CA070907, P30CA125123] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute grants P50 CA70907, P30 CA125123, and R01 CA117965.	Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Brantley DM, 2002, ONCOGENE, V21, P7011, DOI 10.1038/sj.onc.1205679; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Creighton C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r46; Creighton CJ, 2006, CANCER RES, V66, P3903, DOI 10.1158/0008-5472.CAN-05-4363; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fujimoto K, 2001, AM J RESP CELL MOL, V25, P233, DOI 10.1165/ajrcmb.25.2.4275; Fujimoto N, 2005, CANCER RES, V65, P11478, DOI 10.1158/0008-5472.CAN-05-1977; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Lavergne E, 2003, CANCER RES, V63, P7468; LIU M, 2007, AM J RESP CELL MOL B; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Riely GJ, 2006, CLIN CANCER RES, V12, P839, DOI 10.1158/1078-0432.CCR-05-1846; Riely GJ, 2006, CLIN CANCER RES, V12, P7232, DOI 10.1158/1078-0432.CCR-06-0658; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Shulby SA, 2004, CANCER RES, V64, P4693, DOI 10.1158/0008-5472.CAN-03-3437; Song LX, 2006, CANCER RES, V66, P5542, DOI 10.1158/0008-5472.CAN-05-4620; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Walker-Daniels J, 2003, AM J PATHOL, V162, P1037, DOI 10.1016/S0002-9440(10)63899-0; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Wu R, 2005, CLIN CANCER RES, V11, P6155, DOI 10.1158/1078-0432.CCR-04-2664; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang J, 2007, AM J PATHOL, V170, P366, DOI 10.2353/ajpath.2007.060706	38	23	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1226	10.1371/journal.pone.0001226	http://dx.doi.org/10.1371/journal.pone.0001226			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030354	gold, Green Submitted, Green Published			2022-12-25	WOS:000207459200033
J	Gondek, LP; Dunbar, AJ; Szpurka, H; McDevitt, MA; Maciejewski, JP				Gondek, Lukasz P.; Dunbar, Andrew J.; Szpurka, Hadrian; McDevitt, Michael A.; Maciejewski, Jaroslaw P.			SNP Array Karyotyping Allows for the Detection of Uniparental Disomy and Cryptic Chromosomal Abnormalities in MDS/MPD-U and MPD	PLOS ONE			English	Article								We applied single nucleotide polymorphism arrays (SNP-A) to study karyotypic abnormalities in patients with atypical myeloproliferative syndromes (MPD), including myeloproliferative/myelodysplastic syndrome overlap both positive and negative for the JAK2 V617F mutation and secondary acute myeloid leukemia (AML). In typical MPD cases (N = 8), which served as a control group, those with a homozygous V617F mutation showed clear uniparental disomy (UPD) of 9p using SNP-A. Consistent with possible genomic instability, in 19/30 MDS/MPD-U patients, we found additional lesions not identified by metaphase cytogenetics. In addition to UPD9p, we also have detected UPD affecting other chromosomes, including 1 (2/30), 11 (4/30), 12 (1/30) and 22 (1/30). Transformation to AML was observed in 8/30 patients. In 5 V617F+ patients who progressed to AML, we show that SNP-A can allow for the detection of two modes of transformation: leukemic blasts evolving from either a wild-type jak2 precursor carrying other acquired chromosomal defects, or from a V617F+ mutant progenitor characterized by UPD9p. SNP-A-based detection of cryptic lesions in MDS/MPD-U may help explain the clinical heterogeneity of this disorder.	[Gondek, Lukasz P.; Dunbar, Andrew J.; Szpurka, Hadrian; Maciejewski, Jaroslaw P.] Cleveland Clin, Expt Hematol & Hematopoiesis Sect, Taussig Canc Ctr, Cleveland, OH 44106 USA; [McDevitt, Michael A.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [McDevitt, Michael A.] Sidney Kimmel Canc Ctr, Baltimore, MD USA	Cleveland Clinic Foundation; Johns Hopkins University	Maciejewski, JP (corresponding author), Cleveland Clin, Expt Hematol & Hematopoiesis Sect, Taussig Canc Ctr, Cleveland, OH 44106 USA.	maciejj@ccf.org			NIH [R01 HL082983, U54 RR019391, K24 HL077522]; Robert Duggan Cancer Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019391] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082983, K24HL077522] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Duggan Cancer Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH R01 HL082983(JPM), U54 RR019391(JPM), K24 HL077522(JPM) and a charitable donation from Robert Duggan Cancer Research Fund.	Adeyinka A, 2003, HEMATOL ONCOL CLIN N, V17, P1129, DOI 10.1016/S0889-8588(03)00087-X; Andersen CL, 2007, CARCINOGENESIS, V28, P38, DOI 10.1093/carcin/bgl086; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Cabello AI, 2005, LEUKEMIA RES, V29, P365, DOI 10.1016/j.leukres.2004.07.014; Campbell PJ, 2006, BLOOD, V108, P3548, DOI 10.1182/blood-2005-12-013748; Dingli D, 2006, CANCER-AM CANCER SOC, V106, P1985, DOI 10.1002/cncr.21868; Frohling S, 2006, BLOOD, V107, P1242, DOI 10.1182/blood-2005-09-3644; GONDEK L, 2007, BLOOD IN PRESS; Gondek LP, 2007, LEUKEMIA, V21, P2058, DOI 10.1038/sj.leu.2404745; Harir N, 2007, BLOOD, V109, P1678, DOI 10.1182/blood-2006-01-029918; Harris NL, 1999, J CLIN ONCOL, V17, P3835, DOI 10.1200/JCO.1999.17.12.3835; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kralovics R, 2002, EXP HEMATOL, V30, P229, DOI 10.1016/S0301-472X(01)00789-5; Lee JW, 2006, ONCOGENE, V25, P1434, DOI 10.1038/sj.onc.1209163; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; Lippert E, 2006, BLOOD, V108, P1865, DOI 10.1182/blood-2006-01-013540; MOHAMEDALI A, 2007, BLOOD IN PRESS; Morison IM, 2002, BLOOD, V99, P375, DOI 10.1182/blood.V99.1.375; Najfeld V, 2002, BRIT J HAEMATOL, V119, P558, DOI 10.1046/j.1365-2141.2002.03763.x; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Nigro JM, 2001, AM J PATHOL, V158, P1253, DOI 10.1016/S0002-9440(10)64076-X; Nyga R, 2005, BIOCHEM J, V390, P359, DOI 10.1042/BJ20041523; Pei JM, 2006, CANCER GENET CYTOGEN, V170, P65, DOI 10.1016/j.cancergencyto.2006.05.002; Raghavan M, 2005, CANCER RES, V65, P375; SHAFFER LG, 2005, TOMMERUP N INT SYSTE; Steensma DP, 2006, LEUKEMIA, V20, P971, DOI 10.1038/sj.leu.2404206; Steensma DP, 2005, BLOOD, V106, P1207, DOI 10.1182/blood-2005-03-1183; Szpurka H, 2006, BLOOD, V108, P2173, DOI 10.1182/blood-2006-02-005751; Tefferi A, 2005, CANCER, V104, P1656, DOI 10.1002/cncr.21358; Theocharides A, 2007, BLOOD, V110, P375, DOI 10.1182/blood-2006-12-062125; Tiu R, 2007, LEUKEMIA, V21, P1648, DOI 10.1038/sj.leu.2404757; VARDIMAN JW, 2001, WHO CLASSIFICATION T, P45; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88	39	71	76	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1225	10.1371/journal.pone.0001225	http://dx.doi.org/10.1371/journal.pone.0001225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030353	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459200032
J	Grandjean, V; Yaman, R; Cuzin, F; Rassoulzadegan, M				Grandjean, Valerie; Yaman, Ruken; Cuzin, Francois; Rassoulzadegan, Minoo			Inheritance of an Epigenetic Mark: The CpG DNA Methyltransferase 1 Is Required for De Novo Establishment of a Complex Pattern of Non-CpG Methylation	PLOS ONE			English	Article								Site-specific methylation of cytosines is a key epigenetic mark of vertebrate DNA. While a majority of the methylated residues are in the symmetrical (meC)pG:Gp(meC) configuration, a smaller, but significant fraction is found in the CpA, CpT and CpC asymmetric (non-CpG) dinucleotides. CpG methylation is reproducibly maintained by the activity of the DNA methyltransferase 1 (Dnmt1) on the newly replicated hemimethylated substrates (meC)pG:GpC. On the other hand, establishment and hereditary maintenance of non-CpG methylation patterns have not been analyzed in detail. We previously reported the occurrence of site- and allele-specific methylation at both CpG and non-CpG sites. Here we characterize a hereditary complex of non-CpG methylation, with the transgenerational maintenance of three distinct profiles in a constant ratio, associated with extensive CpG methylation. These observations raised the question of the signal leading to the maintenance of the pattern of asymmetric methylation. The complete non-CpG pattern was reinstated at each generation in spite of the fact that the majority of the sperm genomes contained either none or only one methylated non-CpG site. This observation led us to the hypothesis that the stable CpG patterns might act as blueprints for the maintenance of non-CpG DNA methylation. As predicted, non-CpG DNA methylation profiles were abrogated in a mutant lacking Dnmt1, the enzymes responsible for CpG methylation, but not in mutants defective for either Dnmt3a or Dnmt2.	[Grandjean, Valerie; Yaman, Ruken; Cuzin, Francois; Rassoulzadegan, Minoo] Fac Med Nice, INSERM, U636, Nice, France; [Grandjean, Valerie; Yaman, Ruken; Cuzin, Francois; Rassoulzadegan, Minoo] Equipe Labellisee Ligue Natl Canc, Nice, France; [Grandjean, Valerie; Yaman, Ruken; Cuzin, Francois; Rassoulzadegan, Minoo] Univ Nice Sophia Antipolis, Lab Genet Dev Normal & Pathol, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Grandjean, V (corresponding author), Fac Med Nice, INSERM, U636, Nice, France.	grandjea@unice.fr	Hu, Ruogu/B-2203-2008; Grandjean, Valerie/O-3935-2016; Rassoulzadegan, Minoo/O-7939-2016	Valerie, GRANDJEAN/0000-0003-1661-7411	Ligue Nationale Francaise Contre le Cancer	Ligue Nationale Francaise Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by a grant from the Ligue Nationale Francaise Contre le Cancer to Minoo Rassoulzadegan.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Cherry SR, 1999, P NATL ACAD SCI USA, V96, P10788, DOI 10.1073/pnas.96.19.10788; Dodge JE, 2002, GENE, V289, P41, DOI 10.1016/S0378-1119(02)00469-9; Gardiner-Garden M, 1998, MOL CELL BIOL, V18, P3350, DOI 10.1128/MCB.18.6.3350; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Imamura T, 2005, J BIOL CHEM, V280, P20171, DOI 10.1074/jbc.M501749200; Kouidou S, 2006, MUTAT RES-FUND MOL M, V599, P167, DOI 10.1016/j.mrfmmm.2006.03.002; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, COLD SPRING HARB SYM, V58, P297, DOI 10.1101/SQB.1993.058.01.035; MEYER P, 1994, EMBO J, V13, P2084, DOI 10.1002/j.1460-2075.1994.tb06483.x; Mund C, 2004, BIOCHEM J, V378, P763, DOI 10.1042/BJ20031567; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Pelissier T, 2000, RNA, V6, P55, DOI 10.1017/S135583820099201X; Pittoggi C, 1999, J CELL SCI, V112, P3537; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Rassoulzadegan M, 2002, EMBO J, V21, P440, DOI 10.1093/emboj/21.3.440; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; White GP, 2002, J IMMUNOL, V168, P2820, DOI 10.4049/jimmunol.168.6.2820	24	62	63	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1136	10.1371/journal.pone.0001136	http://dx.doi.org/10.1371/journal.pone.0001136			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17989773	gold, Green Submitted, Green Published			2022-12-25	WOS:000207459000020
J	Helton, ES; Zhang, J; Chen, X				Helton, E. S.; Zhang, J.; Chen, X.			The proline-rich domain in p63 is necessary for the transcriptional and apoptosis-inducing activities of TAp63	ONCOGENE			English	Article						p53 family; p63; transcription; cell cycle; apoptosis	TARGET GENES; P53 FAMILY; MOUSE MODELS; TUMOR-CELLS; DELTA-NP63-ALPHA; IDENTIFICATION; HOMOLOG; ARREST; MUTANT; LIMB	p63 shares considerable sequence identity with p53, especially in its DNA-binding, activation and tetramerization domains. When the upstream promoter is used for p63 expression, three major transactivation p63 (TAp63) isoforms (alpha, beta and gamma) are produced. p63 is also expressed from an alternate promoter located in intron 3, producing three major Delta Np63 isoforms. Recent studies demonstrated that p63 has the potential to function as a tumor suppressor or an oncoprotein. To further address this, we generated cell lines that inducibly express each TAp63 isoform. We showed that TAp63 isoforms are capable of inducing p53-responsive genes, inhibiting cell proliferation and promoting apoptosis. Interestingly, we discovered that both the activation domain (residues 1-59) and the proline-rich domain (residues 67-127) are required for TAp63 transcriptional activity. Likewise, TAp63 beta(Delta PRD), deleted of residues 60-133, possessed a greatly attenuated ability to induce endogenous target genes and promote apoptosis, but retained the ability to inhibit cell proliferation when expressed in stable, inducible cell lines. TAp63 beta(Delta PRD) also functioned as a dominant negative to wild-type p63 beta in a dose-dependent manner. Furthermore, the loss of function seen with deletion of the proline-rich domain was not due to a DNA-binding defect, as TAp63 beta(Delta PRD) was found to strongly bind endogenous promoters using chromatin immunoprecipitation assay. Finally, mutational analysis revealed that a PXXP motif at residues 124-127 contributes to the transcriptional activity of TAp63. Altogether, our findings suggest that TAp63 transcriptional activity can be regulated by modification(s) of, or protein interactions with, the p63 proline-rich domain.	[Helton, E. S.; Zhang, J.; Chen, X.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Ctr Comparat Oncol, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, X (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Ctr Comparat Oncol, 2128 Tupper Hall, Davis, CA 95616 USA.	xbchen@ucdavis.edu			NATIONAL CANCER INSTITUTE [R01CA102188] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA102188, R01 CA102188-07, CA102188] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Attardi LD, 2005, MUTAT RES-FUND MOL M, V576, P4, DOI 10.1016/j.mrfmmm.2004.08.022; Baptiste N, 2002, ONCOGENE, V21, P9, DOI 10.1038/sj/onc/1205015; Boyle JM, 1998, BRIT J CANCER, V77, P2181, DOI 10.1038/bjc.1998.364; Brunner HG, 2002, AM J MED GENET, V112, P284, DOI 10.1002/ajmg.10778; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Edwards SJ, 2003, ONCOGENE, V22, P4517, DOI 10.1038/sj.onc.1206726; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Ghioni P, 2002, MOL CELL BIOL, V22, P8659, DOI 10.1128/MCB.22.24.8659-8668.2002; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Harms KL, 2005, MOL CELL BIOL, V25, P2014, DOI 10.1128/MCB.25.5.2014-2030.2005; Helton ES, 2006, J BIOL CHEM, V281, P2533, DOI 10.1074/jbc.M507964200; King KE, 2003, ONCOGENE, V22, P3635, DOI 10.1038/sj.onc.1206536; Liu G, 2002, ONCOGENE, V21, P7195, DOI 10.1038/sj.onc.1205862; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Phang BH, 2007, ONCOGENE, V26, P2964, DOI 10.1038/sj.onc.1210112; Senoo M, 2004, CANCER CELL, V6, P85, DOI 10.1016/j.ccr.2004.06.005; Walker KK, 1996, P NATL ACAD SCI USA, V93, P15335, DOI 10.1073/pnas.93.26.15335; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zhu JH, 1999, ONCOGENE, V18, P2149, DOI 10.1038/sj.onc.1202533	24	23	25	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 1	2008	27	20					2843	2850		10.1038/sj.onc.1210948	http://dx.doi.org/10.1038/sj.onc.1210948			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	295VR	18037962	Green Accepted			2022-12-25	WOS:000255502500005
J	Johnson, J; Lagowski, J; Lawson, S; Liu, Y; Kulesz-Martin, M				Johnson, J.; Lagowski, J.; Lawson, S.; Liu, Y.; Kulesz-Martin, M.			P73 expression modulates p63 and Mdm2 protein presence in complex with p53 family-specific DNA target sequence in squamous cell carcinogenesis	ONCOGENE			English	Article						p73; squamous cell carcinoma; keratinocyte; p53 family interplay	TRANSCRIPTIONAL ACTIVITY; ACTIVATION; CARCINOMA; CANCER; ANTAGONISTS; ISOFORMS; DOMAIN; DEATH; FORMS	The expression of p73 and p63 isoforms is frequently deregulated in human epithelial tumors. We previously showed that loss of p73 protein expression associates with malignant conversion in vivo and ionizing radiation (IR) resistance in vitro in a clonal model of mouse epidermal carcinogenesis. Here we show that loss of endogenous p73 expression in squamous cell carcinoma (SCC) cells and tumors was concomitant with preferential DNA binding of the inhibitory Delta Np63 alpha isoform and reduction of transcriptionally active p63 gamma isoforms binding to a p21 promoter sequence in vitro. Reconstitution of TAp73 alpha in malignant cells increased the steady state DNA-binding capabilities of the endogenous transcriptionally active TAp63 gamma and Delta Np63 gamma isoforms, correlating with restoration of tumor suppression but not IR sensitivity. Loss of p73 in malignant cells also coincided with increased presence of p53 family inhibitor Mdm2 in p53-specific DNA-bound complexes, whereas reconstitution of TAp73 alpha expression resulted in exclusion of Mdm2 from these complexes. These results suggest a dual mechanism for TAp73 alpha to foster tumor suppression through enhancement of the DNA-binding activity of p63 gamma isoforms, and through inhibition of transcriptional repressors Mdm2 or DNp63a.	[Johnson, J.; Lagowski, J.; Lawson, S.; Liu, Y.; Kulesz-Martin, M.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97239 USA; [Johnson, J.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Kulesz-Martin, M.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Kulesz-Martin, M (corresponding author), Oregon Hlth & Sci Univ, Dept Dermatol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	kuleszma@ohsu.edu			NCI NIH HHS [CA98893, 1-T32-CA106195, CA98577, CA69533] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098577, T32CA106195, P30CA069533, R01CA098893] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alarcon-Vargas D, 2000, ONCOGENE, V19, P831, DOI 10.1038/sj.onc.1203311; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Carvajal D, 2005, CANCER RES, V65, P1918, DOI 10.1158/0008-5472.CAN-04-3576; Cui Rutao, 2005, Biochem Biophys Res Commun, V336, P339; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; DeYoung MP, 2006, CANCER RES, V66, P9362, DOI 10.1158/0008-5472.CAN-06-1619; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Ghioni P, 2002, MOL CELL BIOL, V22, P8659, DOI 10.1128/MCB.22.24.8659-8668.2002; Goldschneider D, 2003, CANCER LETT, V197, P99, DOI 10.1016/S0304-3835(03)00089-2; Gu JJ, 2001, CANCER RES, V61, P6703; Hofseth LJ, 2004, TRENDS PHARMACOL SCI, V25, P177, DOI 10.1016/j.tips.2004.02.009; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Irwin MS, 2001, APOPTOSIS, V6, P17, DOI 10.1023/A:1009663809458; Jin YT, 2002, J BIOL CHEM, V277, P30838, DOI 10.1074/jbc.M204078200; Johnson J, 2007, CANCER RES, V67, P7723, DOI 10.1158/0008-5472.CAN-07-1195; Kadakia M, 2001, DNA CELL BIOL, V20, P321, DOI 10.1089/10445490152122433; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; King KE, 2006, CARCINOGENESIS, V27, P53, DOI 10.1093/carcin/bgi200; Knights CD, 2003, J BIOL CHEM, V278, P52890, DOI 10.1074/jbc.M300279200; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KULESZMARTIN MF, 1988, CARCINOGENESIS, V9, P171, DOI 10.1093/carcin/9.1.171; Liu G, 2005, J BIOL CHEM, V280, P20111, DOI 10.1074/jbc.M413889200; Liu G, 2004, MOL CELL BIOL, V24, P487, DOI 10.1128/MCB.24.2.487-501.2004; Liu YG, 2001, CANCER RES, V61, P5402; Liu YG, 2004, CANCER BIOL THER, V3, P1102, DOI 10.4161/cbt.3.11.1189; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; Moll UM, 2004, MOL CANCER RES, V2, P371; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Rocco JW, 2006, CELL CYCLE, V5, P936, DOI 10.4161/cc.5.9.2716; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wu Y, 1997, P NATL ACAD SCI USA, V94, P8982, DOI 10.1073/pnas.94.17.8982; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zeng XY, 1999, MOL CELL BIOL, V19, P3257	35	10	10	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 24	2008	27	19					2780	2787		10.1038/sj.onc.1210941	http://dx.doi.org/10.1038/sj.onc.1210941			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	292IK	18026135				2022-12-25	WOS:000255259500013
J	Thaxton, C; Lopera, J; Bott, M; Fernandez-Valle, C				Thaxton, C.; Lopera, J.; Bott, M.; Fernandez-Valle, C.			Neuregulin and laminin stimulate phosphorylation of the NF2 tumor suppressor in Schwann cells by distinct protein kinase A and p21-activated kinase-dependent pathways	ONCOGENE			English	Article						nerve; merlin; beta 1 integrin; ErbB2; Cdc42	MERLIN; PAXILLIN; ACTIVATION; RECEPTORS; ADHESION; LOCALIZATION; MYELINATION; ASSOCIATION; EXPRESSION; GENE	Mutations in the neuro. bromatosis type 2 (NF2) gene cause formation of schwannomas and other tumors in the nervous system. The NF2 protein, Schwannomin/Merlin, is a cytoskeleton-associated tumor suppressor regulated by phosphorylation at serine 518 (S518). Unphosphorylated Schwannomin restricts cell proliferation in part by inhibiting Rac- and p21-activated kinase (Pak). In a negative-feedback loop, Pak phosphorylates Schwannomin inactivating its ability to inhibit Pak. Little is known about receptor mechanisms that promote Pak activity and Schwannomin phosphorylation. Here we demonstrate in primary Schwann cells (SCs) that Schwannomin is rapidly phosphorylated on S518 by Pak following laminin-1 binding to b1 integrin, and by protein kinase A following neuregulin-1b (NRG1b) binding to ErbB2/ErbB3 receptors. These receptors, together with phosphorylated Schwannomin, P-Pak, Cdc42 and paxillin are enriched at the distal tips of SC processes, and can be isolated as a complex using b1 integrin antibody. Dual stimulation with laminin-1 and NRG1 beta does not synergistically increase Schwannomin phosphorylation because ErbB2 kinase partially antagonizes integrin-dependent activation of Pak. These results identify two parallel, but interactive pathways that inactivate the tumor suppressor activity of Schwannomin to allow proliferation of subconfluent SCs. Moreover, they identify ErbB2, ErbB3 and beta 1 integrins as potential therapeutic targets for NF2.	[Thaxton, C.; Lopera, J.; Bott, M.; Fernandez-Valle, C.] Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32826 USA	State University System of Florida; University of Central Florida	Fernandez-Valle, C (corresponding author), Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32826 USA.	cfernand@mail.ucf.edu		Thaxton, Courtney/0000-0002-6733-369X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034499] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS034499] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Alfthan K, 2004, J BIOL CHEM, V279, P18559, DOI 10.1074/jbc.M313916200; Brown MC, 2002, MOL BIOL CELL, V13, P1550, DOI 10.1091/mbc.02-02-0015; Chen LM, 2000, J NEUROSCI, V20, P3776, DOI 10.1523/JNEUROSCI.20-10-03776.2000; Chen ZL, 2003, J CELL BIOL, V163, P889, DOI 10.1083/jcb.200307068; Chernousov MA, 2000, HISTOL HISTOPATHOL, V15, P593, DOI 10.14670/HH-15.593; Coles LC, 2002, ONCOGENE, V21, P2236, DOI 10.1038/sj.onc.1205302; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Dubovy P, 1999, Gen Physiol Biophys, V18 Suppl 1, P63; Fernandez-Valle C, 2002, NAT GENET, V31, P354, DOI 10.1038/ng930; FERNANDEZVALLE C, 1994, J NEUROBIOL, V25, P1207, DOI 10.1002/neu.480251004; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Hansen MR, 2004, OTOL NEUROTOL, V25, P155, DOI 10.1097/00129492-200403000-00013; Howe AK, 2000, NAT CELL BIOL, V2, P593, DOI 10.1038/35023536; Iacovelli J, 2007, GLIA, V55, P1638, DOI 10.1002/glia.20578; James MF, 2001, BIOCHEM J, V356, P377, DOI 10.1042/0264-6021:3560377; Kaempchen K, 2003, HUM MOL GENET, V12, P1211, DOI 10.1093/hmg/ddg146; Kim HA, 1997, J NEUROSCI RES, V49, P236; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Lee JW, 2004, MOL CELLS, V17, P188; LOTTI LV, 1992, EXP CELL RES, V202, P274, DOI 10.1016/0014-4827(92)90075-J; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; Milner R, 1997, DEV BIOL, V185, P215, DOI 10.1006/dbio.1997.8547; Monje PV, 2006, GLIA, V53, P649, DOI 10.1002/glia.20330; Okada T, 2007, TRENDS CELL BIOL, V17, P222, DOI 10.1016/j.tcb.2007.03.006; OSHEROV N, 1993, J BIOL CHEM, V268, P11134; Rong R, 2004, ONCOGENE, V23, P8447, DOI 10.1038/sj.onc.1207794; Rosenbaum C, 1997, EXP NEUROL, V148, P604, DOI 10.1006/exnr.1997.6696; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Scoles DR, 2005, BIOCHEM BIOPH RES CO, V335, P385, DOI 10.1016/j.bbrc.2005.07.083; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Taylor AR, 2003, GLIA, V41, P94, DOI 10.1002/glia.10170; Thaxton C, 2007, MOL CELL NEUROSCI, V34, P231, DOI 10.1016/j.mcn.2006.11.003; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Turner CE, 2000, J CELL SCI, V113, P4139; Utermark T, 2003, BRAIN PATHOL, V13, P352; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200; Yang DR, 2005, J CELL BIOL, V168, P655, DOI 10.1083/jcb.200411158	39	27	27	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 24	2008	27	19					2705	2715		10.1038/sj.onc.1210923	http://dx.doi.org/10.1038/sj.onc.1210923			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	292IK	17998937				2022-12-25	WOS:000255259500005
J	De Rosa, MF; Ackerley, C; Wang, B; Ito, S; Clarke, DM; Lingwood, C				De Rosa, Maria Fabiana; Ackerley, Cameron; Wang, Bernice; Ito, Shinya; Clarke, David M.; Lingwood, Clifford			Inhibition of multidrug resistance by AdamantylGb(3), a globotriaosylceramide analog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P-GLYCOPROTEIN; SHIGA-LIKE TOXIN; LIPID RAFTS; CANCER-CELLS; B-SUBUNIT; GLYCOSPHINGOLIPID GLOBOTRIAOSYLCERAMIDE; DRUG-RESISTANCE; CROSS-LINKING; BINDING; GLUCOSYLCERAMIDE	Multidrug resistance (MDR) via the ABC drug transporter (ABCB1), P-glycoprotein (P-gp/MDR1) overexpression, is a major obstacle in cancer chemotherapy. Many inhibitors reverse MDR but, like cyclosporin A (CsA), have significant toxicities. MDR1 is also a translocase that flips glucosylceramide inside the Golgi to enhance neutral glycosphingolipid (GSL) synthesis. We observed partial MDR1/globotriaosylceramide (Gb(3)) cell surface co-localization, and GSL removal depleted cell surface MDR1. MDR1 may therefore interact with GSLs. AdamantylGb(3), a water-soluble Gb(3) mimic, but not other GSL analogs, reversed MDR1-MDCK cell drug resistance. Cell surface MDR1 was up-regulated 1 h after treatment with CsA or adaGb(3), but at 72 h, cell surface expression was lost. Intracellular MDR1 accumulated throughout, suggesting long term defects in plasma membrane MDR1 trafficking. AdaGb(3) or CsA rapidly reduced rhodamine 123 cellular efflux. MDR1 also mediates gastrointestinal epithelial drug efflux, restricting oral bioavailability. Vinblastine apical-to-basal transport in polarized human intestinal C2BBe1 cells was significantly increased when adaGb3 was added to both sides, or to the apical side only, comparable with verapamil, a standard MDR1 inhibitor. Disulfide cross-linking of mutant MDR1s showed no binding of adaGb3 to the MDR1 verapamil/cyclosporin-binding site between surface proximal helices of transmembrane segments (TM)6 and TM7, but rather to an adjacent site nearer the center of TM6 and the TM7 extracellular face, i.e. close to the bilayer leaflet interface. Verotoxin-mediated Gb(3) endocytosis also upregulated total MDR1 and inhibited drug efflux. Thus, a functional interplay between membrane Gb(3) and MDR1 provides a more physiologically based approach to MDR1 regulation to increase the bioavailability of chemotherapeutic drugs.	[De Rosa, Maria Fabiana; Lingwood, Clifford] Hosp Sick Children, Div Mol Struct & Func, Toronto, ON M5G 1X8, Canada; [De Rosa, Maria Fabiana; Ackerley, Cameron; Lingwood, Clifford] Hosp Sick Children, Dept Pediat, Lab Med, Toronto, ON M5G 1X8, Canada; [Wang, Bernice; Ito, Shinya] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada; [De Rosa, Maria Fabiana; Lingwood, Clifford] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Wang, Bernice; Ito, Shinya] Univ Toronto, Dept Pediat & Pharmacol, Toronto, ON M5S 1A8, Canada; [De Rosa, Maria Fabiana; Clarke, David M.] Univ Toronto, Dept Med Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Lingwood, C (corresponding author), Hosp Sick Children, Div Mol Struct & Func, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	cling@sickkids.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184				ABE A, 1992, J BIOCHEM-TOKYO, V111, P191, DOI 10.1093/oxfordjournals.jbchem.a123736; Arab S, 1997, ONCOL RES, V9, P553; Barakat S, 2005, BIOCHEM J, V388, P563, DOI 10.1042/BJ20041999; Bast DJ, 1997, INFECT IMMUN, V65, P2019, DOI 10.1128/IAI.65.6.2019-2028.1997; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BOULANGER J, 1994, ANAL BIOCHEM, V217, P1, DOI 10.1006/abio.1994.1075; BOYD B, 1991, INFECT IMMUN, V59, P750, DOI 10.1128/IAI.59.3.750-757.1991; BRADLEY G, 1989, CANCER RES, V49, P2790; Dantzig AH, 1996, CANCER RES, V56, P4171; De Rosa MF, 2004, J BIOL CHEM, V279, P7867, DOI 10.1074/jbc.M305645200; Demeule M, 2000, FEBS LETT, V466, P219, DOI 10.1016/S0014-5793(00)01087-5; Eckford PDW, 2005, BIOCHEM J, V389, P517, DOI 10.1042/BJ20050047; Falguieres T, 2006, FEBS J, V273, P5205, DOI 10.1111/j.1742-4658.2006.05516.x; Fisher GA, 1996, EUR J CANCER, V32A, P1082, DOI 10.1016/0959-8049(96)00111-6; Fontaine M, 1996, LIFE SCI, V59, P1521, DOI 10.1016/0024-3205(96)00483-3; Ford J M, 1996, Cancer Treat Res, V87, P3; Gayet L, 2005, BIOCHEMISTRY-US, V44, P4499, DOI 10.1021/bi048669w; Germann UA, 1996, EUR J CANCER, V32A, P927, DOI 10.1016/0959-8049(96)00057-3; Ghetie MA, 2004, BLOOD, V104, P178, DOI 10.1182/blood-2003-12-4255; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Hammerle SP, 2000, EUR J PHARM SCI, V12, P69, DOI 10.1016/S0928-0987(00)00142-1; HERZOG CE, 1993, J BIOL CHEM, V268, P2946; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Hooper NM, 1999, MOL MEMBR BIOL, V16, P145, DOI 10.1080/096876899294607; HYAFIL F, 1993, CANCER RES, V53, P4595; Jarvis RM, 2007, BIOCHEM BIOPH RES CO, V355, P944, DOI 10.1016/j.bbrc.2007.02.053; Jette L, 1996, AM J PHYSIOL-RENAL, V270, pF756, DOI 10.1152/ajprenal.1996.270.5.F756; Katagiri YU, 1999, J BIOL CHEM, V274, P35278, DOI 10.1074/jbc.274.49.35278; KHINE AA, 1994, J CELL PHYSIOL, V161, P319, DOI 10.1002/jcp.1041610217; Kimura Y, 2007, BIOCHEM J, V401, P597, DOI 10.1042/BJ20060632; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; Kovbasnjuk O, 2001, J CELL SCI, V114, P4025; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lala P, 2000, J BIOL CHEM, V275, P6246, DOI 10.1074/jbc.275.9.6246; Lavie Y, 1998, J BIOL CHEM, V273, P32380, DOI 10.1074/jbc.273.49.32380; Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530; Le Goff W, 2006, J LIPID RES, V47, P51, DOI 10.1194/jlr.M500255-JLR200; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 2002, J BIOL CHEM, V277, P44332, DOI 10.1074/jbc.M208433200; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Loo TW, 2001, J BIOL CHEM, V276, P31800, DOI 10.1074/jbc.M103498200; LOO TW, 1994, BIOCHEMISTRY-US, V33, P14049, DOI 10.1021/bi00251a013; LOO TW, 1994, J BIOL CHEM, V269, P28683; Lucci A, 1998, ANTICANCER RES, V18, P475; Luker GD, 1999, J BIOL CHEM, V274, P6979, DOI 10.1074/jbc.274.11.6979; Luker GD, 2001, J LIPID RES, V42, P1389; Lund N, 2006, AIDS, V20, P333, DOI 10.1097/01.aids.0000206499.78664.58; Mahfoud R, 2002, J LIPID RES, V43, P1670, DOI 10.1194/jlr.M200165-JLR200; Mattocks M, 2006, FEBS J, V273, P2064, DOI 10.1111/j.1742-4658.2006.05223.x; Morjani H, 2001, INT J CANCER, V94, P157, DOI 10.1002/ijc.1449; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mylvaganam M, 1999, BIOCHEM BIOPH RES CO, V257, P391, DOI 10.1006/bbrc.1999.0474; MYLVAGANAM M, 2003, CARBOHYDRATE BASED D, P761; Nicholson KM, 1999, BRIT J CANCER, V81, P423, DOI 10.1038/sj.bjc.6690711; Norris-Cervetto E, 2004, J BIOL CHEM, V279, P40412, DOI 10.1074/jbc.M404466200; Orlowski S, 2006, CELL MOL LIFE SCI, V63, P1038, DOI 10.1007/s00018-005-5554-9; Oswald S, 2006, CLIN PHARMACOL THER, V79, P206, DOI 10.1016/j.clpt.2005.11.004; PASTAN I, 1988, P NATL ACAD SCI USA, V85, P4486, DOI 10.1073/pnas.85.12.4486; Plo I, 2002, MOL PHARMACOL, V62, P304, DOI 10.1124/mol.62.2.304; Puri A, 1998, P NATL ACAD SCI USA, V95, P14435, DOI 10.1073/pnas.95.24.14435; RAMOTAR K, 1990, BIOCHEM J, V272, P805, DOI 10.1042/bj2720805; Rawat SS, 2006, GLYCOCONJUGATE J, V23, P189, DOI 10.1007/s10719-006-7924-4; RIORDAN JR, 1985, NATURE, V316, P817, DOI 10.1038/316817a0; Rothnie A, 2005, FEBS LETT, V579, P3984, DOI 10.1016/j.febslet.2005.06.030; Rowinsky EK, 1998, J CLIN ONCOL, V16, P2964, DOI 10.1200/JCO.1998.16.9.2964; Schapiro FB, 1998, AM J PHYSIOL-CELL PH, V274, pC319, DOI 10.1152/ajpcell.1998.274.2.C319; Sikic BI, 1997, CANCER CHEMOTH PHARM, V40, pS13, DOI 10.1007/s002800051055; Sillence DJ, 2002, J LIPID RES, V43, P1837, DOI 10.1194/jlr.M200232-JLR200; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; Smith DC, 2006, MOL BIOL CELL, V17, P1375, DOI 10.1091/mbc.e05-11-1035; Sugawara S, 2005, BIOL PHARM BULL, V28, P434, DOI 10.1248/bpb.28.434; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Veldman RJ, 2002, FASEB J, V16, P1111, DOI 10.1096/fj.01-0863fje; Veldman RJ, 1999, BIOCHEM BIOPH RES CO, V266, P492, DOI 10.1006/bbrc.1999.1850; Wang Y, 2007, MOL PHARMACOL, V71, P751, DOI 10.1124/mol.106.029926; Zhao YL, 2002, BRAIN RES, V956, P246, DOI 10.1016/S0006-8993(02)03546-1	78	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4501	4511		10.1074/jbc.M705473200	http://dx.doi.org/10.1074/jbc.M705473200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18003606	hybrid			2022-12-25	WOS:000253426500006
J	Bundgaard, JR; Rehfeld, JF				Bundgaard, Jens R.; Rehfeld, Jens F.			Distinct linkage between post-translational processing and differential secretion of progastrin derivatives in endocrine cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-O-SULFATION; TRANS-GOLGI NETWORK; GRANULE BIOGENESIS; MUTATIONAL ANALYSIS; BETA-CELL; PATHWAY; PROTEINS; SEQUENCE; RADIOIMMUNOASSAY; NEUROENDOCRINE	Prohormones often undergo extensive cellular processing prior to secretion. These post-translational processing events occur in organelles of the constitutive or regulated secretory pathway. The aim of this study was to examine the relationship between post-translational modifications and the secretory pathways taken by peptides derived from progastrin, the prohormone of gastrin, which in vivo is secreted by cells of the pyloric glands and stimulates the release of gastric acid. Targeting progastrin to compartments of the early secretory pathway shows that endoproteolytic processing is initiated in a pre-trans-Golgi network compartment of endocrine but not non-endocrine cells. The resulting N-terminal fragments of progastrin are secreted via the constitutive pathway, whereas endoproteolytically processed C-terminal fragments are secreted via the regulated or constitutive-like pathways. C-terminal fragments derived from progastrin differ in characteristic manners in levels and patterns of carboxyamidation and tyrosine sulfation in accordance with the secretory pathway taken. Point mutations introduced into a sorting motif disrupt these patterns, suggesting that differences in post-translational modifications are attributable to differential intracellular sorting of precursors. The results suggest a two-step sorting mechanism for progastrin leading to differential secretion of processed fragments via different secretory pathways.	[Bundgaard, Jens R.; Rehfeld, Jens F.] Univ Copenhagen, Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Bundgaard, JR (corresponding author), Univ Copenhagen, Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, KB 3014,Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	jrb@rh.dk		Bundgaard, Jens Rene/0000-0001-9600-1224				Arvan P, 2004, TRAFFIC, V5, P53, DOI 10.1111/j.1600-0854.2004.00152.x; Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; BARDRAM L, 1989, SCAND J CLIN LAB INV, V49, P173, DOI 10.3109/00365518909105418; Bundgaard Jens R, 2002, Methods Mol Biol, V194, P223; BUNDGAARD JR, 1995, EMBO J, V14, P3073, DOI 10.1002/j.1460-2075.1995.tb07310.x; Bundgaard JR, 1997, J BIOL CHEM, V272, P21700, DOI 10.1074/jbc.272.35.21700; Bundgaard JR, 1996, DNA CELL BIOL, V15, P147, DOI 10.1089/dna.1996.15.147; Bundgaard JR, 2004, J BIOL CHEM, V279, P5488, DOI 10.1074/jbc.M310547200; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Dikeakos JD, 2007, J CELL BIOL, V177, P191, DOI 10.1083/jcb.200701024; Dockray GJ, 2001, ANNU REV PHYSIOL, V63, P119, DOI 10.1146/annurev.physiol.63.1.119; Ferraro F, 2007, MOL BIOL CELL, V18, P4813, DOI 10.1091/mbc.E07-05-0503; Glombik MM, 2000, BIOCHIMIE, V82, P315, DOI 10.1016/S0300-9084(00)00195-4; Goetze JP, 2006, REGUL PEPTIDES, V133, P47, DOI 10.1016/j.regpep.2005.09.016; Hauri HP, 2000, J CELL SCI, V113, P587; HILSTED L, 1987, J BIOL CHEM, V262, P16953; HILSTED L, 1986, ANAL BIOCHEM, V152, P119, DOI 10.1016/0003-2697(86)90129-6; HILSTED L, 1988, AM J PHYSIOL, V255, pG665, DOI 10.1152/ajpgi.1988.255.5.G665; HUTTNER WB, 1988, ANNU REV PHYSIOL, V50, P363, DOI 10.1146/annurev.ph.50.030188.002051; Kim T, 2006, PHYSIOLOGY, V21, P124, DOI 10.1152/physiol.00043.2005; Kuiper RP, 2000, BIOCHEM CELL BIOL, V78, P289, DOI 10.1139/bcb-78-3-289; Lahtinen U, 1996, J BIOL CHEM, V271, P4031; Molinete M, 2000, SEMIN CELL DEV BIOL, V11, P243, DOI 10.1006/scdb.2000.0173; Muller L, 2000, PROG NUCLEIC ACID RE, V63, P69, DOI 10.1016/S0079-6603(08)60720-5; REHFELD JF, 1978, J BIOL CHEM, V253, P4016; Rehfeld JF, 2004, REGUL PEPTIDES, V120, P177, DOI 10.1016/j.regpep.2004.03.006; Rehfeld JF, 2002, FEBS LETT, V510, P89, DOI 10.1016/S0014-5793(01)03234-3; Rehfeld JF, 1998, PHYSIOL REV, V78, P1087, DOI 10.1152/physrev.1998.78.4.1087; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; SEVA C, 1994, SCIENCE, V265, P410, DOI 10.1126/science.8023165; Smith KA, 2006, GASTROENTEROLOGY, V131, P1463, DOI 10.1053/j.gastro.2006.08.040; TAMBURINI PP, 1990, INT J PEPT PROT RES, V35, P153; TOOZE J, 1987, J CELL BIOL, V105, P1215, DOI 10.1083/jcb.105.3.1215; Tooze SA, 1998, BBA-MOL CELL RES, V1404, P231, DOI 10.1016/S0167-4889(98)00059-7; TOOZE SA, 1991, J CELL BIOL, V115, P1491, DOI 10.1083/jcb.115.6.1491; Tooze SA, 2001, TRENDS CELL BIOL, V11, P116, DOI 10.1016/S0962-8924(00)01907-3; VANSOLINGE WW, 1990, CLIN CHIM ACTA, V192, P35, DOI 10.1016/0009-8981(90)90269-X; VARRO A, 1990, J BIOL CHEM, V265, P21476	39	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4014	4021		10.1074/jbc.M707908200	http://dx.doi.org/10.1074/jbc.M707908200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18057001	hybrid			2022-12-25	WOS:000253083500036
J	Hess, CR; McGuirl, MM; Klinman, JP				Hess, Corinna R.; McGuirl, Michele M.; Klinman, Judith P.			Mechanism of the insect enzyme, tyramine beta-monooxygenase, reveals differences from the mammalian enzyme, dopamine beta-monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-HYDROXYLATING MONOOXYGENASE; ELECTRON-TRANSFER; KINETIC MECHANISM; FINE-STRUCTURE; COPPER; OCTOPAMINE; DROSOPHILA; DEFICIENCY; ACTIVATION; AMIDATION	Tyramine beta-monooxygenase (T beta M) catalyzes the synthesis of the neurotransmitter, octopamine, in insects. Kinetic and isotope effect studies have been carried out to determine the kinetic mechanism of T beta M for comparison with the homologous mammalian enzymes, dopamine beta-monooxygenase and peptidylglycine alpha-hydroxylating monooxygenase. A new and distinctive feature of T beta M is very strong substrate inhibition that is dependent on the level of the co-substrate, O-2, and reductant as well as substrate deuteration. This has led to a model in which tyramine can bind to either the Cu(I) or Cu(II) forms of T beta M, with substrate inhibition ameliorated at very high ascorbate levels. The rate of ascorbate reduction of the E-Cu(II) form of T beta M is also reduced at high tyramine, leading us to propose the existence of a binding site for ascorbate to this class of enzymes. These findings may be relevant to the control of octopamine production in insect cells.	[Hess, Corinna R.; Klinman, Judith P.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Hess, Corinna R.; Klinman, Judith P.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [McGuirl, Michele M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [McGuirl, Michele M.] Univ Montana, Biomol Struct & Dynam Program, Missoula, MT 59812 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Montana System; University of Montana; University of Montana System; University of Montana	Klinman, JP (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	klinman@berkeley.edu	McGuirl, Michele/N-2311-2014; Hess, Corinna/J-1504-2012	Hess, Corinna/0000-0002-9607-9184	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025765, F32GM067351, R01GM025765] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM25765, GM067351] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHN N, 1983, BIOCHEMISTRY-US, V22, P3096, DOI 10.1021/bi00282a012; Blackburn NJ, 2000, J BIOL INORG CHEM, V5, P341, DOI 10.1007/PL00010663; BLACKBURN NJ, 1991, J BIOL CHEM, V266, P23120; BLACKBURN NJ, 1990, J BIOL CHEM, V265, P15383; Chen P, 2004, J AM CHEM SOC, V126, P4991, DOI 10.1021/ja031564g; Cubells JF, 2004, PSYCHOPHARMACOLOGY, V174, P463, DOI 10.1007/s00213-004-1840-8; Evans JP, 2003, J BIOL CHEM, V278, P49691, DOI 10.1074/jbc.M300797200; EVANS PD, 1976, J PHYSIOL-LONDON, V262, P51, DOI 10.1113/jphysiol.1976.sp011585; Francisco WA, 2004, J AM CHEM SOC, V126, P13168, DOI 10.1021/ja046888z; Francisco WA, 1998, BIOCHEMISTRY-US, V37, P8244, DOI 10.1021/bi973004y; Gray EE, 2006, PROTEIN EXPRES PURIF, V47, P162, DOI 10.1016/j.pep.2005.11.008; HOYLE G, 1980, J NEUROBIOL, V11, P103, DOI 10.1002/neu.480110109; HOYLE G, 1975, J EXP ZOOL, V193, P425, DOI 10.1002/jez.1401930321; Kim CH, 2002, AM J MED GENET, V108, P140, DOI 10.1002/ajmg.10196; Klinman JP, 2006, J BIOL CHEM, V281, P3013, DOI 10.1074/jbc.R500011200; KLINMAN JP, 1980, J BIOL CHEM, V255, P1648; Lehman HK, 2006, J EXP BIOL, V209, P2774, DOI 10.1242/jeb.02296; LJONES T, 1978, FEBS LETT, V92, P81, DOI 10.1016/0014-5793(78)80726-1; MILLER SM, 1982, METHOD ENZYMOL, V87, P711; MILLER SM, 1985, BIOCHEMISTRY-US, V24, P2114, DOI 10.1021/bi00330a004; MILLER SM, 1983, BIOCHEMISTRY-US, V22, P3091, DOI 10.1021/bi00282a011; Monastirioti M, 1996, J NEUROSCI, V16, P3900; Monastirioti M, 2003, DEV BIOL, V264, P38, DOI 10.1016/j.ydbio.2003.07.019; Prigge ST, 1999, NAT STRUCT BIOL, V6, P976; Prigge ST, 1997, SCIENCE, V278, P1300, DOI 10.1126/science.278.5341.1300; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Saraswati S, 2004, J NEUROBIOL, V58, P425, DOI 10.1002/neu.10298; Segel I. H., 1993, ENZYME KINETICS BEHA, p[273, 626, 660]; STEWART LC, 1987, BIOCHEMISTRY-US, V26, P5302, DOI 10.1021/bi00391a013; STEWART LC, 1991, J BIOL CHEM, V266, P11537; Timmers HJLM, 2004, ANN NY ACAD SCI, V1018, P520, DOI 10.1196/annals.1296.064	32	27	28	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3042	3049		10.1074/jbc.M705911200	http://dx.doi.org/10.1074/jbc.M705911200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18032384	hybrid			2022-12-25	WOS:000253083000007
J	Watatani, Y; Ichikawa, K; Nakanishi, N; Fujimoto, M; Takeda, H; Kimura, N; Hirose, H; Takahashi, S; Takahashi, Y				Watatani, Yujiro; Ichikawa, Kenji; Nakanishi, Noriko; Fujimoto, Maki; Takeda, Hitoshi; Kimura, Natsumi; Hirose, Hidenori; Takahashi, Shigeru; Takahashi, Yuji			Stress-induced translation of ATF5 mRNA is regulated by the 5 '-untranslated region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN READING FRAME; TRANSCRIPTION FACTORS; MAMMALIAN-CELLS; GENE-EXPRESSION; INITIATION; PROTEIN; KINASE; PHOSPHORYLATION; INHIBITION; ELEMENT	Activating transcription factor (ATF) 5 is a transcription factor belonging to the ATF/cAMP-response element-binding protein gene family. We previously reported that ATF5 mRNA expression increased in response to amino acid limitation. The ATF5 gene allows transcription of mRNAs with at least two alternative 5 '-untranslated regions (5 '-UTRs), 5 '-UTR alpha and 5 '-UTR beta, derived from exon1 alpha and exon1 beta. 5 '-UTR alpha contains highly conserved sequences, in which the upstream open reading frames (uORFs) uORF1 and uORF2 are found in many species. This study was designed to investigate the potential role of 5 '-UTRs in translational control. These 5 '-UTRs differentially determined translation efficiency from mRNA. The presence of 5 '-UTR alpha or 5 '-UTR beta represses translation from the downstream ATF5 ORF. Moreover, 5 '-UTR alpha-regulated translational repression is released by amino acid limitation or NaAsO2 exposure. This release was not seen for 5 '-UTR beta. Mutation of uAUG2 in the uORF2 of 5 '-UTR alpha restored the basal expression and abolished the positive regulation by amino acid limitation or arsenite exposure. Wedemonstrated that phosphorylation of eukaryotic initiation factor 2 alpha was required for amino acid limitation-induced translational regulation of ATF5. Furthermore, arsenite exposure activated the exogenously expressed heme-regulated inhibitor kinase and induced the phosphorylation of eukaryotic initiation factor 2 alpha in nonerythroid cells. These results suggest that translation of ATF5 is regulated by the alternative 5 '-UTR region of its mRNA, and ATF5 may play a role in protecting cells from amino acid limitation or arsenite-induced oxidative stress.	[Watatani, Yujiro; Ichikawa, Kenji; Nakanishi, Noriko; Fujimoto, Maki; Takeda, Hitoshi; Kimura, Natsumi; Hirose, Hidenori; Takahashi, Shigeru; Takahashi, Yuji] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Environm Mol Physiol, Tokyo 1920392, Japan	Tokyo University of Pharmacy & Life Sciences	Takahashi, S (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Environm Mol Physiol, 1432-1 Horinouchi, Tokyo 1920392, Japan.	shigeru@ls.toyaku.ac.jp	Ichikawa, Kenji/AAW-1613-2021					Angelastro JM, 2003, J NEUROSCI, V23, P4590; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Fernandez J, 2002, J BIOL CHEM, V277, P2050, DOI 10.1074/jbc.M109199200; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hansen MB, 2002, GENOMICS, V80, P344, DOI 10.1006/geno.2002.6838; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; HOPLICK M, 2005, NAT REV MOL CELL BIO, V6, P318; Hughes TA, 2005, J BIOL CHEM, V280, P8581, DOI 10.1074/jbc.M410806200; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jousse C, 2001, NUCLEIC ACIDS RES, V29, P4341, DOI 10.1093/nar/29.21.4341; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lincoln AJ, 1998, J BIOL CHEM, V273, P9552, DOI 10.1074/jbc.273.16.9552; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Monaco SE, 2007, INT J CANCER, V120, P1883, DOI 10.1002/ijc.22469; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Muller EA, 2004, J BIOL CHEM, V279, P44645, DOI 10.1074/jbc.M406550200; NISHIZAWA M, 1992, FEBS LETT, V299, P36, DOI 10.1016/0014-5793(92)80094-W; PAROLA AL, 1994, J BIOL CHEM, V269, P4497; Pati D, 1999, MOL CELL BIOL, V19, P5001; PERRY FS, 2002, BIOL CHEM, V277, P24120; Persengiev SP, 2002, GENE DEV, V16, P1806, DOI 10.1101/gad.992202; Rohwedel J, 2003, CELL MOL LIFE SCI, V60, P1705, DOI 10.1007/s00018-003-3134-4; Ruan HJ, 1996, J BIOL CHEM, V271, P29576, DOI 10.1074/jbc.271.47.29576; SARRAJ JA, 2005, BIOL CHEM, V386, P873; Shinomura T, 2006, BIOCHEM BIOPH RES CO, V341, P167, DOI 10.1016/j.bbrc.2005.12.169; Tonelli DD, 2004, NUCLEIC ACIDS RES, V32, P1808, DOI 10.1093/nar/gkh348; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Watatani Y, 2007, LIFE SCI, V80, P879, DOI 10.1016/j.lfs.2006.11.013; Wilusz CJ, 2001, GENE DEV, V15, P2781; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3; Zhan K, 2004, GENETICS, V168, P1867, DOI 10.1534/genetics.104.031443	39	98	103	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2543	2553		10.1074/jbc.M707781200	http://dx.doi.org/10.1074/jbc.M707781200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18055463	hybrid			2022-12-25	WOS:000252622300011
J	Ueda, H; Nagae, R; Kozawa, M; Morishita, R; Kimura, S; Nagase, T; Ohara, O; Yoshida, S; Asano, T				Ueda, Hiroshi; Nagae, Rika; Kozawa, Mika; Morishita, Rika; Kimura, Shinji; Nagase, Takahiro; Ohara, Osamu; Yoshida, Satoshi; Asano, Tomiko			Heterotrimeric G protein beta gamma subunits stimulate FLJ00018, a guanine nucleotide exchange factor for Rac1 and Cdc42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-GTPASES; P115 RHOGEF; CELL; DBL; REORGANIZATION; PURIFICATION; ACTIVATION; NUCLEATION; MECHANISM; ADHESION	We previously reported that G beta gamma signaling regulates cell spreading or cell shape change through activation of a Rho family small GTPase, suggesting the existence of a G beta gamma-regulated Rho guanine-nucleotide exchange factor ( RhoGEF). In this study we examined various RhoGEF clones, found FLJ00018 to be a G beta gamma-activated RhoGEF, and investigated the molecular mechanism of G beta gamma-induced activation of Rho family GTPases. Co-expression of the genes for FLJ00018 and G beta gamma enhanced serum response element-mediated gene transcription in HEK-293 cells. Combined expression of G beta gamma and FLJ00018 significantly induced activation of Rac and Cdc42 but not RhoA. FLJ00018 also enhanced gene transcription induced by carbachol-stimulated m2 muscarinic acetylcholine receptor, and this enhancement was blocked by pertussis toxin. Furthermore, we demonstrated G beta gamma to interact directly with the N-terminal region of FLJ00018 and the N-terminal fragment of this molecule to inhibit serum response element-dependent transcription induced by G beta gamma/FLJ00018 and carbachol. In NIH3T3 cells, FLJ00018 enhanced lysophosphatidic acid-induced cell spreading, which was also blocked by the N-terminal fragment of FLJ00018. These results provide evidence for a signaling pathway by which G(i)-coupled receptor specifically induces Rac and Cdc42 activation through direct interaction of G beta gamma with FLJ00018.	[Ueda, Hiroshi; Nagae, Rika; Kozawa, Mika; Kimura, Shinji; Yoshida, Satoshi] Gifu Univ, Fac Engn, Dept Biomol Sci, Gifu 5011193, Japan; [Morishita, Rika; Asano, Tomiko] Aichi Human Serv Ctr, Inst Dev Res, Aichi 4800392, Japan; [Nagase, Takahiro; Ohara, Osamu] Kazusa DNA Res Inst, Kisarazu 2920818, Japan; [Ohara, Osamu] RIKEN Res Ctr Allergy & Immunol, Tsurumi Ku, Kanagawa 2300045, Japan	Gifu University; Kazusa DNA Research Institute; RIKEN	Ueda, H (corresponding author), Gifu Univ, Fac Engn, Dept Biomol Sci, Yanagido 1-1, Gifu 5011193, Japan.	hueda@gifu-u.ac.jp	Ohara, Osamu/A-9119-2012; Yoshida, Satoshi/B-6779-2012; Ohara, Osamu/G-5448-2015	Ohara, Osamu/0000-0002-3328-9571				ASANO T, 1993, J BIOL CHEM, V268, P20512; Belisle B, 2000, J BIOL CHEM, V275, P26225, DOI 10.1074/jbc.M002743200; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Donald S, 2004, FEBS LETT, V572, P172, DOI 10.1016/j.febslet.2004.06.096; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fleming IN, 2000, BIOCHEM J, V351, P173, DOI 10.1042/0264-6021:3510173; Fleming IN, 1998, FEBS LETT, V429, P229, DOI 10.1016/S0014-5793(98)00566-3; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Himmel KL, 2002, J BIOL CHEM, V277, P13463, DOI 10.1074/jbc.M110981200; Kato J, 2000, BIOCHEM BIOPH RES CO, V268, P141, DOI 10.1006/bbrc.2000.2106; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kiyono M, 1999, P NATL ACAD SCI USA, V96, P4826, DOI 10.1073/pnas.96.9.4826; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ma AD, 1998, MOL CELL BIOL, V18, P4744, DOI 10.1128/MCB.18.8.4744; Mayeenuddin LH, 2006, J BIOL CHEM, V281, P1913, DOI 10.1074/jbc.M506034200; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; MORISHITA R, 1988, EUR J BIOCHEM, V174, P87, DOI 10.1111/j.1432-1033.1988.tb14066.x; Nakajima D, 2002, DNA RES, V9, P99, DOI 10.1093/dnares/9.3.99; Nishida K, 1999, FEBS LETT, V459, P186, DOI 10.1016/S0014-5793(99)01244-2; Niu JX, 2003, CIRC RES, V93, P848, DOI 10.1161/01.RES.0000097607.14733.0C; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Rosenfeldt H, 2004, FEBS LETT, V572, P167, DOI 10.1016/j.febslet.2004.06.097; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Ueda H, 2001, J BIOL CHEM, V276, P6846, DOI 10.1074/jbc.M007541200; Ueda H, 2000, J BIOL CHEM, V275, P2098, DOI 10.1074/jbc.275.3.2098; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yoshizawa M, 2005, J NEUROSCI, V25, P4406, DOI 10.1523/JNEUROSCI.4955-04.2005	42	45	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1946	1953		10.1074/jbc.M707037200	http://dx.doi.org/10.1074/jbc.M707037200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18045877	hybrid			2022-12-25	WOS:000252501000021
J	Cozzolino, M; Amori, I; Pesaresi, MG; Ferri, A; Nencini, M; Carri, MT				Cozzolino, Mauro; Amori, Ilaria; Pesaresi, Maria Grazia; Ferri, Alberto; Nencini, Monica; Carri, Maria Teresa			Cysteine 111 affects aggregation and cytotoxicity of mutant Cu,Zn-superoxide dismutase associated with familial amyotrophic lateral sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT COMPLEXES; CEREBELLAR GRANULE NEURONS; DOPAMINE-INDUCED APOPTOSIS; ZN-SUPEROXIDE-DISMUTASE; ALS-LINKED SOD1; OXIDATIVE STRESS; TRANSGENIC MICE; DISULFIDE; GLUTAREDOXIN; MITOCHONDRIA	Converging evidence indicates that aberrant aggregation of mutant Cu,Zn-superoxide dismutase ( mutSOD1) is strongly implicated in familial amyotrophic lateral sclerosis ( FALS). MutSOD1 forms high molecular weight oligomers, which disappear under reducing conditions, both in neural tissues of FALS transgenic mice and in transfected cultured cells, indicating a role for aberrant intermolecular disulfide cross-linking in the oligomerization and aggregation process. To study the contribution of specific cysteines in the mechanism of aggregation, we mutated human SOD1 in each of its four cysteine residues and, using a cell transfection assay, analyzed the solubility and aggregation of those SOD1s. Our results suggest that the formation of mutSOD1 aggregates are the consequence of covalent disulfide cross-linking and non-covalent interactions. In particular, we found that the removal of Cys-111 strongly reduces the ability of a range of different FALS-associated mutSOD1s to form aggregates and impair cell viability in cultured NSC-34 cells. Moreover, the removal of Cys-111 impairs the ability of mutSOD1s to form disulfide cross-linking. Treatments that deplete the cellular pool of GSH exacerbate mutSOD1s insolubility, whereas an overload of intracellular GSH or overexpression of glutare-doxin-1, which specifically catalyzes the reduction of protein-SSG-mixed disulfides, significantly rescues mutSOD1s solubility. These data are consistent with the view that the redox environment influences the oligomerization/aggregation pathway of mutSOD1 and point to Cys-111 as a key mediator of this process.	[Cozzolino, Mauro; Amori, Ilaria; Pesaresi, Maria Grazia; Ferri, Alberto; Nencini, Monica; Carri, Maria Teresa] Fdn S Lucia Ist Ric & Cura Carattere Sci, Neurochem Lab, I-00179 Rome, Italy; [Ferri, Alberto] CNR, Inst Neurosci, Dept Psychobiol & Psychopharmacol, I-00100 Rome, Italy; [Carri, Maria Teresa] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Rome Tor Vergata	Carri, MT (corresponding author), Fdn S Lucia Ist Ric & Cura Carattere Sci, Neurochem Lab, I-00179 Rome, Italy.	carri@bio.uniroma2.it	FERRI, ALBERTO/B-7660-2015; cozzolino, mauro/AAY-2244-2020; Nencini, Monica/ABI-6619-2020; Carri, Maria Teresa/K-5480-2016	FERRI, ALBERTO/0000-0002-4097-0605; Carri, Maria Teresa/0000-0002-1789-1546; COZZOLINO, MAURO/0000-0003-0342-8961; Nencini, Monica/0000-0001-9602-1954	Telethon [GGP07018] Funding Source: Medline	Telethon(Fondazione Telethon)		Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Carri MT, 2006, TRENDS PHARMACOL SCI, V27, P267, DOI 10.1016/j.tips.2006.03.009; Carroll MC, 2006, J BIOL CHEM, V281, P28648, DOI 10.1074/jbc.M600138200; Ciriolo MR, 1997, J BIOL CHEM, V272, P2700, DOI 10.1074/jbc.272.5.2700; Daily D, 2001, J BIOL CHEM, V276, P21618, DOI 10.1074/jbc.M101400200; Daily D, 2001, J BIOL CHEM, V276, P1335, DOI 10.1074/jbc.M008121200; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Ferri A, 2006, P NATL ACAD SCI USA, V103, P13860, DOI 10.1073/pnas.0605814103; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hashemy SI, 2007, J BIOL CHEM, V282, P14428, DOI 10.1074/jbc.M700927200; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; Jaarsma D, 2000, NEUROBIOL DIS, V7, P623, DOI 10.1006/nbdi.2000.0299; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Qanungo S, 2007, J BIOL CHEM, V282, P18427, DOI 10.1074/jbc.M610934200; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2006, J NEUROCHEM, V96, P1277, DOI 10.1111/j.1471-4159.2005.03642.x; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Watanabe S, 2007, FREE RADICAL BIO MED, V42, P1534, DOI 10.1016/j.freeradbiomed.2007.02.004; Welker E, 2001, P NATL ACAD SCI USA, V98, P4334, DOI 10.1073/pnas.071066598; Wong ESP, 2007, J BIOL CHEM, V282, P12310, DOI 10.1074/jbc.M609466200	30	100	104	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					866	874		10.1074/jbc.M705657200	http://dx.doi.org/10.1074/jbc.M705657200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18006498	hybrid, Green Accepted			2022-12-25	WOS:000252128100027
J	Mio, K; Kubo, Y; Ogura, T; Yamamoto, T; Arisaka, F; Sato, C				Mio, Kazuhiro; Kubo, Yoshihiro; Ogura, Toshihiko; Yamamoto, Tomomi; Arisaka, Fumio; Sato, Chikara			The motor protein prestin is a bullet-shaped molecule with inner cavities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER HAIR CELL; AUTOMATIC PARTICLE PICKUP; PLASMA-MEMBRANE; MECHANICAL RESPONSES; NEURAL-NETWORK; RECONSTRUCTION; MICROSCOPY; RESOLUTION; TOPOLOGY; RECEPTOR	Prestin is a transmembrane motor protein localized at the outer hair cells (OHCs) of the mammalian inner ear. Voltage-dependent conformational changes in prestin generate changes in the length of OHCs. A loss of prestin function is reported to induce severe auditory deficiencies, suggesting prestin-dependent changes of OHC length may be at least a part of cochlear amplification. Here we expressed the recombinant FLAG-fused prestin proteins in Sf9 cells and purified to particles of a uniform size in EM. The square-shaped top view of purified prestin, the binding of multiple anti-FLAG antibodies to each prestin particle, the native-PAGE analysis, and the much larger molecular weight obtained from size exclusion chromatography than the estimation for the monomer all support that prestin is a tetramer (Zheng, J., Du, G. G., Anderson, C. T., Keller, J. P., Orem, A., Dallos, P., and Cheatham, M. (2006) J. Biol. Chem. 281, 19916-19924). From negatively stained prestin particles, the three-dimensional structure was reconstructed at 2 nm resolution assuming 4-fold symmetry. Prestin is shown to be a bullet-shaped particle with a large cytoplasmic domain. The surface representation demonstrates indentations on the molecule, and the slice images indicate the inner cavities of sparse densities. The dimensions, 77 x 77 x 115 angstrom, are consistent with the previously reported sizes of motor proteins on the surface of OHCs.	[Mio, Kazuhiro; Ogura, Toshihiko; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Mio, Kazuhiro; Ogura, Toshihiko; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tsukuba, Ibaraki 3058568, Japan; [Kubo, Yoshihiro; Yamamoto, Tomomi] Natl Inst Physiol Sci, Div Biophys & Neurobiol, Dept Mol Physiol, Aichi 4448585, Japan; [Kubo, Yoshihiro] Tokyo Med & Dent Univ, Grad Sch, Bunkyo Ku, COE Program Brain Integrad & Disorders, Tokyo 1138519, Japan; [Kubo, Yoshihiro] Japan Sci & Technol Corp, SORST, Kawaguchi, Saitama 3320012, Japan; [Ogura, Toshihiko] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Arisaka, Fumio] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Tokyo Institute of Technology	Sato, C (corresponding author), Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Umezono 1-1-4, Tsukuba, Ibaraki 3058568, Japan.	ti-sato@aist.go.jp	Sato, Chikara/M-7183-2016; Ogura, Toshihiko/M-4089-2018; Mio, Kazuhiro/L-7488-2018	Sato, Chikara/0000-0001-5543-4496; Mio, Kazuhiro/0000-0002-1655-8231; Kubo, Yoshihiro/0000-0001-6707-0837				ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Cazals Y, 2000, PROG NEUROBIOL, V62, P583, DOI 10.1016/S0301-0082(00)00027-7; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; DALLOS P, 1992, J NEUROSCI, V12, P4575; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; Frank J, 2006, 3 DIMENSIONAL ELECT; Geleoc GSG, 1999, NAT NEUROSCI, V2, P713, DOI 10.1038/11174; Geleoc GSG, 2003, TRENDS NEUROSCI, V26, P115, DOI 10.1016/S0166-2236(03)00030-4; Greeson JN, 2006, BRAIN RES, V1091, P140, DOI 10.1016/j.brainres.2006.02.084; HARAUZ G, 1986, OPTIK, V73, P146; Henderson R, 2004, Q REV BIOPHYS, V37, P3, DOI 10.1017/S0033583504003920; KACHAR B, 1986, NATURE, V322, P365, DOI 10.1038/322365a0; KALINEC F, 1992, P NATL ACAD SCI USA, V89, P8671, DOI 10.1073/pnas.89.18.8671; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; Le Grimellec C, 2002, J COMP NEUROL, V451, P62, DOI 10.1002/cne.10338; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Ludwig J, 2001, P NATL ACAD SCI USA, V98, P4178, DOI 10.1073/pnas.071613498; Mio K, 2005, BIOCHEM BIOPH RES CO, V337, P998, DOI 10.1016/j.bbrc.2005.09.141; Mio K, 2005, BIOCHEM BIOPH RES CO, V333, P768, DOI 10.1016/j.bbrc.2005.05.181; Murakoshi M, 2006, JARO-J ASSOC RES OTO, V7, P267, DOI 10.1007/s10162-006-0041-z; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Ogura T, 2004, J STRUCT BIOL, V145, P63, DOI 10.1016/S1047-8477(03)00139-4; Ogura T, 2004, J STRUCT BIOL, V146, P344, DOI 10.1016/j.jsb.2004.01.007; Ogura T, 2001, J STRUCT BIOL, V136, P227, DOI 10.1006/jsbi.2002.4442; Ogura T, 2006, J STRUCT BIOL, V156, P371, DOI 10.1016/j.jsb.2006.05.016; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; SANTOS-SACCHI J, 1988, HEARING RES, V35, P143, DOI 10.1016/0378-5955(88)90113-X; Sato C, 2004, J MOL BIOL, V336, P155, DOI 10.1016/j.jmb.2003.11.024; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Weber T, 2002, P NATL ACAD SCI USA, V99, P2901, DOI 10.1073/pnas.052609899; Yu N, 2006, BRAIN RES, V1095, P51, DOI 10.1016/j.brainres.2006.04.017; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2001, NEUROREPORT, V12, P1929, DOI 10.1097/00001756-200107030-00032; Zheng J, 2006, J BIOL CHEM, V281, P19916, DOI 10.1074/jbc.M513854200	45	52	53	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1137	1145		10.1074/jbc.M702681200	http://dx.doi.org/10.1074/jbc.M702681200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17998209	hybrid			2022-12-25	WOS:000252128100054
J	Yagishita, S; Morishima-Kawashima, M; Ishiura, S; Ihara, Y				Yagishita, Sosuke; Morishima-Kawashima, Maho; Ishiura, Shoichi; Ihara, Yasuo			A beta 46 is processed to A beta 40 and A beta 43, but not to A beta 42, in the low density membrane domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE ACTIVITY; C-TERMINAL FRAGMENT; BETA-PROTEIN; INTRAMEMBRANE CLEAVAGE; LIPID RAFTS; PRESENILIN; BETA-PROTEIN-42; INHIBITOR; MECHANISM	gamma-Secretase cleaves the transmembrane domain of beta-amyloid precursor protein at multiple sites referred to as gamma-, epsilon-, and zeta-cleavage sites. We previously showed that N-[N-( 3,5-difluoro-phenacetyl)-L- alanyl]-S-phenylglycine t-butyl ester (DAPT), a potent dipeptide gamma- secretase inhibitor, causes differential accumulation of longer amyloid beta-proteins (A beta s) within Chinese hamster ovary cells co-expressing beta C-terminal fragment and wild-type presenilin 1(C99/wtPS1 cells). In this study, we used sucrose density gradient centrifugation to fractionate the membranes from C99/wtPS1 cells that had been pretreated with DAPT. We found that accumulating A beta 46 localized exclusively to low density membrane (LDM) domains. Incubating the A beta 46-accumulating LDM domains at 37 degrees C produced A beta 40, A beta 42, A beta 43, and beta-amyloid precursor protein intracellular domain. The addition of L685,458 completely prevented beta-amyloid precursor protein intracellular domain generation and resulted in a large decrease in the level of A beta 46 and the concomitant appearance of A beta 40 and A beta 43 but not A beta 42. Further addition of DAPT suppressed the production of A beta 40/43 and abolished the decrease in the amount of A beta 46. These data indicate that preaccumulated A beta 46 is processed by gamma-secretase to A beta 40/43 but not to A beta 42 in the LDM domains. The amount of newly produced A beta 40 and A beta 43 was roughly equivalent to the decrease in the amount of A beta 46. Temporal profiles did not show a maximal concentration for A beta 43, suggesting that A beta 46 is processed to A beta 40 and A beta 43 through a nonsuccessive process.	[Ihara, Yasuo] Doshisha Univ, Fac Life & Med Sci, Planning Off, Kizugawa Shi, Kyoto 6190225, Japan; [Yagishita, Sosuke; Morishima-Kawashima, Maho; Ihara, Yasuo] Univ Tokyo, Fac Med, Dept Neuropathol, Tokyo 1130033, Japan; [Yagishita, Sosuke; Ishiura, Shoichi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan; [Morishima-Kawashima, Maho] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Mol Neuropathol, Sapporo, Hokkaido 0600812, Japan	Doshisha University; University of Tokyo; University of Tokyo; Hokkaido University	Ihara, Y (corresponding author), Doshisha Univ, Fac Life & Med Sci, Planning Off, 4-1-1 Kizugawadai, Kizugawa Shi, Kyoto 6190225, Japan.	yihara@mail.doshisha.ac.jp						Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Morishima-Kawashima M, 1998, BIOCHEMISTRY-US, V37, P15247, DOI 10.1021/bi981843u; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Riddell DR, 2001, CURR BIOL, V11, P1288, DOI 10.1016/S0960-9822(01)00394-3; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato T, 2005, FEBS LETT, V579, P2907, DOI 10.1016/j.febslet.2005.04.037; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Wada S, 2003, BIOCHEMISTRY-US, V42, P13977, DOI 10.1021/bi034904j; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wolfe MS, 2001, J BIOL CHEM, V276, P5413, DOI 10.1074/jbc.R000026200; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200; Zhao GJ, 2007, J NEUROCHEM, V100, P1234, DOI 10.1111/j.1471-4159.2006.04302.x	26	41	41	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					733	738		10.1074/jbc.M707103200	http://dx.doi.org/10.1074/jbc.M707103200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18024430	hybrid			2022-12-25	WOS:000252128100011
J	Dheekollu, J; Deng, Z; Wiedmer, A; Weitzman, MD; Lieberman, PM				Dheekollu, Jayaraju; Deng, Zhong; Wiedmer, Andreas; Weitzman, Matthew D.; Lieberman, Paul M.			A Role for MRE11, NBS1, and Recombination Junctions in Replication and Stable Maintenance of EBV Episomes	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; ORIGIN RECOGNITION COMPLEX; DNA-DAMAGE RESPONSE; CELL-CYCLE; HOMOLOGOUS RECOMBINATION; LATENT ORIGIN; IN-VITRO; ORIP; PROTEIN; INITIATION	Recombination-like structures formed at origins of DNA replication may contribute to replication fidelity, sister chromatid cohesion, chromosome segregation, and overall genome stability. The Epstein-Barr Virus (EBV) origin of plasmid replication ( OriP) provides episomal genome stability through a poorly understood mechanism. We show here that recombinational repair proteins MRE11 and NBS1 are recruited to the Dyad Symmetry (DS) region of OriP in a TRF2- and cell cycle-dependent manner. Depletion of MRE11 or NBS1 by siRNA inhibits OriP replication and destabilized viral episomes. OriP plasmid maintenance was defective in MRE11 and NBS1 hypomorphic fibroblast cell lines and only integrated, non-episomal forms of EBV were detected in a lympoblastoid cell line derived from an NBS1-mutated individual. Two-dimensional agarose gel analysis of OriP DNA revealed that recombination-like structures resembling Holliday-junctions form at OriP in mid S phase. MRE11 and NBS1 association with DS coincided with replication fork pausing and origin activation, which preceded the formation of recombination structures. We propose that NBS1 and MRE11 promote replication-associated recombination junctions essential for EBV episomal maintenance and genome stability.	[Dheekollu, Jayaraju; Deng, Zhong; Wiedmer, Andreas; Lieberman, Paul M.] Wistar Inst Anat & Biol, Philadelphia, PA USA; [Weitzman, Matthew D.] Salk Inst Biol Studies, La Jolla, CA USA	The Wistar Institute; Salk Institute	Lieberman, PM (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA USA.	lieberman@wistar.org			NIH [CA93606]; PA Department of Health;  [DAMD17-03-1-0313]; NATIONAL CANCER INSTITUTE [R01CA093606] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PA Department of Health; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	DAMD17-03-1-0313, NIH CA93606, PA Department of Health	Allers T, 2000, Nucleic Acids Res, V28, pe6, DOI 10.1093/nar/28.2.e6; Atanasiu C, 2006, EMBO REP, V7, P716, DOI 10.1038/sj.embor.7400730; Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Benard M, 2001, MOL CELL, V7, P971, DOI 10.1016/S1097-2765(01)00237-4; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Chaudhuri B, 2001, P NATL ACAD SCI USA, V98, P10085, DOI 10.1073/pnas.181347998; Davis PK, 2001, BIOTECHNIQUES, V30, P1322, DOI 10.2144/01306rv01; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; De Lange T, 2000, COLD SPRING HARB SYM, V65, P265, DOI 10.1101/sqb.2000.65.265; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Deng Z, 2003, J VIROL, V77, P11992, DOI 10.1128/JVI.77.22.11992-12001.2003; Deng Z, 2002, MOL CELL, V9, P493, DOI 10.1016/S1097-2765(02)00476-8; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; DHAR V, 1991, MOL CELL BIOL, V11, P6268, DOI 10.1128/MCB.11.12.6268; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; Eppink B, 2006, EXP CELL RES, V312, P2660, DOI 10.1016/j.yexcr.2006.06.011; Ermakova OV, 1996, J BIOL CHEM, V271, P33009, DOI 10.1074/jbc.271.51.33009; FOUCHE N, 2006, J BIOL CHEM; GAHN TA, 1989, CELL, V58, P527, DOI 10.1016/0092-8674(89)90433-9; Gerhardt J, 2006, MOL CELL BIOL, V26, P7731, DOI 10.1128/MCB.01392-06; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; GULLEY ML, 1992, CANCER, V70, P185, DOI 10.1002/1097-0142(19920701)70:1<185::AID-CNCR2820700129>3.0.CO;2-J; Hadden JM, 2001, NAT STRUCT BIOL, V8, P62; HARRISON JC, 2006, SURVIVING BREAKUP DN; Humme S, 2003, P NATL ACAD SCI USA, V100, P10989, DOI 10.1073/pnas.1832776100; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Julien MD, 2004, VIROLOGY, V326, P317, DOI 10.1016/j.virol.2004.05.026; Kanda T, 2007, J CELL SCI, V120, P1529, DOI 10.1242/jcs.03434; Kapoor P, 2005, MOL CELL BIOL, V25, P4934, DOI 10.1128/MCB.25.12.4934-4945.2005; Kieff E., 1996, FIELDS VIROLOGY, V2, P2343; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Kraus E, 2001, P NATL ACAD SCI USA, V98, P8255, DOI 10.1073/pnas.151008198; Lee MA, 1999, J VIROL, V73, P2974, DOI 10.1128/JVI.73.4.2974-2982.1999; Liberi G, 2006, METHOD ENZYMOL, V409, P442, DOI 10.1016/S0076-6879(05)09026-9; Lilley CE, 2005, P NATL ACAD SCI USA, V102, P5844, DOI 10.1073/pnas.0501916102; LITTLE RD, 1995, MOL CELL BIOL, V15, P2893; Lopes M, 2003, MOL CELL, V12, P1499, DOI 10.1016/S1097-2765(03)00473-8; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Maser RS, 2004, DNA REPAIR, V3, P979, DOI 10.1016/j.dnarep.2004.05.009; MULLER B, 1990, NUCLEIC ACIDS RES, V18, P5633, DOI 10.1093/nar/18.19.5633; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Nasmyth K, 2004, PHILOS T R SOC B, V359, P99, DOI 10.1098/rstb.2003.1417; NILLER HH, 1995, J BIOL CHEM, V270, P12864, DOI 10.1074/jbc.270.21.12864; Norio P, 2004, PLOS BIOL, V2, P816, DOI 10.1371/journal.pbio.0020152; Norio P, 2001, SCIENCE, V294, P2361, DOI 10.1126/science.1064603; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Pichierri P, 2004, EMBO J, V23, P3154, DOI 10.1038/sj.emboj.7600277; RAWLINS DR, 1985, CELL, V42, P859, DOI 10.1016/0092-8674(85)90282-X; RICKINSON AB, 1996, EPSTEIN BARR VIRUS F, P2397; Ritzi M, 2003, J CELL SCI, V116, P3971, DOI 10.1242/jcs.00708; Schepers A, 2001, EMBO J, V20, P4588, DOI 10.1093/emboj/20.16.4588; Sears J, 2004, J VIROL, V78, P11487, DOI 10.1128/JVI.78.21.11487-11505.2004; Segurado M, 2002, MOL CELL, V10, P907, DOI 10.1016/S1097-2765(02)00684-6; Shimada K, 2007, CELL, V128, P85, DOI 10.1016/j.cell.2006.11.045; Stansel RM, 2001, EMBO J, V20, P5532; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Sugden B, 2001, CURR TOP MICROBIOL, V258, P3; Tauchi H, 2002, NATURE, V420, P93, DOI 10.1038/nature01125; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Vogel M, 1998, BIOTECHNIQUES, V24, P540; Wang LD, 2005, J CELL BIOCHEM, V94, P247, DOI 10.1002/jcb.20324; Wang P, 2005, J VIROL, V79, P13298, DOI 10.1128/JVI.79.21.13298-13309.2005; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; Yates JL, 2000, J VIROL, V74, P4512, DOI 10.1128/JVI.74.10.4512-4522.2000; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhou J, 2005, EMBO J, V24, P1406, DOI 10.1038/sj.emboj.7600609; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	72	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1257	10.1371/journal.pone.0001257	http://dx.doi.org/10.1371/journal.pone.0001257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18040525	Green Submitted, gold, Green Published			2022-12-25	WOS:000207459400006
J	Kelly, CR; Grinband, J; Hirsch, J				Kelly, Christopher R.; Grinband, Jack; Hirsch, Joy			Repeated Exposure to Media Violence Is Associated with Diminished Response in an Inhibitory Frontolimbic Network	PLOS ONE			English	Article								Background. Media depictions of violence, although often claimed to induce viewer aggression, have not been shown to affect the cortical networks that regulate behavior. Methodology/Principal Findings. Using functional magnetic resonance imaging ( fMRI), we found that repeated exposure to violent media, but not to other equally arousing media, led to both diminished response in right lateral orbitofrontal cortex (right ItOFC) and a decrease in right ItOFC-amygdala interaction. Reduced function in this network has been previously associated with decreased control over a variety of behaviors, including reactive aggression. Indeed, we found reduced right ItOFC responses to be characteristic of those subjects that reported greater tendencies toward reactive aggression. Furthermore, the violence-induced reduction in right ItOFC response coincided with increased throughput to behavior planning regions. Conclusions. These novel findings establish that even short-term exposure to violent media can result in diminished responsiveness of a network associated with behaviors such as reactive aggression.	[Kelly, Christopher R.; Grinband, Jack; Hirsch, Joy] Columbia Univ, Neurol Inst, Funct MRI Res Ctr, Dept Radiol, New York, NY 10027 USA; [Hirsch, Joy] Columbia Univ, Neurol Inst, Dept Psychol, New York, NY USA; [Grinband, Jack; Hirsch, Joy] Columbia Univ, Neurol Inst, Dept Neurosci, New York, NY USA; [Kelly, Christopher R.] Columbia Univ, Neurol Inst, Coll Phys & Surg, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University	Kelly, CR (corresponding author), Columbia Univ, Neurol Inst, Funct MRI Res Ctr, Dept Radiol, New York, NY 10027 USA.	crk2002@columbia.edu; jg2269@columbia.edu; jh2155@columbia.edu	Grinband, Jack/AAX-7675-2020	Grinband, Jack/0000-0001-7658-6755; Hirsch, Joy/0000-0002-1418-6489	James S. McDonnell Foundation; Whitehall Radiology Fellowship	James S. McDonnell Foundation; Whitehall Radiology Fellowship	Work was supported via grants from the James S. McDonnell Foundation and the Whitehall Radiology Fellowship (JG), as well as start-up training funds (JH).	Anderson CA, 2000, J PERS SOC PSYCHOL, V78, P772, DOI 10.1037//0022-3514.78.4.772; Anderson CA, 2002, SCIENCE, V295, P2377, DOI 10.1126/science.1070765; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Averill J.R., 1982, ANGER AGGRESSION ESS; Berthoz S, 2002, BRAIN, V125, P1696, DOI 10.1093/brain/awf190; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blair RJR, 2004, BRAIN COGNITION, V55, P198, DOI 10.1016/s0278-2626(03)00276-8; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Bufkin JL, 2005, TRAUMA VIOLENCE ABUS, V6, P176, DOI 10.1177/1524838005275089; Bushman BJ, 1998, J APPL PSYCHOL, V83, P969, DOI 10.1037/0021-9010.83.6.969; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; FEDERMAN J, 1998, NATL TELEVISION VIOL; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; GOYER PF, 1994, NEUROPSYCHOPHARMACOL, V10, P21, DOI 10.1038/npp.1994.3; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Harlow JM, 1848, BOSTON MED SURGICAL, V39, P389, DOI DOI 10.1056/NEJM184812130392001; Horn NR, 2003, NEUROPSYCHOLOGIA, V41, P1959, DOI 10.1016/S0028-3932(03)00077-0; Huesmann LR, 2003, DEV PSYCHOL, V39, P201, DOI 10.1037/0012-1649.39.2.201; Johnson JG, 2002, SCIENCE, V295, P2468, DOI 10.1126/science.1062929; Kandel E., 2000, PRINCIPLES NEURAL SC; Kim E, 2002, NEUROREHABILITATION, V17, P297; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; PETRIDES M, 1994, HDB NEUROPSYCHOLOGY; Raine A, 1998, BEHAV SCI LAW, V16, P319, DOI 10.1002/(SICI)1099-0798(199822)16:3<319::AID-BSL311>3.0.CO;2-G; Singer MI, 1998, J AM ACAD CHILD PSY, V37, P1041, DOI 10.1097/00004583-199810000-00014; Smith SK, 2004, POPUL RES POLICY REV, V23, P1, DOI 10.1023/B:POPU.0000019918.24143.c9; STARKSTEIN SE, 2000, FRONTAL SUBCORTICAL; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Zillmann D, 1999, J APPL SOC PSYCHOL, V29, P145, DOI 10.1111/j.1559-1816.1999.tb01379.x	35	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1268	10.1371/journal.pone.0001268	http://dx.doi.org/10.1371/journal.pone.0001268			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060062	Green Published, gold			2022-12-25	WOS:000207459400015
J	Keller, EF; Harel, D				Keller, Evelyn Fox; Harel, David			Beyond the Gene	PLOS ONE			English	Article							DNA	This paper is a response to the increasing difficulty biologists find in agreeing upon a definition of the gene, and indeed, the increasing disarray in which that concept finds itself. After briefly reviewing these problems, we propose an alternative to both the concept and the word gene-an alternative that, like the gene, is intended to capture the essence of inheritance, but which is both richer and more expressive. It is also clearer in its separation of what the organism statically is (what it tangibly inherits) and what it dynamically does (its functionality and behavior). Our proposal of a genetic functor, or genitor, is a sweeping extension of the classical genotype/phenotype paradigm, yet it appears to be faithful to the findings of contemporary biology, encompassing many of the recently emerging- and surprisingly complex-links between structure and functionality.	[Harel, David] Weizmann Inst Sci, Dept Appl Math & Comp Sci, IL-76100 Rehovot, Israel; [Keller, Evelyn Fox] MIT, Program Sci Technol & Soc, Cambridge, MA 02139 USA	Weizmann Institute of Science; Massachusetts Institute of Technology (MIT)	Harel, D (corresponding author), Weizmann Inst Sci, Dept Appl Math & Comp Sci, IL-76100 Rehovot, Israel.	dharel@weizmann.ac.il			EPSRC; EPSRC [EP/E031161/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E031161/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Evelyn Fox Keller's work was carried out while she was in Paris as Chaire Blaise Pascal, at REHSEIS. David Harel's work was carried out during a visit to the School of Informatics at the University of Edinburgh, which was supported by a grant from the EPSRC.	[Anonymous], 2005, PLAUSIBILITY LIFE; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BORGES JL, 1941, LIB BABEL; Brenner S, 2000, SCIENCE, V287, P2173, DOI 10.1126/science.287.5461.2173; Clarke EM, 1999, MODEL CHECKING, P1; Gingeras TR, 2007, GENOME RES, V17, P682, DOI 10.1101/gr.6525007; GOLDENFELD N, 2007, BIOL NEXT REVOLUTION; Harel D., 2003, Bulletin of the European Association for Theoretical Computer Science, P226; HAREL D, 1985, NATO ASI SERIES F, V13, P477; HAREL D, 2001, COMPUTERS LTD WHAT T; Hsu PWC, 2006, NUCLEIC ACIDS RES, V34, pD135, DOI 10.1093/nar/gkj135; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Keller Evelyn Fox, 2000, CENTURY GENE; King DG, 1997, ENDEAVOUR, V21, P36, DOI 10.1016/S0160-9327(97)01005-3; Klein RJ, 2002, P NATL ACAD SCI USA, V99, P7542, DOI 10.1073/pnas.112063799; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Pearson H, 2006, NATURE, V441, P398, DOI 10.1038/441398a; Pennisi E, 2003, SCIENCE, V300, P282, DOI 10.1126/science.300.5617.282; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Smale ST, 2003, NAT IMMUNOL, V4, P607, DOI 10.1038/ni0703-607; Snyder M, 2003, SCIENCE, V300, P258, DOI 10.1126/science.1084354; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Yuh CH, 2001, DEVELOPMENT, V128, P617	23	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1231	10.1371/journal.pone.0001231	http://dx.doi.org/10.1371/journal.pone.0001231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043738	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459300012
J	Mathews, JD; McCaw, CT; McVernon, J; McBryde, ES; McCaw, JM				Mathews, John D.; McCaw, Christopher T.; McVernon, Jodie; McBryde, Emma S.; McCaw, James M.			A Biological Model for Influenza Transmission: Pandemic Planning Implications of Asymptomatic Infection and Immunity	PLOS ONE			English	Article							A VIRUS-INFECTION; STRATEGIES; HOUSEHOLD; OUTBREAK; FAMILY	Background. The clinical attack rate of influenza is influenced by prior immunity and mixing patterns in the host population, and also by the proportion of infections that are asymptomatic. This complexity makes it difficult to directly estimate R-0 from the attack rate, contributing to uncertainty in epidemiological models to guide pandemic planning. We have modelled multiple wave outbreaks of influenza from different populations to allow for changing immunity and asymptomatic infection and to make inferences about R-0. Data and Methods. On the island of Tristan da Cunha (TdC), 96% of residents reported illness during an H3N2 outbreak in 1971, compared with only 25% of RAF personnel in military camps during the 1918 H1N1 pandemic. Monte Carlo Markov Chain (MCMC) methods were used to estimate model parameter distributions. Findings. We estimated that most islanders on TdC were non-immune (susceptible) before the first wave, and that almost all exposures of susceptible persons caused symptoms. The median R0 of 6.4 (95% credibility interval 3.7-10.7) implied that most islanders were exposed twice, although only a minority became ill in the second wave because of temporary protection following the first wave. In contrast, only 51% of RAF personnel were susceptible before the first wave, and only 38% of exposed susceptibles reported symptoms. R0 in this population was also lower [2.9 (2.3-4.3)], suggesting reduced viral transmission in a partially immune population. Interpretation. Our model implies that the RAF population was partially protected before the summer pandemic wave of 1918, arguably because of prior exposure to interpandemic influenza. Without such protection, each symptomatic case of influenza would transmit to between 2 and 10 new cases, with incidence initially doubling every 12 days. Containment of a novel virus could be more difficult than hitherto supposed.	[Mathews, John D.; McCaw, Christopher T.; McVernon, Jodie; McCaw, James M.] Univ Melbourne, Murdoch Childrens Res Inst, Vaccine & Immunisat Res Grp, Parkville, Vic 3052, Australia; [Mathews, John D.; McCaw, Christopher T.; McVernon, Jodie; McCaw, James M.] Univ Melbourne, Sch Populat Hlth, Parkville, Vic 3052, Australia; [McBryde, Emma S.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Ctr Clin Res Excellence Infect Dis, Parkville, Vic 3050, Australia; [McBryde, Emma S.] Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; University of Melbourne	McCaw, JM (corresponding author), Univ Melbourne, Murdoch Childrens Res Inst, Vaccine & Immunisat Res Grp, Parkville, Vic 3052, Australia.	jamesm@unimelb.edu.au	; McBryde, Emma/D-2220-2018	Mathews, John/0000-0001-9029-7140; McCaw, James/0000-0002-2452-3098; McBryde, Emma/0000-0002-9570-9172; McVernon, Jodie/0000-0001-9774-1961	National Health and Medical Research Council (NHMRC) [400588, 454645, 358425, 359238]; Centre for Clinical Research Excellence in Infectious Diseases [219275]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Centre for Clinical Research Excellence in Infectious Diseases	External funding was received from the National Health and Medical Research Council (NHMRC) (Project Grant Nos 400588 and 454645, Capacity Building Grant No 358425 and Centre for Clinical Research Excellence in Infectious Diseases No 219275). Jodie McVernon is supported by an NHMRC Australian Training Research Fellowship (No 359238).	ANDERSON R M, 1991; ARMSTRONG C, 1921, PUBLIC HLTH REPORTS, V36; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; CALEY P, 2007, J R SOC INTERFACE; Cox RJ, 2006, VACCINE, V24, P6577, DOI 10.1016/j.vaccine.2006.05.041; CROSBY A, 2003, SAMOA ALASKA AM FORG, pCH12; DAVIS LE, 1970, AM J EPIDEMIOL, V92, P240, DOI 10.1093/oxfordjournals.aje.a121203; Dowdle WR, 2006, EMERG INFECT DIS, V12, P34, DOI 10.3201/eid1201.051013; DUDLEY S, 1926, MED RES COUNCIL SPEC, V111; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Frost W H, 2006, Public Health Rep, V121 Suppl 1, P149; Frost W.H., 2006, PUBLIC HEALTH REP, V121, P148; GELMAN A, 2004, BAYSESIAN DATA ANAL; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Halloran ME, 2007, AM J EPIDEMIOL, V165, P212, DOI 10.1093/aje/kwj362; Hope-Simpson R.E., 1992, TRANSMISSION EPIDEMI; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; MANTLE J, 1973, J HYG-CAMBRIDGE, V71, P89, DOI 10.1017/S0022172400046246; McVernon J, 2007, INFLUENZA OTHER RESP, V1, P43, DOI 10.1111/j.1750-2659.2007.00008.x; *MIN HLTH, 1920, REP PUBL HLTH MED SU, V4; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Nishiura H, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-20; Reid AH, 2004, NAT REV MICROBIOL, V2, P909, DOI 10.1038/nrmicro1027; Roberts MG, 2007, J R SOC INTERFACE, V4, P325, DOI 10.1098/rsif.2006.0176; ROBERTS MG, 2007, J MATH BIOL; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; Tamura SI, 2005, JPN J INFECT DIS, V58, P195	35	72	75	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1220	10.1371/journal.pone.0001220	http://dx.doi.org/10.1371/journal.pone.0001220			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043733	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000207459300007
J	Heiny, AT; Miotto, O; Srinivasan, KN; Khan, AM; Zhang, GL; Brusic, V; Tan, TW; August, JT				Heiny, A. T.; Miotto, Olivo; Srinivasan, Kellathur N.; Khan, Asif M.; Zhang, G. L.; Brusic, Vladimir; Tan, Tin Wee; August, J. Thomas			Evolutionarily Conserved Protein Sequences of Influenza A Viruses, Avian and Human, as Vaccine Targets	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; MHC CLASS-I; PROTECTIVE IMMUNITY; CELL EPITOPES; DNA VACCINE; CTL EPITOPES; PEPTIDE; INFECTION; BINDING; IMMUNIZATION	Background. Influenza A viruses generate an extreme genetic diversity through point mutation and gene segment exchange, resulting in many new strains that emerge from the animal reservoirs, among which was the recent highly pathogenic H5N1 virus. This genetic diversity also endows these viruses with a dynamic adaptability to their habitats, one result being the rapid selection of genomic variants that resist the immune responses of infected hosts. With the possibility of an influenza A pandemic, a critical need is a vaccine that will recognize and protect against any influenza A pathogen. One feasible approach is a vaccine containing conserved immunogenic protein sequences that represent the genotypic diversity of all current and future avian and human influenza viruses as an alternative to current vaccines that address only the known circulating virus strains. Methodology/Principal Findings. Methodologies for large-scale analysis of the evolutionary variability of the influenza A virus proteins recorded in public databases were developed and used to elucidate the amino acid sequence diversity and conservation of 36,343 sequences of the 11 viral proteins of the recorded virus isolates of the past 30 years. Technologies were also applied to identify the conserved amino acid sequences from isolates of the past decade, and to evaluate the predicted human lymphocyte antigen (HLA) supertype-restricted class I and II T-cell epitopes of the conserved sequences. Fifty-five (55) sequences of 9 or more amino acids of the polymerases (PB2, PB1, and PA), nucleoprotein (NP), and matrix 1 (M1) proteins were completely conserved in at least 80%, many in 95 to 100%, of the avian and human influenza A virus isolates despite the marked evolutionary variability of the viruses. Almost all (50) of these conserved sequences contained putative supertype HLA class I or class II epitopes as predicted by 4 peptide-HLA binding algorithms. Additionally, data of the Immune Epitope Database (IEDB) include 29 experimentally identified HLA class I and II T-cell epitopes present in 14 of the conserved sequences. Conclusions/Significance. This study of all reported influenza A virus protein sequences, avian and human, has identified 55 highly conserved sequences, most of which are predicted to have immune relevance as T-cell epitopes. This is a necessary first step in the design and analysis of a polyepitope, pan-influenza A vaccine. In addition to the application described herein, these technologies can be applied to other pathogens and to other therapeutic modalities designed to attack DNA, RNA, or protein sequences critical to pathogen function.	[Srinivasan, Kellathur N.; August, J. Thomas] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21218 USA; [Heiny, A. T.; Miotto, Olivo; Khan, Asif M.; Tan, Tin Wee] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Miotto, Olivo] Natl Univ Singapore, Inst Syst Sci, Singapore 117595, Singapore; [Srinivasan, Kellathur N.] Hlth Sci Author, Ctr Drug Adm, Prod Evaluat & Registrat Div, Singapore, Singapore; [Khan, Asif M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Zhang, G. L.] Inst Infocomm Res, Singapore, Singapore; [Brusic, Vladimir] Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02115 USA	Johns Hopkins University; National University of Singapore; National University of Singapore; Health Sciences Authority (HSA); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R); Harvard University; Dana-Farber Cancer Institute	August, JT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21218 USA.	taugust@bs.jhmi.edu	Khan, Mohammad Asif/F-4663-2010; Tan, Tin Wee/B-8963-2009; Brusic, Vladimir/B-1478-2008; Khan, M. Asif/ABE-7839-2021; Miotto, Olivo/AAE-7124-2019	Khan, Mohammad Asif/0000-0001-9202-279X; Tan, Tin Wee/0000-0002-4062-2854; Brusic, Vladimir/0000-0003-0523-5266; Khan, M. Asif/0000-0001-9202-279X; Miotto, Olivo/0000-0001-8060-6771	National Institute of Allergy and Infectious Diseases; National Institutes of Health; Department of Health and Human Services, USA [5 U19 AI56541, HHSN2662-00400085C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056541] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The development of the computational tools reported herein was supported by in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, USA, under Grant No. 5 U19 AI56541 and Contract No. HHSN2662-00400085C.	Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; ASKONAS BA, 1988, ANN NY ACAD SCI, V532, P230, DOI 10.1111/j.1749-6632.1988.tb36342.x; BENACERRAF B, 1978, J IMMUNOL, V120, P1809; Bian HJ, 2004, METHODS, V34, P468, DOI 10.1016/j.ymeth.2004.06.002; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Blaney JE, 1998, J VIROL, V72, P9567, DOI 10.1128/JVI.72.12.9567-9574.1998; Botten J, 2007, J VIROL, V81, P2307, DOI 10.1128/JVI.02063-06; Brusic V, 2004, PHARMACOGENOMICS, V5, P597, DOI 10.1517/14622416.5.6.597; Bui HH, 2005, IMMUNOGENETICS, V57, P304, DOI 10.1007/s00251-005-0798-y; CASTRUCCI MR, 1994, J VIROL, V68, P3486, DOI 10.1128/JVI.68.6.3486-3490.1994; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Coleman JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-9; Corbet S, 2003, J GEN VIROL, V84, P2409, DOI 10.1099/vir.0.19152-0; COX NJ, 2005, TOPLEY WILSONS MICRO, V1, pCH32; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Crowe SR, 2006, VACCINE, V24, P452, DOI 10.1016/j.vaccine.2005.07.090; De Groot AS, 2005, VACCINE, V23, P2136, DOI 10.1016/j.vaccine.2005.01.097; de Jong JC, 2000, J INFECTION, V40, P218, DOI 10.1053/jinf.2000.0652; DELVAL M, 1991, J VIROL, V65, P3641, DOI 10.1128/JVI.65.7.3641-3646.1991; Doytchinova IA, 2005, J IMMUNOL, V174, P7085, DOI 10.4049/jimmunol.174.11.7085; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; ENGELHARD VH, 1994, ANNU REV IMMUNOL, V12, P181, DOI 10.1146/annurev.iy.12.040194.001145; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Epstein SL, 2002, EMERG INFECT DIS, V8, P796; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FELTKAMP MCW, 1995, EUR J IMMUNOL, V25, P2638, DOI 10.1002/eji.1830250935; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Fomsgaard A, 1999, VACCINE, V18, P681, DOI 10.1016/S0264-410X(99)00279-0; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Fu TM, 1999, J IMMUNOL, V162, P4163; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Gonzalez-Aseguinolaza G, 2003, J VIROL, V77, P11859, DOI 10.1128/JVI.77.21.11859-11866.2003; HAMMER J, 1993, CELL, V74, P197, DOI 10.1016/0092-8674(93)90306-B; Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0; HARTY JT, 1992, J EXP MED, V175, P1531, DOI 10.1084/jem.175.6.1531; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Khan AM, 2006, CELL IMMUNOL, V244, P141, DOI 10.1016/j.cellimm.2007.02.005; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; KLAVINSKIS LS, 1989, J VIROL, V63, P4311, DOI 10.1128/JVI.63.10.4311-4316.1989; LAMB JR, 1987, HUM IMMUNOL, V19, P79, DOI 10.1016/0198-8859(87)90096-6; Lambkin Robert, 2004, Am J Pharmacogenomics, V4, P293, DOI 10.2165/00129785-200404050-00002; LAPOSTA VJ, 1993, J VIROL, V67, P3497, DOI 10.1128/JVI.67.6.3497-3506.1993; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; LAWSON CM, 1994, J VIROL, V68, P3505, DOI 10.1128/JVI.68.6.3505-3511.1994; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; Mazumder R, 2007, VIRUS GENES, V35, P175, DOI 10.1007/s11262-007-0103-2; MCMICHAEL AJ, 1989, ADV EXP MED BIOL, V257, P109; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S7; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S18; Moorthy VS, 2004, J INFECT DIS, V189, P2213, DOI 10.1086/421118; Moskophidis D, 1998, J EXP MED, V188, P223, DOI 10.1084/jem.188.2.223; Nickle DC, 2007, PLOS COMPUT BIOL, V3, P754, DOI 10.1371/journal.pcbi.0030075; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Oukka M, 1996, J IMMUNOL, V157, P3039; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Plotnicky H, 2003, VIROLOGY, V309, P320, DOI 10.1016/S0042-6822(03)00072-2; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; RAMMENSEE HG, 1995, CURR OPIN IMMUNOL, V7, P85, DOI 10.1016/0952-7915(95)80033-6; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Sette A, 2003, CURR OPIN IMMUNOL, V15, P461, DOI 10.1016/S0952-7915(03)00083-9; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; SIDNEY J, 1995, J IMMUNOL, V154, P247; Snyder JT, 2004, J VIROL, V78, P7052, DOI 10.1128/JVI.78.13.7052-7060.2004; Stemmer C, 1999, J BIOL CHEM, V274, P5550, DOI 10.1074/jbc.274.9.5550; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Thakar MR, 2005, J INFECT DIS, V192, P749, DOI 10.1086/432547; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; TOWNSEND ARM, 1987, IMMUNOL RES, V6, P80, DOI 10.1007/BF02918106; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5; Treanor J, 2004, NEW ENGL J MED, V351, P2037, DOI 10.1056/NEJMp048290; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Tsuji M, 1998, J VIROL, V72, P6907, DOI 10.1128/JVI.72.8.6907-6910.1998; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Ulmer JB, 1998, J VIROL, V72, P5648, DOI 10.1128/JVI.72.7.5648-5653.1998; Uscher-Pines L, 2006, PLOS MED, V3, P1721, DOI 10.1371/journal.pmed.0030436; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; VANBLEEK GM, 1991, P NATL ACAD SCI USA, V88, P11032, DOI 10.1073/pnas.88.24.11032; Wilson CC, 2003, J IMMUNOL, V171, P5611, DOI 10.4049/jimmunol.171.10.5611; Yokomaku Y, 2004, J VIROL, V78, P1324, DOI 10.1128/JVI.78.3.1324-1332.2004; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002; Zhang GL, 2005, NUCLEIC ACIDS RES, V33, pW172, DOI 10.1093/nar/gki452	91	129	146	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1190	10.1371/journal.pone.0001190	http://dx.doi.org/10.1371/journal.pone.0001190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030326	Green Published, gold			2022-12-25	WOS:000207459200005
J	Tschritter, O; Hennige, AM; Preissl, H; Porubska, K; Schafer, SA; Lutzenberger, W; Machicao, F; Birbaumer, N; Fritsche, A; Haring, HU				Tschritter, Otto; Hennige, Anita M.; Preissl, Hubert; Porubska, Katarina; Schaefer, Silke A.; Lutzenberger, Werner; Machicao, Fausto; Birbaumer, Niels; Fritsche, Andreas; Haering, Hans-Ulrich			Cerebrocortical Beta Activity in Overweight Humans Responds to Insulin Detemir	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; OBESITY; MEMORY; PROTRACTION; MECHANISM; TRANSPORT; ALBUMIN; WEIGHT; PLASMA; TISSUE	Background. Insulin stimulates cerebrocortical beta and theta activity in lean humans. This effect is reduced in obese individuals indicating cerebrocortical insulin resistance. In the present study we tested whether insulin detemir is a suitable tool to restore the cerebral insulin response in overweight humans. This approach is based on studies in mice where we could recently demonstrate increased brain tissue concentrations of insulin and increased insulin signaling in the hypothalamus and cerebral cortex following peripheral injection of insulin detemir. Methodology/Principal Findings. We studied activity of the cerebral cortex using magnetoencephalography in 12 lean and 34 overweight non-diabetic humans during a 2-step hyperinsulinemic euglycemic clamp (each step 90 min) with human insulin (HI) and saline infusion (S). In 10 overweight subjects we additionally performed the euglycemic clamp with insulin detemir (D). While human insulin administration did not change cerebrocortical activity relative to saline (p = 0.90) in overweight subjects, beta activity increased during D administration (basal 59 +/- 3 fT, 1(st) step 62 +/- 3 fT, 2(nd) step 66 +/- 5, p = 0.001, D vs. HI). As under this condition glucose infusion rates were lower with D than with HI (p = 0.003), it can be excluded that the cerebral effect is the consequence of a systemic effect. The total effect of insulin detemir on beta activity was not different from the human insulin effect in lean subjects (p = 0.78). Conclusions/Significance. Despite cerebrocortical resistance to human insulin, insulin detemir increased beta activity in overweight human subjects similarly as human insulin in lean subjects. These data suggest that the decreased cerebral beta activity response in overweight subjects can be restored by insulin detemir.	[Tschritter, Otto; Hennige, Anita M.; Schaefer, Silke A.; Machicao, Fausto; Fritsche, Andreas; Haering, Hans-Ulrich] Univ Tubingen, Dept Internal Med 4, Tubingen, Germany; [Preissl, Hubert; Porubska, Katarina; Lutzenberger, Werner; Birbaumer, Niels] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Preissl, Hubert] Univ Arkansas Med Sci, Coll Med, Dept Obstet & Gynecol, Little Rock, AR 72205 USA; [Porubska, Katarina] Univ Eye Hosp, Dept Neuroophthalmol, Tubingen, Germany; [Birbaumer, Niels] NINDS, NIH, Bethesda, MD 20892 USA	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Arkansas System; University of Arkansas Medical Sciences; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Haring, HU (corresponding author), Univ Tubingen, Dept Internal Med 4, Tubingen, Germany.	hans-ulrich.haering@med.uni-tuebingen.de	Preißl, Hubert/E-9070-2012	Preißl, Hubert/0000-0002-8859-4661; Birbaumer, Niels/0000-0002-6786-5127	Deutsche Forschungsgemeinschaft ( DFG) [KFO114]; NovoNordisk, Copenhagen, Denmark	Deutsche Forschungsgemeinschaft ( DFG)(German Research Foundation (DFG)); NovoNordisk, Copenhagen, Denmark(Novo Nordisk)	This is an investigator initiated study. The study has been supported by a grant of the Deutsche Forschungsgemeinschaft ( DFG) as a part of the project "Klinische Forschergruppe 114'' ( KFO114) and by a research grant of NovoNordisk, Copenhagen, Denmark. NovoNordisk provided information about pharmacokinetics of insulin detemir for intravenous application. The funders had no further role in study design, collection and analysis of data, decision to publish, or preparation of the manuscript.	BAURA GD, 1993, J CLIN INVEST, V92, P1824, DOI 10.1172/JCI116773; Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003; Biessels GJ, 1998, BRAIN RES, V800, P125, DOI 10.1016/S0006-8993(98)00510-1; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; BRUNING JC, 2000, REPROD SCI, V289, P2122; Dea MK, 2002, DIABETES, V51, P762, DOI 10.2337/diabetes.51.3.762; Ellmerer M, 2000, AM J PHYSIOL-ENDOC M, V278, pE352, DOI 10.1152/ajpendo.2000.278.2.E352; Fritsche A, 2004, INT J OBESITY, V28, pS41, DOI 10.1038/sj.ijo.0802749; Havelund S, 2004, PHARM RES-DORDR, V21, P1498, DOI 10.1023/B:PHAM.0000036926.54824.37; Hennige AM, 2006, DIABETOLOGIA, V49, P1274, DOI 10.1007/s00125-006-0192-9; Kaiyala KJ, 2000, DIABETES, V49, P1525, DOI 10.2337/diabetes.49.9.1525; Kurtzhals P, 2004, INT J OBESITY, V28, pS23, DOI 10.1038/sj.ijo.0802746; Lutzenberger W, 2002, J NEUROSCI, V22, P5630; Messier Claude, 2005, Neural Plasticity, V12, P311, DOI 10.1155/NP.2005.311; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Novitski N, 2004, COGNITIVE BRAIN RES, V20, P26, DOI 10.1016/j.cogbrainres.2003.12.011; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Okamoto H, 2005, J CLIN INVEST, V115, P1314, DOI 10.1172/JCI200523096; Pitcher H, 2006, LANCET NEUROL, V5, P388, DOI 10.1016/S1474-4422(06)70434-3; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Porte D, 1998, DIABETOLOGIA, V41, P863, DOI 10.1007/s001250051002; Sauseng P, 2004, NEUROSCI LETT, V354, P123, DOI 10.1016/j.neulet.2003.10.002; SCHWARTZ MW, 1991, J CLIN INVEST, V88, P1272, DOI 10.1172/JCI115431; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seyfert S, 2002, J NEUROL, V249, P1021, DOI 10.1007/s00415-002-0777-2; Tschritter O, 2007, DIABETOLOGIA, V50, P2602, DOI 10.1007/s00125-007-0839-1; Tschritter O, 2006, P NATL ACAD SCI USA, V103, P12103, DOI 10.1073/pnas.0604404103; Vardy ERLC, 2006, EXPERT REV NEUROTHER, V6, P695, DOI 10.1586/14737175.6.5.695; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Woods SC, 2003, CURR PHARM DESIGN, V9, P795, DOI 10.2174/1381612033455323	30	40	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1196	10.1371/journal.pone.0001196	http://dx.doi.org/10.1371/journal.pone.0001196			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030331	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459200010
J	Samways, DSK; Migita, K; Li, Z; Egan, TM				Samways, Damien S. K.; Migita, Keisuke; Li, Zhiyuan; Egan, Terrance M.			On the role of the first transmembrane domain in cation permeability and flux of the ATP-gated P2X(2) receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE ACCESSIBILITY METHOD; TRANSMEMBRANE SEGMENTS; CHANNEL PERMEABILITY; ION-CHANNEL; DOMAIN; RESIDUES; CALCIUM; NEURONS; IDENTIFICATION; SELECTIVITY	P2X receptors are a family of seven ligand-gated ion channels (P2X(1)-P2X(7)) that open in the presence of ATP. We used ala-nine-scanning mutagenesis and patch clamp photometry to study the role of the first transmembrane domain of the rat P2X(2) receptor in cation permeability and flux. Three alanine-substituted mutants did not respond to ATP, and 19 of the 22 functional receptors resembled the wild-type receptor with regard to the fraction of the total ATP-gated current carried by calcium or the permeability of calcium relative to cesium. The remaining three mutants showed modest changes in calcium dynamics. Two of these occurred at sites (Gly(30) and Phe(44)) that are unlikely to interact with permeating cations in a meaningful way. The third was a conserved tyrosine (Tyr(43)) that may form an inter-pore binding site for calcium. The data suggest that, with the possible exception of Tyr(43), the first transmembrane domain contributes little to the permeation properties of the P2X(2) receptor.	[Samways, Damien S. K.; Migita, Keisuke; Li, Zhiyuan; Egan, Terrance M.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	Saint Louis University	Egan, TM (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 S Grand Blvd, St Louis, MO 63104 USA.	egantm@slu.edu	Migita, Keisuke/E-8274-2013	Egan, Terrance/0000-0002-7249-3161				Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; CHAUMONT S, 2006, BIOPHYS ASPECTS LIGA, P445; CHOTHIA C, 1975, NATURE, V254, P304, DOI 10.1038/254304a0; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DeLano WL, 2002, PYMOL USERS MANUAL; Ding SH, 1999, J GEN PHYSIOL, V113, P695, DOI 10.1085/jgp.113.5.695; Dutton JL, 2000, NEUROPHARMACOLOGY, V39, P2054, DOI 10.1016/S0028-3908(00)00058-7; Egan TM, 2006, PFLUG ARCH EUR J PHY, V452, P501, DOI 10.1007/s00424-006-0078-1; Egan TM, 1998, J NEUROSCI, V18, P2350; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Eickhorst AN, 2002, J GEN PHYSIOL, V120, P119, DOI 10.1085/jgp.20028535; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; Fisher JA, 2004, J NEUROSCI, V24, P10475, DOI 10.1523/JNEUROSCI.3250-04.2004; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Frings S, 2000, METHOD ENZYMOL, V315, P797; Haines WR, 2001, J NEUROSCI, V21, P5885, DOI 10.1523/JNEUROSCI.21-16-05885.2001; HILLE B, 2004, IONIC CHANNELS EXCIT, P441; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 2005, J BIOL CHEM, V280, P6118, DOI 10.1074/jbc.M411324200; Khakh BS, 2001, P NATL ACAD SCI USA, V98, P5288, DOI 10.1073/pnas.081089198; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Li ZY, 2004, J NEUROSCI, V24, P7378, DOI 10.1523/JNEUROSCI.1423-04.2004; Liu DM, 2001, J PHYSIOL-LONDON, V534, P423, DOI 10.1111/j.1469-7793.2001.00423.x; Migita K, 2001, J BIOL CHEM, V276, P30934, DOI 10.1074/jbc.M103366200; Nakazawa K, 1998, EUR J PHARMACOL, V347, P141, DOI 10.1016/S0014-2999(98)00207-6; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Petsko G. A., 2004, PROTEIN STRUCTURE FU, P50; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Samways DSK, 2007, J GEN PHYSIOL, V129, P245, DOI 10.1085/jgp.200609677; SAMWAYS DS, 2006, BIOPHYSICAL ASPECTS, P419; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; Silberberg SD, 2005, J GEN PHYSIOL, V125, P347, DOI 10.1085/jgp.200409221; Spencer RH, 2002, ANNU REV BIOPH BIOM, V31, P207, DOI 10.1146/annurev.biophys.31.082901.134329; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Wollmuth LP, 1998, J GEN PHYSIOL, V112, P623, DOI 10.1085/jgp.112.5.623	41	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5110	5117		10.1074/jbc.M708713200	http://dx.doi.org/10.1074/jbc.M708713200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18048351	hybrid			2022-12-25	WOS:000253426500068
J	Cook, PD; Holden, HM				Cook, Paul D.; Holden, Hazel M.			GDP-4-keto-6-deoxy-D-mannose 3-dehydratase, accommodating a sugar substrate in the active site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; MOLECULAR ARCHITECTURE; PSEUDAMINIC ACID; BIOSYNTHESIS; ENZYME; AMINOTRANSFERASE; HELICOBACTER; DESOSAMINE	Colitose is a dideoxysugar found in the O-antigen of the lipopolysaccharide that coats the outer membrane of some Gram-negative bacteria. Four enzymes are required for its production starting from D-mannose-1-phosphate and GTP. The focus of this investigation is GDP-4-keto-6-deoxy-D-mannose 3-dehydratase or ColD, which catalyzes the removal of the C3'-hydroxyl group from GDP-4-keto-6-deoxymannose. The enzyme is pyridoxal 5'-phosphate-dependent, but unlike most of these proteins, the conserved lysine residue that covalently holds the cofactor in the active site is replaced with a histidine residue. Here we describe the three-dimensional structure of ColD, determined to 1.7 angstrom resolution, whereby the active site histidine has been replaced with an asparagine residue. For this investigation, crystals of the site-directed mutant protein were grown in the presence of GDP-4-amino-4,6-dideoxy-D-mannose (GDP-perosamine). The electron density map clearly reveals the presence of the sugar analog trapped in the active site as an external aldimine. The active site is positioned between the two subunits of the dimer. Whereas the pyrophosphoryl groups of the ligand are anchored to the protein via Arg-219 and Arg-331, the hydroxyl groups of the hexose only lie within hydrogen bonding distance to ordered water molecules. Interestingly, the hexose moiety of the ligand adopts a boat rather than the typically observed chair conformation. Activity assays demonstrate that this mutant protein cannot catalyze the dehydration step. Additionally, we report data revealing that wild-type ColD is able to catalyze the production of GDP-4-keto-3,6-dideoxymannose using GDP-perosamine instead of GDP-4-keto-6-deoxymannose as a substrate.	[Cook, Paul D.; Holden, Hazel M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Holden, HM (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	Hazel_Holden@biochem.wisc.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047814, R56DK047814] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK47814] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alam J, 2004, BIOCHEMISTRY-US, V43, P16450, DOI 10.1021/bi0483763; Burgie ES, 2007, BIOCHEMISTRY-US, V46, P8999, DOI 10.1021/bi700751d; Burgie ES, 2007, PROTEIN SCI, V16, P887, DOI 10.1110/ps.062711007; Cook PD, 2007, BIOCHEMISTRY-US, V46, P14215, DOI 10.1021/bi701686s; Cook PD, 2006, PROTEIN SCI, V15, P2093, DOI 10.1110/ps.062328306; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; Noland BW, 2002, STRUCTURE, V10, P1569, DOI 10.1016/S0969-2126(02)00879-1; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Schoenhofen IC, 2006, J BIOL CHEM, V281, P8907, DOI 10.1074/jbc.M512987200; Schoenhofen IC, 2006, J BIOL CHEM, V281, P723, DOI 10.1074/jbc.M511021200; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124	14	8	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4295	4303		10.1074/jbc.M708893200	http://dx.doi.org/10.1074/jbc.M708893200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18045869	hybrid			2022-12-25	WOS:000253083500064
J	Kainov, DE; Mancini, EJ; Telenius, J; Lisai, J; Grimes, JM; Bamford, DH; Stuart, DI; Tuma, R				Kainov, Denis E.; Mancini, Erika J.; Telenius, Jelena; Lisai, Jiri; Grimes, Jonathan M.; Bamford, Dennis H.; Stuart, David I.; Tuma, Roman			Structural basis of mechanochemical coupling in a hexameric molecular motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; AMINO-ACID-RESIDUES; STRANDED-RNA BACTERIOPHAGES; TERMINATION FACTOR-RHO; ATP HYDROLYSIS; CRYSTAL-STRUCTURE; PACKAGING MOTOR; PCRA HELICASE; DNA HELICASE; CONFORMATIONAL-CHANGES	The P4 protein of bacteriophage phi 12 is a hexameric molecular motor closely related to superfamily 4 helicases. P4 converts chemical energy from ATP hydrolysis into mechanical work, to translocate single-stranded RNA into a viral capsid. The molecular basis of mechanochemical coupling, i.e. how small similar to 1 angstrom changes in the ATP-binding site are amplified into nanometer scale motion along the nucleic acid, is not understood at the atomic level. Here we study in atomic detail the mechanochemical coupling using structural and biochemical analyses of P4 mutants. We show that a conserved region, consisting of superfamily 4 helicase motifs H3 and H4 and loop L2, constitutes the moving lever of the motor. The lever tip encompasses an RNA-binding site that moves along the mechanical reaction coordinate. The lever is flanked by gamma-phosphate sensors (Asn-234 and Ser-252) that report the nucleotide state of neighboring subunits and control the lever position. Insertion of an arginine finger (Arg-279) into the neighboring catalytic site is concomitant with lever movement and commences ATP hydrolysis. This ensures cooperative sequential hydrolysis that is tightly coupled to mechanical motion. Given the structural conservation, the mutated residues may play similar roles in other hexameric helicases and related molecular motors.	[Tuma, Roman] Univ Leeds, Inst Cell & Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Kainov, Denis E.; Telenius, Jelena; Lisai, Jiri; Bamford, Dennis H.; Tuma, Roman] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Kainov, Denis E.; Telenius, Jelena; Lisai, Jiri; Bamford, Dennis H.; Tuma, Roman] Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; [Mancini, Erika J.; Grimes, Jonathan M.; Stuart, David I.] Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England	University of Leeds; University of Helsinki; University of Helsinki; University of Oxford	Tuma, R (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	r.tuma@leeds.ac.uk	Tuma, Roman/AAL-4436-2020; kainov, denis/I-5526-2019; Mancini, Erika J/J-9880-2013	Tuma, Roman/0000-0003-0047-0013; kainov, denis/0000-0001-7716-6955; Mancini, Erika J/0000-0001-9591-7898; Grimes, Jonathan Mark/0000-0001-9698-0389; Bamford, Dennis/0000-0002-6438-8118; Telenius, Jelena/0000-0003-4353-3854; Stuart, David/0000-0002-3426-4210	Medical Research Council [G0500367, G0500365] Funding Source: Medline; MRC [G0500367, G0500365] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adelman JL, 2006, MOL CELL, V22, P611, DOI 10.1016/j.molcel.2006.04.022; ADMIRAAL SJ, 1995, CHEM BIOL, V2, P729, DOI 10.1016/1074-5521(95)90101-9; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Allin C, 2001, P NATL ACAD SCI USA, V98, P7754, DOI 10.1073/pnas.131549798; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Datta S, 2003, PROTEINS, V50, P474, DOI 10.1002/prot.10315; Dillingham MS, 1999, NUCLEIC ACIDS RES, V27, P3310, DOI 10.1093/nar/27.16.3310; Dillingham MS, 2001, P NATL ACAD SCI USA, V98, P8381, DOI 10.1073/pnas.131009598; Dittrich M, 2004, BIOPHYS J, V87, P2954, DOI 10.1529/biophysj.104.046128; Dittrich M, 2003, BIOPHYS J, V85, P2253, DOI 10.1016/S0006-3495(03)74650-5; Dittrich M, 2006, STRUCTURE, V14, P1345, DOI 10.1016/j.str.2006.06.017; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; GOTTLIEB P, 1992, J VIROL, V66, P6220, DOI 10.1128/JVI.66.10.6220-6222.1992; Kainov DE, 2004, NUCLEIC ACIDS RES, V32, P3515, DOI 10.1093/nar/gkh680; Kainov DE, 2003, J BIOL CHEM, V278, P48084, DOI 10.1074/jbc.M306928200; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; LAKOWICZ J, 1999, PRINCIPLES FLUORESCE, P45; Levin M.K., 2003, MOL MOTORS, P179; Liao JC, 2005, J MOL BIOL, V350, P452, DOI 10.1016/j.jmb.2005.04.051; Lisal J, 2005, J BIOL CHEM, V280, P23157, DOI 10.1074/jbc.M502658200; Lisal J, 2005, NAT STRUCT MOL BIOL, V12, P460, DOI 10.1038/nsmb927; Lisal J, 2004, J BIOL CHEM, V279, P1343, DOI 10.1074/jbc.M309587200; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Mancini EJ, 2004, ACTA CRYSTALLOGR D, V60, P588, DOI 10.1107/S0907444904001052; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; MIWA Y, 1995, J MOL BIOL, V254, P815, DOI 10.1006/jmbi.1995.0658; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Nadanaciva S, 1999, BIOCHEMISTRY-US, V38, P15493, DOI 10.1021/bi9917683; Niedenzu T, 2001, J MOL BIOL, V306, P479, DOI 10.1006/jmbi.2000.4398; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Pirttimaa MJT, 2000, RNA, V6, P880, DOI 10.1017/S1355838200992598; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; SOGA S, 1989, ARCH BIOCHEM BIOPHYS, V268, P643, DOI 10.1016/0003-9861(89)90332-9; Soultanas P, 2002, NUCLEIC ACIDS RES, V30, P4051, DOI 10.1093/nar/gkf527; Soultanas P, 1999, J MOL BIOL, V290, P137, DOI 10.1006/jmbi.1999.2873; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Sun S, 2003, EUR BIOPHYS J BIOPHY, V32, P676, DOI 10.1007/s00249-003-0335-6; Sun SY, 2007, MOL CELL, V25, P943, DOI 10.1016/j.molcel.2007.02.013; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825; Ziegelin G, 2003, NUCLEIC ACIDS RES, V31, P5917, DOI 10.1093/nar/gkg790	53	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3607	3617		10.1074/jbc.M706366200	http://dx.doi.org/10.1074/jbc.M706366200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18057007	hybrid			2022-12-25	WOS:000253083000066
J	Mittra, B; Zamudio, JR; Bujnicki, JM; Stepinski, J; Darzynkiewicz, E; Campbell, DA; Sturm, NR				Mittra, Bidyottam; Zamudio, Jesse R.; Bujnicki, Janusz M.; Stepinski, Janusz; Darzynkiewicz, Edward; Campbell, David A.; Sturm, Nancy R.			The TbMTr1 spliced leader RNA cap 1 2 '-O-Ribose methyltransferase from trypanosoma brucei acts with substrate specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEAR-RNA; MESSENGER-RNA; VACCINIA VIRUS; CRYSTAL-STRUCTURE; GUANINE N-7; PROTEIN; METHYLATION; VP39; TRIPHOSPHATASE; RECOGNITION	In metazoa cap 1 (m(7)GpppNmp-RNA) is linked to higher levels of translation; however, the enzyme responsible remains unidentified. We have validated the first eukaryotic encoded cap 1 2 '-O-ribose methyltransferase, TbMTr1, a member of a conserved family that modifies the first transcribed nucleotide of spliced leader and U1 small nuclear RNAs in the kinetoplastid protozoan Trypanosoma brucei. In addition to cap 0 (m(7)GpppNp-RNA), mRNA in these parasites has ribose methylations on the first four nucleotides with base methylations on the first and fourth (m(7)Gpppm(6,6)AmpAmpCmpm(3)Ump-SL RNA) conveyed via transsplicing of a universal spliced leader. The function of this cap 4 is unclear. Spliced leader is the majority RNA polymerase II transcript; the RNA polymerase III-transcribed U1 small nuclear RNA has the same first four nucleotides as spliced leader, but it receives an m(2,2,7)G cap with hypermethylation at position one only (m(2,2,7)Gpppm(6,6)AmpApCpUp-U1 snRNA). Here we examine the biochemical properties of recombinant TbMTr1. Active over a pH range of 6.0 to 9.5, TbMTr1 is sensitive to Mg2+. Positions Lys(95)-Asp(204)- Lys(259)-Glu(285) constitute the conserved catalytic core. A guanosine cap on RNA independent of its N-7 methylation status is required for substrate recognition, but an m(2,2,7G)-cap is not recognized. TbMTr1 favors the spliced leader 5 ' sequence, as reflected by a preference for A at position 1 and modulation of activity for substrates with base changes at positions 2 and 3. With similarities to human cap 1 methyltransferase activity, TbMTr1 is an excellent model for higher eukaryotic cap 1 methyltransferases and the consequences of cap 1 modification.	[Mittra, Bidyottam; Zamudio, Jesse R.; Campbell, David A.; Sturm, Nancy R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Bujnicki, Janusz M.] Int Inst Mol & Cell Biol, Lab Bioinformat & Peotein Engn, PL-02109 Warsaw, Poland; [Bujnicki, Janusz M.] Adam Mickiewicz Univ, Fac Biol, Inst Mol Biol & Biotechnol, PL-61614 Poznan, Poland; [Darzynkiewicz, Edward] Univ Warsaw, Inst Expt Phys, Dept Biophys, PL-02089 Warsaw, Poland	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Adam Mickiewicz University; University of Warsaw	Campbell, DA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, 609 Charles E Young Dr, Los Angeles, CA 90095 USA.	dc@ucla.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056034] Funding Source: NIH RePORTER; NIAID NIH HHS [AI056034] Funding Source: Medline; NIGMS NIH HHS [GM07104] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arhin GK, 2006, MOL BIOCHEM PARASIT, V147, P137, DOI 10.1016/j.molbiopara.2006.01.011; Arhin GK, 2006, RNA, V12, P53, DOI 10.1261/rna.2223406; BANERJEE AK, 1980, MICROBIOL REV, V44, P175, DOI 10.1128/MMBR.44.2.175-205.1980; BANGS JD, 1992, J BIOL CHEM, V267, P9805; BARBOSA E, 1978, J BIOL CHEM, V253, P7698; Bugl H, 2000, MOL CELL, V6, P349, DOI 10.1016/S1097-2765(00)00035-6; Bujnicki JM, 2001, GENOME BIOL, V2; Bujnicki Janusz M., 1999, In Silico Biology, V1, P175; Caldas T, 2000, J BIOL CHEM, V275, P16414, DOI 10.1074/jbc.M001854200; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; Coleman TM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh007; Dong HP, 2007, J VIROL, V81, P4412, DOI 10.1128/JVI.02455-06; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; FAURNAN EB, 1999, S ADENOSYL METHIONIN, P1; Feder M, 2003, GENE, V302, P129, DOI 10.1016/S0378-1119(02)01097-1; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; Gong CL, 2003, J BIOL CHEM, V278, P50843, DOI 10.1074/jbc.M309188200; Hager J, 2002, J BIOL CHEM, V277, P41978, DOI 10.1074/jbc.M205423200; Hall MP, 2006, NUCLEIC ACIDS RES, V34, P5594, DOI 10.1093/nar/gkl573; Hall MP, 2006, RNA, V12, P488, DOI 10.1261/rna.2250606; Ho CK, 2001, J BIOL CHEM, V276, P46182, DOI 10.1074/jbc.M108706200; Hodel AE, 1998, MOL CELL, V1, P443, DOI 10.1016/S1097-2765(00)80044-1; Hodel AE, 1996, CELL, V85, P247, DOI 10.1016/S0092-8674(00)81101-0; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; LABAHN J, 1994, P NATL ACAD SCI USA, V91, P10957, DOI 10.1073/pnas.91.23.10957; LANGBERG SR, 1981, J BIOL CHEM, V256, P54; LEBOWITZ JH, 1993, GENE DEV, V7, P996, DOI 10.1101/gad.7.6.996; Li JR, 2006, P NATL ACAD SCI USA, V103, P8493, DOI 10.1073/pnas.0509821103; Li JR, 2005, J VIROL, V79, P13373, DOI 10.1128/JVI.79.21.13373-13384.2005; Lockless SW, 1998, BIOCHEMISTRY-US, V37, P8564, DOI 10.1021/bi980178m; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Mandelboim M, 2002, J BIOL CHEM, V277, P35210, DOI 10.1074/jbc.M201910200; MARONEY PA, 1990, EMBO J, V9, P3667, DOI 10.1002/j.1460-2075.1990.tb07578.x; MARONEY PA, 1995, RNA, V1, P714; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; PERRY RP, 1976, CELL, V8, P433, DOI 10.1016/0092-8674(76)90156-2; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Ruan JP, 2007, MOL BIOCHEM PARASIT, V155, P66, DOI 10.1016/j.molbiopara.2007.05.008; Schnare MN, 1999, J BIOL CHEM, V274, P23691, DOI 10.1074/jbc.274.34.23691; Shuman S, 2007, MOL CELL, V27, P517, DOI 10.1016/j.molcel.2007.08.001; Sturm NR, 1998, J BIOL CHEM, V273, P18689, DOI 10.1074/jbc.273.30.18689; Takagi Y, 2007, J BIOL CHEM, V282, P15995, DOI 10.1074/jbc.M701569200; ULLU E, 1991, P NATL ACAD SCI USA, V88, P10074, DOI 10.1073/pnas.88.22.10074; ULLU E, 1995, J BIOL CHEM, V270, P20365, DOI 10.1074/jbc.270.35.20365; Wu XF, 2003, J VIROL, V77, P3430, DOI 10.1128/JVI.77.6.3430-3440.2003; Zamudio JR, 2007, MOL CELL BIOL, V27, P6084, DOI 10.1128/MCB.00647-07; Zamudio JR, 2006, EUKARYOT CELL, V5, P905, DOI 10.1128/EC.00080-06; Zeiner GM, 2003, J BIOL CHEM, V278, P38269, DOI 10.1074/jbc.M304295200; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	53	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3161	3172		10.1074/jbc.M707367200	http://dx.doi.org/10.1074/jbc.M707367200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18048356	hybrid			2022-12-25	WOS:000253083000019
J	Yang, PC; Yang, CH; Huang, CC; Hsu, KS				Yang, Ping-Chun; Yang, Chih-Hao; Huang, Chiung-Chun; Hsu, Kuei-Sen			Phosphatidylinositol 3-kinase activation is required for stress protocol-induced modification of hippocampal synaptic plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; NMDA RECEPTOR; PHOSPHOINOSITIDE 3-KINASE; TYROSINE PHOSPHORYLATION; DEPENDENT MECHANISMS; RETROGRADE-AMNESIA; SIGNALING PATHWAY; NEURONAL SURVIVAL; PROTEIN-SYNTHESIS	Stress dramatically affects the induction of hippocampal synaptic plasticity; however, the molecular details of how it does so remain unclear. Phosphatidylinositol 3-kinase (PI3K) signaling plays a crucial role in promoting neuronal survival and neuroplasticity, but its role, if any, in stress-induced alterations of long term potentiation (LTP) and long term depression (LTD) is unknown. We found here that inhibitors of PI3K signaling blocked the effects of acute restraint-tail shock stress protocol on LTP and LTD. Therefore, the purpose of the present study is to explore the signaling events involving PI3K in terms of its role in mediating stress protocol-induced alterations of LTP and LTD. We found that stress protocol- induced PI3K activation can be blocked by various inhibitors, including RU38486 for glucocorticoid receptors, LY294002 for PI3K, and DL-2-amino5- phosphonopentanoic acid for N-methyl-D-aspartate receptors or brain-derived neurotrophic factor antisense oligonucleotides. Also, immunoblotting analyses revealed that stress protocol induced a profound and prolonged phosphorylation of numbers of PI3K downstream effectors, including 3-phosphoinositide-dependent protein kinase-1, protein kinase B, mammalian target of rapamycin ( mTOR), p70 S6 kinase, and eukaryotic initiation factor 4B in hippocampal CA1 homogenate, which was prevented by the PI3K inhibitor pretreatment. More importantly, we found that stress protocol significantly increased the protein expression of dendritic scaffolding protein PSD-95 ( postsynaptic density-95), which is known to be involved in LTP and LTD, in an mTOR-dependent manner. These results identify a key role of PI3K signaling in mediating the stress protocol- induced modification of hippocampal synaptic plasticity and further suggest that PI3K may do so by invoking the protein expression of PSD-95.	[Yang, Ping-Chun; Yang, Chih-Hao; Huang, Chiung-Chun; Hsu, Kuei-Sen] Natl Cheng Kung Univ, Dept Pharmacol, Coll Med, Tainan 701, Taiwan; [Hsu, Kuei-Sen] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 701, Taiwan	National Cheng Kung University; National Cheng Kung University	Hsu, KS (corresponding author), Natl Cheng Kung Univ, Dept Pharmacol, Coll Med, 1 Univ Rd, Tainan 701, Taiwan.	richard@mail.ncku.edu.tw	Hsu, Kuei-Sen/AAV-8386-2021					ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; Akama KT, 2003, J NEUROSCI, V23, P2333; Baker-Herman TL, 2004, NAT NEUROSCI, V7, P48, DOI 10.1038/nn1166; Barros DM, 2001, BEHAV PHARMACOL, V12, P629, DOI 10.1097/00008877-200112000-00007; Bhave SV, 1999, J NEUROSCI, V19, P3277, DOI 10.1523/jneurosci.19-09-03277.1999; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Brunn GJ, 1997, J BIOL CHEM, V272, P32547, DOI 10.1074/jbc.272.51.32547; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chandler LJ, 2001, J BIOL CHEM, V276, P2627, DOI 10.1074/jbc.M003390200; Chen X, 2005, NAT NEUROSCI, V8, P925, DOI 10.1038/nn1482; Dash PK, 2006, J NEUROSCI, V26, P8048, DOI 10.1523/JNEUROSCI.0671-06.2006; DIAMOND DM, 1990, PSYCHOBIOLOGY, V18, P273; Diamond DM, 2004, HIPPOCAMPUS, V14, P281, DOI 10.1002/hipo.10186; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; DUNCAN R, 1985, J BIOL CHEM, V260, P5486; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; FAVARON M, 1993, NEUROREPORT, V4, P1171; FOY MR, 1987, BEHAV NEURAL BIOL, V48, P138, DOI 10.1016/S0163-1047(87)90664-9; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Frebel K, 2006, BIOCHEM SOC T, V34, P1287, DOI 10.1042/BST0341287; Garcia R, 2001, SYNAPSE, V40, P180, DOI 10.1002/syn.1040; Hagemann C, 2001, CELL SIGNAL, V13, P863, DOI 10.1016/S0898-6568(01)00220-0; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huang CC, 2006, J NEUROCHEM, V96, P179, DOI 10.1111/j.1471-4159.2005.03527.x; Huang CC, 2005, MOL NEUROBIOL, V32, P223, DOI 10.1385/MN:32:3:223; Izquierdo I, 1999, EUR J NEUROSCI, V11, P3323, DOI 10.1046/j.1460-9568.1999.00742.x; Kalia LV, 2006, EMBO J, V25, P4971, DOI 10.1038/sj.emboj.7601342; Kelly A, 2000, NEUROPHARMACOLOGY, V39, P643, DOI 10.1016/S0028-3908(99)00169-0; KERR DS, 1994, PSYCHOBIOLOGY, V22, P123; Kim JJ, 1998, TRENDS NEUROSCI, V21, P505, DOI 10.1016/S0166-2236(98)01322-8; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kim JJ, 1996, P NATL ACAD SCI USA, V93, P4750, DOI 10.1073/pnas.93.10.4750; Lee CC, 2005, J BIOL CHEM, V280, P18543, DOI 10.1074/jbc.M414112200; Leemhuis J, 2004, N-S ARCH PHARMACOL, V370, P211, DOI 10.1007/s00210-004-0965-y; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Marini AM, 1998, J BIOL CHEM, V273, P29394, DOI 10.1074/jbc.273.45.29394; Marmigere F, 2003, HIPPOCAMPUS, V13, P646, DOI 10.1002/hipo.10109; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mizuno M, 2003, MOL PSYCHIATR, V8, P217, DOI 10.1038/sj.mp.4001215; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Okragly AJ, 1997, EXP NEUROL, V145, P592, DOI 10.1006/exnr.1997.6500; Opazo P, 2003, J NEUROSCI, V23, P3679; PAVLIDES C, 1993, HIPPOCAMPUS, V3, P183, DOI 10.1002/hipo.450030210; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; PETROS AM, 1992, J BIOMOL NMR, V2, P11, DOI 10.1007/BF02192797; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Raymond CR, 2002, NEUROSCIENCE, V109, P531, DOI 10.1016/S0306-4522(01)00500-0; Rolls ET, 2002, P ROY SOC B-BIOL SCI, V269, P1087, DOI 10.1098/rspb.2002.2009; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sanna PP, 2002, J NEUROSCI, V22, P3359; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SELIGMAN ME, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024514; SHORS TJ, 1995, NEUROREPORT, V6, P677, DOI 10.1097/00001756-199503000-00023; SHORS TJ, 1989, SCIENCE, V244, P224, DOI 10.1126/science.2704997; SHORS TJ, 1992, SYNAPSE, V11, P262, DOI 10.1002/syn.890110311; Stein V, 2003, J NEUROSCI, V23, P5503; Sutton G, 2002, J NEUROCHEM, V82, P1097, DOI 10.1046/j.1471-4159.2002.01031.x; Takahashi T, 2002, J NEUROCHEM, V83, P1441, DOI 10.1046/j.1471-4159.2002.01251.x; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; TAOKA T, 1990, BIOCHEM BIOPH RES CO, V170, P1151, DOI 10.1016/0006-291X(90)90513-M; TRACHSEL H, 1977, J MOL BIOL, V116, P755, DOI 10.1016/0022-2836(77)90269-8; Wells DG, 2001, J NEUROSCI, V21, P9541, DOI 10.1523/JNEUROSCI.21-24-09541.2001; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0; Xu L, 1998, P NATL ACAD SCI USA, V95, P3204, DOI 10.1073/pnas.95.6.3204; Yang CH, 2005, J NEUROSCI, V25, P4288, DOI 10.1523/JNEUROSCI.0406-05.2005; Yang CH, 2004, J NEUROSCI, V24, P11029, DOI 10.1523/JNEUROSCI.3968-04.2004; Yang CH, 2006, J PHYSIOL-LONDON, V577, P601, DOI 10.1113/jphysiol.2006.120386; Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903	83	69	73	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2631	2643		10.1074/jbc.M706954200	http://dx.doi.org/10.1074/jbc.M706954200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18057005	hybrid			2022-12-25	WOS:000252622300020
J	Yin, QY; Wang, X; McBride, J; Fewell, C; Flemington, E				Yin, Qinyan; Wang, Xia; McBride, Jane; Fewell, Claire; Flemington, Erik			B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-INDUCED LYMPHOMAS; NF-KAPPA-B; GENE; MIR-155; TRANSCRIPTION; MICRORNA-155; HODGKIN; FOSB; RNA	microRNA-155 is an oncogenic microRNA that has been shown to be critical for B-cell maturation and immunoglobulin production in response to antigen. In line with its function in B-cell activation, miR-155, and its primary transcript, B-cell integration cluster (BIC), is induced by B-cell receptor (BCR) cross-linking. Using pharmacological inhibitors in the human B-cell line, Ramos, we show that activation of BIC and miR-155 expression by BCR signaling occurs through the extracellular signaling-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) pathways but not the p38 pathway. BCR activation results in the induction of c-Fos, FosB, and JunB, and expression of these are suppressed by ERK and JNK inhibitors. Reporter analysis established a key role for a conserved AP-1 site similar to 40 bp upstream from the site of initiation but not an upstream NF-kappa B site or a putative c-Ets located at the site of initiation. Lastly, chromatin immunoprecipitation analysis demonstrated the recruitment of FosB and JunB to the miR-155 promoter following BCR activation. These results identify key determinants of BCR-mediated induction of BIC/miR-155.	[Yin, Qinyan; Wang, Xia; McBride, Jane; Fewell, Claire; Flemington, Erik] Tulane Univ, Hlth Sci Ctr, Dept Pathol, New Orleans, LA 70112 USA; [Yin, Qinyan; Wang, Xia; McBride, Jane; Fewell, Claire; Flemington, Erik] Tulane Canc Ctr, New Orleans, LA 70112 USA	Tulane University; Tulane University	Flemington, E (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Pathol, SL79, New Orleans, LA 70112 USA.	eflemin@tulane.edu			NATIONAL CANCER INSTITUTE [R01CA130752, R01CA124311] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE017008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048045, R29GM048045] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA130752-02, R01 CA124311-03, R01 CA124311, R01 CA130752, R01 CA 124311, R01 CA130752-01A1] Funding Source: Medline; NCRR NIH HHS [P20 RR020152, P20 RR 020152] Funding Source: Medline; NIDCR NIH HHS [DE 017008, R21 DE017008] Funding Source: Medline; NIGMS NIH HHS [GM 48045, R01 GM048045] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; CAMERON J, 2007, IN PRESS J VIROL; Carrozza ML, 1997, ONCOGENE, V14, P1083, DOI 10.1038/sj.onc.1200921; CLURMAN BE, 1989, MOL CELL BIOL, V9, P2657, DOI 10.1128/MCB.9.6.2657; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang JM, 2006, GENE CHROMOSOME CANC, V45, P103, DOI 10.1002/gcc.20264; Joseph AM, 2000, J VIROL, V74, P9964, DOI 10.1128/JVI.74.21.9964-9971.2000; Kluiver J, 2006, GENE CHROMOSOME CANC, V45, P147, DOI 10.1002/gcc.20273; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; LAZO PS, 1992, NUCLEIC ACIDS RES, V20, P343, DOI 10.1093/nar/20.2.343; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rosenberger SF, 1999, J BIOL CHEM, V274, P1124, DOI 10.1074/jbc.274.2.1124; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tam W, 2002, J VIROL, V76, P4275, DOI 10.1128/JVI.76.9.4275-4286.2002; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; TREISMAN R, 1992, EMBO J, V11, P4631, DOI 10.1002/j.1460-2075.1992.tb05565.x; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036	30	181	187	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2654	2662		10.1074/jbc.M708218200	http://dx.doi.org/10.1074/jbc.M708218200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18048365	hybrid, Green Accepted			2022-12-25	WOS:000252622300022
J	Masip, L; Klein-Marcuschamer, D; Quan, S; Bardwell, JCA; Georgiou, G				Masip, Lluis; Klein-Marcuschamer, Daniel; Quan, Shu; Bardwell, James C. A.; Georgiou, George			Laboratory evolution of Escherichia coli thioredoxin for enhanced catalysis of protein oxidation in the periplasm reveals a phylogenetically conserved substrate specificity determinant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; IN-VIVO; DSBA; PATHWAY; MECHANISM; EFFICIENT; VARIANTS; EXPORT; OXIDOREDUCTASES; SUPERFAMILY	Thioredoxin exported into the Escherichia coli periplasm catalyzes the oxidation of protein thiols in a DsbB-dependent function. However, the oxidative activity of periplasmic thioredoxin is insufficient to render dsbA(-) cells susceptible to infection by M13, a phenotype that is critically dependent on disulfide bond formation in the cell envelope. We sought to examine the molecular determinants that are required in order to convert thioredoxin from a reductant into an efficient periplasmic oxidant. A genetic screen for mutations in thioredoxin that render dsbA(-) cells sensitive to infection by M13 led to the isolation of a single amino acid substitution, G74S. In vivo the TrxA(G74S) mutant exhibited enhanced catalytic activity in the oxidation of alkaline phosphatase but was unable to oxidize FlgI and restore cell motility. In vitro studies revealed that the G74S substitution does not affect the redox potential of the thioredoxin-active site or its kinetics of oxidation by DsbB. Thus, the gain of function afforded by G74S stems in part from its altered substrate specificity, which also rendered the protein more resistant to reduction by DsbD/DsbC in the periplasm.	[Masip, Lluis; Klein-Marcuschamer, Daniel; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Quan, Shu; Bardwell, James C. A.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Michigan System; University of Michigan	Georgiou, G (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.	gg@che.utexas.edu	Masip, Lluis/F-9919-2015; Quan, Shu/O-4562-2015	Masip, Lluis/0000-0002-3938-4633; Quan, Shu/0000-0002-6672-4947	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055090, R01GM069872] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM069872, GM55090] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1996, ESCHERICHIA COLI SAL; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bessette PH, 2001, J BACTERIOL, V183, P980, DOI 10.1128/JB.183.3.980-988.2001; CHATRENET B, 1992, J BIOL CHEM, V267, P3038; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Debarbieux L, 2000, J BACTERIOL, V182, P723, DOI 10.1128/JB.182.3.723-727.2000; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; EKLUND H, 1984, EMBO J, V3, P1443, DOI 10.1002/j.1460-2075.1984.tb01994.x; Elton TC, 2005, J BACTERIOL, V187, P8267, DOI 10.1128/JB.187.24.8267-8277.2005; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Grzyska PK, 2005, BIOCHEMISTRY-US, V44, P3845, DOI 10.1021/bi048746n; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Himawan JS, 1996, J BIOL CHEM, V271, P19999, DOI 10.1074/jbc.271.33.19999; Hizukuri Y, 2006, J BACTERIOL, V188, P4190, DOI 10.1128/JB.01896-05; Huber D, 2005, P NATL ACAD SCI USA, V102, P18872, DOI 10.1073/pnas.0509583102; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Inaba K, 2004, J BIOL CHEM, V279, P6761, DOI 10.1074/jbc.M310765200; Jonda S, 1999, EMBO J, V18, P3271, DOI 10.1093/emboj/18.12.3271; Karlsson F, 2003, J BACTERIOL, V185, P2628, DOI 10.1128/JB.185.8.2628-2634.2003; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Masip L, 2004, SCIENCE, V303, P1185, DOI 10.1126/science.1092612; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mossner E, 1998, PROTEIN SCI, V7, P1233; Mossner E, 1999, J BIOL CHEM, V274, P25254, DOI 10.1074/jbc.274.36.25254; Pille S, 1996, EUR J BIOCHEM, V235, P713, DOI 10.1111/j.1432-1033.1996.00713.x; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; RUSSEL M, 1988, J BACTERIOL, V170, P5312, DOI 10.1128/jb.170.11.5312-5316.1988; RUSSEL M, 1986, J BIOL CHEM, V261, P4997; SAMBROOK J, 2000, MOL CLONING LAB MANU; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Tapley TL, 2007, J BIOL CHEM, V282, P10263, DOI 10.1074/jbc.M611541200; Tullman-Ercek D, 2007, J BIOL CHEM, V282, P8309, DOI 10.1074/jbc.M610507200; WUNDERLICH M, 1995, J MOL BIOL, V247, P28, DOI 10.1006/jmbi.1995.0119	44	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					840	848		10.1074/jbc.M705147200	http://dx.doi.org/10.1074/jbc.M705147200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18003618	hybrid			2022-12-25	WOS:000252128100024
J	Liu, SL; Fewkes, N; Ricketson, D; Penkert, RR; Prehoda, KE				Liu, Su-Ling; Fewkes, Natasha; Ricketson, Derek; Penkert, Rhiannon R.; Prehoda, Kenneth E.			Filament-dependent and -independent localization modes of Drosophila non-muscle myosin II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; HEAVY-CHAIN; CAENORHABDITIS-ELEGANS; PAR PROTEINS; PHOSPHORYLATION; DICTYOSTELIUM; CYTOKINESIS; TRANSPORT; EMBRYOS; DOMAIN	Myosin II assembles into force- generating filaments that drive cytokinesis and the organization of the cell cortex. Regulation of myosin II activity can occur through modulation of filament assembly and by targeting to appropriate cellular sites. Here we show, using salt-dependent solubility and a novel fluorescence resonance energy transfer assay, that assembly of the Drosophila non-muscle myosin II heavy chain, zipper, is mediated by a 90-residue region (1849-1940) of the coiled-coil tail domain. This filament assembly domain, transiently expressed in Drosophila S2 cells, does not localize to the interphase cortex or the cytokinetic cleavage furrow, whereas a 500-residue region (1350-1865) that overlaps the NH2 terminus of the assembly domain localizes to the interphase cortex but not the cytokinetic cleavage furrow. Targeting to these two sites appears to utilize distinct localization mechanisms as the assembly domain is required for cleavage furrow recruitment of a truncated coiled-coil tail region but not targeting to the interphase cortex. These results delineate the requirements for zipper filament assembly and indicate that the ability to form filaments is necessary for targeting to the cleavage furrow but not to the interphase cortex.	[Liu, Su-Ling; Fewkes, Natasha; Ricketson, Derek; Penkert, Rhiannon R.; Prehoda, Kenneth E.] Univ Oregon, Inst Mol Biol, Dept Chem, Eugene, OR USA	University of Oregon	Prehoda, KE (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	prehoda@molbio.uoregon.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759, R01GM068032] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM068032-05S1, GM 068032, R01 GM068032-04, R01 GM068032, R01 GM068032-05, R01 GM068032-03S1, T32 GM007759] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATKINSON SJ, 1992, J MOL BIOL, V226, P7, DOI 10.1016/0022-2836(92)90118-4; Barros CS, 2003, DEV CELL, V5, P829, DOI 10.1016/S1534-5807(03)00359-9; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Dean SO, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000131; Dean SO, 2005, P NATL ACAD SCI USA, V102, P13473, DOI 10.1073/pnas.0506810102; Edwards KA, 1996, DEVELOPMENT, V122, P1499; Even-Faitelson L, 2006, MOL BIOL CELL, V17, P2869, DOI 10.1091/mbc.e05-11-1001; Frank S, 2000, J BIOL CHEM, V275, P11672, DOI 10.1074/jbc.275.16.11672; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; GOLDMAN Y, 2000, CELL, V93, P1; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; Hostetter D, 2004, PLOS BIOL, V2, P1880, DOI 10.1371/journal.pbio.0020356; Ikebe M, 2001, J BIOL CHEM, V276, P30293, DOI 10.1074/jbc.M101969200; LEE RJ, 1994, J CELL SCI, V107, P2875; Liang WC, 1999, J CELL BIOL, V147, P1039, DOI 10.1083/jcb.147.5.1039; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Murakami N, 1995, BIOCHEMISTRY-US, V34, P16046, DOI 10.1021/bi00049a019; Nakasawa T, 2005, BIOCHEMISTRY-US, V44, P174, DOI 10.1021/bi048807h; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; OHALLORAN TJ, 1990, J CELL BIOL, V110, P63, DOI 10.1083/jcb.110.1.63; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Pollard T.D., 1981, Journal of Cell Biology, V91, P156; Robinson DN, 2004, CURR OPIN CELL BIOL, V16, P182, DOI 10.1016/j.ceb.2004.02.002; Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Severson AF, 2003, J CELL BIOL, V161, P21, DOI 10.1083/jcb.200210171; Shoffner JD, 1996, BIOCHEM BIOPH RES CO, V218, P860, DOI 10.1006/bbrc.1996.0153; Sohn RL, 1997, J MOL BIOL, V266, P317, DOI 10.1006/jmbi.1996.0790; STRAND D, 1994, J CELL BIOL, V127, P1361, DOI 10.1083/jcb.127.5.1361; Su ZW, 2001, BIOCHEMISTRY-US, V40, P3606, DOI 10.1021/bi010082j; Turbedsky K, 2005, J MOL BIOL, V345, P351, DOI 10.1016/j.jmb.2004.10.049; WHEATLEY S, 1995, DEVELOPMENT, V121, P1937; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29; Yumura S, 2005, MOL BIOL CELL, V16, P4256, DOI 10.1091/mbc.E05-03-0219; Yumura S, 2001, J CELL BIOL, V154, P137, DOI 10.1083/jcb.200011013; Zang JH, 1998, P NATL ACAD SCI USA, V95, P13652, DOI 10.1073/pnas.95.23.13652	38	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					380	387		10.1074/jbc.M703924200	http://dx.doi.org/10.1074/jbc.M703924200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17989074	hybrid			2022-12-25	WOS:000251940300042
J	Barot, S; Blouin, M; Fontaine, S; Jouquet, P; Lata, JC; Mathieu, J				Barot, Sebastien; Blouin, Manuel; Fontaine, Sebastien; Jouquet, Pascal; Lata, Jean-Christophe; Mathieu, Jerome			A Tale of Four Stories: Soil Ecology, Theory, Evolution and the Publication System	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; CARBON; POPULATION; STRATEGY; MINERALIZATION; ORGANISMS; PROTOZOA; LIFE	Background. Soil ecology has produced a huge corpus of results on relations between soil organisms, ecosystem processes controlled by these organisms and links between belowground and aboveground processes. However, some soil scientists think that soil ecology is short of modelling and evolutionary approaches and has developed too independently from general ecology. We have tested quantitatively these hypotheses through a bibliographic study (about 23000 articles) comparing soil ecology journals, generalist ecology journals, evolutionary ecology journals and theoretical ecology journals. Findings. We have shown that soil ecology is not well represented in generalist ecology journals and that soil ecologists poorly use modelling and evolutionary approaches. Moreover, the articles published by a typical soil ecology journal (Soil Biology and Biochemistry) are cited by and cite low percentages of articles published in generalist ecology journals, evolutionary ecology journals and theoretical ecology journals. Conclusion. This confirms our hypotheses and suggests that soil ecology would benefit from an effort towards modelling and evolutionary approaches. This effort should promote the building of a general conceptual framework for soil ecology and bridges between soil ecology and general ecology. We give some historical reasons for the parsimonious use of modelling and evolutionary approaches by soil ecologists. We finally suggest that a publication system that classifies journals according to their Impact Factors and their level of generality is probably inadequate to integrate "particularity" (empirical observations) and "generality" (general theories), which is the goal of all natural sciences. Such a system might also be particularly detrimental to the development of a science such as ecology that is intrinsically multidisciplinary.	[Barot, Sebastien; Blouin, Manuel; Jouquet, Pascal] IRD, UMR 137, Bondy, France; [Fontaine, Sebastien] INRA, Unite Agron, Clermont Ferrand, France; [Lata, Jean-Christophe] Univ Paris 11, UMR 8079, Orsay, France; [Mathieu, Jerome] Univ Paris 06, UMR 137, Bondy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut de Recherche pour le Developpement (IRD); INRAE; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite	Barot, S (corresponding author), IRD, UMR 137, Bondy, France.	barot@bondy.ird.fr	mathieu, jerome/B-8478-2008; Lata, Jean-Christophe/A-8733-2008; barot, sébastien/A-8447-2012; Blouin, Manuel/K-6013-2019	mathieu, jerome/0000-0002-9106-6106; barot, sébastien/0000-0002-5910-538X; Blouin, Manuel/0000-0002-3928-9070; Jouquet, Pascal/0000-0002-4189-5133	ANR [JC05_52230]	ANR(French National Research Agency (ANR))	Funding: Our work has been supported by the programme "jeune chercheur 2005" of the ANR (SolEcoEvo project, JC05_52230).	Bardgett R. D., 2005, The biology of soil: a community and ecosystem approach; Bardgett R.D., 2005, Biological Diversity and Function in Soil; Barnes R. S. K, 1991, FUNDAMENTALS AQUATIC; Barot S, 2007, FUNCT ECOL, V21, P1, DOI 10.1111/j.1365-2435.2006.01225.x; Bonkowski M, 2004, NEW PHYTOL, V162, P617, DOI 10.1111/j.1469-8137.2004.01066.x; CLARHOLM M, 1985, SOIL BIOL BIOCHEM, V17, P181, DOI 10.1016/0038-0717(85)90113-0; Crawford JW, 2005, TRENDS ECOL EVOL, V20, P81, DOI 10.1016/j.tree.2004.11.014; Crawley M. J., 1996, PLANT ECOLOGY; Daufresne T, 2005, P NATL ACAD SCI USA, V102, P9212, DOI 10.1073/pnas.0406427102; Deleage Jean-Paul, 1991, HIST ECOLOGIE; DERUITER PC, 1993, J APPL ECOL, V30, P95, DOI 10.2307/2404274; Dodds WK, 2002, FRESHWATER ECOLOGY C; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; FAGERSTROM T, 1987, OIKOS, V50, P258, DOI 10.2307/3566010; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Fitter AH, 2005, J ECOL, V93, P231, DOI 10.1111/j.0022-0477.2005.00990.x; Fontaine S, 2005, ECOL LETT, V8, P1075, DOI 10.1111/j.1461-0248.2005.00813.x; GILL DS, 1991, ECOL MONOGR, V61, P183, DOI 10.2307/1943007; Goddard MR, 2003, ECOL LETT, V6, P594, DOI 10.1046/j.1461-0248.2003.00478.x; Graham MH, 2002, ECOLOGY, V83, P1481; GUREVITCH J, 2006, ECOLOGY PLANTS; Hodge A, 2001, NATURE, V413, P297, DOI 10.1038/35095041; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kuhn T., 1970, STRUCTURE SCI REVOLU; Lavelle P., 2001, SOIL ECOLOGY; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Leimu R, 2005, TRENDS ECOL EVOL, V20, P28, DOI 10.1016/j.tree.2004.10.010; LEVINS R, 1966, AM SCI, V54, P421; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; MARTEL YA, 1974, SOIL SCI SOC AM J, V38, P501, DOI 10.2136/sssaj1974.03615995003800030033x; MAY RM, 1981, AM ZOOL, V21, P903; McArthur J.V., 2006, MICROBIAL ECOLOGY EV; Nobis M, 2004, OIKOS, V106, P411, DOI 10.1111/j.0030-1299.2004.13496.x; Odenbaugh J, 2006, BIOL PHILOS, V21, P607, DOI 10.1007/s10539-006-9049-3; OHTONEN R, 1997, SOIL BIOL BIOCHEM, V29, P1549; Pennisi E, 2004, SCIENCE, V304, P1620, DOI 10.1126/science.304.5677.1620; Pickett STA, 2007, ECOLOGICAL UNDERSTAN; Price PW., 1997, INSECT ECOLOGY, V3rd edn; Rumpel C, 2002, ORG GEOCHEM, V33, P1131, DOI 10.1016/S0146-6380(02)00088-8; SCHOWALTER TD, 2000, INSECT ECOLOGY ECOSY; Setala H, 1998, APPL SOIL ECOL, V9, P25, DOI 10.1016/S0929-1393(98)00049-3; SIQUEIRA JO, 1991, CRIT REV PLANT SCI, V10, P63, DOI 10.1080/07352689109382307; Staddon PL, 2004, TRENDS ECOL EVOL, V19, P148, DOI 10.1016/j.tree.2003.12.003; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Tunlid A, 1999, OIKOS, V85, P177, DOI 10.2307/3546484; Turchin P, 2001, OIKOS, V94, P17, DOI 10.1034/j.1600-0706.2001.11310.x; Wardle DA, 1996, SOIL BIOL BIOCHEM, V28, P1549, DOI 10.1016/S0038-0717(96)00293-3; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; WARDLE DA, 2002, INTRO COMMUNITY ECOS, P1; Weisberg M, 2006, BIOL PHILOS, V21, P623, DOI 10.1007/s10539-006-9051-9	50	29	30	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1248	10.1371/journal.pone.0001248	http://dx.doi.org/10.1371/journal.pone.0001248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043755	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459300029
J	Briva, A; Vadasz, I; Lecuona, E; Welch, LC; Chen, JW; Dada, LA; Trejo, HE; Dumasius, V; Azzam, ZS; Myrianthefs, PM; Batlle, D; Gruenbaum, Y; Sznajder, JI				Briva, Arturo; Vadasz, Istvan; Lecuona, Emilia; Welch, Lynn C.; Chen, Jiwang; Dada, Laura A.; Trejo, Humberto E.; Dumasius, Vidas; Azzam, Zaher S.; Myrianthefs, Pavlos M.; Batlle, Daniel; Gruenbaum, Yosef; Sznajder, Jacob I.			High CO2 Levels Impair Alveolar Epithelial Function Independently of pH	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; CARBON-DIOXIDE; RESPIRATORY-FAILURE; INDUCED ENDOCYTOSIS; FLUID TRANSPORT; K-ATPASE; KINASE-C; LUNG; NA,K-ATPASE; CELLS	Background. In patients with acute respiratory failure, gas exchange is impaired due to the accumulation of fluid in the lung airspaces. This life-threatening syndrome is treated with mechanical ventilation, which is adjusted to maintain gas exchange, but can be associated with the accumulation of carbon dioxide in the lung. Carbon dioxide (CO2) is a by-product of cellular energy utilization and its elimination is affected via alveolar epithelial cells. Signaling pathways sensitive to changes in CO2 levels were described in plants and neuronal mammalian cells. However, it has not been fully elucidated whether non-neuronal cells sense and respond to CO2. The Na, K-ATPase consumes similar to 40% of the cellular metabolism to maintain cell homeostasis. Our study examines the effects of increased pCO(2) on the epithelial Na, K-ATPase a major contributor to alveolar fluid reabsorption which is a marker of alveolar epithelial function. Principal Findings. We found that short-term increases in pCO(2) impaired alveolar fluid reabsorption in rats. Also, we provide evidence that non-excitable, alveolar epithelial cells sense and respond to high levels of CO2, independently of extracellular and intracellular pH, by inhibiting Na,K-ATPase function, via activation of PKC zeta which phosphorylates the Na,K-ATPase, causing it to endocytose from the plasma membrane into intracellular pools. Conclusions. Our data suggest that alveolar epithelial cells, through which CO2 is eliminated in mammals, are highly sensitive to hypercapnia. Elevated CO2 levels impair alveolar epithelial function, independently of pH, which is relevant in patients with lung diseases and altered alveolar gas exchange.	[Briva, Arturo; Vadasz, Istvan; Lecuona, Emilia; Welch, Lynn C.; Chen, Jiwang; Dada, Laura A.; Trejo, Humberto E.; Dumasius, Vidas; Azzam, Zaher S.; Myrianthefs, Pavlos M.; Gruenbaum, Yosef; Sznajder, Jacob I.] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Batlle, Daniel] Northwestern Univ, Feinberg Sch Med, Div Nephrol, Chicago, IL 60611 USA; [Briva, Arturo] Univ Republica, Fac Med, Dept Fisiopatol, Montevideo, Uruguay; [Vadasz, Istvan] Univ Giessen, Lung Ctr, Giessen, Germany; [Azzam, Zaher S.] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel; [Azzam, Zaher S.] Technion Israel Inst Technol, Res Inst, Haifa, Israel; [Myrianthefs, Pavlos M.] Univ Athens, KAT Gen Hosp, Intens Care Unit, Athens, Greece; [Gruenbaum, Yosef] Hebrew Univ Jerusalem, Dept Genet, IL-91904 Jerusalem, Israel	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Universidad de la Republica, Uruguay; Justus Liebig University Giessen; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; National & Kapodistrian University of Athens; Hebrew University of Jerusalem	Sznajder, JI (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA.	j-sznajder@northwestern.edu	Vadasz, Istvan/AAO-8288-2021; Myrianthefs, Pavlos/AAF-4388-2019	Myrianthefs, Pavlos/0000-0002-8830-031X; Vadasz, Istvan/0000-0003-1370-9783	 [HL-85534];  [T32-HL76139];  [DFG/SFB 547]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085534, T32HL076139] Funding Source: NIH RePORTER	; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported in part by: HL-85534, T32-HL76139 and DFG/SFB 547.	*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; AVERY WG, 1970, AM J MED, V48, P320, DOI 10.1016/0002-9343(70)90062-8; BATLLE DC, 1991, AM J PHYSIOL, V261, pC845, DOI 10.1152/ajpcell.1991.261.5.C845; BERTORELLO AM, 1990, NATURE, V347, P386, DOI 10.1038/347386a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN J, 2007, CARBONIC ANHYDRASE 2; CHERNIACK NS, 1970, PHYSIOL REV, V50, P196, DOI 10.1152/physrev.1970.50.2.196; Chibalin AV, 1999, J BIOL CHEM, V274, P1920, DOI 10.1074/jbc.274.4.1920; Comellas AP, 2006, CIRC RES, V98, P1314, DOI 10.1161/01.RES.0000222418.99976.1d; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Dada LA, 2003, J CLIN INVEST, V111, P1057, DOI 10.1172/JCI200316826; Dada LA, 2003, CRIT CARE MED, V31, pS248, DOI 10.1097/01.CCM.0000057895.22008.EC; Dumasius V, 2001, CIRC RES, V89, P907, DOI 10.1161/hh2201.100204; Efendiev R, 1999, FEBS LETT, V456, P45, DOI 10.1016/S0014-5793(99)00925-4; Feschenko MS, 1997, J BIOL CHEM, V272, P17726, DOI 10.1074/jbc.272.28.17726; Garcia A, 2000, J BIOL CHEM, V275, P9385, DOI 10.1074/jbc.275.13.9385; Hashimoto M, 2006, NAT CELL BIOL, V8, P391, DOI 10.1038/ncb1387; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kregenow DA, 2002, EUR RESPIR J, V20, P6, DOI 10.1183/09031936.02.00400802; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laffey JG, 2004, AM J RESP CRIT CARE, V169, P46, DOI 10.1164/rccm.200205-394OC; Laffey JG, 1999, LANCET, V354, P1283, DOI 10.1016/S0140-6736(99)02388-0; Lang JD, 2000, AM J PHYSIOL-LUNG C, V279, pL994, DOI 10.1152/ajplung.2000.279.5.L994; Lang JD, 2005, AM J RESP CRIT CARE, V171, P147, DOI 10.1164/rccm.200302-305OC; Lecuona E, 2006, FASEB J, V20, P2618, DOI 10.1096/fj.06-6503fje; Litvan J, 2006, J BIOL CHEM, V281, P19892, DOI 10.1074/jbc.M602064200; Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002; Mutlu GM, 2005, AM J PHYSIOL-LUNG C, V289, pL685, DOI 10.1152/ajplung.00247.2005; ODONOVAN R, 1991, NEPHRON, V57, P416, DOI 10.1159/000186305; Pfeiffer B, 2002, CRIT CARE MED, V30, P285, DOI 10.1097/00003246-200202000-00003; Putnam RW, 2004, AM J PHYSIOL-CELL PH, V287, pC1493, DOI 10.1152/ajpcell.00282.2004; Ridge KM, 2003, CIRC RES, V92, P453, DOI 10.1161/01.RES.0000059414.10360.F2; Ridge KM, 2002, MOL BIOL CELL, V13, P1381, DOI 10.1091/mbc.01-07-0323; Ridge KM, 1997, AM J PHYSIOL-LUNG C, V273, pL246, DOI 10.1152/ajplung.1997.273.1.L246; RUTSCHMAN DH, 1993, J APPL PHYSIOL, V75, P1574, DOI 10.1152/jappl.1993.75.4.1574; SAUMON G, 1993, J APPL PHYSIOL, V74, P1; SIBLEY DR, 1987, CELL, V48, P913, DOI 10.1016/0092-8674(87)90700-8; Skou JC, 1998, BIOSCIENCE REP, V18, P155, DOI 10.1023/A:1020196612909; Vertrees RA, 2004, CHEST, V125, P1472, DOI 10.1378/chest.125.4.1472; Wang XR, 2003, CIRC RES, V92, P1225, DOI 10.1161/01.RES.0000075601.95738.6D; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Zhou YH, 2005, P NATL ACAD SCI USA, V102, P3875, DOI 10.1073/pnas.0500423102	45	92	95	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1238	10.1371/journal.pone.0001238	http://dx.doi.org/10.1371/journal.pone.0001238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043745	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459300019
J	Havlioglu, N; Wang, J; Fushimi, K; Vibranovski, MD; Kan, ZY; Gish, W; Fedorov, A; Long, MY; Wu, JY				Havlioglu, Necat; Wang, Jun; Fushimi, Kazuo; Vibranovski, Maria D.; Kan, Zhengyan; Gish, Warren; Fedorov, Alexei; Long, Manyuan; Wu, Jane Y.			An Intronic Signal for Alternative Splicing in the Human Genome	PLOS ONE			English	Article							RNA; SEQUENCE; IDENTIFICATION; APOPTOSIS; ELEMENT; GENE; MECHANISM; ENHANCERS; PROTEINS; RESOURCE	An important level at which the expression of programmed cell death (PCD) genes is regulated is alternative splicing. Our previous work identified an intronic splicing regulatory element in caspase-2 (casp-2) gene. This 100-nucleotide intronic element, In100, consists of an upstream region containing a decoy 3' splice site and a downstream region containing binding sites for splicing repressor PTB. Based on the signal of In100 element in casp-2, we have detected the In100-like sequences as a family of sequence elements associated with alternative splicing in the human genome by using computational and experimental approaches. A survey of human genome reveals the presence of more than four thousand In100-like elements in 2757 genes. These In100-like elements tend to locate more frequent in intronic regions than exonic regions. EST analyses indicate that the presence of In100- like elements correlates with the skipping of their immediate upstream exons, with 526 genes showing exon skipping in such a manner. In addition, In100-like elements are found in several human caspase genes near exons encoding the caspase active domain. RT-PCR experiments show that these caspase genes indeed undergo alternative splicing in a pattern predicted to affect their functional activity. Together, these results suggest that the In100-like elements represent a family of intronic signals for alternative splicing in the human genome.	[Wang, Jun; Vibranovski, Maria D.; Long, Manyuan] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Havlioglu, Necat] St Louis Univ, Dept Pathol, St Louis, MO 63103 USA; [Fushimi, Kazuo; Wu, Jane Y.] Northwestern Univ, Feinberg Sch Med, Ctr Genet Med, Lurie Comprehens Canc Ctr,Dept Neurol, Chicago, IL 60611 USA; [Kan, Zhengyan; Gish, Warren] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Fedorov, Alexei] Med Univ Ohio, Dept Med, Toledo, OH USA; [Fedorov, Alexei] Med Univ Ohio, Program Bioinformat & Proteom Genom, Toledo, OH USA	University of Chicago; Saint Louis University; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Washington University (WUSTL)	Long, MY (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	mlong@midway.uchicago.edu; jane-wu@northwestern.edu	Gish, Warren/C-8123-2012; Vibranovski, Maria D./C-5599-2013	Vibranovski, Maria/0000-0001-8313-9726	NIH [EY014576, AG17518, GM070967, GM065429]; Muscular Dystrophy Association; Leukemia Society of America; NSF [MCB0238168]; Packard Fellowship for Science and Engineering; Pew Latin America Fellowship; NATIONAL EYE INSTITUTE [R01EY014576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070967, R01GM065429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Leukemia Society of America(Leukemia and Lymphoma Society); NSF(National Science Foundation (NSF)); Packard Fellowship for Science and Engineering; Pew Latin America Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: This work was supported by grants to JYW from NIH (EY014576; AG17518, GM070967) and Muscular Dystrophy Association. JYW was also supported by a Scholar Award from the Leukemia Society of America. ML was supported by NIH (GM065429), NSF CAREER Award (MCB0238168) and Packard Fellowship for Science and Engineering. MDV was supported by Pew Latin America Fellowship.	Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Boyce M, 2004, CELL DEATH DIFFER, V11, P29, DOI 10.1038/sj.cdd.4401339; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chabot B, 2003, Prog Mol Subcell Biol, V31, P59; Cote J, 2001, J BIOL CHEM, V276, P8535, DOI 10.1074/jbc.M008924200; Cote J, 2001, P NATL ACAD SCI USA, V98, P938, DOI 10.1073/pnas.031564098; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Fu XD, 2004, CELL, V119, P736, DOI 10.1016/j.cell.2004.11.039; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; Horiuchi T, 2000, BIOCHEM BIOPH RES CO, V272, P877, DOI 10.1006/bbrc.2000.2841; Huang YH, 2001, BIOCHEM BIOPH RES CO, V283, P762, DOI 10.1006/bbrc.2001.4871; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jiang ZH, 1998, P NATL ACAD SCI USA, V95, P9155, DOI 10.1073/pnas.95.16.9155; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Ladd AN, 2002, GENOME BIOL, V3; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Long MY, 1998, P NATL ACAD SCI USA, V95, P219, DOI 10.1073/pnas.95.1.219; LOU H, 1995, MOL CELL BIOL, V15, P7135; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; Minovitsky S, 2005, NUCLEIC ACIDS RES, V33, P714, DOI 10.1093/nar/gki210; Miriami E, 2003, NUCLEIC ACIDS RES, V31, P1974, DOI 10.1093/nar/gkg279; SIEBEL CW, 1992, GENE DEV, V6, P1386, DOI 10.1101/gad.6.8.1386; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Srinivasula SM, 1999, CANCER RES, V59, P999; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wu J Y, 2003, Prog Mol Subcell Biol, V31, P153; WU JY, 2004, ENCY MOL CELL BIOL M, V1, P125; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Zhang XHF, 2005, METHODS, V37, P292, DOI 10.1016/j.ymeth.2005.07.011; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zorio DAR, 1997, MOL CELL BIOL, V17, P946, DOI 10.1128/MCB.17.2.946	43	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1246	10.1371/journal.pone.0001246	http://dx.doi.org/10.1371/journal.pone.0001246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043753	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459300027
J	Lu, TL; Chang, JL; Liang, CC; You, LR; Chen, CM				Lu, Tsai-Ling; Chang, Junn-Liang; Liang, Chih-Chia; You, Li-Ru; Chen, Chun-Ming			Tumor Spectrum, Tumor Latency and Tumor Incidence of the Pten-Deficient Mice	PLOS ONE			English	Article							SUPPRESSOR GENE; CELL-PROLIFERATION; EMBRYONIC-DEVELOPMENT; NEGATIVE REGULATION; COWDEN-SYNDROME; STEM-CELLS; IN-VITRO; PROSTATE; PTEN/MMAC1; INACTIVATION	Background. Pten functionally acts as a tumor suppressor gene. Lately, tissue-specific ablation of Pten gene in mice has elucidated the role of Pten in different tumor progression models. However, a temporally controlled Pten loss in all adult tissues to examine susceptibility of various tissues to Pten-deficient tumorigenesis has not been addressed yet. Our goal was to explore the genesis of Pten-deficient malignancies in multiple tissue lineages of the adult mouse. Methods and Findings. We utilized an inducible Cre/loxP system to delete Pten exon 5 in the systemic organs of ROSA26 (R26)-CreER(T);Pten(fx/fx) mice. On reaching 45 weeks 4OHT-induced Pten loss, we found that the R26-CreER(T); Pten(fx/fx) mice developed a variety of malignancies. Overall tumor mean latency was 17 weeks in the Pten-deficient mice. Interestingly, mutant females developed malignancies more quickly at 10 similar to 11 weeks compared with a tumor latency of 21 weeks for mutant males. Lymphoma incidence (76.9% in females; 40.0% in males) was higher than the other malignancies found in the mutant mice. Mutant males developed prostate (20.0%), intestinal cancer (35.0%) and squamous cell carcinoma (10.0%), whereas the mutant females developed squamous cell carcinoma (15.4%) and endometrial cancer (46.1%) in addition to lymphomas. Furthermore, we tested the pharmacological inhibition of the PTEN downstream effectors using LY294002 on Pten-deficient prostate hyperplasia. Our data revealed that, indeed, the prostate hyperplasia resulting from the induced Pten loss was significantly suppressed by LY294002 (p = 0.007). Conclusions. Through monitoring a variety of Pten-deficient tumor formation, our results revealed that the lymphoid lineages and the epithelium of the prostate, endometrium, intestine and epidermis are highly susceptible to tumorigenesis after the Pten gene is excised. Therefore, this R26-CreER(T); Pten(fx/fx) mouse model may provide an entry point for understanding the role of Pten in the tumorigenesis of different organs and extend the search for potential therapeutic approaches to prevent Pten-deficient malignancies.	[Lu, Tsai-Ling; Liang, Chih-Chia; Chen, Chun-Ming] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Lu, Tsai-Ling; Liang, Chih-Chia; Chen, Chun-Ming] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Chang, Junn-Liang] Taoyuan Armed Forces Gen Hosp, Dept Pathol, Lungtan, Taoyuan County, Taiwan; [You, Li-Ru] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, CM (corresponding author), Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan.	cmchen@ym.edu.tw		You, Li-Ru/0000-0003-1775-0097; Chen, Chun-Ming/0000-0001-8873-7602	Ministry of Education, Aim for the Top University Plan; National Science Council, Taiwan (NSC) [95-2320-B-010-004, 95-2320-B-010-014, 96-3112-B-010-016]; Research Foundation of Taoyuan Armed Forces General Hospital [9519, 9612]	Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan); National Science Council, Taiwan (NSC)(Ministry of Science and Technology, Taiwan); Research Foundation of Taoyuan Armed Forces General Hospital	Supported by the Ministry of Education, Aim for the Top University Plan and the National Science Council, Taiwan, (NSC 95-2320-B-010-004, NSC 95-2320-B-010-014 and NSC 96-3112-B-010-016) to C-MC. Supported by the Research Foundation of Taoyuan Armed Forces General Hospital (9519 and 9612) to J-LC.	Abate-Shen C, 2003, CANCER RES, V63, P3886; Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Badea TC, 2003, J NEUROSCI, V23, P2314; Bondar VM, 2002, MOL CANCER THER, V1, P989; Cairns P, 1997, CANCER RES, V57, P4997; Chen CM, 2004, ONCOGENE, V23, P7722, DOI 10.1038/sj.onc.1208037; Chen CM, 2004, GENE DEV, V18, P320, DOI 10.1101/gad.1162204; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Eng C, 2000, J MED GENET, V37, P828, DOI 10.1136/jmg.37.11.828; Freeman D, 2006, CANCER RES, V66, P6492, DOI 10.1158/0008-5472.CAN-05-4143; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hu LM, 2000, CLIN CANCER RES, V6, P880; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P2884, DOI 10.1073/pnas.042688999; Kwan KM, 2002, GENESIS, V32, P49, DOI 10.1002/gene.10068; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Milam MR, 2007, AM J OBSTET GYNECOL, V196, P247, DOI 10.1016/j.ajog.2006.10.872; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Risinger JI, 1997, CANCER RES, V57, P4736; Sakai A, 1998, BLOOD, V92, P3410, DOI 10.1182/blood.V92.9.3410.421a06_3410_3415; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2000, CANCER RES, V60, P3605; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Teng DHF, 1997, CANCER RES, V57, P5221; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	44	25	25	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1237	10.1371/journal.pone.0001237	http://dx.doi.org/10.1371/journal.pone.0001237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043744	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459300018
J	Ghosh, T; Pandey, N; Maitra, A; Brahmachari, SK; Pillai, B				Ghosh, Tanay; Pandey, Neeraj; Maitra, Arindam; Brahmachari, Samir K.; Pillai, Beena			A Role for Voltage-Dependent Anion Channel Vdac1 in Polyglutamine-Mediated Neuronal Cell Death	PLOS ONE			English	Article								Expansion of trinucleotide repeats in coding and non-coding regions of genes is associated with sixteen neurodegenerative disorders. However, the molecular effects that lead to neurodegeneration have remained elusive. We have explored the role of transcriptional dysregulation by TATA-box binding protein (TBP) containing an expanded polyglutamine stretch in a mouse neuronal cell culture based model. We find that mouse neuronal cells expressing a variant of human TBP harboring an abnormally expanded polyQ tract not only form intranuclear aggregates, but also show transcription dysregulation of the voltage dependent anion channel, Vdac1, increased cytochrome c release from the mitochondria and upregulation of genes involved in localized neuronal translation. On the other hand, unfolded protein response seemed to be unaffected. Consistent with an increased transcriptional effect, we observe an elevated promoter occupancy by TBP in vivo in TATA containing and TATA-less promoters of differentially expressed genes. Our study suggests a link between transcriptional dysfunction and cell death in trinucleotide repeat mediated neuronal dysfunction through voltage dependent anion channel, Vdac1, which has been recently recognized as a critical determinant of cell death.	[Ghosh, Tanay; Pandey, Neeraj; Brahmachari, Samir K.; Pillai, Beena] IGIB, New Delhi, India; [Maitra, Arindam] Ctr Genom Applicat, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Pillai, B (corresponding author), IGIB, New Delhi, India.	beenapillai@igib.res		Pandey, Neeraj/0000-0003-4872-7201; Pillai, Beena/0000-0002-9302-9878	Department of Science and Technology (DST), India; Council of Scientific and Industrial Research (CSIR)	Department of Science and Technology (DST), India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This research was supported by grants from the Department of Science and Technology (DST), India. TG is a recipient of senior research fellowship from Council of Scientific and Industrial Research (CSIR). The funders played no role in design and conducting of the study, or in the collection, analysis or interpretation of the data. The same is the case for the preparation, review and approval of the manuscript. The funders did not provide the publication fee.	BUHAMAD S, 2006, P NATL ACAD SCI USA, V103, P5787; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Cummings CJ, 2000, ANNU REV GENOM HUM G, V1, P281, DOI 10.1146/annurev.genom.1.1.281; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Gill G, 1992, CURR OPIN GENET DEV, V2, P236, DOI 10.1016/S0959-437X(05)80279-5; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1927, DOI 10.1093/hmg/11.17.1927; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; McMurray CT, 2001, TRENDS NEUROSCI, V24, pS32, DOI 10.1016/S0166-2236(00)01997-4; Nahon E, 2005, FEBS LETT, V579, P5105, DOI 10.1016/j.febslet.2005.08.020; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Ruan QM, 2004, HUM MOL GENET, V13, P669, DOI 10.1093/hmg/ddh082; Sampson MJ, 1997, J BIOL CHEM, V272, P18966, DOI 10.1074/jbc.272.30.18966; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shoshan-Barmatz V, 2004, BBA-BIOENERGETICS, V1657, P105, DOI 10.1016/j.bbabio.2004.02.009; Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279; Stevanin G, 2003, BRAIN, V126, P1599, DOI 10.1093/brain/awg155; Van Roon-Mom WMC, 2005, NEUROSCIENCE, V133, P863, DOI 10.1016/j.neuroscience.2005.03.024; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599; ZHOU Q, 1992, GENE DEV, V6, P1964, DOI 10.1101/gad.6.10.1964; Zuhlke C, 2001, EUR J HUM GENET, V9, P160, DOI 10.1038/sj.ejhg.5200617	30	58	60	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1170	10.1371/journal.pone.0001170	http://dx.doi.org/10.1371/journal.pone.0001170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000542	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459100012
J	Maddika, S; Wiechec, E; Ande, SR; Poon, IK; Fischer, U; Wesselborg, S; Jans, DA; Schulze-Osthoff, K; Los, M				Maddika, S.; Wiechec, E.; Ande, S. R.; Poon, I. K.; Fischer, U.; Wesselborg, S.; Jans, D. A.; Schulze-Osthoff, K.; Los, M.			Interaction with PI3-kinase contributes to the cytotoxic activity of Apoptin	ONCOGENE			English	Article						anticancer drugs; apoptin; apoptosis; PI3-kinase	INDUCED CELL-DEATH; PHOSPHATIDYLINOSITOL 3-KINASE; T-CELLS; APOPTOSIS; ACTIVATION; BINDING; KINASE; PATHWAY; P85	Apoptin, a small protein from the chicken anemia virus, has attracted attention because of its specificity in killing tumor cells. Localization of apoptin in the nucleus of tumor cells has been shown to be vital for proapoptotic activity, however, targeted expression of apoptin in the nucleus of normal cells does not harm the cells, indicating that nuclear localization of apoptin is insufficient for its cytotoxicity. Here, we demonstrate for the first time that apoptin interacts with the SH3 domain of p85, the regulatory subunit of phosphoinositide 3-kinase (PI3-K), through its proline-rich region. Apoptin derivatives devoid of this proline-rich region do not interact with p85, are unable to activate PI3-K, and show impaired apoptosis induction. Moreover, apoptin mutants containing the proline-rich domain are sufficient to elevate PI3-K activity and to induce apoptosis in cancer cells. Downregulation of p85 leads to nuclear exclusion of apoptin and impairs cell death induction, indicating that interaction with the p85 PI3-K subunit essentially contributes to the cytotoxic activity of apoptin.	[Los, M.] BioApplicat Enterprises, Winnipeg, MB R2V 2N6, Canada; [Maddika, S.; Wiechec, E.; Ande, S. R.; Los, M.] Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB, Canada; [Maddika, S.; Ande, S. R.; Los, M.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Wiechec, E.] Univ Aarhus, Inst Human Genet, Aarhus, Denmark; [Poon, I. K.; Jans, D. A.] Monash Univ, Dept Biochem & Mol Biol, Nucl Signaling Lab, Clayton, Vic 3168, Australia; [Fischer, U.; Schulze-Osthoff, K.] Univ Dusseldorf, Inst Mol Med, Dusseldorf, Germany; [Wesselborg, S.] Univ Tubingen, Dept Internal Med 1, Tubingen, Germany; [Los, M.] Univ Manitoba, Manitoba Inst Child Hlth, Winnipeg, MB, Canada; [Los, M.] Univ Manitoba, Dept Human Anat & Cell Biol, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; Aarhus University; Monash University; Heinrich Heine University Dusseldorf; Eberhard Karls University of Tubingen; University of Manitoba; University of Manitoba	Los, M (corresponding author), BioApplicat Enterprises, Winnipeg, MB R2V 2N6, Canada.	mjelos@gmail.com	Schulze-Osthoff, Klaus/N-9025-2013; Ande, Sudharsana Rao/AAU-6950-2021	Schulze-Osthoff, Klaus/0000-0003-1443-2720; Ande, Sudharsana Rao/0000-0001-8194-2902; Wesselborg, Sebastian/0000-0002-5236-942X; Los, Marek/0000-0001-9518-1411; Poon, Ivan/0000-0002-9119-7173; Jans, David/0000-0001-5115-4745	CIHR [81237, 82359] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		Alvisi G, 2006, DRUG RESIST UPDATE, V9, P40, DOI 10.1016/j.drup.2006.02.003; Burek M, 2006, ONCOGENE, V25, P2213, DOI 10.1038/sj.onc.1209258; Danen-van Oorschot AAAM, 2003, J BIOL CHEM, V278, P27729, DOI 10.1074/jbc.M303114200; Fischer U, 2005, PHARMACOL REV, V57, P187, DOI 10.1124/pr.57.2.6; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Guelen L, 2004, ONCOGENE, V23, P1153, DOI 10.1038/sj.onc.1207224; Janssen K, 2007, ONCOGENE, V26, P1557, DOI 10.1038/sj.onc.1209923; Jascur T, 1997, J BIOL CHEM, V272, P14483, DOI 10.1074/jbc.272.22.14483; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; LIU XQ, 1993, MOL CELL BIOL, V13, P5225, DOI 10.1128/MCB.13.9.5225; Maddika S, 2007, CELL PROLIFERAT, V40, P835, DOI 10.1111/j.1365-2184.2007.00475.x; Maddika S, 2005, J CELL SCI, V118, P4485, DOI 10.1242/jcs.02580; Neri LM, 2002, BBA-MOL CELL BIOL L, V1584, P73, DOI 10.1016/S1388-1981(02)00300-1; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Poon IH, 2005, CANCER RES, V65, P7059, DOI 10.1158/0008-5472.CAN-05-1370; PRASAD KVS, 1993, P NATL ACAD SCI USA, V90, P7366, DOI 10.1073/pnas.90.15.7366; Rohn JL, 2002, J BIOL CHEM, V277, P50820, DOI 10.1074/jbc.M208557200; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	19	38	40	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 8	2008	27	21					3060	3065		10.1038/sj.onc.1210958	http://dx.doi.org/10.1038/sj.onc.1210958			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	298IP	18059340	Green Published, Green Accepted			2022-12-25	WOS:000255681700013
J	Pietrement, C; Da Silva, N; Silberstein, C; James, M; Marsolais, M; Van Hoek, A; Brown, D; Pastor-Soler, N; Ameen, N; Laprade, R; Ramesh, V; Breton, S				Pietrement, Christine; Da Silva, Nicolas; Silberstein, Claudia; James, Marianne; Marsolais, Mireille; Van Hoek, Alfred; Brown, Dennis; Pastor-Soler, Nuria; Ameen, Nadia; Laprade, Raynald; Ramesh, Vijaya; Breton, Sylvie			Role of NHERF1, cystic fibrosis transmembrane conductance regulator, and cAMP in the regulation of aquaporin 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL BILATERAL ABSENCE; VAS-DEFERENS; MOLECULAR CHARACTERIZATION; WATER REABSORPTION; INITIAL SEGMENT; RAT EPIDIDYMIS; ION-TRANSPORT; CFTR; PROTEIN; CHANNEL	Water and solute transport across the plasma membrane of cells is a crucial biological function that is mediated mainly by aquaporins and aquaglyceroporins. The regulation of these membrane proteins is still incompletely understood. Using the male reproductive tract as a model system in which water and glycerol transport are critical for the establishment of fertility, we now report a novel pathway for the regulation of aquaporin 9 (AQP9) permeability. AQP9 is the major aquaglyceroporin of the epididymis, liver, and peripheral leukocytes, and its COOH-terminal portion contains a putative PDZ binding motif (SVIM). Here we show that NHERF1, cystic fibrosis transmembrane conductance regulator (CFTR), and AQP9 co-localize in the apical membrane of principal cells of the epididymis and the vas deferens, and that both NHERF1 and CFTR co-immunoprecipitate with AQP9. Overlay assays revealed that AQP9 binds to both the PDZ1 and PDZ2 domains of NHERF1, with an apparently higher affinity for PDZ1 versus PDZ2. Pull-down assays showed that the AQP9 COOH-terminal SVIM motif is essential for interaction with NHERF1. Functional assays on isolated tubules perfused in vitro showed a high permeability of the apical membrane to glycerol, which is inhibited by the AQP9 inhibitor, phloretin, and is markedly activated by cAMP. The CFTR inhibitors DPC, GlyH-101 and CFTRinh-172 all significantly reduced the cAMP-activated glycerol-induced cell swelling. We propose that CFTR is an important regulator of AQP9 and that the interaction between AQP9, NHERF1, and CFTR may facilitate the activation of AQP9 by cAMP.	[Pietrement, Christine; Da Silva, Nicolas; Silberstein, Claudia; Van Hoek, Alfred; Brown, Dennis; Breton, Sylvie] Massachusetts Gen Hosp, Ctr Syst Biol, Program Membrane Biol, Div Nephrol, Boston, MA 02114 USA; [James, Marianne; Ramesh, Vijaya] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Van Hoek, Alfred; Brown, Dennis; Ramesh, Vijaya; Breton, Sylvie] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Marsolais, Mireille; Laprade, Raynald] Univ Montreal, Grp Proteins Membranaires, Montreal, PQ, Canada; [Ameen, Nadia] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Universite de Montreal; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Breton, S (corresponding author), Massachusetts Gen Hosp, Simches Res Ctr, Program Membrane Biol, 185 Cambridge St,Suite 8204, Boston, MA 02114 USA.	sbreton@partners.org	Da Silva, Nicolas/T-3528-2019	Van Hoek, Alfred/0000-0003-2724-6855	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, P30DK043351] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 045821] Funding Source: Medline; NIDDK NIH HHS [DK 57521, DK 43351] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANGUIANO A, 1992, JAMA-J AM MED ASSOC, V267, P1794, DOI 10.1001/jama.267.13.1794; Badran HH, 2002, J ANDROL, V23, P358; Bagnis C, 2001, AM J PHYSIOL-RENAL, V280, pF426, DOI 10.1152/ajprenal.2001.280.3.F426; Blau H, 2002, ARCH DIS CHILD, V87, P135, DOI 10.1136/adc.87.2.135; Breton S, 2000, J BIOL CHEM, V275, P18219, DOI 10.1074/jbc.M909857199; BRETON S, 1992, AM J PHYSIOL, V263, pF656, DOI 10.1152/ajprenal.1992.263.4.F656; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Brone B, 2005, AM J PHYSIOL-CELL PH, V288, pC20, DOI 10.1152/ajpcell.00368.2004; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; BROWN D, 1995, HISTOCHEM CELL BIOL, V104, P1, DOI 10.1007/BF01464780; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; Cheung KH, 2003, BIOL REPROD, V68, P1505, DOI 10.1095/biolreprod.102.010017; CLULOW J, 1994, EXP PHYSIOL, V79, P915, DOI 10.1113/expphysiol.1994.sp003817; Clulow J, 1998, J REPROD FERTIL, P1; COOPER TG, 1981, J REPROD FERTIL, V61, P163, DOI 10.1530/jrf.0.0610163; CRABO B, 1965, ACTA VET SCAND, VS  6, P1; Cuppens H, 2004, INT J ANDROL, V27, P251, DOI 10.1111/j.1365-2605.2004.00485.x; Da Silva N, 2006, BIOL REPROD, V74, P427, DOI 10.1095/biolreprod.105.044735; Deliot N, 2005, AM J PHYSIOL-CELL PH, V289, pC159, DOI 10.1152/ajpcell.00456.2004; Elkjaer ML, 2000, BIOCHEM BIOPH RES CO, V276, P1118, DOI 10.1006/bbrc.2000.3505; Gaillard DA, 1997, J UROLOGY, V158, P1549, DOI 10.1016/S0022-5347(01)64278-2; Golin-Bisello F, 2005, AM J PHYSIOL-CELL PH, V289, pC708, DOI 10.1152/ajpcell.00544.2004; Gonzalez-Agosti C, 1999, J BIOL CHEM, V274, P34438, DOI 10.1074/jbc.274.48.34438; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hamann S, 1998, AM J PHYSIOL-CELL PH, V274, pC1332, DOI 10.1152/ajpcell.1998.274.5.C1332; Hansen LA, 1999, EXP PHYSIOL, V84, P521, DOI 10.1111/j.1469-445X.1999.01788.x; HINTON BT, 1995, MICROSC RES TECHNIQ, V30, P67, DOI 10.1002/jemt.1070300106; HOHLBRUGGER G, 1983, ARCH ANDROLOGY, V11, P265, DOI 10.3109/01485018308987492; James MF, 2004, J CELL SCI, V117, P2951, DOI 10.1242/jcs.01156; JOHNSON AL, 1977, SCIENCE, V195, P492, DOI 10.1126/science.835008; Jones RC, 1996, REPROD FERT DEVELOP, V8, P553, DOI 10.1071/RD9960553; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kreda SM, 2001, AM J RESP CELL MOL, V24, P224, DOI 10.1165/ajrcmb.24.3.4367; LEVINE N, 1971, J PHYSIOL-LONDON, V213, P557, DOI 10.1113/jphysiol.1971.sp009400; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Nicchia GP, 2001, J HISTOCHEM CYTOCHEM, V49, P1547, DOI 10.1177/002215540104901208; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Nielsen S, 1997, AM J PHYSIOL-CELL PH, V273, pC1549, DOI 10.1152/ajpcell.1997.273.5.C1549; OATES RD, 1994, J ANDROL, V15, P1; Oliveira CA, 2005, BIOL CELL, V97, P385, DOI 10.1042/BC20040078; Pastor-Soler L, 2002, BIOL REPROD, V66, P1716, DOI 10.1095/biolreprod66.6.1716; Pastor-Soler N, 2001, BIOL REPROD, V65, P384, DOI 10.1095/biolreprod65.2.384; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Robaire B., 1988, P999; ROBAIRE B, 1995, BIOL REPROD, V52, P226, DOI 10.1095/biolreprod52.2.226; Ruz R, 2004, J ANDROL, V25, P265; Sedlacek RL, 2001, AM J PHYSIOL-RENAL, V281, pF557, DOI 10.1152/ajprenal.2001.281.3.F557; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Sidhaye V, 2005, J BIOL CHEM, V280, P3590, DOI 10.1074/jbc.M411038200; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Tsukaguchi H, 1999, AM J PHYSIOL-RENAL, V277, pF685, DOI 10.1152/ajprenal.1999.277.5.F685; TURNER TT, 1984, J REPROD FERTIL, V72, P509, DOI 10.1530/jrf.0.0720509; TURNER TT, 1995, J ANDROL, V16, P292; TURNER TT, 1983, J ANDROL, V4, P197; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; Weinman EJ, 2005, J PHYSIOL-LONDON, V567, P27, DOI 10.1113/jphysiol.2005.086777; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; WONG PYD, 1978, J PHYSIOL-LONDON, V275, P13, DOI 10.1113/jphysiol.1978.sp012174; Wong PYD, 1998, MOL HUM REPROD, V4, P107, DOI 10.1093/molehr/4.2.107; WONG YC, 1978, EXPERIENTIA, V34, P485, DOI 10.1007/BF01935943; YEUNG CH, 1993, BIOL REPROD, V49, P274, DOI 10.1095/biolreprod49.2.274; Yoo D, 2004, J BIOL CHEM, V279, P6863, DOI 10.1074/jbc.M311599200; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134	67	57	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2986	2996		10.1074/jbc.M704678200	http://dx.doi.org/10.1074/jbc.M704678200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18055461	hybrid			2022-12-25	WOS:000252622300054
J	Qian, YJ; Zhang, J; Yan, BF; Chen, XB				Qian, Yingjuan; Zhang, Jin; Yan, Bingfang; Chen, Xinbin			DEC1, a basic helix-loop-helix transcription factor and a novel target gene of the p53 family, mediates p53-dependent premature senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; CELLULAR SENESCENCE; TUMOR-CELLS; IN-VIVO; FUNCTIONAL DOMAINS; INDUCED APOPTOSIS; ONCOGENIC RAS; EXPRESSION; ACTIVATION; PATHWAY	Cellular senescence plays an important role in tumor suppression. p53 tumor suppressor has been reported to be crucial in cellular senescence. However, the underlying mechanism is poorly understood. In this regard, a cDNA microarray assay was performed to identify p53 targets involved in senescence. Among the many candidates is DEC1, a basic helix-loop-helix transcription factor that has been recently shown to be up- regulated in K-ras-induced premature senescence. However, it is not clear whether DEC1 is capable of inducing senescence. Here, we found that DEC1 is a novel target gene of the p53 family and mediates p53-dependent premature senescence. Specifically, we showed that DEC1 is induced by the p53 family and DNA damage in a p53-dependent manner. We also found that the p53 family proteins bind to, and activate, the promoter of the DEC1 gene. In addition, we showed that overexpression of DEC1 induces G(1) arrest and promotes senescence. Moreover, we found that targeting endogenous DEC1 attenuates p53-mediated premature senescence in response to DNA damage. Furthermore, overexpression of DEC1 induces cellular senescence in p53-knockdown cells, albeit to a lesser extent. Finally, we showed that DEC1-induced senescence is p21-independent. Taken together, our data provided strong evidence that DEC1 is one of the effectors downstream of p53 to promote premature senescence.	[Qian, Yingjuan; Zhang, Jin; Chen, Xinbin] Univ Calif Davis, Ctr Comparat Oncol, Davis, CA 95616 USA; [Qian, Yingjuan] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Yan, Bingfang] Univ Rhode Isl, Kingston, RI 02881 USA	University of California System; University of California Davis; University of Alabama System; University of Alabama Birmingham; University of Rhode Island	Chen, XB (corresponding author), Univ Calif Davis, Ctr Comparat Oncol, 2128 Tupper Hall, Davis, CA 95616 USA.	xbchen@ucdavis.edu			NATIONAL CANCER INSTITUTE [R01CA076069, R01CA102188, R01CA081237, R29CA076069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061988] Funding Source: NIH RePORTER; NCI NIH HHS [R29 CA076069, R01 CA076069, CA 076009, CA 081237, R01 CA081237, R01 CA102188, CA 102188] Funding Source: Medline; NIEHS NIH HHS [R01 ES 007965, R01 ES007965] Funding Source: Medline; NIGMS NIH HHS [R01 GM061988, R01 GM 061988] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Chang BD, 1999, CANCER RES, V59, P3761; CHEN XB, 1995, CANCER RES, V55, P4257; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Elmore LW, 2002, J BIOL CHEM, V277, P35509, DOI 10.1074/jbc.M205477200; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HU QJ, 1991, MOL CELL BIOL, V11, P5792, DOI 10.1128/MCB.11.11.5792; Jackson JG, 2006, MOL CELL BIOL, V26, P2501, DOI 10.1128/MCB.26.7.2501-2510.2006; Jin SK, 2001, J CELL SCI, V114, P4139; Jung EJ, 2006, MOL CELL BIOL, V26, P2175, DOI 10.1128/MCB.26.6.2175-2186.2006; Kapic A, 2006, CELL DEATH DIFFER, V13, P324, DOI 10.1038/sj.cdd.4401756; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Li YX, 2003, J BIOL CHEM, V278, P16899, DOI 10.1074/jbc.M300596200; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; Liu G, 2005, J BIOL CHEM, V280, P20111, DOI 10.1074/jbc.M413889200; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Nozell S, 2003, ONCOGENE, V22, P4333, DOI 10.1038/sj.onc.1206470; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; PARRY D, 1995, EMBO J, V14, P503, DOI 10.1002/j.1460-2075.1995.tb07026.x; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Prives C, 1999, J PATHOL, V187, P112; Schmitt CA, 2007, BBA-REV CANCER, V1775, P5, DOI 10.1016/j.bbcan.2006.08.005; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shen M, 2002, J BIOL CHEM, V277, P50112, DOI 10.1074/jbc.M206771200; Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; te Poele RH, 2002, CANCER RES, V62, P1876; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Wang YC, 1999, ONCOGENE, V18, P2643, DOI 10.1038/sj.onc.1202632; Yamada K, 2005, FRONT BIOSCI-LANDMRK, V10, P3151, DOI 10.2741/1772; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200; Zawel L, 2002, P NATL ACAD SCI USA, V99, P2848, DOI 10.1073/pnas.261714999; Zhou J, 1998, ONCOGENE, V17, P2719, DOI 10.1038/sj.onc.1202198; Zhu JH, 2000, J BIOL CHEM, V275, P39927, DOI 10.1074/jbc.M005676200	49	96	100	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2896	2905		10.1074/jbc.M708624200	http://dx.doi.org/10.1074/jbc.M708624200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18025081	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000252622300046
J	Christoffersen, C; Jauhiainen, M; Moser, M; Porse, B; Ehnholm, C; Boesl, M; Dahlback, B; Nielsen, LB				Christoffersen, Christina; Jauhiainen, Matti; Moser, Markus; Porse, Bo; Ehnholm, Christian; Boesl, Michael; Dahlback, Bjorn; Nielsen, Lars Bo			Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LECITHIN-CHOLESTEROL ACYLTRANSFERASE; PHOSPHOLIPID TRANSFER PROTEIN; APO A-I; HUMAN-PLASMA; CELLULAR CHOLESTEROL; TRANSGENIC MICE; HDL CONVERSION; EFFLUX; BINDING; DISEASE	To investigate the role of apoM in high density lipoprotein (HDL) metabolism and atherogenesis, we generated human apoM transgenic (apoM-Tg) and apoM-deficient ( apoM(-/-)) mice. Plasma apoM was predominantly associated with 10-12-nm alpha-migrating HDL particles. Human apoM overexpression (11-fold) increased plasma cholesterol concentration by 13-22%, whereas apoM deficiency decreased it by 17-21%. The size and charge of apoA-I-containing HDL in plasma were not changed in apoM-Tg or apoM(-/-) mice. However, in plasma incubated at 37 C, lecithin: cholesterol acyltransferase-dependent conversion of alpha- to pre-alpha-migrating HDL was delayed in apoM-Tg mice. Moreover, lecithin: cholesterol acyltransferase-independent generation of pre-beta-migrating apoA-I-containing particles in plasma was increased in apoM-Tg mice (4.2 +/- 1.1%, p = 0.06) and decreased in apoM(-/-) mice (0.5 +/- 0.3%, p = 0.03) versus controls ( 1.8 +/- 0.05%). In the setting of low density lipoprotein receptor deficiency, apoM-Tg mice with similar to 2-fold increased plasma apoM concentrations developed smaller atherosclerotic lesions than controls. The effect of apoM on atherosclerosis may be facilitated by enzymatic modulation of plasma HDL particles, increased cholesterol efflux from foam cells, and an antioxidative effect of apoM-containing HDL.	[Christoffersen, Christina; Porse, Bo; Nielsen, Lars Bo] Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Nielsen, Lars Bo] Univ Copenhagen, Dept Biomed Sci, DK-2100 Copenhagen, Denmark; [Ehnholm, Christian] Natl Publ Hlth Inst, Dept Mol Med, Helsinki 00290, Finland; [Moser, Markus; Boesl, Michael] Max Planck Inst Biochem, Dept Mol Med, D-82152 Matinsried, Germany; [Dahlback, Bjorn] Lund Univ, Univ Hosp, Dept Lab Med, Div Clin Chem, S-20502 Malmo, Sweden	Rigshospitalet; University of Copenhagen; University of Copenhagen; Finland National Institute for Health & Welfare; Max Planck Society; Lund University; Skane University Hospital	Nielsen, LB (corresponding author), Rigshosp, Dept Clin Biochem, KB3011,Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	larsbo@rh.dk	Porse, Bo/B-1332-2012	Porse, Bo/0000-0001-6043-0844; Christoffersen, Christina/0000-0003-3751-5203; Dahlback, Bjorn/0000-0003-1546-0328				Ahnstrom J, 2007, J LIPID RES, V48, P1754, DOI 10.1194/jlr.M700103-JLR200; Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; Alexander ET, 2005, BIOCHEMISTRY-US, V44, P5409, DOI 10.1021/bi047412v; Axler O, 2007, J LIPID RES, V48, P1772, DOI 10.1194/jlr.M700113-JLR200; BARRANS A, 1994, J BIOL CHEM, V269, P11572; Bartels ED, 2002, DIABETES, V51, P1233, DOI 10.2337/diabetes.51.4.1233; Bro S, 2003, J AM SOC NEPHROL, V14, P2466, DOI 10.1097/01.ASN.0000088024.72216.2E; Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242; Christoffersen C, 2006, J LIPID RES, V47, P1833, DOI 10.1194/jlr.M600055-JLR200; CLAY MA, 1992, BIOCHIM BIOPHYS ACTA, V1124, P52, DOI 10.1016/0005-2760(92)90125-F; Costet P, 2000, J BIOL CHEM, V275, P28240; Dahlback B, 2006, CURR OPIN LIPIDOL, V17, P291, DOI 10.1097/01.mol.0000226122.10005.88; Deakin JE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-281; Duan JX, 2001, FEBS LETT, V499, P127, DOI 10.1016/S0014-5793(01)02544-3; Ehnholm C, 1986, Methods Enzymol, V129, P716; Faber K, 2006, MOL ENDOCRINOL, V20, P212, DOI 10.1210/me.2005-0209; Faber K, 2004, J LIPID RES, V45, P1272, DOI 10.1194/jlr.M300451-JLR200; FLOWER DR, 1994, FEBS LETT, V354, P7, DOI 10.1016/0014-5793(94)01078-1; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; GLOMSET JA, 1968, J LIPID RES, V9, P155; GLOMSET JA, 1962, BIOCHIM BIOPHYS ACTA, V65, P128, DOI 10.1016/0006-3002(62)90156-7; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Holvoet P, 2000, ARTERIOSCL THROM VAS, V20, P459, DOI 10.1161/01.ATV.20.2.459; Huuskonen J, 2000, BIOCHEMISTRY-US, V39, P16092, DOI 10.1021/bi0019287; ISHIDA BY, 1990, J LIPID RES, V31, P227; JAUHIAINEN M, 1993, J BIOL CHEM, V268, P4032; JAUHIAINEN M, 1986, J BIOL CHEM, V261, P7032; Jiang XC, 1996, J CLIN INVEST, V98, P2373, DOI 10.1172/JCI119050; KAWANO M, 1993, BIOCHEMISTRY-US, V32, P5025, DOI 10.1021/bi00070a008; Korhonen A, 1998, BIOCHEM BIOPH RES CO, V249, P910, DOI 10.1006/bbrc.1998.9162; KUNITAKE ST, 1985, J LIPID RES, V26, P549; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; LIU M, 1993, BIOCHIM BIOPHYS ACTA, V1168, P144, DOI 10.1016/0005-2760(93)90118-S; Lund-Katz S, 2003, FRONT BIOSCI-LANDMRK, V8, pD1044, DOI 10.2741/1077; MIIDA T, 1992, BIOCHEMISTRY-US, V31, P11112, DOI 10.1021/bi00160a022; NISHIDA HI, 1986, J BIOL CHEM, V261, P2028; Nobecourt E, 2007, DIABETOLOGIA, V50, P643, DOI 10.1007/s00125-006-0574-z; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; Pussinen PJ, 2001, ATHEROSCLEROSIS, V155, P297, DOI 10.1016/S0021-9150(00)00568-2; Rader DJ, 2007, NAT CLIN PRACT CARD, V4, P102, DOI 10.1038/ncpcardio0768; Rye K, 2006, J LIPID RES, V47, P1025, DOI 10.1194/jlr.M500525-JLR200; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Siggins S, 2003, J LIPID RES, V44, P1698, DOI 10.1194/jlr.M300059-JLR200; Sviridov D, 2002, ARTERIOSCL THROM VAS, V22, P1482, DOI 10.1161/01.ATV.0000029120.44088.FE; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; van Haperen R, 2000, ARTERIOSCL THROM VAS, V20, P1082, DOI 10.1161/01.ATV.20.4.1082; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; von Eckardstein A, 1998, ATHEROSCLEROSIS, V138, P25, DOI 10.1016/S0021-9150(97)00280-3; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499; Wolfrum C, 2005, NAT MED, V11, P418, DOI 10.1038/nm1211; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286	54	148	159	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1839	1847		10.1074/jbc.M704576200	http://dx.doi.org/10.1074/jbc.M704576200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18006500	hybrid			2022-12-25	WOS:000252501000009
J	Whitford, PC; Gosavi, S; Onuchic, JN				Whitford, Paul C.; Gosavi, Shachi; Onuchic, Jose N.			Conformational transitions in adenylate kinase - Allosteric communication reduces misligation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; FUNCTIONAL TRANSITIONS; ENERGY LANDSCAPES; SINGLE-PARAMETER; DOMAIN CLOSURE; NETWORK MODEL; PROTEINS; MECHANISMS; FRUSTRATION; CATALYSIS	Large conformational changes in the LID and NMP domains of adenylate kinase (AKE) are known to be key to ligand binding and catalysis, yet the order of binding events and domain motion is not well understood. Combining the multiple available structures for AKE with the energy landscape theory for protein folding, a theoretical model was developed for allostery, order of binding events, and efficient catalysis. Coarse-grained models and nonlinear normal mode analysis were used to infer that intrinsic structural fluctuations dominate LID motion, whereas ligand-protein interactions and cracking ( local unfolding) are more important during NMP motion. In addition, LID-NMP domain interactions are indispensable for efficient catalysis. LID domain motion precedes NMP domain motion, during both opening and closing. These findings provide a mechanistic explanation for the observed 1: 1: 1 correspondence between LID domain closure, NMP domain closure, and substrate turnover. This catalytic cycle has likely evolved to reduce misligation, and thus inhibition, of AKE. The separation of allosteric motion into intrinsic structural fluctuations and ligand-induced contributions can be generalized to further our understanding of allosteric transitions in other proteins.	[Whitford, Paul C.; Gosavi, Shachi; Onuchic, Jose N.] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Whitford, Paul C.; Gosavi, Shachi; Onuchic, Jose N.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Onuchic, JN (corresponding author), Univ Calif San Diego, Ctr Theoret Biol Phys, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jonuchic@ucsd.edu			NIGMS NIH HHS [T32 GM08326] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008326] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bae E, 2006, P NATL ACAD SCI USA, V103, P2132, DOI 10.1073/pnas.0507527103; Bae E, 2004, J BIOL CHEM, V279, P28202, DOI 10.1074/jbc.M401865200; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; DIEDERICHS K, 1991, J MOL BIOL, V217, P541, DOI 10.1016/0022-2836(91)90756-V; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; FERSHT AR, 1994, CURR OPIN STRUC BIOL, V4, P67, DOI 10.1016/S0959-440X(94)90061-2; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; HORIUCHI T, 1991, PROTEINS, V10, P106, DOI 10.1002/prot.340100204; Kong YF, 2006, J MOL BIOL, V356, P237, DOI 10.1016/j.jmb.2005.10.064; Krishnamurthy H, 2005, PROTEINS, V58, P88, DOI 10.1002/prot.20301; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; Levy Y, 2005, J MOL BIOL, V346, P1121, DOI 10.1016/j.jmb.2004.12.021; Levy Y, 2005, P NATL ACAD SCI USA, V102, P2373, DOI 10.1073/pnas.0409572102; Lieser SA, 2006, J BIOL CHEM, V281, P38004, DOI 10.1074/jbc.M607824200; Lou HF, 2006, J PHYS CHEM B, V110, P24121, DOI 10.1021/jp064303c; Maragakis P, 2005, J MOL BIOL, V352, P807, DOI 10.1016/j.jmb.2005.07.031; MCLACHLAN AD, 1982, ACTA CRYSTALLOGR A, V38, P871, DOI 10.1107/S0567739482001806; Miyashita O, 2005, J PHYS CHEM B, V109, P1959, DOI 10.1021/jp046736q; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; Moritsugu K, 2004, J PHYS CHEM B, V108, P3890, DOI 10.1021/jp037155o; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Nymeyer H, 1998, P NATL ACAD SCI USA, V95, P5921, DOI 10.1073/pnas.95.11.5921; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; SANDERS CR, 1989, BIOCHEMISTRY-US, V28, P9028, DOI 10.1021/bi00449a011; Schlauderer GJ, 1996, J MOL BIOL, V256, P223, DOI 10.1006/jmbi.1996.0080; Sinev MA, 1996, BIOCHEMISTRY-US, V35, P6425, DOI 10.1021/bi952687j; Snow C, 2007, PROTEINS, V67, P325, DOI 10.1002/prot.21280; Sobolev V, 1996, PROTEINS, V25, P120, DOI 10.1002/(SICI)1097-0134(199605)25:1<120::AID-PROT10>3.3.CO;2-1; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Temiz NA, 2004, PROTEINS, V57, P468, DOI 10.1002/prot.20226; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Whitford PC, 2007, J MOL BIOL, V366, P1661, DOI 10.1016/j.jmb.2006.11.085; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Yang SC, 2004, P NATL ACAD SCI USA, V101, P13786, DOI 10.1073/pnas.0403724101	38	88	89	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2042	2048		10.1074/jbc.M707632200	http://dx.doi.org/10.1074/jbc.M707632200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17998210	hybrid			2022-12-25	WOS:000252501000031
J	Ernst, OP; Murcia, PAS; Daldrop, P; Tsunoda, SP; Kateriya, S; Hegemann, P				Ernst, Oliver P.; Murcia, Pedro A. Sanchez; Daldrop, Peter; Tsunoda, Satoshi P.; Kateriya, Suneel; Hegemann, Peter			Photoactivation of channelrhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; OPTICAL CONTROL; LIGHT; RHODOPSIN; CHLAMYDOMONAS; ACTIVATION; PHOTOISOMERIZATION; CHROMOPHORE; PHOTOTAXIS; RESPONSES	Channelrhodopsins (ChRs) are light-gated ion channels that control photomovement of microalgae. In optogenetics, ChRs are widely applied for light-triggering action potentials in cells, tissues, and living animals, yet the spectral properties and photocycle of ChR remain obscure. In this study, we cloned a ChR from the colonial alga Volvox carteri, VChR. After electrophysiological characterization in Xenopus oocytes, VChR was expressed in COS-1 cells and purified. Time-resolved UV-visible spectroscopy revealed a pH-dependent equilibrium of two dark species, D-470/D-480. Laser flashes converted both with tau approximate to 200 mu s into major photointermediates P-510/P-530, which reverted back to the dark states with tau approximate to 15-100 ms. Both intermediates were assigned to conducting states. Three early intermediates P-500/P-515 and P-390 were detected on a ns to mu s time scale. The spectroscopic and electrical data were unified in a photocycle model. The functional expression of VChR we report here paves the way toward a broader structure/function analysis of the recently identified class of light-gated ion channels.	[Ernst, Oliver P.; Murcia, Pedro A. Sanchez] Charite Univ Med Berlin, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Daldrop, Peter; Tsunoda, Satoshi P.; Hegemann, Peter] Humboldt Univ, Inst Biol Expt Biophys, D-10115 Berlin, Germany; [Kateriya, Suneel] Univ Delhi S Campus, Dept Biochem, New Delhi 110021, India	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; University of Delhi	Ernst, OP (corresponding author), Charite Univ Med Berlin, Inst Med Phys & Biophys, Charitepl 1, D-10117 Berlin, Germany.	oliver.ernst@charite.de; hegemape@rz.hu-berlin.de	Sánchez-Murcia, Pedro A./I-2473-2015; Sánchez-Murcia, Pedro Alejandro/AAM-6790-2020; Tsunoda, Satoshi/AAN-7023-2021; Daldrop, Peter/A-6001-2013	Sánchez-Murcia, Pedro A./0000-0001-8415-870X; Sánchez-Murcia, Pedro Alejandro/0000-0001-8415-870X; Tsunoda, Satoshi/0000-0003-3636-1521				Abbott A, 2007, NATURE, V446, P588, DOI 10.1038/446588a; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Braun FJ, 1999, BIOPHYS J, V76, P1668, DOI 10.1016/S0006-3495(99)77326-1; Ehlenbeck S, 2002, BIOPHYS J, V82, P740, DOI 10.1016/S0006-3495(02)75436-2; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; GROENENDIJK GWT, 1979, ANAL BIOCHEM, V99, P304, DOI 10.1016/S0003-2697(79)80011-1; Hausser M, 2007, NATURE, V446, P617, DOI 10.1038/446617a; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; HEGEMANN P, 1991, BIOPHYS J, V60, P1477, DOI 10.1016/S0006-3495(91)82183-X; Herlitze S, 2007, CURR OPIN NEUROBIOL, V17, P87, DOI 10.1016/j.conb.2006.12.002; Holland EM, 1996, BIOPHYS J, V70, P924, DOI 10.1016/S0006-3495(96)79635-2; Huber R, 2005, BIOCHEMISTRY-US, V44, P1800, DOI 10.1021/bi048318h; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; LAWSON MA, 1991, BIOPHYS J, V60, P1490, DOI 10.1016/S0006-3495(91)82184-1; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Meyer CK, 2000, J BIOL CHEM, V275, P19713, DOI 10.1074/jbc.M000603200; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nikolic Konstantin, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1626; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; SINESHCHEKOV OA, 1990, BIOPHYS J, V57, P33, DOI 10.1016/S0006-3495(90)82504-2; SINESHCHEKOV OA, 2006, HDB PHOTOSENSORY REC, P25; SONG L, 1993, SCIENCE, V261, P891, DOI 10.1126/science.261.5123.891; Tsunoda SP, 2006, BIOPHYS J, V91, P1471, DOI 10.1529/biophysj.106.086421; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	32	120	155	2	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1637	1643		10.1074/jbc.M708039200	http://dx.doi.org/10.1074/jbc.M708039200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17993465	hybrid			2022-12-25	WOS:000252282700050
J	Liden, A; van Wieringen, T; Lannergard, J; Kassner, A; Heinegard, D; Reed, RK; Guss, B; Rubin, K				Liden, Asa; van Wieringen, Tijs; Lannergard, Jonas; Kassner, Anja; Heinegard, Dick; Reed, Rolf K.; Guss, Bengt; Rubin, Kristofer			A secreted collagen- and fibronectin-binding streptococcal protein modulates cell-mediated collagen gel contraction and interstitial fluid pressure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BB; MOLECULAR-BASIS; EQUI; INTEGRIN; EDEMA; ALPHA(11)BETA(1); ALPHA(1)BETA(1); IDENTIFICATION; ADHERENCE; RECEPTOR	Fibroblast-mediated collagen gel contraction depends on collagen-binding beta 1 integrins. Perturbation of these integrins reveals an alternative contraction process that is integrin alpha V beta 3-dependent and platelet-derived growth factor ( PDGF) BB-stimulated. Connective tissue cells actively control interstitial fluid pressure (IFP), and inflammation-induced lowering of IFP provides a driving force for edema formation. PDGF-BB normalizes a lowered IFP by an alpha V beta 3-dependent process. A potential modulation of IFP by extracellular matrix-binding bacterial proteins has previously not been addressed. The fibronectin (FN)-binding protein FNE is specifically secreted by the highly virulent Streptococcus equi subspecies equi. FNE bound FN and native collagen type I with K-d values of similar to 20 and similar to 50 nM determined by solid-phase binding assays. Rotary shadowing revealed a single FNE binding site located at on average 122 nm from the C terminus of procollagen type I. FNE induced alpha V beta 3-mediated contraction by C2C12 cells in a concentration-dependent manner having a maximal effect at similar to 100 nM. This activity of FNE required cellular FN, and FNE acted synergistically to added plasma FN or PDGF-BB. FNE enhanced binding of soluble FN to immobilized collagen, and conversely the binding of collagen to immobilized FN. Marked bell-shaped concentration dependences for these interactions suggest that FNE forms a bridge between FN and collagen. Finally, FNE normalized dermal IFP lowered by anaphylaxis. Our data suggest that secreted FNE normalized lowering of IFP by stimulating connective tissue cell contraction.	[Liden, Asa; van Wieringen, Tijs; Rubin, Kristofer] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Liden, Asa; Reed, Rolf K.] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway; [Lannergard, Jonas; Guss, Bengt] Swedish Univ Agr Sci, Dept Microbiol, SE-75007 Uppsala, Sweden; [Kassner, Anja; Heinegard, Dick] Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden	Uppsala University; University of Bergen; Swedish University of Agricultural Sciences; Lund University	Rubin, K (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, BMC,Box 582, SE-75123 Uppsala, Sweden.	Kristofer.Rubin@imbim.uu.se	Reed, Rolf K./B-9422-2017; Lannergård, Jonas/L-6513-2013; Rubin, Kristofer/AAC-1810-2020	Reed, Rolf K./0000-0002-2633-6595; Rubin, Kristofer/0000-0003-2789-6276; Lannergard, Jonas/0000-0001-9072-6486; Guss, Bengt/0000-0002-7044-0701				Ahlen K, 1998, CELL ADHES COMMUN, V5, P461, DOI 10.3109/15419069809005604; AUKLAND K, 1993, PHYSIOL REV, V73, P1, DOI 10.1152/physrev.1993.73.1.1; Berg A, 1998, AM J PHYSIOL-HEART C, V274, pH663, DOI 10.1152/ajpheart.1998.274.2.H663; Berg A, 2001, AM J PHYSIOL-HEART C, V281, pH7, DOI 10.1152/ajpheart.2001.281.1.H7; Cooke ME, 2000, J CELL SCI, V113, P2375; ENGVALL E, 1978, J EXP MED, V147, P1584, DOI 10.1084/jem.147.6.1584; Grundstrom G, 2003, EXP CELL RES, V291, P463, DOI 10.1016/j.yexcr.2003.07.010; GULLBERG D, 1992, EMBO J, V11, P3865, DOI 10.1002/j.1460-2075.1992.tb05479.x; GULLBERG D, 1990, EXP CELL RES, V186, P264, DOI 10.1016/0014-4827(90)90305-T; Harrington DJ, 2002, MICROBES INFECT, V4, P501, DOI 10.1016/S1286-4579(02)01565-4; Heuchel R, 1999, P NATL ACAD SCI USA, V96, P11410, DOI 10.1073/pnas.96.20.11410; Hong KS, 2005, FEMS IMMUNOL MED MIC, V45, P231, DOI 10.1016/j.femsim.2005.04.006; KADLER KE, 1987, J BIOL CHEM, V262, P15696; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Lannergard J, 2005, INFECT IMMUN, V73, P7243, DOI 10.1128/IAI.73.11.7243-7251.2005; Liden A, 2006, CIRC RES, V98, P635, DOI 10.1161/01.RES.0000207393.67851.d4; Liden A, 2006, BIOCHEM BIOPH RES CO, V340, P604, DOI 10.1016/j.bbrc.2005.12.043; Lindmark H, 1999, INFECT IMMUN, V67, P2383, DOI 10.1128/IAI.67.5.2383-2388.1999; Lindmark H, 2001, INFECT IMMUN, V69, P3159, DOI 10.1128/IAI.69.5.3159-3163.2001; Lindmark H, 1996, INFECT IMMUN, V64, P3993, DOI 10.1128/IAI.64.10.3993-3999.1996; MIEKKA SI, 1982, THROMB RES, V27, P1, DOI 10.1016/0049-3848(82)90272-9; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; REED RK, 1992, CIRC RES, V71, P978, DOI 10.1161/01.RES.71.4.978; RODT SA, 1994, CIRC RES, V75, P942, DOI 10.1161/01.RES.75.5.942; Rodt SA, 1996, J PHYSIOL-LONDON, V495, P193, DOI 10.1113/jphysiol.1996.sp021584; RUBIN K, 1981, CELL, V24, P463, DOI 10.1016/0092-8674(81)90337-8; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Wiig H, 2003, ACTA ANAESTH SCAND, V47, P111, DOI 10.1034/j.1399-6576.2003.00050.x; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200	34	14	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1234	1242		10.1074/jbc.M704827200	http://dx.doi.org/10.1074/jbc.M704827200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18003607	hybrid			2022-12-25	WOS:000252282700006
J	Zhu, CH; Sato, M; Yanagisawa, T; Fujimoto, M; Tsubata, T				Zhu, Chenghua; Sato, Motohiko; Yanagisawa, Teruhiko; Fujimoto, Manabu; Tsubata, Takeshi			Novel binding site for src homology 2-containing protein-tyrosine phosphatase-1 in CD22 activated by B lymphocyte stimulation with antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED SIGNALS; NEGATIVE REGULATOR; CELL ACTIVATION; CD22-DEFICIENT MICE; SHP-1; PHOSPHORYLATION; LYN; DOMAINS; PATHWAY; REQUIREMENT	CD22, a B lymphocyte membrane glycoprotein, contains immunoreceptor tyrosine-based inhibition motifs (ITIMs) in the cytoplasmic region and recruits Src homology 2-containing protein-tyrosine phosphatase-1 (SHP-1) to the phosphorylated ITIMs upon ligation of B lymphocyte antigen receptor (BCR), thereby negatively regulating BCR signaling. Among the three previously identified ITIMs, both ITIMs containing tyrosine residues at position 843 (Tyr(843)) and 863 (Tyr(863)), respectively, are shown to be required for CD22 to recruit SHP-1 and regulate BCR signaling upon BCR ligation by anti-Ig antibody ( Ab), indicating that CD22 has the SHP-1-binding domain at the region containing Tyr(843) and Tyr(863). Here we address the requirement of CD22 for SHP-1 recruitment and BCR regulation upon BCR ligation by antigen, which induces much stronger CD22 phosphorylation than anti-Ig Ab does. We demonstrate that the CD22 mutant in which both Tyr(843) and Tyr(863) are replaced by phenylalanine (CD22F5/6) recruits SHP-1 and regulates BCR signaling upon stimulation with antigen but not anti-Ig Ab. This result strongly suggests that CD22 contains another SHP-1 binding domain that is specifically activated upon stimulation with antigen. Both of the flanking sequences of Tyr(783) and Tyr(817) fit the consensus sequence of ITIM, and the CD22F5/6 mutant requires these tyrosine residues for SHP-1 binding and BCR regulation. Thus, these ITIMs constitute a novel conditional SHP-1-binding site of CD22 that is activated upon BCR ligation by antigen but not by anti-Ig Ab.	[Zhu, Chenghua; Sato, Motohiko; Yanagisawa, Teruhiko; Tsubata, Takeshi] Tokyo Med & Dent Univ, Immunol Lab, Sch Biomed Sci, Bunkyo Ku, Tokyo 1138510, Japan; [Zhu, Chenghua; Sato, Motohiko; Yanagisawa, Teruhiko; Tsubata, Takeshi] Tokyo Med & Dent Univ, Dept Immunol, Med Res Inst, Tokyo 1138510, Japan; [Fujimoto, Manabu] Kanazawa Univ, Dept Dermatol, Grad Sch Med Sci, Kanazawa, Ishikawa 9208641, Japan; [Zhu, Chenghua; Tsubata, Takeshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Kanazawa University; Japan Science & Technology Agency (JST)	Tsubata, T (corresponding author), Tokyo Med & Dent Univ, Immunol Lab, Sch Biomed Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	tsubata.imm@mri.tmd.ac.jp	Tsubata, Takeshi/AAI-7489-2021	Tsubata, Takeshi/0000-0003-0760-1258; Fujimoto, Manabu/0000-0002-3062-4872				Blasioli J, 1999, J BIOL CHEM, V274, P2303, DOI 10.1074/jbc.274.4.2303; Chan VWF, 1998, CURR BIOL, V8, P545, DOI 10.1016/S0960-9822(98)70223-4; Chen J, 2004, NAT IMMUNOL, V5, P651, DOI 10.1038/ni1072; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Fujimoto M, 2006, J IMMUNOL, V176, P873, DOI 10.4049/jimmunol.176.2.873; Grignani F, 1998, CANCER RES, V58, P14; Hokazono Y, 2003, J IMMUNOL, V171, P1835, DOI 10.4049/jimmunol.171.4.1835; Law CL, 1996, J EXP MED, V183, P547, DOI 10.1084/jem.183.2.547; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nishizumi H, 1998, J EXP MED, V187, P1343, DOI 10.1084/jem.187.8.1343; Nitschke L, 2005, CURR OPIN IMMUNOL, V17, P290, DOI 10.1016/j.coi.2005.03.005; Nitschke L, 2004, TRENDS IMMUNOL, V25, P543, DOI 10.1016/j.it.2004.08.002; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Onishi M, 1996, EXP HEMATOL, V24, P324; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Otipoby KL, 2001, J BIOL CHEM, V276, P44315, DOI 10.1074/jbc.M105446200; Poe JC, 2000, J BIOL CHEM, V275, P17420, DOI 10.1074/jbc.M001892200; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; Smith KGC, 1998, J EXP MED, V187, P807, DOI 10.1084/jem.187.5.807; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Sweeney MC, 2005, BIOCHEMISTRY-US, V44, P14932, DOI 10.1021/bi051408h; THOMAS ML, 1995, J EXP MED, V181, P1953, DOI 10.1084/jem.181.6.1953; Tooze RM, 1997, IMMUNITY, V7, P59, DOI 10.1016/S1074-7613(00)80510-5; Wakabayashi C, 2002, SCIENCE, V298, P2392, DOI 10.1126/science.1076963; Yamanashi Y, 1997, J EXP MED, V185, P1387, DOI 10.1084/jem.185.7.1387; Yang J, 2003, J BIOL CHEM, V278, P6516, DOI 10.1074/jbc.M210430200; Yohannan J, 1999, J BIOL CHEM, V274, P18769, DOI 10.1074/jbc.274.26.18769; Yu J, 2007, BIOCHEM BIOPH RES CO, V360, P759, DOI 10.1016/j.bbrc.2007.06.110; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	33	10	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1653	1659		10.1074/jbc.M706584200	http://dx.doi.org/10.1074/jbc.M706584200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024433	hybrid			2022-12-25	WOS:000252282700052
J	D'Alessio, S; Ferrari, G; Cinnante, K; Scheerer, W; Galloway, AC; Roses, DF; Rozanov, DV; Remacle, AG; Oh, ES; Shiryaev, SA; Strongin, AY; Pintucci, G; Mignatti, P				D'Alessio, Silvia; Ferrari, Giovanni; Cinnante, Karma; Scheerer, William; Galloway, Aubrey C.; Roses, Daniel F.; Rozanov, Dmitri V.; Remacle, Albert G.; Oh, Eok-Soo; Shiryaev, Sergey A.; Strongin, Alex Y.; Pintucci, Giuseppe; Mignatti, Paolo			Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL EXTRACELLULAR-MATRIX; INVASIVE BREAST CARCINOMAS; ENDOTHELIAL-CELLS; TUMOR-CELLS; PRO-MMP-2 ACTIVATION; PROMOTING ACTIVITY; PEPTIDE SEQUENCE; CATALYTIC DOMAIN; MT1-MMP; TIMP-2	Membrane-type 1 matrix metalloproteinase (MT1-MMP), a transmembrane proteinase with a short cytoplasmic domain and an extracellular catalytic domain, controls a variety of physiological and pathological processes through the proteolytic degradation of extracellular or transmembrane proteins. MT1-MMP forms a complex on the cell membrane with its physiological protein inhibitor, tissue inhibitor of metalloproteinases-2 (TIMP-2). Here we show that, in addition to extracellular proteolysis, MT1-MMP and TIMP-2 control cell proliferation and migration through a non-proteolytic mechanism. TIMP-2 binding to MT1-MMP induces activation of ERK1/2 by a mechanism that does not require the proteolytic activity and is mediated by the cytoplasmic tail of MT1-MMP. MT1-MMP-mediated activation of ERK1/2 up-regulates cell migration and proliferation in vitro independently of extracellular matrix proteolysis. Proteolytically inactive MT1-MMP promotes tumor growth in vivo, whereas proteolytically active MT1-MMP devoid of cytoplasmic tail does not have this effect. These findings illustrate a novel role for MT1-MMP-TIMP-2 interaction, which controls cell functions by a mechanism independent of extracellular matrix degradation.	[D'Alessio, Silvia; Ferrari, Giovanni; Cinnante, Karma; Scheerer, William; Galloway, Aubrey C.; Pintucci, Giuseppe; Mignatti, Paolo] NYU, Sch Med, Dept Cardiothorac Surg, New York, NY 10016 USA; [Mignatti, Paolo] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Roses, Daniel F.] NYU, Sch Med, Dept Surg, New York, NY 10016 USA; [Rozanov, Dmitri V.; Remacle, Albert G.; Oh, Eok-Soo; Shiryaev, Sergey A.; Strongin, Alex Y.] Burnham Inst, Med Res, La Jolla, CA 92037 USA	New York University; New York University; New York University; Sanford Burnham Prebys Medical Discovery Institute	Mignatti, P (corresponding author), NYU, Ctr Med, 550 1St Ave, New York, NY 10016 USA.	mignap01@med.nyu.edu	Strongin, Alex/R-6609-2019; Danese, Silvio/ABH-9571-2020	Strongin, Alex/0000-0003-3765-3016; Danese, Silvio/0000-0001-7341-1351; Ferrari, Giovanni/0000-0002-8863-2496; Galoway, Aubrey/0000-0001-5461-3820; Mignatti, Paolo/0000-0002-8157-457X	NCI NIH HHS [CA 77470, CA 83017] Funding Source: Medline; NCRR NIH HHS [RR 020843] Funding Source: Medline; NHLBI NIH HHS [R01 HL 070203] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA083017, R01CA077470] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070203] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBINI A, 1991, J NATL CANCER I, V83, P775, DOI 10.1093/jnci/83.11.775; Alfonso-Jaume MA, 2006, AM J PHYSIOL-HEART C, V291, pH1838, DOI 10.1152/ajpheart.00026.2006; Anilkumar N, 2005, FASEB J, V19, P1326, DOI 10.1096/fj.04-3651fje; Apte SS, 1997, J BIOL CHEM, V272, P25511, DOI 10.1074/jbc.272.41.25511; Baker EA, 2006, BRIT J ORAL MAX SURG, V44, P482, DOI 10.1016/j.bjoms.2005.10.005; Cao J, 1998, J BIOL CHEM, V273, P34745, DOI 10.1074/jbc.273.52.34745; Cao J, 2004, J BIOL CHEM, V279, P14129, DOI 10.1074/jbc.M312120200; Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001; CORCORAN ML, 1995, J BIOL CHEM, V270, P13453, DOI 10.1074/jbc.270.22.13453; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Feldman AL, 2004, CANCER RES, V64, P4481, DOI 10.1158/0008-5472.CAN-03-2929; Filippov S, 2005, J EXP MED, V202, P663, DOI 10.1084/jem.20050607; Gingras D, 2001, FEBS LETT, V507, P231, DOI 10.1016/S0014-5793(01)02985-4; HAYAKAWA T, 1994, J CELL SCI, V107, P2373; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; Hoegy SE, 2001, J BIOL CHEM, V276, P3203, DOI 10.1074/jbc.M008157200; Holmbeck K, 2003, J CELL BIOL, V163, P661, DOI 10.1083/jcb.200307061; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; Labrecque L, 2004, J BIOL CHEM, V279, P52132, DOI 10.1074/jbc.M409617200; Lark AL, 2005, MODERN PATHOL, V18, P1289, DOI 10.1038/modpathol.3800424; Lehti K, 2000, J BIOL CHEM, V275, P15006, DOI 10.1074/jbc.M910220199; Lehti K, 2005, GENE DEV, V19, P979, DOI 10.1101/gad.1294605; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; Mignatti P, 2000, ADV CANCER RES, V78, P103; Murawaki Y, 1999, CLIN CHIM ACTA, V281, P109, DOI 10.1016/S0009-8981(98)00215-0; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Oblander SA, 2005, DEV BIOL, V277, P255, DOI 10.1016/j.ydbio.2004.09.033; Overall CM, 2000, J BIOL CHEM, V275, P39497, DOI 10.1074/jbc.M005932200; Pasieka Zbigniew, 2004, Endocr Regul, V38, P57; Pintucci G, 2003, J CELL BIOCHEM, V90, P1015, DOI 10.1002/jcb.10721; Pintucci G, 2002, FASEB J, V16, P598, DOI 10.1096/fj.01-0815fje; Potapova O, 1996, INT J CANCER, V66, P669, DOI 10.1002/(SICI)1097-0215(19960529)66:5<669::AID-IJC15>3.0.CO;2-#; Ratnikov B, 2000, ANAL BIOCHEM, V286, P149, DOI 10.1006/abio.2000.4798; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; Rozanov DV, 2003, J BIOL CHEM, V278, P8257, DOI 10.1074/jbc.M213246200; Rozanov DV, 2002, FEBS LETT, V527, P51, DOI 10.1016/S0014-5793(02)03153-8; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Seo DW, 2006, J BIOL CHEM, V281, P3711, DOI 10.1074/jbc.M509932200; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Sounni NE, 2004, J BIOL CHEM, V279, P13564, DOI 10.1074/jbc.M307688200; STETLERSTEVENSON WG, 1992, FEBS LETT, V296, P231, DOI 10.1016/0014-5793(92)80386-U; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Tsunezuka Y, 1996, CANCER RES, V56, P5678; Ueno H, 1997, CANCER RES, V57, P2055; Uhich D, 2004, PLAST RECONSTR SURG, V114, P229, DOI 10.1097/01.PRS.0000129079.19089.6C; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang ZP, 2000, J BIOL CHEM, V275, P26411, DOI 10.1074/jbc.M001270200; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	58	93	94	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					87	99		10.1074/jbc.M705492200	http://dx.doi.org/10.1074/jbc.M705492200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17991754	hybrid			2022-12-25	WOS:000251940300011
J	Brooke, GN; Parker, MG; Bevan, CL				Brooke, G. N.; Parker, M. G.; Bevan, C. L.			Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression	ONCOGENE			English	Article						androgen receptor; prostate cancer; co-activators; anti-androgens; SARMs	LIGAND-BINDING DOMAIN; MOLECULAR-MECHANISMS; CELL-GROWTH; WILD-TYPE; COREGULATORS; RECOGNITION; COFACTORS; MUTATION; LNCAP; FXXLF	Prostate tumour growth depends on androgens; hence treatment includes androgen ablation and anti-androgens. Eventually tumours progress and in approximately 30% of patients this is associated with mutation of the androgen receptor. Several receptor variants associated with advanced disease show promiscuous activation by other hormones and anti-androgens. Such loss of speci.city could promote receptor activation, hence tumour growth, in the absence of conventional ligands, explaining therapy failure. We aimed to elucidate mechanisms by which alternative ligands promote receptor activation. The three most commonly identified variants in tumours (with amino-acid substitutions H874Y, T877A and T877S) and wild-type receptor showed differences in co-activator recruitment dependent upon ligand and the interaction motif utilized. Co-expression and knockdown of co-activators that bind via leucine or phenylalanine motifs, combined with chromatin immunoprecipitation and quantitative PCR, revealed these preferences extend to co-activator recruitment in vivo and affect receptor activity at the transcriptional level, with subsequent effects on target gene regulation. The findings suggest that mutant receptors, activated by alternative ligands, drive growth via different mechanisms to androgenactivated wild-type receptor. Tumours may hence behave differently dependent upon any androgen receptor mutation present and what ligand is driving growth, as distinct subsets of genes may be regulated.	[Brooke, G. N.; Bevan, C. L.] Univ London Imperial Coll Sci Technol & Med, Androgen Signalling Lab, Dept Oncol, London W12 0NN, England; [Parker, M. G.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London W12 0NN, England	Imperial College London; Imperial College London	Bevan, CL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Androgen Signalling Lab, Dept Oncol, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.	charlotte.bevan@imperial.ac.uk	Brooke, Greg/C-9426-2013; Brooke, Greg/ABF-4859-2020; Bevan, Charlotte L/K-2276-2012; Bevan, Charlotte/T-7769-2019	Bevan, Charlotte L/0000-0002-7533-0552; Brooke, Greg/0000-0003-4501-4134	Medical Research Council Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agoulnik IU, 2005, CANCER RES, V65, P7959, DOI 10.1158/0008-5472.CAN-04-3541; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; BERREVOETS CA, 1993, J STEROID BIOCHEM, V46, P731, DOI 10.1016/0960-0760(93)90313-L; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Callewaert L, 2004, MOL ENDOCRINOL, V18, P1438, DOI 10.1210/me.2003-0313; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chmelar R, 2007, INT J CANCER, V120, P719, DOI 10.1002/ijc.22365; Dubbink HJ, 2004, MOL ENDOCRINOL, V18, P2132, DOI 10.1210/me.2003-0375; Duff J, 2005, MOL ENDOCRINOL, V19, P2943, DOI 10.1210/me.2005-0231; Estebanez-Perpina E, 2005, J BIOL CHEM, V280, P8060, DOI 10.1074/jbc.M407046200; Fujimoto N, 2001, UROLOGY, V58, P289, DOI 10.1016/S0090-4295(01)01117-7; Gamble SC, 2007, ONCOGENE, V26, P1757, DOI 10.1038/sj.onc.1209967; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Goktas S, 1999, SEMIN ONCOL, V26, P162; Gottlieb B, 2004, HUM MUTAT, V23, P527, DOI 10.1002/humu.20044; Gregory CW, 1998, CANCER RES, V58, P5718; Gregory CW, 2001, CANCER RES, V61, P4315; He B, 2002, J BIOL CHEM, V277, P25631, DOI 10.1074/jbc.M202809200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; Hsu CL, 2003, J BIOL CHEM, V278, P23691, DOI 10.1074/jbc.M211908200; Hu YC, 2004, J BIOL CHEM, V279, P33438, DOI 10.1074/jbc.M401781200; Hur E, 2004, PLOS BIOL, V2, P1303, DOI 10.1371/journal.pbio.0020274; Kalkhoven E, 1998, EMBO J, V17, P232, DOI 10.1093/emboj/17.1.232; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; Kazmin D, 2006, MOL ENDOCRINOL, V20, P1201, DOI 10.1210/me.2005-0309; Kemppainen JA, 1999, MOL ENDOCRINOL, V13, P440, DOI 10.1210/me.13.3.440; LI J, 2007, MOL ENDOCRINOL; Li P, 2002, AM J PATHOL, V161, P1467, DOI 10.1016/S0002-9440(10)64422-7; Li XT, 2003, MOL CELL BIOL, V23, P3763, DOI 10.1128/MCB.23.11.3763-3773.2003; Linja MJ, 2004, CLIN CANCER RES, V10, P1032, DOI 10.1158/1078-0432.CCR-0990-3; Linja MJ, 2001, CANCER RES, V61, P3550; Lu S, 1997, CANCER RES, V57, P4511; Maki HE, 2006, PROSTATE, V66, P1391, DOI 10.1002/pros.20427; Marcelli M, 2000, CANCER RES, V60, P944; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; McDonald S, 2000, CANCER RES, V60, P2317; McEwan IJ, 2004, ENDOCR-RELAT CANCER, V11, P281, DOI 10.1677/erc.0.0110281; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Mestayer C, 2003, PROSTATE, V56, P192, DOI 10.1002/pros.10229; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Miyamoto H, 1998, P NATL ACAD SCI USA, V95, P7379, DOI 10.1073/pnas.95.13.7379; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Ozers MS, 2007, BIOCHEMISTRY-US, V46, P683, DOI 10.1021/bi061321b; Powell SM, 2004, ENDOCR-RELAT CANCER, V11, P117, DOI 10.1677/erc.0.0110117; Rogatsky I, 2001, EMBO J, V20, P6071, DOI 10.1093/emboj/20.21.6071; Segal S, 2006, EXPERT OPIN INV DRUG, V15, P377, DOI 10.1517/13543784.15.4.377; Steketee K, 2002, INT J CANCER, V100, P309, DOI 10.1002/ijc.10495; Taplin ME, 2007, NAT CLIN PRACT ONCOL, V4, P236, DOI 10.1038/ncponc0765; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Ulrix W, 1999, FEBS LETT, V455, P23, DOI 10.1016/S0014-5793(99)00845-5; van de Wijngaart DJ, 2006, J BIOL CHEM, V281, P19407, DOI 10.1074/jbc.M602567200; VELDSCHOLTE J, 1994, J STEROID BIOCHEM, V49, P341, DOI 10.1016/0960-0760(94)90277-1; Verrijdt G, 2003, MOL GENET METAB, V78, P175, DOI 10.1016/S1096-7192(03)00003-9; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922	55	62	64	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 8	2008	27	21					2941	2950		10.1038/sj.onc.1210955	http://dx.doi.org/10.1038/sj.onc.1210955			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	298IP	18037956	Green Submitted			2022-12-25	WOS:000255681700001
J	Nakamura, K; Ichise, H; Nakao, K; Hatta, T; Otani, H; Sakagami, H; Kondo, H; Katsuki, M				Nakamura, K.; Ichise, H.; Nakao, K.; Hatta, T.; Otani, H.; Sakagami, H.; Kondo, H.; Katsuki, M.			Partial functional overlap of the three ras genes in mouse embryonic development	ONCOGENE			English	Article						H-Ras; N-Ras; K-Ras; gene targeting; knockout mice; transgenic mice	H-RAS; K-RAS; PLASMA-MEMBRANE; N-RAS; EXPRESSION; LOCALIZATION; PROTEIN; GROWTH; CELLS; MICE	In mammals, three ras genes, H-ras, N-ras and K-ras, encode homologous but distinct 21-kDa Ras proteins. We examined the in vivo functional relationship of the three ras genes in mouse embryonic development by investigating the phenotypes of mice deficient in one or multiple ras genes. H-ras(-/-) mice and N-ras(-/-) mice as well as a substantial proportion of H-ras(-/-)/N-ras(-/-) mice expressing only the K-ras gene were viable, while K-ras(-/-) mice were embryonically lethal, as have been reported previously. N-ras(-/-)/K-ras(+/-) mice died neonatally, while H-ras(-/-)/K-ras(-/-) embryos died much earlier than K-ras homozygous mutant fetuses. To further investigate the functional relationship of the ras genes in embryonic development, we introduced a human H-ras transgene into single or multiple ras mutant mice and found that the transgene rescued mice, including triple ras mutants, from embryonic lethality in association with correction of thin ventricular walls of the heart in null K-ras mutant mice. In situ hybridization revealed that the expression of the H-ras transgene on embryonic day E13.5 and E15.5 was more intense in major organs, including the heart, than those of endogenous ras genes. We therefore conclude that the functions of the ras genes are partially overlapping in mouse embryonic development.	[Nakamura, K.] Mitsubishi kagaku Inst Life Sci, Mouse Genome Technol Lab, Tokyo, Japan; [Ichise, H.] Univ Tokyo, Lab Gene Express & Regulat, Ctr Med Expt, Inst Med Sci,Minato Ku, Tokyo, Japan; [Nakao, K.] Ctr Dev Biol, Lab Anim Resources & Genet Engn, Chuo Ku, Kobe, Hyogo, Japan; [Hatta, T.; Otani, H.] Shimane Univ, Fac Med, Dept Anat, Izumo, Shimane, Japan; [Sakagami, H.; Kondo, H.] Tohoku Univ, Div Histol, Dept Cell Biol, Grad Sch Med Sci, Sendai, Miyagi 980, Japan; [Katsuki, M.] Natl Inst Basic Biol, Okazaki, Aichi 444, Japan	Mitsubishi Kagaku Institute of Life Sciences (MITILS); University of Tokyo; Shimane University; Tohoku University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Katsuki, M (corresponding author), Natl Inst Nat Sci, Minato Ku, Toranomon 4-3-13, Tokyo 1050001, Japan.	katsuki@nibb.ac.jp	Ichise, Hirotake/V-3536-2019	Ichise, Hirotake/0000-0002-3424-6637; zhong wei, he gui/0000-0002-3066-3564				Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; BALMAIN A, 1988, ADV CANCER RES, V51, P147, DOI 10.1016/S0065-230X(08)60222-5; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOS JL, 1989, CANCER RES, V49, P4682; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; HENKEMEYER M, 1995, NATURE, V377, P695, DOI 10.1038/377695a0; Ise K, 2000, ONCOGENE, V19, P2951, DOI 10.1038/sj.onc.1203600; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Jones MK, 1998, J BIOL CHEM, V273, P1782, DOI 10.1074/jbc.273.3.1782; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; LEON J, 1987, MOL CELL BIOL, V7, P1535, DOI 10.1128/MCB.7.4.1535; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MAHER J, 1995, ONCOGENE, V11, P1639; Malumbres M, 1998, FRONT BIOSCI-LANDMRK, V3, P887; Manabe T, 2000, J NEUROSCI, V20, P2504; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; Perez de Castro I, 2003, CANCER RES, V63, P1615; Plowman SJ, 2005, BBA-MOL CELL RES, V1746, P274, DOI 10.1016/j.bbamcr.2005.06.004; Plowman SJ, 2003, MOL CELL BIOL, V23, P9245, DOI 10.1128/MCB.23.24.9245-9250.2003; Potenza N, 2005, EMBO REP, V6, P432, DOI 10.1038/sj.embor.7400397; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; SAITOH A, 1990, ONCOGENE, V5, P1195; UMANOFF H, 1995, P NATL ACAD SCI USA, V92, P1709, DOI 10.1073/pnas.92.5.1709; WILLINGHAM MC, 1980, CELL, V19, P1005, DOI 10.1016/0092-8674(80)90091-4; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Yamaguchi H, 1996, GENES CELLS, V1, P253, DOI 10.1046/j.1365-2443.1996.d01-238.x	30	29	30	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 8	2008	27	21					2961	2968		10.1038/sj.onc.1210956	http://dx.doi.org/10.1038/sj.onc.1210956			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	298IP	18059342				2022-12-25	WOS:000255681700003
J	Persson, F; Winnes, M; Andren, Y; Wedell, B; Dahlenfors, R; Asp, J; Mark, J; Enlund, F; Stenman, G				Persson, F.; Winnes, M.; Andren, Y.; Wedell, B.; Dahlenfors, R.; Asp, J.; Mark, J.; Enlund, F.; Stenman, G.			High-resolution array CGH analysis of salivary gland tumors reveals fusion and amplification of the FGFR1 and PLAG1 genes in ring chromosomes	ONCOGENE			English	Article						array-CGH; gene amplification; fusion oncogene; FGFR1; PLAG1; salivary gland tumor	COMPARATIVE GENOMIC HYBRIDIZATION; DIFFERENTIAL EXPRESSION; PLEOMORPHIC ADENOMAS; IN-VITRO; CANCER; REARRANGEMENTS; TRANSLOCATION; DELETIONS; PROTEIN; BREAST	We have previously identified a subgroup of pleomorphic salivary gland adenomas with ring chromosomes of uncertain derivation. Here, we have used spectral karyotyping (SKY), fluorescence in situ hybridization (FISH) and high-resolution oligonucleotide array-CGH to determine the origin and content of these rings and to identify genes disrupted as a result of ring formation. Of 16 tumors with rings, 11 were derived from chromosome 8, 3 from chromosome 5 and 1 each from chromosomes 1, 6 and 9. Array-CGH revealed that 10/11 r(8) consisted of amplification of a 19Mb pericentromeric segment with recurrent breakpoints in FGFR1 in 8p12 and in PLAG1 in 8q12.1. Molecular analyses revealed that ring formation consistently generated novel FGFR1-PLAG1 gene fusions in which the 5'-part of FGFR1 is linked to the coding sequence of PLAG1. An alternative mechanism of PLAG1 activation was found in tumors with copy number gain of an intact PLAG1 gene. Rings derived from chromosomes 1, 5, 6 or 9 did not result in gene fusions, but rather resulted in losses indicative of the involvement of putative tumor suppressor genes on 8p, 5p, 5q and/or 6q. Our findings also reveal a novel mechanism by which FGFR1 contributes to oncogenesis and further illustrate the versatility of the FGFR1 and PLAG1 genes tumorigenesis.	[Persson, F.; Winnes, M.; Andren, Y.; Wedell, B.; Asp, J.; Enlund, F.; Stenman, G.] Sahlgrens Univ Hosp, Dept Pathol, Lundberg Lab Canc Res, SE-41345 Gothenburg, Sweden; [Dahlenfors, R.; Mark, J.] Cent Hosp Skovde, Dept Pathol, Skovde, Sweden	Sahlgrenska University Hospital	Stenman, G (corresponding author), Sahlgrens Univ Hosp, Dept Pathol, Lundberg Lab Canc Res, SE-41345 Gothenburg, Sweden.	goran.stenman@llcr.med.gu.se	Asp, Julia/AAE-5624-2019	Enlund, Fredrik/0000-0003-0030-9393				Abbott JJ, 2006, MODERN PATHOL, V19, P1512, DOI 10.1038/modpathol.3800695; Asp J, 2006, GENE CHROMOSOME CANC, V45, P820, DOI 10.1002/gcc.20346; Astrom AK, 1999, CANCER RES, V59, P918; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; Brennan C, 2004, CANCER RES, V64, P4744, DOI 10.1158/0008-5472.CAN-04-1241; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; EVESON JW, 2005, WHO CLASSIFICATION T, P254; Geurts JMW, 1997, CANCER RES, V57, P13; Gisselsson D, 1999, HUM GENET, V104, P315, DOI 10.1007/s004390050960; Gisselsson D, 2000, P NATL ACAD SCI USA, V97, P5357, DOI 10.1073/pnas.090013497; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; Hoffman MP, 2002, DEVELOPMENT, V129, P5767, DOI 10.1242/dev.00172; Hughes SE, 1997, J HISTOCHEM CYTOCHEM, V45, P1005, DOI 10.1177/002215549704500710; Johansson B, 2002, ACTA HAEMATOL-BASEL, V107, P76, DOI 10.1159/000046636; Kas K, 1998, J BIOL CHEM, V273, P23026, DOI 10.1074/jbc.273.36.23026; Kas K, 1997, NAT GENET, V15, P170, DOI 10.1038/ng0297-170; Kok K, 1997, ADV CANCER RES, V71, P27, DOI 10.1016/S0065-230X(08)60096-2; Kost-Alimova M, 2003, P NATL ACAD SCI USA, V100, P6622, DOI 10.1073/pnas.0430971100; Kost-Alimova M, 2007, SEMIN CANCER BIOL, V17, P19, DOI 10.1016/j.semcancer.2006.11.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARK J, 1988, CANCER GENET CYTOGEN, V33, P229, DOI 10.1016/0165-4608(88)90033-7; Mark J, 1997, CANCER GENET CYTOGEN, V95, P9, DOI 10.1016/S0165-4608(96)00204-X; MARK J, 1983, ACTA PATH MICRO IM A, V91, P397; Nakao K, 2004, CARCINOGENESIS, V25, P1345, DOI 10.1093/carcin/bgh134; NORDKVIST A, 1994, GENE CHROMOSOME CANC, V10, P115, DOI 10.1002/gcc.2870100206; Pole JCM, 2006, ONCOGENE, V25, P5693, DOI 10.1038/sj.onc.1209570; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Reis JS, 2006, CLIN CANCER RES, V12, P6652, DOI 10.1158/1078-0432.CCR-06-1164; Roijer E, 2002, AM J PATHOL, V160, P433, DOI 10.1016/S0002-9440(10)64862-6; Roumiantsev S, 2004, CANCER CELL, V5, P287, DOI 10.1016/S1535-6108(04)00053-4; SCHOENMAKERS EFPM, 1995, NAT GENET, V10, P436, DOI 10.1038/ng0895-436; Sjogren H, 2000, CANCER RES, V60, P6832; Stenman G, 2005, SEMIN CANCER BIOL, V15, P224, DOI 10.1016/j.semcancer.2005.01.002; Ugolini F, 1999, ONCOGENE, V18, P1903, DOI 10.1038/sj.onc.1202739; Voz ML, 1998, ONCOGENE, V16, P1409, DOI 10.1038/sj.onc.1201660; Voz ML, 2004, ONCOGENE, V23, P179, DOI 10.1038/sj.onc.1207013; Xiao S, 1998, NAT GENET, V18, P84, DOI 10.1038/ng0198-84	38	50	50	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 8	2008	27	21					3072	3080		10.1038/sj.onc.1210961	http://dx.doi.org/10.1038/sj.onc.1210961			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	298IP	18059337				2022-12-25	WOS:000255681700015
J	Rottmann, S; Speckgens, S; Luscher-Firzlaff, J; Luscher, B				Rottmann, Sabine; Speckgens, Stefanie; Luescher-Firzlaff, Juliane; Luescher, Bernhard			Inhibition of apoptosis by MAD1 is mediated lay repression of the PTEN tumor suppression gene	FASEB JOURNAL			English	Article						AKT; MYC; PI3K; transcription	NF-KAPPA-B; MYC ANTAGONIST MAD1; TRANSCRIPTIONAL REPRESSOR; MYC/MAX/MAD NETWORK; CELL-GROWTH; MAX NETWORK; CYCLIN D2; E-BOX; PROTEIN; EXPRESSION	The MYC/MAX/MAD network of transcriptional regulators controls distinct aspects of cell physiology, including cell proliferation and apoptosis. Within the network MAD proteins antagonize the functions of MYC oncoproteins, and the latter are deregulated in the majority of human cancers. While MYC sensitizes cells to proapoptotic signals, the transcriptional repressor MAD1 inhibits apoptosis in response to a broad range of stimuli, including oncoproteins. The molecular targets of MAD1 that mediate inhibition of apoptosis are not known. Here we describe the phosphatase and tensin homologue deleted on chromosome ten (PTEN) tumor suppressor gene as a target of MAD1. By binding to the proximal promoter region, MAD I downregulated PTEN expression. PTEN functions as a lipid phosphatase that regulates the phosphatidylinositol 3-kinase/AKT pathway. Indeed MAD1-dependent repression of PTEN led to activation of AKT and subsequent stimulation of the antiapoptotic NF-kappa B pathway. Interfering with AKT function affected the control of Fas-induced apoptosis by MAD1. In addition, knockdown of PTEN using small interfering RNA (siRNA) or the lack of PTEN rendered cells insensitive to inhibition of apoptosis by MAD1. These findings identify the PTEN gene as a target of the MYC-antagonist MAD1 and provide a molecular framework critical for the ability of MAD1 to inhibit apoptosis.	[Rottmann, Sabine; Speckgens, Stefanie; Luescher-Firzlaff, Juliane; Luescher, Bernhard] Rhein Westfal TH Aachen, Univ Klinikum, Inst Biochem, Abt Biochem & Molekularbiol, D-52074 Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	Luscher, B (corresponding author), Rhein Westfal TH Aachen, Univ Klinikum, Inst Biochem, Abt Biochem & Molekularbiol, Pauwelsstr 30, D-52074 Aachen, Germany.	luescher@rwth-aachen.de	Luscher, Bernhard/A-7330-2011	Luscher, Bernhard/0000-0002-9622-8709				AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; Baudino TA, 2001, MOL CELL BIOL, V21, P691, DOI 10.1128/MCB.21.3.691-702.2001; Bejarano MT, 2000, EXP CELL RES, V260, P61, DOI 10.1006/excr.2000.4996; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Bouchard C, 2001, GENE DEV, V15, P2042, DOI 10.1101/gad.907901; CERNI C, 1995, ONCOGENE, V11, P587; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Foley KP, 1998, EMBO J, V17, P774, DOI 10.1093/emboj/17.3.774; Gehring S, 2000, J BIOL CHEM, V275, P10413, DOI 10.1074/jbc.275.14.10413; Grandori C, 1997, TRENDS BIOCHEM SCI, V22, P177, DOI 10.1016/S0968-0004(97)01025-6; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; Hettinger K, 2007, CELL DEATH DIFFER, V14, P218, DOI 10.1038/sj.cdd.4401946; Holzel M, 2001, EMBO REP, V2, P1125, DOI 10.1093/embo-reports/kve251; Hurlin PJ, 2003, EMBO J, V22, P4584, DOI 10.1093/emboj/cdg442; HURLIN PJ, 1995, EMBO J, V14, P5646, DOI 10.1002/j.1460-2075.1995.tb00252.x; Hurlin PJ, 1997, GENE DEV, V11, P44, DOI 10.1101/gad.11.1.44; Iritani BM, 2002, EMBO J, V21, P4820, DOI 10.1093/emboj/cdf492; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Li WQ, 1999, ONCOGENE, V18, P6564, DOI 10.1038/sj.onc.1203065; Luscher B, 1999, ONCOGENE, V18, P2955, DOI 10.1038/sj.onc.1202750; Luscher B, 2001, GENE, V277, P1, DOI 10.1016/S0378-1119(01)00697-7; Luscher-Firzlaff JM, 1999, ONCOGENE, V18, P5620, DOI 10.1038/sj.onc.1202967; Meroni G, 1997, EMBO J, V16, P2892, DOI 10.1093/emboj/16.10.2892; Neiman PE, 2001, P NATL ACAD SCI USA, V98, P6378, DOI 10.1073/pnas.111144898; Nilsson JA, 2004, MOL CELL BIOL, V24, P1560, DOI 10.1128/MCB.24.4.1560-1569.2004; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Patel L, 2001, CURR BIOL, V11, P764, DOI 10.1016/S0960-9822(01)00225-1; Perkins ND, 2004, TRENDS CELL BIOL, V14, P64, DOI 10.1016/j.tcb.2003.12.004; Pezzolesi MG, 2007, HUM MOL GENET, V16, P1058, DOI 10.1093/hmg/ddm053; Queva C, 1999, CELL GROWTH DIFFER, V10, P785; Queva C, 2001, MOL CELL BIOL, V21, P703, DOI 10.1128/MCB.21.3.703-712.2001; Rohn JL, 1998, ONCOGENE, V17, P2811, DOI 10.1038/sj.onc.1202393; Rottmann S, 2006, CURR TOP MICROBIOL, V302, P63; ROTTMANN S, 2003, THESIS U HANNOVER GE; Sommer A, 1997, CURR BIOL, V7, P357, DOI 10.1016/S0960-9822(06)00183-7; Sommer A, 1998, J BIOL CHEM, V273, P6632, DOI 10.1074/jbc.273.12.6632; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Strutt H, 1999, METH MOL B, V119, P455; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Vasudevan KM, 2004, MOL CELL BIOL, V24, P1007, DOI 10.1128/MCB.24.3.1007-1021.2004; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Whelan JT, 2007, CELL CYCLE, V6, P80, DOI 10.4161/cc.6.1.3648; Zbuk KM, 2007, NAT REV CANCER, V7, P35, DOI 10.1038/nrc2037; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A; Zhou XP, 2003, AM J HUM GENET, V73, P404, DOI 10.1086/377109; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	55	6	7	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2008	22	4					1124	1134		10.1096/fj.07-9627com	http://dx.doi.org/10.1096/fj.07-9627com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	17998413				2022-12-25	WOS:000254581000018
J	Beck, EJ; Yang, Y; Yaemsiri, S; Raghuram, V				Beck, Edward J.; Yang, Yu; Yaemsiri, Sirin; Raghuram, Viswanathan			Conformational changes in a pore-lining helix coupled to cystic fibrosis transmembrane conductance regulator channel gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CFTR CHLORIDE CHANNEL; ACETYLCHOLINE-RECEPTOR CHANNEL; NUCLEOTIDE-BINDING DOMAIN; ABC TRANSPORTER; P-GLYCOPROTEIN; ANION-BINDING; CL-CHANNELS; CYSTEINE; MECHANISM; SITE	Cystic fibrosis transmembrane conductance regulator (CFTR), the protein dysfunctional in cystic fibrosis, is unique among ATP-binding cassette transporters in that it functions as an ion channel. In CFTR, ATP binding opens the channel, and its subsequent hydrolysis causes channel closure. We studied the conformational changes in the pore-lining sixth transmembrane segment upon ATP binding by measuring state-dependent changes in accessibility of substituted cysteines to methanethiosulfonate reagents. Modification rates of three residues (resides 331, 333, and 335) near the extracellular side were 10-1000-fold slower in the open state than in the closed state. Introduction of a charged residue by chemical modification at two of these positions (resides 331 and 333) affected CFTR single-channel gating. In contrast, modifications of pore-lining residues 334 and 338 were not state-dependent. Our results suggest that ATP binding induces a modest conformational change in the sixth transmembrane segment, and this conformational change is coupled to the gating mechanism that regulates ion conduction. These results may establish a structural basis of gating involving the dynamic rearrangement of transmembrane domains necessary for vectorial transport of substrates in ATP-binding cassette transporters.	[Beck, Edward J.; Yang, Yu; Yaemsiri, Sirin; Raghuram, Viswanathan] NHLBI, Kidney & Electrolyte Metab Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Raghuram, V (corresponding author), NHLBI, Kidney & Electrolyte Metab Lab, NIH, 9000 Rockville Pike,Bldg 10,Rm 7D13, Bethesda, MD 20892 USA.	raghuramv@mail.nih.gov			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL001286, ZIAHL001286] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Al-Nakkash L, 1999, PFLUG ARCH EUR J PHY, V437, P553, DOI 10.1007/s004240050817; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Cheung M, 1996, BIOPHYS J, V70, P2688, DOI 10.1016/S0006-3495(96)79838-7; Csanady L, 2000, BIOPHYS J, V78, P785, DOI 10.1016/S0006-3495(00)76636-7; Csanady L, 2006, J GEN PHYSIOL, V128, P523, DOI 10.1085/jgp.200609558; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Dawson David C., 1999, Physiological Reviews, V79, pS47; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gong XD, 2003, J PHYSIOL-LONDON, V549, P387, DOI 10.1113/jphysiol.2002.038232; Gupta J, 2003, MOL MEMBR BIOL, V20, P45, DOI 10.1080/0968031000045824; HASEGAWA H, 1992, SCIENCE, V258, P1477, DOI 10.1126/science.1279809; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; HWANG TC, 1994, P NATL ACAD SCI USA, V91, P4698, DOI 10.1073/pnas.91.11.4698; Linsdell P, 2006, EXP PHYSIOL, V91, P123, DOI 10.1113/expphysiol.2005.031757; Linsdell P, 2005, J BIOL CHEM, V280, P8945, DOI 10.1074/jbc.M414354200; LINTON KJ, 2007, PFLUG ARCH EUR J PHY, V453, P355; Liu XH, 2004, BIOPHYS J, V87, P3826, DOI 10.1529/biophysj.104.050534; Liu XH, 2001, J GEN PHYSIOL, V118, P433, DOI 10.1085/jgp.118.4.433; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Mansoura MK, 1998, BIOPHYS J, V74, P1320, DOI 10.1016/S0006-3495(98)77845-2; McCarty NA, 2000, J EXP BIOL, V203, P1947; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Ramjeesingh M, 1999, BIOCHEMISTRY-US, V38, P1463, DOI 10.1021/bi982243y; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Rosenberg MF, 2003, J BIOL CHEM, V278, P8294, DOI 10.1074/jbc.M211758200; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Smith SS, 2001, J GEN PHYSIOL, V118, P407, DOI 10.1085/jgp.118.4.407; Stratford FLL, 2007, BIOCHEM J, V401, P581, DOI 10.1042/BJ20060968; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wilkinson DJ, 1996, J GEN PHYSIOL, V107, P103, DOI 10.1085/jgp.107.1.103; Wilson GG, 2000, J GEN PHYSIOL, V115, P93, DOI 10.1085/jgp.115.2.93; Zhang ZR, 2005, J BIOL CHEM, V280, P41997, DOI 10.1074/jbc.M510242200	38	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4957	4966		10.1074/jbc.M702235200	http://dx.doi.org/10.1074/jbc.M702235200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18056267	hybrid			2022-12-25	WOS:000253426500053
J	Hellman, NE; SpectorO, J; Robinson, J; Zuo, XF; Saunier, S; Antignac, C; Tobias, JW; Lipschutz, JH				Hellman, Nathan E.; SpectorO, June; Robinson, Jonathan; Zuo, Xiaofeng; Saunier, Sophie; Antignac, Corinne; Tobias, John W.; Lipschutz, Joshua H.			Matrix metalloproteinase 13 (MMP13) and tissue inhibitor of matrix metalloproteinase 1 (TIMP1), regulated by the MAPK pathway, are both necessary for Madin-Darby canine kidney tubulogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; POLARIZED EPITHELIAL-CELLS; MATRIX METALLOPROTEINASES; IN-VITRO; BRANCHING MORPHOGENESIS; COLLAGEN ACCUMULATION; RNA INTERFERENCE; MOUSE KIDNEY; MDCK CELLS; LINE MDCK	A classic model of tubulogenesis utilizes Madin-Darby canine kidney (MDCK) cells. MDCK cells form monoclonal cysts in three-dimensional collagen and tubulate in response to hepatocyte growth factor, which activates multiple signaling pathways, including the mitogen-activated protein kinase (MAPK) pathway. It was shown previously that MAPK activation is necessary and sufficient to induce the first stage of tubulogenesis, the partial epithelial to mesenchymal transition (p-EMT), whereas matrix metalloproteinases (MMPs) are necessary for the second redifferentiation stage. To identify specific MMP genes, their regulators, tissue inhibitors of matrix metalloproteinases (TIMPs), and the molecular pathways by which they are activated, we used two distinct MAPK inhibitors and a technique we have termed subtraction pathway microarray analysis. Of the 19 MMPs and 3 TIMPs present on the Canine Genome 2.0 Array, MMP13 and TIMP1 were up-regulated 198- and 169-fold, respectively, via the MAPK pathway. This was confirmed by two-dimensional and three-dimensional real time PCR, as well as in MDCK cells inducible for the MAPK gene Raf. Knockdown of MMP13 using short hairpin RNA prevented progression past the initial phase of p-EMT. Knockdown of TIMP1 prevented normal cystogenesis, although the initial phase of p-EMT did occasionally occur. The MMP13 knockdown phenotype is likely because of decreased collagenase activity, whereas the TIMP1 knockdown phenotype appears due to increased apoptosis. These data suggest a model, which may also be important for development of other branched organs, whereby the MAPK pathway controls both MDCK p-EMT and redifferentiation, in part by activating MMP13 and TIMP1.	[Hellman, Nathan E.; SpectorO, June; Robinson, Jonathan; Zuo, Xiaofeng; Lipschutz, Joshua H.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Lipschutz, Joshua H.] Univ Penn, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA; [Lipschutz, Joshua H.] Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Saunier, Sophie; Antignac, Corinne] Univ Paris 05, Hop Necker Enfants Malades, INSERM, U 574, F-75015 Paris, France; [Tobias, John W.] Univ Penn, Genom Inst Bioinformat Core, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania	Lipschutz, JH (corresponding author), 431 Hill Pavil,380 S Univ Ave, Philadelphia, PA 19104 USA.	jhlipsch@mail.med.upenn.edu	ANTIGNAC, Corinne/H-8945-2017; Saunier, Sophie/G-6044-2015	ANTIGNAC, Corinne/0000-0002-9934-4940; Saunier, Sophie/0000-0002-1069-0047	NIDDK NIH HHS [DK069909, DK070980] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK070980, R01DK069909] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Balkovetz DF, 2004, AM J PHYSIOL-RENAL, V286, pF702, DOI 10.1152/ajprenal.00270.2003; Balkovetz DF, 1999, INT REV CYTOL, V186, P225; Balkovetz DF, 1997, J BIOL CHEM, V272, P3471, DOI 10.1074/jbc.272.6.3471; Balkovetz DF, 1999, KIDNEY INT, V56, P910, DOI 10.1046/j.1523-1755.1999.00623.x; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Chaillan FA, 2006, BEHAV BRAIN RES, V173, P191, DOI 10.1016/j.bbr.2006.06.020; CREPALDI T, 1994, J CELL BIOL, V125, P313, DOI 10.1083/jcb.125.2.313; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; EKBLOM P, 1992, KIDNEY PHYSL PATHOPH, P475; Fisher CE, 2001, DEVELOPMENT, V128, P4329; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Gabay L, 1997, DEVELOPMENT, V124, P3535; GUMBINER BM, 1992, CELL, V69, P385, DOI 10.1016/0092-8674(92)90440-N; Hansen SH, 2000, MOL CELL BIOL, V20, P9364, DOI 10.1128/MCB.20.24.9364-9375.2000; Hellman NE, 2005, AM J PHYSIOL-RENAL, V289, pF777, DOI 10.1152/ajprenal.00429.2004; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Kanwar YS, 1999, AM J PHYSIOL-RENAL, V277, pF934, DOI 10.1152/ajprenal.1999.277.6.F934; Lee MM, 2005, INFECT IMMUN, V73, P661, DOI 10.1128/IAI.73.1.661-665.2005; Legallicier B, 2001, J AM SOC NEPHROL, V12, P2358, DOI 10.1681/ASN.V12112358; LEIGHTON J, 1970, CANCER-AM CANCER SOC, V26, P1022, DOI 10.1002/1097-0142(197011)26:5<1022::AID-CNCR2820260509>3.0.CO;2-M; Lipschutz JH, 2003, J BIOL CHEM, V278, P20954, DOI 10.1074/jbc.M213210200; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; Lipschutz JH, 2007, AM J PHYSIOL-RENAL, V293, pF985, DOI 10.1152/ajprenal.00292.2007; Liu XW, 2005, CANCER RES, V65, P898; Liu Z, 2007, BIOCHEM BIOPH RES CO, V353, P793, DOI 10.1016/j.bbrc.2006.12.106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MADIN SH, 1957, AM J VET RES, V18, P932; McAteer J A, 1986, Scan Electron Microsc, P1135; MCATEER JA, 1987, ANAT REC, V217, P229, DOI 10.1002/ar.1092170303; MCATEER JA, 1988, SCANNING MICROSCOPY, V2, P1739; Mohammed FF, 2005, HEPATOLOGY, V41, P857, DOI 10.1002/hep.20618; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; Nakopoulou L, 2007, NEPHROL DIAL TRANSPL, V22, P109, DOI 10.1093/ndt/gfl618; O'Brien LE, 2004, DEV CELL, V7, P21, DOI 10.1016/j.devcel.2004.06.001; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pollack AL, 1998, DEV BIOL, V204, P64, DOI 10.1006/dbio.1998.9091; RudolphOwen LA, 1997, ENDOCRINOLOGY, V138, P4902, DOI 10.1210/en.138.11.4902; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Sakurai H, 1997, AM J PHYSIOL-RENAL, V273, pF463, DOI 10.1152/ajprenal.1997.273.3.F463; Sakurai H, 1997, P NATL ACAD SCI USA, V94, P6279, DOI 10.1073/pnas.94.12.6279; SAXEN L, 1987, ORGANOGENESIS KIDNEY, P1; SIMONS K, 1985, ANNU REV CELL BIOL, V1, P243, DOI 10.1146/annurev.cb.01.110185.001331; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Vainio S, 1997, CELL, V90, P975, DOI 10.1016/S0092-8674(00)80363-3; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Yu W, 2007, MOL BIOL CELL, V18, P1693, DOI 10.1091/mbc.E06-11-1052; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9; Zeng F, 2007, MOL BIOL CELL, V18, P4446, DOI 10.1091/mbc.E07-03-0223; Zhou HE, 2004, BIOL REPROD, V71, P534, DOI 10.1095/biolreprod.104.029181	58	43	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4272	4282		10.1074/jbc.M708027200	http://dx.doi.org/10.1074/jbc.M708027200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18039671	hybrid			2022-12-25	WOS:000253083500062
J	Kimura, I; Nakayama, Y; Yamauchi, H; Konishi, M; Miyake, A; Mori, M; Ohta, M; Itoh, N; Fujimoto, M				Kimura, Ikuo; Nakayama, Yoshiaki; Yamauchi, Hajime; Konishi, Morichika; Miyake, Ayumi; Mori, Masahiro; Ohta, Mitsuhiro; Itoh, Nobuyuki; Fujimoto, Masafumi			Neurotrophic activity of neudesin, a novel extracellular heme-binding protein, is dependent on the binding of heme to its cytochrome b(5)-like heme/steroid-binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; RAT; IDENTIFICATION; PROLIFERATION; TRANSCRIPTION; MECHANISMS; EXPRESSION; OXIDATION; RECEPTOR	Neudesin is a secreted protein with neurotrophic activity in neurons and undifferentiated neural cells. We report here that neudesin is an extracellular heme-binding protein and that its neurotrophic activity is dependent on the binding of heme to its cytochrome b(5)-like heme/steroid-binding domain. At first, we found that at least a portion of the purified recombinant neudesin appeared to bind hemin because the purified neudesin solution was tinged with green and had a sharp absorbance peak at 402 nm. The addition of exogenous hemin extensively increased the amount of hemin-bound neudesin. In contrast, neudesin Delta HBD, a mutant lacking the heme-binding domain, could not bind hemin. The neurotrophic activity of the recombinant neudesin that bound exogenous hemin (neudesin-hemin) was significantly greater than that of the recombinant neudesin in either primary cultured neurons or Neuro2a cells, suggesting that the activity of neudesin depends on hemin. The neurotrophic activity of neudesin was enhanced by the binding of Fe(III)-protoporphyrin IX, but neither Fe(II)-protoporphyrin IX nor protoporphyrin IX alone. The inhibition of endogenous neudesin by RNA interference significantly decreased cell survival in Neuro2a cells. This indicates that endogenous neudesin possibly contains hemin. The experiment with anti-neudesin antibody suggested that the endogenous neudesin detected in the culture medium of Neuro2a cells was associated with hemin because it was not retained on a heme-affinity column at all. Neudesin is the first extracellular heme-binding protein that shows signal transducing activity by itself. The present findings may shed new light on the function of extracellular heme-binding proteins.	[Kimura, Ikuo; Mori, Masahiro; Fujimoto, Masafumi] Chiba Inst Sci, Fac Pharm, Lab Appl Pharmacol, Chiba 2880025, Japan; [Nakayama, Yoshiaki; Yamauchi, Hajime; Konishi, Morichika; Miyake, Ayumi; Itoh, Nobuyuki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Sakyo Ku, Kyoto 6068501, Japan; [Ohta, Mitsuhiro] Kobe Pharmaceut Univ, Dept Med Biochem, Kobe, Hyogo 6588558, Japan	Kyoto University; Kobe Pharmaceutical University	Kimura, I (corresponding author), Chiba Inst Sci, Fac Pharm, Lab Appl Pharmacol, Shiomi Choshi, Chiba 2880025, Japan.	ikimura@cis.ac.jp	Kimura, Ikuo/B-4193-2015	Nakayama, Yoshiaki/0000-0003-2187-3292				BALLA G, 1991, ARTERIOSCLER THROMB, V11, P1700, DOI 10.1161/01.ATV.11.6.1700; BALLA G, 1992, J BIOL CHEM, V267, P18148; BLACK SM, 1994, P NATL ACAD SCI USA, V91, P7247, DOI 10.1073/pnas.91.15.7247; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Camejo G, 1998, J LIPID RES, V39, P755; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Druzhyna NM, 2005, J BIOL CHEM, V280, P21673, DOI 10.1074/jbc.m411531200; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hoshikawa M, 2002, MOL BRAIN RES, V105, P60, DOI 10.1016/S0169-328X(02)00393-5; HRKAL Z, 1974, EUR J BIOCHEM, V43, P73, DOI 10.1111/j.1432-1033.1974.tb03386.x; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Kimura I, 2005, J NEUROSCI RES, V79, P287, DOI 10.1002/jnr.20356; Kimura I, 2006, J NEUROSCI RES, V83, P1415, DOI 10.1002/jnr.20849; Krebs CJ, 2000, P NATL ACAD SCI USA, V97, P12816, DOI 10.1073/pnas.97.23.12816; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; Meyer C, 1996, EUR J BIOCHEM, V239, P726, DOI 10.1111/j.1432-1033.1996.0726u.x; Min L, 2005, FEBS J, V272, P5832, DOI 10.1111/j.1742-4658.2005.04977.x; Min L, 2004, MOL CELL ENDOCRINOL, V215, P143, DOI 10.1016/j.mce.2003.11.025; MITSUD W, 2002, GENOME BIOL, V3, P12; Nakanishi N, 2006, J BIOCHEM, V140, P561, DOI 10.1093/jb/mvj189; Sawada H, 1996, J NEUROSCI RES, V43, P503, DOI 10.1002/(SICI)1097-4547(19960215)43:4<503::AID-JNR12>3.0.CO;2-2; Selmin O, 1996, CARCINOGENESIS, V17, P2609, DOI 10.1093/carcin/17.12.2609; SEO HG, 1995, BIOCHEM BIOPH RES CO, V208, P10, DOI 10.1006/bbrc.1995.1298; Shinohara H, 2004, J BIOL CHEM, V279, P41141, DOI 10.1074/jbc.M406721200; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; SONO M, 1995, J BIOL CHEM, V270, P19943, DOI 10.1074/jbc.270.34.19943; Taketani S, 1998, J BIOL CHEM, V273, P31388, DOI 10.1074/jbc.273.47.31388; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; Yamashita T, 2002, J BIOL CHEM, V277, P28265, DOI 10.1074/jbc.M202527200; Zhu LJ, 2005, ANAL BIOCHEM, V345, P102, DOI 10.1016/j.ab.2005.07.028	33	43	47	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4323	4331		10.1074/jbc.M706679200	http://dx.doi.org/10.1074/jbc.M706679200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18056703	hybrid			2022-12-25	WOS:000253083500067
J	Whorton, MR; Jastrzebska, B; Park, PSH; Fotiadis, D; Engel, A; Palczewski, K; Sunahara, RK				Whorton, Matthew R.; Jastrzebska, Beata; Park, Paul S. -H.; Fotiadis, Dimitrios; Engel, Andreas; Palczewski, Krzysztof; Sunahara, Roger K.			Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; G-PROTEIN ACTIVATION; CRYSTAL-STRUCTURE; GPCR FUNCTION; RECEPTOR; HETERODIMERIZATION; LIGHT; ARRESTIN; BINDING; DIMERS	G protein-coupled receptors (GPCRs) are seven transmembrane domain proteins that transduce extracellular signals across the plasma membrane and couple to the heterotrimeric family of G proteins. Like most intrinsic membrane proteins, GPCRs are capable of oligomerization, the function of which has only been established for a few different receptor systems. One challenge in understanding the function of oligomers relates to the inability to separate monomeric and oligomeric receptor complexes in membrane environments. Here we report the reconstitution of bovine rhodopsin, a GPCR expressed in the retina, into an apolipoprotein A-I phospholipid particle, derived from high density lipoprotein (HDL). We demonstrate that rhodopsin, when incorporated into these 10 nm reconstituted HDL (rHDL) particles, is monomeric and functional. Rhodopsin . rHDL maintains the appropriate spectral properties with respect to photoactivation and formation of the active form, metarhodopsin II. Additionally, the kinetics of metarhodopsin II decay is similar between rhodopsin in native membranes and rhodopsin in rHDL particles. Photoactivation of monomeric rhodopsin . rHDL also results in the rapid activation of transducin, at a rate that is comparable with that found in native rod outer segments and 20-fold faster than rhodopsin in detergent micelles. These data suggest that monomeric rhodopsin is the minimal functional unit in G protein activation and that oligomerization is not absolutely required for this process.	[Whorton, Matthew R.; Sunahara, Roger K.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Jastrzebska, Beata; Park, Paul S. -H.; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Fotiadis, Dimitrios; Engel, Andreas] Univ Basel, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland	University of Michigan System; University of Michigan; Case Western Reserve University; University of Basel	Sunahara, RK (corresponding author), 1301 Med Sci Res Bldg 3, Ann Arbor, MI 48109 USA.	sunahara@umich.edu	Sunahara, Roger/AAJ-8667-2020		NATIONAL EYE INSTITUTE [R01EY008061, R29EY008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079191, R01GM068603] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Baas BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P218, DOI 10.1016/j.abb.2004.07.003; BAEHR W, 1982, J BIOL CHEM, V257, P6452; BALDWIN PA, 1985, BIOCHEMISTRY-US, V24, P2633, DOI 10.1021/bi00332a007; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8; Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; CERIONE RA, 1991, METHOD ENZYMOL, V195, P329; Cha KW, 2000, P NATL ACAD SCI USA, V97, P3016, DOI 10.1073/pnas.97.7.3016; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; DEGRIP WJ, 1982, METHOD ENZYMOL, V81, P197; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P9165, DOI 10.1021/bi00086a023; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c; FORTE TM, 1986, METHOD ENZYMOL, V128, P442; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; GAN KN, 1991, DRUG METAB DISPOS, V19, P100; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Hague C, 2004, J BIOL CHEM, V279, P15541, DOI 10.1074/jbc.M314014200; Heck M, 2003, J BIOL CHEM, V278, P3162, DOI 10.1074/jbc.M209675200; Herrmann R, 2006, VISION RES, V46, P4582, DOI 10.1016/j.visres.2006.07.027; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Jastrzebska B, 2004, J BIOL CHEM, V279, P54663, DOI 10.1074/jbc.M408691200; Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200; JONAS A, 1990, J BIOL CHEM, V265, P22123; JONAS A, 1986, METHOD ENZYMOL, V128, P553; JONES AL, 1968, J HISTOCHEM CYTOCHEM, V16, P366, DOI 10.1177/16.5.366; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kisselev OG, 2006, BIOCHEMISTRY-US, V45, P9386, DOI 10.1021/bi060806x; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169; Lewis GF, 2006, CURR OPIN CARDIOL, V21, P345, DOI 10.1097/01.hco.0000231405.76930.a0; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; MATTHEWS RG, 1963, J GEN PHYSIOL, V47, P215, DOI 10.1085/jgp.47.2.215; Modzelewska A, 2006, CELL BIOCHEM BIOPHYS, V46, P1, DOI 10.1385/CBB:46:1:1; OBRIEN DF, 1977, BIOCHEMISTRY-US, V16, P1295, DOI 10.1021/bi00626a009; OKADA T, 2005, PROTEIN COUPLED RECE, P245; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; POWNALL HJ, 1986, METHOD ENZYMOL, V128, P515; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Ramon E, 2003, VISION RES, V43, P3055, DOI 10.1016/j.visres.2003.08.009; Ridge KD, 2007, J BIOL CHEM, V282, P9297, DOI 10.1074/jbc.R600032200; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; Segrest JP, 2000, CURR OPIN LIPIDOL, V11, P105, DOI 10.1097/00041433-200004000-00002; Skegro D, 2007, PHOTOCHEM PHOTOBIOL, V83, P385, DOI 10.1562/2006-08-25-RA-1014; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vogel R, 2003, BIOCHEMISTRY-US, V42, P9863, DOI 10.1021/bi034684+; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104	62	209	209	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4387	4394		10.1074/jbc.M703346200	http://dx.doi.org/10.1074/jbc.M703346200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18033822	Green Accepted, hybrid			2022-12-25	WOS:000253083500073
J	Avenson, TJ; Ahn, TK; Zigmantas, D; Niyogi, KK; Li, Z; Ballottari, M; Bassi, R; Fleming, GR				Avenson, Thomas J.; Ahn, Tae Kyu; Zigmantas, Donatas; Niyogi, Krishna K.; Li, Zhirong; Ballottari, Matteo; Bassi, Roberto; Fleming, Graham R.			Zeaxanthin radical cation formation in minor light-harvesting complexes of higher plant antenna	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLVED FLUORESCENCE ANALYSIS; PHOTOSYSTEM-II; CHLOROPHYLL FLUORESCENCE; XANTHOPHYLL CYCLE; GREEN PLANTS; OXYGENIC PHOTOSYNTHESIS; ENERGY-DISSIPATION; EXCITED-STATES; PROTEIN CP26; IN-VIVO	Previous work on intact thylakoid membranes showed that transient formation of a zeaxanthin radical cation was correlated with regulation of photosynthetic light-harvesting via energy-dependent quenching. A molecular mechanism for such quenching was proposed to involve charge transfer within a chlorophyll-zeaxanthin heterodimer. Using near infrared (880 - 1100 nm) transient absorption spectroscopy, we demonstrate that carotenoid (mainly zeaxanthin) radical cation generation occurs solely in isolated minor light-harvesting complexes that bind zeaxanthin, consistent with the engagement of charge transfer quenching therein. We estimated that less than 0.5% of the isolated minor complexes undergo charge transfer quenching in vitro, whereas the fraction of minor complexes estimated to be engaged in charge transfer quenching in isolated thylakoids was more than 80 times higher. We conclude that minor complexes which bind zeaxanthin are sites of charge transfer quenching in vivo and that they can assume Non-quenching and Quenching conformations, the equilibrium LHC(N) reversible arrow LHC(Q) of which is modulated by the transthylakoid pH gradient, the PsbS protein, and protein-protein interactions.	[Avenson, Thomas J.; Ahn, Tae Kyu; Fleming, Graham R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Ahn, Tae Kyu; Zigmantas, Donatas; Niyogi, Krishna K.; Li, Zhirong; Fleming, Graham R.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Avenson, Thomas J.; Zigmantas, Donatas; Niyogi, Krishna K.; Li, Zhirong] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Ballottari, Matteo; Bassi, Roberto] Univ Verona, Dept Sci & TEchnol, I-37134 Verona, Italy	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Verona	Fleming, GR (corresponding author), Univ Calif Berkeley, Dept Chem, Hildebrand B77, Berkeley, CA 94720 USA.	GRFleming@lbl.gov	Ahn, Tae Kyu/A-5838-2013; Ballottari, Matteo/N-1916-2019; Zigmantas, Donatas/E-5541-2014	Ahn, Tae Kyu/0000-0002-7474-6513; Ballottari, Matteo/0000-0001-8410-3397; Zigmantas, Donatas/0000-0003-2007-5256; bassi, roberto/0000-0002-4140-8446				Amarie S, 2007, J PHYS CHEM B, V111, P3481, DOI 10.1021/jp066458q; Andersson J, 2001, PLANT CELL, V13, P1193, DOI 10.1105/tpc.13.5.1193; Avenson TJ, 2004, P NATL ACAD SCI USA, V101, P5530, DOI 10.1073/pnas.0401269101; BASSI R, 1987, J BIOL CHEM, V262, P13333; BASSI R, 1992, EUR J BIOCHEM, V204, P317, DOI 10.1111/j.1432-1033.1992.tb16640.x; Crimi M, 2001, EUR J BIOCHEM, V268, P260, DOI 10.1046/j.1432-1033.2001.01874.x; Croce R, 2003, BIOPHYS J, V84, P2508, DOI 10.1016/S0006-3495(03)75056-5; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; Dreuw A, 2005, BIOCHEM SOC T, V33, P858, DOI 10.1042/BST0330858; Dreuw A, 2003, PHYS CHEM CHEM PHYS, V5, P3247, DOI 10.1039/b304944b; Dreuw A, 2004, J AM CHEM SOC, V126, P4007, DOI 10.1021/ja039556n; Edge R, 1998, J AM CHEM SOC, V120, P4087, DOI 10.1021/ja974191q; FRANK HA, 1994, PHOTOSYNTH RES, V41, P389, DOI 10.1007/BF02183041; Galinato MGI, 2007, PHOTOSYNTH RES, V94, P67, DOI 10.1007/s11120-007-9218-5; GILMORE AM, 1995, P NATL ACAD SCI USA, V92, P2273, DOI 10.1073/pnas.92.6.2273; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; Han RM, 2006, PHOTOCHEM PHOTOBIOL, V82, P538, DOI 10.1562/2005-09-30-RA-705; Harrer R, 1998, EUR J BIOCHEM, V255, P196, DOI 10.1046/j.1432-1327.1998.2550196.x; Hendrickson L, 2005, PHOTOSYNTH RES, V84, P43, DOI 10.1007/s11120-004-6430-4; Hendrickson L, 2004, PHOTOSYNTH RES, V82, P73, DOI 10.1023/B:PRES.0000040446.87305.f4; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Ma YZ, 2003, P NATL ACAD SCI USA, V100, P4377, DOI 10.1073/pnas.0736959100; Morosinotto T, 2002, J BIOL CHEM, V277, P36913, DOI 10.1074/jbc.M205339200; Mortensen A, 1997, J AGR FOOD CHEM, V45, P2970, DOI 10.1021/jf970010s; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Polivka T, 2002, BIOCHEMISTRY-US, V41, P439, DOI 10.1021/bi011589x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Tracewell CA, 2003, BIOCHEMISTRY-US, V42, P9127, DOI 10.1021/bi0345844; YAMAMOTO HY, 1962, ARCH BIOCHEM BIOPHYS, V97, P168, DOI 10.1016/0003-9861(62)90060-7	45	188	189	1	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3550	3558		10.1074/jbc.M705645200	http://dx.doi.org/10.1074/jbc.M705645200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	17991753	Green Submitted, hybrid			2022-12-25	WOS:000253083000060
J	Kainu, V; Hermansson, M; Somerharju, P				Kainu, Ville; Hermansson, Martin; Somerharju, Pentti			Electrospray lonization mass spectrometry and exogenous heavy isotope-labeled lipid species provide detailed information on aminophospholipid acyl chain remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRIVEN FRAGMENTATION PROCESSES; ENERGY COLLISIONAL ACTIVATION; RAT-LIVER MICROSOMES; CDP-CHOLINE PATHWAY; MAMMALIAN-CELLS; PLASMA-MEMBRANE; MOLECULAR HYDROPHOBICITY; MECHANISTIC PROPOSAL; CULTURED-CELLS; FATTY-ACIDS	Mammalian cells maintain the phospholipid compositions of their different membranes remarkably constant. Beside de novo synthesis, degradation, and intracellular trafficking, acyl chain remodeling plays an important role in phospholipid homeostasis. However, many key details of this process remain unresolved, largely because of limitations of existing methodologies. Here we describe a novel approach that allows one to study metabolism of individual phospholipid species in unprecedented detail. Forty different phosphatidylethanolamine (PE) or-serine (PS) species with a deuterium-labeled head group were synthesized and introduced to BHK21 or HeLa cells using cyclodextrin-mediated transfer. Their metabolism was then monitored in detail by electrospray ionization mass spectrometry. Atypical PE and PS species were rapidly remodeled at both sn1 and sn2 position, yielding a molecular species profile similar to that the endogenous PE and PS. In contrast, remodeling of exogenous species identical or similar to major endogenous ones was more limited and much slower. Major differences in remodeling pathways and kinetics were observed between species within a class, as well as between corresponding PE and PS species. These data along with those obtained with pharmacological inhibitors strongly suggest that multiple lipid class-specific A-type phospholipases and acyl transferases are involved in aminophospholipid remodeling. In conclusion, the approach described here provides highly detailed information on remodeling of exogenously added (amino) glycerophospholipids and should thus be very helpful when elucidating the proteins and processes maintaining molecular species homeostasis.	[Kainu, Ville; Hermansson, Martin; Somerharju, Pentti] Univ Helsinki, Dept Biochem, Inst Biomed, FIN-00014 Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki	Hermansson, M (corresponding author), Univ Helsinki, Dept Biochem, Inst Biomed, PL 63, FIN-00014 Helsinki, Finland.	martin.hermansson@helsinki.fi	Hermansson, Martin/B-7854-2008	Hermansson, Martin/0000-0003-3387-8365				Asai K, 2003, J BIOL CHEM, V278, P8809, DOI 10.1074/jbc.M212117200; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Bao SZ, 2006, J BIOL CHEM, V281, P187, DOI 10.1074/jbc.M509105200; BARTLETT EM, 1970, ANAL BIOCHEM, V36, P159, DOI 10.1016/0003-2697(70)90343-X; Binder M, 2006, J BIOL CHEM, V281, P21869, DOI 10.1074/jbc.M603025200; Boumann HA, 2006, MOL BIOL CELL, V17, P1006, DOI 10.1091/mbc.E05-04-0344; Boumann HA, 2003, BIOCHEMISTRY-US, V42, P3054, DOI 10.1021/bi026801r; CAESAR PA, 1991, AM J RESP CELL MOL, V5, P363, DOI 10.1165/ajrcmb/5.4.363; Chambers K, 2004, BIOCHEM BIOPH RES CO, V313, P681, DOI 10.1016/j.bbrc.2003.12.016; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; DOI O, 1978, BIOCHIM BIOPHYS ACTA, V509, P239, DOI 10.1016/0005-2736(78)90044-5; FOLCH J, 1957, J BIOL CHEM, V226, P497; GAMBLE W, 1978, J LIPID RES, V19, P1068; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Haimi P, 2006, ANAL CHEM, V78, P8324, DOI 10.1021/ac061390w; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Heikinheimo L, 2002, BBA-MOL CELL RES, V1591, P75, DOI 10.1016/S0167-4889(02)00253-7; Heikinheimo L, 1998, J BIOL CHEM, V273, P3327, DOI 10.1074/jbc.273.6.3327; Hermansson M, 2005, ANAL CHEM, V77, P2166, DOI 10.1021/ac048489s; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P892, DOI 10.1016/S1044-0305(00)00159-8; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P797, DOI 10.1016/S1044-0305(00)00151-3; Hunt AN, 2006, METHODS, V39, P104, DOI 10.1016/j.ymeth.2006.05.005; Hunt AN, 2001, J BIOL CHEM, V276, P8492, DOI 10.1074/jbc.M009878200; Hvattum E, 1998, RAPID COMMUN MASS SP, V12, P1405, DOI 10.1002/(SICI)1097-0231(19981015)12:19<1405::AID-RCM338>3.0.CO;2-B; Ivanova PT, 2001, P NATL ACAD SCI USA, V98, P7152, DOI 10.1073/pnas.131195098; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Kakela R, 2003, J NEUROCHEM, V84, P1051, DOI 10.1046/j.1471-4159.2003.01602.x; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kinsey GR, 2005, BIOCHEM BIOPH RES CO, V327, P287, DOI 10.1016/j.bbrc.2004.12.016; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Koivusalo M, 2001, J LIPID RES, V42, P663; Kol MA, 2004, BBA-MOL CELL BIOL L, V1636, P205, DOI 10.1016/j.bbalip.2004.01.002; KRAMER RM, 1984, J BIOL CHEM, V259, P2403; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; LANDS WEM, 1982, J BIOL CHEM, V257, P4968; Lucas KK, 2005, PROSTAG OTH LIPID M, V77, P235, DOI 10.1016/j.prostaglandins.2005.02.004; MACDONALD JIS, 1991, BIOCHIM BIOPHYS ACTA, V1084, P105, DOI 10.1016/0005-2760(91)90209-Z; Maxfield FR, 2006, BIOCHEM SOC T, V34, P335, DOI 10.1042/BST0340335; Murakami M, 2005, J BIOL CHEM, V280, P14028, DOI 10.1074/jbc.M413766200; Nixon AB, 1996, BBA-LIPID LIPID MET, V1300, P187, DOI 10.1016/0005-2760(96)00011-2; OUSLEY AH, 1992, J BIOL CHEM, V267, P10362; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Perez R, 2006, J LIPID RES, V47, P484, DOI 10.1194/jlr.M500397-JLR200; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Postle AD, 2007, PROG LIPID RES, V46, P200, DOI 10.1016/j.plipres.2007.04.001; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; REDDY PV, 1987, BIOCHIM BIOPHYS ACTA, V922, P379, DOI 10.1016/0005-2760(87)90062-2; Rouzer CA, 2007, BIOCHEMISTRY-US, V46, P6026, DOI 10.1021/bi0621617; SAMBORSKI RW, 1990, J BIOL CHEM, V265, P18322; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; SCHMID PC, 1991, J BIOL CHEM, V266, P13690; SCHMID PC, 1995, ARCH BIOCHEM BIOPHYS, V319, P168, DOI 10.1006/abbi.1995.1279; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; SHIAO YJ, 1995, J BIOL CHEM, V270, P11190, DOI 10.1074/jbc.270.19.11190; Silversand C, 1997, J CHROMATOGR B, V703, P7, DOI 10.1016/S0378-4347(97)00385-X; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; SOMERHARJU PJ, 1987, BIOCHEMISTRY-US, V26, P7193, DOI 10.1021/bi00396a048; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Tanhuanpaa K, 1999, J BIOL CHEM, V274, P35359, DOI 10.1074/jbc.274.50.35359; Tanhuanpaa K, 2000, BBA-MOL CELL RES, V1497, P308, DOI 10.1016/S0167-4889(00)00068-9; Tanhuanpaa K, 2001, BIOPHYS J, V81, P1501, DOI 10.1016/S0006-3495(01)75804-3; THOMPSON W, 1986, BIOCHIM BIOPHYS ACTA, V876, P379, DOI 10.1016/0005-2760(86)90023-8; TIJBURG LBM, 1991, BIOCHIM BIOPHYS ACTA, V1085, P184, DOI 10.1016/0005-2760(91)90093-W; TOMODA H, 1987, BIOCHIM BIOPHYS ACTA, V921, P595; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Yamashita A, 1997, J BIOCHEM-TOKYO, V122, P1; Yang YZ, 2004, J BIOL CHEM, V279, P55866, DOI 10.1074/jbc.M406710200	71	38	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3676	3687		10.1074/jbc.M709176200	http://dx.doi.org/10.1074/jbc.M709176200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056998	hybrid			2022-12-25	WOS:000253083000072
J	Li, Z; Nardi, MA; Wu, J; Pan, R; Zhang, W; Karpatkin, S				Li, Zongdong; Nardi, Michael A.; Wu, Jing; Pan, Ruimin; Zhang, Wei; Karpatkin, Simon			Platelet fragmentation requires a specific structural conformation of human monoclonal antibody against beta 3 integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; PHAGE DISPLAY; GLYCOPROTEIN IIIA; IMMUNIZED DONORS; POLYMORPHISM; INTEGRINS; INTEGRIN-ALPHA(IIB)BETA(3); LIBRARIES; SELECTION; THERAPY	We have described an autoantibody against beta 3 (GPIIIa49-66), a region of platelet integrin alpha IIb beta 3 that is unique. It induces platelet fragmentation in the absence of complement via antibody activation of platelet NADPH oxidase and 12-lipoxygenase to release reactive oxygen species, which destroy platelets. To study the mechanism of anti-GPIIIa antibody-induced platelet fragmentation, we screened a human single chain Fv antibody library with the GPIIIa49-66 peptide. Nine monoclonal antibodies were identified that were capable of binding to GPIIIa49-66. Surprisingly, binding avidity for GPIIIa49-66 did not correlate with activity of induction of platelet fragmentation. We therefore investigated the requirements for platelet fragmentation. Mutations were introduced into the heavy chain complementary-determining region-3 of clones 11, 43, and 54 by site-directed mutagenesis. The capability of these clones to induce platelet fragmentation or bind to GPIIIa49-66 subsequently changed. Molecular modeling of these clones with their mutants revealed that the ability to induce platelet fragmentation is affected by the side chain orientation of positively charged amino acids in the heavy chain of residues 99-102. Thus, a structural change in the conformation of anti-GPIIIa49-66 antibody contributes to its binding to the beta 3 integrin and subsequent antibody-induced platelet fragmentation and aggregate dissolution.	[Li, Zongdong; Wu, Jing; Pan, Ruimin; Zhang, Wei; Karpatkin, Simon] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Nardi, Michael A.] NYU, Sch Med, Dept Pediat, New York, NY 10016 USA	New York University; New York University	Li, Z (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10016 USA.	liz04@med.nyu.edu		Nardi, Michael/0000-0002-3276-3198	NHLBI NIH HHS [HL13336] Funding Source: Medline; NIDA NIH HHS [K01 DA020816] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA020816] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Andrioli G, 2000, BRIT J HAEMATOL, V110, P911, DOI 10.1046/j.1365-2141.2000.02300.x; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Bhatt DL, 2003, NAT REV DRUG DISCOV, V2, P15, DOI 10.1038/nrd985; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; Davoren A, 2004, TRANSFUSION, V44, P1220, DOI 10.1111/j.1537-2995.2004.04026.x; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; Jacobin MJ, 2002, J IMMUNOL, V168, P2035, DOI 10.4049/jimmunol.168.4.2035; Jacobin MJ, 2003, CLIN IMMUNOL, V108, P199, DOI 10.1016/S1521-6616(03)00143-8; Li ZD, 2005, BLOOD, V106, P572, DOI 10.1182/blood-2005-01-0243; Michelson AD, 2000, CIRCULATION, V101, P1013, DOI 10.1161/01.CIR.101.9.1013; MORRIS L, 1982, ANN INTERN MED, V96, P714, DOI 10.7326/0003-4819-96-6-714; NAJEAN Y, 1994, J LAB CLIN MED, V123, P415; Nardi M, 2004, J CLIN INVEST, V113, P973, DOI 10.1172/JCI200420726; Nardi M, 2001, CELL, V106, P551, DOI 10.1016/S0092-8674(01)00477-9; NISSIM A, 1994, EMBO J, V13, P692, DOI 10.1002/j.1460-2075.1994.tb06308.x; Sanz L, 2002, GENE THER, V9, P1049, DOI 10.1038/sj.gt.3301725; Schwarz M, 2004, FASEB J, V18, P1704, DOI 10.1096/fj.04-1513fje; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Szczeklik A, 2000, BRIT J HAEMATOL, V110, P965, DOI 10.1046/j.1365-2141.2000.02267.x; Undas A, 2001, CIRCULATION, V104, P2666, DOI 10.1161/hc4701.099787; Winters JL, 1998, VOX SANG, V74, P256, DOI 10.1046/j.1423-0410.1998.7440256.x; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976	22	18	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3224	3230		10.1074/jbc.M705902200	http://dx.doi.org/10.1074/jbc.M705902200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056258	hybrid			2022-12-25	WOS:000253083000026
J	Xu, C; Prasad, AM; Inesi, G; Toyoshima, C				Xu, Cheng; Prasad, Anand Mohan; Inesi, Giuseppe; Toyoshima, Chikashi			Critical role of Val-304 in conformational transitions that allow Ca2+ occlusion and phosphoenzyme turnover in the Ca2+ transport ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; CALCIUM-PUMP; CRYSTAL-STRUCTURE; PHOSPHORYLATION; DOMAIN; ANALOG; CA(2+)-ATPASE; INTERMEDIATE; INHIBITION; MECHANISM	Site-directed mutations were produced in the distal segments of the Ca2+-ATPase (SERCA) transmembrane region. Mutations of Arg-290 (M3-M4 loop), Lys-958, and Thr-960 (M9-M10 loop) had minor effects on ATPase activity and Ca2+ transport. On the other hand, Val-304 (M4) mutations to Ile, Thr, Lys, Ala, or Glu inhibited transport by 90-95% while reducing ATP hydrolysis by 83% (Ile, Thr, and Lys), 56% (Ala), or 45% (Glu). Val-304 participates in Ca2+ coordination with its main-chain carbonyl oxygen, and this function is not expected to be altered by mutations of its side chain. In fact, despite turnover inhibition, the Ca2+ concentration dependence of residual ATPase activity remained unchanged in Val-304 mutants. However, the rates (but not the final levels) of phosphoenzyme formation, as well the rates of its hydrolytic cleavage, were reduced in proportion to the ATPase activity. Furthermore, with the Val-304 -> Glu mutant, which retained the highest residual ATPase activity, it was possible to show that occlusion of bound Ca2+ was also impaired, thereby explaining the stronger inhibition of Ca2+ transport relative to ATPase activity. The effects of Val-304 mutations on phosphoenzyme turnover are attributed to interference with mechanical links that couple movements of transmembrane segments and headpiece domains. The effects of thermal activation energy on reaction rates are thereby reduced. Furthermore, inadequate occlusion of bound Ca2+ following utilization of ATP in Val-304 side-chain mutations is attributed to inadequate stabilization of the Glu-309 side chain and consequent defect of its gating function.	[Xu, Cheng; Prasad, Anand Mohan; Inesi, Giuseppe] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA; [Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biol, Bunkyo Ku, Tokyo 113, Japan	California Pacific Medical Center; California Pacific Medical Center Research Institute; University of Tokyo	Inesi, G (corresponding author), Calif Pacific Med Ctr, Res Inst, 475 Brannan St, San Francisco, CA 94107 USA.	ginesi@CPMCRI.com	Toyoshima, Chikashi/R-4153-2019	Toyoshima, Chikashi/0000-0001-9640-0778	PHS HHS [R01-69830] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Andersen JP, 1998, ACTA PHYSIOL SCAND, V163, P45; ANDERSEN JP, 1992, J BIOL CHEM, V267, P19383; BIGELOW DJ, 1992, J BIOL CHEM, V267, P6952; Chen L, 1996, J BIOL CHEM, V271, P10745, DOI 10.1074/jbc.271.18.10745; CLARKE DM, 1993, J BIOL CHEM, V268, P18359; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Daiho T, 2003, J BIOL CHEM, V278, P39197, DOI 10.1074/jbc.M305200200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; DEMEIS L, 1982, ANN NY ACAD SCI, V402, P535; Einholm AP, 2004, J BIOL CHEM, V279, P15888, DOI 10.1074/jbc.M400158200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; INESI G, 1980, J BIOL CHEM, V255, P3025; KARIN NJ, 1989, MOL CELL BIOL, V9, P1978, DOI 10.1128/MCB.9.5.1978; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; MOLLER JV, 1986, BIOCHIM BIOPHYS ACTA, V1286, P1; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Picard M, 2005, J BIOL CHEM, V280, P18745, DOI 10.1074/jbc.M501596200; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Strock C, 1998, J BIOL CHEM, V273, P15104, DOI 10.1074/jbc.273.24.15104; SUMBILLA C, 1993, J BIOL CHEM, V268, P21185; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; TOYOSHIMA C, 1993, NATURE, V362, P469, DOI 10.1038/362469a0; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; ZHANG Z, 1995, J BIOL CHEM, V270, P16283	32	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3297	3304		10.1074/jbc.M706315200	http://dx.doi.org/10.1074/jbc.M706315200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056991	hybrid			2022-12-25	WOS:000253083000034
J	Radjabi, AR; Sawada, K; Jagadeeswaran, S; Eichbichler, A; Kenny, HA; Montag, A; Bruno, K; Lengyel, E				Radjabi, A. Reza; Sawada, Kenjiro; Jagadeeswaran, Sujatha; Eichbichler, Alfred; Kenny, Hilary A.; Montag, Anthony; Bruno, Katharina; Lengyel, Ernst			Thrombin induces tumor invasion through the induction and association of matrix metalloproteinase-9 and beta 1-integrin on the cell surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV COLLAGENASE EXPRESSION; C-MET OVEREXPRESSION; PLASMINOGEN-ACTIVATOR; GENE-EXPRESSION; MATRIX METALLOPROTEINASE-9; PROMOTER ACTIVITY; TISSUE INHIBITOR; INTEGRIN; UROKINASE; RECEPTOR	The procoagulatory serine protease, thrombin, is known to induce invasion and metastasis in various cancers, but the mechanisms by which it promotes tumorigenesis are poorly understood. Because the 92-kDa gelatinase (MMP-9) is a known mediator of tumor cell invasion, we sought to determine whether and how thrombin regulates MMP-9. The thrombin receptor, PAR-1, and MMP-9 are expressed in osteosarcomas, as determined by immunohistochemistry. Stimulation of U2-OS osteosarcoma cells with thrombin and a thrombin receptor-activating peptide induced pro-MMP-9 secretion as well as cell surface-associated pro-MMP-9 expression and proteolytic activity. This was paralleled by an increase in MMP-9 mRNA and MMP-9 promoter activity. Thrombin-induced invasion of U2-OS cells through Matrigel was mediated by the phosphatidylinositol 3-kinase signaling pathway and could be inhibited with an MMP-9 antibody. The stimulation of MMP-9 by thrombin was paralleled by an increase in beta 1-integrin mRNA and beta 1-integrin expression on the cell surface, which was also mediated by phosphatidylinositol 3-kinase and was required for invasion. Thrombin activation induced and co-localized both beta 1-integrin and proMMP-9 on the cell membrane, as evidenced by co-immunoprecipitation, confocal microscopy, and a protein binding assay. The thrombin-mediated association of these two proteins, as well as thrombin-mediated invasion of U2-OS cells, could be blocked with a cyclic peptide and with an antibody preventing binding of the MMP-9 hemopexin domain to beta 1-integrin. These results suggest that thrombin induces expression and association of beta 1-integrin with MMP-9 and that the cell surface localization of the protease by the integrin promotes tumor cell invasion.	[Radjabi, A. Reza; Sawada, Kenjiro; Jagadeeswaran, Sujatha; Kenny, Hilary A.; Lengyel, Ernst] Univ Chicago, Dept Obstet & Gynecol, Gynecol Oncol Sect, Ctr Integrat Sci, Chicago, IL 60637 USA; [Montag, Anthony] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Bruno, Katharina] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Lengyel, Ernst] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; [Eichbichler, Alfred] Bogenhausen Med Ctr, Dept Orthoped Surg, D-81925 Munich, Germany	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Lengyel, E (corresponding author), MC 20650,5841 S Maryland Ave, Chicago, IL 60637 USA.	elengyel@uchicago.edu	Lengyel, Ernst/D-9220-2014	Lengyel, Ernst/0000-0001-8624-1507	NATIONAL CANCER INSTITUTE [R01CA111882] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 111882, R01 CA111882-03, R01 CA111882] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bannikov GA, 2002, J BIOL CHEM, V277, P16022, DOI 10.1074/jbc.M110931200; Bjorklund M, 2004, J BIOL CHEM, V279, P29589, DOI 10.1074/jbc.M401601200; Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Chapman HA, 2001, THROMB HAEMOSTASIS, V86, P124; Coe APF, 2001, J BIOL CHEM, V276, P35854, DOI 10.1074/jbc.M103639200; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dass CR, 2006, CLIN EXP METASTAS, V23, P367, DOI 10.1007/s10585-006-9046-6; Ellerbroek SM, 2001, CANCER RES, V61, P1855; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Even-Ram SC, 2001, J BIOL CHEM, V276, P10952, DOI 10.1074/jbc.M007027200; Falanga A, 2005, CURR OPIN PULM MED, V11, P403, DOI 10.1097/01.mcp.0000174247.23009.06; Ferrari C, 2004, ACTA ORTHOP SCAND, V75, P487, DOI 10.1080/00016470410001295-1; Fridman R, 2003, CANCER METAST REV, V22, P153, DOI 10.1023/A:1023091214123; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; Grisaru-Granovsky S, 2005, INT J CANCER, V113, P372, DOI 10.1002/ijc.20607; Gum R, 1996, J BIOL CHEM, V271, P10672, DOI 10.1074/jbc.271.18.10672; Gum R, 1997, ONCOGENE, V14, P1481, DOI 10.1038/sj.onc.1200973; Henrikson KP, 1999, BRIT J CANCER, V79, P401, DOI 10.1038/sj.bjc.6690063; Hernandez-Rodriguez NA, 2002, INT J BIOL MARKER, V17, P189, DOI 10.1177/172460080201700308; Hu L, 2004, BLOOD, V104, P2746, DOI 10.1182/blood-2004-03-1047; HUHTALA P, 1990, J BIOL CHEM, V265, P11077; JONES L, 2002, THEORY PRACTICE HIST, P152; KANTHOU C, 1995, THROMB HAEMOSTASIS, V74, P1340; Koivunen E, 1999, NAT BIOTECHNOL, V17, P768, DOI 10.1038/11703; KRAMER RM, 1995, J BIOL CHEM, V270, P27395, DOI 10.1074/jbc.270.46.27395; LAMORTE VJ, 1993, J BIOL CHEM, V268, P19411; Lengyel E, 2005, INT J CANCER, V113, P678, DOI 10.1002/ijc.20598; LENGYEL E, 1995, CANCER RES, V55, P963; LENGYEL E, 1995, J BIOL CHEM, V270, P23007, DOI 10.1074/jbc.270.39.23007; Maragoudakis ME, 2001, ENDOTHELIUM-J ENDOTH, V8, P195; Mira E, 1999, ENDOCRINOLOGY, V140, P1657, DOI 10.1210/en.140.4.1657; Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3; Munshi HG, 2006, CANCER METAST REV, V25, P45, DOI 10.1007/s10555-006-7888-7; Mylona E, 2007, HISTOPATHOLOGY, V50, P338, DOI 10.1111/j.1365-2559.2007.02615.x; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RAMOSDESIMONE N, 1993, HYBRIDOMA, V12, P349, DOI 10.1089/hyb.1993.12.349; Rolli M, 2003, P NATL ACAD SCI USA, V100, P9482, DOI 10.1073/pnas.1633689100; SATO H, 1993, J BIOL CHEM, V268, P23460; SATO H, 1993, ONCOGENE, V8, P395; Sawada K, 2007, CANCER RES, V67, P1670, DOI 10.1158/0008-5472.CAN-06-1147; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Shi XL, 2004, MOL CANCER RES, V2, P395; Su G, 2007, AM J RESP CELL MOL, V36, P377, DOI 10.1165/rcmb.2006-0238OC; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Toth M, 2003, BIOCHEM BIOPH RES CO, V308, P386, DOI 10.1016/S0006-291X(03)01405-0; Toth M, 1997, CANCER RES, V57, P3159; TROUSSEAU A, 1965, CLIN MED HOTEL DIEU; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Watabe T, 1998, INT J CANCER, V77, P128, DOI 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; WOJTUKIEWICZ MZ, 1993, INT J CANCER, V54, P793, DOI 10.1002/ijc.2910540514; Yebra M, 1996, J BIOL CHEM, V271, P29393, DOI 10.1074/jbc.271.46.29393; YOSHIDA E, 1994, CANCER RES, V54, P3300; ZUCKER S, 1995, J BIOL CHEM, V270, P23730, DOI 10.1074/jbc.270.40.23730	58	61	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2822	2834		10.1074/jbc.M704855200	http://dx.doi.org/10.1074/jbc.M704855200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18048360	Green Accepted, hybrid			2022-12-25	WOS:000252622300040
J	Wen, YF; Golubkov, VS; Strongin, AY; Jiang, W; Reed, JC				Wen, Yunfei; Golubkov, Vladislav S.; Strongin, Alex Y.; Jiang, Wei; Reed, John C.			Interaction of hepatitis B viral oncoprotein with cellular target HBXIP dysregulates centrosome dynamics and mitotic spindle formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-X-PROTEIN; TRANSCRIPTIONAL TRANSACTIVATION; CYCLE PROGRESSION; EPITHELIAL-CELLS; CYTOKINESIS; APOPTOSIS; REPLICATION; EXPRESSION; CENTRIOLE; DIFFERENTIATION	Hepatitis B virus infection is associated with hepatocellular carcinoma, claiming 1 million lives annually worldwide. To understand the carcinogenic mechanism of hepatitis B virus-encoded oncoprotein HBx, we explored the function of HBx interaction with its cellular target HBXIP. Previously, we demonstrated that viral HBx and cellular HBXIP control mitotic spindle formation, regulating centrosome splitting. By using various fragments of HBx, we determined that residues (CRHK140)-C-137 within HBx are necessary for binding HBXIP. Mutation of the 137CRHK140 motif in HBx abolished its ability to bind HBXIP and to dysregulate centrosome dynamics in HeLa and immortal diploid RPE-1 cells. Unlike wild-type HBx, which targets to centrosomes as determined by subcellular fractionation and immunofluorescence microscopy, HBx mutants failed to localize to centrosomes. Overexpression of viral HBx wildtype protein and knockdown of endogenous HBXIP altered centrosome assembly and induced modifications of pericentrin and centrin-2, two essential proteins required for centrosome formation and function, whereas HBXIP nonbinding mutants of HBx did not. Overexpression of HBXIP or fragments of HBXIP that bind HBx neutralized the effects of viral HBx on centrosome dynamics and spindle formation. These results suggest that HBXIP is a critical target of viral HBx for promoting genetic instability through formation of defective spindles and subsequent aberrant chromosome segregation.	[Wen, Yunfei; Reed, John C.] Burnham Inst Med Res, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA; [Golubkov, Vladislav S.; Strongin, Alex Y.] Burnham Inst Med Res, Program Cell Adhes & Extracellular Matrix Biol, La Jolla, CA 92037 USA; [Jiang, Wei] Burnham Inst Med Res, Program Canc Genet & Epigenet, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	reedoffice@burnham.org	Strongin, Alex/R-6609-2019; Golubkov, Vladislav/L-6828-2017	Strongin, Alex/0000-0003-3765-3016; Jiang, Wei/0000-0002-2309-9571	NCI NIH HHS [CA 12053] Funding Source: Medline; NIA NIH HHS [AG 15402] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG015402] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; Birrer RB, 2003, ANN CLIN LAB SCI, V33, P39; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; Christodoulou A, 2006, J CELL SCI, V119, P2035, DOI 10.1242/jcs.02922; Cougot D, 2007, J BIOL CHEM, V282, P4277, DOI 10.1074/jbc.M606774200; Deryugina EI, 2002, CANCER RES, V62, P580; Forgues M, 2003, MOL CELL BIOL, V23, P5282, DOI 10.1128/MCB.23.15.5282-5292.2003; Fujii R, 2006, CANCER RES, V66, P9099, DOI 10.1158/0008-5472.CAN-06-1886; Golubkov VS, 2006, CANCER RES, V66, P10460, DOI 10.1158/0008-5472.CAN-06-2997; Golubkov VS, 2005, J BIOL CHEM, V280, P25079, DOI 10.1074/jbc.M502779200; Gromley A, 2003, J CELL BIOL, V161, P535, DOI 10.1083/jcb.200301105; HOPPESEYLER F, 1995, J MOL MED, V73, P529; JOHNS RH, 1996, NATL WEA DIG, V20, P2; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kanda T, 2004, SCAND J GASTROENTERO, V39, P478, DOI 10.1080/00365520310008719; Kang SG, 2001, CURR EYE RES, V22, P174, DOI 10.1076/ceyr.22.3.174.5513; Karki S, 1998, J CELL BIOL, V142, P1023, DOI 10.1083/jcb.142.4.1023; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kim SY, 2005, IUBMB LIFE, V57, P651, DOI 10.1080/15216540500239697; Laoukili J, 2000, J CELL SCI, V113, P1355; Lok ASF, 2000, J HEPATOL, V32, P89, DOI 10.1016/S0168-8278(00)80418-3; Marusawa H, 2000, HEPATOLOGY, V31, P488, DOI 10.1002/hep.510310232; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; McArthur GA, 1998, COLD SPRING HARB SYM, V63, P423, DOI 10.1101/sqb.1998.63.423; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; MITCHISON TJ, 1986, METHOD ENZYMOL, V134, P261; Mohammad RM, 1999, INT J ONCOL, V14, P945; Murakami S, 2001, J GASTROENTEROL, V36, P651, DOI 10.1007/s005350170027; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Tang H, 2005, J VIROL, V79, P5548, DOI 10.1128/JVI.79.9.5548-5556.2005; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; Uetake Y, 2007, J CELL BIOL, V176, P173, DOI 10.1083/jcb.200607073; Warner AK, 2006, TRAFFIC, V7, P205, DOI 10.1111/j.1600-0854.2005.00377.x; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	41	64	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2793	2803		10.1074/jbc.M708419200	http://dx.doi.org/10.1074/jbc.M708419200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18032378	hybrid			2022-12-25	WOS:000252622300037
J	Altman, JK; Yoon, P; Katsoulidis, E; Kroczynska, B; Sassano, A; Redig, AJ; Glaser, H; Jordan, A; Tallman, MS; Hay, N; Platanias, LC				Altman, Jessica K.; Yoon, Patrick; Katsoulidis, Efstratios; Kroczynska, Barbara; Sassano, Antonella; Redig, Amanda J.; Glaser, Heather; Jordan, Alison; Tallman, Martin S.; Hay, Nissim; Platanias, Leonidas C.			Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACTIVATED PROTEIN-KINASE; P70 S6 KINASE; MESSENGER-RNA TRANSLATION; MYELOID-LEUKEMIA; INDUCED APOPTOSIS; DOWN-REGULATION; CELL APOPTOSIS; IN-VITRO; PATHWAY	Arsenic trioxide (As2O3) is a potent inducer of apoptosis of leukemic cells in vitro and in vivo, but the mechanisms that mediate such effects are not well understood. We provide evidence that the Akt kinase is phosphorylated/activated during treatment of leukemia cells with As2O3, to regulate downstream engagement of mammalian target of rapamycin (mTOR) and its effectors. Using cells with targeted disruption of both the Akt1 and Akt2 genes, we found that induction of arsenic trioxide-dependent apoptosis is strongly enhanced in the absence of these kinases, suggesting that Akt1/Akt2 are activated in a negative feedback regulatory manner, to control generation of As2O3 responses. Consistent with this, As2O3-dependent pro-apoptotic effects are enhanced in double knock-out cells for both isoforms of the p70 S6 kinase (S6k1/S6k2), a downstream effector of Akt and mTOR. On the other hand, As2O3-dependent induction of apoptosis is diminished in cells with targeted disruption of TSC2, a negative upstream effector of mTOR. In studies using primary hematopoietic progenitors from patients with acute myeloid leukemia, we found that pharmacological inhibition of mTOR enhances the suppressive effects of arsenic trioxide on leukemic progenitor colony formation. Moreover, short interfering RNA-mediated inhibition of expression of the negative downstream effector, translational repressor 4E-BP1, partially reverses the effects of As2O3. Altogether, these data provide evidence for a key regulatory role of the Akt/mTOR pathway in the generation of the effects of As2O3, and suggest that targeting this signaling cascade may provide a novel therapeutic approach to enhance the anti-leukemic properties of As2O3.	[Altman, Jessica K.; Yoon, Patrick; Katsoulidis, Efstratios; Kroczynska, Barbara; Sassano, Antonella; Redig, Amanda J.; Glaser, Heather; Jordan, Alison; Tallman, Martin S.; Platanias, Leonidas C.] Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Altman, Jessica K.; Yoon, Patrick; Katsoulidis, Efstratios; Kroczynska, Barbara; Sassano, Antonella; Redig, Amanda J.; Glaser, Heather; Jordan, Alison; Tallman, Martin S.; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Altman, Jessica K.; Yoon, Patrick; Katsoulidis, Efstratios; Kroczynska, Barbara; Sassano, Antonella; Redig, Amanda J.; Glaser, Heather; Jordan, Alison; Tallman, Martin S.; Platanias, Leonidas C.] Lakeside Vet Adm Med Ctr, Chicago, IL 60611 USA; [Hay, Nissim] Univ Illinois, Dept Mol Genet, Chicago, IL 60607 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Platanias, LC (corresponding author), Robert H Lurie Comprehens Canc Ctr, 303 E Super St,Lurie 3-107, Chicago, IL 60611 USA.	l-platanias@northwestern.edu			NCI NIH HHS [CA121192, CA77816, T32 CA079447, CA100579] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA079447, R01CA100579, R01CA077816, R01CA121192] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alsayed Y, 2001, J BIOL CHEM, V276, P4012, DOI 10.1074/jbc.M007431200; ANDERSON KC, 2002, CANCER J, V28, P12; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; BIORNSTI MAM, 2004, NAT REV CANCER, V4, P335; Chen D, 2006, CANCER RES, V66, P11416, DOI 10.1158/0008-5472.CAN-06-0409; Chen GQ, 1996, BLOOD, V88, P1052; Chen Z, 2002, SEMIN HEMATOL, V39, P22, DOI 10.1053/shem.2002.33611; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davison K, 2004, BLOOD, V103, P3496, DOI 10.1182/blood-2003-05-1412; Davison K, 2003, LEUKEMIA, V17, P931, DOI 10.1038/sj.leu.2402876; Davison K, 2002, SEMIN HEMATOL, V39, P3, DOI 10.1053/shem.2002.33610; DEL PL, 1997, SCIENCE, V278, P687; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Gartenhaus RB, 2002, CLIN CANCER RES, V8, P566; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; Gingras AC, 2001, GENE DEV, V15, P2852; Grad JM, 2001, BLOOD, V98, P805, DOI 10.1182/blood.V98.3.805; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; He H, 2003, MOL CELL BIOL, V23, P5431, DOI 10.1128/MCB.23.15.5431-5445.2003; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Kapahi P, 2000, J BIOL CHEM, V275, P36062, DOI 10.1074/jbc.M007204200; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; Mahieux R, 2001, BLOOD, V98, P3762, DOI 10.1182/blood.V98.13.3762; METHOT N, 1994, MOL CELL BIOL, V14, P2307, DOI 10.1128/MCB.14.4.2307; Methot N, 1996, RNA, V2, P38; Miller WH, 2002, CANCER RES, V62, P3893; Murgo AJ, 2001, ONCOLOGIST, V6, P22, DOI 10.1634/theoncologist.6-suppl_2-22; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; O'Dwyer ME, 2002, SEMIN HEMATOL, V39, P18, DOI 10.1053/shem.2002.33612; Ozpolat B, 2007, MOL CANCER RES, V5, P95, DOI 10.1158/1541-7786.MCR-06-0125; Parmar S, 2005, BLOOD, V106, P2436, DOI 10.1182/blood-2004-10-4003; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; SMALL EJ, 2003, CANCER, V15, P2090; Soignet SL, 2001, J CLIN ONCOL, V19, P3852, DOI 10.1200/JCO.2001.19.18.3852; Sun H. D., 1992, CHIN J INTEGRAT CHIN, V12, P170; Tallman MS, 2002, BLOOD, V99, P759, DOI 10.1182/blood.V99.3.759; Tallman MS, 2001, BLOOD REV, V15, P133, DOI 10.1054/blre.2001.0160; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Verma A, 2002, J BIOL CHEM, V277, P44988, DOI 10.1074/jbc.M207176200; Verstovsek S, 2006, HEMATOL ONCOL, V24, P181, DOI 10.1002/hon.787; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wang ZG, 1998, BLOOD, V92, P1497, DOI 10.1182/blood.V92.5.1497.417k41_1497_1504; Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8; Yan W, 2007, BIOCHEM BIOPH RES CO, V355, P1038, DOI 10.1016/j.bbrc.2007.02.064; Yoon P, 2006, MOL CANCER THER, V5, P2815, DOI 10.1158/1535-7163.MCT-06-0263; Yoshida C, 2004, INT J HEMATOL, V79, P420, DOI 10.1532/IJH97.04032; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	58	35	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1992	2001		10.1074/jbc.M705227200	http://dx.doi.org/10.1074/jbc.M705227200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18048359	hybrid			2022-12-25	WOS:000252501000026
J	Finetti, F; Solito, R; Morbidelli, L; Giachetti, A; Ziche, M; Donnini, S				Finetti, Federica; Solito, Raffaella; Morbidelli, Lucia; Giachetti, Antonio; Ziche, Marina; Donnini, Sandra			Prostaglandin E-2 regulates angiogenesis via activation of fibroblast growth factor receptor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; BREAST-CANCER; MATRIX-METALLOPROTEINASE; SELECTIVE-INHIBITION; ENDOTHELIAL-CELLS; EGF RECEPTOR; CYCLOOXYGENASE-2; EXPRESSION; CARCINOMA; ADHESION	Prostaglandin E-2 (PGE(2)) behaves as a mitogen in epithelial tumor cells as well as in many other cell types. We investigated the actions of PGE(2) on microvascular endothelial cells ( capillary venular endothelial cells) with the purpose of delineating the signaling pathway leading to the acquisition of the angiogenic phenotype and to new vessel formation. PGE(2) (100 nM) produced activation of the fibroblast growth factor receptor 1 (FGFR-1), as measured by its phosphorylation, but not of vascular endothelial growth factor receptor 2. PGE(2) stimulated the EP3 subtype receptor, as deduced by abrogation of EP3G alpha(i) subunit activity through pertussis toxin. Consistent with this result, in human umbilical venular endothelial cells missing the EP3 receptor, PGE(2) did not phosphorylate FGFR-1. Upon binding to its receptor, PGE2 initiated an autocrine/paracrine signaling cascade involving the intracellular activation of c-Src, activation of matrix metalloproteinase (predominantly MMP2), which in turn caused the mobilization of membrane-anchored fibroblast growth factor-2 (FGF-2). In fact, in cells unable to release FGF-2 the transfection with both FGFR-1 and EP3 did not result in FGFR-1 phosphorylation in response to PGE(2). Relevance for the FGF2-FGFR-1 system was highlighted by confocal analysis, showing receptor internalization after cell exposure to the prostanoid. ERK1/2 appeared to be the distal signal involved, its phosphorylation being sensitive to either cSrc inhibitor or FGFR-1 blocker. Finally, PGE(2) stimulated cell migration and capillary formation in aortic rings, which were severely reduced by inhibitors of signaling molecules or by receptor antagonist. In conclusion, this study provides evidence for the involvement of FGFR-1 through FGF2 in eliciting PGE(2) angiogenic responses. This signaling pattern is similar to the autocrine-paracrine mechanism which operates in endothelial cells to support neovascular growth.	[Finetti, Federica; Solito, Raffaella; Morbidelli, Lucia; Giachetti, Antonio; Ziche, Marina; Donnini, Sandra] Univ Siena, Dept Mol Biol, Pharmacol Angiogenesis Lab, I-53100 Siena, Italy	University of Siena	Donnini, S (corresponding author), Univ Siena, Dept Mol Biol, Pharmacol Angiogenesis Lab, Via Aldo Moro, I-53100 Siena, Italy.	donnini4@unisi.it	Finetti, Federica/J-9089-2016; Morbidelli, Lucia/AAC-7858-2020; Morbidelli, Lucia/K-4053-2016; Donnini, Sandra/K-9252-2019	Morbidelli, Lucia/0000-0001-8148-7049; Donnini, Sandra/0000-0001-6617-1644				Abdelrahim M, 2005, MOL PHARMACOL, V68, P317, DOI 10.1124/mol.105.011825; Backlund MG, 2005, ONCOLOGY-BASEL, V69, P28, DOI 10.1159/000086629; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Casu B, 2002, BIOCHEMISTRY-US, V41, P10519, DOI 10.1021/bi020118n; Chang SH, 2004, P NATL ACAD SCI USA, V101, P591, DOI 10.1073/pnas.2535911100; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Donnini S, 2006, CELL DEATH DIFFER, V13, P1088, DOI 10.1038/sj.cdd.4401803; Donnini S, 2004, LIFE SCI, V74, P2975, DOI 10.1016/j.lfs.2003.09.075; Donnini S, 2007, FASEB J, V21, P2418, DOI 10.1096/fj.06-7581com; Dormond O, 2002, J BIOL CHEM, V277, P45838, DOI 10.1074/jbc.M209213200; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Han S, 2005, INT J CANCER, V116, P536, DOI 10.1002/ijc.21125; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Huang SP, 2005, J BIOMED SCI, V12, P229, DOI 10.1007/s11373-004-8177-5; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; Kamoshita E, 2006, AM J PATHOL, V169, P1458, DOI 10.2353/ajpath.2006.051358; Larkins TL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-181; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Mehrotra S, 2006, J PATHOL, V208, P356, DOI 10.1002/path.1907; Mohammed SI, 2002, CANCER RES, V62, P356; Morbidelli L, 2003, CLIN CANCER RES, V9, P5358; Mutoh M, 2006, CURR PHARM DESIGN, V12, P2375, DOI 10.2174/138161206777698972; Namkoong S, 2005, EXP MOL MED, V37, P588, DOI 10.1038/emm.2005.72; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Pichiule P, 2004, J BIOL CHEM, V279, P12171, DOI 10.1074/jbc.M305146200; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Salcedo R, 2003, BLOOD, V102, P1966, DOI 10.1182/blood-2002-11-3400; SCHELLING ME, 1988, AM J PHYSIOL, V254, pH1211, DOI 10.1152/ajpheart.1988.254.6.H1211; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Wang DZ, 2004, P NATL ACAD SCI USA, V101, P415, DOI 10.1073/pnas.0307640100; Yazawa K, 2005, CANCER SCI, V96, P93, DOI 10.1111/j.1349-7006.2005.00022.x; ZICHE M, 1982, JNCI-J NATL CANCER I, V69, P475	36	95	98	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2139	2146		10.1074/jbc.M703090200	http://dx.doi.org/10.1074/jbc.M703090200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18042549	hybrid			2022-12-25	WOS:000252501000041
J	Hostetler, HA; Huang, H; Kier, AB; Schroeder, F				Hostetler, Heather A.; Huang, Huan; Kier, Ann B.; Schroeder, Friedhelm			Glucose directly links to lipid metabolism through high affinity interaction with peroxisome proliferator-activated receptor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID-BINDING; PPAR-ALPHA; LIGAND SELECTIVITY; LONG-CHAIN; PROTEIN; GAMMA; EXPRESSION; DOMAIN; J(2)	The pathophysiology of diabetes is characterized not only by elevated glucose but also elevated long chain fatty acid levels. We show for the first time that the peroxisome proliferator-activated receptor-alpha(PPAR alpha) binds glucose and glucose metabolites with high affinity, resulting in significantly altered PPAR alpha secondary structure. Glucose decreased PPAR alpha interaction with fatty acid metabolites and steroid receptor coactivator-1 while increasing PPAR alpha interaction with DNA. Concomitantly, glucose increased PPAR alpha interaction with steroid receptor coactivator-1, DNA binding, and transactivation of beta-oxidation pathways in the presence of activating ligands. Heterodimerization of PPAR alpha to the retinoid X receptor-alpha resulted in even larger increases in transactivation with the addition of glucose. These data suggest that PPAR alpha is responsible for maintaining energy homeostasis through a concentration- dependent regulation of both lipids and sugars and that hyperglycemic injury mediated by PPAR alpha occurs not only indirectly through elevated long chain fatty acid levels but also through direct action of glucose on PPAR alpha.	[Hostetler, Heather A.; Huang, Huan; Schroeder, Friedhelm] Texas A&M Univ, Dept Physiol & Pharmacol, TVMC, College Stn, TX 77843 USA; [Kier, Ann B.] Texas A&M Univ, Dept Pathobiol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Schroeder, F (corresponding author), Texas A&M Univ, Dept Physiol & Pharmacol, TVMC, College Stn, TX 77843 USA.	fschroeder@cvm.tamu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK077573, R01DK041402, F32DK066732] Funding Source: NIH RePORTER; NIDDK NIH HHS [F32 DK066732-03, DK066732, F32 DK066732, K99 DK077573, K99 DK077573-01, DK41402, K99 DK77573] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BANNER CD, 1993, J LIPID RES, V34, P1583; Bonilla S, 2000, BRIT J NUTR, V83, P665, DOI 10.1017/S0007114500000842; Buira I, 2004, J CELL PHYSIOL, V198, P12, DOI 10.1002/jcp.10402; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; Cronet P, 2001, STRUCTURE, V9, P699, DOI 10.1016/S0969-2126(01)00634-7; Desvergne B, 2004, MOL ENDOCRINOL, V18, P1321, DOI 10.1210/me.2004-0088; DROCHMANS P, 1975, J CELL BIOL, V66, P1, DOI 10.1083/jcb.66.1.1; Elholm M, 2001, J BIOL CHEM, V276, P21410, DOI 10.1074/jbc.M101073200; Fehr M, 2003, J BIOL CHEM, V278, P19127, DOI 10.1074/jbc.M301333200; Finck BN, 2004, CURR OPIN CLIN NUTR, V7, P391, DOI 10.1097/01.mco.0000134371.70815.32; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Frederiksen KS, 2003, J MOL ENDOCRINOL, V30, P317, DOI 10.1677/jme.0.0300317; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; Hi R, 1999, J BIOL CHEM, V274, P35152, DOI 10.1074/jbc.274.49.35152; Hostetler HA, 2005, J BIOL CHEM, V280, P18667, DOI 10.1074/jbc.M412062200; Hostetler HA, 2006, BIOCHEMISTRY-US, V45, P7669, DOI 10.1021/bi060198l; Huang H, 2002, J BIOL CHEM, V277, P29139, DOI 10.1074/jbc.M202923200; Huang H, 2004, BIOCHEMISTRY-US, V43, P2484, DOI 10.1021/bi0352318; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kersten S, 2001, FASEB J, V15, P1971, DOI 10.1096/fj.01-0147com; Kiec-Wilk B, 2005, J PHYSIOL PHARMACOL, V56, P149; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; Li TL, 1998, J BIOMAT SCI-POLYM E, V9, P327, DOI 10.1080/09205063.1998.9753059; Lin QO, 1999, BIOCHEMISTRY-US, V38, P185, DOI 10.1021/bi9816094; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Murakami K, 2001, BIOCHEM J, V353, P231, DOI 10.1042/0264-6021:3530231; Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468; SPECTOR AA, 1969, ANAL BIOCHEM, V32, P297, DOI 10.1016/0003-2697(69)90089-X; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stewart JM, 1998, BBA-LIPID LIPID MET, V1391, P1, DOI 10.1016/S0005-2760(97)00202-6; Voet D VJ, 1990, BIOCHEMISTRY; Wasserman DH, 1998, ADV EXP MED BIOL, V441, P1; Wolfrum C, 1999, J LIPID RES, V40, P708; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; Yao TP, 1996, P NATL ACAD SCI USA, V93, P10626, DOI 10.1073/pnas.93.20.10626; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103	42	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2246	2254		10.1074/jbc.M705138200	http://dx.doi.org/10.1074/jbc.M705138200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18055466	hybrid			2022-12-25	WOS:000252501000052
J	Krzysiak, TC; Grabe, M; Gilbert, SP				Krzysiak, Troy C.; Grabe, Michael; Gilbert, Susan P.			Getting in sync with dimeric Eg5 - Initiation and regulation of the processive run	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC KINESIN EG5; CROSS-LINKS MICROTUBULES; SMALL-MOLECULE INHIBITOR; ATP HYDROLYSIS; MOTOR PROTEIN; SACCHAROMYCES-CEREVISIAE; DROSOPHILA EMBRYOS; MECHANISTIC MODEL; MEIOTIC SPINDLES; BIPOLAR KINESIN	Eg5/KSP is the kinesin-related motor protein that generates the major plus-end directed force for mitotic spindle assembly and dynamics. Recent work using a dimeric form of Eg5 has found it to be a processive motor; however, its mechanochemical cycle is different from that of conventional Kinesin-1. Dimeric Eg5 appears to undergo a conformational change shortly after collision with the microtubule that primes the motor for its characteristically short processive runs. To better understand this conformational change as well as head-head communication during processive stepping, equilibrium and transient kinetic approaches have been used. By contrast to the mechanism of Kinesin-1, microtubule association triggers ADP release from both motor domains of Eg5. One motor domain releases ADP rapidly, whereas ADP release from the other occurs after a slow conformational change at similar to 1 s(-1). Therefore, dimeric Eg5 begins its processive run with both motor domains associated with the microtubule and in the nucleotide-free state. During processive stepping however, ATP binding and potentially ATP hydrolysis signals rearward head advancement 16nm forward to the next microtubule-binding site. This alternating cycle of processive stepping is proposed to terminate after a few steps because the head-head communication does not sufficiently control the timing to prevent both motor domains from entering the ADP-bound state simultaneously.	[Krzysiak, Troy C.; Grabe, Michael; Gilbert, Susan P.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA.	sgilbert@rpi.edu	Grabe, Michael/B-3705-2009		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K02AR047841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054141] Funding Source: NIH RePORTER; NIAMS NIH HHS [K02 AR047841-05, K02 AR047841-03, K02 AR047841, K02-AR47841, K02 AR047841-04] Funding Source: Medline; NIGMS NIH HHS [R01 GM054141-08, R01 GM054141-13, R01 GM054141-09, R01 GM054141-11, R01 GM054141-10, R01-GM54141, R01 GM054141-12, R01 GM054141] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asenjo AB, 2006, NAT STRUCT MOL BIOL, V13, P648, DOI 10.1038/nsmb1109; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Chakravarty A, 2004, MOL BIOL CELL, V15, P2116, DOI 10.1091/mbc.E03-08-0579; Cochran JC, 2004, J BIOL CHEM, V279, P38861, DOI 10.1074/jbc.M404203200; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; COLE DG, 1994, J BIOL CHEM, V269, P22913; Cox CD, 2005, BIOORG MED CHEM LETT, V15, P2041, DOI 10.1016/j.bmcl.2005.02.055; Cytrynbaum EN, 2003, BIOPHYS J, V84, P757, DOI 10.1016/S0006-3495(03)74895-4; DeBonis S, 2004, MOL CANCER THER, V3, P1079; Duhl DM, 2005, CURR OPIN DRUG DISC, V8, P431; Foster KA, 2000, BIOCHEMISTRY-US, V39, P1784, DOI 10.1021/bi991500b; Foster KA, 2001, J BIOL CHEM, V276, P19259, DOI 10.1074/jbc.M008347200; Gaglio T, 1996, J CELL BIOL, V135, P399, DOI 10.1083/jcb.135.2.399; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; GILBERT SP, 1993, BIOCHEMISTRY-US, V32, P4677, DOI 10.1021/bi00068a028; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Gordon DM, 1999, J BIOL CHEM, V274, P28779, DOI 10.1074/jbc.274.40.28779; Goshima G, 2005, MOL BIOL CELL, V16, P3896, DOI 10.1091/mbc.E05-02-0118; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Hackney DD, 2003, BIOCHEMISTRY-US, V42, P12011, DOI 10.1021/bi0349118; HECK MMS, 1993, J CELL BIOL, V123, P665, DOI 10.1083/jcb.123.3.665; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Krzysiak TC, 2006, EMBO J, V25, P2263, DOI 10.1038/sj.emboj.7601108; Krzysiak TC, 2006, J BIOL CHEM, V281, P39444, DOI 10.1074/jbc.M608056200; Kwok BH, 2004, CURR BIOL, V14, P1783, DOI 10.1016/j.cub.2004.09.052; Kwon M, 2004, TRENDS CELL BIOL, V14, P194, DOI 10.1016/j.tcb.2004.03.003; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; Patel SS, 2003, METHOD ENZYMOL, V370, P668; Press W. H., 1997, NUMERICAL RECIPES; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; Sakowicz R, 2004, CANCER RES, V64, P3276, DOI 10.1158/0008-5472.CAN-03-3839; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; Sharp DJ, 1999, NAT CELL BIOL, V1, P51, DOI 10.1038/9025; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; Shirasu-Hiza M, 2004, CURR BIOL, V14, P1941, DOI 10.1016/j.cub.2004.10.029; T Valentine M, 2007, CURR OPIN CELL BIOL, V19, P75, DOI 10.1016/j.ceb.2006.12.011; Tao L, 2006, CURR BIOL, V16, P2293, DOI 10.1016/j.cub.2006.09.064; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Valentine MT, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-31; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074	58	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2078	2087		10.1074/jbc.M708354200	http://dx.doi.org/10.1074/jbc.M708354200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18037705	Green Accepted, hybrid			2022-12-25	WOS:000252501000035
J	Zhou, XY; He, W; Huang, ZP; Gotto, AM; Hajjar, DP; Han, JH				Zhou, Xiaoye; He, Wei; Huang, Zhiping; Gotto, Antonio M., Jr.; Hajjar, David P.; Han, Jihong			Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression - A new SREBP1-dependent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASSETTE TRANSPORTER A1; VASCULAR ENDOTHELIAL-CELLS; B SCAVENGER RECEPTOR; X-RECEPTOR; CHOLESTEROL EFFLUX; FAMILIAL HYPERCHOLESTEROLEMIA; TANGIER-DISEASE; KNOCKOUT MICE; LDL RECEPTOR; ATHEROSCLEROSIS	Lowdensity lipoprotein receptor (LDLR) mutations cause familial hypercholesterolemia and early atherosclerosis. ABCA1 facilitates free cholesterol efflux from peripheral tissues. We investigated the effects of LDLR deletion (LDLR-/-) on ABCA1 expression. LDLR-/- macrophages had reduced basal levels of ABCA1, ABCG1, and cholesterol efflux. A high fat diet increased cholesterol in LDLR-/- macrophages but not wild type cells. A liver X receptor (LXR) agonist induced expression of ABCA1, ABCG1, and cholesterol efflux in both LDLR-/- and wild type macrophages, whereas expression of LXR alpha or LXR beta was similar. Interestingly, oxidized LDL induced more ABCA1 in wild type macrophages than LDLR-/- cells. LDL induced ABCA1 expression in wild type cells but inhibited it in LDLR-/- macrophages in a concentration-dependent manner. However, lipoproteins regulated ABCG1 expression similarly in LDLR-/- and wild type macrophages. Cholesterol or oxysterols induced ABCA1 expression in wild type macrophages but had little or inhibitory effects on ABCA1 expression in LDLR-/- macrophages. Active sterol regulatory element-binding protein 1a (SREBP1a) inhibited ABCA1 promoter activity in an LXRE-dependent manner and decreased both macrophage ABCA1 expression and cholesterol efflux. Expression of ABCA1 in animal tissues was inversely correlated to active SREBP1. Oxysterols inactivated SREBP1 in wild type macrophages but not in LDLR-/- cells. Oxysterol synergized with nonsteroid LXR ligand induced ABCA1 expression in wild type macrophages but blocked induction in LDLR-/- cells. Taken together, our studies suggest that LDLR is critical in the regulation of cholesterol efflux and ABCA1 expression in macrophage. Lack of the LDLR impairs sterol-induced macrophage ABCA1 expression by a sterol regulatory element-binding protein 1-dependent mechanism that can result in reduced cholesterol efflux and lipid accumulation in macrophages under hypercholesterolemic conditions.	[Zhou, Xiaoye; He, Wei; Huang, Zhiping; Hajjar, David P.; Han, Jihong] Cornell Univ, Weill Cornell Med Coll, Ctr Vasc Biol, New York, NY 10065 USA; [Zhou, Xiaoye; He, Wei; Huang, Zhiping; Hajjar, David P.; Han, Jihong] Cornell Univ, Weill Cornell Med Coll, Dept Pathol, New York, NY 10065 USA; [Gotto, Antonio M., Jr.] Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Han, Jihong] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Cornell University; Cornell University; Cornell University; Nankai University	Han, JH (corresponding author), Cornell Univ, Weill Cornell Med Coll, Ctr Vasc Biol, 1300 York Ave, New York, NY 10065 USA.	Jhan@med.cornell.edu			NHLBI NIH HHS [P01 HL-072942] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL072942] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Baldan A, 2006, ARTERIOSCL THROM VAS, V26, P2301, DOI 10.1161/01.ATV.0000240051.22944.dc; Basso F, 2006, BIOCHEM BIOPH RES CO, V351, P398, DOI 10.1016/j.bbrc.2006.10.044; Bjorkhem I, 2002, ARTERIOSCL THROM VAS, V22, P734, DOI 10.1161/01.ATV.0000013312.32196.49; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; BRINTON EA, 1989, J CLIN INVEST, V84, P262, DOI 10.1172/JCI114149; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CALVERT GD, 1994, AUST NZ J MED, V24, P89, DOI 10.1111/j.1445-5994.1994.tb04442.x; Cavelier LB, 2001, J BIOL CHEM, V276, P18046, DOI 10.1074/jbc.M100565200; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Civeira F, 2004, ATHEROSCLEROSIS, V173, P55, DOI 10.1016/j.atherosclerosis.2003.11.010; Claudel T, 2001, P NATL ACAD SCI USA, V98, P2610, DOI 10.1073/pnas.041609298; Costet P, 2000, J BIOL CHEM, V275, P28240; Defesche Joep C, 2004, Semin Vasc Med, V4, P5; Descamps OS, 2001, ATHEROSCLEROSIS, V157, P514, DOI 10.1016/S0021-9150(01)00533-0; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Edwards PA, 2000, BBA-MOL CELL BIOL L, V1529, P103, DOI 10.1016/S1388-1981(00)00140-2; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Gan XD, 2001, J BIOL CHEM, V276, P48702, DOI 10.1074/jbc.M109402200; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Han JH, 2004, CIRCULATION, V110, P3472, DOI 10.1161/01.CIR.0000148368.79202.F1; Han JH, 1999, J LIPID RES, V40, P830; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jawien J, 2004, J PHYSIOL PHARMACOL, V55, P503; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Joyce CW, 2002, P NATL ACAD SCI USA, V99, P407, DOI 10.1073/pnas.012587699; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lala DS, 1997, P NATL ACAD SCI USA, V94, P4895, DOI 10.1073/pnas.94.10.4895; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Liao HL, 2002, ARTERIOSCL THROM VAS, V22, P127, DOI 10.1161/hq1201.101772; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Ose L, 1999, ANN MED, V31, P13, DOI 10.1080/07853890.1999.11904394; Platt N, 2001, J CLIN INVEST, V108, P649, DOI 10.1172/JCI200113903; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Schmitz G, 2005, BBA-MOL CELL BIOL L, V1735, P1, DOI 10.1016/j.bbalip.2005.04.004; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Sone H, 2004, BIOCHEM BIOPH RES CO, V316, P790, DOI 10.1016/j.bbrc.2004.02.121; Takahashi Kei, 2005, Medical Molecular Morphology, V38, P2, DOI 10.1007/s00795-004-0278-8; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; van Aalst-Cohen Emily S, 2004, Semin Vasc Med, V4, P31; Wang YT, 2002, J BIOL CHEM, V277, P5692, DOI 10.1074/jbc.M109977200; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; Yang XP, 2002, J LIPID RES, V43, P297; Zeng LF, 2004, J BIOL CHEM, V279, P48801, DOI 10.1074/jbc.M407817200	52	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2129	2138		10.1074/jbc.M706636200	http://dx.doi.org/10.1074/jbc.M706636200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18029360	hybrid			2022-12-25	WOS:000252501000040
J	van Grinsven, KWA; Rosnowsky, S; van Weelden, SWH; Putz, S; van der Giezen, M; Martin, W; van Hellemond, JJ; Tielens, AGM; Henze, K				van Grinsven, Koen W. A.; Rosnowsky, Silke; van Weelden, Susanne W. H.; Puetz, Simone; van der Giezen, Mark; Martin, William; van Hellemond, Jaap J.; Tielens, Aloysius G. M.; Henze, Katrin			Acetate : succinate CoA-transferase in the hydrogenosomes of Trichomonas vaginalis - Identification and characterization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRITRICHOMONAS-FETUS; COENZYME-A; MITOCHONDRIAL; SEQUENCE; PROTEIN; ENZYME; LOCALIZATION; METABOLISM; HYDROLASE; PURIFICATION	Acetate: succinate CoA-transferases ( ASCT) are acetate-producing enzymes in hydrogenosomes, anaerobically functioning mitochondria and in the aerobically functioning mitochondria of trypanosomatids. Although acetate is produced in the hydrogenosomes of a number of anaerobic microbial eukaryotes such as Trichomonas vaginalis, no acetate producing enzyme has ever been identified in these organelles. Acetate production is the last unidentified enzymatic reaction of hydrogenosomal carbohydrate metabolism. We identified a gene encoding an enzyme for acetate production in the genome of the hydrogenosome-containing protozoan parasite T. vaginalis. This gene shows high similarity to Saccharomyces cerevisiae acetyl-CoA hydrolase and Clostridium kluyveri succinyl-CoA:CoA-transferase. Here we demonstrate that this protein is expressed and is present in the hydrogenosomes where it functions as the T. vaginalis acetate: succinate CoA-transferase (TvASCT). Heterologous expression of TvASCT in CHO cells resulted in the expression of an active ASCT. Furthermore, homologous overexpression of the TvASCT gene in T. vaginalis resulted in an equivalent increase in ASCT activity. It was shown that the CoA transferase activity is succinate-dependent. These results demonstrate that this acetyl-CoA hydrolase/transferase homolog functions as the hydrogenosomal ASCT of T. vaginalis. This is the first hydrogenosomal acetate-producing enzyme to be identified. Interestingly, TvASCT does not share any similarity with the mitochondrial ASCT from Trypanosoma brucei, the only other eukaryotic succinate-dependent acetyl-CoA-transferase identified so far. The trichomonad enzyme clearly belongs to a distinct class of acetate: succinate CoA-transferases. Apparently, two completely different enzymes for succinate-dependent acetate production have evolved independently in ATP-generating organelles.	[Rosnowsky, Silke; Puetz, Simone; Martin, William; Henze, Katrin] Univ Dusseldorf, Inst Bot 3, D-40225 Dusseldorf, Germany; [van Grinsven, Koen W. A.; van Weelden, Susanne W. H.; van Hellemond, Jaap J.; Tielens, Aloysius G. M.] Univ Utrecht, Fac Vet Med, Dept Biochem & Cell Biol, NL-3584 CM Utrecht, Netherlands; [van der Giezen, Mark] Univ Exeter, Sch Biosci, Ctr Eukaryot Evolutionary Microbiol, Exeter EX4 4QD, Devon, England; [van Hellemond, Jaap J.; Tielens, Aloysius G. M.] ErasmusMC Univ, Med Ctr, Dept Med Microbiol & Infect Dis, NL-3015 GD Rotterdam, Netherlands	Heinrich Heine University Dusseldorf; Utrecht University; University of Exeter; Erasmus University Rotterdam; Erasmus MC	Henze, K (corresponding author), Univ Dusseldorf, Inst Bot 3, Univ Str 1, D-40225 Dusseldorf, Germany.	katrin.henze@uni-duesseldorf.de	van Hellemond, Jaap/T-7555-2019; Martin, William/C-5680-2008; van der Giezen, Mark/J-9550-2019; Martin, William F./O-5446-2015	van Hellemond, Jaap/0000-0003-4862-7796; van der Giezen, Mark/0000-0002-1033-1335; Martin, William F./0000-0003-1478-6449; Tielens, Aloysius/0000-0002-5485-1105				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BENCHIMOL M, 1983, J PROTOZOOL, V30, P422, DOI 10.1111/j.1550-7408.1983.tb02942.x; Bradley PJ, 1997, EMBO J, V16, P3484, DOI 10.1093/emboj/16.12.3484; BROWN TDK, 1977, J GEN MICROBIOL, V102, P327, DOI 10.1099/00221287-102-2-327; Bryant D, 2002, LECT NOTES COMPUT SC, V2452, P375; Bui ETN, 1996, P NATL ACAD SCI USA, V93, P9651, DOI 10.1073/pnas.93.18.9651; Buu LM, 2003, J BIOL CHEM, V278, P17203, DOI 10.1074/jbc.M213268200; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; DIAMOND LS, 1957, J PARASITOL, V43, P488, DOI 10.2307/3274682; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Embley TM, 2003, PHILOS T R SOC B, V358, P191, DOI 10.1098/rstb.2002.1190; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW372, DOI 10.1093/nar/gkh374; Hausler T, 1997, EUR J CELL BIOL, V73, P240; HONIGBERG BM, 1984, J PROTOZOOL, V31, P116, DOI 10.1111/j.1550-7408.1984.tb04300.x; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; LEE FJS, 1990, J BIOL CHEM, V265, P7413; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; MARVINSIKKEMA FD, 1993, ARCH MICROBIOL, V160, P388; MCLAUGHLIN GL, 1986, COMP BIOCHEM PHYS B, V83, P523, DOI 10.1016/0305-0491(86)90290-7; MULLER M, 1988, ANNU REV MICROBIOL, V42, P465, DOI 10.1146/annurev.mi.42.100188.002341; MULLER M, 1993, J GEN MICROBIOL, V139, P2879, DOI 10.1099/00221287-139-12-2879; MULLER M, 1982, PARASITES THEIR WORL; Oulton MM, 2003, EUR J BIOCHEM, V270, P4962, DOI 10.1046/j.1432-1033.2003.03898.x; PERRELLA FW, 1988, ANAL BIOCHEM, V174, P437, DOI 10.1016/0003-2697(88)90042-5; Putz S, 2005, MOL BIOCHEM PARASIT, V142, P212, DOI 10.1016/j.molbiopara.2005.04.003; REEVES RE, 1977, J BIOL CHEM, V252, P726; Riviere L, 2004, J BIOL CHEM, V279, P45337, DOI 10.1074/jbc.M407513200; Sanchez LB, 1996, FEBS LETT, V378, P240, DOI 10.1016/0014-5793(95)01463-2; Saz HJ, 1996, J PARASITOL, V82, P694, DOI 10.2307/3283876; Sohling B, 1996, J BACTERIOL, V178, P871; STEINBUCHEL A, 1986, MOL BIOCHEM PARASIT, V20, P57, DOI 10.1016/0166-6851(86)90142-8; Sutak R, 2004, P NATL ACAD SCI USA, V101, P10368, DOI 10.1073/pnas.0401319101; Thollesson M, 2004, BIOINFORMATICS, V20, P416, DOI 10.1093/bioinformatics/btg422; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tielens AGM, 1998, BBA-BIOENERGETICS, V1365, P71, DOI 10.1016/S0005-2728(98)00045-0; van der Giezen M, 2002, EMBO J, V21, P572, DOI 10.1093/emboj/21.4.572; Van Hellemond JJ, 1998, P NATL ACAD SCI USA, V95, P3036, DOI 10.1073/pnas.95.6.3036; van Hellemond JJ, 2003, PHILOS T ROY SOC B, V358, P205, DOI 10.1098/rstb.2002.1182; van Hoek AHAM, 2000, MOL BIOL EVOL, V17, P251, DOI 10.1093/oxfordjournals.molbev.a026304; vanderGiezen M, 1997, MOL MICROBIOL, V23, P11, DOI 10.1046/j.1365-2958.1997.1891553.x; WITKOWSKI A, 1994, J BIOL CHEM, V269, P379	45	46	89	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1411	1418		10.1074/jbc.M702528200	http://dx.doi.org/10.1074/jbc.M702528200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024431	hybrid			2022-12-25	WOS:000252282700024
J	Wang-Sattler, R; Blandin, S; Ning, Y; Blass, C; Dolo, G; Toure, YT; della Torre, A; Lanzaro, GC; Steinmetz, LM; Kafatos, FC; Zheng, LB				Wang-Sattler, Rui; Blandin, Stephanie; Ning, Ye; Blass, Claudia; Dolo, Guimogo; Toure, Yeya T.; della Torre, Alessandra; Lanzaro, Gregory C.; Steinmetz, Lars M.; Kafatos, Fotis C.; Zheng, Liangbiao			Mosaic Genome Architecture of the Anopheles gambiae Species Complex	PLOS ONE			English	Article							INTEGRATED GENETIC-MAP; MALARIA VECTOR; INCIPIENT SPECIATION; POPULATION-STRUCTURE; RECOMBINATION RATE; CHROMOSOMAL FORMS; X-CHROMOSOME; DIFFERENTIATION; MICROSATELLITE; INTROGRESSION	Background. Attempts over the last three decades to reconstruct the phylogenetic history of the Anopheles gambiae species complex have been important for developing better strategies to control malaria transmission. Methodology. We used fingerprint genotyping data from 414 field-collected female mosquitoes at 42 microsatellite loci to infer the evolutionary relationships of four species in the A. gambiae complex, the two major malaria vectors A. gambiae sensu stricto (A. gambiae s.s.) and A. arabiensis, as well as two minor vectors, A. merus and A. melas. Principal Findings. We identify six taxonomic units, including a clear separation of West and East Africa A. gambiae s.s. S molecular forms. We show that the phylogenetic relationships vary widely between different genomic regions, thus demonstrating the mosaic nature of the genome of these species. The two major malaria vectors are closely related and closer to A. merus than to A. melas at the genome-wide level, which is also true if only autosomes are considered. However, within the Xag inversion region of the X chromosome, the M and two S molecular forms are most similar to A. merus. Near the X centromere, outside the Xag region, the two S forms are highly dissimilar to the other taxa. Furthermore, our data suggest that the centromeric region of chromosome 3 is a strong discriminator between the major and minor malaria vectors. Conclusions. Although further studies are needed to elucidate the basis of the phylogenetic variation among the different regions of the genome, the preponderance of sympatric admixtures among taxa strongly favor introgression of different genomic regions between species, rather than lineage sorting of ancestral polymorphism, as a possible mechanism.	[Dolo, Guimogo; Toure, Yeya T.] Univ Mali, Fac Med Pharm & Odontostomatol, Bamako, Mali; [della Torre, Alessandra] Univ Roma La Sapienza, Sez Parassitol, Dipartimento Sci Santia Pubbl, Rome, Italy; [Lanzaro, Gregory C.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Kafatos, Fotis C.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Sect Infect & Immun, London, England; [Zheng, Liangbiao] Shanghai Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Wang-Sattler, Rui; Blandin, Stephanie; Ning, Ye; Blass, Claudia; Steinmetz, Lars M.] European Mol Biol Lab, Heidelberg, Germany	University of Bamako; Sapienza University Rome; University of California System; University of California Davis; Imperial College London; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; European Molecular Biology Laboratory (EMBL)	Wang-Sattler, R (corresponding author), GSF, Natl Res Ctr Environm & Hlth, Inst Epidemiol, Neuherberg, Germany.	rui.wang-sattler@gsf.de; f.kafatos@imperial.ac.uk	Blandin, Stephanie/ABH-2267-2021; Wang-Sattler, Rui/B-5354-2014; Blandin, Stephanie/I-2786-2016	Blandin, Stephanie/0000-0003-4566-1200; Wang-Sattler, Rui/0000-0002-8794-8229; Blandin, Stephanie/0000-0003-4566-1200; Steinmetz, Lars/0000-0002-3962-2865	Deutsche Forschungsgemeinschaft [SFB 544, STE 1422/2-1]; John D. and Catherine T. MacArthur Foundation; NIH [AI40408]; Italian Ministry for University and Research; EMBO; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040408] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); John D. and Catherine T. MacArthur Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by the Deutsche Forschungsgemeinschaft (SFB 544 to FCK and STE 1422/2-1 to LMS), the John D. and Catherine T. MacArthur Foundation (FCK), the NIH grant AI40408 (GCL and LZ), the Italian Ministry for University and Research, PRIN 2005 programme (AdT), and the EMBO long-term fellowship (SB).	Archak S, 2007, NUCLEIC ACIDS RES, V35, pD36, DOI 10.1093/nar/gkl778; Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102; BESANSKY NJ, 1994, P NATL ACAD SCI USA, V91, P6885, DOI 10.1073/pnas.91.15.6885; Besansky NJ, 2003, P NATL ACAD SCI USA, V100, P10818, DOI 10.1073/pnas.1434337100; Caccone A, 1998, GENETICS, V150, P807; Chandre F, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P319; COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; DAVIDSON G, 1965, RIV MALARIOL, V43, P167; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; dellaTorre A, 1997, GENETICS, V146, P239; Dimopoulos G, 1996, GENETICS, V143, P953; Edillo FE, 2002, J MED ENTOMOL, V39, P70, DOI 10.1603/0022-2585-39.1.70; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Garcia BA, 1996, GENETICS, V143, P1313; Gentile G, 2002, GENETICS, V161, P1561; Gentile G, 2001, INSECT MOL BIOL, V10, P25, DOI 10.1046/j.1365-2583.2001.00237.x; HE X, 1998, CORRES ANAL, P345; HE X, 1998, PRINCIPAL COMPONENT, P281; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hunt RH, 1998, T ROY SOC TROP MED H, V92, P231, DOI 10.1016/S0035-9203(98)90761-1; Kumar V., 1994, Insect Molecular Biology, V3, P41, DOI 10.1111/j.1365-2583.1994.tb00149.x; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Lehmann T, 1996, HEREDITY, V77, P192, DOI 10.1038/hdy.1996.124; Machado CA, 2003, P ROY SOC B-BIOL SCI, V270, P1193, DOI 10.1098/rspb.2003.2333; Pombi M, 2006, AM J TROP MED HYG, V75, P901, DOI 10.4269/ajtmh.2006.75.901; Powell JR, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P101; Pritchard JK, 2000, GENETICS, V155, P945; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Sharakhov IV, 2006, P NATL ACAD SCI USA, V103, P6258, DOI 10.1073/pnas.0509683103; Slotman MA, 2007, MOL ECOL, V16, P639, DOI 10.1111/j.1365-294X.2006.03172.x; Slotman MA, 2005, AM J TROP MED HYG, V73, P326, DOI 10.4269/ajtmh.2005.73.326; Slotman MA, 2006, GENETICS, V174, P2081, DOI 10.1534/genetics.106.059949; Stump AD, 2005, P NATL ACAD SCI USA, V102, P15930, DOI 10.1073/pnas.0508161102; Stump AD, 2005, GENETICS, V169, P1509, DOI 10.1534/genetics.104.035303; Taylor C, 2001, GENETICS, V157, P743; Thomasova D, 2002, P NATL ACAD SCI USA, V99, P8179, DOI 10.1073/pnas.082235599; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; Turner TL, 2007, MOL BIOL EVOL, V24, P2132, DOI 10.1093/molbev/msm143; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; UEBERLA K, 1977, FAKTORENANALYSE; Wang R, 2001, P NATL ACAD SCI USA, V98, P10769, DOI 10.1073/pnas.191003598; Wang R, 1999, PARASITOL TODAY, V15, P33, DOI 10.1016/S0169-4758(98)01360-X; Weill M, 2000, INSECT MOL BIOL, V9, P451, DOI 10.1046/j.1365-2583.2000.00206.x; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2; ZHENG LB, 1993, SCIENCE, V261, P605, DOI 10.1126/science.8342025; Zheng LB, 1996, GENETICS, V143, P941; Zheng LB, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-16	53	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1249	10.1371/journal.pone.0001249	http://dx.doi.org/10.1371/journal.pone.0001249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043756	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459300030
J	Fan, SC; Fang, F; Zhang, XG; Zhang, MQ				Fan, Shicai; Fang, Fang; Zhang, Xuegong; Zhang, Michael Q.			Putative Zinc Finger Protein Binding Sites Are Over-Represented in the Boundaries of Methylation-Resistant CpG Islands in the Human Genome	PLOS ONE			English	Article							DNA METHYLATION; COMPREHENSIVE ANALYSIS; CHROMATIN-STRUCTURE; MOUSE EMBRYO; PATTERNS; PROMOTER; GENES; SP1; HYPOMETHYLATION; PREDICTION	Background. Majority of CpG dinucleotides in mammalian genomes tend to undergo DNA methylation, but most CpG islands are resistant to such epigenetic modification. Understanding about mechanisms that may lead to the methylation resistance of CpG islands is still very poor. Methodology/Principal Findings. Using the genome-scale in vivo DNA methylation data from human brain, we investigated the flanking sequence features of methylation-resistant CpG islands, and discovered that there are several over-represented putative Transcription Factor Binding Sites (TFBSs) in methylation-resistant CpG islands, and a specific group of zinc finger protein binding sites are over-represented in boundary regions (similar to 400 bp) flanking such CpG islands. About 77% of the over-represented putative TFBSs are conserved among human, mouse and rat. We also observed the enrichment of 4 histone methylations in methylation-resistant CpG islands or their boundaries. Conclusions/Significance. Our results suggest a possible mechanism that certain putative zinc finger protein binding sites over-represented in the boundary regions of the methylation-resistant CpG islands may block the spreading of methylation into these islands, and those TFBSs over-represented within the islands may both reinforce the methylation blocking and promote transcription. Some histone modifications may also enhance the immunity of the CpG islands against DNA methylation by augmenting these TFs' binding. We speculate that the dynamical equilibrium between methylation spreading and blocking is likely to be responsible for the establishment and maintenance of the relatively stable DNA methylation pattern in human somatic cells.	[Fan, Shicai; Fang, Fang; Zhang, Xuegong; Zhang, Michael Q.] Tsinghua Univ, Dept Automat, TNLIST, MOE Key Lab Bioinformat & Bioinformat Div, Beijing 100084, Peoples R China; [Zhang, Michael Q.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Fan, Shicai] Univ Elect Sci & Technol China, Sch Automat Engn, Chengdu 610054, Peoples R China	Tsinghua University; Cold Spring Harbor Laboratory; University of Electronic Science & Technology of China	Zhang, MQ (corresponding author), Tsinghua Univ, Dept Automat, TNLIST, MOE Key Lab Bioinformat & Bioinformat Div, Beijing 100084, Peoples R China.	mzhang@cshl.edu		FANG, FANG/0000-0001-9829-2934	NSFC [60540420569, 30625012]; National Basic Research Program of China [2004CB518605]; NIH [HG01696]; Changjiang Scholar Award of China; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696] Funding Source: NIH RePORTER	NSFC(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Changjiang Scholar Award of China; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is supported in part by NSFC grants 60540420569 ( MQZ and XZ) and 30625012 ( XZ), the National Basic Research Program of China ( 2004CB518605) ( XZ and MQZ), NIH grant HG01696 ( MQZ) and the Changjiang Scholar Award of China ( MQZ).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bhasin M, 2005, FEBS LETT, V579, P4302, DOI 10.1016/j.febslet.2005.07.002; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; Bock C, 2006, PLOS GENET, V2, P243, DOI 10.1371/journal.pgen.0020026; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Butcher DT, 2004, INT J CANCER, V111, P669, DOI 10.1002/ijc.20324; Caiafa P, 2005, J CELL BIOCHEM, V94, P257, DOI 10.1002/jcb.20325; Das R, 2006, P NATL ACAD SCI USA, V103, P10713, DOI 10.1073/pnas.0602949103; Fang F, 2006, BIOINFORMATICS, V22, P2204, DOI 10.1093/bioinformatics/btl377; Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Fisher RA, 1935, J R STAT SOC, V98, P39, DOI 10.2307/2342435; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Grunau C, 2000, HUM MOL GENET, V9, P2651, DOI 10.1093/hmg/9.18.2651; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hansen RS, 2000, HUM MOL GENET, V9, P2575, DOI 10.1093/hmg/9.18.2575; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Issa JP, 1999, CRIT REV ONCOL HEMAT, V32, P31, DOI 10.1016/S1040-8428(99)00019-0; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Lewin, 2004, GENES-BASEL; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; MELANIE E, 1982, NUCLEIC ACIDS RES, V10, P2709; Millar DS, 2000, J BIOL CHEM, V275, P24893, DOI 10.1074/jbc.M906538199; MONK M, 1987, DEVELOPMENT, V99, P371; Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98; Mummaneni P, 1998, NUCLEIC ACIDS RES, V26, P5163, DOI 10.1093/nar/26.22.5163; Ogishima T, 2005, ONCOGENE, V24, P6765, DOI 10.1038/sj.onc.1208811; PFEIFER GP, 1990, P NATL ACAD SCI USA, V87, P8252, DOI 10.1073/pnas.87.21.8252; Piotrowski A, 2006, GENE CHROMOSOME CANC, V45, P656, DOI 10.1002/gcc.20331; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2003, THERIOGENOLOGY, V59, P21, DOI 10.1016/S0093-691X(02)01269-4; Robertson KD, 2002, ONCOGENE, V21, P5361, DOI 10.1038/sj.onc.1205609; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Schones DE, 2005, BIOINFORMATICS, V21, P307, DOI 10.1093/bioinformatics/bth480; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Smith AD, 2005, BIOINFORMATICS, V21, pI403, DOI 10.1093/bioinformatics/bti1043; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Turker MS, 1999, SEMIN CANCER BIOL, V9, P329, DOI 10.1006/scbi.1999.0133; Turker MS, 2002, ONCOGENE, V21, P5388, DOI 10.1038/sj.onc.1205599; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; Yu J, 2003, CELL RES, V13, P319, DOI 10.1038/sj.cr.7290177	56	13	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1184	10.1371/journal.pone.0001184	http://dx.doi.org/10.1371/journal.pone.0001184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030324	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459200003
J	Tempel-Brami, C; Pinkas, I; Scherz, A; Salomon, Y				Tempel-Brami, Catherine; Pinkas, Iddo; Scherz, Avigdor; Salomon, Yoram			Detection of Light Images by Simple Tissues as Visualized by Photosensitized Magnetic Resonance Imaging	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; MELANOMA TUMORS; BOLD; TOOKAD; ONLINE; GROWTH; MRI	In this study, we show how light can be absorbed by the body of a living rat due to an injected pigment circulating in the blood stream. This process is then physiologically translated in the tissue into a chemical signature that can be perceived as an image by magnetic resonance imaging (MRI). We previously reported that illumination of an injected photosynthetic bacteriochlorophyll-derived pigment leads to a generation of reactive oxygen species, upon oxygen consumption in the blood stream. Consequently, paramagnetic deoxyhemoglobin accumulating in the illuminated area induces changes in image contrast, detectable by a Blood Oxygen Level Dependent (BOLD)-MRI protocol, termed photosensitized (ps)MRI. Here, we show that laser beam pulses synchronously trigger BOLD-contrast transients in the tissue, allowing representation of the luminous spatiotemporal profile, as a contrast map, on the MR monitor. Regions with enhanced BOLD-contrast (7-61 fold) were deduced as illuminated, and were found to overlap with the anatomical location of the incident light. Thus, we conclude that luminous information can be captured and translated by typical oxygen exchange processes in the blood of ordinary tissues, and made visible by psMRI (Fig. 1). This process represents a new channel for communicating environmental light into the body in certain analogy to light absorption by visual pigments in the retina where image perception takes place in the central nervous system. Potential applications of this finding may include: non-invasive intra-operative light guidance and follow-up of photodynamic interventions, determination of light diffusion in opaque tissues for optical imaging and possible assistance to the blind.	[Tempel-Brami, Catherine; Salomon, Yoram] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Pinkas, Iddo; Scherz, Avigdor] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Salomon, Y (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	yoram.salomon@weizmann.ac.il	Pinkas, Iddo/I-7970-2019	Pinkas, Iddo/0000-0001-7434-9844	Steba Biotech and Negma ( France)	Steba Biotech and Negma ( France)	This work was supported by Steba Biotech and Negma ( France).	Abramovitch R, 1999, CANCER RES, V59, P5012; Brandis A, 2005, PHOTOCHEM PHOTOBIOL, V81, P983, DOI 10.1562/2004-12-01-RA-389R1.1; Brandis Alexander S., 2006, V25, P485; Gross S, 2003, NAT MED, V9, P1327, DOI 10.1038/nm940; Harel N, 2006, J MAGN RESON IMAGING, V23, P945, DOI 10.1002/jmri.20576; Jones RA, 1996, MAGNET RESON MED, V35, P489, DOI 10.1002/mrm.1910350407; Kelleher DK, 2003, BRIT J CANCER, V89, P2333, DOI 10.1038/sj.bjc.6601457; Koudinova NV, 2003, INT J CANCER, V104, P782, DOI 10.1002/ijc.11002; Krishna MC, 2001, SEMIN RADIAT ONCOL, V11, P58, DOI 10.1053/srao.2001.18104; Logothetis NK, 2004, MAGN RESON IMAGING, V22, P1517, DOI 10.1016/j.mri.2004.10.018; MADARBALAKIRSKI N, 2005, THESIS WEIZMANN I SC; Mazor O, 2005, PHOTOCHEM PHOTOBIOL, V81, P342, DOI 10.1562/2004-06-14-RA-199.1; MITCHELL DG, 1999, MRI PRINCIPLES; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Neeman M, 2002, J CELL BIOCHEM, P11, DOI 10.1002/jcb.10399; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Pekar JJ, 2006, IEEE ENG MED BIOL, V25, P24, DOI 10.1109/MEMB.2006.1607665; Posen Y, 2005, J CELL SCI, V118, P1957, DOI 10.1242/jcs.02323; Prasad PV, 1996, CIRCULATION, V94, P3271, DOI 10.1161/01.CIR.94.12.3271; Preise D, 2003, NEOPLASIA, V5, P475, DOI 10.1016/S1476-5586(03)80031-3; Tatum JL, 2006, INT J RADIAT BIOL, V82, P699, DOI 10.1080/09553000601002324; TEMPELBRAMI C, 2005, BOLD CONTRAST DYNAMI; Testoni PA, 2007, THESCIENTIFICWORLDJO, V7, P87, DOI 10.1100/tsw.2007.29; Tyszka JM, 2005, CURR OPIN BIOTECH, V16, P93, DOI 10.1016/j.copbio.2004.11.004; Vakrat-Haglili Y, 2005, J AM CHEM SOC, V127, P6487, DOI 10.1021/ja046210j; Wacker CM, 1999, MAGN RESON MATER PHY, V8, P48; Weersink RA, 2005, J PHOTOCH PHOTOBIO B, V79, P211, DOI 10.1016/j.jphotobiol.2005.01.008; Zilberstein J, 1997, PHOTOCHEM PHOTOBIOL, V65, P1012, DOI 10.1111/j.1751-1097.1997.tb07962.x; Zilberstein J, 2001, PHOTOCHEM PHOTOBIOL, V73, P257, DOI 10.1562/0031-8655(2001)073<0257:ATOSMT>2.0.CO;2	29	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1191	10.1371/journal.pone.0001191	http://dx.doi.org/10.1371/journal.pone.0001191			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030327	gold, Green Submitted, Green Published			2022-12-25	WOS:000207459200006
J	Thorn, A; Egerer-Sieber, C; Jager, CM; Herl, V; Muller-Uri, F; Kreis, W; Muller, YA				Thorn, Andrea; Egerer-Sieber, Claudia; Jaeger, Christof M.; Herl, Vanessa; Mueller-Uri, Frieder; Kreis, Wolfgang; Muller, Yves A.			The crystal structure of progesterone 5 beta-reductase from Digitalis lanata defines a novel class of short chain dehydrogenases/reductases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL ASSIGNMENTS; ALCOHOL DEHYDROGENASES; BIOSYNTHETIC-PATHWAY; LIGAND INTERACTIONS; ACTIVE-SITE; REDUCTASE; PROTEINS; ENZYME; REFINEMENT; FAMILY	Progesterone 5 beta-reductase (5 beta-POR) catalyzes the stereospecific reduction of progesterone to 5 beta-pregnane-3,20-dione and is a key enzyme in the biosynthetic pathway of cardenolides in Digitalis (foxglove) plants. Sequence considerations suggested that 5 beta-POR is a member of the short chain dehydrogenase/reductase (SDR) family of proteins but at the same time revealed that the sequence motifs that in standard SDRs contain the catalytically important residues are missing. Here we present crystal structures of 5 beta-POR from Digitalis lanata in complex with NADP(+) at 2.3 angstrom and without cofactor bound at 2.4 angstrom resolution together with a model of a ternary complex consisting of 5 beta-POR, NADP(+), and progesterone. Indeed, 5 beta-POR displays the fold of an extended SDR. The architecture of the active site is, however, unprecedented because none of the standard catalytic residues are structurally conserved. A tyrosine (Tyr-179) and a lysine residue (Lys-147) are present in the active site, but they are displayed from novel positions and are part of novel sequence motifs. Mutating Tyr-179 to either alanine or phenylalanine completely abolishes the enzymatic activity. We propose that the distinct topology reflects the fact that 5 beta-POR reduces a conjugated double bond in a steroid substrate via a 1-4 addition mechanism and that this requires a repositioning of the catalytically important residues. Our observation that the sequence motifs that line the active site are conserved in a number of bacterial and plant enzymes of yet unknown function leads us to the proposition that 5 beta-POR defines a novel class of SDRs.	[Thorn, Andrea; Egerer-Sieber, Claudia; Jaeger, Christof M.; Muller, Yves A.] Univ Erlangen Nurnberg, Dept Biol, Lehrstuhl Biotech, D-91052 Erlangen, Germany; [Herl, Vanessa; Mueller-Uri, Frieder; Kreis, Wolfgang] Univ Erlangen Nurnberg, Dept Biol, Lehrstuhl Pharmazeut Biol, D-91058 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Muller, YA (corresponding author), Univ Erlangen Nurnberg, Dept Biol, Lehrstuhl Biotech, Henkestr 91, D-91052 Erlangen, Germany.	ymuller@biologie.uni-erlangen.de	Muller, Yves A/R-5397-2016; Thorn, Andrea/HHC-2296-2022; Thorn, Andrea/Q-3142-2017; Jäger, Christof/N-1740-2014	Muller, Yves A/0000-0003-0519-8928; Thorn, Andrea/0000-0003-4503-4258; Jäger, Christof/0000-0002-1802-1892				Alphey MS, 2005, J BIOL CHEM, V280, P3068, DOI 10.1074/jbc.M411069200; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; ANTMAN EM, 1985, ANNU REV MED, V36, P357; Bennett MJ, 1996, BIOCHEMISTRY-US, V35, P10702, DOI 10.1021/bi9604688; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; BJORKHEM I, 1992, J BIOL CHEM, V267, P19872; Bottoms CA, 2002, PROTEIN SCI, V11, P2125, DOI 10.1110/ps.0213502; Breton R, 1996, STRUCTURE, V4, P905, DOI 10.1016/S0969-2126(96)00098-6; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; CASPI E, 1967, SCIENCE, V156, P519, DOI 10.1126/science.156.3774.519; Chayen NE, 1996, PROTEIN ENG, V9, P927, DOI 10.1093/protein/9.10.927; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Edwards KJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P173, DOI 10.1006/abbi.1996.0158; Egerer-Sieber C, 2006, ACTA CRYSTALLOGR F, V62, P186, DOI 10.1107/S1744309106001916; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; GARTNER DE, 1990, FEBS LETT, V271, P239, DOI 10.1016/0014-5793(90)80415-F; Gavidia I, 2007, PHYTOCHEMISTRY, V68, P853, DOI 10.1016/j.phytochem.2006.11.019; Gheorghiade M, 2004, CIRCULATION, V109, P2959, DOI 10.1161/01.CIR.0000132482.95686.87; GHOSH D, 1991, P NATL ACAD SCI USA, V88, P10064, DOI 10.1073/pnas.88.22.10064; Grimm C, 2000, J BIOL CHEM, V275, P41333, DOI 10.1074/jbc.M007559200; Herl V, 2006, PHYTOCHEMISTRY, V67, P225, DOI 10.1016/j.phytochem.2005.11.013; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jez JM, 1998, BIOCHEMISTRY-US, V37, P9695, DOI 10.1021/bi980294p; Jez JM, 2001, CHEM-BIOL INTERACT, V130, P499, DOI 10.1016/S0009-2797(00)00295-7; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Jornvall H, 1999, FEBS LETT, V445, P261, DOI 10.1016/S0014-5793(99)00130-1; JORNVALL H, 1987, EUR J BIOCHEM, V167, P195, DOI 10.1111/j.1432-1033.1987.tb13323.x; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Kallberg Y, 2002, PROTEIN SCI, V11, P636, DOI 10.1110/ps.26902; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; LEACH AR, 1994, J MOL BIOL, V235, P345, DOI 10.1016/S0022-2836(05)80038-5; Major LL, 2005, J AM CHEM SOC, V127, P18309, DOI 10.1021/ja056490i; MATHEWS CK, 2000, BIOCHEMISTRY-US, P340; Michael G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Parikh S, 1999, BIOCHEMISTRY-US, V38, P13623, DOI 10.1021/bi990529c; Penning TM, 2001, CHEM-BIOL INTERACT, V130, P659, DOI 10.1016/S0009-2797(00)00257-X; Persson B, 2003, CHEM-BIOL INTERACT, V143, P271, DOI 10.1016/S0009-2797(02)00223-5; RAFFERTY JB, 1995, STRUCTURE, V3, P927, DOI 10.1016/S0969-2126(01)00227-1; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; ROSSMANN MG, 1976, J MOL BIOL, V105, P75, DOI 10.1016/0022-2836(76)90195-9; Stiebritz MT, 2006, ACTA CRYSTALLOGR D, V62, P648, DOI 10.1107/S0907444906013333; Stuhlemmer U, 1996, PLANT PHYSIOL BIOCH, V34, P85; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Webb NA, 2004, PROTEIN SCI, V13, P529, DOI 10.1110/ps.03393904; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; WITHERING W, 1941, CLASSICS CARDIOLOGY, V1, P231	52	49	50	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2008	283	25					17260	17269		10.1074/jbc.M706185200	http://dx.doi.org/10.1074/jbc.M706185200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	313DF	18032383	hybrid			2022-12-25	WOS:000256720600035
J	Liu, D; Evans, I; Britton, G; Zachary, I				Liu, D.; Evans, I.; Britton, G.; Zachary, I.			The zinc-finger transcription factor, early growth response 3, mediates VEGF-induced angiogenesis	ONCOGENE			English	Article						nuclear receptors; Nur77; protein kinase C; broblast growth factor	ENDOTHELIAL GROWTH-FACTOR; PROTEIN-KINASE-C; SIGNAL-TRANSDUCTION PATHWAY; FOCAL ADHESION KINASE; FACTOR EGR3; TYROSINE PHOSPHORYLATION; PROSTACYCLIN PRODUCTION; REGULATORY FACTORS; ACTIVATION; CELLS	Early growth response 3 (Egr3) is a member of a zinc-finger transcription factor subfamily, which we previously found to be strongly upregulated by vascular endothelial growth factor (VEGF)-A in an oligonucleotide microarray screen of endothelial cells. Here, we show that Egr3 is the predominant Egr family member upregulated by VEGF in endothelial cells at 45 min, and that VEGF induced a rapid increase in Egr-dependent transcriptional activation mediated via its major signalling receptor, VEGFR2/KDR, and the protein kinase C (PKC) pathway. VEGF-induced Egr3 gene expression was also mediated in part via a PKC-dependent activation of protein kinase D. Inhibition of Egr3 gene expression by RNA interference was effective in inhibiting basal and VEGF-induced Egr3 gene expression, and it also inhibited VEGF-mediated endothelial cell proliferation, migration and tubulogenesis. These findings indicate that Egr3 has an essential downstream role in VEGF-mediated endothelial functions leading to angiogenesis and may have particular relevance for adult angiogenic processes involved in vascular repair and neovascular disease.	[Liu, D.; Evans, I.; Britton, G.; Zachary, I.] UCL, BHF Labs, Dept Med, London WC1E 6JJ, England; [Liu, D.] UCL, Dept Med, Ark Therapeut Ltd, London, England	University of London; University College London; University of London; University College London	Zachary, I (corresponding author), UCL, BHF Labs, Dept Med, Rayne Bldg 5 Univ St, London WC1E 6JJ, England.	I.Zachary@ucl.ac.uk	Evans, Ian/C-8533-2009	Evans, Ian/0000-0002-0468-8274	British Heart Foundation [RG/06/003/21131] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Abe Mayumi, 2001, Angiogenesis, V4, P289, DOI 10.1023/A:1016018617152; Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; Abu-Ghazaleh R, 2001, BIOCHEM J, V360, P255, DOI 10.1042/0264-6021:3600255; Arkenbout EK, 2003, ARTERIOSCL THROM VAS, V23, P1535, DOI 10.1161/01.ATV.0000084639.16462.7A; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carter JH, 2007, J IMMUNOL, V178, P3038, DOI 10.4049/jimmunol.178.5.3038; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gliki G, 2001, BIOCHEM J, V353, P503, DOI 10.1042/0264-6021:3530503; Inoue A, 2004, J MOL ENDOCRINOL, V32, P649, DOI 10.1677/jme.0.0320649; Jia HY, 2001, BIOCHEM BIOPH RES CO, V283, P164, DOI 10.1006/bbrc.2001.4761; Laitinen M, 1997, HUM GENE THER, V8, P1737, DOI 10.1089/hum.1997.8.15-1737; Levkovitz Y, 2001, J NEUROSCI, V21, P45, DOI 10.1523/JNEUROSCI.21-01-00045.2001; Liu D, 2003, ARTERIOSCL THROM VAS, V23, P2002, DOI 10.1161/01.ATV.0000098644.03153.6F; Mercier G, 2001, MOL BRAIN RES, V97, P137, DOI 10.1016/S0169-328X(01)00311-4; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; O'Donovan KJ, 1998, J NEUROCHEM, V70, P1241; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; PATWARDHAN S, 1991, ONCOGENE, V6, P917; Qin LL, 2006, J BIOL CHEM, V281, P32550, DOI 10.1074/jbc.M604853200; Rey O, 2001, J BIOL CHEM, V276, P32616, DOI 10.1074/jbc.M101649200; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757; Tourtellotte WG, 2001, DEV BIOL, V232, P388, DOI 10.1006/dbio.2001.0202; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wheeler-Jones C, 1997, FEBS LETT, V420, P28, DOI 10.1016/S0014-5793(97)01481-6; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Xi HK, 2004, J IMMUNOL, V173, P340, DOI 10.4049/jimmunol.173.1.340; Xi HK, 2004, J IMMUNOL, V172, P964, DOI 10.4049/jimmunol.172.2.964; Xi HK, 2006, IMMUNITY, V24, P813, DOI 10.1016/j.immuni.2006.03.023; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006; Zachary I, 2003, BIOCHEM SOC T, V31, P1171; Zeng HY, 2006, J EXP MED, V203, P719, DOI 10.1084/jem.20051523; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	38	51	53	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 8	2008	27	21					2989	2998		10.1038/sj.onc.1210959	http://dx.doi.org/10.1038/sj.onc.1210959			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	298IP	18059339				2022-12-25	WOS:000255681700006
J	Peak, JC; Jones, NP; Hobbs, S; Katan, M; Eccles, SA				Peak, J. C.; Jones, N. P.; Hobbs, S.; Katan, M.; Eccles, S. A.			Phospholipase C gamma 1 regulates the Rap GEF1-Rap1 signalling axis in the control of human prostate carcinoma cell adhesion	ONCOGENE			English	Article						phospholipase c gamma 1; rap GEF1; Rap1; adhesion	C-GAMMA-L; INTEGRIN ALPHA(2)BETA(1); ACTIVATION; RECEPTOR; REQUIREMENT; PLC-GAMMA-1; KINASES; COMPLEX; FAMILY; C3G	C gamma 1 (PLC gamma 1) is activated downstream of a variety of extracellular stimuli and has previously been implicated in the regulation of motility responses central to tumour cell invasion. In this study, we used a novel RNAi vector system to achieve conditional PLC gamma 1 knockdown in PC3LN3 human prostate carcinoma cells for further evaluation of PLC gamma 1 in tumour cell biology. Using this approach, we revealed a role for PLC gamma 1 in the regulation of PC3LN3 cell adhesion that appears to be independent of its effects on tumour cell chemotactic migration and spreading in response to extracellular matrix. Subsequent microarray analysis of PLC gamma 1-knockdown cells revealed Rap GEF1 mRNA to be decreased in response to PLC gamma 1 loss. This translated into a decrease in Rap GEF1 protein levels and a significant loss of Rap1 activity in PLC gamma 1-knockdown cells. Transient knockdown of Rap GEF1 caused a reduction in PC3LN3 adhesion while overexpression of Rap GEF1 rescued the PLC gamma 1 knockdown-induced adhesion defect. These data highlight control of the Rap GEF1-Rap1 molecular switch as a specific requirement for PLC gamma 1-mediated tumour cell adhesion.	[Eccles, S. A.] Canc Res UK Ctr Canc Therapeut, Inst Canc Res, McElwain Labs, Sutton SM2 5NG, Surrey, England; [Jones, N. P.; Katan, M.] Canc Res UK Ctr Cell & Mol Biol, Inst Canc Res, Sutton, Surrey, England	Cancer Research UK; University of London; Institute of Cancer Research - UK; Cancer Research UK; University of London; Institute of Cancer Research - UK	Eccles, SA (corresponding author), Canc Res UK Ctr Canc Therapeut, Inst Canc Res, McElwain Labs, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.	Sue.Eccles@icr.ac.uk			Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Adams JC, 2001, CELL MOL LIFE SCI, V58, P371, DOI 10.1007/PL00000864; Arai A, 1999, BLOOD, V93, P3713, DOI 10.1182/blood.V93.11.3713.411a36_3713_3722; Aydar E, 2006, CANCER LETT, V242, P245, DOI 10.1016/j.canlet.2005.11.011; Bernardi B, 2006, BLOOD, V107, P2728, DOI 10.1182/blood-2005-07-3023; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Choi JH, 2007, CELL SIGNAL, V19, P1784, DOI 10.1016/j.cellsig.2007.04.002; de Jong R, 1998, ONCOGENE, V17, P2805, DOI 10.1038/sj.onc.1202207; Guerrero C, 1998, ONCOGENE, V16, P613, DOI 10.1038/sj.onc.1201569; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Inoue O, 2003, J CELL BIOL, V160, P769, DOI 10.1083/jcb.200208043; Jones NP, 2007, MOL CELL BIOL, V27, P5790, DOI 10.1128/MCB.00778-07; Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374; Katagiri K, 2004, J BIOL CHEM, V279, P11875, DOI 10.1074/jbc.M310717200; Mamoune A, 2004, EXP CELL RES, V299, P91, DOI 10.1016/j.yexcr.2004.05.008; Manos EJ, 2001, ONCOGENE, V20, P2781, DOI 10.1038/sj.onc.1204379; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Nogami M, 2003, FEBS LETT, V536, P71, DOI 10.1016/S0014-5793(03)00013-9; Ohba Y, 2001, EMBO J, V20, P3333, DOI 10.1093/emboj/20.13.3333; Piechulek T, 2005, J BIOL CHEM, V280, P38923, DOI 10.1074/jbc.M509396200; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Regunathan J, 2006, J IMMUNOL, V177, P5365, DOI 10.4049/jimmunol.177.8.5365; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Shepard CR, 2007, ONCOGENE, V26, P3020, DOI 10.1038/sj.onc.1210115; Turner T, 1997, CLIN CANCER RES, V3, P2275; Tvorogov D, 2005, J CELL SCI, V118, P601, DOI 10.1242/jcs.01643; Vuori K, 1996, MOL CELL BIOL, V16, P2606; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Wells A, 2000, ADV CANCER RES, V78, P31; Zhang X, 1999, P NATL ACAD SCI USA, V96, P9021, DOI 10.1073/pnas.96.16.9021	30	12	12	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 1	2008	27	20					2823	2832		10.1038/sj.onc.1210954	http://dx.doi.org/10.1038/sj.onc.1210954			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	295VR	18037957				2022-12-25	WOS:000255502500003
J	Colomba, A; Courilleau, D; Ramel, D; Billadeau, DD; Espinos, E; Delsol, G; Payrastre, B; Gaits-Iacovoni, F				Colomba, A.; Courilleau, D.; Ramel, D.; Billadeau, D. D.; Espinos, E.; Delsol, G.; Payrastre, B.; Gaits-Iacovoni, F.			Activation of Rac1 and the exchange factor Vav3 are involved in NPM-ALK signaling in anaplastic large cell lymphomas	ONCOGENE			English	Article						anaplastic large cell lymphomas; NPM-ALK; Rho GTPases; Vav3	RHO-GTPASES; TYROSINE KINASE; PROTEINS; EXPRESSION; IDENTIFICATION; PROLIFERATION; TRANSLOCATION; ASSOCIATION; INHIBITION; APOPTOSIS	The majority of anaplastic large cell lymphomas (ALCLs) express the nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) fusion protein, which is oncogenic due to its constitutive tyrosine kinase activity. Transformation by NPM-ALK not only increases proliferation, but also modifies cell shape and motility in both lymphoid and fibroblastic cells. We report that the Rac1 GTPase, a known cytoskeletal regulator, is activated by NPM-ALK in ALCL cell lines (Karpas 299 and Cost) and transfected cells (lymphoid Ba/F3 cells, NIH-3T3 fibroblasts). We have identified Vav3 as one of the exchange factors involved in Rac1 activation. Stimulation of Vav3 and Rac1 by NPM-ALK is under the control of Src kinases. It involves formation of a signaling complex between NPM-ALK, pp60(c-src), Lyn and Vav3, in which Vav3 associates with tyrosine 343 of NPM-ALK via its SH2 domain. Moreover, Vav3 is phosphorylated in NPM-ALK positive biopsies from patients suffering from ALCL, demonstrating the pathological relevance of this observation. The use of Vav3-specific shRNA and a dominant negative Rac1 mutant demonstrates the central role of GTPases in NPM-ALK elicited motility and invasion.	[Colomba, A.; Courilleau, D.; Ramel, D.; Espinos, E.; Delsol, G.; Payrastre, B.; Gaits-Iacovoni, F.] CHU Purpan, Ctr Physiopathol Toulouse Purpan, INSERM,U563, Dpt Oncogenese Signalisat & Innovat Theraperut, F-31024 Toulouse 3, France; [Colomba, A.; Courilleau, D.; Ramel, D.; Espinos, E.; Delsol, G.; Payrastre, B.; Gaits-Iacovoni, F.] Univ Toulouse III Paul Sabatier, IFR30, Toulouse, France; [Billadeau, D. D.] Mayo Clin, Coll Med, Div Dev Oncol Res, Rochester, MN USA; [Billadeau, D. D.] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN USA	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Mayo Clinic; Mayo Clinic	Gaits-Iacovoni, F (corresponding author), CHU Purpan, Ctr Physiopathol Toulouse Purpan, INSERM,U563, Dpt Oncogenese Signalisat & Innovat Theraperut, BP 3028, F-31024 Toulouse 3, France.	frgaits@toulouse.inserm.fr	Espinos, Estelle/A-4661-2015	Espinos, Estelle/0000-0002-5693-8941; , Bernard/0000-0002-8693-0190; Colomba, Audrey/0000-0002-5612-8519; Gaits-Iacovoni, Frederique/0000-0002-9853-0442				Ambrogio C, 2005, BLOOD, V106, P3907, DOI 10.1182/blood-2005-03-1204; Amin HM, 2003, ONCOGENE, V22, P5399, DOI 10.1038/sj.onc.1206849; Armstrong F, 2004, ONCOGENE, V23, P6071, DOI 10.1038/sj.onc.1207813; Aznar S, 2004, CANCER LETT, V206, P181, DOI 10.1016/j.canlet.2003.08.035; Bai RY, 1998, MOL CELL BIOL, V18, P6951, DOI 10.1128/MCB.18.12.6951; Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; Bassermann F, 2002, J BIOL CHEM, V277, P12437, DOI 10.1074/jbc.M112397200; Benard V, 2002, METHOD ENZYMOL, V345, P349; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Charvet C, 2005, J BIOL CHEM, V280, P15289, DOI 10.1074/jbc.M500275200; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; Cho YJ, 2005, MOL CELL BIOL, V25, P5777, DOI 10.1128/MCB.25.13.5777-5785.2005; Contri A, 2005, J CLIN INVEST, V115, P369, DOI 10.1172/JC1200522094; Crockett DK, 2004, ONCOGENE, V23, P2617, DOI 10.1038/sj.onc.1207398; Cussac D, 2004, BLOOD, V103, P1464; Cussac D, 2006, PROTEOMICS, V6, P3210, DOI 10.1002/pmic.200500647; Duyster J, 2001, ONCOGENE, V20, P5623, DOI 10.1038/sj.onc.1204594; Falini B, 1998, AM J PATHOL, V153, P875, DOI 10.1016/S0002-9440(10)65629-5; Fawal M, 2006, BLOOD, V108, P2780, DOI 10.1182/blood-2006-04-014902; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Fujimoto J, 1996, P NATL ACAD SCI USA, V93, P4181, DOI 10.1073/pnas.93.9.4181; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Genth H, 2006, FEBS LETT, V580, P3565, DOI 10.1016/j.febslet.2006.04.100; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Honorat JF, 2006, BLOOD, V107, P4130, DOI 10.1182/blood-2005-06-2421; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Lamant L, 2004, LEUKEMIA, V18, P1693, DOI 10.1038/sj.leu.2403464; Lamant L, 1996, BLOOD, V87, P284; Lamant L, 2007, BLOOD, V109, P2156, DOI 10.1182/blood-2006-06-028969; Lim MS, 2006, MOL CELL PROTEOMICS, V5, P1787, DOI 10.1074/mcp.R600005-MCP200; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Llorca O, 2005, EMBO J, V24, P1330, DOI 10.1038/sj.emboj.7600617; Marzec M, 2007, ONCOGENE, V26, P813, DOI 10.1038/sj.onc.1209843; Marzec M, 2005, LAB INVEST, V85, P1544, DOI 10.1038/labinvest.3700348; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Petit P, 2003, CELL MICROBIOL, V5, P761, DOI 10.1046/j.1462-5822.2003.00309.x; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Theodorescu D, 2004, CLIN CANCER RES, V10, P3800, DOI 10.1158/1078-0432.CCR-03-0653; Thompson MA, 2005, HUM PATHOL, V36, P494, DOI 10.1016/j.humpath.2005.03.004; Titus B, 2005, CRIT REV EUKAR GENE, V15, P103, DOI 10.1615/CritRevEukaryotGeneExpr.v15.i2.20; Zakaria S, 2004, J EXP MED, V199, P429, DOI 10.1084/jem.20031228; Zeng LY, 2000, MOL CELL BIOL, V20, P9212, DOI 10.1128/MCB.20.24.9212-9224.2000	47	44	49	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 24	2008	27	19					2728	2736		10.1038/sj.onc.1210921	http://dx.doi.org/10.1038/sj.onc.1210921			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	292IK	17998938				2022-12-25	WOS:000255259500007
J	Redondo, C; Vouropoulou, M; Evans, J; Findlay, JBC				Redondo, Clara; Vouropoulou, Maria; Evans, Jonathan; Findlay, John B. C.			Identification of the retinol-binding protein (RBP) interaction site and functional state of RBPs for the membrane receptor	FASEB JOURNAL			English	Article						apo; holo; surface plasmon resonance; mouse urinary protein; lipocalin	MAJOR URINARY PROTEIN; PLASMA; RAT; TRANSTHYRETIN; ACID; EXPRESSION; MICE	This laboratory has advanced a model whereby retinol is transported around the body bound to retinol-binding protein (RBP), is transferred across the membrane of cells by a specific receptor/transporter, and is picked up from the membrane by an intracellular homolog, cellular retinol-binding protein (CRBP). This process involves a number of protein-protein interactions, and we hypothesized that conformational changes were an integral part of the retinol transfer mechanism. Previously we identified the potential interaction site on RBP for its membrane receptor. Here we confirm by the analysis of chimera containing a grafted CD loop from RBP that this is indeed the receptor interaction site and go on to demonstrate that the conformational changes that occur to this region on the apo to holo transition in RBP also take place in a chimera binding a quite different ligand, thus establishing the concept. We have also gone on to support the hypothesis that CRBP may also bind to a receptor in the membrane. Previous evidence has indicated that one such receptor might be lecithin:retinol acyltransferase, an enzyme that catalyzes retinol esterification. Here we provide the first evidence that the plasma membrane receptor for RBP could be the same as that for CRBP. This observation offers support for the intracellular phase of the uptake process for retinol, providing an efficient and highly unique mechanism in eukaryotic biology.	[Redondo, Clara; Vouropoulou, Maria; Evans, Jonathan; Findlay, John B. C.] Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, LIGHT Labs, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Findlay, JBC (corresponding author), Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, LIGHT Labs, Clarendon Way, Leeds LS2 9JT, W Yorkshire, England.	j.b.c.findlay@bmb.leeds.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barratt E, 2005, J AM CHEM SOC, V127, P11827, DOI 10.1021/ja0527525; BAVIK CO, 1991, J BIOL CHEM, V266, P14978; BAVIK CO, 1992, J BIOL CHEM, V267, P23035; BAVIK CO, 1993, J BIOL CHEM, V268, P20540; Bingham RJ, 2004, J AM CHEM SOC, V126, P1675, DOI 10.1021/ja038461i; BLANER WS, 1987, EUR J BIOCHEM, V164, P301, DOI 10.1111/j.1432-1033.1987.tb11058.x; BLOMHOFF R, 1985, J BIOL CHEM, V260, P3571; Boudjelal M, 1996, BIOCHEM J, V317, P23, DOI 10.1042/bj3170023; BURKE BJ, 2005, LIPOCALINS; CAVAGGIONI A, 1990, COMP BIOCHEM PHYS B, V96, P513, DOI 10.1016/0305-0491(90)90049-Y; CHEN CC, 1977, J BIOL CHEM, V252, P5216; COWAN SW, 1990, PROTEINS, V8, P44, DOI 10.1002/prot.340080108; DAVIS JT, 1992, BIOL REPROD, V47, P528, DOI 10.1095/biolreprod47.4.528; DAVIS JT, 1995, BIOL REPROD, V52, P356, DOI 10.1095/biolreprod52.2.356; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; MELHUS H, 1995, BIOCHEM BIOPH RES CO, V210, P105, DOI 10.1006/bbrc.1995.1633; Moise AR, 2007, BIOCHEMISTRY-US, V46, P4449, DOI 10.1021/bi7003069; Naylor HM, 1999, BIOCHEMISTRY-US, V38, P2647, DOI 10.1021/bi982291i; Newcomer ME, 2000, BBA-PROTEIN STRUCT M, V1482, P57, DOI 10.1016/S0167-4838(00)00150-3; NEWCOMER ME, 1984, EMBO J, V3, P1451, DOI 10.1002/j.1460-2075.1984.tb01995.x; Perazzolo C, 2005, J BIOMOL NMR, V33, P233, DOI 10.1007/s10858-005-3355-y; Perazzolo C, 2007, J BIOMOL NMR, V38, P3, DOI 10.1007/s10858-006-9110-1; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2004, J LIPID RES, V45, P1975, DOI 10.1194/jlr.M400137-JLR200; Quadro L, 2002, J BIOL CHEM, V277, P30191, DOI 10.1074/jbc.M205046200; Redondo C, 2006, HORM METAB RES, V38, P269, DOI 10.1055/s-2006-925349; SIVAPRASADARAO A, 1993, BIOCHEM SOC T, V21, P619, DOI 10.1042/bst0210619; SIVAPRASADARAO A, 1988, BIOCHEM J, V255, P571; SIVAPRASADARAO A, 1988, BIOCHEM J, V255, P561; SIVAPRASADARAO A, 1994, BIOCHEM J, V300, P437, DOI 10.1042/bj3000437; Sivaprasadarao A, 1998, METH MOL B, V89, P155; Sundaram M, 1998, METH MOL B, V89, P141; Sundaram M, 1998, J BIOL CHEM, V273, P3336, DOI 10.1074/jbc.273.6.3336; Sundaram M, 2002, BIOCHEM J, V362, P265, DOI 10.1042/0264-6021:3620265; Timm DE, 2001, PROTEIN SCI, V10, P997, DOI 10.1110/ps.52201; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; vanAalten DMF, 1995, PROTEIN ENG, V8, P1129; Vogel S, 2002, BIOCHEMISTRY-US, V41, P15360, DOI 10.1021/bi0268551; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yamamoto M, 1998, EUR J BIOCHEM, V257, P344, DOI 10.1046/j.1432-1327.1998.2570344.x; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zanotti G, 1998, ACTA CRYSTALLOGR D, V54, P1049, DOI 10.1107/S0907444998002303; ZANOTTI G, 1993, J BIOL CHEM, V268, P10728	46	24	24	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2008	22	4					1043	1054		10.1096/fj.07-8939com	http://dx.doi.org/10.1096/fj.07-8939com			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	17991731				2022-12-25	WOS:000254581000010
J	Baerson, SR; Dayan, FE; Rimando, AM; Nanayakkara, NPD; Liu, CJ; Schroerder, J; Fishbein, M; Pan, Z; Kagan, IA; Pratt, LH; Le Cordonnier-Pratt, MM; Duke, SO				Baerson, Scott R.; Dayan, Franck E.; Rimando, Agnes M.; Nanayakkara, N. P. Dhammika; Liu, Chang-Jun; Schroerder, Joachim; Fishbein, Mark; Pan, Zhiqiang; Kagan, Isabelle A.; Pratt, Lee H.; Le Cordonnier-Pratt, Marie-Miche; Duke, Stephen O.			A functional genomics investigation of allelochemical biosynthesis in Sorghum bicolor root hairs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT O-METHYLTRANSFERASES; EXPRESSED SEQUENCE TAGS; SUBSTRATE-SPECIFICITY; RESORCINOLIC LIPIDS; GLANDULAR TRICHOMES; INHIBITORY-ACTIVITY; NATURAL-PRODUCTS; STRUCTURAL BASIS; SORGOLEONE; METHYLATION	Sorghum is considered to be one of the more allelopathic crop species, producing phytotoxins such as the potent benzoquinone sorgoleone (2-hydroxy-5-methoxy-3-[(Z,Z)-8',11',14'-pentadecatriene]-p-benzoquinone) and its analogs. Sorgoleone likely accounts for much of the allelopathy of Sorghum spp., typically representing the predominant constituent of Sorghum bicolor root exudates. Previous and ongoing studies suggest that the biosynthetic pathway for this plant growth inhibitor occurs in root hair cells, involving a polyketide synthase activity that utilizes an atypical 16:3 fatty acyl-CoA starter unit, resulting in the formation of a pentadecatrienyl resorcinol intermediate. Subsequent modifications of this resorcinolic intermediate are likely to be mediated by S-adenosylmethionine-dependent O-methyltransferases and dihydroxylation by cytochrome P450 monooxygenases, although the precise sequence of reactions has not been determined previously. Analyses performed by gas chromatography-mass spectrometry with sorghum root extracts identified a 3-methyl ether derivative of the likely pentadecatrienyl resorcinol intermediate, indicating that dihydroxylation of the resorcinol ring is preceded by O-methylation at the 3'-position by a novel 5-n-alk(en)ylresorcinol-utilizing O-methyltransferase activity. An expressed sequence tag data set consisting of 5,468 sequences selected at random from an S. bicolor root hair-specific cDNA library was generated to identify candidate sequences potentially encoding enzymes involved in the sorgoleone biosynthetic pathway. Quantitative real time reverse transcription-PCR and recombinant enzyme studies with putative O-methyltransferase sequences obtained from the expressed sequence tag data set have led to the identification of a novel O-methyltransferase highly and predominantly expressed in root hairs (designated SbOMT3), which preferentially utilizes alk(en)ylresorcinols among a panel of benzene-derivative substrates tested. SbOMT3 is therefore proposed to be involved in the biosynthesis of the allelochemical sorgoleone.	[Baerson, Scott R.; Dayan, Franck E.; Rimando, Agnes M.; Pan, Zhiqiang; Kagan, Isabelle A.; Duke, Stephen O.] USDA ARS, Nat Prod Utilizat Res Unit, University, MS 38677 USA; [Nanayakkara, N. P. Dhammika] Univ Mississippi, Sch Pharm, Natl Ctr Nat Prod Res, University, MS 38677 USA; [Liu, Chang-Jun] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Schroerder, Joachim] Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany; [Fishbein, Mark] Portland State Univ, Dept Biol, Portland, OR 97207 USA; [Pratt, Lee H.; Le Cordonnier-Pratt, Marie-Miche] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	United States Department of Agriculture (USDA); University of Mississippi; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Freiburg; Portland State University; University System of Georgia; University of Georgia	Baerson, SR (corresponding author), USDA ARS, Nat Prod Utilizat Res Unit, POB 8048, University, MS 38677 USA.	sbaerson@ars.usda.gov	Dayan, Franck/A-7592-2009; Dayan, Franck E/AAB-6565-2022	Dayan, Franck/0000-0001-6964-2499; Dayan, Franck E/0000-0001-6964-2499; Fishbein, Mark/0000-0003-3099-4387				Achnine L, 2004, PLANT CELL, V16, P3098, DOI 10.1105/tpc.104.024406; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baerson SR, 2005, J BIOL CHEM, V280, P21867, DOI 10.1074/jbc.M500694200; Bais HP, 2004, TRENDS PLANT SCI, V9, P26, DOI 10.1016/j.tplants.2003.11.008; Berardini TZ, 2004, PLANT PHYSIOL, V2, P1; Bertin C, 2003, PLANT SOIL, V256, P67, DOI 10.1023/A:1026290508166; Bowers JE, 2003, GENETICS, V165, P367; Bucher M, 1997, PLANT MOL BIOL, V35, P497, DOI 10.1023/A:1005869717158; Coiner H, 2006, PLANT J, V46, P193, DOI 10.1111/J.1365-313X.2006.02680.x; Cordonnier-Pratt MM, 2004, COMP FUNCT GENOM, V5, P268, DOI 10.1002/cfg.399; Cutter E. G., 1978, PLANT ANATOMY, P94; Czarnota MA, 2003, INT J PLANT SCI, V164, P861, DOI 10.1086/378661; Czarnota MA, 2003, J CHEM ECOL, V29, P2073, DOI 10.1023/A:1025634402071; Czarnota MA, 2001, WEED TECHNOL, V15, P813, DOI 10.1614/0890-037X(2001)015[0813:MOALOP]2.0.CO;2; Dayan FE, 2003, J BIOL CHEM, V278, P28607, DOI 10.1074/jbc.M304185200; Dayan FE, 2007, J EXP BOT, V58, P3263, DOI 10.1093/jxb/erm173; Dayan FE, 2006, PLANTA, V224, P339, DOI 10.1007/s00425-005-0217-5; Dogget H., 1988, SORGHUM; Duke S. O., 2005, Outlooks on Pest Management, V16, P64, DOI 10.1564/16apl05; Duke SO, 2002, J PESTIC SCI, V27, P298; Duke SO, 2003, TRENDS BIOTECHNOL, V21, P192, DOI 10.1016/S0167-7799(03)00056-8; EINHELLIG FA, 1992, J CHEM ECOL, V18, P1, DOI 10.1007/BF00997160; ENGELS WR, 1993, TRENDS BIOCHEM SCI, V18, P448, DOI 10.1016/0968-0004(93)90148-G; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Facchini PJ, 2005, CURR OPIN PLANT BIOL, V8, P657, DOI 10.1016/j.pbi.2005.09.008; Fate GD, 1996, J AM CHEM SOC, V118, P11369, DOI 10.1021/ja961395i; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; FRANKE I, 1980, HELV CHIM ACTA, V63, P2508, DOI 10.1002/hlca.19800630845; Fridman E, 2005, PLANT CELL, V17, P1252, DOI 10.1105/tpc.104.029736; Gang DR, 2002, PLANT CELL, V14, P505, DOI 10.1105/tpc.010327; Gossett RE, 1996, LIPIDS, V31, P895, DOI 10.1007/BF02522684; Grierson Claire, 2002, Arabidopsis Book, V1, pe0060, DOI 10.1199/tab.0060; Guterman I, 2002, PLANT CELL, V14, P2325, DOI 10.1105/tpc.005207; He XZ, 1998, PLANT MOL BIOL, V36, P43, DOI 10.1023/A:1005938121453; Hejl AM, 2004, J CHEM ECOL, V30, P2181, DOI 10.1023/B:JOEC.0000048782.87862.7f; HELD BM, 1993, PLANT PHYSIOL, V102, P1001, DOI 10.1104/pp.102.3.1001; Inderjit, 2003, PLANTA, V217, P529, DOI 10.1007/s00425-003-1054-z; Kagan IA, 2003, J AGR FOOD CHEM, V51, P7589, DOI 10.1021/jf034789j; KOZUBEK A, 1995, ACTA BIOCHIM POL, V42, P241; Kozubek A, 1999, CHEM REV, V99, P1, DOI 10.1021/cr970464o; KOZUBEK A, 1989, ACTA U WRATISL, V868, P27; Lange BM, 2000, P NATL ACAD SCI USA, V97, P2934, DOI 10.1073/pnas.97.6.2934; Lavid N, 2002, PLANT PHYSIOL, V129, P1899, DOI 10.1104/pp.005330; Liang C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-115; Liu CJ, 2006, PLANT CELL, V18, P3656, DOI 10.1105/tpc.106.041376; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Meazza G, 2002, PHYTOCHEMISTRY, V60, P281, DOI 10.1016/S0031-9422(02)00121-8; Menz MA, 2002, PLANT MOL BIOL, V48, P483, DOI 10.1023/A:1014831302392; NETZLY DH, 1986, CROP SCI, V26, P775, DOI 10.2135/cropsci1986.0011183X002600040031x; NETZLY DH, 1988, WEED SCI, V36, P441, DOI 10.1017/S0043174500075172; Nimbal CI, 1996, J AGR FOOD CHEM, V44, P1343, DOI 10.1021/jf950561n; Noel JP, 2003, RECENT ADV PHYTOCHEM, V37, P37; Ohlrogge J, 2000, CURR OPIN PLANT BIOL, V3, P224, DOI 10.1016/S1369-5266(00)00068-6; Ohyanagi H, 2006, NUCLEIC ACIDS RES, V34, pD741, DOI 10.1093/nar/gkj094; Pan ZQ, 2007, J BIOL CHEM, V282, P4326, DOI 10.1074/jbc.M606343200; Paramashivappa R, 2001, J AGR FOOD CHEM, V49, P2548, DOI 10.1021/jf001222j; Paterson Andrew H, 2006, Genome Biol, V7, P311, DOI 10.1186/gb-2006-7-3-311; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pratt LH, 2005, PLANT PHYSIOL, V139, P869, DOI 10.1104/pp.105.066134; RASMUSSEN JA, 1992, J CHEM ECOL, V18, P197, DOI 10.1007/BF00993753; Rimando AM, 2003, J NAT PROD, V66, P42, DOI 10.1021/np0203842; Rimando AM, 1998, J NAT PROD, V61, P927, DOI 10.1021/np9800708; RIMANDO AM, 2005, SEMIOCHEMICALS PEST, V906, P59; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J, 1989, MOL CLONING LAB MANU, P9; Schulz M, 1999, CHEMOECOLOGY, V9, P133, DOI 10.1007/s000490050044; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang JH, 1999, ARCH BIOCHEM BIOPHYS, V368, P172, DOI 10.1006/abbi.1999.1304; Wang JH, 1997, PLANT PHYSIOL, V114, P213, DOI 10.1104/pp.114.1.213; Weston LA, 2003, CRIT REV PLANT SCI, V22, P367, DOI 10.1080/713610861; Wu CH, 2002, NUCLEIC ACIDS RES, V30, P35, DOI 10.1093/nar/30.1.35; Yang XH, 2004, J EXP BOT, V55, P2251, DOI 10.1093/jxb/erh252; Zubieta C, 2002, PLANT CELL, V14, P1265, DOI 10.1105/tpc.001412; Zubieta C, 2001, NAT STRUCT BIOL, V8, P271, DOI 10.1038/85029	76	55	69	3	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3231	3247		10.1074/jbc.M706587200	http://dx.doi.org/10.1074/jbc.M706587200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	17998204	hybrid			2022-12-25	WOS:000253083000027
J	van der Merwe, M; Bjornsti, MA				van der Merwe, Marie; Bjornsti, Mary-Ann			Mutation of Gly(721) alters DNA topoisomerase I active site architecture and sensitivity to camptothecin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; YEAST; CLEAVAGE; MECHANISMS; RESISTANCE; DOMAIN; COVALENT; LINKER; DRUGS; FLEXIBILITY	DNA topoisomerase I (Top1p) catalyzes the relaxation of supercoiled DNA via a concerted mechanism of DNA strand cleavage and religation. Top1p is the cellular target of the anticancer drug camptothecin (CPT), which reversibly stabilizes a covalent enzyme-DNA intermediate. Top1p clamps around duplex DNA, wherein the core and C-terminal domains are connected by extended alpha-helices (linker domain), which position the active site Tyr of the C-terminal domain within the catalytic pocket. The physical connection of the linker with the Top1p clamp as well as linker flexibility affect enzyme sensitivity to CPT. Crystallographic data reveal that a conserved Gly residue (located at the juncture between the linker and C-terminal domains) is at one end of a short alpha-helix, which extends to the active site Tyr covalently linked to the DNA. In the presence of drug, the linker is rigid and this alpha-helix extends to include Gly and the preceding Leu. We report that mutation of this conserved Gly in yeast Top1p alters enzyme sensitivity to CPT. Mutating Gly to Asp, Glu, Asn, Gln, Leu, or Ala enhanced enzyme CPT sensitivity, with the acidic residues inducing the greatest increase in drug sensitivity in vivo and in vitro. By contrast, Val or Phe substituents rendered the enzyme CPT-resistant. Mutation-induced alterations in enzyme architecture preceding the active site Tyr suggest these structural transitions modulate enzyme sensitivity to CPT, while enhancing the rate of DNA cleavage. We postulate that this conserved Gly residue provides a flexible hinge within the Top1p catalytic pocket to facilitate linker dynamics and the structural alterations that accompany drug binding of the covalent enzyme-DNA intermediate.	[van der Merwe, Marie; Bjornsti, Mary-Ann] St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Bjornsti, MA (corresponding author), St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA.	mary-ann.bjornsti@stjude.org			NCI NIH HHS [R01 CA058755, CA58755, P30 CA021765, CA21765] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA058755] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BJORNSTI MA, 1987, P NATL ACAD SCI USA, V84, P8971, DOI 10.1073/pnas.84.24.8971; Bjornsti MA, 2002, CANCER CELL, V2, P267, DOI 10.1016/S1535-6108(02)00160-5; BURGIN AB, 1995, NUCLEIC ACIDS RES, V23, P2973, DOI 10.1093/nar/23.15.2973; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chillemi G, 2003, NUCLEIC ACIDS RES, V31, P1525, DOI 10.1093/nar/gkg242; Chrencik JE, 2004, J MOL BIOL, V339, P773, DOI 10.1016/j.jmb.2004.03.007; Colley WC, 2004, J BIOL CHEM, V279, P54069, DOI 10.1074/jbc.M409764200; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Fertala J, 2000, J BIOL CHEM, V275, P15246, DOI 10.1074/jbc.275.20.15246; Fiorani P, 1999, MOL PHARMACOL, V56, P1105, DOI 10.1124/mol.56.6.1105; Fiorani P, 2003, J BIOL CHEM, V278, P43268, DOI 10.1074/jbc.M303899200; Fiorani P, 2006, NUCLEIC ACIDS RES, V34, P5093, DOI 10.1093/nar/gkl670; Kaiser C., 1994, METHODS YEAST GENETI; KAUH EA, 1995, P NATL ACAD SCI USA, V92, P6299, DOI 10.1073/pnas.92.14.6299; KNAB AM, 1993, J BIOL CHEM, V268, P22322; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; LEVIN NA, 1993, GENETICS, V133, P799; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lisby M, 2001, J BIOL CHEM, V276, P20220, DOI 10.1074/jbc.M010991200; Losasso C, 2007, J BIOL CHEM, V282, P9855, DOI 10.1074/jbc.M608200200; Megonigal MD, 1997, J BIOL CHEM, V272, P12801, DOI 10.1074/jbc.272.19.12801; Montaudon D, 2007, J BIOL CHEM, V282, P14403, DOI 10.1074/jbc.M611673200; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pourquier P, 1997, J BIOL CHEM, V272, P26441, DOI 10.1074/jbc.272.42.26441; Pourquier P, 1999, J BIOL CHEM, V274, P8516, DOI 10.1074/jbc.274.13.8516; Pourquier P, 1997, J BIOL CHEM, V272, P7792, DOI 10.1074/jbc.272.12.7792; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Reid RJD, 1998, BBA-GENE STRUCT EXPR, V1400, P289, DOI 10.1016/S0167-4781(98)00142-0; Staker BL, 2005, J MED CHEM, V48, P2336, DOI 10.1021/jm049146p; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stewart L, 1999, J BIOL CHEM, V274, P32950, DOI 10.1074/jbc.274.46.32950; Stewart L, 1997, J MOL BIOL, V269, P355, DOI 10.1006/jmbi.1997.1056; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Stewart L, 1996, J BIOL CHEM, V271, P7602, DOI 10.1074/jbc.271.13.7602; STIVERS JT, 1994, BIOCHEMISTRY-US, V33, P327, DOI 10.1021/bi00167a043; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Woo MH, 2003, P NATL ACAD SCI USA, V100, P13767, DOI 10.1073/pnas.2235886100; Woo MH, 2002, J BIOL CHEM, V277, P3813, DOI 10.1074/jbc.M110484200	40	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3305	3315		10.1074/jbc.M705781200	http://dx.doi.org/10.1074/jbc.M705781200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056711	Green Accepted, hybrid			2022-12-25	WOS:000253083000035
J	Irarrazabal, CE; Williams, CK; Ely, MA; Birrer, MJ; Garcia-Perez, A; Burg, MB; Ferraris, JD				Irarrazabal, Carlos E.; Williams, Chester K.; Ely, Megan A.; Birrer, Michael J.; Garcia-Perez, Arlyn; Burg, Maurice B.; Ferraris, Joan D.			Activator protein-1 contributes to high NaCl-induced increase in tonicity-responsive enhancer/osmotic response element-binding protein transactivating activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ALDOSE REDUCTASE GENE; INOSITOL COTRANSPORTER GENE; OSMOTIC RESPONSE; DNA-BINDING; C-JUN; STIMULATES TRANSCRIPTION; STRUCTURAL ORGANIZATION; HYPEROSMOTIC STRESS; EXPRESSION	Tonicity-responsive enhancer/osmotic response element-binding protein (TonEBP/OREBP) is a Rel protein that activates transcription of osmoprotective genes at high extracellular NaCl. Other Rel proteins NFAT1-4 and NF-kappa B complex with activator protein-1 (AP-1) to transactivate target genes through interaction at composite NFAT/NF-kappa B center dot AP-1 sites. TonEBP/OREBP target genes commonly have one or more conserved AP-1 binding sites near TonEBP/OREBPcognateelements(OREs). Also, TonEBP/OREBP and the AP-1 proteins c-Fos and c-Jun are all activated by high NaCl. We now find, using an ORE center dot AP-1 reporter from the target aldose reductase gene or the same reporter with a mutated AP-1 site, that upon stimulation by high extracellular NaCl, 1) the presence of a wild type, but not a mutated, AP-1 site contributes to TonEBP/OREBP-dependent transcription and 2) AP-1 dominant negative constructs inhibit TonEBP/OREBP-dependent transcription provided the AP-1 site is not mutated. Using supershifts and an ORE center dot AP-1 probe, we find c-Fos and c-Jun present in combination with TonEBP/ OREBP. Also, c-Fos and c-Jun coimmunoprecipitate with TonEBP/ OREBP, indicating physical association. Small interfering RNA knockdown of either c-Fos or c-Jun inhibits high NaCl-induced increase of mRNA abundance of the TonEBP/ OREBP target genes AR and BGT1. Furthermore, a dominant negative AP-1 also reduces high NaCl-induced increase of TonEBP/ OREBP transactivating activity. Inhibition of p38, which is known to stimulate TonEBP/OREBP transcriptional activity, reduces high NaCl-dependent transcription of anORE center dot AP-1 reporter only if the AP-1 site is intact. Thus, AP-1 is part of the TonEBP/ OREBP enhanceosome, and its role in high NaCl-induced activation of TonEBP/ OREBP may require p38 activity.	[Irarrazabal, Carlos E.; Williams, Chester K.; Ely, Megan A.; Garcia-Perez, Arlyn; Burg, Maurice B.; Ferraris, Joan D.] NHLBI, Kidney & Electrolyte Metab Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Birrer, Michael J.] NCI, Cell & Canc Biol Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ferraris, JD (corresponding author), NHLBI, Kidney & Electrolyte Metab Lab, NIH, Dept Hlth & Human Serv, 10 Ctr Dr,MSC 1603, Bethesda, MD 20892 USA.	ferraris@nhlbi.nih.gov		Irarrazabal, Carlos Ernesto/0000-0002-6538-5314	NATIONAL CANCER INSTITUTE [Z01SC000165, ZIASC000165] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001283, Z01HL001283] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aida K, 1999, ENDOCRINOLOGY, V140, P609, DOI 10.1210/en.140.2.609; Alvarez M, 2003, GENE, V313, P43, DOI 10.1016/S0378-1119(03)00627-9; BORSOOK D, 1994, MOL ENDOCRINOL, V8, P240, DOI 10.1210/me.8.2.240; BROWN PH, 1994, ONCOGENE, V9, P791; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Cai Q, 2005, AM J PHYSIOL-RENAL, V289, pF803, DOI 10.1152/ajprenal.00448.2004; Cai Q, 2004, AM J PHYSIOL-RENAL, V286, pF58, DOI 10.1152/ajprenal.00037.2003; Chen Y, 2007, AM J PHYSIOL-RENAL, V292, pP981, DOI 10.1152/ajprenal.00493.2005; CHOWDHURY M, 1993, ONCOGENE, V8, P887; Clerk A, 1997, BIOCHEM J, V325, P801, DOI 10.1042/bj3250801; COHEN DM, 1991, AM J PHYSIOL, V261, pC594, DOI 10.1152/ajpcell.1991.261.4.C594; COLLA E, 2003, BIOCHEM J, V393, P411; Dahl SC, 2001, AM J PHYSIOL-CELL PH, V280, pC248, DOI 10.1152/ajpcell.2001.280.2.C248; Daoudal S, 1997, J BIOL CHEM, V272, P2615, DOI 10.1074/jbc.272.5.2615; Esensten JH, 2005, NUCLEIC ACIDS RES, V33, P3845, DOI 10.1093/nar/gki701; FERRARIS JD, 1994, P NATL ACAD SCI USA, V91, P10742, DOI 10.1073/pnas.91.22.10742; Ferraris JD, 1999, AM J PHYSIOL-CELL PH, V276, pC667, DOI 10.1152/ajpcell.1999.276.3.C667; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P16800, DOI 10.1073/pnas.222659799; Ferraris JD, 2001, AM ZOOL, V41, P734, DOI 10.1668/0003-1569(2001)041[0734:ORGTMO]2.0.CO;2; Ferraris JD, 1996, J BIOL CHEM, V271, P18318, DOI 10.1074/jbc.271.31.18318; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; Ha H, 2003, J BIOL CHEM, V278, P18573, DOI 10.1074/jbc.M212626200; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Irarrazabal CE, 2006, P NATL ACAD SCI USA, V103, P8882, DOI 10.1073/pnas.0602911103; Irarrazabal CE, 2004, P NATL ACAD SCI USA, V101, P8809, DOI 10.1073/pnas.0403062101; Jones WK, 2005, CARDIOVASC TOXICOL, V5, P183, DOI 10.1385/CT:5:2:183; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Ko BCB, 2000, BIOCHEM BIOPH RES CO, V270, P52, DOI 10.1006/bbrc.2000.2376; Ko BCB, 2002, J BIOL CHEM, V277, P46085, DOI 10.1074/jbc.M208138200; Ko BCB, 1997, J BIOL CHEM, V272, P16431, DOI 10.1074/jbc.272.26.16431; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lee SD, 2002, BIOCHEM BIOPH RES CO, V294, P968, DOI 10.1016/S0006-291X(02)00572-7; Liu GM, 2006, MOL CARCINOGEN, V45, P582, DOI 10.1002/mc.20189; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Mallee JJ, 1997, GENOMICS, V46, P459, DOI 10.1006/geno.1997.5055; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; Miyakawa H, 1999, BBA-GENE STRUCT EXPR, V1446, P359, DOI 10.1016/S0167-4781(99)00122-0; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; Rauchman MI, 1997, AM J PHYSIOL-RENAL, V273, pF9, DOI 10.1152/ajprenal.1997.273.1.F9; Rim JS, 1997, ARCH BIOCHEM BIOPHYS, V341, P193, DOI 10.1006/abbi.1997.9950; SMARDO FL, 1992, AM J PHYSIOL, V262, pC776, DOI 10.1152/ajpcell.1992.262.3.C776; Stroud JC, 2002, NAT STRUCT BIOL, V9, P90, DOI 10.1038/nsb749; TAKENAKA M, 1994, J BIOL CHEM, V269, P29379; Tanaka M, 1996, P NATL ACAD SCI USA, V93, P4311, DOI 10.1073/pnas.93.9.4311; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; Thomas RS, 1997, ONCOGENE, V14, P2845, DOI 10.1038/sj.onc.1201125; Trama J, 2000, J IMMUNOL, V165, P4884, DOI 10.4049/jimmunol.165.9.4884; UCHIDA S, 1987, AM J PHYSIOL, V253, pC230, DOI 10.1152/ajpcell.1987.253.2.C230; Westermarck J, 2002, EMBO J, V21, P451, DOI 10.1093/emboj/21.3.451; Wiese S, 1998, BIOL CHEM, V379, P667, DOI 10.1515/bchm.1998.379.6.667; WOLLNIK B, 1993, BIOCHEM BIOPH RES CO, V194, P642, DOI 10.1006/bbrc.1993.1869; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; Xiao WH, 2004, CANCER BIOL THER, V3, P1007, DOI 10.4161/cbt.3.10.1141; Ying Z, 1996, MOL BRAIN RES, V39, P109, DOI 10.1016/0169-328X(96)00015-0; Zhang Z, 2005, AM J PHYSIOL-RENAL, V289, pF506, DOI 10.1152/ajprenal.00417.2004; Zhou C, 1997, EXP EYE RES, V65, P349, DOI 10.1006/exer.1997.0335	61	32	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2554	2563		10.1074/jbc.M703490200	http://dx.doi.org/10.1074/jbc.M703490200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18056707	hybrid			2022-12-25	WOS:000252622300012
J	Klewpatinond, M; Davies, P; Bowen, S; Brown, DR; Viles, JH				Klewpatinond, Mark; Davies, Paul; Bowen, Suzanne; Brown, David R.; Viles, John H.			Deconvoluting the Cu2+ binding modes of full-length prion protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRP KNOCKOUT MICE; COPPER-BINDING; CIRCULAR-DICHROISM; OCTAREPEAT DOMAIN; REPEAT REGION; METAL-BINDING; N-TERMINUS; AFFINITY; DISEASE; RECOMBINANT	The prion protein (PrP) is a cell-surface Cu2+-binding glycoprotein that when misfolded is responsible for a number of transmissible spongiform encephalopathies. Full-length PrP(23-231) and constructs in which the octarepeat region has been removed, or His(95) and His(110) is replaced by alanine residues, have been used to elucidate the order and mode of Cu2+ coordination to PrP-(23-231). We have built on our understanding of the appearance of visible CD spectra and EPR for various PrP fragments to characterize Cu2+ coordination to full-length PrP. At physiological pH, Cu2+ initially binds to full-length PrP in the amyloidogenic region between the octarepeats and the structured domain at His(95) and His(110). Only subsequent Cu2+ ions bind to single histidine residues within the octarepeat region. Ni2+ ions are used to further probe metal binding and, like Cu2+, Ni2+ will bind individually to His(95) and His(110), involving preceding main chain amides. Competitive chelators are used to determine the affinity of the first mole equivalent of Cu2+ bound to full-length PrP; this approach places the affinity in the nanomolar range. The affinity and number of Cu2+ binding sites support the suggestion that PrP could act as a sacrificial quencher of free radicals generated by copper redox cycling.	[Klewpatinond, Mark; Viles, John H.] Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Davies, Paul; Bowen, Suzanne; Brown, David R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of London; University of Bath	Viles, JH (corresponding author), Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	j.viles@qmul.ac.uk		Davies, Paul/0000-0001-8022-2719	BBSRC [BB/D005027/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D005027/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abdelraheim SR, 2006, INT J BIOCHEM CELL B, V38, P1429, DOI 10.1016/j.biocel.2006.02.007; Bocharova OV, 2005, BIOCHEMISTRY-US, V44, P6776, DOI 10.1021/bi050251q; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; Brown DR, 2004, DALTON T, P1907, DOI 10.1039/b401985g; Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; Brown DR, 2002, J NEUROSCI RES, V67, P211, DOI 10.1002/jnr.10118; Burns CS, 2002, BIOCHEMISTRY-US, V41, P3991, DOI 10.1021/bi011922x; Burns CS, 2003, BIOCHEMISTRY-US, V42, P6794, DOI 10.1021/bi027138+; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Florio T, 2003, J NEUROCHEM, V85, P62, DOI 10.1046/j.1471-4159.2003.01664.x; Garnett AP, 2003, J BIOL CHEM, V278, P6795, DOI 10.1074/jbc.M209280200; Garnett AP, 2006, DALTON T, P509, DOI 10.1039/b511553a; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hasnain SS, 2001, J MOL BIOL, V311, P467, DOI 10.1006/jmbi.2001.4795; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; Hopt A, 2003, J NEUROSCI METH, V128, P159, DOI 10.1016/S0165-0270(03)00173-0; Horwich AL, 1997, CELL, V89, P499, DOI 10.1016/S0092-8674(00)80232-9; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Joergstuerenburg H, 1999, J NEUROL NEUROSUR PS, V67, P252, DOI 10.1136/jnnp.67.2.252; Jones CE, 2005, J MOL BIOL, V346, P1393, DOI 10.1016/j.jmb.2004.12.043; Jones CE, 2004, J BIOL CHEM, V279, P32018, DOI 10.1074/jbc.M403467200; KARDOS J, 1989, NEUROSCI LETT, V103, P139, DOI 10.1016/0304-3940(89)90565-X; Klewpatinond M, 2007, FEBS LETT, V581, P1430, DOI 10.1016/j.febslet.2007.02.068; Klewpatinond M, 2007, BIOCHEM J, V404, P393, DOI 10.1042/BJ20061893; Kramer ML, 2001, J BIOL CHEM, V276, P16711, DOI 10.1074/jbc.M006554200; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; MASUOKA J, 1993, J BIOL CHEM, V268, P21533; Millhauser GL, 2004, ACCOUNTS CHEM RES, V37, P79, DOI 10.1021/ar0301678; Muramoto T, 1997, NAT MED, V3, P750, DOI 10.1038/nm0797-750; Muramoto T, 1996, P NATL ACAD SCI USA, V93, P15457, DOI 10.1073/pnas.93.26.15457; Nadal RC, 2007, FREE RADICAL BIO MED, V42, P79, DOI 10.1016/j.freeradbiomed.2006.09.019; Osz K, 2002, POLYHEDRON, V21, P2149, DOI 10.1016/S0277-5387(02)01151-8; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; PELSACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Rachidi W, 2003, J BIOL CHEM, V278, P14595, DOI 10.1074/jbc.C300092200; Rachidi W, 2003, J BIOL CHEM, V278, P9064, DOI 10.1074/jbc.M211830200; Requena JR, 2001, P NATL ACAD SCI USA, V98, P7170, DOI 10.1073/pnas.121190898; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Ruiz FH, 2000, BIOCHEM BIOPH RES CO, V269, P491, DOI 10.1006/bbrc.2000.2270; Sigurdsson EM, 2003, J BIOL CHEM, V278, P46199, DOI 10.1074/jbc.C300303200; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Thackray AM, 2002, BIOCHEM J, V362, P253, DOI 10.1042/0264-6021:3620253; Thompsett AR, 2005, J BIOL CHEM, V280, P42750, DOI 10.1074/jbc.M506521200; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Viles JH, 2001, BIOCHEMISTRY-US, V40, P2743, DOI 10.1021/bi002898a; Wadsworth JDF, 1999, NAT CELL BIOL, V1, P55, DOI 10.1038/9030; Waggoner DJ, 2000, J BIOL CHEM, V275, P7455, DOI 10.1074/jbc.275.11.7455; Walter ED, 2006, BIOCHEMISTRY-US, V45, P13083, DOI 10.1021/bi060948r; Watt NT, 2005, J BIOL CHEM, V280, P35914, DOI 10.1074/jbc.M507327200; Wells MA, 2006, BIOCHEM J, V400, P501, DOI 10.1042/BJ20060721; Wells MA, 2006, BIOCHEM J, V399, P435, DOI 10.1042/BJ20060458; Wong BS, 2001, J NEUROCHEM, V78, P1400, DOI 10.1046/j.1471-4159.2001.00522.x	61	94	95	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1870	1881		10.1074/jbc.M708472200	http://dx.doi.org/10.1074/jbc.M708472200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18042548	hybrid			2022-12-25	WOS:000252501000013
J	Adhikari, S; Uren, A; Roy, R				Adhikari, Sanjay; Uren, Aykut; Roy, Rabindra			Dipole-dipole interaction stabilizes the transition state of apurinic/apyrimidinic endonuclease - Abasic site interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; DNA-POLYMERASE-BETA; HUMAN APURINIC ENDONUCLEASE; ESCHERICHIA-COLI; SUBSTRATE-BINDING; MECHANISM; DAMAGE; GLYCOSYLASE; KINETICS; IDENTIFICATION	Human apurinic/apyrimidinic (AP) endonuclease (hAPE) initiates the repair of an abasic site AP site). To gain insight into the mechanisms of damage recognition of hAPE, we conducted surface plasmon resonance spectroscopy to study the thermodynamics and kinetics of its interaction with substrate DNA containing an abasic site AP DNA). The affinity of hAPE binding toward DNA increased as much as 6-fold after replacing a single adenine equilibrium dissociation constant, K-D, 5.3 nM) with an AP site K-D, 0.87 nM). The enzyme-substrate complex formation appears to be thermodynamically stabilized and favored by a large change in Gibbs free energy, Delta G degrees -50 kJ/mol). The latter is supported by a high negative change in enthalpy, Delta H degrees -43 kJ/ mol) and also positive change in entropy, Delta S degrees 24 J/ K mol)), and thus the binding process is spontaneous at all temperatures. Analysis of kinetic parameters reveals small enthalpy of activation for association, Delta H-ass degrees double dagger -17 kJ/ mol), and activation energy for association E-a, -14 kJ/ mol) when compared with the enthalpy of activation for dissociation, Delta H-diss degrees double dagger 26 kJ/ mol), and activation energy in the reverse direction E-d, 28 kJ/ mol). Furthermore, varying concentration of KCl showed an increase in binding affinity at low concentration but complete abrogation of the binding at higher concentration, implying the importance of hydrophobic, but predominately ionic, forces in the Michaelis-Menten complex formation. Thus, low activation energy and the enthalpy of activation, which are perhaps a result of dipole-dipole interactions, play critical roles in AP site binding of APE.	[Adhikari, Sanjay; Uren, Aykut; Roy, Rabindra] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA	Georgetown University	Adhikari, S (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, LL Level,S-120,3800 Reservoir Rd, Washington, DC 20057 USA.	sa354@georgetown.edu; rr228@georgetown.edu			NCI NIH HHS [R01 CA 108641, R01 CA092306, R01 CA 92306] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA108641, R01CA092306] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adhikari S, 2008, DNA REPAIR, V7, P31, DOI 10.1016/j.dnarep.2007.07.012; Adhikari S, 2007, J BIOL CHEM, V282, P30078, DOI 10.1074/jbc.M704051200; Adhikari S, 2006, J BIOL CHEM, V281, P29525, DOI 10.1074/jbc.M602673200; Beard WA, 2004, J BIOL CHEM, V279, P31921, DOI 10.1074/jbc.M404016200; Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; Berg BJV, 2001, J BIOL CHEM, V276, P3408, DOI 10.1074/jbc.M002884200; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Chou KM, 2002, NATURE, V415, P655, DOI 10.1038/415655a; DAY YSN, 2007, PROTEIN SCI, V2002, P1017; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; DOETSCH PW, 1990, MUTAT RES, V236, P173, DOI 10.1016/0921-8777(90)90004-O; Donny W, 2004, J BIOL CHEM, V279, P25268, DOI 10.1074/jbc.M400804200; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES, P59; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Hadd AG, 1996, J ORG CHEM, V61, P2657, DOI 10.1021/jo951627g; LARSON K, 1985, MUTAT RES, V233, P211; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425; Liu YA, 2007, J BIOL CHEM, V282, P13532, DOI 10.1074/jbc.M611295200; Madhusudan Srinivasan, 2004, Proceedings of the American Association for Cancer Research Annual Meeting, V45, P1237; Maher RL, 2007, J BIOL CHEM, V282, P30577, DOI 10.1074/jbc.M704341200; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; MAZUR SJ, 1991, BIOCHEMISTRY-US, V30, P4432, DOI 10.1021/bi00232a009; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, P81, DOI 10.1093/nar/gki148; Mitra S, 2001, ENVIRON MOL MUTAGEN, V38, P180, DOI 10.1002/em.1070; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; MOSBAUGH DW, 1994, PROG NUCLEIC ACID RE, V48, P315, DOI 10.1016/S0079-6603(08)60859-4; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Ohkubo K, 2005, J PHYS CHEM A, V109, P1105, DOI 10.1021/jp0453008; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Pischel U, 2001, J AM CHEM SOC, V123, P9727, DOI 10.1021/ja011212e; ROE JH, 1984, J MOL BIOL, V176, P495, DOI 10.1016/0022-2836(84)90174-8; Roy R, 1998, BIOCHEMISTRY-US, V37, P580, DOI 10.1021/bi972313l; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Sokhansanj BA, 2002, NUCLEIC ACIDS RES, V30, P1817, DOI 10.1093/nar/30.8.1817; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; Suetake I, 2006, J BIOCHEM, V140, P553, DOI 10.1093/jb/mvj185; VANHOUTEN B, 1987, J BIOL CHEM, V262, P13180; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Wilson DM, 1997, P NATL ACAD SCI USA, V94, P12754, DOI 10.1073/pnas.94.24.12754; Zou Y, 1998, J MOL BIOL, V281, P107, DOI 10.1006/jmbi.1998.1903	44	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1334	1339		10.1074/jbc.M704594200	http://dx.doi.org/10.1074/jbc.M704594200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18025089	hybrid			2022-12-25	WOS:000252282700016
J	Frankel, LB; Christoffersen, NR; Jacobsen, A; Lindow, M; Krogh, A; Lund, AH				Frankel, Lisa B.; Christoffersen, Nanna R.; Jacobsen, Anders; Lindow, Morten; Krogh, Anders; Lund, Anders H.			Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; NF-KAPPA-B; TRANSFORMATION SUPPRESSOR; TRANSLATION INITIATION; SMALL RNAS; EXPRESSION; APOPTOSIS; AP-1; INVOLVEMENT; REPRESSION	MicroRNAs are emerging as important regulators of cancer-related processes. The miR-21 microRNA is overexpressed in a wide variety of cancers and has been causally linked to cellular proliferation, apoptosis, and migration. Inhibition of mir-21 in MCF-7 breast cancer cells causes reduced cell growth. Using array expression analysis of MCF-7 cells depleted of miR-21, we have identified mRNA targets of mir-21 and have shown a link between miR-21 and the p53 tumor suppressor protein. We furthermore found that the tumor suppressor protein Programmed Cell Death 4 (PDCD4) is regulated by miR-21 and demonstrated that PDCD4 is a functionally important target for miR-21 in breast cancer cells.	[Frankel, Lisa B.; Christoffersen, Nanna R.; Jacobsen, Anders; Lindow, Morten; Krogh, Anders; Lund, Anders H.] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark; [Jacobsen, Anders; Lindow, Morten; Krogh, Anders] Univ Copenhagen, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Lund, Anders H.] Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Lund, AH (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	anders.lund@bric.dk	Skanderup, Anders Jacobsen/K-1081-2013; Lund, Anders H./F-4786-2014; Krogh, Anders/M-1541-2014	Skanderup, Anders Jacobsen/0000-0001-6847-4980; Lund, Anders H./0000-0002-7407-3398; Frankel, Lisa/0000-0001-7249-3607; Krogh, Anders/0000-0002-5147-6282				Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2007, J CLIN INVEST, V117, P2059, DOI 10.1172/JCI32577; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gao F, 2007, ONCOL REP, V17, P123; Goke A, 2002, BIOCHEM BIOPH RES CO, V297, P78, DOI 10.1016/S0006-291X(02)02129-0; Goke R, 2004, AM J PHYSIOL-CELL PH, V287, pC1541, DOI 10.1152/ajpcell.00025.2004; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Hwang SK, 2007, GENE THER, V14, P1353, DOI 10.1038/sj.gt.3302983; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Jansen AP, 2004, MOL CANCER THER, V3, P103; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jovanovic M, 2006, ONCOGENE, V25, P6176, DOI 10.1038/sj.onc.1209912; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lankat-Buttgereit B, 2003, BIOL CELL, V95, P515, DOI 10.1016/j.biolcel.2003.09.003; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Sage C Ie, 2007, EMBO J, V26, P3699; Sevignani C, 2007, P NATL ACAD SCI USA, V104, P8017, DOI 10.1073/pnas.0702177104; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Yang HS, 2001, ONCOGENE, V20, P669, DOI 10.1038/sj.onc.1204137; Young MR, 2003, TRENDS MOL MED, V9, P36, DOI 10.1016/S1471-4914(02)00009-6; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	61	915	995	0	77	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1026	1033		10.1074/jbc.M707224200	http://dx.doi.org/10.1074/jbc.M707224200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17991735	hybrid			2022-12-25	WOS:000252128100042
J	He, R; Drury, GE; Rotari, VI; Gordon, A; Willer, M; Farzaneh, T; Woltering, EJ; Gallois, P				He, Rui; Drury, Georgina E.; Rotari, Vitalie I.; Gordon, Anna; Willer, Martin; Farzaneh, Tabasum; Woltering, Ernst J.; Gallois, Patrick			Metacaspase-8 modulates programmed cell death induced by ultraviolet light and H2O2 in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAYS; APOPTOSIS; THALIANA; YEAST; GENE; RESISTANCE; JASMONATE; ETHYLENE; PROTEIN; FAMILY	Programmed cell death (PCD) is a genetically controlled cell death that is regulated during development and activated in response to environmental stresses or pathogen infection. The degree of conservation of PCD across kingdoms and phylum is not yet clear; however, whereas caspases are proteases that act as key components of animal apoptosis, plants have no orthologous caspase sequences in their genomes. The discovery of plant and fungi metacaspases as proteases most closely related to animal caspases led to the hypothesis that metacaspases are the functional homologues of animal caspases in these organisms. Arabidopsis thaliana has nine metacaspase genes, and so far it is unknown which members of the family if any are involved in the regulation of PCD. We show here that metacaspase-8 (AtMC8) is a member of the gene family strongly up-regulated by oxidative stresses caused by UVC, H2O2, or methyl viologen. This up-regulation was dependent of RCD1, a mediator of the oxidative stress response. Recombinant metacaspase-8 cleaved after arginine, had a pH optimum of 8, and complemented the H2O2 no-death phenotype of a yeast metacaspase knock-out. Overexpressing AtMC8 up-regulated PCD induced by UVC or H2O2, and knocking out AtMC8 reduced cell death triggered by UVC and H2O2 in protoplasts. Knock-out seeds and seedlings had an increased tolerance to the herbicide methyl viologen. We suggest that metacaspase-8 is part of an evolutionary conserved PCD pathway activated by oxidative stress.	[He, Rui; Drury, Georgina E.; Rotari, Vitalie I.; Gordon, Anna; Willer, Martin; Farzaneh, Tabasum; Gallois, Patrick] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Woltering, Ernst J.] Univ Wageningen & Res Ctr, Agrotechnol & Food Sci Grp, NL-6700 AA Wageningen, Netherlands	University of Manchester; Wageningen University & Research	Gallois, P (corresponding author), Univ Manchester, Fac Life Sci, 3 614 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	patrick.gallois@manchester.ac.uk		GALLOIS, Patrick/0000-0002-6305-2807				Ahlfors R, 2004, PLANT CELL, V16, P1925, DOI 10.1105/tpc.021832; Asai T, 2000, PLANT CELL, V12, P1823, DOI 10.1105/tpc.12.10.1823; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Belenghi B, 2007, J BIOL CHEM, V282, P1352, DOI 10.1074/jbc.M608931200; Belles-Boix E, 2000, FEBS LETT, V482, P19, DOI 10.1016/S0014-5793(00)02016-0; Bozhkov PV, 2004, CELL DEATH DIFFER, V11, P175, DOI 10.1038/sj.cdd.4401330; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; Chandra-Shekara AC, 2006, PLANT J, V45, P320, DOI 10.1111/j.1365-313X.2005.02618.x; Chen SR, 2004, J EXP BOT, V55, P2617, DOI 10.1093/jxb/erh275; Danon A, 1998, FEBS LETT, V437, P131, DOI 10.1016/S0014-5793(98)01208-3; Danon A, 2004, J BIOL CHEM, V279, P779, DOI 10.1074/jbc.M304468200; Danon A, 2006, P NATL ACAD SCI USA, V103, P17036, DOI 10.1073/pnas.0608139103; Desikan R, 1998, BIOCHEM J, V330, P115, DOI 10.1042/bj3300115; Dietrich RA, 1997, CELL, V88, P685, DOI 10.1016/S0092-8674(00)81911-X; Fujibe T, 2004, PLANT PHYSIOL, V134, P275, DOI 10.1104/pp.103.033480; Gunawardena AHLAN, 2005, PLANTA, V221, P607, DOI 10.1007/s00425-005-1545-1; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hauptmann P, 2006, MOL MICROBIOL, V59, P765, DOI 10.1111/j.1365-2958.2005.04981.x; Helms MJ, 2006, J CELL SCI, V119, P1105, DOI 10.1242/jcs.02809; Hoeberichts FA, 2003, PLANTA, V217, P517, DOI 10.1007/s00425-003-1049-9; Ivanovska I, 2005, J CELL BIOL, V170, P391, DOI 10.1083/jcb.200503069; Koonin EV, 2002, CELL DEATH DIFFER, V9, P394, DOI 10.1038/sj.cdd.4400991; Los M, 1999, IMMUNITY, V10, P629, DOI 10.1016/S1074-7613(00)80062-X; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Matsumura H, 2003, PLANT J, V33, P425, DOI 10.1046/j.1365-313X.2003.01639.x; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Overmyer K, 2000, PLANT CELL, V12, P1849, DOI 10.1105/tpc.12.10.1849; PIETRZAK M, 1986, NUCLEIC ACIDS RES, V14, P5857, DOI 10.1093/nar/14.14.5857; Richie DL, 2007, MOL MICROBIOL, V63, P591, DOI 10.1111/j.1365-2958.2006.05534.x; Rotari VI, 2005, PHYSIOL PLANTARUM, V123, P376, DOI 10.1111/j.1399-3054.2005.00465.x; SAMBROOK J, 2000, MOL CLONING LAB MANU; Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x; Suarez MF, 2004, CURR BIOL, V14, pR339, DOI 10.1016/j.cub.2004.04.019; Szallies A, 2002, FEBS LETT, V517, P144, DOI 10.1016/S0014-5793(02)02608-X; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vachova L, 2005, J CELL BIOL, V169, P711, DOI 10.1083/jcb.200410064; van Baarlen P, 2007, MOL PLANT PATHOL, V8, P41, DOI 10.1111/j.1364-3703.2006.00367.x; Vercammen D, 2004, J BIOL CHEM, V279, P45329, DOI 10.1074/jbc.M406329200; Vercammen D, 2006, J MOL BIOL, V364, P625, DOI 10.1016/j.jmb.2006.09.010; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200; Zhang NN, 2006, MOL BIOL CELL, V17, P3409, DOI 10.1091/mbc.E06-03-0177	41	180	195	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					774	783		10.1074/jbc.M704185200	http://dx.doi.org/10.1074/jbc.M704185200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17998208	hybrid			2022-12-25	WOS:000252128100016
J	Moriuchi, H; Koda, N; Okuda-Ashitaka, E; Daiyasu, H; Ogasawara, K; Toh, H; Ito, S; Woodward, DF; Watanabe, K				Moriuchi, Hiroshi; Koda, Noriko; Okuda-Ashitaka, Emiko; Daiyasu, Hiromi; Ogasawara, Kensuke; Toh, Hiroyuki; Ito, Seiji; Woodward, David F.; Watanabe, Kikuko			Molecular characterization of a novel type of prostamide/prostaglandin F synthase, belonging to the thioredoxin-like superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE LUNG; PROSTAGLANDIN-ETHANOLAMIDES; CANNABINOID RECEPTOR; PHYSIOLOGICAL FUNCTIONS; GLYCEROL ESTERS; CDNA CLONING; IN-VITRO; ANANDAMIDE; BIMATOPROST; EXPRESSION	Prostaglandin F (PGF) ethanolamide (prostamide F) synthase, which catalyzed the reduction of prostamide H-2 to prostamide F-2 alpha,F-, was found in mouse and swine brain. The enzyme was purified from swine brain, and its amino acid sequence was defined. The mouse enzyme consisted of a 603-bp open reading frame coding for a 201-amino acid polypeptide with a molecular weight of 21,669. The amino acid sequence placed the enzyme in the thioredoxin-like superfamily with Cys(44) being the active site. The enzyme expressed in Escherichia coli as well as the native enzyme catalyzed not only the reduction of prostamide H-2 to prostamide F-2 alpha but also that of PGH(2) to PGF(2 alpha). The V-max and Km values for prostamide H-2 were about 0.25 mu mol/min center dot mg of protein and 7.6 mu M, respectively, and those for PGH(2) were about 0.69 mu mol/min center dot mg of protein and 6.9 mu M, respectively. Neither PGE(2) nor PGD(2) served as a substrate for this synthase. Based on these data, we named the enzyme prostamide/PGF synthase. Although the enzyme showed a broad specificity for reductants, reduced thioredoxin preferentially served as a reducing equivalent donor for this enzyme. Moreover, Northern and Western blot analyses in addition to the prostamide F synthase activity showed that the enzyme was mainly distributed in the brain and spinal cord, and the immunohistochemical study in the spinal cord showed that the enzyme was found mainly in the cytosol. These results suggest that prostamide/PGF synthase may play an important functional role in the central nervous system.	[Moriuchi, Hiroshi; Koda, Noriko; Ogasawara, Kensuke; Watanabe, Kikuko] Univ E Asia, Grad Sch Integrated Sci & Art, Div Life Sci, Yamaguchi 7518503, Japan; [Okuda-Ashitaka, Emiko; Ito, Seiji] Kansai Med Univ, Dept Med Chem, Osaka 5708506, Japan; [Daiyasu, Hiromi] Osaka Univ, Ctr Adv Med Engn & Informat, Osaka 5608531, Japan; [Toh, Hiroyuki] Kyushu Univ, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Woodward, David F.] Allergan Pharmaceut Inc, Dept Biol Sci, Irvine, CA 92612 USA	Kansai Medical University; Osaka University; Kyushu University; AbbVie; Allergan	Watanabe, K (corresponding author), Univ E Asia, Grad Sch Integrated Sci & Art, Div Life Sci, 2-1 Ichinomiyagakuen, Yamaguchi 7518503, Japan.	watanabe@toua-u.ac.jp		ito, Seiji/0000-0002-0942-1624				Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; CHEN LY, 1992, ARCH BIOCHEM BIOPHYS, V296, P17, DOI 10.1016/0003-9861(92)90539-9; Ciceri P, 2002, J PHARMACOL EXP THER, V302, P846, DOI 10.1124/jpet.302.3.846; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2002, PROSTAG LEUKOTR ESS, V66, P91, DOI 10.1054/plef.2001.0339; FELDER CC, 1993, P NATL ACAD SCI USA, V90, P7656, DOI 10.1073/pnas.90.16.7656; Gandolfi SA, 2003, OPHTHALMOLOGY, V110, P609, DOI 10.1016/S0161-6420(02)01891-2; GRIPPO JF, 1985, J BIOL CHEM, V260, P93; Koda N, 2004, ARCH BIOCHEM BIOPHYS, V424, P128, DOI 10.1016/j.abb.2004.02.009; Kozak KR, 2002, J BIOL CHEM, V277, P44877, DOI 10.1074/jbc.M206788200; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kozak KR, 2001, J BIOL CHEM, V276, P36993, DOI 10.1074/jbc.M105854200; Lee KK, 1998, J BIOL CHEM, V273, P19160, DOI 10.1074/jbc.273.30.19160; LEVINE L, 1975, PROSTAGLANDINS, V9, P531, DOI 10.1016/0090-6980(75)90059-3; Li S, 2005, J MOL BIOL, V346, P1035, DOI 10.1016/j.jmb.2004.12.046; Liang YB, 2003, J BIOL CHEM, V278, P27267, DOI 10.1074/jbc.M301009200; Maione S, 2007, BRIT J PHARMACOL, V150, P766, DOI 10.1038/sj.bjp.0707145; Matias I, 2004, J PHARMACOL EXP THER, V309, P745, DOI 10.1124/jpet.103.061705; Moon S, 2005, INVEST OPHTH VIS SCI, V46, P3783, DOI 10.1167/iovs.05-0237; Muratani T, 2003, J NEUROCHEM, V86, P374, DOI 10.1046/j.1471-4159.2003.01840.x; Okuda K, 2002, DOMEST ANIM ENDOCRIN, V23, P255, DOI 10.1016/S0739-7240(02)00161-3; Pekkari K, 2004, ANTIOXID REDOX SIGN, V6, P53, DOI 10.1089/152308604771978345; Shima S, 1998, EUR J BIOCHEM, V258, P85, DOI 10.1046/j.1432-1327.1998.2580085.x; Sugiura T, 2000, J BIOL CHEM, V275, P605, DOI 10.1074/jbc.275.1.605; Suzuki T, 1999, J BIOL CHEM, V274, P241, DOI 10.1074/jbc.274.1.241; Suzuki-Yamamoto T, 1999, FEBS LETT, V462, P335, DOI 10.1016/S0014-5793(99)01551-3; Tanikawa N, 2002, BIOCHEM BIOPH RES CO, V291, P884, DOI 10.1006/bbrc.2002.6531; URADE Y, 1995, J LIPID MEDIAT CELL, V12, P257, DOI 10.1016/0929-7855(95)00032-L; Wan Z, 2007, INVEST OPHTH VIS SCI, V48, P4107, DOI 10.1167/iovs.07-0080; WATANABE K, 1986, P NATL ACAD SCI USA, V83, P1583, DOI 10.1073/pnas.83.6.1583; WATANABE K, 1991, BIOCHEM BIOPH RES CO, V181, P272, DOI 10.1016/S0006-291X(05)81413-5; WATANABE K, 1981, BIOCHEM INT, V2, P603; WATANABE K, 1985, J BIOL CHEM, V260, P7035; WATANABE K, 1988, P NATL ACAD SCI USA, V85, P11, DOI 10.1073/pnas.85.1.11; Weber A, 2004, J LIPID RES, V45, P757, DOI 10.1194/jlr.M300475-JLR200; Woodward DF, 2007, BRIT J PHARMACOL, V150, P342, DOI 10.1038/sj.bjp.0706989; Woodward DF, 2003, J PHARMACOL EXP THER, V305, P772, DOI 10.1124/jpet.102.047837; Yoshikawa K, 2006, J BIOL CHEM, V281, P14663, DOI 10.1074/jbc.M511089200; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	40	36	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					792	801		10.1074/jbc.M705638200	http://dx.doi.org/10.1074/jbc.M705638200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18006499	hybrid			2022-12-25	WOS:000252128100018
J	Shibata, H; Yoshioka, Y; Ohkawa, A; Minowa, K; Mukai, Y; Abe, Y; Taniai, M; Nomura, T; Kayamuro, H; Nabeshi, H; Sugita, T; Imai, S; Nagano, K; Yoshikawa, T; Fujita, T; Nakagawa, S; Yamamoto, A; Ohta, T; Hayakawa, T; Mayumi, T; Vandenabeele, P; Aggarwal, BB; Nakamura, T; Yamagata, Y; Tsunoda, S; Kamada, H; Tsutsumi, Y				Shibata, Hiroko; Yoshioka, Yasuo; Ohkawa, Akiko; Minowa, Kyoko; Mukai, Yohei; Abe, Yasuhiro; Taniai, Madoka; Nomura, Tetsuya; Kayamuro, Hiroyuki; Nabeshi, Hiromi; Sugita, Toshiki; Imai, Sunao; Nagano, Kazuya; Yoshikawa, Tomoaki; Fujita, Takuya; Nakagawa, Shinsaku; Yamamoto, Akira; Ohta, Tsunetaka; Hayakawa, Takao; Mayumi, Tadanori; Vandenabeele, Peter; Aggarwal, Bharat B.; Nakamura, Teruya; Yamagata, Yuriko; Tsunoda, Shin-ichi; Kamada, Haruhiko; Tsutsumi, Yasuo			Creation and x-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-alpha antagonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF RECEPTOR-TYPE; RHEUMATOID-ARTHRITIS; MEDIATED APOPTOSIS; TRANSMEMBRANE TNF; SECRETED TNF; INFECTION; THERAPY; MICE; BINDING; PROLIFERATION	Tumor necrosis factor-alpha (TNF) induces inflammatory response predominantly through the TNF receptor-1 (TNFR1). Thus, blocking the binding of TNF to TNFR1 is an important strategy for the treatment of many inflammatory diseases, such as hepatitis and rheumatoid arthritis. In this study, we identified a TNFR1-selective antagonistic mutant TNF from a phage library displaying structural human TNF variants in which each one of the six amino acid residues at the receptor-binding site ( amino acids at positions 84-89) was replaced with other amino acids. Consequently, a TNFR1-selective antagonistic mutant TNF (R1antTNF), containing mutations A84S, V85T, S86T, Y87H, Q88N, and T89Q, was isolated from the library. The R1antTNF did not activate TNFR1-mediated responses, although its affinity for the TNFR1 was almost similar to that of the human wild-type TNF (wtTNF). Additionally, the R1antTNF neutralized the TNFR1-mediated bioactivity of wtTNF without influencing its TNFR2-mediated bioactivity and inhibited hepatic injury in an experimental hepatitis model. To understand the mechanism underlying the antagonistic activity of R1antTNF, we analyzed this mutant using the surface plasmon resonance spectroscopy and x-ray crystallography. Kinetic association/dissociation parameters of the R1antTNF were higher than those of the wtTNF, indicating very fast bond dissociation. Furthermore, x-ray crystallographic analysis of R1antTNF suggested that the mutation Y87H changed the binding mode from the hydrophobic to the electrostatic interaction, which may be one of the reasons why R1antTNF behaved as an antagonist. Our studies demonstrate the feasibility of generating TNF receptor subtype-specific antagonist by extensive substitution of amino acids of the wild-type ligand protein.	[Shibata, Hiroko; Yoshioka, Yasuo; Ohkawa, Akiko; Minowa, Kyoko; Mukai, Yohei; Abe, Yasuhiro; Nomura, Tetsuya; Kayamuro, Hiroyuki; Nabeshi, Hiromi; Sugita, Toshiki; Imai, Sunao; Nagano, Kazuya; Yoshikawa, Tomoaki; Tsunoda, Shin-ichi; Kamada, Haruhiko; Tsutsumi, Yasuo] Natl Inst Biomed Innovat, Lab Pharmaceut Prote, Osaka 5670085, Japan; [Shibata, Hiroko; Hayakawa, Takao] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan; [Yoshioka, Yasuo; Nakagawa, Shinsaku; Tsunoda, Shin-ichi; Kamada, Haruhiko; Tsutsumi, Yasuo] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan; [Minowa, Kyoko; Fujita, Takuya; Yamamoto, Akira] Kyoto Pharmaceut Univ, Yamashina Ku, Kyoto 6078414, Japan; [Mukai, Yohei; Abe, Yasuhiro; Nomura, Tetsuya; Kayamuro, Hiroyuki; Nabeshi, Hiromi; Sugita, Toshiki; Imai, Sunao; Nagano, Kazuya; Nakagawa, Shinsaku; Tsutsumi, Yasuo] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Taniai, Madoka; Ohta, Tsunetaka] Hayashibara Biochem Labs Inc, Okayama 7028006, Japan; [Mayumi, Tadanori] Kobe Gakuin Univ, Grad Sch Pharmaceut Sci, Nishi Ku, Kobe, Hyogo 6512180, Japan; [Vandenabeele, Peter] Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium; [Vandenabeele, Peter] Univ Ghent, Dept Mol Biol, B-9052 Ghent, Belgium; [Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Nakamura, Teruya; Yamagata, Yuriko] Kumamoto Univ, Fac Med & Pharmaceut Sci, Kumamoto 8620973, Japan	National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan; Osaka University; Kyoto Pharmaceutical University; Osaka University; Hayashibara Biochemical Laboratories, Inc.; Kobe Gakuin University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of Texas System; UTMD Anderson Cancer Center; Kumamoto University	Kamada, H (corresponding author), Natl Inst Biomed Innovat, Lab Pharmaceut Prote, 7-6-8 Saito Asagi, Osaka 5670085, Japan.	kamada@nibio.go.jp	Vandenabeele, Peter/AAD-5793-2022; Abe, Yasuhiro/F-5206-2016; Vandenabeele, Peter/C-8597-2009; Fujita, Takuya/AAC-3442-2022; Yamamoto, Akira/AAC-1635-2022; Aggarwal, Bharat B/G-3388-2013	Vandenabeele, Peter/0000-0002-6669-8822; Abe, Yasuhiro/0000-0002-5931-6590; Fujita, Takuya/0000-0002-7724-6522; Kamada, Haruhiko/0000-0002-2478-3818; Nakamura, Teruya/0000-0003-2013-3057; Tsunoda, Shin-ichi/0000-0003-3299-2182				ADERKA D, 1992, J EXP MED, V175, P323, DOI 10.1084/jem.175.2.323; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; AGGARWAL BB, 1985, NATURE, V318, P665, DOI 10.1038/318665a0; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BARBARA JAJ, 1994, EMBO J, V13, P843, DOI 10.1002/j.1460-2075.1994.tb06327.x; Brown SL, 2002, ARTHRITIS RHEUM-US, V46, P3151, DOI 10.1002/art.10679; Brunetti CR, 2003, P NATL ACAD SCI USA, V100, P4831, DOI 10.1073/pnas.0737244100; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carter PH, 2001, P NATL ACAD SCI USA, V98, P11879, DOI 10.1073/pnas.211178398; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; ECK MJ, 1989, J BIOL CHEM, V264, P17595; ENGELMANN H, 1990, J BIOL CHEM, V265, P14497; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Fremond C, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-136; Goldbach-Mansky R, 2003, ANNU REV MED, V54, P197, DOI 10.1146/annurev.med.54.101601.152342; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Grell M, 1998, EUR J IMMUNOL, V28, P257, DOI 10.1002/(SICI)1521-4141(199801)28:01<257::AID-IMMU257>3.0.CO;2-G; Harrop JA, 1998, J BIOL CHEM, V273, P27548, DOI 10.1074/jbc.273.42.27548; HISHINUMA I, 1990, HEPATOLOGY, V12, P1187, DOI 10.1002/hep.1840120518; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kafrouni MI, 2003, J LEUKOCYTE BIOL, V74, P564, DOI 10.1189/jlb.0103035; Kamada H, 2003, NAT BIOTECHNOL, V21, P399, DOI 10.1038/nbt798; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kim EY, 2006, J IMMUNOL, V176, P1026, DOI 10.4049/jimmunol.176.2.1026; Krippner-Heidenreich A, 2002, J BIOL CHEM, V277, P44155, DOI 10.1074/jbc.M207399200; LEIST M, 1995, J IMMUNOL, V154, P1307; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; MACKAY F, 1993, J EXP MED, V177, P1277, DOI 10.1084/jem.177.5.1277; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mori L, 1996, J IMMUNOL, V157, P3178; Murali R, 2005, P NATL ACAD SCI USA, V102, P10970, DOI 10.1073/pnas.0504301102; MUTO Y, 1988, LANCET, V2, P72; Nagaki M, 1999, J HEPATOL, V31, P997, DOI 10.1016/S0168-8278(99)80311-0; Nathan DM, 2006, J GASTROEN HEPATOL, V21, P1366, DOI 10.1111/j.1440-1746.2006.04559.x; Olleros ML, 2002, J IMMUNOL, V168, P3394, DOI 10.4049/jimmunol.168.7.3394; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Ruuls SR, 2001, IMMUNITY, V15, P533, DOI 10.1016/S1074-7613(01)00215-1; Saunders BM, 2005, J IMMUNOL, V174, P4852, DOI 10.4049/jimmunol.174.8.4852; Shakoor N, 2002, LANCET, V359, P579, DOI 10.1016/S0140-6736(02)07714-0; Sicotte NL, 2001, NEUROLOGY, V57, P1885, DOI 10.1212/WNL.57.10.1885; TSUTSUMI Y, 1995, BRIT J CANCER, V71, P963, DOI 10.1038/bjc.1995.186; VANDENABEELE P, 1992, J EXP MED, V176, P1015, DOI 10.1084/jem.176.4.1015; Yamamoto Y, 2003, NAT BIOTECHNOL, V21, P546, DOI 10.1038/nbt812; ZHANG XM, 1992, J BIOL CHEM, V267, P24069; Zhou A, 2003, ONCOGENE, V22, P2054, DOI 10.1038/sj.onc.1206262	49	78	87	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					998	1007		10.1074/jbc.M707933200	http://dx.doi.org/10.1074/jbc.M707933200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18003610	hybrid			2022-12-25	WOS:000252128100039
J	Lee, YJ; Lee, HJ; Lee, JS; Jeoung, D; Kang, CM; Bae, S; Lee, SJ; Kwon, SH; Kang, D; Lee, YS				Lee, Y. J.; Lee, H. J.; Lee, J. S.; Jeoung, D.; Kang, C. M.; Bae, S.; Lee, S. J.; Kwon, S. H.; Kang, D.; Lee, Y. S.			A novel function for HSF1-induced mitotic exit failure and genomic instability through direct interaction between HSF1 and Cdc20	ONCOGENE			English	Article						HSF1; interaction with Cdc20; mitotic arrest; aneuploidy; inhibition of APC activity	SHOCK; DEPHOSPHORYLATION; EXPRESSION; FACTOR-1; CANCERS; MITOSIS; ROLES; CELLS	Although heat-shock factor (HSF) 1 is a known transcriptional factor of heat-shock proteins, other pathwayslike production of aneuploidy and increased protein stability of cyclin B1 have been proposed. In the present study, the regulatory domain of HSF1 (amino-acid sequence 212-380) was found to interact directly with the amino-acid sequence 106-171 of Cdc20. The association between HSF1 and Cdc20 inhibited the interaction between Cdc27 and Cdc20, the phosphorylation of Cdc27 and the ubiquitination activity of anaphase-promoting complex (APC). The overexpression of HSF1 inhibited mitotic exit and the degradations of cyclin B1 and securin, which resulted in production of aneuploidy and multinucleated cells, but regulatory domain-deficient HSF1 did not. Moreover, HSF1-overexpressing cells showed elevated levels of micronuclei and genomic alteration. The depletion of HSF1 from cells highly expressing HSF1 reduced nocodazole-mediated aneuploidy in cells. These findingss suggest a novel function of HSF1 frequently overexpressed in cancer cells, to inhibit APC/C activity by interacting with Cdc20, and to result in aneuploidy development and genomic instability.	[Lee, Y. J.; Lee, H. J.; Kang, C. M.; Bae, S.; Lee, Y. S.] Korea Inst Radiol & Med Sci, Div Radiat Effect, Seoul 139706, South Korea; [Lee, J. S.; Lee, S. J.] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul 139706, South Korea; [Jeoung, D.] Kangwon Natl Univ, Coll Nat Sci, Chunchon, South Korea; [Kwon, S. H.; Kang, D.] Korea basic Sci Inst, Chunchon Ctr, Chunchon, South Korea	Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences; Kangwon National University; Korea Basic Science Institute (KBSI)	Lee, YS (corresponding author), Korea Inst Radiol & Med Sci, Div Radiat Effect, 215-4 Gongneung Dong, Seoul 139706, South Korea.	yslee@kcch.re.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850				Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Cen H, 2004, WORLD J GASTROENTERO, V10, P3122; Cross FR, 2003, DEV CELL, V4, P741, DOI 10.1016/S1534-5807(03)00119-9; HAHN GM, 1988, CANCER RES, V48, P1803; Hida K, 2005, CANCER RES, V65, P2507, DOI 10.1158/0008-5472.CAN-05-0002; Hoang AT, 2000, AM J PATHOL, V156, P857, DOI 10.1016/S0002-9440(10)64954-1; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; LI GC, 1982, P NATL ACAD SCI-BIOL, V79, P3218, DOI 10.1073/pnas.79.10.3218; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Ricaniadis N, 2001, EUR J SURG ONCOL, V27, P88, DOI 10.1053/ejso.1999.1018; Seo HR, 2006, J BIOL CHEM, V281, P17220, DOI 10.1074/jbc.M600062200; SHIN CR, 2003, CANC LETT, V201, P203; Soh JW, 1999, MOL CELL BIOL, V19, P1313; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Su TT, 1998, GENE DEV, V12, P1495, DOI 10.1101/gad.12.10.1495; Wang YQ, 2004, J BIOL CHEM, V279, P32651, DOI 10.1074/jbc.M401475200	17	34	34	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 8	2008	27	21					2999	3009		10.1038/sj.onc.1210966	http://dx.doi.org/10.1038/sj.onc.1210966			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	298IP	18059335				2022-12-25	WOS:000255681700007
J	Avignolo, C; Bagnasco, L; Biasotti, B; Melchiori, A; Tomati, V; Bauer, I; Salis, A; Chiossone, L; Mingari, MC; Orecchia, P; Carnemolla, B; Neri, D; Zardi, L; Parodi, S				Avignolo, C.; Bagnasco, L.; Biasotti, B.; Melchiori, A.; Tomati, V.; Bauer, I.; Salis, A.; Chiossone, L.; Mingari, M. C.; Orecchia, P.; Carnemolla, B.; Neri, D.; Zardi, L.; Parodi, S.			Internalization via Antennapedia protein transduction domain of an scFv antibody toward c-Myc protein	FASEB JOURNAL			English	Article						intracellular delivery; PTD; miniantibody; fluorescence labeling; oncoprotein targeting	CELL; PEPTIDES; INHIBITORS; MEMBRANE; DELIVERY; HELIX-1; POTENT	We constructed a single-chain variable fragment miniantibody (G11-scFv) directed toward the transactivation. domain of c-Myc, which is fused with the internalization domain Int of Antennapedia at its carboxyl terminus (a cargo-carrier construct). In ELISA experiments, an EC50 for binding saturation was achieved at concentrations of G11-scFv-Int(-) of similar to 10(-8) M. Internalization of a fluoresceinated Fl-G11-scFv-Int(+) construct was observed in intact human cultured cells with confocal microscopy. After 5 h of incubation in medium containing 1 mu M Fl-G11-scFv-Int(+) or Fl-G11-scFv-Int(-), fluorescence intensity was determined in individual cells, both for cytoplasmic and nuclear compartments: concentration levels of Fl-G11-scFv-Int(+), relative to the extracellular culture medium concentration, were 4-5 times higher in the cytoplasm, 7-8 times higher in the nucleus, and 10 times higher in the nucleoli. In the same experimental conditions, the Fl-G11-scFv-Int(-) construct was 3-4 times more concentrated outside of the cells than inside. Cell membranes kept their integrity after 5 h of incubation. The antiproliferative activity of our miniantibody was studied on HCT116 cells. Incubation with 4 mu M G11-scFv-Int(+) for 4 days induced very significant statistical and biological growth inhibition, whereas Int alone was completely inactive. Miniantibodies capable of penetrating cell membranes dramatically broaden the potential for innovative therapeutic agents and attack of new targets.	[Avignolo, C.; Bagnasco, L.; Biasotti, B.; Tomati, V.; Bauer, I.; Parodi, S.] Univ Genoa, Dept Oncol Biol & Genet, I-16132 Genoa, Italy; [Salis, A.] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Salis, A.; Mingari, M. C.] Univ Genoa, Dept Expt Med, I-16132 Genoa, Italy; [Avignolo, C.; Bagnasco, L.; Biasotti, B.; Melchiori, A.; Parodi, S.] Natl Canc Inst IST, Expt Oncol Lab, Genoa, Italy; [Chiossone, L.; Mingari, M. C.; Carnemolla, B.] Natl Canc Inst IST, Immunol Lab, Genoa, Italy; [Bagnasco, L.; Biasotti, B.; Parodi, S.] ISO, Genoa, Italy; [Orecchia, P.] Inst Giannina Gaslini, Genoa, Italy; [Neri, D.] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, Zurich, Switzerland; [Zardi, L.] Adv Biotechnol Ctr, Lab Innovat Therapies, Genoa, Italy	University of Genoa; University of Genoa; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bagnasco, L (corresponding author), Univ Genoa, Dept Oncol Biol & Genet, L Go R Benzi 10, I-16132 Genoa, Italy.	luca.bagnasco@unige.it	Chiossone, Laura/D-3062-2011; Neri, Dario/P-4368-2016; orecchia, paola/AAH-3509-2019; Mingari, Maria Cristina/AAB-1315-2019; Tomati, Valeria/AAB-4543-2021; Salis, Annalisa/R-9241-2018	Chiossone, Laura/0000-0002-9097-5869; Neri, Dario/0000-0001-5234-7370; Tomati, Valeria/0000-0003-3761-1916; orecchia, paola/0000-0003-0556-9784; Salis, Annalisa/0000-0002-3082-2908				Albrecht H, 2006, CANCER BIOTHER RADIO, V21, P285, DOI 10.1089/cbr.2006.21.285; Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Bagnasco L, 2007, FASEB J, V21, P1256, DOI 10.1096/fj.06-7082com; BRINKLEY M, 1992, BIOCONJUGATE CHEM, V3, P2, DOI 10.1021/bc00013a001; Carnemolla B, 1996, INT J CANCER, V68, P397, DOI 10.1002/(SICI)1097-0215(19961104)68:3<397::AID-IJC20>3.3.CO;2-D; Cohen-Saidon C, 2003, BLOOD, V102, P2506, DOI 10.1182/blood-2002-12-3921; Colby DW, 2004, P NATL ACAD SCI USA, V101, P17616, DOI 10.1073/pnas.0408134101; Corey DR, 2007, NAT CHEM BIOL, V3, P8, DOI 10.1038/nchembio0107-8; CREIGHTON TE, 1984, PROTEINS STRUCTURE A, P6; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; GRAESSMANN M, 1983, METHOD ENZYMOL, V101, P482; Hanes J, 2000, NAT BIOTECHNOL, V18, P1287, DOI 10.1038/82407; HAZLETT T, 2004, PRINCIPLES FLUORESCE, V2004, P14; Heng BC, 2005, MED HYPOTHESES, V64, P1105, DOI 10.1016/j.mehy.2005.01.011; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Hermeking H, 2003, CURR CANCER DRUG TAR, V3, P163, DOI 10.2174/1568009033481949; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Hudson PJ, 2003, NAT MED, V9, P129, DOI 10.1038/nm0103-129; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; LAMB NJ, 1996, FRONT BIOSCI, V1, P19; Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4; Lindsay MA, 2002, CURR OPIN PHARMACOL, V2, P587, DOI 10.1016/S1471-4892(02)00199-6; McCormick F, 2000, CURR OPIN BIOTECH, V11, P593, DOI 10.1016/S0958-1669(00)00149-X; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Neri D, 1996, NAT BIOTECHNOL, V14, P485, DOI 10.1038/nbt0496-485; Nieddu E, 2005, FASEB J, V19, P632, DOI 10.1096/fj.04-2369fje; Olofsson J, 2003, CURR OPIN BIOTECH, V14, P29, DOI 10.1007/s00216-010-3744-2; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Perez Norma, 2004, Genet Vaccines Ther, V2, P2, DOI 10.1186/1479-0556-2-2; Pescarolo MP, 2001, FASEB J, V15, P31; Reff Mitchell E, 2002, Cancer Control, V9, P152; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; UCHIDA T, 1988, EXP CELL RES, V178, P1, DOI 10.1016/0014-4827(88)90372-2; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; WILLIAMS SC, 1993, EUR J IMMUNOL, V23, P1456, DOI 10.1002/eji.1830230709	37	19	22	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2008	22	4					1237	1245		10.1096/fj.07-8865com	http://dx.doi.org/10.1096/fj.07-8865com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	18048579				2022-12-25	WOS:000254581000028
J	Chien, MP; Jiang, SB; Chang, DK				Chien, Miao-Ping; Jiang, Shibo; Chang, Ding-Kwo			The function of coreceptor as a basis for the kinetic dissection of HIV type 1 envelope protein-mediated cell fusion	FASEB JOURNAL			English	Article						gp120 shedding; NC-1 sensitive conformation; lipid and content mixing; recruitment; fusion peptide	IMMUNODEFICIENCY-VIRUS TYPE-1; MEMBRANE-FUSION; SOLUBLE CD4; CONFORMATIONAL-CHANGES; RECEPTOR-BINDING; TRANSMEMBRANE GLYCOPROTEIN; NEUTRALIZATION RESISTANCE; ACTIVE CONFORMATION; SYNTHETIC PEPTIDE; ATOMIC-STRUCTURE	The function of HIV-1 HXB2 envelope (Env) glycoprotein (gp) was investigated by surface plasmon resonance and fluorescence imaging techniques. Strikingly, it was found that gp120 shedding requires the presence of the X4 coreceptor. A similar coreceptor requirement was observed for the membrane mixing and the Env recruitment on the cell surface. However, exposure and membrane penetration of the fusion peptide do not require X4 and occur within the first minute after incubation of Env with CD4 and/or X4. Analogously X4 was not required but enhanced binding of the fusion inhibitor. In contrast, bundle formation of the gp41 ectodomain, as monitored by NC-1, was accelerated by the presence of X4. The kinetics of these key post-Env binding events as determined in real time by fluorescence microscopic imaging, coupled with the differential coreceptor requirement, led to the proposition that gp120 shedding, which takes place from 1 to 10 min after engagement of receptor and coreceptor to Env, is a primary function of the coreceptor. The shedding of the surface subunits is needed for the subsequent processes including hemifusion, full fusion, and Env recruitment. The temporal order of these fusogenic steps allows construction of a refined model on the Env-mediated cell fusion event.	[Chien, Miao-Ping; Chang, Ding-Kwo] Acad Sinica, Inst Chem, Taipei 11529, Taiwan; [Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA	Academia Sinica - Taiwan; New York Blood Center	Chang, DK (corresponding author), Acad Sinica, Inst Chem, Taipei 11529, Taiwan.	dkc@chem.sinica.edu.tw	Chang, Ding-Kwo/E-7079-2015; Jiang, Shibo/L-4500-2014	Jiang, Shibo/0000-0001-8283-7135; Chien, Miao-Ping/0000-0002-6087-4688				ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; Berger EA, 1997, AIDS, V11, pS3; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Buzon V, 2005, BIOCHEMISTRY-US, V44, P13354, DOI 10.1021/bi050382r; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; CAO J, 1993, J VIROL, V67, P2747, DOI 10.1128/JVI.67.5.2747-2755.1993; Center RJ, 2002, J VIROL, V76, P7863, DOI 10.1128/JVI.76.15.7863-7867.2002; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CHEN CH, 1995, J VIROL, V69, P3771, DOI 10.1128/JVI.69.6.3771-3777.1995; Danieli T, 1996, J CELL BIOL, V133, P559, DOI 10.1083/jcb.133.3.559; de Rosny E, 2004, J VIROL, V78, P2627, DOI 10.1128/JVI.78.5.2627-2631.2004; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dimitrov AS, 2005, BIOCHEMISTRY-US, V44, P12471, DOI 10.1021/bi051092d; Dimitrov AS, 2003, BIOCHEMISTRY-US, V42, P14150, DOI 10.1021/bi035154g; Doms RW, 2000, VIROLOGY, V276, P229, DOI 10.1006/viro.2000.0612; Dumonceaux J, 1998, J VIROL, V72, P512, DOI 10.1128/JVI.72.1.512-519.1998; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Finnegan CM, 2001, J VIROL, V75, P11096, DOI 10.1128/JVI.75.22.11096-11105.2001; FU YK, 1993, J VIROL, V67, P3818, DOI 10.1128/JVI.67.7.3818-3825.1993; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gallo SA, 2001, BIOCHEMISTRY-US, V40, P12231, DOI 10.1021/bi0155596; GREWE C, 1990, J ACQ IMMUN DEF SYND, V3, P965; Haque ME, 2005, BIOPHYS J, V89, P3183, DOI 10.1529/biophysj.105.063032; Hoffman T L, 1998, AIDS, V12 Suppl A, pS17; Iyengar S, 2000, J VIROL, V74, P6720, DOI 10.1128/JVI.74.15.6720-6724.2000; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; Jolly C, 2005, J VIROL, V79, P12088, DOI 10.1128/JVI.79.18.12088-12094.2005; Jones PLS, 1998, J BIOL CHEM, V273, P404, DOI 10.1074/jbc.273.1.404; Korazim O, 2006, J MOL BIOL, V364, P1103, DOI 10.1016/j.jmb.2006.08.091; KORTE T, 1994, EUR BIOPHYS J BIOPHY, V23, P105; Kuhmann SE, 2000, J VIROL, V74, P7005, DOI 10.1128/JVI.74.15.7005-7015.2000; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lapham CK, 1996, SCIENCE, V274, P602, DOI 10.1126/science.274.5287.602; LASKY LA, 1987, CELL, V50, P975, DOI 10.1016/0092-8674(87)90524-1; Leavitt M, 2003, J VIROL, V77, P560, DOI 10.1128/JVI.77.1.560-570.2003; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Markosyan RM, 2003, MOL BIOL CELL, V14, P926, DOI 10.1091/mbc.E02-09-0573; Markosyan RM, 2005, MOL BIOL CELL, V16, P5502, DOI 10.1091/mbc.E05-06-0496; MATTHEWS TJ, 1994, IMMUNOL REV, V140, P93, DOI 10.1111/j.1600-065X.1994.tb00866.x; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Mkrtchyan SR, 2005, J VIROL, V79, P11161, DOI 10.1128/JVI.79.17.11161-11169.2005; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; NEURATH AR, 1992, VIROLOGY, V188, P1, DOI 10.1016/0042-6822(92)90729-9; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; Park EJ, 2000, J VIROL, V74, P4183, DOI 10.1128/JVI.74.9.4183-4191.2000; Reeves JD, 1997, J VIROL, V71, P1453, DOI 10.1128/JVI.71.2.1453-1465.1997; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Sackett K, 2006, J BIOL CHEM, V281, P21755, DOI 10.1074/jbc.M603135200; Salzwedel K, 2000, P NATL ACAD SCI USA, V97, P12794, DOI 10.1073/pnas.230438497; Salzwedel K, 2000, J VIROL, V74, P326, DOI 10.1128/JVI.74.1.326-333.2000; SATTENTAU QJ, 1993, PHILOS T R SOC B, V342, P59, DOI 10.1098/rstb.1993.0136; SCHNITTMAN SM, 1988, J IMMUNOL, V141, P4181; Sullivan N, 1998, J VIROL, V72, P6332, DOI 10.1128/JVI.72.8.6332-6338.1998; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; THALI M, 1992, J VIROL, V66, P5516, DOI 10.1128/JVI.66.9.5516-5524.1992; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weng YK, 1998, J VIROL, V72, P9676, DOI 10.1128/JVI.72.12.9676-9682.1998; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; WILLEY RL, 1994, J VIROL, V68, P1029, DOI 10.1128/JVI.68.2.1029-1039.1994; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000	74	15	15	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2008	22	4					1179	1192		10.1096/fj.07-9576com	http://dx.doi.org/10.1096/fj.07-9576com			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	18032634				2022-12-25	WOS:000254581000023
J	Siddiqui, IA; Malik, A; Adhami, VM; Asim, M; Hafeez, BB; Sarfaraz, S; Mukhtar, H				Siddiqui, I. A.; Malik, A.; Adhami, V. M.; Asim, M.; Hafeez, B. B.; Sarfaraz, S.; Mukhtar, H.			Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis	ONCOGENE			English	Article						EGCG; TRAIL; intrinsic pathway; extrinsic pathway; angiogenesis; metastasis	CANCER CELLS; PROTEASOME INHIBITOR; DEATH RECEPTOR-5; IN-VIVO; EXPRESSION; PATHWAY; GROWTH; (-)-EPIGALLOCATECHIN-3-GALLATE; CHEMOPREVENTION; MODULATION	Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL/Apo2L) is a promising candidate for cancer therapy, however, emergence of drug resistance limits its potential use. Here, we report for the first time that epigallocatechin-3-gallate (EGCG), the major polyphenolic constituent of green tea, sensitizes TRAIL-resistant LNCaP cells to TRAIL-mediated apoptosis through modulation of intrinsic and extrinsic apoptotic pathways. When combined with EGCG, Apo2L/TRAIL exhibited enhanced apoptotic activity in LNCaP cells characterized by three major molecular events. First, apoptosis induction was accompanied by the upregulation of poly (ADP-ribose) polymerase cleavage and modulation of pro-and antiapoptotic Bcl2 family of proteins. A synergistic inhibition of inhibitors of apoptosis with concomitant increase in caspase cleavage was observed. Second, pretreatment of cells with EGCG resulted in modulation of death-inducing signaling cascade complex involving DR4/TRAIL R1, Fas-associated death domain and FLICE-inhibitory protein proteins. Last, we observed a synergistic inhibition in the invasion and migration of LNCaP cells. This effect was observed to be mediated through inhibition in the protein expression of vascular endothelial growth factor, uPA and angiopoietin 1 and 2. Further, the activity and protein expression of MMP-2, -3 and -9 and upregulation of TIMP1 in cells treated with a combination of EGCG and TRAIL was observed. These data might have implications for developing new strategies aimed at eliminating prostate cancer cells resistant to TRAIL.	[Siddiqui, I. A.; Malik, A.; Adhami, V. M.; Asim, M.; Hafeez, B. B.; Sarfaraz, S.; Mukhtar, H.] Univ Wisconsin, Med Sci Ctr B 25, Dept Dermatol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Mukhtar, H (corresponding author), Univ Wisconsin, Med Sci Ctr B 25, Dept Dermatol, 1300 Univ Ave, Madison, WI 53706 USA.	hmukhtar@wisc.edu	Siddiqui, Imtiaz/B-6587-2009; Adhami, Vaqar/AAY-2837-2020	Adhami, Vaqar/0000-0002-2048-4570	NATIONAL CANCER INSTITUTE [R01CA120451, R01CA101039, R01CA078809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK065303] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 101039, R01 CA 120451, R01 CA 78809] Funding Source: Medline; NIDDK NIH HHS [P50 DK065303-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adhami VM, 2007, CLIN CANCER RES, V13, P1611, DOI 10.1158/1078-0432.CCR-06-2269; Adhami VM, 2004, CANCER RES, V64, P8715, DOI 10.1158/0008-5472.CAN-04-2840; Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145; Bigelow RLH, 2006, ONCOGENE, V25, P1922, DOI 10.1038/sj.onc.1209227; Cantarella G, 2006, BRIT J CANCER, V94, P1428, DOI 10.1038/sj.bjc.6603092; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; de Bock CE, 2004, MED RES REV, V24, P13, DOI 10.1002/med.10054; Deeb D, 2004, MOL CANCER THER, V3, P803; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Gao S, 2005, MOL ENDOCRINOL, V19, P1792, DOI 10.1210/me.2004-0445; He Q, 2004, ONCOGENE, V23, P2554, DOI 10.1038/sj.onc.1207351; He Q, 2002, ONCOGENE, V21, P2623, DOI 10.1038/sj.onc.1205345; Hu HB, 2006, MOL CANCER THER, V5, P1873, DOI 10.1158/1535-7163.MCT-06-0063; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jian L, 2004, INT J CANCER, V108, P130, DOI 10.1002/ijc.11550; Koshida K, 2004, INT J UROL, V11, P1114, DOI 10.1111/j.1442-2042.2004.00961.x; Lakshmikanthan V, 2006, INT J CANCER, V119, P221, DOI 10.1002/ijc.21824; Lam WH, 2004, BIOORGAN MED CHEM, V12, P5587, DOI 10.1016/j.bmc.2004.08.002; Landis-Piwowar KR, 2005, INT J MOL MED, V15, P735; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Munshi A, 2002, CANCER CHEMOTH PHARM, V50, P46, DOI 10.1007/s00280-002-0465-z; Nencioni A, 2005, CLIN CANCER RES, V11, P4259, DOI 10.1158/1078-0432.CCR-04-2496; Ozawa F, 2001, CANCER LETT, V163, P71, DOI 10.1016/S0304-3835(00)00660-1; Qin J, 2007, BIOCHEM BIOPH RES CO, V354, P852, DOI 10.1016/j.bbrc.2007.01.003; Saleem M, 2006, P NATL ACAD SCI USA, V103, P14825, DOI 10.1073/pnas.0606747103; Schimmer AD, 2004, CANCER RES, V64, P7183, DOI 10.1158/0008-5472.CAN-04-1918; Siddiqui IA, 2006, MOL NUTR FOOD RES, V50, P130, DOI 10.1002/mnfr.200500113; Siddiqui IA, 2004, J CELL BIOCHEM, V91, P232, DOI 10.1002/jcb.10737; Siddiqui IA, 2007, ACTA PHARMACOL SIN, V28, P1392, DOI 10.1111/j.1745-7254.2007.00693.x; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Thurston G, 2003, CELL TISSUE RES, V314, P61, DOI 10.1007/s00441-003-0749-6; Yamaguchi K, 2005, ONCOGENE, V24, P5868, DOI 10.1038/sj.onc.1208742; Zhang XD, 2000, FEBS LETT, V482, P193, DOI 10.1016/S0014-5793(00)02042-1	33	168	170	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 27	2008	27	14					2055	2063		10.1038/sj.onc.1210840	http://dx.doi.org/10.1038/sj.onc.1210840			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	279MK	17998943				2022-12-25	WOS:000254359100010
J	Fan, J; Ren, HG; Jia, NL; Fei, E; Zhou, T; Jiang, P; Wu, M; Wang, GH				Fan, Jun; Ren, Haigang; Jia, Nali; Fei, Erkang; Zhou, Tian; Jiang, Peng; Wu, Mian; Wang, Guanghui			DJ-1 decreases Bax expression through repressing p53 transcriptional activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONSET PARKINSONS-DISEASE; CELL-DEATH; ALPHA-SYNUCLEIN; NEURONAL APOPTOSIS; PROTEASOME INHIBITION; TYROSINE-HYDROXYLASE; DOPAMINERGIC-NEURONS; NEGATIVE REGULATOR; ANDROGEN RECEPTOR; OXIDATIVE STRESS	DJ-1, originally identified as an oncogene product, is a protein with various functions in cellular transformation, oxidative stress response, and transcriptional regulation. Although previous studies suggest that DJ-1 is cytoprotective, the mechanism by which DJ-1 exerts its survival functions remains largely unknown. Here we show that DJ-1 exerts its cytoprotection through inhibiting p53-Bax-caspase pathway. DJ-1 interacts with p53 in vitro and in vivo. Overexpression of DJ-1 decreases the expression of Bax and inhibits caspase activation, whereas knock- down of DJ-1 increases Bax protein levels and accelerates caspase-3 activation and cell death induced by UV exposure. Our data provide evidence that the protective effects of DJ-1 on apoptosis are associated with its ability of decreasing Bax level through inhibiting p53 transcriptional activity.	[Fan, Jun; Ren, Haigang; Jia, Nali; Fei, Erkang; Zhou, Tian; Jiang, Peng; Wu, Mian; Wang, Guanghui] Univ Sci & Technol China, Lab Mol Neuropathol, Hefei Natl Lab Phys Sci Microscale, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wang, GH (corresponding author), Univ Sci & Technol China, Lab Mol Neuropathol, Hefei Natl Lab Phys Sci Microscale, Sch Life Sci, Hefei 230027, Anhui, Peoples R China.	wghui@ustc.edu.cn	Wang, Guanghui/U-3979-2017; Jiang, Peng/A-1946-2013; Fan, Jun/F-8224-2012; FEI, Erkang/AAI-9825-2021; Ren, Haigang/U-6034-2017	Wang, Guanghui/0000-0001-8551-6468; Ren, Haigang/0000-0001-8844-4754; Wu, Mian/0000-0002-2714-0500; FEI, Erkang/0000-0002-3581-9521				Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; da Costa CA, 2002, J BIOL CHEM, V277, P50980, DOI 10.1074/jbc.M207825200; de la Monte SM, 1998, LAB INVEST, V78, P401; Dornan D, 2004, CANCER RES, V64, P7226, DOI 10.1158/0008-5472.CAN-04-2601; Duan WZ, 2002, ANN NEUROL, V52, P597, DOI 10.1002/ana.10350; Eberhardt O, 2003, TOXICOL LETT, V139, P135, DOI 10.1016/S0378-4274(02)00428-9; Grzmil M, 2004, INT J ONCOL, V24, P97; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; Hartmann A, 2000, P NATL ACAD SCI USA, V97, P2875, DOI 10.1073/pnas.040556597; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hod Y, 2004, J CELL BIOCHEM, V92, P1221, DOI 10.1002/jcb.20159; Jeong H, 2006, NEUROSCI LETT, V396, P57, DOI 10.1016/j.neulet.2005.11.011; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Le Naour F, 2001, CLIN CANCER RES, V7, P3328; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; McNeill-Blue C, 2006, BRAIN RES, V1112, P1, DOI 10.1016/j.brainres.2006.07.024; Miura K, 2002, CANCER RES, V62, P3244; Morrison RS, 2003, NEUROCHEM RES, V28, P15, DOI 10.1023/A:1021687810103; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Nair VD, 2006, J BIOL CHEM, V281, P39550, DOI 10.1074/jbc.M603950200; Niki T, 2003, MOL CANCER RES, V1, P247; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Olzmann JA, 2007, J COMP NEUROL, V500, P585, DOI 10.1002/cne.21191; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Shinbo YM, 2005, INT J ONCOL, V26, P641; Spillare EA, 1999, GENE DEV, V13, P1355, DOI 10.1101/gad.13.11.1355; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; TAN TH, 1986, J VIROL, V59, P574, DOI 10.1128/JVI.59.3.574-583.1986; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Tatton NA, 2000, EXP NEUROL, V166, P29, DOI 10.1006/exnr.2000.7489; Thornborrow EC, 2001, J BIOL CHEM, V276, P15598, DOI 10.1074/jbc.M011643200; Vaghefi H, 2004, ONCOGENE, V23, P8078, DOI 10.1038/sj.onc.1207953; Vila M, 2001, P NATL ACAD SCI USA, V98, P2837, DOI 10.1073/pnas.051633998; Viswanath V, 2001, J NEUROSCI, V21, P9519, DOI 10.1523/JNEUROSCI.21-24-09519.2001; Wagenfeld A, 1998, BIOCHEM BIOPH RES CO, V251, P545, DOI 10.1006/bbrc.1998.9512; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yamada M, 2004, J NEUROCHEM, V91, P451, DOI 10.1111/j.1471-4159.2004.02728.x; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	56	190	198	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4022	4030		10.1074/jbc.M707176200	http://dx.doi.org/10.1074/jbc.M707176200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18042550	hybrid			2022-12-25	WOS:000253083500037
J	Rutkowska, A; Mayer, MP; Hoffmann, A; Merz, F; Zachmann-Brand, B; Schaffitzel, C; Ban, N; Deuerling, E; Bukau, B				Rutkowska, Anna; Mayer, Matthias P.; Hoffmann, Anja; Merz, Frieder; Zachmann-Brand, Beate; Schaffitzel, Christiane; Ban, Nenad; Deuerling, Elke; Bukau, Bernd			Dynamics of trigger factor interaction with translating ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEWLY SYNTHESIZED PROTEINS; NASCENT CHAIN COMPLEXES; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PROLYL ISOMERASE; RNA-POLYMERASE; IN-VIVO; DNAK; BINDING; DOMAIN	In all organisms ribosome-associated chaperones assist early steps of protein folding. To elucidate the mechanism of their action, we determined the kinetics of individual steps of the ribosome binding/release cycle of bacterial trigger factor (TF), using fluorescently labeled chaperone and ribosome-nascent chain complexes. Both the association and dissociation rates of TF-ribosome complexes are modulated by nascent chains, whereby their length, sequence, and folding status are influencing parameters. However, the effect of the folding status is modest, indicating that TF can bind small globular domains and accommodate them within its substrate binding cavity. In general, the presence of a nascent chain causes an up to 9-fold increase in the rate of TF association, which provides a kinetic explanation for the observed ability of TF to efficiently compete with other cytosolic chaperones for binding to nascent chains. Furthermore, a subset of longer nascent polypeptides promotes the stabilization of TF-ribosome complexes, which increases the half-life of these complexes from 15 to 50 s. Nascent chains thus regulate their folding environment generated by ribosome-associated chaperones.	[Rutkowska, Anna; Mayer, Matthias P.; Hoffmann, Anja; Merz, Frieder; Zachmann-Brand, Beate; Deuerling, Elke; Bukau, Bernd] Univ Heidelberg, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Schaffitzel, Christiane; Ban, Nenad] ETH, Inst Mol & Biophys, CH-8093 Zurich, Switzerland	Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Deuerling, E (corresponding author), Univ Heidelberg, Zentrum Mol Biol, D-69120 Heidelberg, Germany.	e.deuerling@zmbh.uni-heidelberg.de; bukau@zmbh.uni-heidelberg.de	Mayer, Matthias P./B-9340-2013	Mayer, Matthias P./0000-0002-7859-3112; Bukau, Bernd/0000-0003-0521-7199; Berger-Schaffitzel, Christiane Helene/0000-0002-1516-9760				Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Blanco FJ, 1999, J MOL BIOL, V285, P741, DOI 10.1006/jmbi.1998.2333; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Campbell EA, 2005, EMBO J, V24, P674, DOI 10.1038/sj.emboj.7600499; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Evans MS, 2005, NAT METHODS, V2, P757, DOI 10.1038/NMETH790; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; Hesterkamp T, 1996, FEBS LETT, V385, P67, DOI 10.1016/0014-5793(96)00351-1; Hesterkamp T, 1997, J BIOL CHEM, V272, P21865, DOI 10.1074/jbc.272.35.21865; Hesterkamp T, 1996, P NATL ACAD SCI USA, V93, P4437, DOI 10.1073/pnas.93.9.4437; Hoffmann A, 2006, J BIOL CHEM, V281, P6539, DOI 10.1074/jbc.M512345200; HURLEY JH, 1989, P NATL ACAD SCI USA, V86, P8635, DOI 10.1073/pnas.86.22.8635; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; LILL R, 1988, CELL, V54, P1013, DOI 10.1016/0092-8674(88)90116-X; Ludlam AV, 2004, P NATL ACAD SCI USA, V101, P13436, DOI 10.1073/pnas.0405868101; Maier R, 2003, J MOL BIOL, V326, P585, DOI 10.1016/S0022-2836(02)01427-4; Maier R, 2001, J MOL BIOL, V314, P1181, DOI 10.1006/jmbi.2000.5192; MAUGUEN Y, 1982, NATURE, V297, P162, DOI 10.1038/297162a0; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; MOSSAKOWSKA DE, 1989, BIOCHEMISTRY-US, V28, P3843, DOI 10.1021/bi00435a033; MUSACCHIO A, 1992, NATURE, V359, P851, DOI 10.1038/359851a0; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Neira JL, 1999, J MOL BIOL, V285, P1309, DOI 10.1006/jmbi.1998.2249; Patzelt H, 2002, BIOL CHEM, V383, P1611, DOI 10.1515/BC.2002.182; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Raine A, 2004, BIOCHIMIE, V86, P495, DOI 10.1016/j.biochi.2004.05.004; Raine A, 2006, J BIOL CHEM, V281, P28033, DOI 10.1074/jbc.M605753200; Schaffitzel C, 2007, J STRUCT BIOL, V158, P463, DOI 10.1016/j.jsb.2007.01.005; Siegenthaler RK, 2006, J BIOL CHEM, V281, P34448, DOI 10.1074/jbc.M606382200; STOLLER G, 1995, EMBO J, V14, P4939, DOI 10.1002/j.1460-2075.1995.tb00177.x; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Tomoyasu T, 1998, MOL MICROBIOL, V30, P567, DOI 10.1046/j.1365-2958.1998.01090.x; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	39	72	72	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4124	4132		10.1074/jbc.M708294200	http://dx.doi.org/10.1074/jbc.M708294200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18045873	Green Submitted, hybrid			2022-12-25	WOS:000253083500048
J	Li, L; Kobayashi, M; Kaneko, H; Nakajima-Takagi, Y; Nakayama, Y; Yamamoto, M				Li, Li; Kobayashi, Makoto; Kaneko, Hiroshi; Nakajima-Takagi, Yaeko; Nakayama, Yuko; Yamamoto, Masayuki			Molecular evolution of Keap1 - Two Keap1 molecules with distinctive intervening region structures are conserved among fish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; RECOGNITION MODEL; PHASE-2 RESPONSE; DLG MOTIFS; NRF2; ZEBRAFISH; PROTEIN; DOMAIN; GENES; ELECTROPHILES	Keap1 is a BTB-Kelch-type substrate adaptor protein of the Cul3-dependent ubiquitin ligase complex. Keap1 facilitates the degradation of Nrf2, a transcription factor regulating the inducible expression of many cytoprotective genes. Through comparative genome analyses, we found that amino acid residues composing the pocket of Keap1 that interacts with Nrf2 are highly conserved among Keap1 orthologs and related proteins in all vertebrates and in certain invertebrates, including flies and mosquitoes. The interaction between Nrf2 and Keap1 appears to be widely preserved in vertebrates. Similarly, cysteine residues corresponding to Cys-273 and Cys-288 in the intervening region of mouse Keap1, which are essential for the repression of Nrf2 activity in cultured cells, are conserved among Keap1 orthologs in vertebrates and invertebrates, except fish. We found that fish have two types of Keap1, Keap1a and Keap1b. To our surprise, Keap1a and Keap1b contain the cysteine residue corresponding to Cys-288 and Cys-273, respectively. In our analysis of zebrafish Keap1a and Keap1b activities, both Keap1a and Keap1b were able to facilitate the degradation of Nrf2 protein and repress Nrf2-mediated target gene activation. Individual mutation of either residual cysteine residue in Keap1a and Keap1b disrupted the ability of Keap1 to repress Nrf2, indicating that the presence of either Cys-273 or Cys-288 is sufficient for fish Keap1 molecules to fully function. These results provide an important insight into the means by which Keap1 cysteines act as sensors of electrophiles and oxidants.	[Li, Li; Kobayashi, Makoto; Nakayama, Yuko; Yamamoto, Masayuki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Environm Response Project, Tsukuba, Ibaraki 3058575, Japan; [Kobayashi, Makoto; Kaneko, Hiroshi; Nakajima-Takagi, Yaeko; Yamamoto, Masayuki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Inst Basic Med Sci, Tsukuba, Ibaraki 3058575, Japan; [Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Grad Sch Med, Sendai, Miyagi 9808575, Japan	University of Tsukuba; University of Tsukuba; Tohoku University	Kobayashi, M (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Environm Response Project, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	makobayash@md.tsukuba.ac.jp	Kobayashi, Makoto/B-2537-2008; Yamamoto, Masayuki/A-4873-2010	Kobayashi, Makoto/0000-0001-6660-450X; Yamamoto, Masayuki/0000-0002-9073-9436				Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Appel B, 1998, DEVELOPMENT, V125, P371; Dinkova-Kostova AT, 2005, BIOCHEMISTRY-US, V44, P6889, DOI 10.1021/bi047434h; Hukriede N, 2001, GENOME RES, V11, P2127, DOI 10.1101/gr.210601; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Katoh Y, 2005, ARCH BIOCHEM BIOPHYS, V433, P342, DOI 10.1016/j.abb.2004.10.012; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Kobayashi M, 2001, DEVELOPMENT, V128, P2341; Kobayashi M, 2001, DEV BIOL, V232, P315, DOI 10.1006/dbio.2001.0185; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Onodera K, 1999, J BIOL CHEM, V274, P21162, DOI 10.1074/jbc.274.30.21162; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Suzuki T, 2005, BIOCHEM J, V388, P65, DOI 10.1042/BJ20041860; Takagi Y, 2004, BIOCHEM BIOPH RES CO, V320, P62, DOI 10.1016/j.bbrc.2004.05.131; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	35	88	92	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3248	3255		10.1074/jbc.M708702200	http://dx.doi.org/10.1074/jbc.M708702200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18057000	Green Submitted, hybrid			2022-12-25	WOS:000253083000028
J	Barnett, JP; Eijlander, RT; Kuipers, OP; Robinson, C				Barnett, James P.; Eijlander, Robyn T.; Kuipers, Oscar P.; Robinson, Colin			A minimal tat system from a gram-positive organism - A bifunctional TatA subunit participates in discrete TatAC and TatA complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TWIN-ARGININE TRANSLOCASE; SEC-INDEPENDENT PROTEIN; ESCHERICHIA-COLI; SIGNAL PEPTIDE; STREPTOMYCES-LIVIDANS; EXPORT PATHWAY; TRANSPORT; COMPONENT; BACTERIAL; BACILLUS	The Tat system transports folded proteins across bacterial and thylakoid membranes. In Gram-negative organisms, a TatABC substrate-binding complex and separate TatA complex are believed to coalesce to form an active translocon, with all three subunits essential for translocation. Most Gram-positive organisms lack a tatB gene, indicating major differences in organization and possible differences in mode of action. Here, we have studied Tat complexes encoded by the tatAdCd genes of Bacillus subtilis. Expression of tatAdCd in an Escherichia coli tat null mutant results in efficient export of a large, cofactor-containing E. coli Tat substrate, TorA. We show that the tatAd gene complements E. coli mutants lacking either tatAE or tatB, indicating a bifunctional role for this subunit in B. subtilis. Second, we have identified and characterized two distinct Tat complexes that are novel in key respects: a TatAdCd complex of similar to 230 kDa that is significantly smaller than the analogous E. coli TatABC complex (similar to 370 kDa on BN gels) and a separate TatAd complex. The latter is a discrete entity of similar to 270 kDa as judged by gel filtration chromatography, very different from the highly heterogeneous E. coli TatA complex that ranges in size from similar to 50 kDa to over 600 kDa. TatA heterogeneity has been linked to the varying size of Tat substrates being translocated, but the singular nature of the B. subtilis TatAd complex suggests that discrete TatAC and TatA complexes may form a single form of translocon.	[Barnett, James P.; Robinson, Colin] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Eijlander, Robyn T.; Kuipers, Oscar P.] Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, NL-9751 NN Haren, Netherlands	University of Warwick; University of Groningen	Robinson, C (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	colin.robinson@warwick.ac.uk	Kuipers, Oscar/B-6752-2009	Kuipers, Oscar/0000-0001-5596-7735; Barnett, James/0000-0003-1827-036X	Biotechnology and Biological Sciences Research Council [BB/E010245/1] Funding Source: Medline; BBSRC [BB/E010245/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Barrett CML, 2005, J MOL BIOL, V347, P453, DOI 10.1016/j.jmb.2005.01.026; Barrett CML, 2003, BIOCHEM BIOPH RES CO, V304, P279, DOI 10.1016/S0006-291X(03)00583-7; Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; CLINE K, 1992, J BIOL CHEM, V267, P2688; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Dalbey RE, 2000, ANNU REV CELL DEV BI, V16, P51, DOI 10.1146/annurev.cellbio.16.1.51; De Keersmaeker S, 2007, MICROBIOL-SGM, V153, P1087, DOI 10.1099/mic.0.2006/003053-0; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Jongbloed JDH, 2006, TRENDS MICROBIOL, V14, P2, DOI 10.1016/j.tim.2005.11.001; Jongbloed JDH, 2000, J BIOL CHEM, V275, P41350, DOI 10.1074/jbc.M004887200; Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; Oates J, 2003, J MOL BIOL, V330, P277, DOI 10.1016/S0022-2836(03)00621-1; Pop O, 2002, J BIOL CHEM, V277, P3268, DOI 10.1074/jbc.M110829200; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Schaerlaekens K, 2001, J BACTERIOL, V183, P6727, DOI 10.1128/JB.183.23.6727-6732.2001; Schreiber S, 2006, J BIOL CHEM, V281, P19977, DOI 10.1074/jbc.M513900200; SILVESTRO A, 1989, BIOCHIM BIOPHYS ACTA, V999, P208, DOI 10.1016/0167-4838(89)90220-3; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200; Thomas JD, 2001, MOL MICROBIOL, V39, P47, DOI 10.1046/j.1365-2958.2001.02253.x; Voss S, 1997, PROTEIN ENG, V10, P975, DOI 10.1093/protein/10.8.975; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; WERTMAN KF, 1986, GENE, V49, P253, DOI 10.1016/0378-1119(86)90286-6; Westermann M, 2006, BBA-BIOMEMBRANES, V1758, P443, DOI 10.1016/j.bbamem.2006.03.018	40	61	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2534	2542		10.1074/jbc.M708134200	http://dx.doi.org/10.1074/jbc.M708134200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18029357	hybrid, Green Published			2022-12-25	WOS:000252622300010
J	Chutkow, WA; Patwari, P; Yoshioka, J; Lee, RT				Chutkow, William A.; Patwari, Parth; Yoshioka, Jun; Lee, Richard T.			Thioredoxin-interacting protein (Txnip) is a critical regulator of hepatic glucose production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; ISOLATED HEPATOCYTES; INSULIN-RESISTANCE; LENTIVIRAL VECTOR; REDOX REGULATION; MICE LACKING; GLUCONEOGENESIS; GENE; HOMEOSTASIS; METABOLISM	Thioredoxin-interacting protein (Txnip) has been recently described as a possible link between cellular redox state and metabolism; Txnip binds thioredoxin and inhibits its disulfide reductase activity in vitro, while a naturally occurring strain of Txnip-deficient mice has hyperlipidemia, hypoglycemia, and ketosis exacerbated by fasting. We generated Txnip-null mice to investigate the role of Txnip in glucose homeostasis. Txnip-null mice were hypoglycemic, hypoinsulinemic, and had blunted glucose production following a glucagon challenge, consistent with a central liver glucose-handling defect. Glucose release from isolated Txnip-null hepatocytes was 2-fold lower than wild-type hepatocytes, whereas beta-hydroxybutyrate release was increased 2-fold, supporting an intrinsic defect in hepatocyte glucose metabolism. While hepatocyte-specific gene deletion of Txnip did not alter glucose clearance compared with littermate controls, Txnip expression in the liver was required for maintaining normal fasting glycemia and glucose production. In addition, hepatic overexpression of a Txnip transgene in wildtype mice resulted in elevated serum glucose levels and decreased ketone levels. Liver homogenates from Txnip-null mice had no significant differences in the glutathione oxidation state or in the amount of available thioredoxin. However, overexpression of wild-type Txnip in Txnip-null hepatocytes rescued cellular glucose production, whereas overexpression of a C247S mutant Txnip, which does not bind thioredoxin, had no effect. These data demonstrate that Txnip is required for normal glucose homeostasis in the liver. While available thioredoxin is not changed in Txnip-null mice, the effects of Txnip on glucose homeostasis are abolished by a single cysteine mutation that inhibits binding to thioredoxin.	[Chutkow, William A.; Patwari, Parth; Yoshioka, Jun; Lee, Richard T.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Cambridge, MA 02139 USA; [Chutkow, William A.; Patwari, Parth; Yoshioka, Jun; Lee, Richard T.] Harvard Univ, Sch Med, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University	Chutkow, WA (corresponding author), Partners Res Facil, 65 Landsdowne St,Rm 280, Cambridge, MA 02139 USA.	wchutkow@partners.org		Lee, Richard/0000-0003-4687-1381	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743, R01HL073809] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL048743, HL073809] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Berry MN, 1997, CELL BIOL TOXICOL, V13, P223, DOI 10.1023/A:1007402505482; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Brown M, 2003, ADULT EDUC QUART, V54, P75, DOI 10.1177/0741713603257017; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; CONSOLI A, 1989, DIABETES, V38, P550, DOI 10.2337/diabetes.38.5.550; Emilsson V. e. a., 2005, Patent No. [2005/111239, 2005111239]; Engelgau MM, 2004, ANN INTERN MED, V140, P945, DOI 10.7326/0003-4819-140-11-200406010-00035; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; EXTON J, 1972, INTERACTION INSULIN; FELIG P, 1970, NEW ENGL J MED, V282, P166; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; GILBERT HF, 1984, METHOD ENZYMOL, V107, P330; GROOP LC, 1989, J CLIN INVEST, V84, P205, DOI 10.1172/JCI114142; Guo Y, 2004, STEM CELLS, V22, P259, DOI 10.1634/stemcells.22-3-259; Hausler N, 2006, BIOCHEM J, V394, P465, DOI 10.1042/BJ20051174; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Hui TY, 2004, J BIOL CHEM, V279, P24387, DOI 10.1074/jbc.M401280200; HULTMAN E, 1974, ACTA ANAESTH SCAND, P28; JAHOOR F, 1990, AM J PHYSIOL, V258, pE288, DOI 10.1152/ajpendo.1990.258.2.E288; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Meuillet EJ, 2004, ARCH BIOCHEM BIOPHYS, V429, P123, DOI 10.1016/j.abb.2004.04.020; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Morizono K, 2005, NAT MED, V11, P346, DOI 10.1038/nm1192; NEESE RA, 1995, J BIOL CHEM, V270, P14452, DOI 10.1074/jbc.270.24.14452; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Oka S, 2006, FASEB J, V20, pA45, DOI 10.1096/fj.05-4439fje; Pan D, 2002, MOL THER, V6, P19, DOI 10.1006/mthe.2002.0630; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; PRYOR HJ, 1987, BIOCHEM J, V247, P449, DOI 10.1042/bj2470449; QUINLAN PT, 1986, BIOCHEM J, V236, P789, DOI 10.1042/bj2360789; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Schulze PC, 2002, CIRC RES, V91, P689, DOI 10.1161/01.RES.0000037982.55074.F6; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Sheth SS, 2005, J LIPID RES, V46, P123, DOI 10.1194/jlr.M400341-JLR200; SISTARE FD, 1985, J BIOL CHEM, V260, P2748; SPIEGELMAN BM, 1993, CELL, V73, P625, DOI 10.1016/0092-8674(93)90243-J; TRENT DF, 1984, HORM RES, V19, P70, DOI 10.1159/000179869; Wang YL, 2002, J BIOL CHEM, V277, P26496, DOI 10.1074/jbc.M202133200; Wang Z, 2006, ONCOGENE, V25, P1903, DOI 10.1038/sj.onc.1209218; Yamanaka H, 2000, BIOCHEM BIOPH RES CO, V271, P796, DOI 10.1006/bbrc.2000.2699; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yoshioka J, 2007, CIRC RES, V101, P1328, DOI 10.1161/CIRCRESAHA.106.160515	52	145	148	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2397	2406		10.1074/jbc.M708169200	http://dx.doi.org/10.1074/jbc.M708169200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17998203	hybrid			2022-12-25	WOS:000252501000066
J	Woodall, BP; Nystrom, A; Iozzo, RA; Eble, JA; Niland, S; Krieg, T; Eckes, B; Pozzi, A; Iozzo, RV				Woodall, Benjamin P.; Nystrom, Alexander; Iozzo, Rex A.; Eble, Johannes A.; Niland, Stephan; Krieg, Thomas; Eckes, Beate; Pozzi, Ambra; Iozzo, Renato V.			Integrin alpha 2 beta 1 is the required receptor for endorepellin angiostatic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; EXTRACELLULAR-MATRIX; ALPHA-DYSTROGLYCAN; CRYSTAL-STRUCTURE; HEPARAN-SULFATE; CELL-ADHESION; PROTEIN CORE; TUMOR-GROWTH; I DOMAIN; PERLECAN	Endorepellin, the C- terminal module of perlecan, has angiostatic activity. Here we provide definitive genetic and biochemical evidence that the functional endorepellin receptor is the alpha 2 beta 1 integrin. Notably, the specific endorepellin binding to the receptor was cation- independent and was mediated by the alpha 2 I domain. We show that the anti- angiogenic effects of endorepellin cannot occur in the absence of alpha 2 beta 1. Microvascular endothelial cells from alpha 2 beta 1(-/-) mice, but not those isolated from either wild- type or alpha 1 beta 1(-/-) mice, did not respond to endorepellin. Moreover, syngeneic Lewis lung carcinoma xenografts in alpha 2 beta 1(-/-) mice failed to respond to systemic delivery of endorepellin. In contrast, endorepellin inhibited tumor growth and angiogenesis in the wild- type mice expressing integrin alpha 2 beta 1. We conclude that the angiostatic effects of endorepellin in vivo are mediated by a specific interaction of endorepellin with the alpha 2 beta 1 integrin receptor.	[Woodall, Benjamin P.; Nystrom, Alexander; Iozzo, Rex A.; Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Eble, Johannes A.; Niland, Stephan] Muenster Univ Hosp, Inst Physiol Chem, D-48149 Munster, Germany; [Krieg, Thomas; Eckes, Beate] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany; [Pozzi, Ambra] Vanderbilt Univ, Dept Med, Div Nephrol, Nashville, TN 37232 USA	Jefferson University; University of Munster; University of Cologne; Vanderbilt University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Rm 249 JAH, Philadelphia, PA 19107 USA.	iozzo@mail.jci.tju.edu	Iozzo, Renato/AAS-1980-2020	Iozzo, Renato/0000-0002-5908-5112; Nystrom, Alexander/0000-0002-4666-2240	NCI NIH HHS [R01 CA47282, R01 CA39481, R01 CA120975] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA039481, R01CA047282, R01CA120975] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adatia R, 1997, ANN ONCOL, V8, P1257, DOI 10.1023/A:1008243115385; Aviezer D, 1997, MOL CELL BIOL, V17, P1938, DOI 10.1128/MCB.17.4.1938; Bix G, 2005, TRENDS CELL BIOL, V15, P52, DOI 10.1016/j.tcb.2004.11.008; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Bix G, 2007, BLOOD, V109, P3745, DOI 10.1182/blood-2006-08-039925; Bix G, 2006, J NATL CANCER I, V98, P1634, DOI 10.1093/jnci/djj441; Brown JC, 1997, EUR J BIOCHEM, V250, P39, DOI 10.1111/j.1432-1033.1997.t01-1-00039.x; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Datta MW, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-9; Datta S, 2006, INT J BIOCHEM CELL B, V38, P1855, DOI 10.1016/j.biocel.2006.03.022; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Eble JA, 2005, CURR PHARM DESIGN, V11, P867, DOI 10.2174/1381612053381738; Eble JA, 2003, BIOCHEM J, V376, P77, DOI 10.1042/BJ20030373; EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x; Eble JA, 2001, J BIOL CHEM, V276, P12274, DOI 10.1074/jbc.M009338200; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Farach-Carson MC, 2007, GLYCOBIOLOGY, V17, P897, DOI 10.1093/glycob/cwm043; Funahashi Y, 2002, CANCER RES, V62, P6116; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; Grenache DG, 2007, J INVEST DERMATOL, V127, P455, DOI 10.1038/sj.jid.5700611; HASSELL JR, 2003, GLYCOCONJ J, V19, P263; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; Hohenester E, 2002, MATRIX BIOL, V21, P115, DOI 10.1016/S0945-053X(01)00191-3; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Horii K, 2004, J MOL BIOL, V341, P519, DOI 10.1016/j.jmb.2004.06.036; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; IOZZO RV, 1994, MATRIX BIOL, V14, P203, DOI 10.1016/0945-053X(94)90183-X; Jin H, 2004, BRIT J CANCER, V90, P561, DOI 10.1038/sj.bjc.6601576; KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x; King SL, 1997, J BIOL CHEM, V272, P28518, DOI 10.1074/jbc.272.45.28518; Knox SM, 2006, CELL MOL LIFE SCI, V63, P2435, DOI 10.1007/s00018-006-6162-z; Laplante P, 2006, J BIOL CHEM, V281, P30383, DOI 10.1074/jbc.M606412200; Marcinkiewicz C, 2000, BIOCHEMISTRY-US, V39, P9859, DOI 10.1021/bi000428a; Mathiak M, 1997, CANCER RES, V57, P2130; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Mongiat M, 2001, J BIOL CHEM, V276, P10263, DOI 10.1074/jbc.M011493200; Mongiat M, 2000, J BIOL CHEM, V275, P7095, DOI 10.1074/jbc.275.10.7095; Nugent MA, 2000, P NATL ACAD SCI USA, V97, P6722, DOI 10.1073/pnas.97.12.6722; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Pozzi A, 2000, P NATL ACAD SCI USA, V97, P2202, DOI 10.1073/pnas.040378497; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Rudenko G, 2001, TRENDS BIOCHEM SCI, V26, P363, DOI 10.1016/S0968-0004(01)01832-1; Savore C, 2005, CLIN EXP METASTAS, V22, P377, DOI 10.1007/s10585-005-2339-3; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Senger DR, 1997, P NATL ACAD SCI USA, V94, P13612, DOI 10.1073/pnas.94.25.13612; Sharma B, 1998, J CLIN INVEST, V102, P1599, DOI 10.1172/JCI3793; Sher I, 2006, J BIOL CHEM, V281, P5178, DOI 10.1074/jbc.M509500200; Stricker TP, 2001, J BIOL CHEM, V276, P29375, DOI 10.1074/jbc.M102217200; Sweeney SM, 2003, J BIOL CHEM, V278, P30516, DOI 10.1074/jbc.M304237200; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1; Zhang ZG, 2006, J CELL SCI, V119, P1886, DOI 10.1242/jcs.02921; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546	60	90	93	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2335	2343		10.1074/jbc.M708364200	http://dx.doi.org/10.1074/jbc.M708364200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18024432	hybrid			2022-12-25	WOS:000252501000060
J	Laval, F; Haites, R; Movahedzadeh, F; Lemassu, A; Wong, CY; Stoker, N; Billman-Jacobe, H; Daffe, M				Laval, Francoise; Haites, Ruth; Movahedzadeh, Farahnaz; Lemassu, Anne; Wong, Chinn Yi; Stoker, Neil; Billman-Jacobe, Helen; Daffe, Mamadou			Investigating the function of the putative mycolic acid methyltransferase UmaA - Divergence between the Mycobacterium smegmatis and Mycobacterium tuberculosis proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOPROPANE SYNTHETASE; FATTY-ACIDS; BIOSYNTHESIS; GENE; VIRULENCE; MUTANT; IDENTIFICATION; FORTUITUM; ENVELOPE; ENCODES	Mycolic acids are major and specific lipid components of the cell envelope of mycobacteria that include the causative agents of tuberculosis and leprosy, Mycobacterium tuberculosis and Mycobacterium leprae, respectively. Subtle structural variations that are known to be crucial for both their virulence and the permeability of their cell envelope occur in mycolic acids. Among these are the introduction of cyclopropyl groups and methyl branches by mycolic acid S-adenosylmethionine-dependent methyltransferases (MA-MTs). While the functions of seven of the M. tuberculosis MA-MTs have been either established or strongly presumed nothing is known of the roles of the remaining umaA gene product and those of M. smegmatis MA-MTs. Mutants of the M. tuberculosis umaA gene and its putative M. smegmatis orthologue, MSMEG0913, were created. The lipid extracts of the resulting mutants were analyzed in detail using a combination of analytical techniques such as matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and proton nuclear magnetic resonance spectroscopy, and chemical degradation methods. The M. smegmatis mutants no longer synthesized subtypes of mycolates containing a methyl branch adjacent to either trans cyclopropyl group or trans double bond at the "proximal" position of both alpha- and epoxy-mycolates. Complementation with MSMEG0913, but not with umaA, fully restored the wild-type phenotype in M. smegmatis.	[Laval, Francoise; Lemassu, Anne; Daffe, Mamadou] Univ Toulouse 3, IPBS, F-31077 Toulouse, France; [Laval, Francoise; Lemassu, Anne; Daffe, Mamadou] CNRS, Unite Mixte Rech 5089, IPBS, F-31077 Toulouse, France; [Haites, Ruth; Wong, Chinn Yi; Billman-Jacobe, Helen] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Movahedzadeh, Farahnaz; Stoker, Neil] Univ London Royal Vet Coll, Dept Pathol & Infect Dis, London NW1 0TU, England	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Melbourne; University of London; University of London Royal Veterinary College	Daffe, M (corresponding author), Univ Toulouse 3, IPBS, 205 Route Narbonne, F-31077 Toulouse, France.	daffe@ipbs.fr	LAUZERAL-VIZCAINO, Françoise/W-8898-2019; Stoker, Neil G/L-8812-2016	LAUZERAL-VIZCAINO, Françoise/0000-0002-9741-3252; Stoker, Neil G/0000-0001-7055-6184; Billman-Jacobe, Helen/0000-0001-5713-4657	Wellcome Trust [073237, 051880] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; ASSELINEAU C, 1981, ANN INST PASTEUR MIC, VA132, P19; Asselineau C, 2002, PROG LIPID RES, V41, P501, DOI 10.1016/S0163-7827(02)00008-5; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DAFFE M, 1981, TETRAHEDRON LETT, V22, P4515, DOI 10.1016/S0040-4039(01)93029-1; DAFFE M, 1983, ANN INST PASTEUR MIC, VB134, P241, DOI 10.1016/S0769-2609(83)80037-4; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dinadayala P, 2003, J BIOL CHEM, V278, P7310, DOI 10.1074/jbc.M210501200; DRAPER P, 1982, ANN INST PASTEUR MIC, VB133, P39; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; ETEMADI AH, 1965, THESIS U PARIS; Gao LY, 2003, MOL MICROBIOL, V49, P1547, DOI 10.1046/j.1365-2958.2003.03667.x; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Glickman MS, 2003, J BIOL CHEM, V278, P7844, DOI 10.1074/jbc.M212458200; Glickman MS, 2001, J BIOL CHEM, V276, P2228, DOI 10.1074/jbc.C000652200; GRAY G R, 1982, Progress in Lipid Research, V21, P91, DOI 10.1016/0163-7827(82)90001-7; GUILHOT C, 1994, J BACTERIOL, V176, P535, DOI 10.1128/JB.176.2.535-539.1994; Jeevarajah D, 2004, J BACTERIOL, V186, P6792, DOI 10.1128/JB.186.20.6792-6799.2004; LACAVE C, 1987, EUR J BIOCHEM, V163, P369, DOI 10.1111/j.1432-1033.1987.tb10809.x; Laval F, 2001, ANAL CHEM, V73, P4537, DOI 10.1021/ac0105181; McAdam RA, 2002, MICROBIOL-SGM, V148, P2975, DOI 10.1099/00221287-148-10-2975; MINNIKIN DE, 1982, BIOCHIM BIOPHYS ACTA, V712, P616, DOI 10.1016/0005-2760(82)90290-9; MINNIKIN DE, 1984, ARCH MICROBIOL, V139, P225, DOI 10.1007/BF00402005; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Puech V, 2002, MOL MICROBIOL, V44, P1109, DOI 10.1046/j.1365-2958.2002.02953.x; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Schroeder BG, 2001, BIOORG CHEM, V29, P164, DOI 10.1006/bioo.2001.1207; Shin SJ, 2006, INFECT IMMUN, V74, P3825, DOI 10.1128/IAI.01742-05; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; VONRUDLOFF E, 1956, CAN J CHEM, V34, P1413; Yuan Y, 1998, MOL MICROBIOL, V29, P1449, DOI 10.1046/j.1365-2958.1998.01026.x; YUAN Y, 1995, P NATL ACAD SCI USA, V92, P6630, DOI 10.1073/pnas.92.14.6630; Yuan Y, 1996, P NATL ACAD SCI USA, V93, P12828, DOI 10.1073/pnas.93.23.12828	37	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1419	1427		10.1074/jbc.M708859200	http://dx.doi.org/10.1074/jbc.M708859200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18006503	hybrid			2022-12-25	WOS:000252282700025
J	Massengo-Tiasse, RP; Cronan, JE				Massengo-Tiasse, R. Prisca; Cronan, John E.			Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID BIOSYNTHESIS; ANTIBACTERIAL DRUG DISCOVERY; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; STREPTOCOCCUS-PNEUMONIAE; TRICLOSAN; INHIBITION; SINGLE; GENE; COLLECTION	Enoyl-acyl carrier protein (ACP) reductase catalyzes the last step of the fatty acid elongation cycle. The paradigm enoyl-ACP reductase is the FabI protein of Escherichia coli that is the target of the antibacterial compound, triclosan. However, some Gram-positive bacteria are naturally resistant to triclosan due to the presence of the triclosan-resistant enoyl-ACP reductase isoforms, FabK and FabL. The genome of the Gram-negative bacterium, Vibrio cholerae lacks a gene encoding a homologue of any of the three known enoyl-ACP reductase isozymes suggesting that this organism encodes a novel fourth enoyl-ACP reductase isoform. We report that this is the case. The gene encoding the new isoform, called FabV, was isolated by complementation of a conditionally lethal E. coli fabI mutant strain and was shown to restore fatty acid synthesis to the mutant strain both in vivo and in vitro. Like FabI and FabL, FabV is a member of the short chain dehydrogenase reductase superfamily, although it is considerably larger ( 402 residues) than either FabI ( 262 residues) or FabL ( 250 residues). The FabV, FabI and FabL sequences can be aligned, but only poorly. Alignment requires many gaps and yields only 15% identical residues. Thus, FabV defines a new class of enoyl-ACP reductase. The native FabV protein has been purified to homogeneity and is active with both crotonyl-ACP and the model substrate, crotonyl-CoA. In contrast to FabI and FabL, FabV shows a very strong preference for NADH over NADPH. Expression of FabV in E. coli results in markedly increased resistance to triclosan and the purified enzyme is much more resistant to triclosan than is E. coli FabI.	[Massengo-Tiasse, R. Prisca; Cronan, John E.] Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, 601 S Goodwin Ave, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Cronan, John/V-6626-2019	Yoder, Prisca/0000-0003-0845-152X				Bergler H, 1996, EUR J BIOCHEM, V242, P689, DOI 10.1111/j.1432-1033.1996.0689r.x; BERGLER H, 1992, J GEN MICROBIOL, V138, P2093, DOI 10.1099/00221287-138-10-2093; BERGLER H, 1994, J BIOL CHEM, V269, P5493; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Cronan JE, 2006, NAT CHEM BIOL, V2, P232, DOI 10.1038/nchembio0506-232; Cronan JE, 2006, PLASMID, V55, P152, DOI 10.1016/j.plasmid.2005.07.001; Cronan JE, 2006, CELL, V126, P641, DOI 10.1016/j.cell.2006.08.001; De Lay NR, 2007, J BIOL CHEM, V282, P20319, DOI 10.1074/jbc.M703789200; Duax WL, 1996, CURR OPIN STRUC BIOL, V6, P813, DOI 10.1016/S0959-440X(96)80012-1; Escalada MG, 2005, LETT APPL MICROBIOL, V41, P476, DOI 10.1111/j.1472-765X.2005.01790.x; GELMANN EP, 1972, J BACTERIOL, V112, P381, DOI 10.1128/JB.112.1.381-387.1972; Heath Richard J, 2004, Curr Opin Investig Drugs, V5, P146; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; HEATH RJ, 1995, J BIOL CHEM, V270, P26538, DOI 10.1074/jbc.270.44.26538; Heath RJ, 2000, J BIOL CHEM, V275, P40128, DOI 10.1074/jbc.M005611200; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; JACKOWSKI S, 1987, J BIOL CHEM, V262, P7927; Kim KH, 2007, ACTA CRYSTALLOGR F, V63, P246, DOI 10.1107/S1744309107008469; Kouzminova EA, 2004, MOL MICROBIOL, V51, P1279, DOI 10.1111/j.1365-2958.2003.03924.x; Lai CY, 2004, J BACTERIOL, V186, P1869, DOI 10.1128/JB.186.6.1869-1878.2004; Marrakchi H, 2003, BIOCHEM J, V370, P1055, DOI 10.1042/BJ20021699; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; Nichols BP, 1998, J BACTERIOL, V180, P6408; Payne DJ, 2001, DRUG DISCOV TODAY, V6, P537, DOI 10.1016/S1359-6446(01)01774-3; Persson B, 2003, CHEM-BIOL INTERACT, V143, P271, DOI 10.1016/S0009-2797(02)00223-5; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; SINGER M, 1989, MICROBIOL REV, V53, P1; Sivaraman S, 2003, BIOCHEMISTRY-US, V42, P4406, DOI 10.1021/bi0300229; STELLWAGEN E, 1977, ACCOUNTS CHEM RES, V10, P92, DOI 10.1021/ar50111a004; Thomas J, 2005, J BIOL CHEM, V280, P34675, DOI 10.1074/jbc.M505736200; Ward WHJ, 1999, BIOCHEMISTRY-US, V38, P12514, DOI 10.1021/bi9907779; Wild J, 2002, GENOME RES, V12, P1434, DOI 10.1101/gr.130502; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zhang YM, 2006, J BIOL CHEM, V281, P17541, DOI 10.1074/jbc.R600004200; Zheng CJ, 2007, BIOCHEM BIOPH RES CO, V362, P1107, DOI 10.1016/j.bbrc.2007.08.144; Zheng CJ, 2006, J ANTIBIOT, V59, P808, DOI 10.1038/ja.2006.108	40	89	102	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1308	1316		10.1074/jbc.M708171200	http://dx.doi.org/10.1074/jbc.M708171200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18032386	hybrid			2022-12-25	WOS:000252282700013
J	Pugh, RA; Honda, M; Leesley, H; Thomas, A; Lin, YY; Nilges, MJ; Cann, IKO; Spies, M				Pugh, Robert A.; Honda, Masayoshi; Leesley, Haley; Thomas, Alvin; Lin, Yuyen; Nilges, Mark J.; Cann, Isaac K. O.; Spies, Maria			The iron-containing domain is essential in Rad3 helicases for coupling of ATP hydrolysis to DNA translocation and for targeting the helicase to the single-stranded DNA-double-stranded DNA junction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; GENE ENCODES; REPAIR; PROTEIN; TFIIH; CORE; FANCJ; BACH1	Helicases often achieve functional specificity through utilization of unique structural features incorporated into an otherwise conserved core. The archaeal Rad3 (xeroderma pigmentosum group D protein (XPD)) helicase is a prototypical member of the Rad3 family, distinct from other related ( superfamily II) SF2 enzymes because of a unique insertion containing an iron-sulfur (FeS) cluster. This insertion may represent an auxiliary domain responsible for modifying helicase activity or for conferring specificity for selected DNA repair intermediates. The importance of the FeS cluster for the fine-tuning of Rad3-DNA interactions is illustrated by several clinically relevant point mutations in the FeS domain of human Bach1 (FancJ) and XPD helicases that result in distinct disease phenotypes. Here we analyzed the substrate specificity of the Rad3 (XPD) helicase from Ferroplasma acidarmanus (FacRad3) and probed the importance of the FeS cluster for Rad3-DNA interactions. We found that the FeS cluster stabilizes secondary structure of the auxiliary domain important for coupling of single-stranded (ss) DNA-dependent ATP hydrolysis to ssDNA translocation. Additionally, we observed specific quenching of the Cy5 fluorescent dye when the FeS cluster of a bound helicase is positioned in close proximity to a Cy5 fluorophore incorporated into the DNA molecule. Taking advantage of this Cy5 quenching, we developed an equilibrium assay for analysis of the Rad3 interactions with various DNA substrates. We determined that the FeS cluster-containing domain recognizes the ssDNA-double-stranded DNA junction and positions the helicase in an orientation consistent with duplex unwinding. Although it interacts specifically with the junction, the enzyme binds tightly to ssDNA, and the single-stranded regions of the substrate are the major contributors to the energetics of FacRad3-substrate interactions.	[Pugh, Robert A.; Honda, Masayoshi; Leesley, Haley; Spies, Maria] Univ Illinois, Dept Biochem, Roger Adams Lab 493 MC 712, Urbana, IL 61801 USA; [Thomas, Alvin; Lin, Yuyen; Cann, Isaac K. O.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Thomas, Alvin; Cann, Isaac K. O.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Nilges, Mark J.] Univ Illinois, Illinois EPR Res Ctr, Urbana, IL 61801 USA; [Cann, Isaac K. O.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Spies, M (corresponding author), Univ Illinois, Dept Biochem, Roger Adams Lab 493 MC 712, Urbana, IL 61801 USA.	mspies@life.uiuc.edu		Honda, Masayoshi/0000-0001-8920-6301; Spies, Maria/0000-0002-7375-8037				Boal AK, 2005, BIOCHEMISTRY-US, V44, P8397, DOI 10.1021/bi047494n; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chang WH, 2000, CELL, V102, P609, DOI 10.1016/S0092-8674(00)00083-0; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Dopson M, 2004, APPL ENVIRON MICROB, V70, P2079, DOI 10.1128/AEM.70.4.2079-2088.2004; Egly JM, 2001, FEBS LETT, V498, P124, DOI 10.1016/S0014-5793(01)02458-9; Fan L, 2006, MOL CELL, V22, P27, DOI 10.1016/j.molcel.2006.02.017; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Guan Y, 1998, NAT STRUCT BIOL, V5, P1058, DOI 10.1038/4168; Gupta R, 2006, NUCLEIC ACIDS RES, V34, P6673, DOI 10.1093/nar/gkl964; Hanawalt PC, 2003, MUTAT RES-REV MUTAT, V544, P107, DOI 10.1016/j.mrrev.2003.06.002; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P1497, DOI 10.1093/nar/21.6.1497; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Liu ZR, 2003, PLANT PHYSIOL, V132, P1405, DOI 10.1104/pp.103.021808; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Salerno V, 2003, NUCLEIC ACIDS RES, V31, P6127, DOI 10.1093/nar/gkg831; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; Schultz P, 2000, CELL, V102, P599, DOI 10.1016/S0092-8674(00)00082-9; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Soultanas P, 2001, TRENDS BIOCHEM SCI, V26, P47, DOI 10.1016/S0968-0004(00)01734-5; Sung P, 1996, J BIOL CHEM, V271, P10821, DOI 10.1074/jbc.271.18.10821; SUNG P, 1987, P NATL ACAD SCI USA, V84, P8951, DOI 10.1073/pnas.84.24.8951; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; Takagi Y, 2003, J BIOL CHEM, V278, P43897, DOI 10.1074/jbc.C300417200; Tuteja N, 2004, EUR J BIOCHEM, V271, P1835, DOI 10.1111/j.1432-1033.2004.04093.x; Voloshin ON, 2007, J BIOL CHEM, V282, P18437, DOI 10.1074/jbc.M700376200; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371	34	77	80	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1732	1743		10.1074/jbc.M707064200	http://dx.doi.org/10.1074/jbc.M707064200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18029358	hybrid			2022-12-25	WOS:000252282700060
J	Fonte, V; Kipp, DR; Yerg, J; Merin, D; Forrestal, M; Wagner, E; Roberts, CM; Link, CD				Fonte, Virginia; Kipp, D. Randal; Yerg, John, III; Merin, David; Forrestal, Margaret; Wagner, Eileen; Roberts, Christine M.; Link, Christopher D.			Suppression of in vivo beta-amyloid peptide toxicity by overexpression of the HSP-16.2 small chaperone protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; TRANSGENIC CAENORHABDITIS-ELEGANS; INCLUSION-BODY MYOSITIS; HEAT-SHOCK PROTEINS; ALZHEIMERS-DISEASE; C-ELEGANS; A-BETA; EXPRESSION; AGGREGATION; MODEL	Expression of the human beta-amyloid peptide (A beta) in a transgenic Caenorhabditis elegans Alzheimer disease model leads to the induction of HSP-16 proteins, a family of small heat shock-inducible proteins homologous to vertebrate alpha B crystallin. These proteins also co-localize and co-immunoprecipitate with A beta in this model (Fonte, V., Kapulkin, V., Taft, A., Fluet, A., Friedman, D., and Link, C. D. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 9439-9444). To investigate the molecular basis and biological function of this interaction between HSP-16 and A beta, we generated transgenic C. elegans animals with high level, constitutive expression of HSP-16.2. We find that constitutive expression of wild type, but not mutant, HSP-16.2 partially suppresses A beta toxicity. Wild type A beta-(1-42), but not A beta single chain dimer, was observed to become sequestered in HSP-16.2-containing inclusions, indicating a conformation-dependent interaction between HSP-16.2 and A beta in vivo. Constitutive expression of HSP-16.2 could reduce amyloid fibril formation, but it did not reduce the overall accumulation of A beta peptide or alter the pattern of the predominant oligomeric species. Studies with recombinant HSP-16.2 demonstrated that HSP-16.2 can bind directly to A beta in vitro, with a preferential affinity for oligomeric A beta species. This interaction between A beta and HSP-16.2 also influences the formation of A beta oligomers in in vitro assays. These studies are consistent with a model in which small chaperone proteins reduce A beta toxicity by interacting directly with the A beta peptide and altering its oligomerization pathways, thereby reducing the formation of a minor toxic species.	[Fonte, Virginia; Kipp, D. Randal; Yerg, John, III; Merin, David; Forrestal, Margaret; Wagner, Eileen; Roberts, Christine M.; Link, Christopher D.] Univ Colorado, Inst Behav Genet Integrat Physiol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Link, CD (corresponding author), Univ Colorado, Inst Behav Genet Integrat Physiol, Boulder, CO 80309 USA.	linkc@colorado.edu		Kipp, Randy/0000-0002-4094-6250	NATIONAL INSTITUTE ON AGING [R01AG021037] Funding Source: NIH RePORTER; NIA NIH HHS [AG21037] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ASKANAS V, 1992, AM J PATHOL, V141, P31; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Banwell BL, 2000, NEUROLOGY, V54, P1033, DOI 10.1212/WNL.54.5.1033; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; DAHL R, 1989, J ELECTRON MICR TECH, V13, P165, DOI 10.1002/jemt.1060130305; Drake J, 2003, NEUROBIOL AGING, V24, P415, DOI 10.1016/S0197-4580(02)00225-7; Fay DS, 1998, J NEUROCHEM, V71, P1616; Florez-McClure ML, 2007, AUTOPHAGY, V3, P569, DOI 10.4161/auto.4776; Fonte V, 2002, P NATL ACAD SCI USA, V99, P9439, DOI 10.1073/pnas.152313999; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Kapulkin V, 2005, FEBS LETT, V579, P3063, DOI 10.1016/j.febslet.2005.04.062; Katoh Y, 2004, FEBS LETT, V565, P28, DOI 10.1016/j.febslet.2003.12.085; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Kitazawa M, 2006, AM J PATHOL, V168, P1986, DOI 10.2353/ajpath.2006.051232; Kudva YC, 1997, FEBS LETT, V416, P117, DOI 10.1016/S0014-5793(97)01180-0; Lee S, 2005, PROTEIN SCI, V14, P593, DOI 10.1110/ps.041020705; Leroux MR, 1997, J BIOL CHEM, V272, P24646, DOI 10.1074/jbc.272.39.24646; Liang JJN, 2000, FEBS LETT, V484, P98, DOI 10.1016/S0014-5793(00)02136-0; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2001, NEUROBIOL AGING, V22, P217, DOI 10.1016/S0197-4580(00)00237-2; Link CD, 2003, NEUROBIOL AGING, V24, P397, DOI 10.1016/S0197-4580(02)00224-5; Link CD, 2006, J BIOL CHEM, V281, P1808, DOI 10.1074/jbc.M505581200; Link CD, 2006, EXP GERONTOL, V41, P1007, DOI 10.1016/j.exger.2006.06.059; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Moussa CEH, 2006, FASEB J, V20, P2165, DOI 10.1096/fj.06-5763fje; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P155, DOI 10.1007/BF00296185; Sanbe A, 2007, J BIOL CHEM, V282, P555, DOI 10.1074/jbc.M605481200; Santhoshkumar P, 2004, MOL CELL BIOCHEM, V267, P147, DOI 10.1023/B:MCBI.0000049373.15558.b8; SHINOHARA H, 1993, J NEUROL SCI, V119, P203, DOI 10.1016/0022-510X(93)90135-L; Stege GJJ, 1999, BIOCHEM BIOPH RES CO, V262, P152, DOI 10.1006/bbrc.1999.1167; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Wilhelmus MMM, 2006, ACTA NEUROPATHOL, V111, P139, DOI 10.1007/s00401-005-0030-z; Yoo BC, 2001, BIOCHEM BIOPH RES CO, V280, P249, DOI 10.1006/bbrc.2000.4109; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	47	124	130	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					784	791		10.1074/jbc.M703339200	http://dx.doi.org/10.1074/jbc.M703339200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17993648	hybrid			2022-12-25	WOS:000252128100017
J	Kim, JH; Kim, JE; Liu, HY; Cao, WH; Chen, J				Kim, Jeong-Ho; Kim, Jae Eun; Liu, Hui-Yu; Cao, Wenhong; Chen, Jie			Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; DIET-INDUCED OBESITY; SERINE PHOSPHORYLATION; ADIPOCYTE DIFFERENTIATION; RECEPTOR SUBSTRATE-1; MAXIMAL ACTIVATION; AMINO-ACID; MTOR; PROTEIN; 3T3-L1	The proinflammatory cytokine interleukin (IL)-6 has been proposed to be one of the mediators that link obesity-derived chronic inflammation with insulin resistance. Signaling through the mammalian target of rapamycin ( mTOR) has been found to impact insulin sensitivity under various pathological conditions, through serine phosphorylation and inhibition of insulin receptor substrate by the downstream effector of mTOR, ribosomal S6 kinase 1 (S6K1). However, an involvement of mTOR in IL-6-induced insulin resistance has not yet been reported. Here we show that rapamycin, the inhibitor of mTOR signaling, rescues insulin signaling and glycogen synthesis from IL-6 inhibition in HepG2 hepatocarcinoma cells as well as in mouse primary hepatocytes. IL-6 activates S6K1 in these cells, but unexpectedly, S6K1 is not involved in IL-6 inhibition of insulin signaling, since the effect of IL-6 persists in cells with drastically reduced S6K1 levels induced by RNA interference, suggesting that the function of mTOR signaling is through a mechanism different from the prevailing model of S6K1 phosphorylation of insulin receptor substrate-1. Interestingly, we find that the phosphorylation of STAT3 on Ser(727) and STAT3 transcriptional activity are regulated by mTOR upon IL-6 stimulation and that STAT3 is required for IL-6 inhibition of insulin signaling. Furthermore, IL-6-induced SOCS3 expression is inhibited by rapamycin, and ectopic expression of SOCS3 blocks the ability of rapamycin to enhance insulin sensitivity in the presence of IL-6. Taken together, we propose that mTOR plays a key role in IL-6-induced hepatic insulin resistance by regulating STAT3 activation and subsequent SOCS3 expression.	[Kim, Jeong-Ho; Kim, Jae Eun; Chen, Jie] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Liu, Hui-Yu; Cao, Wenhong] Hamner Inst Hlth Sci, Res Triangle Pk, NC USA	University of Illinois System; University of Illinois Urbana-Champaign; The Hamner Institutes for Health Sciences	Chen, J (corresponding author), 601 S Goodwin Ave B107, Urbana, IL 61801 USA.	jiechen@uiuc.edu		Chen, Jie/0000-0002-7887-3747	NIAMS NIH HHS [R01 AR48914] Funding Source: Medline; NIDDK NIH HHS [R01DK76039] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076039] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bell A, 2000, OBES RES, V8, P249, DOI 10.1038/oby.2000.29; Berg CE, 2002, BIOCHEM BIOPH RES CO, V293, P1021, DOI 10.1016/S0006-291X(02)00333-9; Carey AL, 2004, DIABETOLOGIA, V47, P1135, DOI 10.1007/s00125-004-1447-y; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Carter-Su C, 1998, RECENT PROG HORM RES, V53, P61; Chen J, 2002, BIOCHEM PHARMACOL, V64, P1071, DOI 10.1016/S0006-2952(02)01263-7; Cho HJ, 2004, BIOCHEM BIOPH RES CO, V321, P942, DOI 10.1016/j.bbrc.2004.07.050; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Erbay E., 2005, Nutrients and cell signaling, P353; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Gagnon A, 2001, J CELL PHYSIOL, V189, P14, DOI 10.1002/jcp.1132; Giraud J, 2004, J BIOL CHEM, V279, P3447, DOI 10.1074/jbc.M308631200; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Krebs DL, 2000, J CELL SCI, V113, P2813; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; McManus EJ, 2002, NAT CELL BIOL, V4, pE214, DOI 10.1038/ncb0902-e214; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shiba T, 1998, DIABETIC MED, V15, P435, DOI 10.1002/(SICI)1096-9136(199805)15:5<435::AID-DIA566>3.0.CO;2-N; Torisu T, 2007, GENES CELLS, V12, P143, DOI 10.1111/j.1365-2443.2007.01044.x; Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674; Tremblay F, 2005, ENDOCRINOLOGY, V146, P1328, DOI 10.1210/en.2004-0777; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tsigos C, 1997, J CLIN ENDOCR METAB, V82, P4167, DOI 10.1210/jc.82.12.4167; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Ueno M, 2005, DIABETOLOGIA, V48, P506, DOI 10.1007/s00125-004-1662-6; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Ventre J, 1997, DIABETES, V46, P1526, DOI 10.2337/diabetes.46.9.1526; Vozarova B, 2001, OBES RES, V9, P414, DOI 10.1038/oby.2001.54; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; YEH WC, 1995, P NATL ACAD SCI USA, V92, P11086, DOI 10.1073/pnas.92.24.11086; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321	53	108	113	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					708	715		10.1074/jbc.M708568200	http://dx.doi.org/10.1074/jbc.M708568200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17993646	hybrid			2022-12-25	WOS:000252128100008
J	Romney, SJ; Thacker, C; Leibold, EA				Romney, S. Joshua; Thacker, Colin; Leibold, Elizabeth A.			An iron enhancer element in the FTN-1 gene directs iron-dependent expression in Caenorhabditis elegans intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; FERRITIN MESSENGER-RNA; RESPONSIVE ELEMENT; C-ELEGANS; SCHIZOSACCHAROMYCES-POMBE; SIDEROPHORE BIOSYNTHESIS; REGULATORY PROTEIN-2; ARABIDOPSIS-THALIANA; CELLULAR-REGULATION; MUTATION	Ferritin is a ubiquitous protein that sequesters iron and protects cells from iron toxicity. Caenorhabditis elegans express two ferritins, FTN-1 and FTN-2, which are transcriptionally regulated by iron. To identify the cis-acting sequences and proteins required for iron-dependent regulation of ftn-1 and ftn-2 expression, we generated transcriptional GFP reporters corresponding to 5'-upstream sequences of the ftn-1 and ftn-2 genes. We identified a conserved 63-bp sequence, the iron-dependent element (IDE), that is required for iron-dependent regulation of a ftn-1 GFP reporter in intestine. The IDE contains two GATA-binding motifs and three octameric direct repeats. Site-directed mutagenesis of the GATA sequences, singly or in combination, reduces ftn-1 GFP reporter expression in the intestine. In vitro DNA mobility shift assays show that the intestine-specific GATA protein ELT-2 binds to both GATA sequences. Inhibition of ELT-2 function by RNA interference blocks ftn-1 GFP reporter expression in vivo. Insertion of the IDE into the promoter region of a heterologous reporter activates iron-dependent transcription in intestine. These data demonstrate that the activation of ftn-1 and ftn-2 transcription by iron requires ELT-2 and that the IDE functions as an iron-dependent enhancer in intestine.	[Romney, S. Joshua; Leibold, Elizabeth A.] Univ Utah, Eccles Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA; [Leibold, Elizabeth A.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Leibold, Elizabeth A.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Thacker, Colin] Univ Utah, Hlth Sci Ctr Core Res Facil, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Leibold, EA (corresponding author), Univ Utah, Eccles Program Human Mol Biol & Genet, 2030 E,Rm 3240, Salt Lake City, UT 84112 USA.	betty.leibold@hmbg.utah.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068602, P30DK072437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045201] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK068602, 1P30DK072437, R01DK068602] Funding Source: Medline; NIGMS NIH HHS [R01 GM045201] Funding Source: Medline; PHS HHS [R01GMS45201] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Arnaud N, 2007, BIOCHEM J, V405, P523, DOI 10.1042/BJ20061874; Arnaud N, 2006, J BIOL CHEM, V281, P23579, DOI 10.1074/jbc.M602135200; BEAUMONT C, 1995, NAT GENET, V11, P444, DOI 10.1038/ng1295-444; Britton C, 1998, J MOL BIOL, V283, P15, DOI 10.1006/jmbi.1998.2093; CAIRO G, 1985, BIOCHEM BIOPH RES CO, V133, P314, DOI 10.1016/0006-291X(85)91877-7; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; DICKEY LF, 1987, J BIOL CHEM, V262, P7901; EGAN CR, 1995, DEV BIOL, V170, P397, DOI 10.1006/dbio.1995.1225; Ferreira C, 2001, BLOOD, V98, P525, DOI 10.1182/blood.V98.3.525; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Fukushige T, 2005, DEV BIOL, V279, P446, DOI 10.1016/j.ydbio.2004.12.012; Georgieva T, 1999, P NATL ACAD SCI USA, V96, P2716, DOI 10.1073/pnas.96.6.2716; GIRELLI D, 1995, BLOOD, V86, P4050, DOI 10.1182/blood.V86.11.4050.bloodjournal86114050; Gourley BL, 2003, J BIOL CHEM, V278, P3227, DOI 10.1074/jbc.M210333200; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; Haas H, 1999, J BIOL CHEM, V274, P4613, DOI 10.1074/jbc.274.8.4613; Harrison KA, 2002, BIOCHEMISTRY-US, V41, P15288, DOI 10.1021/bi0204995; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; HAWKINS MG, 1995, J BIOL CHEM, V270, P14666, DOI 10.1074/jbc.270.24.14666; Hintze KJ, 2006, CELL MOL LIFE SCI, V63, P591, DOI 10.1007/s00018-005-5285-y; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; Jakoby M, 2004, FEBS LETT, V577, P528, DOI 10.1016/j.febslet.2004.10.062; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kato J, 2001, AM J HUM GENET, V69, P191, DOI 10.1086/321261; Kim YI, 2004, J MOL BIOL, V342, P421, DOI 10.1016/j.jmb.2004.07.036; Koh K, 2001, DEVELOPMENT, V128, P2867; LEGGETT BA, 1993, J GASTROEN HEPATOL, V8, P21, DOI 10.1111/j.1440-1746.1993.tb01170.x; LESCURE AM, 1991, P NATL ACAD SCI USA, V88, P8222, DOI 10.1073/pnas.88.18.8222; Lind MI, 2006, J BIOL CHEM, V281, P18707, DOI 10.1074/jbc.M603354200; Ling HQ, 2002, P NATL ACAD SCI USA, V99, P13938, DOI 10.1073/pnas.212448699; Maduro MF, 2002, DEV BIOL, V246, P68, DOI 10.1006/dbio.2002.0655; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Moilanen LH, 1999, J BIOL CHEM, V274, P29655, DOI 10.1074/jbc.274.42.29655; Muckenthaler M, 2003, BLOOD, V101, P3690, DOI 10.1182/blood-2002-07-2140; Nichol H, 2002, ANNU REV ENTOMOL, V47, P535, DOI 10.1146/annurev.ento.47.091201.145237; OMICHINSKI JG, 1993, P NATL ACAD SCI USA, V90, P1676, DOI 10.1073/pnas.90.5.1676; Oskouian B, 2005, J BIOL CHEM, V280, P18403, DOI 10.1074/jbc.M410928200; Page BD, 1997, GENE DEV, V11, P1651, DOI 10.1101/gad.11.13.1651; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Pauli F, 2006, DEVELOPMENT, V133, P287, DOI 10.1242/dev.02185; Pelletier B, 2005, J BIOL CHEM, V280, P25146, DOI 10.1074/jbc.M502947200; Pelletier B, 2003, NUCLEIC ACIDS RES, V31, P4332, DOI 10.1093/nar/gkg647; Petit JM, 2001, J BIOL CHEM, V276, P5584, DOI 10.1074/jbc.M005903200; Pham DQD, 1999, EUR J BIOCHEM, V266, P236, DOI 10.1046/j.1432-1327.1999.00849.x; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Shimizu R, 2007, J BIOL CHEM, V282, P15862, DOI 10.1074/jbc.M701936200; Theil EC, 2003, J NUTR, V133, p1549S, DOI 10.1093/jn/133.5.1549S; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; VOISARD C, 1993, MOL CELL BIOL, V13, P7091, DOI 10.1128/MCB.13.11.7091; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wei JZ, 2000, J BIOL CHEM, V275, P17488, DOI 10.1074/jbc.M910334199; Welch KD, 2002, FREE RADICAL BIO MED, V32, P577, DOI 10.1016/S0891-5849(02)00760-8; WHITE K, 1988, J BIOL CHEM, V263, P8938; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; Yuan YX, 2005, CELL RES, V15, P613, DOI 10.1038/sj.cr.7290331; Zhao J, 2007, MECH DEVELOP, V124, P377, DOI 10.1016/j.mod.2007.01.005	60	35	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					716	725		10.1074/jbc.M707043200	http://dx.doi.org/10.1074/jbc.M707043200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18024960	hybrid			2022-12-25	WOS:000252128100009
J	McClintock, D; Ratner, D; Lokuge, M; Owens, DM; Gordon, LB; Collins, FS; Djabali, K				McClintock, Dayle; Ratner, Desiree; Lokuge, Meepa; Owens, David M.; Gordon, Leslie B.; Collins, Francis S.; Djabali, Karima			The Mutant Form of Lamin A that Causes Hutchinson-Gilford Progeria Is a Biomarker of Cellular Aging in Human Skin	PLOS ONE			English	Article								Hutchinson-Gilford progeria syndrome (HGPS, OMIM 176670) is a rare disorder characterized by accelerated aging and early death, frequently from stroke or coronary artery disease. 90% of HGPS cases carry the LMNA G608G (GGC>GGT) mutation within exon 11 of LMNA, activating a splice donor site that results in production of a dominant negative form of lamin A protein, denoted progerin. Screening 150 skin biopsies from unaffected individuals ( newborn to 97 years) showed that a similar splicing event occurs in vivo at a low level in the skin at all ages. While progerin mRNA remains low, the protein accumulates in the skin with age in a subset of dermal fibroblasts and in a few terminally differentiated keratinocytes. Progerin-positive fibroblasts localize near the basement membrane and in the papillary dermis of young adult skin; however, their numbers increase and their distribution reaches the deep reticular dermis in elderly skin. Our findings demonstrate that progerin expression is a biomarker of normal cellular aging and may potentially be linked to terminal differentiation and senescence in elderly individuals.	[McClintock, Dayle; Ratner, Desiree; Lokuge, Meepa; Owens, David M.; Djabali, Karima] Columbia Univ, Coll Phys & Surg, Dept Dermatol, New York, NY 10027 USA; [Owens, David M.] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA; [Gordon, Leslie B.] Brown Univ, Dept BioMed Pediat, Providence, RI 02912 USA; [Collins, Francis S.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA	Columbia University; Columbia University; Brown University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Djabali, K (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Dermatol, New York, NY 10027 USA.	kd206@columbia.edu	Gordon, Leslie B./AAJ-5793-2021	Ratner, Desiree/0000-0002-1217-1929	Progeria Research Foundation; Irving Foundation; NIH [K01AR048594, RO1AG025302, NCI R01CA114010]; National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR048594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025302] Funding Source: NIH RePORTER	Progeria Research Foundation; Irving Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by The Progeria Research Foundation, The Irving Foundation, and NIH Grants K01AR048594 and RO1AG025302 (to KD), NCI R01CA114010 (to DMO), and from the intramural program of the National Human Genome Research Institute (to FSC).	AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; BENAVENTE R, 1985, CELL, V41, P177, DOI 10.1016/0092-8674(85)90072-8; BRIDGER JM, 1993, J CELL SCI, V104, P297; BROWN WT, 1992, AM J CLIN NUTR, V55, P1222; BROWN WT, 1985, ADV EXP MED BIOL, V190, P229; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Cao HN, 2003, J HUM GENET, V48, P271, DOI 10.1007/s10038-003-0025-3; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Csoka AB, 2004, J MED GENET, V41, P304, DOI 10.1136/jmg.2003.015651; CURRIGAN DP, 2005, BIOCHEM J, P129; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Delbarre E, 2006, HUM MOL GENET, V15, P1113, DOI 10.1093/hmg/ddl026; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; FERNANDEZPALAZZI F, 1992, EUR J PEDIATR SURG, V2, P378, DOI 10.1055/s-2008-1063486; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; FUNAYAMA R, 2007, CHROMOSOMA; FURUKAWA K, 1993, EMBO J, V12, P97, DOI 10.1002/j.1460-2075.1993.tb05635.x; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; HOZAK P, 1995, J CELL SCI, V108, P635; Hutchison CJ, 2004, NAT CELL BIOL, V6, P1062, DOI 10.1038/ncb1104-1062; LENHER CF, 1987, J CELL BIOL, V105; LIN F, 1995, GENOMICS, V27, P230, DOI 10.1006/geno.1995.1036; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Machiels BM, 1996, J BIOL CHEM, V271, P9249, DOI 10.1074/jbc.271.16.9249; McClintock D, 2006, P NATL ACAD SCI USA, V103, P2154, DOI 10.1073/pnas.0511133103; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Paradisi M, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-27; Plasilova M, 2004, J MED GENET, V41, P609, DOI 10.1136/jmg.2004.019661; Rankin J, 2006, CLIN GENET, V70, P261, DOI 10.1111/j.1399-0004.2006.00677.x; ROBER RA, 1989, DEVELOPMENT, V105, P365; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Shumaker DK, 2003, CURR OPIN CELL BIOL, V15, P358, DOI 10.1016/S0955-0674(03)00050-4; SINENSKY M, 1994, J CELL SCI, V107, P61; Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005; STICK R, 1985, CELL, V41, P191, DOI 10.1016/0092-8674(85)90073-X; SWEENEY KJ, 1992, GERONTOLOGY, V38, P139; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; VOLZ A, 1993, GENOMICS, V18, P92, DOI 10.1006/geno.1993.1430; Wang HJ, 2004, IN VITRO CELL DEV-AN, V40, P268; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Wydner KL, 1996, GENOMICS, V32, P474, DOI 10.1006/geno.1996.0146; Young SG, 2006, J BIOL CHEM, V281, P39741, DOI 10.1074/jbc.R600033200; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	51	244	250	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1269	10.1371/journal.pone.0001269	http://dx.doi.org/10.1371/journal.pone.0001269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060063	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459400016
J	Hoshida, Y; Brunet, JP; Tamayo, P; Golub, TR; Mesirov, JP				Hoshida, Yujin; Brunet, Jean-Philippe; Tamayo, Pablo; Golub, Todd R.; Mesirov, Jill P.			Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets	PLOS ONE			English	Article								Whole genome expression profiles are widely used to discover molecular subtypes of diseases. A remaining challenge is to identify the correspondence or commonality of subtypes found in multiple, independent data sets generated on various platforms. While model-based supervised learning is often used to make these connections, the models can be biased to the training data set and thus miss inherent, relevant substructure in the test data. Here we describe an unsupervised subclass mapping method (SubMap), which reveals common subtypes between independent data sets. The subtypes within a data set can be determined by unsupervised clustering or given by predetermined phenotypes before applying SubMap. We define a measure of correspondence for subtypes and evaluate its significance building on our previous work on gene set enrichment analysis. The strength of the SubMap method is that it does not impose the structure of one data set upon another, but rather uses a bi-directional approach to highlight the common substructures in both. We show how this method can reveal the correspondence between several cancer-related data sets. Notably, it identifies common subtypes of breast cancer associated with estrogen receptor status, and a subgroup of lymphoma patients who share similar survival patterns, thus improving the accuracy of a clinical outcome predictor.	[Hoshida, Yujin; Brunet, Jean-Philippe; Tamayo, Pablo; Golub, Todd R.; Mesirov, Jill P.] MIT, Eli & Edythe L Broad Inst, Cambridge, MA 02139 USA; [Hoshida, Yujin; Brunet, Jean-Philippe; Tamayo, Pablo; Golub, Todd R.; Mesirov, Jill P.] Harvard Univ, Cambridge, MA 02138 USA; [Hoshida, Yujin; Golub, Todd R.] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute	Hoshida, Y (corresponding author), MIT, Eli & Edythe L Broad Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hoshida@broad.mit.edu	Mesirov, Jill/AGF-7626-2022; Hoshida, Yujin/R-7513-2019		Charles A King Trust Fellowship	Charles A King Trust Fellowship	Yujin Hoshida is supported by Charles A King Trust Fellowship. There was no contribution from the funder in any aspects of the current study including the design, analysis, interpretation, and preparation of the manuscript.	[Anonymous], 1932, STAT METHODS RES WOR; Becker B.J., 1994, HDB RES SYNTHESIS, P215; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Kapp AV, 2007, BIOSTATISTICS, V8, P9, DOI 10.1093/biostatistics/kxj029; Lakhani SR, 1998, JNCI-J NATL CANCER I, V90, P1138, DOI 10.1093/jnci/90.15.1138; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998	20	291	294	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1195	10.1371/journal.pone.0001195	http://dx.doi.org/10.1371/journal.pone.0001195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030330	Green Published, gold			2022-12-25	WOS:000207459200009
J	Jin, GX; Zhang, SH; Zhang, XS; Chen, LN				Jin, Guangxu; Zhang, Shihua; Zhang, Xiang-Sun; Chen, Luonan			Hubs with Network Motifs Organize Modularity Dynamically in the Protein-Protein Interaction Network of Yeast	PLOS ONE			English	Article								Background. It has been recognized that modular organization pervades biological complexity. Based on network analysis, 'party hubs' and 'date hubs' were proposed to understand the basic principle of module organization of biomolecular networks. However, recent study on hubs has suggested that there is no clear evidence for coexistence of 'party hubs' and 'date hubs'. Thus, an open question has been raised as to whether or not 'party hubs' and 'date hubs' truly exist in yeast interactome. Methodology. In contrast to previous studies focusing on the partners of a hub or the individual proteins around the hub, our work aims to study the network motifs of a hub or interactions among individual proteins including the hub and its neighbors. Depending on the relationship between a hub's network motifs and protein complexes, we define two new types of hubs, 'motif party hubs' and 'motif date hubs', which have the same characteristics as the original 'party hubs' and 'date hubs' respectively. The network motifs of these two types of hubs display significantly different features in spatial distribution (or cellular localizations), co-expression in microarray data, controlling topological structure of network, and organizing modularity. Conclusion. By virtue of network motifs, we basically solved the open question about 'party hubs' and 'date hubs' which was raised by previous studies. Specifically, at the level of network motifs instead of individual proteins, we found two types of hubs, motif party hubs (mPHs) and motif date hubs (mDHs), whose network motifs display distinct characteristics on biological functions. In addition, in this paper we studied network motifs from a different viewpoint. That is, we show that a network motif should not be merely considered as an interaction pattern but be considered as an essential function unit in organizing modules of networks.	[Jin, Guangxu; Zhang, Shihua; Zhang, Xiang-Sun] Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China; [Jin, Guangxu; Zhang, Shihua] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Chen, Luonan] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Chen, Luonan] Osaka Sangyo Univ, Dept Elect Engn & Elect, Osaka, Japan; [Chen, Luonan] Japan Sci & Technol Corp JST, Aihara Complex Modelling Project, Exploratory Res Adv Technol, Tokyo, Japan; [Chen, Luonan] Univ Tokyo, Inst Ind Sci, Tokyo, Japan	Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai University; Japan Science & Technology Agency (JST); University of Tokyo	Zhang, XS (corresponding author), Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China.	zxs@amt.ac.cn; chen@eic.osaka-sandai.ac.jp	Zhang, Shihua/A-6764-2010; Jin, Guangxu/B-4627-2012	Jin, Guangxu/0000-0002-6616-6981; Jin, Guangxu/0000-0001-9451-4886	National Natural Science Foundation of China [10631070]; Ministry of Science and Technology, China [2006CB503905]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, China(Ministry of Science and Technology, China)	This work was partially supported by the National Natural Science Foundation of China under grant No. 10631070, and the Ministry of Science and Technology, China, under grant No. 2006CB503905.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Balazsi G, 2005, P NATL ACAD SCI USA, V102, P7841, DOI 10.1073/pnas.0500365102; Barabasi A. L., 2002, FORMULA UNIVERSAL LA; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batada NN, 2006, PLOS COMPUT BIOL, V2, P748, DOI 10.1371/journal.pcbi.0020088; Batada NN, 2006, PLOS BIOL, V4, P1720, DOI 10.1371/journal.pbio.0040317; Bernard R, 1986, FUNDAMENTALS BIOSTAT; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Enright AJ, 2001, BIOINFORMATICS, V17, P853, DOI 10.1093/bioinformatics/17.9.853; Fromont-Racine M, 2000, YEAST, V17, P95, DOI 10.1002/1097-0061(20000630)17:2<95::AID-YEA16>3.0.CO;2-H; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Han JDJ, 2005, NAT BIOTECHNOL, V23, P839, DOI 10.1038/nbt1116; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HE X, 2006, PLOS GENET, V2; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ideker T, 2003, TRENDS BIOTECHNOL, V21, P255, DOI 10.1016/S0167-7799(03)00115-X; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kemmeren P, 2002, MOL CELL, V9, P1133, DOI 10.1016/S1097-2765(02)00531-2; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Li CG, 2007, IEEE SIGNAL PROC MAG, V24, P136, DOI 10.1109/MSP.2007.323279; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sole RV, 2006, TRENDS ECOL EVOL, V21, P419, DOI 10.1016/j.tree.2006.05.013; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Thomas JA, 2003, ASTM STAND NEWS, V31, P6; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8	54	43	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1207	10.1371/journal.pone.0001207	http://dx.doi.org/10.1371/journal.pone.0001207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030341	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459200020
J	Lin, W; Zhou, GF; Cheng, XY; Xu, RM				Lin, Wen; Zhou, Guofa; Cheng, Xinyue; Xu, Rumei			Fast Economic Development Accelerates Biological Invasions in China	PLOS ONE			English	Article								Increasing levels of global trade and intercontinental travel have been cited as the major causes of biological invasion. However, indirect factors such as economic development that affect the intensity of invasion have not been quantitatively explored. Herein, using principal factor analysis, we investigated the relationship between biological invasion and economic development together with climatic information for China from the 1970s to present. We demonstrate that the increase in biological invasion is coincident with the rapid economic development that has occurred in China over the past three decades. The results indicate that the geographic prevalence of invasive species varies substantially on the provincial scale, but can be surprisingly well predicted using the combination of economic development (R-2 = 0.378) and climatic factors (R-2 = 0.347). Economic factors are proven to be at least equal to if not more determinant of the occurrence of invasive species than climatic factors. International travel and trade are shown to have played a less significant role in accounting for the intensity of biological invasion in China. Our results demonstrate that more attention should be paid to economic factors to improve the understanding, prediction and management of biological invasions.	[Lin, Wen; Cheng, Xinyue; Xu, Rumei] Beijing Normal Univ, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Beijing 100875, Peoples R China; [Zhou, Guofa] Univ Calif Irvine, Coll Hlth Sci, Irvine, CA USA	Beijing Normal University; University of California System; University of California Irvine	Xu, RM (corresponding author), Beijing Normal Univ, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Beijing 100875, Peoples R China.	xurumei@bnu.edu.cn			The Nature Conservancy and also by the National Basic Research Program of China [2002CB111400]; National Natural Science Foundation of China [30370207]	The Nature Conservancy and also by the National Basic Research Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by The Nature Conservancy and also by the National Basic Research Program of China ( No. 2002CB111400) and the National Natural Science Foundation of China ( No. 30370207).	[Anonymous], 2007, XINHUA NEWS AGENCY; BAKER H. G., 1965, The genetics of colonizing species: Proc. 1st Internat, Union biol Sci., Asilomar, California., P147; Baker H. G., 1975, Annual Review of Ecology and Systematics, V5, P1, DOI 10.1146/annurev.es.05.110174.000245; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Elton C. S., 1958, ECOLOGY INVASIONS AN; Enserink M, 1999, SCIENCE, V285, P1834, DOI 10.1126/science.285.5435.1834; Joshi J, 2005, ECOL LETT, V8, P704, DOI 10.1111/j.1461-0248.2005.00769.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Lavoie C, 2005, ECOSCIENCE, V12, P366, DOI 10.2980/i1195-6860-12-3-366.1; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McKinney ML, 2002, DIVERS DISTRIB, V8, P311, DOI 10.1046/j.1472-4642.2002.00153.x; McNeely JA, 2006, EUPHYTICA, V148, P5, DOI 10.1007/s10681-006-5937-5; Melbourne BA, 2007, ECOL LETT, V10, P77, DOI 10.1111/j.1461-0248.2006.00987.x; Muller JC, 2002, P ROY SOC B-BIOL SCI, V269, P1139, DOI 10.1098/rspb.2002.1994; *NAT BUR STAT CHIN, 1986, CHIN NAT STAT YB; National Research Council, 2002, PRED INV NON PLANTS; Perrings C, 2002, CONSERV ECOL, V6; Reichard SH, 1997, CONSERV BIOL, V11, P193, DOI 10.1046/j.1523-1739.1997.95473.x; REJMANEK M, 1995, PLANT INVASIONS, P3; Rixon CAM, 2005, BIODIVERS CONSERV, V14, P1365, DOI 10.1007/s10531-004-9663-9; Schreiber ESG, 2003, FRESHWATER BIOL, V48, P951, DOI 10.1046/j.1365-2427.2003.01070.x; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Strong D.R., 1984, INSECTS PLANTS COMMU; Sutherst RW, 1999, CLIMEX PREDICTING EF; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; WAN FH, 2002, INT WORKSH BIOD MAN, P77; Williamson M., 1996, BIOL INVASIONS; Xie Y, 2001, BIODIVERS CONSERV, V10, P1317, DOI 10.1023/A:1016695609745; Xu R., 2003, BIOL INVASION THEORY; XU RM, 2003, BIOL INVASION DATA A	35	77	95	13	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1208	10.1371/journal.pone.0001208	http://dx.doi.org/10.1371/journal.pone.0001208			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030342	gold, Green Published			2022-12-25	WOS:000207459200021
J	Palacios, R; Goni, J; Martinez-Forero, I; Iranzo, J; Sepulcre, J; Melero, I; Villoslada, P				Palacios, Ricardo; Goni, Joaquin; Martinez-Forero, Ivan; Iranzo, Jaime; Sepulcre, Jorge; Melero, Ignacio; Villoslada, Pablo			A Network Analysis of the Human T-Cell Activation Gene Network Identifies Jagged1 as a Therapeutic Target for Autoimmune Diseases	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; NOTCH LIGANDS; EXPRESSION; MECHANISMS; PROTEIN; MOLECULES; CYTOKINES	Understanding complex diseases will benefit the recognition of the properties of the gene networks that control biological functions. Here, we set out to model the gene network that controls T-cell activation in humans, which is critical for the development of autoimmune diseases such as Multiple Sclerosis (MS). The network was established on the basis of the quantitative expression from 104 individuals of 20 genes of the immune system, as well as on biological information from the Ingenuity database and Bayesian inference. Of the 31 links (gene interactions) identified in the network, 18 were identified in the Ingenuity database and 13 were new and we validated 7 of 8 interactions experimentally. In the MS patients network, we found an increase in the weight of gene interactions related to Th1 function and a decrease in those related to Treg and Th2 function. Indeed, we found that IFN-beta therapy induces changes in gene interactions related to T cell proliferation and adhesion, although these gene interactions were not restored to levels similar to controls. Finally, we identify JAG1 as a new therapeutic target whose differential behaviour in the MS network was not modified by immunomodulatory therapy. In vitro treatment with a Jagged1 agonist peptide modulated the T-cell activation network in PBMCs from patients with MS. Moreover, treatment of mice with experimental autoimmune encephalomyelitis with the Jagged1 agonist ameliorated the disease course, and modulated Th2, Th1 and Treg function. This study illustrates how network analysis can predict therapeutic targets for immune intervention and identified the immunomodulatory properties of Jagged1 making it a new therapeutic target for MS and other autoimmune diseases.	[Palacios, Ricardo; Goni, Joaquin; Martinez-Forero, Ivan; Iranzo, Jaime; Sepulcre, Jorge; Villoslada, Pablo] Univ Navarra, Dept Neurol, Univ Navarra Clin, E-31080 Pamplona, Spain; [Palacios, Ricardo; Goni, Joaquin; Martinez-Forero, Ivan; Iranzo, Jaime; Sepulcre, Jorge; Melero, Ignacio; Villoslada, Pablo] Univ Navarra, Ctr Appl Med Res, E-31080 Pamplona, Spain; [Goni, Joaquin; Martinez-Forero, Ivan] Univ Navarra, Dept Appl Math & Phys, E-31080 Pamplona, Spain	University of Navarra; University of Navarra; University of Navarra	Villoslada, P (corresponding author), Univ Navarra, Dept Neurol, Univ Navarra Clin, E-31080 Pamplona, Spain.	pvilloslada@unav.es	Iranzo, Jaime/H-5197-2011; Melero, Ignacio/T-7600-2019; Sepulcre, Jorge/ABE-6375-2020; Villoslada, Pablo/AAF-9547-2019	Iranzo, Jaime/0000-0002-4538-7726; Melero, Ignacio/0000-0002-1360-348X; Villoslada, Pablo/0000-0002-8735-6119; Sepulcre, Jorge/0000-0002-4199-2304	Begona Fernandez-Diez; Spanish Ministry of Health [FIS PI051201, FIS PI060117]	Begona Fernandez-Diez; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	This work was supported by grants from the Spanish Ministry of Health (FIS PI051201, FIS PI060117) and from the Fundacion Uriach to PV.	Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Baecher-Allan C, 2006, IMMUNOL REV, V212, P203, DOI 10.1111/j.0105-2896.2006.00417.x; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; de la Fuente A, 2002, TRENDS GENET, V18, P395, DOI 10.1016/S0168-9525(02)02692-6; Feldmann M, 1998, Int Rev Immunol, V17, P217, DOI 10.3109/08830189809084493; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Galimberti Daniela, 2004, Expert Rev Neurother, V4, P439, DOI 10.1586/14737175.4.3.439; *GAM COLL G, 2006, J NEUROIMMUNOL, V23, P23; Germain RN, 2001, SCIENCE, V293, P240, DOI 10.1126/science.1062946; Glover F., 1997, TABU SEARCH; GOH KI, 2007, P NATL ACAD SCI US; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hayes AL, 1999, J BIOL CHEM, V274, P33455, DOI 10.1074/jbc.274.47.33455; Hill N, 2002, CURR OPIN IMMUNOL, V14, P791, DOI 10.1016/S0952-7915(02)00403-X; Hohlfeid R, 2004, P NATL ACAD SCI USA, V101, P14599, DOI 10.1073/pnas.0404874101; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Kang BY, 2006, CURR MED CHEM, V13, P1149, DOI 10.2174/092986706776360879; Kang BY, 2005, CELL SIGNAL, V17, P665, DOI 10.1016/j.cellsig.2004.12.010; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Kitano H, 2004, DIABETES, V53, pS6, DOI 10.2337/diabetes.53.suppl_3.S6; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Klamt S, 2006, BIOSYSTEMS, V83, P233, DOI 10.1016/j.biosystems.2005.04.009; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; Le YY, 2005, INT IMMUNOPHARMACOL, V5, P1771, DOI 10.1016/j.intimp.2005.07.006; Leon K, 2004, J AUTOIMMUN, V22, P31, DOI 10.1016/j.jaut.2003.10.002; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Liu ZG, 2005, CELL RES, V15, P24, DOI 10.1038/sj.cr.7290259; Melero I, 2005, IMMUNOL RES, V33, P135, DOI 10.1385/IR:33:2:135; MONTALBAN X, 2007, J NEUROL SCI; Moreno B, 2006, ANN NEUROL, V60, P323, DOI 10.1002/ana.20895; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Neuhaus O, 2003, TRENDS PHARMACOL SCI, V24, P131, DOI 10.1016/S0165-6147(03)00028-2; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Peter HH, 2005, EXPERT OPIN BIOL TH, V5, pS61, DOI 10.1517/14712598.5.1.S61; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; QUELLE FW, 1995, MOL CELL BIOL, V15, P3336; Rice GPA, 2005, NEUROLOGY, V64, P1336, DOI 10.1212/01.WNL.0000158329.30470.D0; Roncarolo MG, 2003, J AUTOIMMUN, V20, P269, DOI 10.1016/S0896-8411(03)00047-7; Rutz S, 2005, EUR J IMMUNOL, V35, P2443, DOI 10.1002/eji.200526294; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Segel LA, 1999, J IMMUNOL, V163, P1342; Sontag E, 2004, BIOINFORMATICS, V20, P1877, DOI 10.1093/bioinformatics/bth173; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Stallwood Y, 2006, J IMMUNOL, V177, P885, DOI 10.4049/jimmunol.177.2.885; Steinman L, 2003, NAT REV IMMUNOL, V3, P483, DOI 10.1038/nri1108; Styczynski MP, 2005, COMPUT CHEM ENG, V29, P519, DOI 10.1016/j.compchemeng.2004.08.029; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	56	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1222	10.1371/journal.pone.0001222	http://dx.doi.org/10.1371/journal.pone.0001222			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030350	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459200029
J	Siva, K; Venu, P; Mahadevan, A; Shankar, SK; Inamdar, MS				Siva, Kavitha; Venu, Parvathy; Mahadevan, Anita; Shankar, S. K.; Inamdar, Maneesha S.			Human BCAS3 Expression in Embryonic Stem Cells and Vascular Precursors Suggests a Role in Human Embryogenesis and Tumor Angiogenesis	PLOS ONE			English	Article								Cancer is often associated with multiple and progressive genetic alterations in genes that are important for normal development. BCAS3 (Breast Cancer Amplified Sequence 3) is a gene of unknown function on human chromosome 17q23, a region associated with breakpoints of several neoplasms. The normal expression pattern of BCAS3 has not been studied, though it is implicated in breast cancer progression. Rudhira, a murine WD40 domain protein that is 98% identical to BCAS3 is expressed in embryonic stem (ES) cells, erythropoiesis and angiogenesis. This suggests that BCAS3 expression also may not be restricted to mammary tissue and may have important roles in other normal as well as malignant tissues. We show that BCAS3 is also expressed in human ES cells and during their differentiation into blood vascular precursors. We find that BCAS3 is aberrantly expressed in malignant human brain lesions. In glioblastoma, hemangiopericytoma and brain abscess we note high levels of BCAS3 expression in tumor cells and some blood vessels. BCAS3 may be associated with multiple cancerous and rapidly proliferating cells and hence the expression, function and regulation of this gene merits further investigation. We suggest that BCAS3 is mis-expressed in brain tumors and could serve as a human ES cell and tumor marker.	[Siva, Kavitha; Venu, Parvathy; Inamdar, Maneesha S.] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560012, Karnataka, India; [Mahadevan, Anita; Shankar, S. K.] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore; National Institute of Mental Health & Neurosciences - India	Inamdar, MS (corresponding author), Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560012, Karnataka, India.	inamdar@jncasr.ac.in		Siva, Kavitha/0000-0001-9480-4496	Jawaharlal Nehru Centre for Advanced Scientific Research; Department of Biotechnology, Government of India; University Grants Commission	Jawaharlal Nehru Centre for Advanced Scientific Research(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); University Grants Commission(University Grants Commission, India)	This work was supported by the Jawaharlal Nehru Centre for Advanced Scientific Research, and Department of Biotechnology, Government of India. KS was supported by a fellowship from University Grants Commission.	Barbouti A, 2004, AM J HUM GENET, V74, P1, DOI 10.1086/380648; Barlund M, 2000, CANCER RES, V60, P5340; Bautch VL, 2000, BLOOD, V95, P1979, DOI 10.1182/blood.V95.6.1979; Bergwerff M, 1998, CIRC RES, V82, P221; Brinkschmidt C, 1997, J PATHOL, V181, P394; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Courjal F, 1997, CANCER RES, V57, P4368; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; DEFOUGEROLLES AR, 1991, J EXP MED, V174, P253, DOI 10.1084/jem.174.1.253; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Ehrbrecht A, 2006, J PATHOL, V208, P554, DOI 10.1002/path.1925; Etchevers HC, 2002, TRENDS CARDIOVAS MED, V12, P299, DOI 10.1016/S1050-1738(02)00178-0; Gerecht-Nir S, 2005, DEV DYNAM, V232, P487, DOI 10.1002/dvdy.20247; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; Gururaj AE, 2006, CELL CYCLE, V5, P1407, DOI 10.4161/cc.5.13.2924; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; Kielian T, 2000, AM J PATHOL, V157, P647, DOI 10.1016/S0002-9440(10)64575-0; Lane D., 1995, COMPLEXITY, V1, P9; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; MULERIS M, 1994, GENE CHROMOSOME CANC, V10, P160, DOI 10.1002/gcc.2870100303; Nishizaki T, 1997, INT J CANCER, V74, P513, DOI 10.1002/(SICI)1097-0215(19971021)74:5<513::AID-IJC6>3.3.CO;2-X; Park SS, 2002, GENOME RES, V12, P729, DOI 10.1101/gr.82802; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Siva K, 2006, GENE EXPR PATTERNS, V6, P225, DOI 10.1016/j.modgep.2005.06.002; Tirkkonen M, 1998, GENE CHROMOSOME CANC, V21, P177, DOI 10.1002/(SICI)1098-2264(199803)21:3<177::AID-GCC1>3.3.CO;2-C; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; Zhang XY, 2005, P NATL ACAD SCI USA, V102, P13968, DOI 10.1073/pnas.0502330102	32	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1202	10.1371/journal.pone.0001202	http://dx.doi.org/10.1371/journal.pone.0001202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030336	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459200015
J	Rodriguez-Campos, A; Azorin, F				Rodriguez-Campos, Antonio; Azorin, Fernando			RNA Is an Integral Component of Chromatin that Contributes to Its Structural Organization	PLOS ONE			English	Article								Chromatin structure is influenced by multiples factors, such as pH, temperature, nature and concentration of counterions, post-translational modifications of histones and binding of structural non-histone proteins. RNA is also known to contribute to the regulation of chromatin structure as chromatin-induced gene silencing was shown to depend on the RNAi machinery in S. pombe, plants and Drosophila. Moreover, both in Drosophila and mammals, dosage compensation requires the contribution of specific non-coding RNAs. However, whether RNA itself plays a direct structural role in chromatin is not known. Here, we report results that indicate a general structural role for RNA in eukaryotic chromatin. RNA is found associated to purified chromatin prepared from chicken liver, or cultured Drosophila S2 cells, and treatment with RNase A alters the structural properties of chromatin. Our results indicate that chromatin-associated RNAs, which account for 2%-5% of total chromatin-associated nucleic acids, are polyA(-) and show a size similar to that of the DNA contained in the corresponding chromatin fragments. Chromatin-associated RNA(s) are not likely to correspond to nascent transcripts as they are also found bound to chromatin when cells are treated with alpha-amanitin. After treatment with RNase A, chromatin fragments of molecular weight >3.000 bp of DNA showed reduced sedimentation through sucrose gradients and increased sensitivity to micrococcal nuclease digestion. This structural transition, which is observed both at euchromatic and heterochromatic regions, proceeds without loss of histone H1 or any significant change in core-histone composition and integrity.	[Rodriguez-Campos, Antonio] CSIC, Inst Mol Biol Barcelona IBMB, Barcelona, Spain; IRB, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Rodriguez-Campos, A (corresponding author), CSIC, Inst Mol Biol Barcelona IBMB, Barcelona, Spain.	arobmc@gmail.com	Azorin, Fernando/N-4388-2014	Azorin, Fernando/0000-0002-8426-7858	MCyT [BMC2003-243]; CIRIT [2001SGR00344, 2005SGR00678]; EU [LSHB-CT-2004-511965]; CSIC	MCyT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIRIT; EU(European Commission); CSIC	This work was financed by grants from the MCyT (BMC2003-243), the CIRIT (2001SGR00344 and 2005SGR00678), and the EU (LSHB-CT-2004-511965). A.R.-C. acknowledges receipt of an I3P postdoctoral contract from CSIC.	AUGENLICHT LH, 1976, BIOCHEMISTRY-US, V15, P3818, DOI 10.1021/bi00662a026; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bender J, 2004, CURR OPIN PLANT BIOL, V7, P521, DOI 10.1016/j.pbi.2004.07.003; CLARK DJ, 1990, J MOL BIOL, V211, P883, DOI 10.1016/0022-2836(90)90081-V; FINCH JT, 1977, NATURE, V269, P29, DOI 10.1038/269029a0; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; FURUNO M, 2006, PLOS GENETICS, V2; GARCIARAMIREZ M, 1992, J BIOL CHEM, V267, P19587; Ghirlando R, 2004, J MOL BIOL, V336, P597, DOI 10.1016/j.jmb.2003.12.049; Gilbert N, 2001, P NATL ACAD SCI USA, V98, P11949, DOI 10.1073/pnas.211322798; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; KEDINGER C, 1970, BIOCHEM BIOPH RES CO, V38, P165, DOI 10.1016/0006-291X(70)91099-5; Kelley RL, 2000, CELL, V103, P9, DOI 10.1016/S0092-8674(00)00099-4; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Manak JR, 2006, NAT GENET, V38, P1151, DOI 10.1038/ng1875; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; MATZKE MA, 1990, CHROMOSOMA, V99, P131, DOI 10.1007/BF01735329; MCGHEE JD, 1980, ANNU REV BIOCHEM, V49, P1115, DOI 10.1146/annurev.bi.49.070180.005343; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; NOHNO T, 1993, DEV BIOL, V158, P254, DOI 10.1006/dbio.1993.1184; NOLL H, 1989, METHOD ENZYMOL, V170, P55; NOLL M, 1974, NATURE, V251, P249, DOI 10.1038/251249a0; NOLL M, 1977, J MOL BIOL, V109, P393, DOI 10.1016/S0022-2836(77)80019-3; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; RICHMOND TJ, 1984, NATURE, V311, P532, DOI 10.1038/311532a0; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SHIMAMURA A, 1989, MOL CELL BIOL, V9, P5573, DOI 10.1128/MCB.9.12.5573; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427; van Holde K.E., 1988, CHROMATIN; WARNER JR, 1963, P NATL ACAD SCI USA, V49, P122, DOI 10.1073/pnas.49.1.122; WETTSTEIN FO, 1963, NATURE, V197, P430, DOI 10.1038/197430a0; WIDOM J, 1989, ANNU REV BIOPHYS BIO, V18, P365, DOI 10.1146/annurev.biophys.18.1.365; WUTZ A, 2003, NONCODING RNAS MOL B	38	73	78	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1182	10.1371/journal.pone.0001182	http://dx.doi.org/10.1371/journal.pone.0001182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000552	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459100023
J	Wang, X; Green, DS; Roberts, SP; de Belle, JS				Wang, Xia; Green, David S.; Roberts, Stephen P.; de Belle, J. Steven			Thermal Disruption of Mushroom Body Development and Odor Learning in Drosophila	PLOS ONE			English	Article								Environmental stress (nutritive, chemical, electromagnetic and thermal) has been shown to disrupt central nervous system (CNS) development in every model system studied to date. However, empirical linkages between stress, specific targets in the brain, and consequences for behavior have rarely been established. The present study experimentally demonstrates one such linkage by examining the effects of ecologically-relevant thermal stress on development of the Drosophila melanogaster mushroom body (MB), a conserved sensory integration and associative center in the insect brain. We show that a daily hyperthermic episode throughout larval and pupal development (1) severely disrupts MB anatomy by reducing intrinsic Kenyon cell (KC) neuron numbers but has little effect on other brain structures or general anatomy, and (2) greatly impairs associative odor learning in adults, despite having little effect on memory or sensory acuity. Hence, heat stress of ecologically relevant duration and intensity can impair brain development and learning potential.	[Wang, Xia; Green, David S.; Roberts, Stephen P.; de Belle, J. Steven] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Green, David S.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of California System; University of California San Diego	de Belle, JS (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	steven.debelle@unlv.edu			National Science Foundation [0213921]; National Center for Research Resources, a component of the National Institutes of Health [2 P20 RR016464]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources, a component of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by grants to JSdB and SPR from the National Science Foundation (0213921) and the National Center for Research Resources, a component of the National Institutes of Health (2 P20 RR016464).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahmad K, 2001, CELL, V104, P839, DOI 10.1016/S0092-8674(01)00281-1; Akalal DBG, 2006, LEARN MEMORY, V13, P659, DOI 10.1101/lm.221206; Armstrong JD, 1998, LEARN MEMORY, V5, P102; BALLING A, 1987, J NEUROGENET, V4, P65, DOI 10.3109/01677068709102334; Barth M, 1997, LEARN MEMORY, V4, P219, DOI 10.1101/lm.4.2.219; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campos-Ortega Jose A., 1993, P1091; de Belle J. Steven, 1999, P243; deBelle JS, 1996, P NATL ACAD SCI USA, V93, P9875, DOI 10.1073/pnas.93.18.9875; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Feder ME, 1997, J THERM BIOL, V22, P1, DOI 10.1016/S0306-4565(96)00028-9; Gerber B, 2004, CURR OPIN NEUROBIOL, V14, P737, DOI 10.1016/j.conb.2004.10.014; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; Groh C, 2006, BRAIN BEHAV EVOLUT, V68, P1, DOI 10.1159/000092309; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; HEISENBERG M, 1979, Z NATURFORSCH C, V34, P143; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Ito K, 1997, CELL TISSUE RES, V290, P1, DOI 10.1007/s004410050901; Ito K, 1997, DEVELOPMENT, V124, P761; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Lee T, 1999, DEVELOPMENT, V126, P4065; MADER MT, 2004, THESIS U WURZBURG; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; Mattson SN, 1998, ALCOHOL CLIN EXP RES, V22, P279, DOI 10.1111/j.1530-0277.1998.tb03651.x; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; MILUNSKY A, 1992, JAMA-J AM MED ASSOC, V268, P882, DOI 10.1001/jama.268.7.882; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pinto S, 1999, NEURON, V23, P45, DOI 10.1016/S0896-6273(00)80752-7; Rhees RW, 1999, BRAIN RES BULL, V50, P193, DOI 10.1016/S0361-9230(99)00191-4; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Roberts SP, 1999, OECOLOGIA, V121, P323, DOI 10.1007/s004420050935; Robertson K, 2003, DEV BIOL, V260, P124, DOI 10.1016/S0012-1606(03)00220-3; Roebuck TM, 1998, ALCOHOL CLIN EXP RES, V22, P339, DOI 10.1111/j.1530-0277.1998.tb03658.x; Schulz RA, 1996, ONCOGENE, V12, P1827; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Suarez L, 2004, BIRTH DEFECTS RES A, V70, P815, DOI 10.1002/bdra.20077; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; TECHNAU G, 1982, NATURE, V295, P405, DOI 10.1038/295405a0; Technau GM, 1984, J NEUROGENET, V1, P113, DOI 10.3109/01677068409107077; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Urbach R, 2003, DEVELOPMENT, V130, P3589, DOI 10.1242/dev.00528; Weinstock M, 2001, PROG NEUROBIOL, V65, P427, DOI 10.1016/S0301-0082(01)00018-1; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x; YANG MY, 1995, NEURON, V15, P45; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Zar J. H., 1996, BIOSTATISTICAL ANAL; Zars T, 2000, CURR OPIN NEUROBIOL, V10, P790, DOI 10.1016/S0959-4388(00)00147-1; Zars T., 2000, Science (Washington D C), V288, P672, DOI 10.1126/science.288.5466.672	55	29	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1125	10.1371/journal.pone.0001125	http://dx.doi.org/10.1371/journal.pone.0001125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17992254	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459000009
J	Shafiei, F; Rahnama, F; Pawella, L; Mitchell, MD; Gluckman, PD; Lobie, PE				Shafiei, F.; Rahnama, F.; Pawella, L.; Mitchell, M. D.; Gluckman, P. D.; Lobie, P. E.			DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells	ONCOGENE			English	Article						DNA methylation; DNA methyltransferases; human growth hormone; plakoglobin; mammary carcinoma	HUMAN GROWTH-HORMONE; DNA METHYLTRANSFERASES DNMT3A; TUMOR-SUPPRESSOR GENES; GAMMA-CATENIN GENE; PROMOTER METHYLATION; COLON-CANCER; EXPRESSION; ACTIVATION; KINASE; IDENTIFICATION	Directed by microarray analyses, we report that autocrine human growth hormone (hGH) increased the mRNA and protein expression of DNA methyltransferase 1 (DNMT1), DNMT3A and DNMT3B in mammary carcinoma cells. Autocrine hGH stimulation of DNMT3A and DNMT3B expression was mediated by JAK2 and Src kinases, and treatment of mammary carcinoma cells with the DNMT inhibitor, 5'-aza-2'-deoxycytidine (AZA), abrogated autocrine hGH-stimulated cellular proliferation, apoptosis and anchorage-independent growth. AZA reversed the epitheliomesenchymal transition of mammary carcinoma cells induced by autocrine hGH, to an epithelioid morphology and abrogated cell migration stimulated by autocrine hGH. Autocrine hGH-stimulated hypermethylation of the first exon of the PLAKOGLOBIN gene and AZA abrogated the ability of autocrine hGH to repress plakoglobin gene transcription. Small interfering RNA (siRNA)-mediated depletion of the individual DNMT molecules did not release autocrine hGH repression of PLAKOGLOBIN promoter activity nor did individual DNMT depletion affect autocrine hGH-stimulated migration. However, concomitant siRNA-mediated depletion of both DNMT3A and DNMT3B abrogated hypermethylation of the PLAKOGLOBIN gene stimulated by autocrine hGH and subsequent repression of plakoglobin gene transcription and increased cell migration. Thus, the autocrine hGH-stimulated increases in DNMT3A and DNMT3B expression mediate repression of plakoglobin gene transcription by direct hypermethylation of its promoter and consequent phenotypic conversion of mammary carcinoma cells. Autocrine hGH, therefore, utilizes DNA methylation as a mechanism to exert its oncogenic effects in mammary carcinoma cells.	[Lobie, P. E.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; Univ Auckland, Natl Res Ctr Growth & Dev, Auckland 1, New Zealand	University of Auckland; University of Auckland	Lobie, PE (corresponding author), Univ Auckland, Liggins Inst, 2-6 Pk Ave, Auckland 1, New Zealand.	p.lobie@auckland.ac.nz	Mitchell, Murray/A-8639-2010	Mitchell, Murray/0000-0002-6167-7176				Bai SM, 2005, MOL CELL BIOL, V25, P751, DOI 10.1128/MCB.25.2.751-766.2005; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Belinsky SA, 1996, P NATL ACAD SCI USA, V93, P4045, DOI 10.1073/pnas.93.9.4045; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Breault JE, 2005, CLIN CANCER RES, V11, P557; Cameron EE, 1999, BLOOD, V94, P2445, DOI 10.1182/blood.V94.7.2445.419k19_2445_2451; ELDEIRY WS, 1991, P NATL ACAD SCI USA, V88, P3470, DOI 10.1073/pnas.88.8.3470; Fukunaga Y, 2005, CELL STRUCT FUNCT, V30, P25, DOI 10.1247/csf.30.25; Hausherr A, 2007, ONCOGENE, V26, P4987, DOI 10.1038/sj.onc.1210306; Herman JG, 1999, SEMIN CANCER BIOL, V9, P359, DOI 10.1006/scbi.1999.0138; Hodge DR, 2005, CANCER RES, V65, P4673, DOI 10.1158/0008-5472.CAN-04-3589; Hodge DR, 2001, J BIOL CHEM, V276, P39508, DOI 10.1074/jbc.C100343200; ISSA JPJ, 1993, J NATL CANCER I, V85, P1235, DOI 10.1093/jnci/85.15.1235; Jaenisch R, 1998, CIBA F SYMP, V214, P200; Jones PA, 2002, ONCOGENE, V21, P5358, DOI 10.1038/sj.onc.1205597; Kaulsay KK, 1999, EXP CELL RES, V250, P35, DOI 10.1006/excr.1999.4492; Kaulsay KK, 2001, ENDOCRINOLOGY, V142, P767, DOI 10.1210/en.142.2.767; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Ling L, 2004, J BIOL CHEM, V279, P32737, DOI 10.1074/jbc.M400601200; Ling L, 2003, J BIOL CHEM, V278, P27301, DOI 10.1074/jbc.M302516200; MENG F, 2007, ONCOGENE        0709; Mertani HC, 2001, J BIOL CHEM, V276, P21464, DOI 10.1074/jbc.M100437200; Mukhina S, 2004, P NATL ACAD SCI USA, V101, P15166, DOI 10.1073/pnas.0405881101; NEMETH SP, 1989, MOL CELL BIOL, V9, P1109, DOI 10.1128/MCB.9.3.1109; Oka M, 2005, ONCOGENE, V24, P3091, DOI 10.1038/sj.onc.1208540; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Perry JK, 2006, GROWTH HORM IGF RES, V16, P277, DOI 10.1016/j.ghir.2006.09.006; Potter E, 2001, EUR J ENDOCRINOL, V145, P625, DOI 10.1530/eje.0.1450625; Rahnama F, 2006, ENDOCRINOLOGY, V147, P5275, DOI 10.1210/en.2006-0288; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; SERRANO J, 1993, J CHROMATOGR-BIOMED, V615, P203, DOI 10.1016/0378-4347(93)80334-Z; Shiina H, 2005, CANCER RES, V65, P2130, DOI 10.1158/0008-5472.CAN-04-3398; Sung J, 2005, CARCINOGENESIS, V26, P487, DOI 10.1093/carcin/bgh318; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Waters MJ, 1999, CLIN EXP PHARMACOL P, V26, P760, DOI 10.1046/j.1440-1681.1999.03129.x; Wehbe H, 2006, CANCER RES, V66, P10517, DOI 10.1158/0008-5472.CAN-06-2130; Winn RA, 2002, ONCOGENE, V21, P7497, DOI 10.1038/sj.onc.1205963; Yanagisawa Y, 2002, BBA-GENE STRUCT EXPR, V1577, P457, DOI 10.1016/S0167-4781(02)00482-7; Zhang X, 2003, J BIOL CHEM, V278, P7580, DOI 10.1074/jbc.M212050200; Zhu T, 2005, CANCER RES, V65, P317; Zhu T, 2002, J BIOL CHEM, V277, P45592, DOI 10.1074/jbc.M201385200	44	34	35	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2008	27	18					2602	2612		10.1038/sj.onc.1210917	http://dx.doi.org/10.1038/sj.onc.1210917			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	289LW	17998942				2022-12-25	WOS:000255057000010
J	Mao, G; Pan, X; Gu, L				Mao, Guogen; Pan, Xiaoyu; Gu, Liya			Evidence that a mutation in the MLH1 3 '-untranslated region confers a mutator phenotype and mismatch repair deficiency in patients with relapsed leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; UNTRANSLATED REGION; CANCER; IDENTIFICATION	Defects in DNA mismatch repair (MMR) are the molecular basis of certain cancers, including hematological malignancies. The defects are often caused by mutations in coding regions of MMR genes or promoter methylation of the genes. However, in many cases, despite that a hypermutable phenotype is detected in a patient, no mutations/hypermethylations of MMR genes can be detected. We report here a novel mechanism that a mutation in the MLH1 3 '-untranslated region (3 '-UTR) leads to MMR deficiency. A relapsed leukemia patient displayed micro-satellite instability, but no genetic and epigenetic alterations in key MMR genes were identifiable. Instead, a 3-nucleotide (TTC) deletion in the MLH1 3 '-UTR was found in the patient's blood sample. The mutant MLH1 3 '-UTR was found to significantly reduce the expressions of both a firefly luciferase reporter gene and an ectopic MLH1 gene in model cell lines. Consistent with these observations, a significant reduction in the steady-state level of MLH1 mRNA was observed in white blood cells of the patient. These findings suggest that the mutant MLH1 3 '-UTR can cause a severely reduced/defective MMR activity conferring leukemia relapse, likely by down-regulating MLH1 expression at the mRNA level. Although the exact mechanism by which the mutant 3 '-UTR down-regulates the MLH1 mRNA is not known, our findings provide a novel marker for cancers with MMR defects.	[Mao, Guogen; Pan, Xiaoyu; Gu, Liya] Univ Kentucky, Coll Med, Dept Toxicol, Lexington, KY 40536 USA; [Gu, Liya] Univ Kentucky, Coll Med, Dept Pathol, Lexington, KY 40536 USA; [Gu, Liya] Univ Kentucky, Coll Med, Media Lab, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky	Gu, L (corresponding author), 136 Hlth Sci Res Bldg,1095 VA Dr, Lexington, KY 40536 USA.	lgu0@email.uky.edu			NATIONAL CANCER INSTITUTE [R01CA104333] Funding Source: NIH RePORTER; NCI NIH HHS [CA104333] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allamand V, 2006, EMBO REP, V7, P450, DOI 10.1038/sj.embor.7400648; Boland CR, 1998, CANCER RES, V58, P5248; Buermeyer AB, 1999, ANNU REV GENET, V33, P533, DOI 10.1146/annurev.genet.33.1.533; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Chung DC, 2003, ANN INTERN MED, V138, P560, DOI 10.7326/0003-4819-138-7-200304010-00012; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Gu LY, 2002, ONCOGENE, V21, P5758, DOI 10.1038/sj.onc.1205695; Hew Y, 2000, J BIOL CHEM, V275, P24857, DOI 10.1074/jbc.M002776200; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Li GM, 2003, FRONT BIOSCI-LANDMRK, V8, pD997, DOI 10.2741/1121; Li XL, 2007, J BIOL CHEM, V282, P7950, DOI 10.1074/jbc.M607939200; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; MAO G, 2008, IN PRESS CELL RES; Mao GG, 2007, NUCLEIC ACIDS RES, V35, P2759, DOI 10.1093/nar/gkm189; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Murata H, 2002, ONCOGENE, V21, P5696, DOI 10.1038/sj.onc.1205683; Offman J, 2005, MOL CANCER RES, V3, P251, DOI 10.1158/1541-7786.MCR-04-0182; Rustgi AK, 2006, GENE DEV, V20, P3049, DOI 10.1101/gad.1501106; WANG XM, 1995, MOL CELL BIOL, V15, P1769; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	21	19	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3211	3216		10.1074/jbc.M709276200	http://dx.doi.org/10.1074/jbc.M709276200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056700	hybrid			2022-12-25	WOS:000253083000024
J	Tian, L; McClafferty, H; Chen, L; Shipston, MJ				Tian, Lijun; McClafferty, Heather; Chen, Lie; Shipston, Michael J.			Reversible tyrosine protein phosphorylation regulates large conductance voltage- and calcium-activated potassium channels via cortactin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; MAXI-K CHANNELS; GROWTH-FACTOR; BKCA CHANNEL; STIMULATION; MODULATION; PHOSPHATASES; INHIBITION; DYNAMICS; SUBUNIT	Large conductance calcium- and voltage-activated potassium (BK) channels assemble as macromolecular signaling complexes and are potently regulated by reversible protein phosphorylation. However, although numerous studies have revealed regulation of BK channels through changes in direct phosphorylation of the pore-forming alpha-subunits the functional role of changes in phosphorylation of defined adapter/signaling proteins within the complex on channel function are essentially not known. Here, we demonstrate that mammalian BK channels are potently regulated by endogenous protein-tyrosine kinase and protein-tyrosine phosphatase activity closely associated with the channel. BK channel regulation was not dependent upon direct phosphorylation of the BK alpha-subunit, rather channel function was controlled by the tyrosine phosphorylation status of the adapter protein cortactin that assembles directly with the BK channel. Our data thus reveal a novel mode for BK channel regulation by reversible tyrosine phosphorylation and strongly support the hypothesis that phosphorylation-dependent regulation of accessory proteins within the BK channel signaling complex represents an important target for control of BK channel function.	[Tian, Lijun; McClafferty, Heather; Chen, Lie; Shipston, Michael J.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland	University of Edinburgh	Shipston, MJ (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Hugh Robson Bldg,George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.	mike.shipston@ed.ac.uk	Shipston, Mike/C-7309-2013	Shipston, Mike/0000-0001-7544-582X; Chen, Lie/0000-0001-9764-4299	Wellcome Trust [082407, 067683] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abedi H, 1998, BIOCHEM BIOPH RES CO, V245, P646, DOI 10.1006/bbrc.1998.8284; Alioua A, 2002, P NATL ACAD SCI USA, V99, P14560, DOI 10.1073/pnas.222348099; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Cowan-Jacob SW, 2006, CELL MOL LIFE SCI, V63, P2608, DOI 10.1007/s00018-006-6202-8; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; Fan LZ, 2004, BIOCHEM J, V380, P581, DOI 10.1042/BJ20040178; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Holm NR, 1997, P NATL ACAD SCI USA, V94, P1002, DOI 10.1073/pnas.94.3.1002; HSU CYJ, 1991, J BIOL CHEM, V266, P21105; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Jin P, 2002, J BIOL CHEM, V277, P10014, DOI 10.1074/jbc.M107682200; Ling SZ, 2004, AM J PHYSIOL-CELL PH, V287, pC698, DOI 10.1152/ajpcell.00030.2004; Ling SZ, 2000, J BIOL CHEM, V275, P30683, DOI 10.1074/jbc.M004292200; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; Ma XY, 2006, FASEB J, V20, pA1208; Mehta D, 2002, J PHYSIOL-LONDON, V539, P779, DOI 10.1113/jphysiol.2001.013289; Nara M, 1998, J BIOL CHEM, V273, P14920, DOI 10.1074/jbc.273.24.14920; Olsen ML, 2005, J NEUROSCI RES, V81, P179, DOI 10.1002/jnr.20543; Rezzonico R, 2003, J BONE MINER RES, V18, P1863, DOI 10.1359/jbmr.2003.18.10.1863; Rezzonico R, 2002, J BONE MINER RES, V17, P869, DOI 10.1359/jbmr.2002.17.5.869; Stumpff F, 1999, INVEST OPHTH VIS SCI, V40, P1404; Tian L, 2004, P NATL ACAD SCI USA, V101, P11897, DOI 10.1073/pnas.0402590101; Tian LJ, 2003, J BIOL CHEM, V278, P8669, DOI 10.1074/jbc.M211661200; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Wang H, 1999, J NEUROSCI, V19, pU1; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; XIONG ZG, 1995, EUR J PHARM-MOLEC PH, V290, P117, DOI 10.1016/0922-4106(95)90023-3; Zhou R, 2005, CARDIOVASC RES, V68, P327, DOI 10.1016/j.cardiores.2005.06.005; Zhou XB, 2001, J BIOL CHEM, V276, P43239, DOI 10.1074/jbc.M104202200; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4	34	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3067	3076		10.1074/jbc.M706826200	http://dx.doi.org/10.1074/jbc.M706826200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18039661	hybrid			2022-12-25	WOS:000253083000010
J	Zhao, B; Yu, M; Neitzel, M; Marugg, J; Jagodzinski, J; Lee, M; Hu, K; Schenk, D; Yednock, T; Basi, G				Zhao, Byron; Yu, Mei; Neitzel, Martin; Marugg, Jennifer; Jagodzinski, Jacek; Lee, Mike; Hu, Kang; Schenk, Dale; Yednock, Ted; Basi, Guriqbal			Identification of gamma-secretase inhibitor potency determinants on presenilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; TRANSGENIC MICE; CELL DIFFERENTIATION; SYNAPTIC PLASTICITY; MISSENSE MUTATIONS; PEPTIDE PRODUCTION; KNOCKOUT MICE; IN-VIVO; NOTCH	Production of amyloid beta peptides (A beta), followed by their deposition in the brain as amyloid plaques, contributes to the hallmark pathology of Alzheimer disease. The enzymes responsible for production of A beta, BACE1 and gamma-secretase, are therapeutic targets for treatment of Alzheimer disease. Two presenilin (PS) homologues, referred to as PS1 and PS2, comprise the catalytic core of gamma-secretase. In comparing presenilin selectivity of several classes of gamma-secretase inhibitors, we observed that sulfonamides in general tend to be more selective for inhibition of PS1-comprising gamma-secretase, as exemplified by ELN318463 and BMS299897. We employed a combination of chimeric constructs and point mutants to identify structural determinants for PS1-selective inhibition by ELN318463. Our studies identified amino acid residues Leu(172), Thr(281), and Leu(282) in PS1 as necessary for PS1-selective inhibition by ELN318463. These residues also contributed in part to the PS1-selective inhibition by BMS299897. Alanine scanning mutagenesis of areas flanking Leu(172), Thr(281), and Leu(282) identified additional amino acids that affect inhibitor potency of not only these sulfonamides but also nonsulfonamide inhibitors, without affecting A beta production and presenilin endoproteolysis. Interestingly, many of these same residues have been identified previously to be important for gamma-secretase function. These findings implicate TM3 and a second region near the carboxyl terminus of PS1 amino-terminal fragment in mediating the activity of gamma-secretase inhibitors. Our observations demonstrate that PS-selective inhibitors of gamma-secretase are feasible, and such inhibitors may allow differential inhibition of A beta peptide production and Notch signaling.	[Zhao, Byron; Yu, Mei; Neitzel, Martin; Marugg, Jennifer; Jagodzinski, Jacek; Lee, Mike; Hu, Kang; Schenk, Dale; Yednock, Ted; Basi, Guriqbal] Elan Pharmaceut Inc, San Francisco, CA 94080 USA		Basi, G (corresponding author), Elan Pharmaceut Inc, 700 Gateway Blvd, San Francisco, CA 94080 USA.	guriq.basi@elan.com						Anderson JJ, 2005, BIOCHEM PHARMACOL, V69, P689, DOI 10.1016/j.bcp.2004.11.015; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Barten DM, 2005, J PHARMACOL EXP THER, V312, P635, DOI 10.1124/jpet.104.075408; BERKNER KL, 1987, J VIROL, V61, P1213, DOI 10.1128/JVI.61.4.1213-1220.1987; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Czirr E, 2007, J BIOL CHEM, V282, P24504, DOI 10.1074/jbc.M700618200; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Feng RB, 2004, P NATL ACAD SCI USA, V101, P8162, DOI 10.1073/pnas.0402733101; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Henricson A, 2005, FEBS J, V272, P2727, DOI 10.1111/j.1742-4658.2005.04691.x; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Hyde LA, 2006, J PHARMACOL EXP THER, V319, P1133, DOI 10.1124/jpet.106.111716; Ikeuchi T, 2003, J BIOL CHEM, V278, P7010, DOI 10.1074/jbc.M209252200; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Kulic L, 2000, P NATL ACAD SCI USA, V97, P5913, DOI 10.1073/pnas.100049897; Kwok JBJ, 1997, NEUROREPORT, V8, P1537, DOI 10.1097/00001756-199704140-00043; Kwok JBJ, 2003, J BIOL CHEM, V278, P6748, DOI 10.1074/jbc.M211827200; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Laudon H, 2004, J BIOL CHEM, V279, P23925, DOI 10.1074/jbc.M401277200; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li T, 2007, J NEUROSCI, V27, P10849, DOI 10.1523/JNEUROSCI.2152-07.2007; Marjaux E, 2004, NEURON, V42, P189, DOI 10.1016/S0896-6273(04)00218-1; Mastrangelo P, 2005, P NATL ACAD SCI USA, V102, P8972, DOI 10.1073/pnas.0500940102; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nakaya Y, 2005, J BIOL CHEM, V280, P19070, DOI 10.1074/jbc.M501130200; NEITZEL M, 2005, Patent No. 2005042489; Oh YS, 2005, AM J PHYSIOL-CELL PH, V289, pC576, DOI 10.1152/ajpcell.00636.2004; Podlisny MB, 1997, NEUROBIOL DIS, V3, P325, DOI 10.1006/nbdi.1997.0129; Qyang YB, 2004, BIOCHEMISTRY-US, V43, P5352, DOI 10.1021/bi049826u; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Saura CA, 2005, J NEUROSCI, V25, P6755, DOI 10.1523/JNEUROSCI.1247-05.2005; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SMITH DW, 2000, Patent No. 6967196; Stanger BZ, 2005, P NATL ACAD SCI USA, V102, P12443, DOI 10.1073/pnas.0505690102; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065; Steiner H, 1999, BIOCHEMISTRY-US, V38, P14600, DOI 10.1021/bi9914210; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tian GC, 2003, J BIOL CHEM, V278, P28968, DOI 10.1074/jbc.M300905200; Tournoy J, 2004, HUM MOL GENET, V13, P1321, DOI 10.1093/hmg/ddh151; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Xia WM, 2000, NEUROBIOL DIS, V7, P673, DOI 10.1006/nbdi.2000.0322; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200	63	50	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2927	2938		10.1074/jbc.M708870200	http://dx.doi.org/10.1074/jbc.M708870200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18032377	hybrid			2022-12-25	WOS:000252622300049
J	Fujioka, Y; Noda, NN; Fujii, K; Yoshimoto, K; Ohsumi, Y; Inagaki, F				Fujioka, Yuko; Noda, Nobuo N.; Fujii, Kiyonaga; Yoshimoto, Kohki; Ohsumi, Yoshinori; Inagaki, Fuyuhiko			In vitro reconstitution of plant ATG8 and ATG12 conjugation systems essential for autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; YEAST; ENZYME; GENES; LC3; SENESCENCE; HOMOLOG; GABARAP; MAP-LC3; GATE-16	Genetic and biochemical analyses using yeast Saccharomyces cerevisiae showed that two ubiquitin-like conjugation systems, the Atg8 and Atg12 systems, exist and play essential roles in autophagy, the bulk degradation system conserved in yeast and mammals. These conjugation systems are also conserved in Arabidopsis thaliana; however, further detailed study of plant ATG (autophagy-related) conjugation systems in relation to those in yeast and mammals is needed. Here, we describe the in vitro reconstitution of Arabidopsis thaliana ATG8 and ATG12 (AtATG8 and AtATG12) conjugation systems using purified recombinant proteins. AtATG12b was conjugated to AtATG5 in a manner dependent on AtATG7, AtATG10, and ATP, whereas AtATG8a was conjugated to phosphatidylethanolamine (PE) in a manner dependent on AtATG7, AtATG3, and ATP. Other AtATG8 homologs (AtATG8b-8i) were similarly conjugated to PE. The AtATG8 conjugates were deconjugated by AtATG4a and AtATG4b. These results support the hypothesis that the ATG conjugation systems in Arabidopsis are very similar to those in yeast and mammals. Intriguingly, in vitro analyses showed that AtATG12-AtATG5 conjugates accelerated the formation of AtATG8-PE, whereas AtATG3 inhibited the formation of AtATG12-AtATG5 conjugates. The in vitro conjugation systems reported here will afford a tool with which to investigate the cross-talk mechanism between two conjugation systems.	[Fujioka, Yuko; Noda, Nobuo N.; Fujii, Kiyonaga; Inagaki, Fuyuhiko] Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Dept Biol Struct, Sapporo, Hokkaido 0010021, Japan; [Yoshimoto, Kohki; Ohsumi, Yoshinori] Natl Inst Basic Biol, Dept Mol Cell Biol, Okazaki, Aichi 4448585, Japan	Hokkaido University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Inagaki, F (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Dept Biol Struct, N-21,W-11, Sapporo, Hokkaido 0010021, Japan.	finagaki@pharm.hokudai.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Yoshimoto, Kohki/C-6322-2011; Noda, Nobuo/P-1397-2015	Ohsumi, Yoshinori/0000-0003-2384-2166; Yoshimoto, Kohki/0000-0003-3948-3751; Noda, Nobuo/0000-0002-6940-8069; Fujioka, Yuko/0000-0002-6905-0669				Bassham DC, 2006, AUTOPHAGY, V2, P2, DOI 10.4161/auto.2092; Doelling JH, 2002, J BIOL CHEM, V277, P33105, DOI 10.1074/jbc.M204630200; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; Hashida S, 2004, J BIOL CHEM, V279, P26378, DOI 10.1074/jbc.M309724200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Nemoto T, 2003, J BIOL CHEM, V278, P39517, DOI 10.1074/jbc.M300550200; Rose TL, 2006, BIOL CELL, V98, P53, DOI 10.1042/BC20040516; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; Shao W, 2007, AUTOPHAGY, V3, P10, DOI 10.4161/auto.3270; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Slavikova S, 2005, J EXP BOT, V56, P2839, DOI 10.1093/jxb/eri276; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki NN, 2005, AUTOPHAGY, V1, P119, DOI 10.4161/auto.1.2.1859; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tanida I, 2002, BIOCHEM BIOPH RES CO, V296, P1164, DOI 10.1016/S0006-291X(02)02057-0; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Thompson AR, 2005, CURR OPIN PLANT BIOL, V8, P165, DOI 10.1016/j.pbi.2005.01.013; UEMURA M, 1995, PLANT PHYSIOL, V109, P15, DOI 10.1104/pp.109.1.15; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395	27	91	96	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1921	1928		10.1074/jbc.M706214200	http://dx.doi.org/10.1074/jbc.M706214200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039664	hybrid			2022-12-25	WOS:000252501000018
J	Jacobs, RL; Lingrell, S; Zhao, Y; Francis, GA; Vance, DE				Jacobs, Rene L.; Lingrell, Susanne; Zhao, Yang; Francis, Gordon A.; Vance, Dennis E.			Hepatic CTP : phosphocholine cytidylyltransferase-alpha is a critical predictor of plasma high density lipoprotein and very low density lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY HEART-DISEASE; PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; BINDING CASSETTE TRANSPORTERS; FATTY-ACIDS PHOSPHORYLATE; CDP-CHOLINE PATHWAY; APOLIPOPROTEIN-A-I; RAT-LIVER CTP; PHOSPHATIDYLCHOLINE SYNTHESIS; CELLULAR CHOLESTEROL; TARGETED DELETION	CTP:phosphocholine cytidylyltransferase (CT) is the key regulatory enzyme in the CDP-choline pathway for the biosynthesis of phosphatidylcholine (PC). We previously generated a mouse in which the hepatic CT alpha gene was specifically inactivated by the cre/loxP procedure. In CT alpha knock-out mice, plasma high density lipoprotein (HDL) and very low density lipoprotein (VLDL) levels were markedly lower than in wild type mice (Jacobs, R.L., Devlin, C., Tabas, I., and Vance, D. E. (2004) J. Biol. Chem. 279, 47402-47410.) To investigate the mechanism(s) responsible for the decrease in plasma lipoprotein levels, we isolated primary hepatocytes from knock-out and wild type mice. ABCA1 expression was reduced in knock-out hepatocytes and apoAI-dependent cholesterol, and PC efflux was impaired. When knock-out hepatocytes were infected with an adenovirus expressing CT alpha, apoAI-dependent PC efflux returned partially, whereas cholesterol efflux and ABCA1 levels were not restored to normal levels. Adenoviral expression of CT alpha did not increase VLDL secretion in knock-out hepatocytes, even though cellular PC levels returned to normal. However, in vivo adenoviral delivery of CT alpha normalized plasma HDL and VLDL levels in knock-out mice. The observations demonstrate that hepatic PC biosynthesis is a key player in maintaining plasma VLDL and HDL, and further underscores the importance of the liver in HDL formation.	[Jacobs, Rene L.; Lingrell, Susanne; Zhao, Yang; Vance, Dennis E.] Univ Alberta, Dept Biochem, Canadian Inst, Hlth Res Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Francis, Gordon A.] Univ Alberta, Dept Med, Canadian Inst, Hlth Res Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta	Vance, DE (corresponding author), Univ Alberta, Dept Biochem, Canadian Inst, Hlth Res Grp Mol & Cell Biol Lipids, 328 HMRC, Edmonton, AB T6G 2S2, Canada.	dennis.vance@ualberta.ca		Jacobs, Rene/0000-0002-5525-1355				Abe-Dohmae S, 2006, FEBS LETT, V580, P1178, DOI 10.1016/j.febslet.2005.12.029; Best CH, 1932, J PHYSIOL-LONDON, V75, P405, DOI 10.1113/jphysiol.1932.sp002899; BOJANOVSKI D, 1987, J CLIN INVEST, V80, P1742, DOI 10.1172/JCI113266; BUCHMAN AL, 1995, HEPATOLOGY, V22, P1399, DOI 10.1002/hep.1840220510; Choi JY, 2004, J BIOL CHEM, V279, P42321, DOI 10.1074/jbc.M405074200; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Despres JP, 2000, ATHEROSCLEROSIS, V153, P263, DOI 10.1016/S0021-9150(00)00603-1; FAST DG, 1995, BBA-LIPID LIPID MET, V1258, P159, DOI 10.1016/0005-2760(95)00116-T; FOLCH J, 1957, J BIOL CHEM, V226, P497; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gotto AM, 2001, CIRCULATION, V103, P2213, DOI 10.1161/01.CIR.103.17.2213; Hayden MR, 2000, CURR OPIN LIPIDOL, V11, P117, DOI 10.1097/00041433-200004000-00003; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hoekstra M, 2003, J BIOL CHEM, V278, P25448, DOI 10.1074/jbc.M301189200; Jacobs RL, 2007, J BIOL CHEM, V282, P4516, DOI 10.1074/jbc.M605702200; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Jacobs RL, 2005, J BIOL CHEM, V280, P28299, DOI 10.1074/jbc.M501971200; JOHNSON JE, 1992, BIOCHEM J, V285, P815, DOI 10.1042/bj2850815; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kiss RS, 2003, J BIOL CHEM, V278, P10119, DOI 10.1074/jbc.M300137200; Kulinski A, 2004, J BIOL CHEM, V279, P23916, DOI 10.1074/jbc.M312676200; Lawn RM, 2001, ARTERIOSCL THROM VAS, V21, P378, DOI 10.1161/01.ATV.21.3.378; Li ZY, 2007, BBA-MOL CELL BIOL L, V1771, P486, DOI 10.1016/j.bbalip.2007.01.003; Lykidis A, 2001, BIOCHEMISTRY-US, V40, P494, DOI 10.1021/bi002140r; MYHER JJ, 1989, LIPIDS, V24, P408, DOI 10.1007/BF02535148; Noga AA, 2003, J LIPID RES, V44, P1998, DOI 10.1194/jlr.M300226-JLR200; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Reo NV, 2002, BBA-MOL CELL BIOL L, V1580, P171, DOI 10.1016/S1388-1981(01)00202-5; ROBINSON BS, 1989, BIOCHEM J, V260, P207, DOI 10.1042/bj2600207; Sahoo D, 2004, J LIPID RES, V45, P1122, DOI 10.1194/jlr.M300529-JLR200; Schmitz G, 2001, FRONT BIOSCI, V6, pD505, DOI 10.2741/Schmitz; Selzner N, 2006, J HEPATOL, V44, P694, DOI 10.1016/j.jhep.2005.07.032; Singaraja RR, 2006, CIRCULATION, V114, P1301, DOI 10.1161/CIRCULATIONAHA.106.621433; Singaraja RR, 2006, ARTERIOSCL THROM VAS, V26, P1821, DOI 10.1161/01.ATV.0000229219.13757.a2; Storey MK, 2001, J BIOL CHEM, V276, P48539, DOI 10.1074/jbc.M109043200; SWEITZER TD, 1994, ARCH BIOCHEM BIOPHYS, V311, P107, DOI 10.1006/abbi.1994.1215; Tian Y, 2007, MOL CELL BIOL, V27, P975, DOI 10.1128/MCB.01512-06; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Van Eck M, 2005, CURR OPIN LIPIDOL, V16, P307; VANCE DE, 1988, PROG LIPID RES, V27, P61, DOI 10.1016/0163-7827(88)90005-7; VANCE DE, 1990, BIOCHEM CELL BIOL, V68, P1151, DOI 10.1139/o90-172; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; VERKADE HJ, 1993, J BIOL CHEM, V268, P24990; Waite KA, 2002, J NUTR, V132, P68, DOI 10.1093/jn/132.1.68; Walkey CJ, 1998, J BIOL CHEM, V273, P27043, DOI 10.1074/jbc.273.42.27043; WALKEY CJ, 1994, J BIOL CHEM, V269, P5742; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2003, J BIOL CHEM, V278, P42906, DOI 10.1074/jbc.M307831200; Wang YT, 2005, J BIOL CHEM, V280, P35896, DOI 10.1074/jbc.M506210200; Wang YT, 2007, J LIPID RES, V48, P1062, DOI 10.1194/jlr.M600437-JLR200; Wellington CL, 2003, J LIPID RES, V44, P1470, DOI 10.1194/jlr.M300110-JLR200; YAO Z, 1990, BIOCHEM CELL BIOL, V68, P552, DOI 10.1139/o90-079; YAO ZM, 1988, J BIOL CHEM, V263, P2998; YAO ZM, 1989, J BIOL CHEM, V264, P11373; ZEISEL SH, 1991, FASEB J, V5, P2093, DOI 10.1096/fasebj.5.7.2010061; Zhang DJ, 2000, J BIOL CHEM, V275, P35368, DOI 10.1074/jbc.M007099200; Zheng H, 2005, J BIOL CHEM, V280, P21612, DOI 10.1074/jbc.m502200200; Zhou JM, 2004, J LIPID RES, V45, P1758, DOI 10.1194/jlr.M400179-JLR200; ZHOU X, 1992, J LIPID RES, V33, P1233	63	60	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2147	2155		10.1074/jbc.M706628200	http://dx.doi.org/10.1074/jbc.M706628200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18042552	hybrid			2022-12-25	WOS:000252501000042
J	Thompson, C; Cloutier, A; Bosse, Y; Poisson, C; Larivee, P; McDonald, PP; Stankova, J; Rola-Pleszczynski, M				Thompson, Charles; Cloutier, Alexandre; Bosse, Ynuk; Poisson, Caroline; Larivee, Pierre; McDonald, Patrick P.; Stankova, Jana; Rola-Pleszczynski, Marek			Signaling by the cysteinyl-leukotriene receptor 2 - Involvement in chemokine gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; INTERLEUKIN-8 GENE; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; EXPRESSION; ACTIVATION; PATHWAY; PHOSPHORYLATION	Cysteinyl-leukotrienes are involved in inflammation and act on at least two G-protein-coupled receptors, CysLT1 and CysLT2. However, the role of the CysLT2 receptor as well as its signaling remain poorly understood. Here we show that leukotriene (LT)C-4 induced the production of the chemokine interleukin (IL)-8 in endothelial cells. To further study the signaling cascade involved, HEK293 cells were stably transfected with CysLT2 and used to study the transcriptional regulation of the IL-8 promoter. Stimulation of the cells with increasing concentrations of LTC4 resulted in a time- and concentration-dependent induction of IL-8 transcription and protein synthesis. Use of IL-8 promoter mutants with substitutions in their NF-kappa B, AP-1, or NF-IL-6 binding elements revealed an almost total requirement for NF-kappa B and AP-1 elements, and a lesser requirement for the NF-IL-6 element. Overexpression of dominant-negative I kappa B alpha prevented the IL-8 transactivation induced by LTC4. LTC4 stimulation induced NF-kappa B and AP-1 DNA binding, which involved the formation of a p50/p65 and a c-JUN.c-FOS complex, respectively. Transfection of the cells with a dominant negative (dn) form of PKC epsilon prevented p65 phosphorylation, whereas dnPKC delta prevented AP-1 binding. Moreover, dnPKC delta, dnPKC epsilon, and dnPKC delta prevented LTC4-induced IL-8 transcription in response to LTC4. Our data show for the first time that LTC4 can act via the CysLT2 receptor to transcriptionally activate chemokine production through induction of NF-kappa B and AP-1 transcription factors. These findings suggest the potential implication of CysLT2 in the inflammatory response through the modulation of chemokine gene transcription.	[Thompson, Charles; Bosse, Ynuk; Poisson, Caroline; Stankova, Jana; Rola-Pleszczynski, Marek] Univ Sherbrooke, Div Immunol, Dept Pediat, Fac Med, Sherbrooke, PQ J1H 5N4, Canada; [Cloutier, Alexandre; Larivee, Pierre; McDonald, Patrick P.] Univ Sherbrooke, Fac Med, Div Pulm, Dept Med, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke; University of Sherbrooke	Rola-Pleszczynski, M (corresponding author), 3001 N 12th Ave, Sherbrooke, PQ J1H 5N4, Canada.	marek.rola-pleszczynski@usherbrooke.ca						ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Anrather J, 1999, J BIOL CHEM, V274, P13594, DOI 10.1074/jbc.274.19.13594; BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; Barnes PJ, 1998, EUR RESPIR J, V12, P221, DOI 10.1183/09031936.98.12010221; Beller TC, 2004, J BIOL CHEM, V279, P46129, DOI 10.1074/jbc.M407057200; BRACH MA, 1992, EUR J IMMUNOL, V22, P2705, DOI 10.1002/eji.1830221034; Chen LC, 2004, BBA-MOL CELL BIOL L, V1683, P38, DOI 10.1016/j.bbalip.2004.04.003; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LY, 2005, J BIOL CHEM, V280, P22497, DOI 10.1074/jbc.M413033200; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; Cummings R, 2004, J BIOL CHEM, V279, P41085, DOI 10.1074/jbc.M404045200; Devillier P, 1999, PHARMACOL RES, V40, P15, DOI 10.1006/phrs.1998.0461; DIAZMECO MT, 1993, MOL CELL BIOL, V13, P4770, DOI 10.1128/MCB.13.8.4770; Drazen JM, 1998, AM J RESP CRIT CARE, V158, pS193, DOI 10.1164/ajrccm.158.supplement_2.13tac180; Dupre DJ, 2007, CELL SIGNAL, V19, P2068, DOI 10.1016/j.cellsig.2007.05.015; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Figueroa DJ, 2003, CLIN EXP ALLERGY, V33, P1380, DOI 10.1046/j.1365-2222.2003.01786.x; Gibson PG, 2001, CHEST, V119, P1329, DOI 10.1378/chest.119.5.1329; Guo BC, 2007, J IMMUNOL, V178, P4726, DOI 10.4049/jimmunol.178.8.4726; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Kaminska B, 2000, ACTA NEUROBIOL EXP, V60, P395; Koon HW, 2005, J PHARMACOL EXP THER, V314, P1393, DOI 10.1124/jpet.105.088013; Kuriyama M, 2004, BIOCHEM BIOPH RES CO, V325, P843, DOI 10.1016/j.bbrc.2004.10.102; LABAT C, 1992, J PHARMACOL EXP THER, V263, P800; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; LAM S, 1988, J ALLERGY CLIN IMMUN, V81, P711, DOI 10.1016/0091-6749(88)91043-3; LeHoux JG, 2001, J BIOL CHEM, V276, P8021, DOI 10.1074/jbc.M009495200; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotzer K, 2003, ARTERIOSCL THROM VAS, V23, pE32, DOI 10.1161/01.ATV.0000082690.23131.CB; Lynch KR, 1999, NATURE, V399, P789; Macfarlane AJ, 2000, AM J RESP CRIT CARE, V161, P1553, DOI 10.1164/ajrccm.161.5.9906068; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; Norzila MZ, 2000, AM J RESP CRIT CARE, V161, P769, DOI 10.1164/ajrccm.161.3.9809071; Nothacker HP, 2000, MOL PHARMACOL, V58, P1601, DOI 10.1124/mol.58.6.1601; Ordonez CL, 2000, AM J RESP CRIT CARE, V161, P1185, DOI 10.1164/ajrccm.161.4.9812061; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pavord ID, 1999, AM J RESP CRIT CARE, V160, P1905, DOI 10.1164/ajrccm.160.6.9903114; Pillai SG, 2004, PHARMACOGENETICS, V14, P627, DOI 10.1097/00008571-200409000-00007; Qiu H, 2006, P NATL ACAD SCI USA, V103, P8161, DOI 10.1073/pnas.0602414103; Sarau HM, 1999, MOL PHARMACOL, V56, P657, DOI 10.1124/mol.56.3.657; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; Senftleben U, 2002, CRIT CARE MED, V30, pS18, DOI 10.1097/00003246-200201001-00003; Sjostrom M, 2003, ARTERIOSCL THROM VAS, V23, pE37, DOI 10.1161/01.ATV.0000082689.46538.DF; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Stankova J, 1996, AM J PHYSIOL-CELL PH, V271, pC1073, DOI 10.1152/ajpcell.1996.271.4.C1073; STEIN B, 1993, MOL CELL BIOL, V13, P7191, DOI 10.1128/MCB.13.11.7191; Takasaki J, 2000, BIOCHEM BIOPH RES CO, V274, P316, DOI 10.1006/bbrc.2000.3140; Tan SL, 2003, BIOCHEM J, V376, P545, DOI 10.1042/BJ20031406; Thodeti CK, 2001, EXP CELL RES, V262, P95, DOI 10.1006/excr.2000.5077; Thompson C, 2006, AM J RESP CELL MOL, V35, P697, DOI 10.1165/rcmb.2005-0407OC; Thompson MD, 2003, PHARMACOGENETICS, V13, P641, DOI 10.1097/00008571-200310000-00008; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Uzonyi B, 2006, P NATL ACAD SCI USA, V103, P6326, DOI 10.1073/pnas.0601223103; Vlahopoulos S, 1999, BLOOD, V94, P1878, DOI 10.1182/blood.V94.6.1878; WENZEL SE, 1990, AM REV RESPIR DIS, V142, P112, DOI 10.1164/ajrccm/142.1.112; WEYRICH AS, 1995, J CLIN INVEST, V95, P2297, DOI 10.1172/JCI117921; Zingarelli B, 2003, CRIT CARE MED, V31, pS105, DOI 10.1097/00003246-200301001-00015	63	26	27	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1974	1984		10.1074/jbc.M608197200	http://dx.doi.org/10.1074/jbc.M608197200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18048362	hybrid			2022-12-25	WOS:000252501000024
J	Dai, JQ; Zhu, XJ; Liu, FQ; Xiang, JH; Nagasawa, H; Yang, WJ				Dai, Jie-Qiong; Zhu, Xiao-Jing; Liu, Feng-Qi; Xiang, Jian-Hai; Nagasawa, Hiromichi; Yang, Wei-Jun			Involvement of p90 ribosomal S6 kinase in termination of cell cycle arrest during development of Artemia-encysted embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MAP KINASE; RSK; PHOSPHORYLATION; P90(RSK); IDENTIFICATION; REPLICATION; DOMAINS; SALINA; GENES	Artemia has evolved a unique developmental pattern of encysted embryos to cope with various environmental threats. Cell divisions totally cease during the preemergence developmental stage from gastrula to prenauplius. The molecular mechanism of this, however, remains unknown. Our study focuses on the involvement of p90 ribosomal S6 kinase (RSK), a family of serine/threonine kinase-mediating signal transduction downstream of mitogen-activated protein kinase cascades, in the termination of cell cycle arrest during the post-embryonic development of Artemia-encysted gastrula. With immunochemistry, morphology, and cell cycle analysis, the identified Artemia RSK was established to be specifically activated during the post-embryonic and early larval developmental stages when arrested cells of encysted embryos resumed mitoses. In vivo knockdown of RSK activity by RNA interference, kinase inhibition, and antibody neutralization consistently induced defective larvae with distinct gaps between the exoskeleton and internal tissues. In these abnormal individuals, mitoses were detected to be largely inhibited in the affected regions. These results display the requirement of RSK activity during Artemia development and suggest its role in termination of cell cycle (G(2)/M phase) arrest and promotion of mitogenesis. Our findings may, thus, provide insights into the regulation of cell division during Artemia post-embryonic development and reveal further aspects of RSK functions.	[Dai, Jie-Qiong; Zhu, Xiao-Jing; Yang, Wei-Jun] Zhejiang Univ, Inst Cell Biol & Genet, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Liu, Feng-Qi] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Xiang, Jian-Hai] Chinese Acad Sci, Inst Oceanol, Qingdao 266071, Shandong, Peoples R China; [Nagasawa, Hiromichi] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan	Zhejiang University; Nankai University; Chinese Academy of Sciences; Institute of Oceanology, CAS; University of Tokyo	Yang, WJ (corresponding author), Zhejiang Univ, Inst Cell Biol & Genet, Coll Life Sci, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China.	w_jyang@cls.zju.edu.cn	xiang, jianhai/A-4767-2012	xiang, jianhai/0000-0001-5395-7787; Yang, Wei-Jun/0000-0002-4591-8830				Benesch R., 1969, Zoologische Jahrbuecher (Anatomie), V86, P307; Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; BJORBAEK C, 1995, J BIOL CHEM, V270, P18848, DOI 10.1074/jbc.270.32.18848; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clegg J.S., 1978, P117; Clegg James S., 2002, P129; Copf T, 2004, P NATL ACAD SCI USA, V101, P17711, DOI 10.1073/pnas.0407327102; Copf T, 2006, DEV BIOL, V298, P87, DOI 10.1016/j.ydbio.2006.07.024; Criel Godelieve R.J., 2002, P39; Dai ZM, 2007, J BIOTECHNOL, V128, P435, DOI 10.1016/j.jbiotec.2006.10.018; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Drinkwater L.E., 1991, P93; FINAMORE FJ, 1969, CELL CYCLE GENE ENZY, P249; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; FREEMAN JA, 1992, DEV BIOL, V152, P279, DOI 10.1016/0012-1606(92)90135-4; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Fujita N, 2003, J BIOL CHEM, V278, P49254, DOI 10.1074/jbc.M306614200; Gajardo Gonzalo, 2002, P225; Godeny MD, 2006, AM J PHYSIOL-CELL PH, V291, pC1308, DOI 10.1152/ajpcell.00618.2005; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; Gross SD, 2001, J BIOL CHEM, V276, P46099, DOI 10.1074/jbc.C100496200; Hans A, 2001, J BIOL CHEM, V276, P7258, DOI 10.1074/jbc.M005107200; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; HENTSCHEL CC, 1976, TRENDS BIOCHEM SCI, V1, P97, DOI 10.1016/0968-0004(76)90317-0; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majka M, 2000, BLOOD, V96, P4142, DOI 10.1182/blood.V96.13.4142.h8004142_4142_4151; Mori M, 2006, DEVELOPMENT, V133, P1823, DOI 10.1242/dev.02348; NAKANISHI YHT, 1963, P JPN ACAD, V39, P306, DOI 10.2183/pjab1945.39.306; NAKANISHI Yu.H., 1962, ANNOT ZOOL JAPON, V35, P223; OLSON C, 1976, EXPERIENTIA, V32, P864, DOI 10.1007/BF02003733; OLSON CS, 1978, ROUX ARCH DEV BIOL, V184, P1, DOI 10.1007/BF00848665; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Slegers H., 1991, P37; Smith JA, 2005, CANCER RES, V65, P1027; Tomas-Zuber M, 2000, J BIOL CHEM, V275, P23549, DOI 10.1074/jbc.M002586200; WASSARMAN DA, 1994, GENE, V144, P309, DOI 10.1016/0378-1119(94)90396-4; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186	40	32	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1705	1712		10.1074/jbc.M707853200	http://dx.doi.org/10.1074/jbc.M707853200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17999958	hybrid			2022-12-25	WOS:000252282700057
J	Jin, W; Yun, C; Jeong, J; Park, Y; Lee, HD; Kim, SJ				Jin, Wook; Yun, Chohee; Jeong, Joon; Park, Yangho; Lee, Hy-De; Kim, Seong-Jin			c-Src is required for tropomyosin receptor kinase C (TrkC)-induced activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; SIGNAL-TRANSDUCTION; NEUROTROPHIN RECEPTORS; INSULIN-RECEPTOR; PERINEURAL INVASION; TRK RECEPTORS; EXPRESSION; CELL; FAMILY; SURVIVAL	TrkC mediates many aspects of growth and development in the central nervous system. TrkC is expressed in a variety of non-neuronal tissues as well as human cancers. TrkC overexpression may drive tumorigenesis, invasion, and metastatic capability in cancer cells. However, relatively little is known about whether TrkC activity is also essential to maintain the malignant properties in human tumors. TrkC expression leads to the constitutive activation of two major effector pathways, namely the Ras-MAP kinase ( MAPK) mitogenic pathway and the phosphatidylinositol 3-kinase (PI3K)-AKT pathway mediating cell survival. However, it remains unclear how TrkC activates Ras-Erk1/2 and/or PI3K-Akt cascades. Here we define some aspects of the molecular mechanisms regulating TrkC-dependent Ras-Erk1/2 and PI3K/Akt activation. We show that endogenous TrkC associated with c-Src in human and mouse cancer cells which express TrkC. TrkC-c-Src complexes were also detected in primary human breast cancer tissues. Suppression of c-Src by RNA interference in highly metastatic 4T1 mammary cancer cells, which express endogenous TrkC, resulted in markedly decreased expression of cyclin D1 and suppression of activation of Ras-Erk1/2 and PI3K-Akt. Moreover, inhibition of c-Src expression almost completely blocks colony formation of 4T1 cells in soft agar. Furthermore, in c-Src-deficient SYF cells, TrkC failed to activate the PI3K-Atk pathway, but not the Ras-Erk1/2 pathway. Therefore these data indicate that TrkC induces the PI3K-Akt cascade through the activation of c-Src.	[Jin, Wook; Kim, Seong-Jin] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Lab Cell Regulat & Carcinogenesis, Inchon 406840, South Korea; [Yun, Chohee; Kim, Seong-Jin] Case Western Reserve Univ, Ireland Canc Ctr, Dept Pediat, Cleveland, OH 44106 USA; [Jeong, Joon; Lee, Hy-De] Yonsei Univ, Yongdong Severance Hosp, Seoul 135720, South Korea; [Park, Yangho] BRM Inst, Seoul 135822, South Korea	Gachon University; Case Western Reserve University; Yonsei University	Kim, SJ (corresponding author), Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Lab Cell Regulat & Carcinogenesis, Inchon 406840, South Korea.	jasonsjkim@gachon.ac.kr	, 정준/I-2133-2019	, 정준/0000-0003-0397-0005				ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Astolfi A, 2001, EUR J CANCER, V37, P1719, DOI 10.1016/S0959-8049(01)00190-3; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; Bates RC, 2000, CRIT REV ONCOL HEMAT, V36, P61, DOI 10.1016/S1040-8428(00)00077-9; BELLACOSA A, 1995, INT J CANCER, V64, P280, DOI 10.1002/ijc.2910640412; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bonfini L, 1996, TRENDS BIOCHEM SCI, V21, P257, DOI 10.1016/S0968-0004(96)10033-5; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Brodeur GM, 1997, J NEURO-ONCOL, V31, P49, DOI 10.1023/A:1005729329526; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Chen-Tsai CP, 2004, DERMATOL SURG, V30, P1009, DOI 10.1111/j.1524-4725.2004.30306.x; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Descamps S, 2001, J BIOL CHEM, V276, P17864, DOI 10.1074/jbc.M010499200; Dixon SJ, 2006, BBA-MOL CELL RES, V1763, P366, DOI 10.1016/j.bbamcr.2006.02.009; Downward J, 1996, CANCER SURV, V27, P87; Eggert A, 2000, MED PEDIATR ONCOL, V35, P569, DOI 10.1002/1096-911X(20001201)35:6<569::AID-MPO16>3.0.CO;2-A; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; Funakoshi-Tago M, 2005, J BIOCHEM, V137, P189, DOI 10.1093/jb/mvi018; Goi T, 2000, EMBO J, V19, P623, DOI 10.1093/emboj/19.4.623; Grotzer MA, 2000, J CLIN ONCOL, V18, P1027, DOI 10.1200/JCO.2000.18.5.1027; Guate JL, 1999, BJU INT, V84, P495; Gunther S, 2007, CANCER LETT, V250, P25, DOI 10.1016/j.canlet.2006.09.014; GUITON M, 1995, J BIOL CHEM, V270, P20384, DOI 10.1074/jbc.270.35.20384; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; Hallberg B, 1998, ONCOGENE, V17, P691, DOI 10.1038/sj.onc.1201980; Hisaoka M, 2002, J PATHOL, V197, P661, DOI 10.1002/path.1138; Hu XH, 2004, J NEUROCHEM, V90, P1339, DOI 10.1111/j.1471-4159.2004.02594.x; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; Jones RJ, 2000, EUR J CANCER, V36, P1595, DOI 10.1016/S0959-8049(00)00153-2; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kopnin BP, 2000, BIOCHEMISTRY-MOSCOW+, V65, P2; KREMER NE, 1991, J CELL BIOL, V115, P809, DOI 10.1083/jcb.115.3.809; Lannon CL, 2004, J BIOL CHEM, V279, P6225, DOI 10.1074/jbc.M307388200; LEE SB, 1995, CURR OPIN CELL BIOL, V7, P183, DOI 10.1016/0955-0674(95)80026-3; LEMMON MA, 1994, TRENDS BIOCHEM SCI, V19, P459, DOI 10.1016/0968-0004(94)90130-9; Lentz SI, 1999, J NEUROSCI, V19, P1038; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARCHETTI D, 1993, INT J CANCER, V55, P692, DOI 10.1002/ijc.2910550430; McGregor LM, 1999, P NATL ACAD SCI USA, V96, P4540, DOI 10.1073/pnas.96.8.4540; MENTER DG, 1994, INVAS METAST, V14, P372; Miknyoczki SJ, 1999, INT J CANCER, V81, P417, DOI 10.1002/(SICI)1097-0215(19990505)81:3<417::AID-IJC16>3.0.CO;2-6; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; Ness JK, 2002, DEV NEUROSCI-BASEL, V24, P437, DOI 10.1159/000069050; NICHOLSON KM, BREAST CANC RES TREA, V81, P117; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Ricci A, 2001, AM J RESP CELL MOL, V25, P439, DOI 10.1165/ajrcmb.25.4.4470; Rickert CH, 2004, J NEUROPATH EXP NEUR, V63, P1211, DOI 10.1093/jnen/63.12.1211; Ryden M, 1996, BRIT J CANCER, V74, P773, DOI 10.1038/bjc.1996.435; Sakamoto Y, 2001, ONCOL REP, V8, P477; Satoh F, 2001, INT J UROL, V8, pS28, DOI 10.1046/j.1442-2042.2001.00331.x; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Shibayama E, 1996, AM J PATHOL, V148, P1807; Singer HS, 1999, J NEURO-ONCOL, V45, P1, DOI 10.1023/A:1006323523437; Sun XJ, 1996, J BIOL CHEM, V271, P10583, DOI 10.1074/jbc.271.18.10583; Tessarollo L, 1998, CYTOKINE GROWTH F R, V9, P125, DOI 10.1016/S1359-6101(98)00003-3; Tognon C, 2001, CANCER RES, V61, P8909; Weeraratna AT, 2001, CLIN CANCER RES, V7, P2237; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Yamamoto M, 1996, NEUROCHEM RES, V21, P929, DOI 10.1007/BF02532343; Yan KS, 2002, FEBS LETT, V513, P67, DOI 10.1016/S0014-5793(01)03305-1; Yenush L, 1996, J BIOL CHEM, V271, P24300, DOI 10.1074/jbc.271.39.24300; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	70	25	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1391	1400		10.1074/jbc.M705052200	http://dx.doi.org/10.1074/jbc.M705052200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17991742	hybrid			2022-12-25	WOS:000252282700022
J	Yamamoto, H; Takematsu, H; Fujinawa, R; Naito, Y; Okuno, Y; Tsujimoto, G; Suzuki, A; Kozutsumi, Y				Yamamoto, Harumi; Takematsu, Hiromu; Fujinawa, Reiko; Naito, Yuko; Okuno, Yasushi; Tsujimoto, Gozoh; Suzuki, Akemi; Kozutsumi, Yasunori			Correlation Index-Based Responsible-Enzyme Gene Screening (CIRES), a Novel DNA Microarray-Based Method for Enzyme Gene Involved in Glycan Biosynthesis	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE-III; COMPLEX-TYPE OLIGOSACCHARIDES; MOLECULAR-CLONING; MAACKIA-AMURENSIS; HUMAN BREAST; EXPRESSION; LECTIN; CDNA; ACID; GLYCOPROTEINS	Background. Glycan biosynthesis occurs though a multi-step process that requires a variety of enzymes ranging from glycosyltransferases to those involved in cytosolic sugar metabolism. In many cases, glycan biosynthesis follows a glycan-specific, linear pathway. As glycosyltransferases are generally regulated at the level of transcription, assessing the overall transcriptional profile for glycan biosynthesis genes seems warranted. However, a systematic approach for assessing the correlation between glycan expression and glycan-related gene expression has not been reported previously. Methodology. To facilitate genetic analysis of glycan biosynthesis, we sought to correlate the expression of genes involved in cell-surface glycan formation with the expression of the glycans, as detected by glycan-recognizing probes. We performed cross-sample comparisons of gene expression profiles using a newly developed, glycan-focused cDNA microarray. Cell-surface glycan expression profiles were obtained using flow cytometry of cells stained with plant lectins. Pearson's correlation coefficients were calculated for these profiles and were used to identify enzyme genes correlated with glycan biosynthesis. Conclusions. This method, designated correlation index-based responsible-enzyme gene screening (CIRES), successfully identified genes already known to be involved in the biosynthesis of certain glycans. Our evaluation of CIRES indicates that it is useful for identifying genes involved in the biosynthesis of glycan chains that can be probed with lectins using flow cytometry.	[Yamamoto, Harumi; Takematsu, Hiromu; Naito, Yuko; Kozutsumi, Yasunori] Kyoto Univ, Grad Sch Biostudies, Lab Membrane Biochem & Biophys, Sakyo Ku, Kyoto, Japan; [Okuno, Yasushi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept PharmacoInformat, Sakyo Ku, Kyoto, Japan; [Tsujimoto, Gozoh] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery, Sakyo Ku, Kyoto, Japan; [Yamamoto, Harumi; Fujinawa, Reiko; Suzuki, Akemi; Kozutsumi, Yasunori] RIKEN, RIKEN Frontier Res Syst, Supra Biomol Syst Res Grp, Wako, Saitama, Japan; [Takematsu, Hiromu; Naito, Yuko; Kozutsumi, Yasunori] Japan Sci & Technol Corp JST, CREST, Kawaguchi, Saitama, Japan	Kyoto University; Kyoto University; Kyoto University; RIKEN; Japan Science & Technology Agency (JST)	Takematsu, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Membrane Biochem & Biophys, Sakyo Ku, Kyoto, Japan.	htakema@pharm.kyoto-u.ac.jp			CREST; JST; Ministry of Education, Culture, Sports, Science and Technology of Japan; RIKEN	CREST(Core Research for Evolutional Science and Technology (CREST)); JST(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN	This work was supported by CREST, JST, a grant- in-aid program from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by RIKEN.	ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; BIERHUIZEN MFA, 1993, GENE DEV, V7, P468, DOI 10.1101/gad.7.3.468; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; CHEN YX, 1995, GLYCOCONJUGATE J, V12, P55, DOI 10.1007/BF00731869; Comelli EM, 2006, GLYCOBIOLOGY, V16, P117, DOI 10.1093/glycob/cwj048; CROWLEY JF, 1984, ARCH BIOCHEM BIOPHYS, V231, P524, DOI 10.1016/0003-9861(84)90417-X; Edwards D, 2003, BIOINFORMATICS, V19, P825, DOI 10.1093/bioinformatics/btg083; FERNANDES B, 1991, CANCER RES, V51, P718; Freeze H. H., 1999, ESSENTIALS GLYCOBIOL, P69; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; Furukawa K, 1999, BBA-GEN SUBJECTS, V1473, P54, DOI 10.1016/S0304-4165(99)00169-5; GILLESPIE W, 1993, J BIOL CHEM, V268, P3801; Granovsky M, 2000, NAT MED, V6, P306; Hakomori S, 2004, ARCH BIOCHEM BIOPHYS, V426, P173, DOI 10.1016/j.abb.2004.02.032; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; IHARA Y, 1995, GLYCOCONJUGATE J, V12, P787, DOI 10.1007/BF00731240; Ito N, 1996, HISTOCHEM CELL BIOL, V106, P331, DOI 10.1007/BF02473243; KAIFU R, 1975, CARBOHYD RES, V40, P111, DOI 10.1016/S0008-6215(00)82673-7; Kamekawa N, 2006, J BIOCHEM, V140, P337, DOI 10.1093/jb/mvj154; Kawano S, 2005, BIOINFORMATICS, V21, P3976, DOI 10.1093/bioinformatics/bti666; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; KNIBBS RN, 1991, J BIOL CHEM, V266, P83; KONAMI Y, 1994, FEBS LETT, V342, P334, DOI 10.1016/0014-5793(94)80527-X; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; LARSEN RD, 1989, P NATL ACAD SCI USA, V86, P8227, DOI 10.1073/pnas.86.21.8227; MATSUMOT.I, 1969, BIOCHIM BIOPHYS ACTA, V194, P180, DOI 10.1016/0005-2795(69)90193-7; MIYOSHI E, 1994, CANCER RES, V54, P1854; Moremen KW, 2002, BBA-GEN SUBJECTS, V1573, P225, DOI 10.1016/S0304-4165(02)00388-4; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Nakamura-Tsuruta S, 2006, BIOCHEM BIOPH RES CO, V347, P215, DOI 10.1016/j.bbrc.2006.06.073; Narimatsu H, 2004, GLYCOCONJUGATE J, V21, P17, DOI 10.1023/B:GLYC.0000043742.99482.01; Okajima T, 1999, J BIOL CHEM, V274, P11479, DOI 10.1074/jbc.274.17.11479; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Sasai K, 2002, FEBS LETT, V522, P151, DOI 10.1016/S0014-5793(02)02916-2; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; Sultan AS, 1997, J BIOL CHEM, V272, P2866, DOI 10.1074/jbc.272.5.2866; TAKEMATSU H, 2007, COMPREHENSIVE GLYCOS, V2, P428; Team RDC, 2004, R LANG ENV STAT COMP; Varki A, 1999, ESSENTIALS GLYCOBIOL, P455; WANG WC, 1988, J BIOL CHEM, V263, P4576; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Yamamoto H, 2000, CANCER RES, V60, P134; YAMASHITA K, 1987, J BIOL CHEM, V262, P1602	51	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1232	10.1371/journal.pone.0001232	http://dx.doi.org/10.1371/journal.pone.0001232			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043739	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459300013
J	Haller, C; Rauch, S; Fackler, OT				Haller, Claudia; Rauch, Susanne; Fackler, Oliver T.			HIV-1 Nef Employs Two Distinct Mechanisms to Modulate Lck Subcellular Localization and TCR Induced Actin Remodeling	PLOS ONE			English	Article								The Nef protein acts as critical factor during HIV pathogenesis by increasing HIV replication in vivo via the modulation of host cell vesicle transport and signal transduction processes. Recent studies suggested that Nef alters formation and function of immunological synapses (IS), thereby modulating exogenous T-cell receptor (TCR) stimulation to balance between partial T cell activation required for HIV-1 spread and prevention of activation induced cell death. Alterations of IS function by Nef include interference with cell spreading and actin polymerization upon TCR engagement, a pronounced intracellular accumulation of the Src kinase Lck and its reduced IS recruitment. Here we use a combination of Nef mutagenesis and pharmacological inhibition to analyze the relative contribution of these effects to Nef mediated alterations of IS organization and function on TCR stimulatory surfaces. Inhibition of actin polymerization and IS recruitment of Lck were governed by identical Nef determinants and correlated well with Nef's association with Pak2 kinase activity. In contrast, Nef mediated Lck endosomal accumulation was separable from these effects, occurred independently of Pak2, required integrity of the microtubule rather than the actin filament system and thus represents a distinct Nef activity. Finally, reduction of TCR signal transmission by Nef was linked to altered actin remodeling and Lck IS recruitment but did not require endosomal Lck rerouting. Thus, Nef affects IS function via multiple independent mechanisms to optimize virus replication in the infected host.	[Haller, Claudia; Rauch, Susanne; Fackler, Oliver T.] Univ Klinikum Heidelberg, Abt Virol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Fackler, OT (corresponding author), Univ Klinikum Heidelberg, Abt Virol, Heidelberg, Germany.	oliver_fackler@med.uni-heidelberg.de		Fackler, Oliver Till/0000-0003-2982-4209	Deutsche Forschungsgemeinschaft [SFB 638]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft ( SFB 638, project A11).	Agopian K, 2006, J VIROL, V80, P3050, DOI 10.1128/JVI.80.6.3050-3061.2006; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Baur AS, 1997, IMMUNITY, V6, P283, DOI 10.1016/S1074-7613(00)80331-3; BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Casartelli N, 2006, J GEN VIROL, V87, P2291, DOI 10.1099/vir.0.81775-0; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dohner K, 2002, MOL BIOL CELL, V13, P2795, DOI 10.1091/mbc.01-07-0348; Fackler OT, 2007, NAT REV IMMUNOL, V7, P310, DOI 10.1038/nri2041; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Giese SI, 2006, VIROLOGY, V355, P175, DOI 10.1016/j.virol.2006.07.003; Haller C, 2006, J BIOL CHEM, V281, P19618, DOI 10.1074/jbc.M513802200; Harder T, 2007, CURR OPIN IMMUNOL, V19, P470, DOI 10.1016/j.coi.2007.05.002; Huang YP, 2007, J CELL SCI, V120, P723, DOI 10.1242/jcs.000786; Jordan S, 2003, J IMMUNOL, V171, P78, DOI 10.4049/jimmunol.171.1.78; Keppler OT, 2006, J LEUKOCYTE BIOL, V79, P616, DOI 10.1189/jlb.0805461; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Krautkramer E, 2004, J VIROL, V78, P4085, DOI 10.1128/JVI.78.8.4085-4097.2004; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; Madrid R, 2005, FEBS LETT, V579, P441, DOI 10.1016/j.febslet.2004.12.009; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Manninen A, 2000, J BIOL CHEM, V275, P16513, DOI 10.1074/jbc.M910032199; Manninen A, 1998, VIROLOGY, V250, P273, DOI 10.1006/viro.1998.9381; Matarrese P, 2005, CELL DEATH DIFFER, V12, P932, DOI 10.1038/sj.cdd.4401582; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Michel N, 2006, MOL BIOL CELL, V17, P3578, DOI 10.1091/mbc.E06-02-0117; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Saito T, 2006, CURR OPIN IMMUNOL, V18, P305, DOI 10.1016/j.coi.2006.03.014; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; SAWAI ET, 1995, J BIOL CHEM, V270, P15307, DOI 10.1074/jbc.270.25.15307; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schrager JA, 1999, P NATL ACAD SCI USA, V96, P8167, DOI 10.1073/pnas.96.14.8167; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Tavano R, 2004, J IMMUNOL, V173, P5392, DOI 10.4049/jimmunol.173.9.5392; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Tskvitaria-Fuller I, 2003, J IMMUNOL, V171, P2287, DOI 10.4049/jimmunol.171.5.2287; Wang JK, 2000, P NATL ACAD SCI USA, V97, P394, DOI 10.1073/pnas.97.1.394	47	60	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1212	10.1371/journal.pone.0001212	http://dx.doi.org/10.1371/journal.pone.0001212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030346	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459200025
J	Qiu, Y; Bevan, H; Weeraperuma, S; Wratting, D; Murphy, D; Neal, CR; Bates, DO; Harper, SJ				Qiu, Yan; Bevan, Heather; Weeraperuma, Sudath; Wratting, Daniel; Murphy, David; Neal, Christopher R.; Bates, David O.; Harper, Steven J.			Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF(165)b	FASEB JOURNAL			English	Article						angiogenesis; splicing; transgenic	INCREASES HYDRAULIC CONDUCTIVITY; RAT SKELETAL-MUSCLE; SPLICE VARIANT; IN-VIVO; VASCULAR-PERMEABILITY; FACTOR FAMILY; VEGF; GLAND; ANGIOGENESIS; EXPRESSION	Extensive tissue remodeling occurs in breast tissue during pregnancy, resulting in growth and development of the mammary gland associated with extensive vascular remodeling, which is thought to be dependent on vascular endothelial growth factor (VEGF). We show here that the endogenous antiangiogenic splice isoform of VEGF, VEGF(165)b, is normally expressed in nonlactating human and mouse breast, and is down-regulated in WT mice during lactation. To demonstrate the physiological role of VEGF165b in mammary tissue, we generated transgenic (TG) mice expressing VEGF165b, under the control of the mouse mammary tumor virus (MMTV) enhancer/promoter. These mice increase expression of VEGF165b in mammary tissue during mammary development. The offspring of TG mothers, but not TG fathers, die shortly after birth. The female TG mice have fewer blood vessels, less blood in the mammary tissue, and impaired alveolar coverage of the fat pad, and do not produce sufficient milk for nourishment of their pups. These findings demonstrate that endogenous overexpression of VEGF165b in the mammary gland inhibits physiological angiogenesis and that the regulation of the balance of VEGF isoforms is a requirement for mammary alveolar development and milk production. This study provides the first evidence for the role of endogenous antiangiogenic VEGF isoforms in normal physiology - their down-regulation is required for effective milk production.	[Qiu, Yan; Bevan, Heather; Weeraperuma, Sudath; Wratting, Daniel; Neal, Christopher R.; Bates, David O.; Harper, Steven J.] Univ Bristol, Sch Vet Sci, Microvasc Res Labs, Bristol BS18 7DU, Avon, England; [Murphy, David] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol BS18 7DU, Avon, England	University of Bristol; University of Bristol	Bates, DO (corresponding author), Univ Bristol, Preclin Vet Sch, Dept Physiol, Microvasc Res Labs, Southwell St, Bristol BS2 8EJ, Avon, England.	dave.bates@bris.ac.uk; s.harper@bris.ac.uk	Murphy, David/C-3967-2012	Murphy, David/0000-0003-2946-0353; Bates, David/0000-0003-4850-2360	British Heart Foundation [BB2000007] Funding Source: Medline; Wellcome Trust [69029, 058083] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)		Bates DO, 1996, AM J PHYSIOL-HEART C, V271, pH2520, DOI 10.1152/ajpheart.1996.271.6.H2520; Bates DO, 2006, CLIN SCI, V110, P575, DOI 10.1042/CS20050292; Bates DO, 2002, CANCER RES, V62, P4123; Benest AV, 2006, MICROCIRCULATION, V13, P423, DOI 10.1080/10739680600775940; Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Djonov V, 2003, CELL TISSUE RES, V314, P107, DOI 10.1007/s00441-003-0784-3; Djonov V, 2001, MICROSC RES TECHNIQ, V52, P182, DOI 10.1002/1097-0029(20010115)52:2<182::AID-JEMT1004>3.3.CO;2-D; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FERRARA N, 1991, J CELL BIOCHEM, V47, P211, DOI 10.1002/jcb.240470305; FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P857; Fu BMM, 2004, MICROVASC RES, V68, P51, DOI 10.1016/j.mvr.2004.03.004; Glass CA, 2006, J PHYSIOL-LONDON, V572, P243, DOI 10.1113/jphysiol.2005.103127; Goldhar AS, 2005, MOL CELL ENDOCRINOL, V232, P9, DOI 10.1016/j.mce.2005.01.005; HansenSmith FM, 1996, CELL TISSUE RES, V286, P123, DOI 10.1007/s004410050681; HARALDSSON B, 1984, ACTA PHYSIOL SCAND, V122, P497, DOI 10.1111/j.1748-1716.1984.tb07538.x; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; Jeffers KR, 1935, AM J ANAT, V56, P257, DOI 10.1002/aja.1000560204; Konopatskaya O, 2006, MOL VIS, V12, P626; KORDON EC, 1995, DEV BIOL, V168, P47, DOI 10.1006/dbio.1995.1060; KU DD, 1993, AM J PHYSIOL, V265, pH586, DOI 10.1152/ajpheart.1993.265.2.H586; MATSUMOTO M, 1992, J VET MED SCI, V54, P937, DOI 10.1292/jvms.54.937; MATSUMOTO M, 1994, J VET MED SCI, V56, P65, DOI 10.1292/jvms.56.65; Pepper MS, 2000, DEV DYNAM, V218, P507, DOI 10.1002/1097-0177(200007)218:3<507::AID-DVDY1012>3.0.CO;2-5; Perrin RM, 2005, DIABETOLOGIA, V48, P2422, DOI 10.1007/s00125-005-1951-8; Pritchard-Jones RO, 2007, BRIT J CANCER, V97, P223, DOI 10.1038/sj.bjc.6603839; Roberts WG, 1997, CANCER RES, V57, P765; Rossiter H, 2007, FASEB J, V21, P3994, DOI 10.1096/fj.07-8720com; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; SENGER DR, 1990, CANCER RES, V50, P1774; Suarez SC, 2006, CELL MOL LIFE SCI, V63, P2067, DOI 10.1007/s00018-006-6254-9; VAREY AHR, 2007, MICROCIRCULATION, V14, P637; Vuorela P, 2000, AM J CLIN NUTR, V72, P1196; Woolard J, 2006, FASEB J, V20, pA539; Zhou AL, 1998, CELL TISSUE RES, V293, P293, DOI 10.1007/s004410051121	36	50	56	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2008	22	4					1104	1112		10.1096/fj.07-9718com	http://dx.doi.org/10.1096/fj.07-9718com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	18032632				2022-12-25	WOS:000254581000016
J	Johnson, AC; Li, XX; Pearlman, E				Johnson, Angela C.; Li, Xiaoxia; Pearlman, Eric			MyD88 functions as a negative regulator of TLR3/TRIF-induced corneal inflammation by inhibiting activation of c-Jun N-terminal kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR; DOUBLE-STRANDED-RNA; PROINFLAMMATORY GENE-EXPRESSION; KAPPA-B ACTIVATION; IFN-BETA PROMOTER; EPITHELIAL-CELLS; MOLECULAR-CLONING; CUTTING EDGE; RECOGNITION; RESPONSES	The adaptor molecule MyD88 is necessary for responses to all Toll-like receptors except TLR3 and a subset of TLR4 signaling events, which are mediated by the adaptor molecule TRIF. To determine the role of TRIF in host inflammatory responses, corneal epithelium of C57BL/6, TLR3(-/-), TRIF-/-, and MyD88(-/-) mice was abraded and stimulated with the synthetic TLR3 ligand poly(I: C). We found that poly(I:C) induced a pronounced cellular infiltration into the corneal stroma, which was TLR3- and TRIF-dependent. Unexpectedly, the inflammatory response was exacerbated in MyD88(-/-) mice, with enhanced neutrophil and F4/80(+) cell infiltration into the corneal stroma and elevated corneal haze, which is an indicator of loss of corneal transparency. To determine whether MyD88-dependent inhibition of TLR3/TRIF responses is a general phenomenon, we examined cytokine production by MyD88(-/-) bone marrow-derived macrophages; however, no significant difference was observed between MyD88(+/+) or MyD88(-/-) macrophages. In contrast, human corneal epithelial cells (HCECs) transfected with MyD88 small interfering RNA had significantly increased (2.5-fold) CCL5/RANTES production compared with control HCECs, demonstrating a negative regulatory role for MyD88 in TLR3/TRIF responses in these cells. Finally, knockdown of MyD88 in HCECs resulted in increased phosphorylation of c-Jun N-terminal kinase (JNK), but not p38, IRF-3, or NF-kappa B. Consistent with this finding, the JNK inhibitor SP600125, but not p38 inhibitor SB203580, ablated this response. Taken together, these findings demonstrate a novel JNK-dependent inhibitory role for MyD88 in the TLR3/TRIF activation pathway.	[Johnson, Angela C.; Pearlman, Eric] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Li, Xiaoxia] Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation	Pearlman, E (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 10900 Euclid Ave, Cleveland, OH 44106 USA.	eric.pearlman@case.edu			NEI NIH HHS [R01EY14362, P30EY11373, P30 EY011373] Funding Source: Medline; NIGMS NIH HHS [R01GM060020] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014362, P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060020] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; ADHIKARY G, 2008, IN PRESS J LEUKOCYTE; Adib-Conquy M, 2006, CRIT CARE MED, V34, P2377, DOI 10.1097/01.CCM.0000233875.93866.88; Aksoy E, 2005, EUR J IMMUNOL, V35, P2200, DOI 10.1002/eji.200425801; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Barton GM, 2007, SEMIN IMMUNOL, V19, P33, DOI 10.1016/j.smim.2007.01.003; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brissette-Storkus CS, 2002, INVEST OPHTH VIS SCI, V43, P2264; Caminschi I, 2001, J IMMUNOL, V167, P3570, DOI 10.4049/jimmunol.167.7.3570; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Cenni V, 2003, BIOCHEM J, V376, P303, DOI 10.1042/BJ20030028; Chang JH, 2006, BRIT J OPHTHALMOL, V90, P103, DOI 10.1136/bjo.2005.072686; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Hayashi K, 2006, J GEN VIROL, V87, P2161, DOI 10.1099/vir.0.81772-0; Hazlett LD, 2004, PROG RETIN EYE RES, V23, P1, DOI 10.1016/j.preteyeres.2003.10.002; Janssens S, 2003, FEBS LETT, V548, P103, DOI 10.1016/S0014-5793(03)00747-6; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Johnson A, 2005, OCUL SURF, V3, pS187; Johnson AC, 2005, INVEST OPHTH VIS SCI, V46, P589, DOI 10.1167/iovs.04-1077; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kaye S, 2006, PROG RETIN EYE RES, V25, P355, DOI 10.1016/j.preteyeres.2006.05.001; Khatri S, 2002, INVEST OPHTH VIS SCI, V43, P2278; Kumar A, 2006, MICROBES INFECT, V8, P380, DOI 10.1016/j.micinf.2005.07.006; Kumar A, 2006, IMMUNOLOGY, V117, P11, DOI 10.1111/j.1365-2567.2005.02258.x; Kumar A, 2006, CURR MOL MED, V6, P327, DOI 10.2174/156652406776894572; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; LOPEZ AF, 1984, MOL IMMUNOL, V21, P371, DOI 10.1016/0161-5890(84)90033-6; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; McKnight AJ, 1996, J BIOL CHEM, V271, P486, DOI 10.1074/jbc.271.1.486; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Schmausser B, 2004, CLIN EXP IMMUNOL, V136, P521, DOI 10.1111/j.1365-2249.2004.02464.x; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Sen GC, 2005, CYTOKINE GROWTH F R, V16, P1, DOI 10.1016/j.cytogfr.2005.01.006; Song PI, 2001, INVEST OPHTH VIS SCI, V42, P2867; Sun Y, 2006, INFECT IMMUN, V74, P5325, DOI 10.1128/IAI.00645-06; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Ueta M, 2005, BIOCHEM BIOPH RES CO, V331, P285, DOI 10.1016/j.bbrc.2005.02.196; Ueta M, 2004, J IMMUNOL, V173, P3337, DOI 10.4049/jimmunol.173.5.3337; Visintin A, 2006, J LEUKOCYTE BIOL, V80, P1584, DOI 10.1189/jlb.0606388; Weighardt H, 2006, INFECT IMMUN, V74, P3618, DOI 10.1128/IAI.01681-05; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang J, 2003, INVEST OPHTH VIS SCI, V44, P4247, DOI 10.1167/iovs.03-0219	55	59	62	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3988	3996		10.1074/jbc.M707264200	http://dx.doi.org/10.1074/jbc.M707264200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18057004	hybrid			2022-12-25	WOS:000253083500033
J	Milstein, ML; McFarland, TP; Marsh, JD; Cala, SE				Milstein, Michelle L.; McFarland, Timothy P.; Marsh, James D.; Cala, Steven E.			Inefficient glycosylation leads to high steady-state levels of actively degrading cardiac triadin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTIONAL SARCOPLASMIC-RETICULUM; RYANODINE RECEPTOR; MOLECULAR-CLONING; SKELETAL-MUSCLE; IMPORTANT DETERMINANT; N-GLYCOSYLATION; RELEASE CHANNEL; AMINO-ACID; CALSEQUESTRIN; PROTEIN	In junctional sarcoplasmic reticulum, binding to cardiac triadin-1 provides a mechanism by which the Ca2+-release channel/ryanodine receptor may link with calsequestrin to regulate Ca2+ release. Calsequestrin and triadin-1 both contain N-linked glycans, but about half of triadin-1 in the heart remains unglycosylated. To investigate mechanisms for this incomplete glycosylation, we overexpressed triadin-1 as a series of glycoform variants in non-muscle cell lines and neonatal heart cells using plasmid and adenoviral vectors. We showed that the characteristic incomplete glycosylation stemmed from properties of the glycosylation sequence that are conserved among triadin splice variants, including the close proximity of Asn(75) to the sarcoplasmic reticulum inner membrane. Although triadin-1 appeared by SDS-PAGE analysis as a 35/40-kDa doublet in all cells, variations occurred in the relative levels of the two glycoforms depending on the cell type and whether overexpression involved a plasmid or adenoviral vector. Treatment of triadin-1 with the proteasome inhibitor MG-132 led to striking changes in the relative levels of triadin-1 that indicated active breakdown of unglycosylated, but not glycosylated, triadin-1. Besides substantial increases in the relative levels of unglycosylated triadin-1, proteasome inhibition led to an accumulation of two new modified forms of triadin-1 that were seen with triadin-1 only when it is not glycosylated on Asn(75). Effects of tunicamycin and endoglycosidase H confirmed that these novel isoforms represent two alternative N-linked glycosylation sites, indicating that an alternative topology occurs infrequently leading to yet other glycoforms with short half-lives.	[McFarland, Timothy P.; Cala, Steven E.] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Milstein, Michelle L.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Marsh, James D.] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA	Wayne State University; Wayne State University; University of Arkansas System; University of Arkansas Medical Sciences	Cala, SE (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, Elliman Bldg 421 E Canfield Ave, Detroit, MI 48201 USA.	s.cala@wayne.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062586] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL62586] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Bers DM, 2004, J MOL CELL CARDIOL, V37, P417, DOI 10.1016/j.yjmcc.2004.05.026; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CASWELL AH, 1991, BIOCHEMISTRY-US, V30, P7507, DOI 10.1021/bi00244a020; Guo W, 1996, J BIOL CHEM, V271, P458, DOI 10.1074/jbc.271.1.458; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Holscher C, 2001, J BIOL CHEM, V276, P13388, DOI 10.1074/jbc.M007331200; Hong CS, 2001, GENE, V278, P193, DOI 10.1016/S0378-1119(01)00718-1; Houle TD, 2006, EXP CELL RES, V312, P4150, DOI 10.1016/j.yexcr.2006.09.010; INUI M, 1987, J BIOL CHEM, V262, P15637; Jones LR, 1995, J BIOL CHEM, V270, P30787, DOI 10.1074/jbc.270.51.30787; KIM KC, 1990, BIOCHEMISTRY-US, V29, P9281, DOI 10.1021/bi00491a025; Kirchhof P, 2007, J MOL CELL CARDIOL, V42, P962, DOI 10.1016/j.yjmcc.2007.02.012; KNUDSON CM, 1993, J BIOL CHEM, V268, P12646; Kobayashi YM, 2000, J BIOL CHEM, V275, P17639, DOI 10.1074/jbc.M002091200; Kobayashi YM, 1999, J BIOL CHEM, V274, P28660, DOI 10.1074/jbc.274.40.28660; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JM, 2004, J BIOL CHEM, V279, P6994, DOI 10.1074/jbc.M312446200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maki T, 1996, J CLIN INVEST, V97, P656, DOI 10.1172/JCI118462; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; NAKAI J, 1990, FEBS LETT, V271, P169, DOI 10.1016/0014-5793(90)80399-4; O'Brian JJ, 2002, J BIOL CHEM, V277, P37154, DOI 10.1074/jbc.M204370200; OTSU K, 1990, J BIOL CHEM, V265, P13472; Popov M, 1997, J BIOL CHEM, V272, P18325, DOI 10.1074/jbc.272.29.18325; Ram ML, 2004, MOL CELL BIOCHEM, V266, P209, DOI 10.1023/B:MCBI.0000049164.28580.56; ShakinEshleman SH, 1996, J BIOL CHEM, V271, P6363, DOI 10.1074/jbc.271.11.6363; Terentyev D, 2005, CIRC RES, V96, P651, DOI 10.1161/01.RES.0000160609.98948.25; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389	30	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1929	1935		10.1074/jbc.M704623200	http://dx.doi.org/10.1074/jbc.M704623200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18025088	hybrid			2022-12-25	WOS:000252501000019
J	Rubenstein, EM; McCartney, RR; Zhang, C; Shokat, KM; Shirra, MK; Arndt, KM; Schmidt, MC				Rubenstein, Eric M.; McCartney, Rhonda R.; Zhang, Chao; Shokat, Kevan M.; Shirra, Margaret K.; Arndt, Karen M.; Schmidt, Martin C.			Access denied: Snf1 activation loop phosphorylation is controlled by availability of the phosphorylated threonine 210 to the PP1 phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE KINASE; YEAST SNF1; GLUCOSE REPRESSION; UPSTREAM KINASE; BETA-SUBUNITS; SNF1-ACTIVATING KINASES; TYPE-1; LKB1; LOCALIZATION; MUTATIONS	Phosphorylation of the Saccharomyces cerevisiae Snf1 kinase activation loop is determined by the integration of two reaction rates: the rate of phosphorylation by upstream kinases and the rate of dephosphorylation by Glc7. The activities of the Snf1-activating kinases do not appear to be glucose-regulated, since immune complex kinase assays with each of the three Snf1-activating kinases show similar levels of activity when prepared from cells grown in either high or low glucose. In contrast, the dephosphorylation of the Snf1 activation loop was strongly regulated by glucose. When de novo phosphorylation of Snf1 was inhibited, phosphorylation of the Snf1 activation loop was found to be stable in low glucose but rapidly lost upon the addition of glucose. A greater than 10-fold difference in the rates of Snf1 activation loop dephosphorylation was detected. However, the activity of the Glc7-Reg1 phosphatase may not itself be directly regulated by glucose, since the Glc7-Reg1 enzyme was active in low glucose toward another substrate, the transcription factor Mig1. Glucose-mediated regulation of Snf1 activation loop dephosphorylation is controlled by changes in the ability of the Snf1 activation loop to act as a substrate for Glc7.	[Rubenstein, Eric M.; McCartney, Rhonda R.; Schmidt, Martin C.] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; [Shirra, Margaret K.; Arndt, Karen M.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Schmidt, MC (corresponding author), Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA.	mcs2@pitt.edu		Rubenstein, Eric/0000-0003-4983-1430	NIAID NIH HHS [R01 AI044009, AI 44009] Funding Source: Medline; NIDDK NIH HHS [R21 DK074654-01, DK 74654, R21 DK074654-02, R21 DK074654] Funding Source: Medline; NIGMS NIH HHS [R01 GM052593-11, R01 GM046443, R01 GM052593, GM 52593, GM 46443, R01 GM046443-20] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK074654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052593, R01GM046443, R29GM046443] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Bouquin N, 2000, J CELL SCI, V113, P1435; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; De Wever V, 2005, EMBO J, V24, P4115, DOI 10.1038/sj.emboj.7600871; Dombek KM, 2004, J BIOL CHEM, V279, P39165, DOI 10.1074/jbc.M400433200; Dombek KM, 1999, MOL CELL BIOL, V19, P6029; Elbing K, 2006, BIOCHEM J, V393, P797, DOI 10.1042/BJ20051213; Elbing K, 2006, J BIOL CHEM, V281, P26170, DOI 10.1074/jbc.M603811200; ESTRUCH F, 1992, GENETICS, V132, P639; Goldstein A, 1975, Methods Enzymol, V42, P504; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hedbacker K, 2004, MOL CELL BIOL, V24, P8255, DOI 10.1128/MCB.24.18.8255-8263.2004; Hedbacker K, 2006, EUKARYOT CELL, V5, P1950, DOI 10.1128/EC.00256-06; Hong SP, 2005, J BIOL CHEM, V280, P21804, DOI 10.1074/jbc.M501887200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Jiang R, 1996, GENE DEV, V10, P3105, DOI 10.1101/gad.10.24.3105; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; McCartney R, 2005, CURR GENET, V47, P335, DOI 10.1007/s00294-005-0576-2; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Nath N, 2003, MOL CELL BIOL, V23, P3909, DOI 10.1128/MCB.23.11.3909-3917.2003; Nayak V, 2006, STRUCTURE, V14, P477, DOI 10.1016/j.str.2005.12.008; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Schmidt MC, 2000, EMBO J, V19, P4936, DOI 10.1093/emboj/19.18.4936; Scott JW, 2007, EMBO J, V26, P806, DOI 10.1038/sj.emboj.7601542; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; SIKORSKI RS, 1989, GENETICS, V122, P19; Sreenivasan A, 2003, MOL CELL BIOL, V23, P6327, DOI 10.1128/MCB.23.17.6327-6337.2003; Sreenivasan A, 1999, MOL CELL BIOL, V19, P7983; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; TREITEL MA, 1995, P NATL ACAD SCI USA, V92, P3132, DOI 10.1073/pnas.92.8.3132; TU JL, 1994, MOL CELL BIOL, V14, P6789, DOI 10.1128/MCB.14.10.6789; TU JL, 1995, EMBO J, V14, P5939, DOI 10.1002/j.1460-2075.1995.tb00282.x; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu XL, 2001, BIOCHEMISTRY-US, V40, P7410, DOI 10.1021/bi002796k; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	46	86	87	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					222	230		10.1074/jbc.M707957200	http://dx.doi.org/10.1074/jbc.M707957200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17991748	Green Accepted, hybrid			2022-12-25	WOS:000251940300025
J	Sereno, PC; Wilson, JA; Witmer, LM; Whitlock, JA; Maga, A; Ide, O; Rowe, TA				Sereno, Paul C.; Wilson, Jeffrey A.; Witmer, Lawrence M.; Whitlock, John A.; Maga, Abdoulaye; Ide, Oumarou; Rowe, Timothy A.			Structural Extremes in a Cretaceous Dinosaur	PLOS ONE			English	Article							SAUROPOD DINOSAUR; EARLY EVOLUTION; PHYLOGENY; POSTURE; NECK	Fossils of the Early Cretaceous dinosaur, Nigersaurus taqueti, document for the first time the cranial anatomy of a rebbachisaurid sauropod. Its extreme adaptations for herbivory at ground-level challenge current hypotheses regarding feeding function and feeding strategy among diplodocoids, the larger clade of sauropods that includes Nigersaurus. We used high resolution computed tomography, stereolithography, and standard molding and casting techniques to reassemble the extremely fragile skull. Computed tomography also allowed us to render the first endocast for a sauropod preserving portions of the olfactory bulbs, cerebrum and inner ear, the latter permitting us to establish habitual head posture. To elucidate evidence of tooth wear and tooth replacement rate, we used photographic-casting techniques and crown thin sections, respectively. To reconstruct its 9-meter postcranial skeleton, we combined and size-adjusted multiple partial skeletons. Finally, we used maximum parsimony algorithms on character data to obtain the best estimate of phylogenetic relationships among diplodocoid sauropods. Nigersaurus taqueti shows extreme adaptations for a dinosaurian herbivore including a skull of extremely light construction, tooth batteries located at the distal end of the jaws, tooth replacement as fast as one per month, an expanded muzzle that faces directly toward the ground, and hollow presacral vertebral centra with more air sac space than bone by volume. A cranial endocast provides the first reasonably complete view of a sauropod brain including its small olfactory bulbs and cerebrum. Skeletal and dental evidence suggests that Nigersaurus was a ground-level herbivore that gathered and sliced relatively soft vegetation, the culmination of a low-browsing feeding strategy first established among diplodocoids during the Jurassic.	[Sereno, Paul C.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Wilson, Jeffrey A.; Whitlock, John A.] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; [Wilson, Jeffrey A.; Whitlock, John A.] Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; [Witmer, Lawrence M.] Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [Maga, Abdoulaye; Ide, Oumarou] Univ Niamey, Inst Human Sci, Niamey, Niger; [Rowe, Timothy A.] Univ Texas Austin, Jackson Sch Geol Sci, Austin, TX 78712 USA	University of Chicago; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Ohio; Ohio University; University of Texas System; University of Texas Austin	Sereno, PC (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	dinosaur@uchicago.edu	Whitlock, John/A-3079-2009; Wilson, Jeffrey/C-2737-2008; Whitlock, John/G-5814-2018	Whitlock, John/0000-0002-1118-2925; Whitlock, John/0000-0002-1118-2925; Maga, Abdoulaye/0000-0002-4684-217X	David and Lucile Packard Foundation; National Geographic Society; Island Fund; Women's Board of the University of Chicago (to PCS); National Science Foundation [IOB-0343744, IOB-0517257]; Ohio University College of Osteopathic Medicine; Scott Turner Award of the University of Michigan and Geological Society of America [8689-07]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Geographic Society(National Geographic Society); Island Fund; Women's Board of the University of Chicago (to PCS); National Science Foundation(National Science Foundation (NSF)); Ohio University College of Osteopathic Medicine; Scott Turner Award of the University of Michigan and Geological Society of America	Supported by the David and Lucile Packard Foundation, National Geographic Society, Island Fund, and Women's Board of the University of Chicago (to PCS); National Science Foundation (IOB-0343744, IOB-0517257) and the Ohio University College of Osteopathic Medicine (to LMW); Scott Turner Award of the University of Michigan and Geological Society of America (8689-07) (to JAW-2).	BAKKER RT, 1978, NATURE, V274, P661, DOI 10.1038/274661a0; Bakker RT., 1986, DINOSAUR HERESIES; Barrett Paul M., 1995, P107; Barrett Paul M., 1994, Gaia, V10, P195; Barrett PM, 2001, BIOL REV, V76, P411, DOI 10.1017/S1464793101005735; Calvo Jorge O., 1994, Gaia, V10, P183; Calvo Jorge O., 1995, Gaia, V11, P13; Coe M.J., 1987, P225; Dalla Vecchia Fabio Marco, 1998, Geologia Croatica, V51, P105; Dalla Vecchia FM, 2005, LIFE O PAST, P395; Dodson P., 1990, P402; Erickson GM, 1996, P NATL ACAD SCI USA, V93, P14623, DOI 10.1073/pnas.93.25.14623; Fiorillo Anthony R., 1998, Historical Biology, V13, P1; Gallina Pablo A., 2005, Revista del Museo Argentino de Ciencias Naturales, V7, P153; Gheerbrant E, 2006, PALAEOGEOGR PALAEOCL, V241, P224, DOI 10.1016/j.palaeo.2006.03.016; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Hatcher JB., 1901, MEM CARNEGIE MUS, V1, P1, DOI [10.5962/p.234818, DOI 10.5962/P.234818]; Holland W. J., 1924, Memoirs of the Carnegie Museum, V9, P379; HOLLAND WJ, 1906, MEM CARNEGIE MUS, V2, P225; Hopson J.A., 1979, P39; JANENSCH W, 1929, PALAEONTOGRAPHICA, V2, P39; JANIS CM, 1988, ZOOL J LINN SOC-LOND, V92, P267, DOI 10.1111/j.1096-3642.1988.tb01513.x; Kellner Alexander W. A., 1996, Memoirs of the Queensland Museum, V39, P611; KRASSILOV VA, 1981, PALAEOGEOGR PALAEOCL, V34, P207, DOI 10.1016/0031-0182(81)90065-1; Larsson HCE, 2000, J VERTEBR PALEONTOL, V20, P615, DOI 10.1671/0272-4634(2000)020[0615:FEANTD]2.0.CO;2; LAVOCAT R, 1954, COMPTES RENDUS DIX N, V21, P65; MARSH OC, 1896, ANN REPORT US GEOLOG, V16, P133; MARTIN J, 1987, 4 S MES TERR EC SHOR, P150; NAISH D, 2001, DINOSAURS ISLE WIGHT, P185; Pereda Suberbiola Xabier, 2003, Bulletin de la Societe Geologique de France, V174, P471; Prasad V, 2005, SCIENCE, V310, P1177, DOI 10.1126/science.1118806; Rauhut OWM, 2005, NATURE, V435, P670, DOI 10.1038/nature03623; ROSS C, 2005, ANAT REC PART A, V238, P391; Salgado L, 2004, J VERTEBR PALEONTOL, V24, P903, DOI 10.1671/0272-4634(2004)024[0903:LCRSFC]2.0.CO;2; SALGADO L, 1991, Ameghiniana, V28, P333; Schwarz D, 2007, ACTA PALAEONTOL POL, V52, P167; Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2; Sereno PC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P157; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; SOLOUNIAS N, 1993, J MAMMAL, V74, P1059, DOI 10.2307/1382445; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; Stevens KA, 2005, LIFE O PAST, P212; Stevens KA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P178; Taquet Philippe, 1999, Annales de Paleontologie, V85, P85, DOI 10.1016/S0753-3969(99)80009-3; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; WEAVER JC, 1983, PALEOBIOLOGY, V9, P173, DOI 10.1017/S0094837300007557; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; WITMER LM, ANATOMICAL IN PRESS; Witzel U, 2005, ANAT REC PART A, V283A, P391, DOI 10.1002/ar.a.20174	52	239	244	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1230	10.1371/journal.pone.0001230	http://dx.doi.org/10.1371/journal.pone.0001230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030355	Green Published, gold			2022-12-25	WOS:000207459200034
J	Thedieck, K; Polak, P; Kim, ML; Molle, KD; Cohen, A; Jeno, P; Arrieumerlou, C; Hall, MN				Thedieck, Kathrin; Polak, Pazit; Kim, Man Lyang; Molle, Klaus D.; Cohen, Adiel; Jenoe, Paul; Arrieumerlou, Cecile; Hall, Michael N.			PRAS40 and PRR5-Like Protein Are New mTOR Interactors that Regulate Apoptosis	PLOS ONE			English	Article								TOR (Target of Rapamycin) is a highly conserved protein kinase and a central controller of cell growth. TOR is found in two functionally and structurally distinct multiprotein complexes termed TOR complex 1 (TORC1) and TOR complex 2 (TORC2). In the present study, we developed a two-dimensional liquid chromatography tandem mass spectrometry (2D LC-MS/MS) based proteomic strategy to identify new mammalian TOR ( mTOR) binding proteins. We report the identification of Proline-rich Akt substrate (PRAS40) and the hypothetical protein Q6MZQ0/FLJ14213/CAE45978 as new mTOR binding proteins. PRAS40 binds mTORC1 via Raptor, and is an mTOR phosphorylation substrate. PRAS40 inhibits mTORC1 autophosphorylation and mTORC1 kinase activity toward eIF-4E binding protein (4E-BP) and PRAS40 itself. HeLa cells in which PRAS40 was knocked down were protected against induction of apoptosis by TNF alpha and cycloheximide. Rapamycin failed to mimic the pro-apoptotic effect of PRAS40, suggesting that PRAS40 mediates apoptosis independently of its inhibitory effect on mTORC1. Q6MZQ0 is structurally similar to proline rich protein 5 (PRR5) and was therefore named PRR5-Like (PRR5L). PRR5L binds specifically to mTORC2, via Rictor and/or SIN1. Unlike other mTORC2 members, PRR5L is not required for mTORC2 integrity or kinase activity, but dissociates from mTORC2 upon knock down of tuberous sclerosis complex 1 (TSC1) and TSC2. Hyperactivation of mTOR by TSC1/2 knock down enhanced apoptosis whereas PRR5L knock down reduced apoptosis. PRR5L knock down reduced apoptosis also in mTORC2 deficient cells. The above suggests that mTORC2-dissociated PRR5L may promote apoptosis when mTOR is hyperactive. Thus, PRAS40 and PRR5L are novel mTOR-associated proteins that control the balance between cell growth and cell death.	[Thedieck, Kathrin; Polak, Pazit; Kim, Man Lyang; Molle, Klaus D.; Cohen, Adiel; Jenoe, Paul; Arrieumerlou, Cecile; Hall, Michael N.] Univ Basel, Biozentrum, Basel, Switzerland	University of Basel	Hall, MN (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	m.hall@unibas.ch		Polak, Pazit/0000-0001-8363-0734; Hall, Michael N/0000-0002-2998-0757; Thedieck, Kathrin/0000-0002-9069-2930; ARRIEUMERLOU, Cecile/0000-0002-6463-2897	Peter und Traudl Engelhorn Stiftung zur Forderung der Biotechnologie und Gentechnik; Roche Research Foundation; Swiss National Science Foundation; Canton of Basel (MNH)	Peter und Traudl Engelhorn Stiftung zur Forderung der Biotechnologie und Gentechnik; Roche Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canton of Basel (MNH)	We acknowledge support from the Peter und Traudl Engelhorn Stiftung zur Forderung der Biotechnologie und Gentechnik (KT), the Roche Research Foundation (PP), and the Swiss National Science Foundation and the Canton of Basel (MNH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avellino R, 2005, BLOOD, V106, P1400, DOI 10.1182/blood-2005-03-0929; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Brunn GJ, 1997, J BIOL CHEM, V272, P32547, DOI 10.1074/jbc.272.51.32547; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Edinger AL, 2004, ONCOGENE, V23, P5654, DOI 10.1038/sj.onc.1207738; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n; Ghosh S, 2006, CANCER CELL, V10, P215, DOI 10.1016/j.ccr.2006.08.007; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hahn M, 2005, MOL CANCER THER, V4, P457; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Huang B, 2005, ACTA PHARMACOL SIN, V26, P1253, DOI 10.1111/j.1745-7254.2005.00184.x; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Johnstone CN, 2005, GENOMICS, V85, P338, DOI 10.1016/j.ygeno.2004.11.002; Kettritz R, 2002, KIDNEY INT, V61, P502, DOI 10.1046/j.1523-1755.2002.00161.x; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Menand B, 2002, P NATL ACAD SCI USA, V99, P6422, DOI 10.1073/pnas.092141899; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Saito A, 2004, J NEUROSCI, V24, P1584, DOI 10.1523/JNEUROSCI.5209-03.2004; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Teachey DT, 2006, BLOOD, V107, P1149, DOI 10.1182/blood-2005-05-1935; Thimmaiah KN, 2003, CANCER RES, V63, P364; Treeck O, 2006, GYNECOL ONCOL, V102, P292, DOI 10.1016/j.ygyno.2005.12.019; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	56	221	228	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1217	10.1371/journal.pone.0001217	http://dx.doi.org/10.1371/journal.pone.0001217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030348	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459200027
J	Chigurupati, S; Arumugam, TV; Son, TG; Lathia, JD; Jameel, S; Mughal, MR; Tang, SC; Jo, DG; Camandola, S; Giunta, M; Rakova, I; McDonnell, N; Miele, L; Mattson, MP; Poosala, S				Chigurupati, Srinivasulu; Arumugam, Thiruma V.; Son, Tae Gen; Lathia, Justin D.; Jameel, Shafaq; Mughal, Mohamed R.; Tang, Sung-Chun; Jo, Dong-Gyu; Camandola, Simonetta; Giunta, Marialuisa; Rakova, Irina; McDonnell, Nazli; Miele, Lucio; Mattson, Mark P.; Poosala, Suresh			Involvement of Notch Signaling in Wound Healing	PLOS ONE			English	Article								The Notch signaling pathway is critically involved in cell fate decisions during development of many tissues and organs. In the present study we employed in vivo and cell culture models to elucidate the role of Notch signaling in wound healing. The healing of full-thickness dermal wounds was significantly delayed in Notch antisense transgenic mice and in normal mice treated with gamma-secretase inhibitors that block proteolytic cleavage and activation of Notch. In contrast, mice treated with a Notch ligand Jagged peptide showed significantly enhanced wound healing compared to controls. Activation or inhibition of Notch signaling altered the behaviors of cultured vascular endothelial cells, keratinocytes and fibroblasts in a scratch wound healing model in ways consistent with roles for Notch signaling in wound healing functions all three cell types. These results suggest that Notch signaling plays important roles in wound healing and tissue repair, and that targeting the Notch pathway might provide a novel strategy for treatment of wounds and for modulation of angiogenesis in other pathological conditions.	[Chigurupati, Srinivasulu; Arumugam, Thiruma V.; Son, Tae Gen; Lathia, Justin D.; Jameel, Shafaq; Mughal, Mohamed R.; Tang, Sung-Chun; Jo, Dong-Gyu; Camandola, Simonetta; Giunta, Marialuisa; Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA; [Rakova, Irina; McDonnell, Nazli] NIA, Clin Invest Lab, Intramural Res Program, Baltimore, MD 21224 USA; [Chigurupati, Srinivasulu; Poosala, Suresh] NIA, Res Resources Branch, Intramural Res Program, Baltimore, MD 21224 USA; [Arumugam, Thiruma V.] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Sch Pharm, Amarillo, TX USA; [Jo, Dong-Gyu] Sungkyunkwan Univ, Coll Pharm, Suwon, South Korea; [Miele, Lucio] Loyola Univ, Dept Pathol, Breast Canc Program, Hlth Sci Ctr, Maywood, IL 60153 USA; [Mattson, Mark P.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Sungkyunkwan University (SKKU); Loyola University Chicago; Johns Hopkins University	Mattson, MP (corresponding author), NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA.	mattsonm@grc.nia.nih.gov	Jo, Dong-Gyu/AAN-9278-2021; Lathia, Justin/AHB-8296-2022; Mattson, Mark P/F-6038-2012; Arumugam, Thiruma/AAG-6958-2019; Arumugam, Thiruma Valavan/B-4898-2011	Jo, Dong-Gyu/0000-0003-2271-1076; Arumugam, Thiruma/0000-0002-3377-0939; Miele, Lucio/0000-0002-5853-7287; Tang, Sung-Chun/0000-0003-3731-5973	National Institute on Aging, NIH; NATIONAL INSTITUTE ON AGING [Z01AG000893, ZIAAG000893] Funding Source: NIH RePORTER	National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the Intramural Research Program of the National Institute on Aging, NIH.	Aho S, 2004, J CELL BIOCHEM, V92, P1271, DOI 10.1002/jcb.20125; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Arumugam TV, 2006, NAT MED, V12, P621, DOI 10.1038/nm1403; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cereseto A, 2000, J CELL PHYSIOL, V185, P425, DOI 10.1002/1097-4652(200012)185:3<425::AID-JCP13>3.0.CO;2-U; Cheng PY, 2001, J IMMUNOL, V167, P4458, DOI 10.4049/jimmunol.167.8.4458; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dorsch M, 2002, BLOOD, V100, P2046, DOI 10.1182/blood.V100.6.2046.h81802002046_2046_2055; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Hunt T K, 2000, Adv Skin Wound Care, V13, P6; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Kared H, 2006, IMMUNITY, V25, P823, DOI 10.1016/j.immuni.2006.09.008; Krebs LT, 2000, GENE DEV, V14, P1343; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; Limbourg FP, 2005, CIRCULATION, V111, P1826, DOI 10.1161/01.CIR.0000160870.93058.DD; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Monsalve E, 2006, J IMMUNOL, V176, P5362, DOI 10.4049/jimmunol.176.9.5362; Nakajima M, 2003, MECH DEVELOP, V120, P657, DOI 10.1016/S0925-4773(03)00064-9; Nickoloff BJ, 2002, CELL DEATH DIFFER, V9, P842, DOI 10.1038/sj.cdd.4401036; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X; Ostroukhova M, 2006, J CLIN INVEST, V116, P996, DOI 10.1172/JCI26490; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Paris D, 2005, EUR J PHARMACOL, V514, P1, DOI 10.1016/j.ejphar.2005.02.050; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; SARMA V, 1992, J IMMUNOL, V148, P3302; Savill NJ, 2003, DEV BIOL, V258, P141, DOI 10.1016/S0012-1606(03)00107-6; Shi SL, 2006, CELL CYCLE, V5, P274, DOI 10.4161/cc.5.3.2396; Six EM, 2004, J BIOL CHEM, V279, P55818, DOI 10.1074/jbc.M408022200; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Uyttendaele H, 2000, MICROVASC RES, V60, P91, DOI 10.1006/mvre.2000.2254; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9; Zheng Y, 2007, ARTERIOSCL THROM VAS, V27, P503, DOI 10.1161/01.ATV.0000256459.06671.3c; Zimrin AB, 1996, J BIOL CHEM, V271, P32499, DOI 10.1074/jbc.271.51.32499	45	100	101	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1167	10.1371/journal.pone.0001167	http://dx.doi.org/10.1371/journal.pone.0001167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000539	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459100009
J	Wang, L; Dutta, SK; Kojima, T; Xu, XL; Khosravi-Far, R; Ekker, SC; Mukhopadhyay, D				Wang, Ling; Dutta, Shamit K.; Kojima, Tatsuyoshi; Xu, Xiaolei; Khosravi-Far, Roya; Ekker, Stephen C.; Mukhopadhyay, Debabrata			Neuropilin-1 Modulates p53/Caspases Axis to Promote Endothelial Cell Survival	PLOS ONE			English	Article								Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF), one of the crucial pro-angiogenic factors, functions as a potent inhibitor of endothelial cell (EC) apoptosis. Previous progress has been made towards delineating the VPF/VEGF survival signaling downstream of the activation of VEGFR-2. Here, we seek to define the function of NRP-1 in VPF/VEGF-induced survival signaling in EC and to elucidate the concomitant molecular signaling events that are pivotal for our understanding of the signaling of VPF/VEGF. Utilizing two different in vitro cell culture systems and an in vivo zebrafish model, we demonstrate that NRP-1 mediates VPF/VEGF-induced EC survival independent of VEGFR-2. Furthermore, we show here a novel mechanism for NRP-1-specific control of the anti-apoptotic pathway in EC through involvement of the NRP-1-interacting protein (NIP/GIPC) in the activation of PI-3K/Akt and subsequent inactivation of p53 pathways and FoxOs, as well as activation of p21. This study, by elucidating the mechanisms that govern VPF/VEGF-induced EC survival signaling via NRP-1, contributes to a better understanding of molecular mechanisms of cardiovascular development and disease and widens the possibilities for better therapeutic targets.	[Wang, Ling; Dutta, Shamit K.; Kojima, Tatsuyoshi; Xu, Xiaolei; Mukhopadhyay, Debabrata] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Ekker, Stephen C.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Khosravi-Far, Roya] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School	Mukhopadhyay, D (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	Mukhopadhyay.debabrata@mayo.edu		Ekker, Stephen/0000-0003-0726-4212	NIH [CA78383, HL072178, HL70567]; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA078383, R29CA078383] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072178, R01HL070567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is partly supported by NIH grants CA78383, HL072178, HL70567 to DM. LW is a fellow of the American Heart Association.	ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Bachelder RE, 2001, CANCER RES, V61, P5736; Bachelder RE, 2003, CANCER RES, V63, P5230; Barboule N, 1997, ONCOGENE, V15, P2867, DOI 10.1038/sj.onc.1201469; Barr MP, 2005, BRIT J CANCER, V92, P328, DOI 10.1038/sj.bjc.6602308; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Brusselmans K, 2005, J BIOL CHEM, V280, P3493, DOI 10.1074/jbc.M406613200; Cailhier JF, 2006, AM J TRANSPLANT, V6, P247, DOI 10.1111/j.1600-6143.2005.01165.x; Chang DW, 2003, J BIOL CHEM, V278, P16466, DOI 10.1074/jbc.C300089200; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Dimmeler S, 1998, EUR CYTOKINE NETW, V9, P697; DOWNWARD J, 1995, NATURE, V376, P553, DOI 10.1038/376553a0; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Ekker SC, 2001, GENESIS, V30, P89, DOI 10.1002/gene.1038; Erber R, 1997, INT J CANCER, V74, P383, DOI 10.1002/(SICI)1097-0215(19970822)74:4<383::AID-IJC4>3.0.CO;2-R; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fukuchi K, 2000, BBA-MOL CELL RES, V1496, P207, DOI 10.1016/S0167-4889(00)00018-5; Gagnon ML, 2000, P NATL ACAD SCI USA, V97, P2573, DOI 10.1073/pnas.040337597; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gobe G, 1997, J STRUCT BIOL, V118, P63, DOI 10.1006/jsbi.1996.3835; Gorospe M, 1999, GENE EXPRESSION, V7, P377; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; Haffter P, 1996, DEVELOPMENT, V123, P1; HANSSON GK, 1994, BASIC RES CARDIOL, V89, P41; HARPER JW, 1993, CELL, V75, P805; Jain RK, 1998, P NATL ACAD SCI USA, V95, P10820, DOI 10.1073/pnas.95.18.10820; Johannessen LE, 1999, BIOCHEM J, V337, P599, DOI 10.1042/0264-6021:3370599; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Khosravi-Far R, 2004, CANCER BIOL THER, V3, P1051, DOI 10.4161/cbt.3.11.1173; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KLIPPEL A, 1994, MOL CELL BIOL, V14, P2675, DOI 10.1128/MCB.14.4.2675; KOHN AD, 1995, EMBO J, V4288, P4295; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lawlor MA, 2000, MOL CELL BIOL, V20, P8983, DOI 10.1128/MCB.20.23.8983-8995.2000; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Liedtke C, 2003, J BIOL CHEM, V278, P27593, DOI 10.1074/jbc.M304077200; Littlewood TD, 2003, CURR OPIN LIPIDOL, V14, P469, DOI 10.1097/00041433-200310000-00007; Liu JW, 2005, ONCOGENE, V24, P2020, DOI 10.1038/sj.onc.1208385; MICHIELI P, 1994, CANCER RES, V54, P3391; Mitsuuchi Y, 2000, CANCER RES, V60, P5390; Murga M, 2005, BLOOD, V105, P1992, DOI 10.1182/blood-2004-07-2598; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakamura Y, 2004, CANCER SCI, V95, P7, DOI 10.1111/j.1349-7006.2004.tb03163.x; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Parrizas M, 1997, J BIOL CHEM, V272, P154; Pauli SA, 2005, ENDOCRINOLOGY, V146, P1301, DOI 10.1210/en.2004-0765; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Potente M, 2003, J BIOL CHEM, V278, P29619, DOI 10.1074/jbc.M305385200; Raj K, 2001, NATURE, V412, P914, DOI 10.1038/35091082; ROSS R, 1977, AM J PATHOL, V86, P675; Rossig L, 2001, BASIC RES CARDIOL, V96, P11, DOI 10.1007/s003950170073; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Sohn D, 2006, CANCER RES, V66, P11254, DOI 10.1158/0008-5472.CAN-06-1569; Soker S, 1997, J BIOL CHEM, V272, P31582, DOI 10.1074/jbc.272.50.31582; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 1996, J BIOL CHEM, V271, P5761, DOI 10.1074/jbc.271.10.5761; STEMERMAN MB, 1972, J EXP MED, V136, P769, DOI 10.1084/jem.136.4.769; Suhara T, 2002, MOL CELL BIOL, V22, P680, DOI 10.1128/MCB.22.2.680-691.2002; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Tricot O, 2000, CIRCULATION, V101, P2450, DOI 10.1161/01.CIR.101.21.2450; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Waltenberger J, 1997, CIRCULATION, V96, P4083; Wang L, 2003, J BIOL CHEM, V278, P48848, DOI 10.1074/jbc.M310047200; Wang L, 2006, FASEB J, V20, P1513, DOI 10.1096/fj.05-5504fje; Weiss RH, 2000, J BIOL CHEM, V275, P10285, DOI 10.1074/jbc.275.14.10285; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Yilmaz A, 2003, BIOCHEM BIOPH RES CO, V306, P730, DOI 10.1016/S0006-291X(03)01064-7; You H, 2004, P NATL ACAD SCI USA, V101, P14057, DOI 10.1073/pnas.0406286101; Zeng YX, 1996, ONCOGENE, V12, P1557; Zhang W, 1995, CLIN CANCER RES, V1, P1051; Zhang YK, 1999, ONCOGENE, V18, P1131, DOI 10.1038/sj.onc.1202426	83	59	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1161	10.1371/journal.pone.0001161	http://dx.doi.org/10.1371/journal.pone.0001161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000534	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459100004
J	Reddy, BM; Langstieh, BT; Kumar, V; Nagaraja, T; Reddy, ANS; Meka, A; Reddy, AG; Thangaraj, K; Singh, L				Reddy, B. Mohan; Langstieh, B. T.; Kumar, Vikrant; Nagaraja, T.; Reddy, A. N. S.; Meka, Aruna; Reddy, A. G.; Thangaraj, K.; Singh, Lalji			Austro-Asiatic Tribes of Northeast India Provide Hitherto Missing Genetic Link between South and Southeast Asia	PLOS ONE			English	Article								Northeast India, the only region which currently forms a land bridge between the Indian subcontinent and Southeast Asia, has been proposed as an important corridor for the initial peopling of East Asia. Given that the Austro-Asiatic linguistic family is considered to be the oldest and spoken by certain tribes in India, Northeast India and entire Southeast Asia, we expect that populations of this family from Northeast India should provide the signatures of genetic link between Indian and Southeast Asian populations. In order to test this hypothesis, we analyzed mtDNA and Y-Chromosome SNP and STR data of the eight groups of the Austro-Asiatic Khasi from Northeast India and the neighboring Garo and compared with that of other relevant Asian populations. The results suggest that the Austro-Asiatic Khasi tribes of Northeast India represent a genetic continuity between the populations of South and Southeast Asia, thereby advocating that northeast India could have been a major corridor for the movement of populations from India to East/Southeast Asia.	[Reddy, B. Mohan; Langstieh, B. T.; Kumar, Vikrant; Nagaraja, T.; Reddy, A. N. S.; Meka, Aruna] Indian Stat Inst, Biol Anthropol Unit, Hyderabad, Andhra Pradesh, India; [Kumar, Vikrant] Genome Inst Singapore, Singapore, Singapore; [Reddy, A. G.; Thangaraj, K.; Singh, Lalji] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Langstieh, B. T.] NE Hill Univ, Dept Anthropol, Shillong 793014, Meghalaya, India	Indian Statistical Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); North Eastern Hill University	Reddy, BM (corresponding author), Indian Stat Inst, Biol Anthropol Unit, Hyderabad, Andhra Pradesh, India.	bmr@isical.ac.in	Thangaraj, Kumarasamy/G-5596-2010	Thangaraj, Kumarasamy/0000-0002-0075-0106	Indian Statistical Institute	Indian Statistical Institute	This project was funded by Indian Statistical Institute.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Butler JM, 2002, FORENSIC SCI INT, V129, P10, DOI 10.1016/S0379-0738(02)00195-0; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cordaux R, 2004, MOL BIOL EVOL, V21, P1525, DOI 10.1093/molbev/msh151; Diffloth G., 2005, PEOPLING E ASIA PUTT, P77; Ellis N, 2002, GENOME RES, V12, P339; Endicott P, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000081; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fucharoen G, 2001, J HUM GENET, V46, P115, DOI 10.1007/s100380170098; HUSSAIN Z, 1991, ARCHAEOLOGY N E INDI, P74; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Krithika S, 2006, ANN HUM BIOL, V33, P26, DOI 10.1080/03014460500424043; Kumar V, 2003, J BIOSCIENCES, V28, P507, DOI 10.1007/BF02705125; Kumar V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-47; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Nei M., 1987, MOL EVOLUTIONARY GEN; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Palanichamy MG, 2006, SCIENCE, V311, DOI 10.1126/science.1120176; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Prasad BVR, 2001, HUM BIOL, V73, P715; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Roychoudhury S, 2001, HUM GENET, V109, P339, DOI 10.1007/s004390100577; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; SHARMA TC, 1984, TRIBES N E INDIA, P1; SHARMA TC, 1966, JR ASSAM SC SOC, V9, P1; SHARMA TC, 1980, E HIMALAYAS, P102; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Thangaraj K, 2003, CURR BIOL, V13, P86, DOI 10.1016/S0960-9822(02)01336-2; Thanseem I, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-42; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Yao YG, 2002, AM J PHYS ANTHROPOL, V118, P63, DOI 10.1002/ajpa.10052; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999	43	56	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1141	10.1371/journal.pone.0001141	http://dx.doi.org/10.1371/journal.pone.0001141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17989774	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459000024
J	Bergamaschi, C; Rosati, M; Jalah, R; Valentin, A; Kulkarni, V; Alicea, C; Zhang, GM; Patel, V; Felber, BK; Pavlakis, GN				Bergamaschi, Cristina; Rosati, Margherita; Jalah, Rashmi; Valentin, Antonio; Kulkarni, Viraj; Alicea, Candido; Zhang, Gen-Mu; Patel, Vainav; Felber, Barbara K.; Pavlakis, George N.			Intracellular interaction of interleukin-15 with its receptor alpha during production leads to mutual stabilization and increased bioactivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETRACTED ARTICLE. SEE; NATURAL-KILLER-CELLS; CD8(+) T-CELLS; IL-15 ACTIVITY; CUTTING EDGE; BETA-CHAIN; EXPRESSION; CYTOKINE; REV; PROLIFERATION	We show that co-expression of interleukin 15 (IL-15) and IL-15 receptor alpha(IL-15R alpha) in the same cell allows for the intracellular interaction of the two proteins early after translation, resulting in increased stability and secretion of both molecules as a complex. In the absence of co-expressed IL-15R alpha, a large portion of the produced IL-15 is rapidly degraded immediately after synthesis. Co-injection into mice of IL-15 and IL-15R alpha expression plasmids led to significantly increased levels of the cytokine in serum as well as increased biological activity of IL-15. Examination of natural killer cells and T lymphocytes in mouse organs showed a great expansion of both cell types in the lung, liver, and spleen. The presence of IL-15R alpha also increased the number of CD44(high) memory cells with effector phenotype (CD44(high)CD62L-). Thus, mutual stabilization of IL-15 and IL-15R alpha leads to remarkable increases in production, stability, and tissue availability of bioactive IL-15 in vivo. The in vivo data show that the most potent form of IL-15 is as part of a complex with its receptor alpha either on the surface of the producing cells or as a soluble extracellular complex. These results explain the reason for coordinate expression of IL-15 and IL-15R alpha in the same cell and suggest that the IL-15R alpha is part of the active IL-15 cytokine rather than part of the receptor.	[Bergamaschi, Cristina; Rosati, Margherita; Valentin, Antonio; Zhang, Gen-Mu; Patel, Vainav; Pavlakis, George N.] NCI, Canc Res Ctr, Vaccine Branch, Human Retrovirus Sect,NIH, Frederick, MD 21702 USA; [Jalah, Rashmi; Kulkarni, Viraj; Alicea, Candido; Zhang, Gen-Mu; Felber, Barbara K.] NCI, Canc Res Ctr, Vaccine Branch, Human Retrovirus Pathogenesis Sect,NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pavlakis, GN (corresponding author), NCI, Canc Res Ctr, Vaccine Branch, Human Retrovirus Sect,NIH, Bldg 535,Rm 210, Frederick, MD 21702 USA.	pavlakis@ncifcrf.gov			NATIONAL CANCER INSTITUTE [ZIABC010334, ZIABC010750, Z01BC010334, ZIABC010350, Z01BC010350, Z01BC010750] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ANDERSON DM, 1995, J BIOL CHEM, V270, P29862; Azimi N, 2001, P NATL ACAD SCI USA, V98, P14559, DOI 10.1073/pnas.251540598; Bamford RN, 1998, J IMMUNOL, V160, P4418; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Budagian V, 2004, J BIOL CHEM, V279, P40368, DOI 10.1074/jbc.M404125200; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Bulanova E, 2003, J IMMUNOL, V170, P5045, DOI 10.4049/jimmunol.170.10.5045; Bulanova E, 2007, J BIOL CHEM, V282, P13167, DOI 10.1074/jbc.M610036200; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Burkett PR, 2003, P NATL ACAD SCI USA, V100, P4724, DOI 10.1073/pnas.0737048100; BURTON JD, 1994, P NATL ACAD SCI USA, V91, P4935, DOI 10.1073/pnas.91.11.4935; Dubois S, 1999, J BIOL CHEM, V274, P26978, DOI 10.1074/jbc.274.38.26978; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; GIRI JG, 1995, EMBO J, V14, P3654, DOI 10.1002/j.1460-2075.1995.tb00035.x; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Jalah R, 2007, DNA CELL BIOL, V26, P827, DOI 10.1089/dna.2007.0645; Jiang JJ, 2001, BIOCHEM BIOPH RES CO, V289, P1088, DOI 10.1006/bbrc.2001.6100; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Koka R, 2003, J EXP MED, V197, P977, DOI 10.1084/jem.20021836; Kutzler MA, 2005, J IMMUNOL, V175, P112, DOI 10.4049/jimmunol.175.1.112; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lodolce JP, 2001, J EXP MED, V194, P1187, DOI 10.1084/jem.194.8.1187; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Mariner JM, 2002, J IMMUNOL, V168, P5667, DOI 10.4049/jimmunol.168.11.5667; Mortier E, 2006, J BIOL CHEM, V281, P1612, DOI 10.1074/jbc.M508624200; Mortier E, 2004, J IMMUNOL, V173, P1681, DOI 10.4049/jimmunol.173.3.1681; Onu A, 1997, J IMMUNOL, V158, P255; Ortaldo JR, 2005, J IMMUNOL, V175, P693, DOI 10.4049/jimmunol.175.2.693; Picker LJ, 2006, J CLIN INVEST, V116, P1514, DOI 10.1172/JCI27564; Rosati M, 2005, J VIROL, V79, P8480, DOI 10.1128/JVI.79.13.8480-8492.2005; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Ruchatz H, 1998, J IMMUNOL, V160, P5654; Ruckert R, 2003, EUR J IMMUNOL, V33, P3493, DOI 10.1002/eji.200324545; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sandau MM, 2004, J IMMUNOL, V173, P6537, DOI 10.4049/jimmunol.173.11.6537; Sato N, 2007, P NATL ACAD SCI USA, V104, P588, DOI 10.1073/pnas.0610115104; Schluns KS, 2004, P NATL ACAD SCI USA, V101, P5616, DOI 10.1073/pnas.0307442101; Schluns KS, 2004, BLOOD, V103, P988, DOI 10.1182/blood-2003-08-2814; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; Schneider R, 1997, J VIROL, V71, P4892, DOI 10.1128/JVI.71.7.4892-4903.1997; SCHWARTZ S, 1992, J VIROL, V66, P150, DOI 10.1128/JVI.66.1.150-159.1992; SCHWARTZ S, 1992, J VIROL, V66, P7176, DOI 10.1128/JVI.66.12.7176-7182.1992; Smith XG, 2000, J IMMUNOL, V165, P3444, DOI 10.4049/jimmunol.165.6.3444; STAUBER R, 1995, VIROLOGY, V213, P439, DOI 10.1006/viro.1995.0016; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Tagaya Y, 1996, IMMUNITY, V4, P329, DOI 10.1016/S1074-7613(00)80246-0; Teague RM, 2006, NAT MED, V12, P335, DOI 10.1038/nm1359; VARKI A, 1991, FASEB J, V5, P226, DOI 10.1096/fasebj.5.2.2004668; Villinger F, 2004, VACCINE, V22, P3510, DOI 10.1016/j.vaccine.2003.07.022; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9	56	125	148	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4189	4199		10.1074/jbc.M705725200	http://dx.doi.org/10.1074/jbc.M705725200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18055460	hybrid			2022-12-25	WOS:000253083500054
J	Bierings, R; Beato, M; Edel, MJ				Bierings, Ruben; Beato, Miguel; Edel, Michael J.			An endothelial cell genetic screen identifies the GTPase Rem2 as a suppressor of p19(ARF) expression that promotes endothelial cell proliferation and angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-CHANNEL ACTIVITY; TUMOR-SUPPRESSOR; MOUSE EYE; SENESCENCE; CANCER; P53; 14-3-3-GAMMA; INHIBITORS; FAMILY; SHAPE	Angiogenesis requires an increase in endothelial cell proliferation to support an increase in mass of blood vessels. We designed an in vitro endothelial cell model to functionally screen for genes that regulate endothelial cell proliferation. A gain of function screen for genes that bypass p53 endothelial cell arrest identified Rem2, a Ras-like GTPase. We show that ectopic Rem2 suppresses p14(ARF) (human) or p19(ARF) (mouse) expression that leads to increased endothelial cell proliferation. Conversely, loss of ectopic Rem2 by RNA interference restores p19ARF expression in endothelial cells. We further show that Rem2-interacting 14-3-3 proteins are involved in the cell localization of Rem2, regulation of p19ARF expression, and endothelial cell proliferation. Finally, we demonstrate using the RIP1 tag2 mouse model of pancreatic disease that Rem2 is up-regulated in endothelial cells of stage IV disease. The data unravel a possible molecular mechanism for Rem2-induced angiogenesis and suggests Rem2 as a potential novel target for treating pathological angiogenesis.	[Bierings, Ruben] Sanquin Res & Landsteiner Lab, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands; [Beato, Miguel; Edel, Michael J.] Univ Pompeu Fabra, CRG, Barcelona, Spain	University of Amsterdam; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Bierings, R (corresponding author), Sanquin Res & Landsteiner Lab, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands.		Bierings, Ruben/AAQ-8854-2020; Edel, Michael J/L-1954-2014; Beato, Miguel/B-5564-2015	Bierings, Ruben/0000-0002-1205-9689; Edel, Michael J/0000-0002-5619-8680; Beato, Miguel/0000-0002-2878-2222				Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Beguin P, 2005, BIOCHEM J, V390, P67, DOI 10.1042/BJ20050414; Beguin P, 2005, J CELL SCI, V118, P1923, DOI 10.1242/jcs.02321; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brummelkamp TR, 2002, J BIOL CHEM, V277, P6567, DOI 10.1074/jbc.M110492200; DelVillar K, 1996, BIOCHEM SOC T, V24, P709; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Esteller M, 2001, CANCER RES, V61, P3225; Finlin BS, 2005, J BIOL CHEM, V280, P41864, DOI 10.1074/jbc.M414261200; Finlin BS, 2000, BIOCHEM J, V347, P223, DOI 10.1042/0264-6021:3470223; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; FOLKMAN J, 1989, NEW ENGL J MED, V320, P1211, DOI 10.1056/NEJM198905043201811; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Kanda S, 1996, CELL GROWTH DIFFER, V7, P383; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; McKeller RN, 2002, P NATL ACAD SCI USA, V99, P3848, DOI 10.1073/pnas.052484199; Pan JY, 2000, J CELL BIOL, V149, P1107, DOI 10.1083/jcb.149.5.1107; Piddini E, 2001, EMBO J, V20, P4076, DOI 10.1093/emboj/20.15.4076; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Silva RLA, 2005, EMBO J, V24, P2803, DOI 10.1038/sj.emboj.7600751; Sumioka A, 2005, J BIOL CHEM, V280, P42364, DOI 10.1074/jbc.M504278200; Towbin H, 2003, J BIOL CHEM, V278, P52964, DOI 10.1074/jbc.M309039200; Weidner Noel, 1996, P167	26	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4408	4416		10.1074/jbc.M707438200	http://dx.doi.org/10.1074/jbc.M707438200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18056257	hybrid			2022-12-25	WOS:000253083500075
J	Fischer, A; Garcia-Rodriguez, C; Geren, I; Lou, JL; Marks, JD; Nakagawa, T; Montal, M				Fischer, Audrey; Garcia-Rodriguez, Consuelo; Geren, Isin; Lou, Jianlong; Marks, James D.; Nakagawa, Terunaga; Montal, Mauricio			Molecular architecture of botulinum neurotoxin E revealed by single particle electron microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PROTEASE; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE; TETANUS NEUROTOXIN; SEROTYPE-A; CLOSTRIDIAL NEUROTOXINS; SUBSTRATE RECOGNITION; ANGSTROM RESOLUTION; CATALYTIC DOMAIN; SYNAPTOTAGMIN-I	Clostridial botulinum neurotoxin (BoNT) causes a neuroparalytic condition recognized as botulism by arresting synaptic vesicle exocytosis. Although the crystal structures of full-length BoNT/A and BoNT/B holotoxins are known, the molecular architecture of the five other serotypes remains elusive. Here, we present the structures of BoNT/A and BoNT/E using single particle electron microscopy. Labeling of the particles with three different monoclonal antibodies raised against BoNT/E revealed the positions of their epitopes in the electron microscopy structure, thereby identifying the three hallmark domains of BoNT (protease, translocation, and receptor binding). Correspondingly, these antibodies selectively inhibit BoNT translocation activity as detected using a single molecule assay. The global structure of BoNT/E is strikingly different from that of BoNT/A despite strong sequence similarity. We postulate that the unique architecture of functionally conserved modules underlies the distinguishing attributes of BoNT/E and contributes to differences with BoNT/A.	[Fischer, Audrey; Montal, Mauricio] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Nakagawa, Terunaga] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Garcia-Rodriguez, Consuelo; Geren, Isin; Lou, Jianlong; Marks, James D.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA; [Garcia-Rodriguez, Consuelo; Geren, Isin; Lou, Jianlong; Marks, James D.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nakagawa, T (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	nakagawa@ucsd.edu; mmontal@ucsd.edu	Taylor, Graham/A-4027-2012; Pacific-Southwest, RCE/B-6155-2009; Geren, Isin/AAG-7281-2019		NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI056493, U54AI065359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033050, R37GM033050] Funding Source: NIH RePORTER; NCRR NIH HHS [1S10RR20016] Funding Source: Medline; NIAID NIH HHS [U01 AI056493, AI065359] Funding Source: Medline; NIGMS NIH HHS [GM033050] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal R, 2005, BIOCHEMISTRY-US, V44, P11758, DOI 10.1021/bi0510072; Agarwal R, 2004, BIOCHEMISTRY-US, V43, P6637, DOI 10.1021/bi036278w; Arndt JW, 2006, BIOCHEMISTRY-US, V45, P3255, DOI 10.1021/bi052518r; Arndt JW, 2005, BIOCHEMISTRY-US, V44, P9574, DOI 10.1021/bi0505924; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Bade S, 2004, J NEUROCHEM, V91, P1461, DOI 10.1111/j.1471-4159.2004.02844.x; Bajohrs M, 2004, EMBO REP, V5, P1090, DOI 10.1038/sj.embor.7400278; Breidenbach MA, 2005, BIOCHEMISTRY-US, V44, P7450, DOI 10.1021/bi050262j; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Chai Q, 2006, NATURE, V444, P1096, DOI 10.1038/nature05411; Davletov B, 2005, TRENDS NEUROSCI, V28, P446, DOI 10.1016/j.tins.2005.06.001; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Fernandez-Salas E, 2004, P NATL ACAD SCI USA, V101, P3208, DOI 10.1073/pnas.0400229101; Ferrer-Montiel AV, 1998, FEBS LETT, V435, P84, DOI 10.1016/S0014-5793(98)01012-6; FerrerMontiel AV, 1996, J BIOL CHEM, V271, P18322, DOI 10.1074/jbc.271.31.18322; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; Fotinou C, 2001, J BIOL CHEM, V276, P32274, DOI 10.1074/jbc.M103285200; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; HOCH DH, 1985, P NATL ACAD SCI USA, V82, P1692, DOI 10.1073/pnas.82.6.1692; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jayaraman S, 2005, PROTEINS, V61, P288, DOI 10.1002/prot.20595; Jin RS, 2007, BIOCHEMISTRY-US, V46, P10685, DOI 10.1021/bi701162d; Jin RS, 2006, NATURE, V444, P1092, DOI 10.1038/nature05387; Keller JE, 2001, J BIOL CHEM, V276, P13476, DOI 10.1074/jbc.M010992200; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Nishiki T, 1996, NEUROSCI LETT, V208, P105, DOI 10.1016/0304-3940(96)12557-X; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Rao KN, 2005, TOXICON, V45, P929, DOI 10.1016/j.toxicon.2005.02.032; Rickman C, 2004, J BIOL CHEM, V279, P644, DOI 10.1074/jbc.M310879200; ROBINSON JP, 1988, J MOL BIOL, V200, P367, DOI 10.1016/0022-2836(88)90247-1; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; SATHYAMOORTHY V, 1985, J BIOL CHEM, V260, P461; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHIAVO G, 1993, J BIOL CHEM, V268, P23784; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Stewart A, 2004, ULTRAMICROSCOPY, V102, P67, DOI 10.1016/j.ultramic.2004.08.008; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Vaidyanathan VV, 1999, J NEUROCHEM, V72, P327, DOI 10.1046/j.1471-4159.1999.0720327.x; Verderio C, 1999, J NEUROSCI, V19, P6723, DOI 10.1523/JNEUROSCI.19-16-06723.1999; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X	49	32	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3997	4003		10.1074/jbc.M707917200	http://dx.doi.org/10.1074/jbc.M707917200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18032388	hybrid			2022-12-25	WOS:000253083500034
J	Flock, U; Thorndycroft, FH; Matorin, AD; Richardson, DJ; Watmough, NJ; Ardelroth, P				Flock, Ulrika; Thorndycroft, Faye H.; Matorin, Andrey D.; Richardson, David J.; Watmough, Nicholas J.; Ardelroth, Pia			Defining the proton entry point in the bacterial respiratory nitric-oxide reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME-COPPER OXIDASE; CYTOCHROME-C-OXIDASE; PARACOCCUS-DENITRIFICANS; PATHWAY; ENZYME; EXISTENCE; CHANNEL; OXYGEN; SITE	The bacterial respiratory nitric-oxide reductase (NOR) is a member of the superfamily of O-2-reducing, proton-pumping, heme-copper oxidases. Even although nitric oxide reduction is a highly exergonic reaction, NOR is not a proton pump and rather than taking up protons from the cytoplasmic (membrane potential-negative) side of the membrane, like the heme-copper oxidases, NOR derives its substrate protons from the periplasmic (membrane potential-positive) side of the membrane. The molecular details of this non-electrogenic proton transfer are not yet resolved, so in this study we have explored a role in a proposed proton pathway for a conserved surface glutamate (Glu-122) in the catalytic subunit (NorB). The effect of substituting Glu-122 with Ala, Gln, or Asp on a single turnover of the reduced NOR variants with O-2, an alternative and experimentally tractable substrate for NOR, was determined. Electron transfer coupled to proton uptake to the bound O-2 is severely and specifically inhibited in both the E122A and E122Q variants, establishing the importance of a protonatable side chain at this position. In the E122D mutant, proton uptake is retained but it is associated with a significant increase in the observed pK(a) of the group donating protons to the active site. This suggests that Glu-122 is important in defining this proton donor. A second nearby glutamate (Glu-125) is also required for the electron transfer coupled to proton uptake, further emphasizing the importance of this region of NorB in proton transfer. Because Glu-122 is predicted to lie near the periplasmic surface of NOR, the results provide strong experimental evidence that this residue contributes to defining the aperture of a non-electrogenic "E-pathway" that serves to deliver protons from the periplasm to the buried active site in NOR.	[Flock, Ulrika; Ardelroth, Pia] Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden; [Thorndycroft, Faye H.; Matorin, Andrey D.; Richardson, David J.; Watmough, Nicholas J.] Univ E Anglia, Ctr Mol Struct & Biochem, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	Stockholm University; University of East Anglia	Ardelroth, P (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden.	piaa@dbb.su.se	Watmough, Nicholas J/A-6643-2010; Richardson, David J/E-2275-2011	Watmough, Nicholas J/0000-0001-5901-6750; 	Biotechnology and Biological Sciences Research Council [B19851, BB/C007719/1, BBC0077191] Funding Source: Medline; Medical Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arslan E, 2000, FEBS LETT, V470, P7, DOI 10.1016/S0014-5793(00)01277-1; BELL LC, 1992, J GEN MICROBIOL, V138, P437, DOI 10.1099/00221287-138-3-437; Blomberg LM, 2006, BBA-BIOENERGETICS, V1757, P31, DOI 10.1016/j.bbabio.2005.11.004; BLOMBERG LM, 2006, THESIS STOCKHOLM U S; Branden M, 2001, P NATL ACAD SCI USA, V98, P5013, DOI 10.1073/pnas.081088398; Butland G, 2001, J BACTERIOL, V183, P189, DOI 10.1128/JB.183.1.189-199.2001; Cheesman MR, 1998, BIOCHEMISTRY-US, V37, P3994, DOI 10.1021/bi972437y; Dioumaev AK, 1998, BIOCHEMISTRY-US, V37, P2496, DOI 10.1021/bi971842m; Flock U, 2005, BIOCHEMISTRY-US, V44, P10711, DOI 10.1021/bi050524h; Flock U, 2006, BIOCHEM SOC T, V34, P188, DOI 10.1042/BST0340188; Fujiwara T, 1996, J BACTERIOL, V178, P1866, DOI 10.1128/jb.178.7.1866-1871.1996; Garczarek F, 2005, P NATL ACAD SCI USA, V102, P3633, DOI 10.1073/pnas.0500421102; Girsch P, 1997, BBA-BIOENERGETICS, V1318, P202, DOI 10.1016/S0005-2728(96)00138-7; Hemp J, 2007, BIOCHEMISTRY-US, V46, P9963, DOI 10.1021/bi700659y; Hendriks J, 1998, BIOCHEMISTRY-US, V37, P13102, DOI 10.1021/bi980943x; Hendriks JHM, 2002, BIOCHEMISTRY-US, V41, P2331, DOI 10.1021/bi0121050; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Lancaster CRD, 2002, BBA-BIOMEMBRANES, V1565, P215, DOI 10.1016/S0005-2736(02)00571-0; Reimann J, 2007, BBA-BIOENERGETICS, V1767, P362, DOI 10.1016/j.bbabio.2007.03.006; SARASTE M, 1994, FEBS LETT, V341, P1, DOI 10.1016/0014-5793(94)80228-9; SHAPLEIGH JP, 1985, J BACTERIOL, V163, P837, DOI 10.1128/JB.163.3.837-840.1985; Silverman DN, 2000, BBA-BIOENERGETICS, V1458, P88, DOI 10.1016/S0005-2728(00)00061-X; Tartof K.D., 1987, BETHESDA RES LAB FOC, V9, P12; Thorndycroft FH, 2007, BIOCHEM J, V401, P111, DOI 10.1042/BJ20060856; Toledo-Cuevas M, 1998, BBA-BIOENERGETICS, V1365, P421, DOI 10.1016/S0005-2728(98)00095-4; VANDEROOST J, 1994, FEMS MICROBIOL LETT, V121, P1, DOI 10.1016/0378-1097(94)90137-6; Vijgenboom G.W.E., 1998, BIOL ELECT TRANSFER, P279; Watmough NJ, 1999, BBA-BIOENERGETICS, V1411, P456, DOI 10.1016/S0005-2728(99)00032-8; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997; Zumft WG, 2005, J INORG BIOCHEM, V99, P194, DOI 10.1016/j.jinorgbio.2004.09.024	30	48	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3839	3845		10.1074/jbc.M704615200	http://dx.doi.org/10.1074/jbc.M704615200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18056717	hybrid			2022-12-25	WOS:000253083500018
J	Van Dijk, J; Miro, J; Strub, JM; Lacroix, B; Van Dorsselaer, A; Edde, B; Janke, C				Van Dijk, Juliette; Miro, Julie; Strub, Jean-Marc; Lacroix, Benjamin; Van Dorsselaer, Alain; Edde, Bernard; Janke, Carsten			Polyglutamylation is a post-translational modification with a broad range of substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TUBULIN; BETA-TUBULIN; STRUCTURAL INSIGHTS; PROTEIN; CELLS; PURIFICATION; DOMAIN; ACID; TAU	Polyglutamylation is a post-translational modification that generates lateral acidic side chains on proteins by sequential addition of glutamate amino acids. This modification was first discovered on tubulins, and it is important for several microtubule functions. Besides tubulins, only the nucleosome assembly proteins NAP1 and NAP2 have been shown to be polyglutamylated. Here, using a proteomic approach, we identify a large number of putative substrates for polyglutamylation in HeLa cells. By analyzing a selection of these putative substrates, we show that several of them can serve as in vitro substrates for two of the recently discovered polyglutamylases, TTLL4 and TTLL5. We further show that TTLL4 is the main polyglutamylase enzyme present in HeLa cells and that new substrates of polyglutamylation are indeed modified by TTLL4 in a cellular context. No clear consensus polyglutamylation site could be defined from the primary sequence of the here-identified new substrates of polyglutamylation. However, we demonstrate that glutamate-rich stretches are important for a protein to become polyglutamylated. Most of the newly identified substrates of polyglutamylation are nucleocytoplasmic shuttling proteins, including many chromatin-binding proteins. Our work reveals that polyglutamylation is a much more widespread post-translational modification than initially thought and thus that it might be a regulator of many cellular processes.	[Van Dijk, Juliette; Miro, Julie; Lacroix, Benjamin; Edde, Bernard; Janke, Carsten] Univ Montpellier 2 & 1, CNRS, CRBM, F-34293 Montpellier, France; [Strub, Jean-Marc; Van Dorsselaer, Alain] CNRS, Lab Spectometrie Masse BioOrgan, F-67087 Strasbourg, France; [Edde, Bernard] Univ Paris 06, F-75252 Paris, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Sorbonne Universite	Janke, C (corresponding author), Univ Montpellier 2 & 1, CNRS, CRBM, 1919 Route De Mende, F-34293 Montpellier, France.	carsten.janke@crbm.cnrs.fr	Lacroix, Benjamin/AAL-8428-2020; Janke, Carsten/A-7279-2011	Lacroix, Benjamin/0000-0003-2533-9150; Janke, Carsten/0000-0001-7053-2000; Miro, Julie/0000-0003-0913-6126; Strub, Jean-Marc/0000-0001-6224-3428				AUDEBERT S, 1993, MOL BIOL CELL, V4, P615, DOI 10.1091/mbc.4.6.615; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Bonnet C, 2001, J BIOL CHEM, V276, P12839, DOI 10.1074/jbc.M011380200; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; BOUCHER D, 1994, BIOCHEMISTRY-US, V33, P12471, DOI 10.1021/bi00207a014; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Gagnon C, 1996, J CELL SCI, V109, P1545; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; JUHASZ P, 1994, P NATL ACAD SCI USA, V91, P4333, DOI 10.1073/pnas.91.10.4333; Kjellstrom S, 2004, ANAL CHEM, V76, P5109, DOI 10.1021/ac0400257; Larcher JC, 1996, J BIOL CHEM, V271, P22117, DOI 10.1074/jbc.271.36.22117; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; Million K, 1999, J CELL SCI, V112, P4357; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Regnard C, 2000, J BIOL CHEM, V275, P15969, DOI 10.1074/jbc.M000045200; Regnard C, 1999, J CELL SCI, V112, P4281; RUDIGER M, 1992, FEBS LETT, V308, P101, DOI 10.1016/0014-5793(92)81061-P; Santa-Coloma TA, 2003, CEREBELLUM, V2, P310, DOI 10.1080/14734220310017212; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Wilson CL, 2006, J PEPT SCI, V12, P721, DOI 10.1002/psc.784; WOLFF A, 1992, EUR J CELL BIOL, V59, P425	27	72	73	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3915	3922		10.1074/jbc.M705813200	http://dx.doi.org/10.1074/jbc.M705813200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18045879	Green Submitted, hybrid			2022-12-25	WOS:000253083500025
J	Yu, PB; Deng, DY; Beppu, H; Hong, CC; Lai, C; Hoyng, SA; Kawai, N; Bloch, KD				Yu, Paul B.; Deng, Donna Y.; Beppu, Hideyuki; Hong, Charles C.; Lai, Carol; Hoyng, Stefan A.; Kawai, Noriko; Bloch, Kenneth D.			Bone morphogenetic protein (BMP) type II receptor is required for BMP-mediated growth arrest and differentiation in pulmonary artery smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA RECEPTOR; VASCULAR CALCIFICATION; INHIBITS PROLIFERATION; GERMLINE MUTATIONS; SIGNALING PATHWAYS; EXPRESSION; ACTIVATION; HYPERTENSION; NOTCH; APOPTOSIS	Bone morphogenetic protein (BMP) signals regulate the growth and differentiation of diverse lineages. The association of mutations in the BMP type II receptor (BMPRII) with idiopathic pulmonary arterial hypertension suggests an important role of this receptor in vascular remodeling. Pulmonary artery smooth muscle cells lacking BMPRII can transduce BMP signals using ActRIIa (Activin type II receptor). We investigated whether or not BMP signaling via the two receptors leads to differential effects on vascular smooth muscle cells. BMP4, but not BMP7, inhibited platelet-derived growth factor-activated proliferation in wild-type pulmonary artery smooth muscle cells, whereas neither ligand inhibited the growth of BMPRII-deficient cells. Adenoviral gene transfer of BMPRII enabled BMP4, as well as BMP7, to inhibit proliferation in BMPRII-deficient cells. BMP-mediated growth inhibition was also reconstituted by the BMPRII short isoform, lacking the C-terminal domain present in the long form. BMP4, but not BMP7, induced the expression of osteoblast markers in wild-type cells, whereas neither ligand induced these markers in BMPRII-deficient cells. Overexpression of short or long forms of BMPRII in BMPRII-deficient cells enabled BMP4 and BMP7 to induce osteogenic differentiation. Although signaling via BMPRII or ActRIIa transiently activated SMAD1/5/8, only BMPRII signaling led to persistent SMAD1/5/8 activation and sustained increases in Id1 mRNA and protein expression. Pharmacologic blockade of BMPtype I receptor function within 24 h after BMP stimulation abrogated differentiation. These data suggest that sustained BMP pathway activation, such as that mediated by BMPRII, is necessary for growth and differentiation control in vascular smooth muscle.	[Yu, Paul B.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Anesthesia Ctr Crit Care Res, Harvard Med Sch, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Yu, PB (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Anesthesia Ctr Crit Care Res, Harvard Med Sch, Boston, MA 02114 USA.	pbyu@partners.org	Yu, Paul B./J-7540-2019; Hong, Charles/C-9989-2010	Yu, Paul B./0000-0003-2145-4944; Hoyng, Stefan/0000-0001-8371-3871	NHLBI NIH HHS [R01 HL074352, 1K08HL079943, K08 HL079943, K08 HL079943-02, 5R01HL074352] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079943, R01HL074352] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871; Archer S, 2000, CIRCULATION, V102, P2781, DOI 10.1161/01.CIR.102.22.2781; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Baba Y, 2005, MICROBIOL IMMUNOL, V49, P559, DOI 10.1111/j.1348-0421.2005.tb03753.x; Bennett BJ, 2006, ARTERIOSCL THROM VAS, V26, P2117, DOI 10.1161/01.ATV.0000236428.91125.e6; Beppu H, 2005, GENESIS, V41, P133, DOI 10.1002/gene.20099; Beppu H, 1997, BIOCHEM BIOPH RES CO, V235, P499, DOI 10.1006/bbrc.1997.6816; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Chiche JD, 1998, J BIOL CHEM, V273, P34263, DOI 10.1074/jbc.273.51.34263; Cogan JD, 2005, GENET MED, V7, P169, DOI 10.1097/01.GIM.0000156525.09595.E9; Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; de Jong DS, 2004, BIOCHEM BIOPH RES CO, V320, P100, DOI 10.1016/j.bbrc.2004.05.150; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dorai H, 2000, J CELL PHYSIOL, V184, P37, DOI 10.1002/(SICI)1097-4652(200007)184:1<37::AID-JCP4>3.0.CO;2-M; Dorai H, 2001, J BONE JOINT SURG AM, V83A, pS70; Duan XY, 2006, J BIOL CHEM, V281, P36526, DOI 10.1074/jbc.M605169200; Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060; Forrest S, 2004, ARTERIOSCL THROM VAS, V24, P2014, DOI 10.1161/01.ATV.0000143932.03151.ad; Frank DB, 2005, CIRC RES, V97, P496, DOI 10.1161/01.RES.0000181152.65534.07; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Goto K, 2007, J BIOL CHEM, V282, P20603, DOI 10.1074/jbc.M702100200; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; Hassel S, 2004, PROTEOMICS, V4, P1346, DOI 10.1002/pmic.200300770; Hayashi Y, 2006, MOL BIOL CELL, V17; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; Izumi M, 2001, J BIOL CHEM, V276, P31133, DOI 10.1074/jbc.M101463200; Jeffery TK, 2005, AM J PHYSIOL-LUNG C, V288, pL370, DOI 10.1152/ajplung.00242.2004; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Jono S, 2006, J BONE MINER METAB, V24, P176, DOI 10.1007/s00774-005-0668-6; Kim IY, 2000, CANCER RES, V60, P2840; Kim IY, 2004, ONCOGENE, V23, P7651, DOI 10.1038/sj.onc.1207924; Kim IY, 2003, CLIN CANCER RES, V9, P6046; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; King KE, 2003, J BIOL CHEM, V278, P11661, DOI 10.1074/jbc.M211337200; Kluppel M, 2005, BIOESSAYS, V27, P115, DOI 10.1002/bies.20187; Lagna G, 2006, AM J PHYSIOL-LUNG C, V291, pL1059, DOI 10.1152/ajplung.00180.2006; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Li IWS, 1996, J CELL PHYSIOL, V169, P115, DOI 10.1002/(SICI)1097-4652(199610)169:1<115::AID-JCP12>3.0.CO;2-C; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; LIU F, 1995, MOL CELL BIOL, V15, P3479; Machado RD, 2003, HUM MOL GENET, V12, P3277, DOI 10.1093/hmg/ddg365; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; Morrell Nicholas W, 2006, Proc Am Thorac Soc, V3, P680, DOI 10.1513/pats.200605-118SF; Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152; Moser M, 2005, THROMB HAEMOSTASIS, V94, P713, DOI 10.1160/TH05-05-0312; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakaoka T, 1997, J CLIN INVEST, V100, P2824, DOI 10.1172/JCI119830; Nicolas FJ, 2003, ONCOGENE, V22, P3698, DOI 10.1038/sj.onc.1206420; Nishihara A, 2002, MOL BIOL CELL, V13, P3055, DOI 10.1091/mbc.E02-02-0063; Nohe A, 2005, J CELL SCI, V118, P643, DOI 10.1242/jcs.01402; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Shioi A, 2002, CIRC RES, V91, P9, DOI 10.1161/01.RES.0000026421.61398.F2; Takizawa T, 2003, NUCLEIC ACIDS RES, V31, P5723, DOI 10.1093/nar/gkg778; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Tintut Y, 2005, J MOL CELL CARDIOL, V39, P389, DOI 10.1016/j.yjmcc.2005.03.019; Tintut Y, 2003, CIRCULATION, V108, P2505, DOI 10.1161/01.CIR.0000096485.64373.C5; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178; Willette RN, 1999, J VASC RES, V36, P120, DOI 10.1159/000025634; Wong GA, 2003, AM J PHYSIOL-ENDOC M, V284, pE972, DOI 10.1152/ajpendo.00385.2002; Wong WKP, 2005, AM J RESP CELL MOL, V33, P438, DOI 10.1165/rcmb.2005-0103OC; YANG X, 2005, CIRC RES; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200; YU PB, 2007, IN PRESS NAT CHEM BI; Zakrzewicz A, 2007, CIRCULATION, V115, P2957, DOI 10.1161/CIRCULATIONAHA.106.670026; Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, pL740, DOI 10.1152/ajplung.00284.2002; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	79	80	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3877	3888		10.1074/jbc.M706797200	http://dx.doi.org/10.1074/jbc.M706797200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18042551	hybrid			2022-12-25	WOS:000253083500022
J	Jones, NG; Nietlispach, D; Sharma, R; Burke, DF; Eyres, I; Mues, M; Mott, HR; Carrington, M				Jones, Nicola G.; Nietlispach, Daniel; Sharma, Reuben; Burke, David F.; Eyres, Isobel; Mues, Marsilius; Mott, Helen R.; Carrington, Mark			Structure of a glycosylphosphatidylinositol-anchored domain from a trypanosome variant surface glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BONDS; BRUCEI; GLYCAN; FORMS; COAT	The cell surface of African trypanosomes is covered by a densely packed monolayer of a single protein, the variant surface glycoprotein (VSG). The VSG protects the trypanosome cell surface from effector molecules of the host immune system and is the mediator of antigenic variation. The sequence divergence between VSGs that is necessary for antigenic variation can only occur within the constraints imposed by the structural features necessary to form the monolayer barrier. Here, the structures of the two domains that together comprise the C-terminal di-domain of VSG IL Tat 1.24 have been determined. The first domain has a structure similar to the single C-terminal domain of VSG MIT at 1.2 and provides proof of structural conservation in VSG C-terminal domains complementing the conservation of structure present in the N-terminal domain. The second domain, although based on the same fold, is a minimized version missing several structural features. The structure of the second domain contains the C-terminal residue that in the native VSG is attached to a glycosylphosphatidylinositol (GPI) anchor that retains the VSG on the external face of the plasma membrane. The solution structures of this domain and a VSG GPI glycan have been combined to produce the first structure-based model of a GPI-anchored protein. The model suggests that the core glycan of the GPI anchor lies in a groove on the surface of the domain and that there is a close association between the GPI glycan and protein. More widely, the GPI glycan may be an integral part of the structure of other GPI-anchored proteins.	[Jones, Nicola G.; Nietlispach, Daniel; Sharma, Reuben; Burke, David F.; Eyres, Isobel; Mues, Marsilius; Mott, Helen R.; Carrington, Mark] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge	Jones, NG (corresponding author), Tech Univ Darmstadt, Dept Genet & Microbiol, Schnittspahnstr 10, D-64287 Darmstadt, Germany.	jones@bio.tu-darmstadt.de	Sharma, Reuben/AAI-6444-2020; Carrington, Mark/N-3653-2019; Carrington, Mark/N-4892-2018; Jones, Nicola/AAP-5835-2021; Burke, David F/C-2091-2013; Mott, Helen/AAV-3873-2020	Carrington, Mark/0000-0002-6435-7266; Carrington, Mark/0000-0002-6435-7266; Jones, Nicola/0000-0003-3384-0156; Burke, David F/0000-0001-8830-3951; Mott, Helen/0000-0002-7890-7097; Nietlispach, Daniel/0000-0003-4364-9291	Biotechnology and Biological Sciences Research Council [BB/E013228/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		ALLEN G, 1983, BIOCHEM J, V209, P481, DOI 10.1042/bj2090481; BARBONI E, 1995, J CELL SCI, V108, P487; Barry David, 2004, P25, DOI 10.1079/9780851994758.0025; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BLUM ML, 1993, NATURE, V362, P603, DOI 10.1038/362603a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BULOW R, 1988, BIOCHEMISTRY-US, V27, P2384; Bussler H, 1998, J BIOL CHEM, V273, P32582, DOI 10.1074/jbc.273.49.32582; Butikofer P, 2001, FASEB J, V15, P545, DOI 10.1096/fj.00-0415hyp; CARRINGTON M, 1991, J MOL BIOL, V221, P823, DOI 10.1016/0022-2836(91)80178-W; Chattopadhyay A, 2005, J BIOL CHEM, V280, P7228, DOI 10.1074/jbc.M410787200; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; FREYMANN D, 1990, J MOL BIOL, V216, P141, DOI 10.1016/S0022-2836(05)80066-X; GARMAN SC, 1994, THESIS HARVARD U; GASTEIGER J, 1981, ORG MAGN RESONANCE, V15, P353, DOI 10.1002/mrc.1270150408; HOMANS SW, 1989, BIOCHEMISTRY-US, V28, P2881, DOI 10.1021/bi00433a020; Hornemann S, 2004, EMBO REP, V5, P1159, DOI 10.1038/sj.embor.7400297; JACKSON DG, 1985, BIOCHEM J, V230, P195, DOI 10.1042/bj2300195; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P868; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; Mehlert A, 2002, GLYCOBIOLOGY, V12, P607, DOI 10.1093/glycob/cwf079; Mehlert A, 1998, J MOL BIOL, V277, P379, DOI 10.1006/jmbi.1997.1600; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; O'Beirne C, 1998, MOL BIOCHEM PARASIT, V91, P165, DOI 10.1016/S0166-6851(97)00191-6; Pal A, 2003, BIOCHEM J, V374, P443, DOI 10.1042/BJ20030469; RADEMACHER T W, 1991, Current Biology, V1, P41, DOI 10.1016/0960-9822(91)90123-E; Reverter D, 2004, J MOL BIOL, V338, P257, DOI 10.1016/j.jmb.2004.02.058; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; ZAMZE SE, 1990, EUR J BIOCHEM, V187, P657, DOI 10.1111/j.1432-1033.1990.tb15350.x; Zhou JL, 2004, ACTA TROP, V90, P271, DOI 10.1016/j.actatropica.2004.02.002; ZIEGELBAUER K, 1993, INFECT IMMUN, V61, P4540, DOI 10.1128/IAI.61.11.4540-4545.1993	34	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3584	3593		10.1074/jbc.M706207200	http://dx.doi.org/10.1074/jbc.M706207200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18003615	Green Accepted, hybrid			2022-12-25	WOS:000253083000064
J	Kwofie, MA; Skowronski, J				Kwofie, Michael A.; Skowronski, Jacek			Specific recognition of Rac2 and Cdc42 by DOCK2 and DOCK9 guanine nucleotide exchange factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-FAMILY GTPASES; T-LYMPHOCYTE; ACTIVATION; GEF; COMPLEX; DOMAIN; PROTEINS; PHAGOCYTOSIS; MULTIPLE; SCAFFOLD	Recognition of cognate Rho GTPases by guanine-nucleotide exchange factors (GEF) is fundamental to Rho GTPase signaling specificity. Two main GEF families use either the Dbl homology (DH) or the DOCK homology region 2 (DHR-2) catalytic domain. How DHR-2-containing GEFs distinguish between the GTPases Rac and Cdc42 is not known. To determine how these GEFs specifically recognize the two Rho GTPases, we studied the amino acid sequences in Rac2 and Cdc42 that are crucial for activation by DOCK2, a Rac-specific GEF, and DOCK9, a distantly related Cdc42-specific GEF. Two elements in the N-terminal regions of Rac2 and Cdc42 were found to be essential for specific interactions with DOCK2 and DOCK9. One element consists of divergent amino acid residues in the switch 1 regions of the GTPases. Significantly, these residues were also found to be important for GTPase recognition by Rac-specific DOCK180, DOCK3, and DOCK4 GEFs. These findings were unexpected because the same residues were shown previously to interact with GTPase effectors rather than GEFs. The other element comprises divergent residues in the beta 3 strand that are known to mediate specific recognition by DH domain containing GEFs. Remarkably, Rac2-to-Cdc42 substitutions of four of these residues were sufficient for Rac2 to be specifically activated by DOCK9. Thus, DOCK2 and DOCK9 specifically recognize Rac2 and Cdc42 through their switch 1 as well as beta 2-beta 3 regions and the mode of recognition via switch 1 appears to be conserved among diverse Rac-specific DHR-2 GEFs.	[Kwofie, Michael A.; Skowronski, Jacek] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Kwofie, Michael A.] SUNY Stony Brook, Genet Program, Stony Brook, NY 11790 USA; [Kwofie, Michael A.] SUNY Stony Brook, Med Sci Training Program, Stony Brook, NY 11790 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Skowronski, J (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	skowrons@cshl.edu		Kwofie, Michael/0000-0003-4632-5436	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042561] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-42561] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aghazadeh B, 1998, NAT STRUCT BIOL, V5, P1098, DOI 10.1038/4209; Aktories K, 2000, BIOL CHEM, V381, P421, DOI 10.1515/BC.2000.054; Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Buchsbaum RJ, 2003, J BIOL CHEM, V278, P18833, DOI 10.1074/jbc.M207876200; Buchsbaum RJ, 2002, MOL CELL BIOL, V22, P4073, DOI 10.1128/MCB.22.12.4073-4085.2002; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Cote JF, 2006, METHOD ENZYMOL, V406, P41, DOI 10.1016/S0076-6879(06)06004-6; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gao Y, 2001, J BIOL CHEM, V276, P47530, DOI 10.1074/jbc.M108865200; Garcia-Bernal D, 2006, J IMMUNOL, V177, P5215, DOI 10.4049/jimmunol.177.8.5215; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hiramoto K, 2006, EXP CELL RES, V312, P4205, DOI 10.1016/j.yexcr.2006.09.006; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Horiguchi Y, 2001, TOXICON, V39, P1619, DOI 10.1016/S0041-0101(01)00149-0; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Janardhan A, 2004, PLOS BIOL, V2, P65, DOI 10.1371/journal.pbio.0020006; Karnoub AE, 2001, NAT STRUCT BIOL, V8, P1037, DOI 10.1038/nsb719; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; KWONG CH, 1995, J BIOL CHEM, V270, P19868, DOI 10.1074/jbc.270.34.19868; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Li R, 1997, J BIOL CHEM, V272, P4671, DOI 10.1074/jbc.272.8.4671; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Namekata K, 2004, J BIOL CHEM, V279, P14331, DOI 10.1074/jbc.M311275200; Nishihara H, 2002, BIOCHEM BIOPH RES CO, V296, P716, DOI 10.1016/S0006-291X(02)00931-2; Nombela-Arrieta C, 2004, IMMUNITY, V21, P429, DOI 10.1016/j.immuni.2004.07.012; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Ridley AJ, 2001, J CELL SCI, V114, P2713; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sanui T, 2003, BLOOD, V102, P2948, DOI 10.1182/blood-2003-01-0173; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Swigut T, 2003, J VIROL, V77, P8116, DOI 10.1128/JVI.77.14.8116-8126.2003; VAN AL, 1997, GENE DEV, V11, P2295; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; Williams DA, 2000, BLOOD, V96, P1646; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014	51	25	26	4	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3088	3096		10.1074/jbc.M705170200	http://dx.doi.org/10.1074/jbc.M705170200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056264	hybrid			2022-12-25	WOS:000253083000012
J	Yoshizaki, K; Yamamoto, S; Yamada, A; Yuasa, K; Iwamoto, T; Fukumoto, E; Harada, H; Saito, M; Nakasima, A; Nonaka, K; Yamada, Y; Fukumoto, S				Yoshizaki, Keigo; Yamamoto, Shinya; Yamada, Aya; Yuasa, Kenji; Iwamoto, Tsutomu; Fukumoto, Emiko; Harada, Hidemitsu; Saito, Masahiro; Nakasima, Akihiko; Nonaka, Kazuaki; Yamada, Yoshihiko; Fukumoto, Satoshi			Neurotrophic factor neurotrophin-4 regulates ameloblastin expression via full-length TrkB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SP3; GROWTH-FACTOR RECEPTOR; MICE LACKING; TOOTH DEVELOPMENT; EXTRACELLULAR-MATRIX; RAT TRKC; DIFFERENTIATION; CELLS; MORPHOGENESIS; DEFICITS	Neurotrophic factors play an important role in the development and maintenance of not only neural but also nonneural tissues. Several neurotrophic factors are expressed in dental tissues, but their role in tooth development is not clear. Here, we report that neurotrophic factor neurotrophin (NT)-4 promotes differentiation of dental epithelial cells and enhances the expression of enamel matrix genes. Dental epithelial cells from 3-day-old mice expressed NT-4 and three variants of TrkB receptors for neurotrophins (full-length TrkB-FL and truncated TrkB-T1 and -T2). Dental epithelial cell line HAT-7 expressed these genes, similar to those in dental epithelial cells. We found that NT-4 reduced HAT-7 cell proliferation and induced the expression of enamel matrix genes, such as ameloblastin (Ambn). Transfection of HAT-7 cells with the TrkB-FL expression construct enhanced the NT-4-mediated induction of Ambn expression. This enhancement was blocked by K252a, an inhibitor for Trk tyrosine kinases. Phosphorylation of ERK1/2, a downstream molecule of TrkB, was induced in HAT-7 cells upon NT-4 treatment. TrkB-FL but not TrkB-T1 transfection increased the phosphorylation level of ERK1/2 in NT-4-treated HAT-7 cells. These results suggest that NT-4 induced Ambn expression via the TrkB-MAPK pathway. The p75 inhibitor TAT-pep5 decreased NT-4-mediated induction of the expression of Ambn, TrkB-FL, and TrkB-T1, suggesting that both high affinity and low affinity neurotrophin receptors were required for NT-4 activity. We found that NT-4-null mice developed a thin enamel layer and had a decrease in Ambn expression. Our results suggest that NT-4 regulates proliferation and differentiation of the dental epithelium and promotes production of the enamel matrix.	[Yoshizaki, Keigo; Yamamoto, Shinya; Yamada, Aya; Yuasa, Kenji; Iwamoto, Tsutomu; Nonaka, Kazuaki; Fukumoto, Satoshi] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Pediat Dent, Fukuoka 8128582, Japan; [Fukumoto, Emiko] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528521, Japan; [Harada, Hidemitsu] Iwate Med Coll, Sch Dent, Dept Oral Anat 2, Morioka, Iwate 0208505, Japan; [Saito, Masahiro] Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biochem, Suita, Osaka 5650871, Japan; [Yamada, Yoshihiko] NIH, NIDCR, Craniofacial Dev Biol & Regenerat Biol Branch, Bethesda, MD 20892 USA; [Fukumoto, Satoshi] Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Div Pediat, Sendai, Miyagi 9808575, Japan	Kyushu University; Nagasaki University; Iwate Medical University; Osaka University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Tohoku University	Fukumoto, S (corresponding author), Tohoku Univ, Dept Oral Hlth & Dev, Div Pediat Detn, Sendai, Miyagi 9808575, Japan.	fukumoto@mail.tains.tohoku.ac.jp	Harada, Hidemitsu/P-5692-2017; Iwamoto, Tsutomu/AAI-8952-2021; Iwamoto, Tsutomu/AAA-6597-2019	Harada, Hidemitsu/0000-0002-9724-8568; Iwamoto, Tsutomu/0000-0001-8472-605X; Yoshizaki, Keigo/0000-0002-0598-5879; Fukumoto, Satoshi/0000-0002-5046-6891	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000720] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; BARRETT GL, 1994, P NATL ACAD SCI USA, V91, P6501, DOI 10.1073/pnas.91.14.6501; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; CONOVER JC, 1995, NATURE, V375, P235, DOI 10.1038/375235a0; Dhamija S, 2001, J BIOL CHEM, V276, P35159, DOI 10.1074/jbc.M010719200; DIMARCO E, 1993, J BIOL CHEM, V268, P22838; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eide FF, 1996, J NEUROSCI, V16, P3123; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Frank RN, 2003, INVEST OPHTH VIS SCI, V44, P1; Fukumoto S, 2005, CONNECT TISSUE RES, V46, P220, DOI 10.1080/03008200500344017; Fukumoto S, 2006, J BIOL CHEM, V281, P5008, DOI 10.1074/jbc.M509295200; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gollner H, 2001, MECH DEVELOP, V106, P77, DOI 10.1016/S0925-4773(01)00420-8; KALCHEIM C, 1992, P NATL ACAD SCI USA, V89, P1661, DOI 10.1073/pnas.89.5.1661; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; LIU X, 1995, NATURE, V375, P238, DOI 10.1038/375238a0; Luukko K, 1997, DEV DYNAM, V210, P117, DOI 10.1002/(SICI)1097-0177(199710)210:2<117::AID-AJA5>3.0.CO;2-J; Luukko K, 1996, DEV DYNAM, V206, P87, DOI 10.1002/(SICI)1097-0177(199605)206:1<87::AID-AJA8>3.0.CO;2-X; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Nosrat CA, 1997, CELL TISSUE RES, V290, P569, DOI 10.1007/s004410050962; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; SARIOLA H, 1991, SCIENCE, V254, P571, DOI 10.1126/science.1658930; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; THESLEFF I, 1995, INT J DEV BIOL, V39, P35; TSOULFAS P, 1993, NEURON, V10, P975, DOI 10.1016/0896-6273(93)90212-A; VALENZUELA DM, 1993, NEURON, V10, P963, DOI 10.1016/0896-6273(93)90211-9; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yuasa K, 2004, J BIOL CHEM, V279, P10286, DOI 10.1074/jbc.M310013200; ZEICHNERDAVID M, 1995, INT J DEV BIOL, V39, P69	40	46	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3385	3391		10.1074/jbc.M704913200	http://dx.doi.org/10.1074/jbc.M704913200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18045880	hybrid			2022-12-25	WOS:000253083000043
J	Kojima, K; Tsuzuki, S; Fushiki, T; Inouye, K				Kojima, Kenji; Tsuzuki, Satoshi; Fushiki, Tohru; Inouye, Kuniyo			Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE 1/MATRIPTASE; FACTOR-XA INHIBITION; PLASMINOGEN-ACTIVATOR; SLOW-BINDING; EXPRESSION; CANCER; RECEPTOR; KINETICS; HAI-1; LOCALIZATION	Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is a membrane-bound, Kunitz-type serine protease inhibitor. HAI-1 inhibits serine proteases that have potent pro-hepatocyte growth factor-converting activity, such as the membrane-type serine protease, matriptase. HAI-1 comprises an N-terminaldomain, followed by an internal domain, first protease inhibitory domain (Kunitz domain I), low-density lipoprotein receptor A module (LDLRA) domain, and a second Kunitz domain (Kunitz domain II) in the extracellular region. Our aim was to assess the roles of these domains in the inhibition of matriptase. Soluble forms of recombinant rat HAI-1 mutants made up with various combinations of domains were produced, and their inhibitory activities toward the hydrolysis of a chromogenic substrate were analyzed using a soluble recombinant rat matriptase. Kunitz domain I exhibited inhibitory activity against matriptase, but Kunitz domain II did not. The N-terminal domain and Kunitz domain II decreased the association rate between Kunitz domain I and matriptase, whereas the internal domain increased this rate. The LDLRA domain suppressed the dissociation of the Kunitz domain I-matriptase complex. Surprisingly, an HAI-1 mutant lacking the N- terminal domain and Kunitz domain II showed an inhibitor constant of 1.6 pM, and the inhibitory activity was 400 times higher in this HAI-1 mutant than in the mutant with all domains. These findings, together with the known occurrence of an HAI-1 species lacking the N- terminal domain and Kunitz domain II in vivo, suggest that the domain structure of HAI-1 is organized in a way that allows HAI-1 to flexibly control matriptase activity.	[Kojima, Kenji; Inouye, Kuniyo] Kyoto Univ, Div Food Sci & Biotechnol, Lab Enzyme Chem, Grad Sch Agr,Sakyo Ku, Kyoto 6068502, Japan; [Tsuzuki, Satoshi; Fushiki, Tohru] Kyoto Univ, Div Food Sci & Biotechnol, Nutr Chem Lab, Grad Sch Agr,Sakyo Ku, Kyoto 6068502, Japan	Kyoto University; Kyoto University	Inouye, K (corresponding author), Kyoto Univ, Div Food Sci & Biotechnol, Lab Enzyme Chem, Grad Sch Agr,Sakyo Ku, Kyoto 6068502, Japan.	inouye@kais.kyoto-u.ac.jp		Tsuzuki, Satoshi/0000-0003-4385-0075				Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Bond JS, 2005, FEBS LETT, V579, P3317, DOI 10.1016/j.febslet.2005.03.045; Brown MS, 1997, NATURE, V388, P629, DOI 10.1038/41672; COPELAND RA, 2005, EVALUATION ENZYME IN, P141; Denda K, 2002, J BIOL CHEM, V277, P14053, DOI 10.1074/jbc.M112263200; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Dharmasena SP, 2002, BIOCHEMISTRY-US, V41, P12414, DOI 10.1021/bi0262606; ESSER V, 1988, J BIOL CHEM, V263, P13282; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; HUANG ZF, 1993, J BIOL CHEM, V268, P26950; Itoh H, 2000, AM J PHYSIOL-GASTR L, V278, pG635, DOI 10.1152/ajpgi.2000.278.4.G635; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673, DOI 10.1177/002215549904700509; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lu DS, 1997, J BIOL CHEM, V272, P31293, DOI 10.1074/jbc.272.50.31293; Mazzone M, 2006, FASEB J, V20, P1611, DOI 10.1096/fj.06-5947rev; MIYAZAWA K, 1993, J BIOL CHEM, V268, P10024; MOESTRUP SK, 1994, BBA-REV BIOMEMBRANES, V1197, P197, DOI 10.1016/0304-4157(94)90005-1; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Nozaki S, 2006, ANTI-CANCER DRUG, V17, P1109, DOI 10.1097/01.cad.0000231483.09439.3a; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Oberst MD, 2002, CLIN CANCER RES, V8, P1101; Rezaie AR, 2004, BIOCHEMISTRY-US, V43, P3368, DOI 10.1021/bi036177y; Rosmann S, 2002, J BIOL CHEM, V277, P40650, DOI 10.1074/jbc.M206203200; Satomi S, 2001, BIOCHEM BIOPH RES CO, V287, P995, DOI 10.1006/bbrc.2001.5686; Scandura JM, 1997, BIOCHEMISTRY-US, V36, P412, DOI 10.1021/bi9612576; Shimomura T, 1999, J BIOCHEM-TOKYO, V126, P821, DOI 10.1093/oxfordjournals.jbchem.a022522; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Tsuzuki S, 2005, BIOCHEM J, V388, P679, DOI 10.1042/BJ20041639; Vogel LK, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-176; Yamasaki Y, 2003, J NUTR SCI VITAMINOL, V49, P27, DOI 10.3177/jnsv.49.27	37	51	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2478	2487		10.1074/jbc.M709073200	http://dx.doi.org/10.1074/jbc.M709073200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18048349	hybrid			2022-12-25	WOS:000252622300004
J	Bissonnette, SA; Glazier, CM; Stewart, MQ; Brown, GE; Ellson, CD; Yaffe, MB				Bissonnette, Sarah A.; Glazier, Christina M.; Stewart, Mary Q.; Brown, Glenn E.; Ellson, Chris D.; Yaffe, Michael B.			Phosphatidylinositol 3-phosphate-dependent and -independent functions of p40(phox) in activation of the neutrophil NADPH oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE SYSTEM; ADENINE-DINUCLEOTIDE PHOSPHATE; PX DOMAIN; PROTEIN P40(PHOX); CYTOSOLIC SUBUNIT; MOLECULAR-BASIS; PC MOTIF; P67(PHOX); BINDING; P47(PHOX)	In response to bacterial infection, the neutrophil NADPH oxidase assembles on phagolysosomes to catalyze the transfer of electrons from NADPH to oxygen, forming superoxide and downstream reactive oxygen species (ROS). The active oxidase is composed of a membrane-bound cytochrome together with three cytosolic phox proteins, p40(phox), p47(phox), and p67(phox), and the small GTPase Rac2, and is regulated through a process involving protein kinase C, MAPK, and phosphatidylinositol 3-kinase. The role of p40(phox) remains less well defined than those of p47(phox) and p67(phox). We investigated the biological role of p40(phox) in differentiated PLB-985 neutrophils, and we show that depletion of endogenous p40(phox) using lentiviral short hairpin RNA reduces ROS production and impairs bacterial killing under conditions where p67(phox) levels remain constant. Biochemical studies using a cytosol-reconstituted permeabilized human neutrophil cores system that recapitulates intracellular oxidase activation revealed that depletion of p40(phox) reduces both the maximal rate and total amount of ROS produced without altering the K-M value of the oxidase for NADPH. Using a series of mutants, p47PX-p40(phox) chimeras, and deletion constructs, we found that the p40(phox) PX domain has phosphatidylinositol 3-phosphate(PtdIns(3) P)-dependentand - independent functions. Translocation of p67(phox) requires the PX domain but not 3- phosphoinositide binding. Activation of the oxidase by p40(phox), however, requires both PtdIns(3) P binding and an Src homology 3 (SH3) domain competent to bind to poly-Pro ligands. Mutations that disrupt the closed auto-inhibited form of full-length p40(phox) can increase oxidase activity similar to 2.5-fold above that of wild-type p40(phox) but maintain the requirement for PX and SH3 domain function. We present a model where p40(phox) translocates p67(phox) to the region of the cytochrome and subsequently switches the oxidase to an activated state dependent upon PtdIns(3) P and SH3 domain engagement.	[Bissonnette, Sarah A.; Glazier, Christina M.; Stewart, Mary Q.; Ellson, Chris D.; Yaffe, Michael B.] MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA; [Yaffe, Michael B.] MIT, Ctr Canc Res, Div Biol Engn, Cambridge, MA 02139 USA; [Brown, Glenn E.; Yaffe, Michael B.] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02130 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center	Yaffe, MB (corresponding author), MIT, Ctr Canc Res, Dept Biol, 77 Massachusetts Ave,E18-580, Cambridge, MA 02139 USA.	myaffe@mit.edu		Stewart, Mary Q/0000-0001-6924-0123	NIGMS NIH HHS [GM59281, R01 GM059281-09, R01 GM059281] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059281] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Brown GE, 2004, J BIOL CHEM, V279, P27059, DOI 10.1074/jbc.M314258200; Brown GE, 2003, MOL CELL, V11, P35, DOI 10.1016/S1097-2765(03)00005-4; Clark RA, 1999, J INFECT DIS, V179, pS309, DOI 10.1086/513849; Cross AR, 1999, BIOCHEM J, V341, P251, DOI 10.1042/0264-6021:3410251; Cross AR, 2000, BIOCHEM J, V349, P113, DOI 10.1042/0264-6021:3490113; CURNUTTE JT, 1987, J BIOL CHEM, V262, P5563; Dagher MC, 2007, BIOCHIMIE, V89, P1123, DOI 10.1016/j.biochi.2007.03.002; Dang PMC, 1999, BIOCHEMISTRY-US, V38, P5746, DOI 10.1021/bi982750f; Dang PMC, 2000, BIOCHEMISTRY-US, V39, P3069, DOI 10.1021/bi9919807; DeLeo FR, 1999, J IMMUNOL, V163, P6732; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Ellson CD, 2001, NAT CELL BIOL, V3, P679, DOI 10.1038/35083076; Ellson CD, 2006, J EXP MED, V203, P1927, DOI 10.1084/jem.20052069; Fuchs A, 1996, BBA-MOL CELL RES, V1312, P39, DOI 10.1016/0167-4889(96)00020-1; Grogan A, 1997, J CELL SCI, V110, P3071; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; Honbou K, 2007, EMBO J, V26, P1176, DOI 10.1038/sj.emboj.7601561; Ito T, 2001, EMBO J, V20, P3938, DOI 10.1093/emboj/20.15.3938; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Karlsson A, 2000, J LEUKOCYTE BIOL, V67, P396, DOI 10.1002/jlb.67.3.396; Kobayashi T, 1998, J CELL SCI, V111, P81; Kuribayashi F, 2002, EMBO J, V21, P6312, DOI 10.1093/emboj/cdf642; Li YM, 2002, P NATL ACAD SCI USA, V99, P8289, DOI 10.1073/pnas.122244799; Massenet C, 2005, J BIOL CHEM, V280, P13752, DOI 10.1074/jbc.M412897200; Meischl C, 1998, SPRINGER SEMIN IMMUN, V19, P417, DOI 10.1007/BF00792600; Nakamura R, 1998, EUR J BIOCHEM, V251, P583, DOI 10.1046/j.1432-1327.1998.2510583.x; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Park JW, 1997, J BIOL CHEM, V272, P11035; Pedruzzi E, 2002, BRIT J HAEMATOL, V117, P719, DOI 10.1046/j.1365-2141.2002.03521.x; QUINN MT, 1993, J BIOL CHEM, V268, P20983; ROTROSEN D, 1990, J BIOL CHEM, V265, P19910; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sathyamoorthy M, 1997, J BIOL CHEM, V272, P9141; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Smith RM, 1996, J CLIN INVEST, V98, P977, DOI 10.1172/JCI118882; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; Tu YZ, 2001, BIOCHEM J, V354, P315, DOI 10.1042/0264-6021:3540315; Ueyama T, 2007, MOL BIOL CELL, V18, P441, DOI 10.1091/mbc.E06-08-0731; Vaissiere C, 1999, J LEUKOCYTE BIOL, V65, P629, DOI 10.1002/jlb.65.5.629; van Bruggen R, 2004, J BIOL CHEM, V279, P9097, DOI 10.1074/jbc.M309284200; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Wientjes FB, 2001, BIOCHEM BIOPH RES CO, V289, P382, DOI 10.1006/bbrc.2001.5982	50	42	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2108	2119		10.1074/jbc.M706639200	http://dx.doi.org/10.1074/jbc.M706639200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18029359	Green Accepted, hybrid			2022-12-25	WOS:000252501000038
J	Hoffmeister, M; Riha, P; Neumueller, O; Danielewski, O; Schultess, J; Smolenski, AP				Hoffmeister, Meike; Riha, Pavel; Neumueller, Olga; Danielewski, Oliver; Schultess, Jan; Smolenski, Albert P.			Cyclic nucleotide-dependent protein kinases inhibit binding of 14-3-3 to the GTPase-activating protein Rap1GAP2 in platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION; CELL; SPECIFICITY; ISOFORMS; MICE; ADHESION; PATHWAY; RAP	GTPase-activating proteins are required to terminate signaling by Rap1, a small guanine nucleotide-binding protein that controls integrin activity and cell adhesion. Recently, we identified Rap1GAP2, a GTPase-activating protein of Rap1 in platelets. Here we show that 14-3-3 proteins interact with phosphorylated serine 9 at the N terminus of Rap1GAP2. Platelet activation by ADP and thrombin enhances serine 9 phosphorylation and increases 14-3-3 binding to endogenous Rap1GAP2. Conversely, inhibition of platelets by endothelium-derived factors nitric oxide and prostacyclin disrupts 14-3-3 binding. These effects are mediated by cGMP-and cAMP-dependent protein kinases that phosphorylate Rap1GAP2 at serine 7, adjacent to the 14-3-3 binding site. 14-3-3 binding does not change the GTPase-activating function of Rap1GAP2 in vitro. However, 14-3-3 binding attenuates Rap1GAP2 mediated inhibition of cell adhesion. Our findings define a novel crossover point of activatory and inhibitory signaling pathways in platelets.	[Hoffmeister, Meike; Riha, Pavel; Neumueller, Olga; Danielewski, Oliver; Schultess, Jan; Smolenski, Albert P.] Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany; [Riha, Pavel] Charles Univ Prague, Fac Med 1, Prague 12108, Czech Republic	Goethe University Frankfurt; Charles University Prague	Smolenski, AP (corresponding author), Univ Frankfurt, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	smolenski@biochem2.de	Riha, Pavel/C-3309-2009	Smolenski, Albert/0000-0001-9210-9406				Aitken A, 2002, BIOCHEM SOC T, V30, P351, DOI 10.1042/bst0300351; Aitken A, 2002, PLANT MOL BIOL, V50, P993, DOI 10.1023/A:1021261931561; Andrews RK, 1998, BIOCHEMISTRY-US, V37, P638, DOI 10.1021/bi970893g; Barry FA, 2003, FEBS LETT, V553, P173, DOI 10.1016/S0014-5793(03)01015-9; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Butt E, 2003, J BIOL CHEM, V278, P15601, DOI 10.1074/jbc.M209009200; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Danielewski O, 2005, THROMB HAEMOSTASIS, V93, P319, DOI 10.1160/TH04-09-0582; Daumke O, 2004, NATURE, V429, P197, DOI 10.1038/nature02505; Dittrich M, 2006, THROMB HAEMOSTASIS, V95, P643, DOI 10.1160/TH05-11-0764; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Kjarland E, 2006, CURR PHARM BIOTECHNO, V7, P217, DOI 10.2174/138920106777549777; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; Lohmann SM, 2005, FRONT BIOSCI, V10, P1313, DOI 10.2741/1621; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mundell SJ, 2006, MOL PHARMACOL, V70, P1132, DOI 10.1124/mol.106.023549; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Schultess J, 2005, BLOOD, V105, P3185, DOI 10.1182/blood-2004-09-3605; Smolenski A, 2000, J BIOL CHEM, V275, P25723, DOI 10.1074/jbc.M909632199; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Stafford MJ, 2003, BLOOD, V101, P1392, DOI 10.1182/blood-2002-08-2384; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; WheelerJones CPD, 1996, BIOCHEM J, V315, P41, DOI 10.1042/bj3150041; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; Yacoub D, 2006, J BIOL CHEM, V281, P30024, DOI 10.1074/jbc.M604504200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	41	34	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2297	2306		10.1074/jbc.M706825200	http://dx.doi.org/10.1074/jbc.M706825200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039662	Green Submitted, hybrid			2022-12-25	WOS:000252501000057
J	Hale, BG; Batty, IH; Downes, CP; Randall, RE				Hale, Benjamin G.; Batty, Ian H.; Downes, C. Peter; Randall, Richard E.			Binding of influenza A virus NS1 protein to the inter-SH2 domain of p85 beta suggests a novel mechanism for phosphoinositide 3-kinase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P85 REGULATORY SUBUNIT; RNA-BINDING; PHOSPHATIDYLINOSITOL 3-KINASE; CATALYTIC SUBUNIT; EFFECTOR DOMAIN; INFECTED-CELLS; PI 3-KINASE; SH2 DOMAINS; PATHWAY; KINASE	Influenza A virus NS1 protein stimulates host-cell phosphoinositide 3-kinase (PI3K) signaling by binding to the p85 beta regulatory subunit of PI3K. Here, in an attempt to establish a mechanism for this activation, we report further on the functional interaction between NS1 and p85 beta. Complex formation was found to be independent of NS1 RNA binding activity and is mediated by the C-terminal effector domain of NS1. Intriguingly, the primary direct binding site for NS1 on p85 beta is the inter-SH2 domain, a coiled-coil structure that acts as a scaffold for the p110 catalytic subunit of PI3K. In vitro kinase activity assays, together with protein binding competition studies, reveal that NS1 does not displace p110 from the inter-SH2 domain, and indicate that NS1 can form an active heterotrimeric complex with PI3K. In addition, it was established that residues at the C terminus of the inter-SH2 domain are essential for mediating the interaction between p85 beta and NS1. Equivalent residues in p85 alpha have previously been implicated in the basal inhibition of p110. However, such p85 alpha residues were unable to substitute for those in p85 alpha with regards NS1 binding. Overall, these data suggest a model by which NS1 activates PI3K catalytic activity by masking a normal regulatory element specific to the p85 beta inter-SH2 domain.	[Hale, Benjamin G.; Randall, Richard E.] Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland; [Batty, Ian H.; Downes, C. Peter] Univ Dundee, Fac Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland	University of St Andrews; University of Dundee	Hale, BG (corresponding author), Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland.	bgh1@st-andrews.ac.uk	Hale, Benjamin G./D-4958-2015	Hale, Benjamin G./0000-0002-3891-9480	Medical Research Council [G9403619, G0601126] Funding Source: Medline; MRC [G0601126, G9403619] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Batty IH, 2004, BIOCHEM J, V379, P641, DOI 10.1042/BJ20031700; Bornholdt ZA, 2006, NAT STRUCT MOL BIOL, V13, P559, DOI 10.1038/nsmb1099; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; CARPENTER CL, 1993, J BIOL CHEM, V268, P9478; CARPENTER CL, 1993, MOL CELL BIOL, V13, P1657, DOI 10.1128/MCB.13.3.1657; Chan TO, 2002, CANCER CELL, V1, P181, DOI 10.1016/S1535-6108(02)00033-8; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Ehrhardt C, 2006, CELL MICROBIOL, V8, P1336, DOI 10.1111/j.1462-5822.2006.00713.x; Foukas LC, 2004, MOL CELL BIOL, V24, P966, DOI 10.1128/MCB.24.3.966-975.2004; Fu Z, 2004, ARCH BIOCHEM BIOPHYS, V432, P244, DOI 10.1016/j.abb.2004.09.032; Fu Z, 2003, P NATL ACAD SCI USA, V100, P3275, DOI 10.1073/pnas.0535975100; Garcia-Sastre A, 2005, MODULATION OF HOST GENE EXPRESSION AND INNATE IMMUNITY BY VIRUSES, P95, DOI 10.1007/1-4020-3242-0_5; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Gout I, 2000, EMBO J, V19, P4015, DOI 10.1093/emboj/19.15.4015; GREENSPAN D, 1988, J VIROL, V62, P3020, DOI 10.1128/JVI.62.8.3020-3026.1988; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Ichaso N, 2001, ONCOGENE, V20, P7908, DOI 10.1038/sj.onc.1204859; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864; Linnemann T, 2002, VIROLOGY, V294, P246, DOI 10.1006/viro.2002.1365; Ludwig S, 2002, J VIROL, V76, P11166, DOI 10.1128/JVI.76.21.11166-11171.2002; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Qian XY, 1995, RNA, V1, P948; RORDORFNIKOLIC T, 1995, J BIOL CHEM, V270, P3662, DOI 10.1074/jbc.270.8.3662; Shekar SC, 2005, J BIOL CHEM, V280, P27850, DOI 10.1074/jbc.M506005200; Shin YK, 2007, J VIROL, V81, P12730, DOI 10.1128/JVI.01427-07; Shin YK, 2007, J GEN VIROL, V88, P942, DOI 10.1099/vir.0.82483-0; Shin YK, 2007, J GEN VIROL, V88, P13, DOI 10.1099/vir.0.82419-0; Street A, 2004, J BIOL CHEM, V279, P12232, DOI 10.1074/jbc.M312245200; Talon J, 2000, J VIROL, V74, P7989, DOI 10.1128/JVI.74.17.7989-7996.2000; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Twu KY, 2006, J VIROL, V80, P3957, DOI 10.1128/JVI.80.8.3957-3965.2006; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Wang W, 1999, RNA, V5, P195, DOI 10.1017/S1355838299981621; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; ZHENG Y, 1994, J BIOL CHEM, V269, P18727; Zhirnov OP, 2007, APOPTOSIS, V12, P1419, DOI 10.1007/s10495-007-0071-y; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zhu ZQ, 2007, BIOCHEM BIOPH RES CO, V358, P66, DOI 10.1016/j.bbrc.2007.04.096	53	55	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1372	1380		10.1074/jbc.M708862200	http://dx.doi.org/10.1074/jbc.M708862200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18029356	hybrid			2022-12-25	WOS:000252282700020
J	Su, Q; Wang, S; Gao, HQ; Kazemi, S; Harding, HP; Ron, D; Koromilas, AE				Su, Qiaozhu; Wang, Shuo; Gao, Hong Qing; Kazemi, Shirin; Harding, Heather P.; Ron, David; Koromilas, Antonis E.			Modulation of the eukaryotic initiation factor 2 alpha-subunit kinase PERK by tyrosine phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; NF-KAPPA-B; TRANSLATIONAL CONTROL; EIF2-ALPHA KINASE; PKR; ACTIVATION; SUBSTRATE; STRESS; ELF2-ALPHA; INTERACT	The endoplasmic reticulum (ER)-resident protein kinase PERK attenuates protein synthesis in response to ER stress through the phosphorylation of translation initiation factor eIF2 alpha at serine 51. ER stress induces PERK autophosphorylation at several serine/threonine residues, a process that is required for kinase activation and phosphorylation of eIF2 alpha. Herein, we demonstrate that PERK also possesses tyrosine kinase activity. Specifically, we show that PERK is capable of autophosphorylating on tyrosine residues in vitro and in vivo. We further show that tyrosine 615, which is embedded in a highly conserved region of the kinase domain of PERK, is essential for autocatalytic activity. That is, mutation of Tyr-615 to phenylalanine compromises the autophosphorylation capacity of PERK and the phosphorylation of eIF2 alpha in vitro and in vivo. The Y615F mutation also impairs the ability of PERK to induce translation of ATF4. Immunoblot analyses with a phospho-specific antibody confirm the phosphorylation of PERK at Tyr- 615 both in vitro and in vivo. Thus, our data classify PERK as a dual specificity kinase whose regulation by tyrosine phosphorylation contributes to its optimal activation in response to ER stress.	[Su, Qiaozhu; Wang, Shuo; Gao, Hong Qing; Kazemi, Shirin; Koromilas, Antonis E.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Harding, Heather P.; Ron, David] NYU, Sch Med, Skirball Inst, New York, NY 10016 USA	Lady Davis Institute; McGill University; New York University	Koromilas, AE (corresponding author), Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, 3999 Cote-Ste-Catherine St, Montreal, PQ H3T 1E2, Canada.	antonis.koromilas@mcgill.ca		Ron, David/0000-0002-3014-5636; Harding, Heather P/0000-0002-7359-7974				Abbott CM, 2004, TRENDS BIOCHEM SCI, V29, P25, DOI 10.1016/j.tibs.2003.11.006; Baltzis D, 2004, J VIROL, V78, P12747, DOI 10.1128/JVI.78.23.12747-12761.2004; Baltzis D, 2002, J BIOL CHEM, V277, P38364, DOI 10.1074/jbc.M203564200; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Brand SR, 1997, J BIOL CHEM, V272, P8388, DOI 10.1074/jbc.272.13.8388; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chen JJ, 2000, COLD SPRING HARBOR M, V39, P529; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Cuddihy AR, 1999, ONCOGENE, V18, P2690, DOI 10.1038/sj.onc.1202620; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Ibarra-Sanchez MD, 2000, SEMIN IMMUNOL, V12, P379, DOI 10.1006/smim.2000.0220; Ibarra-Sanchez MD, 2001, ONCOGENE, V20, P4728, DOI 10.1038/sj.onc.1204648; Kaufman RJ, 2000, COLD SPRING HARBOR M, V39, P503; Kazemi S, 2004, MOL CELL BIOL, V24, P3415, DOI 10.1128/MCB.24.8.3415-3429.2004; Kimball S R, 2001, Prog Mol Subcell Biol, V26, P155; Kimball Sr, 2000, COLD SPRING HARBOR M, V39, P561; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Li SY, 2001, J BIOL CHEM, V276, P13881, DOI 10.1074/jbc.M008140200; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Ma YL, 2001, RAPID COMMUN MASS SP, V15, P1693, DOI 10.1002/rcm.426; MCMILLAN NAJ, 1995, VIROLOGY, V213, P413, DOI 10.1006/viro.1995.0014; Proud C G, 2001, Prog Mol Subcell Biol, V26, P95; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Ron D, 2000, COLD SPRING HARBOR M, V39, P547; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Saunders LR, 2001, J BIOL CHEM, V276, P32300, DOI 10.1074/jbc.M104207200; Su QZ, 2007, EMBO REP, V8, P265, DOI 10.1038/sj.embor.7400891; Su QZ, 2006, P NATL ACAD SCI USA, V103, P63, DOI 10.1073/pnas.0508207103; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang S, 2006, J BIOL CHEM, V281, P9439, DOI 10.1074/jbc.M504977200; Wong AHT, 2001, J BIOL CHEM, V276, P13727, DOI 10.1074/jbc.M011240200; Zhu SH, 1996, J BIOL CHEM, V271, P24989, DOI 10.1074/jbc.271.40.24989	40	56	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					469	475		10.1074/jbc.M704612200	http://dx.doi.org/10.1074/jbc.M704612200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17998206	hybrid			2022-12-25	WOS:000251940300052
J	Varma, H; Skildum, AJ; Conrad, SE				Varma, Hemant; Skildum, Andrew J.; Conrad, Susan E.			Functional Ablation of pRb Activates Cdk2 and Causes Antiestrogen Resistance in Human Breast Cancer Cells	PLOS ONE			English	Article								Estrogens are required for the proliferation of hormone dependent breast cancer cells, making estrogen receptor ( ER) positive tumors amenable to endocrine therapies such as antiestrogens. However, resistance to these agents remains a significant cause of treatment failure. We previously demonstrated that inactivation of the retinoblastoma protein (pRb) family tumor suppressors causes antiestrogen resistance in MCF-7 cells, a widely studied model of estrogen responsive human breast cancers. In this study, we investigate the mechanism by which pRb inactivation leads to antiestrogen resistance. Cdk4 and cdk2 are two key cell cycle regulators that can phosphorylate and inactivate pRb, therefore we tested whether these kinases are required in cells lacking pRb function. pRb family members were inactivated in MCF-7 cells by expressing polyomavirus large tumor antigen (PyLT), and cdk activity was inhibited using the cdk inhibitors p16(INK4A) and p21(Waf1/Cip1). Cdk4 activity was no longer required in cells lacking functional pRb, while cdk2 activity was required for proliferation in both the presence and absence of pRb function. Using inducible PyLT cell lines, we further demonstrated that pRb inactivation leads to increased cyclin A expression, cdk2 activation and proliferation in antiestrogen arrested cells. These results demonstrate that antiestrogens do not inhibit cdk2 activity or proliferation of MCF-7 cells in the absence of pRb family function, and suggest that antiestrogen resistant breast cancer cells resulting from pRb pathway inactivation would be susceptible to therapies that target cdk2.	[Varma, Hemant] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Skildum, Andrew J.; Conrad, Susan E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Varma, H (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	hv2108@columbia.edu			NIH [CA76647]; Jean P. Schultz Endowed Oncology Fund for Cancer Research, Michigan State University; NATIONAL CANCER INSTITUTE [R01CA076647] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jean P. Schultz Endowed Oncology Fund for Cancer Research, Michigan State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH Grant CA76647 and Jean P. Schultz Endowed Oncology Fund for Cancer Research, Michigan State University	Alevizopoulos K, 1998, EMBO J, V17, P5987, DOI 10.1093/emboj/17.20.5987; Bosco EE, 2007, CELL CYCLE, V6, P667, DOI 10.4161/cc.6.6.3988; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Brodsky JL, 1998, J VIROL, V72, P5329, DOI 10.1128/JVI.72.7.5329-5334.1998; BRUNNER N, 1989, CANCER RES, V49, P1515; Camarda G, 2004, J CELL BIOL, V167, P417, DOI 10.1083/jcb.200408164; Cariou S, 2000, P NATL ACAD SCI USA, V97, P9042, DOI 10.1073/pnas.160016897; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Chu I, 2005, CANCER RES, V65, P18; Cigler T, 2007, CANCER J, V13, P148, DOI 10.1097/PPO.0b013e318074d363; DARBRE P, 1983, CANCER RES, V43, P349; Dublin EA, 1998, INT J CANCER, V79, P71, DOI 10.1002/(SICI)1097-0215(19980220)79:1<71::AID-IJC14>3.0.CO;2-K; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; Fischer PM, 2005, EXPERT OPIN INV DRUG, V14, P457, DOI 10.1517/13543784.14.4.457; Foster JS, 2001, MOL CELL BIOL, V21, P794, DOI 10.1128/MCB.21.3.794-810.2001; Howes SH, 1996, J VIROL, V70, P3581, DOI 10.1128/JVI.70.6.3581-3588.1996; Jares P, 1997, J PATHOL, V182, P160; Levenson AS, 1997, CANCER RES, V57, P3071; LIPPMAN M, 1976, CANCER RES, V36, P4595; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; Mann DJ, 1996, CURR BIOL, V6, P474, DOI 10.1016/S0960-9822(02)00515-8; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; MELORA DB, 1998, PRINCIPLES MOL MED, P625; Mukherjee S, 2005, J BIOL CHEM, V280, P17617, DOI 10.1074/jbc.M502278200; OSBORNE CK, 1984, CANCER RES, V44, P1433; PlanasSilva MD, 1997, MOL CELL BIOL, V17, P4059, DOI 10.1128/MCB.17.7.4059; Prall OWJ, 1998, MOL CELL BIOL, V18, P4499, DOI 10.1128/MCB.18.8.4499; Prall OWJ, 1997, J BIOL CHEM, V272, P10882; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; SCHULZE A, 1995, P NATL ACAD SCI USA, V92, P11264, DOI 10.1073/pnas.92.24.11264; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Skildum AJ, 2002, J BIOL CHEM, V277, P5145, DOI 10.1074/jbc.M109179200; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; VARLEY JM, 1989, ONCOGENE, V4, P725; Varma H, 2000, ONCOGENE, V19, P4746, DOI 10.1038/sj.onc.1203827; Varma H, 2002, CANCER RES, V62, P3985; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Zhang XH, 2000, MOL BIOL CELL, V11, P2117, DOI 10.1091/mbc.11.6.2117	40	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1256	10.1371/journal.pone.0001256	http://dx.doi.org/10.1371/journal.pone.0001256			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060053	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459400005
J	Ruiz, MF; Milano, A; Salvemini, M; Eirin-Lopez, JM; Perondini, ALP; Selivon, D; Polito, C; Saccone, G; Sanchez, L				Fernanda Ruiz, Maria; Milano, Andreina; Salvemini, Marco; Maria Eirin-Lopez, Jose; Perondini, Andre L. P.; Selivon, Denise; Polito, Catello; Saccone, Giuseppe; Sanchez, Lucas			The Gene Transformer of Anastrepha Fruit Flies (Diptera, Tephritidae) and Its Evolution in Insects	PLOS ONE			English	Article							SEX-DETERMINING GENE; DROSOPHILA-MELANOGASTER; DOUBLESEX; RNA; DIFFERENTIATION; SEQUENCE; LETHAL; CONSERVATION; MAINTAINS; ENCODES	In the tephritids Ceratitis capitata and Bactrocera oleae, the gene transformer acts as the memory device for sex determination, via an auto-regulatory function; and functional Tra protein is produced only in females. This paper investigates the evolution of the gene tra, which was characterised in twelve tephritid species belonging to the less extensively analysed genus Anastrepha. Our study provided the following major conclusions. Firstly, the memory device mechanism used by this gene in sex determination in tephritids likely existed in the common ancestor of the Ceratitis, Bactrocera and Anastrepha phylogenetic lineages. This mechanism would represent the ancestral state with respect to the extant cascade seen in the more evolved Drosophila lineage. Secondly, Transformer2-specific binding intronic splicing silencer sites were found in the splicing regulatory region of transformer but not in doublesex pre-mRNAs in these tephritids. Thus, these sites probably provide the discriminating feature for the putative dual splicing activity of the Tra-Tra2 complex in tephritids. It acts as a splicing activator in dsx pre-mRNA splicing (its binding to the female-specific exon promotes the inclusion of this exon into the mature mRNA), and as a splicing inhibitor in tra pre-mRNA splicing (its binding to the male-specific exons prevents the inclusion of these exons into the mature mRNA). Further, a highly conserved region was found in the specific amino-terminal region of the tephritid Tra protein that might be involved in Tra auto-regulatory function and hence in its repressive splicing behaviour. Finally, the Tra proteins conserved the SR dipeptides, which are essential for Tra functionality.	[Fernanda Ruiz, Maria; Sanchez, Lucas] CSIC, Ctr Invest Biol, Madrid, Spain; [Milano, Andreina; Salvemini, Marco; Polito, Catello; Saccone, Giuseppe] Univ Naples Federico II, Sez Genet & Biol Mol, Dipartimento Sci Biol, Naples, Italy; [Polito, Catello] CNR, Inst Genet & Biofis Adriano Buzzati Traverso ABT, I-80125 Naples, Italy; [Maria Eirin-Lopez, Jose] Univ A Coruna, Dept Biol Celular & Mol, Coruna, Spain; [Perondini, Andre L. P.; Selivon, Denise] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Universidade da Coruna; Universidade de Sao Paulo	Sanchez, L (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	lsanchez@cib.csic.es	Eirin-Lopez, Jose Maria/A-5618-2008; Ruiz, Maria Fernanda/F-3290-2016; saccone, giuseppe/F-8627-2013; Sánchez, Lucas/K-4238-2015; Perondini, André/B-2393-2014; Salvemini, Marco/AAJ-5560-2021	Eirin-Lopez, Jose Maria/0000-0002-8041-9770; saccone, giuseppe/0000-0002-9835-3693; Sánchez, Lucas/0000-0002-7725-8961; SALVEMINI, Marco/0000-0003-2297-9267; Ruiz, Maria Fernanda/0000-0002-1649-2105	D.G.I.C.Y.T. [BFU2005-03000]; PRIN; Insect Biotechnology PhD Programme; CSIC [20004BR0005, 20004IT0017]; CNPq [690088/02-7]; FAPESP [03/02698-3]; Fondo PRIN 2006 (Ministero dell'Istruzione, dell'Universita e della Ricerca); ASTF [168-05]; European Community	D.G.I.C.Y.T.(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Insect Biotechnology PhD Programme; CSIC; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fondo PRIN 2006 (Ministero dell'Istruzione, dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); ASTF; European Community(European Commission)	This work was financed by grants BFU2005-03000 awarded to L. Sanchez by the D.G.I.C.Y.T., by grant PRIN 2004 to C. Polito, by the Insect Biotechnology PhD Programme for A. Milano; by grants from a Joint Programme of the CSIC (20004BR0005 to L. Sanchez, Spain) and CNPq (690088/02-7 to ALP Perondini, Brazil), and a grant to D. Selivon (FAPESP, 03/02698-3, Brazil), and grant from a Joint Programme of the CSIC (20004IT0017) to L. Sanchez (Spain) and C. Polito (Italy). The work was partially supported by Fondo PRIN 2006 (Ministero dell'Istruzione, dell'Universita e della Ricerca) to C. Polito. M. F. Ruiz was recipient of a Short-term EMBO fellowship (ASTF Nu 168-05). J. M. Eirin-Lopez was awarded a Postdoctoral Marie Curie International Fellowship within the 6th European Community Framework Programme.	AMREIN H, 1990, EMBO J, V9, P3619, DOI 10.1002/j.1460-2075.1990.tb07573.x; Barr NB, 2005, ANN ENTOMOL SOC AM, V98, P173, DOI 10.1603/0013-8746(2005)098[0173:MSONGP]2.0.CO;2; BELL LR, 1991, CELL, V65, P229, DOI 10.1016/0092-8674(91)90157-T; BELOTE JM, 1989, DEV GENET, V10, P143, DOI 10.1002/dvg.1020100304; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BOGGS RT, 1987, CELL, V50, P739, DOI 10.1016/0092-8674(87)90332-1; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; CLINE TW, 1984, GENETICS, V107, P231; Ruiz MF, 2007, DEV GENES EVOL, V217, P725, DOI 10.1007/s00427-007-0178-8; GORALSKI TJ, 1989, CELL, V56, P1011, DOI 10.1016/0092-8674(89)90634-X; HEDLEY ML, 1991, CELL, V65, P579, DOI 10.1016/0092-8674(91)90090-L; HEINRICHS V, 1995, EMBO J, V14, P3987, DOI 10.1002/j.1460-2075.1995.tb00070.x; Hertel KJ, 1996, RNA, V2, P969; HOSHIJIMA K, 1991, SCIENCE, V252, P833, DOI 10.1126/science.1902987; INOUE K, 1990, NATURE, V344, P461, DOI 10.1038/344461a0; IRMINGERFINGER I, 1995, GENE, V163, P203, DOI 10.1016/0378-1119(95)00326-2; Kulathinal RJ, 2003, MOL BIOL EVOL, V20, P441, DOI 10.1093/molbev/msg053; Lagos D, 2007, INSECT MOL BIOL, V16, P221, DOI 10.1111/j.1365-2583.2006.00717.x; Maniatis T., 1982, MOL CLONING; McAllister BF, 2000, GENETICS, V154, P1711; MCKEOWN M, 1987, CELL, V48, P489, DOI 10.1016/0092-8674(87)90199-1; NAGOSHI RN, 1988, CELL, V53, P229, DOI 10.1016/0092-8674(88)90384-4; Norrbom AL, 2002, P ENTOMOL SOC WASH, V104, P390; Norrbom AL, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P299; ONEIL MT, 1992, GENETICS, V131, P113; Pane A, 2005, GENETICS, V171, P615, DOI 10.1534/genetics.105.041004; Pane A, 2002, DEVELOPMENT, V129, P3715; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pomiankowski A, 2004, GENETICS, V166, P1761, DOI 10.1534/genetics.166.4.1761; Qi JL, 2007, MOL CELL BIOL, V27, P699, DOI 10.1128/MCB.01572-06; Ruiz MF, 2005, GENETICS, V171, P849, DOI 10.1534/genetics.105.044925; RYNER LC, 1991, GENE DEV, V5, P2071, DOI 10.1101/gad.5.11.2071; SANCHEZ L, 2005, COMPREHENSIVE MOL IN, V1, P1; Selivon D., 2004, Proceedings of the 6th International Symposium on fruit flies of economic importance, Stellenbosch, South Africa, 6-10 May 2002, P253; Selivon D, 2005, ANN ENTOMOL SOC AM, V98, P367, DOI 10.1603/0013-8746(2005)098[0367:AGCOTC]2.0.CO;2; Serna E, 2004, GENETICS, V168, P907, DOI 10.1534/genetics.104.031278; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TIAN M, 1993, CELL, V74, P105, DOI 10.1016/0092-8674(93)90298-5; WILKINS AS, 1995, BIOESSAYS, V17, P71, DOI 10.1002/bies.950170113; Willhoeft U, 1996, GENETICS, V144, P737	40	72	77	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1239	10.1371/journal.pone.0001239	http://dx.doi.org/10.1371/journal.pone.0001239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043746	Green Published, gold			2022-12-25	WOS:000207459300020
J	Stoddart, CA; Joshi, P; Sloan, B; Bare, JC; Smith, PC; Allaway, GP; Wild, CT; Martin, DE				Stoddart, Cheryl A.; Joshi, Pheroze; Sloan, Barbara; Bare, Jennifer C.; Smith, Philip C.; Allaway, Graham P.; Wild, Carl T.; Martin, David E.			Potent Activity of the HIV-1 Maturation Inhibitor Bevirimat in SCID-hu Thy/Liv Mice	PLOS ONE			English	Article								Background. The HIV-1 maturation inhibitor, 3-O-(39,39-dimethylsuccinyl) betulinic acid (bevirimat, PA-457) is a promising drug candidate with 10 nM in vitro antiviral activity against multiple wild-type (WT) and drug-resistant HIV-1 isolates. Bevirimat has a novel mechanism of action, specifically inhibiting cleavage of spacer peptide 1 (SP1) from the C-terminus of capsid which results in defective core condensation. Methods and Findings. Oral administration of bevirimat to HIV-1-infected SCID-hu Thy/Liv mice reduced viral RNA by >2 log(10) and protected immature and mature T cells from virus-mediated depletion. This activity was observed at plasma concentrations that are achievable in humans after oral dosing, and bevirimat was active up to 3 days after inoculation with both WT HIV-1 and an AZT-resistant HIV-1 clinical isolate. Consistent with its mechanism of action, bevirimat caused a dose-dependent inhibition of capsid-SP1 cleavage in HIV-1-infected human thymocytes obtained from these mice. HIV-1 NL4-3 with an alanine-to-valine substitution at the N-terminus of SP1 (SP1/A1V), which is resistant to bevirimat in vitro, was also resistant to bevirimat treatment in the mice, and SP1/AIV had replication and thymocyte kinetics similar to that of WT NL4-3 with no evidence of fitness impairment in in vivo competition assays. Interestingly, protease inhibitor-resistant HIV-1 with impaired capsid-SP1 cleavage was hypersensitive to bevirimat in vitro with a 50% inhibitory concentration 140 times lower than for WT HIV-1. Conclusions. These results support further clinical development of this first-in-class maturation inhibitor and confirm the usefulness of the SCID-hu Thy/Liv model for evaluation of in vivo antiretroviral efficacy, drug resistance, and viral fitness.	[Stoddart, Cheryl A.; Joshi, Pheroze; Sloan, Barbara; Bare, Jennifer C.] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA; [Smith, Philip C.] Univ N Carolina, Sch Pharm, Chapel Hill, NC USA; [Allaway, Graham P.; Wild, Carl T.; Martin, David E.] Panacos Pharmaceut, Gaithersburg, MD USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of North Carolina; University of North Carolina Chapel Hill	Stoddart, CA (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Expt Med, San Francisco, CA 94143 USA.	cheryl.stoddart@ucsf.edu		Martin, David/0000-0003-2820-5983	NIAID; NIH [N01-AI-05418, N01-AI-70002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005418] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This project has been funded in whole or in part with Federal funds from NIAID, NIH, under contract no. N01-AI-05418 and N01-AI-70002.	Accola MA, 1998, J VIROL, V72, P2072, DOI 10.1128/JVI.72.3.2072-2078.1998; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Adamson CS, 2006, J VIROL, V80, P10957, DOI 10.1128/JVI.01369-06; BAST RC, 2000, CANC MED E 5 ONLINE; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Hashimoto F, 1997, BIOORGAN MED CHEM, V5, P2133, DOI 10.1016/S0968-0896(97)00158-2; Kanamoto T, 2001, ANTIMICROB AGENTS CH, V45, P1225, DOI 10.1128/AAC.45.4.1225-1230.2001; Kashiwada Y, 1996, J MED CHEM, V39, P1016, DOI 10.1021/jm950922q; Li F, 2003, P NATL ACAD SCI USA, V100, P13555, DOI 10.1073/pnas.2234683100; Li F, 2006, VIROLOGY, V356, P217, DOI 10.1016/j.virol.2006.07.023; Liang C, 2002, J VIROL, V76, P11729, DOI 10.1128/JVI.76.22.11729-11737.2002; Mammano F, 1998, J VIROL, V72, P7632, DOI 10.1128/JVI.72.9.7632-7637.1998; Martin DE, 2007, ANTIMICROB AGENTS CH, V51, P3063, DOI 10.1128/AAC.01391-06; Martin DE, 2007, CLIN PHARMACOKINET, V46, P589, DOI 10.2165/00003088-200746070-00004; NAMIKAWA R, 1990, J EXP MED, V172, P1055, DOI 10.1084/jem.172.4.1055; Pillay D, 2005, J INFECT DIS, V192, P967, DOI 10.1086/432763; Rabin L, 1996, ANTIMICROB AGENTS CH, V40, P755, DOI 10.1128/AAC.40.3.755; Sakalian M, 2006, J VIROL, V80, P5716, DOI 10.1128/JVI.02743-05; Smith PF, 2007, ANTIMICROB AGENTS CH, V51, P3574, DOI 10.1128/AAC.00152-07; Stoddart CA, 2000, ANTIMICROB AGENTS CH, V44, P783, DOI 10.1128/AAC.44.3.783-786.2000; Stoddart CA, 2001, NAT MED, V7, P712, DOI 10.1038/89090; Stoddart CA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000655; Vogt VM, 1996, CURR TOP MICROBIOL, V214, P95; Wen ZM, 2006, DRUG METAB DISPOS, V34, P1436, DOI 10.1124/dmd.106.009233; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998; Yu DG, 2005, EXPERT OPIN INV DRUG, V14, P681, DOI 10.1517/13543784.14.6.681; Zennou V, 1998, J VIROL, V72, P3300, DOI 10.1128/JVI.72.4.3300-3306.1998; Zhou J, 2005, J BIOL CHEM, V280, P42149, DOI 10.1074/jbc.M508951200; Zhou J, 2004, J VIROL, V78, P922, DOI 10.1128/JVI.78.2.922-929.2004; Zhou J, 2006, J VIROL, V80, P12095, DOI 10.1128/JVI.01626-06; Zhou Jing, 2004, Retrovirology, V1, P15, DOI 10.1186/1742-4690-1-15	33	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1251	10.1371/journal.pone.0001251	http://dx.doi.org/10.1371/journal.pone.0001251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043758	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459300032
J	Rechavi, O; Goldstein, I; Vernitsky, H; Rotblat, B; Kloog, Y				Rechavi, Oded; Goldstein, Itamar; Vernitsky, Helly; Rotblat, Barak; Kloog, Yoel			Intercellular Transfer of Oncogenic H-Ras at the Immunological Synapse	PLOS ONE			English	Article								Immune cells establish dynamic adhesive cell-cell interactions at a specific contact region, termed the immunological synapse (IS). Intriguing features of the IS are the formation of regions of plasma membrane fusion and the intercellular exchange of membrane fragments between the conjugated cells. It is not known whether upon IS formation, intact intracellular proteins can transfer from target cells to lymphocytes to allow the transmission of signals across cell boundaries. Here we show by both FACS and confocal microscopy that human lymphocytes acquire from the cells they scan the inner-membrane protein H-Ras, a G-protein vital for common lymphocyte functions and a prominent participant in human cancer. The transfer was cell contact-dependent and occurred in the context of cell-conjugate formation. Moreover, the acquisition of oncogenic H-RasG12V by natural killer (NK) and T lymphocytes had important biological functions in the adopting lymphocytes: the transferred H-RasG12V induced ERK phosphorylation, increased interferon-gamma and tumor necrosis factor-alpha secretion, enhanced lymphocyte proliferation, and augmented NK-mediated target cell killing. Our findings reveal a novel mode of cell-to-cell communication-allowing lymphocytes to extend the confines of their own proteome-which may moreover play an important role in natural tumor immunity.	[Goldstein, Itamar; Vernitsky, Helly] Chaim Sheba Med Ctr, Canc Res Ctr, Program Immunol, IL-52621 Tel Hashomer, Israel; [Goldstein, Itamar; Vernitsky, Helly] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Rechavi, Oded; Rotblat, Barak; Kloog, Yoel] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Goldstein, I (corresponding author), Chaim Sheba Med Ctr, Canc Res Ctr, Program Immunol, IL-52621 Tel Hashomer, Israel.	Itamar.Goldstein@sheba.health.gov.il; kloog@post.tau.ac.il	Rotblat, Barak/H-5970-2019	Rotblat, Barak/0000-0003-2985-7115; Goldstein, Itamar/0000-0001-5393-186X; Rechavi, Oded/0000-0001-6172-3024	Wolfson Foundation; Israel Science Foundation [912/06]	Wolfson Foundation; Israel Science Foundation(Israel Science Foundation)	This work was supported in part by grants to YK from the Wolfson Foundation and the Israel Science Foundation grant 912/06.	Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Caumartin J, 2007, EMBO J, V26, P1423, DOI 10.1038/sj.emboj.7601570; Chen X, 2006, P NATL ACAD SCI USA, V103, P10346, DOI 10.1073/pnas.0604236103; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Delon J, 2000, CURR BIOL, V10, pR923, DOI 10.1016/S0960-9822(00)00870-8; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; Goldstein I, 2003, J CLIN INVEST, V112, P1444, DOI 10.1172/JCI200319607; Goldstein I, 2007, J IMMUNOL, V178, P201, DOI 10.4049/jimmunol.178.1.201; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hudrisier D, 2007, J IMMUNOL, V178, P3637, DOI 10.4049/jimmunol.178.6.3637; Hwang IY, 2003, P NATL ACAD SCI USA, V100, P6670, DOI 10.1073/pnas.1131852100; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; JOHNSON PW, 1987, J IMMUNOL, V138, P3996; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Kienzle N, 2002, J IMMUNOL METHODS, V267, P99, DOI 10.1016/S0022-1759(02)00150-3; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mainiero F, 1998, J EXP MED, V188, P1267, DOI 10.1084/jem.188.7.1267; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; MARRACK P, 1988, NATURE, V332, P840, DOI 10.1038/332840a0; McCann FE, 2007, J IMMUNOL, V178, P3418, DOI 10.4049/jimmunol.178.6.3418; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Poupot M, 2005, J IMMUNOL, V174, P1717, DOI 10.4049/jimmunol.174.3.1717; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Rotblat B, 2006, CANCER RES, V66, P1974, DOI 10.1158/0008-5472.CAN-05-3791; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Saha K, 1996, J IMMUNOL, V157, P3876; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; SPRENT J, 2005, SCI STKE, pPE8; Wei S, 1998, J EXP MED, V187, P1753, DOI 10.1084/jem.187.11.1753; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394	35	34	34	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1204	10.1371/journal.pone.0001204	http://dx.doi.org/10.1371/journal.pone.0001204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030338	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459200017
J	Gonzalez, RD; Pertejo, YP; Ordonez, D; Balana-Fouce, R; Reguera, RM				Diaz Gonzalez, Rosario; Perez Pertejo, Yolanda; Ordonez, David; Balana-Fouce, Rafael; Reguera, Rosa M.			Deletion Study of DNA Topoisomerase IB from Leishmania donovani: Searching for a Minimal Functional Heterodimer	PLOS ONE			English	Article							CAMPTOTHECIN; RESISTANCE; INHIBITOR; PROTEIN; LINKER	The substantial differences between trypanosomal and leishmanial DNA topoisomerase IB concerning to their homologues in mammals have provided a new lead in the study of the structural determinants that can be effectively targeted. Leishmania donovani, the causative agent of visceral leishmaniasis, contains an unusual heterodimeric DNA topoisomerase IB. The catalytically active enzyme consists of a large subunit (LdTopIL), which contains the non-conserved N-terminal end and the phylogenetically conserved "core'' domain, and of a small subunit (LdTopIS) which harbors the C-terminal region with the characteristic tyrosine residue in the active site. Heterologous co-expression of LdTopIL and LdTopIS genes in a topoisomerase I deficient yeast strain, reconstitutes a fully functional enzyme LdTopIL/S which can be used for structural studies. An approach by combinatorial cloning of deleted genes encoding for truncated versions of both subunits was used in order to find out structural insights involved in enzyme activity or protein-protein interaction. The role played by the non-conserved N-terminal extension of LdTopIL in both relaxation activity and CPT sensitivity has been examined co-expressing the full-length LdTopIS and a fully active LdTopI Delta S deletion with several deletions of LdTopIL lacking growing sequences of the N-terminal end. The sequential deletion study shows that the first 26 amino acids placed at the N-terminal end and a variable region comprised between Ala548 to end of the C-terminal extension of LdTopIL were enzymatically dispensable. Altogether this combinatorial approach provides important structural insights of the regions involved in relaxation activity and for understanding the atypical structure of this heterodimeric enzyme.	[Diaz Gonzalez, Rosario; Perez Pertejo, Yolanda; Ordonez, David; Balana-Fouce, Rafael; Reguera, Rosa M.] Univ Leon, Dept Farmacol & Toxicol INTOXCAL, E-24071 Leon, Spain	Universidad de Leon	Balana-Fouce, R (corresponding author), Univ Leon, Dept Farmacol & Toxicol INTOXCAL, E-24071 Leon, Spain.	rbalf@unileon.es	Díaz, Rosario/GPW-5555-2022; Pérez-Pertejo, Yolanda/K-6609-2017; Balana-Fouce, Rafael/AAK-9485-2021; Balana-Fouce, Rafael/K-4890-2014; Reguera, Rosa M/K-6027-2017	Pérez-Pertejo, Yolanda/0000-0003-2361-3785; Balana-Fouce, Rafael/0000-0003-0418-6116; Balana-Fouce, Rafael/0000-0003-0418-6116; Reguera, Rosa M/0000-0001-9148-2997; Diaz Gonzalez, Rosario/0000-0002-3187-2704	Ministerio de Ciencia y Tecnologia [BMC2002-04107-C02-02, AGL2003 06976/GAN, GL2006-07420/GAN]; Instituto de Salud Carlos III [PI06302]; "Ministerio de Sanidad y Consumo'' from Spain	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); "Ministerio de Sanidad y Consumo'' from Spain	This research was supported by Ministerio de Ciencia y Tecnologia (grants BMC2002-04107-C02-02, AGL2003 06976/GAN and AGL2006-07420/GAN) and Instituto de Salud Carlos III (grant PI06302) from "Ministerio de Sanidad y Consumo'' from Spain.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bakshi RP, 2004, MOL BIOCHEM PARASIT, V136, P249, DOI 10.1016/j.molbiopara.2004.04.006; Balana-Fouce R, 1998, GEN PHARMACOL-VASC S, V30, P435, DOI 10.1016/S0306-3623(97)00268-1; Balana-Fouce R, 2006, DRUG DISCOV TODAY, V11, P733, DOI 10.1016/j.drudis.2006.06.014; Bodley AL, 2003, P NATL ACAD SCI USA, V100, P7539, DOI 10.1073/pnas.1330762100; BODLEY AL, 1995, P NATL ACAD SCI USA, V92, P3726, DOI 10.1073/pnas.92.9.3726; Bodley AL, 1998, BIOCHEM PHARMACOL, V55, P709, DOI 10.1016/S0006-2952(97)00556-X; Bosedasgupta S, 2008, BIOCHEM J, V409, P481, DOI 10.1042/BJ20071358; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broccoli S, 1999, NUCLEIC ACIDS RES, V27, P2745, DOI 10.1093/nar/27.13.2745; Cheesman SJ, 2000, PARASITOL TODAY, V16, P277, DOI 10.1016/S0169-4758(00)01697-5; Das A, 2004, TRENDS PARASITOL, V20, P381, DOI 10.1016/j.pt.2004.06.005; Das A, 2002, NUCLEIC ACIDS RES, V30, P794, DOI 10.1093/nar/30.3.794; Davies DR, 2006, J MOL BIOL, V357, P1202, DOI 10.1016/j.jmb.2006.01.022; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Desai SD, 2001, CANCER RES, V61, P5926; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Gonzalez RD, 2007, BIOCHIMIE, V89, P1517, DOI 10.1016/j.biochi.2007.07.015; Hann CL, 1998, J BIOL CHEM, V273, P31519, DOI 10.1074/jbc.273.47.31519; Ireton GC, 2000, J BIOL CHEM, V275, P25820, DOI 10.1074/jbc.M002144200; JAZWINSKI SM, 1990, METHOD ENZYMOL, V182, P154; Marquis JF, 2005, ANTIMICROB AGENTS CH, V49, P1441, DOI 10.1128/AAC.49.4.1441-1446.2005; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Park H, 1998, CHROMOSOMA, V107, P211, DOI 10.1007/s004120050299; Pommier Y, 2003, MUTAT RES-FUND MOL M, V532, P173, DOI 10.1016/j.mrfmmm.2003.08.016; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Yves, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P429, DOI 10.2174/1568011043352777; PORTER SE, 1989, NUCLEIC ACIDS RES, V17, P8521, DOI 10.1093/nar/17.21.8521; Proulx ME, 2001, ANTIMICROB AGENTS CH, V45, P2623, DOI 10.1128/AAC.45.9.2623-2627.2001; Reguera RM, 2006, BBA-GENE STRUCT EXPR, V1759, P117, DOI 10.1016/j.bbaexp.2006.03.006; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Stewart L, 1999, J BIOL CHEM, V274, P32950, DOI 10.1074/jbc.274.46.32950; Stewart L, 1997, J MOL BIOL, V269, P355, DOI 10.1006/jmbi.1997.1056; THRASH C, 1984, J BIOL CHEM, V259, P1375; Villa H, 2003, J BIOL CHEM, V278, P3521, DOI 10.1074/jbc.M203991200	35	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1177	10.1371/journal.pone.0001177	http://dx.doi.org/10.1371/journal.pone.0001177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000548	Green Submitted, gold, Green Published			2022-12-25	WOS:000207459100019
J	Mash, DC; Ffrench-Mullen, J; Adi, N; Qin, YJ; Buck, A; Pablo, J				Mash, Deborah C.; Ffrench-Mullen, Jarlath; Adi, Nikhil; Qin, Yujing; Buck, Andrew; Pablo, John			Gene Expression in Human Hippocampus from Cocaine Abusers Identifies Genes which Regulate Extracellular Matrix Remodeling	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ADDICTION; MATRIX-METALLOPROTEINASE-9; ASSOCIATION; CHANNELS; METALLOPROTEINASES; PLASTICITY; DOPAMINE; TISSUE; BRAIN	The chronic effects of cocaine abuse on brain structure and function are blamed for the inability of most addicts to remain abstinent. Part of the difficulty in preventing relapse is the persisting memory of the intense euphoria or cocaine "rush''. Most abused drugs and alcohol induce neuroplastic changes in brain pathways subserving emotion and cognition. Such changes may account for the consolidation and structural reconfiguration of synaptic connections with exposure to cocaine. Adaptive hippocampal plasticity could be related to specific patterns of gene expression with chronic cocaine abuse. Here, we compare gene expression profiles in the human hippocampus from cocaine addicts and age-matched drug-free control subjects. Cocaine abusers had 151 gene transcripts upregulated, while 91 gene transcripts were downregulated. Topping the list of cocaine-regulated transcripts was RECK in the human hippocampus (FC = 2.0; p<0.05). RECK is a membrane-anchored MMP inhibitor that is implicated in the coordinated regulation of extracellular matrix integrity and angiogenesis. In keeping with elevated RECK expression, active MMP9 protein levels were decreased in the hippocampus from cocaine abusers. Pathway analysis identified other genes regulated by cocaine that code for proteins involved in the remodeling of the cytomatrix and synaptic connections and the inhibition of blood vessel proliferation (PCDH8, LAMB1, ITGB6, CTGF and EphB4). The observed microarray phenotype in the human hippocampus identified RECK and other region-specific genes that may promote long-lasting structural changes with repeated cocaine abuse. Extracellular matrix remodeling in the hippocampus may be a persisting effect of chronic abuse that contributes to the compulsive and relapsing nature of cocaine addiction.	[Mash, Deborah C.; Adi, Nikhil; Qin, Yujing; Buck, Andrew; Pablo, John] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Mash, Deborah C.] Univ Miami, Miller Sch Med, Dept Cellular & Mol Pharmacol, Miami, FL 33136 USA; [Ffrench-Mullen, Jarlath] GeneLogic Inc, Gaithersburg, MD USA	University of Miami; University of Miami	Mash, DC (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.	dmash@med.miami.edu			PHS [DA06227]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006227] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by PHS grant DA06227 (DCM).	Bozdagi O, 2007, J NEUROPHYSIOL, V98, P334, DOI 10.1152/jn.00202.2007; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Corrado D, 2001, CARDIOVASC RES, V50, P399, DOI 10.1016/S0008-6363(01)00254-1; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Erber R, 2006, EMBO J, V25, P628, DOI 10.1038/sj.emboj.7600949; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Fridman R, 2003, CANCER METAST REV, V22, P153, DOI 10.1023/A:1023091214123; Goto Y, 2001, J NEUROSCI, V21; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Hernandez PJ, 2005, NEURON, V47, P772, DOI 10.1016/j.neuron.2005.09.001; Huntley GW, 2002, CELL, V108, P1, DOI 10.1016/S0092-8674(01)00631-6; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; ISHIGURO H, 2007, ADDICTION IN PRESS; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Kramar EA, 2003, J BIOL CHEM, V278, P10722, DOI 10.1074/jbc.M210225200; Krasnova IN, 2008, GENES BRAIN BEHAV, V7, P193, DOI 10.1111/j.1601-183X.2007.00338.x; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; Lehrmann E, 2003, PHARMACOGENOMICS J, V3, P27, DOI 10.1038/sj.tpj.6500146; Li JZ, 2004, HUM MOL GENET, V13, P609, DOI 10.1093/hmg/ddh065; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Liu QR, 2006, AM J MED GENET B, V141B, P918, DOI 10.1002/ajmg.b.30436; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Mellor J, 2002, SCIENCE, V295, P143, DOI 10.1126/science.1064285; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Muraguchi T, 2007, NAT NEUROSCI, V10, P838, DOI 10.1038/nn1922; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Nakagami Y, 2000, J NEUROSCI, V20, P2003; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Noble EP, 2000, EUR PSYCHIAT, V15, P79, DOI 10.1016/S0924-9338(00)00208-X; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Papapetropoulos S, 2006, GENE EXPRESSION, V13, P205, DOI 10.3727/000000006783991827; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Post RM, 2004, EPILEPSIA, V45, P5, DOI 10.1111/j.0013-9580.2004.452001.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Sasahara RM, 2002, CANCER DETECT PREV, V26, P435, DOI 10.1016/S0361-090X(02)00123-X; Sequeira A, 2007, MOL PSYCHIATR, V12, P640, DOI 10.1038/sj.mp.4001969; Sequeira A, 2006, ARCH GEN PSYCHIAT, V63, P35, DOI 10.1001/archpsyc.63.1.35; SETLERSTEVENSON WG, 1996, AM J PATHOL, V148, P1345; Shapiro ML, 1999, HIPPOCAMPUS, V9, P365, DOI 10.1002/(SICI)1098-1063(1999)9:4<365::AID-HIPO4>3.3.CO;2-K; Smolen P, 2006, BIOPHYS J, V90, P2760, DOI 10.1529/biophysj.105.072470; Staubli U, 1998, J NEUROSCI, V18, P3460; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Stephens BG, 2004, AM J FOREN MED PATH, V25, P11, DOI 10.1097/01.paf.0000114041.70865.24; Stephens BG, 2004, AM J FOREN MED PATH, V25, P1, DOI 10.1097/01.paf.0000118960.58334.a9; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Thompson AM, 2002, NEUROPHARMACOLOGY, V42, P1039, DOI 10.1016/S0028-3908(02)00059-X; UHL G, 1993, TRENDS NEUROSCI, V16, P83, DOI 10.1016/0166-2236(93)90128-9; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Vorel SR, 2001, SCIENCE, V292, P1175, DOI 10.1126/science.1058043; Wang XQ, 2003, J BIOL CHEM, V278, P25591, DOI 10.1074/jbc.M302211200; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; WOESSNER JF, 1994, ANN NY ACAD SCI, V732, P11; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang JW, 1997, J NEUROSCI METH, V76, P15, DOI 10.1016/S0165-0270(97)00065-4	64	83	86	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1187	10.1371/journal.pone.0001187	http://dx.doi.org/10.1371/journal.pone.0001187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000554	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459100025
J	van Orsouw, NJ; Hogers, RCJ; Janssen, A; Yalcin, F; Snoeijers, S; Verstege, E; Schneiders, H; van der Poel, H; van Oeveren, J; Verstegen, H; van Eijk, MJT				van Orsouw, Nathalie J.; Hogers, Rene C. J.; Janssen, Antoine; Yalcin, Feyruz; Snoeijers, Sandor; Verstege, Esther; Schneiders, Harrie; van der Poel, Hein; van Oeveren, Jan; Verstegen, Harold; van Eijk, Michiel J. T.			Complexity Reduction of Polymorphic Sequences (CRoPS (TM)): A Novel Approach for Large-Scale Polymorphism Discovery in Complex Genomes	PLOS ONE			English	Article							MAIZE; RETROTRANSPOSONS; TRANSCRIPTOME; TECHNOLOGY; ENRICHMENT; GENES; AFLP	Application of single nucleotide polymorphisms (SNPs) is revolutionizing human bio-medical research. However, discovery of polymorphisms in low polymorphic species is still a challenging and costly endeavor, despite widespread availability of Sanger sequencing technology. We present CRoPS (TM) as a novel approach for polymorphism discovery by combining the power of reproducible genome complexity reduction of AFLP (R) with Genome Sequencer (GS) 20/GS FLX next-generation sequencing technology. With CRoPS, hundreds-of-thousands of sequence reads derived from complexity-reduced genome sequences of two or more samples are processed and mined for SNPs using a fully-automated bioinformatics pipeline. We show that over 75% of putative maize SNPs discovered using CRoPS are successfully converted to SNPWave (R) assays, confirming them to be true SNPs derived from unique (single-copy) genome sequences. By using CRoPS, polymorphism discovery will become affordable in organisms with high levels of repetitive DNA in the genome and/or low levels of polymorphism in the (breeding) germplasm without the need for prior sequence information.	[van Orsouw, Nathalie J.; Hogers, Rene C. J.; Janssen, Antoine; Yalcin, Feyruz; Snoeijers, Sandor; Verstege, Esther; Schneiders, Harrie; van der Poel, Hein; van Oeveren, Jan; Verstegen, Harold; van Eijk, Michiel J. T.] Keygene NV, Wageningen, Netherlands	Keygene N.V.	van Orsouw, NJ (corresponding author), Keygene NV, Wageningen, Netherlands.	nathalie.van-orsouw@keygene.com			Keygene N. V	Keygene N. V(Keygene N.V.)	This work was funded by Keygene N. V.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; An Chung Sun, 1996, Journal of Plant Biology, V39, P57; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; BENNETZEN JL, 1994, GENOME, V37, P565, DOI 10.1139/g94-081; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Emberton J, 2005, GENOME RES, V15, P1441, DOI 10.1101/gr.3362105; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Li WL, 2004, PLANT J, V40, P500, DOI 10.1111/j.1365-313X.2004.02228.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matsuda T, 2004, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2004/10/014; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Oliphant A, 2002, BIOTECHNIQUES, P56; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Peterson DG, 2002, TRENDS GENET, V18, P547, DOI 10.1016/S0168-9525(02)02764-6; Rabinowicz PD, 1999, NAT GENET, V23, P305, DOI 10.1038/15479; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Swaminathan K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-132; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; van Eijk MJT, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh045; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vos P, 1993, Publication, Patent No. [0 534 858 A1, 0534858]; Vuylsteke M, 2007, NAT PROTOC, V2, P1387, DOI 10.1038/nprot.2007.175; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Whitelaw CA, 2003, SCIENCE, V302, P2118, DOI 10.1126/science.1090047; ZABEAU M, 1993, Patent No. 6045994	30	159	197	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1172	10.1371/journal.pone.0001172	http://dx.doi.org/10.1371/journal.pone.0001172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000544	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459100014
J	Silva, FP; Hamamoto, R; Kunizaki, M; Tsuge, M; Nakamura, Y; Furukawa, Y				Silva, F. Pittella; Hamamoto, R.; Kunizaki, M.; Tsuge, M.; Nakamura, Y.; Furukawa, Y.			Enhanced methyltransferase activity of SMYD3 by the cleavage of its N-terminal region in human cancer cells	ONCOGENE			English	Article						SMYD3; methyltransferase; cancer	SET DOMAIN; HISTONE METHYLATION	Histone methylation is involved in the regulation of gene expression and DNA replication through alteration of chromatin structure. We earlier showed that SMYD3, a histone H3-lysine 4-specific methyltransferase, is frequently upregulated in human colorectal, liver and breast cancer compared to their matched non-cancerous cells, and that its activity is associated with the growth of these tumors. In the present study, we found that human cancer cells express both the full-length and a cleaved form of SMYD3 protein. Amino acid sequence analysis uncovered that the cleaved form lacks the 34 amino acids in the N-terminal region of the full-length protein. Interestingly, the cleaved protein and mutant protein containing substitutions at glycines 15 and 17, two highly conserved amino acids in the N-terminal region, revealed a higher histone methyltransferase (HMTase) activity compared to the full-length protein. Furthermore, the N-terminal region is responsible for the association with heat shock protein 90 alpha (HSP90 alpha). These data indicate that the N-terminal region plays an important role for the regulation of its methyltransferase activity and suggest that a structural change of the protein through the cleavage of the region or interaction with HSP90a may be involved in the modulation. These findings may help for a better understanding of the mechanisms that modulate the HMTase activity of SMYD3, and contribute to the development of novel anticancer drugs targeting SMYD3 methyltransferase activity.	[Furukawa, Y.] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Promot Genome Based Med Project,Minato Ku, Tokyo 1088639, Japan; [Silva, F. Pittella; Hamamoto, R.; Kunizaki, M.; Tsuge, M.; Nakamura, Y.] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan	University of Tokyo; University of Tokyo	Furukawa, Y (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Promot Genome Based Med Project,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	furukawa@ims.u-tokyo.ac.jp	Hamamoto, Ryuji/AAF-9600-2019; Silva, Fabio Pittella/B-2621-2013; Tsuge, Masataka/G-5246-2019	Hamamoto, Ryuji/0000-0002-2632-1334; Silva, Fabio Pittella/0000-0002-9644-7098; Tsuge, Masataka/0000-0001-7591-8287				Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Fasulo L, 2000, J NEUROCHEM, V75, P624, DOI 10.1046/j.1471-4159.2000.0750624.x; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hamamoto R, 2006, CANCER SCI, V97, P113, DOI 10.1111/j.1349-7006.2006.00146.x; Jacobs SA, 2002, NAT STRUCT BIOL, V9, P833, DOI 10.1038/nsb861; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Marmorstein R, 2003, TRENDS BIOCHEM SCI, V28, P59, DOI 10.1016/S0968-0004(03)00007-0; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Tresaugues L, 2006, J MOL BIOL, V359, P1170, DOI 10.1016/j.jmb.2006.04.050; Tsuge M, 2005, NAT GENET, V37, P1104, DOI 10.1038/ng1638; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6	18	47	50	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 24	2008	27	19					2686	2692		10.1038/sj.onc.1210929	http://dx.doi.org/10.1038/sj.onc.1210929			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	292IK	17998933				2022-12-25	WOS:000255259500003
J	Spees, JL; Whitney, MJ; Sullivan, DE; Lasky, JA; Laboy, M; Ylostalo, J; Prockop, DJ				Spees, Jeffrey L.; Whitney, Mandolin J.; Sullivan, Deborah E.; Lasky, Joseph A.; Laboy, Miguel; Ylostalo, Joni; Prockop, Darwin J.			Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension	FASEB JOURNAL			English	Article						stem cell; monocrotaline; cardiac hypertrophy	GENE-THERAPY; STROMAL CELLS; STEM-CELLS; TRANSPLANTATION; CHIMERISM; CARDIOMYOCYTES; DIFFERENTIATE; PROLIFERATION; RESTORATION; ENGRAFTMENT	Infusion of bone marrow stem or progenitor cells may provide powerful therapies for injured tissues such as the lung and heart. We examined the potential of bone marrow-derived (BMD) progenitor cells to contribute to repair and remodeling of lung and heart in a rat monocrotaline (MCT) model of pulmonary hypertension. Bone marrow from green fluorescent protein (GFP)-transgenic male rats was transplanted into GFP-negative female rats. The chimeric animals were injected with MCT to produce pulmonary hypertension. Significant numbers of male GFP-positive BMD cells engrafted in the lungs of MCT-treated rats. Microarray analyses and double-immunohistochemistry demonstrated that many of the cells were interstitial fibroblasts or myofibroblasts, some of the cells were hematopoietic cells, and some were pulmonary epithelial cells (Clara cells), vascular endothelial cells, and smooth muscle cells. A few BMD cells fused with pulmonary cells from the host, but the frequency was low. In the hypertrophied hearts of MCT-treated rats, we found a significant increase in the relative numbers of BMD cells in the tight ventricle wall as compared with the left ventricle. Some of the BMD cells in the right ventricle were vascular cells and cardiomyocytes. We report BMD cardiomyocytes with a normal chromosome number, fusion of BMD cells with host cardiomyocytes, and, in some cases, nuclear fusion.	[Spees, Jeffrey L.] Univ Vermont, Cardiovasc Res Inst, Dept Med, Colchester, VT 05446 USA; [Spees, Jeffrey L.; Whitney, Mandolin J.; Ylostalo, Joni; Prockop, Darwin J.] Tulane Univ, Hlth Sci Ctr, Ctr Gene Therapy, Dept Med, New Orleans, LA 70118 USA; [Sullivan, Deborah E.; Lasky, Joseph A.; Laboy, Miguel] Tulane Univ, Hlth Sci Ctr, Sect Pulm Dis Crit Care & Environm Med, New Orleans, LA USA	University of Vermont; Tulane University; Tulane University	Spees, JL (corresponding author), Univ Vermont, Cardiovasc Res Inst, Dept Med, 208 South Pk Dr,Ste 2, Colchester, VT 05446 USA.	jeffrey.spees@uvm.edu	Ylostalo, Joni/AAH-9457-2019	Ylostalo, Joni/0000-0001-9746-1994	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL077570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048323, R21AR047796] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL077570-01] Funding Source: Medline; NIAMS NIH HHS [AR48323, AR47796] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Caplice NM, 2003, P NATL ACAD SCI USA, V100, P4754, DOI 10.1073/pnas.0730743100; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Deb A, 2003, CIRCULATION, V107, P1247, DOI 10.1161/01.CIR.0000061910.39145.F0; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fukuhara S, 2004, CELL TRANSPLANT, V13, P741, DOI 10.3727/000000004783983486; GHODSI F, 1981, AM J PHYSIOL, V240, pH149, DOI 10.1152/ajpheart.1981.240.2.H149; Hattan N, 2005, CARDIOVASC RES, V65, P334, DOI 10.1016/j.cardiores.2004.10.004; Hayashida K, 2005, CHEST, V127, P1793, DOI 10.1378/chest.127.5.1793; Herzog EL, 2003, BLOOD, V102, P3483, DOI 10.1182/blood-2003-05-1664; Jiang SG, 2004, P NATL ACAD SCI USA, V101, P16891, DOI 10.1073/pnas.0404398101; Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60; Kotton DN, 2001, DEVELOPMENT, V128, P5181; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Loi R, 2006, AM J RESP CRIT CARE, V173, P171, DOI 10.1164/rccm.200502-309OC; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mengel M, 2004, AM J PATHOL, V165, P2079, DOI 10.1016/S0002-9440(10)63258-0; Mengel M, 2004, J AM SOC NEPHROL, V15, P978, DOI 10.1097/01.ASN.0000120369.92378.54; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Mouquet F, 2005, CIRC RES, V97, P1090, DOI 10.1161/01.RES.0000194330.66545.f5; Nagaya N, 2003, CIRCULATION, V108, P889, DOI 10.1161/01.CIR.0000079161.56080.22; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Pereira RF, 1998, P NATL ACAD SCI USA, V95, P1142, DOI 10.1073/pnas.95.3.1142; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Prockop DJ, 2003, P NATL ACAD SCI USA, V100, P11917, DOI 10.1073/pnas.1834138100; SPECS L, 2006, P NATL ACAD SCI USA, V103, P1283; Spyridonidis A, 2004, AM J PATHOL, V164, P1147, DOI 10.1016/S0002-9440(10)63203-8; Suratt BT, 2003, AM J RESP CRIT CARE, V168, P318, DOI 10.1164/rccm.200301-145OC; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Thiele J, 2004, TRANSPLANTATION, V77, P1902, DOI 10.1097/01.TP.0000127591.34203.8E; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b	36	103	112	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2008	22	4					1226	1236		10.1096/fj.07-8076com	http://dx.doi.org/10.1096/fj.07-8076com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	18032636				2022-12-25	WOS:000254581000027
J	Wang, JR; Yen, A				Wang, Jianrong; Yen, Andrew			A MAPK-positive feedback mechanism for BLR1 signaling propels retinoic acid-triggered differentiation and cell cycle arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; HL-60 CELLS; MONOCYTIC DIFFERENTIATION; NUCLEAR TRANSLOCATION; LEUKEMIA-CELLS; GROWTH-FACTOR; RAR-ALPHA; G0 ARREST; EXPRESSION; ACTIVATION	MAPK signaling is required for retinoic acid (RA)-triggered G(0) cell cycle arrest and cell differentiation, but the mechanism is not well defined. In this study, RA is found to cause MAPK activation with sustained association of RAF to MEK or ERK, leading to a MAPK-dependent accumulation of p21(Waf1/Cip1) and binding to CDK2 blocking G(1)/S transition. BLR1, a chemokine receptor, was found to function as a critical component of RA-triggered MAPK signaling. Unlike wild-type parental cells, RA-treated BLR1 knockout cells failed to show RAF and consequential MEK and ERK phosphorylation, failed to accumulate CDK inhibitors that control G(1)/S transition, and failed to differentiate and arrest in response to RA, whereas ectopically overexpressing BLR1 enhanced MAPK signaling and caused accelerated RA-induced differentiation and arrest. Ectopic overexpression of RAF enhanced BLR1 expression in response to RA, whereas inhibition of RAF or MEK by inhibitors or knockdown of RAF by short interfering RNA diminished RA-induced BLR1 expression and attenuated differentiation and growth arrest. Ectopic expression of the RAF CR3, the catalytically active domain, in the BLR1 knock-out restored RA-induced MAPK activation and the ability to differentiate and arrest, indicating that RAF effects MAPK signaling by BLR1 to propel differentiation/arrest. Taken together, RA induces cell differentiation and growth arrest through activation of a novel MAPK pathway with BLR1 as a critical component in a positive feedback mechanism that may contribute to the prolonged MAPK signaling propelling RA-induced cell cycle arrest and differentiation.	[Wang, Jianrong; Yen, Andrew] Cornell Univ, Dept Biomed Sci, VRT, Ithaca, NY 14853 USA	Cornell University	Yen, A (corresponding author), Cornell Univ, Dept Biomed Sci, VRT, TB013, Ithaca, NY 14853 USA.	ay13@cornell.edu						Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Battle TE, 2000, EXP CELL RES, V254, P287, DOI 10.1006/excr.1999.4766; Battle TE, 2001, EUR J CELL BIOL, V80, P59, DOI 10.1078/0171-9335-00141; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; COLCH W, 2000, BIOCHEM J, V351, P289; Cutler RE, 1998, P NATL ACAD SCI USA, V95, P9214, DOI 10.1073/pnas.95.16.9214; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; DOBNER T, 1992, EUR J IMMUNOL, V22, P2795, DOI 10.1002/eji.1830221107; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; FORSTER R, 1994, BLOOD, V84, P830; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; Hong HY, 2001, DIFFERENTIATION, V68, P55, DOI 10.1046/j.1432-0436.2001.068001055.x; KAISER E, 1993, EUR J IMMUNOL, V23, P2532, DOI 10.1002/eji.1830231023; KATAGIRI K, 1994, BLOOD, V84, P1780; Lamkin TJ, 2006, AM J HEMATOL, V81, P603, DOI 10.1002/ajh.20667; Lamkin TJ, 2006, J CELL BIOCHEM, V97, P1328, DOI 10.1002/jcb.20745; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; MICHAUD NR, 1995, MOL CELL BIOL, V15, P3390; Mischak H, 1996, MOL CELL BIOL, V16, P5409; Reiterer G, 2007, CANCER RES, V67, P7765, DOI 10.1158/0008-5472.CAN-07-0014; Schmidt M, 2000, J BIOL CHEM, V275, P41011, DOI 10.1074/jbc.M003716200; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; Tanaka T, 2007, J BIOL CHEM, V282, P29987, DOI 10.1074/jbc.M701700200; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Wang JR, 2004, MOL CELL BIOL, V24, P2423, DOI 10.1128/MCB.24.6.2423-2443.2004; YEN A, 1984, J CELL PHYSIOL, V118, P277, DOI 10.1002/jcp.1041180310; Yen A, 2000, IN VITRO CELL DEV-AN, V36, P249; YEN A, 1994, EUR J CELL BIOL, V65, P103; YEN A, 1986, LEUKEMIA RES, V10, P619, DOI 10.1016/0145-2126(86)90264-X; Yen A, 1998, CANCER RES, V58, P3163	34	42	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4375	4386		10.1074/jbc.M708471200	http://dx.doi.org/10.1074/jbc.M708471200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18006504	hybrid			2022-12-25	WOS:000253083500072
J	Esser, L; Elberry, M; Zhou, F; Yu, CA; Yu, L; Xia, D				Esser, Lothar; Elberry, Maria; Zhou, Fei; Yu, Chang-An; Yu, Linda; Xia, Di			Inhibitor-complexed structures of the cytochrome bc(1) from the photosynthetic bacterium Rhodobacter sphaeroides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; MITOCHONDRIAL RESPIRATORY-CHAIN; ELECTRON-TRANSFER; CRYSTAL-STRUCTURE; EXTRA FRAGMENT; B(6)F COMPLEX; C REDUCTASE; SUBUNIT; BINDING; SITE	The cytochrome bc(1) complex (bc(1)) is a major contributor to the proton motive force across the membrane by coupling electron transfer to proton translocation. The crystal structures of wild type and mutant bc(1) complexes from the photosynthetic purple bacterium Rhodobacter sphaeroides(Rsbc(1)), stabilized with the quinol oxidation (Q(P)) site inhibitor stigmatellin alone or in combination with the quinone reduction (Q(N)) site inhibitor antimycin, were determined. The high quality electron density permitted assignments of a new metal-binding site to the cytochrome c(1) subunit and a number of lipid and detergent molecules. Structural differences between Rsbc(1) and its mitochondrial counterparts are mostly extra membranous and provide a basis for understanding the function of the predominantly longer sequences in the bacterial subunits. Functional implications for the bc(1) complex are derived from analyses of 10 independent molecules in various crystal forms and from comparisons with mitochondrial complexes.	[Esser, Lothar; Xia, Di] NCI, Natl Inst Hlth, Cell Biol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Elberry, Maria; Zhou, Fei; Yu, Chang-An; Yu, Linda] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Oklahoma State University System; Oklahoma State University - Stillwater	Xia, D (corresponding author), NCI, Natl Inst Hlth, Cell Biol Lab, Ctr Canc Res, Bethesda, MD 20892 USA.	dixia@helix.nih.gov			Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [GM 30721] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030721, R01GM030721] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; BRANDT U, 1994, CRIT REV BIOCHEM MOL, V29, P165, DOI 10.3109/10409239409086800; BROWN MD, 1992, GENETICS, V130, P163; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen YR, 1996, J BIOL CHEM, V271, P2057, DOI 10.1074/jbc.271.4.2057; Covian R, 2002, J BIOL CHEM, V277, P48449, DOI 10.1074/jbc.M208060200; CROFTS AR, 2004, ANN REV PHYSL, V66; Darrouzet E, 2000, BIOCHEMISTRY-US, V39, P15475, DOI 10.1021/bi000750l; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Elberry M, 2006, BIOCHEMISTRY-US, V45, P4991, DOI 10.1021/bi0522246; Elberry M, 2006, BBA-BIOENERGETICS, V1757, P835, DOI 10.1016/j.bbabio.2006.05.031; ESNOUSF BM, 1997, J MOL GRAPHICS, V15, P138; Esser L, 2004, J MOL BIOL, V341, P281, DOI 10.1016/j.jmb.2004.05.065; Esser L, 2006, P NATL ACAD SCI USA, V103, P13045, DOI 10.1073/pnas.0601149103; Gao XG, 2003, BIOCHEMISTRY-US, V42, P9067, DOI 10.1021/bi0341814; Gao XG, 2002, BIOCHEMISTRY-US, V41, P11692, DOI 10.1021/bi026252p; GENNIS RB, 1993, J BIOENERG BIOMEMBR, V25, P195, DOI 10.1007/BF00762582; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; HAYERHARTL M, 1992, EUR J BIOCHEM, V209, P423, DOI 10.1111/j.1432-1033.1992.tb17305.x; HOPE AB, 1993, BIOCHIM BIOPHYS ACTA, V1143, P1, DOI 10.1016/0005-2728(93)90210-7; Huang BS, 2005, CEMENT CONCRETE RES, V35, P2008, DOI 10.1016/j.cemconres.2005.05.002; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Hunte C, 2003, FEBS LETT, V545, P39, DOI 10.1016/S0014-5793(03)00391-0; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jordan DB, 1999, PESTIC SCI, V55, P105, DOI 10.1002/(SICI)1096-9063(199902)55:2&lt;105::AID-PS879&gt;3.0.CO;2-D; Kessl JJ, 2003, J BIOL CHEM, V278, P31312, DOI 10.1074/jbc.M304042200; Kim H, 1999, J AM CHEM SOC, V121, P4902, DOI 10.1021/ja990190h; Kim H, 1998, P NATL ACAD SCI USA, V95, P8026, DOI 10.1073/pnas.95.14.8026; Kolling DRJ, 2003, J BIOL CHEM, V278, P39747, DOI 10.1074/jbc.M305913200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Liu XY, 2004, J BIOL CHEM, V279, P47363, DOI 10.1074/jbc.M406497200; MIYOSHI H, 1995, BBA-BIOENERGETICS, V1229, P149, DOI 10.1016/0005-2728(94)00185-8; Nett JH, 2000, EUR J BIOCHEM, V267, P5777, DOI 10.1046/j.1432-1327.2000.01650.x; OHNISHI T, 1988, EUR J BIOCHEM, V176, P385, DOI 10.1111/j.1432-1033.1988.tb14293.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rodgers S, 2000, EUR J BIOCHEM, V267, P3753, DOI 10.1046/j.1432-1327.2000.01411.x; Sauter H, 1999, ANGEW CHEM INT EDIT, V38, P1329, DOI 10.1002/(SICI)1521-3773(19990517)38:10<1328::AID-ANIE1328>3.0.CO;2-1; Schnaufer A, 2000, CURR GENET, V37, P234, DOI 10.1007/s002940050525; Staniek K, 2002, FREE RADICAL RES, V36, P381, DOI 10.1080/10715760290021225; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Tian H, 1998, J BIOL CHEM, V273, P27953, DOI 10.1074/jbc.273.43.27953; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P101, DOI 10.1128/MMBR.54.2.101-129.1990; TRUMPOWER BL, 1980, J BIOENERG BIOMEMBR, V12, P151, DOI 10.1007/BF00744680; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253; VONJAGOW G, 1986, BIOCHEMISTRY-US, V25, P775, DOI 10.1021/bi00352a006; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xiao KH, 2004, BIOCHEMISTRY-US, V43, P1488, DOI 10.1021/bi035378z; Yamashita E, 2007, J MOL BIOL, V370, P39, DOI 10.1016/j.jmb.2007.04.011; Yu L, 1999, J BIOENERG BIOMEMBR, V31, P251, DOI 10.1023/A:1005423913639; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	58	118	119	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2846	2857		10.1074/jbc.M708608200	http://dx.doi.org/10.1074/jbc.M708608200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18039651	hybrid			2022-12-25	WOS:000252622300042
J	Sciara, G; Blangy, S; Siponen, M; Mc Grath, S; van Sinderen, D; Tegoni, M; Cambillau, C; Campanacci, V				Sciara, Giuliano; Blangy, Stephanie; Siponen, Marina; Mc Grath, Stephen; van Sinderen, Douwe; Tegoni, Mariella; Cambillau, Christian; Campanacci, Valerie			A topological model of the baseplate of lactococcal phage Tuc2009	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING PROTEIN; BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN; CELL-WALL; BACTERIOPHAGE TP901-1; CRYSTAL-STRUCTURE; IDENTIFICATION; LACTIS; TAIL; SPECIFICITY	Phages infecting Lactococcus lactis, a Gram-positive bacterium, are a recurrent problem in the dairy industry. Despite their economical importance, the knowledge on these phages, belonging mostly to Siphoviridae, lags behind that accumulated for members of Myoviridae. The three-dimensional structures of the receptor-binding proteins (RBP) of three lactococcal phages have been determined recently, illustrating their modular assembly and assigning the nature of their bacterial receptor. These RBPs are attached to the baseplate, a large phage organelle, located at the tip of the tail. Tuc2009 baseplate is formed by the products of 6 open read frames, including the RBP. Because phage binding to its receptor induces DNA release, it has been postulated that the baseplate might be the trigger for DNA injection. We embarked on a structural study of the lactococcal phages baseplate, ultimately to gain insight into the triggering mechanism following receptor binding. Structural features of the Tuc2009 baseplate were established using size exclusion chromatography coupled to on-line UV-visible absorbance, light scattering, and refractive index detection (MALS/UV/RI). Combining the results of this approach with literature data led us to propose a "low resolution" model of Tuc2009 baseplate. This model will serve as a knowledge base to submit relevant complexes to crystallization trials.	[Sciara, Giuliano; Blangy, Stephanie; Siponen, Marina; Tegoni, Mariella; Cambillau, Christian; Campanacci, Valerie] CNRS, Architecture & Fonct Macromol Biol, UMR 6098, F-13288 Marseille, France; [Sciara, Giuliano; Blangy, Stephanie; Siponen, Marina; Tegoni, Mariella; Cambillau, Christian; Campanacci, Valerie] Univ Aix Marseille 1, F-13288 Marseille, France; [Sciara, Giuliano; Blangy, Stephanie; Siponen, Marina; Tegoni, Mariella; Cambillau, Christian; Campanacci, Valerie] Univ Aix Marseille 2, F-13288 Marseille, France; [Mc Grath, Stephen; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University College Cork; University College Cork	Cambillau, C (corresponding author), CNRS, Architecture & Fonct Macromol Biol, UMR 6098, F-13288 Marseille, France.	cambillau@afmb.univ-mrs.fr; valerie.campanacci@afmb.univ-mrs.fr	Van Sinderen, Douwe/A-6778-2015; sciara, giuliano/AAL-4478-2020	Van Sinderen, Douwe/0000-0003-1823-7957; Campanacci, Valerie/0000-0001-6407-6395				BOURNE Y, 1990, PROTEINS, V8, P365, DOI 10.1002/prot.340080410; BOURNE Y, 1994, STRUCTURE, V2, P209, DOI 10.1016/S0969-2126(00)00022-8; Deveau H, 2006, APPL ENVIRON MICROB, V72, P4338, DOI 10.1128/AEM.02517-05; Duplessis M, 2001, MOL MICROBIOL, V41, P325, DOI 10.1046/j.1365-2958.2001.02521.x; Dupont K, 2004, APPL ENVIRON MICROB, V70, P5818, DOI 10.1128/AEM.70.10.5818-5824.2004; Dupont K, 2004, APPL ENVIRON MICROB, V70, P5825, DOI 10.1128/AEM.70.10.5825-5832.2004; Geller BL, 2005, J DAIRY SCI, V88, P900, DOI 10.3168/jds.S0022-0302(05)72756-9; HELLER KJ, 1984, VIROLOGY, V139, P11, DOI 10.1016/0042-6822(84)90325-8; Kenny JG, 2004, J BACTERIOL, V186, P3480, DOI 10.1128/JB.186.11.3480-3491.2004; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Mc Grath S, 2006, J BACTERIOL, V188, P3972, DOI 10.1128/JB.00024-06; MONTEVILLE MR, 1994, APPL ENVIRON MICROB, V60, P3204, DOI 10.1128/AEM.60.9.3204-3211.1994; Olia AS, 2007, BIOCHEMISTRY-US, V46, P8776, DOI 10.1021/bi700186e; Pedersen M, 2000, VIROLOGY, V276, P315, DOI 10.1006/viro.2000.0497; Plancon L, 2002, J MOL BIOL, V318, P557, DOI 10.1016/S0022-2836(02)00089-X; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Rabsch W, 2007, J BACTERIOL, V189, P5658, DOI 10.1128/JB.00437-07; Ricagno S, 2006, J VIROL, V80, P9331, DOI 10.1128/JVI.01160-06; Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Spinelli S, 2006, NAT STRUCT MOL BIOL, V13, P85, DOI 10.1038/nsmb1029; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; VALYASEVI R, 1994, J DAIRY SCI, V77, P1, DOI 10.3168/jds.S0022-0302(94)76921-6; Vegge CS, 2006, J BACTERIOL, V188, P55, DOI 10.1128/JB.188.1.55-63.2006; Vegge CS, 2005, J BACTERIOL, V187, P4187, DOI 10.1128/JB.187.12.4187-4197.2005; Vincentelli R, 2005, ANAL BIOCHEM, V346, P77, DOI 10.1016/j.ab.2005.07.039; Vincentelli R, 2003, ACCOUNTS CHEM RES, V36, P165, DOI 10.1021/ar010130s; Ye HP, 2006, ANAL BIOCHEM, V356, P76, DOI 10.1016/j.ab.2006.05.025	30	52	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2716	2723		10.1074/jbc.M707533200	http://dx.doi.org/10.1074/jbc.M707533200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18045876	hybrid			2022-12-25	WOS:000252622300029
J	Cocheme, HM; Murphy, MP				Cocheme, Helena M.; Murphy, Michael P.			Complex I is the major site of mitochondrial superoxide production by paraquat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; OXIDATIVE STRESS; UBIQUINONE OXIDOREDUCTASE; GLUTATHIONE-PEROXIDASE; LIPID-PEROXIDATION; RESPIRATORY-CHAIN; RADICAL FORMATION; NULL MUTANTS; NITRIC-OXIDE; YEAST-CELLS	Paraquat (1,1'-dimethyl-4,4'-bipyridinium dichloride) is widely used as a redox cycler to stimulate superoxide production in organisms, cells, and mitochondria. This superoxide production causes extensive mitochondrial oxidative damage, however, there is considerable uncertainty over the mitochondrial sites of paraquat reduction and superoxide formation. Here we show that in yeast and mammalian mitochondria, superoxide production by paraquat occurs in the mitochondrial matrix, as inferred from manganese superoxide dismutase-sensitive mitochondrial DNA damage, as well as from superoxide assays in isolated mitochondria, which were unaffected by exogenous superoxide dismutase. This paraquat-induced superoxide production in the mitochondrial matrix required a membrane potential that was essential for paraquat uptake into mitochondria. This uptake was of the paraquat dication, not the radical monocation, and was carrier-mediated. Experiments with disrupted mitochondria showed that once in the matrix paraquat was principally reduced by complex I (mammals) or by NADPH dehydrogenases (yeast) to form the paraquat radical cation that then reacted with oxygen to form superoxide. Together this membrane potential-dependent uptake across the mitochondrial inner membrane and the subsequent rapid reduction to the paraquat radical cation explain the toxicity of paraquat to mitochondria.	[Cocheme, Helena M.; Murphy, Michael P.] Wellcome Trust Res Labs, Med Res Council Diunn Human Nutr Unit, Cambridge CB2 0XY, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Wellcome Trust Sanger Institute	Murphy, MP (corresponding author), Wellcome Trust Res Labs, Med Res Council Diunn Human Nutr Unit, MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	mpm@mrc-dunn.cam.ac.uk	Murphy, Michael P/C-2120-2009	Murphy, Michael P/0000-0003-1115-9618; Cocheme, Helena/0000-0001-8637-0042	MRC [MC_U105663142] Funding Source: UKRI; Medical Research Council [MC_U105663142] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDERSEN OS, 1978, BIOPHYS J, V21, P35, DOI 10.1016/S0006-3495(78)85507-6; BLASZCZYNSKI M, 1985, ACTA MICROBIOL POL, V34, P243; Brand M. D., 1995, BIOENERGETICS, V154, P62; BUS JS, 1974, BIOCHEM BIOPH RES CO, V58, P749, DOI 10.1016/S0006-291X(74)80481-X; BUS JS, 1984, ENVIRON HEALTH PERSP, V55, P37, DOI 10.2307/3429690; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Chappell J. B., 1972, SUBCELLULAR COMPONEN, P77; DAVEY GP, 1992, BIOCHEM J, V288, P439, DOI 10.1042/bj2880439; Day BJ, 1995, J PHARMACOL EXP THER, V275, P1227; de Haan JB, 1998, J BIOL CHEM, V273, P22528, DOI 10.1074/jbc.273.35.22528; Dinis-Oliveira RJ, 2006, NEUROTOXICOLOGY, V27, P1110, DOI 10.1016/j.neuro.2006.05.012; Esteves TC, 2004, BIOCHEM J, V379, P309, DOI 10.1042/BJ20031682; FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x; Fridell YWC, 2005, CELL METAB, V1, P145, DOI 10.1016/j.cmet.2005.01.005; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; FUKUSHIMA T, 1993, EXP TOXICOL PATHOL, V45, P345, DOI 10.1016/S0940-2993(11)80424-0; Fukushima Tetsuhito, 2002, Environ Health Prev Med, V7, P89, DOI 10.1265/ehpm.2002.89; GAGE JC, 1968, BIOCHEM J, V109, P757, DOI 10.1042/bj1090757; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; GORNALL AG, 1949, J BIOL CHEM, V177, P751; GRALLA EB, 1991, J BACTERIOL, V173, P5918, DOI 10.1128/jb.173.18.5918-5920.1991; HASSAN HM, 1984, METHOD ENZYMOL, V105, P523; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; HIRAI KI, 1992, TOXICOLOGY, V72, P1, DOI 10.1016/0300-483X(92)90081-O; Hsu AY, 2000, BBA-MOL CELL BIOL L, V1484, P287, DOI 10.1016/S1388-1981(00)00019-6; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; Kervinen M, 2004, ANAL BIOCHEM, V324, P45, DOI 10.1016/j.ab.2003.09.004; Kirby K, 2002, P NATL ACAD SCI USA, V99, P16162, DOI 10.1073/pnas.252342899; KRALL J, 1988, J BIOL CHEM, V263, P1910; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; LANOUE KF, 1979, ARCH BIOCHEM BIOPHYS, V195, P578, DOI 10.1016/0003-9861(79)90384-9; LIU XF, 1992, J BIOL CHEM, V267, P18298; LUCAS M, 1992, ANAL BIOCHEM, V206, P273, DOI 10.1016/0003-2697(92)90366-F; Magwere T, 2006, MECH AGEING DEV, V127, P356, DOI 10.1016/j.mad.2005.12.009; MAJIMA E, 1993, J BIOL CHEM, V268, P22181; Margolis AS, 2000, BBA-GEN SUBJECTS, V1524, P253, DOI 10.1016/S0304-4165(00)00167-7; McCarthy S, 2004, TOXICOL APPL PHARM, V201, P21, DOI 10.1016/j.taap.2004.04.019; Mockett RJ, 2003, FREE RADICAL BIO MED, V34, P207, DOI 10.1016/S0891-5849(02)01190-5; Mollace V, 2003, NEUROSCI LETT, V335, P163, DOI 10.1016/S0304-3940(02)01168-0; Murakami K, 1997, BIOCHEM MOL BIOL INT, V41, P481; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Murphy MP, 2003, J BIOL CHEM, V278, P48534, DOI 10.1074/jbc.M308529200; Nguyen-nhu NT, 2003, FEBS LETT, V544, P148, DOI 10.1016/S0014-5793(03)00493-9; NICHOLLS DG, 2002, BIOENERGITICS, V3; O'Brien KM, 2004, J BIOL CHEM, V279, P51817, DOI 10.1074/jbc.M405958200; O'Rourke TW, 2002, MOL CELL BIOL, V22, P4086, DOI 10.1128/MCB.22.12.4086-4093.2002; OGUR M, 1957, SCIENCE, V125, P928, DOI 10.1126/science.125.3254.928; Peixoto F, 2004, TOXICOL IN VITRO, V18, P733, DOI 10.1016/j.tiv.2004.02.009; Peng J, 2005, J BIOL CHEM, V280, P29194, DOI 10.1074/jbc.M500984200; Rees JF, 1998, J EXP BIOL, V201, P1211; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; Rodriguez-Juarez F, 2007, BIOCHEM J, V405, P223, DOI 10.1042/BJ20070033; Ross MF, 2006, BIOCHEM J, V400, P199, DOI 10.1042/BJ20060919; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; Sampayo JN, 2003, AGING CELL, V2, P319, DOI 10.1046/j.1474-9728.2003.00063.x; Shimada H, 1998, ARCH BIOCHEM BIOPHYS, V351, P75, DOI 10.1006/abbi.1997.0557; Shimizu K, 2001, BRAIN RES, V906, P135, DOI 10.1016/S0006-8993(01)02577-X; SMITH LL, 1981, BIOCHEM PHARMACOL, V30, P1053, DOI 10.1016/0006-2952(81)90441-X; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sturtz LA, 2002, METHOD ENZYMOL, V349, P167, DOI 10.1016/S0076-6879(02)49332-9; Tampo Y, 1999, FREE RADICAL BIO MED, V27, P588, DOI 10.1016/S0891-5849(99)00110-0; Thiruchelvam M, 2005, J BIOL CHEM, V280, P22530, DOI 10.1074/jbc.M500417200; Thiruchelvam M, 2000, J NEUROSCI, V20, P9207; Tsukamoto M, 2002, TOXICOL APPL PHARM, V178, P82, DOI 10.1006/taap.2001.9325; Van Remmen H, 2004, FREE RADICAL BIO MED, V36, P1625, DOI 10.1016/j.freeradbiomed.2004.03.016; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; VANLOON APGM, 1986, P NATL ACAD SCI USA, V83, P3820; Walker JE, 1995, METHOD ENZYMOL, V260, P14, DOI 10.1016/0076-6879(95)60127-9; Wallace MA, 2005, CHEM RES TOXICOL, V18, P1279, DOI 10.1021/tx050050n; WANG GY, 1992, J ELECTRON MICROSC, V41, P181; WATANABE K, 1992, JPN J TOX ENV HEALTH, V38, P142	74	399	418	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1786	1798		10.1074/jbc.M708597200	http://dx.doi.org/10.1074/jbc.M708597200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039652	hybrid			2022-12-25	WOS:000252501000004
J	Greenberg, ME; Li, XM; Gugiu, BG; Gu, XD; Qin, J; Salomon, RG; Hazen, SL				Greenberg, Michael E.; Li, Xin-Min; Gugiu, Bogdan G.; Gu, Xiaodong; Qin, Jun; Salomon, Robert G.; Hazen, Stanley L.			The lipid whisker model of the structure of oxidized cell membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; PLATELET-ACTIVATING-FACTOR; SCAVENGER RECEPTOR CD36; MOUSE PERITONEAL-MACROPHAGES; APOPTOTIC CELLS; ETHANOLAMINE PHOSPHOLIPIDS; FACTOR ACETYLHYDROLASE; PROTEIN MOIETIES; OXIDANT STRESS; VESICLE FUSION	An essential feature of the innate immune system is maintaining cellular homeostasis by identifying and removing senescent and apoptotic cells and modified lipoproteins. Identification is achieved through the recognition of molecular patterns, including structurally distinct oxidized phospholipids, on target cells by macrophage receptors. Both the structural nature of the molecular patterns recognized and their orientation within membranes has remained elusive. We recently described the membrane conformation of an endogenous oxidized phospholipid ligand for macrophage scavenger receptor CD36, where the truncated oxidized sn-2 fatty acid moiety protrudes into the aqueous phase, rendering it accessible for recognition. Herein we examine the generality of this conformational motif for peroxidized glycerophospholipids within membranes. Our data reveal that the addition of a polar oxygen atom on numerous peroxidized fatty acids reorients the acyl chain, whereby it no longer remains buried within the membrane interior but rather protrudes into the aqueous compartment. Moreover, we show that neither a conformational change in the head group relative to the membrane surface nor the presence of a polar head group is essential for CD36 recognition of free oxidized phospholipid ligands within membranes. Rather, our results suggest the following global phenomenon. As cellular membranes undergo lipid peroxidation, such as during senescence or apoptosis, previously hydrophobic portions of fatty acids will move from the interior of the lipid bilayer to the aqueous exterior. This enables physical contact between pattern recognition receptor and molecular pattern ligand. Cell membranes thus " grow whiskers" as phospholipids undergo peroxidation, and many of their oxidized fatty acids protrude at the surface.	[Greenberg, Michael E.; Li, Xin-Min; Hazen, Stanley L.] Cleveland Clin Fdn, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Greenberg, Michael E.; Li, Xin-Min; Hazen, Stanley L.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA; [Qin, Jun] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Greenberg, Michael E.; Li, Xin-Min; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Hazen, SL (corresponding author), Cleveland Clin Fdn, Ctr Cardiovasc Diagnost & Prevent, 9500 Euclid Ave, Cleveland, OH 44195 USA.	hazens@ccf.org	Gu, Xiaodong/N-9017-2013; Salomon, Robert G/C-3463-2008; Hazen, Stanley L/ABD-5845-2021	Salomon, Robert/0000-0001-9456-3557; Qin, Jun/0000-0002-2647-9270	NEI NIH HHS [R01 EY016813, EY016813] Funding Source: Medline; NHLBI NIH HHS [HL70621, HL53315, R01 HL053315, P01 HL076491, P01 HL077107] Funding Source: Medline; NIGMS NIH HHS [GM21249, R01 GM021249] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY016813] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, P50HL077107, R01HL070621, R01HL053315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021249] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi H, 2006, PROG LIPID RES, V45, P379, DOI 10.1016/j.plipres.2006.03.002; BABER J, 1995, BIOCHEMISTRY-US, V34, P6533, DOI 10.1021/bi00019a035; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Binder CJ, 2005, J LIPID RES, V46, P1353, DOI 10.1194/jlr.R500005-JLR200; Bird DA, 1999, P NATL ACAD SCI USA, V96, P6347, DOI 10.1073/pnas.96.11.6347; Bjorkbacka H, 2006, CURR OPIN LIPIDOL, V17, P527; Boullier A, 2005, J LIPID RES, V46, P969, DOI 10.1194/jlr.M400496-JLR200; Boullier A, 2000, J BIOL CHEM, V275, P9163, DOI 10.1074/jbc.275.13.9163; Boullier A, 2001, ANN NY ACAD SCI, V947, P214; Chang MK, 2002, P NATL ACAD SCI USA, V99, P13043, DOI 10.1073/pnas.192399699; de Assis EF, 2003, J IMMUNOL, V171, P2090, DOI 10.4049/jimmunol.171.4.2090; ELLENA JF, 1987, BIOCHEMISTRY-US, V26, P4584, DOI 10.1021/bi00388a062; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Fadok VA, 1998, J IMMUNOL, V161, P6250; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Finneman SC, 2001, J EXP MED, V194, P1289, DOI 10.1084/jem.194.9.1289; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Gough PJ, 2000, MICROBES INFECT, V2, P305, DOI 10.1016/S1286-4579(00)00297-5; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Gugiu BG, 2006, CHEM RES TOXICOL, V19, P262, DOI 10.1021/tx050247f; Gugiu BG, 2003, ORG LETT, V5, P2797, DOI 10.1021/ol034729z; HAN XL, 1990, BIOCHEMISTRY-US, V29, P4992, DOI 10.1021/bi00472a032; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Knecht V, 2007, BIOPHYS J, V92, P4254, DOI 10.1529/biophysj.106.103572; KOURODA Y, 1984, J AM CHEM SOC, V106, P1; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Li XM, 2007, BIOCHEMISTRY-US, V46, P5009, DOI 10.1021/bi700163y; Marathe GK, 2001, TRENDS CARDIOVAS MED, V11, P139, DOI 10.1016/S1050-1738(01)00100-1; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; PACE RJ, 1982, J CHEM PHYS, V76, P4241, DOI 10.1063/1.443501; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; SAMBRANO GR, 1995, P NATL ACAD SCI USA, V92, P1396, DOI 10.1073/pnas.92.5.1396; SAMBRANO GR, 1994, P NATL ACAD SCI USA, V91, P3265, DOI 10.1073/pnas.91.8.3265; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Shimada H, 1998, BIOCHEMISTRY-US, V37, P854, DOI 10.1021/bi972348l; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Smeijers AF, 2006, J PHYS CHEM B, V110, P13212, DOI 10.1021/jp060824o; STREMLER KE, 1989, J BIOL CHEM, V264, P5331; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Sun MJ, 2006, J BIOL CHEM, V281, P4222, DOI 10.1074/jbc.M509769200; Terpstra V, 1998, P NATL ACAD SCI USA, V95, P1806, DOI 10.1073/pnas.95.4.1806; WAGNER G, 1979, J MAGN RESON, V26, P629	52	218	225	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2385	2396		10.1074/jbc.M707348200	http://dx.doi.org/10.1074/jbc.M707348200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18045864	hybrid			2022-12-25	WOS:000252501000065
J	Kang, YH; Zhang, XZ; Dobie, F; Wu, HY; Craig, AM				Kang, Yunhee; Zhang, XueZhao; Dobie, Frederick; Wu, Huaiyang; Craig, Ann Marie			Induction of GABAergic postsynaptic differentiation by alpha-neurexins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA1 PYRAMIDAL NEURONS; INHIBITORY SYNAPSES; BETA-NEUREXINS; CELL-ADHESION; SYNAPTIC-TRANSMISSION; EXCITATORY SYNAPSES; HIPPOCAMPAL-NEURONS; RECEPTOR SUBTYPES; EPHB RECEPTORS; CA2+ CHANNELS	beta-Neurexin and neuroligin cell adhesion molecules contribute to synapse development in the brain. The longer beta-neurexins function at both glutamate and gamma-aminobutyric acid (GABA) synapses in coupling to presynaptic calcium channels. Binding of alpha-neurexins to neuroligins was recently reported, but the role of the alpha-neurexins in synapse development has not been well studied. Here we report that in COS cell neuron coculture assays, all three alpha-neurexins induce clustering of the GABAergic postsynaptic scaffolding protein gephyrin and neuroligin 2 but not of the glutamatergic postsynaptic scaffolding protein PSD-95 or neuroligin 1/ 3/ 4. alpha-Neurexins also induce clustering of the GABAA receptor gamma 2 subunit. This synapse promoting activity of alpha-neurexins is mediated by the sixth LNS (laminin neurexin sex hormone-binding protein) domain and negatively modulated by upstream sequences. Although inserts at splice site 4 (S4) in beta-neurexins promote greater clustering activity for GABA than glutamate proteins in coculture assay, alpha-neurexinspecific sequences confer complete specificity for GABA proteins. We further report a developmental increase in the ratio of -S4 to + S4 forms of neurexins correlating with an increase in glutamate relative to GABA synaptogenesis and activity regulation of splicing at S4. Thus, + S4 beta-neurexins and, even more selectively, alpha-neurexins may be mediators of GABAergic synaptic protein recruitment and stabilization.	[Kang, Yunhee; Dobie, Frederick; Craig, Ann Marie] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; [Kang, Yunhee; Dobie, Frederick; Craig, Ann Marie] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B5, Canada; [Kang, Yunhee; Zhang, XueZhao; Wu, Huaiyang; Craig, Ann Marie] Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA	University of British Columbia; University of British Columbia; Washington University (WUSTL)	Craig, AM (corresponding author), Univ British Columbia, Brain Res Ctr, Rm F149,2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	amcraig@interchange.ubc.ca	Craig, Ann Marie/M-2054-2014	Dobie, Frederick/0000-0002-0550-8095	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070860] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH-070860, R01 MH070860-03, R01 MH070860-02, R01 MH070860-01A1, R01 MH070860] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ben-Ari Y, 2004, TRENDS NEUROSCI, V27, P422, DOI 10.1016/j.tins.2004.05.002; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Bolliger MF, 2001, BIOCHEM J, V356, P581, DOI 10.1042/0264-6021:3560581; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; Conroy WG, 2007, DEV BIOL, V307, P79, DOI 10.1016/j.ydbio.2007.04.017; Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Dudanova I, 2007, J COMP NEUROL, V502, P261, DOI 10.1002/cne.21305; Dudanova I, 2006, J NEUROSCI, V26, P10599, DOI 10.1523/JNEUROSCI.1913-06.2006; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Goslin K., 1998, CULTURING NERVE CELL, P339; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; Grootjans JJ, 2000, J BIOL CHEM, V275, P19933, DOI 10.1074/jbc.M002459200; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; Hata Y, 1996, J NEUROSCI, V16, P2488; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; KIM S, 2006, FEBS LETT, V9, P1294; Knuesel I, 1999, EUR J NEUROSCI, V11, P4457, DOI 10.1046/j.1460-9568.1999.00887.x; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Levi S, 2002, J NEUROSCI, V22, P4274, DOI 10.1523/JNEUROSCI.22-11-04274.2002; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J BIOL CHEM, V273, P34716, DOI 10.1074/jbc.273.52.34716; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Patzke H, 2000, MOL CELL NEUROSCI, V15, P561, DOI 10.1006/mcne.2000.0853; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sons MS, 2006, NEUROSCIENCE, V138, P433, DOI 10.1016/j.neuroscience.2005.11.040; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Tyzio R, 1999, J NEUROSCI, V19, P10372; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Zeng ZH, 2006, INT J DEV BIOL, V50, P39, DOI 10.1387/ijdb.052068zz; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005	59	99	100	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2323	2334		10.1074/jbc.M703957200	http://dx.doi.org/10.1074/jbc.M703957200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18006501	Green Accepted, hybrid			2022-12-25	WOS:000252501000059
J	Lunn, FA; MacDonnell, JE; Bearne, SL				Lunn, Faylene A.; MacDonnell, Jennifer E.; Bearne, Stephen L.			Structural requirements for the activation of Escherichia coli CTP synthase by the allosteric effector GTP are stringent, but requirements for inhibition are lax	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTIDINE TRIPHOSPHATE SYNTHETASE; PROTEIN-KINASE-A; GLUTAMINE AMIDOTRANSFERASE DOMAIN; AFRICAN SLEEPING SICKNESS; SACCHAROMYCES-CEREVISIAE; CYCLOPENTENYL CYTOSINE; LACTOCOCCUS-LACTIS; DRUG-RESISTANCE; PHOSPHORYLATION; IDENTIFICATION	Cytidine 5 '-triphosphate synthase catalyzes the ATP-dependent formation of CTP from UTP using either NH3 or L-glutamine (Gln) as the source of nitrogen. GTP acts as an allosteric effector promoting Gln hydrolysis but inhibiting Gln-dependent CTP formation at concentrations of > 0.15 mM and NH3-dependent CTP formation at all concentrations. A structure-activity study using a variety of GTP and guanosine analogues revealed that only a few GTP analogues were capable of activating Gln-dependent CTP formation to varying degrees: GTP approximate to 6-thio-GTP > ITP approximate to guanosine 5 '-tetraphosphate > O-6-methyl-GTP > 2 '-deoxy-GTP. No activation was observed with guanosine, GMP, GDP, 2 ', 3 '-dideoxy- GTP, acycloguanosine, and acycloguanosine monophosphate, indicating that the 5 '-triphosphate, 2 '-OH, and 3 '-OH are required for full activation. The 2-NH2 group plays an important role in binding recognition, whereas substituents at the 6-position play an important role in activation. The presence of a 6-NH2 group obviates activation, consistent with the inability of ATP to substitute for GTP. Nucleotide and nucleoside analogues of GTP and guanosine, respectively, all inhibited NH3- and Gln-dependent CTP formation ( often in a cooperative manner) to a similar extent ( IC50 approximate to 0.2-0.5 mM). This inhibition appeared to be due solely to the purine base and was relatively insensitive to the identity of the purine with the exception of inosine, ITP, and adenosine ( IC50 approximate to 4-12 mM). 8-Oxoguanosine was the best inhibitor identified ( IC50 = 80 mu M). Our findings suggest that modifying 2-aminopurine or 2-aminopurine riboside may serve as an effective strategy for developing cytidine 5 '-triphosphate synthase inhibitors.	[Lunn, Faylene A.; MacDonnell, Jennifer E.; Bearne, Stephen L.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada	Dalhousie University	Bearne, SL (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada.	sbearne@dal.ca	Bearne, Stephen/ABF-8338-2021					Aronow B, 1986, Adv Exp Med Biol, V195 Pt B, P263; Bearne SL, 2001, BIOCHEM J, V356, P223, DOI 10.1042/0264-6021:3560223; Chang YF, 2007, J BIOL CHEM, V282, P17613, DOI 10.1074/jbc.M702799200; Choi MG, 2007, J BIOL CHEM, V282, P5367, DOI 10.1074/jbc.M610993200; De Clercq E, 2001, CLIN MICROBIOL REV, V14, P382, DOI 10.1128/CMR.14.2.382-397.2001; DECLERCQ E, 1993, ADV VIRUS RES, V42, P1, DOI 10.1016/S0065-3527(08)60082-2; Endrizzi JA, 2005, BIOCHEMISTRY-US, V44, P13491, DOI 10.1021/bi051282o; Endrizzi JA, 2004, BIOCHEMISTRY-US, V43, P6447, DOI 10.1021/bi0496945; Fijolek A, 2007, J BIOL CHEM, V282, P11858, DOI 10.1074/jbc.M611580200; Gao WY, 2000, NUCLEOS NUCLEOT NUCL, V19, P371, DOI 10.1080/15257770008033015; Goto M, 2004, STRUCTURE, V12, P1413, DOI 10.1016/j.str.2004.05.013; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Hatse S, 1999, BIOCHEM PHARMACOL, V58, P539, DOI 10.1016/S0006-2952(99)00035-0; Higgins MJ, 2007, J BIOL CHEM, V282, P29493, DOI 10.1074/jbc.M703948200; Hofer A, 2001, P NATL ACAD SCI USA, V98, P6412, DOI 10.1073/pnas.111139498; Iyengar A, 2003, BIOCHEM J, V369, P497, DOI 10.1042/BJ20021110; Iyengar A, 2002, ANAL BIOCHEM, V308, P396, DOI 10.1016/S0003-2697(02)00240-3; JENCKS WP, 1968, HDB BIOCH, pJ165; Kennedy E. P., 1986, LIPIDS MEMBRANES PRE, P171; KENSLER TW, 1989, DESIGN ENZYME INHIBI, P379; Koshland DE., 1974, ENZYMES, P539; Kursula P, 2006, ACTA CRYSTALLOGR F, V62, P613, DOI 10.1107/S1744309106018136; LEVITZKI A, 1971, BIOCHEMISTRY-US, V10, P3371, DOI 10.1021/bi00794a009; LEVITZKI A, 1969, P NATL ACAD SCI USA, V62, P1121, DOI 10.1073/pnas.62.4.1121; LEVITZKI A, 1972, BIOCHEMISTRY-US, V11, P247, DOI 10.1021/bi00752a016; LEVITZKI A, 1972, BIOCHEMISTRY-US, V11, P241, DOI 10.1021/bi00752a015; Lim RLH, 1996, MOL BIOCHEM PARASIT, V78, P249, DOI 10.1016/S0166-6851(96)02635-7; LOFTFIELD RB, 1969, SCIENCE, V164, P305, DOI 10.1126/science.164.3877.305; Long C, 1978, Methods Enzymol, V51, P79; LONG CW, 1967, J BIOL CHEM, V242, P4715; Lunn FA, 2004, EUR J BIOCHEM, V271, P4204, DOI 10.1111/j.1432-1033.2004.04360.x; MacDonnell JE, 2004, BBA-PROTEINS PROTEOM, V1699, P213, DOI 10.1016/j.bbapap.2004.03.002; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; Park TS, 2003, J BIOL CHEM, V278, P20785, DOI 10.1074/jbc.M301394200; Park TS, 1999, BIOCHEMISTRY-US, V38, P8839, DOI 10.1021/bi990784x; Seela F, 2007, ORG BIOMOL CHEM, V5, P3034, DOI 10.1039/b708736e; SEGEL IH, 1975, ENZYME KINETICS, P470; Simard D, 2003, EUR J BIOCHEM, V270, P2195, DOI 10.1046/j.1432-1033.2003.03588.x; Stoychev G, 2002, EUR J BIOCHEM, V269, P4048, DOI 10.1046/j.1432-1033.2002.03097.x; Verschuur AC, 2004, NUCLEOS NUCLEOT NUCL, V23, P1517, DOI 10.1081/NCN-200027733; Verschuur AC, 2000, EUR J CANCER, V36, P627, DOI 10.1016/S0959-8049(00)00021-6; Verschuur AC, 2001, LEUKEMIA RES, V25, P891, DOI 10.1016/S0145-2126(01)00047-9; VONDERSAAL W, 1985, J AM CHEM SOC, V107, P703, DOI 10.1021/ja00289a031; VONDERSAAL W, 1985, J BIOL CHEM, V260, P4993; WENG M, 1987, J BACTERIOL, V169, P3023, DOI 10.1128/jb.169.7.3023-3028.1987; WENG M, 1986, J BIOL CHEM, V261, P5568; WHELAN J, 1994, LEUKEMIA, V8, P264; WHELAN J, 1993, NAT GENET, V3, P317, DOI 10.1038/ng0493-317; Willemoes M, 2005, FEBS J, V272, P856, DOI 10.1111/j.1742-4658.2004.04525.x; Willemoes M, 2003, J BIOL CHEM, V278, P9407, DOI 10.1074/jbc.M212995200; Willemoes M, 2002, EUR J BIOCHEM, V269, P4772, DOI 10.1046/j.1432-1033.2002.03175.x; Wylie JL, 1996, J BIOL CHEM, V271, P15393, DOI 10.1074/jbc.271.26.15393; Yuan P, 2005, MOL BIOCHEM PARASIT, V143, P200, DOI 10.1016/j.molbiopara.2005.06.004; ZALKIN H, 1985, METHOD ENZYMOL, V113, P282; Zalkin H, 1993, Adv Enzymol Relat Areas Mol Biol, V66, P203	55	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2010	2020		10.1074/jbc.M707803200	http://dx.doi.org/10.1074/jbc.M707803200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18003612	hybrid			2022-12-25	WOS:000252501000028
J	Pinto, JR; Parvatiyar, MS; Jones, MA; Liang, JS; Potter, JD				Pinto, Jose R.; Parvatiyar, Michelle S.; Jones, Michelle A.; Liang, Jingsheng; Potter, James D.			A troponin T mutation that causes infantile restrictive cardiomyopathy increases Ca2+ sensitivity of force development and impairs the inhibitory properties of troponin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; CARDIAC-MUSCLE CONTRACTION; THIN FILAMENT REGULATION; ATPASE ACTIVITY; DILATED CARDIOMYOPATHY; TROPOMYOSIN-BINDING; VENTRICULAR MUSCLE; FUNCTIONAL REGIONS; ISOFORMS AFFECT; HEART-FAILURE	Restrictive cardiomyopathy (RCM) is a rare disorder characterized by impaired ventricular filling with decreased diastolic volume. We are reporting the functional effects of the first cardiac troponin T (CTnT) mutation linked to infantile RCM resulting from a de novo deletion mutation of glutamic acid 96. The mutation was introduced into adult and fetal isoforms of human cardiac TnT (HCTnT3-Delta E96 and HCTnT1-Delta E106, respectively) and studied with either cardiac troponin I (CTnI) or slow skeletal troponin I (SSTnI). Skinned cardiac fiber measurements showed a large leftward shift in the Ca2+ sensitivity of force development with no differences in the maximal force. HCTnT1-Delta E106 showed a significant increase in the activation of actomyosin ATPase with either CTnI or SSTnI, whereas HCTnT3-Delta E96 was only able to increase the ATPase activity with CTnI. Both mutants showed an impaired ability to inhibit the ATPase activity. The capacity of the CTnI center dot CTnC and SSTnI center dot CTnC complexes to fully relax the fibers after TnT displacement was also compromised. Experiments performed using fetal troponin isoforms showed a less severe impact compared with the adult isoforms, which is consistent with the cardioprotective role of SSTnI and the rapid onset of RCM after birth following the isoform switch. These data indicate that troponin mutations related to RCM may have specific functional phenotypes, including large leftward shifts in the Ca2+ sensitivity and impaired abilities to inhibit ATPase and to relax skinned fibers. All of this would account for and contribute to the severe diastolic dysfunction seen in RCM.	[Pinto, Jose R.; Parvatiyar, Michelle S.; Jones, Michelle A.; Liang, Jingsheng; Potter, James D.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami	Potter, JD (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, 1600 NW 10th Ave, Miami, FL 33136 USA.	jdpotter@miami.edu	parvatiyar, michelle/ABH-7542-2020; Pinto, Jose Renato/H-2631-2017	Pinto, Jose Renato/0000-0001-9092-4976; Parvatiyar, Michelle/0000-0002-9416-0069	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042325, R37HL042325] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-42325, HL-674154] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abusamhadneh E, 2001, FEBS LETT, V506, P51, DOI 10.1016/S0014-5793(01)02790-9; Ammash NM, 2000, CIRCULATION, V101, P2490, DOI 10.1161/01.CIR.101.21.2490; ANDERSON PAW, 1995, CIRC RES, V76, P681, DOI 10.1161/01.RES.76.4.681; Belin RJ, 2006, AM J PHYSIOL-HEART C, V291, pH2344, DOI 10.1152/ajpheart.00541.2006; Biesiadecki BJ, 2007, BIOCHEMISTRY-US, V46, P1368, DOI 10.1021/bi061949m; Chandra M, 2005, AM J PHYSIOL-HEART C, V289, pH2112, DOI 10.1152/ajpheart.00571.2005; Chandra M, 2001, AM J PHYSIOL-HEART C, V280, pH705, DOI 10.1152/ajpheart.2001.280.2.H705; CHANDRA M, 2001, AM J PHYSIOL, V280, pH706; Chen SC, 2001, J HEART LUNG TRANSPL, V20, P90, DOI 10.1016/S1053-2498(00)00162-5; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Fiske CH, 1925, J BIOL CHEM, V66, P375; FRYER MW, 1988, J PHYSIOL-LONDON, V407, P53, DOI 10.1113/jphysiol.1988.sp017403; GODT RE, 1989, J PHYSIOL-LONDON, V412, P155, DOI 10.1113/jphysiol.1989.sp017609; Gomes AV, 2005, J BIOL CHEM, V280, P30909, DOI 10.1074/jbc.M500287200; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P115, DOI 10.1023/B:MCBI.0000041853.20588.a0; Gomes AV, 2004, J BIOL CHEM, V279, P49579, DOI 10.1074/jbc.M407340200; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; GUTH K, 1987, J BIOL CHEM, V262, P13627; Harada K, 2004, J BIOL CHEM, V279, P14488, DOI 10.1074/jbc.M309355200; HEALD RW, 1988, J BIOL CHEM, V263, P5254; HEELEY DH, 1987, J BIOL CHEM, V262, P9971; Hernandez OM, 2001, J APPL PHYSIOL, V90, P1125, DOI 10.1152/jappl.2001.90.3.1125; HILL LE, 1992, J BIOL CHEM, V267, P16106; Hinkle A, 2003, J BIOL CHEM, V278, P506, DOI 10.1074/jbc.M209194200; HITCHCOCKDEGREGORI SE, 1985, BIOCHEMISTRY-US, V24, P3305, DOI 10.1021/bi00334a035; Huang XP, 2004, ACTA PHARMACOL SIN, V25, P1569; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Kimberlin MT, 2002, J HEART LUNG TRANSPL, V21, P455, DOI 10.1016/S1053-2498(01)00400-4; Kleerekoper Q, 1998, J BIOL CHEM, V273, P8153, DOI 10.1074/jbc.273.14.8153; Kubo T, 2007, J AM COLL CARDIOL, V49, P2419, DOI 10.1016/j.jacc.2007.02.061; Kushwaha SS, 1997, NEW ENGL J MED, V336, P267, DOI 10.1056/NEJM199701233360407; Lang R, 2002, J BIOL CHEM, V277, P11670, DOI 10.1074/jbc.M108912200; Li Y, 2000, P NATL ACAD SCI USA, V97, P5140, DOI 10.1073/pnas.090098997; Marian AJ, 2003, J AM COLL CARDIOL, V41, P994, DOI 10.1016/S0735-1097(02)03003-6; Moraczewska J, 1999, BIOCHEMISTRY-US, V38, P15885, DOI 10.1021/bi991816j; Oliveira DM, 2000, J BIOL CHEM, V275, P27513; Palm T, 2001, BIOPHYS J, V81, P2827, DOI 10.1016/S0006-3495(01)75924-3; Palm T, 2003, BIOPHYS J, V84, P3181, DOI 10.1016/S0006-3495(03)70042-3; Peddy SB, 2006, PEDIATRICS, V117, P1830, DOI 10.1542/peds.2005-2301; Perry SV, 1999, MOL CELL BIOCHEM, V190, P9, DOI 10.1023/A:1006939307715; POTTER JD, 1995, J BIOL CHEM, V270, P2557, DOI 10.1074/jbc.270.6.2557; Regnier M, 1995, AM J PHYSIOL-CELL PH, V269, pC1532, DOI 10.1152/ajpcell.1995.269.6.C1532; Rivenes SM, 2000, CIRCULATION, V102, P876; SASSE S, 1993, CIRC RES, V72, P932, DOI 10.1161/01.RES.72.5.932; Schaertl S, 1995, BIOCHEMISTRY-US, V34, P15890, DOI 10.1021/bi00049a003; SOLARO RJ, 1986, J PHARMACOL EXP THER, V238, P502; SOLARO RJ, 1988, CIRC RES, V63, P779, DOI 10.1161/01.RES.63.4.779; SWARTZ DR, 1992, J BIOL CHEM, V267, P20497; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Venkatraman G, 2005, J BIOL CHEM, V280, P17584, DOI 10.1074/jbc.M409337200; Venkatraman G, 2003, J BIOL CHEM, V278, P41670, DOI 10.1074/jbc.M302148200; Wahr PA, 1999, BIOPHYS J, V76, P2166, DOI 10.1016/S0006-3495(99)77371-6; Wang YC, 2007, FASEB J, V21, P2205, DOI 10.1096/fj.06-7538com; WILLADSEN KA, 1992, J BIOL CHEM, V267, P23746; Yumoto F, 2005, BIOCHEM BIOPH RES CO, V338, P1519, DOI 10.1016/j.bbrc.2005.10.116; Zhang J, 2001, CLIN GENET, V59, P248, DOI 10.1034/j.1399-0004.2001.590406.x; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535; ZOT AS, 1989, BIOCHEMISTRY-US, V28, P6751, DOI 10.1021/bi00442a031	59	40	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2156	2166		10.1074/jbc.M707066200	http://dx.doi.org/10.1074/jbc.M707066200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18032382	hybrid			2022-12-25	WOS:000252501000043
J	Reinehr, R; Sommerfeld, A; Keitel, V; Grether-Beck, S; Haussinger, D				Reinehr, Roland; Sommerfeld, Annika; Keitel, Verena; Grether-Beck, Susanne; Haeussinger, Dieter			Amplification of CD95 activation by caspase 8-induced endosomal acidification in rat hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; NADPH OXIDASE ISOFORMS; FAMILY KINASE YES; TYROSINE PHOSPHORYLATION; MEMBRANE TRAFFICKING; CHLORIDE CHANNELS; INDUCED APOPTOSIS; CELL-MEMBRANE; CL-CHANNELS; SPHINGOMYELINASE	Although in rat hepatocytes CD95 is predominantly located inside the cell with almost undetectable immunostaining at the plasma membrane, the addition of CD95-ligand (CD95L) induces hepatocyte apoptosis, which is preceded by a targeting and activation of intracellularly localized CD95 to the plasma membrane including formation of the death-inducing signaling complex. This process involves an NADPH oxidase-dependent generation of reactive oxygen species (ROS) through a ceramide- and protein kinase C zeta-dependent pathway, which leads to an activating phosphorylation of p47(phox). The mechanisms underlying CD95L-induced ceramide formation were addressed in the present study. It was found that CD95L lowered within seconds the apparent vesicular pH from 6.0 to 5.7 in a fluorescein isothiocyanate-dextran-accessible endosomal compartment, which was previously shown to contain acidic sphingomyelinase, and decreased N-(ethoxycarbonylmethyl)-6-methoxyquinolinium bromide fluorescence, suggestive for an increase of cytosolic [Cl-]. Bafilomycin or 4,4 '-diisothiocyanostilbene-2,2 '-disulfonic acid disodium salt largely abolished the CD95L-induced endosomal acidification, ceramide formation, and downstream events, such as p47phox phosphorylation, ROS formation, CD95 activation, and apoptosis. These responses were also abolished after knock-down of acidic sphingomyelinase in rat hepatocytes. Interestingly, caspase 8 inhibitors abolished these CD95L-induced signaling events, including the increase in cytosolic [Cl-], endosomal acidification, ceramide formation, and ROS generation as well as CD95 targeting to the plasma membrane and CD95 activation. The data suggest that CD95L initiates a rapid caspase 8-dependent endosomal acidification, which triggers ceramide- dependent ROS formation as an upstream event of trafficking of intracellularly stored CD95 to the plasma membrane. It is concluded that a rapid caspase 8 activation in response to CD95L signals to intracellularly stored CD95, which becomes activated and targeted to the plasma membrane. This autoamplification of CD95-activation is required for apoptosis induction.	[Reinehr, Roland; Sommerfeld, Annika; Keitel, Verena; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect, D-40225 Dusseldorf, Germany; [Grether-Beck, Susanne] Inst Umweltmed Forsch, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Haussinger, D (corresponding author), Univ Klinikum Dusseldorf, Klin Gastroeneterol Hepetol & Infektol, Moorenstr 5, D-40225 Dusseldorf, Germany.	haeussin@uni-duesseldorf.de	Reinehr, Roland/G-6118-2016; Keitel, Verena/AAF-3471-2019; Keitel, Verena/AAH-9016-2021	Keitel, Verena/0000-0003-1383-7662				Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Becker S, 2007, BIOL CHEM, V388, P185, DOI 10.1515/BC.2007.021; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; CHEN JQ, 1995, J BIOL CHEM, V270, P25233, DOI 10.1074/jbc.270.42.25233; Dang PMC, 2001, J IMMUNOL, V166, P1206, DOI 10.4049/jimmunol.166.2.1206; Eberle A, 2005, HEPATOLOGY, V41, P315, DOI 10.1002/hep.20564; Eberle A, 2007, APOPTOSIS, V12, P719, DOI 10.1007/s10495-006-0003-2; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Faundez Victor, 2004, Sci STKE, V2004, pre8, DOI 10.1126/stke.2332004re8; FOLCH J, 1957, J BIOL CHEM, V226, P497; FOWLER S, 1969, BIOCHIM BIOPHYS ACTA, V191, P481, DOI 10.1016/0005-2744(69)90271-X; GRAF J, 1987, J MEMBRANE BIOL, V95, P241, DOI 10.1007/BF01869486; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Grether-Beck S, 2000, EMBO J, V19, P5793, DOI 10.1093/emboj/19.21.5793; Grullich C, 2000, J BIOL CHEM, V275, P8650, DOI 10.1074/jbc.275.12.8650; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Higuchi H, 2001, J BIOL CHEM, V276, P38610, DOI 10.1074/jbc.M105300200; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; Kirschnek S, 2000, J BIOL CHEM, V275, P27316; Lambeth JD, 2002, CURR OPIN HEMATOL, V9, P11, DOI 10.1097/00062752-200201000-00003; Li XH, 2002, ANNU REV PHYSIOL, V64, P609, DOI 10.1146/annurev.physiol.64.090501.145429; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Marandi N, 2002, PFLUG ARCH EUR J PHY, V445, P357, DOI 10.1007/s00424-002-0933-7; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Mauricio AC, 1999, EXP PHYSIOL, V84, P489; MORIYAMA Y, 1987, J BIOL CHEM, V262, P9175; MUALLEM S, 1988, J BIOL CHEM, V263, P14703; Nakashima S, 2003, J BIOCHEM, V134, P359, DOI 10.1093/jb/mvg153; NISHIHARA T, 1995, BIOCHEM BIOPH RES CO, V212, P255, DOI 10.1006/bbrc.1995.1964; Nolte F, 2004, FEBS LETT, V578, P85, DOI 10.1016/j.febslet.2004.10.075; Pazoles C J, 1980, Ann N Y Acad Sci, V358, P354, DOI 10.1111/j.1749-6632.1980.tb15417.x; Piiper A, 2003, J BIOL CHEM, V278, P7065, DOI 10.1074/jbc.M211234200; Reinehr R, 2003, FASEB J, V17, P731, DOI 10.1096/fj.02-0915fje; Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200; Reinehr R, 2004, GASTROENTEROLOGY, V127, P1540, DOI 10.1053/j.gastro.2004.08.056; Reinehr R, 2004, J BIOL CHEM, V279, P23977, DOI 10.1074/jbc.M401519200; Reinehr R, 2004, J BIOL CHEM, V279, P10364, DOI 10.1074/jbc.M311997200; Reinehr R, 2003, GASTROENTEROLOGY, V125, P839, DOI 10.1016/S0016-5085(03)01055-2; Reinehr R, 2002, HEPATOLOGY, V36, P602, DOI 10.1053/jhep.2002.35447; Reinehr R, 2005, GASTROENTEROLOGY, V129, P2009, DOI 10.1053/j.gastro.2005.09.023; Reinehr R, 2006, J BIOL CHEM, V281, P23150, DOI 10.1074/jbc.M601451200; Rotolo JA, 2005, J BIOL CHEM, V280, P26425, DOI 10.1074/jbc.M414569200; Sawada M, 2002, EXP CELL RES, V273, P157, DOI 10.1006/excr.2001.5437; SCHREIBER R, 1994, BIOCHEM J, V303, P113, DOI 10.1042/bj3030113; Schreiber R, 1996, BIOCHEM J, V315, P385, DOI 10.1042/bj3150385; SCHREIBER R, 1995, BIOCHEM J, V309, P19, DOI 10.1042/bj3090019; Seki Shuichi, 1999, Medical Electron Microscopy, V32, P199; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Talanian RV, 1997, J BIOL CHEM, V272, P9677; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; TIMMER A, 2004, PLANAR CHROMATOGR, V93, P2; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Wang KW, 2005, J BIOL CHEM, V280, P23490, DOI 10.1074/jbc.M411607200; Wang XM, 2005, CELL PHYSIOL BIOCHEM, V16, P147, DOI 10.1159/000089840; WEHNER F, 1993, PFLUG ARCH EUR J PHY, V424, P145, DOI 10.1007/BF00374605; Weinman SA, 1998, J BIOL CHEM, V273, P34691, DOI 10.1074/jbc.273.52.34691; YOSHIDA Y, 1985, J BIOCHEM-TOKYO, V98, P1669, DOI 10.1093/oxfordjournals.jbchem.a135438; Zsembery A, 2000, FASEB J, V14, P2345, DOI 10.1096/fj.99-0509com	59	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2211	2222		10.1074/jbc.M706853200	http://dx.doi.org/10.1074/jbc.M706853200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18045865	hybrid			2022-12-25	WOS:000252501000049
J	Ing, NH; Massuto, DA; Jaeger, LA				Ing, Nancy H.; Massuto, Dana A.; Jaeger, Laurie A.			Estradiol up-regulates AUF1p45 binding to stabilizing regions within the 3 '-untranslated region of estrogen receptor alpha mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; AU-RICH ELEMENT; BREAST-CANCER CELLS; GENE-EXPRESSION; RIBONUCLEIC-ACID; RAT UTERUS; HNRNP-D; MEDIATED TRANSCRIPTION; PROTEIN INTERACTIONS; SHEEP ENDOMETRIUM	Estradiol up-regulates expression of the estrogen receptor alpha gene in the uterus by stabilizing estrogen receptor alpha mRNA. Previously, we defined two discrete minimal estradiol-modulated stability sequences (MEMSS) within the extensive 3'-untranslated region of estrogen receptor alpha mRNA with an in vitro stability assay using cytosolic extracts from sheep uterus. We report here that excess MEMSS RNA inhibited the enhanced stability of estrogen receptor alpha mRNA in extracts from estradiol-treated ewes compared with those from control ewes. Several estradiol-induced MEMSS-binding proteins were characterized by UV cross-linking in uterine extracts from ewes in a time course study ( 0, 8, 16, and 24 h after estradiol injection). The pattern of binding proteins changed at 16 h post-injection, concurrent with enhanced estrogen receptor alpha mRNA stability and the highest rate of accumulation of estrogen receptor alpha mRNA. The predominant MEMSS-binding protein induced by estradiol treatment was identified as AUF1 (A+U-rich RNA-binding factor 1) protein isoform p45 (a product of the heterogeneous nuclear ribonucleoprotein D gene). Immunoblot analysis indicated that only two of four AUF1 protein isoforms were present in the uterine cytosolic extracts and that estradiol treatment strongly increased the ratio of AUF1 isoforms p45 to p37. Non-phosphorylated recombinant AUF1p45 protected estrogen receptor alpha mRNA in vitro in a dose-dependent manner. These studies describe estrogenic induction of AUF1p45 binding to the estrogen receptor alpha mRNA as a molecular mechanism for post-transcriptional up-regulation of gene expression.	[Ing, Nancy H.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Ing, Nancy H.; Massuto, Dana A.; Jaeger, Laurie A.] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Ing, NH (corresponding author), Texas A&M Univ, Dept Anim Sci, 2471 TAMU, College Stn, TX 77843 USA.	ning@cvm.tamu.edu	Ing, Nancy/AAC-9927-2020					Arao Y, 2004, MOL ENDOCRINOL, V18, P2255, DOI 10.1210/me.2004-0103; Arao Y, 2002, BIOCHEM J, V361, P125, DOI 10.1042/0264-6021:3610125; Bell O, 2005, MOL ENDOCRINOL, V19, P516, DOI 10.1210/me.2004-0108; Bhattacharya S, 1999, NUCLEIC ACIDS RES, V27, P1464, DOI 10.1093/nar/27.6.1464; Blaxall BC, 2000, MOL CARCINOGEN, V28, P76; Blum JL, 2005, AM J PHYSIOL-HEART C, V289, pH2543, DOI 10.1152/ajpheart.00545.2005; Buzby JS, 1996, BLOOD, V88, P2889, DOI 10.1182/blood.V88.8.2889.bloodjournal8882889; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Cunningham KS, 2000, P NATL ACAD SCI USA, V97, P12498, DOI 10.1073/pnas.220425497; DeMaria CT, 1996, J BIOL CHEM, V271, P12179, DOI 10.1074/jbc.271.21.12179; Dodson RE, 2002, PROG NUCLEIC ACID RE, V72, P129, DOI 10.1016/S0079-6603(02)72069-2; Fan J, 2005, EUR RESPIR J, V26, P933, DOI 10.1183/09031936.05.00120204; Farhana L, 2000, CELL GROWTH DIFFER, V11, P541; Fialcowitz EJ, 2005, J BIOL CHEM, V280, P22406, DOI 10.1074/jbc.M500618200; Ford LP, 1999, METHODS, V17, P21, DOI 10.1006/meth.1998.0703; Friend KE, 1997, MOL CELL ENDOCRINOL, V131, P147, DOI 10.1016/S0303-7207(97)00098-1; FRITZ DT, 2000, SCI STKE 2000; Fritzemeier KH, 2004, E SCHERING RES FDN W, V46, P127; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; Gouble A, 2002, CANCER RES, V62, P1489; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; Hewitt SC, 2005, ANNU REV PHYSIOL, V67, P285, DOI 10.1146/annurev.physiol.67.040403.115914; Hewitt SC, 2003, REPRODUCTION, V125, P143, DOI 10.1530/rep.0.1250143; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Hu YL, 2000, ARCH BIOCHEM BIOPHYS, V383, P215, DOI 10.1006/abbi.2000.2063; Ikeda K, 2004, MOL ENDOCRINOL, V18, P1131, DOI 10.1210/me.2003-0308; Ing NH, 1999, BIOL REPROD, V60, P134, DOI 10.1095/biolreprod60.1.134; Ing NH, 2005, BIOL REPROD, V72, P1290, DOI 10.1095/biolreprod.105.040014; Ing NH, 1997, BIOL REPROD, V56, P1205, DOI 10.1095/biolreprod56.5.1205; Ing NH, 1996, BIOL REPROD, V54, P591, DOI 10.1095/biolreprod54.3.591; ING NH, 1999, EMBRYO IMPLANTATION, P287; Inoue A, 2003, BIOCHEM J, V372, P775, DOI 10.1042/BJ20021719; INOUE A, 1986, J BIOCHEM-TOKYO, V100, P747, DOI 10.1093/oxfordjournals.jbchem.a121767; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Keen JC, 2005, J BIOL CHEM, V280, P29519, DOI 10.1074/jbc.M505317200; Kenealy MR, 2000, ENDOCRINOLOGY, V141, P2805, DOI 10.1210/en.141.8.2805; Kiledjian M, 1997, MOL CELL BIOL, V17, P4870, DOI 10.1128/MCB.17.8.4870; KRAUS WL, 1993, ENDOCRINOLOGY, V132, P2371, DOI 10.1210/en.132.6.2371; Lafon I, 1998, ONCOGENE, V16, P3413, DOI 10.1038/sj.onc.1201895; Lal A, 2006, MOL CELL, V22, P117, DOI 10.1016/j.molcel.2006.03.016; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Likhite VS, 2006, MOL ENDOCRINOL, V20, P3120, DOI 10.1210/me.2006-0068; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; Lu JY, 2006, RNA, V12, P883, DOI 10.1261/rna.2308106; Lu Q, 2003, J BIOL CHEM, V278, P4639, DOI 10.1074/jbc.M210949200; Medunjanin S, 2005, J BIOL CHEM, V280, P33006, DOI 10.1074/jbc.M506758200; Mitchell DC, 2003, MOL ENDOCRINOL, V17, P562, DOI 10.1210/me.2002-0313; Moraes KCM, 2003, BIOL CHEM, V384, P25, DOI 10.1515/BC.2003.004; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; NARDULLI AM, 1986, ENDOCRINOLOGY, V119, P2038, DOI 10.1210/endo-119-5-2038; Pan YX, 2005, J BIOL CHEM, V280, P34609, DOI 10.1074/jbc.M507802200; PINOLROMA S, 1988, GENE DEV, V2, P215, DOI 10.1101/gad.2.2.215; Proia DA, 2006, J BIOL CHEM, V281, P7089, DOI 10.1074/jbc.M511839200; Rodriguez-Pinon M, 2005, DOMEST ANIM ENDOCRIN, V28, P442, DOI 10.1016/j.domaniend.2005.02.011; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; ROSS J, 1993, CONTROL MESSENGER RN, P417; Sarkar B, 2003, MOL CELL BIOL, V23, P6685, DOI 10.1128/MCB.23.18.6685-6693.2003; Sarkar B, 2003, J BIOL CHEM, V278, P20700, DOI 10.1074/jbc.M301176200; Sela-Brown A, 2000, J BIOL CHEM, V275, P7424, DOI 10.1074/jbc.275.10.7424; Sheflin LG, 2001, ENDOCRINOLOGY, V142, P2361, DOI 10.1210/en.142.6.2361; SMITH DB, 2000, CURRENT PROTOCOLS MO; Sommer S, 2005, J STEROID BIOCHEM, V97, P219, DOI 10.1016/j.jsbmb.2005.09.002; *STAT AN SYST I IN, 1982, SAS US GUID BAS; Staton JM, 2000, J MOL ENDOCRINOL, V25, P17, DOI 10.1677/jme.0.0250017; Tabaska JE, 1999, GENE, V231, P77, DOI 10.1016/S0378-1119(99)00104-3; Thomson AM, 1999, BIOTECHNIQUES, V27, P1032, DOI 10.2144/99275rr03; Tolnay M, 2000, BIOCHEM J, V348, P151, DOI 10.1042/0264-6021:3480151; Tolnay M, 1999, BIOCHEM J, V338, P417, DOI 10.1042/0264-6021:3380417; Tsai M-J, 1998, WILLIAMS TXB ENDOCRI, P55; VOKAER A, 1974, P NATL ACAD SCI USA, V71, P4482, DOI 10.1073/pnas.71.11.4482; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Wang H, 1999, BIOL REPROD, V61, P955, DOI 10.1095/biolreprod61.4.955; Watson CS, 1999, P SOC EXP BIOL MED, V220, P9, DOI 10.1046/j.1525-1373.1999.d01-2.x; Wilson GM, 1999, J BIOL CHEM, V274, P33374, DOI 10.1074/jbc.274.47.33374; Wilson GM, 2003, J BIOL CHEM, V278, P33029, DOI 10.1074/jbc.M305772200; Wilson GM, 2003, J BIOL CHEM, V278, P33039, DOI 10.1074/jbc.M305775200; Wilson GM, 1999, PROG NUCLEIC ACID RE, V62, P257; Wilson GM, 2001, J BIOL CHEM, V276, P44450, DOI 10.1074/jbc.M108521200; Xu NH, 2001, MOL CELL BIOL, V21, P6960, DOI 10.1128/MCB.21.20.6960-6971.2001; Yeap BB, 2004, BIOESSAYS, V26, P672, DOI 10.1002/bies.20051; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652	85	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1764	1772		10.1074/jbc.M704745200	http://dx.doi.org/10.1074/jbc.M704745200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18029355	hybrid			2022-12-25	WOS:000252282700063
J	Levesque, M; Gatien, S; Finnson, K; Desmeules, S; Villiard, E; Pilote, M; Philip, A; Roy, S				Levesque, Mathieu; Gatien, Samuel; Finnson, Kenneth; Desmeules, Sophie; Villiard, Eric; Pilote, Mireille; Philip, Anie; Roy, Stephane			Transforming Growth Factor: beta Signaling Is Essential for Limb Regeneration in Axolotls 2	PLOS ONE			English	Article								Axolotls (urodele amphibians) have the unique ability, among vertebrates, to perfectly regenerate many parts of their body including limbs, tail, jaw and spinal cord following injury or amputation. The axolotl limb is the most widely used structure as an experimental model to study tissue regeneration. The process is well characterized, requiring multiple cellular and molecular mechanisms. The preparation phase represents the first part of the regeneration process which includes wound healing, cellular migration, dedifferentiation and proliferation. The redevelopment phase represents the second part when dedifferentiated cells stop proliferating and redifferentiate to give rise to all missing structures. In the axolotl, when a limb is amputated, the missing or wounded part is regenerated perfectly without scar formation between the stump and the regenerated structure. Multiple authors have recently highlighted the similarities between the early phases of mammalian wound healing and urodele limb regeneration. In mammals, one very important family of growth factors implicated in the control of almost all aspects of wound healing is the transforming growth factor-beta family (TGF-beta). In the present study, the full length sequence of the axolotl TGF-beta 1 cDNA was isolated. The spatio-temporal expression pattern of TGF-beta 1 in regenerating limbs shows that this gene is up-regulated during the preparation phase of regeneration. Our results also demonstrate the presence of multiple components of the TGF-beta signaling machinery in axolotl cells. By using a specific pharmacological inhibitor of TGF-beta type I receptor, SB-431542, we show that TGF-beta signaling is required for axolotl limb regeneration. Treatment of regenerating limbs with SB-431542 reveals that cellular proliferation during limb regeneration as well as the expression of genes directly dependent on TGF-beta signaling are down-regulated. These data directly implicate TGF-beta signaling in the initiation and control of the regeneration process in axolotls.	[Levesque, Mathieu; Gatien, Samuel; Pilote, Mireille; Roy, Stephane] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Desmeules, Sophie; Villiard, Eric; Roy, Stephane] Univ Montreal, Fac Dent, Montreal, PQ H3C 3J7, Canada; [Finnson, Kenneth; Philip, Anie] McGill Univ, Fac Med, Dept Surg, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; McGill University	Roy, S (corresponding author), Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada.	stephane.roy@umontreal.ca		Finnson, Kenneth/0000-0003-2930-0595	CIHR; FRSQ; Network for oral and bone health research	CIHR(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec); Network for oral and bone health research	Research funded by the CIHR, FRSQ and the Network for oral and bone health research.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bayliss PE, 2006, NAT CHEM BIOL, V2, P265, DOI 10.1038/nchembio778; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Burt David W., 1994, Progress in Growth Factor Research, V5, P99; Callahan JF, 2002, J MED CHEM, V45, P999, DOI 10.1021/jm010493y; Carlson MRJ, 1998, J EXP ZOOL, V282, P715, DOI 10.1002/(SICI)1097-010X(19981215)282:6<715::AID-JEZ7>3.0.CO;2-F; Cash DE, 1998, GENE, V222, P119, DOI 10.1016/S0378-1119(98)00478-8; CHALKLEY DT, 1954, J MORPHOL, V94, P21, DOI 10.1002/jmor.1050940103; Chang J, 2000, PLAST RECONSTR SURG, V105, P148, DOI 10.1097/00006534-200001000-00025; Chodorowska Grazyna, 2004, Ann Univ Mariae Curie Sklodowska Med, V59, P403; Christensen RN, 2000, DEV DYNAM, V217, P216, DOI 10.1002/(SICI)1097-0177(200002)217:2<216::AID-DVDY8>3.0.CO;2-8; CLARK RAF, 1985, J AM ACAD DERMATOL, V13, P701, DOI 10.1016/S0190-9622(85)70213-7; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Finnson KW, 2006, FASEB J, V20, P1525, DOI 10.1096/fj.05-5229fje; Frank S, 1996, J BIOL CHEM, V271, P10188, DOI 10.1074/jbc.271.17.10188; GAILIT J, 1994, J INVEST DERMATOL, V103, P221, DOI 10.1111/1523-1747.ep12393176; GARDINER DM, 1995, DEVELOPMENT, V121, P1731; Gardiner DM, 1999, SEMIN CELL DEV BIOL, V10, P385, DOI 10.1006/scdb.1999.0325; GOSS RJ, 1980, CLIN ORTHOP RELAT R, P270; Grose R, 1999, SEMIN CELL DEV BIOL, V10, P395, DOI 10.1006/scdb.1999.0326; Han Manjong, 2005, Anatomical Record Part B:The New Anatomist, V287, P14, DOI 10.1002/ar.b.20082; Harty M, 2003, DEV DYNAM, V226, P268, DOI 10.1002/dvdy.10239; Ho DM, 2006, DEV BIOL, V295, P730, DOI 10.1016/j.ydbio.2006.03.050; Huang SS, 2005, J CELL BIOCHEM, V96, P447, DOI 10.1002/jcb.20558; Hutchison C, 2007, BONE, V40, P45, DOI 10.1016/j.bone.2006.07.005; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; ITEN LE, 1973, ROUX ARCH DEV BIOL, V173, P263, DOI 10.1007/BF00575834; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Jazwinska A, 2007, CURR BIOL, V17, P1390, DOI 10.1016/j.cub.2007.07.019; Jester JV, 1997, CORNEA, V16, P177; Kahari VM, 1997, EXP DERMATOL, V6, P199, DOI 10.1111/j.1600-0625.1997.tb00164.x; KANE CJM, 1991, J CELL PHYSIOL, V148, P157, DOI 10.1002/jcp.1041480119; KAUFMAN J, 1995, IMMUNOL REV, V143, P63, DOI 10.1111/j.1600-065X.1995.tb00670.x; KESKIOJA J, 1988, J BIOL CHEM, V263, P3111; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Letterio JJ, 1996, J LEUKOCYTE BIOL, V59, P769, DOI 10.1002/jlb.59.6.769; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Levesque M, 2005, DEV DYNAM, V233, P1525, DOI 10.1002/dvdy.20458; Liu XJ, 2005, BIOTECHNOL LETT, V27, P1609, DOI 10.1007/s10529-005-2516-0; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; Lu L, 2005, J AM COLL SURGEONS, V201, P391, DOI 10.1016/j.jamcollsurg.2005.03.032; LUNA LG, 1968, MANUAL HISTOLOGIC ST, pR12; Madlener M, 1998, ARCH DERMATOL RES, V290, pS24, DOI 10.1007/PL00007450; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MARTIN P, 1993, DEV GENET, V14, P225, DOI 10.1002/dvg.1020140309; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Mescher AL, 2006, THESCIENTIFICWORLDJO, V6, P1, DOI 10.1100/tsw.2006.323; Montesano R, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-7; Mori Y, 2004, ARTHRITIS RHEUM-US, V50, P4008, DOI 10.1002/art.20658; Mullen LM, 1996, DEVELOPMENT, V122, P3487; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; Nath RK, 1998, PLAST RECONSTR SURG, V102, P1100, DOI 10.1097/00006534-199809040-00027; Ninomiya K, 2006, HYPERTENS RES, V29, P269, DOI 10.1291/hypres.29.269; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Piek E, 1997, J CELL PHYSIOL, V173, P447, DOI 10.1002/(SICI)1097-4652(199712)173:3<447::AID-JCP17>3.0.CO;2-8; Pierce G F, 1988, Prog Clin Biol Res, V266, P93; POSTLETHWAITE AE, 1987, J EXP MED, V165, P251, DOI 10.1084/jem.165.1.251; Prud'homme GJ, 2000, J AUTOIMMUN, V14, P23, DOI 10.1006/jaut.1999.0339; Putta S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-54; Quan G, 2005, ARCH DERMATOL RES, V297, P84, DOI 10.1007/s00403-005-0582-8; Quan TH, 2004, AM J PATHOL, V165, P741, DOI 10.1016/S0002-9440(10)63337-8; Quan TH, 2001, J BIOL CHEM, V276, P26349, DOI 10.1074/jbc.M010835200; Roberts Anita B., 1995, Wound Repair and Regeneration, V3, P408, DOI 10.1046/j.1524-475X.1995.30405.x; ROY S, 1994, ENDOCRINOLOGY, V134, P1761, DOI 10.1210/en.134.4.1761; Roy S, 2000, DEV BIOL, V218, P199, DOI 10.1006/dbio.1999.9556; Roy S, 2006, THESCIENTIFICWORLDJO, V6, P12, DOI 10.1100/tsw.2006.324; Schultze-Mosgau S, 2004, BRIT J ORAL MAX SURG, V42, P112, DOI 10.1016/S0266-4356(03)00257-2; SHAH M, 1995, J CELL SCI, V108, P985; SHAH M, 1994, J CELL SCI, V107, P1137; SHAH M, 1992, LANCET, V339, P213, DOI 10.1016/0140-6736(92)90009-R; SICARD RE, 1985, REGULATION VERTEBRAT, pR9; Singer M., 1961, GROWTH LIVING SYSTEM, P277; Sun ZH, 2006, BIOCHEM BIOPH RES CO, V345, P694, DOI 10.1016/j.bbrc.2006.04.148; Tam BYY, 2003, J BIOL CHEM, V278, P49610, DOI 10.1074/jbc.M308492200; TANK PW, 1976, J MORPHOL, V150, P117, DOI 10.1002/jmor.1051500106; Tournefier A, 1998, IMMUNOL REV, V166, P259, DOI 10.1111/j.1600-065X.1998.tb01268.x; TSONIS PA, 1996, LIMB REGENERATION, pR12; Vinarsky V, 2005, DEV BIOL, V279, P86, DOI 10.1016/j.ydbio.2004.12.003; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; WALLACE H, 1981, VERTEBRATE LIMB REGE, pR12; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; Wang XJ, 2006, J INVEST DERM SYMP P, V11, P112, DOI 10.1038/sj.jidsymp.5650004; Wu S, 2007, AM J RESP CELL MOL, V36, P552, DOI 10.1165/rcmb.2006-0320OC; YANG EV, 1994, DEV BIOL, V166, P696, DOI 10.1006/dbio.1994.1348; Yang EV, 1999, DEV DYNAM, V216, P2, DOI 10.1002/(SICI)1097-0177(199909)216:1<2::AID-DVDY2>3.3.CO;2-G	95	104	105	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1227	10.1371/journal.pone.0001227	http://dx.doi.org/10.1371/journal.pone.0001227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043735	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459300009
J	Ruddell, A; Kelly-Spratt, KS; Furuya, M; Parghi, SS; Kemp, CJ				Ruddell, A.; Kelly-Spratt, K. S.; Furuya, M.; Parghi, S. S.; Kemp, C. J.			p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis	ONCOGENE			English	Article						lymph node; lymphangiogenesis; metastasis; p53; p19/Arf	PROMOTES TUMOR-METASTASIS; GROWTH FACTOR-C; VEGF-C; MELANOMA METASTASIS; BREAST-CANCER; SKIN TUMORS; INDUCTION; CELLS; MICE; VASCULATURE	The ability of tumor cells to metastasize is increasingly viewed as an interaction between the primary tumor and host tissues. Deletion of the p19/Arf or p53 tumor suppressor genes accelerates malignant progression and metastatic spread of 7,12-dimethylbenz(a) anthracene (DMBA)/12-O-tetradecanoyl-phorbol-13-acetate (TPA)induced squamous cell carcinomas, providinga model system to address mechanisms of metastasis. Here, we show that benign pre-metastatic papillomas from wildtype mice trigger lymphangiogenesis within draining lymph nodes, whereas there is no growth of primary tumor lymphatic vessels. Lymph node lymphangiogenesis is greatly accelerated in papilloma-bearing p19/Arf- or p53-deficient mice, which coincides with the greater propensity of these tumors to progress to carcinomas and to metastasize. The extent of accumulation of B cells within the tumor-draininglymph nodes of wild-type mice predicted the level of lymph node lymphangiogenesis and metastatic potential. Arf or p53 deficiency strongly accelerated lymph node immune cell accumulation, in a manner that was associated with the extent of lymph node lymphatic sinus growth. This immune cell accumulation and lymph node lymphangiogenesis phenotype identifies host anti-tumor responses that could drive metastatic spread of cancers via the lymphatics.	[Ruddell, A.; Kelly-Spratt, K. S.; Furuya, M.; Parghi, S. S.; Kemp, C. J.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Ruddell, A (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,MS-C2-023,POB 19024, Seattle, WA 98109 USA.	aruddell@fhcrc.org		Ruddell, Alanna/0000-0002-0195-5576	NCI NIH HHS [R01-CA99517, R01-CA68328] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA099517, R01CA068328] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Achen MG, 2006, INT J CANCER, V119, P1755, DOI 10.1002/ijc.21899; Ajiro K, 1996, J BIOL CHEM, V271, P13197, DOI 10.1074/jbc.271.22.13197; Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Baldwin ME, 2002, BIOESSAYS, V24, P1030, DOI 10.1002/bies.10173; Brown DM, 2001, IMMUNOLOGY, V102, P486, DOI 10.1046/j.1365-2567.2001.01213.x; BURNS PA, 1991, ONCOGENE, V6, P2363; Cao YH, 2005, NAT REV CANCER, V5, P735, DOI 10.1038/nrc1693; Dadras SS, 2005, MODERN PATHOL, V18, P1232, DOI 10.1038/modpathol.3800410; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; FARR A, 1993, J IMMUNOL, V150, P1160; Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; IOACHIM HL, 2002, IOACHIMS LYMPH NODE; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kelly-Spratt KS, 2004, PLOS BIOL, V2, P1138, DOI 10.1371/journal.pbio.0020242; Kemp CJ, 2005, SEMIN CANCER BIOL, V15, P460, DOI 10.1016/j.semcancer.2005.06.003; KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Krishnan J, 2003, CANCER RES, V63, P713; LEPPINK DM, 1989, TRANSPLANTATION, V48, P874, DOI 10.1097/00007890-198911000-00032; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Nagy JA, 2002, J EXP MED, V196, P1497, DOI 10.1084/jem.20021244; Nathanson SD, 2003, CANCER, V98, P413, DOI 10.1002/cncr.11464; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Roberts N, 2006, CANCER RES, V66, P2650, DOI 10.1158/0008-5472.CAN-05-1843; Ruddell A, 2003, AM J PATHOL, V163, P2233, DOI 10.1016/S0002-9440(10)63581-X; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Schoppmann SF, 2002, AM J PATHOL, V161, P947, DOI 10.1016/S0002-9440(10)64255-1; Shimizu K, 2004, CANCER SCI, V95, P328, DOI 10.1111/j.1349-7006.2004.tb03211.x; Skelton D, 2001, GENE THER, V8, P1813, DOI 10.1038/sj.gt.3301586; Skobe M, 2001, AM J PATHOL, V159, P893, DOI 10.1016/S0002-9440(10)61765-8; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Stacker SA, 2002, FASEB J, V16, P922, DOI 10.1096/fj.01-0945rev; Van den Eynden GG, 2006, BRIT J CANCER, V95, P1362, DOI 10.1038/sj.bjc.6603443; Wong SY, 2006, CELL CYCLE, V5, P812, DOI 10.4161/cc.5.8.2646	42	38	39	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2008	27	22					3145	3155		10.1038/sj.onc.1210973	http://dx.doi.org/10.1038/sj.onc.1210973			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	301LL	18059331				2022-12-25	WOS:000255897600007
J	Toschi, A; Edelstein, J; Rockwell, P; Ohh, M; Foster, DA				Toschi, A.; Edelstein, J.; Rockwell, P.; Ohh, M.; Foster, D. A.			HIF alpha expression in VHL-deficient renal cancer cells is dependent on phospholipase	ONCOGENE			English	Article						phospholipase D; HIF alpha; VHL; survival; signals; apoptosis; hypoxia	TUMOR-SUPPRESSOR PROTEIN; HYPOXIA-INDUCIBLE FACTORS; HIPPEL-LINDAU PROTEIN; PHOSPHATIDIC-ACID; SURVIVAL SIGNALS; FIBRONECTIN MATRIX; MTOR; PATHWAY; D2; INHIBITION	Loss of the von Hippel-Lindau (VHL) tumor suppressor gene contributes to proliferative disorders including renal cell carcinoma. The consequence of VHL loss is increased levels of hypoxia-inducible factor-alpha (HIF alpha), which is targeted for proteolytic degradation by the VHL gene product pVHL. HIF is a transcription factor that increases the expression of factors critical for tumorigenesis in renal cell carcinoma. We report here another regulatory component of HIFa expression in renal cancer cells. Phospholipase D (PLD), which is commonly elevated in renal and other cancers, is required for elevated levels of both HIF1 alpha and HIF2 alpha in VHL-deficient renal cancer cells. The induction of both HIF1 alpha and HIF2 alpha by hypoxic mimetic conditions was also dependent on PLD in renal cancer cells with restored pVHL expression. The effect of PLD activity upon HIFa expression was at the level of translation. PLD activity also provides a survival signal that suppresses apoptosis induced by serum deprivation in the renal cancer cells. Suppression of HIF2 alpha has been shown to reverse tumorigenesis with renal cancer cells. The finding here that HIF2a expression is dependent on PLD in renal cancer cells suggests that targeting PLD signals may represent an alternative therapeutic strategy for targeting HIF2 alpha in renal cancers where HIF2 alpha is critical for tumorigenesis and elevated PLD activity is common.	[Toschi, A.; Edelstein, J.; Rockwell, P.; Foster, D. A.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Ohh, M.] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada	City University of New York (CUNY) System; Hunter College (CUNY); University of Toronto	Foster, DA (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.	foster@genectr.hunter.cuny.edu			NATIONAL CANCER INSTITUTE [R01CA046677, R29CA046677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM060654] Funding Source: NIH RePORTER; NCI NIH HHS [CA46677] Funding Source: Medline; NCRR NIH HHS [RR-03037] Funding Source: Medline; NIGMS NIH HHS [GM60654] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Chen YH, 2005, ONCOGENE, V24, P672, DOI 10.1038/sj.onc.1208099; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Foster DA, 2003, MOL CANCER RES, V1, P789; Foster DA, 2006, CURR SIGNAL TRANSD T, V1, P295, DOI 10.2174/157436206778226941; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Foster David A, 2004, Expert Rev Anticancer Ther, V4, P691, DOI 10.1586/14737140.4.4.691; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hickey MM, 2006, CURR TOP DEV BIOL, V76, P217, DOI 10.1016/S0070-2153(06)76007-0; Hui L, 2005, J BIOL CHEM, V280, P35829, DOI 10.1074/jbc.M504192200; Hui L, 2004, MOL CELL BIOL, V24, P5677, DOI 10.1128/MCB.24.13.5677-5686.2004; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Kaelin WG, 2007, CLIN CANCER RES, V13, p680S, DOI 10.1158/1078-0432.CCR-06-1865; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; Maxwell PH, 2005, SEMIN CELL DEV BIOL, V16, P523, DOI 10.1016/j.semcdb.2005.03.001; Maynard MA, 2004, AM J NEPHROL, V24, P1, DOI 10.1159/000075346; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Ohh M, 2006, NEOPLASIA, V8, P623, DOI 10.1593/neo.06442; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; Rodrik V, 2005, MOL CELL BIOL, V25, P7917, DOI 10.1128/MCB.25.17.7917-7925.2005; Rodrik V, 2006, FEBS LETT, V580, P5647, DOI 10.1016/j.febslet.2006.09.013; Sawyers CL, 2003, CANCER CELL, V4, P343, DOI 10.1016/S1535-6108(03)00275-7; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Shen YJ, 2001, MOL CELL BIOL, V21, P595, DOI 10.1128/MCB.21.2.595-602.2001; Stickle NH, 2004, MOL CELL BIOL, V24, P3251, DOI 10.1128/MCB.24.8.3251-3261.2004; Sung TC, 1999, J BIOL CHEM, V274, P494, DOI 10.1074/jbc.274.1.494; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; Zhao YT, 2000, BIOCHEM BIOPH RES CO, V278, P140, DOI 10.1006/bbrc.2000.3719; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200; Zhong MG, 2003, BIOCHEM BIOPH RES CO, V302, P615, DOI 10.1016/S0006-291X(03)00229-8	37	36	41	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 24	2008	27	19					2746	2753		10.1038/sj.onc.1210927	http://dx.doi.org/10.1038/sj.onc.1210927			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	292IK	17998935				2022-12-25	WOS:000255259500009
J	Relini, A; De Stefano, S; Torrassa, S; Cavalleri, O; Rolandi, R; Gliozzi, A; Giorgetti, S; Raimondi, S; Marchese, L; Verga, L; Rossi, A; Stoppini, M; Bellotti, V				Relini, Annalisa; De Stefano, Silvia; Torrassa, Silvia; Cavalleri, Ornella; Rolandi, Ranieri; Gliozzi, Alessandra; Giorgetti, Sofia; Raimondi, Sara; Marchese, Loredana; Verga, Laura; Rossi, Antonio; Stoppini, Monica; Bellotti, Vittorio			Heparin strongly enhances the formation of beta(2)-microglobulin amyloid fibrils in the presence of type I collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIALYSIS-RELATED AMYLOIDOSIS; HUMAN BETA-2-MICROGLOBULIN; ALZHEIMERS-DISEASE; NEUTRAL PH; GLYCOSAMINOGLYCANS; AGGREGATION; SULFATE; HEMODIALYSIS; AFFINITY; AMYLOIDOGENESIS	The tissue specificity of fibrillar deposition in dialysis-related amyloidosis is most likely associated with the peculiar interaction of beta(2)-microglobulin (beta(2)-m) with collagen fibers. However, other co-factors such as glycosaminoglycans might facilitate amyloid formation. In this study we have investigated the role of heparin in the process of collagen-driven amyloidogenesis. In fact, heparin is a well known positive effector of fibrillogenesis, and the elucidation of its potential effect in this type of amyloidosis is particularly relevant because heparin is regularly given to patients subject to hemodialysis to prevent blood clotting. We have monitored by atomic force microscopy the formation of beta(2)-m amyloid fibrils in the presence of collagen fibers, and we have discovered that heparin strongly accelerates amyloid deposition. The mechanism of this effect is still largely unexplained. Using dynamic light scattering, we have found that heparin promotes beta(2)-m aggregation in solution at pH 6.4. Morphology and structure of fibrils obtained in the presence of collagen and heparin are highly similar to those of natural fibrils. The fibril surface topology, investigated by limited proteolysis, suggests that the general assembly of amyloid fibrils grown under these conditions and in vitro at low pH is similar. The exposure of these fibrils to trypsin generates a cleavage at the C-terminal of lysine 6 and creates the 7-99 truncated form of beta(2)-m (Delta N6 beta(2)-m) that is a ubiquitous constituent of the natural beta(2)-m fibrils. The formation of this beta(2)-m species, which has a strong propensity to aggregate, might play an important role in the acceleration of local amyloid deposition.	[Giorgetti, Sofia; Raimondi, Sara; Marchese, Loredana; Rossi, Antonio; Bellotti, Vittorio] Univ Pavia, Dipartimento Biochim, I-27100 Pavia, Italy; [Relini, Annalisa; De Stefano, Silvia; Torrassa, Silvia; Cavalleri, Ornella; Rolandi, Ranieri; Gliozzi, Alessandra] Univ Genoa, Dept Phys, I-16146 Genoa, Italy; [Relini, Annalisa; Cavalleri, Ornella; Rolandi, Ranieri; Gliozzi, Alessandra] CNISM, I-16146 Genoa, Italy; [Giorgetti, Sofia; Verga, Laura; Stoppini, Monica; Bellotti, Vittorio] Policlin San Matteo, IRCCS, Biotechnol Lab, I-27100 Pavia, Italy; [Stoppini, Monica; Bellotti, Vittorio] INBB, Consorzio Interuniv Ist Nazl Biostrutture & Biosi, I-00136 Rome, Italy	University of Pavia; University of Genoa; IRCCS Fondazione San Matteo; University of Pavia	Bellotti, V (corresponding author), Univ Pavia, Dipartimento Biochim, Via Taramelli,3B-27100, I-27100 Pavia, Italy.	vbellot@unipv.it	Giorgetti, Sofia/AAD-4341-2019; Verga, Laura/AAG-5105-2020; Rolandi, Ranieri/C-4765-2012; Bellotti, Vittorio/A-6201-2014; Rossi, Antonio/E-9935-2012; Relini, Annalisa/AHC-3105-2022	Giorgetti, Sofia/0000-0001-9438-6511; Rolandi, Ranieri/0000-0002-0580-1611; Bellotti, Vittorio/0000-0001-8678-662X; RELINI, ANNALISA/0000-0002-4040-9279				Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Bellotti V, 1998, EUR J BIOCHEM, V258, P61, DOI 10.1046/j.1432-1327.1998.2580061.x; Borysik AJ, 2007, KIDNEY INT, V72, P174, DOI 10.1038/sj.ki.5002270; Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653; Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Fareed J, 2004, CURR PHARM DESIGN, V10, P983, DOI 10.2174/1381612043452811; Giorgetti S, 2005, PROTEIN SCI, V14, P696, DOI 10.1110/ps.041194005; Giorgetti S, 2007, PROTEIN SCI, V16, P343, DOI 10.1110/ps.062563507; HOMMA N, 1989, NEPHRON, V53, P37, DOI 10.1159/000185699; HUSZAR G, 1980, ANAL BIOCHEM, V105, P424, DOI 10.1016/0003-2697(80)90481-9; Ikizler TA, 2005, AM J KIDNEY DIS, V46, P976, DOI 10.1053/j.ajkd.2005.07.037; Khlebtsov NG, 2003, COLLOID J+, V65, P652, DOI 10.1023/A:1026148512418; Kielty Cay M., 1993, P103; KISILEVSKY R, 1995, NAT MED, V1, P143, DOI 10.1038/nm0295-143; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; Lindahl U, 2007, THROMB HAEMOSTASIS, V98, P109, DOI 10.1160/Th07-04-0310; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; MINTON AP, 1995, BIOPHYS J, V68, P1311, DOI 10.1016/S0006-3495(95)80304-8; Miyata T, 2005, J DERMATOL, V32, P410, DOI 10.1111/j.1346-8138.2005.tb00918.x; Monti M, 2002, PROTEIN SCI, V11, P2362, DOI 10.1110/ps.0206902; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Ohashi K, 2002, NEPHRON, V90, P158, DOI 10.1159/000049037; OKON M, 1992, BIOCHEMISTRY-US, V31, P8906, DOI 10.1021/bi00152a030; Piazza R, 2006, EUR BIOPHYS J BIOPHY, V35, P439, DOI 10.1007/s00249-006-0051-0; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; SNOW AD, 1985, LAB INVEST, V53, P37; Suk JY, 2006, BIOCHEMISTRY-US, V45, P2234, DOI 10.1021/bi0519295; Verdone G, 2002, PROTEIN SCI, V11, P487, DOI 10.1110/ps.29002; Yamaguchi I, 2003, KIDNEY INT, V64, P1080, DOI 10.1046/j.1523-1755.2003.00167.x; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7	36	95	99	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4912	4920		10.1074/jbc.M702712200	http://dx.doi.org/10.1074/jbc.M702712200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18056266	hybrid			2022-12-25	WOS:000253426500049
J	Prieto, J; Epinat, JC; Redondo, P; Ramos, E; Padro, D; Cedrone, F; Montoya, G; Paques, F; Blanco, FJ				Prieto, Jesus; Epinat, Jean-Charles; Redondo, Pilar; Ramos, Elena; Padro, Daniel; Cedrone, Frederic; Montoya, Guillermo; Paques, Frederic; Blanco, Francisco J.			Generation and analysis of mesophilic variants of the thermostable archaeal I-DmoI homing endonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENTIAL RANDOM MUTAGENESIS; DIRECTED EVOLUTION; CRYSTAL-STRUCTURE; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; PROTEIN STABILITY; DNA-BINDING; SACCHAROMYCES-CEREVISIAE; SUBSTRATE-SPECIFICITY; CLEAVAGE SPECIFICITY	The hyperthermophilic archaeon Desulfurococcus mobilis I-DmoI protein belongs to the family of proteins known as homing endonucleases (HEs). HEs are highly specific DNA-cleaving enzymes that recognize long stretches of DNA and are powerful tools for genome engineering. Because of its monomeric nature, I-DmoI is an ideal scaffold for generating mutant enzymes with novel DNA specificities, similarly reported for homodimeric HEs, but providing single chain endonucleases instead of dimers. However, this would require the use of a mesophilic variant cleaving its substrate at temperatures of 37 C and below. We have generated mesophilic mutants of I-DmoI, using a single round of directed evolution that relies on a functional assay in yeast. The effect of mutations identified in the novel proteins has been investigated. These mutations are located distant to the DNA-binding site and cause changes in the size and polarity of buried residues, suggesting that they act by destabilizing the protein. Two of the novel proteins have been produced and analyzed in vitro. Their overall structures are similar to that of the parent protein, but they are destabilized against thermal and chemical denaturation. The temperature-dependent activity profiles for the mutants shifted toward lower temperatures with respect to the wild-type activity profile. However, the most destabilized mutant was not the most active at low temperatures, suggesting that other effects, like local structural distortions and/or changes in the protein dynamics, also influence their activity. These mesophilic I-DmoI mutants form the basis for generating new variants with tailored DNA specificities.	[Epinat, Jean-Charles; Cedrone, Frederic; Paques, Frederic] Cellectis SA, F-93235 Romainville, France; [Prieto, Jesus; Ramos, Elena; Padro, Daniel] Spanish Natl Canc Ctr, NMR Grp, Struct Biol & Biocomp Programme, Madrid, Spain; [Redondo, Pilar; Montoya, Guillermo] Spanish Natl Canc Ctr, Macromol Crystallog Grp, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Paques, F (corresponding author), Cellectis SA, 102 Route Noisy, F-93235 Romainville, France.	paques@cellectis.com; fblanco@cicbiogune.es	Redondo, Pilar/L-7612-2014; Padro, Daniel/L-4091-2015; Blanco, Francisco J/D-4401-2009; Padro, Daniel/AAG-3529-2021; biomaGUNE, CIC/J-9136-2014	Redondo, Pilar/0000-0002-6723-0818; Padro, Daniel/0000-0002-3932-9351; Blanco, Francisco J/0000-0003-2545-4319; Padro, Daniel/0000-0002-3932-9351; biomaGUNE, CIC/0000-0001-7690-0660				Aagaard C, 1997, NUCLEIC ACIDS RES, V25, P1523, DOI 10.1093/nar/25.8.1523; Adekoya OA, 2006, PROTEINS, V62, P435, DOI 10.1002/prot.20773; Argast GM, 1998, J MOL BIOL, V280, P345, DOI 10.1006/jmbi.1998.1886; Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; Arnould S, 2006, J MOL BIOL, V355, P443, DOI 10.1016/j.jmb.2005.10.065; Arnould S, 2007, J MOL BIOL, V371, P49, DOI 10.1016/j.jmb.2007.04.079; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; Bibikova M, 2002, GENETICS, V161, P1169; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; CADWELL RC, 1994, PCR METH APPL, V3, pS136; Chames P, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni175; CHEN KQ, 1993, P NATL ACAD SCI USA, V90, P5618, DOI 10.1073/pnas.90.12.5618; Chevalier BS, 2002, MOL CELL, V10, P895, DOI 10.1016/S1097-2765(02)00690-1; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; Chevalier BS, 2001, NAT STRUCT BIOL, V8, P312, DOI 10.1038/86181; Chodorge M, 2005, ADV SYNTH CATAL, V347, P1022, DOI 10.1002/adsc.200505055; CHOULIKA A, 1994, CR ACAD SCI III-VIE, V317, P1013; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Dalgaard JZ, 1998, ACTA CRYSTALLOGR D, V54, P1435, DOI 10.1107/S0907444998006222; DALGAARD JZ, 1993, P NATL ACAD SCI USA, V90, P5414, DOI 10.1073/pnas.90.12.5414; DALGAARD JZ, 1994, J BIOL CHEM, V269, P28885; Doyon JB, 2006, J AM CHEM SOC, V128, P2477, DOI 10.1021/ja057519l; Duan XQ, 1997, CELL, V89, P555, DOI 10.1016/S0092-8674(00)80237-8; Epinat JC, 2003, NUCLEIC ACIDS RES, V31, P2952, DOI 10.1093/nar/gkg375; Flick KE, 1997, PROTEIN SCI, V6, P2677; Gimble FS, 2003, J MOL BIOL, V334, P993, DOI 10.1016/j.jmb.2003.10.013; HICKS JB, 1979, COLD SPRING HARB SYM, V43, P1305, DOI 10.1101/SQB.1979.043.01.149; Ichiyanagi K, 2000, J MOL BIOL, V300, P889, DOI 10.1006/jmbi.2000.3873; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; Jurica NS, 1998, MOL CELL, V2, P469, DOI 10.1016/S1097-2765(00)80146-X; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Lebbink JHG, 2000, BIOCHEMISTRY-US, V39, P3656, DOI 10.1021/bi991483q; Lehmann M, 2002, PROTEIN ENG, V15, P403, DOI 10.1093/protein/15.5.403; Lehmann M, 2000, PROTEIN ENG, V13, P49, DOI 10.1093/protein/13.1.49; Lucas P, 2001, NUCLEIC ACIDS RES, V29, P960, DOI 10.1093/nar/29.4.960; LYKKEANDERSEN J, 1994, NUCLEIC ACIDS RES, V22, P4583, DOI 10.1093/nar/22.22.4583; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; MARSHALL P, 1994, EUR J BIOCHEM, V220, P855, DOI 10.1111/j.1432-1033.1994.tb18688.x; Moure CM, 2003, J MOL BIOL, V334, P685, DOI 10.1016/j.jmb.2003.09.068; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nakayama H, 2007, J MOL BIOL, V365, P362, DOI 10.1016/j.jmb.2006.09.066; Pace CN, 2000, PROTEINS, P1; PANTOLIANO MW, 1987, BIOCHEMISTRY-US, V26, P2077, DOI 10.1021/bi00382a002; Perl D, 2002, CHEMBIOCHEM, V3, P39, DOI 10.1002/1439-7633(20020104)3:1<39::AID-CBIC39>3.0.CO;2-D; PERRY LJ, 1984, SCIENCE, V226, P555, DOI 10.1126/science.6387910; Poland BW, 2000, J BIOL CHEM, V275, P16408, DOI 10.1074/jbc.275.22.16408; Prieto J, 2007, NUCLEIC ACIDS RES, V35, P3262, DOI 10.1093/nar/gkm183; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Rubin-Pitel SB, 2006, COMB CHEM HIGH T SCR, V9, P247, DOI 10.2174/138620706776843183; Seligman LM, 2002, NUCLEIC ACIDS RES, V30, P3870, DOI 10.1093/nar/gkf495; SERRANO L, 1993, J MOL BIOL, V233, P305, DOI 10.1006/jmbi.1993.1508; SERRANO L, 1992, J MOL BIOL, V224, P783, DOI 10.1016/0022-2836(92)90562-X; Silva GH, 2004, NUCLEIC ACIDS RES, V32, P3156, DOI 10.1093/nar/gkh618; Silva GH, 1999, J MOL BIOL, V286, P1123, DOI 10.1006/jmbi.1998.2519; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; Spiegel PC, 2006, STRUCTURE, V14, P869, DOI 10.1016/j.str.2006.03.009; Sriprapundh D, 2003, PROTEIN ENG, V16, P683, DOI 10.1093/protein/gzg082; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Steuer S, 2004, CHEMBIOCHEM, V5, P206, DOI 10.1002/cbic.200300718; Sussman D, 2004, J MOL BIOL, V342, P31, DOI 10.1016/j.jmb.2004.07.031; Taguchi S, 1998, APPL ENVIRON MICROB, V64, P492; Tindbaek N, 2004, PROTEIN ENG DES SEL, V17, P149, DOI 10.1093/protein/gzh019; VIGUERA AR, 1994, BIOCHEMISTRY-US, V33, P2142, DOI 10.1021/bi00174a022; Wang JS, 1997, NUCLEIC ACIDS RES, V25, P3767, DOI 10.1093/nar/25.19.3767; WELLS JA, 1986, J BIOL CHEM, V261, P6564; Werner E, 2002, NUCLEIC ACIDS RES, V30, P3962, DOI 10.1093/nar/gkf523; Wintrode PL, 2000, J BIOL CHEM, V275, P31635, DOI 10.1074/jbc.M004503200; Wintrode PL, 2001, ADV PROTEIN CHEM, V55, P161, DOI 10.1016/S0065-3233(01)55004-4	70	15	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4364	4374		10.1074/jbc.M706323200	http://dx.doi.org/10.1074/jbc.M706323200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	17999959	hybrid, Green Published			2022-12-25	WOS:000253083500071
J	Cuthbertson, BJ; Liao, Y; Birnbaumer, L; Blackshear, PJ				Cuthbertson, Brandon J.; Liao, Yanhong; Birnbaumer, Lutz; Blackshear, Perry J.			Characterization of zfs1 as an mRNA-binding and -destabilizing protein in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AU-RICH ELEMENT; ZINC-FINGER PROTEINS; GENE-EXPRESSION; CONFORMATIONAL-CHANGES; IRON-DEFICIENCY; GLOBAL ANALYSIS; HUMAN HOMOLOG; SWISS-MODEL; TRISTETRAPROLIN; DEADENYLATION	Tristetraprolin is a vertebrate CCCH tandem zinc finger protein that can bind to and destabilize certain mRNAs containing AU-rich element binding sites. zfs1 is the single gene in the fission yeast, Schizosaccharomyces pombe, that encodes a protein containing the critical features of the tristetraprolin zinc finger domain. zfs1 has been linked to pheromone signal transduction control and to the coordination of mitosis, but no biological function has been ascribed to the zfs1 protein. Through a functional genomics approach we compared transcript levels in wild-type and zfs1-deficient S. pombe strains; those elevated in the zfs1-deficient strain were examined for the presence of potential tristetraprolin-like binding sites. One such potential target transcript was encoded by arz1, a gene encoding a protein of unknown function that contains armadillo repeats. arz1 mRNA decay was inhibited in the zfs1-deficient strain when it was expressed under the control of a thiamine-repressible promoter. Mutations within one AU-rich element present in the arz1 3 '- untranslated region protected this transcript from zfs1-promoted decay, whereas mutating another potential binding site had no effect. Binding assays confirmed a direct interaction between zfs1 and arz1 mRNA-based probes; this interaction was eliminated when key residues were mutated in either zfs1 zinc finger. zfs1 and its targets in S. pombe represent a useful model system for studies of zinc finger protein/AU-rich element interactions that result in mRNA decay.	[Cuthbertson, Brandon J.; Blackshear, Perry J.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Liao, Yanhong; Birnbaumer, Lutz] NIEHS, Neurobiol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Blackshear, Perry J.] NIEHS, Clin Res Program, NIH, Res Triangle Pk, NC 27709 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Duke University	Blackshear, PJ (corresponding author), NIEHS, Lab Signal Transduct, NIH, 111 TW Alexander Dr,MD A2-05, Res Triangle Pk, NC 27709 USA.	black009@niehs.nih.gov	Blackshear, Perry J./C-6206-2019	Blackshear, Perry J./0000-0002-9561-8529	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101684, Z01ES101643, ZIAES090080] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 ES999999, Z01 ES101643-05, Z01 ES101684-05] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARNARD RC, 1993, NUCLEIC ACIDS RES, V21, P3580, DOI 10.1093/nar/21.15.3580; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; BEACH D, 1982, MOL GEN GENET, V187, P326, DOI 10.1007/BF00331138; Beltraminelli N, 1999, J CELL SCI, V112, P3103; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Brewer BY, 2006, BIOCHEMISTRY-US, V45, P13807, DOI 10.1021/bi061320j; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GUMBINER BM, 1995, CURR OPIN CELL BIOL, V7, P634, DOI 10.1016/0955-0674(95)80104-9; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; KANOH J, 1995, MOL BIOL CELL, V6, P1185, DOI 10.1091/mbc.6.9.1185; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Labbe S, 2007, BIOMETALS, V20, P523, DOI 10.1007/s10534-006-9056-5; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 2005, J BIOL CHEM, V280, P34365, DOI 10.1074/jbc.M506757200; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Lo PCH, 1998, MECH DEVELOP, V72, P65, DOI 10.1016/S0925-4773(98)00016-1; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; NIE XF, 1995, GENE, V152, P285, DOI 10.1016/0378-1119(94)00696-P; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Schwede T, 2000, RES MICROBIOL, V151, P107, DOI 10.1016/S0923-2508(00)00121-2; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Thompson MJ, 1996, GENE, V174, P225, DOI 10.1016/0378-1119(96)00084-4; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	25	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2586	2594		10.1074/jbc.M707154200	http://dx.doi.org/10.1074/jbc.M707154200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18042546	Green Accepted, hybrid			2022-12-25	WOS:000252622300015
J	Bagamasbad, P; Howdeshell, KL; Sachs, LM; Demeneix, BA; Denver, RJ				Bagamasbad, Pia; Howdeshell, Kembra L.; Sachs, Laurent M.; Demeneix, Barbara A.; Denver, Robert J.			A role for basic transcription element-binding protein 1 (BTEB1) in the autoinduction of thyroid hormone receptor beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS METAMORPHOSIS; ENDOMETRIAL EPITHELIAL-CELLS; GENE-EXPRESSION PROGRAM; BREAST-CANCER CELLS; KRUPPEL-LIKE FAMILY; AMPHIBIAN METAMORPHOSIS; ESTROGEN-RECEPTOR; NUCLEAR-LOCALIZATION; FUNCTIONAL-ANALYSIS; PROMOTER ACTIVITY	Thyroid hormone (T-3) induces gene regulation programs necessary for tadpole metamorphosis. Among the earliest responses to T3 are the up-regulation of T3 receptor beta (TR beta; autoinduction) and BTEB1 (basic transcription element-binding protein 1). BTEB1 is a member of the Kruppel family of transcription factors that bind to GC-rich regions in gene promoters. The proximal promoter of the Xenopus laevis Tr beta A gene has seven GC-rich sequences, which led us to hypothesize that BTEB1 binds to and regulates Tr beta A. In tadpoles and the frog fibroblast-derived cell line XTC-2, T3 up-regulated Bteb1 mRNA with faster kinetics than Tr beta A, and Bteb1 mRNA correlated with increased BTEB1 protein expression. BTEB1 bound to GC-rich sequences in the proximal Tr beta A promoter in vitro. By using chromatin immunoprecipitation assay, we show that BTEB1 associates with the Tr beta A promoter in vivo in a T3 and developmental stage-dependent manner. Induced expression of BTEB1 in XTC-2 cells caused accelerated and enhanced autoinduction of the Tr beta A gene. This enhancement was lost in N-terminal truncated mutants of BTEB1. However, point mutations in the zinc fingers of BTEB1 that destroyed DNA binding did not alter the activity of the protein on Tr beta A autoinduction, suggesting that BTEB1 can function in this regard through protein-protein interactions. Our findings support the hypothesis that BTEB1 associates with the Tr beta A promoter in vivo and enhances autoinduction, but this action does not depend on its DNA binding activity. Cooperation among the protein products of immediate early genes may be a common mechanism for driving developmental signaling pathways.	[Bagamasbad, Pia; Howdeshell, Kembra L.; Denver, Robert J.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Sachs, Laurent M.; Demeneix, Barbara A.] USM 501 Museum Natl Hist Nat, Dept Regulat Dev & Divers Mol, F-75231 Paris 05, France	University of Michigan System; University of Michigan; Museum National d'Histoire Naturelle (MNHN)	Denver, RJ (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 830 N Univ Ave, Ann Arbor, MI 48109 USA.	rdenver@umich.edu	Sachs, Laurent/AAE-1504-2020; Denver, Robert/AAT-7481-2021	Bagamasbad, Pia/0000-0001-9751-7521	NINDS NIH HHS [1 R01 NS046690] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046690] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brown DD, 1996, P NATL ACAD SCI USA, V93, P1924, DOI 10.1073/pnas.93.5.1924; BROWN DD, 1995, RECENT PROG HORM RES, V50, P309; BUCKBINDER L, 1992, J BIOL CHEM, V262, P11221; Cayrou C, 2002, ENDOCRINOLOGY, V143, P2242, DOI 10.1210/en.143.6.2242; Chen AP, 2000, MOL CELL BIOL, V20, P2818, DOI 10.1128/MCB.20.8.2818-2826.2000; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Das B, 2006, DEV BIOL, V291, P342, DOI 10.1016/j.ydbio.2005.12.032; Denver RJ, 1999, J BIOL CHEM, V274, P23128, DOI 10.1074/jbc.274.33.23128; Denver RJ, 1997, J BIOL CHEM, V272, P8179, DOI 10.1074/jbc.272.13.8179; Duan R, 1998, ENDOCRINOLOGY, V139, P1981, DOI 10.1210/en.139.4.1981; Foti D, 1998, BIOCHEM BIOPH RES CO, V253, P109, DOI 10.1006/bbrc.1998.9759; Furlow JD, 1999, MOL ENDOCRINOL, V13, P2076, DOI 10.1210/me.13.12.2076; Furlow JD, 2002, ENDOCRINOLOGY, V143, P3295, DOI 10.1210/en.2002-220126; Helbing CC, 2003, MOL ENDOCRINOL, V17, P1395, DOI 10.1210/me.2002-0274; Hoopfer ED, 2002, DEV GROWTH DIFFER, V44, P365; Hsiang CH, 2002, ONCOGENE, V21, P2212, DOI 10.1038/sj.onc.1205293; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; IMATAKA H, 1993, AIDS RES HUM RETROV, V9, P825, DOI 10.1089/aid.1993.9.825; Imhof A, 1999, MOL CELL BIOL, V19, P194; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kaczynski JA, 2002, BIOCHEM J, V366, P873, DOI 10.1042/BJ20020388; KANAMORI A, 1993, P NATL ACAD SCI USA, V90, P6013, DOI 10.1073/pnas.90.13.6013; KOBAYASHI A, 1995, J BIOCHEM-TOKYO, V117, P91, DOI 10.1093/oxfordjournals.jbchem.a124727; MACHUCA I, 1995, MOL ENDOCRINOL, V9, P96, DOI 10.1210/me.9.1.96; Manzon RG, 2004, J ENDOCRINOL, V182, P273, DOI 10.1677/joe.0.1820273; Martin KM, 2000, BIOCHEM J, V345, P529, DOI 10.1042/0264-6021:3450529; MeunierDurmort C, 1997, GENE THER, V4, P808, DOI 10.1038/sj.gt.3300450; Morita M, 2003, MOL CELL BIOL, V23, P2489, DOI 10.1128/MCB.23.7.2489-2500.2003; NIEWKOOP PD, 1956, NORMAL TABLE XENOPUS; Pandya K, 2002, J BIOL CHEM, V277, P16304, DOI 10.1074/jbc.M200866200; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Porter W, 1997, MOL ENDOCRINOL, V11, P1569, DOI 10.1210/me.11.11.1569; PUDNEY M, 1973, EXPERIENTIA, V29, P466, DOI 10.1007/BF01926785; RANJAN M, 1994, J BIOL CHEM, V269, P24699; Sachs LM, 2000, P NATL ACAD SCI USA, V97, P13138, DOI 10.1073/pnas.260141297; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Shi Y.B., 2000, AMPHIBIAN METAMORPHO; SHI YB, 1992, J BIOL CHEM, V267, P733; SHI YB, 1994, DEV BIOL, V161, P48, DOI 10.1006/dbio.1994.1006; SHI YB, 1993, J BIOL CHEM, V268, P20312; Simmen RCM, 1999, ENDOCRINOLOGY, V140, P2517, DOI 10.1210/en.140.6.2517; Simmen RCM, 2002, DNA CELL BIOL, V21, P115, DOI 10.1089/104454902753604998; Simmen RCM, 2000, MOL CELL ENDOCRINOL, V159, P159, DOI 10.1016/S0303-7207(99)00191-4; Sjottem E, 1996, J VIROL, V70, P188; SOGAWA K, 1993, J BIOCHEM, V114, P605, DOI 10.1093/oxfordjournals.jbchem.a124224; SOGAWA K, 1993, NUCLEIC ACIDS RES, V21, P1527, DOI 10.1093/nar/21.7.1527; Sun GL, 1998, MOL ENDOCRINOL, V12, P882, DOI 10.1210/me.12.6.882; Tata JR, 2000, INSECT BIOCHEM MOLEC, V30, P645, DOI 10.1016/S0965-1748(00)00035-7; Veldhoen N, 2002, DEV DYNAM, V225, P457, DOI 10.1002/dvdy.10175; WANG Z, 1991, P NATL ACAD SCI USA, V88, P11505, DOI 10.1073/pnas.88.24.11505; WANG Z, 1993, J BIOL CHEM, V268, P16270; Wong JM, 1998, J BIOL CHEM, V273, P14186, DOI 10.1074/jbc.273.23.14186; YANAGIDA A, 1990, MOL CELL BIOL, V10, P1470, DOI 10.1128/MCB.10.4.1470; Yang ML, 1999, J BIOL CHEM, V274, P27399, DOI 10.1074/jbc.274.39.27399; YAOITA Y, 1990, GENE DEV, V4, P1917, DOI 10.1101/gad.4.11.1917; YAOITA Y, 1990, P NATL ACAD SCI USA, V87, P7090, DOI 10.1073/pnas.87.18.7090; Zhang DY, 2002, ENDOCRINOLOGY, V143, P62, DOI 10.1210/en.143.1.62	57	48	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2275	2285		10.1074/jbc.M709306200	http://dx.doi.org/10.1074/jbc.M709306200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18045867	hybrid			2022-12-25	WOS:000252501000055
J	Sidera, K; Gaitanou, M; Stellas, D; Matsas, R; Patsavoudi, E				Sidera, Katerina; Gaitanou, Maria; Stellas, Dimitris; Matsas, Rebecca; Patsavoudi, Evangelia			A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; DEVELOPING NERVOUS-SYSTEM; MONOCLONAL-ANTIBODY 4C5; ERBB SIGNALING NETWORK; BREAST-CANCER; RECEPTOR INTERACTIONS; ACTIN CYTOSKELETON; TYROSINE KINASES; SURFACE-ANTIGEN; PROTEIN	HSP90 is a ubiquitously expressed molecular chaperone that controls the folding, assembly, intracellular disposition, and proteolytic turnover of many proteins, most of which are involved in signal transduction processes. Recently, a surface form of HSP90 has been identified and associated with cell migration events. In this paper, we explore the interaction of surface HSP90 with HER-2, a receptor-like glycoprotein and member of the ErbB family of receptor tyrosine kinases that play central roles in cellular proliferation, differentiation, and migration as well as in cancer progress. The involvement of HSP90 in the regulation of HER-2 has been attributed so far to receptor stabilization via interaction with its cytoplasmic kinase domain. Here we present evidence, using glutathione S-transferase pull-down and transfection assays, for a novel interaction between surface HSP90 and the extracellular domain of HER-2. Specific disruption of this interaction using mAb 4C5, a function-blocking monoclonal antibody against HSP90, inhibits cell invasion accompanied by altered actin dynamics in human breast cancer cells under ligand stimulation conditions with heregulin. Additionally, disruption of surface HSP90/HER-2 interaction leads to inhibition of heregulin-induced HER-2-HER-3 heterodimer formation, reduced HER-2 phosphorylation, and impaired downstream kinase signaling. Interestingly, this disruption does not affect HER-2 internalization. Our data suggest that surface HSP90 is involved in heregulin-induced HER-2 activation and signaling, leading to cytoskeletal rearrangement, essential for cell invasion.	[Sidera, Katerina; Gaitanou, Maria; Stellas, Dimitris; Matsas, Rebecca; Patsavoudi, Evangelia] Helen Pasteur Inst, Dept Biochem, Athens 11521, Greece; [Stellas, Dimitris; Matsas, Rebecca; Patsavoudi, Evangelia] Technol Educat Inst Athens, Dept Med Instrumentat, Athens 12210, Greece	University of West Attica	Patsavoudi, E (corresponding author), Helen Pasteur Inst, Dept Biochem, 127 Vasilissis Sofias Ave, Athens 11521, Greece.	epatsavoudi@pasteur.gr	Stellas, Dimitris/AAP-8958-2021; Stellas, Dimitris/AAG-2473-2021	Stellas, Dimitris/0000-0002-7787-3921; Stellas, Dimitris/0000-0002-9587-6288				Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Becker B, 2004, EXP DERMATOL, V13, P27, DOI 10.1111/j.0906-6705.2004.00114.x; Berven LA, 2004, EXP CELL RES, V296, P183, DOI 10.1016/j.yexer.2003.12.032; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Carpenter G, 2003, CURR OPIN CELL BIOL, V15, P143, DOI 10.1016/S0955-0674(03)00015-2; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Citri A, 2004, CELL CYCLE, V3, P51; Eustace BK, 2004, CELL CYCLE, V3, P1098; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Goetz MP, 2005, J CLIN ONCOL, V23, P1078, DOI 10.1200/JCO.2005.09.119; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Hijazi MM, 2000, INT J ONCOL, V17, P629; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Jackson JG, 2004, CANCER RES, V64, P2601, DOI 10.1158/0008-5472.CAN-03-3106; Johannessen LE, 2001, BIOCHEM J, V356, P87, DOI 10.1042/0264-6021:3560087; KANG KI, 1994, P NATL ACAD SCI USA, V91, P340, DOI 10.1073/pnas.91.1.340; Lavdas AA, 2006, GLIA, V53, P868, DOI 10.1002/glia.20340; Lee KJ, 2006, EXP MOL MED, V38, P364, DOI 10.1038/emm.2006.43; Mahajan VB, 2000, P NATL ACAD SCI USA, V97, P12062, DOI 10.1073/pnas.97.22.12062; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Meintanis S, 2001, GLIA, V34, P39, DOI 10.1002/glia.1038; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; MUSS HB, 1994, NEW ENGL J MED, V330, P1260, DOI 10.1056/NEJM199405053301802; Neckers Len, 2003, Current Opinion in Oncology, V15, P419, DOI 10.1097/00001622-200311000-00003; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nollen EAA, 2002, J CELL SCI, V115, P2809; PATSAVOUDI E, 1991, J NEUROCHEM, V56, P782, DOI 10.1111/j.1471-4159.1991.tb01992.x; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Pick E, 2007, CANCER RES, V67, P2932, DOI 10.1158/0008-5472.CAN-06-4511; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pratt WB, 1998, P SOC EXP BIOL MED, V217, P420; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V319, P1, DOI 10.1016/j.bbrc.2004.04.150; Rubin I, 2001, ANN ONCOL, V12, P3, DOI 10.1023/A:1011195320446; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Stellas D, 2007, CLIN CANCER RES, V13, P1831, DOI 10.1158/1078-0432.CCR-06-1585; Tago K, 2004, MOL CELL ENDOCRINOL, V213, P131, DOI 10.1016/j.mce.2003.10.057; THOMAIDOU D, 1995, J NEUROCHEM, V64, P1937; THOMAIDOU D, 1993, NEUROSCIENCE, V53, P813, DOI 10.1016/0306-4522(93)90626-Q; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Vadlamudi RK, 2002, J CELL PHYSIOL, V190, P189, DOI 10.1002/JCP.10054; Wells A, 2002, NAT REV MOL CELL BIO, V3, P697, DOI 10.1038/nrm905; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yfanti E, 1998, J NEUROCHEM, V71, P1381; Yfanti E, 2004, GLIA, V45, P39, DOI 10.1002/glia.10307; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zeigler ME, 1999, J CELL PHYSIOL, V180, P271; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	58	124	136	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2031	2041		10.1074/jbc.M701803200	http://dx.doi.org/10.1074/jbc.M701803200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18056992	hybrid			2022-12-25	WOS:000252501000030
J	Kono, N; Inoue, T; Yoshida, Y; Sato, H; Matsusue, T; Itabe, H; Niki, E; Aoki, J; Arai, H				Kono, Nozomu; Inoue, Takao; Yoshida, Yasukazu; Sato, Hiroyuki; Matsusue, Tomokazu; Itabe, Hiroyuki; Niki, Etsuo; Aoki, Junken; Arai, Hiroyuki			Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRACHLORIDE-INDUCED HEPATOTOXICITY; CARBON-TETRACHLORIDE; HUMAN-PLASMA; PAF-ACETYLHYDROLASE; LIPID-PEROXIDATION; CAENORHABDITIS-ELEGANS; MISSENSE MUTATION; RECEPTOR-GAMMA; LIVER-INJURY; RISK-FACTOR	Membrane phospholipids are susceptible to oxidation, which is involved in various pathological processes such as inflammation, atherogenesis, neurodegeneration, and aging. One enzyme that may help to remove oxidized phospholipids from cells is intracellular type II platelet-activating factor acetylhydrolase (PAF-AH (II)), which hydrolyzes oxidatively fragmented fatty acyl chains attached to phospholipids. Overexpression of PAF-AH (II) in cells or tissues was previously shown to suppress oxidative stress-induced cell death. In this study we investigated the functions of PAF-AH (II) by generating PAF-AH (II)-deficient (Pafah2(-/-)) mice. PAF-AH (II) was predominantly expressed in epithelial cells such as kidney proximal and distal tubules, intestinal column epithelium, and hepatocytes. Although PAF- AH activity was almost abolished in the liver and kidney of Pafah2(-/-) mice, Pafah2(-/-) mice developed normally and were phenotypically indistinguishable from wild- type mice. However, mouse embryonic fibroblasts derived from Pafah2(-/-) mice were more sensitive to tert- butylhydroperoxide treatment than those derived from wild- type mice. When carbon tetrachloride (CCl4) was injected into mice, Pafah2(-/-) mice showed a delay in hepatic injury recovery. Moreover, after CCl4 administration, liver levels of the esterified form of 8-iso-PGF(2 alpha), a known in vitro substrate of PAF-AH (II), were higher in Pafah2(-/-) mice than in wild-type mice. These results indicate that PAF-AH (II) is involved in the metabolism of esterified 8-isoprostaglandin F-2 alpha and protects tissue from oxidative stress-induced injury.	[Kono, Nozomu; Inoue, Takao; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Yoshida, Yasukazu; Niki, Etsuo] Natl Inst Adv Ind Sci & Technol, Human Stress Signal Res Ctr, Osaka 5638577, Japan; [Sato, Hiroyuki; Matsusue, Tomokazu] Mochida Pharmaceut Co Ltd, Pharmaceut Res Ctr, Shizuoka 4128524, Japan; [Itabe, Hiroyuki] Showa Univ, Sch Pharmaceut Sci, Dept Biol Chem, Shinagawa Ku, Tokyo 1428555, Japan; [Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Kono, Nozomu; Inoue, Takao; Arai, Hiroyuki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kono, Nozomu; Inoue, Takao; Arai, Hiroyuki] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Mochida Pharmaceutical Co Ltd; Showa University; Tohoku University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Arai, H (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	harai@mol.f.u-tokyo.ac.jp	板部板部, 洋之/ABC-7746-2020; KONO, nozomu/AAM-3178-2020; YOSHIDA, YASUKAZU/H-8510-2016	YOSHIDA, YASUKAZU/0000-0001-6034-2502; Aoki, Junken/0000-0001-9435-1896				AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; Bae KA, 2000, J BIOL CHEM, V275, P26704; BIASI F, 1991, CELL BIOCHEM FUNCT, V9, P111, DOI 10.1002/cbf.290090208; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Campo GM, 2001, FREE RADICAL RES, V34, P379, DOI 10.1080/10715760100300321; Chen R, 2007, J BIOL CHEM, V282, P24842, DOI 10.1074/jbc.M702865200; Davies SS, 2001, J BIOL CHEM, V276, P16015, DOI 10.1074/jbc.M100878200; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Fruhwirth GO, 2007, BBA-MOL BASIS DIS, V1772, P718, DOI 10.1016/j.bbadis.2007.04.009; Fukuda Y, 2000, EUR J PHARMACOL, V390, P203, DOI 10.1016/S0014-2999(99)00920-6; HALL BH, 1990, BROOKINGS PAP ECO AC, P85; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; HATTORI M, 1993, J BIOL CHEM, V268, P18748; Henderson WR, 2000, J IMMUNOL, V164, P3360, DOI 10.4049/jimmunol.164.6.3360; Hiramoto M, 1997, STROKE, V28, P2417, DOI 10.1161/01.STR.28.12.2417; Hofbauer B, 1998, GASTROENTEROLOGY, V115, P1238, DOI 10.1016/S0016-5085(98)70096-4; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Inoue T, 2004, P NATL ACAD SCI USA, V101, P13233, DOI 10.1073/pnas.0405507101; ITABE H, 1988, BIOCHIM BIOPHYS ACTA, V962, P8; Karabina SA, 2006, BBA-MOL CELL BIOL L, V1761, P1351, DOI 10.1016/j.bbalip.2006.05.008; Karasawa K, 2006, BBA-MOL CELL BIOL L, V1761, P1359, DOI 10.1016/j.bbalip.2006.06.017; KAYGANICHHARRISON KA, 1993, J LIPID RES, V34, P1229; KINNUNEN PKJ, 1991, CHEM PHYS LIPIDS, V57, P375, DOI 10.1016/0009-3084(91)90087-R; Kriska T, 2007, J BIOL CHEM, V282, P100, DOI 10.1074/jbc.M608135200; Kruse S, 2000, AM J HUM GENET, V66, P1522, DOI 10.1086/302901; Lawson JA, 1999, J BIOL CHEM, V274, P24441, DOI 10.1074/jbc.274.35.24441; Liu P, 2001, LIVER, V21, P384, DOI 10.1034/j.1600-0676.2001.210604.x; Marques M, 2002, J INVEST DERMATOL, V119, P913, DOI 10.1046/j.1523-1747.2002.01859.x; Matsuzawa A, 1997, J BIOL CHEM, V272, P32315, DOI 10.1074/jbc.272.51.32315; Min JH, 1999, BIOCHEMISTRY-US, V38, P12935, DOI 10.1021/bi991149u; Min JH, 2001, BIOCHEMISTRY-US, V40, P4539, DOI 10.1021/bi002600g; MIWA M, 1988, J CLIN INVEST, V82, P1983, DOI 10.1172/JCI113818; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; MORROW JD, 1994, BBA-LIPID LIPID MET, V1210, P244, DOI 10.1016/0005-2760(94)90128-7; MORROW JD, 1992, P NATL ACAD SCI USA, V89, P10721, DOI 10.1073/pnas.89.22.10721; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Nigam S, 2000, BBA-MOL CELL BIOL L, V1488, P167, DOI 10.1016/S1388-1981(00)00119-0; Oberley TD, 2001, FREE RADICAL BIO MED, V30, P412, DOI 10.1016/S0891-5849(00)00486-X; Ohshima N, 2002, J BIOL CHEM, V277, P9722, DOI 10.1074/jbc.M112406200; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Quarck R, 2001, CIRCULATION, V103, P2495; Satoh N, 1999, AM J RESP CRIT CARE, V159, P974, DOI 10.1164/ajrccm.159.3.9807093; SATOUCHI K, 1993, LIPIDS, V28, P837, DOI 10.1007/BF02536239; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Sotelo-Felix JI, 2002, EUR J GASTROEN HEPAT, V14, P1001, DOI 10.1097/00042737-200209000-00011; SOUTHORN PA, 1988, MAYO CLIN PROC, V63, P390, DOI 10.1016/S0025-6196(12)64862-9; Stafforini DM, 2006, J BIOL CHEM, V281, P4616, DOI 10.1074/jbc.M507340200; Stafforini DM, 1999, J CLIN INVEST, V103, P989, DOI 10.1172/JCI5574; Stafforini DM, 1996, J CLIN INVEST, V97, P2784, DOI 10.1172/JCI118733; Stafforini DM, 1997, J BIOL CHEM, V272, P17895, DOI 10.1074/jbc.272.29.17895; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4223; Stafforini DM, 1996, BBA-LIPID LIPID MET, V1301, P161, DOI 10.1016/0005-2760(96)00040-9; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4215; STREMLER KE, 1989, J BIOL CHEM, V264, P5331; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; TAKAHASHI K, 1992, J CLIN INVEST, V90, P136, DOI 10.1172/JCI115826; Tanaka M, 2004, FEBS LETT, V571, P197, DOI 10.1016/j.febslet.2004.06.083; Theilmeier G, 2000, FASEB J, V14, P2032, DOI 10.1096/fj.99-1029com; Tjoelker LW, 2000, BBA-MOL CELL BIOL L, V1488, P102, DOI 10.1016/S1388-1981(00)00114-1; TJOELKER LW, 1995, NATURE, V374, P549, DOI 10.1038/374549a0; TSELEPIS AD, 1995, ARTERIOSCL THROM VAS, V15, P1764, DOI 10.1161/01.ATV.15.10.1764; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Umemura K, 2007, STROKE, V38, P1063, DOI 10.1161/01.STR.0000257981.09329.d2; Wang XS, 2003, J BIOL CHEM, V278, P25179, DOI 10.1074/jbc.M302706200; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Wong FWY, 1998, TOXICOL APPL PHARM, V153, P109, DOI 10.1006/taap.1998.8547; Wu Y, 2007, TOXICOLOGY, V232, P50, DOI 10.1016/j.tox.2006.12.013; Yamada Y, 1997, BIOCHEM BIOPH RES CO, V236, P772, DOI 10.1006/bbrc.1997.7047; Yamada Y, 1998, METABOLISM, V47, P177, DOI 10.1016/S0026-0495(98)90216-5; Yoshida Y, 2005, TOXICOL APPL PHARM, V208, P87, DOI 10.1016/j.taap.2005.01.015; Zhang QW, 2005, J BIOL CHEM, V280, P73, DOI 10.1074/jbc.M409795200	71	59	62	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1628	1636		10.1074/jbc.M708622200	http://dx.doi.org/10.1074/jbc.M708622200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024956	hybrid			2022-12-25	WOS:000252282700049
J	Tavares-Carreon, F; Camacho-Villasana, Y; Zamudio-Ochoa, A; Shingu-Vazquez, M; Torres-Larios, A; Perez-Martinez, X				Tavares-Carreon, Faviola; Camacho-Villasana, Yolanda; Zamudio-Ochoa, Angelica; Shingu-Vazquez, Miguel; Torres-Larios, Alfredo; Perez-Martinez, Xochitl			The pentatricopeptide repeats present in pet309 are necessary for translation but not for stability of the mitochondrial COX1 mRNA in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; INNER MEMBRANE; CYTOCHROME-OXIDASE; REVEALS SIMILARITY; SHUTTLE VECTORS; IN-VIVO; PROTEIN; ARABIDOPSIS; ACTIVATOR	Pet309 is a protein essential for respiratory growth. It is involved in translation of the yeast mitochondrial COX1 gene, which encodes subunit I of the cytochrome c oxidase. Pet309 is also involved in stabilization of the COX1 mRNA. Mutations in a similar human protein, Lrp130, are associated with Leigh syndrome, where cytochrome c oxidase activity is affected. The sequence of Pet309 reveals the presence of at least seven pentatricopeptide repeats (PPRs) located in tandem in the central portion of the protein. Proteins containing PPR motifs are present in mitochondria and chloroplasts and are in general involved in RNA metabolism. Despite the increasing number of proteins from this family found to play essential roles in mitochondria and chloroplasts, little is understood about the mechanism of action of the PPR domains present in these proteins. In a series of in vivo analyses we constructed a pet309 mutant lacking the PPR motifs. Although the stability of the COX1 mRNA was not affected, synthesis of Cox1 was abolished. The deletion of one PPR motif at a time showed that all the PPR motifs are required for COX1 mRNA translation and respiratory growth. Mutations of basic residues in PPR3 caused reduced respiratory growth. According to a molecular model, these residues are facing a central cavity that could be involved in mRNA-binding activity, forming a possible path for this molecule on Pet309. Our results show that the RNA metabolism function of Pet309 is found in at least two separate domains of the protein.	[Tavares-Carreon, Faviola; Camacho-Villasana, Yolanda; Zamudio-Ochoa, Angelica; Shingu-Vazquez, Miguel; Torres-Larios, Alfredo; Perez-Martinez, Xochitl] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Perez-Martinez, X (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim, Circuito Exterior S-N,Ciudad Univ,Apartado Postal, Mexico City 04510, DF, Mexico.	xperez@ifc.unam.mx	Zamudio-Ochoa, Angelica/AAC-3684-2020	Zamudio-Ochoa, Angelica/0000-0002-6347-5789; Torres-Larios, Alfredo/0000-0002-0702-350X; Tavares-Carreon, Faviola/0000-0002-5914-6640				Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; Bonnefoy N, 2001, MOL CELL BIOL, V21, P2359, DOI 10.1128/MCB.21.7.2359-2372.2001; BROWN NG, 1994, MOL CELL BIOL, V14, P1045, DOI 10.1128/MCB.14.2.1045; Coffin JW, 1997, CURR GENET, V32, P273, DOI 10.1007/s002940050277; COSTANZO MC, 1990, ANNU REV GENET, V24, P91; DIECKMANN CL, 1994, INT REV CYTOL, V152, P145, DOI 10.1016/S0074-7696(08)62556-5; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Fiori A, 2005, MOL MICROBIOL, V56, P1689, DOI 10.1111/j.1365-2958.2005.04658.x; Fisk DG, 1999, EMBO J, V18, P2621, DOI 10.1093/emboj/18.9.2621; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gillman JD, 2007, PLANT J, V49, P217, DOI 10.1111/j.1365-313X.2006.02953.x; Glick BS, 1995, METHOD ENZYMOL, V260, P224, DOI 10.1016/0076-6879(95)60140-6; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Green-Willms NS, 2001, J BIOL CHEM, V276, P6392, DOI 10.1074/jbc.M009856200; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Hattori M, 2007, J BIOL CHEM, V282, P10773, DOI 10.1074/jbc.M608034200; Herrmann JM, 2005, GENE, V354, P43, DOI 10.1016/j.gene.2005.03.017; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Kim K, 2006, BIOCHEM BIOPH RES CO, V340, P1028, DOI 10.1016/j.bbrc.2005.12.108; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Krause K, 2004, MOL BIOL CELL, V15, P2674, DOI 10.1091/mbc.E04-02-0126; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lahmy S, 2000, FEBS LETT, V480, P255, DOI 10.1016/S0014-5793(00)01935-9; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; MANTHEY GM, 1995, EMBO J, V14, P4031, DOI 10.1002/j.1460-2075.1995.tb00074.x; Manthey GM, 1998, EUR J BIOCHEM, V255, P156, DOI 10.1046/j.1432-1327.1998.2550156.x; Maslov DA, 2007, MOL BIOCHEM PARASIT, V152, P203, DOI 10.1016/j.molbiopara.2007.01.012; Meierhoff K, 2003, PLANT CELL, V15, P1480, DOI 10.1105/tpc.010397; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Naithani S, 2003, MOL BIOL CELL, V14, P324, DOI 10.1091/mbc.E02-08-0490; Nakamura T, 2003, EUR J BIOCHEM, V270, P4070, DOI 10.1046/j.1432-1033.2003.03796.x; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pusnik M, 2007, MOL CELL BIOL, V27, P6876, DOI 10.1128/MCB.00708-07; ROSE MD, 1988, METHODS YEAST GENETI; Sanchirico ME, 1998, EMBO J, V17, P5796, DOI 10.1093/emboj/17.19.5796; Schmitz-Linneweber C, 2005, PLANT CELL, V17, P2791, DOI 10.1105/tpc.105.034454; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHEN ZH, 1989, NUCLEIC ACIDS RES, V17, P4535, DOI 10.1093/nar/17.12.4535; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; SIKORSKI RS, 1989, GENETICS, V122, P19; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Tzschoppe K, 2000, BIOL CHEM, V381, P1175, DOI 10.1515/BC.2000.145; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Westermann B, 2001, METHOD CELL BIOL, V65, P429, DOI 10.1016/S0091-679X(01)65025-8; Williams EH, 2003, RNA, V9, P419, DOI 10.1261/rna.2182903; Williams PM, 2003, PLANT J, V36, P675, DOI 10.1046/j.1365-313X.2003.01915.x; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469; YAFFE MP, 1991, METHOD ENZYMOL, V194, P627; Yamazaki H, 2004, PLANT J, V38, P152, DOI 10.1111/j.1365-313X.2004.02035.x	63	68	71	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1472	1479		10.1074/jbc.M708437200	http://dx.doi.org/10.1074/jbc.M708437200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18039654	hybrid			2022-12-25	WOS:000252282700031
J	Xu, Y; Harton, JA; Smith, BD				Xu, Yong; Harton, Jonathan A.; Smith, Barbara D.			CIITA mediates interferon-gamma repression of collagen transcription through phosphorylation-dependent interactions with co-repressor molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-II TRANSACTIVATOR; BARE LYMPHOCYTE SYNDROME; CREB BINDING-PROTEIN; IL-4 GENE-TRANSCRIPTION; NOD-LIKE RECEPTORS; HISTONE DEACETYLASES; BETA-CATENIN; MICE LACKING; IFN-GAMMA; SACCHAROMYCES-CEREVISIAE	Previously, we have demonstrated that major histocompatibility class II trans-activator ( CIITA) is crucial in mediating interferon-gamma(IFN-gamma)-induced repression of collagen type I gene transcription. Here we report that CIITA represses collagen transcription through a phosphorylation-dependent interaction between its proline/serine/threonine domain and co-repressor molecules such as histone deacetylase (HDAC2) and Sin3B. Mutation of a serine (S373A) in CIITA, within a glycogen synthase kinase 3 (GSK3) consensus site, decreases repression of collagen transcription by blocking interaction with Sin3B. In vitro phosphorylation of CIITA by GSK3 relies on a casein kinase I site three amino acids C-terminal to the GSK3 site in CIITA. Both GSK3 and casein kinase I inhibitors alleviate collagen repression and disrupt IFN-gamma-mediated recruitment of Sin3B and HDAC2 to the collagen start site. Therefore, we have identified the region within CIITA responsible for mediating IFN-gamma-induced inhibition of collagen synthesis.	[Xu, Yong; Smith, Barbara D.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Harton, Jonathan A.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	Boston University; Albany Medical College	Smith, BD (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St, Boston, MA 02118 USA.	smith@biochem.bumc.bu.edu	Harton, Jonathan/F-2848-2010; Harton, Jonathan A/AAW-5283-2021	Harton, Jonathan/0000-0002-0350-1877; Harton, Jonathan A/0000-0002-0350-1877; Smith, Barbara/0000-0002-5375-7627	NATIONAL CANCER INSTITUTE [K01CA095582] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068094, P01HL013262] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA095582] Funding Source: Medline; NHLBI NIH HHS [HL 68094, HL 013262-31] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Armstrong TD, 1997, P NATL ACAD SCI USA, V94, P6886, DOI 10.1073/pnas.94.13.6886; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bontron S, 1997, MOL CELL BIOL, V17, P4249, DOI 10.1128/MCB.17.8.4249; Bontron S, 1997, HUM GENET, V99, P541, DOI 10.1007/s004390050403; Boss JM, 1997, CURR OPIN IMMUNOL, V9, P107, DOI 10.1016/S0952-7915(97)80166-5; Boucher MJ, 2006, J BIOL CHEM, V281, P6395, DOI 10.1074/jbc.M511597200; Bradley MB, 1997, J IMMUNOL, V159, P1086; Bustos VH, 2006, P NATL ACAD SCI USA, V103, P19725, DOI 10.1073/pnas.0609424104; Buttice G, 2006, CIRC RES, V98, P472, DOI 10.1161/01.RES.0000204725.46332.97; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Ellenrieder V, 2002, EMBO J, V21, P2451, DOI 10.1093/emboj/21.10.2451; Fontes JD, 1997, NUCLEIC ACIDS RES, V25, P2522, DOI 10.1093/nar/25.12.2522; Fontes JD, 1999, MOL CELL BIOL, V19, P941; Fritz JH, 2005, J ENDOTOXIN RES, V11, P390, DOI 10.1179/096805105X76850; GOLDBERG H, 1992, J BIOL CHEM, V267, P19622; Gourley T, 1999, IMMUNITY, V10, P377, DOI 10.1016/S1074-7613(00)80037-0; Gourley TS, 2001, J IMMUNOL, V166, P2917, DOI 10.4049/jimmunol.166.5.2917; Greer SF, 2003, NAT IMMUNOL, V4, P1074, DOI 10.1038/ni985; Greer SF, 2004, J IMMUNOL, V173, P376, DOI 10.4049/jimmunol.173.1.376; HALLECK MS, 1995, GENOMICS, V26, P403, DOI 10.1016/0888-7543(95)80229-F; Harte D, 1998, J NONLINEAR SCI, V8, P581, DOI 10.1007/s003329900060; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hergovich A, 2006, MOL CELL BIOL, V26, P5784, DOI 10.1128/MCB.00232-06; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Itoh-Lindstrom Y, 1999, J IMMUNOL, V163, P2425; Jabrane-Ferrat N, 2003, INT IMMUNOL, V15, P467, DOI 10.1093/intimm/dxg048; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kretsovali A, 1998, MOL CELL BIOL, V18, P6777, DOI 10.1128/MCB.18.11.6777; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lee E, 2001, J CELL BIOL, V154, P983, DOI 10.1083/jcb.200102074; Li GX, 2001, MOL CELL BIOL, V21, P4626, DOI 10.1128/MCB.21.14.4626-4635.2001; Linhoff MW, 2001, MOL CELL BIOL, V21, P3001, DOI 10.1128/MCB.21.9.3001-3011.2001; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Mahanta SK, 1997, P NATL ACAD SCI USA, V94, P6324, DOI 10.1073/pnas.94.12.6324; Masternak K, 2000, GENE DEV, V14, P1156; Masternak K, 2000, Rev Immunogenet, V2, P267; Mori-Aoki A, 2000, BIOCHEM BIOPH RES CO, V278, P58, DOI 10.1006/bbrc.2000.3769; Mudhasani R, 2002, MOL CELL BIOL, V22, P5019, DOI 10.1128/MCB.22.14.5019-5026.2002; Nozell S, 2004, J BIOL CHEM, V279, P38577, DOI 10.1074/jbc.M403738200; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Otten LA, 2006, EUR J IMMUNOL, V36, P1548, DOI 10.1002/eji.200535687; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; RILEY JL, 1995, IMMUNITY, V2, P533, DOI 10.1016/1074-7613(95)90033-0; Rosenstiel P, 2007, MICROBES INFECT, V9, P648, DOI 10.1016/j.micinf.2007.01.015; Sartoris S, 1996, EUR J IMMUNOL, V26, P2456, DOI 10.1002/eji.1830261028; SASAKI A, 1990, J NEUROIMMUNOL, V29, P213, DOI 10.1016/0165-5728(90)90164-I; Scholl T, 1997, P NATL ACAD SCI USA, V94, P6330, DOI 10.1073/pnas.94.12.6330; Scott KL, 2003, MOL CELL BIOL, V23, P4522, DOI 10.1128/MCB.23.13.4522-4531.2003; Sengupta P, 2005, J BIOL CHEM, V280, P21004, DOI 10.1074/jbc.M413191200; Sengupta PK, 2003, CANCER RES, V63, P1789; Sengupta PK, 2002, J BIOL CHEM, V277, P24926, DOI 10.1074/jbc.M111712200; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Sisk TJ, 2000, J IMMUNOL, V165, P2511, DOI 10.4049/jimmunol.165.5.2511; Sisk TJ, 2003, INT IMMUNOL, V15, P1195, DOI 10.1093/intimm/dxg116; Spilianakis C, 2003, EMBO J, V22, P5125, DOI 10.1093/emboj/cdg496; Spilianakis C, 2000, MOL CELL BIOL, V20, P8489, DOI 10.1128/MCB.20.22.8489-8498.2000; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; STERNBERG PW, 1987, CELL, V48, P567, DOI 10.1016/0092-8674(87)90235-2; Tosi G, 2002, EMBO J, V21, P5467, DOI 10.1093/emboj/cdf557; Turenne GA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-12; Um JH, 2007, J BIOL CHEM, V282, P20794, DOI 10.1074/jbc.C700070200; Williams GS, 1998, INT IMMUNOL, V10, P1957, DOI 10.1093/intimm/10.12.1957; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; Wu G, 2006, BIOCHEMISTRY-US, V45, P5319, DOI 10.1021/bi0601149; Xu Y, 2006, J BIOL CHEM, V281, P9260, DOI 10.1074/jbc.M511724200; Xu Y, 2004, J BIOL CHEM, V279, P41319, DOI 10.1074/jbc.M404174200; Xu Y, 2003, J BIOL CHEM, V278, P49134, DOI 10.1074/jbc.M309003200; Xu Y, 2007, MOL IMMUNOL, V44, P1709, DOI 10.1016/j.molimm.2006.07.294; Yang L, 2003, BIOCHEM J, V369, P651, DOI 10.1042/BJ20020854; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yee CSK, 2005, J IMMUNOL, V174, P1222, DOI 10.4049/jimmunol.174.3.1222; Yee CSK, 2004, J IMMUNOL, V172, P5528, DOI 10.4049/jimmunol.172.9.5528; Zhang XH, 2004, MOL CELL BIOL, V24, P5106, DOI 10.1128/MCB.24.12.5106-5118.2004; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhou XR, 2007, IMMUNOLOGY, V122, P476, DOI 10.1111/j.1365-2567.2007.02674.x; Zhu XS, 2001, MOL CELL BIOL, V21, P7078, DOI 10.1128/MCB.21.20.7078-7088.2001; Zika E, 2003, MOL CELL BIOL, V23, P3091, DOI 10.1128/MCB.23.9.3091-3102.2003; Zilfou JT, 2001, MOL CELL BIOL, V21, P3974, DOI 10.1128/MCB.21.12.3974-3985.2001	83	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1243	1256		10.1074/jbc.M707180200	http://dx.doi.org/10.1074/jbc.M707180200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17991736	hybrid			2022-12-25	WOS:000252282700007
J	Lee, CM; Kim, BY; Li, LA; Morgan, ET				Lee, Choon-Myung; Kim, Bong-Yoon; Li, Lian; Morgan, Edward T.			Nitric oxide-dependent proteasomal degradation of cytochrome P4502B proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION; RAT-LIVER; GENE-EXPRESSION; PRIMARY CULTURES; MESSENGER-RNAS; KAPPA-B; INHIBITION; INDUCTION; ENDOTOXIN; HEPATOCYTES	Exposure to inflammatory agents or cytokines causes the suppression of cytochrome P450 (CYP) enzyme activities and expression in liver and primary hepatocyte cultures. We showed previously that phenobarbital-induced CYP2B protein is down-regulated in primary cultures of rat hepatocytes after exposure to bacterial endotoxin ( lipopolysaccharide) in a nitric oxide (NO)-dependent manner. In this study, we found that CYP2B proteins in primary rat hepatocyte cultures were suppressed > 60% after 6 h of treatment with interleukin-1 beta (IL-1). This effect was NO-dependent, and treatment of cells with the NO donors (Z)-1-[2-(2-aminoethyl)-N-(2-ammonioethyl) aminodiazen-1-ium-1,2-diolate (NOC-18), S-nitrosoglutathione, and S-nitroso-N-acetylpenicillamine also suppressed CYP2B proteins. However, the down-regulation by IL-1 was insensitive to inhibition of cGMP-dependent protein kinases. The down-regulation by IL-1 or NO donors was abolished by treatments with the proteasome inhibitors MG132 and lactacystin that did not affect NO production. The calpain inhibitor E64-d or the lysosomal protease inhibitors NH4Cl and chloroquine did not attenuate the down-regulation of CYP2B by IL-1. Treatment of HeLa cells expressing c-Myc-tagged CYP2B1 with NOC-18 down-regulated its expression and enhanced its ubiquitination. Treatment of rat liver microsomes with S-nitrosoglutathione caused S-nitrosylation of CYP2B protein and enhanced the ubiquitination pattern of CYP2B compared with unmodified CYP2B in an in vitro ubiquitination assay. These data are consistent with the hypothesis that NO-dependent CYP2B ubiquitination and proteasomal degradation are dependent on protein modification by reactive nitrogen species.	[Lee, Choon-Myung; Kim, Bong-Yoon; Li, Lian; Morgan, Edward T.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Morgan, ET (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.	edward.morgan@emory.edu		Li, Lian/0000-0003-4700-1134; Morgan, Edward/0000-0003-4273-2261	NIEHS NIH HHS [T32 ES012870, T32 ES012870-03, T32ES01287, T32 ES012870-04] Funding Source: Medline; NIGMS NIH HHS [R01 GM069971-03, R01 GM069971-01, R01 GM069971-04, R01 GM069971-02, GM066971, R01 GM069971] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES012870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069971] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal AK, 1996, MOL PHARMACOL, V49, P523; Aitken AE, 2006, ANNU REV PHARMACOL, V46, P123, DOI 10.1146/annurev.pharmtox.46.120604.141059; Baldwin SJ, 2006, DRUG METAB DISPOS, V34, P1063, DOI 10.1124/dmd.105.008185; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Carlson TJ, 1996, MOL PHARMACOL, V49, P796; CHEN JQ, 1995, MOL PHARMACOL, V47, P940; Correia MA, 2005, ANNU REV PHARMACOL, V45, P439, DOI 10.1146/annurev.pharmtox.45.120403.100127; Dedon PC, 2004, ARCH BIOCHEM BIOPHYS, V423, P12, DOI 10.1016/j.abb.2003.12.017; Eum HA, 2006, NITRIC OXIDE-BIOL CH, V15, P423, DOI 10.1016/j.niox.2006.06.004; Ferrari L, 2001, MOL PHARMACOL, V60, P209, DOI 10.1124/mol.60.1.209; GELLER DA, 1994, ARCH SURG-CHICAGO, V129, P165; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guengerich FP, 2004, DRUG METAB REV, V36, P159, DOI 10.1081/DMR-120033996; Hara H, 2000, FREE RADICAL RES, V33, P279, DOI 10.1080/10715760000301441; Hara H, 2002, MOL PHARMACOL, V61, P194, DOI 10.1124/mol.61.1.194; HONKAKOSKI P, 1992, BIOCHEM J, V285, P979, DOI 10.1042/bj2850979; Huan JY, 2004, TOXICOL APPL PHARM, V199, P332, DOI 10.1016/j.taap.2003.12.019; Ingelman-Sundberg M, 2004, TRENDS PHARMACOL SCI, V25, P193, DOI 10.1016/j.tips.2004.02.007; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Khatsenko OG, 1997, TOXICOL LETT, V90, P207, DOI 10.1016/S0378-4274(96)03857-X; Khatsenko OG, 1998, BIOCHEM PHARMACOL, V55, P1835, DOI 10.1016/S0006-2952(98)00066-5; Kim S, 2004, MOL CELL BIOL, V24, P330, DOI 10.1128/MCB.24.1.330-337.2004; KIM YM, 1995, J BIOL CHEM, V270, P5710, DOI 10.1074/jbc.270.11.5710; Korsmeyer KK, 1999, ARCH BIOCHEM BIOPHYS, V365, P31, DOI 10.1006/abbi.1999.1138; Kotamraju S, 2003, P NATL ACAD SCI USA, V100, P10653, DOI 10.1073/pnas.1933581100; Li HC, 1998, J BIOCHEM MOL TOXIC, V12, P315; Li-Masters T, 2002, BIOCHEM PHARMACOL, V64, P1703, DOI 10.1016/S0006-2952(02)01423-5; Liao MX, 2005, MOL PHARMACOL, V67, P1460, DOI 10.1124/mol.104.009654; Lin HL, 2003, CHEM RES TOXICOL, V16, P129, DOI 10.1021/tx020040b; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mannick JB, 2004, FREE RADICAL RES, V38, P1, DOI 10.1080/10715760310001629065; MASAKI R, 1987, J CELL BIOL, V104, P1207, DOI 10.1083/jcb.104.5.1207; MCGOWAN EB, 1989, BIOCHEM BIOPH RES CO, V158, P432, DOI 10.1016/S0006-291X(89)80065-8; Milligan SA, 1996, ARCH BIOCHEM BIOPHYS, V335, P388, DOI 10.1006/abbi.1996.9998; Minamiyama Y, 1997, J PHARMACOL EXP THER, V283, P1479; MISKO TP, 1993, EUR J PHARMACOL, V233, P119, DOI 10.1016/0014-2999(93)90357-N; Morgan ET, 1997, DRUG METAB REV, V29, P1129, DOI 10.3109/03602539709002246; MORGAN ET, 1985, MOL PHARMACOL, V27, P471; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Roberts BJ, 1997, J BIOL CHEM, V272, P9771; Roberts ES, 1998, CHEM RES TOXICOL, V11, P1067, DOI 10.1021/tx980099b; RONIS MJJ, 1991, EUR J BIOCHEM, V198, P383, DOI 10.1111/j.1432-1033.1991.tb16026.x; Sewer MB, 1998, J PHARMACOL EXP THER, V287, P352; Sewer MB, 1997, BIOCHEM PHARMACOL, V54, P729, DOI 10.1016/S0006-2952(97)00226-8; Sewer MB, 1998, MOL PHARMACOL, V54, P273, DOI 10.1124/mol.54.2.273; SHIRAKI H, 1984, ARCH BIOCHEM BIOPHYS, V235, P86, DOI 10.1016/0003-9861(84)90257-1; Song BL, 2004, J BIOL CHEM, V279, P28798, DOI 10.1074/jbc.M402442200; Spencer NY, 2000, J BIOL CHEM, V275, P36562, DOI 10.1074/jbc.M005347200; STADLER J, 1994, P NATL ACAD SCI USA, V91, P3559, DOI 10.1073/pnas.91.9.3559; Takemura S, 1999, J HEPATOL, V30, P1035, DOI 10.1016/S0168-8278(99)80257-8; Tong LM, 2001, DRUG METAB DISPOS, V29, P252; Tunctan B, 2006, NITRIC OXIDE-BIOL CH, V14, P51, DOI 10.1016/j.niox.2005.09.006; VILLA P, 1995, CLIN DIAGN LAB IMMUN, V2, P549, DOI 10.1128/CDLI.2.5.549-553.1995; Vuppugalla R, 2004, J PHARMACOL EXP THER, V310, P718, DOI 10.1124/jpet.104.065557; Willmott N, 1996, J BIOL CHEM, V271, P3699; WINK DA, 1993, ARCH BIOCHEM BIOPHYS, V300, P115, DOI 10.1006/abbi.1993.1016; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P874, DOI 10.1016/j.freeradbiomed.2004.12.012; Zou MH, 2000, ARCH BIOCHEM BIOPHYS, V376, P149, DOI 10.1006/abbi.2000.1699	61	57	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					889	898		10.1074/jbc.M708821200	http://dx.doi.org/10.1074/jbc.M708821200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17993647	hybrid, Green Accepted			2022-12-25	WOS:000252128100029
J	Mac, TT; von Hacht, A; Hung, KC; Dutton, RJ; Boyd, D; Bardwell, JCA; Ulmer, TS				Mac, Thien-Thi; von Hacht, Annekathrin; Hung, Kuo-Chan; Dutton, Rachel J.; Boyd, Dana; Bardwell, James C. A.; Ulmer, Tobias S.			Insight into disulfide bond catalysis in Chlamydia from the structure and function of DsbH, a novel oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPOLAR COUPLINGS; CRYSTAL-STRUCTURE; HUMAN THIOREDOXIN; CHEMICAL-SHIFT; NMR STRUCTURES; PROTEIN; ISOMERASE; DYNAMICS; REVEALS; PEPTIDE	The Chlamydia family of human pathogens uses outer envelope proteins that are highly cross-linked by disulfide bonds but nevertheless keeps an unusually high number of unpaired cysteines in its secreted proteins. To gain insight into chlamydial disulfide bond catalysis, the structure, function, and substrate interaction of a novel periplasmic oxidoreductase, termed DsbH, were determined. The structure of DsbH, its redox potential of -269 mV, and its functional properties are similar to thioredoxin and the C-terminal domain of DsbD, i.e.characteristic of a disulfide reductase. As compared with these proteins, the two central residues of the DsbH catalytic motif (CMWC) shield the catalytic disulfide bond and are selectively perturbed by a peptide ligand. This shows that these oxidoreductase family characteristic residues are not only important in determining the redox potential of the catalytic disulfide bond but also in influencing substrate interactions. For DsbH, three functional roles are conceivable; that is, reducing intermolecular disulfides between proteins and small molecules, keeping a specific subset of exported proteins reduced, or maintaining the periplasm of Chlamydia in a generally reducing state.	[Mac, Thien-Thi; Hung, Kuo-Chan; Ulmer, Tobias S.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Mac, Thien-Thi; Hung, Kuo-Chan; Ulmer, Tobias S.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [von Hacht, Annekathrin; Bardwell, James C. A.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [von Hacht, Annekathrin; Bardwell, James C. A.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Dutton, Rachel J.; Boyd, Dana] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	University of Southern California; University of Southern California; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School	Ulmer, TS (corresponding author), 1501 San Pablo St,ZNI 111, Los Angeles, CA 90033 USA.	tulmer@usc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041883] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM041883] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bessette PH, 1999, J BIOL CHEM, V274, P7784, DOI 10.1074/jbc.274.12.7784; Chou JJ, 2000, J BIOMOL NMR, V18, P101, DOI 10.1023/A:1008358318863; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Collet JF, 2002, J BIOL CHEM, V277, P26886, DOI 10.1074/jbc.M203028200; Cornilescu G, 2000, J AM CHEM SOC, V122, P10143, DOI 10.1021/ja0016194; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Delaglio F, 2000, J AM CHEM SOC, V122, P2142, DOI 10.1021/ja993603n; EVERETT KDE, 1995, J BACTERIOL, V177, P877, DOI 10.1128/jb.177.4.877-882.1995; Fabianek RA, 2000, FEMS MICROBIOL REV, V24, P303, DOI 10.1111/j.1574-6976.2000.tb00544.x; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gehring K, 1998, J MAGN RESON, V135, P185, DOI 10.1006/jmre.1998.1543; Glockshuber R, 1999, NATURE, V401, P30, DOI 10.1038/43344; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Grayston JT, 2000, J INFECT DIS, V181, pS402, DOI 10.1086/315596; Grishaev A, 2004, J AM CHEM SOC, V126, P7281, DOI 10.1021/ja0319994; Grove J, 1996, MOL GEN GENET, V252, P332; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Hatch TP, 1996, J BACTERIOL, V178, P1; Hu JS, 1997, J AM CHEM SOC, V119, P1803, DOI 10.1021/ja963625z; Inaba K, 2006, P NATL ACAD SCI USA, V103, P287, DOI 10.1073/pnas.0507570103; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Jaroniec CP, 2004, J BIOMOL NMR, V30, P181, DOI 10.1023/B:JNMR.0000048946.71249.2f; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Kim JH, 2003, FEBS LETT, V543, P164, DOI 10.1016/S0014-5793(03)00434-4; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; Kuszewski J, 2000, J MAGN RESON, V146, P249, DOI 10.1006/jmre.2000.2142; Kuszewski J, 1999, J AM CHEM SOC, V121, P2337, DOI 10.1021/ja9843730; Lin Z, 2006, ANGEW CHEM INT EDIT, V45, P1960, DOI 10.1002/anie.200503558; Maeda K, 2006, STRUCTURE, V14, P1701, DOI 10.1016/j.str.2006.09.012; McCoy AJ, 2006, TRENDS MICROBIOL, V14, P70, DOI 10.1016/j.tim.2005.12.004; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; OWENS RA, 1986, J BACTERIOL, V168, P109, DOI 10.1128/jb.168.1.109-114.1986; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pan JL, 2006, PROTEIN SCI, V15, P2217, DOI 10.1110/ps.062268106; PEEK JA, 1992, P NATL ACAD SCI USA, V89, P6210, DOI 10.1073/pnas.89.13.6210; Pittman MS, 2005, J BIOL CHEM, V280, P32254, DOI 10.1074/jbc.M503075200; Pittman MS, 2002, J BIOL CHEM, V277, P49841, DOI 10.1074/jbc.M205615200; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; Qin J, 1996, STRUCTURE, V4, P613, DOI 10.1016/S0969-2126(96)00065-2; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Sako T, 2002, ATHEROSCLEROSIS, V162, P253, DOI 10.1016/S0021-9150(01)00710-9; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Segatori L, 2006, J BIOL CHEM, V281, P4911, DOI 10.1074/jbc.M505453200; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Ulmer TS, 2003, J AM CHEM SOC, V125, P9179, DOI 10.1021/ja0350684; Yu J, 1999, MICROBES INFECT, V1, P1221, DOI 10.1016/S1286-4579(99)00239-7; Zhao Z, 2003, J BIOL CHEM, V278, P43292, DOI 10.1074/jbc.M306945200	57	18	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					824	832		10.1074/jbc.M707863200	http://dx.doi.org/10.1074/jbc.M707863200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18003611	hybrid			2022-12-25	WOS:000252128100022
J	Yan, D; Mayranpaa, MI; Wong, J; Perttila, J; Lehto, M; Jauhiainen, M; Kovanen, PT; Ehnholm, C; Brown, AJ; Olkkonen, VM				Yan, Daoguang; Mayranpaa, Mikko I.; Wong, Jenny; Perttila, Julia; Lehto, Markku; Jauhiainen, Matti; Kovanen, Petri T.; Ehnholm, Christian; Brown, Andrew J.; Olkkonen, Vesa M.			OSBP-related protein 8 (ORP8) suppresses ABCA1 expression and cholesterol efflux from macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYSTEROL-BINDING-PROTEIN; LIVER-X-RECEPTOR; CELLULAR LIPID-METABOLISM; ABCG1(-/-) BONE-MARROW; OSBP-RELATED PROTEINS; CARDIOVASCULAR-DISEASE; DENSITY-LIPOPROTEIN; GENE-EXPRESSION; KNOCKOUT MICE; ATHEROSCLEROSIS	ORP8 is a previously unexplored member of the family of oxysterol-binding protein- related proteins (ORP). We now report the expression pattern, the subcellular distribution, and data on the ligand binding properties and the physiological function of ORP8. ORP8 is localized in the endoplasmic reticulum ( ER) via its C-terminal transmembrane span and binds 25-hydroxycholesterol, identifying it as a new ER oxysterol-binding protein. ORP8 is expressed at highest levels in macrophages, liver, spleen, kidney, and brain. Immunohistochemical analysis revealed ORP8 in the shoulder regions of human coronary atherosclerotic lesions, where it is present in CD68(+) macrophages. In advanced lesions the ORP8 mRNA was up-regulated 2.7-fold as compared with healthy coronary artery wall. Silencing of ORP8 by RNA interference in THP-1 macrophages increased the expression of ATP binding cassette transporter A1 (ABCA1) and concomitantly cholesterol efflux to lipid-free apolipoprotein A-I but had no significant effect on ABCG1 expression or cholesterol efflux to spherical high density lipoprotein HDL2. Experiments employing an ABCA1 promoter-luciferase reporter confirmed that ORP8 silencing enhances ABCA1 transcription. The silencing effect was partially attenuated by mutation of the DR4 element in the ABCA1 promoter and synergized with that of the liver X receptor agonist T0901317. Furthermore, inactivation of the E-box in the promoter synergized with ORP8 silencing, suggesting that the suppressive effect of ORP8 involves both the liver X receptor and the E-box functions. Our data identify ORP8 as a negative regulator of ABCA1 expression and macrophage cholesterol efflux. ORP8 may, thus, modulate the development of atherosclerosis.	[Yan, Daoguang; Perttila, Julia; Lehto, Markku; Jauhiainen, Matti; Ehnholm, Christian; Olkkonen, Vesa M.] Natl Publ Hlth Inst, Dept Mol Med, FI-00251 Helsinki, Finland; [Mayranpaa, Mikko I.; Kovanen, Petri T.] Wihuri Res Inst, FI-00140 Helsinki, Finland; [Mayranpaa, Mikko I.] Univ Helsinki, Dept Forens Med, FI-00014 Helsinki, Finland; [Wong, Jenny; Brown, Andrew J.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	Finland National Institute for Health & Welfare; Wihuri Research Institute; University of Helsinki; University of New South Wales Sydney	Olkkonen, VM (corresponding author), Natl Publ Hlth Inst, Dept Mol Med, Biomedicum,P Box 104, FI-00251 Helsinki, Finland.	vesa.olkkonen@ktl.fi		Olkkonen, Vesa/0000-0001-5553-7997; Mayranpaa, Mikko/0000-0002-0877-9640				Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Baldan A, 2006, ARTERIOSCL THROM VAS, V26, P2301, DOI 10.1161/01.ATV.0000240051.22944.dc; Beyea MM, 2007, J BIOL CHEM, V282, P5207, DOI 10.1074/jbc.M611063200; Bjorkhem I, 2002, J CLIN INVEST, V110, P725, DOI 10.1172/JCI200216388; Bjorkhem I, 2002, ARTERIOSCL THROM VAS, V22, P734, DOI 10.1161/01.ATV.0000013312.32196.49; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Colles SM, 2001, TRENDS CARDIOVAS MED, V11, P131, DOI 10.1016/S1050-1738(01)00106-2; Costet P, 2000, J BIOL CHEM, V275, P28240; Costet P, 2003, MOL CELL BIOL, V23, P7756, DOI 10.1128/MCB.23.21.7756-7766.2003; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; DAWSON PA, 1989, J BIOL CHEM, V264, P9046; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Frikke-Schmidt R, 2005, J AM COLL CARDIOL, V46, P1516, DOI 10.1016/j.jacc.2005.06.066; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Fujiyoshi M, 2007, J NEUROCHEM, V100, P968, DOI 10.1111/j.1471-4159.2006.04240.x; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hu X, 2003, MOL ENDOCRINOL, V17, P1019, DOI 10.1210/me.2002-0399; Jakobsson T, 2007, BIOCHEM J, V405, P31, DOI 10.1042/BJ20070004; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jaworski CJ, 2001, GENOMICS, V78, P185, DOI 10.1006/geno.2001.6663; Kaplan R, 2002, J LIPID RES, V43, P952; Khovidhunkit W, 2003, J LIPID RES, V44, P1728, DOI 10.1194/jlr.M300100-JLR200; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lehto M, 2003, BBA-MOL CELL BIOL L, V1631, P1, DOI 10.1016/S1388-1981(02)00364-5; Lehto M, 2001, J LIPID RES, V42, P1203; Li AC, 2004, J LIPID RES, V45, P2161, DOI 10.1194/jlr.R400010-JLR200; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Lindstedt KA, 2004, ARTERIOSCL THROM VAS, V24, P2205, DOI 10.1161/01.ATV.0000149753.74793.88; Mayranpaa MI, 2006, CORONARY ARTERY DIS, V17, P611; Moreira EF, 2001, J BIOL CHEM, V276, P18570, DOI 10.1074/jbc.M011259200; Olkkonen VM, 2006, BIOCHEM SOC T, V34, P389, DOI 10.1042/BST0340389; Olkkonen VM, 2004, ANN MED, V36, P562, DOI 10.1080/07853890410018907; Olkkonen VM, 2004, CURR OPIN LIPIDOL, V15, P321, DOI 10.1097/00041433-200406000-00013; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Out R, 2006, ARTERIOSCL THROM VAS, V26, P2295, DOI 10.1161/01.ATV.0000237629.29842.4c; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Ranalletta M, 2006, ARTERIOSCL THROM VAS, V26, P2308, DOI 10.1161/01.ATV.0000242275.92915.43; Rowe AH, 2003, CIRC RES, V93, P717, DOI 10.1161/01.RES.0000097606.43659.F4; Schmitz G, 2005, BBA-MOL CELL BIOL L, V1735, P1, DOI 10.1016/j.bbalip.2005.04.004; SERFATYLACROSNIERE C, 1994, ATHEROSCLEROSIS, V107, P85, DOI 10.1016/0021-9150(94)90144-9; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; Szanto A, 2004, MOL CELL BIOL, V24, P8154, DOI 10.1128/MCB.24.18.8154-8166.2004; TAYLOR FR, 1985, METHOD ENZYMOL, V110, P9; TAYLOR FR, 1984, J BIOL CHEM, V259, P2382; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003; Wang C, 2002, BIOCHEM J, V361, P461, DOI 10.1042/0264-6021:3610461; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Wong J, 2004, ARTERIOSCL THROM VAS, V24, P2365, DOI 10.1161/01.ATV.0000148707.93054.7d; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Yang XP, 2002, J LIPID RES, V43, P297; Yokoyama S, 2005, CURR OPIN LIPIDOL, V16, P269, DOI 10.1097/01.mol.0000169346.15450.90; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	61	101	109	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					332	340		10.1074/jbc.M705313200	http://dx.doi.org/10.1074/jbc.M705313200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17991739	hybrid			2022-12-25	WOS:000251940300037
J	Weng, W; Sukowati, EW; Sheng, GJ				Weng, Wei; Sukowati, Erike W.; Sheng, Guojun			On Hemangioblasts in Chicken	PLOS ONE			English	Article								Hemangioblasts are bi-potential precursors for blood and endothelial cells (BCs and ECs). Existence of the hemangioblast in vivo by its strict definition, i.e. a clonal precursor giving rise to these two cell types after division, is still debated. Using a combination of mitotic figure analysis, cell labeling and long-term cell tracing, we show that, in chicken, cell division does not play a major role during the entire ventral mesoderm differentiation process after gastrulation. One eighth of cells do undergo at least one round of division, but mainly give rise to daughter cells contributing to the same lineage. Approximately 7% of the dividing cells that contribute to either the BC or EC lineage meet the criteria of true hemangioblasts, with one daughter cell becoming a BC and the other an EC. Our data suggest that hemangioblast-type generation of BC/EC occurs, but is not used as a major mechanism during early chicken development. It remains unclear, however, whether hemangioblast-like progenitor cells play a more prominent role in later development.	[Weng, Wei; Sukowati, Erike W.; Sheng, Guojun] RIKEN, Ctr Dev Biol, Lab Early Embryogenesis, Kobe, Hyogo, Japan	RIKEN	Sheng, GJ (corresponding author), RIKEN, Ctr Dev Biol, Lab Early Embryogenesis, Kobe, Hyogo, Japan.	sheng@cdb.riken.jp	Sheng, Guojun/I-4900-2015; Sheng, Guojun/G-4116-2014; Sheng, Guojun/G-8746-2013		RIKEN	RIKEN	This work is supported by RIKEN.	Choi K, 1998, DEVELOPMENT, V125, P725; Darnell DK, 2000, METH MOL B, V135, P31; Derrick GE, 1937, J MORPHOL, V61, P257, DOI 10.1002/jmor.1050610203; DONDUA AK, 1966, ACTA BIOL ACAD SCI H, V17, P127; Duval M. M., 1889, ATLAS DEMBRYOLOGIE; EMANUELSSON H, 1961, ACTA PHYSIOL SCAND, V52, P211, DOI 10.1111/j.1748-1716.1961.tb02220.x; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Jaffredo T, 2005, INT J DEV BIOL, V49, P269, DOI 10.1387/ijdb.041948tj; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Lillie FR., 1908, DEV CHICK; MURRAY PDF, 1932, P R SOC LOND, V11, P497; Nakazawa F, 2006, BLOOD, V108, P3335, DOI 10.1182/blood-2006-05-021386; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; OZATO K, 1969, EMBRYOLOGIA, V10, P297, DOI 10.1111/j.1440-169X.1969.tb00242.x; Park C, 2005, EXP HEMATOL, V33, P965, DOI 10.1016/j.exphem.2005.06.003; PATTEN BM, 1951, EARLY EMBRYOLOGY CHI, pR13; PRIMMETT DRN, 1989, DEVELOPMENT, V105, P119; ROMANOFF AL, 1960, AVIAN EMBRYO STRUCTU, pR15; ROSENQUIST GC, 1982, ANAT REC, V202, P95, DOI 10.1002/ar.1092020111; Sabin F, 1920, CONTRIB EMBRYOL, V9, P213; Sabin FR, 1917, ANAT REC, V13, P199, DOI 10.1002/ar.1090130403; SABIN FR, 1917, CARNEGIE I WASH PUBL, V61, P124; SANDERS EJ, 1993, DEVELOPMENT, V118, P389; SCHULTZ AF, 1922, P OKLA ACAD SCI, V52, P45; SOLOMON JB, 1957, BIOCHIM BIOPHYS ACTA, V23, P24, DOI 10.1016/0006-3002(57)90280-9; STERN CD, 1984, ANAT EMBRYOL, V169, P97, DOI 10.1007/BF00300591; STERN CD, 1979, ANAT EMBRYOL, V156, P319, DOI 10.1007/BF00299630; STERN CD, 1981, ANAT EMBRYOL, V163, P245, DOI 10.1007/BF00315703; Ueno H, 2006, DEV CELL, V11, P519, DOI 10.1016/j.devcel.2006.08.001; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; WILT FH, 1974, ANN NY ACAD SCI, V241, P99, DOI 10.1111/j.1749-6632.1974.tb21870.x; WOODARD TM, 1948, AM NAT, V82, P129, DOI 10.1086/281573; Yokomizo T, 2007, EMBO J, V26, P184, DOI 10.1038/sj.emboj.7601480	34	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1228	10.1371/journal.pone.0001228	http://dx.doi.org/10.1371/journal.pone.0001228			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043736	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459300010
J	Leotoing, L; Meunier, L; Manin, M; Mauduit, C; Decaussin, M; Verrijdt, G; Claessens, F; Benahmed, M; Veyssiere, G; Morel, L; Beaudoin, C				Leotoing, L.; Meunier, L.; Manin, M.; Mauduit, C.; Decaussin, M.; Verrijdt, G.; Claessens, F.; Benahmed, M.; Veyssiere, G.; Morel, L.; Beaudoin, C.			Influence of nucleophosmin/B23 on DNA binding and transcriptional activity of the androgen receptor in prostate cancer cell	ONCOGENE			English	Article						nucleophosmin/B23; androgen receptor; transcription and prostate cancer	NUCLEOLAR PROTEIN B23; MOUSE VAS-DEFERENS; IN-VITRO; GENE; ACTIVATION; PROMOTER; TRANSACTIVATION; DIFFERENTIATION; IDENTIFICATION; EXPRESSION	The promotion and progression of prostate cancer (PCa) are associated with androgen receptor (AR) signalling. AR functions are modulated by a variety of co-factors amongst which we identified the nucleophosmin (NPM/B23), a member of the histone chaperone family. Here, we show that NPM is overexpressed in PCa compared to normal adjacent tissues. AR and NPM interact in vitro and in vivo, and NPM is critical for androgen-dependent transcriptional activation in LNCaP cells as an anti-NPM siRNA downregulates transcription of a transfected androgen response element (ARE)-containing reporter promoter as well as expression of the endogenous androgen responsive prostate-specific antigen (PSA) gene. By investigating the effect of NPM on AR, we have also observed that NPM enhances AR binding to an ARE in vitro in electrophoretic gel mobility-shift assay experiments. Chromatin immunoprecipitation studies further demonstrated that both AR and NPM associate with AREs of the PSA gene in vivo. Altogether, our data suggest that the molecular histone chaperone NPM could regulate AR functions by promoting assembly of AR-containing regulatory complexes and that high levels of NPM might alter AR functions in PCa.	[Leotoing, L.; Manin, M.; Veyssiere, G.; Morel, L.; Beaudoin, C.] Univ Blaise Pascal Clermont Ferrand II, CNRS, UMR 6547, F-63177 Aubiere, France; [Meunier, L.; Mauduit, C.; Decaussin, M.; Benahmed, M.] Fac Med Lyon Sud, INSERM, U 407, Oullins, France; [Verrijdt, G.; Claessens, F.] Katholieke Univ Leuven, Mol Endocrinol Lab, Louvain, Belgium	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); KU Leuven	Morel, L (corresponding author), Univ Blaise Pascal Clermont Ferrand II, CNRS, UMR 6547, 24 Ave Landais, F-63177 Aubiere, France.	laurent.morel@univ-bpclermont.fr	Claessens, Frank/M-8565-2016	Claessens, Frank/0000-0002-8676-7709; meunier, leo/0000-0001-8573-5687				Baron S, 2004, J BIOL CHEM, V279, P14579, DOI 10.1074/jbc.M306143200; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; BOCKER T, 1995, MODERN PATHOL, V8, P226; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Darne CH, 1997, MOL CELL ENDOCRINOL, V132, P13, DOI 10.1016/S0303-7207(97)00116-0; Dhar SK, 2004, J BIOL CHEM, V279, P28209, DOI 10.1074/jbc.M403553200; FABRE S, 1994, J BIOL CHEM, V269, P5857; Fu MF, 2000, J BIOL CHEM, V275, P20853, DOI 10.1074/jbc.M000660200; Haelens A, 2007, CANCER RES, V67, P4514, DOI 10.1158/0008-5472.CAN-06-1701; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Hsing AW, 2000, INT J CANCER, V85, P60, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;60::AID-IJC11&gt;3.0.CO;2-B; Hu YC, 2004, J BIOL CHEM, V279, P33438, DOI 10.1074/jbc.M401781200; INOUYE CJ, 1994, J BIOL CHEM, V269, P6506; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; Kim J, 2003, NUCLEIC ACIDS RES, V31, P6741, DOI 10.1093/nar/gkg909; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Leotoing L, 2007, J MOL ENDOCRINOL, V39, P151, DOI 10.1677/JME-07-0021; Liu H, 2007, EMBO REP, V8, P394, DOI 10.1038/sj.embor.7400909; Maiguel DA, 2004, MOL CELL BIOL, V24, P3703, DOI 10.1128/MCB.24.9.3703-3711.2004; Melvin VS, 1999, STEROIDS, V64, P576, DOI 10.1016/S0039-128X(99)00036-7; Morimoto RI, 2002, CELL, V110, P281, DOI 10.1016/S0092-8674(02)00860-7; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; Ranganathan S, 1997, PROSTATE, V30, P263, DOI 10.1002/(SICI)1097-0045(19970301)30:4<263::AID-PROS6>3.0.CO;2-M; Savkur RS, 1998, NUCLEIC ACIDS RES, V26, P4508, DOI 10.1093/nar/26.19.4508; Shatkina L, 2003, MOL CELL BIOL, V23, P7189, DOI 10.1128/MCB.23.20.7189-7197.2003; Subong ENP, 1999, PROSTATE, V39, P298; Swaminathan V, 2005, MOL CELL BIOL, V25, P7534, DOI 10.1128/MCB.25.17.7534-7545.2005; SZEBENI A, 1995, BIOCHEMISTRY-US, V34, P8037, DOI 10.1021/bi00025a009; Takemura M, 1999, J BIOCHEM-TOKYO, V125, P904, DOI 10.1093/oxfordjournals.jbchem.a022367; Verrijdt G, 2002, BIOCHEM J, V361, P97, DOI 10.1042/0264-6021:3610097; Volle DH, 2004, MOL ENDOCRINOL, V18, P888, DOI 10.1210/me.2003-0338; Wang L, 2005, PROSTATE, V63, P117, DOI 10.1002/pros.20170; Weng JJ, 2005, BIOCHEM BIOPH RES CO, V335, P826, DOI 10.1016/j.bbrc.2005.07.150	35	49	49	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 1	2008	27	20					2858	2867		10.1038/sj.onc.1210942	http://dx.doi.org/10.1038/sj.onc.1210942			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	295VR	18037965				2022-12-25	WOS:000255502500007
J	Ricke, WA; McPherson, SJ; Bianco, JJ; Cunha, GR; Wang, Y; Risbridger, GP				Ricke, William A.; McPherson, Stephen J.; Bianco, Joseph J.; Cunha, Gerald R.; Wang, Yuzhuo; Risbridger, Gail P.			Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling	FASEB JOURNAL			English	Article						prostate cancer; hormone action; mouse models	MESENCHYMAL-EPITHELIAL INTERACTIONS; MESSENGER-RNA EXPRESSION; NOBLE RATS; INTRAEPITHELIAL NEOPLASIA; MICE; ANDROGEN; BETA; CANCER; MOUSE; GLAND	It was recently demonstrated that antiestrogens prevented prostate cancer (PRCA) in men. The source of estradiol (E2) that contributes to carcinogenesis, as well as the selected estrogen receptor (ER) signaling pathway, is unknown. To evaluate estrogen's effects in carcinogenesis, we developed a new model of PRCA utilizing testosterone and E2 to stimulate PRCA. To determine whether local in situ production of E2 affected incidence of PRCA, aromatase-knockout (ArKO) mice were evaluated. In contrast to the wildtype mice, ArKO mice had reduced incidences of PRCA, which implicates in situ production of E2 as an important determinant of PRCA. To determine whether E2-mediated responses were due to ER alpha or ER beta signaling, ER alpha-knockout (alpha ERKO) or ER beta-knock-out (beta ERKO) mice were used. Prostates from beta ERKO mice underwent biochemical and histological carcinogenesis similar to wild-type mice, whereas prostates from alpha ERKO mice remained free of pathology. These data suggest that effective prevention of carcinogenesis will require antagonism of ER alpha but not ER beta. This mouse model provides a means to examine genetic gain and loss of function and determine the efficacy of therapeutics on prostatic carcinogenesis.	[Ricke, William A.] Univ Rochester, Med Ctr, Dept Urol, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [Ricke, William A.] Univ Rochester, Med Ctr, Dept Pathol, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [Ricke, William A.] Univ Rochester, Med Ctr, Dept Lab Med, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [McPherson, Stephen J.; Bianco, Joseph J.; Risbridger, Gail P.] Monash Univ, Monash Inst Med Res, Ctr Urol Res, Clayton, Vic 3168, Australia; [Cunha, Gerald R.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Cunha, Gerald R.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Wang, Yuzhuo] Univ British Columbia, British Columbia Canc Agcy, Dept Canc Endocrinol, Vancouver, BC V5Z 1M9, Canada; [Wang, Yuzhuo] Univ British Columbia, British Columbia Canc Agcy, Prostate Ctr, Vancouver, BC V5Z 1M9, Canada	University of Rochester; University of Rochester; University of Rochester; Monash University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Ricke, WA (corresponding author), Univ Rochester, Med Ctr, Dept Urol, James P Wilmot Canc Ctr, 601 Elmwood Ave,Box 656, Rochester, NY 14642 USA.	william_ricke@urmc.rochester.edu	McPherson, Stephen/A-9490-2009; Risbridger, Gail P/B-8655-2008	Risbridger, Gail P/0000-0003-3089-4028; Bianco, Joseph/0000-0001-5403-348X; Wang, Yuzhuo/0000-0002-9749-8591; Ricke, William/0000-0002-9807-2090	NATIONAL CANCER INSTITUTE [R01CA123199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER; NCI NIH HHS [1R01 CA123199] Funding Source: Medline; NIEHS NIH HHS [P30 ES01247] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BELANGER A, 1994, J CLIN ENDOCR METAB, V79, P1086; Carmichael PL, 2001, TOXICOL PATHOL, V29, P155, DOI 10.1080/019262301753178564; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Cunha GR, 1996, ACTA ANAT, V155, P63; CUNHA GR, 1992, J ANDROL, V13, P465; DONJACOUR AA, 1993, ENDOCRINOLOGY, V132, P2342, DOI 10.1210/en.132.6.2342; Dore M, 2005, VET PATHOL, V42, P100, DOI 10.1354/vp.42-1-100; Hayward SW, 1998, INT J ONCOL, V13, P35; Hayward SW, 1996, ANN NY ACAD SCI, V784, P50, DOI 10.1111/j.1749-6632.1996.tb16227.x; Hollmer M, 2006, NAT BIOTECHNOL, V24, P1455, DOI 10.1038/nbt1206-1455; ISAACS JT, 1994, SEMIN CANCER BIOL, V5, P391; Konac E, 2005, MOL CELL BIOCHEM, V276, P45, DOI 10.1007/s11010-005-2815-8; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Lau KM, 1998, ENDOCRINOLOGY, V139, P424, DOI 10.1210/en.139.1.424; LEAV I, 1988, J NATL CANCER I, V80, P1045, DOI 10.1093/jnci/80.13.1045; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; MAWHINNEY MG, 1979, INVEST UROL, V16, P409; McPherson SJ, 2001, ENDOCRINOLOGY, V142, P2458, DOI 10.1210/en.142.6.2458; McPherson SJ, 2007, ENDOCRINOLOGY, V148, P566, DOI 10.1210/en.2006-0906; NASLUND MJ, 1986, J UROLOGY, V136, P1136, DOI 10.1016/S0022-5347(17)45239-6; NEUBAUER B, 1981, INVEST UROL, V18, P229; NEVALAINEN MT, 1993, CANCER RES, V53, P5199; NOBLE RL, 1977, CANCER RES, V37, P1929; NOBLE RL, 1980, CANCER RES, V40, P3574; POLLARD M, 1987, PROSTATE, V10, P325, DOI 10.1002/pros.2990100406; Price D, 2006, J UROLOGY, V176, P965, DOI 10.1016/j.juro.2006.04.011; Prins G.S., 1997, PROSTATE BASIC CLIN, P245; Prins GS, 2001, CANCER RES, V61, P6089; Ricke WA, 2006, INT J CANCER, V118, P2123, DOI 10.1002/ijc.21614; Risbridger G, 2001, DEV BIOL, V229, P432, DOI 10.1006/dbio.2000.9994; Russo J, 2003, J STEROID BIOCHEM, V87, P1, DOI 10.1016/S0960-0760(03)00390-X; Saji S, 2000, P NATL ACAD SCI USA, V97, P337, DOI 10.1073/pnas.97.1.337; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Spearow JL, 1999, SCIENCE, V285, P1259, DOI 10.1126/science.285.5431.1259; Stanbrough M, 2001, P NATL ACAD SCI USA, V98, P10823, DOI 10.1073/pnas.191235898; THOMPSON SA, 1979, INVEST UROL, V17, P83; THOMPSON TC, 1993, MOL CARCINOGEN, V7, P165, DOI 10.1002/mc.2940070307; UMBAS R, 1992, CANCER RES, V52, P5104; vomSaal FS, 1997, P NATL ACAD SCI USA, V94, P2056; WALSH PC, 1976, J CLIN INVEST, V57, P1093, DOI 10.1172/JCI108353; Wang YH, 2000, CANCER RES, V60, P6008; Wang YZ, 2001, CANCER RES, V61, P6064; Weihua Zhang, 2001, Proceedings of the National Academy of Sciences of the United States of America, V98, P6330, DOI 10.1073/pnas.111150898; WILSON JD, 1980, AM J MED, V68, P745, DOI 10.1016/0002-9343(80)90267-3; YU M, 1993, LAB INVEST, V68, P33	46	166	174	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2008	22	5					1512	1520		10.1096/fj.07-9526com	http://dx.doi.org/10.1096/fj.07-9526com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18055862				2022-12-25	WOS:000255898700023
J	Sato-Jin, K; Nishimura, EK; Akasaka, E; Huber, W; Nakano, H; Miller, A; Du, JY; Wu, M; Hanada, K; Sawamura, D; Fisher, DE; Imokawa, G				Sato-Jin, Kayo; Nishimura, Emi K.; Akasaka, Eijiro; Huber, Wade; Nakano, Hajime; Miller, Arlo; Du, Jinyan; Wu, Min; Hanada, Katsumi; Sawamura, Daisuke; Fisher, David E.; Imokawa, Genji			Epistatic connections between microphthalmia-associated transcription factor and endothelin signaling in Waardenburg syndrome and other pigmentary disorders	FASEB JOURNAL			English	Article						cAMP response element-binding protein; CREB; cyclin-dependent kinase 2; melanocyte; endothelin B receptor	B RECEPTOR GENE; GROWTH-FACTOR; SYNDROME TYPE-2; MELANOCYTE DEVELOPMENT; HUMAN KERATINOCYTES; HUMAN HOMOLOG; MITF; EXPRESSION; ACTIVATION; DIFFERENTIATION	Waardenburg syndrome (WS) is an inherited sensorineural deafness condition in humans caused by melanocyte deficiencies in the inner ear and forelock. Mutation of microphthalmia-associated transcription factor (MITF) is known to produce WS type IIA whereas mutations of either endothelin (EDN) or its receptor endothelin receptor B (EDNRB) produce WS type IV. However, a link between MITF haploinsufficiency and EDN signaling has not yet been established. Here we demonstrate mechanistic connections between EDN and MITF and their functional importance in melanocytes. Addition of EDN to cultured human melanocytes stimulated the phosphorylation of MITF in an EDNRB-dependent manner, which was completely abolished by mitogen-activated protein kinase kinase inhibition. The expression of melanocyte-specific MITF mRNA transcripts was markedly augmented after incubation with EDN1 and was followed by increased expression of MITF protein. Up-regulated expression of MITF was found to be mediated via both the mitogen-activated protein kinase-p90 ribosomal S6 kinase-cAMP response element-binding protein (CREB) and CAMP-protein kinase A-CREB pathways. In addition, EDNRB expression itself was seen to be dependent on MITE. The functional importance of these connections is illustrated by the ability of EDN to stimulate expression of melanocytic pigmentation and proliferation markers in an MITF-dependent fashion. Collectively these data provide mechanistic and epistatic links between MITF and EDN/EDNRB, critical melanocytic survival factors and WS genes.	[Imokawa, Genji] Tokyo Univ Technol, Sch Bion, Katayanagi Inst, Hachioji, Tokyo 1920982, Japan; [Sato-Jin, Kayo; Akasaka, Eijiro; Nakano, Hajime; Hanada, Katsumi; Sawamura, Daisuke; Imokawa, Genji] Hirosaki Univ, Grad Sch Med, Dept Dermatol, Hirosaki, Aomori, Japan; [Nishimura, Emi K.] Kanazawa Univ, Canc Res Inst, Dept Stem Cell Med, Kanazawa, Ishikawa 920, Japan; [Nishimura, Emi K.; Huber, Wade; Miller, Arlo; Du, Jinyan; Wu, Min; Fisher, David E.] Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat Hematol Oncol, Boston, MA 02115 USA; [Nishimura, Emi K.; Huber, Wade; Miller, Arlo; Du, Jinyan; Wu, Min; Fisher, David E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Melanoma Program, Boston, MA 02115 USA	Tokyo University of Technology; Hirosaki University; Kanazawa University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Imokawa, G (corresponding author), Tokyo Univ Technol, Sch Bion, Katayanagi Inst, W204,1404-1 Katakura, Hachioji, Tokyo 1920982, Japan.	imokawag@dream.ocn.ne.jp						BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; BENTLEY NJ, 1994, MOL CELL BIOL, V14, P7996, DOI 10.1128/MCB.14.12.7996; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; BOHM M, 1995, CELL GROWTH DIFFER, V6, P291; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; Fuse N, 1996, BIOCHEM BIOPH RES CO, V219, P702, DOI 10.1006/bbrc.1996.0298; HALABAN R, 1988, J CELL BIOL, V107, P1611, DOI 10.1083/jcb.107.4.1611; Halaban R., 2003, FITZPATRICKS DERMATO, V6th edn., P127; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Huber WE, 2003, J BIOL CHEM, V278, P45224, DOI 10.1074/jbc.M309036200; HUGHES AE, 1994, NAT GENET, V7, P509, DOI 10.1038/ng0894-509; Imokawa G, 1998, BIOCHEM J, V330, P1235, DOI 10.1042/bj3301235; Imokawa G, 2000, J BIOL CHEM, V275, P33321, DOI 10.1074/jbc.M004346200; Imokawa G, 1997, PIGM CELL RES, V10, P218, DOI 10.1111/j.1600-0749.1997.tb00488.x; IMOKAWA G, 1995, J INVEST DERMATOL, V105, P32, DOI 10.1111/1523-1747.ep12312500; IMOKAWA G, 1992, J BIOL CHEM, V267, P24675; KOBAYASHI T, 1994, J BIOL CHEM, V269, P29198; Lee M, 2000, J BIOL CHEM, V275, P37978, DOI 10.1074/jbc.M003816200; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; MATSUMOTO K, 1991, BIOCHEM BIOPH RES CO, V176, P45, DOI 10.1016/0006-291X(91)90887-D; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Orlow SJ, 1998, CANCER RES, V58, P1521; PAVAN WJ, 1994, P NATL ACAD SCI USA, V91, P7159, DOI 10.1073/pnas.91.15.7159; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Price ER, 1998, J BIOL CHEM, V273, P33042, DOI 10.1074/jbc.273.49.33042; Price ER, 1998, J BIOL CHEM, V273, P17983, DOI 10.1074/jbc.273.29.17983; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Reid K, 1996, DEVELOPMENT, V122, P3911; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Tachibana M, 1996, NAT GENET, V14, P50, DOI 10.1038/ng0996-50; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; Verastegui C, 2000, J BIOL CHEM, V275, P30757, DOI 10.1074/jbc.C000445200; Watanabe A, 1998, NAT GENET, V18, P283, DOI 10.1038/ng0398-283; Weilbaecher KN, 2001, MOL CELL, V8, P749, DOI 10.1016/S1097-2765(01)00360-4; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049; Wu M, 2000, GENE DEV, V14, P301; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; YAAR M, 1991, J INVEST DERMATOL, V97, P611, DOI 10.1111/1523-1747.ep12482985; YADA Y, 1991, J BIOL CHEM, V266, P18352; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; YASUMOTO K, 1995, J BIOCHEM-TOKYO, V118, P874, DOI 10.1093/jb/118.5.874; YAVUZER U, 1995, ONCOGENE, V10, P123; Yoshida H, 1996, DEVELOPMENT, V122, P1207; ZAKUT R, 1993, ONCOGENE, V8, P2221	56	73	77	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2008	22	4					1155	1168		10.1096/fj.07-9080com	http://dx.doi.org/10.1096/fj.07-9080com			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	18039926				2022-12-25	WOS:000254581000021
J	Richards, JD; Johnson, KA; Liu, H; McRobbie, AM; McMahon, S; Oke, M; Carter, L; Naismith, JH; White, MF				Richards, Jodi D.; Johnson, Kenneth A.; Liu, Huanting; McRobbie, Anne-Marie; McMahon, Stephen; Oke, Muse; Carter, Lester; Naismith, James H.; White, Malcolm F.			Structure of the DNA repair helicase Hel308 reveals DNA binding and autoinhibitory domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STALLED REPLICATION FORKS; SINGLE-STRANDED-DNA; SULFOLOBUS-SOLFATARICUS; FLUORESCENCE POLARIZATION; ESCHERICHIA-COLI; PROTEIN; POLYMERASE; OLIGONUCLEOTIDES; ENDONUCLEASE; DISPLACEMENT	Hel308 is a superfamily 2 helicase conserved in eukaryotes and archaea. It is thought to function in the early stages of recombination following replication fork arrest and has a specificity for removal of the lagging strand in model replication forks. A homologous helicase constitutes the N-terminal domain of human DNA polymerase Q. The Drosophila homologue mus301 is implicated in double strand break repair and meiotic recombination. We have solved the high resolution crystal structure of Hel308 from the cre-narchaeon Sulfolobus solfataricus, revealing a five-domain structure with a central pore lined with essential DNA binding residues. The fifth domain is shown to act as an autoinhibitory domain or molecular brake, clamping the single-stranded DNA extruded through the central pore of the helicase structure to limit the helicase activity of the enzyme. This provides an elegant mechanism to tune the processivity of the enzyme to its functional role. Hel308 can displace streptavidin from a biotinylated DNA molecule, and this activity is only partially inhibited when the DNA is pre-bound with abundant DNA-binding proteins RPA or Alba1, whereas pre-binding with the recombinase RadA has no effect on activity. These data suggest that one function of the enzyme may be in the removal of bound proteins at stalled replication forks and recombination intermediates.	[Richards, Jodi D.; Johnson, Kenneth A.; Liu, Huanting; McRobbie, Anne-Marie; McMahon, Stephen; Oke, Muse; Carter, Lester; Naismith, James H.; White, Malcolm F.] Univ St Andrews, Ctr Biomed Sci, St Andrews KY16 9ST, Fife, Scotland	University of St Andrews	Naismith, JH (corresponding author), Univ St Andrews, Ctr Biomed Sci, St Andrews KY16 9ST, Fife, Scotland.	jhn@st-and.ac.uk; mfw2@st-and.ac.uk	White, Malcolm F/A-6055-2010; Naismith, James Henderson/AAB-8614-2020; Carter, Lester/G-6561-2014; Naismith, James Henderson/H-3408-2012	White, Malcolm F/0000-0003-1543-9342; Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061; Oke, Muse/0000-0002-0169-752X	Biotechnology and Biological Sciences Research Council [BBS/B/14426] Funding Source: Medline; Medical Research Council [G0500367] Funding Source: Medline; MRC [G0500367] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ariza A, 2005, NUCLEIC ACIDS RES, V33, P1465, DOI 10.1093/nar/gki288; BOYD JB, 1976, GENETICS, V84, P485; Brendza KM, 2005, P NATL ACAD SCI USA, V102, P10076, DOI 10.1073/pnas.0502886102; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Byrd AK, 2006, NUCLEIC ACIDS RES, V34, P3020, DOI 10.1093/nar/gkl369; Cowtan K, 2001, ACTA CRYSTALLOGR D, V57, P1435, DOI 10.1107/S0907444901010812; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Fujikane R, 2006, GENES CELLS, V11, P99, DOI 10.1111/j.1365-2443.2006.00925.x; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Guy CP, 2005, NUCLEIC ACIDS RES, V33, P3678, DOI 10.1093/nar/gki685; Hanada K, 2007, CELL MOL LIFE SCI, V64, P2306, DOI 10.1007/s00018-007-7121-z; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Jelinska C, 2005, STRUCTURE, V13, P963, DOI 10.1016/j.str.2005.04.016; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kvaratskhelia M, 2000, J MOL BIOL, V295, P193, DOI 10.1006/jmbi.1999.3363; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Marini F, 2002, J BIOL CHEM, V277, P8716, DOI 10.1074/jbc.M110271200; Marsh VL, 2006, J MOL BIOL, V357, P1345, DOI 10.1016/j.jmb.2006.01.074; McCaffrey R, 2006, GENETICS, V174, P1273, DOI 10.1534/genetics.106.058289; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Reid SL, 2001, BIOCHEMISTRY-US, V40, P2484, DOI 10.1021/bi001956p; Roberts JA, 2005, J BIOL CHEM, V280, P5924, DOI 10.1074/jbc.M412766200; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Schelert J, 2004, J BACTERIOL, V186, P427, DOI 10.1128/JB.186.2.427-437.2004; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Seki M, 2003, NUCLEIC ACIDS RES, V31, P6117, DOI 10.1093/nar/gkg814; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Smith AJ, 2007, NUCLEIC ACIDS RES, V35, P1802, DOI 10.1093/nar/gkm019; Takata K, 2006, J BIOL CHEM, V281, P23445, DOI 10.1074/jbc.M604317200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Wadsworth RIM, 2001, NUCLEIC ACIDS RES, V29, P914, DOI 10.1093/nar/29.4.914; Wang H, 2006, J BIOL CHEM, V281, P15227, DOI 10.1074/jbc.M601476200; Yoshimura M, 2006, MOL CELL, V24, P115, DOI 10.1016/j.molcel.2006.07.032	46	69	83	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5118	5126		10.1074/jbc.M707548200	http://dx.doi.org/10.1074/jbc.M707548200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18056710	Green Accepted, hybrid			2022-12-25	WOS:000253426500069
J	Sampath, V; Balakrishnan, B; Verma-Gaur, J; Onesti, S; Sadhale, PP				Sampath, Vinaya; Balakrishnan, Bindu; Verma-Gaur, Jiyoti; Onesti, Silvia; Sadhale, Parag P.			Unstructured N terminus of the RNA polymerase II subunit Rpb4 contributes to the interaction of Rpb4 center dot Rpb7 subcomplex with the core RNA polymerase II of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 DISSOCIABLE SUBUNITS; FUNCTIONAL CONSERVATION; NONESSENTIAL SUBUNIT; STRESS SURVIVAL; IN-VITRO; YEAST; TRANSCRIPTION; INITIATION; ORGANIZATION; TEMPERATURE	Two subunits of eukaryotic RNA polymerase II, Rpb7 and Rpb4, form a subcomplex that has counterparts in RNA polymerases I and III. Although a medium resolution structure has been solved for the 12-subunit RNA polymerase II, the relative contributions of the contact regions between the subcomplex and the core polymerase and the consequences of disrupting them have not been studied in detail. We have identified mutations in the N-terminal ribonucleoprotein-like domain of Saccharomyces cerevisiae Rpb7 that affect its role in certain stress responses, such as growth at high temperature and sporulation. These mutations increase the dependence of Rpb7 on Rpb4 for interaction with the rest of the polymerase. Complementation analysis and RNA polymerase pulldown assays reveal that the Rpb4 center dot Rbp7 subcomplex associates with the rest of the core RNA polymerase II through two crucial interaction points: one at the N-terminal ribonucleoprotein-like domain of Rpb7 and the other at the partially ordered N-terminal region of Rpb4. These findings are in agreement with the crystal structure of the 12-subunit polymerase. We show here that the weak interaction predicted for the N-terminal region of Rpb4 with Rpb2 in the crystal structure actually plays a significant role in interaction of the subcomplex with the core in vivo. Our mutant analysis also suggests that Rpb7 plays an essential role in the cell through its ability to interact with the rest of the polymerase.	[Sampath, Vinaya; Balakrishnan, Bindu; Verma-Gaur, Jiyoti; Sadhale, Parag P.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Onesti, Silvia] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Cell & Mol Biol, London SW7 2AZ, England	Indian Institute of Science (IISC) - Bangalore; Imperial College London	Sadhale, PP (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	pps@mcbl.iisc.ernet.in	Sadhale, PArag/A-7799-2009	Onesti, Silvia/0000-0002-0612-7948				Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; CHODER M, 1993, MOL CELL BIOL, V13, P6984, DOI 10.1128/MCB.13.11.6984; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Farago M, 2003, MOL BIOL CELL, V14, P2744, DOI 10.1091/mbc.E02-11-0740; FINLEY RL, 1997, YEAST 2 HYBRID SYSTE, P197; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Jasiak AJ, 2006, MOL CELL, V23, P71, DOI 10.1016/j.molcel.2006.05.013; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; KHAZAK V, 1995, MOL BIOL CELL, V6, P759, DOI 10.1091/mbc.6.7.759; KOLODZIEJ PA, 1990, MOL CELL BIOL, V10, P1915, DOI 10.1128/MCB.10.5.1915; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; MCKUNE K, 1993, YEAST, V9, P295, DOI 10.1002/yea.320090309; Meka H, 2005, NUCLEIC ACIDS RES, V33, P6435, DOI 10.1093/nar/gki945; Orlicky SM, 2001, J BIOL CHEM, V276, P10097, DOI 10.1074/jbc.M003165200; Pillai B, 2003, J BIOL CHEM, V278, P3339, DOI 10.1074/jbc.M112180200; Pillai B, 2001, J BIOL CHEM, V276, P30641, DOI 10.1074/jbc.M010952200; Rosenheck S, 1998, J BACTERIOL, V180, P6187; SADHALE PP, 1994, MOL CELL BIOL, V14, P6164, DOI 10.1128/MCB.14.9.6164; Sampath V, 2005, IUBMB LIFE, V57, P93, DOI 10.1080/15216540500078905; Sampath V, 2003, J BIOL CHEM, V278, P51566, DOI 10.1074/jbc.M305863200; Selitrennik M, 2006, EUKARYOT CELL, V5, P2092, DOI 10.1128/EC.00288-06; Sharma N, 1999, J GENET, V78, P149, DOI 10.1007/BF02934460; Sheffer A, 1999, MOL CELL BIOL, V19, P2672; Sherman F., 1983, METHODS YEAST GENETI; Shpakovski GV, 2000, J MOL BIOL, V295, P1119, DOI 10.1006/jmbi.1999.3399; Singh SR, 2004, NUCLEIC ACIDS RES, V32, P201, DOI 10.1093/nar/gkh163; Singh SR, 2007, BIOCHEM BIOPH RES CO, V356, P266, DOI 10.1016/j.bbrc.2007.02.120; Tan Q, 2003, MOL CELL BIOL, V23, P3329, DOI 10.1128/MCB.23.9.3329-3338.2003; Todone F, 2001, MOL CELL, V8, P1137, DOI 10.1016/S1097-2765(01)00379-3; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; WOYCHIK NA, 1989, MOL CELL BIOL, V9, P2854, DOI 10.1128/MCB.9.7.2854	33	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3923	3931		10.1074/jbc.M708746200	http://dx.doi.org/10.1074/jbc.M708746200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18056993	hybrid			2022-12-25	WOS:000253083500026
J	Bhardwaj, K; Palaninathan, S; Alcantara, JMO; Yi, LL; Guarino, L; Sacchettini, JC; Kao, CC				Bhardwaj, Kanchan; Palaninathan, Satheesh; Alcantara, Joanna Maria Ortiz; Yi, Lillian Li; Guarino, Linda; Sacchettini, James C.; Kao, C. Cheng			Structural and functional analyses of the severe acute respiratory syndrome coronavirus endoribonuclease Nsp15	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARS-CORONAVIRUS; VIRUS; GENOME; IDENTIFICATION; TRANSCRIPTION; REPLICATION; DOCKING; PROTEIN	The severe acute respiratory syndrome (SARS) coronavirus encodes several RNA-processing enzymes that are unusual for RNA viruses, including Nsp15 (nonstructural protein 15), a hexameric endoribonuclease that preferentially cleaves 3' of uridines. We solved the structure of a catalytically inactive mutant version of Nsp15, which was crystallized as a hexamer. The structure contains unreported flexibility in the active site of each subunit. Substitutions in the active site residues serine 293 and proline 343 allowed Nsp15 to cleave at cytidylate, whereas mutation of leucine 345 rendered Nsp15 able to cleave at purines as well as pyrimidines. Mutations that targeted the residues involved in subunit interactions generally resulted in the formation of catalytically inactive monomers. The RNA-binding residues were mapped by a method linking reversible cross-linking, RNA affinity purification, and peptide fingerprinting. Alanine substitution of several residues in the RNA-contacting portion of Nsp15 did not affect hexamer formation but decreased the affinity of RNA binding and reduced endonuclease activity. This suggests a model for Nsp15 hexamer interaction with RNA.	[Bhardwaj, Kanchan; Palaninathan, Satheesh; Alcantara, Joanna Maria Ortiz; Yi, Lillian Li; Guarino, Linda; Sacchettini, James C.; Kao, C. Cheng] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Yi, Lillian Li; Guarino, Linda] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Kao, CC (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	ckao@tamu.edu	Bhardwaj, Kanchan/CAH-2291-2022	Bhardwaj, Kanchan/0000-0002-7331-7717; Ortiz-Alcantara, Joanna Maria/0000-0003-2894-3652	NIAID NIH HHS [1R45AI06164] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		An SW, 1998, J VIROL, V72, P8517, DOI 10.1128/JVI.72.11.8517-8524.1998; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhardwaj K, 2004, J VIROL, V78, P12218, DOI 10.1128/JVI.78.22.12218-12224.2004; Bhardwaj K, 2006, J MOL BIOL, V361, P243, DOI 10.1016/j.jmb.2006.06.021; Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; Deshpande RA, 2002, CRIT REV MICROBIOL, V28, P79, DOI 10.1080/1040-840291046704; Eckerle LD, 2007, J VIROL, V81, P12135, DOI 10.1128/JVI.01296-07; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; Gioia U, 2005, J BIOL CHEM, V280, P18996, DOI 10.1074/jbc.M501160200; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Guarino LA, 2005, J MOL BIOL, V353, P1106, DOI 10.1016/j.jmb.2005.09.007; Ivanov KA, 2004, P NATL ACAD SCI USA, V101, P12694, DOI 10.1073/pnas.0403127101; Kang H, 2007, J VIROL, V81, P13587, DOI 10.1128/JVI.00547-07; Kim YC, 2005, J BIOL CHEM, V280, P38011, DOI 10.1074/jbc.M508145200; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; LAI MMC, 1990, ANNU REV MICROBIOL, V44, P303, DOI 10.1146/annurev.mi.44.100190.001511; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasternak AO, 2006, J GEN VIROL, V87, P1403, DOI 10.1099/vir.0.81611-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Posthuma CC, 2006, J VIROL, V80, P1653, DOI 10.1128/JVI.80.4.1653-1661.2006; Ricagno S, 2006, P NATL ACAD SCI USA, V103, P11892, DOI 10.1073/pnas.0601708103; Saida F, 2003, NUCLEIC ACIDS RES, V31, P2751, DOI 10.1093/nar/gkg377; Sawicki S G, 1995, Adv Exp Med Biol, V380, P499; SHOICHET BK, 1992, J COMPUT CHEM, V13, P380, DOI 10.1002/jcc.540130311; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; SPAAN W, 1988, J GEN VIROL, V69, P2939, DOI 10.1099/0022-1317-69-12-2939; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Xu XL, 2006, J VIROL, V80, P7909, DOI 10.1128/JVI.00525-06	34	74	76	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3655	3664		10.1074/jbc.M708375200	http://dx.doi.org/10.1074/jbc.M708375200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18045871	hybrid, Green Published			2022-12-25	WOS:000253083000070
J	Emami, N; Diamandis, EP				Emami, Nashmil; Diamandis, Eleftherios P.			Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade - Possible function in seminal plasma and skin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-SPECIFIC ANTIGEN; HUMAN TISSUE KALLIKREINS; PROTEIN-C INHIBITOR; FACTOR PATHWAY INHIBITOR; STRATUM-CORNEUM; SERINE-PROTEASES; HUMAN SEMEN; SUBSTRATE-SPECIFICITY; CANCER BIOMARKER; ENZYMATIC ACTION	Human kallikrein-related peptidases (KLKs) are a family of 15 serine proteases mainly known for their biomarker utility in various neoplastic and non-neoplastic diseases. Despite significant progress in understanding their clinical application, little is known about the activation mechanism(s) of this important family of enzymes. Emerging evidence indicates that KLKs are activated in a stepwise manner, which is a characteristic of proteolytic cascades. Thus far, KLK cascades have been implicated in semen liquefaction and skin desquamation. Many members of the KLK family have been reported to be active in seminal plasma and/or skin, suggesting their involvement in common proteolytic cascades. KLK14, in particular, is highly active and has recently been proposed as one of the key trypsin-like proteases involved in skin desquamation. This study aims to elucidate a probable cascade-mediated role of KLK14 by 1) examining KLK14-mediated cleavage of a heptapeptide library encompassing activation sites of the 15 KLKs and 2) verifying activation of certain candidate downstream targets of KLK14 (i.e. pro-KLK1, -KLK3, and -KLK11). Heptapeptides encompassing activation motifs of KLK2, -3, -5, and -11 were cleaved with a high (>= 85%) cleavage efficiency. Activation of these candidates was confirmed using full-length recombinant proteins. Pro-KLK11, -KLK3, and -KLK1 were rapidly activated in a concentration-dependent manner. Pro-KLK3 regulation was bidirectional because activation was followed by inactivation via internal cleavage of active KLK3. We are proposing a putative cascade model, operating through multiple KLKs. Identification of novel members of such proteolytic cascades will aid in further defining mechanisms involved in seminal/skin homeostasis.	[Diamandis, Eleftherios P.] Mt Sinai Hosp, Dept Pathol, Toronto, ON M5G 1X5, Canada; [Emami, Nashmil; Diamandis, Eleftherios P.] Mt Sinai Hosp, Lab Med, Toronto, ON M5G 1X5, Canada; [Emami, Nashmil; Diamandis, Eleftherios P.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto	Diamandis, EP (corresponding author), Mt Sinai Hosp, Dept Pathol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	ediamandis@mtsinai.on.ca		Diamandis, Eleftherios/0000-0002-1589-820X				Amour A, 2004, BIOCHEM SOC T, V32, P15, DOI 10.1042/BST0320015; Balk SP, 2003, J CLIN ONCOL, V21, P383, DOI 10.1200/JCO.2003.02.083; Borg TK, 2004, AM J PATHOL, V164, P1141, DOI 10.1016/S0002-9440(10)63201-4; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Borgono CA, 2004, MOL CANCER RES, V2, P257; Borgono CA, 2003, CANCER RES, V63, P9032; BORGONO CA, 2006, J BIOL CHEM; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Brattsand M, 1999, J BIOL CHEM, V274, P30033, DOI 10.1074/jbc.274.42.30033; Campbell DJ, 2001, CLIN EXP PHARMACOL P, V28, P1060, DOI 10.1046/j.1440-1681.2001.03564.x; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; CHRISTENSSON A, 1990, EUR J BIOCHEM, V194, P755, DOI 10.1111/j.1432-1033.1990.tb19466.x; Davie E W, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P277; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; de Lamirande E, 2007, SEMIN THROMB HEMOST, V33, P60, DOI 10.1055/s-2006-958463; Denmeade SR, 2001, PROSTATE, V48, P122, DOI 10.1002/pros.1088; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; ESPANA F, 1995, EUR J BIOCHEM, V234, P641, DOI 10.1111/j.1432-1033.1995.641_b.x; Espana F, 2007, SEMIN THROMB HEMOST, V33, P41, DOI 10.1055/s-2006-958460; Felber LM, 2005, BIOL CHEM, V386, P291, DOI 10.1515/BC.2005.035; Fernandez JA, 2007, SEMIN THROMB HEMOST, V33, P13, DOI 10.1055/s-2006-958457; FINK E, 1985, BIOL CHEM H-S, V366, P917, DOI 10.1515/bchm3.1985.366.2.917; Giusti B, 2005, ARTHRITIS RHEUM-US, V52, P3618, DOI 10.1002/art.21383; HANSSON L, 1994, J BIOL CHEM, V269, P19420; Jessani N, 2005, NAT METHODS, V2, P691, DOI 10.1038/NMETH778; Jonsson M, 2005, BIOCHEM J, V387, P447, DOI 10.1042/BJ20041424; Kim R, 2005, ONCOL REP, V14, P595; Komatsu N, 2005, J INVEST DERMATOL, V125, P1182, DOI 10.1111/j.0022-202X.2005.23933.x; Komatsu N, 2006, J INVEST DERMATOL, V126, P2338, DOI 10.1038/sj.jid.5700379; Kumar A, 1997, CANCER RES, V57, P3111; LILJA H, 1987, J CLIN INVEST, V80, P281, DOI 10.1172/JCI113070; LILJA H, 1985, SCAND J CLIN LAB INV, V45, P635, DOI 10.3109/00365518509155271; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Lovgren J, 1999, EUR J BIOCHEM, V262, P781, DOI 10.1046/j.1432-1327.1999.00433.x; Lovgren J, 1997, BIOCHEM BIOPH RES CO, V238, P549, DOI 10.1006/bbrc.1997.7333; Luo LY, 2006, CLIN CANCER RES, V12, P742, DOI 10.1158/1078-0432.CCR-05-1696; Lwaleed BA, 2005, THROMB HAEMOSTASIS, V93, P847, DOI 10.1160/TH04-09-0600; Lwaleed BA, 2004, THROMB HAEMOSTASIS, V92, P752, DOI 10.1160/TH04-03-0142; Lwaleed BA, 2007, SEMIN THROMB HEMOST, V33, P3, DOI 10.1055/s-2006-958456; LYNCH MJ, 1994, J PHARMACEUT BIOMED, V12, P5, DOI 10.1016/0731-7085(94)80004-9; Malm J, 2000, PROSTATE, V45, P132, DOI 10.1002/1097-0045(20001001)45:2<132::AID-PROS7>3.0.CO;2-3; MANDAL A, 1988, ARCH ANDROLOGY, V20, P141, DOI 10.3109/01485018808987065; Matsuda Y, 2002, ARCH ANDROLOGY, V48, P295, DOI 10.1080/01485010290031600; Michael IP, 2006, J BIOL CHEM, V281, P12743, DOI 10.1074/jbc.M600326200; Mikhailichenko VV, 2005, FERTIL STERIL, V84, P256, DOI 10.1016/j.fertnstert.2004.11.086; MISKA W, 1994, ARCH ANDROLOGY, V33, P1; MISKA W, 1990, ARCH ANDROLOGY, V25, P63, DOI 10.3109/01485019008987595; Paliouras M, 2007, CANCER LETT, V249, P61, DOI 10.1016/j.canlet.2006.12.018; POLAK B, 1990, EUR J OBSTET GYN R B, V35, P223, DOI 10.1016/0028-2243(90)90166-X; POLAK B, 1989, INT J ANDROL, V12, P187, DOI 10.1111/j.1365-2605.1989.tb01303.x; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Robert M, 1997, BIOCHEMISTRY-US, V36, P3811, DOI 10.1021/bi9626158; Schechter NM, 2005, BIOL CHEM, V386, P1173, DOI 10.1515/BC.2005.134; SCHILL WB, 1992, ANDROLOGIA, V24, P69; SENSABAUGH GF, 1990, J UROLOGY, V144, P1523, DOI 10.1016/S0022-5347(17)39790-2; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Sidera C, 2004, BIOCHEM SOC T, V32, P33, DOI 10.1042/BST0320033; Siems WE, 2003, ANDROLOGIA, V35, P44, DOI 10.1046/j.1439-0272.2003.00536.x; Stefansson K, 2006, BIOL CHEM, V387, P761, DOI 10.1515/BC.2006.095; Suzuki K, 2007, SEMIN THROMB HEMOST, V33, P46, DOI 10.1055/s-2006-958461; Takayama TK, 2001, BIOCHEMISTRY-US, V40, P15341, DOI 10.1021/bi015775e; Thyzel E, 2003, THROMB RES, V109, P329, DOI 10.1016/S0049-3848(03)00210-X; Vaisanen V, 1999, PROSTATE CANCER P D, V2, P91, DOI 10.1038/sj.pcan.4500289; Van Dreden P, 2007, SEMIN THROMB HEMOST, V33, P21, DOI 10.1055/s-2006-958458; WATT KWK, 1986, P NATL ACAD SCI USA, V83, P3166, DOI 10.1073/pnas.83.10.3166; Wennemuth G, 2003, BRIT J PHARMACOL, V138, P351, DOI 10.1038/sj.bjp.0705039; WILSON VB, 1975, J UROLOGY, V113, P509, DOI 10.1016/S0022-5347(17)59513-0; Woessner JF, 2004, HDB PROTEOLYTIC ENZY; Yamakoshi Y, 2006, EUR J ORAL SCI, V114, P45, DOI 10.1111/j.1600-0722.2006.00281.x; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com; Yousef GM, 2002, BIOL CHEM, V383, P1045, DOI 10.1515/BC.2002.113; Yousef GM, 2001, ENDOCR REV, V22, P184, DOI 10.1210/er.22.2.184; ZHANG WM, 1995, CLIN CHEM, V41, P1567	76	55	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3031	3041		10.1074/jbc.M707253200	http://dx.doi.org/10.1074/jbc.M707253200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056261	hybrid			2022-12-25	WOS:000253083000006
J	Esteban, O; Bernal, RA; Donohoe, M; Videler, H; Sharon, M; Robinson, CV; Stock, D				Esteban, Olga; Bernal, Ricardo A.; Donohoe, Mhairi; Videler, Hortense; Sharon, Michal; Robinson, Carol V.; Stock, Daniela			Stoichiometry and localization of the stator subunits E and G in Thermus thermophilus H+-ATPase/synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROSPRAY MASS-SPECTROMETRY; MITOCHONDRIAL ATP SYNTHASE; YEAST V-ATPASE; MEMBRANE-PROTEINS; ESCHERICHIA-COLI; VACUOLAR ATPASE; MACROMOLECULAR ASSEMBLIES; 3-DIMENSIONAL STRUCTURE; PERIPHERAL STALK; PHAGE DISPLAY	Proton-translocating ATPases are central to biological energy conversion. Although eukaryotes contain specialized F-ATPases for ATP synthesis and V-ATPases for proton pumping, eubacteria and archaea typically contain only one enzyme for both tasks. Although many eubacteria contain ATPases of the F-type, some eubacteria and all known archaea contain ATPases of the A-type. A-ATPases are closely related to V-ATPases but simpler in design. Although the nucleotide-binding and transmembrane rotor subunits share sequence homology between A-, V-, and F-ATPases, the peripheral stalk is strikingly different in sequence, composition, and stoichiometry. We have analyzed the peripheral stalk of Thermus thermophilus A- ATPase by using phage display-derived single-domain antibody fragments in combination with electron microscopy and tandem mass spectrometry. Our data provide the first direct evidence for the existence of two peripheral stalks in the A- ATPase, each one composed of heterodimers of subunits E and G arranged symmetrically around the soluble A(1) domain. To our knowledge, this is the first description of phage display-derived antibody selection against a multi-subunit membrane protein used for purification and single particle analysis by electron microscopy. It is also the first instance of the derivation of subunit stoichiometry by tandem mass spectrometry to an intact membrane protein complex. Both approaches could be applicable to the structural analysis of other membrane protein complexes.	[Donohoe, Mhairi; Stock, Daniela] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia; [Esteban, Olga; Bernal, Ricardo A.; Donohoe, Mhairi; Stock, Daniela] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Bernal, Ricardo A.] Univ Texas El Paso, Dept Chem, El Paso, TX 79968 USA; [Stock, Daniela] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia; [Videler, Hortense; Sharon, Michal; Robinson, Carol V.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Victor Chang Cardiac Research Institute; MRC Laboratory Molecular Biology; University of Texas System; University of Texas El Paso; University of New South Wales Sydney; University of Cambridge	Stock, D (corresponding author), Victor Chang Cardiac Res Inst, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	d.stock@victorchang.edu.au	Bernal, Ricardo A/B-2124-2010	Videler, Hortense/0000-0002-6369-5984; Sharon, Michal/0000-0003-3933-0595; robinson, carol/0000-0001-7829-5505; Bernal, Ricardo A./0000-0001-5849-8647	MRC [MC_U105170645] Funding Source: UKRI; Medical Research Council [MC_U105170645] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; Benesch JL, 2006, CURR OPIN STRUC BIOL, V16, P245, DOI 10.1016/j.sbi.2006.03.009; Bernal RA, 2004, STRUCTURE, V12, P1789, DOI 10.1016/j.str.2004.07.017; Betts S, 1999, METHOD ENZYMOL, V309, P333; Biukovic G, 2007, BIOCHEMISTRY-US, V46, P2070, DOI 10.1021/bi062123n; Boekema EJ, 1999, NATURE, V401, P37, DOI 10.1038/43369; Bottcher B, 1998, J MOL BIOL, V281, P757, DOI 10.1006/jmbi.1998.1957; Carbajo RJ, 2007, J MOL BIOL, V368, P310, DOI 10.1016/j.jmb.2007.02.059; Chernushevich IV, 2004, ANAL CHEM, V76, P1754, DOI 10.1021/ac035406j; Coskun U, 2004, J BIOL CHEM, V279, P38644, DOI 10.1074/jbc.M406196200; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Domgall I, 2002, J BIOL CHEM, V277, P13115, DOI 10.1074/jbc.M112011200; Fethiere J, 2005, BIOCHEMISTRY-US, V44, P15906, DOI 10.1021/bi051762f; Gruber G, 2001, J EXP BIOL, V204, P2597; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Hunte C, 2002, CURR OPIN STRUC BIOL, V12, P503, DOI 10.1016/S0959-440X(02)00354-8; Karrasch S, 1999, J MOL BIOL, V290, P379, DOI 10.1006/jmbi.1999.2897; KIBAK H, 1992, J BIOENERG BIOMEMBR, V24, P415, DOI 10.1007/BF00762534; KOHLER G, 1975, NATURE, V256, P497; Lokanath NK, 2007, J MOL BIOL, V366, P933, DOI 10.1016/j.jmb.2006.11.088; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mirzabekov T, 2000, NAT BIOTECHNOL, V18, P649, DOI 10.1038/76501; Muller V, 2003, CELL MOL LIFE SCI, V60, P474, DOI 10.1007/s000180300040; Nettleton EJ, 1998, J MOL BIOL, V281, P553, DOI 10.1006/jmbi.1998.1937; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Norgett EE, 2007, J BIOL CHEM, V282, P14421, DOI 10.1074/jbc.M701226200; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; Rothlisberger D, 2004, FEBS LETT, V564, P340, DOI 10.1016/S0014-5793(04)00359-X; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; Rubinstein JL, 2003, ANAL BIOCHEM, V314, P294, DOI 10.1016/S0003-2697(02)00649-8; Schafer IB, 2006, J MOL BIOL, V358, P725, DOI 10.1016/j.jmb.2006.02.057; Sharon M, 2006, PLOS BIOL, V4, P1314, DOI 10.1371/journal.pbio.0040267; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Speed MA, 1997, PROTEIN SCI, V6, P99; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Venzke D, 2005, J MOL BIOL, V349, P659, DOI 10.1016/j.jmb.2005.04.033; Wilkens S, 2000, J MOL BIOL, V295, P387, DOI 10.1006/jmbi.1999.3381; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Wilkens S, 1998, BBA-BIOENERGETICS, V1365, P93, DOI 10.1016/S0005-2728(98)00048-6; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Yokoyama K, 2003, J BIOL CHEM, V278, P42686, DOI 10.1074/jbc.M305853200; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zhang ZY, 2006, FEBS LETT, V580, P2006, DOI 10.1016/j.febslet.2006.03.001	44	47	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2595	2603		10.1074/jbc.M704941200	http://dx.doi.org/10.1074/jbc.M704941200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18055467	hybrid			2022-12-25	WOS:000252622300016
J	Gore, Y; Starlets, D; Maharshak, N; Becker-Herman, S; Kaneyuki, U; Leng, L; Bucala, R; Shachar, I				Gore, Yael; Starlets, Diana; Maharshak, Nitsan; Becker-Herman, Shirly; Kaneyuki, Utako; Leng, Lin; Bucala, Richard; Shachar, Idit			Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVARIANT CHAIN; FACTOR MIF; LEISHMANIA-MAJOR; REGULATORY ROLE; EXPRESSION; CD44; MATURATION; GROWTH; CD74; PROLIFERATION	Macrophage migration inhibitory factor (MIF) is an upstream activator of innate immunity that regulates subsequent adaptive responses. It was previously shown that in macrophages, MIF binds to a complex of CD74 and CD44, resulting in initiation of a signaling pathway. In the current study, we investigated the role of MIF in B cell survival. We show that in B lymphocytes, MIF initiates a signaling cascade that involves Syk and Akt, leading to NF-kappa B activation, proliferation, and survival in a CD74-and CD44-dependent manner. Thus, MIF regulates the adaptive immune response by maintaining the mature B cell population.	[Gore, Yael; Starlets, Diana; Maharshak, Nitsan; Becker-Herman, Shirly; Shachar, Idit] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Leng, Lin; Bucala, Richard] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA	Weizmann Institute of Science; Yale University	Shachar, I (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	idit.shachar@weizmann.ac.il		Leng, Lin/0000-0002-0605-358X	NIAID NIH HHS [AI 042310] Funding Source: Medline; NIAMS NIH HHS [AR 049610, AR 050498] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI042310, R01AI042310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050498, R01AR049610] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Bando H, 2002, JPN J CANCER RES, V93, P389, DOI 10.1111/j.1349-7006.2002.tb01269.x; Becker-Herman S, 2005, MOL BIOL CELL, V16, P5061, DOI 10.1091/mbc.E05-04-0327; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 1996, J EXP MED, V183, P277, DOI 10.1084/jem.183.1.277; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Cantrell D, 2002, SEMIN IMMUNOL, V14, P19, DOI 10.1006/smim.2001.0338; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; Datta MW, 2000, APPL IMMUNOHISTO M M, V8, P210, DOI 10.1097/00022744-200009000-00007; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Dios A, 2002, J MED CHEM, V45, P2410, DOI 10.1021/jm010534q; Donnelly SC, 1997, MOL MED TODAY, V3, P502, DOI 10.1016/S1357-4310(97)01133-7; ELLIOTT EA, 1994, J EXP MED, V179, P681, DOI 10.1084/jem.179.2.681; ERICKSON AH, 1979, J BIOL CHEM, V254, P1771; Fruman DA, 2004, CURR OPIN IMMUNOL, V16, P314, DOI 10.1016/j.coi.2004.03.014; GEORGE M, 1962, P SOC EXP BIOL MED, V111, P514; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Ioachim HL, 1996, AM J SURG PATHOL, V20, P64, DOI 10.1097/00000478-199601000-00007; Ishigami S, 2001, CANCER LETT, V168, P87, DOI 10.1016/S0304-3835(01)00503-1; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; Juttner S, 1998, J IMMUNOL, V161, P2383; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Lazova R, 1997, CANCER-AM CANCER SOC, V79, P2115, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2115::AID-CNCR8>3.0.CO;2-N; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Matza D, 2003, TRENDS IMMUNOL, V24, P264, DOI 10.1016/S1471-4906(03)00073-5; Matza D, 2002, IMMUNITY, V17, P549, DOI 10.1016/S1074-7613(02)00455-7; Matza D, 2002, P NATL ACAD SCI USA, V99, P3018, DOI 10.1073/pnas.052703299; Matza D, 2001, J BIOL CHEM, V276, P27203, DOI 10.1074/jbc.M104684200; Meyer-Siegler KL, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-34; MeyerSiegler K, 1996, UROLOGY, V48, P448, DOI 10.1016/S0090-4295(96)00207-5; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Mizue Y, 2000, INT J MOL MED, V5, P397; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; NATHAN CF, 1973, J EXP MED, V137, P275, DOI 10.1084/jem.137.2.275; NAUJOKAS MF, 1993, CELL, V74, P257, DOI 10.1016/0092-8674(93)90417-O; Nebreda AR, 2006, CURR OPIN CELL BIOL, V18, P192, DOI 10.1016/j.ceb.2006.01.001; Nishihira J, 2000, J INTERF CYTOK RES, V20, P751, DOI 10.1089/10799900050151012; Nishihira J, 2003, ANN NY ACAD SCI, V995, P171, DOI 10.1111/j.1749-6632.2003.tb03220.x; Satoskar AR, 2001, INFECT IMMUN, V69, P906, DOI 10.1128/IAI.69.2.906-911.2001; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; SHACHAR I, 1995, IMMUNITY, V3, P373, DOI 10.1016/1074-7613(95)90121-3; Shachar I, 1996, SCIENCE, V274, P106, DOI 10.1126/science.274.5284.106; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; STAMENKOVIC I, 1991, EMBO J, V10, P343, DOI 10.1002/j.1460-2075.1991.tb07955.x; Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334; Stein R, 2004, BLOOD, V104, P3705, DOI 10.1182/blood-2004-03-0890; Stumptner-Cuvelette P, 2002, BBA-MOL CELL RES, V1542, P1, DOI 10.1016/S0167-4889(01)00166-5; Takano T, 2002, ANTIOXID REDOX SIGN, V4, P533, DOI 10.1089/15230860260196335; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Young AN, 2001, AM J PATHOL, V158, P1639, DOI 10.1016/S0002-9440(10)64120-X	54	180	196	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2784	2792		10.1074/jbc.M703265200	http://dx.doi.org/10.1074/jbc.M703265200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18056708	hybrid			2022-12-25	WOS:000252622300036
J	Li, YC; Chiang, CW; Yeh, HC; Hsu, PY; Whitby, FG; Wang, LH; Chan, NL				Li, Yi-Ching; Chiang, Chia-Wang; Yeh, Hui-Chun; Hsu, Pei-Yung; Whitby, Frank G.; Wang, Lee-Ho; Chan, Nei-Li			Structures of prostacyclin synthase and its complexes with substrate analog and inhibitor reveal a ligand-specific heme conformation change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; CYTOCHROME P450S; CAMPHOR; HYDROXYLATION; ENVIRONMENT; SYNTHETASE; PORPHYRINS; MECHANISMS; CATALYSIS; CLEAVAGE	Prostacyclin synthase (PGIS) is a cytochrome P450 ( P450) enzyme that catalyzes production of prostacyclin from prostaglandin H-2. PGIS is unusual in that it catalyzes an isomerization rather than a monooxygenation, which is typical of P450 enzymes. To understand the structural basis for prostacyclin biosynthesis in greater detail, we have determined the crystal structures of ligand-free, inhibitor ( minoxidil)-bound and substrate analog U51605-bound PGIS. These structures demonstrate a stereo-specific substrate binding and suggest features of the enzyme that facilitate isomerization. Unlike most microsomal P450s, where large substrate-induced conformational changes take place at the distal side of the heme, conformational changes in PGIS are observed at the proximal side and in the heme itself. The conserved and extensive heme propionate-protein interactions seen in all other P450s, which are largely absent in the ligand-free PGIS, are recovered upon U51605 binding accompanied by water exclusion from the active site. In contrast, when minoxidil binds, the propionate-protein interactions are not recovered and water molecules are largely retained. These findings suggest that PGIS represents a divergent evolution of the P450 family, in which a heme barrier has evolved to ensure strict binding specificity for prostaglandin H-2, leading to a radical-mediated isomerization with high product fidelity. The U51605-bound structure also provides a view of the substrate entrance and product exit channels.	[Chan, Nei-Li] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 10764, Taiwan; [Yeh, Hui-Chun; Hsu, Pei-Yung; Wang, Lee-Ho] Univ Texas Houston, Hlth Sci Ctr, Div Hematol, Dept Internal Med, Houston, TX 77030 USA; [Li, Yi-Ching; Chiang, Chia-Wang; Chan, Nei-Li] Natl Chung Hsing Univ, Coll Life Sci, Inst Biochem, Taichung 40227, Taiwan; [Whitby, Frank G.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA	National Taiwan University; University of Texas System; University of Texas Health Science Center Houston; National Chung Hsing University; Utah System of Higher Education; University of Utah	Wang, LH (corresponding author), Univ Texas Houston, Hlth Sci Ctr, Div Hematol, Dept Internal Med, 6431 Fannin, Houston, TX 77030 USA.	lee-ho.wang@uth.tmc.edu; nlchan@ntu.edu.tw		CHAN, NEI-LI/0000-0003-0139-6513	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060625] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL060625, R01 HL060625-08, HL 60625] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altun A, 2006, J AM CHEM SOC, V128, P3924, DOI 10.1021/ja058196w; Altun A, 2007, J AM CHEM SOC, V129, P8978, DOI 10.1021/ja066847y; Chiang CW, 2006, J MOL BIOL, V364, P266, DOI 10.1016/j.jmb.2006.09.039; CHO MJ, 1978, PROSTAGLANDINS, V15, P943, DOI 10.1016/0090-6980(78)90037-0; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; *COLL COMP PROJ, 1994, ACTA CRYSTALLOGR D, V50, P764; Coon MJ, 2005, ANNU REV PHARMACOL, V45, P1, DOI 10.1146/annurev.pharmtox.45.120403.100030; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Guallar V, 2006, J INORG BIOCHEM, V100, P755, DOI 10.1016/j.jinorgbio.2006.01.019; HARA S, 1994, J BIOL CHEM, V269, P19897; HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4; He YA, 1997, BIOCHEMISTRY-US, V36, P8831, DOI 10.1021/bi970182i; HECKER M, 1988, BIOCHEM PHARMACOL, V37, P3363, DOI 10.1016/0006-2952(88)90652-1; HECKER M, 1989, J BIOL CHEM, V264, P141; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KADISH KM, 1995, INORG CHEM, V34, P2984, DOI 10.1021/ic00115a028; KOGA H, 1993, FEBS LETT, V331, P109, DOI 10.1016/0014-5793(93)80307-G; Li HY, 2004, CURR TOP MED CHEM, V4, P1789, DOI 10.2174/1568026043387205; Lounnas V, 1997, BIOCHEMISTRY-US, V36, P5402, DOI 10.1021/bi9622940; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otyepka M, 2007, BBA-GEN SUBJECTS, V1770, P376, DOI 10.1016/j.bbagen.2006.09.013; PEREIRA B, 1994, BIOCHEM BIOPH RES CO, V203, P59, DOI 10.1006/bbrc.1994.2148; SANDUJA SK, 1991, BLOOD, V78, P3178; Schleinkofer K, 2005, EMBO REP, V6, P584, DOI 10.1038/sj.embor.7400420; Shelnutt JA, 1998, CHEM SOC REV, V27, P31; SHIMIZU T, 1994, J BIOL CHEM, V269, P13296; TAI CL, 1980, PROSTAG LEUKOTR ESS, V4, P399, DOI 10.1016/0161-4630(80)90048-8; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P45, DOI 10.1107/S0907444902018048; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; ULLRICH V, 1981, BIOCHEM PHARMACOL, V30, P2033, DOI 10.1016/0006-2952(81)90218-5; ULLRICH V, 1994, ANGEW CHEM INT EDIT, V33, P1911, DOI 10.1002/anie.199419111; Yeh HC, 2005, BBA-MOL CELL BIOL L, V1738, P121, DOI 10.1016/j.bbalip.2005.11.007; Yeh HC, 2007, ARCH BIOCHEM BIOPHYS, V461, P159, DOI 10.1016/j.abb.2007.03.012; Zhao YH, 2007, BBA-GEN SUBJECTS, V1770, P402, DOI 10.1016/j.bbagen.2006.07.006; Zurek J, 2006, ORG BIOMOL CHEM, V4, P3931, DOI 10.1039/b611653a	38	41	45	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2917	2926		10.1074/jbc.M707470200	http://dx.doi.org/10.1074/jbc.M707470200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18032380	hybrid, Green Accepted			2022-12-25	WOS:000252622300048
J	Chambers, JE; Jessop, CE; Bulleid, NJ				Chambers, Joseph E.; Jessop, Catherine E.; Bulleid, Neil J.			Formation of a major histocompatibility complex class I tapasin disulfide indicates a change in spatial organization of the peptide-loading complex during assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; DEPENDENT REDUCTASE ERP57; BOND FORMATION; OXIDOREDUCTASE ERP57; TRANSLATION SYSTEM; REDOX REGULATION; MAMMALIAN-CELLS; HEAVY-CHAIN; BETA(2)-MICROGLOBULIN; MOLECULES	The assembly and peptide loading of major histocompatibility complex Class I molecules within the endoplasmic reticulum are essential for antigen presentation at the cell surface and are facilitated by the peptide-loading complex. The formation of a mixed disulfide between the heavy chain of Class I and components of the loading complex (ERp57, protein disulfide isomerase, and tapasin) suggests that these molecules are involved in the redox regulation of components during assembly and peptide loading. We demonstrate here that a disulfide formed between heavy chain and tapasin can occur between cysteine residues located in the cytosolic regions of these proteins following translation of heavy chain in an in vitro translation system. The formation of this disulfide occurs after assembly into the loading complex and is coincident with the stabilization of the alpha 2 disulfide bond within the peptide binding grove. A ternary complex between heavy chain, ERp57, and tapasin was observed and shown to be stabilized by a disulfide between both tapasin-heavy chain and tapasin-ERp57. No disulfides were observed between ERp57 and heavy chain within the loading complex. The results provide a detailed evaluation of the various transient disulfides formed within the peptide-loading complex during biosynthesis. In addition, the absence of the disulfide between tapasin and heavy chain in TAP-deficient cells indicates that a change in the spatial organization of tapasin and heavy chain occurs following assembly into the loading complex.	[Chambers, Joseph E.; Jessop, Catherine E.; Bulleid, Neil J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Bulleid, NJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	neil.bulleid@manchester.ac.uk	Chambers, Joseph/Z-5212-2019	Chambers, Joseph/0000-0003-4675-0053; Bulleid, Neil/0000-0002-9839-5279	Biotechnology and Biological Sciences Research Council [BB/D00764X/1, C17806] Funding Source: Medline; BBSRC [BB/D00764X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Antoniou AN, 2002, EMBO J, V21, P2655, DOI 10.1093/emboj/21.11.2655; DEMARS R, 1985, P NATL ACAD SCI USA, V82, P8183, DOI 10.1073/pnas.82.23.8183; Dick TP, 2004, CELL MOL LIFE SCI, V61, P547, DOI 10.1007/s00018-003-3271-9; Dick TP, 2002, METHOD ENZYMOL, V348, P49, DOI 10.1016/S0076-6879(02)48625-9; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Farmery MR, 2000, J BIOL CHEM, V275, P14933, DOI 10.1074/jbc.275.20.14933; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Grandea AG, 1997, IMMUNOGENETICS, V46, P477, DOI 10.1007/s002510050308; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Hughes EA, 1998, CURR BIOL, V8, P709, DOI 10.1016/S0960-9822(98)70278-7; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200; Kienast A, 2007, NAT IMMUNOL, V8, P864, DOI 10.1038/ni1483; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; Lindquist JA, 2001, FASEB J, V15, P1448, DOI 10.1096/fj.00-0720fje; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Morrice NA, 1998, CURR BIOL, V8, P713, DOI 10.1016/S0960-9822(98)70279-9; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; RIBAUDO RK, 1992, J IMMUNOL, V149, P2935; Santos SG, 2007, J BIOL CHEM, V282, P17587, DOI 10.1074/jbc.M702212200; SMITH JD, 1995, MOL IMMUNOL, V32, P531, DOI 10.1016/0161-5890(95)00013-5; Tector M, 1997, MOL IMMUNOL, V34, P401, DOI 10.1016/S0161-5890(97)00045-X; WANG H, 1994, J BIOL CHEM, V269, P22276; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679	28	19	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1862	1869		10.1074/jbc.M708196200	http://dx.doi.org/10.1074/jbc.M708196200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039656	hybrid			2022-12-25	WOS:000252501000012
J	Kapoor, M; Zhou, Q; Otero, F; Myers, CA; Bates, A; Belani, R; Liu, J; Luo, JK; Tzima, E; Zhang, DE; Yang, XL; Schimmel, P				Kapoor, Mili; Zhou, Quansheng; Otero, Francella; Myers, Christopher A.; Bates, Alison; Belani, Rajesh; Liu, Jianming; Luo, Jiann-Kae; Tzima, Eleni; Zhang, Dong-Er; Yang, Xiang-Lei; Schimmel, Paul			Evidence for annexin II-S100A10 complex and plasmin in mobilization of cytokine activity of human TrpRS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; ENDOTHELIAL-CELLS; ANGIOGENESIS; FRAGMENT; LOCALIZATION; SECRETION; RETENTION; PROTEINS; SUBUNIT; CANCER	In mammalian cells, specific aminoacyl-transfer RNA (tRNA) synthetases have cytokine functions that require interactions with partners outside of the translation apparatus. Little is known about these interactions and how they facilitate expanded functions that link protein translation to other cellular pathways. For example, an alternative splice fragment of tryptophanyl-tRNA synthetase (TrpRS) and a similar natural proteolytic fragment are potent angiostatic factors that act through the vascular endothelial-cadherin receptor and Akt signaling pathway. Here we demonstrate mobilization of TrpRS for exocytosis from endothelial cells and the potential for plasmin to activate the cytokine function of the extracellular synthetase. Direct physical evidence showed that the annexin II-S100A10 complex, which regulates exocytosis, forms a ternary complex with TrpRS. Functional studies demonstrate that both annexin II and S100A10 regulate trafficking of TrpRS. Thus, complexes of mammalian tRNA synthetases with seemingly disparate proteins may in general be relevant to understanding how their expanded functions are implemented.	[Luo, Jiann-Kae; Zhang, Dong-Er] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Kapoor, Mili; Zhou, Quansheng; Otero, Francella; Myers, Christopher A.; Bates, Alison; Belani, Rajesh; Liu, Jianming; Yang, Xiang-Lei; Schimmel, Paul] Skaggs Inst Chem Biol, Dept Mol Biol, La Jolla, CA 92037 USA; [Tzima, Eleni] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	Scripps Research Institute; Scripps Research Institute; University of North Carolina; University of North Carolina Chapel Hill	Schimmel, P (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu	Yang, Xiang-Lei/AAR-7107-2020; Tzima, Ellie/L-9256-2017	Tzima, Ellie/0000-0002-3437-0902; Zhou, Quansheng/0000-0003-4712-0731; Yang, Xiang-Lei/0000-0003-2554-084X	NATIONAL CANCER INSTITUTE [R01CA092577] Funding Source: NIH RePORTER; NCI NIH HHS [CA092577] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Chang SY, 2002, J BIOL CHEM, V277, P8388, DOI 10.1074/jbc.M108792200; Dorrell MI, 2007, P NATL ACAD SCI USA, V104, P967, DOI 10.1073/pnas.0607542104; FARBER JM, 1993, BIOCHEM BIOPH RES CO, V192, P223, DOI 10.1006/bbrc.1993.1403; FAVOROVA OO, 1989, EUR J BIOCHEM, V184, P583, DOI 10.1111/j.1432-1033.1989.tb15053.x; FLECKNER J, 1991, P NATL ACAD SCI USA, V88, P11520, DOI 10.1073/pnas.88.24.11520; Gromov P, 2003, MOL CELL PROTEOMICS, V2, P70, DOI 10.1074/mcp.M200051-MCP200; Halwani R, 2004, J VIROL, V78, P7553, DOI 10.1128/JVI.78.14.7553-7564.2004; Han JM, 2007, AM J PATHOL, V170, P2042, DOI 10.2353/ajpath.2007.061266; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Kim MJ, 2003, NAT GENET, V34, P330, DOI 10.1038/ng1182; Kise Y, 2004, NAT STRUCT MOL BIOL, V11, P149, DOI 10.1038/nsmb722; Knop M, 2004, EMBO J, V23, P2982, DOI 10.1038/sj.emboj.7600319; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; Ko YG, 2001, J BIOL CHEM, V276, P6030, DOI 10.1074/jbc.M006189200; Ko YG, 2000, J CELL BIOL, V149, P567, DOI 10.1083/jcb.149.3.567; Konig J, 1998, J BIOL CHEM, V273, P19679, DOI 10.1074/jbc.273.31.19679; Kwon MJ, 2005, FRONT BIOSCI-LANDMRK, V10, P300, DOI 10.2741/1529; Liu JM, 2004, NUCLEIC ACIDS RES, V32, P719, DOI 10.1093/nar/gkh240; Martinis Susan A., 1999, EMBO (European Molecular Biology Organization) Journal, V18, P4591, DOI 10.1093/emboj/18.17.4591; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Otani A, 2002, P NATL ACAD SCI USA, V99, P178, DOI 10.1073/pnas.012601899; Otani A, 2002, NAT MED, V8, P1004, DOI 10.1038/nm744; Park BJ, 2005, CELL, V120, P209, DOI 10.1016/j.cell.2004.11.054; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Seshaiah P, 1999, MOL BIOL CELL, V10, P1595, DOI 10.1091/mbc.10.5.1595; Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; STRIETER RM, 1995, J LEUKOCYTE BIOL, V57, P752, DOI 10.1002/jlb.57.5.752; TOLSTRUP AB, 1995, J BIOL CHEM, V270, P397, DOI 10.1074/jbc.270.1.397; Turpaev KT, 1996, EUR J BIOCHEM, V240, P732, DOI 10.1111/j.1432-1033.1996.0732h.x; Tzima E, 2005, J BIOL CHEM, V280, P2405, DOI 10.1074/jbc.C400431200; Tzima E, 2003, P NATL ACAD SCI USA, V100, P14903, DOI 10.1073/pnas.2436330100; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Wakasugi K, 2002, J BIOL CHEM, V277, P20124, DOI 10.1074/jbc.C200126200; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Yang D, 2001, J BIOCHEM-TOKYO, V129, P561, DOI 10.1093/oxfordjournals.jbchem.a002891	43	31	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2070	2077		10.1074/jbc.M706028200	http://dx.doi.org/10.1074/jbc.M706028200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17999956	Green Published, hybrid			2022-12-25	WOS:000252501000034
J	Katsoulotos, GP; Qi, M; Qi, JC; Tanaka, K; Hughes, WE; Molloy, TJ; Adachi, R; Stevens, RL; Krilis, SA				Katsoulotos, Gregory P.; Qi, Miao; Qi, Jian Cheng; Tanaka, Kumiko; Hughes, William E.; Molloy, Timothy J.; Adachi, Roberto; Stevens, Richard L.; Krilis, Steven A.			The diacylglycerol-dependent translocation of Ras guanine nucleotide-releasing protein 4 inside a human mast cell line results in substantial phenotypic changes, including expression of interleukin 13 receptor alpha 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE RELEASING PROTEIN-4; EXCHANGE FACTOR; SIGNAL-TRANSDUCTION; PROSTAGLANDIN D-2; GENE-EXPRESSION; PHORBOL ESTERS; BINDING MOTIFS; RAS ACTIVATION; W/WV MICE; RECEPTOR	Ras guanine nucleotide- releasing protein 4 (RasGRP4) is a mast cell (MC)-restricted guanine nucleotide exchange factor and diacylglycerol (DAG)/phorbol ester receptor. An RasGRP4-defective variant of the human MC line HMC-1 was used to create stable clones expressing green fluorescent protein-labeled RasGRP4 for monitoring the movement of this protein inside MCs after exposure to phorbol 12-myristate 13-acetate (PMA), and for evaluating the protein's ability to control gene expression. RasGRP4 resided primarily in the cytosol. After exposure to PMA, RasGRP4 quickly translocated to the inner leaflet of the cell's plasma membrane. 15-30 min later, this signaling protein translocated from the plasma membrane to other intracellular sites. The translocation of RasGRP4 from the cytosol to its varied membrane compartments was found to be highly dependent on Phe(548) in the protein's C1 DAG/PMA-binding domain. Extracellular signal-regulated kinases 1 and 2 were activated during this translocation process, and c-kit/CD117 was lost from the cell's surface. Transcript- profiling approaches revealed that RasGRP4 profoundly regulated the expression of hundreds of genes in HMC-1 cells. For example, the expression of the transcript that encodes the interleukin ( IL) 13 receptor IL-13R alpha 2 increased 61- to 860-fold in RasGRP4-expressing HMC1 cells. A marked increase in IL-13R alpha 2 protein levels also was found. The accumulated data suggest RasGRP4 translocates to varied intracellular compartments via its DAG/PMA-binding domain to regulate signaling pathways that control gene and protein expression in MCs, including the cell's ability to respond to IL-13.	[Katsoulotos, Gregory P.; Qi, Miao; Qi, Jian Cheng; Tanaka, Kumiko; Krilis, Steven A.] Univ New S Wales, Dept Med, Kogarah, NSW 2217, Australia; [Katsoulotos, Gregory P.; Qi, Miao; Qi, Jian Cheng; Tanaka, Kumiko; Krilis, Steven A.] St George Hosp, Dept Immunol Allergy & Infect Dis, Kogarah, NSW 2217, Australia; [Hughes, William E.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Molloy, Timothy J.] St Vincents Hosp, Blood Dis & Canc Res Lab, Sydney, NSW 2010, Australia; [Adachi, Roberto] Univ Texas Houston, MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; [Stevens, Richard L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Stevens, Richard L.] Brigham & Womens Hosp, Boston, MA 02115 USA	University of New South Wales Sydney; St George Hospital; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Krilis, SA (corresponding author), Univ New S Wales, Dept Med, 2 S St Ctr, Kogarah, NSW 2217, Australia.	S.Krilis@unsw.edu.au		Adachi, Roberto/0000-0002-0146-0768; Hughes, William/0000-0002-7149-3987	NHLBI NIH HHS [HL 36110] Funding Source: Medline; NIAID NIH HHS [AI 54950] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054950] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrews AL, 2006, J ALLERGY CLIN IMMUN, V118, P858, DOI 10.1016/j.jaci.2006.06.041; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; BROWN KD, 1989, J IMMUNOL, V142, P679; BURD PR, 1995, J EXP MED, V181, P1373, DOI 10.1084/jem.181.4.1373; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; Chiaramonte MG, 2003, J EXP MED, V197, P687, DOI 10.1084/jem.20020903; Clyde-Smith J, 2000, J BIOL CHEM, V275, P32260, DOI 10.1074/jbc.M006087200; Coughlin JJ, 2005, J IMMUNOL, V175, P7179, DOI 10.4049/jimmunol.175.11.7179; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Daines MO, 2006, J IMMUNOL, V176, P7495, DOI 10.4049/jimmunol.176.12.7495; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fushimi T, 1998, J ALLERGY CLIN IMMUN, V102, P134, DOI 10.1016/S0091-6749(98)70064-8; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GEISSLER EN, 1983, EXP HEMATOL, V11, P461; GORDON JR, 1990, BLOOD, V75, P1637; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Hsieh FH, 2001, J EXP MED, V193, P123, DOI 10.1084/jem.193.1.123; Irie K, 2004, BIOORGAN MED CHEM, V12, P4575, DOI 10.1016/j.bmc.2004.07.008; JAFFERY G, 1994, INT ARCH ALLERGY IMM, V105, P274, DOI 10.1159/000236769; KANAKURA Y, 1988, BLOOD, V72, P877; Kaur D, 2006, ALLERGY, V61, P1047, DOI 10.1111/j.1398-9995.2006.01139.x; Kawakami K, 2001, BLOOD, V97, P2673, DOI 10.1182/blood.V97.9.2673; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kedra D, 1997, HUM GENET, V100, P611, DOI 10.1007/s004390050562; KITAMURA Y, 1978, BLOOD, V52, P447; Layer K, 2003, IMMUNITY, V19, P243, DOI 10.1016/S1074-7613(03)00209-7; LEWIS RA, 1982, J IMMUNOL, V129, P1627; Li JY, 1999, NAT GENET, V23, P348, DOI 10.1038/15531; Li LX, 2003, J IMMUNOL, V171, P390, DOI 10.4049/jimmunol.171.1.390; Li LX, 2003, J BIOL CHEM, V278, P4725, DOI 10.1074/jbc.C200635200; Li LX, 2002, MOL IMMUNOL, V38, P1283, DOI 10.1016/S0161-5890(02)00076-7; Liu Y, 2007, J EXP MED, V204, P93, DOI 10.1084/jem.20061598; Lorentz A, 2005, J IMMUNOL, V174, P6751, DOI 10.4049/jimmunol.174.11.6751; Lorenzo PS, 2001, CANCER RES, V61, P943; MACCHIA L, 1995, BBA-LIPID LIPID MET, V1257, P58, DOI 10.1016/0005-2760(95)00048-H; MURAKAMI M, 1995, J BIOL CHEM, V270, P3239, DOI 10.1074/jbc.270.7.3239; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Okamura SM, 2006, J BIOL CHEM, V281, P36132, DOI 10.1074/jbc.M605093200; OTSU K, 1987, J EXP MED, V165, P615, DOI 10.1084/jem.165.3.615; PEREZ DI, 2004, MOL CELL BIOL, V24, P3485; RAZIN E, 1984, J IMMUNOL, V132, P1479; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Reuther GW, 2002, J BIOL CHEM, V277, P30508, DOI 10.1074/jbc.M111330200; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Stassen M, 2001, J IMMUNOL, V166, P4391, DOI 10.4049/jimmunol.166.7.4391; Stone JC, 2006, BIOCHEM SOC T, V34, P858, DOI 10.1042/BST0340858; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Tang L, 2001, VET IMMUNOL IMMUNOP, V79, P181, DOI 10.1016/S0165-2427(01)00271-9; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; VALENT P, 1989, BLOOD, V73, P1778; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Yang Y, 2002, J BIOL CHEM, V277, P25756, DOI 10.1074/jbc.M202575200; Zheng Y, 2005, BLOOD, V105, P3648, DOI 10.1182/blood-2004-10-3916	59	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1610	1621		10.1074/jbc.M707042200	http://dx.doi.org/10.1074/jbc.M707042200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024961	hybrid			2022-12-25	WOS:000252282700047
J	Panka, DJ; Cho, DC; Atkins, MB; Mier, JW				Panka, David J.; Cho, Daniel C.; Atkins, Michael B.; Mier, James W.			GSK-3 beta inhibition enhances sorafenib-induced apoptosis in melanoma cell lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; CASPASE-INDEPENDENT APOPTOSIS; CASEIN KINASE-II; MULTISITE PHOSPHORYLATION; MEMBRANE PERMEABILIZATION; MCL-1; ACTIVATION; P53; INACTIVATION; SPECIFICITY	Glycogen synthase kinase-3 beta(GSK-3 beta) can participate in the induction of apoptosis or, alternatively, provide a survival signal that minimizes cellular injury. We previously demonstrated that the multikinase inhibitor sorafenib induces apoptosis in melanoma cell lines. In this report, we show that sorafenib activates GSK-3 beta in multiple subcellular compartments and that this activation undermines the lethality of the drug. Pharmacologic inhibition and/or down-modulation of the kinase enhances sorafenib-induced apoptosis as determined by propidium iodide staining and by assessing the mitochondrial release of apoptosis-inducing factor and Smac/DIABLO. Conversely, the forced expression of a constitutively active form of the enzyme (GSK-3 beta(S9A)) protects the cells from the apoptotic effects of the drug. This protective effect is associated with a marked increase in basal levels of Bcl-2, Bcl-x(L), and survivin and a diminution in the degree to which these anti-apoptotic proteins are down-modulated by sorafenib exposure. Sorafenib down-modulates the pro-apoptotic Bcl-2 family member Noxa in cells with high constitutive GSK-3 beta activity. Pharmacologic inhibition of GSK-3 beta prevents the disappearance of Noxa induced by sorafenib and enhances the down-modulation of Mcl-1. Down-modulation of Noxa largely eliminates the enhancing effect of GSK-3 inhibition on sorafenib-induced apoptosis. These data provide a strong rationale for the use of GSK-3 beta inhibitors as adjuncts to sorafenib treatment and suggest that preservation of Noxa may contribute to their efficacy.	[Panka, David J.; Cho, Daniel C.; Atkins, Michael B.; Mier, James W.] Beth Israel Deaconess Med Ctr, Div Oncol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Mier, JW (corresponding author), Beth Israel Deaconess Med Ctr, Div Oncol, Boston, MA 02215 USA.	jmier@bidmc.harvard.edu			NATIONAL CANCER INSTITUTE [P50CA093683] Funding Source: NIH RePORTER; NCI NIH HHS [P50CA93683] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dong JJ, 2005, CANCER RES, V65, P1961, DOI 10.1158/0008-5472.CAN-04-2501; Ghosh JC, 2005, CLIN CANCER RES, V11, P4580, DOI 10.1158/1078-0432.CCR-04-2624; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Liu T, 2004, ONCOGENE, V23, P39, DOI 10.1038/sj.onc.1206978; LOMAX MI, 1992, P NATL ACAD SCI USA, V89, P5266, DOI 10.1073/pnas.89.12.5266; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; NEVINS JR, 1987, METHOD ENZYMOL, V152, P234; Panka DJ, 2006, CANCER RES, V66, P1611, DOI 10.1158/0008-5472.CAN-05-0808; PICTON C, 1982, FEBS LETT, V150, P191, DOI 10.1016/0014-5793(82)81332-X; Rottmann S, 2005, P NATL ACAD SCI USA, V102, P15195, DOI 10.1073/pnas.0505114102; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; SKURAT AV, 1995, J BIOL CHEM, V270, P12491, DOI 10.1074/jbc.270.21.12491; Smalley KSM, 2007, CANCER RES, V67, P209, DOI 10.1158/0008-5472.CAN-06-1538; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Summers SA, 1999, J BIOL CHEM, V274, P17934, DOI 10.1074/jbc.274.25.17934; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Turenne GA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-12; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Williams DD, 1999, FEBS LETT, V448, P86, DOI 10.1016/S0014-5793(99)00342-7; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; WOODGETT JR, 1984, BIOCHIM BIOPHYS ACTA, V788, P339, DOI 10.1016/0167-4838(84)90047-5; WOODGETT JR, 2001, SCI STKE, V100, P1; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841	30	50	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					726	732		10.1074/jbc.M705343200	http://dx.doi.org/10.1074/jbc.M705343200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17991738	hybrid			2022-12-25	WOS:000252128100010
J	Srividhya, KV; Alaguraj, V; Poornima, G; Kumar, D; Singh, GP; Raghavenderan, L; Katta, AVSKM; Mehta, P; Krishnaswamy, S				Srividhya, K. V.; Alaguraj, V.; Poornima, G.; Kumar, Dinesh; Singh, G. P.; Raghavenderan, L.; Katta, A. V. S. K. Mohan; Mehta, Preeti; Krishnaswamy, S.			Identification of Prophages in Bacterial Genomes by Dinucleotide Relative Abundance Difference	PLOS ONE			English	Article								Background. Prophages are integrated viral forms in bacterial genomes that have been found to contribute to interstrain genetic variability. Many virulence-associated genes are reported to be prophage encoded. Present computational methods to detect prophages are either by identifying possible essential proteins such as integrases or by an extension of this technique, which involves identifying a region containing proteins similar to those occurring in prophages. These methods suffer due to the problem of low sequence similarity at the protein level, which suggests that a nucleotide based approach could be useful. Methodology. Earlier dinucleotide relative abundance (DRA) have been used to identify regions, which deviate from the neighborhood areas, in genomes. We have used the difference in the dinucleotide relative abundance (DRAD) between the bacterial and prophage DNA to aid location of DNA stretches that could be of prophage origin in bacterial genomes. Prophage sequences which deviate from bacterial regions in their dinucleotide frequencies are detected by scanning bacterial genome sequences. The method was validated using a subset of genomes with prophage data from literature reports. A web interface for prophage scan based on this method is available at http://bicmku.in:8082/prophagedb/dra.html. Two hundred bacterial genomes which do not have annotated prophages have been scanned for prophage regions using this method. Conclusions. The relative dinucleotide distribution difference helps detect prophage regions in genome sequences. The usefulness of this method is seen in the identification of 461 highly probable loci pertaining to prophages which have not been annotated so earlier. This work emphasizes the need to extend the efforts to detect and annotate prophage elements in genome sequences.	[Srividhya, K. V.; Alaguraj, V.; Poornima, G.; Kumar, Dinesh; Singh, G. P.; Raghavenderan, L.; Katta, A. V. S. K. Mohan; Mehta, Preeti; Krishnaswamy, S.] Madurai Kamaraj Univ, Sch Biotechnol, Ctr Excellence Bioinformat, Madurai 625021, Tamil Nadu, India	Madurai Kamaraj University	Krishnaswamy, S (corresponding author), Madurai Kamaraj Univ, Sch Biotechnol, Ctr Excellence Bioinformat, Madurai 625021, Tamil Nadu, India.	krishna@mrna.tn.nic.in	Veluchamy, Alaguraj/AAW-1680-2020; Kalra, D/H-6661-2019; Singh, Gajinder/I-6062-2015	Veluchamy, Alaguraj/0000-0002-5349-5794; Kalra, D/0000-0001-5254-4067; Singh, Gajinder/0000-0002-3972-3324; Krishnaswamy, Sankaran/0000-0002-6797-4614	Dept of Biotechnology, Govt of India under CoE; CSIR	Dept of Biotechnology, Govt of India under CoE; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Bioinformatics facilities provided by Dept of Biotechnology, Govt of India under CoE. CSIR for fellowship to PM, KVS, AVSKKM, UGC for fellowship to VA. The funding organisation had no role in the design and conduct of the study; collection, analysis, interpretation of data; and in the preparation, review or approval of the manuscript.	Arber W, 2000, FEMS MICROBIOL REV, V24, P1, DOI 10.1111/j.1574-6976.2000.tb00529.x; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Blaisdell BE, 1996, P NATL ACAD SCI USA, V93, P5854, DOI 10.1073/pnas.93.12.5854; Bose M., 2006, In Silico Biology, V6, P223; Boyd EF, 2001, TRENDS MICROBIOL, V9, P137, DOI 10.1016/S0966-842X(01)01960-6; Boyd EF, 2000, INFECT IMMUN, V68, P1507, DOI 10.1128/IAI.68.3.1507-1513.2000; Boyd EF, 2000, J BACTERIOL, V182, P5530, DOI 10.1128/JB.182.19.5530-5538.2000; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; CAMPBELL A, 2001, LYSOGENY ENCY LIFE S, P1; Canchaya C, 2004, MOL MICROBIOL, V53, P9, DOI 10.1111/j.1365-2958.2004.04113.x; Canchaya C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; CHITRA D, 2002, J BIOSCIENCE, V27, P27; Chiu CH, 2005, NUCLEIC ACIDS RES, V33, P1690, DOI 10.1093/nar/gki297; Covacci A, 1997, TRENDS MICROBIOL, V5, P205, DOI 10.1016/S0966-842X(97)01035-4; Fouts DE, 2006, NUCLEIC ACIDS RES, V34, P5839, DOI 10.1093/nar/gkl732; Garcia-Vallve S, 2003, NUCLEIC ACIDS RES, V31, P187, DOI 10.1093/nar/gkg004; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; KARLIN S, 1994, P NATL ACAD SCI USA, V91, P12837, DOI 10.1073/pnas.91.26.12837; KARLIN S, 1995, TRENDS GENET, V11, P283; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; KOEN AL, 1999, MICROBIOLOGY, V145, P3177; Lan RT, 1996, MOL BIOL EVOL, V13, P47, DOI 10.1093/oxfordjournals.molbev.a025569; Lerat E, 2002, MOL BIOL EVOL, V19, P964, DOI 10.1093/oxfordjournals.molbev.a004154; Li MR, 2003, APPL ENVIRON MICROB, V69, P1728, DOI 10.1128/AEM.69.3.1728-1738.2003; Makarov Vladimir, 2002, Brief Bioinform, V3, P195, DOI 10.1093/bib/3.2.195; Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; Ohnishi M, 2001, TRENDS MICROBIOL, V9, P481, DOI 10.1016/S0966-842X(01)02173-4; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; RAO GV, 2005, GENOME BIOL, V6, P11; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Smith J, 2001, P ROY SOC B-BIOL SCI, V268, P61, DOI 10.1098/rspb.2000.1330; Sozhamannan S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-34; Srividhya KV, 2006, LECT NOTES CONTR INF, V344, P863; Tinsley CR, 2006, MICROBES INFECT, V8, P1365, DOI 10.1016/j.micinf.2005.12.013; Wagner PL, 2002, INFECT IMMUN, V70, P3985, DOI 10.1128/IAI.70.8.3985-3993.2002; Wilson JW, 2002, POSTGRAD MED J, V78, P216, DOI 10.1136/pmj.78.918.216; Yoon SH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-184	47	38	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1193	10.1371/journal.pone.0001193	http://dx.doi.org/10.1371/journal.pone.0001193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030328	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459200007
J	Ayyar, S; Pistillo, D; Calleja, M; Brookfield, A; Gittins, K; Goldstone, C; Simpson, P				Ayyar, Savita; Pistillo, Daniela; Calleja, Manuel; Brookfield, Anna; Gittins, Kelly; Goldstone, Claire; Simpson, Pat			NF-kappa B/Rel-Mediated Regulation of the Neural Fate in Drosophila	PLOS ONE			English	Article								Two distinct roles are described for Dorsal, Dif and Relish, the three NF-kappa B/Rel proteins of Drosophila, in the development of the peripheral nervous system. First, these factors regulate transcription of scute during the singling out of sensory organ precursors from clusters of cells expressing the proneural genes achaete and scute. This effect is possibly mediated through binding sites for NF-kappa B/Rel proteins in a regulatory module of the scute gene required for maintenance of scute expression in precursors as well as repression in cells surrounding precursors. Second, genetic evidence suggests that the receptor Toll-8, Relish, Dif and Dorsal, and the caspase Dredd pathway are active over the entire imaginal disc epithelium, but Toll-8 expression is excluded from sensory organ precursors. Relish promotes rapid turnover of transcripts of the target genes scute and asense through an indirect, post-transcriptional mechanism. We propose that this buffering of gene expression levels serves to keep the neuro-epithelium constantly poised for neurogenesis.	[Ayyar, Savita; Pistillo, Daniela; Calleja, Manuel; Brookfield, Anna; Gittins, Kelly; Goldstone, Claire; Simpson, Pat] Univ Cambridge, Dept Zool, Cambridge, England; [Calleja, Manuel] Univ Autonoma Madrid, Ctr Biol Mol, E-28049 Madrid, Spain	University of Cambridge; Autonomous University of Madrid	Simpson, P (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	pas49@cam.ac.uk	Pistillo, Daniela/AAC-2367-2020	Pistillo, Daniela/0000-0002-7665-3783; Ayyar, Savita/0000-0002-6323-7211	The Wellcome Trust [29156]	The Wellcome Trust(Wellcome TrustEuropean Commission)	The Wellcome Trust [29156]	Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; BRAND M, 1993, DEVELOPMENT, V119, P1; Calleja M, 2002, GENE, V292, P1, DOI 10.1016/S0378-1119(02)00628-5; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; CAMPUZANO S, 1986, CELL, V44, P303, DOI 10.1016/0092-8674(86)90764-6; Cantera R, 1999, J NEUROBIOL, V38, P16, DOI 10.1002/(SICI)1097-4695(199901)38:1<16::AID-NEU2>3.0.CO;2-0; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; Culi J, 1998, GENE DEV, V12, P2036, DOI 10.1101/gad.12.13.2036; DELIDAKIS C, 1991, GENETICS, V129, P803; DOMINGUEZ M, 1993, EMBO J, V12, P2049, DOI 10.1002/j.1460-2075.1993.tb05854.x; Dubnicoff T, 1997, GENE DEV, V11, P2952, DOI 10.1101/gad.11.22.2952; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; GONZALEZ F, 1989, EMBO J, V8, P3553, DOI 10.1002/j.1460-2075.1989.tb08527.x; GONZALEZCRESPO S, 1993, GENE DEV, V7, P1703, DOI 10.1101/gad.7.9.1703; Han ZS, 1999, J BIOL CHEM, V274, P21355, DOI 10.1074/jbc.274.30.21355; Heitzler P, 1996, DEVELOPMENT, V122, P161; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Jafar-Nejad H, 2003, GENE DEV, V17, P2966, DOI 10.1101/gad.1122403; JARMAN AP, 1993, DEVELOPMENT, V119, P19; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Jimenez G, 1997, MOL CELL BIOL, V17, P4355, DOI 10.1128/MCB.17.8.4355; Kambris Zakaria, 2002, Gene Expression Patterns, V2, P311, DOI 10.1016/S1567-133X(02)00020-0; Kim S, 2006, GENESIS, V44, P541, DOI 10.1002/dvg.20245; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Lai EC, 2003, GENETICS, V163, P1413; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Loercher A, 2004, CANCER RES, V64, P6511, DOI 10.1158/0008-5472.CAN-04-0852; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Ratnaparkhi GS, 2006, DEVELOPMENT, V133, P4409, DOI 10.1242/dev.02643; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; Seppo A, 2003, DEVELOPMENT, V130, P1439, DOI 10.1242/dev.00347; Sitcheran R, 2003, GENE DEV, V17, P2368, DOI 10.1101/gad.1114503; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; Stein D, 1998, DEVELOPMENT, V125, P2159; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Valentine SA, 1998, MOL CELL BIOL, V18, P6584, DOI 10.1128/MCB.18.11.6584; Wu LP, 1998, NATURE, V392, P93, DOI 10.1038/32195	42	24	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1178	10.1371/journal.pone.0001178	http://dx.doi.org/10.1371/journal.pone.0001178			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000549	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459100020
J	Loffredo, JT; Friedrich, TC; Leon, EJ; Stephany, JJ; Rodrigues, DS; Spencer, SP; Bean, AT; Beal, DR; Burwitz, BJ; Rudersdorf, RA; Wallace, LT; Piaskowski, SM; May, GE; Sidney, J; Gostick, E; Wilson, NA; Price, DA; Kallas, EG; Piontkivska, H; Hughes, AL; Sette, A; Watkins, DI				Loffredo, John T.; Friedrich, Thomas C.; Leon, Enrique J.; Stephany, Jason J.; Rodrigues, Denise S.; Spencer, Sean P.; Bean, Alex T.; Beal, Dominic R.; Burwitz, Benjamin J.; Rudersdorf, Richard A.; Wallace, Lyle T.; Piaskowski, Shari M.; May, Gemma E.; Sidney, John; Gostick, Emma; Wilson, Nancy A.; Price, David A.; Kallas, Esper G.; Piontkivska, Helen; Hughes, Austin L.; Sette, Alessandro; Watkins, David I.			CD8(+) T Cells from SIV Elite Controller Macaques Recognize Mamu-B*08-Bound Epitopes and Select for Widespread Viral Variation	PLOS ONE			English	Article								Background. It is generally accepted that CD8(+) T cell responses play an important role in control of immunodeficiency virus replication. The association of HLA-B27 and -B57 with control of viremia supports this conclusion. However, specific correlates of viral control in individuals expressing these alleles have been difficult to define. We recently reported that transient in vivo CD8(+) cell depletion in simian immunodeficiency virus (SIV)-infected elite controller (EC) macaques resulted in a brief period of viral recrudescence. SIV replication was rapidly controlled with the reappearance of CD8(+) cells, implicating that these cells actively suppress viral replication in ECs. Methods and Findings. Here we show that three ECs in that study made at least seven robust CD8(+) T cell responses directed against novel epitopes in Vif, Rev, and Nef restricted by the MHC class I molecule Mamu-B*08. Two of these Mamu-B*08-positive animals subsequently lost control of SIV replication. Their breakthrough virus harbored substitutions in multiple Mamu-B*08-restricted epitopes. Indeed, we found evidence for selection pressure mediated by Mamu-B*08-restricted CD8(+) T cells in all of the newly identified epitopes in a cohort of chronically infected macaques. Conclusions. Together, our data suggest that Mamu-B*08-restricted CD8(+) T cell responses effectively control replication of pathogenic SIV(mac)239. All seven regions encoding Mamu-B*08-restricted CD8(+) T cell epitopes also exhibit amino acid replacements typically seen only in the presence of Mamu-B*08, suggesting that the variation we observe is indeed selected by CD8(+) T cell responses. SIVmac239 infection of Indian rhesus macaques expressing Mamu-B*08 may therefore provide an animal model for understanding CD8(+) T cell-mediated control of HIV replication in humans.	[Loffredo, John T.; Friedrich, Thomas C.; Leon, Enrique J.; Stephany, Jason J.; Rodrigues, Denise S.; Spencer, Sean P.; Bean, Alex T.; Beal, Dominic R.; Burwitz, Benjamin J.; Rudersdorf, Richard A.; Wallace, Lyle T.; May, Gemma E.; Wilson, Nancy A.; Watkins, David I.] Univ Wisconsin, WNPRC, Madison, WI 53706 USA; [Rodrigues, Denise S.; Kallas, Esper G.] Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil; [Piaskowski, Shari M.; Watkins, David I.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Sidney, John; Sette, Alessandro] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Gostick, Emma; Price, David A.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Piontkivska, Helen] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA; [Hughes, Austin L.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of Wisconsin System; University of Wisconsin Madison; Universidade Federal de Sao Paulo (UNIFESP); University of Wisconsin System; University of Wisconsin Madison; La Jolla Institute for Immunology; University of Oxford; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Loffredo, JT (corresponding author), Univ Wisconsin, WNPRC, Madison, WI 53706 USA.	loffredo@primate.wisc.edu	Sette, Alessandro/AFO-8916-2022; Kallas, Esper G/C-9539-2012; Price, David A/C-7876-2013	Price, David A/0000-0001-9416-2737; Friedrich, Thomas/0000-0001-9831-6895; Wallace, Lyle/0000-0002-6985-5854; Kallas, Esper/0000-0003-2026-6925; Spencer, Sean/0000-0002-7328-5399; Wilson, Nancy/0000-0002-9472-6026	National Institutes of Health (NIH) [HHSN266200400088C, R01 AI049120, R01 AI052056, R24 RR015371, R24 RR016038, R21 AI068586]; National Center for Research Resources (NCRR) [P51 RR000167]; Japan Health Sciences Foundation [GM43940]; Kent State University Research Council; Ohio Board of Regents Research Challenge; Research Facilities Improvement [RR15459-01, RR020141-01]; MRC [G0501963] Funding Source: UKRI; Medical Research Council [G0501963] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR015371, C06RR020141, R24RR016038, P51RR000167, C06RR015459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI068586, R01AI049120, R01AI052056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043940] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Japan Health Sciences Foundation; Kent State University Research Council; Ohio Board of Regents Research Challenge; Research Facilities Improvement(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (NIH) contract HHSN266200400088C, NIH grants R01 AI049120, R01 AI052056, R24 RR015371, and R24 RR016038 to D. I. W. as well as R21 AI068586 to T. C. F. Additionally, this publication was made possible in part by grant number P51 RR000167 from the National Center for Research Resources (NCRR), a component of the NIH, awarded to the WNPRC. This project has also been funded in part by a grant from the Japan Health Sciences Foundation to D. I. W., NIH grant GM43940 to A. L. H., and support to H. P. through the Kent State University Research Council and Ohio Board of Regents Research Challenge Grant. D. A. P. is a Medical Research Council (UK) Senior Clinical Fellow. This work was conducted in part at a facility constructed with support from Research Facilities Improvement grant numbers RR15459-01 and RR020141-01 (WNPRC). This publication's contents are solely the responsibility of the authors and do not necessarily represent the official views of NCRR or NIH.	Alexander L, 2000, J VIROL, V74, P4361, DOI 10.1128/JVI.74.9.4361-4376.2000; Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Allen TM, 2001, J VIROL, V75, P738, DOI 10.1128/JVI.75.2.738-749.2001; Barassi C, 2004, BLOOD, V104, P2205, DOI 10.1182/blood-2004-06-2134; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2005, P NATL ACAD SCI USA, V102, P4512, DOI 10.1073/pnas.0408773102; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Borroto R J, 1997, Rev Panam Salud Publica, V1, P3; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Boyson JE, 1996, J IMMUNOL, V156, P4656; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Cline AN, 2005, J MED PRIMATOL, V34, P303; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Dzuris JL, 2000, J IMMUNOL, V164, P283, DOI 10.4049/jimmunol.164.1.283; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; Evans DT, 2000, J VIROL, V74, P7400, DOI 10.1128/JVI.74.16.7400-7410.2000; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Friedrich TC, 2004, J VIROL, V78, P10064, DOI 10.1128/JVI.78.18.10064-10073.2004; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Harrer T, 1996, AIDS RES HUM RETROV, V12, P585, DOI 10.1089/aid.1996.12.585; Harrer T, 1996, J IMMUNOL, V156, P2616; Hendel H, 1999, J IMMUNOL, V162, P6942; Herberts CA, 2006, J IMMUNOL, V176, P2697, DOI 10.4049/jimmunol.176.5.2697; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Hughes AL, 2005, BIOINFORMATICS, V21, P39, DOI 10.1093/bioinformatics/bti1203; Hughes AL, 2006, CURR GENOMICS, V7, P227, DOI 10.2174/138920206778426942; Hutchinson SL, 2003, J BIOL CHEM, V278, P24285, DOI 10.1074/jbc.M300633200; Ioannidis JPA, 2001, ANN INTERN MED, V135, P782, DOI 10.7326/0003-4819-135-9-200111060-00008; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kaizu M, 2007, IMMUNOGENETICS, V59, P693, DOI 10.1007/s00251-007-0233-7; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Keet IPM, 1999, J INFECT DIS, V180, P299, DOI 10.1086/314862; KESTLER H, 1990, SCIENCE, V248, P1109, DOI 10.1126/science.2160735; KOENIG WJ, 1995, PLAST RECONSTR SURG, V95, P1; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuroda MJ, 1999, J IMMUNOL, V162, P5127; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Liu HL, 2004, J INFECT DIS, V190, P1055, DOI 10.1086/423209; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Loffredo JT, 2007, J VIROL, V81, P2624, DOI 10.1128/JVI.01912-06; Loffredo JT, 2005, J IMMUNOL, V175, P5986, DOI 10.4049/jimmunol.175.9.5986; Loffredo JT, 2004, J IMMUNOL, V173, P5064, DOI 10.4049/jimmunol.173.8.5064; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Mao HW, 2005, J VIROL, V79, P14887, DOI 10.1128/JVI.79.23.14887-14898.2005; Marsh SG, 2000, HLA FACTS BOOK; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2003, J VIROL, V77, P6889, DOI 10.1128/JVI.77.12.6889-6898.2003; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Mothe BR, 2002, J IMMUNOL, V169, P210, DOI 10.4049/jimmunol.169.1.210; Muhl T, 2002, J IMMUNOL, V169, P3438, DOI 10.4049/jimmunol.169.6.3438; NEI M, 1986, MOL BIOL EVOL, V3, P418; O'Connor DH, 2003, J VIROL, V77, P9029, DOI 10.1128/JVI.77.16.9029-9040.2003; O'Connor DH, 2002, NAT MED, V8, P493, DOI 10.1038/nm0502-493; O'Connor DH, 2004, J VIROL, V78, P14012, DOI 10.1128/JVI.78.24.14012-14022.2004; Pal R, 2002, J VIROL, V76, P292, DOI 10.1128/JVI.76.1.292-302.2002; Pastori C, 2006, BLOOD, V107, P4825, DOI 10.1182/blood-2005-06-2463; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; REIMANN KA, 1994, J VIROL, V68, P2362, DOI 10.1128/JVI.68.4.2362-2370.1994; Rhodes DI, 2000, J VIROL, V74, P10581, DOI 10.1128/JVI.74.22.10581-10588.2000; Robinson S, 2001, J VIROL, V75, P10179, DOI 10.1128/JVI.75.21.10179-10186.2001; Salvi R, 1998, J VIROL, V72, P3646, DOI 10.1128/JVI.72.5.3646-3657.1998; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; SHIMIZU Y, 1986, MOL CELL BIOL, V6, P1074, DOI 10.1128/MCB.6.4.1074; Soriano A, 2002, J INFECT DIS, V186, P922, DOI 10.1086/343741; Vogel TU, 2002, J VIROL, V76, P11623, DOI 10.1128/JVI.76.22.11623-11636.2002; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; Zhang ZQ, 2002, J VIROL, V76, P12845, DOI 10.1128/JVI.76.24.12845-12854.2002	82	69	69	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1152	10.1371/journal.pone.0001152	http://dx.doi.org/10.1371/journal.pone.0001152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000532	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000207459100001
J	Greif, PA; Tizazu, B; Krause, A; Kremmer, E; Bohlander, SK				Greif, P. A.; Tizazu, B.; Krause, A.; Kremmer, E.; Bohlander, S. K.			The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros	ONCOGENE			English	Article						AF10; CALM/AF10; Ikaros; leukemia; translocation	ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; DNA-BINDING PROTEINS; U937 CELL-LINE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; LEUCINE-ZIPPER; FINGER; ISOFORMS; AF10	The t(10; 11)(p13; q14) translocation leads to the fusion of the CALM and AF10 genes. This translocation can be found as the sole cytogenetic abnormality in acute lymphoblastic leukemia, acute myeloid leukemia and in malignant lymphomas. The expression of CALM/AF10 in primary murine bone marrow cells results in the development of an aggressive leukemia in a murine bone marrow transplantation model. Using a yeast two-hybrid screen, we identified the lymphoid regulator Ikaros as an AF10 interacting protein. Interestingly, Ikaros is required for normal development of lymphocytes, and aberrant expression of Ikaros has been found in leukemia. In a murine model, the expression of a dominant negative isoform of Ikaros causes leukemias and lymphomas. The Ikaros interaction domain of AF10 was mapped to the leucine zipper domain of AF10, which is required for malignant transformation both by the CALM/AF10 and the MLL/AF10 fusion proteins. The interaction between AF10 and Ikaros was confirmed by GST pull down and co-immunoprecipitation. Coexpression of CALM/AF10 but not of AF10 alters the subcellular localization of Ikaros in murine fibroblasts. The transcriptional repressor activity of Ikaros is reduced by AF10. These results suggest that CALM/AF10 might interfere with normal Ikaros function, and thereby block lymphoid differentiation in CALM/AF10 positive leukemias.	[Bohlander, S. K.] Univ Munich, Dept Med 3, Klinikum Grosshadern, Med Klin 3, D-81377 Munich, Germany; [Kremmer, E.] GSF Forschungszentrum Umwelt & Gesundheit, Inst Mol Immunol, Munich, Germany; [Greif, P. A.; Tizazu, B.; Krause, A.; Bohlander, S. K.] Univ Munich, GSF, Clin Cooperat Grp Leukemia, D-81377 Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Bohlander, SK (corresponding author), Univ Munich, Dept Med 3, Klinikum Grosshadern, Med Klin 3, Marchioninstr 25, D-81377 Munich, Germany.	sbohlan@gwdg.de	Krause, Alexandre/K-7221-2013	Greif, Philipp/0000-0002-3744-7936; Bohlander, Stefan/0000-0002-2202-9088				ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Archangelo LF, 2006, ONCOGENE, V25, P4099, DOI 10.1038/sj.onc.1209438; Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Bohlander SK, 2000, LEUKEMIA, V14, P93, DOI 10.1038/sj.leu.2401614; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Caudell D, 2007, CANCER RES, V67, P8022, DOI 10.1158/0008-5472.CAN-06-3749; CHAPLIN T, 1995, BLOOD, V85, P1435, DOI 10.1182/blood.V85.6.1435.bloodjournal8561435; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Debernardi S, 2002, BLOOD, V99, P275, DOI 10.1182/blood.V99.1.275; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; DiMartino JF, 2002, BLOOD, V99, P3780, DOI 10.1182/blood.V99.10.3780; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; HAHM KM, 1994, MOL CELL BIOL, V14, P7111, DOI 10.1128/MCB.14.11.7111; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; KOBAYASHI H, 1995, GENE CHROMOSOME CANC, V13, P217, DOI 10.1002/gcc.2870130312; Koipally J, 2002, J BIOL CHEM, V277, P13007, DOI 10.1074/jbc.M111371200; Linder B, 2000, J MOL BIOL, V299, P369, DOI 10.1006/jmbi.2000.3766; Linder B, 2001, EMBO REP, V2, P211, DOI 10.1093/embo-reports/kve039; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Nietfeld W, 1996, IMMUNOL LETT, V49, P139, DOI 10.1016/0165-2478(95)02479-4; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Okada Y, 2006, NAT CELL BIOL, V8, P1017, DOI 10.1038/ncb1464; Olivero S, 2000, BRIT J HAEMATOL, V110, P826, DOI 10.1046/j.1365-2141.2000.02297.x; Payne KJ, 2003, J IMMUNOL, V170, P3091, DOI 10.4049/jimmunol.170.6.3091; Payne KJ, 2001, J IMMUNOL, V167, P1867, DOI 10.4049/jimmunol.167.4.1867; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Rebollo A, 2003, IMMUNOL CELL BIOL, V81, P171, DOI 10.1046/j.1440-1711.2003.01159.x; Ronni T, 2007, J BIOL CHEM, V282, P2538, DOI 10.1074/jbc.M605627200; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; ROWLEY JD, 1990, SEMIN HEMATOL, V27, P122; Schoch C, 2002, P NATL ACAD SCI USA, V99, P10008, DOI 10.1073/pnas.142103599; Sun L, 1999, CLIN CANCER RES, V5, P2112; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Sun L, 1999, P NATL ACAD SCI USA, V96, P680, DOI 10.1073/pnas.96.2.680; Sun L, 1999, J CLIN ONCOL, V17, P3753, DOI 10.1200/JCO.1999.17.12.3753; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Trinh LA, 2001, GENE DEV, V15, P1817, DOI 10.1101/gad.905601; Westman BJ, 2002, INT J BIOCHEM CELL B, V34, P1304, DOI 10.1016/S1357-2725(02)00070-5; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314	47	24	24	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 1	2008	27	20					2886	2896		10.1038/sj.onc.1210945	http://dx.doi.org/10.1038/sj.onc.1210945			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	295VR	18037964				2022-12-25	WOS:000255502500010
J	Wierod, L; Rosseland, CM; Lindeman, B; Oksvold, MP; Grosvik, H; Skarpen, E; Huitfeldt, HS				Wierod, L.; Rosseland, C. M.; Lindeman, B.; Oksvold, M. P.; Grosvik, H.; Skarpen, E.; Huitfeldt, H. S.			Activation of the p53-p21(Cip1) pathway is required for CDK2 activation and S-phase entry in primary rat hepatocytes	ONCOGENE			English	Article						cyclin; nuclear translocation; PI3 kinase; DNA synthesis; primary liver cells	CYCLIN-DEPENDENT KINASE; WILD-TYPE P53; RETINOBLASTOMA PROTEIN; NUCLEAR ACCUMULATION; LIVER-REGENERATION; RESTRICTION POINT; DNA-DAMAGE; GROWTH; TUMOR; PHOSPHORYLATION	p53 plays a major role in the prevention of tumor development. It responds to a range of potentially oncogenic stresses by activating protective mechanisms, most notably cell-cycle arrest and apoptosis. The p53 gene is also induced during normal liver regeneration, and it has been hypothesized that p53 serve as a proliferative 'brake' to control excessive proliferation. However, it has lately been shown that p53 inhibition reduces hepatocyte growth factor-induced DNA synthesis of primary hepatocytes. Here we show that epidermal growth factor (EGF) activated p53 in a phosphatidylinositol-3 kinase-dependent way, and thus induced the cyclin-dependent kinase inhibitor p21(Cip1) in primary rat hepatocytes. p53 inactivation with a dominant-negative mutant (p53(V143A)) attenuated EGF-induced DNA synthesis and was associated with reduced CDK2 phosphorylation and retinoblastoma protein hyperphosphorylation. When p21(Cip1) was ectopically expressed in p53-inactivated cells, these effects were neutralized. In conclusion, our results demonstrate that in normal hepatocytes, EGF-induced expression of p53 is involved in regulating CDK2- and CDK4 activity, through p21(Cip1) expression.	[Wierod, L.; Rosseland, C. M.; Oksvold, M. P.; Grosvik, H.; Skarpen, E.; Huitfeldt, H. S.] Univ Oslo, Lab Toxicol Inst Pathol, Rikshosp Radiumhosp Med Ctr, Rikshosp Univ Hosp, N-0027 Oslo, Norway; [Wierod, L.; Rosseland, C. M.; Oksvold, M. P.; Grosvik, H.; Skarpen, E.; Huitfeldt, H. S.] Univ Oslo, Ctr Cellulare Stress Responses, Oslo, Norway; [Lindeman, B.] Norwegian Inst Publ Hlth, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; Norwegian Institute of Public Health (NIPH)	Wierod, L (corresponding author), Univ Oslo, Lab Toxicol Inst Pathol, Rikshosp Radiumhosp Med Ctr, Rikshosp Univ Hosp, N-0027 Oslo, Norway.	lene.wierod@medisin.uio.no						Alt JR, 2002, J BIOL CHEM, V277, P8517, DOI 10.1074/jbc.M108867200; Arora V, 2000, DRUG METAB DISPOS, V28, P131; Bar J, 2005, CELL DEATH DIFFER, V12, P1578, DOI 10.1038/sj.cdd.4401677; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Coutant A, 2002, HEPATOLOGY, V36, P1079, DOI 10.1053/jhep.2002.36160; da Costa CA, 2002, P NATL ACAD SCI USA, V99, P4043, DOI 10.1073/pnas.062059899; Diehl JA, 1997, MOL CELL BIOL, V17, P7362, DOI 10.1128/MCB.17.12.7362; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fang WA, 2001, ACTA CRYSTALLOGR D, V57, P1162, DOI 10.1107/S090744490100926X; Fausto N, 1986, Symp Fundam Cancer Res, V39, P69; Friedlander P, 1996, J BIOL CHEM, V271, P25468, DOI 10.1074/jbc.271.41.25468; Fujiwara Y, 2006, BIOCHEM BIOPH RES CO, V340, P560, DOI 10.1016/j.bbrc.2005.12.039; Gallant P, 1995, J CELL SCI, P21; Geisen C, 2002, J BIOL CHEM, V277, P39909, DOI 10.1074/jbc.M205919200; Ghosh AK, 2004, J BIOL CHEM, V279, P47455, DOI 10.1074/jbc.M403477200; HARPER JW, 1993, CELL, V75, P805; Hirota Y, 1996, JPN J CANCER RES, V87, P735, DOI 10.1111/j.1349-7006.1996.tb00286.x; Hofseth LJ, 2004, TRENDS PHARMACOL SCI, V25, P177, DOI 10.1016/j.tips.2004.02.009; Ilyin GP, 2003, AM J PHYSIOL-GASTR L, V285, pG115, DOI 10.1152/ajpgi.00309.2002; Inoue Y, 2002, HEPATOLOGY, V36, P336, DOI 10.1053/jhep.2002.34942; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kelly BL, 1998, P NATL ACAD SCI USA, V95, P2535, DOI 10.1073/pnas.95.5.2535; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Latonen L, 2003, CELL SIGNAL, V15, P95, DOI 10.1016/S0898-6568(02)00044-X; LIN D, 1992, P NATL ACAD SCI USA, V89, P9210, DOI 10.1073/pnas.89.19.9210; Loyer P, 1996, J BIOL CHEM, V271, P11484, DOI 10.1074/jbc.271.19.11484; LudesMeyers JH, 1996, MOL CELL BIOL, V16, P6009; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; MATSUOKA M, 1994, MOL CELL BIOL, V14, P7265, DOI 10.1128/MCB.14.11.7265; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Mayo LD, 1997, CANCER RES, V57, P5013; Metcalfe AMJ, 1997, NUCLEIC ACIDS RES, V25, P983, DOI 10.1093/nar/25.5.983; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Monti P, 2002, ONCOGENE, V21, P1641, DOI 10.1038/sj.onc.1205250; Naderi S, 2005, MOL BIOL CELL, V16, P1527, DOI 10.1091/mbc.E04-06-0501; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Rosseland CM, 2005, HEPATOLOGY, V42, P200, DOI 10.1002/hep.20762; Saito A, 2005, J CEREBR BLOOD F MET, V25, P267, DOI 10.1038/sj.jcbfm.9600028; Sheikh MS, 1997, ONCOGENE, V15, P1095, DOI 10.1038/sj.onc.1201264; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; SHIN TH, 1995, MOL CELL BIOL, V15, P4694; Skarpen E, 2000, MOL CARCINOGEN, V28, P84, DOI 10.1002/1098-2744(200006)28:2<84::AID-MC4>3.0.CO;2-X; Tang H, 1998, J BIOL CHEM, V273, P29156, DOI 10.1074/jbc.273.44.29156; TASSAN JP, 1994, J CELL BIOL, V127, P467, DOI 10.1083/jcb.127.2.467; THOMPSON NL, 1986, CANCER RES, V46, P3111; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wong KB, 1999, P NATL ACAD SCI USA, V96, P8438, DOI 10.1073/pnas.96.15.8438; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	53	17	19	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 24	2008	27	19					2763	2771		10.1038/sj.onc.1210937	http://dx.doi.org/10.1038/sj.onc.1210937			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	292IK	18026139	Bronze			2022-12-25	WOS:000255259500011
J	Tosha, T; Kagawa, N; Arase, M; Waterman, MR; Kitagawa, T				Tosha, Takehiko; Kagawa, Norio; Arase, Miharu; Waterman, Michael R.; Kitagawa, Teizo			Interaction between substrate and oxygen ligand responsible for effective O-O bond cleavage in bovine cytochrome P450 steroid 21-hydroxylase proved by Raman spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; CONGENITAL ADRENAL-HYPERPLASIA; FERROUS DIOXYGEN COMPLEX; FE-S BOND; RESONANCE RAMAN; ESCHERICHIA-COLI; PSEUDOMONAS-PUTIDA; OXYCYTOCHROME P450CAM; STRUCTURAL-CHANGES; BACILLUS-SUBTILIS	We investigated structural and functional properties of bovine cytochrome P450 steroid 21-hydroxylase (P450c21), which catalyzes hydroxylation at C-21 of progesterone and 17 alpha-hydroxyprogesterone. The uncoupled H2O2 formation was higher in the hydroxylation of progesterone (26% of NADPH consumed) than that of 17 alpha-hydroxyprogesterone (15% of NADPH consumed), indicating that 17 alpha-hydroxyprogesterone can better facilitate the O-O bond scission. In relation to this, it is noted that the O-O stretching mode (nu(O-O)) of the oxygen complex of P450c21 was sensitive to the substrate; the progesterone- or 17 alpha-hydroxyprogesterone-bound enzyme gave single (at 1137 cm(-1)) or split nu(O-O) bands (at 1124 and 1138 cm(-1)), respectively, demonstrating the presence of two forms for the latter. In contrast to nu(O-O), no corresponding difference was observed for the Fe-O-2 stretching mode between two different substrate-bound forms. The Fe-S(Cys) stretching mode in the ferric state was also identical (349 cm(-1)) for each substrate-bound form, suggesting that modulation through the axial thiolate by the substrate is unlikely. Therefore, it is deduced that the hydroxyl group at C-17 of 17 alpha-hydroxyprogesterone forms a hydrogen bond with the terminal oxygen atom of the FeOO complex in one form, yielding a lower nu(O-O) frequency with higher reactivity for O-O cleavage, whereas the other form in which the substrate does not provide a hydrogen bond to the oxygen ligand is essentially the same between the two kinds of substrates. In the hydrogen-bonded species, the substrate changes the geometry of the FeOO moiety, thereby performing the hydroxylation reaction more effectively in 17 alpha-hydroxyprogesterone than in progesterone.	[Tosha, Takehiko; Kitagawa, Teizo] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Kagawa, Norio; Arase, Miharu; Waterman, Michael R.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Kitagawa, Teizo] Toyota Phys & Chem Res Inst, Nagakute, Aichi 4801192, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Vanderbilt University	Kitagawa, T (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan.	Riken-kitagawa@mosk.tytlabs.co.jp	Tosha, Takehiko/AAR-2404-2020	Tosha, Takehiko/0000-0002-8971-0759	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037942, R01GM037942] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES00267] Funding Source: Medline; NIGMS NIH HHS [GM37942] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE M, 1978, J CHEM PHYS, V69, P4526, DOI 10.1063/1.436450; Arase M, 2006, BIOCHEM BIOPH RES CO, V344, P400, DOI 10.1016/j.bbrc.2006.03.067; BANGCHAROENPAURPONG O, 1986, J BIOL CHEM, V261, P8089; BANGCHAROENPAURPONG O, 1986, BIOCHEMISTRY-US, V25, P2374, DOI 10.1021/bi00357a011; Bec N, 1998, J BIOL CHEM, V273, P13502, DOI 10.1074/jbc.273.22.13502; CHAMPION PM, 1978, J AM CHEM SOC, V100, P3743, DOI 10.1021/ja00480a015; CHAMPION PM, 1982, J AM CHEM SOC, V104, P5469, DOI 10.1021/ja00384a037; Chartier FJM, 2006, J BIOL CHEM, V281, P9953, DOI 10.1074/jbc.M513893200; Chartier FJM, 2007, J BIOL CHEM, V282, P20877, DOI 10.1074/jbc.M701800200; Chen ZC, 2003, BIOCHEMISTRY-US, V42, P2542, DOI 10.1021/bi027206s; Chen ZC, 2004, BIOCHEMISTRY-US, V43, P1798, DOI 10.1021/bi034920g; Couture M, 2000, J BIOL CHEM, V275, P3201, DOI 10.1074/jbc.275.5.3201; Das TK, 2001, P NATL ACAD SCI USA, V98, P479, DOI 10.1073/pnas.98.2.479; de Montellano O., 2005, CYTOCHROME P450 STRU; ESTABROOK RW, 1963, BIOCHEM Z, V338, P741; HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841; HIGUCHI A, 1991, BIOCHIM BIOPHYS ACTA, V1084, P240, DOI 10.1016/0005-2760(91)90064-O; HILDEBRAND DP, 1995, BIOCHEMISTRY-US, V34, P1997, DOI 10.1021/bi00006a021; HU SZ, 1993, J AM CHEM SOC, V115, P12446, DOI 10.1021/ja00079a028; HU SZ, 1991, J AM CHEM SOC, V113, P4815, DOI 10.1021/ja00013a016; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; IMAI M, 1989, P NATL ACAD SCI USA, V86, P7823, DOI 10.1073/pnas.86.20.7823; Jameson GNL, 2002, BIOCHEMISTRY-US, V41, P13435, DOI 10.1021/bi026478s; KADKHODAYAN S, 1995, J BIOL CHEM, V270, P28042; Kagawa N, 2004, STEROIDS, V69, P235, DOI 10.1016/j.steroids.2004.01.002; KAGAWA N, 1990, J BIOL CHEM, V265, P11299; Kagawa N, 2003, STEROIDS, V68, P205, DOI 10.1016/S0039-128X(02)00168-X; KAGAWA N, 1991, J BIOL CHEM, V266, P11199; KOMINAMI S, 1980, J BIOL CHEM, V255, P3386; Kominami S, 2001, J BIOL CHEM, V276, P10753, DOI 10.1074/jbc.M006043200; Ledbetter AP, 1999, BIOCHEMISTRY-US, V38, P8014, DOI 10.1021/bi990619h; Li D, 2007, J AM CHEM SOC, V129, P6943, DOI 10.1021/ja070683j; Lu CY, 2007, J BIOL CHEM, V282, P13627, DOI 10.1074/jbc.M609397200; Macdonald IDG, 1999, J AM CHEM SOC, V121, P376, DOI 10.1021/ja9810383; Modi S, 1996, NAT STRUCT BIOL, V3, P414, DOI 10.1038/nsb0596-414; Nagano S, 2003, BIOCHEMISTRY-US, V42, P14507, DOI 10.1021/bi035410p; Nagano S, 2005, J BIOL CHEM, V280, P22102, DOI 10.1074/jbc.M501732200; Nagano S, 2005, J BIOL CHEM, V280, P31659, DOI 10.1074/jbc.M505261200; Neri F, 1999, BIOCHEMISTRY-US, V38, P7819, DOI 10.1021/bi982811+; Nickerson DP, 1997, FEBS LETT, V405, P153, DOI 10.1016/S0014-5793(97)00174-9; Ohta T, 2004, J AM CHEM SOC, V126, P15000, DOI 10.1021/ja046896f; OZAKI Y, 1978, BIOCHEMISTRY-US, V17, P5826, DOI 10.1021/bi00619a033; Peterson ES, 1998, BIOCHEMISTRY-US, V37, P12301, DOI 10.1021/bi980752u; PETERSON JA, 1972, ARCH BIOCHEM BIOPHYS, V149, P197, DOI 10.1016/0003-9861(72)90315-3; Rousseau DL, 2005, J INORG BIOCHEM, V99, P306, DOI 10.1016/j.jinorgbio.2004.11.007; Santolini M, 2006, BIOCHEMISTRY-US, V45, P1480, DOI 10.1021/bi051710q; Schelvis JPM, 2002, BIOCHEMISTRY-US, V41, P5695, DOI 10.1021/bi0118456; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Sjodin T, 2001, BIOCHEMISTRY-US, V40, P6852, DOI 10.1021/bi002510b; SLIGAR SG, 1976, P NATL ACAD SCI USA, V73, P1078, DOI 10.1073/pnas.73.4.1078; Smulevich G, 2005, ACCOUNTS CHEM RES, V38, P433, DOI 10.1021/ar020112q; Spiro TG, 1988, BIOL APPL RAMAN SPEC, V3, P1; Tosha T, 2006, BIOCHEMISTRY-US, V45, P5631, DOI 10.1021/bi060094a; Tosha T, 2004, J BIOL CHEM, V279, P42836, DOI 10.1074/jbc.M404216200; Uchida T, 2005, ACCOUNTS CHEM RES, V38, P662, DOI 10.1021/ar030267d; Vogel KM, 1999, J AM CHEM SOC, V121, P9915, DOI 10.1021/ja990042r; Wei CC, 2003, J BIOL CHEM, V278, P46668, DOI 10.1074/jbc.M307682200; WELLS AV, 1992, BIOCHEMISTRY-US, V31, P4384, DOI 10.1021/bi00133a002; WHITE PC, 1984, P NATL ACAD SCI-BIOL, V81, P7505, DOI 10.1073/pnas.81.23.7505; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245; Yeh SR, 2000, J BIOL CHEM, V275, P1679, DOI 10.1074/jbc.275.3.1679; Yoshimura H, 2006, BIOCHEMISTRY-US, V45, P8301, DOI 10.1021/bi060315c; Yoshioka S, 2002, J AM CHEM SOC, V124, P14571, DOI 10.1021/ja0265409; Yoshioka S, 2000, J INORG BIOCHEM, V81, P141, DOI 10.1016/S0162-0134(00)00097-0	64	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3708	3717		10.1074/jbc.M707338200	http://dx.doi.org/10.1074/jbc.M707338200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18032381	hybrid			2022-12-25	WOS:000253083500004
J	Minamizaki, K; Mizoguchi, T; Goto, T; Tamiaki, H; Fujita, Y				Minamizaki, Kei; Mizoguchi, Tadashi; Goto, Takeaki; Tamiaki, Hitoshi; Fujita, Yuichi			Identification of two homologous genes, chlAI and chlA(II), that are differentially involved in isocyclic ring formation of chlorophyll a in the cyanobacterium Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOBACTER-CAPSULATUS; CHLAMYDOMONAS-REINHARDTII; PHOTOSYSTEM-I; BACTERIOCHLOROPHYLL BIOSYNTHESIS; PROTOCHLOROPHYLLIDE REDUCTASE; OXYGEN; ENZYME; PHOTOSYNTHESIS; CLUSTER; EVOLUTION	The isocyclic ring (E-ring) is a common structural feature of chlorophylls. The E-ring is formed by two structurally unrelated Mg-protoporphyrin IX monomethylester (MPE) cyclase systems, oxygen-dependent (AcsF), and oxygen-independent (BchE) systems, which involve incorporation of an oxygen atom from molecular oxygen and water into the C-131 position of MPE, respectively. Which system operates in cyanobacteria that can thrive in a variety of anaerobic environments remains an open question. The cyanobacterium Synechocystis sp.PCC 6803 has two acsF-like genes, sll1214 (chlA(I)) and sll1874 (chlA(II)), and three bchE-like genes, slr0905, sll1242, and slr0309. Five mutants lacking one of these genes were isolated. The Delta chlA(I) mutant failed to grow under aerobic conditions with anomalous accumulation of a pigment with fluorescence emission peak at 595 nm, which was identified 3,8-divinyl MPE by high-performance liquid chromatography-mass spectrometry analysis. The growth defect of Delta chlA(I) was restored by the cultivation under oxygen-limited (micro-oxic) conditions. MPE accumulation was also detected in Delta chlA(II) grown under microoxic conditions, but not in any of the bchE mutants. The phenotype was consistent with the expression pattern of two chlA genes: chlA(II) was induced under micro-oxic conditions in contrast to the constitutive expression of chlA(I). These findings suggested that ChlA(I) is the sole MPE cyclase system under aerobic conditions and that the induced ChlA(II) operates together with ChlA(I) under micro-oxic conditions. In addition, the accumulation of 3,8-divinyl MPE in the Delta chlA mutants suggested that the reduction of 8-vinyl group occurs after the formation of E-ring in Synechocystis sp. PCC 6803.	[Minamizaki, Kei; Goto, Takeaki; Fujita, Yuichi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Mizoguchi, Tadashi; Tamiaki, Hitoshi] Ritsumeikan Univ, Dept Biosci & Biotechnol, Kusatsu 5258577, Japan	Nagoya University; Ritsumeikan University	Fujita, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	fujita@agr.nagoya-u.ac.jp						AIBA H, 1981, J BIOL CHEM, V256, P1905; [Anonymous], 2002, HIST PHIL LIFE SCI; [Anonymous], 2002, PHOTOSYNTHETICA; Bollivar DW, 2006, PHOTOSYNTH RES, V90, P173, DOI 10.1007/s11120-006-9076-6; BOLLIVAR DW, 1995, PHOTOSYNTH RES, V43, P113, DOI 10.1007/BF00042968; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; Bollivar DW, 1996, PLANT PHYSIOL, V112, P105, DOI 10.1104/pp.112.1.105; BOLLIVAR DW, 2003, PORPHYRIN HDB, V13, P49; Chew AGM, 2007, J BIOL CHEM, V282, P2967, DOI 10.1074/jbc.M609730200; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; FUJITA Y, 1992, PLANT CELL PHYSIOL, V33, P81; Gough SP, 2000, P NATL ACAD SCI USA, V97, P6908, DOI 10.1073/pnas.97.12.6908; He QF, 1998, EUR J BIOCHEM, V253, P161, DOI 10.1046/j.1432-1327.1998.2530161.x; Howitt CA, 1996, BIOTECHNIQUES, V21, P32; KASTING JF, 1987, PRECAMBRIAN RES, V34, P205, DOI 10.1016/0301-9268(87)90001-5; Knoll Andrew H., 2008, P1; Knoll AH, 2003, GEOBIOLOGY, V1, P3, DOI 10.1046/j.1472-4669.2003.00002.x; Layer G, 2004, CURR OPIN CHEM BIOL, V8, P468, DOI 10.1016/j.cbpa.2004.08.001; Moseley J, 2000, EMBO J, V19, P2139, DOI 10.1093/emboj/19.10.2139; Moseley JL, 2002, PLANT CELL, V14, P673, DOI 10.1105/tpc.010420; Nagata N, 2005, PLANT CELL, V17, P233, DOI 10.1105/tpc.104.027276; NASRULHAQBOYCE A, 1987, BIOCHEM J, V243, P23, DOI 10.1042/bj2430023; Naylor GW, 1999, PHOTOSYNTH RES, V62, P121, DOI 10.1023/A:1006350405674; Nomata J, 2006, FEBS LETT, V580, P6151, DOI 10.1016/j.febslet.2006.10.014; Nomata J, 2006, J BIOL CHEM, V281, P15021, DOI 10.1074/jbc.M601750200; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Ouchane S, 2007, J BIOL CHEM, V282, P7690, DOI 10.1074/jbc.M605985200; Pinta V, 2002, J BACTERIOL, V184, P746, DOI 10.1128/JB.184.3.746-753.2002; Porra RJ, 1996, EUR J BIOCHEM, V239, P85, DOI 10.1111/j.1432-1033.1996.0085u.x; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rzeznicka K, 2005, P NATL ACAD SCI USA, V102, P5886, DOI 10.1073/pnas.0501784102; SAMBROOK J, 2000, MOL CLONING LAB MANU; Stal L.J., 2000, ECOLOGY CYANOBACTERI, P61; Stal LJ, 1997, FEMS MICROBIOL REV, V21, P179, DOI 10.1111/j.1574-6976.1997.tb00350.x; Tottey S, 2003, P NATL ACAD SCI USA, V100, P16119, DOI 10.1073/pnas.2136793100; WALKER CJ, 1989, BIOCHEM J, V257, P599, DOI 10.1042/bj2570599; Wallar BJ, 1996, CHEM REV, V96, P2625, DOI 10.1021/cr9500489; Wang SC, 2007, TRENDS BIOCHEM SCI, V32, P101, DOI 10.1016/j.tibs.2007.01.002; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; Xiong J, 1998, P NATL ACAD SCI USA, V95, P14851, DOI 10.1073/pnas.95.25.14851; XU KP, 1994, J BACTERIOL, V176, P3196, DOI 10.1128/jb.176.11.3196-3203.1994; Yamazaki S, 2006, PLANT PHYSIOL, V142, P911, DOI 10.1104/pp.106.086090; ZAGOREC M, 1988, J BIOL CHEM, V263, P9718; Zhang XH, 2005, FEBS J, V272, P1012, DOI 10.1111/j.1742-4658.2004.04535.x	45	68	69	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2684	2692		10.1074/jbc.M708954200	http://dx.doi.org/10.1074/jbc.M708954200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18039649	hybrid			2022-12-25	WOS:000252622300025
J	Swiercz, JM; Worzfeld, T; Offermanns, S				Swiercz, Jakub M.; Worzfeld, Thomas; Offermanns, Stefan			ErbB-2 and met reciprocally regulate cellular signaling via plexin-B1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; CONTROLS INVASIVE GROWTH; AXON GUIDANCE; RECEPTOR PLEXIN-B1; SEMAPHORIN 3A; R-RAS; ACTIVATING PROTEIN; LIGAND-BINDING; ACTIVE RAC; PDZ-RHOGEF	Sema4D-induced activation of plexin-B1 has been reported to evoke different and sometimes opposing cellular responses. The mechanisms underlying the versatility of plexin-B1-mediated effects are not clear. Plexin-B1 can associate with the receptor tyrosine kinases ErbB-2 and Met. Here we show that Sema4D-induced activation and inactivation of RhoA require ErbB-2 and Met, respectively. In breast carcinoma cells, Sema4D can have pro- and anti-migratory effects depending on the presence of ErbB-2 and Met, and the exchange of the two receptor tyrosine kinases is sufficient to convert the cellular response to Sema4D from pro- to anti-migratory and vice versa. This work identifies a novel mechanism by which plexin-mediated signaling can be regulated and explains how Sema4D can exert different biological activities through the differential association of its receptor with ErbB-2 and Met.	[Swiercz, Jakub M.; Worzfeld, Thomas; Offermanns, Stefan] Univ Heidelberg, Inst Pharmacol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Offermanns, S (corresponding author), Univ Heidelberg, Inst Pharmacol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	stefan.offermanns@pharma.uni-heidelberg.de	Offermanns, Stefan/L-3313-2017	Offermanns, Stefan/0000-0001-8676-6805				Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Barberis D, 2005, J CELL SCI, V118, P4689, DOI 10.1242/jcs.02590; Barberis D, 2004, FASEB J, V18, P592, DOI 10.1096/fj.03-0957fje; Basile JR, 2007, J BIOL CHEM, V282, P34888, DOI 10.1074/jbc.M705467200; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Basile JR, 2005, MOL CELL BIOL, V25, P6889, DOI 10.1128/MCB.25.16.6889-6898.2005; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Bussolino F, 2006, ENDOTHELIUM-J ENDOTH, V13, P81, DOI 10.1080/10623320600698003; Chedotal A, 2007, PROG EXP TUMOR RES, V39, P78, DOI 10.1159/000100048; Chikumi H, 2002, J BIOL CHEM, V277, P12463, DOI 10.1074/jbc.M108504200; Conrotto P, 2004, ONCOGENE, V23, P5131, DOI 10.1038/sj.onc.1207650; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Faltus T, 2004, NEOPLASIA, V6, P786, DOI 10.1593/neo.04313; Fujisawa H, 2004, J NEUROBIOL, V59, P24, DOI 10.1002/neu.10337; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Hirotani M, 2002, BIOCHEM BIOPH RES CO, V297, P32, DOI 10.1016/S0006-291X(02)02122-8; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Kolodkin AL, 1998, PROG BRAIN RES, V117, P115; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; Maeda A, 2006, BIOCHEM BIOPH RES CO, V347, P1158, DOI 10.1016/j.bbrc.2006.07.040; Morotti A, 2002, ONCOGENE, V21, P4885, DOI 10.1038/sj.onc.1205622; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Negishi M, 2005, MOL NEUROBIOL, V32, P217, DOI 10.1385/MN:32:3:217; Neufeld G, 2005, FRONT BIOSCI-LANDMRK, V10, P751, DOI 10.2741/1569; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2006, J CELL BIOL, V173, P601, DOI 10.1083/jcb.200508204; Pasterkarnp RJ, 2006, PHILOS T R SOC B, V361, P1499, DOI 10.1098/rstb.2006.1892; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Potiron V, 2007, ADV EXP MED BIOL, V600, P132; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rohm B, 2000, MECH DEVELOP, V93, P95, DOI 10.1016/S0925-4773(00)00269-0; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; Schwamborn JC, 2004, J BIOL CHEM, V279, P30923, DOI 10.1074/jbc.C400082200; Swiercz JM, 2004, J CELL BIOL, V165, P869, DOI 10.1083/jcb.200312094; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; Worzfeld T, 2004, EUR J NEUROSCI, V19, P2622, DOI 10.1111/j.0953-816X.2004.03401.x	48	103	122	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1893	1901		10.1074/jbc.M706822200	http://dx.doi.org/10.1074/jbc.M706822200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18025083	hybrid			2022-12-25	WOS:000252501000015
J	Wang, Y; De Arcangelis, V; Gao, X; Ramani, B; Jung, YS; Xiang, Y				Wang, Yongyu; De Arcangelis, Vania; Gao, Xiaoguang; Ramani, Biswarathan; Jung, Yi-Sook; Xiang, Yang			Norepinephrine-and epinephrine-induced distinct beta(2)-Adrenoceptor signaling is dictated by GRK2 phosphorylation in cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; 7 TRANSMEMBRANE RECEPTORS; CHRONIC HEART-FAILURE; CARDIAC MYOCYTES; ADRENERGIC-RECEPTORS; ACTIVATION; DESENSITIZATION; KINASES; PATHWAY; STIMULATION	Agonist-dependent activation of G protein-coupled receptors induces diversified receptor cellular and signaling properties. Norepinephrine (NE) and epinephrine (Epi) are two endogenous ligands that activate adrenoceptor (AR) signals in a variety of physiological stress responses in animals. Here we use cardiomyocyte contraction rate response to analyze the endogenous beta(2)AR signaling induced by Epi or NE in cardiac tissue. The Epi-activated beta(2)AR induced a rapid contraction rate increase that peaked at 4 min after stimulation. In contrast, the NE-activated beta(2)AR induced a much slower contraction rate increase that peaked at 10 min after stimulation. Whereas both drugs activated beta(2)AR coupling to G(s) proteins, only Epi-activated receptors were capable of coupling to G(i) proteins. Subsequent studies showed that the Epi-activated beta(2)AR underwent a rapid phosphorylation by G protein-coupled receptor kinase 2 (GRK2) and subsequent dephosphorylation on serine residues 355 and 356, which was critical for sufficient receptor recycling and Gi coupling. In contrast, the NE-activated beta(2)ARs underwent slow GRK2 phosphorylation, receptor internalization and recycling, and failed to couple to Gi. Moreover, inhibiting beta(2)AR phosphorylation by beta ARK C terminus or dephosphorylation by okadaic acid prevented sufficient recycling and Gi coupling. Together, our data revealed that distinct temporal phosphorylation of beta(2)AR on serine 355 and 356 by GRK2 plays a critical role for dictating receptor cellular events and signaling properties induced by Epi or NE in cardiomyocytes. This study not only helps us understand the endogenous agonist-dependent beta(2)AR signaling in animal heart but also offers an example of how G protein-coupled receptor signaling may be finely regulated by GRK in physiological settings.	[Wang, Yongyu; De Arcangelis, Vania; Gao, Xiaoguang; Ramani, Biswarathan; Jung, Yi-Sook; Xiang, Yang] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61822 USA	University of Illinois System; University of Illinois Urbana-Champaign	Xiang, Y (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, 523 Burrill Hall 407 S,Goodwin Ave, Urbana, IL 61822 USA.	kevinyx@uiuc.edu	Wang, Yongyu/F-9039-2011	Wang, Yongyu/0000-0002-8804-3472; Wang, Yongyu/0000-0002-6088-8887	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082846] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL082846-03, R01 HL082846-01, R01 HL082846] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Bissantz C, 2003, J RECEPT SIG TRANSD, V23, P123, DOI 10.1081/RRS-120025192; Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807; BRISTOW MR, 1989, MOL PHARMACOL, V35, P295; Choi DJ, 1997, J BIOL CHEM, V272, P17223, DOI 10.1074/jbc.272.27.17223; Currie GP, 2006, DRUG SAFETY, V29, P647, DOI 10.2165/00002018-200629080-00002; Devic E, 2001, MOL PHARMACOL, V60, P577; Eglen RM, 2005, P W PHARMACOL SOC, V48, P31; Flier J, 1996, NEW ENGL J MED, V334, P580, DOI 10.1056/NEJM199602293340907; Hata JA, 2004, J MOL CELL CARDIOL, V37, P11, DOI 10.1016/j.yjmcc.2004.03.014; Heubach JF, 2004, MOL PHARMACOL, V65, P1313, DOI 10.1124/mol.65.5.1313; Iaccarino G, 1999, Expert Opin Investig Drugs, V8, P545, DOI 10.1517/13543784.8.5.545; Johnson M, 1998, AM J RESP CRIT CARE, V158, pS146, DOI 10.1164/ajrccm.158.supplement_2.13tac110; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Lefkowitz RJ, 2000, CIRCULATION, V101, P1634; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Maudsley S, 2005, J PHARMACOL EXP THER, V314, P485, DOI 10.1124/jpet.105.083121; Mialet-Perez J, 2004, J BIOL CHEM, V279, P38603, DOI 10.1074/jbc.M403708200; Packer M, 1998, PROG CARDIOVASC DIS, V41, P39, DOI 10.1016/S0033-0620(98)80030-3; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; PITCHER JA, 1995, P NATL ACAD SCI USA, V92, P8343, DOI 10.1073/pnas.92.18.8343; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Rajagopal K, 2005, J CLIN INVEST, V115, P2971, DOI 10.1172/JCI26950; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Shcherbakova OG, 2007, J CELL BIOL, V176, P521, DOI 10.1083/jcb.200604167; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; von Zastrow M, 2004, NEUROPHARMACOLOGY, V47, P286, DOI 10.1016/j.neuropharm.2004.05.007; von Zastrow M, 2003, LIFE SCI, V74, P217, DOI 10.1016/j.lfs.2003.09.008; Wang YY, 2007, MOL PHARMACOL, V72, P429, DOI 10.1124/mol.107.037747; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Zhu WZ, 2001, P NATL ACAD SCI USA, V98, P1607, DOI 10.1073/pnas.98.4.1607	39	53	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1799	1807		10.1074/jbc.M705747200	http://dx.doi.org/10.1074/jbc.M705747200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18056263	hybrid			2022-12-25	WOS:000252501000005
J	Bowden, MG; Heuck, AP; Ponnuraj, K; Kolosova, E; Choe, D; Gurusiddappa, S; Narayana, SVL; Johnson, AE; Hook, M				Bowden, M. Gabriela; Heuck, Alejandro P.; Ponnuraj, Karthe; Kolosova, Elena; Choe, Damon; Gurusiddappa, Sivashankarappa; Narayana, Sthanam V. L.; Johnson, Arthur E.; Hook, Magnus			Evidence for the "Dock, Lock, and Latch" ligand binding mechanism of the staphylococcal microbial surface component recognizing adhesive matrix molecules (MSCRAMM) SdrG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLUMPING FACTOR; FIBRINOGEN; AUREUS; PROTEIN; COLLAGEN; EPIDERMIDIS; ARTHRITIS; FAMILY; REGION; DOMAIN	Staphylococcus epidermidis is an opportunistic pathogen and a major cause of foreign body infections. The S. epidermidis fibrinogen (Fg)-binding adhesin SdrG is necessary and sufficient for the attachment of this pathogen to Fg-coated materials. Based largely on structural analyses of the ligand binding domain of SdrG as an apo-protein and in complex with a Fg-like peptide, we proposed that SdrG follows a "dock, lock, and latch" mechanism to bind to Fg. This binding mechanism involves the docking of the ligand in a pocket formed between two SdrG subdomains followed by the movement of a C-terminal extension of one subdomain to cover the ligand and to insert and complement a beta-sheet in a neighboring subdomain. These proposed events result in a greatly stabilized closed conformation of the MSCRAMM-ligand complex. In this report, we describe a biochemical analysis of the proposed conformational changes that SdrG undergoes upon binding to its ligand. We have introduced disulfide bonds into SdrG to stabilize the open and closed forms of the apo-form of the MSCRAMM. We show that the stabilized closed form does not bind to the ligand and that binding can be restored in the presence of reducing agents such as dithiothreitol. We have also used Forster resonance energy transfer to dynamically show the conformational changes of SdrG upon binding to its ligand. Finally, we have used isothermic calorimetry to determine that hydrophobic interactions between the ligand and the protein are responsible for re-directing the C-terminal extension of the second subdomain required for triggering the beta-strand complementation event.	[Bowden, M. Gabriela; Kolosova, Elena; Choe, Damon; Gurusiddappa, Sivashankarappa; Hook, Magnus] Texas A&M Univ, Syst Hlth Sci Ctr, Ctr Extracellular Matrix Biol, Inst Biosci & Technol, Houston, TX 77030 USA; [Heuck, Alejandro P.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Heuck, Alejandro P.; Johnson, Arthur E.] Texas A&M Univ, Syst Hlth Sci Ctr, Sch Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Ponnuraj, Karthe; Narayana, Sthanam V. L.] Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA; [Ponnuraj, Karthe] Univ Madras, Ctr Adv Study Crystallog & Biophys, Madras 600025, Tamil Nadu, India	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Massachusetts System; University of Massachusetts Amherst; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Alabama System; University of Alabama Birmingham; University of Madras	Bowden, MG (corresponding author), Texas A&M Univ, Syst Hlth Sci Ctr, Ctr Extracellular Matrix Biol, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	gbowden@ibt.tamhsc.edu	Johnson, Arthur E/G-3457-2012		NIAID NIH HHS [AI 020624, AI 61426] Funding Source: Medline; NIGMS NIH HHS [GM26494] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020624, R21AI061426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026494] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; Eidhin DN, 1998, MOL MICROBIOL, V30, P245; Fisher CA, 1999, J LIPID RES, V40, P93; Hartford O, 2001, MICROBIOL-SGM, V147, P2545, DOI 10.1099/00221287-147-9-2545; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; Josefsson E, 1998, J BIOL CHEM, V273, P31145, DOI 10.1074/jbc.273.47.31145; Liu Q, 2007, J BIOL CHEM, V282, P19629, DOI 10.1074/jbc.M611137200; McCrea KW, 2000, MICROBIOL-SGM, V146, P1535, DOI 10.1099/00221287-146-7-1535; MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Palmqvist N, 2005, J INFECT DIS, V191, P791, DOI 10.1086/427663; Perkins S, 2001, J BIOL CHEM, V276, P44721, DOI 10.1074/jbc.M106741200; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Que YA, 2005, J EXP MED, V201, P1627, DOI 10.1084/jem.20050125; Sillanpaa J, 2004, MICROBIOL-SGM, V150, P2069, DOI 10.1099/mic.0.27074-0; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	24	73	79	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					638	647		10.1074/jbc.M706252200	http://dx.doi.org/10.1074/jbc.M706252200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17991749	hybrid			2022-12-25	WOS:000251940300068
J	Hsu, R; Woodroffe, A; Lai, WS; Cook, MN; Mukai, J; Dunning, JP; Swanson, DJ; Roos, JL; Abecasis, GR; Karayiorgou, M; Gogos, JA				Hsu, Ruby; Woodroffe, Abigail; Lai, Wen-Sung; Cook, Melloni N.; Mukai, Jun; Dunning, Jonathan P.; Swanson, Douglas J.; Roos, J. Louw; Abecasis, Goncalo R.; Karayiorgou, Maria; Gogos, Joseph A.			Nogo Receptor 1 (RTN4R) as a Candidate Gene for Schizophrenia: Analysis Using Human and Mouse Genetic Approaches	PLOS ONE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; 22Q11.2 DELETION SYNDROME; PREPULSE INHIBITION; SEQUENCE VARIANTS; NMDA RECEPTORS; WORKING-MEMORY; ANIMAL-MODELS; FAMILY-MEMBER; BINDS NOGO-66; CHILDREN	Background. NOGO Receptor 1 (RTN4R) regulates axonal growth, as well as axon regeneration after injury. The gene maps to the 22q11.2 schizophrenia susceptibility locus and is thus a strong functional and positional candidate gene. Methodology/Principal Findings. We evaluate evidence for genetic association between common RTN4R polymorphisms and schizophrenia in a large family sample of Afrikaner origin and screen the exonic sequence of RTN4R for rare variants in an independent sample from the U. S. We also employ animal model studies to assay a panel of schizophrenia-related behavioral tasks in an Rtn4r-deficient mouse model. We found weak sex-specific evidence for association between common RTN4R polymorphisms and schizophrenia in the Afrikaner patients. In the U. S. sample, we identified two novel non-conservative RTN4R coding variants in two patients with schizophrenia that were absent in 600 control chromosomes. In our complementary mouse model studies, we identified a haploinsufficient effect of Rtn4r on locomotor activity, but normal performance in schizophrenia-related behavioral tasks. We also provide evidence that Rtn4r deficiency can modulate the long-term behavioral effects of transient postnatal N-methyl-D-aspartate (NMDA) receptor hypofunction. Conclusions. Our results do not support a major role of RTN4R in susceptibility to schizophrenia or the cognitive and behavioral deficits observed in individuals with 22q11 microdeletions. However, they suggest that RTN4R may modulate the genetic risk or clinical expression of schizophrenia in a subset of patients and identify additional studies that will be necessary to clarify the role of RTN4R in psychiatric phenotypes. In addition, our results raise interesting issues about evaluating the significance of rare genetic variants in disease and their role in causation.	[Karayiorgou, Maria] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA; [Hsu, Ruby; Gogos, Joseph A.] Columbia Univ, Dept Neurosci, New York, NY USA; [Woodroffe, Abigail] Univ Michigan, Dept Epidemiol, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Lai, Wen-Sung; Mukai, Jun; Gogos, Joseph A.] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY USA; [Cook, Melloni N.; Dunning, Jonathan P.] Univ Memphis, Dept Psychol, Memphis, TN 38152 USA; [Swanson, Douglas J.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Roos, J. Louw] Univ Pretoria, Dept Psychiat, ZA-0002 Pretoria, South Africa; [Abecasis, Goncalo R.] Weskoppies Hosp, Pretoria, South Africa; [Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA	Columbia University; Columbia University; University of Michigan System; University of Michigan; Columbia University; University of Memphis; University of Tennessee System; University of Tennessee Health Science Center; University of Pretoria; University of Michigan System; University of Michigan	Karayiorgou, M (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA.	mk2758@columbia.edu; jag90@columbia.edu	Abecasis, Goncalo R/B-7840-2010	Roos, Johannes/0000-0002-0572-1072; Mukai, Jun/0000-0003-2065-4784; Lai, Wen-Sung/0000-0001-6918-5531; Abecasis, Goncalo/0000-0003-1509-1825	National Institutes of Health [MH67068, MH61399, U01-MH61971]; New York Academy of Sciences; HHMI; NARSAD Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061399, U01MH061971, R01MH067068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Academy of Sciences; HHMI(Howard Hughes Medical Institute); NARSAD Young Investigator Award(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported in part by the National Institutes of Health (grant MH67068 to MK and JAG, MH61399 to MK, and U01-MH61971 to Tennessee Mouse Genome Consortium) and by the New York Academy of Sciences (JAG). RH is supported by an HHMI pre-doctoral fellowship. JM is supported by a NARSAD Young Investigator Award. JAG is also the recipient of a McKnight Brain Disorders Award, and a NARSAD Award.	Abecasis GR, 2004, AM J HUM GENET, V74, P403, DOI 10.1086/381713; Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Altshuler D, 2005, J CLIN INVEST, V115, P831, DOI 10.1172/JCI200524715; American Psychiatric Association, 1994, DSM IV DIAGN STAT MA; Antshel KM, 2005, CHILD NEUROPSYCHOL, V11, P5, DOI 10.1080/09297040590911185; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; Bearden CE, 2001, J CLIN EXP NEUROPSYC, V23, P447, DOI 10.1076/jcen.23.4.447.1228; Botto LD, 2003, PEDIATRICS, V112, P101, DOI 10.1542/peds.112.1.101; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Cannon TD, 2000, AM J HUM GENET, V67, P369, DOI 10.1086/303006; Chow EWC, 2006, SCHIZOPHR RES, V87, P270, DOI 10.1016/j.schres.2006.04.007; CLONINGER CR, 1989, COMPREHENSIVE TXB PS; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Colonnese MT, 2006, J COMP NEUROL, V494, P738, DOI 10.1002/cne.20841; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Davis KL, 2003, ARCH GEN PSYCHIAT, V60, P443, DOI 10.1001/archpsyc.60.5.443; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Dudchenko PA, 2004, NEUROSCI BIOBEHAV R, V28, P699, DOI 10.1016/j.neubiorev.2004.09.002; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Ellenbroek BA, 2000, BEHAV PHARMACOL, V11, P223, DOI 10.1097/00008877-200006000-00006; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; FALLIN MD, 2006, 2076 ASHG M; Fournier AE, 2002, J NEUROSCI, V22, P8876; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Franks KM, 2005, NEURON, V47, P101, DOI 10.1016/j.neuron.2005.05.024; Gogos JA, 1999, NAT GENET, V21, P434, DOI 10.1038/7777; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Harris LW, 2003, EUR J NEUROSCI, V18, P1706, DOI 10.1046/j.1460-9568.2003.02902.x; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Karayiorgou M, 2004, AM J MED GENET B, V124B, P20, DOI 10.1002/ajmg.b.20090; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Keen-Kim D, 2006, HUM MOL GENET, V15, P3324, DOI 10.1093/hmg/ddl408; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Lee LJ, 2005, J COMP NEUROL, V485, P280, DOI 10.1002/cne.20481; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Liu H, 2002, P NATL ACAD SCI USA, V99, P16859, DOI 10.1073/pnas.232186099; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; MANSCHRECK TC, 1984, BIOL PSYCHIAT, V19, P703; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Meng J, 2007, J NEURAL TRANSM, V114, P249, DOI 10.1007/s00702-006-0538-y; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mitchell AA, 2005, GENOME RES, V15, P960, DOI 10.1101/gr.3761405; MORROW B, 1995, AM J HUM GENET, V56, P1391; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Novak G, 2002, MOL BRAIN RES, V107, P183, DOI 10.1016/S0169-328X(02)00492-8; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; Paylor R, 1997, PSYCHOPHARMACOLOGY, V132, P169, DOI 10.1007/s002130050333; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; PIERCE T, 2006, 14 WORLD C PSYCH GEN, P179; Porsolt RD, 2000, REV NEUROSCIENCE, V11, P53; Puech A, 1997, P NATL ACAD SCI USA, V94, P14608, DOI 10.1073/pnas.94.26.14608; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Putzhammer Albert, 2006, Dialogues Clin Neurosci, V8, P123; Raux G, 2007, HUM MOL GENET, V16, P83, DOI 10.1093/hmg/ddl443; Seeger T, 2004, J NEUROSCI, V24, P10117, DOI 10.1523/JNEUROSCI.3581-04.2004; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Shprintzen RJ, 2000, MENT RETARD DEV D R, V6, P142, DOI 10.1002/1098-2779(2000)6:2<142::AID-MRDD9>3.0.CO;2-H; Simon TJ, 2005, NEUROIMAGE, V25, P169, DOI 10.1016/j.neuroimage.2004.11.018; Sinibaldi Lorenzo, 2004, Hum Mutat, V24, P534, DOI 10.1002/humu.9292; Sobin C, 2005, CHILD NEUROPSYCHOL, V11, P39, DOI 10.1080/09297040590911167; Sobin C, 2005, AM J PSYCHIAT, V162, P1090, DOI 10.1176/appi.ajp.162.6.1090; Sobin C, 2006, MOVEMENT DISORD, V21, P2082, DOI 10.1002/mds.21103; Stefani MR, 2005, BIOL PSYCHIAT, V57, P433, DOI 10.1016/j.biopsych.2004.11.031; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Van Amelsvoort T, 2001, BRIT J PSYCHIAT, V178, P412; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Woodin M, 2001, GENET MED, V3, P34, DOI 10.1097/00125817-200101000-00008	78	49	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1234	10.1371/journal.pone.0001234	http://dx.doi.org/10.1371/journal.pone.0001234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043741	Green Published, gold			2022-12-25	WOS:000207459300015
J	Medina, DC; Findley, SE; Guindo, B; Doumbia, S				Medina, Daniel C.; Findley, Sally E.; Guindo, Boubacar; Doumbia, Seydou			Forecasting Non-Stationary Diarrhea, Acute Respiratory Infection, and Malaria Time-Series in Niono, Mali	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; WEATHER-BASED PREDICTION; EPIDEMIC-PRONE REGIONS; SYNCYTIAL VIRUS; SEASONAL-VARIATION; CLIMATE-CHANGE; PATTERNS; ETHIOPIA; IMPACT; RISK	Background. Much of the developing world, particularly sub-Saharan Africa, exhibits high levels of morbidity and mortality associated with diarrhea, acute respiratory infection, and malaria. With the increasing awareness that the aforementioned infectious diseases impose an enormous burden on developing countries, public health programs therein could benefit from parsimonious general-purpose forecasting methods to enhance infectious disease intervention. Unfortunately, these disease time-series often i) suffer from non-stationarity; ii) exhibit large inter-annual plus seasonal fluctuations; and, iii) require disease-specific tailoring of forecasting methods. Methodology/Principal Findings. In this longitudinal retrospective (01/1996-06/2004) investigation, diarrhea, acute respiratory infection of the lower tract, and malaria consultation time-series are fitted with a general-purpose econometric method, namely the multiplicative Holt-Winters, to produce contemporaneous on-line forecasts for the district of Niono, Mali. This method accommodates seasonal, as well as inter-annual, fluctuations and produces reasonably accurate median 2- and 3-month horizon forecasts for these non-stationary time-series, i.e., 92% of the 24 time-series forecasts generated (2 forecast horizons, 3 diseases, and 4 age categories = 24 time-series forecasts) have mean absolute percentage errors circa 25%. Conclusions/Significance. The multiplicative Holt-Winters forecasting method: i) performs well across diseases with dramatically distinct transmission modes and hence it is a strong general-purpose forecasting method candidate for non-stationary epidemiological time-series; ii) obliquely captures prior non-linear interactions between climate and the aforementioned disease dynamics thus, obviating the need for more complex disease-specific climate-based parametric forecasting methods in the district of Niono; furthermore, iii) readily decomposes time-series into seasonal components thereby potentially assisting with programming of public health interventions, as well as monitoring of disease dynamics modification. Therefore, these forecasts could improve infectious diseases management in the district of Niono, Mali, and elsewhere in the Sahel.	[Findley, Sally E.] Columbia Univ, Mailman Sch Publ Hlth, Dept Populat & Family Hlth, New York, NY 10027 USA; [Medina, Daniel C.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Medina, Daniel C.; Guindo, Boubacar; Doumbia, Seydou] Univ Bamako, FMPOS, Malaria Res & Training Ctr, Bamako, Mali	Columbia University; Columbia University; University of Bamako	Findley, SE (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Populat & Family Hlth, New York, NY 10027 USA.	sef5@columbia.edu			The Climate and Society Program ( Earth Institute, Columbia University, New York, NY, USA)	The Climate and Society Program ( Earth Institute, Columbia University, New York, NY, USA)	The Climate and Society Program ( Earth Institute, Columbia University, New York, NY, USA) partially funded data collection and analyses.	Abeku TA, 2002, TROP MED INT HEALTH, V7, P851, DOI 10.1046/j.1365-3156.2002.00924.x; ADAMS AM, 1994, ECOL FOOD NUTR, V33, P93, DOI 10.1080/03670244.1994.9991418; Baird JK, 2002, AM J TROP MED HYG, V66, P280, DOI 10.4269/ajtmh.2002.66.280; Bloland PB, 2002, MALARIA CONTROL MASS; Breman JG, 2001, AM J TROP MED HYG, V64, P1; BREWSTER DR, 1993, ANN TROP PAEDIATR, V13, P133, DOI 10.1080/02724936.1993.11747637; Burkom HS, 2007, STAT MED, V26, P4202, DOI 10.1002/sim.2835; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Callejas D, 1999, Invest Clin, V40, P81; Chambers Robert., 1981, SEASONAL DIMENSIONS; Chatfield C, 2001, J ROY STAT SOC D-STA, V50, P147, DOI 10.1111/1467-9884.00267; Chaves LF, 2006, PLOS MED, V3, P1320, DOI 10.1371/journal.pmed.0030295; Checon RE, 2002, AM J TROP MED HYG, V67, P490, DOI 10.4269/ajtmh.2002.67.490; Cleveland RB., 1990, J OFF STAT, V6, P3; Connor SJ, 1998, DISASTERS, V22, P39, DOI 10.1111/1467-7717.00074; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103; *DIV SERV SOC, 2005, DIS STAT DISTR GAO M; *DIV SERV SOC, 1996, DIS STAT DISTR NION; Duffy PE, 2005, CURR TOP MICROBIOL, V295, P169; Gemperli A, 2004, AM J EPIDEMIOL, V159, P64, DOI 10.1093/aje/kwh001; Gijbels I, 1999, J ROY STAT SOC B, V61, P39, DOI 10.1111/1467-9868.00161; Guyatt HL, 2001, AM J TROP MED HYG, V64, P36, DOI 10.4269/ajtmh.2001.64.36; Hay SI, 2003, LANCET, V361, P1705, DOI 10.1016/S0140-6736(03)13366-1; HOLT CC, 1957, ONR RES MEMORANDUM, V52; Hyndman RJ, 2002, INT J FORECASTING, V18, P439, DOI 10.1016/S0169-2070(01)00110-8; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Kleinschmidt I, 2000, INT J EPIDEMIOL, V29, P355, DOI 10.1093/ije/29.2.355; Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P779, DOI 10.1046/j.1365-3156.2001.00790.x; LAMB PJ, 1978, TELLUS, V30, P240, DOI 10.1111/j.2153-3490.1978.tb00839.x; Makridakis S, 2000, INT J FORECASTING, V16, P451, DOI 10.1016/S0169-2070(00)00057-1; Musa HA, 1999, J APPL MICROBIOL, V87, P676, DOI 10.1046/j.1365-2672.1999.00907.x; National Research Council, 2001, WEATH CLIM EC INF DI; Ord JK, 1997, J AM STAT ASSOC, V92, P1621, DOI 10.2307/2965433; ORD JK, 1990, P DEC SCI I, P555; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Phillips-Howard PA, 1999, ANN TROP MED PARASIT, V93, pS11, DOI 10.1080/00034989957691; Politis DN, 2003, STAT SCI, V18, P219, DOI 10.1214/ss/1063994977; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Rice AL, 2000, B WORLD HEALTH ORGAN, V78, P1207; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Singh RBK, 2001, ENVIRON HEALTH PERSP, V109, P155, DOI 10.2307/3434769; Siritantikorn Sontana, 2002, Journal of the Medical Association of Thailand, V85, pS1167; Small J, 2003, P NATL ACAD SCI USA, V100, P15341, DOI 10.1073/pnas.2236969100; Sugaya N, 2000, J MED VIROL, V60, P102, DOI 10.1002/(SICI)1096-9071(200001)60:1&lt;102::AID-JMV17&gt;3.0.CO;2-D; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Teklehaimanot HD, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-44; Teklehaimanot HD, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-41; Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503; *USAID, 2004, COUNTR HLTH REP MAL; van der Sande MAB, 2004, PEDIATR INFECT DIS J, V23, P73, DOI 10.1097/01.inf.0000105183.12781.06; Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102; Weber MW, 2002, B WORLD HEALTH ORGAN, V80, P562; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; WINTERS PR, 1960, MANAGE SCI, V6, P324, DOI 10.1287/mnsc.6.3.324	55	34	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1181	10.1371/journal.pone.0001181	http://dx.doi.org/10.1371/journal.pone.0001181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030322	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459200001
J	Stevenson, B; Choy, HA; Pinne, M; Rotondi, ML; Miller, MC; DeMoll, E; Kraiczy, P; Cooley, AE; Creamer, TP; Suchard, MA; Brissette, CA; Verma, A; Haake, DA				Stevenson, Brian; Choy, Henry A.; Pinne, Marija; Rotondi, Matthew L.; Miller, M. Clarke; DeMoll, Edward; Kraiczy, Peter; Cooley, Anne E.; Creamer, Trevor P.; Suchard, Marc A.; Brissette, Catherine A.; Verma, Ashutosh; Haake, David A.			Leptospira interrogans Endostatin-Like Outer Membrane Proteins Bind Host Fibronectin, Laminin and Regulators of Complement	PLOS ONE			English	Article							SURFACE-EXPOSED LIPOPROTEIN; H-RELATED PROTEINS; SECONDARY STRUCTURE; ANTILEPTOSPIRAL ACTIVITY; MOLECULAR-CLONING; SEQUENCE-ANALYSIS; EXPRESSION; SERUM; IDENTIFICATION; TEMPERATURE	The pathogenic spirochete Leptospira interrogans disseminates throughout its hosts via the bloodstream, then invades and colonizes a variety of host tissues. Infectious leptospires are resistant to killing by their hosts' alternative pathway of complement-mediated killing, and interact with various host extracellular matrix (ECM) components. The LenA outer surface protein (formerly called LfhA and Lsa24) was previously shown to bind the host ECM component laminin and the complement regulators factor H and factor H-related protein-1. We now demonstrate that infectious L. interrogans contain five additional paralogs of lenA, which we designated lenB, lenC, lenD, lenE and lenF. All six genes encode domains predicted to bear structural and functional similarities with mammalian endostatins. Sequence analyses of genes from seven infectious L. interrogans serovars indicated development of sequence diversity through recombination and intragenic duplication. LenB was found to bind human factor H, and all of the newly-described Len proteins bound laminin. In addition, LenB, LenC, LenD, LenE and LenF all exhibited affinities for fibronectin, a distinct host extracellular matrix protein. These characteristics suggest that Len proteins together facilitate invasion and colonization of host tissues, and protect against host immune responses during mammalian infection.	[Stevenson, Brian; Cooley, Anne E.; Brissette, Catherine A.; Verma, Ashutosh] Univ Kentucky, Coll Med, Dept Microbiol Mol Genet & Immunol, Lexington, KY 40506 USA; [Choy, Henry A.; Pinne, Marija; Haake, David A.] Vet Affairs Greater Los Angeles Hlth Care Syst, Div Infect Dis, Los Angeles, CA USA; [Choy, Henry A.; Pinne, Marija; Haake, David A.] Univ Calif Los Angeles, Dept Med, Sch Med, Los Angeles, CA 90024 USA; [Rotondi, Matthew L.; Miller, M. Clarke; DeMoll, Edward] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; [Kraiczy, Peter] Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Creamer, Trevor P.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY USA; [Suchard, Marc A.] Univ Calif Los Angeles, Sch Med, Dept Biomath, Los Angeles, CA 90024 USA; [Verma, Ashutosh] Univ Kentucky, Dept Vet Sci, Lexington, KY 40546 USA	University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Kentucky; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Kentucky; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Kentucky	Stevenson, B (corresponding author), Univ Kentucky, Coll Med, Dept Microbiol Mol Genet & Immunol, Lexington, KY 40506 USA.	brian.stevenson@uky.edu	Miller, M. Clarke/C-9483-2011; Creamer, Trevor P/A-5252-2008	Miller, M. Clarke/0000-0002-9877-6581; Brissette, Catherine/0000-0003-0792-1403	VA Medical Research funds; National 10 Institute of Allergy and Infectious Diseases [AI-34431]; Paul Mellon Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI034431, R01AI034431, R29AI034431] Funding Source: NIH RePORTER	VA Medical Research funds(US Department of Veterans Affairs); National 10 Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Paul Mellon Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by VA Medical Research funds and National 10 Institute of Allergy and Infectious Diseases grant AI-34431 to D. Haake. M. Suchard is an Alfred P. Sloan Research Fellow. A. Verma was supported by a Paul Mellon Fellowship in Equine Studies.	ANDREWS P, 1964, BIOCHEM J, V91, P222, DOI 10.1042/bj0910222; Artiushin S, 2004, INFECT IMMUN, V72, P742, DOI 10.1128/IAI.72.2.742-749.2004; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; BRANDTS JF, 1973, BIOCHEMISTRY-US, V12, P2011, DOI 10.1021/bi00734a027; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Cinco M, 2002, MICROB PATHOGENESIS, V33, P299, DOI 10.1006/mpat.2002.0537; CINCO M, 1983, ZBL BAKT-INT J MED M, V254, P261; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Cullen PA, 2005, INFECT IMMUN, V73, P4853, DOI 10.1128/IAI.73.8.4853-4863.2005; Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004; DiScipio RG, 1998, J IMMUNOL, V160, P4057; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; Force A, 1999, GENETICS, V151, P1531; Gogarten JP, 1999, CURR OPIN GENET DEV, V9, P630, DOI 10.1016/S0959-437X(99)00029-5; Haake DA, 2000, MICROBIOL-SGM, V146, P1491, DOI 10.1099/00221287-146-7-1491; Haake DA, 2004, J BACTERIOL, V186, P2818, DOI 10.1128/JB.186.9.2818-2828.2004; Haake DA, 1998, INFECT IMMUN, V66, P1579, DOI 10.1128/IAI.66.4.1579-1587.1998; HAAKE DA, 1993, J BACTERIOL, V175, P4225, DOI 10.1128/JB.175.13.4225-4234.1993; Haake DA, 2002, CLIN INFECT DIS, V34, pE40, DOI 10.1086/339942; Haake DA, 2002, INFECT IMMUN, V70, P4936, DOI 10.1128/IAI.70.9.4936-4945.2002; HAAKE DA, 1991, INFECT IMMUN, V59, P1131, DOI 10.1128/IAI.59.3.1131-1140.1991; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hellwage J, 1999, FEBS LETT, V462, P345, DOI 10.1016/S0014-5793(99)01554-9; Hellwage J, 2006, IMMUNOGENETICS, V58, P883, DOI 10.1007/s00251-006-0153-y; Hohenester E, 1998, EMBO J, V17, P1656, DOI 10.1093/emboj/17.6.1656; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; ITO T, 1987, JPN J VET SCI, V49, P875; JOHNSON RC, 1965, J BACTERIOL, V89, P1625, DOI 10.1128/JB.89.6.1625-1626.1965; JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967; JOHNSON RC, 1966, J BACTERIOL, V91, P1403, DOI 10.1128/JB.91.4.1403-1409.1966; JOHNSON RC, 1967, J BACTERIOL, V93, P513, DOI 10.1128/JB.93.2.513-519.1967; Jokiranta TS, 2005, AM J PATHOL, V167, P1173, DOI 10.1016/S0002-9440(10)61205-9; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Lo M, 2006, INFECT IMMUN, V74, P5848, DOI 10.1128/IAI.00755-06; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Malhotra R, 1999, BIOCHEM J, V341, P61, DOI 10.1042/0264-6021:3410061; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Marneros AG, 2005, FASEB J, V19, P716, DOI 10.1096/fj.04-2134rev; Matsunaga J, 2007, MICROBIOL-SGM, V153, P3390, DOI 10.1099/mic.0.2007/007948-0; Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06; Matsunaga J, 2006, MICROBIOL-SGM, V152, P3777, DOI 10.1099/mic.0.29162-0; McRae JL, 2005, J IMMUNOL, V174, P6250, DOI 10.4049/jimmunol.174.10.6250; Meri T, 2005, MICROB PATHOGENESIS, V39, P139, DOI 10.1016/j.micpath.2005.07.003; Merien F, 2000, FEMS MICROBIOL LETT, V185, P17, DOI 10.1111/j.1574-6968.2000.tb09034.x; Nally JE, 2005, INFECT IMMUN, V73, P3251, DOI 10.1128/IAI.73.6.3251-3260.2005; Nally JE, 2001, INFECT IMMUN, V69, P400, DOI 10.1128/IAI.69.1.400-404.2001; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Park CT, 1996, J BIOL CHEM, V271, P18054, DOI 10.1074/jbc.271.30.18054; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Saito A, 2007, BBA-GEN SUBJECTS, V1770, P241, DOI 10.1016/j.bbagen.2006.10.015; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; Shang ES, 1996, INFECT IMMUN, V64, P2322, DOI 10.1128/IAI.64.6.2322-2330.1996; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Stevenson B, 2002, INFECT IMMUN, V70, P491, DOI 10.1128/IAI.70.2.491-497.2002; Suchard MA, 2005, GENETICS, V170, P419, DOI 10.1534/genetics.103.025692; Suchard MA, 2002, SYST BIOL, V51, P715, DOI 10.1080/10635150290102384; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Putten JPM, 1998, MOL MICROBIOL, V29, P369, DOI 10.1046/j.1365-2958.1998.00951.x; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Vaziri-Sani F, 2005, J THROMB HAEMOST, V3, P154, DOI 10.1111/j.1538-7836.2004.01010.x; Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006; Zipfel PF, 2007, PLOS GENET, V3, P387, DOI 10.1371/journal.pgen.0030041; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971	71	154	159	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1188	10.1371/journal.pone.0001188	http://dx.doi.org/10.1371/journal.pone.0001188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000555	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459100026
J	Schwab, R; Bussolari, R; Corvetta, D; Chayka, O; Santilli, G; Kwok, JMM; Amorotti, GF; Tonini, GP; Iacoviello, L; Bertorelle, R; Menin, C; Hubank, M; Calabretta, B; Sala, A				Schwab, R.; Bussolari, R.; Corvetta, D.; Chayka, O.; Santilli, G.; Kwok, J. M-M; Amorotti, G. F.; Tonini, G. P.; Iacoviello, L.; Bertorelle, R.; Menin, C.; Hubank, M.; Calabretta, B.; Sala, A.			Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk	ONCOGENE			English	Article						transcription; neuroblastoma; colon cancer; leukaemia; apoptosis	CHROMOSOMAL REGION; T-CELLS; APOPTOSIS; GENE; AMPLIFICATION	The B-MYB proto-oncogene is a transcription factor belonging to the MYB family that is frequently over-expressed or amplified in different types of human malignancies. While it is suspected that B-MYB plays a role in human cancer, there is still no direct evidence of its causative role. Looking for mutations of the B-MYB gene in human cell lines and primary cancer samples, we frequently isolated two nonsynonymous B-MYB polymorphic variants (rs2070235 and rs11556379). Compared to the wild-type protein, the B-MYB isoforms display altered conformation, impaired regulation of target genes and decreased antiapoptotic activity, suggesting that they are hypomorphic variants of the major allele. Importantly, the B-MYB polymorphisms are common; rs2070235 and rs11556379 are found, depending on the ethnic background, in 10-50% of human subjects. We postulated that, if B-MYB activity is important for transformation, the presence of common, hypomorphic variants might modify cancer risk. Indeed, the B-MYB polymorphisms are underrepresented in 419 cancer patients compared to 230 controls (odds ratio 0.53; (95%) confidence interval 0.385-0.755; P = 0.001). This data imply that a large fraction of the human population is carrier of B-MYB alleles that might be associated with a reduced risk of developing neoplastic disease.	[Schwab, R.; Corvetta, D.; Chayka, O.; Santilli, G.; Kwok, J. M-M; Hubank, M.; Sala, A.] UCL, Inst Child Hlth, Mol Haematol & Canc Biol Unit, London WC1N 1EH, England; [Bussolari, R.; Amorotti, G. F.; Calabretta, B.] Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy; [Corvetta, D.] Univ Parma, Dipartimento Med Sperimentale, Sezione Biochim, Biochem Clin & Biochim Esercizio Fis, I-43100 Parma, Italy; [Tonini, G. P.] Natl Inst Canc Res, IST, Genoa, Italy; [Iacoviello, L.] Catholic Univ, John Paul II Ctr High Technol Res & Educ Biomed S, Lab Genet & Environm Epidemiol, Campobasso, Italy; [Bertorelle, R.; Menin, C.] IRCCS, IOV, Padua, Italy	University of London; University College London; Universita di Modena e Reggio Emilia; University of Parma; University of Genoa; IRCCS AOU San Martino IST; Catholic University of the Sacred Heart; IRCCS Istituto Oncologico Veneto (IOV)	Sala, A (corresponding author), UCL, Inst Child Hlth, Mol Haematol & Canc Biol Unit, 30 Guilford St, London WC1N 1EH, England.	a.sala@ich.ucl.ac.uk	Bertorelle, Roberta/AAC-2357-2022; sala, arturo/C-4959-2008; Menin, Chiara/L-5770-2016; Iacoviello, Licia/AGX-7071-2022; Hubank, Michael JF/C-1837-2008; Siani, Alfonso/B-7925-2015; Iacoviello, Licia/K-4676-2016	Bertorelle, Roberta/0000-0002-4235-3862; Menin, Chiara/0000-0002-8907-772X; Iacoviello, Licia/0000-0003-0514-5885; Hubank, Michael JF/0000-0002-2901-0742; Iacoviello, Licia/0000-0003-0514-5885; Sala, Arturo/0000-0002-2841-7866				Ahlbory DR, 2005, ONCOGENE, V24, P7127, DOI 10.1038/sj.onc.1208869; Bar-Shira A, 2002, CANCER RES, V62, P6803; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Eckstein LA, 2005, INVEST OPHTH VIS SCI, V46, P782, DOI 10.1167/iovs.04-1022; Forozan F, 2000, CANCER RES, V60, P4519; Grassilli E, 1999, CANCER RES, V59, P2451; Iacoviello L, 1998, NEW ENGL J MED, V338, P79, DOI 10.1056/NEJM199801083380202; Imyanitov EN, 2004, CANCER LETT, V204, P3, DOI 10.1016/j.canlet.2003.09.026; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Masselink H, 2001, CANCER LETT, V171, P87, DOI 10.1016/S0304-3835(01)00631-0; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; Raschella G, 1999, CANCER RES, V59, P3365; Sala A, 2005, EUR J CANCER, V41, P2479, DOI 10.1016/j.ejca.2005.08.004; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; SUGIMURA H, 1990, CANCER RES, V50, P1857; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; Tanner MM, 2000, CLIN CANCER RES, V6, P1833	19	9	10	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 1	2008	27	20					2929	2933		10.1038/sj.onc.1210947	http://dx.doi.org/10.1038/sj.onc.1210947			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	295VR	18026132				2022-12-25	WOS:000255502500014
J	Mascanfroni, I; Montesinos, MD; Susperreguy, S; Cervi, L; Ilarregui, JM; Ramseyer, VD; Masini-Repiso, AM; Targovnik, HM; Rabinovich, GA; Rellizas, CG				Mascanfroni, Ivan; del Mar Montesinos, Maria; Susperreguy, Sebastian; Cervi, Laura; Ilarregui, Juan M.; Ramseyer, Vanesa D.; Masini-Repiso, Ana M.; Targovnik, Heector M.; Rabinovich, Gabriel A.; Rellizas, Claudia G.			Control of dendritic cell maturation and function by triipdothyronine	FASEB JOURNAL			English	Article						adaptive immunity; thyroid hormones; antigen presentation	THYROID-HORMONE ACTION; COLONY-STIMULATING FACTOR; GROWTH-FACTOR-I; NF-KAPPA-B; IMMUNE-SYSTEM; BONE-MARROW; TRIIODOTHYRONINE RECEPTORS; ANTERIOR-PITUITARY; MEDIATED-IMMUNITY; NUCLEAR RECEPTOR	Accumulating evidence indicates a functional crosstalk between immune and endocrine mechanisms in the modulation of innate and adaptive immunity. However, the impact of thyroid hormones (THs) in the initiation of adaptive immune responses has not yet been examined. Here we investigated the presence of thyroid hormone receptors (TRs) and the impact of THs in the physiology of mouse dendritic cells (DCs), specialized antigen-presenting cells with the unique capacity to fully activate naive T cells and orchestrate adaptive immunity. Both immature and lipopolysaccharide-matured bone marrow-derived DCs expressed TRs at mRNA and protein levels, showing a preferential cytoplasmic localization. Remarkably, physiological levels of triiodothyronine (T3) stimulated the expression of DC maturation markers (major histocompatability complex II, CD80, CD86, and CD40), markedly increased the secretion of interleukin-12, and stimulated the ability of DCs to induce naive T cell proliferation and IFN-gamma production in allogeneic T cell cultures. Analysis of the mechanisms involved in these effects revealed the ability of T3 to influence the cytoplasmic-nuclear shuttling of nuclear factor-kappa B on primed DCs. Our study provides the first evidence for the presence of TRs on bone marrow-derived DCs and the ability of THs to regulate DC maturation and function. These results have profound implications in immunopathology, including cancer and autoimmune manifestations of the thyroid gland at the crossroads of the immune and endocrine systems.	[Mascanfroni, Ivan; del Mar Montesinos, Maria; Susperreguy, Sebastian; Cervi, Laura; Ramseyer, Vanesa D.; Masini-Repiso, Ana M.; Rellizas, Claudia G.] Univ Nacl Cordoba, Fac Ciencias Quim, CIBICI CONICET, Dept Bioquim Clin, RA-5000 Cordoba, Argentina; [Ilarregui, Juan M.; Rabinovich, Gabriel A.] Univ Buenos Aires, CONICET, IBYME, Buenos Aires, DF, Argentina; [Ilarregui, Juan M.; Rabinovich, Gabriel A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Targovnik, Heector M.] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Genet & Biol Mol, RA-1113 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires; University of Buenos Aires; University of Buenos Aires	Rellizas, CG (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, CIBICI CONICET, Dept Bioquim Clin, Haya Torre Esq Medina Allende,Ciudad Univ, RA-5000 Cordoba, Argentina.	claudia@mail.fcq.unc.edu.ar		Ilarregui, Juan Martin/0000-0002-6871-6764; Ramseyer Payant, Vanesa/0000-0001-9368-0997				Alkemade A, 2005, J CLIN ENDOCR METAB, V90, P904, DOI 10.1210/jc.2004-0474; Ausubel LJ, 1996, P NATL ACAD SCI USA, V93, P15317, DOI 10.1073/pnas.93.26.15317; Bagriacik EU, 2000, J IMMUNOL, V164, P6158, DOI 10.4049/jimmunol.164.12.6158; BALAZS C, 1980, EUR J CLIN PHARMACOL, V17, P19, DOI 10.1007/BF00561672; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Bassett JHD, 2003, MOL CELL ENDOCRINOL, V213, P1, DOI 10.1016/j.mce.2003.10.033; Baumann CT, 2001, J BIOL CHEM, V276, P11237, DOI 10.1074/jbc.M011112200; Bergh JJ, 2005, ENDOCRINOLOGY, V146, P2864, DOI 10.1210/en.2005-0102; Bonasio R, 2006, CURR OPIN IMMUNOL, V18, P503, DOI 10.1016/j.coi.2006.05.011; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; CHATTERJEE S, 1983, ACTA ENDOCRINOL-COP, V103, P95, DOI 10.1530/acta.0.1030095; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CSABA G, 1977, HORM METAB RES, V9, P499, DOI 10.1055/s-0028-1093509; D'Arezzo S, 2004, ENDOCRINOLOGY, V145, P5694, DOI 10.1210/en.2004-0890; Davis PJ, 2005, TRENDS ENDOCRIN MET, V16, P429, DOI 10.1016/j.tem.2005.09.007; Delgado M, 2004, J LEUKOCYTE BIOL, V75, P1122, DOI 10.1189/jlb.1203626; Diekman MJM, 2001, J ENDOCRINOL, V168, P427, DOI 10.1677/joe.0.1680427; Dorshkind K, 2001, BIOESSAYS, V23, P288, DOI 10.1002/1521-1878(200103)23:3<288::AID-BIES1039>3.0.CO;2-P; Dorshkind K, 2000, ENDOCR REV, V21, P292, DOI 10.1210/er.21.3.292; Doulabi BZ, 2002, ENDOCRINOLOGY, V143, P979; FABRIS N, 1995, HORM RES, V43, P29, DOI 10.1159/000184234; Foster MP, 2000, CLIN IMMUNOL, V96, P140, DOI 10.1006/clim.2000.4889; Freeman L, 2005, BLOOD, V106, P2042, DOI 10.1182/blood-2005-01-0186; Gad M, 2003, APMIS, V111, P766, DOI 10.1034/j.1600-0463.2003.11107808.x; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hager GL, 2000, J STEROID BIOCHEM, V74, P249, DOI 10.1016/S0960-0760(00)00100-X; Hagihara M, 2001, J IMMUNOL METHODS, V253, P45, DOI 10.1016/S0022-1759(01)00386-6; Hewison M, 2003, J IMMUNOL, V170, P5382, DOI 10.4049/jimmunol.170.11.5382; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jakobsen MA, 2006, SCAND J IMMUNOL, V63, P330, DOI 10.1111/j.1365-3083.2006.01745.x; Klecha AJ, 2006, J ENDOCRINOL, V189, P45, DOI 10.1677/joe.1.06137; Komi J, 2000, BLOOD, V95, P2875, DOI 10.1182/blood.V95.9.2875.009k12_2875_2882; Kreuzer KA, 1999, CLIN CHEM, V45, P297; Laderach D, 2003, J IMMUNOL, V171, P1750, DOI 10.4049/jimmunol.171.4.1750; Lipscomb MF, 2002, PHYSIOL REV, V82, P97, DOI 10.1152/physrev.00023.2001; Liu LX, 2003, ENDOCRINOLOGY, V144, P3836, DOI 10.1210/en.2003-0160; Maruvada P, 2003, J BIOL CHEM, V278, P12425, DOI 10.1074/jbc.M202752200; MeierHeusler S, 1995, J ENDOCRINOL INVEST, V18, P767, DOI 10.1007/BF03349809; Montesinos MM, 2006, LIFE SCI, V78, P2584, DOI 10.1016/j.lfs.2005.10.019; MOOIJ P, 1994, J ENDOCRINOL, V140, P503, DOI 10.1677/joe.0.1400503; Nahmod KA, 2003, FASEB J, V17, P491, DOI 10.1096/fj.02-0755fje; Nalbandian G, 2005, J IMMUNOL, V175, P2666, DOI 10.4049/jimmunol.175.4.2666; Roelen DL, 2003, TRANSPLANTATION, V76, P1608, DOI 10.1097/01.TP.0000086340.30817.BA; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Siebler T, 2002, BONE, V30, P259, DOI 10.1016/S8756-3282(01)00631-7; Smithson G, 1998, J IMMUNOL, V161, P27; Storey NM, 2006, P NATL ACAD SCI USA, V103, P5197, DOI 10.1073/pnas.0600089103; Straw AD, 2003, J IMMUNOL, V170, P727, DOI 10.4049/jimmunol.170.2.727; Sundquist M, 2003, APMIS, V111, P715, DOI 10.1034/j.1600-0463.2003.11107804.x; Tamaru M, 1999, EUR J ENDOCRINOL, V141, P111, DOI 10.1530/eje.0.1410111; Tamaru M, 1999, EUR J ENDOCRINOL, V141, P625, DOI 10.1530/eje.0.1410625; Tao YH, 2006, FEMS IMMUNOL MED MIC, V47, P444, DOI 10.1111/j.1574-695X.2006.00108.x; VILLAVERDE DMS, 1992, ENDOCRINOLOGY, V131, P1313, DOI 10.1210/en.131.3.1313; Wang HC, 2001, CRIT REV IMMUNOL, V21, P323; Yamaguchi S, 1999, J MOL ENDOCRINOL, V22, P81, DOI 10.1677/jme.0.0220081; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yen PM, 2006, MOL CELL ENDOCRINOL, V246, P121, DOI 10.1016/j.mce.2005.11.030; Zhu XG, 1998, J BIOL CHEM, V273, P27058, DOI 10.1074/jbc.273.42.27058	60	64	70	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2008	22	4					1032	1042		10.1096/fj.07-8652com	http://dx.doi.org/10.1096/fj.07-8652com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	17991732				2022-12-25	WOS:000254581000009
J	Phartiyal, P; Sale, H; Jones, EMC; Robertson, GA				Phartiyal, Pallavi; Sale, Harinath; Jones, Eugenia M. C.; Robertson, Gail A.			Endoplasmic reticulum retention and rescue by heteromeric assembly regulate human ERG 1a/1b surface channel composition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; K+ CHANNEL; I-KR; MUTANT CHANNELS; HERG; TRAFFICKING; SIGNAL; MOUSE	Defects in the trafficking of subunits encoded by the human ether-a-go-go-related gene (hERG1) can lead to catastrophic arrhythmias and sudden cardiac death due to a reduction in I-Kr-mediated repolarization. Native I-Kr channels are composed of two alpha subunits, hERG 1a and 1b. In heterologous expression systems, hERG 1b subunits efficiently produce current only in heteromeric combination with hERG 1a. We used Western blot analysis and electrophysiological recordings in HEK-293 cells and Xenopus oocytes to monitor hERG 1b maturation in the secretory pathway and to determine the factors regulating surface expression of hERG 1b subunits. We found that 1b subunits expressed alone were largely retained in the endoplasmic reticulum (ER), thus accounting for the poor functional expression of homomeric 1b currents. Association with hERG 1a facilitated 1b ER export and surface expression. We show that hERG 1b subunits fail to mature because of an "RXR" ER retention signal specific to the 1b N terminus of the human sequence and not conserved in other species. Mutating the RXR facilitated maturation and functional expression of homomeric hERG 1b channels in a charge-dependent manner. Co-expression of the 1b RXR mutants with hERG 1a did not further enhance 1b maturation, suggesting that hERG 1a promotes 1b trafficking by overcoming the RXR-mediated retention. Thus, selective trafficking mechanisms regulate subunit composition of surface hERG channels.	[Phartiyal, Pallavi; Sale, Harinath; Jones, Eugenia M. C.; Robertson, Gail A.] Univ Wisconsin, Dept Physiol, Madison, WI 53711 USA; [Phartiyal, Pallavi] Univ Wisconsin, Cellular & Mol Biol Program, Madison, WI 53711 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Robertson, GA (corresponding author), Univ Wisconsin, Satillite Labs, 601 Sci Dr, Madison, WI 53711 USA.	robertson@physiology.wisc.edu		Robertson, Gail/0000-0003-4694-5790	NHLBI NIH HHS [R01HL081780] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081780] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Ficker E, 2000, AM J PHYSIOL-HEART C, V279, pH1748, DOI 10.1152/ajpheart.2000.279.4.H1748; Furutani M, 1999, CIRCULATION, V99, P2290, DOI 10.1161/01.CIR.99.17.2290; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Konstas AA, 2002, J BIOL CHEM, V277, P21346, DOI 10.1074/jbc.M202005200; Kupershmidt S, 2002, J BIOL CHEM, V277, P27442, DOI 10.1074/jbc.M112375200; Lees-Miller JP, 2003, MOL CELL BIOL, V23, P1856, DOI 10.1128/MCB.23.6.1856-1862.2003; LeesMiller JP, 1997, CIRC RES, V81, P719; London B, 1997, CIRC RES, V81, P870; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Phartiyal P, 2007, J BIOL CHEM, V282, P9874, DOI 10.1074/jbc.M610875200; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Viloria CG, 2000, BIOPHYS J, V79, P231, DOI 10.1016/S0006-3495(00)76286-2; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	23	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3702	3707		10.1074/jbc.M708999200	http://dx.doi.org/10.1074/jbc.M708999200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18048364	hybrid			2022-12-25	WOS:000253083500003
J	Kitagawa, N; Mazon, H; Heck, AJR; Wilkens, S				Kitagawa, Norton; Mazon, Hortense; Heck, Albert J. R.; Wilkens, Stephan			Stoichiometry of the peripheral stalk subunits E and G of yeast V-1-ATPase determined by mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; MEDIATED CROSS-LINKING; V-ATPASE; PROTEIN COMPLEXES; C VMA5P; LOCALIZATION; STATOR; FLIGHT; ACIDIFICATION; DOMAIN	The stoichiometry of yeast V-1-ATPase peripheral stalk subunits E and G was determined by two independent approaches using mass spectrometry (MS). First, the subunit ratio was inferred from measuring the molecular mass of the intact V-1-ATPase complex and each of the individual protein components, using native electrospray ionization-MS. The major observed intact complex had a mass of 593,600 Da, with minor components displaying masses of 553,550 and 428,300 Da, respectively. Second, defined amounts of V-1-ATPase purified from yeast grown on N-14-containing medium were titrated with defined amounts of N-15-labeled E and G subunits as internal standards. Following protease digestion of subunit bands, N-14- and N-15-containing peptide pairs were used for quantification of subunit stoichiometry using matrix-assisted laser desorption/ionization-time of flight MS. Results from both approaches are in excellent agreement and reveal that the subunit composition of yeast V-1-ATPase is A(3)B(3)DE(3)FG(3)H.	[Kitagawa, Norton; Wilkens, Stephan] SUNY Syracuse, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Kitagawa, Norton] Univ Calif Riverside, Cept Cell Mol & Dev Biol, Riverside, CA 92521 USA; [Mazon, Hortense; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmacuet Sci, NL-3584 CA Utrecht, Netherlands; [Mazon, Hortense; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Biomol Mass Spectrometry, NL-3584 CA Utrecht, Netherlands	State University of New York (SUNY) System; University of California System; University of California Riverside; Utrecht University; Utrecht University	Wilkens, S (corresponding author), SUNY Syracuse, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu	Heck, Albert/D-7098-2011	Heck, Albert/0000-0002-2405-4404	NCI NIH HHS [CA100246] Funding Source: Medline; NIGMS NIH HHS [GM58600] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arata Y, 2002, BIOCHEMISTRY-US, V41, P11301, DOI 10.1021/bi0262449; Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; Bronstrup M, 2004, EXPERT REV PROTEOMIC, V1, P503, DOI 10.1586/14789450.1.4.503; Chernushevich IV, 2004, ANAL CHEM, V76, P1754, DOI 10.1021/ac035406j; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; Dunn SD, 2000, BBA-BIOENERGETICS, V1458, P356, DOI 10.1016/S0005-2728(00)00086-4; Fethiere J, 2005, BIOCHEMISTRY-US, V44, P15906, DOI 10.1021/bi051762f; Fethiere J, 2004, J BIOL CHEM, V279, P40670, DOI 10.1074/jbc.M407086200; Finbow ME, 1997, BIOCHEM J, V324, P697, DOI 10.1042/bj3240697; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOUGH B, 2006, GNU SCI LIB REFERENC; Gras R, 1999, ELECTROPHORESIS, V20, P3535, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3535::AID-ELPS3535>3.3.CO;2-A; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Heck AJR, 2004, EXPERT REV PROTEOMIC, V1, P317, DOI 10.1586/14789450.1.3.317; Heck AJR, 2004, MASS SPECTROM REV, V23, P368, DOI 10.1002/mas.10081; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; HO MN, 1993, J BIOL CHEM, V268, P18286; Hochleitner EO, 2005, J BIOL CHEM, V280, P2536, DOI 10.1074/jbc.M409587200; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Jones RPO, 2005, BIOCHEMISTRY-US, V44, P3933, DOI 10.1021/bi048402x; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kito K, 2007, J PROTEOME RES, V6, P792, DOI 10.1021/pr060447s; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Lorenzen K, 2007, INT J MASS SPECTROM, V268, P198, DOI 10.1016/j.ijms.2007.06.012; Lu M, 2002, J BIOL CHEM, V277, P38409, DOI 10.1074/jbc.M203521200; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; Pan Sheng, 2007, Methods Mol Biol, V367, P209; Robinson CV, 2002, NAT STRUCT BIOL, V9, P505, DOI 10.1038/nsb0702-505; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Sobott F, 2005, PHILOS T R SOC A, V363, P379, DOI 10.1098/rsta.2004.1498; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Synowsky SA, 2006, MOL CELL PROTEOMICS, V5, P1581, DOI 10.1074/mcp.M600043-MCP200; Tahallah N, 2001, RAPID COMMUN MASS SP, V15, P596, DOI 10.1002/rcm.275; van den Heuvel RH, 2004, CURR OPIN CHEM BIOL, V8, P519, DOI 10.1016/j.cbpa.2004.08.006; van den Heuvel RHH, 2006, ANAL CHEM, V78, P7473, DOI 10.1021/ac061039a; Wilkens S, 2000, J MOL BIOL, V295, P387, DOI 10.1006/jmbi.1999.3381; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Xu T, 1999, J BIOL CHEM, V274, P28909, DOI 10.1074/jbc.274.41.28909; Zhang ZY, 2006, FEBS LETT, V580, P2006, DOI 10.1016/j.febslet.2006.03.001; Zhang ZY, 2003, J BIOL CHEM, V278, P47299, DOI 10.1074/jbc.M309445200	48	79	80	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3329	3337		10.1074/jbc.M707924200	http://dx.doi.org/10.1074/jbc.M707924200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18055462	hybrid			2022-12-25	WOS:000253083000037
J	Sasaki, N; Okishio, K; Ui-Tei, K; Saigo, K; Kinoshita-Toyoda, A; Toyoda, H; Nishimura, T; Suda, Y; Hayasaka, M; Hanaoka, K; Hitoshi, S; Ikenaka, K; Nishihara, S				Sasaki, Norihiko; Okishio, Kazuhiko; Ui-Tei, Kumiko; Saigo, Kaoru; Kinoshita-Toyoda, Akiko; Toyoda, Hidenao; Nishimura, Tomoaki; Suda, Yasuo; Hayasaka, Michiko; Hanaoka, Kazunari; Hitoshi, Seiji; Ikenaka, Kazuhiro; Nishihara, Shoko			Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR SUPPRESSORS EXT1; MOUSE EMBRYOS; TOUT-VELU; ES CELLS; DIFFERENTIATION; ACTIVATION; EXPRESSION; DROSOPHILA; NANOG; STAT3	Embryonic stem (ES) cell self-renewal and pluripotency are maintained by several signaling cascades and by expression of intrinsic factors, such as Oct3/4 and Nanog. The signaling cascades are activated by extrinsic factors, such as leukemia inhibitory factor, bone morphogenic protein, and Wnt. However, the mechanism that regulates extrinsic signaling in ES cells is unknown. Heparan sulfate (HS) chains are ubiquitously present as the cell surface proteoglycans and are known to play crucial roles in regulating several signaling pathways. Here we investigated whether HS chains on ES cells are involved in regulating signaling pathways that are important for the maintenance of ES cells. RNA interference-mediated knockdown of HS chain elongation inhibited mouse ES cell self-renewal and induced spontaneous differentiation of the cells into extraembryonic endoderm. Furthermore, autocrine/paracrine Wnt/beta-catenin signaling through HS chains was found to be required for the regulation of Nanog expression. We propose that HS chains are important for the extrinsic signaling required for mouse ES cell self-renewal and pluripotency.	[Sasaki, Norihiko; Okishio, Kazuhiko; Nishimura, Tomoaki; Suda, Yasuo; Nishihara, Shoko] Soka Univ, Cell Biol Lab, Dept Bioinformat, Fac Engn, Tokyo 1928577, Japan; [Ui-Tei, Kumiko; Saigo, Kaoru] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Toyoda, Hidenao; Nishimura, Tomoaki] Chiba Univ, Grad Sch Pharmaceut Sci, DEpt Bioanal Chem, Chiba 2638522, Japan; [Nishimura, Tomoaki; Suda, Yasuo] Kagoshima Univ, DEpt Nanostruct & Adv Mat, Grad Sch Sci & Engn, Kagoshima 8900065, Japan; [Nishimura, Tomoaki; Suda, Yasuo] Sudx Biotec Corp, Kobe, Hyogo 6500047, Japan; [Hayasaka, Michiko; Hanaoka, Kazunari] Kitasato Univ, Sch Sci, Mol Embryol Lab, Dept Biosci, Kanagawa 228, Japan; [Hitoshi, Seiji; Ikenaka, Kazuhiro] Natl Inst Physiol Sci, Div Neurobiol & Bioinformat, Aichi 4448585, Japan; [Sasaki, Norihiko; Kinoshita-Toyoda, Akiko; Toyoda, Hidenao; Suda, Yasuo; Nishihara, Shoko] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Soka University; University of Tokyo; Chiba University; Kagoshima University; Kitasato University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST)	Nishihara, S (corresponding author), Soka Univ, Cell Biol Lab, Dept Bioinformat, Fac Engn, 1-236 Tangi Cho, Tokyo 1928577, Japan.	shoko@t.soka.ac.jp		Nishihara, Shoko/0000-0002-1668-2603				Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Boeuf H, 1997, J CELL BIOL, V138, P1207, DOI 10.1083/jcb.138.6.1207; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Garcia-Garcia MJ, 2003, CELL, V114, P727, DOI 10.1016/S0092-8674(03)00715-3; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mummery RS, 2000, J IMMUNOL, V165, P5671, DOI 10.4049/jimmunol.165.10.5671; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Panchision DM, 2002, CURR OPIN GENET DEV, V12, P478, DOI 10.1016/S0959-437X(02)00329-5; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; SMITH AG, 1987, DEV BIOL, V121, P1, DOI 10.1016/0012-1606(87)90132-1; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Suda Y, 2006, BIOCONJUGATE CHEM, V17, P1125, DOI 10.1021/bc0600620; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; WICKLUND CL, 1995, AM J MED GENET, V55, P43, DOI 10.1002/ajmg.1320550113; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	51	79	83	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3594	3606		10.1074/jbc.M705621200	http://dx.doi.org/10.1074/jbc.M705621200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18024963	hybrid			2022-12-25	WOS:000253083000065
J	Fredenburgh, JC; Stafford, AR; Leslie, BA; Weitz, JI				Fredenburgh, James C.; Stafford, Alan R.; Leslie, Beverly A.; Weitz, Jeffrey I.			Bivalent binding to gamma a/gamma ' fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; BOUND THROMBIN; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; CATALYTIC SITE; PLASMA; INACTIVATION; AFFINITY; MODULATION; RESISTANCE	Thrombin exosite 1 binds the predominant gamma(A)/gamma(A)-fibrin form with low affinity. A subpopulation of fibrin molecules, gamma(A)/gamma '-fibrin, has an extended COOH terminus gamma '-chain that binds exosite 2 of thrombin. Bivalent binding to gamma A/gamma '-fibrin increases the affinity of thrombin 10-fold, as determined by surface plasmon resonance. Because of its higher affinity, thrombin dissociates 7-fold more slowly from gamma(A)/gamma '-fibrin clots than from gamma(A)/gamma '-fibrin clots. After 24 h of washing, however, both gamma(A)/gamma '- and gamma(A)/gamma(A)-fibrin clots generate fibrinopeptide A when incubated with fibrinogen, indicating the retention of active thrombin. Previous studies demonstrated that heparin heightens the affinity of thrombin for fibrin by simultaneously binding to fibrin and exosite 2 on thrombin to generate a ternary heparin-thrombin-fibrin complex that protects thrombin from inhibition by antithrombin and heparin cofactor II. In contrast, dermatan sulfate does not promote ternary complex formation because it does not bind to fibrin. Heparin-catalyzed rates of thrombin inhibition by antithrombin were 5-fold slower in gamma(A)/gamma-fibrin clots than they were in gamma(A)/gamma(A)-fibrin clots. This difference reflects bivalent binding of thrombin to gamma(A)/gamma '-fibrin because (a) it is abolished by addition of a gamma '-chain-directed antibody that blocks exosite 2-mediated binding of thrombin to the gamma '-chain and (b) the dermatan sulfate-catalyzed rate of thrombin inhibition by heparin cofactor II also is lower with gamma(A)/gamma '-fibrin than with gamma(A)/gamma '-fibrin clots. Thus, bivalent binding of thrombin to gamma(A)/gamma '-fibrin protects thrombin from inhibition, raising the possibility that gamma(A)/gamma '-fibrin serves as a reservoir of active thrombin that renders thrombi thrombogenic.	[Fredenburgh, James C.; Stafford, Alan R.; Leslie, Beverly A.; Weitz, Jeffrey I.] Henderson Res Ctr, Hamilton, ON L8V 1C3, Canada; [Fredenburgh, James C.; Stafford, Alan R.; Leslie, Beverly A.; Weitz, Jeffrey I.] McMaster Univ, Hamilton, ON L8V 1C3, Canada	McMaster University	Weitz, JI (corresponding author), 711 Concess St, Hamilton, ON L8V 1C3, Canada.	jweitz@thrombosis.hhscr.org	Weitz, Jeffrey/AAD-1929-2019	Weitz, Jeffrey/0000-0002-1092-7550				Adams TE, 2006, ARTERIOSCL THROM VAS, V26, P1738, DOI 10.1161/01.ATV.0000228844.65168.d1; Agnelli G, 2002, HAEMATOLOGICA, V87, P757; Becker DL, 1999, J BIOL CHEM, V274, P6226, DOI 10.1074/jbc.274.10.6226; Becker DL, 1997, ADV EXP MED BIOL, V425, P55; Bode W, 2006, SEMIN THROMB HEMOST, V32, P16, DOI 10.1055/s-2006-939551; Celikel R, 2003, SCIENCE, V301, P218, DOI 10.1126/science.1084183; Cooper AV, 2003, BLOOD, V102, P535, DOI 10.1182/blood-2002-10-3150; de Bosch NB, 2002, THROMB HAEMOSTASIS, V88, P253; De Candia E, 2001, J BIOL CHEM, V276, P4692, DOI 10.1074/jbc.M008160200; De Cristofaro R, 1998, CIRCULATION, V98, P1297, DOI 10.1161/01.CIR.98.13.1297; de Willige SU, 2005, BLOOD, V106, P4176, DOI 10.1182/blood-2005-05-2180; DIAMOND SL, 1993, BIOPHYS J, V65, P2622, DOI 10.1016/S0006-3495(93)81314-6; Dumas JJ, 2003, SCIENCE, V301, P222, DOI 10.1126/science.1083917; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; Falls LA, 1997, J BIOL CHEM, V272, P14251, DOI 10.1074/jbc.272.22.14251; Fredenburgh JC, 2004, BIOPHYS CHEM, V112, P277, DOI 10.1016/j.bpc.2004.07.031; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; Hogg PJ, 1996, J BIOL CHEM, V271, P26088, DOI 10.1074/jbc.271.42.26088; Hogg PJ, 1997, THROMB HAEMOSTASIS, V77, P424; Kerlin B, 2004, BLOOD, V103, P1728, DOI 10.1182/blood-2003-08-2886; KEYT BA, 1992, ANAL BIOCHEM, V206, P73, DOI 10.1016/S0003-2697(05)80013-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; Liaw PCY, 2001, J BIOL CHEM, V276, P20959, DOI 10.1074/jbc.M010584200; Lovely RS, 2003, J THROMB HAEMOST, V1, P124, DOI 10.1046/j.1538-7836.2003.00027.x; Lovely RS, 2002, THROMB HAEMOSTASIS, V88, P26; Luo J, 2001, J BIOCHEM-TOKYO, V130, P553, DOI 10.1093/oxfordjournals.jbchem.a003018; Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC; Mannila MN, 2007, J THROMB HAEMOST, V5, P766, DOI 10.1111/j.1538-7836.2007.02406.x; Meh DA, 2001, THROMB HAEMOSTASIS, V85, P470; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; Monteiro RQ, 1999, BIOCHEM BIOPH RES CO, V262, P819, DOI 10.1006/bbrc.1999.1297; Mosesson MW, 2007, J THROMB HAEMOST, V5, P62, DOI 10.1111/j.1538-7836.2006.02270.x; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Mutch NJ, 2001, THROMB HAEMOSTASIS, V86, P1028; Page MJ, 2005, J THROMB HAEMOST, V3, P2401, DOI 10.1111/j.1538-7836.2005.01456.x; Pechik I, 2004, P NATL ACAD SCI USA, V101, P2718, DOI 10.1073/pnas.0303440101; Pike RN, 2005, FEBS J, V272, P4842, DOI 10.1111/j.1742-4658.2005.04880.x; Pineda AO, 2007, BIOPHYS CHEM, V125, P556, DOI 10.1016/j.bpc.2006.08.005; Pospisil CH, 2003, J BIOL CHEM, V278, P21584, DOI 10.1074/jbc.M300545200; Siebenlist KR, 2005, BLOOD, V106, P2730, DOI 10.1182/blood-2005-01-0240; Siebenlist KR, 1996, BIOCHEMISTRY-US, V35, P10448, DOI 10.1021/bi9606206; WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723; Weitz JI, 2002, CIRCULATION, V105, P1004, DOI 10.1161/hc0802.104331; WOLFENSTEINTODEL C, 1981, BIOCHEMISTRY-US, V20, P6146, DOI 10.1021/bi00524a036; YE J, 1994, J BIOL CHEM, V269, P17965	46	50	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2470	2477		10.1074/jbc.M707710200	http://dx.doi.org/10.1074/jbc.M707710200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18055456	hybrid			2022-12-25	WOS:000252622300003
J	Morris, DP; Lei, B; Wu, YX; Michelotti, GA; Schwinn, DA				Morris, Daniel P.; Lei, Beilei; Wu, Yue-Xuan; Michelotti, Gregory A.; Schwinn, Debra A.			The alpha(1a)-adrenergic receptor occupies membrane rafts with its G protein effectors but internalizes via clathrin-coated pits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; RESONANCE ENERGY-TRANSFER; LIPID RAFTS; SIGNALING PATHWAY; SMOOTH-MUSCLE; ACTIN CYTOSKELETON; COUPLED RECEPTORS; CARDIAC MYOCYTES; ADENYLYL-CYCLASE; MYOCARDIAL-CELLS	The alpha(1a)-adrenergic receptor (alpha(1a)AR) occupies intracellular and plasma membranes in both native and heterologous expression systems. Based on multiple independent lines of evidence, we demonstrate the alpha(1a)AR at the cell surface occupies membrane rafts but exits from rafts following stimulation. In non-detergent raft preparations, basal alpha(1a)AR is present in low density membrane rafts and colocalizes with its G protein effectors on density gradients. Raft disruption by cholesterol depletion with methyl-beta-cyclodextrin eliminates these light rafts. To confirm the presence of the alpha(1a)AR in plasma membrane rafts, fluorescence resonance energy transfer measurements were used to demonstrate colocalization of surface receptor and the raft marker, cholera toxin B. This colocalization was largely lost following alpha(1a)AR stimulation with phenylephrine. Similarly, receptor stimulation causes exit of the alpha(1a)AR from light rafts within 3-10 min in contrast to the G proteins, which largely remain in light rafts. Importantly, this delayed exit of the alpha(1a)AR suggests acute receptor signaling and desensitization occur entirely within rafts. Interestingly, both confocal analysis and measurement of surface alpha(1a)AR levels indicate modest receptor internalization during the 10 min following stimulation, suggesting most of the receptor has entered non-raft plasma membrane. Nevertheless, activation does increase the rate of receptor internalization as does disruption of rafts with methyl-beta-cyclodextrin, suggesting raft exit enables internalization. Confocal analysis of surface-labeled hemagglutinin-alpha(1a)AR reveals that basal and stimulated receptor occupies clathrin pits in fixed cells consistent with previous indirect evidence. The evidence presented here strongly suggests the alpha(1a)AR is a lipid raft protein under basal conditions and implies agonist-mediated signaling occurs from rafts.	[Morris, Daniel P.; Lei, Beilei; Wu, Yue-Xuan; Michelotti, Gregory A.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Schwinn, Debra A.] Univ Washington, Dept Anesthesiol Pharmacol & Genome Sci, Seattle, WA 98195 USA	Duke University; University of Washington; University of Washington Seattle	Morris, DP (corresponding author), 595 LaSalle St,Ste 1027, Durham, NC 27710 USA.	morri082@mc.duke.edu		Michelotti, Gregory/0000-0002-7908-1979; Schwinn, Debra/0000-0002-9696-5231	NHLBI NIH HHS [R01 HL049103, R37 HL049103-13, R37 HL049103-12, R37 HL049103-14, HL 49103, R37 HL049103-11, R37 HL049103] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049103, R01HL049103] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Blank N, 2007, IMMUNOL CELL BIOL, V85, P378, DOI 10.1038/sj.icb.7100045; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x; Christian AE, 1999, J LIPID RES, V40, P1475; Clarke CJ, 2007, AM J PHYSIOL-HEART C, V292, pH2248, DOI 10.1152/ajpheart.01170.2006; Devaux PF, 2004, TRAFFIC, V5, P241, DOI 10.1111/j.1600-0854.2004.0170.x; Dreja K, 2002, ARTERIOSCL THROM VAS, V22, P1267, DOI 10.1161/01.ATV.0000023438.32585.A1; Fernandez-Patron C, 2007, CAN J PHYSIOL PHARM, V85, P97, DOI 10.1139/Y06-097; FONSECA MI, 1995, J BIOL CHEM, V270, P8902, DOI 10.1074/jbc.270.15.8902; Fujita T, 2001, CARDIOVASC RES, V51, P709, DOI 10.1016/S0008-6363(01)00348-0; Gamper N, 2007, J PHYSIOL-LONDON, V582, P967, DOI 10.1113/jphysiol.2007.132787; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Holowka D, 2000, J CELL SCI, V113, P1009; Huang Y, 2007, CIRCULATION, V115, P763, DOI 10.1161/CIRCULATIONAHA.106.664862; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; Keys JR, 2002, HYPERTENSION, V40, P660, DOI 10.1161/01.HYP.0000035397.73223.CE; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lanzafame AA, 2006, AM J PHYSIOL-HEART C, V290, pH2059, DOI 10.1152/ajpheart.01210.2005; Lee DW, 2006, J CELL SCI, V119, P3502, DOI 10.1242/jcs.03092; LEEBLUNDBERG LMF, 1987, J BIOL CHEM, V262, P3098; Lei B, 2005, N-S ARCH PHARMACOL, V371, P229, DOI 10.1007/s00210-005-1019-9; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Mackenzie JF, 2000, J PHARMACOL EXP THER, V294, P434; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; Morris DP, 2004, MOL PHARMACOL, V66, P843, DOI 10.1124/mol.104.000430; Morris JB, 2006, J MOL CELL CARDIOL, V41, P17, DOI 10.1016/j.yjmcc.2006.03.011; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pediani JD, 2005, MOL PHARMACOL, V67, P992, DOI 10.1124/mol.104.008417; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; Price RR, 2002, J BIOL CHEM, V277, P9570, DOI 10.1074/jbc.M111762200; Roepstorff K, 2002, J BIOL CHEM, V277, P18954, DOI 10.1074/jbc.M201422200; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Saeed AE, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-47; Salter-Cid L, 1999, P NATL ACAD SCI USA, V96, P5434, DOI 10.1073/pnas.96.10.5434; SCHWINN DA, 1991, MOL PHARMACOL, V40, P619; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; SIMPSON P, 1983, J CLIN INVEST, V72, P732, DOI 10.1172/JCI111023; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; SORKIN A, 1993, BIOESSAYS, V15, P375, DOI 10.1002/bies.950150603; Sundaram M, 2004, BIOCHEM CELL BIOL, V82, P191, DOI 10.1139/o03-087; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; Vazquez-Prado J, 2000, J BIOL CHEM, V275, P6553, DOI 10.1074/jbc.275.9.6553; VENEMA RC, 1993, J BIOL CHEM, V268, P2705; Vicentic A, 2002, J PHARMACOL EXP THER, V302, P58, DOI 10.1124/jpet.302.1.58; Waugh MG, 1999, BIOCHEM J, V337, P591, DOI 10.1042/0264-6021:3370591; Werlen G, 2002, CURR OPIN IMMUNOL, V14, P299, DOI 10.1016/S0952-7915(02)00339-4; Wu XF, 2001, J CELL BIOL, V155, P291, DOI 10.1083/jcb.200104085; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Zhang H, 2004, CIRC RES, V95, P989, DOI 10.1161/01.RES.0000147962.01036.bb	67	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2973	2985		10.1074/jbc.M705795200	http://dx.doi.org/10.1074/jbc.M705795200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18048357	Green Accepted, hybrid			2022-12-25	WOS:000252622300053
J	Cheng, TS; Hsiao, YL; Lin, CC; Yu, CTR; Hsu, CM; Chang, MS; Lee, CI; Huang, CYF; Howng, SL; Hong, YR				Cheng, Tai-Shan; Hsiao, Yun-Ling; Lin, Ching-Chih; Yu, Chang-Tze Ricky; Hsu, Ching-Mei; Chang, Mau-Sun; Lee, Chu-I; Huang, Chi-Ying F.; Howng, Shen-Long; Hong, Yi-Ren			Glycogen synthase kinase 3 beta interacts with and phosphorylates the spindle-associated protein astrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED-MAMMALIAN-CELLS; HUMAN NINEIN PROTEIN; MITOTIC-SPINDLE; ALZHEIMERS-DISEASE; CHROMOSOME SEGREGATION; 2-HYBRID SYSTEM; GENETIC SYSTEM; KINASE 3-BETA; BETA-CATENIN; TAU	Emerging evidence shows that glycogen synthase kinase 3 beta (GSK3 beta) is involved in mitotic division and that inhibiting of GSK3 beta kinase activity causes defects in spindle microtubule length and chromosome alignment. However, the purpose of GSK3 beta involvement in spindle microtubule assembly and accurate chromosome segregation remains obscure. Here, we report that GSK3 beta interacts with the spindle- associated protein Astrin both in vitro and in vivo. Additionally, Astrin acts as a substrate for GSK3 beta and is phosphorylated at Thr- 111, Thr- 937 ((S/ T) P motif) and Ser- 974/ Thr-978 ((S/ T) XXX(S/T)- p motif; p is a phosphorylatable residue). Inhibition of GSK3 beta impairs spindle and kinetochore accumulation of Astrin and spindle formation at mitosis, suggesting that Astrin association with the spindle microtubule and kinetochore may be dependent on phosphorylation by GSK3 beta. Conversely, depletion of Astrin by small interfering RNA has no detectable influence on the localization of GSK3 beta. Interestingly, in vitro assays demonstrated that Astrin enhances GSK3 beta- mediated phosphorylation of other substrates. Moreover, we showed that coexpression of Astrin and GSK3 beta differentially increases GSK3 beta- mediated Tau phosphorylation on an unprimed site. Collectively, these data indicate that GSK3 beta interacts with and phosphorylates the spindle- associated protein Astrin, resulting in targeting Astrin to the spindle microtubules and kinetochores. In turn, the GSK3 beta-Astrin complex may facilitate further physiological and pathological phosphorylation.	[Cheng, Tai-Shan; Hsiao, Yun-Ling; Lin, Ching-Chih; Hsu, Ching-Mei; Hong, Yi-Ren] Kaohsiung Med Univ, Grad Inst Biochem, Kaohsiung 807, Taiwan; [Cheng, Tai-Shan; Hsiao, Yun-Ling; Lin, Ching-Chih; Hsu, Ching-Mei; Hong, Yi-Ren] Kaohsiung Med Univ, Grant Inst Med, Kaohsiung 807, Taiwan; [Lin, Ching-Chih] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 807, Taiwan; [Yu, Chang-Tze Ricky] Natl Chi Nan Univ, Grad Inst Biomed & Biomed Technol, Nantou 545, Taiwan; [Chang, Mau-Sun] Mackay Mem Hosp, Dept Med Res, Taipei 104, Taiwan; [Lee, Chu-I] Fooyin Univ, Dept Med Technol, Kaohsiung 831, Taiwan; [Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Howng, Shen-Long] Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung 807, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; National Chi Nan University; Mackay Memorial Hospital; Fooyin University; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Hong, YR (corresponding author), Kaohsiung Med Univ, Grad Inst Biochem, 100 Shih Chuan 1st Rd, Kaohsiung 807, Taiwan.	m835016@cc.kmu.edu.tw	Howng, Shen-Long/D-5502-2009; Huang, Chi-Ying/AAG-7672-2022; Huang, Chi-Ying/AFL-7729-2022; Hong, Yi-Ren/D-5514-2009	Huang, Chi-Ying/0000-0003-4898-4937; Huang, Chi-Ying/0000-0003-4898-4937; Hong, Yi-Ren/0000-0001-5470-6090; CHANG, MAU-SUN/0000-0002-3703-2386				Abraha A, 2000, J CELL SCI, V113, P3737; Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Chang MS, 2001, BIOCHEM BIOPH RES CO, V287, P116, DOI 10.1006/bbrc.2001.5554; Chen CH, 2003, BIOCHEM BIOPH RES CO, V308, P975, DOI 10.1016/S0006-291X(03)01510-9; Cheng TS, 2007, EXP CELL RES, V313, P1710, DOI 10.1016/j.yexcr.2007.02.023; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Chou HY, 2006, BIOCHEMISTRY-US, V45, P11379, DOI 10.1021/bi061147r; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cohen P, 1999, PHILOS T R SOC B, V354, P485, DOI 10.1098/rstb.1999.0399; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Delobel P, 2002, J NEUROCHEM, V83, P412, DOI 10.1046/j.1471-4159.2002.01143.x; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Goold RG, 2005, MOL CELL NEUROSCI, V28, P524, DOI 10.1016/j.mcn.2004.11.005; Goold RG, 1999, J CELL SCI, V112, P3373; Gruber J, 2002, J CELL SCI, V115, P4053, DOI 10.1242/jcs.00088; Harborth J, 2001, J CELL SCI, V114, P4557; Hong YR, 2000, BBA-GENE STRUCT EXPR, V1492, P513, DOI 10.1016/S0167-4781(00)00127-5; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Liang MH, 2007, J BIOL CHEM, V282, P3904, DOI 10.1074/jbc.M605178200; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; Lin CC, 2006, CELL CYCLE, V5, P2517, DOI 10.4161/cc.5.21.3404; Lovestone S, 1996, NEUROSCIENCE, V73, P1145, DOI 10.1016/0306-4522(96)00126-1; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Mayor T, 1999, FEBS LETT, V452, P92, DOI 10.1016/S0014-5793(99)00534-7; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; POPE WB, 1994, EXP NEUROL, V126, P185, DOI 10.1006/exnr.1994.1057; PREUSS U, 1995, MOL BIOL CELL, V6, P1397, DOI 10.1091/mbc.6.10.1397; Sanchez C, 2000, EUR J CELL BIOL, V79, P252, DOI 10.1078/S0171-9335(04)70028-X; SONG JS, 1995, J PROTEIN CHEM, V14, P95, DOI 10.1007/BF01888367; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Thein KH, 2007, J CELL BIOL, V178, P345, DOI 10.1083/jcb.200701163; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; Tighe A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-34; Vincent I, 1996, J CELL BIOL, V132, P413, DOI 10.1083/jcb.132.3.413; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; WANG QM, 1994, BIOCHEMISTRY-US, V33, P143, DOI 10.1021/bi00167a018; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301; Zhu L, 1997, Methods Mol Biol, V63, P173	55	27	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2454	2464		10.1074/jbc.M706794200	http://dx.doi.org/10.1074/jbc.M706794200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18055457	hybrid, Green Submitted			2022-12-25	WOS:000252501000071
J	Maytum, R; Hatch, V; Konrad, M; Lehman, W; Geeves, MA				Maytum, Robin; Hatch, Victoria; Konrad, Manfred; Lehman, William; Geeves, Michael A.			Ultra short yeast tropomyosins show novel myosin regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE THIN-FILAMENTS; ACTIN-BINDING SITES; ALPHA-TROPOMYOSIN; SMOOTH-MUSCLE; STRIATED-MUSCLE; ESCHERICHIA-COLI; SKELETAL-MUSCLE; COILED-COIL; F-ACTIN; COOPERATIVE REGULATION	Tropomyosin (Tm) is an alpha-helical coiled-coil actin-binding protein present in all eukaryotes from yeast to man. Its functional role has been best described in muscle regulation; however its much wider role in cytoskeletal actin regulation is still to be clarified. Isoforms vary in size from 284 or 248 amino acids in vertebrates, to 199 and 161 amino acids in yeast, spanning from 7 to 4 actin binding sites respectively. In Saccharomyces cerevisiae, the larger yTm1 protein is produced by an internal 38-amino acid duplication, corresponding to a single actin-binding site. We have produced an ultra-short Tm with only 125 amino acids by removing both of the 38 amino acid repeats from yTm1, with the addition of an Ala-Ser extension used to mimic the essential N-terminal acetylation. This short Tm, and an M1T mutant of it, bind to actin with a similar affinity to most Tms previously studied (K-50% similar to 0.5 mu M). However, an equilibrium fluorescence binding assay shows a much greater inhibition of myosin binding to actin than any previously studied Tm. Actin cosedimentation assays show this is caused by direct competition for binding to actin. The M1T mutant shows a reduced inhibition, probably due to weaker end-to-end interactions making it easier for myosin to displace Tm. All previously characterized Tms, although able to sterically block the myosin-binding site, are able to bind to actin along with myosin. By showing that Tm can compete directly with myosin for the same binding site these new Tms provide direct evidence for the steric blocking model.	[Maytum, Robin] Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Hatch, Victoria; Lehman, William] Max Planck Inst Biophys Chem, Inst Biophys Chem, D-73070 Gottingen, Germany; [Hatch, Victoria; Lehman, William] Boston Univ, Dept Physiol & Biophys, Boston, MA 02118 USA; [Geeves, Michael A.] Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England	University of London; Max Planck Society; Boston University; University of Kent	Maytum, R (corresponding author), Univ London, Sch Biol & Chem Sci, London E1 4NS, England.	r.maytum@qmul.ac.uk	Geeves, Michael/F-7583-2011	Geeves, Michael/0000-0002-9364-8898; Maytum, Robin/0000-0003-0395-403X; Lehman, William/0000-0002-9430-9521	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036153, P01HL086655, R01HL036153, R55HL036153] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL86655, HL36153] Funding Source: Medline; Wellcome Trust [055881] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome TrustEuropean Commission)		AMOS LA, 1975, J MOL BIOL, V99, P51, DOI 10.1016/S0022-2836(75)80158-6; Ansari S, 2003, J MUSCLE RES CELL M, V24, P513, DOI 10.1023/B:JURE.0000009812.74980.13; BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0; Borovikov YS, 2001, INT J BIOCHEM CELL B, V33, P1151, DOI 10.1016/S1357-2725(01)00091-7; Cassell M, 1996, J BIOL CHEM, V271, P12867, DOI 10.1074/jbc.271.22.12867; Chen YD, 2001, BIOPHYS J, V80, P2338, DOI 10.1016/S0006-3495(01)76204-2; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; DEROSIER DJ, 1970, J MOL BIOL, V52, P355, DOI 10.1016/0022-2836(70)90036-7; DREES B, 1995, J CELL BIOL, V128, P383, DOI 10.1083/jcb.128.3.383; EATON BL, 1976, SCIENCE, V192, P1337, DOI 10.1126/science.131972; EGELMAN EH, 1986, ULTRAMICROSCOPY, V19, P367, DOI 10.1016/0304-3991(86)90096-3; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Greenfield NJ, 1995, BIOCHEMISTRY-US, V34, P16797, DOI 10.1021/bi00051a030; GREENFIELD NJ, 1993, PROTEIN SCI, V2, P1263, DOI 10.1002/pro.5560020809; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; Hammell RL, 1996, J BIOL CHEM, V271, P4236; Hammell RL, 1997, J BIOL CHEM, V272, P22409, DOI 10.1074/jbc.272.36.22409; Haselgrove J. C., 1972, COLD SPRING HARB SYM, V37, P341; HEELEY DH, 1987, J BIOL CHEM, V262, P9971; Hitchcock-DeGregori SE, 2001, BIOCHEMISTRY-US, V40, P2104, DOI 10.1021/bi002421z; HitchcockDeGregori SE, 1996, J BIOL CHEM, V271, P3600; HITCHCOCKDEGREGORI SE, 1990, J MOL BIOL, V214, P885, DOI 10.1016/0022-2836(90)90343-K; HITCHCOCKDEGREGORI SE, 1987, J BIOL CHEM, V262, P9730; Hodgkinson JL, 1997, BIOPHYS J, V72, P2398, DOI 10.1016/S0006-3495(97)78885-4; HOLMES KC, 1993, ADV EXP MED BIOL, V332, P15; Huxley H. E., 1972, COLD SPRING HARB SYM, V37, P361; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landis C, 1999, J BIOL CHEM, V274, P31279, DOI 10.1074/jbc.274.44.31279; Landis CA, 1997, J BIOL CHEM, V272, P14051, DOI 10.1074/jbc.272.22.14051; LEESMILLER JP, 1991, BIOESSAYS, V13, P429, DOI 10.1002/bies.950130902; Lehman W, 2000, J MOL BIOL, V302, P593, DOI 10.1006/jmbi.2000.4080; Lehrer SS, 1997, BIOCHEMISTRY-US, V36, P13449, DOI 10.1021/bi971568w; LIU H, 1989, CELL, V57, P233, DOI 10.1016/0092-8674(89)90961-6; LIU HP, 1989, P NATL ACAD SCI USA, V86, P90, DOI 10.1073/pnas.86.1.90; Maytum R, 2000, BIOCHEMISTRY-US, V39, P11913, DOI 10.1021/bi000977g; Maytum R, 1999, BIOCHEMISTRY-US, V38, P1102, DOI 10.1021/bi981603e; Maytum R, 2003, BIOPHYS J, V84, p319A; Maytum R, 2003, J BIOL CHEM, V278, P6696, DOI 10.1074/jbc.M210690200; Maytum R, 2001, BIOCHEMISTRY-US, V40, P7334, DOI 10.1021/bi010072i; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MCLACHLAN AD, 1976, J MOL BIOL, V103, P271, DOI 10.1016/0022-2836(76)90313-2; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; MOODY C, 1990, J MUSCLE RES CELL M, V11, P176, DOI 10.1007/BF01766496; Moraczewska J, 2000, BIOCHEMISTRY-US, V39, P6891, DOI 10.1021/bi000242b; Moraczewska J, 1999, BIOCHEMISTRY-US, V38, P15885, DOI 10.1021/bi991816j; NOVY RE, 1993, BIOCHIM BIOPHYS ACTA, V1162, P255, DOI 10.1016/0167-4838(93)90289-4; Owen CH, 1996, J STRUCT BIOL, V116, P167, DOI 10.1006/jsbi.1996.0027; Palm T, 2003, BIOPHYS J, V84, P3181, DOI 10.1016/S0006-3495(03)70042-3; PHILLIPS GN, 1979, NATURE, V278, P413, DOI 10.1038/278413a0; PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7; PITTENGER MF, 1992, J CELL BIOL, V118, P841, DOI 10.1083/jcb.118.4.841; Resetar AM, 2002, BIOPHYS J, V83, P1039, DOI 10.1016/S0006-3495(02)75229-6; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Smith DA, 2003, BIOPHYS J, V84, P3155, DOI 10.1016/S0006-3495(03)70040-X; Smith DA, 2003, BIOPHYS J, V84, P3168, DOI 10.1016/S0006-3495(03)70041-1; Smith L, 1999, BIOPHYS J, V76, P400, DOI 10.1016/S0006-3495(99)77206-1; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Squire JM, 1998, FASEB J, V12, P761, DOI 10.1096/fasebj.12.10.761; Tobacman LS, 2000, J BIOL CHEM, V275, P27587; URBANCIKOVA M, 1994, J BIOL CHEM, V269, P24310; VIBERT P, 1993, J CELL BIOL, V123, P313, DOI 10.1083/jcb.123.2.313; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Vilfan A, 2001, BIOPHYS J, V81, P3146, DOI 10.1016/S0006-3495(01)75951-6; Wagschal K, 1999, J MOL BIOL, V285, P785, DOI 10.1006/jmbi.1998.2284; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; WEGNER A, 1979, J MOL BIOL, V131, P839, DOI 10.1016/0022-2836(79)90204-3	66	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1902	1910		10.1074/jbc.M708593200	http://dx.doi.org/10.1074/jbc.M708593200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18006493	Green Published, hybrid			2022-12-25	WOS:000252501000016
J	Vagin, O; Tokhtaeva, E; Yakubov, I; Shevchenko, E; Sachs, G				Vagin, Olga; Tokhtaeva, Elmira; Yakubov, Iskandar; Shevchenko, Eugenia; Sachs, George			Inverse correlation between the extent of N-glycan branching and intercellular adhesion in epithelia - Contribution of the Na,K-ATPase beta(1) subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEPTATE JUNCTION FUNCTION; PROTEIN-KINASE-C; ACETYLGLUCOSAMINYLTRANSFERASE-V; NA+/K+ ATPASE; CELL-ADHESION; CADHERIN; EXPRESSION; IDENTIFICATION; GLYCOSYLATION; SUPPRESSION	The majority of cell adhesion molecules are N-glycosylated, but the role of N-glycans in intercellular adhesion in epithelia remains ill-defined. Reducing N-glycan branching of cellular glycoproteins by swainsonine, the inhibitor of N-glycan processing, tightens and stabilizes cell-cell junctions as detected by a 3-fold decrease in the paracellular permeability and a 2-3-fold increase in the resistance of the adherens junction proteins to extraction by non-ionic detergent. In addition, exposure of cells to swainsonine inhibits motility of MDCK cells. Mutagenic removal of N-glycosylation sites from the Na,K-ATPase beta(1) subunit impairs cell-cell adhesion and decreases the effect of swainsonine on the paracellular permeability of the cell monolayer and also on detergent resistance of adherens junction proteins, indicating that the extent of N-glycan branching of this subunit is important for intercellular adhesion. The N-glycans of the Na,K-ATPase beta(1) subunit and E-cadherin are less complex in tight renal epithelia than in the leakier intestinal epithelium. The complexity of the N-glycans linked to these proteins gradually decreases upon the formation of a tight monolayer from dispersed MDCK cells. This correlates with a cell-cell adhesion-induced increase in expression of GnT-III (stops N-glycan branching) and a decrease in expression of GnTs IVC and V (promote N-glycan branching) as detected by real-time quantitative PCR. Consistent with these results, partial silencing of the gene encoding GnT-III increases branching of N-glycans linked to the Na,K-ATPase beta(1) subunit and other glycoproteins and results in a 2-fold increase in the paracellular permeability of MDCK cell monolayers. These results suggest epithelial cells can regulate tightness of cell junctions via remodeling of N-glycans, including those linked to the Na,K-ATPase beta(1)-subunit.	[Vagin, Olga; Tokhtaeva, Elmira; Yakubov, Iskandar; Shevchenko, Eugenia; Sachs, George] Vet Adm Greater Los Angeles Hlth Care Syst, Los Angeles, CA 90073 USA; [Vagin, Olga; Tokhtaeva, Elmira; Yakubov, Iskandar; Shevchenko, Eugenia; Sachs, George] Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90073 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Vagin, O (corresponding author), VAGLAHS W LA, 11301 Wilshire Blvd,Rm 324,Bldg 113, Los Angeles, CA 90073 USA.	olgav@ucla.edu	Yakubov, Iskandar/W-6936-2018	Yakubov, Iskandar/0000-0002-7367-428X	NIDDK NIH HHS [R56 DK058333, R01 DK046917-09S2, R01 DK077149-01A1, DK58333, R01 DK053642, DK077149, R01 DK058333-09, R01 DK058333, DK46917, R01 DK077149, R01 DK046917, R01 DK077149-02, R01 DK053642-10] Funding Source: Medline; PHS HHS [D53642] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058333, R01DK046917, R01DK077149, R01DK053642, R56DK058333] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barwe SP, 2006, CELL MOL BIOL, V52, P41, DOI 10.1170/T759; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Diamond J M, 1977, Physiologist, V20, P10; Dosaka-Akita H, 2004, CLIN CANCER RES, V10, P1773, DOI 10.1158/1078-0432.CCR-1047-3; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Genova JL, 2003, J CELL BIOL, V161, P979, DOI 10.1083/jcb.200212054; GLOOR S, 1990, J CELL BIOL, V110, P165, DOI 10.1083/jcb.110.1.165; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; Granovsky M, 2000, NAT MED, V6, P306; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457; Guo HB, 2005, J BIOL CHEM, V280, P8332, DOI 10.1074/jbc.M413532200; Handerson T, 2003, CANCER RES, V63, P5363; Iijima J, 2006, J BIOL CHEM, V281, P13038, DOI 10.1074/jbc.M601961200; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Ishibashi Y, 2005, ONCOLOGY-BASEL, V69, P301, DOI 10.1159/000089680; Kapus A, 2006, BIOCHEM CELL BIOL, V84, P870, DOI 10.1139/O06-202; KINO T, 1985, J ANTIBIOT, V38, P936, DOI 10.7164/antibiotics.38.936; Kroepfl JF, 2001, J NEUROCHEM, V77, P1301, DOI 10.1046/j.1471-4159.2001.00343.x; Laughery MD, 2003, J BIOL CHEM, V278, P34794, DOI 10.1074/jbc.M302899200; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Murata K, 2000, CLIN CANCER RES, V6, P1772; Paul SM, 2007, DEVELOPMENT, V134, P147, DOI 10.1242/dev.02710; Paul SM, 2003, DEVELOPMENT, V130, P4963, DOI 10.1242/dev.00691; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierre SV, 2006, CELL BIOCHEM BIOPHYS, V46, P303, DOI 10.1385/CBB:46:3:303; Rajasekaran AK, 1996, J CELL BIOL, V132, P451, DOI 10.1083/jcb.132.3.451; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; Rothen-Rutishauser B, 2002, J MEMBRANE BIOL, V188, P151, DOI 10.1007/s00232-001-0182-2; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Takahashi T, 2006, J UROLOGY, V175, P90, DOI 10.1016/S0022-5347(05)00044-3; TREUHEIT MJ, 1993, J BIOL CHEM, V268, P13914; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Vagin O, 2005, J BIOL CHEM, V280, P43159, DOI 10.1074/jbc.M508262200; Vagin O, 2006, J BIOL CHEM, V281, P39573, DOI 10.1074/jbc.M606507200; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Youn YH, 2006, INVEST OPHTH VIS SCI, V47, P2675, DOI 10.1167/iovs.05-1335	42	75	75	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2192	2202		10.1074/jbc.M704713200	http://dx.doi.org/10.1074/jbc.M704713200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18025087	Green Accepted, hybrid			2022-12-25	WOS:000252501000047
J	Witting, SR; Brown, M; Saxena, R; Nabinger, S; Morral, N				Witting, Scott R.; Brown, Matthew; Saxena, Romil; Nabinger, Sarah; Morral, Nuria			Helper-dependent adenovirus-mediated short hairpin RNA expression in the liver activates the interferon response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-FACTOR-VIII; GENE-EXPRESSION; IN-VIVO; IMMUNE-RESPONSES; SINGLE INJECTION; STRANDED-RNA; VECTORS; MICE; INDUCTION; MICRORNAS	The use of RNA interference has proven to be an effective means to study the function of genes. Constitutive synthesis of small interfering RNA molecules can be accomplished with the use of viral vectors expressing short hairpin RNA (shRNA). Binding of shRNA to the target mRNA promotes transcript degradation. So far, little is known about the effects that shRNA induce in vivo. To determine the feasibility of using helper-dependent adenoviral vectors for expression of shRNA in liver, we have designed an shRNA construct to mouse fabp5 (fatty acid-binding protein 5). Intravenous administration of this vector resulted in similar to 75% silencing of fabp5. Increasing the dose of vector did not result in higher levels of silencing, indicating that there is a threshold for the level of knockdown that can be achieved. Synthesis of high levels of shRNA molecules did not alter the levels of cellular micro-RNA, such as miR-122 and let-7a, suggesting that the exportin-5 pathway was not affected. However, high level shRNA expression resulted in activation of the interferon response. Thus, an important consideration when using shRNA-based vectors in vivo is to closely monitor signs of interferon-stimulated gene expression, since a narrow window exists between gene silencing efficacy and nonspecific effects.	[Witting, Scott R.; Brown, Matthew; Nabinger, Sarah; Morral, Nuria] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Saxena, Romil] Indiana Univ, Sch Med, Dept Pathol, Indianapolis, IN 46202 USA; [Morral, Nuria] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Morral, N (corresponding author), Indiana Univ, Sch Med, Dept Med & Mol Genet, 975 W Walnut St, Indianapolis, IN 46202 USA.	nmorralc@iupui.edu	Morral, Nuria/AAC-7149-2020	Morral, Nuria/0000-0002-8932-2887	NIDDK NIH HHS [R01 DK078595, R21 DK069432, 1R21DK069432-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078595, R21DK069432] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arts GJ, 2003, GENOME RES, V13, P2325, DOI 10.1101/gr.1332603; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; CARTER BJ, 2003, PHARM GENE DELIVERY, P183; Chen HH, 1997, P NATL ACAD SCI USA, V94, P1645, DOI 10.1073/pnas.94.5.1645; Chen LN, 1996, SOMAT CELL MOLEC GEN, V22, P477, DOI 10.1007/BF02369439; Connelly S, 1996, BLOOD, V87, P4671, DOI 10.1182/blood.V87.11.4671.bloodjournal87114671; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Fish RJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-9; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Haecker SE, 1996, HUM GENE THER, V7, P1907, DOI 10.1089/hum.1996.7.15-1907; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; KAY MA, 1995, HEPATOLOGY, V21, P815, DOI 10.1002/hep.1840210331; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim IH, 2001, P NATL ACAD SCI USA, V98, P13282, DOI 10.1073/pnas.241506298; Kishida T, 2004, J GENE MED, V6, P105, DOI 10.1002/jgm.456; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; KumarSingh R, 1996, HUM MOL GENET, V5, P913, DOI 10.1093/hmg/5.7.913; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Lewis DL, 2002, NAT GENET, V32, P107, DOI 10.1038/ng944; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; Morral N, 1997, HUM GENE THER, V8, P1275, DOI 10.1089/hum.1997.8.10-1275; Morral N, 1998, HUM GENE THER, V9, P2709, DOI 10.1089/hum.1998.9.18-2709; Morral N, 2002, HUM GENE THER, V13, P1561, DOI 10.1089/10430340260201653; Morsy MA, 1998, P NATL ACAD SCI USA, V95, P7866, DOI 10.1073/pnas.95.14.7866; Muruve DA, 2004, J VIROL, V78, P5966, DOI 10.1128/JVI.78.11.5966-5972.2004; Narvaiza I, 2006, J VIROL, V80, P12236, DOI 10.1128/JVI.01205-06; Nguyen LH, 2001, BIOCHEMISTRY-US, V40, P7174, DOI 10.1021/bi010141t; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Pebernard S, 2004, DIFFERENTIATION, V72, P103, DOI 10.1111/j.1432-0436.2004.07202001.x; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Pham HT, 2006, BIOCHEM BIOPH RES CO, V348, P145, DOI 10.1016/j.bbrc.2006.07.061; Reddy PS, 2002, MOL THER, V5, P63, DOI 10.1006/mthe.2001.0510; SAKAMOTO N, IN PRESS J GASTROENT; Sandig V, 2000, P NATL ACAD SCI USA, V97, P1002, DOI 10.1073/pnas.97.3.1002; Schiedner G, 2002, J VIROL, V76, P1600, DOI 10.1128/JVI.76.4.1600-1609.2002; Schiedner G, 1998, NAT GENET, V18, P180, DOI 10.1038/ng0298-180; Schlee M, 2006, MOL THER, V14, P463, DOI 10.1016/j.ymthe.2006.06.001; Sledz CA, 2004, BIOCHEM SOC T, V32, P952, DOI 10.1042/BST0320952; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Toietta G, 2005, P NATL ACAD SCI USA, V102, P3930, DOI 10.1073/pnas.0500930102; Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739; Xu HY, 2006, BIOCHEM BIOPH RES CO, V349, P439, DOI 10.1016/j.bbrc.2006.08.071; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; YANG YP, 1994, IMMUNITY, V1, P433, DOI 10.1016/1074-7613(94)90074-4; Yi R, 2005, RNA, V11, P220, DOI 10.1261/rna.7233305; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Youil R, 2001, J VIROL METHODS, V92, P91, DOI 10.1016/S0166-0934(00)00280-9	61	33	35	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2120	2128		10.1074/jbc.M704178200	http://dx.doi.org/10.1074/jbc.M704178200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18025090	hybrid			2022-12-25	WOS:000252501000039
J	Modha, R; Campbell, LJ; Nietlispach, D; Buhecha, HR; Owen, D; Mott, HR				Modha, Rakhee; Campbell, Louise J.; Nietlispach, Daniel; Buhecha, Heeran R.; Owen, Darerca; Mott, Helen R.			The Rac1 polybasic region is required for interaction with its effector PRK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-RESONANCE EXPERIMENTS; PROTEIN-KINASE N; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; STRUCTURAL BASIS; RHO EFFECTOR; MACROMOLECULAR STRUCTURE; PKN; DOMAIN; ACTIVATION	Protein kinase C-related kinase 1 (PRK1 or PKN) is involved in regulation of the intermediate filaments of the actin cytoskeleton, as well as having effects on processes as diverse as mitotic timing and apoptosis. It is activated by interacting with the Rho family small G proteins and arachidonic acid or by caspase cleavage. We have previously shown that the HR1b of PRK1 binds exclusively to Rac1, whereas the HR1a domain binds to both Rac1 and RhoA. Here, we have determined the solution structure of the HR1b-Rac complex. We show that HR1b binds to the C- terminal end of the effector loop and switch 2 of Rac1. Comparison with the HR1a-RhoA structure shows that this part of the Rac1- HR1b interaction is homologous to one of the contact sites that HR1a makes with RhoA. The Rac1 used in this study included the C-terminal polybasic region, which is frequently omitted from structural studies, as well as the core Gdomain. The Rac1 C-terminal region reverses in direction to interact with residues in switch 2, and the polybasic region itself interacts with residues in HR1b. The interactions with HR1b do not prevent the polybasic region being available to contact the negatively charged membrane phospholipids, which is considered to be its primary role. This is the first structural demonstration that the C terminus of a G protein forms a novel recognition element for effector binding.	[Modha, Rakhee; Campbell, Louise J.; Nietlispach, Daniel; Buhecha, Heeran R.; Owen, Darerca; Mott, Helen R.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge	Owen, D (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	do@bioc.cam.ac.uk; hrm28@bioc.cam.ac.uk	Mott, Helen/AAV-3873-2020	Mott, Helen/0000-0002-7890-7097; Nietlispach, Daniel/0000-0003-4364-9291	Biotechnology and Biological Sciences Research Council [BB/E013228/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Blumenstein L, 2004, J BIOL CHEM, V279, P53419, DOI 10.1074/jbc.M409551200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cottone G, 2006, J CELL PHYSIOL, V207, P232, DOI 10.1002/jcp.20566; Dong LQ, 2000, P NATL ACAD SCI USA, V97, P5089, DOI 10.1073/pnas.090491897; Elliot-Smith AE, 2005, BIOCHEMISTRY-US, V44, P12373, DOI 10.1021/bi0506021; Feltham JL, 1997, BIOCHEMISTRY-US, V36, P8755, DOI 10.1021/bi970694x; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Flynn P, 2000, J BIOL CHEM, V275, P11064, DOI 10.1074/jbc.275.15.11064; Flynn P, 1998, J BIOL CHEM, V273, P2698, DOI 10.1074/jbc.273.5.2698; Gao QS, 2000, J BIOL CHEM, V275, P14824, DOI 10.1074/jbc.275.20.14824; Graham DL, 1999, BIOCHEMISTRY-US, V38, P985, DOI 10.1021/bi9821770; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Kawamata T, 1998, J NEUROSCI, V18, P7402; Kitagawa M, 1996, BIOCHEM BIOPH RES CO, V220, P963, DOI 10.1006/bbrc.1996.0515; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Lu Y, 1999, GENE DEV, V13, P1168, DOI 10.1101/gad.13.9.1168; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Matsuzawa K, 1997, BIOCHEM BIOPH RES CO, V234, P621, DOI 10.1006/bbrc.1997.6669; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Metzger E, 2003, EMBO J, V22, P270, DOI 10.1093/emboj/cdg023; Misaki K, 2001, P NATL ACAD SCI USA, V98, P125, DOI 10.1073/pnas.021541498; Morissette MR, 2000, AM J PHYSIOL-HEART C, V278, pH1769, DOI 10.1152/ajpheart.2000.278.6.H1769; Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019; Nietlispach D, 2002, J AM CHEM SOC, V124, P11199, DOI 10.1021/ja025865m; Owen D, 2003, J BIOL CHEM, V278, P50578, DOI 10.1074/jbc.M304313200; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Shibata H, 1999, MOL BRAIN RES, V74, P126, DOI 10.1016/S0169-328X(99)00273-9; Takahashi M, 1998, P NATL ACAD SCI USA, V95, P11566, DOI 10.1073/pnas.95.20.11566; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Taniguchi T, 2001, J BIOL CHEM, V276, P10025, DOI 10.1074/jbc.M007427200; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Vincent S, 1997, MOL CELL BIOL, V17, P2247, DOI 10.1128/MCB.17.4.2247; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Yoshinaga C, 1999, J BIOCHEM, V126, P475, DOI 10.1093/oxfordjournals.jbchem.a022476; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	49	39	41	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1492	1500		10.1074/jbc.M706760200	http://dx.doi.org/10.1074/jbc.M706760200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18006505	hybrid			2022-12-25	WOS:000252282700033
J	Shieh, HS; Mathis, KJ; Williams, JM; Hills, RL; Wiese, JF; Benson, TE; Kiefer, JR; Marino, MH; Carroll, JN; Leone, JW; Malfait, AM; Arner, EC; Tortorella, MD; Tomasselli, A				Shieh, Huey-Sheng; Mathis, Karl J.; Williams, Jennifer M.; Hills, Robert L.; Wiese, Joe F.; Benson, Timothy E.; Kiefer, James R.; Marino, Margaret H.; Carroll, Jeffery N.; Leone, Joseph W.; Malfait, Anne-Marie; Arner, Elizabeth C.; Tortorella, Micky D.; Tomasselli, Alfredo			High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENOM METALLOPROTEINASE; SNAKE-VENOM; OSTEOARTHRITIS; INHIBITOR; SUBSTRATE; CLEAVAGE; CLONING; FAMILY	Aggrecanase-2 (a disintegrin and metalloproteinase with thrombospondin motifs- 5 (ADAMTS-5)), a member of the ADAMTS protein family, is critically involved in arthritic diseases because of its direct role in cleaving the cartilage component aggrecan. The catalytic domain of aggrecanase-2 has been refolded, purified, and crystallized, and its three-dimensional structure determined to 1.4 angstrom resolution in the presence of an inhibitor. A high resolution structure of an ADAMTS/aggrecanase protein provides an opportunity for the development of therapeutics to treat osteoarthritis.	[Shieh, Huey-Sheng; Mathis, Karl J.; Williams, Jennifer M.; Hills, Robert L.; Wiese, Joe F.; Benson, Timothy E.; Kiefer, James R.; Marino, Margaret H.; Carroll, Jeffery N.; Leone, Joseph W.; Malfait, Anne-Marie; Arner, Elizabeth C.; Tomasselli, Alfredo] Pfizer Global Res & Dev, St Louis, MO 63017 USA	Pfizer	Tortorella, MD (corresponding author), Pfizer Global Res & Dev, 700 Chesterfield Pkwy, Chesterfield, MO 63017 USA.	micky.d.tortorella@pfizer.com		Malfait, Anne-Marie/0000-0003-1428-0384; Benson, Timothy/0000-0001-8633-2142; Kiefer, James/0000-0001-6317-0902				Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Cirilli M, 1997, FEBS LETT, V418, P319, DOI 10.1016/S0014-5793(97)01401-4; COPELAND RA, ENZYMES, P310; GERHARDT S, 2007, T 53 ANN M ORTH RES, V32; Glasson SS, 2004, ARTHRITIS RHEUM-US, V50, P2547, DOI 10.1002/art.20558; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; GOMISRUTH FX, 1993, EMBO J, V12, P4151, DOI 10.1002/j.1460-2075.1993.tb06099.x; Gong WM, 1998, J MOL BIOL, V283, P657, DOI 10.1006/jmbi.1998.2110; Hills R, 2007, J BIOL CHEM, V282, P11101, DOI 10.1074/jbc.M611588200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Lovejoy B, 1999, NAT STRUCT BIOL, V6, P217; Maskos K, 1998, P NATL ACAD SCI USA, V95, P3408, DOI 10.1073/pnas.95.7.3408; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Orth P, 2004, J MOL BIOL, V335, P129, DOI 10.1016/j.jmb.2003.10.037; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; St John RJ, 1999, P NATL ACAD SCI USA, V96, P13029, DOI 10.1073/pnas.96.23.13029; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Tortorella MD, 2000, J BIOL CHEM, V275, P18566, DOI 10.1074/jbc.M909383199; Tortorella MD, 2002, MATRIX BIOL, V21, P499, DOI 10.1016/S0945-053X(02)00069-0; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; ZHANG DC, 1994, P NATL ACAD SCI USA, V91, P8447, DOI 10.1073/pnas.91.18.8447; 1994, ACTA CRYSTALLOGR A, V50, P760	26	60	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1501	1507		10.1074/jbc.M705879200	http://dx.doi.org/10.1074/jbc.M705879200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17991750	hybrid			2022-12-25	WOS:000252282700034
J	Xu, YJ; Johansson, M; Karlsson, A				Xu, Yunjian; Johansson, Magnus; Karlsson, Anna			Human UMP-CMP kinase 2, a novel nucleoside monophosphate kinase localized in mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYCYTIDINE ANALOG MONOPHOSPHATES; DNA DEPLETION SYNDROME; HUMAN UMP/CMP KINASE; DEOXYGUANOSINE KINASE; THYMIDINE KINASE; ADENYLATE KINASE; GENE-EXPRESSION; RIBONUCLEOTIDE REDUCTASE; DIPHOSPHATE KINASE; HERPES-SIMPLEX	Enzyme deficiency in the salvage pathway of deoxyribonucleotide synthesis in mitochondria can cause mtDNA depletion syndromes. We have identified a human mitochondrial UMP-CMP kinase (UMP-CMPK, cytidylate kinase; EC 2.7.4.14), designated as UMP-CMP kinase 2 (UMP-CMPK2). The C-terminal domain of this 449-amino acid protein contains all consensus motifs of a nucleoside monophosphate kinase. Phylogenetic analysis showed that UMP- CMPK2 belonged to a novel nucleoside monophosphate kinase family, which was closer to thymidylate kinase than to cytosolic UMP- CMP kinase. Subcellular localization with green fluorescent protein fusion proteins illustrated that UMP- CMPK2 was localized in the mitochondria of HeLa cells and that the mitochondrial targeting signal was included in the N- terminal 22 amino acids. The enzyme was able to phosphorylate dUMP, dCMP, CMP, and UMP with ATP as phosphate donor, but the kinetic properties were different compared with the cytosolic UMP- CMPK. Its efficacy to convert dUMP was highest, followed by dCMP, whereas CMP and UMP were the poorest substrates. It also phosphorylated the monophosphate forms of the nucleoside analogs ddC, dFdC, araC, BVDU, and FdUrd, which suggests that UMP-CMPK2 may be involved in mtDNA depletion caused by long term treatment with ddC or other pyrimidine analogs. UMP-CMPK2 mRNA expression was exclusively detected in chronic myelogenous leukemia K-562 and lymphoblastic leukemia MOLT-4 among eight studied cancer cell lines. Particular high expression in leukemia cells, dominant expression in bone marrow, and tight correlation with macrophage activation and inflammatory response suggest that UMP-CMPK2 may have other functions in addition to the supply of substrates for mtDNA synthesis.	[Xu, Yunjian; Johansson, Magnus; Karlsson, Anna] Karolinska Inst, Novum, Mitochondrial Med Ctr, Dept Lab Med, S-14186 Stockholm, Sweden	Karolinska Institutet	Xu, YJ (corresponding author), Karolinska Inst, Novum, Mitochondrial Med Ctr, Dept Lab Med, S-14186 Stockholm, Sweden.	Yunjian.Xu@ki.se	Karlsson, Anna/E-7945-2018	Karlsson, Anna/0000-0001-6843-6685				Abad MFC, 2004, J BIOL CHEM, V279, P11521, DOI 10.1074/jbc.M306766200; ARIMA T, 1977, CANCER RES, V37, P1593; Balzarini J, 2003, MOL PHARMACOL, V63, P263, DOI 10.1124/mol.63.2.263; BIANCHI V, 1994, P NATL ACAD SCI USA, V91, P8403, DOI 10.1073/pnas.91.18.8403; Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Cheng Yung-Chi, 2001, Cancer Letters, V162, pS33, DOI 10.1016/S0304-3835(00)00650-9; Collins CA, 2007, FISH SHELLFISH IMMUN, V23, P793, DOI 10.1016/j.fsi.2007.03.001; Cote HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035; Curbo S, 2003, BIOCHEM BIOPH RES CO, V311, P440, DOI 10.1016/j.bbrc.2003.10.018; DANENBERG PV, 1977, BIOCHIM BIOPHYS ACTA, V473, P73, DOI 10.1016/0304-419X(77)90001-4; Falsig J, 2006, J NEUROCHEM, V96, P893, DOI 10.1111/j.1471-4159.2005.03622.x; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Floyd S, 2007, MOL BIOL CELL, V18, P3545, DOI 10.1091/mbc.e06-12-1109; Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129; Gallinaro L, 2002, J BIOL CHEM, V277, P35080, DOI 10.1074/jbc.M203755200; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; Hsu CH, 2005, MOL PHARMACOL, V67, P806, DOI 10.1124/mol.104.006098; HUANG SH, 1994, DNA CELL BIOL, V13, P461, DOI 10.1089/dna.1994.13.461; Johansson M, 1996, GENOMICS, V38, P450, DOI 10.1006/geno.1996.0654; Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454; Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; LEE CG, 1995, J IMMUNOL, V154, P6094; LEE CGL, 1994, MAMM GENOME, V5, P742, DOI 10.1007/BF00426089; Lee H, 2003, BIOCHEMISTRY-US, V42, P14711, DOI 10.1021/bi035596s; Liou JY, 2002, CANCER RES, V62, P1624; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; LUND S, 2005, J IMMUNOL, V175, P4735; LUST J, 1972, J CHROMATOGR, V71, P127, DOI 10.1016/S0021-9673(01)85696-X; Milon L, 2000, J BIOL CHEM, V275, P14264, DOI 10.1074/jbc.275.19.14264; Milon L, 1997, HUM GENET, V99, P550, DOI 10.1007/s004390050405; MUNCHPETERSEN B, 1991, J BIOL CHEM, V266, P9032; Naesens L, 2001, Herpes, V8, P12; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Noble S, 1997, DRUGS, V54, P447, DOI 10.2165/00003495-199754030-00009; Noma T, 1998, BBA-GENE STRUCT EXPR, V1395, P34, DOI 10.1016/S0167-4781(97)00193-0; Noma T, 2001, BIOCHEM J, V358, P225, DOI 10.1042/0264-6021:3580225; Paglinawan R, 2003, GLIA, V44, P219, DOI 10.1002/glia.10286; Pan-Zhou XR, 2000, ANTIMICROB AGENTS CH, V44, P496, DOI 10.1128/AAC.44.3.496-503.2000; Rampazzo C, 2004, J BIOL CHEM, V279, P17019, DOI 10.1074/jbc.M313957200; Rampazzo C, 2000, P NATL ACAD SCI USA, V97, P8239, DOI 10.1073/pnas.97.15.8239; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284; SUGINO Y, 1966, J BIOL CHEM, V241, P961; Tulinius M, 2005, NEUROMUSCULAR DISORD, V15, P412, DOI 10.1016/j.nmd.2005.03.010; Van Rompay AR, 1999, MOL PHARMACOL, V56, P562, DOI 10.1124/mol.56.3.562; Van Rompay AR, 2000, PHARMACOL THERAPEUT, V87, P189, DOI 10.1016/S0163-7258(00)00048-6; Wang JP, 2005, J VIROL, V79, P8295, DOI 10.1128/JVI.79.13.8295-8302.2005; Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005; Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200; Wang LY, 1996, FEBS LETT, V390, P39, DOI 10.1016/0014-5793(96)00623-0; Wutzler P, 1997, INTERVIROLOGY, V40, P343, DOI 10.1159/000150567; Yoneda T, 1998, MOL BRAIN RES, V62, P187, DOI 10.1016/S0169-328X(98)00249-6; Zhu CY, 1998, J BIOL CHEM, V273, P14707, DOI 10.1074/jbc.273.24.14707	56	59	61	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1563	1571		10.1074/jbc.M707997200	http://dx.doi.org/10.1074/jbc.M707997200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17999954	hybrid			2022-12-25	WOS:000252282700041
J	Rusyn, I; Fry, RC; Begley, TJ; Klapacz, J; Svensson, JP; Ambrose, M; Samson, LD				Rusyn, Ivan; Fry, Rebecca C.; Begley, Thomas J.; Klapacz, Joanna; Svensson, J. Peter; Ambrose, Mark; Samson, Leona D.			Transcriptional Networks in S-cerevisiae Linked to an Accumulation of Base Excision Repair Intermediates	PLOS ONE			English	Article								Upon exposure to DNA damaging agents, Saccharomyces cerevisiae respond by activating a massive transcriptional program that reflects the fact that "DNA damaging" agents also damage other cellular macromolecules. To identify the transcriptional response that is specific to DNA damage, we have modulated the first two enzymes in the base excision repair (BER) pathway generating yeast strains with varied levels of the repair intermediates, abasic sites or strand breaks. We show that the number of abasic sites is significantly increased when the 3-methyladenine DNA glycosylase (Mag): AP endonuclease (Apn1) ratio is increased and that spontaneous frame shift mutation is considerably elevated when either Mag, or Mag plus Apn1, expression is elevated. Expression profiling identified 633 ORFs with differential expression associated with BER modulation. Analysis of transcriptional networks associated with the accumulation of DNA repair intermediates identifies an enrichment for numerous biological processes. Moreover, most of the BER-activated transcriptional response was independent of the classical yeast environmental stress response (ESR). This study highlights that DNA damage in the form of abasic sites or strand breaks resulting from BER modulation is a trigger for substantial genome-wide change and that this response is largely ESR-independent. Taken together, these results suggest that a branch point exists in the current model for DNA damage-signaled transcription in S. cerevisiae.	[Samson, Leona D.] MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA; MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Samson, LD (corresponding author), MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA.	lsamson@mit.edu	Svensson, J Peter/B-4276-2008; Rusyn, Ivan/S-2426-2016	Svensson, J Peter/0000-0002-5863-6250; Ambrose, Mark/0000-0002-8031-8240; Rusyn, Ivan/0000-0001-9340-7384; Fry, Rebecca/0000-0003-0899-9018	National Institute of Environmental Health Sciences [ES11399, ES002109]; National Cancer Institute [CA055042]; NATIONAL CANCER INSTITUTE [R01CA055042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109, U19ES011399] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding: This work was supported by the National Institute of Environmental Health Sciences (ES11399 and ES002109), and the National Cancer Institute(CA055042). LDS is an American Cancer Society Research Professor.	Aguilaniu H, 2001, J BIOL CHEM, V276, P35396, DOI 10.1074/jbc.M101796200; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; COOPER DP, 1982, CANCER RES, V42, P4203; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Glassner BJ, 1998, P NATL ACAD SCI USA, V95, P9997, DOI 10.1073/pnas.95.17.9997; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; LAKE RS, 1980, MUTAT RES, V74, P357, DOI 10.1016/0165-1161(80)90194-6; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Memisoglu A, 2000, MUTAT RES-FUND MOL M, V451, P39, DOI 10.1016/S0027-5107(00)00039-7; MONTESANO R, 1980, CANCER RES, V40, P452; Nakamura J, 2000, J BIOL CHEM, V275, P5323, DOI 10.1074/jbc.275.8.5323; Nakamura J, 1999, CANCER RES, V59, P2522; OCONNOR PJ, 1982, BIOCHIMIE, V64, P769, DOI 10.1016/S0300-9084(82)80127-2; Posnick LM, 1999, J BACTERIOL, V181, P6756, DOI 10.1128/JB.181.21.6756-6762.1999; Posnick LM, 1999, J BACTERIOL, V181, P6763, DOI 10.1128/JB.181.21.6763-6771.1999; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; SAMSON L, 1988, EMBO J, V7, P2261, DOI 10.1002/j.1460-2075.1988.tb03066.x; SAMSON L, 1977, NATURE, V267, P281, DOI 10.1038/267281a0; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; WEI X, 1993, P NATL ACAD SCI USA, V90, P2117, DOI 10.1073/pnas.90.6.2117; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4	26	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1252	10.1371/journal.pone.0001252	http://dx.doi.org/10.1371/journal.pone.0001252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043759	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459300033
J	Pavard, S; Metcalf, CJE				Pavard, Samuel; Metcalf, C. Jessica E.			Negative Selection on BRCA1 Susceptibility Alleles Sheds Light on the Population Genetics of Late-Onset Diseases and Aging Theory	PLOS ONE			English	Article							OVARIAN-CANCER; BREAST-CANCER; MUTATIONS; SENESCENCE; FREQUENCY; PENETRANCE; EVOLUTION; PATTERNS; FAMILIES; SERIES	The magnitude of negative selection on alleles involved in age-specific mortality decreases with age. This is the foundation of the evolutionary theory of senescence. Because of this decrease in negative selection with age, and because of the absence of reproduction after menopause, alleles involved in women's late-onset diseases are generally considered evolutionarily neutral. Recently, genetic and epidemiological data on alleles involved in late onset-diseases have become available. It is therefore timely to estimate selection on these alleles. Here, we estimate selection on BRCA1 alleles leading to susceptibility to late-onset breast and ovarian cancer. For this, we integrate estimates of the risk of developing a cancer for BRCA1-carriers into population genetics frameworks, and calculate selection coefficients on BRCA1 alleles for different demographic scenarios varying across the extent of human demography. We then explore the magnitude of negative selection on alleles leading to a diverse range of risk patterns, to capture a variety of late-onset diseases. We show that BRCA1 alleles may have been under significant negative selection during human history. Although the mean age of onset of the disease is long after menopause, variance in age of onset means that there are always enough cases occurring before the end of reproductive life to compromise the selective value of women carrying a susceptibility allele in BRCA1. This seems to be the case for an extended range of risk of onset functions varying both in mean and variance. This finding may explain the distribution of BRCA1 alleles' frequency, and also why alleles for many late-onset diseases, like certain familial forms of cancer, coronary artery diseases and Alzheimer dementia, are typically recent and rare. Finally, we discuss why the two most popular evolutionary theories of aging, mutation accumulation and antagonistic pleiotropy, may underestimate the effect of selection on survival at old ages.	[Pavard, Samuel; Metcalf, C. Jessica E.] Max Planck Inst Demog Res, Lab Survival & Longev, Rostock, Germany; [Pavard, Samuel] Museum Natl Hist Nat, Grp Ecoanthropol, F-75231 Paris, France; [Metcalf, C. Jessica E.] Duke Univ, Duke Populat Res Inst, Durham, NC USA	Max Planck Society; Museum National d'Histoire Naturelle (MNHN); Duke University	Pavard, S (corresponding author), Max Planck Inst Demog Res, Lab Survival & Longev, Rostock, Germany.	pavard@demogr.mpg.de		Pavard, Samuel/0000-0002-6803-8123	Fondation de France; Association pour la Recherche sur le Cancer; Max Planck Institute for Demographic Research	Fondation de France(Fondation de France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Max Planck Institute for Demographic Research	We acknowledge funding from the Fondation de France, the Association pour la Recherche sur le Cancer and the Max Planck Institute for Demographic Research.	ABRAMS PA, 1993, EVOLUTION, V47, P877, DOI 10.1111/j.1558-5646.1993.tb01241.x; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Austerlitz F, 1998, P NATL ACAD SCI USA, V95, P15140, DOI 10.1073/pnas.95.25.15140; CHARBONNEAU H, 1987, NAISSANCE POPULATION; Charlesworth B, 2001, J THEOR BIOL, V210, P47, DOI 10.1006/jtbi.2001.2296; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Charmantier A, 2006, P NATL ACAD SCI USA, V103, P6587, DOI 10.1073/pnas.0511123103; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; CLAUS EB, 1991, AM J HUM GENET, V48, P232; Demeny Coale AJ., 1966, REGIONAL MODEL LIFE; EATON SB, 1994, Q REV BIOL, V69, P353, DOI 10.1086/418650; Goldstein AM, 1997, GENET EPIDEMIOL, V14, P1085, DOI 10.1002/(SICI)1098-2272(1997)14:6<1085::AID-GEPI87>3.0.CO;2-D; Hadwiger H, 1940, SKAND AKTUARIETIDSKR, V23, P101; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; HOEM JM, 1981, DEMOGRAPHY, V18, P231, DOI 10.2307/2061095; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KOVACS BW, 1990, BIOL MAMMALIAN GERM, P351; Lee RD, 2003, P NATL ACAD SCI USA, V100, P9637, DOI 10.1073/pnas.1530303100; LevyLahad E, 1997, AM J HUM GENET, V60, P1059; Morton N. E., 1982, OUTLINE GENETIC EPID; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; Pavard S, 2007, EVOLUTION, V61, P1153, DOI 10.1111/j.1558-5646.2007.00086.x; Rahman N, 1998, ANNU REV GENET, V32, P95, DOI 10.1146/annurev.genet.32.1.95; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Steinsaltz D, 2005, ADV APPL MATH, V35, P16, DOI 10.1016/j.aam.2004.09.003; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Szabo CI, 1997, AM J HUM GENET, V60, P1013; Tuljapurkar SD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000785; Whitlock Michael C., 2004, P155, DOI 10.1017/CBO9780511542022.013; Wright A, 2003, TRENDS GENET, V19, P97, DOI 10.1016/S0168-9525(02)00033-1; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	32	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1206	10.1371/journal.pone.0001206	http://dx.doi.org/10.1371/journal.pone.0001206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030340	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459200019
J	Delacourt, C; Benoist, MR; Le Bourgeois, M; Waernessyckle, S; Rufin, P; Brouard, JJ; de Blic, J; Scheinmann, P				Delacourt, Christophe; Benoist, Marie-Rose; Le Bourgeois, Muriel; Waernessyckle, Serge; Rufin, Patrick; Brouard, Jean-Jacques; de Blic, Jacques; Scheinmann, Pierre			Relationship between Bronchial Hyperresponsiveness and Impaired Lung Function after Infantile Asthma	PLOS ONE			English	Article								Wheezing during infancy has been linked to early loss of pulmonary function. We prospectively investigated the relation between bronchial hyperresponsiveness (BHR) and progressive impairment of pulmonary function in a cohort of asthmatic infants followed until age 9 years. We studied 129 infants who had had at least three episodes of wheezing. Physical examinations, baseline lung function tests and methacholine challenge tests were scheduled at ages 16 months and 5, 7 and 9 years. Eighty-three children completed follow-up. Twenty-four (29%) infants had wheezing that persisted at 9 years of age. Clinical outcome at age 9 years was significantly predicted by symptoms at 5 years of age and by parental atopy. Specific airway resistance (sRaw) was altered in persistent wheezers as early as 5 years of age, and did not change thereafter. Ninety-five per cent of the children still responded to methacholine at the end of follow-up. The degree of BHR at 9 years was significantly related to current clinical status, baseline lung function, and parental atopy. BHR at 16 months and 5 years of age did not predict persistent wheezing between 5 and 9 years of age, or the final degree of BHR, but it did predict altered lung function. Wheezing that persists from infancy to 9 years of age is associated with BHR and to impaired lung function. BHR itself is predictive of impaired lung function in children, strongly pointing to early airway remodeling in infantile asthma.	[Delacourt, Christophe; Benoist, Marie-Rose; Le Bourgeois, Muriel; Waernessyckle, Serge; Rufin, Patrick; Brouard, Jean-Jacques; de Blic, Jacques; Scheinmann, Pierre] Hop Enfants Malad, Serv Pneumol & Allergol Pediat, Lab Explorat Fonct Resp, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP	Delacourt, C (corresponding author), Ctr Hosp Intercommunal, Serv Pediat, Creteil, France.	christophe.delacourt@chicreteil.fr	Delacourt, Christophe/K-6161-2019					BROOKE AM, 1995, AM J RESP CRIT CARE, V152, P1872, DOI 10.1164/ajrccm.152.6.8520749; Brussee JE, 2004, AM J RESP CRIT CARE, V169, P209, DOI 10.1164/rccm.200306-800OC; Brutsche MH, 2006, THORAX, V61, P671, DOI 10.1136/thx.2005.052241; Cockcroft DW, 2006, J ALLERGY CLIN IMMUN, V118, P551, DOI 10.1016/j.jaci.2006.07.012; Delacourt C, 2001, AM J RESP CRIT CARE, V164, P1382, DOI 10.1164/ajrccm.164.8.2007066; Dezateux C, 1999, AM J RESP CRIT CARE, V159, P403, DOI 10.1164/ajrccm.159.2.9712029; Grol MH, 1999, AM J RESP CRIT CARE, V160, P1830, DOI 10.1164/ajrccm.160.6.9812100; Host A, 2003, ALLERGY, V58, P559, DOI 10.1034/j.1398-9995.2003.00238.x; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Lowe L, 2002, LANCET, V359, P1904, DOI 10.1016/S0140-6736(02)08781-0; Lowe LA, 2005, AM J RESP CRIT CARE, V171, P231, DOI 10.1164/rccm.200406-695OC; Marchal Francois, 2005, Paediatr Respir Rev, V6, P278, DOI 10.1016/j.prrv.2005.09.007; MARTINEZ FD, 1995, THORAX, V50, P1067, DOI 10.1136/thx.50.10.1067; Martinez FD, 2007, J ALLERGY CLIN IMMUN, V119, P30, DOI 10.1016/j.jaci.2006.10.020; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; MULLER BA, 1994, J ALLERGY CLIN IMMUN, V94, P77, DOI 10.1016/0091-6749(94)90074-4; OCONNOR GT, 1995, AM J RESP CRIT CARE, V152, P87, DOI 10.1164/ajrccm.152.1.7599868; Palmer LJ, 2001, AM J RESP CRIT CARE, V163, P37, DOI 10.1164/ajrccm.163.1.2005013; PARK ES, 1986, ARCH DIS CHILD, V61, P642, DOI 10.1136/adc.61.7.642; Pascual RM, 2005, J ALLERGY CLIN IMMUN, V116, P477, DOI 10.1016/j.jaci.2005.07.011; Porsbjerg C, 2006, CHEST, V129, P309, DOI 10.1378/chest.129.2.309; Rasmussen F, 2002, AM J RESP CRIT CARE, V165, P1480, DOI 10.1164/rccm.2108009; Saglani S, 2005, AM J RESP CRIT CARE, V171, P722, DOI 10.1164/rccm.200410-1404OC; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; TABACHNIK E, 1981, J ALLERGY CLIN IMMUN, V67, P339, DOI 10.1016/0091-6749(81)90077-4; Ulrik CS, 1996, RESP MED, V90, P623, DOI 10.1016/S0954-6111(96)90021-9; Yang E, 2006, LUNG, V184, P73, DOI 10.1007/s00408-005-2565-0	27	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1180	10.1371/journal.pone.0001180	http://dx.doi.org/10.1371/journal.pone.0001180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000551	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459100022
J	Hammerle, B; Tejedor, FJ				Haemmerle, Barbara; Tejedor, Francisco J.			A Novel Function of DELTA-NOTCH Signalling Mediates the Transition from Proliferation to Neurogenesis in Neural Progenitor Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD; STEM-CELLS; NEURONAL DIFFERENTIATION; NEUROEPITHELIAL CELLS; INTRACELLULAR DOMAIN; CHICK HINDBRAIN; GAMMA-SECRETASE; LIGAND DELTA1; GENE-DELTA	A complete account of the whole developmental process of neurogenesis involves understanding a number of complex underlying molecular processes. Among them, those that govern the crucial transition from proliferative (self-replicating) to neurogenic neural progenitor (NP) cells remain largely unknown. Due to its sequential rostro-caudal gradients of proliferation and neurogenesis, the prospective spinal cord of the chick embryo is a good experimental system to study this issue. We report that the NOTCH ligand DELTA-1 is expressed in scattered cycling NP cells in the prospective chick spinal cord preceding the onset of neurogenesis. These Delta-1-expressing progenitors are placed in between the proliferating caudal neural plate (stem zone) and the rostral neurogenic zone (NZ) where neurons are born. Thus, these Delta-1-expressing progenitors define a proliferation to neurogenesis transition zone (PNTZ). Gain and loss of function experiments carried by electroporation demonstrate that the expression of Delta-1 in individual progenitors of the PNTZ is necessary and sufficient to induce neuronal generation. The activation of NOTCH signalling by DELTA-1 in the adjacent progenitors inhibits neurogenesis and is required to maintain proliferation. However, rather than inducing cell cycle exit and neuronal differentiation by a typical lateral inhibition mechanism as in the NZ, DELTA-1/NOTCH signalling functions in a distinct manner in the PNTZ. Thus, the inhibition of NOTCH signalling arrests proliferation but it is not sufficient to elicit neuronal differentiation. Moreover, after the expression of Delta-1 PNTZ NP continue cycling and induce the expression of Tis21, a gene that is upregulated in neurogenic progenitors, before generating neurons. Together, these experiments unravel a novel function of DELTA-NOTCH signalling that regulates the transition from proliferation to neurogenesis in NP cells. We hypothesize that this novel function is evolutionary conserved.	[Tejedor, Francisco J.] CSIC, Inst Neurociencias, Alicante, Spain; Univ Miguel Hernandez, Alicante, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche	Tejedor, FJ (corresponding author), CSIC, Inst Neurociencias, Alicante, Spain.	f.tejedor@umh.es		Tejedor, Francisco J/0000-0003-1942-2580	Spanish Ministry of Education and Science; Generalitat Valenciana	Spanish Ministry of Education and Science(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by grants from the Spanish Ministry of Education and Science, and the Generalitat Valenciana to FJT.	Akai J, 2005, GENE DEV, V19, P2877, DOI 10.1101/gad.357705; Alexiades MR, 1997, DEVELOPMENT, V124, P1119; Appel B, 2001, BMC Dev Biol, V1, P13, DOI 10.1186/1471-213X-1-13; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; Basak O, 2007, EUR J NEUROSCI, V25, P1006, DOI 10.1111/j.1460-9568.2007.05370.x; Bel-Vialar S, 2007, DEV BIOL, V305, P659, DOI 10.1016/j.ydbio.2007.02.012; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; CAMPOSORTEGA JA, 1993, J NEUROBIOL, V24, P1305, DOI 10.1002/neu.480241005; Canzoniere D, 2004, J NEUROSCI, V24, P3355, DOI 10.1523/JNEUROSCI.3860-03.2004; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Chitnis AB, 1999, CURR OPIN NEUROBIOL, V9, P18, DOI 10.1016/S0959-4388(99)80003-8; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Doe CQ, 1996, CURR OPIN NEUROBIOL, V6, P18, DOI 10.1016/S0959-4388(96)80004-3; Dornseifer P, 1997, MECH DEVELOP, V63, P159, DOI 10.1016/S0925-4773(97)00037-3; Dorsky RI, 1997, NATURE, V385, P67, DOI 10.1038/385067a0; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Fior R, 2005, DEV BIOL, V281, P318, DOI 10.1016/j.ydbio.2005.03.017; FUJITA S, 1962, EXP CELL RES, V28, P52, DOI 10.1016/0014-4827(62)90311-7; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Guillemot F, 2005, CURR OPIN CELL BIOL, V17, P639, DOI 10.1016/j.ceb.2005.09.006; Haddon C, 1998, DEVELOPMENT, V125, P359; Hagting A, 1999, CURR BIOL, V9, P680, DOI 10.1016/S0960-9822(99)80308-X; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hammerle B, 2002, J NEUROSCI METH, V122, P59, DOI 10.1016/S0165-0270(02)00278-9; Hammerle B, 2002, DEV BIOL, V246, P259, DOI 10.1006/dbio.2002.0675; HEMOND SG, 1993, J NEUROSCI, V13, P1387; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Hiratochi M, 2007, NUCLEIC ACIDS RES, V35, P912, DOI 10.1093/nar/gkl1128; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; Huttner WB, 1997, CURR OPIN NEUROBIOL, V7, P29, DOI 10.1016/S0959-4388(97)80117-1; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jacobsen TL, 1998, DEVELOPMENT, V125, P4531; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kolev V, 2005, FEBS LETT, V579, P5798, DOI 10.1016/j.febslet.2005.09.042; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Kos R, 2003, DEV DYNAM, V226, P470, DOI 10.1002/dvdy.10254; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; LANGMAN J, 1966, J COMP NEUROL, V127, P399, DOI 10.1002/cne.901270308; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Le Roux I, 2003, INT J DEV BIOL, V47, P263; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Lewis J, 1998, SEMIN CELL DEV BIOL, V9, P583, DOI 10.1006/scdb.1998.0266; Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Mathis L, 2001, NAT CELL BIOL, V3, P559, DOI 10.1038/35078535; MATTHIAS P, 1989, NUCLEIC ACIDS RES, V17, P6418, DOI 10.1093/nar/17.15.6418; Megason SG, 2002, DEVELOPMENT, V129, P2087; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Nakada Y, 2004, DEVELOPMENT, V131, P1319, DOI 10.1242/dev.01008; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; PRESTIGE MC, 1973, BRAIN RES, V59, P400, DOI 10.1016/0006-8993(73)90280-1; Sakamoto K, 2002, DEV BIOL, V241, P313, DOI 10.1006/dbio.2001.0517; SECHRIST J, 1991, NEURON, V7, P947, DOI 10.1016/0896-6273(91)90340-6; Shen Q, 2002, DEVELOPMENT, V129, P4843; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; SIDMAN RL, 1959, EXP NEUROL, V1, P322, DOI 10.1016/0014-4886(59)90024-X; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; SMART IHM, 1972, J ANAT, V111, P365; Sun X, 1996, DEVELOPMENT, V122, P2465; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Temple S, 1996, CURR OPIN NEUROBIOL, V6, P11, DOI 10.1016/S0959-4388(96)80003-1; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; Torii MA, 1999, DEVELOPMENT, V126, P443; Wilcock AC, 2007, DEVELOPMENT, V134, P1943, DOI 10.1242/dev.002519; Wildner H, 2006, DEVELOPMENT, V133, P2105, DOI 10.1242/dev.02345; Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475	82	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1169	10.1371/journal.pone.0001169	http://dx.doi.org/10.1371/journal.pone.0001169			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000541	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459100011
J	Vazeille, M; Moutailler, S; Coudrier, D; Rousseaux, C; Khun, H; Huerre, M; Thiria, J; Dehecq, JS; Fontenille, D; Schuffenecker, I; Despres, P; Failloux, AB				Vazeille, Marie; Moutailler, Sara; Coudrier, Daniel; Rousseaux, Claudine; Khun, Huot; Huerre, Michel; Thiria, Julien; Dehecq, Jean-Sebastien; Fontenille, Didier; Schuffenecker, Isabelle; Despres, Philippe; Failloux, Anna-Bella			Two Chikungunya Isolates from the Outbreak of La Reunion (Indian Ocean) Exhibit Different Patterns of Infection in the Mosquito, Aedes albopictus	PLOS ONE			English	Article							VALLEY FEVER VIRUS; AEGYPTI; DENGUE; SUSCEPTIBILITY; DIPTERA; TRANSMISSION; REEMERGENCE; MEMBRANE; STRAINS; ISLAND	Background. A Chikungunya (CHIK) outbreak hit La Reunion Island in 2005-2006. The implicated vector was Aedes albopictus. Here, we present the first study on the susceptibility of Ae. albopictus populations to sympatric CHIKV isolates from La Reunion Island and compare it to other virus/vector combinations. Methodology and Findings. We orally infected 8 Ae. albopictus collections from La Reunion and 3 from Mayotte collected in March 2006 with two Chikungunya virus (CHIKV) from La Reunion: (i) strain 05.115 collected in June 2005 with an Alanine at the position 226 of the glycoprotein E1 and (ii) strain 06.21 collected in November 2005 with a substitution A226V. Two other CHIKV isolates and four additional mosquito strains/species were also tested. The viral titer of the infectious blood-meal was 10 7 plaque forming units (pfu)/mL. Dissemination rates were assessed by immunofluorescent staining on head squashes of surviving females 14 days after infection. Rates were at least two times higher with CHIKV 06.21 compared to CHIKV 05.115. In addition, 10 individuals were analyzed every day by quantitative RTPCR. Viral RNA was quantified on (i) whole females and (ii) midguts and salivary glands of infected females. When comparing profiles, CHIKV 06.21 produced nearly 2 log more viral RNA copies than CHIKV 05.115. Furthermore, females infected with CHIKV 05.115 could be divided in two categories: weakly susceptible or strongly susceptible, comparable to those infected by CHIKV 06.21. Histological analysis detected the presence of CHIKV in salivary glands two days after infection. In addition, Ae. albopictus from La Reunion was as efficient vector as Ae. aegypti and Ae. albopictus from Vietnam when infected with the CHIKV 06.21. Conclusions. Our findings support the hypothesis that the CHIK outbreak in La Reunion Island was due to a highly competent vector Ae. albopictus which allowed an efficient replication and dissemination of CHIKV 06.21.	[Vazeille, Marie; Failloux, Anna-Bella] Inst Pasteur, Dept Virol, Chikungunya Program, Paris, France; [Thiria, Julien; Dehecq, Jean-Sebastien] Direct Reg Affaires Sanit & Sociales Reunion, St Denis, France; [Fontenille, Didier] Inst Rech Dev, UR Caracterisat & Controle Populat Vecteurs 016, Montpellier, France; [Schuffenecker, Isabelle] Ctr Natl Reference Arbovirus & Virus Fievres Hemo, Lyon, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut de Recherche pour le Developpement (IRD)	Failloux, AB (corresponding author), Inst Pasteur, Dept Virol, Chikungunya Program, Paris, France.	afaillou@pasteur.fr	FONTENILLE, didier/G-4091-2013; Sara, Moutailler/J-9633-2019	Sara, Moutailler/0000-0003-3010-6968; FONTENILLE, didier/0000-0002-0544-3885	Pasteur Institute [PTR nu 201]; Foundation "Jean et Odette Duranton de Magny''; "Mutuelle du Personnel du Groupe Credit Lyonnais	Pasteur Institute; Foundation "Jean et Odette Duranton de Magny''; "Mutuelle du Personnel du Groupe Credit Lyonnais	This work was funded by the Pasteur Institute (PTR nu 201), the Foundation "Jean et Odette Duranton de Magny'' and the "Mutuelle du Personnel du Groupe Credit Lyonnais.	Ahn A, 2002, J VIROL, V76, P3267, DOI 10.1128/JVI.76.7.3267-3275.2002; Anishchenko M, 2006, P NATL ACAD SCI USA, V103, P4994, DOI 10.1073/pnas.0509961103; Bancroft J. D., 1994, MANUAL HISTOLOGICAL; Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000; BRIEGEL H, 1979, J MED ENTOMOL, V15, P235, DOI 10.1093/jmedent/15.3.235; COULANGES P, 1979, B SOC PATHOL EXOT, V72, P205; Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281; FARAN ME, 1988, AM J TROP MED HYG, V39, P206, DOI 10.4269/ajtmh.1988.39.206; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; HAMON J., 1953, MEM INST SCI MADAGASCAR SER E, V4, P521; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Jupp PG, 1996, S AFR MED J, V86, P35; KARCH S, 1993, B SOC PATHOL EXOT, V86, P68; Khan AH, 2002, J GEN VIROL, V83, P3075, DOI 10.1099/0022-1317-83-12-3075; KLES V, 1994, B SOC PATHOL EXOT, V87, P71; KONISHI E, 1986, J MED ENTOMOL, V23, P92, DOI 10.1093/jmedent/23.1.92; Lam S K, 2001, Southeast Asian J Trop Med Public Health, V32, P447; Laras K, 2005, T ROY SOC TROP MED H, V99, P128, DOI 10.1016/j.trstmh.2004.03.013; MANGIAFICO JA, 1971, AM J TROP MED HYG, V20, P642, DOI 10.4269/ajtmh.1971.20.642; Mourya DT, 1998, INDIAN J MED RES, V107, P10; Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002; Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; ROSS R. W., 1956, JOUR HYG, V54, P177; SALVAN M, 1994, ANN SOC BELG MED TR, V74, P323; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; SMITH C E G, 1956, J Trop Med Hyg, V59, P243; TESH RB, 1976, AM J TROP MED HYG, V25, P326, DOI 10.4269/ajtmh.1976.25.326; TURELL MJ, 1984, AM J TROP MED HYG, V33, P176, DOI 10.4269/ajtmh.1984.33.176; TURELL MJ, 1992, J MED ENTOMOL, V29, P49, DOI 10.1093/jmedent/29.1.49; Vashishtha M, 1998, J CELL BIOL, V140, P91, DOI 10.1083/jcb.140.1.91; Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292	34	445	462	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1168	10.1371/journal.pone.0001168	http://dx.doi.org/10.1371/journal.pone.0001168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000540	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459100010
J	Denley, A; Kang, S; Karst, U; Vogt, PK				Denley, A.; Kang, S.; Karst, U.; Vogt, P. K.			Oncogenic signaling of class IPI3K isoforms	ONCOGENE			English	Article						PI3K; oncogenic transformation; signaling; Ras; MEK; inhibitor	ACUTE MYELOID-LEUKEMIA; PHOSPHOINOSITIDE 3-KINASE INHIBITORS; CATALYTIC SUBUNIT; CELL-PROLIFERATION; PI 3-KINASE; PHOSPHATIDYLINOSITOL 3-KINASES; MEDIATED PHOSPHORYLATION; PROTEASOMAL DEGRADATION; TRANSCRIPTION FACTOR; EMBRYONIC LETHALITY	The catalytic subunits of class I PI3Ks comprise four isoforms: p110 alpha, p110 beta, p110 delta and p110 gamma. Cancer-specific gain-of-function mutations in p110 alpha delta beta have been identified in various malignancies. Cancer-specific mutations in the non-alpha isoforms of class I PI3K have not yet been identified, however overexpression of either wild-type p110 beta, p110 gamma or p110 delta is sufficient to induce cellular transformation in chicken embryo fibroblasts. The mechanism whereby these non-a isoforms of class I mediate oncogenic signals is unknown. Here we show that potently transforming class I isoforms signal via Akt/mTOR, inhibit GSK3 beta and cause degradation of FoxO1. A functional Erk pathway is required for p110 gamma and p110 beta transformation but not for transformation by p110 delta or the H1047R mutant of p110 alpha. Transformation and signaling by p110 gamma and p110 beta are sensitive to loss of interaction with Ras, which acts as a membrane anchor. Mutations in the C2 domain of p110 delta reduce transformation, most likely by interfering with membrane association. Several small molecule inhibitors potently and specifically inhibit the oncogenic signaling and transformation of each of the class I PI3K, and, when used in combination with MEK inhibitors, can additively reduce the transformation induced by p110 beta and p110 gamma.	[Denley, A.; Kang, S.; Karst, U.; Vogt, P. K.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Vogt, PK (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd,BCC-239, La Jolla, CA 92037 USA.	pkvogt@scripps.edu	Vogt, Peter K./R-7547-2019	Vogt, Peter K./0000-0002-4519-7500				Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Aoki M, 2000, J BIOL CHEM, V275, P6267, DOI 10.1074/jbc.275.9.6267; Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Billottet C, 2006, ONCOGENE, V25, P6648, DOI 10.1038/sj.onc.1209670; Blalock WL, 2003, LEUKEMIA, V17, P1058, DOI 10.1038/sj.leu.2402925; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Bony C, 2001, J CELL BIOL, V152, P717, DOI 10.1083/jcb.152.4.717; BOS TJ, 1990, GENE DEV, V4, P1677, DOI 10.1101/gad.4.10.1677; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; Dong JJ, 2005, CANCER RES, V65, P1961, DOI 10.1158/0008-5472.CAN-04-2501; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fan QW, 2006, CELL CYCLE, V5, P2301, DOI 10.4161/cc.5.20.3362; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Grandage VL, 2005, LEUKEMIA, V19, P586, DOI 10.1038/sj.leu.2403653; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hickey FB, 2006, J BIOL CHEM, V281, P2441, DOI 10.1074/jbc.M511173200; HOOSHMANDRAD R, 2000, J CELL SCI, V3, pP110; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Kang S, 2006, P NATL ACAD SCI USA, V103, P1289, DOI 10.1073/pnas.0510772103; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; KAWAI S, 1984, MOL CELL BIOL, V4, P1172, DOI 10.1128/MCB.4.6.1172; Kharas MG, 2004, BLOOD, V103, P4268, DOI 10.1182/blood-2003-07-2193; Klejman A, 2002, ONCOGENE, V21, P5868, DOI 10.1038/sj.onc.1205724; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kubota Y, 2004, LEUKEMIA, V18, P1438, DOI 10.1038/sj.leu.2403402; Leverrier Y, 2003, J BIOL CHEM, V278, P38437, DOI 10.1074/jbc.M306649200; Lyons JF, 2001, ENDOCR-RELAT CANCER, V8, P219, DOI 10.1677/erc.0.0080219; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; McCubrey JA, 2001, CANCER DETECT PREV, V25, P375; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Min YH, 2003, LEUKEMIA, V17, P995, DOI 10.1038/sj.leu.2402874; Mulholland DJ, 2006, ONCOGENE, V25, P329, DOI 10.1038/sj.onc.1209020; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Newton AC, 1998, BBA-REV BIOMEMBRANES, V1376, P155, DOI 10.1016/S0304-4157(98)00003-3; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Okkenhaug K, 2002, SCIENCE, V297, P1031; Orme MH, 2006, NAT CELL BIOL, V8, P1298, DOI 10.1038/ncb1493; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shaw M, 1997, FEBS LETT, V416, P307, DOI 10.1016/S0014-5793(97)01235-0; SKORSKI T, 1995, CANCER RES, V55, P2275; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Sujobert P, 2005, BLOOD, V106, P1063, DOI 10.1182/blood-2004-08-3225; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vanhaesebroeck B, 1999, NAT CELL BIOL, V1, P69, DOI 10.1038/9045; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Vogt PK, 2006, CELL CYCLE, V5, P946, DOI 10.4161/cc.5.9.2725; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Ward S, 2003, CHEM BIOL, V10, P207, DOI 10.1016/S1074-5521(03)00048-6; Ward SG, 2003, CURR OPIN PHARMACOL, V3, P426, DOI 10.1016/S1471-4892(03)00078-X; Yip SC, 2004, CELL MOTIL CYTOSKEL, V59, P180, DOI 10.1002/cm.20032; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x	75	89	91	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2008	27	18					2561	2574		10.1038/sj.onc.1210918	http://dx.doi.org/10.1038/sj.onc.1210918			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	289LW	17998941				2022-12-25	WOS:000255057000006
J	Moehren, U; Papaioannou, M; Reeb, CA; Grassell, A; Nanni, S; Asim, M; Roell, D; Prade, I; Farsetti, A; Baniahmad, A				Moehren, Udo; Papaioannou, Maria; Reeb, Christina A.; Grassell, Annalisa; Nanni, Simona; Asim, Mohammad; Roell, Daniela; Prade, Ina; Farsetti, Antonella; Baniahmad, Aria			Wild-type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: a novel role of AR mutation for prostate cancer development	FASEB JOURNAL			English	Article						transrepression; gene silencing; agonist; antagonist; chromatin	HORMONE REPLACEMENT THERAPY; CELLS IN-VITRO; TRANSCRIPTIONAL REGULATION; PROTEIN-INTERACTION; TESTOSTERONE LEVELS; TARGET; GENE; GROWTH; ANTAGONIST; MODULATION	Androgens play a central role in prostate development and prostate cancer proliferation. Induction of telomerase is an early event in prostate carcinogenesis and is considered as a marker for both primary tumors and metastases. Interestingly, several reports suggest that telomerase activity is regulated by androgens in vivo. Here, we show that the wild-type (WT) human androgen receptor (AR) inhibits the expression of the human telomerase reverse transcriptase (hTERT) and telomerase activity via inhibition of hTERT promoter activity in the presence of androgen receptor agonists. However, pure androgen antagonists failed to repress hTERT transcription. The androgen-mediated repression of hTERT is abrogated in a human prostate cancer cell line exhibiting hormone-dependent growth, which expresses a mutant AR (T877A) frequently occurring in prostate cancer. We reveal that this single amino acid exchange is sufficient for the lack of transrepression. Interestingly, chromatin immunoprecipitation data suggest that, in contrast to the WT AR, the mutant AR is recruited less efficiently to the hTERT promoter in vivo, indicating that loss of transrepression results from reduced chromatin recruitment. Thus, our findings suggest that the WT AR inhibits expression of hTERT, which is indicative of a protective mechanism, whereas the T877A mutation of AR not only broadens the ligand spectrum of the receptor but abrogates this inhibitory mechanism in prostate cancer cells. This novel role of AR mutations in prostate cancer development suggests the benefit to a search for new AR antagonists that inhibit transactivation but allow transrepression.	[Baniahmad, Aria] Inst Human Genet & Anthropol, Fac Med, D-07743 Jena, Germany; [Moehren, Udo] Katholieke Univ Leuven, Div Biochem, Louvain, Belgium; [Grassell, Annalisa; Nanni, Simona; Farsetti, Antonella] Regina Elena Inst Canc Res, Dept Expt Oncol, Mol Oncogenesis Lab, Rome, Italy; [Farsetti, Antonella] CNR, Inst Neurobiol & Mol Med, Rome, Italy; [Baniahmad, Aria] Univ Kuopio, Dept Biochem, FIN-70211 Kuopio, Finland	KU Leuven; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Consiglio Nazionale delle Ricerche (CNR); Finland National Institute for Health & Welfare; University of Eastern Finland	Baniahmad, A (corresponding author), Inst Human Genet & Anthropol, Fac Med, Kollegiengasse 10, D-07743 Jena, Germany.	aban@mti.tini-jena.de	Papaioannou, Maria/AAI-3738-2021; Farsetti, Antonella/I-8710-2018	Papaioannou, Maria/0000-0003-3149-6523; Farsetti, Antonella/0000-0002-8603-7925; Prade, Ina/0000-0001-6951-151X	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; Biroccio A, 2004, ENDOCR-RELAT CANCER, V11, P407, DOI 10.1677/erc.1.00764; Chatterjee B, 2003, MOL CELL BIOCHEM, V253, P89, DOI 10.1023/A:1026057402945; Comhaire FH, 2000, EUR UROL, V38, P655, DOI 10.1159/000020358; Cong YS, 1999, HUM MOL GENET, V8, P137, DOI 10.1093/hmg/8.1.137; Culig Z, 1999, BRIT J CANCER, V81, P242, DOI 10.1038/sj.bjc.6690684; Culig Z, 2002, ENDOCR-RELAT CANCER, V9, P155, DOI 10.1677/erc.0.0090155; DAI WS, 1981, AM J EPIDEMIOL, V114, P804, DOI 10.1093/oxfordjournals.aje.a113251; Dotzlaw H, 2002, MOL ENDOCRINOL, V16, P661, DOI 10.1210/me.16.4.661; Fronsdal K, 2000, PROSTATE, V43, P111, DOI 10.1002/(SICI)1097-0045(20000501)43:2<111::AID-PROS5>3.0.CO;2-4; Fu MF, 2002, MOL CELL BIOL, V22, P3373, DOI 10.1128/MCB.22.10.3373-3388.2002; GAST A, 1995, MOL CELL ENDOCRINOL, V111, P93, DOI 10.1016/0303-7207(95)03554-K; Geserick C, 2006, ONCOGENE, V25, P4310, DOI 10.1038/sj.onc.1209465; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; Guo CH, 2003, J UROLOGY, V170, P615, DOI 10.1097/01.ju.0000074653.22766.c8; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; Hoffman MA, 2000, J UROLOGY, V163, P824, DOI 10.1016/S0022-5347(05)67812-3; Janknecht R, 2004, FEBS LETT, V564, P9, DOI 10.1016/S0014-5793(04)00356-4; KALLIO PJ, 1995, MOL ENDOCRINOL, V9, P1017, DOI 10.1210/me.9.8.1017; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; Kim NW, 2001, UROLOGY, V57, P148, DOI 10.1016/S0090-4295(00)00962-6; Lichtsteiner SP, 1999, ANN NY ACAD SCI, V886, P1, DOI 10.1111/j.1749-6632.1999.tb09395.x; Meeker AK, 1996, ENDOCRINOLOGY, V137, P5743, DOI 10.1210/en.137.12.5743; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Misiti S, 2000, MOL CELL BIOL, V20, P3764, DOI 10.1128/MCB.20.11.3764-3771.2000; Moehren U, 2007, MOL ENDOCRINOL, V21, P1039, DOI 10.1210/me.2006-0468; Morley JE, 1997, METABOLISM, V46, P410, DOI 10.1016/S0026-0495(97)90057-3; Nanni S, 2006, MOL CANCER RES, V4, P79, DOI 10.1158/1541-7786.MCR-05-0098; Prehn RT, 1999, CANCER RES, V59, P4161; Ravindranath N, 2001, PROSTATE, V49, P79, DOI 10.1002/pros.1120; Schatzl G, 2001, PROSTATE, V47, P52; Schindler A, 2001, INT J ONCOL, V19, P25; Schneikert J, 1996, J BIOL CHEM, V271, P23907, DOI 10.1074/jbc.271.39.23907; Shenk JL, 2001, J BIOL CHEM, V276, P38472, DOI 10.1074/jbc.M103652200; Shibata H, 1997, RECENT PROG HORM RES, V52, P141; Slater S, 2000, DRUG AGING, V17, P431, DOI 10.2165/00002512-200017060-00001; Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985; Soda H, 2000, PROSTATE, V43, P161, DOI 10.1002/(SICI)1097-0045(20000515)43:3<161::AID-PROS1>3.0.CO;2-O; Sommerfeld HJ, 1996, CANCER RES, V56, P218; Taplin ME, 1999, CANCER RES, V59, P2511; Teske E, 2002, MOL CELL ENDOCRINOL, V197, P251, DOI 10.1016/S0303-7207(02)00261-7; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; Xu DW, 2000, ONCOGENE, V19, P5123, DOI 10.1038/sj.onc.1203890; Zhang WB, 1998, CANCER RES, V58, P619	45	41	42	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2008	22	4					1258	1267		10.1096/fj.07-9360com	http://dx.doi.org/10.1096/fj.07-9360com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	17991730				2022-12-25	WOS:000254581000030
J	Odell, AF; Van Helden, DF; Scott, JL				Odell, Adam F.; Van Helden, Dirk F.; Scott, Judith L.			The spectrin cytoskeleton influences the surface expression and activation of human transient receptor potential channel 4 channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; STORE-OPERATED CHANNELS; ALPHA-II-SPECTRIN; TRPC CHANNELS; EPITHELIAL-CELLS; PLASMA-MEMBRANE; TERMINAL DOMAIN; BRAIN SPECTRIN; TYROSINE PHOSPHORYLATION; ENDOPLASMIC-RETICULUM	Despite over a decade of research, only recently have the mechanisms governing transient receptor potential channel (TRPC) channel function begun to emerge, with an essential role for accessory proteins in this process. We previously identified a tyrosine phosphorylation event as critical in the plasma membrane translocation and activation of hTRPC4 channels following epidermal growth factor (EGF) receptor activation. To further characterize the signaling events underlying this process, a yeast-two hybrid screen was performed on the C terminus of hTRPC4. The intracellular C-terminal region from proline 686 to leucine 977 was used to screen a human brain cDNA library. Two members of the spectrin family, alpha II- and beta V-spectrin, were identified as binding partners. The interaction of hTRPC4 with alpha II-spectrin and beta V-spectrin was confirmed by glutathione S-transferase pulldown and co-immunoprecipitation experiments. Deletion analysis identified amino acids 730 758 of hTRPC4 as critical for the interaction with this region located within a coiled-coil domain, juxtaposing the Ca2+/calmodulin and IP3R-binding region (CIRB domain). This region is deleted in the proposed delta hTRPC4 splice variant form, which failed to undergo both EGF-induced membrane insertion and activation, providing a genetic mechanism for regulating channel activity. We also demonstrate that the exocytotic insertion and activation of hTRPC4 following EGF application is accompanied by dissociation from alpha II-spectrin. Furthermore, depletion of alpha II-spectrin by small interference RNA reduces the basal surface expression of alpha hTRPC4 and prevents the enhanced membrane insertion in response to EGF application. Importantly, depletion of alpha II-spectrin did not affect the expression of the delta variant. Taken together, these results demonstrate that a direct interaction between hTRPC4 and the spectrin cytoskeleton is involved in the regulation of hTRPC4 surface expression and activation.	[Odell, Adam F.; Van Helden, Dirk F.; Scott, Judith L.] Univ Newcastle, Fac Hlth, Sch Biomed Sci, Newcastle, NSW 2308, Australia	University of Newcastle	Odell, AF (corresponding author), Univ Leeds, Leeds, W Yorkshire, England.	a.f.odell@leeds.ac.uk	Odell, Adam/J-1386-2012					ABDI KM, 2007, IN PRESS MOL BIOL CE; Ambudkar IS, 2006, TRENDS PHARMACOL SCI, V27, P25, DOI 10.1016/j.tips.2005.11.008; Bennett V, 1990, CURR OPIN CELL BIOL, V2, P51, DOI 10.1016/S0955-0674(05)80030-4; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bloch RJ, 1997, SOC GEN PHY, V52, P177; Bollimuntha S, 2005, VISUAL NEUROSCI, V22, P163, DOI 10.1017/S0952523805222058; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Cioffi DL, 2005, CIRC RES, V97, P1164, DOI 10.1161/01.RES.0000193597.65217.00; Cioffi DL, 2003, CELL CALCIUM, V33, P323, DOI 10.1016/S0143-4160(03)00046-0; Cukovic D, 2001, FEBS LETT, V498, P87, DOI 10.1016/S0014-5793(01)02505-4; Devarajan P, 1997, P NATL ACAD SCI USA, V94, P10711, DOI 10.1073/pnas.94.20.10711; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Goel M, 2005, PFLUG ARCH EUR J PHY, V451, P87, DOI 10.1007/s00424-005-1454-y; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Hryniewicz-Jankowska A, 2002, FOLIA HISTOCHEM CYTO, V40, P239; Iga M, 1997, BIOCHEM BIOPH RES CO, V231, P852, DOI 10.1006/bbrc.1997.6202; Itagaki K, 2004, J IMMUNOL, V172, P601, DOI 10.4049/jimmunol.172.1.601; Kiselyov K., 2007, V179, P559; Kiselyov K, 2005, PFLUG ARCH EUR J PHY, V451, P116, DOI 10.1007/s00424-005-1442-2; Kiselyov K, 1999, MOL CELL, V4, P423, DOI 10.1016/S1097-2765(00)80344-5; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Kontrogianni-Konstantopoulos A, 2001, J BIOL CHEM, V276, P20679, DOI 10.1074/jbc.M010581200; Lencesova L, 2004, J BIOL CHEM, V279, P2885, DOI 10.1074/jbc.M310365200; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; McKay RR, 2000, BIOCHEM J, V351, P735, DOI 10.1042/0264-6021:3510735; Mery L, 2002, J CELL SCI, V115, P3497; Mery L, 2001, FEBS LETT, V487, P377, DOI 10.1016/S0014-5793(00)02362-0; Morales S, 2005, CELL SIGNAL, V17, P635, DOI 10.1016/j.cellsig.2004.10.002; Nakano M, 2001, BIOCHEM BIOPH RES CO, V288, P468, DOI 10.1006/bbrc.2001.5795; Nicolas G, 2002, MOL CELL BIOL, V22, P3527, DOI 10.1128/MCB.22.10.3527-3536.2002; Obukhov AG, 2004, J CELL PHYSIOL, V201, P227, DOI 10.1002/jcp.20057; Odell AF, 2005, J BIOL CHEM, V280, P37974, DOI 10.1074/jbc.M503646200; Ordaz B, 2005, J BIOL CHEM, V280, P30788, DOI 10.1074/jbc.M504745200; PERRIN D, 1985, NATURE, V315, P589, DOI 10.1038/315589a0; Schaefer M, 2002, J BIOL CHEM, V277, P3752, DOI 10.1074/jbc.M109850200; SIKORSKI AF, 1991, J CELL BIOL, V114, P313, DOI 10.1083/jcb.114.2.313; Sinkins WG, 2004, J BIOL CHEM, V279, P34521, DOI 10.1074/jbc.M401156200; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Thomas G, 1998, BIOESSAYS, V20, P600, DOI 10.1002/(SICI)1521-1878(199807)20:7<600::AID-BIES13>3.0.CO;2-3; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Trost C, 2001, BIOCHEM J, V355, P663, DOI 10.1042/bj3550663; Voas MG, 2007, CURR BIOL, V17, P562, DOI 10.1016/j.cub.2007.01.071; Wechsler A, 1998, EMBO J, V17, P3931, DOI 10.1093/emboj/17.14.3931; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; Wu SW, 2001, J CELL BIOL, V154, P1225, DOI 10.1083/jcb.200106156; Wu XY, 2002, J BIOL CHEM, V277, P13597, DOI 10.1074/jbc.M110881200; Yang H, 2005, J BIOL CHEM, V280, P32230, DOI 10.1074/jbc.M504553200; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhu Michael X, 2004, Novartis Found Symp, V258, P44; Zuckerman JB, 1999, J BIOL CHEM, V274, P23286, DOI 10.1074/jbc.274.33.23286	53	33	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4395	4407		10.1074/jbc.M709729200	http://dx.doi.org/10.1074/jbc.M709729200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18048348	Green Published, hybrid			2022-12-25	WOS:000253083500074
J	Okoshi, R; Ozaki, T; Yamamoto, H; Ando, K; Koida, N; Ono, S; Koda, T; Kamijo, T; Nakagawara, A; Kizaki, H				Okoshi, Rintaro; Ozaki, Toshinori; Yamamoto, Hideki; Ando, Kiyohiro; Koida, Nami; Ono, Sayaka; Koda, Tadayuki; Kamijo, Takehiko; Nakagawara, Akira; Kizaki, Harutoshi			Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-METABOLISM; P53; PHOSPHORYLATION; EXPRESSION; PATHWAY; CASCADE; DEGRADATION; HOMEOSTASIS; UPSTREAM; DYNAMICS	Tumor suppressor p53-dependent stress response pathways play an important role in cell fate determination. In this study, we have found that glucose depletion promotes the phosphorylation of AMP-activated protein kinase catalytic subunit alpha (AMPK alpha) in association with a significant up-regulation of p53, thereby inducing p53-dependent apoptosis in vivo and in vitro. Thymocytes prepared from glucose-depleted wild-type mice but not from p53-deficient mice underwent apoptosis, which was accompanied by a remarkable phosphorylation of AMPK alpha and a significant induction of p53 as well as pro-apoptotic Bax. Similar results were also obtained in human osteosarcoma-derived U2OS cells bearing wild-type p53 following glucose starvation. Of note, glucose deprivation led to a significant accumulation of p53 phosphorylated at Ser-46, but not at Ser-15 and Ser-20, and a transcriptional induction of p53 as well as proapoptotic p53 AIP1. Small interference RNA-mediated knockdown of p53 caused an inhibition of apoptosis following glucose depletion. Additionally, apoptosis triggered by glucose deprivation was markedly impaired by small interference RNA-mediated depletion of AMPK alpha. Under our experimental conditions, down-regulation of AMPK alpha caused an attenuation of p53 accumulation and its phosphorylation at Ser-46. In support of these observations, enforced expression of AMPK alpha led to apoptosis and resulted in an induction of p53 at protein and mRNA levels. Furthermore, p53 promoter region responded to AMPK alpha and glucose deprivation as judged by luciferase reporter assay. Taken together, our present findings suggest that AMPK-dependent transcriptional induction and phosphorylation of p53 at Ser-46 play a crucial role in the induction of apoptosis under carbon source depletion.	[Okoshi, Rintaro; Ozaki, Toshinori; Yamamoto, Hideki; Ando, Kiyohiro; Koida, Nami; Kamijo, Takehiko; Nakagawara, Akira] Chiba Canc Ctr Res Inst, Div Biochem, Chiba 2608717, Japan; [Okoshi, Rintaro; Kizaki, Harutoshi] Tokyo Dent Coll, Oral Hlth Sci Ctr, Chiba 2618502, Japan; [Ono, Sayaka; Koda, Tadayuki] Hisamitsu Pharmaceut Co Inc, Ctr Funct Gen, Chiba 2608717, Japan	Chiba Cancer Center; Tokyo Dental College; Hisamitsu Pharmaceutical Co Ltd	Nakagawara, A (corresponding author), Chiba Canc Ctr Res Inst, Div Biochem, Chiba 2608717, Japan.	akiranak@chiba-cc.jp; kizaki@tdc.ac.jp						BEG ZH, 1973, BIOCHEM BIOPH RES CO, V54, P1362, DOI 10.1016/0006-291X(73)91137-6; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; CARLSON CA, 1973, J BIOL CHEM, V248, P378; Chao C, 2003, J BIOL CHEM, V278, P41028, DOI 10.1074/jbc.M306938200; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dauth I, 2007, CANCER RES, V67, P2274, DOI 10.1158/0008-5472.CAN-06-2884; DEFROMENTEL CC, 1992, GENE CHROMOSOME CANC, V4, P1; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Garcia SN, 1999, CELL, V97, P825, DOI 10.1016/S0092-8674(00)80794-1; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Karni-Schmidt O, 2007, ONCOGENE, V26, P3878, DOI 10.1038/sj.onc.1210162; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Matsuda K, 2002, CANCER RES, V62, P2883; Mekhail K, 2005, J CELL BIOL, V170, P733, DOI 10.1083/jcb.200506030; Noda A, 2000, ONCOGENE, V19, P21, DOI 10.1038/sj.onc.1203230; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Prives C, 1999, J PATHOL, V187, P112; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Raman V, 2000, J BIOL CHEM, V275, P26551, DOI 10.1074/jbc.C000324200; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; REICH NC, 1984, NATURE, V308, P199, DOI 10.1038/308199a0; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; Stefanelli C, 1998, BIOCHEM BIOPH RES CO, V243, P821, DOI 10.1006/bbrc.1998.8154; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang SL, 2006, CANCER RES, V66, P6982, DOI 10.1158/0008-5472.CAN-06-0511; Wesierska-Gadek J, 2002, INT J CANCER, V101, P128, DOI 10.1002/ijc.10580; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xing YQ, 2003, J BIOL CHEM, V278, P28372, DOI 10.1074/jbc.M303521200; YOSHIDA K, 2006, J BIOL CHEM, V281, P5834	41	231	241	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3979	3987		10.1074/jbc.M705232200	http://dx.doi.org/10.1074/jbc.M705232200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18056705	hybrid			2022-12-25	WOS:000253083500032
J	Rossi, F; Garavaglia, S; Montalbano, V; Walsh, MA; Rizzi, M				Rossi, Franca; Garavaglia, Silvia; Montalbano, Valeria; Walsh, Martin A.; Rizzi, Menico			Crystal structure of human kynurenine aminotransferase II, a drug target for the treatment of schizophrenia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARTATE-AMINOTRANSFERASE; ACID LEVELS; BRAIN; RAT; TRANSMISSION; METABOLISM; EXPRESSION; EVOLUTION; MOLSCRIPT; REVEALS	Kynurenic acid is an endogenous neuroactive compound whose unbalancing is involved in the pathogenesis and progression of several neurological diseases. Kynurenic acid synthesis in the human brain is sustained by the catalytic activity of two kynurenine aminotransferases, hKAT I and hKAT II. A wealth of pharmacological data highlight hKAT II as a sensible target for the treatment of neuropathological conditions characterized by a kynurenic acid excess, such as schizophrenia and cognitive impairment. We have solved the structure of human KAT II by means of the single-wavelength anomalous dispersion method at 2.3-angstrom resolution. Although closely resembling the classical aminotransferase fold, the hKAT II architecture displays unique features. Structural comparison with a prototypical aspartate aminotransferase reveals a novel antiparallel strand-loop-strand motif that forms an unprecedented intersubunit beta-sheet in the functional hKAT II dimer. Moreover, the N-terminal regions of hKAT II and aspartate aminotransferase appear to have converged to highly similar although 2-fold symmetry-related conformations, which fulfill the same functional role. A detailed structural comparison of hKAT I and hKAT II reveals a larger and more aliphatic character to the active site of hKAT II due to the absence of the aromatic cage involved in ligand binding in hKAT I. The observed structural differences could be exploited for the rational design of highly selective hKAT II inhibitors.	[Rossi, Franca; Garavaglia, Silvia; Montalbano, Valeria; Rizzi, Menico] Univ Piemonte Orientale, DiSCAFF INFM, I-28100 Novara, Italy; [Walsh, Martin A.] European Synchrotron Radiat Facil, Med Res Council France, F-38043 Grenoble, France	University of Eastern Piedmont Amedeo Avogadro; European Synchrotron Radiation Facility (ESRF)	Rizzi, M (corresponding author), Univ Piemonte Orientale, DiSCAFF, Via Bovio 6, I-28100 Novara, Italy.	rizzi@pharm.unipmn.it	garavaglia, silvia/C-5588-2013; garavaglia, silvia/AIA-1816-2022; Walsh, Martin A/I-1566-2013	Walsh, Martin A/0000-0001-5683-1151; garavaglia, silvia/0000-0001-8494-1729	Medical Research Council [G0500367] Funding Source: Medline; MRC [G0500367] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x; Alkondon M, 2004, J NEUROSCI, V24, P4635, DOI 10.1523/JNEUROSCI.5631-03.2004; ANDINE P, 1988, NEUROSCI LETT, V90, P208, DOI 10.1016/0304-3940(88)90813-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baran H, 1996, LIFE SCI, V58, P1891, DOI 10.1016/0024-3205(96)00173-7; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; BUCHLI R, 1995, J BIOL CHEM, V270, P29330, DOI 10.1074/jbc.270.49.29330; Chess AC, 2006, BEHAV BRAIN RES, V170, P326, DOI 10.1016/j.bbr.2006.03.006; Chon H, 2005, PROTEINS, V61, P685, DOI 10.1002/prot.20614; Christen P, 2001, CHEM REC, V1, P436, DOI 10.1002/tcr.10005; Clausen T, 1996, J MOL BIOL, V262, P202, DOI 10.1006/jmbi.1996.0508; Cooper AJL, 2004, NEUROCHEM INT, V44, P557, DOI 10.1016/j.neuint.2003.12.002; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denesyuk AI, 2002, J MOL BIOL, V316, P155, DOI 10.1006/jmbi.2001.5310; Erhardt S, 2001, NEUROSCI LETT, V313, P96, DOI 10.1016/S0304-3940(01)02242-X; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FOSTER AC, 1984, NEUROSCI LETT, V48, P273, DOI 10.1016/0304-3940(84)90050-8; FU D, 1992, J COMP NEUROL, V321, P477, DOI 10.1002/cne.903210313; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Guidetti P, 1997, J NEUROSCI RES, V50, P457; Guidetti P, 2007, J NEUROCHEM, V102, P103, DOI 10.1111/j.1471-4159.2007.04556.x; Guidetti P, 2007, GLIA, V55, P78, DOI 10.1002/glia.20432; Han Q, 2005, FEBS J, V272, P2198, DOI 10.1111/j.1742-4658.2005.04643.x; Han Q, 2004, EUR J BIOCHEM, V271, P4804, DOI 10.1111/j.1432-1033.2004.04446.x; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; Jensen RA, 1996, J BACTERIOL, V178, P2161, DOI 10.1128/jb.178.8.2161-2171.1996; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kiss C, 2003, J NEURAL TRANSM, V110, P1, DOI 10.1007/s00702-002-0770-z; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krupka HI, 2000, EMBO J, V19, P3168, DOI 10.1093/emboj/19.13.3168; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Moroni F, 1999, EUR J PHARMACOL, V375, P87, DOI 10.1016/S0014-2999(99)00196-X; Mosca M, 1996, ADV EXP MED BIOL, V398, P449; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai T, 1999, BIOCHEMISTRY-US, V38, P2413, DOI 10.1021/bi9819881; OKUNO E, 1991, BRAIN RES, V542, P307, DOI 10.1016/0006-8993(91)91583-M; Pereira EFR, 2002, J NEUROBIOL, V53, P479, DOI 10.1002/neu.10146; PERKINS MN, 1982, BRAIN RES, V247, P184, DOI 10.1016/0006-8993(82)91048-4; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Poeggeler B, 2007, NEUROSCIENCE, V148, P188, DOI 10.1016/j.neuroscience.2007.05.033; Rassoulpour A, 2005, J NEUROCHEM, V93, P762, DOI 10.1111/j.1471-4159.2005.03134.x; Rossi F, 2004, J BIOL CHEM, V279, P50214, DOI 10.1074/jbc.M409291200; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sapko MT, 2006, EXP NEUROL, V197, P31, DOI 10.1016/j.expneurol.2005.07.004; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schwarcz R, 2001, BIOL PSYCHIAT, V50, P521, DOI 10.1016/S0006-3223(01)01078-2; Schwarcz R, 2002, J PHARMACOL EXP THER, V303, P1, DOI 10.1124/jpet.102.034439; Stone TW, 2001, TOXICON, V39, P61, DOI 10.1016/S0041-0101(00)00156-2; Wu HQ, 2007, J NEURAL TRANSM, V114, P33, DOI 10.1007/s00702-006-0562-y; Yu P, 2006, GENE, V365, P111, DOI 10.1016/J.gene.2005.09.034; Yu P, 2004, MOL CELL BIOL, V24, P6919, DOI 10.1128/MCB.24.16.6919-6930.2004	55	47	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3559	3566		10.1074/jbc.M707925200	http://dx.doi.org/10.1074/jbc.M707925200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056996	hybrid			2022-12-25	WOS:000253083000061
J	Bellon, SF; Kaplan-Lefko, P; Yang, YJ; Zhang, YH; Moriguchi, J; Rex, K; Johnson, CW; Rose, PE; Long, AM; O'Connor, AB; Gu, Y; Coxon, A; Kim, TS; Tasker, A; Burgess, TL; Dussault, I				Bellon, Steven F.; Kaplan-Lefko, Paula; Yang, Yajing; Zhang, Yihong; Moriguchi, Jodi; Rex, Karen; Johnson, Carol W.; Rose, Paul E.; Long, Alexander M.; O'Connor, Anne B.; Gu, Yan; Coxon, Angela; Kim, Tae-Seong; Tasker, Andrew; Burgess, Teresa L.; Dussault, Isabelle			C-met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; GASTROINTESTINAL STROMAL TUMORS; RECEPTOR TYROSINE KINASE; SMALL-MOLECULE INHIBITOR; MONOCLONAL-ANTIBODIES; IMATINIB RESISTANCE; GLIOBLASTOMA GROWTH; ANTITUMOR-ACTIVITY; HGF/SF RECEPTOR; MOUSE MODEL	c-Met is a receptor tyrosine kinase often deregulated in human cancers, thus making it an attractive drug target. One mechanism by which c-Met deregulation leads to cancer is through gain-of-function mutations. Therefore, small molecules capable of targeting these mutations could offer therapeutic benefits for affected patients. SU11274 was recently described and reported to inhibit the activity of the wild-type and some mutant forms of c-Met, whereas other mutants are resistant to inhibition. We identified a novel series of c-Met small molecule inhibitors that are active against multiple mutants previously identified in hereditary papillary renal cell carcinoma patients. AM7 is active against wild-type c-Met as well as several mutants, inhibits c-Met-mediated signaling in MKN-45 and U-87 MG cells, and inhibits tumor growth in these two models grown as xenografts. The crystal structures of AM7 and SU11274 bound to unphosphorylated c- Met have been determined. The AM7 structure reveals a novel binding mode compared with other published c-Met inhibitors and SU11274. The molecule binds the kinase linker and then extends into a new hydrophobic binding site. This binding site is created by a significant movement of the C-helix and so represents an inactive conformation of the c-Met kinase. Thus, our results demonstrate that it is possible to identify and design inhibitors that will likely be active against mutants found in different cancers.	[Kaplan-Lefko, Paula; Yang, Yajing; Zhang, Yihong; Moriguchi, Jodi; Rex, Karen; Coxon, Angela; Burgess, Teresa L.; Dussault, Isabelle] Amgen Inc, Dept Oncol Res, Newbury Pk, CA 91320 USA; [Rose, Paul E.; Long, Alexander M.; O'Connor, Anne B.; Gu, Yan] Amgen Inc, Dept Mol Struct, Newbury Pk, CA 91320 USA; [Johnson, Carol W.] Amgen Inc, Dept Pathol, Newbury Pk, CA 91320 USA; [Kim, Tae-Seong; Tasker, Andrew] Amgen Inc, Dept Med Chem, Newbury Pk, CA 91320 USA	Amgen; Amgen; Amgen; Amgen	Dussault, I (corresponding author), Amgen Inc, Dept Oncol Res, 1 Amgen Ctr Dr, Newbury Pk, CA 91320 USA.	idussaul@amgen.com						Abounader R, 1999, J NATL CANCER I, V91, P1548, DOI 10.1093/jnci/91.18.1548; Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Berthou S, 2004, ONCOGENE, V23, P5387, DOI 10.1038/sj.onc.1207691; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Brockmann MA, 2003, CLIN CANCER RES, V9, P4578; Burgess T, 2006, CANCER RES, V66, P1721, DOI 10.1158/0008-5472.CAN-05-3329; Cao B, 2001, P NATL ACAD SCI USA, V98, P7443, DOI 10.1073/pnas.131200498; Chen LL, 2004, CANCER RES, V64, P5913, DOI 10.1158/0008-5472.CAN-04-0085; Christensen JG, 2003, CANCER RES, V63, P7345; Corso S, 2005, TRENDS MOL MED, V11, P284, DOI 10.1016/j.molmed.2005.04.005; Date K, 1997, FEBS LETT, V420, P1, DOI 10.1016/S0014-5793(97)01475-0; Debiec-Rychter M, 2005, GASTROENTEROLOGY, V128, P270, DOI 10.1053/j.gastro.2004.11.020; Debiec-Rychter M, 2004, EUR J CANCER, V40, P689, DOI 10.1016/j.ejca.2003.11.025; Dharmawardana PG, 2004, CURR MOL MED, V4, P855, DOI 10.2174/1566524043359674; Giordano S, 2000, FASEB J, V14, P399, DOI 10.1096/fasebj.14.2.399; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Hodous BL, 2007, J MED CHEM, V50, P611, DOI 10.1021/jm061107l; Jeffers M, 1998, P NATL ACAD SCI USA, V95, P14417, DOI 10.1073/pnas.95.24.14417; Jeffers M, 1997, P NATL ACAD SCI USA, V94, P11445, DOI 10.1073/pnas.94.21.11445; Kim KJ, 2006, CLIN CANCER RES, V12, P1292, DOI 10.1158/1078-0432.CCR-05-1793; Kim SJ, 2003, CLIN CANCER RES, V9, P5161; KOMADA M, 1994, J BIOL CHEM, V269, P16131; Kong-Beltran M, 2004, CANCER CELL, V6, P75, DOI 10.1016/j.ccr.2004.06.013; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Martens T, 2006, CLIN CANCER RES, V12, P6144, DOI 10.1158/1078-0432.CCR-05-1418; Michieli P, 2004, CANCER CELL, V6, P61, DOI 10.1016/j.ccr.2004.05.032; Nagar B, 2002, CANCER RES, V62, P4236; Nguyen L, 1997, J BIOL CHEM, V272, P20811, DOI 10.1074/jbc.272.33.20811; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Olivero M, 1999, INT J CANCER, V82, P640, DOI 10.1002/(SICI)1097-0215(19990827)82:5<640::AID-IJC4>3.0.CO;2-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Polverino A, 2006, CANCER RES, V66, P8715, DOI 10.1158/0008-5472.CAN-05-4665; REGECAMBRIN G, 1992, CANCER GENET CYTOGEN, V64, P170, DOI 10.1016/0165-4608(92)90350-H; RODRIGUES GA, 1994, ONCOGENE, V9, P2019; Sattler M, 2003, CANCER RES, V63, P5462; Schiering N, 2003, P NATL ACAD SCI USA, V100, P12654, DOI 10.1073/pnas.1734128100; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schmidt L, 1999, ONCOGENE, V18, P2343, DOI 10.1038/sj.onc.1202547; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Tamborini E, 2006, ONCOGENE, V25, P6140, DOI 10.1038/sj.onc.1209639; Tamborini E, 2004, CLIN CANCER RES, V10, P938, DOI 10.1158/1078-0432.CCR-03-0059; Tokarski JS, 2006, CANCER RES, V66, P5790, DOI 10.1158/0008-5472.CAN-05-4187; Tomioka D, 2001, CANCER RES, V61, P7518; Wang WR, 2006, P NATL ACAD SCI USA, V103, P3563, DOI 10.1073/pnas.0600048103; Wang XY, 2003, MOL CANCER THER, V2, P1085; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Young MA, 2006, CANCER RES, V66, P1007, DOI 10.1158/0008-5472.CAN-05-2788; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; ZHU H, 1994, J BIOL CHEM, V269, P29943; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	51	114	126	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2675	2683		10.1074/jbc.M705774200	http://dx.doi.org/10.1074/jbc.M705774200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18055465	hybrid			2022-12-25	WOS:000252622300024
J	Qiu, C; Lienhard, S; Hynes, NE; Badache, A; Leahy, DJ				Qiu, Chen; Lienhard, Susanne; Hynes, Nancy E.; Badache, Ali; Leahy, Daniel J.			Memo is homologous to nonheme iron dioxygenases and binds an ErbB2-derived phosphopeptide in its vestigial active site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERBB SIGNALING NETWORK; PROTOCATECHUATE 4,5-DIOXYGENASE; ACTIVATION; RECEPTORS; PROTEINS; SYSTEM; KINASE; CANCER; SHC	Memo (mediator of ErbB2-driven cell motility) is a 297-aminoacid protein recently shown to co-precipitate with the C terminus of ErbB2 and be required for ErbB2-driven cell motility. Memo is not homologous to any known signaling proteins, and how it mediates ErbB2 signals is not known. To provide a molecular basis for understanding Memo function, we have determined and report here the 2.1 angstrom crystal structure of human Memo and show it be homologous to class III nonheme iron-dependent dioxygenases, a structural class that now includes a zinc-binding protein of unknown function. No metal binding or enzymatic activity can be detected for Memo, but Memo does bind directly to a specific ErbB2-derived phosphopeptide encompassing Tyr-1227 using its vestigial enzymatic active site. Memo thus represents a new class of phosphotyrosine-binding protein.	[Qiu, Chen; Leahy, Daniel J.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Lienhard, Susanne; Hynes, Nancy E.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Leahy, Daniel J.] INSERM, U599, Ctr Rech Cancrol Marseille, F-13009 Marseille, France; [Badache, Ali] Univ Aix Marseille 2, F-13007 Marseille, France; [Badache, Ali] Inst J Paoli I Calmettes, F-13009 Marseille, France	Johns Hopkins University; Friedrich Miescher Institute for Biomedical Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Leahy, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	dleahy@jhmi.edu	Badache, Ali/Q-6098-2017	Badache, Ali/0000-0001-7710-2505	NATIONAL CANCER INSTITUTE [R01CA090466] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 90466] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Bertini I, 1984, Adv Inorg Biochem, V6, P71; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; Hellyer NJ, 2001, J BIOL CHEM, V276, P42153, DOI 10.1074/jbc.M102079200; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lippard S. J., 1994, PRINCIPLES BIOINORGA; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NODA Y, 1990, J BACTERIOL, V172, P2704, DOI 10.1128/jb.172.5.2704-2709.1990; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; RICCI A, 1995, ONCOGENE, V11, P1519; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SEGATTO O, 1993, ONCOGENE, V8, P2105; Sugimoto K, 1999, STRUCTURE, V7, P953, DOI 10.1016/S0969-2126(99)80122-1; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhou MM, 1995, J BIOL CHEM, V270, P31119, DOI 10.1074/jbc.270.52.31119	27	22	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2734	2740		10.1074/jbc.M703523200	http://dx.doi.org/10.1074/jbc.M703523200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18045866	hybrid			2022-12-25	WOS:000252622300031
J	Jia, SJ; Ren, Z; Li, X; Zheng, Y; Meng, AM				Jia, Shunji; Ren, Zhen; Li, Xiang; Zheng, Ying; Meng, Anming			smad2 and smad3 are required for mesendoderm induction by transforming growth factor-beta/Nodal signals in zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-EYED-PINHEAD; NODAL-RELATED SIGNALS; TGF-BETA; VERTEBRATE DEVELOPMENT; TARGETED DISRUPTION; MESODERM INDUCTION; GENE-EXPRESSION; AXIS FORMATION; MOUSE EMBRYO; IDENTIFICATION	The transforming growth factor-beta ligands Nodal, activin, and Vg1 play important roles in mesendoderm induction and patterning during vertebrate embryogenesis. These ligands are believed to transduce the signal through the receptor-activated transcription factors Smad2 and Smad3. However, the roles of smad2/ 3 genes in development of zebrafish embryos are largely unknown because the presence of multiple smad2/ 3 genes and their maternal expression have hampered the investigation of their developmental roles. We generated potent and specific dominant- negative forms of zebrafish Smad2, Smad3a, and Smad3b by mutating multiple amino acids. Overexpression of these mutants abolished mesendoderm induction by ectopic Nodal signaling in zebrafish embryos. Expression of dominantnegative smad2/3 abrogated Smad2/3 activities in wild- type embryos and caused various mesendodermal defects similar to those in Nodal- deficient embryos. Smad2/3-deficient cells transplanted into the blastodermal margin of wild- type hosts preferentially differentiated into ectodermal tissues rather than mesendodermal tissues, supporting the idea that response of cells to mesendoderm inducers requires Smad2/3 activities. Interference with Smad2/3 activities in Zoep, Moep, and MZoep mutant embryos resulted in more severe mesendodermal defects. Thus, our data reveal that Nodal signaling and mesendoderm induction depend on Smad2/3 and suggest that transforming growth factor-beta signals other than Nodal also contribute to Smad2/3 signaling and embryonic patterning.	[Jia, Shunji; Ren, Zhen; Li, Xiang; Zheng, Ying; Meng, Anming] Tsinghua Univ, Dept Biol Sci & Biotechnol, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China	Tsinghua University	Meng, AM (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China.	mengam@mail.tsinghua.edu.cn	Meng, Anming/A-4785-2012	Ren, Zhen/0000-0002-2547-8313; Meng, Anming/0000-0001-7228-3431				Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Agathon A, 2003, NATURE, V424, P448, DOI 10.1038/nature01822; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Datto MB, 1999, MOL CELL BIOL, V19, P2495; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dick A, 2000, GENE, V246, P69, DOI 10.1016/S0378-1119(00)00056-1; Driever W, 1996, DEVELOPMENT, V123, P37; Dunn NR, 2004, DEVELOPMENT, V131, P1717, DOI 10.1242/dev.01072; Feldman B, 2000, CURR BIOL, V10, P531, DOI 10.1016/S0960-9822(00)00469-3; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Haffter P, 1996, DEVELOPMENT, V123, P1; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Hoodless PA, 1999, DEV BIOL, V207, P364, DOI 10.1006/dbio.1998.9168; HUANG HC, 1995, EMBO J, V14, P5965, DOI 10.1002/j.1460-2075.1995.tb00285.x; Huang HZ, 2007, DEVELOPMENT, V134, P979, DOI 10.1242/dev.02782; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kumar A, 2001, J BIOL CHEM, V276, P656, DOI 10.1074/jbc.M004649200; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Pogoda HM, 2002, DEV DYNAM, V224, P334, DOI 10.1002/dvdy.10113; Ramel MC, 2005, DEV BIOL, V287, P237, DOI 10.1016/j.ydbio.2005.08.012; Rebagliati MR, 1998, DEV BIOL, V199, P261, DOI 10.1006/dbio.1998.8935; Renucci A, 1996, DEVELOPMENT, V122, P3735; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Schier AF, 1997, DEVELOPMENT, V124, P327; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Sun BI, 1999, DEVELOPMENT, V126, P1467; Sun ZH, 2006, BIOCHEM BIOPH RES CO, V345, P694, DOI 10.1016/j.bbrc.2006.04.148; Tian T, 2006, CELL MOL LIFE SCI, V63, P672, DOI 10.1007/s00018-005-5503-7; Tremblay KD, 2000, DEVELOPMENT, V127, P3079; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6; Zhao J, 2003, EMBO J, V22, P6078, DOI 10.1093/emboj/cdg593; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	49	48	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2418	2426		10.1074/jbc.M707578200	http://dx.doi.org/10.1074/jbc.M707578200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18025082	hybrid			2022-12-25	WOS:000252501000068
J	Gilmour, DS; Fan, R				Gilmour, David S.; Fan, Ruopeng			Derailing the locomotive: Transcription termination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RNA-POLYMERASE-II; ELONGATION COMPLEX; SACCHAROMYCES-CEREVISIAE; SITE RECOGNITION; GENE-EXPRESSION; NASCENT RNA; DNA HYBRID; YEAST; MECHANISM; RELEASE		[Gilmour, David S.; Fan, Ruopeng] Penn State Univ, Dept Biochem & Mol Biol, Ctr Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gilmour, DS (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Gene Regulat, University Pk, PA 16802 USA.	dsg11@psu.edu	Fan, Ruopeng/A-9489-2011					Arigo JT, 2006, MOL CELL, V21, P641, DOI 10.1016/j.molcel.2006.02.005; ASHFIELD R, 1994, EMBO J, V13, P5656, DOI 10.1002/j.1460-2075.1994.tb06904.x; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; Braglia P, 2005, J BIOL CHEM, V280, P19551, DOI 10.1074/jbc.M412238200; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Ciampi MS, 2006, MICROBIOL-SGM, V152, P2515, DOI 10.1099/mic.0.28982-0; CONNELLY S, 1989, MOL CELL BIOL, V9, P5254, DOI 10.1128/MCB.9.11.5254; CULLEN BR, 1991, FASEB J, V5, P2361, DOI 10.1096/fasebj.5.10.1712325; Deaconescu AM, 2007, CURR OPIN STRUC BIOL, V17, P96, DOI 10.1016/j.sbi.2007.01.005; Fernandez-Tornero C, 2007, MOL CELL, V25, P813, DOI 10.1016/j.molcel.2007.02.016; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gollnick P, 2002, BBA-GENE STRUCT EXPR, V1577, P240, DOI 10.1016/S0167-4781(02)00455-4; Greger IH, 2000, P NATL ACAD SCI USA, V97, P8415, DOI 10.1073/pnas.140217697; Gross S, 2001, P NATL ACAD SCI USA, V98, P6080, DOI 10.1073/pnas.101046598; Gu WG, 1996, P NATL ACAD SCI USA, V93, P6935, DOI 10.1073/pnas.93.14.6935; Hara R, 1999, J BIOL CHEM, V274, P24779, DOI 10.1074/jbc.274.35.24779; Jansa P, 1999, MOL GEN GENET, V262, P508, DOI 10.1007/s004380051112; JEONG SW, 1995, MOL CELL BIOL, V15, P5929; Jiang Y, 2004, MOL CELL, V14, P375, DOI 10.1016/S1097-2765(04)00234-5; KERPPOLA TK, 1990, BIOCHEMISTRY-US, V29, P269, DOI 10.1021/bi00453a037; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Landick R, 1997, CELL, V88, P741, DOI 10.1016/S0092-8674(00)81919-4; Landrieux E, 2006, EMBO J, V25, P118, DOI 10.1038/sj.emboj.7600915; LANG WH, 1995, P NATL ACAD SCI USA, V92, P9781, DOI 10.1073/pnas.92.21.9781; Luo WF, 2006, GENE DEV, V20, P954, DOI 10.1101/gad.1409106; Luo WF, 2004, CELL, V119, P911, DOI 10.1016/j.cell.2004.11.041; MARAIA RJ, 1994, MOL CELL BIOL, V14, P2147, DOI 10.1128/MCB.14.3.2147; Maraia RJ, 2001, MOL CELL BIOL, V21, P367, DOI 10.1128/MCB.21.2.367-379.2001; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Nag A, 2007, NAT STRUCT MOL BIOL, V14, P662, DOI 10.1038/nsmb1253; Park JS, 2006, P NATL ACAD SCI USA, V103, P4870, DOI 10.1073/pnas.0600145103; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rosonina E, 2006, GENE DEV, V20, P1050, DOI 10.1101/gad.1431606; Sadowski M, 2003, EMBO J, V22, P2167, DOI 10.1093/emboj/cdg200; Santangelo TJ, 2004, MOL CELL, V14, P117, DOI 10.1016/S1097-2765(04)00154-6; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; TENNYSON CN, 1995, NAT GENET, V9, P184, DOI 10.1038/ng0295-184; Toulokhonov I, 2003, MOL CELL, V12, P1125, DOI 10.1016/S1097-2765(03)00439-8; Venkataraman K, 2005, GENE DEV, V19, P1315, DOI 10.1101/gad.1298605; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Zhang ZQ, 2007, J BIOL CHEM, V282, P16981, DOI 10.1074/jbc.M610688200; Zhang ZQ, 2007, GENE DEV, V21, P1609, DOI 10.1101/gad.1542707; Zhang ZQ, 2006, MOL CELL, V21, P65, DOI 10.1016/j.molcel.2005.11.002; Zhang ZQ, 2005, GENE DEV, V19, P1572, DOI 10.1101/gad.1296305; Zhou Y, 2007, P NATL ACAD SCI USA, V104, P10352, DOI 10.1073/pnas.0606306104	54	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					661	664		10.1074/jbc.R700032200	http://dx.doi.org/10.1074/jbc.R700032200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17998201	hybrid			2022-12-25	WOS:000252128100002
J	Inesi, G; Lewis, D; Toyoshima, C; Hirata, A; de Meis, L				Inesi, Giuseppe; Lewis, David; Toyoshima, Chikashi; Hirata, Ayami; de Meis, Leopoldo			Conformational fluctuations of the Ca2+-ATPase in the native membrane environment - Effects of pH, temperature, catalytic substrates, and thapsigargin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; CA2+ ATPASE SERCA; CALCIUM-PUMP; CRYSTAL-STRUCTURE; BINDING SITES; ACTIVATION; PHOSPHORYLATION; MECHANISM; OCCLUSION; DOMAINS	Digestion with proteinase K or trypsin yields complementary information on conformational transitions of the Ca2+-ATPase (SERCA) in the native membrane environment. Distinct digestion patterns are obtained with proteinase K, revealing inter-conversion of E1 and E2 or E1-P and E2-P states. The pH dependence of digestion patterns shows that, in the presence of Mg2+, conversion of E2 to E1 pattern occurs ( even when Ca2+ is absent) asH(+) dissociates from acidic residues. Mutational analysis demonstrates that the Glu(309) and Glu(771) acidic residues ( empty Ca2+-binding sites I and II) are required for stabilization of E2. Glu309 ionization is most important to yield E1. However, a further transition produced by Ca2+-binding to E1 (i. e. E1 center dot 2Ca(2+)) is still needed for catalytic activation. Following ATP utilization, H (+)/Ca2+ exchange is involved in the transition from the E1 similar to P center dot 2Ca(2+) to the E2-P pattern, whereby alkaline pH will limit this conformational transition. Complementary experiments on digestion with trypsin exhibit high temperature dependence, indicating that, in the E1 and E2 ground states, the ATPase conformation undergoes strong fluctuations related to internal protein dynamics. The fluctuations are tightly constrained by ATP binding and phosphoenzyme formation, and this constraint must be overcome by thermal activation and substrate-free energy to allow enzyme turnover. In fact, a substantial portion of ATP free energy is utilized for conformational work related to the E1 similar to P center dot 2Ca(2+) to E2-P transition, thereby disrupting high affinity binding and allowing luminal diffusion of Ca2+. The E2 state and luminal path closure follow removal of conformational constraint by phosphate.	[Inesi, Giuseppe; Lewis, David] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA; [Toyoshima, Chikashi; Hirata, Ayami] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [de Meis, Leopoldo] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil	California Pacific Medical Center; California Pacific Medical Center Research Institute; University of Tokyo; Universidade Federal do Rio de Janeiro	Inesi, G (corresponding author), Calif Pacific Med Ctr, Res Inst, 475 Brannan St, San Francisco, CA 94107 USA.	ginesi@cpmcri.com	Toyoshima, Chikashi/R-4153-2019	Toyoshima, Chikashi/0000-0001-9640-0778	PHS HHS [R01-69830] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANDERSEN JP, 1992, J BIOL CHEM, V267, P19383; BIGELOW DJ, 1992, BIOCHIM BIOPHYS ACTA, V1113, P323, DOI 10.1016/0304-4157(92)90005-U; Champeil P, 1998, J BIOL CHEM, V273, P6619, DOI 10.1074/jbc.273.12.6619; Chen BW, 2004, BIOCHEMISTRY-US, V43, P4366, DOI 10.1021/bi0356350; Clausen JD, 2007, J BIOL CHEM, V282, P20686, DOI 10.1074/jbc.M702365200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; de Meis L, 2001, J BIOL CHEM, V276, P25078, DOI 10.1074/jbc.M103318200; de Meis L, 1977, Biochemistry, V16, P4455, DOI 10.1021/bi00639a020; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; GUILLAIN F, 1982, J BIOL CHEM, V257, P7366; INESI G, 1967, ARCH BIOCHEM BIOPHYS, V121, P665, DOI 10.1016/0003-9861(67)90051-3; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; Inesi G, 2002, BIOPHYS J, V83, P2327, DOI 10.1016/S0006-3495(02)75247-8; INESI G, 1985, ANNU REV PHYSIOL, V47, P573, DOI 10.1146/annurev.ph.47.030185.003041; INESI G, 1980, J BIOL CHEM, V255, P3025; Inesi G, 2006, BIOCHEMISTRY-US, V45, P13769, DOI 10.1021/bi061255d; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Ma HL, 2003, J BIOL CHEM, V278, P28938, DOI 10.1074/jbc.M304120200; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; MOLLER M, 1986, ADV PINEAL RES, V1, P51; Mueller B, 2004, BIOCHEMISTRY-US, V43, P12846, DOI 10.1021/bi0489457; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Peinelt C, 2002, BIOPHYS J, V82, P170, DOI 10.1016/S0006-3495(02)75384-8; PICK U, 1982, J BIOL CHEM, V257, P6120; SCALES D, 1976, BIOPHYS J, V16, P735, DOI 10.1016/S0006-3495(76)85725-6; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Tadini-Buoninsegni F, 2006, J BIOL CHEM, V281, P37720, DOI 10.1074/jbc.M606040200; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; TOYOSHIMA C, 1993, NATURE, V362, P469, DOI 10.1038/362469a0; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; ZHANG Z, 1995, J BIOL CHEM, V270, P16283; Zhang ZS, 2000, BIOCHEMISTRY-US, V39, P8758, DOI 10.1021/bi000185m	40	53	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1189	1196		10.1074/jbc.M707189200	http://dx.doi.org/10.1074/jbc.M707189200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17993458	hybrid			2022-12-25	WOS:000252128100059
J	Banerjee, T; DuHadaway, JB; Gaspari, P; Sutanto-Ward, E; Munn, DH; Mellor, AL; Malachowski, WP; Prendergast, GC; Muller, AJ				Banerjee, T.; DuHadaway, J. B.; Gaspari, P.; Sutanto-Ward, E.; Munn, D. H.; Mellor, A. L.; Malachowski, W. P.; Prendergast, G. C.; Muller, A. J.			A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase	ONCOGENE			English	Article						IDO; INDO; tumoral immune tolerance; immunotherapy; targeted therapeutics; tryptophan	CANCER CHEMOPREVENTIVE ACTIVITY; SULFUR-CONTAINING PHYTOALEXINS; SSP PEKINENSIS CRUCIFERAE; TRYPTOPHAN CATABOLISM; DENDRITIC CELLS; T-CELLS; EXPRESSION; PREVENTION; CABBAGE; TOLERANCE	Agents that interfere with tumoral immune tolerance may be useful to prevent or treat cancer. Brassinin is a phytoalexin, a class of natural products derived from plants that includes the widely known compound resveratrol. Brassinin has been demonstrated to have chemopreventive activity in preclinical models but the mechanisms underlying its anticancer properties are unknown. Here, we show that brassinin and a synthetic derivative 5-bromo-brassinin (5-Br-brassinin) are bioavailable inhibitors of indoleamine 2,3-dioxygenase (IDO), a pro-toleragenic enzyme that drives immune escape in cancer. Like other known IDO inhibitors, both of these compounds combined with chemotherapy to elicit regression of autochthonous mammary gland tumors in MMTV-Neu mice. Furthermore, growth of highly aggressive melanoma isograft tumors was suppressed by single agent treatment with 5-Br-brassinin. This response to treatment was lost in athymic mice, indicating a requirement for active host T-cell immunity, and in IDO-null knockout mice, providing direct genetic evidence that IDO inhibition is essential to the antitumor mechanism of action of 5-Br-brassinin. The natural product brassinin thus provides the structural basis for a new class of compounds with in vivo anticancer activity that is mediated through the inhibition of IDO.	[DuHadaway, J. B.; Sutanto-Ward, E.; Prendergast, G. C.; Muller, A. J.] Lankenau Inst Med Res, Wynnewood, PA 19096 USA; [Banerjee, T.] NewLink Genet Corp, Ames, IA USA; [Gaspari, P.; Malachowski, W. P.] Bryn Mawr Coll, Dept Chem, Bryn Mawr, PA 19010 USA; [Munn, D. H.; Mellor, A. L.] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; [Munn, D. H.] Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA; [Mellor, A. L.] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; [Prendergast, G. C.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Prendergast, G. C.; Muller, A. J.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Muller, A. J.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Lankenau Medical Center; Lankenau Institute for Medical Research; Bryn Mawr College; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Jefferson University; Jefferson University; Jefferson University	Muller, AJ (corresponding author), Lankenau Inst Med Res, 100 Lancaster Ave, Wynnewood, PA 19096 USA.	mullera@mlhs.org	Malachowski, Bill/AAD-7744-2022	Munn, David/0000-0002-7711-2858; Muller, Alexander/0000-0001-7854-6933; Malachowski, William/0000-0003-1215-3808	NATIONAL CANCER INSTITUTE [R01CA100123, R01CA109542, R01CA082222] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA109542, R01 CA100123, R01 CA82222] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alberts DS, 1999, CANCER RES, V59, P4743; Baban B, 2004, J REPROD IMMUNOL, V61, P67, DOI 10.1016/j.jri.2003.11.003; Brandacher G, 2006, CLIN CANCER RES, V12, P1144, DOI 10.1158/1078-0432.CCR-05-1966; Cardiff RD, 1999, J MAMMARY GLAND BIOL, V4, P105, DOI 10.1023/A:1018712905244; Csomos P, 2006, BIOORG MED CHEM LETT, V16, P6273, DOI 10.1016/j.bmcl.2006.09.016; Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576; Gaspari P, 2006, J MED CHEM, V49, P684, DOI 10.1021/jm0508888; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hayaishi O, 1984, PROGR TRYPTOPHAN SER, P33; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; Ino K, 2006, BRIT J CANCER, V95, P1555, DOI 10.1038/sj.bjc.6603477; MALABADI RB, 2005, S AFRICA NEWS PA MAR, V2, P3; MEHTA RG, 1995, CARCINOGENESIS, V16, P399, DOI 10.1093/carcin/16.2.399; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mezencev R, 2003, NEOPLASMA, V50, P239; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Muller AJ, 2006, NAT REV CANCER, V6, P613, DOI 10.1038/nrc1929; MULLER K. O., 1958, AUSTRALIAN JOUR BIOL SCI, V11, P275; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Murillo G, 2001, NUTR CANCER, V41, P17, DOI 10.1207/S15327914NC41-1&amp;2_2; Okamoto A, 2005, CLIN CANCER RES, V11, P6030, DOI 10.1158/1078-0432.CCR-04-2671; Park EJ, 2002, CANCER METAST REV, V21, P231, DOI 10.1023/A:1021254725842; Pilatova M, 2005, LEUKEMIA RES, V29, P415, DOI 10.1016/j.leukres.2004.09.003; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Sabol M, 2000, BIOLOGIA, V55, P701; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; TAKASUGI M, 1988, B CHEM SOC JPN, V61, P285, DOI 10.1246/bcsj.61.285; TAKASUGI M, 1986, J CHEM SOC CHEM COMM, P1077, DOI 10.1039/c39860001077; THOMSON JA, 1993, IMMUNOLOGY, V78, P185	31	137	147	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 1	2008	27	20					2851	2857		10.1038/sj.onc.1210939	http://dx.doi.org/10.1038/sj.onc.1210939			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	295VR	18026137				2022-12-25	WOS:000255502500006
J	Hurst, CD; Tomlinson, DC; Williams, SV; Platt, FM; Knowles, MA				Hurst, C. D.; Tomlinson, D. C.; Williams, S. V.; Platt, F. M.; Knowles, M. A.			Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification	ONCOGENE			English	Article						E2F3; Rb; bladder cancer; 6p22 amplification	GENOME-WIDE ASSOCIATION; RETINOBLASTOMA PROTEIN; CELL-CYCLE; ALTERED EXPRESSION; COPY NUMBER; IN-VITRO; CANCER; PRB; PROLIFERATION; CARCINOMA	E2F3 and CDKAL1 are candidate genes from the 6p22 region frequently amplified in bladder cancer. Expression of E2F3 isoforms (E2F3a and b) and CDKAL1 were examined and modulated in 6p22-amplified bladder cell lines. Eight lines with amplification showed overexpression of both E2F3 isoforms and CDKAL1. shRNA-mediated knockdown of CDKAL1 had no effect on proliferation. Knockdown of E2F3a or E2F3b alone induced antiproliferative effects, with the most significant effect on proliferation being observed when both isoforms were knocked down together. As E2Fs interact with the Rb tumour suppressor protein, Rb expression was analysed. There was a striking relationship between 6p22.3 amplification, E2F3 overexpression and lack of Rb expression. This was also examined in primary bladder tumours. Array-CGH detected 6p22.3 amplification in 8/91 invasive tumours. Five were studied in more detail. Four showed 13q14.2 loss (including RB1) and expressed no Rb protein. In the fifth, 13q was unaltered but the CDKN2A locus was deleted. This tumour was negative for p16 and positive for Rb protein. As p16 is a negative regulator of the Rb pathway, its loss represents an alternative mechanism for inactivation. Indeed, a phospho-specific Rb antibody showed much Rb protein in a hyperphosphorylated (inactive) form. We conclude that inactivation of the Rb pathway is required in addition to E2F3 overexpression in this subset of bladder tumours.	[Hurst, C. D.; Tomlinson, D. C.; Williams, S. V.; Platt, F. M.; Knowles, M. A.] St James Univ Hosp, Sect Oncol, Canc Res UK Clin Ctr, Leeds Insts Mol Med, Leeds LS9 7TF, W Yorkshire, England	Cancer Research UK; Saint James's University Hospital; University of Leeds	Knowles, MA (corresponding author), St James Univ Hosp, Sect Oncol, Canc Res UK Clin Ctr, Leeds Insts Mol Med, Beckett St, Leeds LS9 7TF, W Yorkshire, England.	m.a.knowles@leeds.ac.uk		Knowles, Margaret/0000-0002-9363-8657; Tomlinson, Darren/0000-0003-4134-7484	Cancer Research UK [C6228/A5433, A5433] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Aaboe M, 2006, CANCER RES, V66, P3434, DOI 10.1158/0008-5472.CAN-05-3456; Aslanian A, 2004, GENE DEV, V18, P1413, DOI 10.1101/gad.1196704; Benedict WF, 1999, ONCOGENE, V18, P1197, DOI 10.1038/sj.onc.1202452; Blais A, 2004, CURR OPIN GENET DEV, V14, P527, DOI 10.1016/j.gde.2004.07.003; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Bruch J, 1998, GENE CHROMOSOME CANC, V23, P167, DOI 10.1002/(SICI)1098-2264(199810)23:2<167::AID-GCC10>3.0.CO;2-L; Bruch J, 2000, CANCER RES, V60, P4526; Chapman EJ, 2006, ONCOGENE, V25, P5037, DOI 10.1038/sj.onc.1209513; Chapman EJ, 2005, CLIN CANCER RES, V11, P5740, DOI 10.1158/1078-0432.CCR-05-0411; Chatterjee SJ, 2004, J PATHOL, V203, P762, DOI 10.1002/path.1567; CHRISTIAN BJ, 1987, CANCER RES, V47, P6066; Cooper CS, 2006, LUNG CANCER, V54, P155, DOI 10.1016/j.lungcan.2006.07.005; CORDONCARDO C, 1992, J NATL CANCER I, V84, P1251, DOI 10.1093/jnci/84.16.1251; Cote RJ, 1998, CANCER RES, V58, P1090; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Denchi EL, 2005, MOL CELL BIOL, V25, P2660, DOI 10.1128/MCB.25.7.2660-2672.2005; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Evans AJ, 2004, AM J PATHOL, V164, P285, DOI 10.1016/S0002-9440(10)63118-5; Feber A, 2004, ONCOGENE, V23, P1627, DOI 10.1038/sj.onc.1207274; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Frolov MV, 2001, GENE DEV, V15, P2146, DOI 10.1101/gad.903901; He YW, 2000, ONCOGENE, V19, P3422, DOI 10.1038/sj.onc.1203682; Humbert PO, 2000, GENE DEV, V14, P690; Hurst CD, 2004, ONCOGENE, V23, P2250, DOI 10.1038/sj.onc.1207260; KALLIONIEMI A, 1995, GENE CHROMOSOME CANC, V12, P213, DOI 10.1002/gcc.2870120309; Le Frere-Belda MA, 2004, HUM PATHOL, V35, P817, DOI 10.1016/j.humpath.2004.01.019; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; LOGOTHETIS CJ, 1992, J NATL CANCER I, V84, P1256, DOI 10.1093/jnci/84.16.1256; Oeggerli M, 2006, ONCOGENE, V25, P6538, DOI 10.1038/sj.onc.1209946; Oeggerli M, 2004, ONCOGENE, V23, P5616, DOI 10.1038/sj.onc.1207749; Olsson AY, 2007, ONCOGENE, V26, P1028, DOI 10.1038/sj.onc.1209854; Orlic M, 2006, GENE CHROMOSOME CANC, V45, P72, DOI 10.1002/gcc.20263; PAULIE S, 1983, INT J CANCER, V31, P297, DOI 10.1002/ijc.2910310308; Paulson QX, 2006, CELL CYCLE, V5, P184, DOI 10.4161/cc.5.2.2307; Prat E, 2001, UROLOGY, V57, P986, DOI 10.1016/S0090-4295(01)00909-8; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stevens C, 2004, DNA REPAIR, V3, P1071, DOI 10.1016/j.dnarep.2004.03.034; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Tomlinson D, 2007, ONCOGENE, V26, P5889, DOI 10.1038/sj.onc.1210399; Tomovska S, 2001, INT J ONCOL, V18, P1239; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Veltman JA, 2003, CANCER RES, V63, P2872; Wu QO, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-16; XU HJ, 1993, INT J CANCER, V53, P781, DOI 10.1002/ijc.2910530513; YEAGER T, 1995, CANCER RES, V55, P493; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Ziebold U, 2003, MOL CELL BIOL, V23, P6542, DOI 10.1128/MCB.23.18.6542-6552.2003; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	53	69	71	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 24	2008	27	19					2716	2727		10.1038/sj.onc.1210934	http://dx.doi.org/10.1038/sj.onc.1210934			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	292IK	18037967	Green Accepted			2022-12-25	WOS:000255259500006
J	Collom, SL; Laddusaw, RM; Burch, AM; Kuzmic, P; Perry, MD; Miller, GP				Collom, Samuel L.; Laddusaw, Ryan M.; Burch, Amber M.; Kuzmic, Petr; Perry, Martin D., Jr.; Miller, Grover P.			CYP2E1 substrate inhibition - Mechanistic interpretation through an effector site for monocyclic compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-P450 2E1; ACTIVE-SITE; P450 2E1; EXPRESSION; PURIFICATION; METABOLISM; OXIDATION; DYNAMICS; NITROPHENOL; HYDROXYLASE	In this study we offer a mechanistic interpretation of the previously known but unexplained substrate inhibition observed for CYP2E1. At low substrate concentrations, p-nitrophenol (pNP) was rapidly turned over (47 min(-1)) with relatively low K-m (24 mu M); nevertheless, at concentrations of > 100 mu M, the rate of pNP oxidation gradually decreased as a second molecule bound to CYP2E1 through an effector site (K-ss = 260 mu M), which inhibited activity at the catalytic site. 4-Methylpyrazole (4MP) was a potent inhibitor for both sites through a mixed inhibition mechanism. The K-i for the catalytic site was 2.0 mu M. Although we were unable to discriminate whether an EIS or ESI complex formed, the respective inhibition constants were far lower than K-ss. Bicyclic indazole (IND) inhibited catalysis through a single CYP2E1 site (K-i = 0.12 mu M). Similarly, 4MP and IND yielded type II binding spectra that reflected the association of either two 4MP or one IND molecule(s) to CYP2E1, respectively. Based on computational docking studies with a homology model for CYP2E1, the two sites for monocyclic molecules, pNP and 4MP, exist within a narrow channel connecting the active site to the surface of the enzyme. Because of the presence of the heme iron, one site supports catalysis, whereas the other more distal effector site binds molecules that can influence the binding orientation and egress of molecules for the catalytic site. Although IND did not bind these sites simultaneously, the presence of IND at the catalytic site blocked binding at the effector site.	[Collom, Samuel L.; Burch, Amber M.; Miller, Grover P.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Laddusaw, Ryan M.; Perry, Martin D., Jr.] Ouachita Baptist Univ, Dept Chem, Arkadelphia, AR 71998 USA; [Kuzmic, Petr] BioKin Ltd, Pullman, WA 99163 USA	University of Arkansas System; University of Arkansas Medical Sciences	Miller, GP (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, 4301 W Markham St,Slot 516, Little Rock, AR 72205 USA.	millergroverp@uams.edu	Miller, Grover P/AAY-7582-2020; Collom, Samuel/L-9287-2013	Miller, Grover P/0000-0002-4743-8187; Kuzmic, Petr/0000-0001-5250-8381	NCRR NIH HHS [P20 RR015569-060011, P20 RR015569] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015569] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Atkins WM, 2005, ANNU REV PHARMACOL, V45, P291, DOI 10.1146/annurev.pharmtox.45.120403.100004; Banerjee S, 2002, BIOTECHNOL BIOENG, V77, P462, DOI 10.1002/bit.10151; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; Burnham KP., 2002, MODEL SELECTION MULT, V2, P70; Chen WQ, 1996, ARCH BIOCHEM BIOPHYS, V335, P123, DOI 10.1006/abbi.1996.0489; Cheng DM, 2004, PROTEIN EXPRES PURIF, V33, P66, DOI 10.1016/j.pep.2003.08.009; Collom SL, 2007, ARCH BIOCHEM BIOPHYS, V459, P59, DOI 10.1016/j.abb.2006.10.028; COON MJ, 1983, PHARMACOL BIOCHEM BE, V18, P177, DOI 10.1016/0091-3057(83)90168-5; Doty SL, 2000, P NATL ACAD SCI USA, V97, P6287, DOI 10.1073/pnas.97.12.6287; Easterbrook J, 2001, DRUG METAB DISPOS, V29, P141; FUKUDA T, 1993, J BIOCHEM-TOKYO, V113, P7, DOI 10.1093/oxfordjournals.jbchem.a124006; GUENGERICH FP, 1994, TOXICOL LETT, V70, P133; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; HARGREAVES MB, 1994, DRUG METAB DISPOS, V22, P806; Harrelson JP, 2007, BIOCHEM BIOPH RES CO, V352, P843, DOI 10.1016/j.bbrc.2006.11.071; Houston JB, 2005, ARCH BIOCHEM BIOPHYS, V433, P351, DOI 10.1016/j.abb.2004.09.010; Jain AN, 1996, J COMPUT AID MOL DES, V10, P427, DOI 10.1007/BF00124474; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Jamakhandi AP, 2005, ARCH BIOCHEM BIOPHYS, V439, P165, DOI 10.1016/j.abb.2005.04.022; Jamakhandi AP, 2007, BIOCHEMISTRY-US, V46, P10192, DOI 10.1021/bi7003476; Jefcoate C R, 1978, Methods Enzymol, V52, P258; KOOP DR, 1986, MOL PHARMACOL, V29, P399; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LARSON JR, 1991, P NATL ACAD SCI USA, V88, P9141, DOI 10.1073/pnas.88.20.9141; Lewis D. F. V., 2002, Xenobiotica, V32, P305, DOI 10.1080/00498250110112015; Lewis DFV, 2003, J BIOCHEM MOL TOXIC, V17, P47, DOI 10.1002/jbt.10055; Miller GP, 2001, BIOCHEMISTRY-US, V40, P7262, DOI 10.1021/bi010402z; Park JY, 2003, J MED CHEM, V46, P1645, DOI 10.1021/jm020538a; Robertson Graham, 2001, American Journal of Physiology, V281, pG1135; Ronis MJJ, 1996, CYTOCHROMES P450 MET, P211; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Smith SV, 2006, BIOCHEMISTRY-US, V45, P15617, DOI 10.1021/bi061873u; Spatzenegger M, 2003, J PHARMACOL EXP THER, V304, P477, DOI 10.1124/jpet.102.043323; Tan YZ, 1997, XENOBIOTICA, V27, P287, DOI 10.1080/004982597240613; TASSANEEYAKUL W, 1993, BIOCHEM PHARMACOL, V46, P1975, DOI 10.1016/0006-2952(93)90639-E; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; YAMAZAKI H, 1995, DRUG METAB DISPOS, V23, P438	39	56	57	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3487	3496		10.1074/jbc.M707630200	http://dx.doi.org/10.1074/jbc.M707630200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056994	hybrid, Green Accepted			2022-12-25	WOS:000253083000054
J	Ozturk, N; Song, SH; Selby, CP; Sancar, A				Ozturk, Nuri; Song, Sang-Hun; Selby, Christopher P.; Sancar, Aziz			Animal type 1 cryptochromes - Analysis of the redox state of the flavin cofactor by site-directed mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE-LIGHT PHOTORECEPTOR; DNA PHOTOLYASE; CIRCADIAN CLOCK; ACTION SPECTRUM; DROSOPHILA; ARABIDOPSIS; REPAIR; ROLES; GENE	It has recently been realized that animal cryptochromes (CRYs) fall into two broad groups. Type 1 CRYs, the prototype of which is the Drosophila CRY, that is known to be a circadian photoreceptor. Type 2 CRYs, the prototypes of which are human CRY 1 and CRY 2, are known to function as core clock proteins. The mechanism of photosignaling by the Type 1 CRYs is not well understood. We recently reported that the flavin cofactor of the Type 1 CRY of the monarch butterfly may be in the form of flavin anion radical, FAD., in vivo. Here we describe the purification and characterization of wild-type and mutant forms of Type 1 CRYs from fruit fly, butterfly, mosquito, and silk moth. Cryptochromes from all four sources contain FAD(ox) when purified, and the flavin is readily reduced to FAD by light. Interestingly, mutations that block photoreduction in vitro do not affect the photoreceptor activities of these CRYs, but mutations that reduce the stability of FAD. in vitro abolish the photoreceptor function of Type 1 CRYs in vivo. Collectively, our data provide strong evidence for functional similarities of Type 1 CRYs across insect species and further support the proposal that FAD represents the ground state and not the excited state of the flavin cofactor in Type 1 CRYs.	[Sancar, Aziz] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Ozturk, Nuri; Song, Sang-Hun; Selby, Christopher P.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Bldg CB 72600, Chapel Hill, NC 27599 USA.	Aziz_Sancar@med.unc.edu	Ozturk, Nuri/F-4140-2011	Ozturk, Nuri/0000-0001-5206-4127; Song, Sang-Hun/0000-0002-9609-3269	NIGMS NIH HHS [GM31082] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031082, R01GM031082] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Froy O, 2002, CURR BIOL, V12, P147, DOI 10.1016/S0960-9822(01)00656-X; Hitomi K, 1997, J BIOL CHEM, V272, P32591, DOI 10.1074/jbc.272.51.32591; Kao YT, 2007, CELL BIOCHEM BIOPHYS, V48, P32, DOI 10.1007/s12013-007-0034-5; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; LI YF, 1991, BIOCHEMISTRY-US, V30, P6322, DOI 10.1021/bi00239a034; LIN C, 1995, P NATL ACAD SCI USA, V92, P8423, DOI 10.1073/pnas.92.18.8423; Lin CT, 2003, ANNU REV PLANT BIOL, V54, P469, DOI 10.1146/annurev.arplant.54.110901.160901; Losi A, 2007, PHOTOCHEM PHOTOBIOL, V83, P1283, DOI 10.1111/j.1751-1097.2007.00196.x; Ozturk N, 2007, COLD SPRING HARB SYM, V72, P119, DOI 10.1101/sqb.2007.72.015; Ozgur S, 2006, BIOCHEMISTRY-US, V45, P13369, DOI 10.1021/bi061556n; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Partch CL, 2005, PHOTOCHEM PHOTOBIOL, V81, P1291, DOI 10.1562/2005-07-08-IR-607; PAYNE G, 1990, BIOCHEMISTRY-US, V29, P7715, DOI 10.1021/bi00485a021; RUPERT CS, 1962, J GEN PHYSIOL, V45, P725, DOI 10.1085/jgp.45.4.725; Sancar A, 2004, J BIOL CHEM, V279, P34079, DOI 10.1074/jbc.R400016200; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Selby CP, 1999, PHOTOCHEM PHOTOBIOL, V69, P105, DOI 10.1562/0031-8655(1999)069<0105:ATMOTP>2.3.CO;2; Song SH, 2007, J BIOL CHEM, V282, P17608, DOI 10.1074/jbc.M702874200; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Tansey WP, 2001, GENE DEV, V15, P1045, DOI 10.1101/gad.896501; vanVickle-Chavez SJ, 2007, J BIOL CHEM, V282, P10561, DOI 10.1074/jbc.M609314200; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zeugner A, 2005, J BIOL CHEM, V280, P19437, DOI 10.1074/jbc.C500077200; ZHAO X, 2007, J BIOL CHEM, V272, P32580; Zhu HS, 2008, PLOS BIOL, V6, P138, DOI 10.1371/journal.pbio.0060004; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	33	100	102	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3256	3263		10.1074/jbc.M708612200	http://dx.doi.org/10.1074/jbc.M708612200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056988	hybrid			2022-12-25	WOS:000253083000029
J	Charles, RP; Guitard, M; Leyvraz, C; Breiden, B; Haftek, M; Haftek-Terreau, Z; Stehle, JC; Sandhoff, K; Hummler, E				Charles, Roch-Philippe; Guitard, Marjorie; Leyvraz, Celine; Breiden, Bernadette; Haftek, Marek; Haftek-Terreau, Zofia; Stehle, Jean-Christophe; Sandhoff, Konrad; Hummler, Edith			Postnatal requirement of the epithelial sodium channel for maintenance of epidermal barrier function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRATUM-CORNEUM CERAMIDES; TIGHT JUNCTION PROTEINS; LUNG LIQUID CLEARANCE; PERMEABILITY BARRIER; BETA-GLUCOCEREBROSIDASE; NEONATAL DEATH; DEFICIENT MICE; OMEGA-HYDROXYCERAMIDES; TARGETED DISRUPTION; PHOSPHOLIPASE A(2)	In skin, the physiological consequence of an epithelial sodium channel (ENaC) deficiency is not obvious directly at birth. Nevertheless, within hours after birth, mice deficient for the alpha-subunit of the highly amiloride-sensitive epithelial sodium channel (alpha ENaC/Scnn1a) suffer from a significant increased dehydration. This is characterized by a loss of body weight (by 6% in 6 h) and an increased transepidermal water loss, which is accompanied by a higher skin surface pH in 1-day-old pups. Although early and late differentiation markers, as well as tight junction protein distribution and function, seem unaffected, deficiency of alpha ENaC severely disturbs the stratum corneum lipid composition with decreased ceramide and cholesterol levels, and increased pro-barrier lipids, whereas covalently bound lipids are drastically reduced. Ultrastructural analysis revealed morphological changes in the formation of intercellular lamellar lipids and the lamellar body secretion. Extracellular formation of the lamellar lipids proved to be abnormal in the knockouts. In conclusion, ENaC deficiency results in progressive dehydration and, consequently, weight loss due to severe impairment of lipid formation and secretion. Our data demonstrate that ENaC expression is required for the postnatal maintenance of the epidermal barrier function but not for its generation.	[Charles, Roch-Philippe; Guitard, Marjorie; Leyvraz, Celine; Hummler, Edith] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; [Stehle, Jean-Christophe] Univ Lausanne, Dept Pathol, CH-1005 Lausanne, Switzerland; [Breiden, Bernadette; Sandhoff, Konrad] Univ Bonn, Kekule Inst Organ Chem & Biochem, LIMES, Membrane Biol & Lipid Biochem Unit, D-53121 Bonn, Germany; [Haftek, Marek; Haftek-Terreau, Zofia] Ecole Normale Super Lyon, IFR128, Lab Joliot Curie, F-69000 Lyon, France	University of Lausanne; University of Lausanne; University of Bonn; Ecole Normale Superieure de Lyon (ENS de LYON)	Hummler, E (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	Edith.Hummler@unil.ch	Breiden, Bernadette/S-3005-2019; HAFTEK-TERREAU, Zofia/F-5127-2018; Breiden, Bernadette/F-2422-2014	Breiden, Bernadette/0000-0002-4838-4109; HAFTEK-TERREAU, Zofia/0000-0002-4028-3362; Breiden, Bernadette/0000-0002-4838-4109; Charles, Roch-Philippe/0000-0002-5243-3866				ASZTERBAUM M, 1992, PEDIATR RES, V31, P308, DOI 10.1203/00006450-199204000-00002; ASZTERBAUM M, 1993, J CLIN INVEST, V91, P2703, DOI 10.1172/JCI116509; Barker PM, 1998, J CLIN INVEST, V102, P1634, DOI 10.1172/JCI3971; Behne MJ, 2003, J INVEST DERMATOL, V120, P998, DOI 10.1046/j.1523-1747.2003.12262.x; Behne MJ, 2002, J BIOL CHEM, V277, P47399, DOI 10.1074/jbc.M204759200; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; Brandner JM, 2006, SKIN PHARMACOL PHYS, V19, P71, DOI 10.1159/000091973; Brandner JM, 2002, EUR J CELL BIOL, V81, P253, DOI 10.1078/0171-9335-00244; Brouard M, 1999, J CELL SCI, V112, P3343; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Chen YH, 1997, J CELL BIOL, V138, P891, DOI 10.1083/jcb.138.4.891; Chifflet S, 2005, AM J PHYSIOL-CELL PH, V288, pC1420, DOI 10.1152/ajpcell.00259.2004; Choi MJ, 2005, AM J CLIN DERMATOL, V6, P215, DOI 10.2165/00128071-200506040-00002; Doering T, 1999, J BIOL CHEM, V274, P11038, DOI 10.1074/jbc.274.16.11038; Doering T, 1999, FEBS LETT, V447, P167, DOI 10.1016/S0014-5793(99)00274-4; Doering T, 2002, J LIPID RES, V43, P1727, DOI 10.1194/jlr.M200208-JLR200; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Fluhr JW, 2004, J INVEST DERMATOL, V122, P320, DOI 10.1046/j.0022-202X.2003.00204.x; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Guitard M, 2004, NEWS PHYSIOL SCI, V19, P75, DOI 10.1152/nips.01503.2003; Haftek M, 1998, MICROSC RES TECHNIQ, V43, P242, DOI 10.1002/(SICI)1097-0029(19981101)43:3<242::AID-JEMT6>3.0.CO;2-G; Hamanaka S, 2002, J INVEST DERMATOL, V119, P416, DOI 10.1046/j.1523-1747.2002.01836.x; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; HOLLERAN WM, 1992, J LIPID RES, V33, P1201; HOLLERAN WM, 1994, J LIPID RES, V35, P905; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Hummler E, 2005, J AM SOC NEPHROL, V16, P3160, DOI 10.1681/ASN.2005040450; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; Hummler E, 1996, KIDNEY BLOOD PRESS R, V19, P160, DOI 10.1159/000174065; Hummler E, 1997, P NATL ACAD SCI USA, V94, P11710, DOI 10.1073/pnas.94.21.11710; Indra AK, 2005, DEVELOPMENT, V132, P4533, DOI 10.1242/dev.02019; Jensen JM, 1999, J CLIN INVEST, V104, P1761, DOI 10.1172/JCI5307; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; Krien PM, 2000, J INVEST DERMATOL, V115, P414, DOI 10.1046/j.1523-1747.2000.00083.x; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Li WM, 2007, INT J BIOL SCI, V3, P120; Liu YJ, 1998, P NATL ACAD SCI USA, V95, P2503, DOI 10.1073/pnas.95.5.2503; Macheleidt O, 2002, J INVEST DERMATOL, V119, P166, DOI 10.1046/j.1523-1747.2002.01833.x; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; Mauro T, 2002, J INVEST DERMATOL, V118, P589, DOI 10.1046/j.1523-1747.2002.01721.x; MAURO T, 1995, J INVEST DERMATOL, V105, P203, DOI 10.1111/1523-1747.ep12317130; McDonald FJ, 1999, P NATL ACAD SCI USA, V96, P1727, DOI 10.1073/pnas.96.4.1727; NAVARRO JM, 1995, J BIOL CHEM, V270, P21362, DOI 10.1074/jbc.270.36.21362; Nemes Z, 1999, P NATL ACAD SCI USA, V96, P8402, DOI 10.1073/pnas.96.15.8402; Oda Y, 1999, J INVEST DERMATOL, V113, P796, DOI 10.1046/j.1523-1747.1999.00742.x; Park BD, 2003, J INVEST DERMATOL, V121, P794, DOI 10.1046/j.1523-1747.2003.12470.x; PRadervand S, 1999, P NATL ACAD SCI USA, V96, P1732, DOI 10.1073/pnas.96.4.1732; PUOTI A, 1995, AM J PHYSIOL-CELL PH, V269, pC188, DOI 10.1152/ajpcell.1995.269.1.C188; Reichelt J, 2004, EUR J CELL BIOL, V83, P747, DOI 10.1078/0171-9335-00429; ROOP D, 1995, SCIENCE, V267, P474, DOI 10.1126/science.7529942; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; Schadow A, 2001, J INVEST DERMATOL, V116, P31, DOI 10.1046/j.1523-1747.2001.00179.x; Schluter H, 2007, EUR J CELL BIOL, V86, P645, DOI 10.1016/j.ejcb.2007.01.001; Segre JA, 2006, J CLIN INVEST, V116, P1150, DOI 10.1172/JCI28521; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Uchida Y, 2000, J LIPID RES, V41, P2071; Vasireddy V, 2007, HUM MOL GENET, V16, P471, DOI 10.1093/hmg/ddl480; Yosipovitch G, 2000, PEDIATRICS, V106, P105, DOI 10.1542/peds.106.1.105; Zettersten E, 1998, J INVEST DERMATOL, V111, P784, DOI 10.1046/j.1523-1747.1998.00386.x	63	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2622	2630		10.1074/jbc.M708829200	http://dx.doi.org/10.1074/jbc.M708829200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18039670	hybrid			2022-12-25	WOS:000252622300019
J	Goraczniak, R; Gunderson, SI				Goraczniak, Rafal; Gunderson, Samuel I.			The regulatory element in the 3 '-untranslated region of human papillomavirus 16 inhibits expression by binding CUG-binding protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-31; LATE MESSENGER-RNA; U1 SNRNP; POLY(A) POLYMERASE; EPITHELIAL-CELLS; CERVICAL-CANCER; TERMINAL EXONS; DIFFERENTIATION; SEQUENCES; COMPLEX	The 3 '-untranslated regions (UTRs) of human papillomavirus 16 (HPV16) and bovine papillomavirus 1 (BPV1) contain a negative regulatory element (NRE) that inhibits viral late gene expression. The BPV1 NRE consists of a single 9-nucleotide (nt) U1 small nuclear ribonucleoprotein (snRNP) base pairing site (herein called a U1 binding site) that via U1 snRNP binding leads to inhibition of the late poly(A) site. The 79-nt HPV16 NRE is far more complicated, consisting of 4 overlapping very weak U1 binding sites followed by a poorly understood GU-rich element (GRE). We undertook a molecular dissection of the HPV16 GRE and identify via UV cross-linking, RNA affinity chromatography, and mass spectrometry that is bound by the CUG-binding protein 1 (CUGBP1). Reporter assays coupled with knocking down CUGBP1 levels by small interfering RNA and Dox-regulated shRNA, demonstrate CUGBP1 is inhibitory in vivo. CUGBP1 is the first GRE-binding protein to have RNA interfering knockdown evidence in support of its role in vivo. Several fine-scale GRE mutations that inactivate GRE activity in vivo and GRE binding to CUGBP1 in vitro are identified. The CUGBP1 . GRE complex has no activity on its own but specifically synergizes with weak U1 binding sites to inhibit expression in vivo. No synergy is seen if the U1 binding sites are made weaker by a 1-nt down-mutation or made stronger by a 1-nt up-mutation, underscoring that the GRE operates only on weak sites. Interestingly, inhibition occurs at multiple levels, in particular at the level of poly(A) site activity, nuclear-cytoplasmic export, and translation of the mRNA. Implications for understanding the HPV16 life cycle are discussed.	[Goraczniak, Rafal; Gunderson, Samuel I.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Gunderson, SI (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.	gunderson@biology.rutgers.edu			NATIONAL CANCER INSTITUTE [R21CA119934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057286] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA119934] Funding Source: Medline; NIGMS NIH HHS [R01 GM057286] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKER CC, 1990, PAPILLOMAVIRUSES HUM, P91; BARKSDALE SK, 1993, J VIROL, V67, P5605, DOI 10.1128/JVI.67.9.5605-5616.1993; Beckley SA, 2001, MOL CELL BIOL, V21, P2815, DOI 10.1128/MCB.21.8.2815-2825.2001; Bodily JM, 2005, J VIROL, V79, P3309, DOI 10.1128/JVI.79.6.3309-3321.2005; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; CHAN SY, 1995, J VIROL, V69, P3074, DOI 10.1128/JVI.69.5.3074-3083.1995; Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648; Cumming SA, 2003, J VIROL, V77, P5167, DOI 10.1128/JVI.77.9.5167-5177.2003; Cumming SA, 2002, J VIROL, V76, P5993, DOI 10.1128/JVI.76.12.5993-6003.2002; DietrichGoetz W, 1997, P NATL ACAD SCI USA, V94, P163, DOI 10.1073/pnas.94.1.163; Faustino NA, 2005, MOL CELL BIOL, V25, P879, DOI 10.1128/MCB.25.3.879-887.2005; Fortes P, 2003, P NATL ACAD SCI USA, V100, P8264, DOI 10.1073/pnas.1332669100; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; FURTH PA, 1994, MOL CELL BIOL, V14, P5278, DOI 10.1128/MCB.14.8.5278; FURTH PA, 1991, J VIROL, V65, P5806, DOI 10.1128/JVI.65.11.5806-5812.1991; Grassmann K, 1996, VIROLOGY, V223, P185, DOI 10.1006/viro.1996.0467; GUAN F, 2007, IN PRESS RNA; Gunderson SI, 1998, MOL CELL, V1, P255, DOI 10.1016/S1097-2765(00)80026-X; Gunderson SI, 1997, GENE DEV, V11, P761, DOI 10.1101/gad.11.6.761; Howley M. P., 1996, FIELDS VIROLOGY, P2045; KAO PN, 1994, J BIOL CHEM, V269, P20691; KENNEDY IM, 1990, J VIROL, V64, P1825, DOI 10.1128/JVI.64.4.1825-1829.1990; Koffa MD, 2000, P NATL ACAD SCI USA, V97, P4677, DOI 10.1073/pnas.070049097; Longworth MS, 2004, J VIROL, V78, P3533, DOI 10.1128/JVI.78.7.3533-3541.2004; Marquis J, 2006, BIOCHEM J, V400, P291, DOI 10.1042/BJ20060490; McPhillips MG, 2004, J VIROL, V78, P10598, DOI 10.1128/JVI.78.19.10598-10605.2004; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; Sokolowski M, 1998, J VIROL, V72, P1504, DOI 10.1128/JVI.72.2.1504-1515.1998; STOLER MH, 1989, VIROLOGY, V172, P331, DOI 10.1016/0042-6822(89)90135-9; STUMP WT, 1995, RNA, V1, P55; Takahashi N, 2000, BIOCHEM BIOPH RES CO, V277, P518, DOI 10.1006/bbrc.2000.3694; TAN W, 1995, J VIROL, V69, P5607, DOI 10.1128/JVI.69.9.5607-5620.1995; Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; WASSARMAN KM, 1993, GENE DEV, V7, P647, DOI 10.1101/gad.7.4.647; Zheng ZM, 2006, FRONT BIOSCI-LANDMRK, V11, P2286, DOI 10.2741/1971; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55; ZURHAUSEN H, 1987, PAPOVAVIRIDAE PAPILL, P245	41	28	29	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2286	2296		10.1074/jbc.M708789200	http://dx.doi.org/10.1074/jbc.M708789200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18042543	hybrid			2022-12-25	WOS:000252501000056
J	Kuo, YC; Huang, KY; Yang, CH; Yang, YS; Lee, WY; Chiang, CW				Kuo, Yi-Chun; Huang, Kai-Yun; Yang, Chung-Hsiang; Yang, Yu-San; Lee, Wen-Yu; Chiang, Chi-Wu			Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55 alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; AKT/PROTEIN-KINASE-B; SMALL TUMOR-ANTIGEN; POSITIVE REGULATION; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; GENE IEX-1; S6 KINASE; 2A PP2A; ACTIVATION	Akt is a protein serine/threonine kinase that is involved in the regulation of diverse cellular processes. Phosphorylation of Akt at regulatory residues Thr-308 and Ser-473 leads to its full activation. The protein phosphatase 2A ( PP2A) has long been known to negatively regulate Akt activity. The PP2A holoenzyme consists of the structural subunit ( A), catalytic subunit ( C), and a variable regulatory subunit ( B). Here we report the identification of the specific B regulatory subunit that targets the PP2A holoenzyme to Akt. We found endogenous association of PP2A AB55C holoenzymes with Akt by co-immunoprecipitation analyses in pro-lymphoid FL5.12 cells. Akt was shown to associate with ectopically expressed B55 alpha subunit in NIH3T3 cells. The direct interaction between B55 alpha subunit and Akt was confirmed using in vitro pulldown analyses. Intriguingly, we found that overexpression of B55 alpha subunit significantly impaired phosphorylation at Thr-308, but to a lesser extent at Ser-473 of Akt in both FL5.12 and NIH3T3 cells. Concomitantly, phosphorylation of a subset of Akt substrates, including FoxO3a, was substantially decreased by B55 alpha overexpression in these cells. Silencing of B55 alpha expression markedly increased phosphorylation at Thr-308 but not at Ser-473 in both FL5.12 cells and NIH3T3 cells. Consistently, PP2A AB55 alpha C holoenzymes preferentially dephosphorylated phospho-Thr-308 rather than phospho-Ser-473 in in vitro dephosphorylation assays. Furthermore, B55 alpha overexpression retarded proliferation of NIH3T3 cells, and knockdown of B55 alpha expression increased survival of FL5.12 cells upon interleukin-3 deprivation. Together, our data demonstrate that B55 alpha-dependent targeting of the PP2A holoenzyme to Akt selectively regulates Akt phosphorylation at Thr-308 to regulate cell proliferation and survival.	[Kuo, Yi-Chun; Huang, Kai-Yun; Yang, Chung-Hsiang; Yang, Yu-San; Lee, Wen-Yu; Chiang, Chi-Wu] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 701, Taiwan; [Chiang, Chi-Wu] Natl Cheng Kung Univ, Ctr Regulat & Signal Transduct Res, Tainan 701, Taiwan	National Cheng Kung University; National Cheng Kung University	Chiang, CW (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Mol Med, 1 Univ Rd, Tainan 701, Taiwan.	chiangcw@mail.ncku.edu.tw						Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Borgatti P, 2003, J CELL PHYSIOL, V196, P79, DOI 10.1002/jcp.10279; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen D, 1999, MOL CELL BIOL, V19, P4684; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chiang CW, 2001, BLOOD, V97, P1289, DOI 10.1182/blood.V97.5.1289; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Coffer PJ, 1998, BIOCHEM J, V335, P1; Csortos C, 1996, J BIOL CHEM, V271, P2578, DOI 10.1074/jbc.271.5.2578; Dagda RK, 2003, J BIOL CHEM, V278, P24976, DOI 10.1074/jbc.M302832200; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Fu DX, 2003, J BIOL CHEM, V278, P1487, DOI 10.1074/jbc.M210631200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; HEALY AM, 1991, MOL CELL BIOL, V11, P5767, DOI 10.1128/MCB.11.11.5767; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; Kray AE, 2005, J BIOL CHEM, V280, P35974, DOI 10.1074/jbc.M506093200; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Lee T, 2003, J CELL PHYSIOL, V194, P349, DOI 10.1002/jcp.10211; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Liu QH, 2004, AM J PHYSIOL-HEART C, V286, pH2204, DOI 10.1152/ajpheart.01050.2003; Liu W, 2003, CELL DEATH DIFFER, V10, P772, DOI 10.1038/sj.cdd.4401238; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; MAYER RE, 1991, BIOCHEMISTRY-US, V30, P3589, DOI 10.1021/bi00229a001; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; Meier R, 1998, EMBO J, V17, P7294, DOI 10.1093/emboj/17.24.7294; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Resjo S, 2002, CELL SIGNAL, V14, P231, DOI 10.1016/S0898-6568(01)00238-8; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Strack S, 2002, J BIOL CHEM, V277, P41525, DOI 10.1074/jbc.M203767200; Tanabe O, 1996, FEBS LETT, V379, P107, DOI 10.1016/0014-5793(95)01500-0; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yamada T, 2001, J BIOL CHEM, V276, P5339, DOI 10.1074/jbc.M005685200; Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yellaturu CR, 2002, J BIOL CHEM, V277, P40148, DOI 10.1074/jbc.M206376200; Yuan H, 2002, J VIROL, V76, P10685, DOI 10.1128/JVI.76.21.10685-10691.2002; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345; ZOLNIEROWICZ S, 1994, BIOCHEMISTRY-US, V33, P11858, DOI 10.1021/bi00205a023; Zolnierowicz S, 2000, BIOCHEM PHARMACOL, V60, P1225, DOI 10.1016/S0006-2952(00)00424-X	72	277	283	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1882	1892		10.1074/jbc.M709585200	http://dx.doi.org/10.1074/jbc.M709585200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18042541	hybrid			2022-12-25	WOS:000252501000014
J	Liu, C; Mao, K; Zhang, M; Sun, ZG; Hong, WZ; Li, CY; Peng, B; Chang, ZY				Liu, Chong; Mao, Kai; Zhang, Meng; Sun, Zhaogang; Hong, Weizhe; Li, Chuanyou; Peng, Bo; Chang, Zengyi			The SH3-like domain switches its interaction partners to modulate the repression activity of mycobacterial iron-dependent transcription regulator in response to metal ion fluctuations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPHTHERIA-TOXIN REPRESSOR; OXIDATIVE-STRESS-RESPONSE; HOMOLOGY 3-LIKE DOMAIN; DNA-SEQUENCE ANALYSIS; CORYNEBACTERIUM-DIPHTHERIAE; CRYSTAL-STRUCTURE; CROSS-LINKING; DTXR HOMOLOG; TUBERCULOSIS HSP16.3; MOLECULAR-CLONING	Iron-dependent regulator (IdeR), a metal ion-activated pleiotropic transcription factor, plays a critical role in maintaining the intracellular iron homeostasis in Mycobacteria, which is important for the normal growth of the cells. This study was initially performed in an attempt to elucidate all potential interactions between the various domains of IdeR that occur in living mycobacterial cells. This led to a hitherto unidentified self-association for the SH3-like domain of IdeR. Further studies demonstrate that the SH3-like domain interacts with different partners in the dimeric forms of IdeR depending on the levels of metal ions in the environment: it undergoes inter-subunit self-association in the metal-free DNA-non-binding form, but interacts with the N-terminal domain in the metal-bound DNA-binding form in an intra-subunit manner to finely modulate the transcription repression activity of IdeR. Our more detailed mapping studies reveal that the SH3-like domain uses an overlapping surface to participate in these two interactions, which therefore occur in a mutually exclusive fashion. This novel mechanism would allow an effective and cooperative interconversion between the two functional forms of IdeR. Our data also demonstrate that a disturbance of the interactions involving the SH3-like domain impairs the transcription repression activity of IdeR and delays the growth of mycobacterial cells.	[Mao, Kai; Zhang, Meng; Chang, Zengyi] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Liu, Chong; Hong, Weizhe] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Sun, Zhaogang; Li, Chuanyou] Beijing TB & Thorat Tumor Res Inst, Dept Bacteriol & Immunol, Beijing 101149, Peoples R China; [Peng, Bo] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei Province, Peoples R China; [Chang, Zengyi] Peking Univ, Ctr Prot Sci, Beijing 100871, Peoples R China; [Chang, Zengyi] Peking Univ, Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China	Peking University; Tsinghua University; Huazhong University of Science & Technology; Peking University; Peking University	Chang, ZY (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.	changzy@pku.edu.cn	Hong, Weizhe/AAD-7172-2020; Hong, Weizhe/E-3164-2010; Liu, Chong/J-4826-2014; Peng, Bo/A-7125-2017; Peng, Bo/AAU-3941-2021; Liu, Chong/G-3514-2011; Peng, Bo/W-5129-2019	Hong, Weizhe/0000-0003-1523-8575; Hong, Weizhe/0000-0003-1523-8575; Peng, Bo/0000-0003-4183-5939; Peng, Bo/0000-0003-4183-5939; Peng, Bo/0000-0003-4183-5939				Abulimiti A, 2003, J MOL BIOL, V326, P1013, DOI 10.1016/S0022-2836(03)00018-4; Ainsa JA, 1996, GENE, V176, P23, DOI 10.1016/0378-1119(96)00202-8; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; AUSUBEL FM, 1997, CURRENT PROTOCOLS MO, V2; Boland CA, 2000, FEMS MICROBIOL LETT, V191, P1, DOI 10.1111/j.1574-6968.2000.tb09310.x; Bonner JJ, 2000, J MOL BIOL, V302, P581, DOI 10.1006/jmbi.2000.4096; BOYD J, 1990, P NATL ACAD SCI USA, V87, P5968, DOI 10.1073/pnas.87.15.5968; Chen CSY, 2000, BIOCHEMISTRY-US, V39, P10397, DOI 10.1021/bi0009284; Chou CJ, 2004, J BIOL CHEM, V279, P53554, DOI 10.1074/jbc.M407385200; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; Comeau SR, 2005, J STRUCT BIOL, V150, P233, DOI 10.1016/j.jsb.2005.03.006; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; D'Aquino JA, 2005, P NATL ACAD SCI USA, V102, P18408, DOI 10.1073/pnas.0500908102; Ding X, 1996, NAT STRUCT BIOL, V3, P382, DOI 10.1038/nsb0496-382; Dussurget O, 1999, J BACTERIOL, V181, P3402, DOI 10.1128/JB.181.11.3402-3408.1999; Dussurget O, 1996, MOL MICROBIOL, V22, P535, DOI 10.1046/j.1365-2958.1996.1461511.x; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Feese MD, 2001, J BIOL CHEM, V276, P5959, DOI 10.1074/jbc.M007531200; Feng YJ, 2006, PROTEIN SCI, V15, P1441, DOI 10.1110/ps.062175806; FISS EH, 1994, MOL MICROBIOL, V14, P557, DOI 10.1111/j.1365-2958.1994.tb02189.x; Fu XM, 2004, BIOCHEMISTRY-MOSCOW+, V69, P552, DOI 10.1023/B:BIRY.0000029854.86015.61; Gold B, 2001, MOL MICROBIOL, V42, P851, DOI 10.1046/j.1365-2958.2001.02684.x; Gu LX, 2002, J MOL BIOL, V319, P517, DOI 10.1016/S0022-2836(02)00311-X; GUNTERSEEBOTH K, 1995, GENE, V166, P117, DOI 10.1016/0378-1119(95)00628-7; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Kristensen O, 2006, EMBO J, V25, P785, DOI 10.1038/sj.emboj.7600982; LEE GF, 1995, P NATL ACAD SCI USA, V92, P5416, DOI 10.1073/pnas.92.12.5416; Love JF, 2004, P NATL ACAD SCI USA, V101, P2506, DOI 10.1073/pnas.0303794101; Love JF, 2003, J BACTERIOL, V185, P2251, DOI 10.1128/JB.185.7.2251-2258.2003; Love JF, 2002, J MICROBIOL METH, V51, P63, DOI 10.1016/S0167-7012(02)00058-1; Miller S, 2003, J BIOL CHEM, V278, P32246, DOI 10.1074/jbc.M303188200; Mongiovi AM, 1999, EMBO J, V18, P5300, DOI 10.1093/emboj/18.19.5300; OGUIZA JA, 1995, J BACTERIOL, V177, P465, DOI 10.1128/jb.177.2.465-467.1995; Oram DM, 2005, FEMS MICROBIOL LETT, V243, P1, DOI 10.1016/j.femsle.2004.11.031; Pelletier JN, 1998, P NATL ACAD SCI USA, V95, P12141, DOI 10.1073/pnas.95.21.12141; Pohl E, 1999, J MOL BIOL, V285, P1145, DOI 10.1006/jmbi.1998.2339; Pohl E, 1999, J MOL BIOL, V292, P653, DOI 10.1006/jmbi.1999.3073; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; Rodriguez GM, 2003, MOL MICROBIOL, V47, P1485, DOI 10.1046/j.1365-2958.2003.03384.x; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHMITT MP, 1995, INFECT IMMUN, V63, P4284, DOI 10.1128/IAI.63.11.4284-4289.1995; Semavina M, 2006, BIOCHEMISTRY-US, V45, P12480, DOI 10.1021/bi060797s; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; SMYTH DG, 1964, BIOCHEM J, V91, P589, DOI 10.1042/bj0910589; Spatafora G, 2001, MICROBIOL-SGM, V147, P1599, DOI 10.1099/00221287-147-6-1599; Spiering MM, 2003, P NATL ACAD SCI USA, V100, P3808, DOI 10.1073/pnas.0737977100; TAO X, 1995, P NATL ACAD SCI USA, V92, P6803, DOI 10.1073/pnas.92.15.6803; TAO X, 1993, P NATL ACAD SCI USA, V90, P8524, DOI 10.1073/pnas.90.18.8524; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Twigg PD, 2001, P NATL ACAD SCI USA, V98, P11259, DOI 10.1073/pnas.191354798; Wang G, 1999, P NATL ACAD SCI USA, V96, P6119, DOI 10.1073/pnas.96.11.6119; White A, 1998, NATURE, V394, P502, DOI 10.1038/28893; Wisedchaisri G, 2004, J MOL BIOL, V342, P1155, DOI 10.1016/j.jmb.2004.07.083; Wisedchaisri G, 2007, BIOCHEMISTRY-US, V46, P436, DOI 10.1021/bi0609826; Wu JH, 1996, P NATL ACAD SCI USA, V93, P10123, DOI 10.1073/pnas.93.19.10123; Wylie GP, 2005, BIOCHEMISTRY-US, V44, P40, DOI 10.1021/bi048035p	58	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2439	2453		10.1074/jbc.M706580200	http://dx.doi.org/10.1074/jbc.M706580200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18055464	hybrid			2022-12-25	WOS:000252501000070
J	Khan, MA; Miyoshi, H; Gallie, DR; Goss, DJ				Khan, Mateen A.; Miyoshi, Hiroshi; Gallie, Daniel R.; Goss, Dixie J.			Potyvirus genome-linked protein, VPg, directly affects wheat germ in vitro translation - Interactions with translation initiation factors eif4f and eifiso4f	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOBACCO ETCH VIRUS; CAP-INDEPENDENT TRANSLATION; TURNIP-MOSAIC-VIRUS; LONG-DISTANCE MOVEMENT; MESSENGER-RNA; ISOZYME FORM; ELONGATION-FACTORS; ESCHERICHIA-COLI; POTATO-VIRUS; 5' LEADER	Potyvirus genome linked protein, VPg, interacts with translation initiation factors eIF4E and eIFiso4E, but its role in protein synthesis has not been elucidated. We show that addition of VPg to wheat germ extract leads to enhancement of uncapped viral mRNA translation and inhibition of capped viral mRNA translation. This provides a significant competitive advantage to the uncapped viral mRNA. To understand the molecular basis of these effects, we have characterized the interaction of VPg with eIF4F, eIFiso4F, and a structured RNA derived from tobacco etch virus (TEV RNA). When VPg formed a complex with eIF4F, the affinity for TEV RNA increased more than 4-fold compared with eIF4F alone (19.4 and 79.0 nM, respectively). The binding affinity of eIF4F to TEV RNA correlates with translation efficiency. VPg enhanced eIFiso4F binding to TEV RNA 1.6-fold ( 178 nM compared with 108 nM). Kinetic studies of eIF4F and eIFiso4F with VPg show similar to 2.6-fold faster association for eIFiso4F center dot VPg as compared with eIF4F center dot VPg. The dissociation rate was similar to 2.9-fold slower for eIFiso4F than eIF4F with VPg. These data demonstrate that eIFiso4F can kinetically compete with eIF4F for VPg binding. The quantitative data presented here suggest a model where eIF4F center dot VPg interaction enhances cap-independent translation by increasing the affinity of eIF4F for TEV RNA. This is the first evidence of direct participation of VPg in translation initiation.	[Khan, Mateen A.; Goss, Dixie J.] CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA; [Khan, Mateen A.; Goss, Dixie J.] CUNY, Grad Ctr, New York, NY 10065 USA; [Miyoshi, Hiroshi] St Marianna Univ, Sch Med, Dept Microbiol, Kawasaki, Kanagawa 2168511, Japan; [Gallie, Daniel R.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Saint Marianna University; University of California System; University of California Riverside	Goss, DJ (corresponding author), CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA.	dgoss@hunter.cuny.edu		Khan, Mateen A./0000-0002-2300-4595; Miyoshi, Hiroshi/0000-0002-0489-9848	NCRR NIH HHS [RR 03037] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ABRAMSON RD, 1988, J BIOL CHEM, V263, P5462; ALLEN ML, 1992, J BIOL CHEM, V267, P23232; ANDERSON CW, 1983, METHOD ENZYMOL, V101, P635; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWNING KS, 1987, J BIOL CHEM, V262, P11228; BROWNING KS, 1992, J BIOL CHEM, V267, P10096; BROWNING KS, 1990, J BIOL CHEM, V265, P17967; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P4542, DOI 10.1021/bi00232a025; CARRINGTON JC, 1990, J VIROL, V64, P1590, DOI 10.1128/JVI.64.4.1590-1597.1990; CARRINGTON JC, 1993, J VIROL, V67, P6995, DOI 10.1128/JVI.67.12.6995-7000.1993; Cotton S, 2006, VIROLOGY, V351, P92, DOI 10.1016/j.virol.2006.03.019; Daughenbaugh KF, 2003, EMBO J, V22, P2852, DOI 10.1093/emboj/cdg251; DOUGHERTY WG, 1988, ANNU REV PHYTOPATHOL, V26, P123, DOI 10.1146/annurev.py.26.090188.001011; Dunoyer P, 2004, J VIROL, V78, P2301, DOI 10.1128/JVI.78.5.2301-2309.2004; Firpo MA, 1996, J BIOL CHEM, V271, P4693; GALLIE DR, 1995, GENE, V165, P233, DOI 10.1016/0378-1119(95)00521-7; Gallie DR, 2001, J VIROL, V75, P12141, DOI 10.1128/JVI.75.24.12141-12152.2001; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; HARRIS KS, 1994, J BIOL CHEM, V269, P27004; Herbert TP, 1997, J GEN VIROL, V78, P1033, DOI 10.1099/0022-1317-78-5-1033; Keller KE, 1998, MOL PLANT MICROBE IN, V11, P124, DOI 10.1094/MPMI.1998.11.2.124; Khan MA, 2004, BIOCHEMISTRY-US, V43, P9092, DOI 10.1021/bi049602b; Khan MA, 2006, J BIOL CHEM, V281, P28002, DOI 10.1074/jbc.M605479200; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; LAX S, 1985, P NATL ACAD SCI USA, V82, P330, DOI 10.1073/pnas.82.2.330; LAX SR, 1986, METHOD ENZYMOL, V118, P109; LAX SR, 1986, J BIOL CHEM, V261, P5632; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; METZ AM, 1992, NUCLEIC ACIDS RES, V20, P4096, DOI 10.1093/nar/20.15.4096; Miyoshi H, 2006, BIOCHIMIE, V88, P329, DOI 10.1016/j.biochi.2005.09.002; Murphy JF, 1996, VIROLOGY, V220, P535, DOI 10.1006/viro.1996.0344; Nicolas O, 1997, VIROLOGY, V237, P452, DOI 10.1006/viro.1997.8780; Niepel M, 1999, J VIROL, V73, P9080, DOI 10.1128/JVI.73.11.9080-9088.1999; OLSEN K, 1993, BIOCHEMISTRY-US, V32, P9686, DOI 10.1021/bi00088a021; Oruetxebarria I, 2001, VIRUS RES, V73, P103, DOI 10.1016/S0168-1702(00)00216-1; Rajamaki ML, 1999, MOL PLANT MICROBE IN, V12, P1074, DOI 10.1094/MPMI.1999.12.12.1074; Rajamaki ML, 2002, MOL PLANT MICROBE IN, V15, P138, DOI 10.1094/MPMI.2002.15.2.138; Ray S, 2006, J BIOL CHEM, V281, P35826, DOI 10.1074/jbc.M605762200; RIECHMANN JL, 1992, J GEN VIROL, V73, P1, DOI 10.1099/0022-1317-73-1-1; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; Roudet-Tavert G, 2007, J GEN VIROL, V88, P1029, DOI 10.1099/vir.0.82501-0; Schaad MC, 1997, J VIROL, V71, P8624, DOI 10.1128/JVI.71.11.8624-8631.1997; Schaad MC, 1996, J VIROL, V70, P2556, DOI 10.1128/JVI.70.4.2556-2561.1996; Suehiro N, 2004, J GEN VIROL, V85, P2087, DOI 10.1099/vir.0.79825-0; VANHEERDEN A, 1994, J BIOL CHEM, V269, P17454; Wittmann S, 1997, VIROLOGY, V234, P84, DOI 10.1006/viro.1997.8634; Zeenko V, 2005, J BIOL CHEM, V280, P26813, DOI 10.1074/jbc.M503576200	48	77	80	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1340	1349		10.1074/jbc.M703356200	http://dx.doi.org/10.1074/jbc.M703356200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18045881	hybrid			2022-12-25	WOS:000252282700017
J	Wu, GS; Aoyama, C; Young, SG; Vance, DE				Wu, Gengshu; Aoyama, Chieko; Young, Stephen G.; Vance, Dennis E.			Early embryonic lethality caused by disruption of the gene for choline kinase alpha, the first enzyme in phosphatidylcholine biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE-ALPHA; PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; LOW-DENSITY LIPOPROTEINS; TARGETED DELETION; FREE-CHOLESTEROL; LIVER; MICE; CTP; METABOLISM; PLASMA	Choline kinase alpha (CK-alpha) is one of two mammalian enzymes that catalyze the phosphorylation of choline to phosphocholine in the biosynthesis of the major membrane phospholipid, phosphatidylcholine. We created mice lacking CK-alpha with an embryonic stem cell line containing an insertional mutation in the gene for CK-alpha (Chka). Embryos homozygous for the mutant Chka allele were recovered at the blastocyst stage, but not at embryonic day 7.5, indicating that CK-alpha is crucial for the early development of mouse embryos. Heterozygous mutant mice (Chka(+/-)) appeared entirely normal in their embryonic development and gross anatomy, and they were fertile. Although choline kinase activity was decreased by similar to 30%, the amount of phosphatidylcholine in cells and the levels of other enzymes involved in phosphatidylcholine biosynthesis were unaffected. Phosphatidylcholine biosynthesis measured by choline incorporation into hepatocytes was also not compromised in Chka(+/-) mice. Enhanced levels of choline and attenuated levels of phosphocholine were observed in both the livers and testes of Chka(+/-) mice. Triacylglycerol and cholesterol ester were elevated similar to 2-fold in the livers, whereas neutral lipid profiles in plasma were similar in Chka(+/-) and wild-type (Chka(+/+)) mice. Thus, Chka is an essential gene for early embryonic development, but adult mice do not require full expression of the gene for normal levels of phosphatidylcholine.	[Wu, Gengshu; Aoyama, Chieko; Vance, Dennis E.] Univ Alberta, Canadian Inst Hlth Res Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	University of Alberta; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Vance, DE (corresponding author), HMRC 320, Edmonton, AB T6G 2S2, Canada.	dennis.vance@ualberta.ca		Young, Stephen/0000-0001-7270-3176	NHLBI NIH HHS [P01 HL090553-03, U01 HL066621, R01 HL087228-04, R01 HL087228-03, R01 HL087228, P01 HL090553, U01 HL 66621, P01 HL090553-04] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066621, P01HL090553, R01HL087228] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Aoyama C, 2002, BIOCHEM J, V363, P777, DOI 10.1042/0264-6021:3630777; Bhakoo KK, 1996, CANCER RES, V56, P4630; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chung TW, 1997, J BIOL CHEM, V272, P3064, DOI 10.1074/jbc.272.5.3064; CUADRADO A, 1993, ONCOGENE, V8, P2959; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Fisher MC, 2002, FASEB J, V16, P619, DOI 10.1096/fj.01-0564fje; Fullerton MD, 2007, MOL CELL BIOL, V27, P3327, DOI 10.1128/MCB.01527-06; Henneberry AL, 2000, J BIOL CHEM, V275, P29808, DOI 10.1074/jbc.M005786200; ISHIDATE K, 1983, BIOCHEM BIOPH RES CO, V111, P683, DOI 10.1016/0006-291X(83)90360-1; ISHIDATE K, 1992, METHOD ENZYMOL, V209, P121; Jackowski S, 2004, MOL CELL BIOL, V24, P4720, DOI 10.1128/MCB.24.11.4720-4733.2004; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Li ZY, 2005, J BIOL CHEM, V280, P37798, DOI 10.1074/jbc.M508575200; LOHNINGER A, 1990, ANAL BIOCHEM, V186, P243, DOI 10.1016/0003-2697(90)90074-J; MACARA IG, 1989, MOL CELL BIOL, V9, P325, DOI 10.1128/MCB.9.1.325; MCCLUER RH, 1986, ADV CHROMATOGR, V25, P309; Michel V, 2006, EXP BIOL MED, V231, P490; Nakagami K, 1999, JPN J CANCER RES, V90, P419, DOI 10.1111/j.1349-7006.1999.tb00764.x; Noga AA, 2003, J LIPID RES, V44, P1998, DOI 10.1194/jlr.M300226-JLR200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reo NV, 2002, BBA-MOL CELL BIOL L, V1580, P171, DOI 10.1016/S1388-1981(01)00202-5; Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; SUNDLER R, 1975, J BIOL CHEM, V250, P3359; TEEGARDEN D, 1990, J BIOL CHEM, V265, P6042; Tian Y, 2006, J BIOL CHEM, V281, P28438, DOI 10.1074/jbc.M605861200; Titarenko E, 1997, PLANT PHYSIOL, V115, P817, DOI 10.1104/pp.115.2.817; Vance D.E., 2002, BIOCH LIPIDS LIPOPRO, P205; Walkey CJ, 1998, J BIOL CHEM, V273, P27043, DOI 10.1074/jbc.273.42.27043; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; ZEISEL SH, 1981, BIOCHEM J, V198, P565, DOI 10.1042/bj1980565; ZEISEL SH, 1980, LIFE SCI, V26, P1827, DOI 10.1016/0024-3205(80)90585-8; Zeisel SH, 2000, NUTRITION, V16, P669, DOI 10.1016/S0899-9007(00)00349-X; Zeisel SH, 2005, AM J CLIN NUTR, V82, P719, DOI 10.1093/ajcn/82.4.719; Zeisel SH, 2000, J AM COLL NUTR, V19, p528S, DOI 10.1080/07315724.2000.10718976; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zhang DJ, 2000, J BIOL CHEM, V275, P35368, DOI 10.1074/jbc.M007099200	45	70	75	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1456	1462		10.1074/jbc.M708766200	http://dx.doi.org/10.1074/jbc.M708766200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18029352	Green Accepted, hybrid			2022-12-25	WOS:000252282700029
J	Ye, SX; Kohrer, C; Huber, T; Kazmi, M; Sachdev, P; Yan, ECY; Bhagat, A; RajBhandary, UL; Sakmar, TP				Ye, Shixin; Kohrer, Caroline; Huber, Thomas; Kazmi, Manija; Sachdev, Pallavi; Yan, Elsa C. Y.; Bhagat, Aditi; RajBhandary, Uttam L.; Sakmar, Thomas P.			Site-specific incorporation of keto amino acids into functional G protein-coupled receptors using unnatural amino acid mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; LARGE RIBOSOMAL-SUBUNIT; HIGH-LEVEL EXPRESSION; CELL-FREE SYSTEM; MAMMALIAN-CELLS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; GENETIC-CODE; 7-TRANSMEMBRANE RECEPTORS; CONFORMATIONAL-CHANGES	G protein-coupled receptors (GPCRs) are ubiquitous heptahelical transmembrane proteins involved in a wide variety of signaling pathways. The work described here on application of unnatural amino acid mutagenesis to two GPCRs, the chemokine receptor CCR5 (a major co-receptor for the human immunodeficiency virus) and rhodopsin (the visual photoreceptor), adds a new dimension to studies of GPCRs. We incorporated the unnatural amino acids p-acetyl-L-phenylalanine (Acp) and p-benzoyl-L-phenylalanine (Bzp) into CCR5 at high efficiency in mammalian cells to produce functional receptors harboring reactive keto groups at three specific positions. We obtained functional mutant CCR5, at levels up to similar to 50% of wild type as judged by immunoblotting, cell surface expression, and ligand- dependent calcium flux. Rhodopsin containing Acp at three different sites was also purified in high yield (0.5-2 mu g/107 cells) and reacted with fluorescein hydrazide in vitro to produce fluorescently labeled rhodopsin. The incorporation of reactive keto groups such as Acp or Bzp into GPCRs allows their reaction with different reagents to introduce a variety of spectroscopic and other probes. Bzp also provides the possibility of photo-cross-linking to identify precise sites of protein-protein interactions, including GPCR binding to G proteins and arrestins, and for understanding the molecular basis of ligand recognition by chemokine receptors.	[Kohrer, Caroline; RajBhandary, Uttam L.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Ye, Shixin; Huber, Thomas; Kazmi, Manija; Sachdev, Pallavi; Yan, Elsa C. Y.; Bhagat, Aditi; Sakmar, Thomas P.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA	Massachusetts Institute of Technology (MIT); Rockefeller University	RajBhandary, UL (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bhandary@mit.edu; sakmar@rockefeller.edu	Huber, Thomas/A-8016-2008; Sakmar, Thomas P/D-1833-2015	Huber, Thomas/0000-0002-1844-262X; Sakmar, Thomas P/0000-0002-2836-8953; Yan, Elsa/0000-0002-3583-1627; Ye, Shixin/0000-0002-9254-9409	NIGMS NIH HHS [GM 67741] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067741] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAIN JD, 1989, J AM CHEM SOC, V111, P8013, DOI 10.1021/ja00202a052; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BAYER EA, 1988, ANAL BIOCHEM, V170, P271, DOI 10.1016/0003-2697(88)90631-8; Beene DL, 2003, CURR OPIN NEUROBIOL, V13, P264, DOI 10.1016/S0959-4388(03)00068-0; Chang PV, 2007, J AM CHEM SOC, V129, P8400, DOI 10.1021/ja070238o; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Combadiere C, 1996, J LEUKOCYTE BIOL, V60, P147, DOI 10.1002/jlb.60.1.147; CORNISH VW, 1994, P NATL ACAD SCI USA, V91, P2910, DOI 10.1073/pnas.91.8.2910; Cornish VW, 1996, J AM CHEM SOC, V118, P8150, DOI 10.1021/ja961216x; Cypess AM, 1999, J BIOL CHEM, V274, P19455, DOI 10.1074/jbc.274.27.19455; Drabkin HJ, 1996, MOL CELL BIOL, V16, P907; DRABKIN HJ, 1985, J BIOL CHEM, V260, P5588; EDWARDS H, 1990, MOL CELL BIOL, V10, P1633, DOI 10.1128/MCB.10.4.1633; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; HECKLER TG, 1984, BIOCHEMISTRY-US, V23, P1468, DOI 10.1021/bi00302a020; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; Huber T, 2004, BIOPHYS J, V86, P2078, DOI 10.1016/S0006-3495(04)74268-X; Imamoto Y, 2000, BIOCHEMISTRY-US, V39, P15225, DOI 10.1021/bi0018685; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; Kazmi MA, 2000, BIOCHEMISTRY-US, V39, P3734, DOI 10.1021/bi992354c; Kiga D, 2002, P NATL ACAD SCI USA, V99, P9715, DOI 10.1073/pnas.142220099; Kohrer C, 2004, NUCLEIC ACIDS RES, V32, P6200, DOI 10.1093/nar/gkh959; Kohrer C, 2003, CHEM BIOL, V10, P1095, DOI 10.1016/j.chembiol.2003.10.013; Kowal AK, 2001, P NATL ACAD SCI USA, V98, P2268, DOI 10.1073/pnas.031488298; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; LETKOWITZ RJ, 2007, BIOCHIM BIOPHYS ACTA, V1768, P748; Liu WS, 2007, NAT METHODS, V4, P239, DOI 10.1038/NMETH1016; Lummis SCR, 2005, CHEM BIOL, V12, P993, DOI 10.1016/j.chembiol.2005.06.012; Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125; MIN KC, 1993, J BIOL CHEM, V268, P9400; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PAYNE RC, 1987, BIOCHEMISTRY-US, V26, P3197, DOI 10.1021/bi00385a039; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Sakamoto K, 2002, NUCLEIC ACIDS RES, V30, P4692, DOI 10.1093/nar/gkf589; Sakmar TP, 2002, ANNU REV BIOPH BIOM, V31, P443, DOI 10.1146/annurev.biophys.31.082901.134348; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Seibert C, 2006, VIROLOGY, V349, P41, DOI 10.1016/j.virol.2006.01.018; Turcatti G, 1996, J BIOL CHEM, V271, P19991, DOI 10.1074/jbc.271.33.19991; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang L, 2003, P NATL ACAD SCI USA, V100, P56, DOI 10.1073/pnas.0234824100; Wang WY, 2007, NAT NEUROSCI, V10, P1063, DOI 10.1038/nn1932; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang ZW, 2003, BIOCHEMISTRY-US, V42, P6735, DOI 10.1021/bi0300231; Zhang ZW, 2004, P NATL ACAD SCI USA, V101, P8882, DOI 10.1073/pnas.0307029101	58	123	127	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1525	1533		10.1074/jbc.M707355200	http://dx.doi.org/10.1074/jbc.M707355200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17993461	hybrid			2022-12-25	WOS:000252282700037
J	Yao, HB; Ye, J				Yao, Hongbing; Ye, Jin			Long chain Acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is required for assembly of very low density lipoproteins in human hepatoma Huh7 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-RNA REPLICATION; PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; PLASMA HIGH-DENSITY; APOLIPOPROTEIN-B; SECRETION; HEPATOCYTES; TRIACYLGLYCEROL; BIOSYNTHESIS; LIVER; MICE	Hepatocytes play a crucial role in regulating lipid metabolism by exporting cholesterol and triglyceride into plasma through secretion of very low density lipoproteins (VLDL). VLDL production is also required for release of hepatitis C virus (HCV) from infected hepatocytes. Here, we show that long chain acyl-CoA synthetase 3 (ACSL3) plays a crucial role in secretion of VLDL and HCV from hepatocytes. In cultured human hepatoma Huh7 cells, ACSL3 is specifically required for incorporation of fatty acids into phosphatidylcholine. In cells receiving small interfering RNA targeting ACSL3, secretion of apolipoprotein B, the major protein component of VLDL, was inhibited and the lipoprotein was rapidly degraded. This inhibition in secretion was completely eliminated when these cells were treated with phosphatidylcholine. Treatment of cells with small interfering RNA targeting ACSL3 also inhibited secretion of HCV from Huh7-derived cells. These results identify ACSL3 as a new enzymatic target to limit VLDL secretion and HCV infection.	[Yao, Hongbing; Ye, Jin] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Ye, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	jin.ye@utsouthwestern.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-20948] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; Avramoglu RK, 2004, REV ENDOCR METAB DIS, V5, P293, DOI 10.1023/B:REMD.0000045100.66675.92; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Cai ZH, 2005, J VIROL, V79, P13963, DOI 10.1128/JVI.79.22.13963-13973.2005; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; DIXON JL, 1991, J BIOL CHEM, V266, P5080; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; EPAND RM, 1992, BIOCHEMISTRY-US, V31, P1550, DOI 10.1021/bi00120a036; ESKO JD, 1982, P NATL ACAD SCI-BIOL, V79, P1698, DOI 10.1073/pnas.79.6.1698; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Fujino T, 1996, J BIOL CHEM, V271, P16748, DOI 10.1074/jbc.271.28.16748; Gibbons GF, 2004, BIOCHEM SOC T, V32, P59, DOI 10.1042/BST0320059; Gibbons GF, 2000, BBA-MOL CELL BIOL L, V1483, P37, DOI 10.1016/S1388-1981(99)00182-1; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Shelness GS, 2001, CURR OPIN LIPIDOL, V12, P151, DOI 10.1097/00041433-200104000-00008; SUNDLER R, 1975, J BIOL CHEM, V250, P3359; TOMODA H, 1991, J BIOL CHEM, V266, P4214; VERKADE HJ, 1993, J BIOL CHEM, V268, P24990; YAO ZM, 1989, J BIOL CHEM, V264, P11373	32	80	87	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					849	854		10.1074/jbc.M706160200	http://dx.doi.org/10.1074/jbc.M706160200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18003621	hybrid			2022-12-25	WOS:000252128100025
J	Santhi, N; Horowitz, TS; Duffy, JF; Czeisler, CA				Santhi, Nayantara; Horowitz, Todd S.; Duffy, Jeanne F.; Czeisler, Charles A.			Acute Sleep Deprivation and Circadian Misalignment Associated with Transition onto the First Night of Work Impairs Visual Selective Attention	PLOS ONE			English	Article							RESPONSE-TIME DISTRIBUTIONS; SHIFT WORK; PSYCHOMOTOR VIGILANCE; SUBJECTIVE ALERTNESS; BRIGHT LIGHT; PERFORMANCE DEGRADATION; EXTENDED WAKEFULNESS; DOSE-RESPONSE; PHASE; CAFFEINE	Background. Overnight operations pose a challenge because our circadian biology promotes sleepiness and dissipates wakefulness at night. Since the circadian effect on cognitive functions magnifies with increasing sleep pressure, cognitive deficits associated with night work are likely to be most acute with extended wakefulness, such as during the transition from a day shift to night shift. Methodology/Principal Findings. To test this hypothesis we measured selective attention (with visual search), vigilance (with Psychomotor Vigilance Task [PVT]) and alertness (with a visual analog scale) in a shift work simulation protocol, which included four day shifts followed by three night shifts. There was a nocturnal decline in cognitive processes, some of which were most pronounced on the first night shift. The nighttime decrease in visual search sensitivity was most pronounced on the first night compared with subsequent nights (p=.04), and this was accompanied by a trend towards selective attention becoming 'fast and sloppy'. The nighttime increase in attentional lapses on the PVT was significantly greater on the first night compared to subsequent nights (p <.05) indicating an impaired ability to sustain focus. The nighttime decrease in subjective alertness was also greatest on the first night compared with subsequent nights (p <.05). Conclusions/Significance. These nocturnal deficits in attention and alertness offer some insight into why occupational errors, accidents, and injuries are pronounced during night work compared to day work. Examination of the nighttime vulnerabilities underlying the deployment of attention can be informative for the design of optimal work schedules and the implementation of effective countermeasures for performance deficits during night work.	[Santhi, Nayantara; Duffy, Jeanne F.; Czeisler, Charles A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Sleep Med, Boston, MA 02115 USA; [Horowitz, Todd S.] Brigham & Womens Hosp, Visual Attent Lab, Cambridge, MA USA; [Horowitz, Todd S.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Santhi, N (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Sleep Med, Boston, MA 02115 USA.	nsanthi@rics.bwh.harvard.edu	Duffy, Jeanne F./AAJ-4845-2020; Horowitz, Todd S/J-3376-2013	Duffy, Jeanne F./0000-0003-4177-4179; Santhi, Nayantara/0000-0003-4568-1447; Horowitz, Todd/0000-0001-5571-6266	National Heart Lung and Blood Institute [R01 HL52992]; National Heart, Lung and Blood Institute to the Division of Sleep Medicine (NHLBI) [T32 HL079010]; National Center for Research Resources [M01 RR02635]; National Space Biomedical Research Institute through the National Aeronautics and Space Administration [NCC 98-58]; Air Force Office of Scientific Research (AFOSR) [FA9550-06-0080/O5NL132]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052992] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung and Blood Institute to the Division of Sleep Medicine (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Space Biomedical Research Institute through the National Aeronautics and Space Administration; Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by a grant from the National Heart Lung and Blood Institute (R01 HL52992) to CAC; NS was supported by an Institutional NRSA in Sleep, Circadian and Respiratory Neurobiology from the National Heart, Lung and Blood Institute to the Division of Sleep Medicine (NHLBI; T32 HL079010); the studies were carried out on the BWH GCRC supported by the General Clinical Research Center Program of the National Center for Research Resources (M01 RR02635). CAC is supported in part by the National Space Biomedical Research Institute through the National Aeronautics and Space Administration (NCC 98-58) and by the Air Force Office of Scientific Research (AFOSR FA9550-06-0080/O5NL132).	Akerstedt T., 1994, Journal of Sleep Research, V3, P195; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Bartel P, 2004, OCCUP ENVIRON MED, V61, P167, DOI 10.1136/oem.2002.006197; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; BUDNICK LD, 1994, J OCCUP ENVIRON MED, V36, P1295, DOI 10.1097/00043764-199412000-00010; Bureau of Labor Statistics, 2005, WORK FLEX SHIFT SCHE; Caputo G, 1998, VISION RES, V38, P669, DOI 10.1016/S0042-6989(97)00189-2; Crowley SJ, 2003, J BIOL RHYTHM, V18, P513, DOI 10.1177/0748730403258422; Czeisler CA, 1995, J SLEEP RES, V4, P70, DOI 10.1111/j.1365-2869.1995.tb00231.x; De Gennaro L, 2001, PHYSIOL BEHAV, V74, P197, DOI 10.1016/S0031-9384(01)00551-0; DECOSTRE P, 1971, METABOLISM, V20, P782, DOI 10.1016/S0026-0495(71)80008-2; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; Dinges D, 1988, SLEEP RES, V17, P84; DINGES DF, 1987, SLEEP, V10, P313; DINGES DF, 1988, WORK STRESS, V2, P139, DOI 10.1080/02678378808259158; DINGES DF, 1994, SLEEP, V23, P129; Dorrian J., 2005, THESIS, P39; Drake CL, 2004, SLEEP, V27, P1453, DOI 10.1093/sleep/27.8.1453; Dula DJ, 2001, ANN EMERG MED, V38, P152, DOI 10.1067/mem.2001.116024; EASTMAN CI, 1995, PHYSIOL BEHAV, V58, P1287, DOI 10.1016/0031-9384(95)02031-4; Falleti MG, 2003, J SLEEP RES, V12, P265, DOI 10.1111/j.1365-2869.2003.00363.x; FOLKARD S, 1992, ERGONOMICS, V35, P1453, DOI 10.1080/00140139208967414; Folkard S, 2003, OCCUP MED-OXFORD, V53, P95, DOI 10.1093/occmed/kqg047; FOLKARD S, 2006, AM J IND MED; FOLKARD S, 1975, P 3 INT S NIGHT SHIF, P113; Graw P, 2004, PHYSIOL BEHAV, V80, P695, DOI 10.1016/j.physbeh.2003.12.004; Horowitz TS, 2003, PSYCHOL SCI, V14, P549, DOI 10.1046/j.0956-7976.2003.psci_1464.x; Horowitz TS, 2001, AM J PHYSIOL-ENDOC M, V281, pE384, DOI 10.1152/ajpendo.2001.281.2.E384; Horrocks N, 2006, WORKING NIGHT SHIFT; Jewett ME, 1999, SLEEP, V22, P171, DOI 10.1093/sleep/22.2.171; Jewett ME, 1999, J BIOL RHYTHM, V14, P588, DOI 10.1177/074873099129000920; Lamond N, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.11.e13; Lamond N, 1999, J SLEEP RES, V8, P255, DOI 10.1046/j.1365-2869.1999.00167.x; Landolt HP, 2004, NEUROPSYCHOPHARMACOL, V29, P1933, DOI 10.1038/sj.npp.1300526; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Macmillan N. A., 2004, DETECTION THEORY USE; MIKULINCER M, 1989, BRIT J PSYCHOL, V80, P145, DOI 10.1111/j.2044-8295.1989.tb02309.x; Monk TH, 1997, J SLEEP RES, V6, P9, DOI 10.1046/j.1365-2869.1997.00023.x; NERI DF, 1996, SLEEP RES, V25, P144; Parasuraman, 1998, ATTENTIVE BRAIN; PTERNITIS C, 1981, NIGHT SHIFT WORK BIO, P171; Purnell MT, 2002, J SLEEP RES, V11, P219, DOI 10.1046/j.1365-2869.2002.00309.x; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Rouder JN, 2004, PSYCHON B REV, V11, P419, DOI 10.3758/BF03196589; Santhi N, 2005, NEUROSCI LETT, V384, P316, DOI 10.1016/j.neulet.2005.04.094; Scheffers MK, 1999, PSYCHOPHYSIOLOGY, V36, P149, DOI 10.1111/1469-8986.3620149; Schweitzer PK, 2006, SLEEP, V29, P39, DOI 10.1093/sleep/29.1.39; Smith PL, 2004, VISION RES, V44, P1297, DOI 10.1016/j.visres.2004.01.002; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Suzuki K, 2004, J OCCUP HEALTH, V46, P448, DOI 10.1539/joh.46.448; TREISMAN A, 1990, J EXP PSYCHOL HUMAN, V16, P459, DOI 10.1037/0096-1523.16.3.459; Van Dongen HPA, 2005, CLIN SPORT MED, V24, P237, DOI 10.1016/j.csm.2004.12.007; Van Dongen HPA, 2003, J SLEEP RES, V12, P181, DOI 10.1046/j.1365-2869.2003.00357.x; Wiener E., 1984, SUSTAINED ATTENTION, P207; WILLIAMS HL, 1959, PSYCHOL MONOGR, V73, P1; Williamson AM, 2001, ACCIDENT ANAL PREV, V33, P313, DOI 10.1016/S0001-4575(00)00045-2; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Wyatt JK, 2004, SLEEP, V27, P374, DOI 10.1093/sleep/27.3.374	60	97	99	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1233	10.1371/journal.pone.0001233	http://dx.doi.org/10.1371/journal.pone.0001233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043740	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459300014
J	Di Dio, C; Macaluso, E; Rizzolatti, G				Di Dio, Cinzia; Macaluso, Emiliano; Rizzolatti, Giacomo			The Golden Beauty: Brain Response to Classical and Renaissance Sculptures	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; AMYGDALA; EMOTION; ACTIVATION; RETRIEVAL; STIMULI; INSULA; IMAGES	Is there an objective, biological basis for the experience of beauty in art? Or is aesthetic experience entirely subjective? Using fMRI technique, we addressed this question by presenting viewers, naive to art criticism, with images of masterpieces of Classical and Renaissance sculpture. Employing proportion as the independent variable, we produced two sets of stimuli: one composed of images of original sculptures; the other of a modified version of the same images. The stimuli were presented in three conditions: observation, aesthetic judgment, and proportion judgment. In the observation condition, the viewers were required to observe the images with the same mind-set as if they were in a museum. In the other two conditions they were required to give an aesthetic or proportion judgment on the same images. Two types of analyses were carried out: one which contrasted brain response to the canonical and the modified sculptures, and one which contrasted beautiful vs. ugly sculptures as judged by each volunteer. The most striking result was that the observation of original sculptures, relative to the modified ones, produced activation of the right insula as well as of some lateral and medial cortical areas (lateral occipital gyrus, precuneus and prefrontal areas). The activation of the insula was particularly strong during the observation condition. Most interestingly, when volunteers were required to give an overt aesthetic judgment, the images judged as beautiful selectively activated the right amygdala, relative to those judged as ugly. We conclude that, in observers naive to art criticism, the sense of beauty is mediated by two non-mutually exclusive processes: one based on a joint activation of sets of cortical neurons, triggered by parameters intrinsic to the stimuli, and the insula (objective beauty); the other based on the activation of the amygdala, driven by one's own emotional experiences (subjective beauty).	[Di Dio, Cinzia; Rizzolatti, Giacomo] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; [Di Dio, Cinzia; Macaluso, Emiliano] Fdn Santa Lucia, Neuroimaging Lab, Rome, Italy	University of Parma; IRCCS Santa Lucia	Rizzolatti, G (corresponding author), Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy.	giacomo.rizzolatti@unipr.it	Macaluso, Emiliano/AAE-9185-2019; Di Dio, Cinzia/HGB-3168-2022; Macaluso, Emiliano/H-3139-2017	Macaluso, Emiliano/0000-0002-1919-5288; Macaluso, Emiliano/0000-0002-1919-5288	Italian Ministero Universita Ricerca	Italian Ministero Universita Ricerca(Ministry of Education, Universities and Research (MIUR))	This study was supported by a grant from Italian Ministero Universita Ricerca to G Rizzolatti. Funders had no role in the design and conduct of the study, in the collection, analysis, or interpretation of the data, and in the preparation, review, or approval of the manuscript.	Armony JL, 2002, NEUROPSYCHOLOGIA, V40, P817, DOI 10.1016/S0028-3932(01)00178-6; ASTAFIEV SV, 2005, NAT NEUROSCI, V7, P542; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; BAYLES D, 2007, ART FEAR OBSERVATION; BOLLER F, 2001, HDB NEUROPSYCHOLOGY; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cela-Conde CJ, 2004, P NATL ACAD SCI USA, V101, P6321, DOI 10.1073/pnas.0401427101; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2005, NEUROIMAGE, V24, P751, DOI 10.1016/j.neuroimage.2004.10.013; Damasio A. R., 1999, FEELING WHAT HAPPENS; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Dougherty DD, 2004, ARCH GEN PSYCHIAT, V61, P795, DOI 10.1001/archpsyc.61.8.795; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; DUPONT P, 1994, J NEUROPHYSIOL, V72, P1420, DOI 10.1152/jn.1994.72.3.1420; Dupont S, 2003, SURG RADIOL ANAT, V25, P113, DOI 10.1007/s00276-003-0103-4; Freedberg D, 2007, TRENDS COGN SCI, V11, P197, DOI 10.1016/j.tics.2007.02.003; Friston KJ, 2002, NEUROIMAGE, V16, P513, DOI 10.1006/nimg.2001.1044; Gombrich EH, 1984, TRIBUTES INTERPRETER; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Henson R.N.A., 1999, NEUROIMAGE, V9, P125, DOI DOI 10.1016/J.NEUROIMAGE.2011.06.078; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Huntley H.E., 1970, DIVINE PROPORTION ST; Jacobsen T, 2006, NEUROIMAGE, V29, P276, DOI 10.1016/j.neuroimage.2005.07.010; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kleist K, 1937, Z GESAMTE NEUROL PSY, V158, P159, DOI 10.1007/BF02870728; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; LeDoux, 1996, EMOTIONAL BRAIN MYST, P384; Livio M., 2008, GOLDEN RATIO STORY P; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Mesulam M-M., 1985, CEREB CORTEX, P179, DOI DOI 10.1007/978-1-4757-9619-3_5; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Nelissen K, 2005, SCIENCE, V310, P332, DOI 10.1126/science.1115593; ORBAN GA, 1995, P NATL ACAD SCI USA, V92, P993, DOI 10.1073/pnas.92.4.993; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Ramachandran VS, 2004, BRIEF TOUR HUMAN CON; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rotshtein P, 2001, NEURON, V32, P747, DOI 10.1016/S0896-6273(01)00513-X; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; Tatarkiewicz W., 1970, HIST AESTHETICS; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2012, DOI 10.1073/pnas.91.6.2012; Valentine C.W., 1962, INTRO EXPT PSYCHOL B, V1st ed., DOI [10.4324/9781315707617, DOI 10.4324/9781315707617]; Vartanian O, 2004, NEUROREPORT, V15, P893, DOI 10.1097/00001756-200404090-00032; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Winkielman P, 2001, J PERS SOC PSYCHOL, V81, P989, DOI 10.1037//0022-3514.81.6.989; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	52	193	195	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1201	10.1371/journal.pone.0001201	http://dx.doi.org/10.1371/journal.pone.0001201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030335	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459200014
J	Eisenberg, DTA; Campbell, B; MacKillop, J; Lum, JK; Wilson, DS				Eisenberg, Dan T. A.; Campbell, Benjamin; MacKillop, James; Lum, J. Koji; Wilson, David S.			Season of Birth and Dopamine Receptor Gene Associations with Impulsivity, Sensation Seeking and Reproductive Behaviors	PLOS ONE			English	Article							MORNINGNESS-EVENINGNESS; ENVIRONMENT INTERACTION; VNTR POLYMORPHISM; ANOREXIA-NERVOSA; NOVELTY SEEKING; PRENATAL STRESS; FETAL ORIGINS; DRD4; VARIANTS; PERSONALITY	Season of birth (SOB) has been associated with many physiological and psychological traits including novelty seeking and sensation seeking. Similar traits have been associated with genetic polymorphisms in the dopamine system. SOB and dopamine receptor genetic polymorphisms may independently and interactively influence similar behaviors through their common effects on the dopaminergic system. Methodology/Principal Findings. Based on a sample of 195 subjects, we examined whether SOB was associated with impulsivity, sensation seeking and reproductive behaviors. Additionally we examined potential interactions of dopamine receptor genes with SOB for the same set of traits. Phenotypes were evaluated using the Sociosexual Orientation Inventory, the Barratt Impulsivity Scale, the Eysenck Impulsivity Questionnaire, the Sensation Seeking Scale, and the Delay Discounting Task. Subjects were also asked about their age at first sex as well as their desired age at the birth of their first child. The dopamine gene polymorphisms examined were Dopamine Receptor D2 (DRD2) TaqI A and D4 (DRD4) 48 bp VNTR. Primary analyses included factorial genderxSOB ANOVAs or binary logistic regression models for each dependent trait. Secondary analysis extended the factorial models by also including DRD2 and DRD4 genotypes as independent variables. Winter-born males were more sensation seeking than non-winter born males. In factorial models including both genotype and season of birth as variables, two previously unobserved effects were discovered: (1) a SOB x DRD4 interaction effect on venturesomeness and (2) a DRD2 x DRD4 interaction effect on sensation seeking. Conclusion. These results are consistent with past findings that SOB is related to sensation seeking. Additionally, these results provide tentative support for the hypothesis that SOB modifies the behavioral expression of dopaminergic genetic polymorphism. These findings suggest that SOB should be included in future studies of risky behaviors and behavioral genetic studies of the dopamine system.	[Eisenberg, Dan T. A.] Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA; [Eisenberg, Dan T. A.; Lum, J. Koji; Wilson, David S.] SUNY Binghamton, Dept Anthropol, Binghamton, NY USA; [Eisenberg, Dan T. A.; Lum, J. Koji; Wilson, David S.] SUNY Binghamton, Dept Biol, Binghamton, NY USA; [Eisenberg, Dan T. A.; Lum, J. Koji] SUNY Binghamton, Lab Evolutionary Anthropol & Hlth, Binghamton, NY USA; [Campbell, Benjamin] Univ Wisconsin, Dept Anthropol, Milwaukee, WI 53201 USA; [MacKillop, James] SUNY Binghamton, Dept Psychol, Binghamton, NY USA; [MacKillop, James] Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA	Northwestern University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University of Wisconsin System; University of Wisconsin Milwaukee; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Brown University	Eisenberg, DTA (corresponding author), Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA.	dtae@dtae.net	, James/ABI-3641-2020; Eisenberg, Dan T.A./D-7691-2011	, James/0000-0002-8695-1071; Eisenberg, Dan T.A./0000-0003-0812-1862	Harpur College Awards Committee of the State University of New York at Binghamton to DTAE; Research Foundation of Binghamton University to JKL [T32 AA007459-20]; National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007459] Funding Source: NIH RePORTER	Harpur College Awards Committee of the State University of New York at Binghamton to DTAE; Research Foundation of Binghamton University to JKL; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported in part by Undergraduate Research Awards from the Harpur College Awards Committee of the State University of New York at Binghamton to DTAE; by a start up grant from the Research Foundation of Binghamton University to JKL; and by grant T32 AA007459-20 from the National Institute on Alcohol Abuse and Alcoholism. Study sponsors had no influence on the study design, collection, analysis, interpretation, writing or submission.	Adams J, 1999, PROG PHYS GEOG, V23, P1, DOI 10.1177/030913339902300101; ASGHARI V, 1994, MOL PHARMACOL, V46, P364; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Banegas JR, 2000, J HYPERTENS, V18, P1763, DOI 10.1097/00004872-200018120-00009; Bergen AW, 2005, NEUROPSYCHOPHARMACOL, V30, P1703, DOI 10.1038/sj.npp.1300719; Bland M, 2000, MULTIPLE SIGNIFICANC, P148; Blum K, 2000, J PSYCHOACTIVE DRUGS, V32; BOLTON P, 1992, J CHILD PSYCHOL PSYC, V33, P509, DOI 10.1111/j.1469-7610.1992.tb00888.x; Boor K, 2002, CURR MED CHEM, V9, P793, DOI 10.2174/0929867024606821; Brody AL, 2006, ARCH GEN PSYCHIAT, V63, P808, DOI 10.1001/archpsyc.63.7.808; Bronson EH, 2004, J BIOL RHYTHM, V19, P180, DOI 10.1177/0748730404264658; BRZUSTOWSKI J, HARDYWEINBERG EQUILI; Caci H, 2005, ENCEPHALE, V31, P56; Callier S, 2003, BIOL CELL, V95, P489, DOI 10.1016/S0248-4900(03)00089-3; Castrogiovanni P, 1999, NEUROPSYCHOBIOLOGY, V40, P177, DOI 10.1159/000026616; Cho DI, 2006, BIOCHEM BIOPH RES CO, V350, P634, DOI 10.1016/j.bbrc.2006.09.090; Chotai J, 1999, ARCH SUICIDE RES, V5, P245, DOI 10.1080/13811119908258335; Chotai J, 2003, PERS INDIV DIFFER, V35, P897, DOI 10.1016/S0191-8869(02)00306-9; Chotai J, 2003, PSYCHIAT RES, V119, P99, DOI 10.1016/S0165-1781(03)00112-4; Chotai J, 2002, EUR ARCH PSY CLIN N, V252, P130, DOI 10.1007/s00406-002-0372-7; Chotai J, 2002, PSYCHIAT RES, V111, P45, DOI 10.1016/S0165-1781(02)00107-5; Chotai J, 2002, J AFFECT DISORDERS, V69, P69, DOI 10.1016/S0165-0327(00)00379-7; Chotai J, 1999, NEUROPSYCHOBIOLOGY, V39, P57, DOI 10.1159/000026561; Chotai J, 2001, NEUROPSYCHOBIOLOGY, V44, P19, DOI 10.1159/000054909; Clarke AS, 1996, BIOL PSYCHIAT, V40, P338, DOI 10.1016/0006-3223(95)00663-X; Comings DE, 2000, GENETIC INFLUENCES ON HUMAN FERTILITY AND SEXUALITY, P271; Czermak C, 2006, EUR J PHARMACOL, V531, P20, DOI 10.1016/j.ejphar.2005.11.063; Davies G, 2003, SCHIZOPHRENIA BULL, V29, P587, DOI 10.1093/oxfordjournals.schbul.a007030; DEVONA J, 2005, DELAY DISCOUNTING TA; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Doblhammer G, 2001, P NATL ACAD SCI USA, V98, P2934, DOI 10.1073/pnas.041431898; Dubertret C, 2004, SCHIZOPHR RES, V67, P75, DOI 10.1016/S0920-9964(03)00220-2; Eisenberg DTA, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-2; EISENBERG DTA, 2007, EVOLUTIONARY PSYCHOL, V5, P696; EYSENCK SBG, 1985, PERS INDIV DIFFER, V6, P613, DOI 10.1016/0191-8869(85)90011-X; EYSENCK SBG, 1978, PSYCHOL REP, V43, P1247, DOI 10.2466/pr0.1978.43.3f.1247; Fieder M, 2006, AM J HUM BIOL, V18, P714, DOI 10.1002/ajhb.20539; Frisch A, 2001, MOL PSYCHIATR, V6, P243, DOI 10.1038/sj.mp.4000830; Gerardin DCC, 2005, PHYSIOL BEHAV, V84, P97, DOI 10.1016/j.physbeh.2004.10.014; Goldman BD, 1999, STEROIDS, V64, P679, DOI 10.1016/S0039-128X(99)00052-5; *GSFL RES GROUP, 2003, GSFL GEN PROT DRD2 D; Guo GA, 2006, HUM MUTAT, V27, P236, DOI 10.1002/humu.20282; Hamarman S, 2004, J CHILD ADOL PSYCHOP, V14, P564, DOI 10.1089/cap.2004.14.564; Hartman DS, 1997, POL J PHARMACOL, V49, P191; Horn NR, 2003, NEUROPSYCHOLOGIA, V41, P1959, DOI 10.1016/S0028-3932(03)00077-0; Hur YM, 1997, BEHAV GENET, V27, P455, DOI 10.1023/A:1025674417078; Hutchison KE, 2003, NEUROPSYCHOPHARMACOL, V28, P1882, DOI 10.1038/sj.npp.1300264; Hutchison KE, 2006, NEUROPSYCHOPHARMACOL, V31, P1310, DOI 10.1038/sj.npp.1300917; Joinson C, 2005, PERS INDIV DIFFER, V38, P859, DOI 10.1016/j.paid.2004.06.010; Jongbloet PH, 2005, INT J EAT DISORDER, V38, P236, DOI 10.1002/eat.20173; JONGBLOET PH, 1994, ANN HUM BIOL, V21, P511, DOI 10.1080/03014469400003522; Jovanovic V, 1999, PHARMACOGENETICS, V9, P561, DOI 10.1097/00008571-199910000-00003; Kluger AN, 2002, MOL PSYCHIATR, V7, P712, DOI 10.1038/sj.mp.4001082; Kuzawa CW, 2005, AM J HUM BIOL, V17, P5, DOI 10.1002/ajhb.20091; Kuzawa CW, 2005, AM J HUM BIOL, V17, P1, DOI 10.1002/ajhb.20090; LEGRO RS, 1994, HUM REPROD, V9, P1271, DOI 10.1093/oxfordjournals.humrep.a138693; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Levitan RD, 2004, NEUROPSYCHOPHARMACOL, V29, P179, DOI 10.1038/sj.npp.1300314; LEVITAN RD, 2006, NEUROPSYCHOPHARMACOL; Limosin F, 2003, PSYCHIAT GENET, V13, P127, DOI 10.1097/01.ypg.0000066963.66429.00; MacMurray J, 2003, BIODEMOGRAPHY OF HUMAN REPRODUCTION AND FERTILITY, P187; MACMURRAY J, 2006, COMMUNICATION; Martin M, 1999, CORTEX, V35, P123, DOI 10.1016/S0010-9452(08)70790-1; Mazur J.E., 1987, QUANTITATIVE ANAL BE, V5, P55; McClure WO, 2004, DEV BRAIN RES, V149, P21, DOI 10.1016/j.devbrainres.2003.11.015; McGough J, 2006, J AM ACAD CHILD PSY, V45, P1314, DOI 10.1097/01.chi.0000235083.40285.08; McGrath JJ, 2006, SCHIZOPHR RES, V81, P91, DOI 10.1016/j.schres.2005.07.017; McGrath JJ, 2005, EARLY HUM DEV, V81, P609, DOI 10.1016/j.earlhumdev.2005.03.013; Meek LR, 2006, PHYSIOL BEHAV, V89, P133, DOI 10.1016/j.physbeh.2006.05.006; MIURA T, 1983, ARCH GYNECOL, V233, P263, DOI 10.1007/BF02133800; Mongrain V, 2006, NEUROSCI LETT, V406, P113, DOI 10.1016/j.neulet.2006.07.002; Natale V, 2002, NEUROPSYCHOBIOLOGY, V46, P209, DOI 10.1159/000067803; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Nir I, 2002, J NEUROSCI, V22, P2063, DOI 10.1523/JNEUROSCI.22-06-02063.2002; Noble EP, 2003, AM J MED GENET B, V116B, P103, DOI 10.1002/ajmg.b.10005; Oak JN, 2001, MOL PHARMACOL, V60, P92, DOI 10.1124/mol.60.1.92; Patin V, 2005, DEV BRAIN RES, V160, P265, DOI 10.1016/j.devbrainres.2005.09.010; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Phillips DIW, 2000, INT J OBESITY, V24, P281, DOI 10.1038/sj.ijo.0801125; Pijl H, 2003, EUR J PHARMACOL, V480, P125, DOI 10.1016/j.ejphar.2003.08.100; Ratsma JE, 2001, ALCOHOL CLIN EXP RES, V25, P960, DOI 10.1097/00000374-200107000-00003; Retz W, 2003, J NEURAL TRANSM, V110, P561, DOI 10.1007/s00702-002-0805-5; Reynolds B, 2004, BEHAV PROCESS, V67, P343, DOI 10.1016/j.beproc.2004.06.003; Roberti JW, 2004, J RES PERS, V38, P256, DOI 10.1016/S0092-6566(03)00067-9; Rock D, 2006, EUR ARCH PSY CLIN N, V256, P98, DOI 10.1007/s00406-005-0614-6; Salib E, 2006, BRIT J PSYCHIAT, V188, P416, DOI 10.1192/bjp.bp.105.009118; Savitz JB, 2004, AM J MED GENET B, V131B, P20, DOI 10.1002/ajmg.b.20155; Schinka JA, 2002, AM J MED GENET, V114, P643, DOI 10.1002/ajmg.10649; Schmitt DP, 2005, BEHAV BRAIN SCI, V28, P247, DOI 10.1017/S0140525X05000051; Schoots O, 2003, PHARMACOGENOMICS J, V3, P343, DOI 10.1038/sj.tpj.6500208; Seeger G, 2004, NEUROSCI LETT, V366, P282, DOI 10.1016/j.neulet.2004.05.049; Sen S, 2005, AM J HYPERTENS, V18, P1206, DOI 10.1016/j.amjhyper.2005.04.010; Shinohara M, 2004, J PSYCHIATR NEUROSCI, V29, P134; SIMPSON JA, 1991, J PERS SOC PSYCHOL, V60, P870, DOI 10.1037/0022-3514.60.6.870; Smits LJ, 1997, HUM REPROD, V12, P2572, DOI 10.1093/humrep/12.11.2572; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Tochigi M, 2004, NEUROSCI RES, V48, P1, DOI 10.1016/j.neures.2003.09.002; Torrey EF, 1997, SCHIZOPHR RES, V28, P1, DOI 10.1016/S0920-9964(97)00092-3; Tosini G, 2000, NEUROSCI LETT, V286, P119, DOI 10.1016/S0304-3940(00)01117-4; Van Craenenbroeck K, 2005, J BIOL CHEM, V280, P19350, DOI 10.1074/jbc.M414043200; VANTOL HHM, 1992, NATURE, V358, P149; Waldie KE, 2000, EARLY HUM DEV, V60, P35, DOI 10.1016/S0378-3782(00)00102-X; Watts VJ, 1999, PSYCHOPHARMACOLOGY, V141, P83, DOI 10.1007/s002130050810; Zawilska JB, 1997, POL J PHARMACOL, V49, P201; Zhang DD, 2006, CLIMATIC CHANGE, V76, P459, DOI 10.1007/s10584-005-9024-z; Zuckerman M., 1979, SENSATION SEEKING OP	107	58	59	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1216	10.1371/journal.pone.0001216	http://dx.doi.org/10.1371/journal.pone.0001216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030347	Green Submitted, gold, Green Published			2022-12-25	WOS:000207459200026
J	Wu, D; Townsley, E; Tartakoff, AM				Wu, Di; Townsley, Elizabeth; Tartakoff, Alan Michael			Covert Genetic Selections to Optimize Phenotypes	PLOS ONE			English	Article								In many high complexity systems (cells, organisms, institutions, societies, economies, etc.), it is unclear which components should be regulated to affect overall performance. To identify and prioritize molecular targets which impact cellular phenotypes, we have developed a selection procedure ("SPI''-single promoting/inhibiting target identification) which monitors the abundance of ectopic cDNAs. We have used this approach to identify growth regulators. For this purpose, complex pools of S. cerevisiae cDNA transformants were established and we quantitated the evolution of the spectrum of cDNAs which was initially present. These data emphasized the importance of translation initiation and ER-Golgi traffic for growth. SPI provides functional insight into the stability of cellular phenotypes under circumstances in which established genetic approaches cannot be implemented. It provides a functional "synthetic genetic signature'' for each state of the cell (i.e. genotype and environment) by surveying complex genetic libraries, and does not require specialized arrays of cDNAs/shRNAs, deletion strains, direct assessment of clonal growth or even a conditional phenotype. Moreover, it establishes a hierarchy of importance of those targets which can contribute, either positively or negatively, to modify the prevailing phenotype. Extensions of these proof-of-principle experiments to other cell types should provide a novel and powerful approach to analyze multiple aspects of the basic biology of yeast and animal cells as well as clinically-relevant issues.	[Townsley, Elizabeth; Tartakoff, Alan Michael] Case Western Reserve Univ, Sch Med, Dept Pathol, Cell Biol Program, Cleveland, OH 44106 USA; [Wu, Di] Monash Univ, Monash Med Ctr, Monash Inst Med Res, Melbourne, Vic 3004, Australia	Case Western Reserve University; Monash University	Tartakoff, AM (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Cell Biol Program, Cleveland, OH 44106 USA.	amt10@case.edu	Wu, Di/AAB-7566-2021	Wu, Di/0000-0001-8331-2357	NSF [MCB04311496]; NIH [P30CA43703]; Case Western Presidential Research Initiative Grant; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Presidential Research Initiative Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NSF MCB04311496; NIH P30CA43703, Case Western Presidential Research Initiative Grant. None of the above played any active role in the design, review, or approval of this manuscript.	Abruzzi K, 2007, MOL CELL BIOL, V27, P1044, DOI 10.1128/MCB.01299-06; Akada R, 1997, MOL GEN GENET, V254, P267, DOI 10.1007/s004380050415; Beggs JD, 2005, BIOCHEM SOC T, V33, P433, DOI 10.1042/BST0330433; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyer J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r72; Butcher RA, 2006, NAT PROTOC, V1, P569, DOI 10.1038/nprot.2006.80; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; DESHMUKH M, 1995, J BIOL CHEM, V270, P30148; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; ESPINET C, 1995, YEAST, V11, P25, DOI 10.1002/yea.320110104; Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.e04-07-0564; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Guillon L, 2005, BIOCHEMISTRY-US, V44, P15594, DOI 10.1021/bi051514j; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Lim TS, 2000, MACH LEARN, V40, P203, DOI 10.1023/A:1007608224229; LIU HP, 1992, GENETICS, V132, P665; Luo JY, 2004, J CELL BIOL, V165, P843, DOI 10.1083/jcb.200401040; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Meunier JR, 1999, YEAST, V15, P1159, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1159::AID-YEA441>3.0.CO;2-D; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; OGUR M, 1960, GENETICS, V45, P189; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Peng RW, 2000, J BIOL CHEM, V275, P11521, DOI 10.1074/jbc.275.15.11521; PESTOV DG, 1994, P NATL ACAD SCI USA, V91, P12549, DOI 10.1073/pnas.91.26.12549; RAMER SW, 1992, P NATL ACAD SCI USA, V89, P11589, DOI 10.1073/pnas.89.23.11589; Reimann B, 1999, YEAST, V15, P397, DOI 10.1002/(SICI)1097-0061(19990330)15:5<397::AID-YEA384>3.3.CO;2-L; ROSSI G, 1991, NATURE, V351, P158, DOI 10.1038/351158a0; Simons JF, 1998, EMBO J, V17, P396, DOI 10.1093/emboj/17.2.396; Singhi AD, 2004, P NATL ACAD SCI USA, V101, P9327, DOI 10.1073/pnas.0403080101; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Speed TP, 2003, STAT ANAL GENE EXPRE, Vxiii; Stansfield I, 1998, J MOL BIOL, V282, P13, DOI 10.1006/jmbi.1998.1976; Stevenson LF, 2001, P NATL ACAD SCI USA, V98, P3946, DOI 10.1073/pnas.051013498; Tomishige N, 2003, MOL GENET GENOMICS, V269, P562, DOI 10.1007/s00438-003-0864-9; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	42	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1200	10.1371/journal.pone.0001200	http://dx.doi.org/10.1371/journal.pone.0001200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030334	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459200013
J	Jeong, YH; Kim, MC; Ahn, EK; Seol, SY; Do, EJ; Choi, HJ; Chu, IS; Kim, WJ; Kim, WJ; Sunwoo, Y; Leem, SH				Jeong, Yun Hee; Kim, Min Chan; Ahn, Eun-Kyung; Seol, So-Young; Do, Eun-Ju; Choi, Hong-Jo; Chu, In-Sun; Kim, Wun-Jae; Kim, Woo Jin; Sunwoo, Yangil; Leem, Sun-Hee			Rare Exonic Minisatellite Alleles in MUC2 Influence Susceptibility to Gastric Carcinoma	PLOS ONE			English	Article							HUMAN TELOMERASE GENE; TANDEM REPEATS; MICROSATELLITE INSTABILITY; VARIABLE NUMBER; EXPRESSION; POLYMORPHISM; ASSOCIATION; IDENTIFICATION; SEQUENCE; CANCER	Background. Mucins are the major components of mucus and their genes share a common, centrally-located region of sequence that encodes tandem repeats. Mucins are well known genes with respect to their specific expression levels; however, their genomic levels are unclear because of complex genomic properties. In this study, we identified eight novel minisatellites from the entire MUC2 region and investigated how allelic variation in these minisatellites may affect susceptibility to gastrointestinal cancer. Methodology/Principle Findings. We analyzed genomic DNA from the blood of normal healthy individuals and multi-generational family groups. Six of the eight minisatellites exhibited polymorphism and were transmitted meiotically in seven families, following Mendelian inheritance. Furthermore, a case-control study was performed that compared genomic DNA from 457 cancer-free controls with DNA from individuals with gastric (455), colon (192) and rectal (271) cancers. A statistically significant association was identified between rare exonic MUC2-MS6 alleles and the occurrence of gastric cancer: odds ratio (OR), 2.56; 95% confidence interval (CI), 1.31-5.04; and p = 0.0047. We focused on an association between rare alleles and gastric cancer. Rare alleles were divided into short (40, 43 and 44) and long (47, 50 and 54), according to their TR (tandem repeats) lengths. Interestingly, short rare alleles were associated with gastric cancer (OR = 5.6, 95% CI: 1.93-16.42; p=0.00036). Moreover, hypervariable MUC2 minisatellites were analyzed in matched blood and cancer tissue from 28 patients with gastric cancer and in 4 cases of MUC2-MS2, minisatellites were found to have undergone rearrangement. Conclusions/Significance. Our observations suggest that the short rare MUC2-MS6 alleles could function as identifiers for risk of gastric cancer. Additionally, we suggest that minisatellite instability might be associated with MUC2 function in cancer cells.	[Jeong, Yun Hee; Ahn, Eun-Kyung; Seol, So-Young; Do, Eun-Ju; Sunwoo, Yangil; Leem, Sun-Hee] Dong A Univ, Dept Biol Sci, Pusan, South Korea; [Kim, Min Chan; Choi, Hong-Jo] Dong A Univ, Dept Surg, Coll Med, Pusan, South Korea; [Chu, In-Sun] KRIBB, Med Genom Res Ctr, Taejon, South Korea; [Kim, Wun-Jae] Chungbuk Natl Univ, Dept Urol, Coll Med, Cheongju, South Korea; [Kim, Woo Jin] Kangwon Natl Univ, Dept Internal Med, Coll Med, Chunchon, Kangwon Do, South Korea	Dong A University; Dong A University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungbuk National University; Kangwon National University	Leem, SH (corresponding author), Dong A Univ, Dept Biol Sci, Pusan, South Korea.	shleem@dau.ac.kr			Ministry of Science & Technology, Korea [FG06-11-06]	Ministry of Science & Technology, Korea(Ministry of Science & Technology (MOST), Republic of Korea)	This work was supported by a grant (FG06-11-06) from the 21C Frontier Functional Human Genome Project, Ministry of Science & Technology, Korea.	Bailly S, 1996, MOL IMMUNOL, V33, P999, DOI 10.1016/S0161-5890(96)00042-9; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Biemer-Huttmann AE, 2000, CLIN CANCER RES, V6, P1909; BLANK M, 1994, INT J CANCER, V59, P301, DOI 10.1002/ijc.2910590302; BRAGA VMM, 1992, DEVELOPMENT, V115, P427; Byrd JC, 2004, CANCER METAST REV, V23, P77, DOI 10.1023/A:1025815113599; Carvalho F, 1997, GLYCOCONJUGATE J, V14, P107, DOI 10.1023/A:1018573201347; CHAKRAVARTI A, 2004, GENOME ANAL LAB MANU, V4; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; CIMERMAN M, 1994, INT SURG, V79, P27; Debailleul V, 1998, J BIOL CHEM, V273, P881, DOI 10.1074/jbc.273.2.881; Desseyn JL, 1999, ELECTROPHORESIS, V20, P493, DOI 10.1002/(SICI)1522-2683(19990301)20:3<493::AID-ELPS493>3.0.CO;2-7; Fuke S., 2001, Pharmacogenomics Journal, V1, P152; GUM JR, 1994, J BIOL CHEM, V269, P2440; Guzman K, 1996, AM J PHYSIOL-LUNG C, V270, pL846, DOI 10.1152/ajplung.1996.270.5.L846; Herrmann A, 1999, J BIOL CHEM, V274, P15828, DOI 10.1074/jbc.274.22.15828; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; Kirkbride HJ, 2001, EUR J HUM GENET, V9, P347, DOI 10.1038/sj.ejhg.5200642; KRONTIRIS TG, 1993, NEW ENGL J MED, V329, P517, DOI 10.1056/NEJM199308193290801; KRONTIRIS TG, 1985, NATURE, V313, P369, DOI 10.1038/313369a0; Kyo K, 1999, HUM MOL GENET, V8, P307, DOI 10.1093/hmg/8.2.307; Lee HS, 2001, CANCER, V92, P1427, DOI 10.1002/1097-0142(20010915)92:6<1427::AID-CNCR1466>3.0.CO;2-L; Leem SH, 2002, ONCOGENE, V21, P769, DOI 10.1038/sj.onc.1205122; LENGAUER C, NATURE, V8396, P643; Paquette J, 1998, J BIOL CHEM, V273, P14158, DOI 10.1074/jbc.273.23.14158; Pigny P, 1996, GENOMICS, V38, P340, DOI 10.1006/geno.1996.0637; Rousseau K, 2004, GENOMICS, V83, P936, DOI 10.1016/j.ygeno.2003.11.003; ROYLE NJ, 1988, GENOMICS, V3, P352, DOI 10.1016/0888-7543(88)90127-9; Rozen S, 2000, Methods Mol Biol, V132, P365; Sternberg LR, 2004, ARCH BIOCHEM BIOPHYS, V421, P21, DOI 10.1016/j.abb.2003.10.002; Szutorisz H, 2001, ONCOGENE, V20, P2600, DOI 10.1038/sj.onc.1204346; The Information Committee of the Korean Gastric Cancer Association, 2007, J KOREAN GASTRIC CAN, V7, P47; TREPICCHIO WL, 1992, NUCLEIC ACIDS RES, V20, P2427, DOI 10.1093/nar/20.10.2427; Utsunomiya T, 1998, CLIN CANCER RES, V4, P2605; Vinall LE, 1998, HUM GENET, V102, P357, DOI 10.1007/s004390050705; Vinall LE, 2000, AM J RESP CELL MOL, V23, P678, DOI 10.1165/ajrcmb.23.5.4176; Wang L, 2003, ONCOGENE, V22, P7123, DOI 10.1038/sj.onc.1206852; Weitzel JN, 2000, CANCER RES, V60, P259; YEE CJ, 1994, CANCER RES, V54, P1641; Yi XM, 2000, NEOPLASIA, V2, P433, DOI 10.1038/sj.neo.7900113	41	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1163	10.1371/journal.pone.0001163	http://dx.doi.org/10.1371/journal.pone.0001163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000536	Green Submitted, gold, Green Published			2022-12-25	WOS:000207459100006
J	Sale, A; Cenni, MC; Ciucci, F; Putignano, E; Chierzi, S; Maffei, L				Sale, Alessandro; Cenni, Maria Cristina; Ciucci, Francesca; Putignano, Elena; Chierzi, Sabrina; Maffei, Lamberto			Maternal Enrichment during Pregnancy Accelerates Retinal Development of the Fetus	PLOS ONE			English	Article								The influence of maternal environment on fetal development is largely unexplored, the available evidence concerns only the deleterious effects elicited by prenatal stress. Here we investigated the influence of prenatal enrichment on the early development of the visual system in the fetus. We studied the anatomical development of the rat retina, by analyzing the migration of neural progenitors and the process of retinal ganglion cell death, which exerts a key role in sculpturing the developing retinal system at perinatal ages. The number of apoptotic cells in the retinal ganglion cell layer was analyzed using two distinct methods: the presence of pyknotic nuclei stained for cresyl violet and the appearance of DNA fragmentation (Tunel method). We report that environmental enrichment of the mother during pregnancy affects the structural maturation of the retina, accelerating the migration of neural progenitors and the dynamics of natural cell death. These effects seem to be under the control of insulin-like growth factor-I: its levels, higher in enriched pregnant rats and in their milk, are increased also in their offspring, its neutralization abolishes the action of maternal enrichment on retinal development and chronic insulin-like growth factor-I injection to standard-reared females mimics the effects of enrichment in the fetuses. Thus, the development of the visual system is sensitive to environmental stimulation during prenatal life. These findings could have a bearing in orienting clinical research in the field of prenatal therapy.	[Sale, Alessandro; Ciucci, Francesca; Putignano, Elena; Chierzi, Sabrina; Maffei, Lamberto] Scuola Normale Super Pisa, Pisa, Italy; [Cenni, Maria Cristina; Maffei, Lamberto] CNR, Inst Neurosci, I-56100 Pisa, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Sale, A (corresponding author), Scuola Normale Super Pisa, Pisa, Italy.	sale@sns.it	Sale, Alessandro/K-7760-2016	Putignano, Elena/0000-0002-4313-408X; Sale, Alessandro/0000-0001-7608-4456	PRIN 04; FISR CNR/MIUR	PRIN 04; FISR CNR/MIUR(Ministry of Education, Universities and Research (MIUR))	This research was supported by PRIN 04, FISR CNR/MIUR.	BARLOW SM, 1978, TERATOLOGY, V18, P211, DOI 10.1002/tera.1420180206; Bartoletti A, 2004, NAT NEUROSCI, V7, P215, DOI 10.1038/nn1201; BENESOVA O, 1989, NEUROPHARMACOLOGY, V28, P89, DOI 10.1016/0028-3908(89)90073-7; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Carro E, 2000, J NEUROSCI, V20, P2926; Ciucci F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000475; Fowden AL, 2003, PLACENTA, V24, P803, DOI 10.1016/S0143-4004(03)00080-8; Frade JN, 1996, DEVELOPMENT, V122, P2497; Gramsbergen A, 1998, PEDIATR RES, V44, P105, DOI 10.1203/00006450-199807000-00017; HERNANDEZSANCHEZ C, 1995, P NATL ACAD SCI USA, V92, P9834, DOI 10.1073/pnas.92.21.9834; HORSBURGH GM, 1987, J COMP NEUROL, V263, P553, DOI 10.1002/cne.902630407; Imai Y, 1999, ENDOCRINOLOGY, V140, P4228, DOI 10.1210/en.140.9.4228; Javaid MK, 2004, J BONE MINER RES, V19, P56, DOI 10.1359/JBMR.0301211; Kofman O, 2002, NEUROSCI BIOBEHAV R, V26, P457, DOI 10.1016/S0149-7634(02)00015-5; Landi S, 2007, FASEB J, V21, P130, DOI 10.1096/fj.06-6083com; Lee EJ, 2003, EUR J NEUROSCI, V17, P1542, DOI 10.1046/j.1460-9568.2003.02583.x; LEE WH, 1992, J NEUROSCI, V12, P4737; Lordi B, 1997, PHYSIOL BEHAV, V62, P1087, DOI 10.1016/S0031-9384(97)00261-8; MILLER NM, 1981, J COMP NEUROL, V202, P493, DOI 10.1002/cne.902020404; Mulder EJH, 2002, EARLY HUM DEV, V70, P3, DOI 10.1016/S0378-3782(02)00075-0; OWENS JA, 1991, REPROD FERT DEVELOP, V3, P501, DOI 10.1071/RD9910501; PERRY VH, 1981, NEUROSCIENCE, V6, P931, DOI 10.1016/0306-4522(81)90174-3; PERRY VH, 1983, J COMP NEUROL, V219, P356, DOI 10.1002/cne.902190309; Poltyrev T, 1996, DEV PSYCHOBIOL, V29, P453, DOI 10.1002/(SICI)1098-2302(199607)29:5<453::AID-DEV4>3.0.CO;2-N; REESE BE, 1992, NEUROSCIENCE, V46, P419, DOI 10.1016/0306-4522(92)90062-7; RODRIGUES M, 1988, BRAIN RES, V443, P389, DOI 10.1016/0006-8993(88)91639-3; Sale A, 2004, NEUROPHARMACOLOGY, V47, P649, DOI 10.1016/j.neuropharm.2004.07.008; SCHNEIDER ML, 1992, DEV PSYCHOBIOL, V25, P529, DOI 10.1002/dev.420250706; Shigematsu Satoshi, 1999, Endocrine Journal, V46, pS59, DOI 10.1507/endocrj.46.Suppl_S59; SHIOTA K, 1989, BIOL NEONATE, V56, P6; Szuran TF, 2000, PHYSIOL BEHAV, V71, P353, DOI 10.1016/S0031-9384(00)00351-6; TORRESALEMAN I, 1994, J NEUROSCI RES, V39, P117, DOI 10.1002/jnr.490390202; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; WALDBILLIG RJ, 1988, EXP EYE RES, V47, P587, DOI 10.1016/0014-4835(88)90097-8; Weinstock M, 1997, NEUROSCI BIOBEHAV R, V21, P1, DOI 10.1016/S0149-7634(96)00014-0; WILLIAMS MA, 1990, EXP BRAIN RES, V82, P393	37	56	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1160	10.1371/journal.pone.0001160	http://dx.doi.org/10.1371/journal.pone.0001160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000533	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459100003
J	Noda, K; Miyahara, S; Nakazawa, T; Almulki, L; Nakao, S; Hisatomi, T; She, H; Thomas, KL; Garland, RC; Miller, JW; Gragoudas, ES; Kawai, Y; Mashima, Y; Hafezi-Moghadam, A				Noda, Kousuke; Miyahara, Shinsuke; Nakazawa, Torn; Almulki, Lama; Nakao, Shintaro; Hisatomi, Toshio; She, Haicheng; Thomas, Kennard L.; Garland, Rebecca C.; Miller, Joan W.; Gragoudas, Evangelos S.; Kawai, Yosuke; Mashima, Yukihiko; Hafezi-Moghadam, Ali			Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveifs	FASEB JOURNAL			English	Article						semicarbazide-sensitize amine oxidase; ocular inflammation; leukocyte recruitment	SENSITIVE AMINE OXIDASE; NECROSIS-FACTOR-ALPHA; IN-VIVO EVALUATION; INDUCED UVEITIS; P-SELECTIN; RETINAL MICROCIRCULATION; ENDOTHELIAL INTERACTIONS; OCULAR INFLAMMATION; MONOAMINE-OXIDASE; LEUKOCYTE BINDING	Inflammatory leukocyte accumulation is a common feature of major ocular diseases, such as uveitis, diabetic retinopathy, and age-related macular degeneration. Vascular adhesion protein-1 (VAP-1), a cell surface and soluble molecule that possesses semicarbazide-sensitive amine oxidase (SSAO) activity, is involved in leukocyte recruitment. However, the expression of VAP-1 in the eye and its contribution to ocular inflammation are unknown. Here, we investigated the role of VAP-1 in an established model of ocular inflammation, the endotoxin-induced uveitis (EIU), using a novel and specific inhibitor. Our inhibitor has a half-maximal inhibitory concentration (IC50) of 0.007 mu M against human and 0.008 mu M against rat SSAO, while its IC50 against the functionally related monoamine oxidase (MAO) -A and MAO-B is > 10 mu M. In the retina, VAP-1 was exclusively expressed in the vasculature, and its expression level was elevated during EIU. VAP-1 inhibition in EIU animals significantly suppressed leukocyte recruitment to the anterior chamber, vitreous, and retina, as well as retinal endothelial P-selectin expression. Our data suggest an important role for VAP-1 in the recruitment of leukocytes to the immune-privileged ocular tissues during acute inflammation. VAP-1 inhibition may become a novel strategy in the treatment of ocular inflammatory diseases.	[Noda, Kousuke; Miyahara, Shinsuke; Nakazawa, Torn; Almulki, Lama; Nakao, Shintaro; Hisatomi, Toshio; She, Haicheng; Thomas, Kennard L.; Garland, Rebecca C.; Miller, Joan W.; Gragoudas, Evangelos S.; Hafezi-Moghadam, Ali] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; [Kawai, Yosuke; Mashima, Yukihiko] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School	Hafezi-Moghadam, A (corresponding author), Angiogenesis Lab, 325 Cambridge St,3rd Floor, Boston, MA 02114 USA.	ahm@meei.harvard.edu		Hafezi-Moghadam, Ali/0000-0002-5336-0697; Miller, Joan/0000-0003-2046-3996; Hisatomi, Toshio/0000-0003-2552-9595	NATIONAL EYE INSTITUTE [P30EY014104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI050775] Funding Source: NIH RePORTER; NEI NIH HHS [EY14104] Funding Source: Medline; NIAID NIH HHS [AI-050775] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akin E, 2001, INFECT IMMUN, V69, P1774, DOI 10.1128/IAI.69.3.1774-1780.2001; Avunduk AM, 2002, CURR EYE RES, V24, P92, DOI 10.1076/ceyr.24.2.92.8157; Becker MD, 2001, INVEST OPHTH VIS SCI, V42, P2563; Bosch-Morell F, 2002, FREE RADICAL BIO MED, V33, P669, DOI 10.1016/S0891-5849(02)00954-1; Bucolo C, 2003, INVEST OPHTH VIS SCI, V44, P1178, DOI 10.1167/iovs.02-0559; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; DEARRIBA AF, 1990, J NEUR TR S, P327; Hafezi-Moghadam A, 2007, FASEB J, V21, P464, DOI 10.1096/fj.06-6390com; Holt A, 1997, ANAL BIOCHEM, V244, P384, DOI 10.1006/abio.1996.9911; Ishimoto S, 1996, INVEST OPHTH VIS SCI, V37, P630; Jaakkola K, 2000, J AM COLL CARDIOL, V36, P122, DOI 10.1016/S0735-1097(00)00706-3; Jalkanen S, 2007, BLOOD, V110, P1864, DOI 10.1182/blood-2007-01-069674; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Lakshminarayanan V, 1997, J BIOL CHEM, V272, P32910, DOI 10.1074/jbc.272.52.32910; Lalor PF, 2007, HEPATOLOGY, V45, P465, DOI 10.1002/hep.21497; LO SK, 1993, AM J PHYSIOL, V264, pL406; Martelius T, 2000, AM J PATHOL, V157, P1229, DOI 10.1016/S0002-9440(10)64638-X; Marttila-Ichihara F, 2006, ARTHRITIS RHEUM-US, V54, P2852, DOI 10.1002/art.22061; MCMENAMIN PG, 1995, INVEST OPHTH VIS SCI, V36, P1949; Miyahara S, 2004, INVEST OPHTH VIS SCI, V45, P4197, DOI 10.1167/iovs.04-0192; Miyamoto K, 1998, MICROVASC RES, V55, P230, DOI 10.1006/mvre.1998.2084; Nagai N, 2005, INVEST OPHTH VIS SCI, V46, P2925, DOI 10.1167/iovs.04-1476; Nakazawa T, 2007, J NEUROCHEM, V100, P1018, DOI 10.1111/j.1471-4159.2006.04274.x; Nishijima K, 2001, INVEST OPHTH VIS SCI, V42, P2102; O'Sullivan J, 2004, NEUROTOXICOLOGY, V25, P303, DOI 10.1016/S0161-813X(03)00117-7; Rao N A, 1990, Trans Am Ophthalmol Soc, V88, P797; Reed KL, 2005, DIGEST DIS SCI, V50, P2366, DOI 10.1007/s10620-005-3066-y; ROSENBAUM JT, 1980, NATURE, V286, P611, DOI 10.1038/286611a0; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; SALMI M, 1992, SCIENCE, V257, P1407, DOI 10.1126/science.1529341; SALMI M, 1993, J EXP MED, V178, P2255, DOI 10.1084/jem.178.6.2255; Singh B, 2003, VIRCHOWS ARCH, V442, P491, DOI 10.1007/s00428-003-0802-6; Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Tamura H, 2005, BRIT J OPHTHALMOL, V89, P1052, DOI 10.1136/bjo.2004.061929; WELLER A, 1992, J BIOL CHEM, V267, P15176; Whitcup SM, 1997, CLIN IMMUNOL IMMUNOP, V83, P45, DOI 10.1006/clin.1996.4324; Wilhelm J, 2003, CHEMBIOCHEM, V4, P1120, DOI 10.1002/cbic.200300662; Wung BS, 2005, J BIOMED SCI, V12, P91, DOI 10.1007/s11373-004-8170-z; Yamashiro K, 2001, INVEST OPHTH VIS SCI, V42, P1553; Yu PH, 2003, BBA-PROTEINS PROTEOM, V1647, P193, DOI 10.1016/S1570-9639(03)00101-8; Zhao S, 2000, THROMB RES, V100, P501, DOI 10.1016/S0049-3848(00)00363-7; ZUO DM, 1994, BRAIN RES BULL, V33, P307, DOI 10.1016/0361-9230(94)90198-8	43	46	60	2	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2008	22	4					1094	1103		10.1096/fj.07-9377com	http://dx.doi.org/10.1096/fj.07-9377com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	18032635				2022-12-25	WOS:000254581000015
J	Dallagiovanna, B; Correa, A; Probst, CM; Holetz, F; Smircich, P; de Aguiar, AM; Mansur, F; da Silva, CV; Mortara, RA; Garat, B; Buck, GA; Goldenberg, S; Krieger, MA				Dallagiovanna, Bruno; Correa, Alejandro; Probst, Christian M.; Holetz, Fabiola; Smircich, Pablo; de Aguiar, Alessandra Melo; Mansur, Fernanda; da Silva, Claudio Vieira; Mortara, Renato A.; Garat, Beatriz; Buck, Gregory A.; Goldenberg, Samuel; Krieger, Marco A.			Functional genomic characterization of mRNAs associated with TcPUF6, a pumilio-like protein from Trypanosoma cruzi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEINS; FAMILY; NANOS; DIFFERENTIATION; RECOGNITION; RECRUITMENT; LEISHMANIA; EXPRESSION; DROSOPHILA; COMPLEXES	Trypanosoma cruzi is the protozoan parasite that causes Chagas disease or American trypanosomiasis. Kinetoplastid parasites could be considered as model organisms for studying factors involved in posttranscriptional regulation because they control gene expression almost exclusively at this level. The PUF(Pumilio/FBF1) protein family regulates mRNA stability and translation in eukaryotes, and several members have been identified in trypano-somatids. We used a ribonomic approach to identify the putative target mRNAs associated with TcPUF6, a member of the T. cruzi PUF family. TcPUF6 is expressed in discrete sites in the cytoplasm at various stages of the parasite life cycle and is not associated with the translation machinery. The overexpression of a tandem affinity purification-tagged TcPUF6 protein allowed the identification of associated mRNAs by affinity purification assays and microarray hybridization yielding nine putative target mRNAs. Whole expression analysis of transfected parasites showed that the mRNAs associated with TcPUF6 were down-regulated in populations overexpressing TcPUF6. The association of TcPUF6 with the TcDhh1 helicase in vivo and the cellular co-localization of these proteins in epimastigote forms suggest that TcPUF6 promotes degradation of its associated mRNAs through interaction with RNA degradation complexes. Analysis of the mRNA levels of the putative TcPUF6-regulated genes during the parasite life cycle showed that their transcripts were up-regulated in metacyclic trypomastigotes. In these infective forms no co-localization between TcPUF6 and TcDhh1 was observed. Our results suggest that TcPUF6 regulates the half-lives of its associated transcripts via differential association with mRNA degradation complexes throughout its life cycle.	[Dallagiovanna, Bruno; Correa, Alejandro; Probst, Christian M.; Holetz, Fabiola; de Aguiar, Alessandra Melo; Mansur, Fernanda; Goldenberg, Samuel; Krieger, Marco A.] Inst Biol Mol Parana, BR-81350010 Curitiba, Parana, Brazil; [Dallagiovanna, Bruno; Probst, Christian M.; de Aguiar, Alessandra Melo; Goldenberg, Samuel; Krieger, Marco A.] Fundacao Oswaldo Cruz, BR-21040900 Rio De Janeiro, Brazil; [Smircich, Pablo; Garat, Beatriz] Fac Ciencias, Lab Interacc Mol, Montevideo 11400, Uruguay; [da Silva, Claudio Vieira; Mortara, Renato A.] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, BR-04023062 Sao Paulo, Brazil; [Buck, Gregory A.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23284 USA	Fundacao Oswaldo Cruz; Universidad de la Republica, Uruguay; Universidade Federal de Sao Paulo (UNIFESP); Virginia Commonwealth University	Krieger, MA (corresponding author), Rua Professor Algacyr Munhoz Mader 3775, BR-81350010 Curitiba, Parana, Brazil.	mkrieger@tecpar.br	Aguiar, Alessandra/B-4899-2010; P, CM/B-1358-2013; Probst, Christian/B-8678-2009; Holetz, Fabíola Barbieri/AAA-4831-2019; Goldenberg, Samuel/ABD-8908-2022; GOLDENBERG, SAMUEL/B-4116-2009; Krieger, Marco/AAE-8611-2020; Mortara, Renato A./C-1864-2012; da Silva, Claudio Vieira/AAK-1485-2021; Mansur, Fernanda C B/N-9283-2018; Dallagiovanna, Bruno/AAA-3603-2019; Publica, Inct Saude/J-9544-2013	Aguiar, Alessandra/0000-0002-6167-8478; Probst, Christian/0000-0001-9993-6375; GOLDENBERG, SAMUEL/0000-0002-4892-163X; Mortara, Renato A./0000-0002-2311-8349; da Silva, Claudio Vieira/0000-0002-5052-3139; Dallagiovanna, Bruno/0000-0001-6992-7048; Krieger, Marco Aurelio/0000-0003-0030-3952; Garat, Beatriz/0000-0003-2679-8244; Smircich, Pablo/0000-0002-3856-3920	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050196] Funding Source: NIH RePORTER; NIAID NIH HHS [5 R01 AI 050196-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Brecht M, 1998, MOL BIOCHEM PARASIT, V97, P189, DOI 10.1016/S0166-6851(98)00151-0; Caro F, 2006, EXP PARASITOL, V113, P112, DOI 10.1016/j.exppara.2005.12.015; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016; Contreras VT, 2002, MEM I OSWALDO CRUZ, V97, P1213, DOI 10.1590/S0074-02762002000800025; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Dallagiovanna B, 2005, EXP PARASITOL, V109, P260, DOI 10.1016/j.exppara.2005.01.003; DESOUZA W, 2002, KINETOPLASTID BIOL D, V31, P1; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; HOEK M, 2001, MOL BIOCHEM PARASIT, V57, P706; Holetz FB, 2007, BIOCHEM BIOPH RES CO, V356, P1062, DOI 10.1016/j.bbrc.2007.03.104; Jaruzelska J, 2003, DEV GENES EVOL, V213, P120, DOI 10.1007/s00427-003-0303-2; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; KELLY JM, 1992, NUCLEIC ACIDS RES, V20, P3963, DOI 10.1093/nar/20.15.3963; Luu VD, 2006, MOL BIOCHEM PARASIT, V150, P340, DOI 10.1016/j.molbiopara.2006.09.007; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Mishra KK, 2003, EUKARYOT CELL, V2, P1009, DOI 10.1128/EC.2.5.1009-1017.2003; Nardelli SC, 2007, EUKARYOT CELL, V6, P337, DOI 10.1128/EC.00279-06; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Teixeira SMR, 1998, BRAZ J MED BIOL RES, V31, P1503, DOI 10.1590/S0100-879X1998001200001; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Vessey JP, 2006, J NEUROSCI, V26, P6496, DOI 10.1523/JNEUROSCI.0649-06.2006; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; WHARTON RP, 2006, SCI STKE, pPE37, DOI DOI 10.1126/STKE.3542006PE37; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wreden C, 1997, DEVELOPMENT, V124, P3015	35	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8266	8273		10.1074/jbc.M703097200	http://dx.doi.org/10.1074/jbc.M703097200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18056709	Green Published, hybrid			2022-12-25	WOS:000254288000024
J	Abrahams, A; Mowla, S; Parker, MI; Goding, CR; Prince, S				Abrahams, Amaal; Mowla, Shaheen; Parker, M. Iqbal; Goding, Colin R.; Prince, Sharon			UV-mediated regulation of the anti-senescence factor Tbx2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-BOX GENES; NUCLEOTIDE EXCISION-REPAIR; TRANSCRIPTION FACTOR; DNA-BINDING; P38 KINASE; EXPRESSION; SENESCENCE; ACTIVATION; STRESS; SIGNAL	Several lines of evidence have implicated members of the developmentally important T-box gene family in cell cycle regulation and in cancer. Importantly, the highly related T-box factors Tbx2 and Tbx3 can suppress senescence through repressing the cyclin-dependent kinase inhibitors p19(ARF) and p21(WAF1/CIP1/SDII). Furthermore, Tbx2 is up-regulated in several cancers, including melanomas where it was shown to function as an anti-senescence factor, suggesting that this may be one of the mechanisms by which T-box proteins contribute to the oncogenic process. However, very little is known about whether Tbx2 is regulated by p21-mediated stress-induced senescence signaling pathways. In this study, using the MCF-7 breast cancer cell line known to overexpress Tbx2, we show that in response to stress induced by ultraviolet irradiation the Tbx2 protein is specifically phosphorylated by the p38 mitogen-activated protein kinase. Using site-directed mutagenesis and in vitro kinase assays, we have identified serine residues 336, 623, and 675 in the Tbx2 protein as the p38 target sites and show that these sites are phosphorylated in vivo. Importantly, we show by Western blotting, immunofluorescence, and reporter assays that this phosphorylation leads to increased Tbx2 protein levels, predominant nuclear localization of the protein, and an increase in the ability of Tbx2 to repress the p21(WAF1/CIP1/SDII) promoter. These results show for the first time that the ability of Tbx2 to repress the p21 gene is enhanced in response to a stress-induced senescence pathway, which leads to a better understanding of the regulation of the anti-senescence function of Tbx2.	[Mowla, Shaheen; Prince, Sharon] Univ Cape Town, Fac Hlth Sci, Div Cell Biol, ZA-7925 Cape Town, South Africa; [Abrahams, Amaal; Parker, M. Iqbal] Univ Cape Town, Fac Hlth Sci, Div Med Biochem, ZA-7925 Cape Town, South Africa; [Goding, Colin R.] Marie Curie Res Inst, Signal & Dev Lab, Surrey RH8 OTL, England	University of Cape Town; University of Cape Town	Prince, S (corresponding author), Univ Cape Town, Fac Hlth Sci, Div Cell Biol, ZA-7925 Cape Town, South Africa.	sharon.prince@uct.ac.za	Prince, Sharon/AFU-4911-2022; Mowla, Shaheen/AAR-8297-2021	Prince, Sharon/0000-0002-6975-5255; Mowla, Shaheen/0000-0001-6802-0495; Goding, Colin/0000-0002-1614-3909	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AGULNIK SI, 1995, GENOMICS, V25, P214, DOI 10.1016/0888-7543(95)80128-9; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Bilican B, 2006, EXP CELL RES, V312, P2358, DOI 10.1016/j.yexcr.2006.03.033; BOLLAG RJ, 1994, NAT GENET, V7, P383, DOI 10.1038/ng0794-383; Brummelkamp TR, 2002, J BIOL CHEM, V277, P6567, DOI 10.1074/jbc.M110492200; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Carlson H, 2002, ONCOGENE, V21, P3827, DOI 10.1038/sj.onc.1205476; Carlson H, 2001, HUM MOL GENET, V10, P2403, DOI 10.1093/hmg/10.21.2403; Carreira S, 2000, J BIOL CHEM, V275, P21920, DOI 10.1074/jbc.M000035200; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Casanovas O, 2000, J BIOL CHEM, V275, P35091, DOI 10.1074/jbc.M006324200; Cooper MP, 1999, MOL BIOL CELL, V10, P2119, DOI 10.1091/mbc.10.7.2119; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fan WW, 2004, CANCER RES, V64, P5132, DOI 10.1158/0008-5472.CAN-04-0615; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Hansel DE, 2004, CLIN CANCER RES, V10, P6152, DOI 10.1158/1078-0432.CCR-04-0285; Haq R, 2002, CANCER RES, V62, P5076; He ML, 1999, P NATL ACAD SCI USA, V96, P10212, DOI 10.1073/pnas.96.18.10212; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Ito A, 2005, CANCER LETT, V219, P105, DOI 10.1016/j.canlet.2004.07.051; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Keller D, 1999, BIOCHEM BIOPH RES CO, V261, P464, DOI 10.1006/bbrc.1999.1023; Kim GY, 2002, J BIOL CHEM, V277, P29792, DOI 10.1074/jbc.M201299200; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lingbeek ME, 2002, J BIOL CHEM, V277, P26120, DOI 10.1074/jbc.M200403200; Lomnytska M, 2006, INT J CANCER, V118, P412, DOI 10.1002/ijc.21332; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; McDonald E, 1996, CANCER RES, V56, P2250; McKay BC, 1998, ONCOGENE, V17, P545, DOI 10.1038/sj.onc.1201963; Miyahara K, 2004, J NEUROBIOL, V58, P392, DOI 10.1002/neu.10299; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; PAN ZQ, 1995, J BIOL CHEM, V270, P22008, DOI 10.1074/jbc.270.37.22008; Papaioannou VE, 2001, INT REV CYTOL, V207, P1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prince S, 2004, CANCER RES, V64, P1669, DOI 10.1158/0008-5472.CAN-03-3286; Renard CA, 2007, CANCER RES, V67, P901, DOI 10.1158/0008-5472.CAN-06-2344; Roninson IB, 2003, CANCER RES, V63, P2705; Sheikh MS, 1997, ONCOGENE, V14, P1875, DOI 10.1038/sj.onc.1201004; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Sinclair CS, 2002, CANCER RES, V62, P3587; Sinha S, 2000, GENE, V258, P15, DOI 10.1016/S0378-1119(00)00417-0; Stoller JZ, 2005, HUM MOL GENET, V14, P885, DOI 10.1093/hmg/ddi081; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Wang JA, 1999, INT J RADIAT BIOL, V75, P301, DOI 10.1080/095530099140483; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	49	35	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2223	2230		10.1074/jbc.M705651200	http://dx.doi.org/10.1074/jbc.M705651200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18025091	hybrid, Green Published			2022-12-25	WOS:000252501000050
J	Harper, DC; Theos, AC; Herman, KE; Tenza, D; Raposo, G; Marks, MS				Harper, Dawn C.; Theos, Alexander C.; Herman, Kathryn E.; Tenza, Daniele; Raposo, Graca; Marks, Michael S.			Premelanosome amyloid-like fibrils are composed of only Golgi-processed forms of Pmel17 that have been proteolytically processed in Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-LINKED GLYCOSYLATION; SILVER COAT COLOR; MONOCLONAL-ANTIBODY; MELANOSOME BIOGENESIS; MELANOCYTE LINEAGE; ENDOPLASMIC-RETICULUM; GENOMIC ORGANIZATION; ME20 ANTIGEN; CELLS; LOCALIZATION	Melanin pigments are synthesized within specialized organelles called melanosomes and polymerize on intraluminal fibrils that form within melanosome precursors. The fibrils consist of proteolytic fragments derived from Pmel17, a pigment cell-specific integral membrane protein. The intracellular pathways by which Pmel17 accesses melanosome precursors and the identity of the Pmel17 derivatives within fibrillar melanosomes have been a matter of debate. Weshow here that antibodies that detect Pmel17 within fibrillar melanosomes recognize only the luminal products of proprotein convertase cleavage and not the remaining products linked to the transmembrane domain. Moreover, antibodies to the N and C termini detect only Pmel17 isoforms present in early biosynthetic compartments, which constitute a large fraction of detectable steady state Pmel17 in cell lysates because of slow early biosynthetic transport and rapid consumption by fibril formation. Using an antibody to a luminal epitope that is destroyed upon modification by O-linked oligosaccharides, we show that all post-endoplasmic reticulum Pmel17 isoforms are modified by Golgi-associated oligosaccharide transferases, and that only processed forms contribute to melanosome biogenesis. These data indicate that Pmel17 follows a single biosynthetic route from the endoplasmic reticulum through the Golgi complex and endosomes to melanosomes, and that only fragments encompassing previously described functional luminal determinants are present within the fibrils. These data have important implications for the site and mechanism of fibril formation.	[Harper, Dawn C.; Theos, Alexander C.; Herman, Kathryn E.; Marks, Michael S.] Univ Penn, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19104 USA; [Theos, Alexander C.] Georgetown Univ, Sch Nursing & Hlth Studies, Dept Human Sci, Washington, DC 20057 USA; [Tenza, Daniele; Raposo, Graca] Inst Curie, UMR CNRS 144, Sect Rech, F-75248 Paris, France	University of Pennsylvania; Georgetown University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Marks, MS (corresponding author), Univ Penn, Dept Pathol & Lab Med, Sch Med, 513 Stellar Chance Labs,422 Curie Blvd, Philadelphia, PA 19104 USA.	marksm@mail.med.upenn.edu	Marks, Michael S/Q-7223-2019	Marks, Michael S/0000-0001-7435-7262; Raposo, graca/0000-0001-9590-1298; Theos, Alexander/0000-0002-1826-8705	NATIONAL CANCER INSTITUTE [T32CA009140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048155] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009140, T32-CA-009140] Funding Source: Medline; NIAMS NIH HHS [R01 AR048155, R01 AR048155-05A1] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADEMA GJ, 1993, AM J PATHOL, V143, P1579; ADEMA GJ, 1994, J BIOL CHEM, V269, P20126; Bailin T, 1996, J INVEST DERMATOL, V106, P24, DOI 10.1111/1523-1747.ep12326976; Basrur V, 2003, J PROTEOME RES, V2, P69, DOI 10.1021/pr025562r; Berson JF, 2000, J BIOL CHEM, V275, P12281, DOI 10.1074/jbc.275.16.12281; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Brunberg E, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-46; CARLSSON SR, 1993, ARCH BIOCHEM BIOPHYS, V304, P65, DOI 10.1006/abbi.1993.1322; Chiamenti AM, 1996, MELANOMA RES, V6, P291, DOI 10.1097/00008390-199608000-00003; Clark LA, 2006, P NATL ACAD SCI USA, V103, P1376, DOI 10.1073/pnas.0506940103; CUOMO M, 1991, J INVEST DERMATOL, V96, P446, DOI 10.1111/1523-1747.ep12470092; DONATIEN PD, 1995, EUR J BIOCHEM, V232, P159, DOI 10.1111/j.1432-1033.1995.tb20794.x; ESCLAMADO RM, 1986, AM J SURG, V152, P376, DOI 10.1016/0002-9610(86)90308-9; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; GOWN AM, 1986, AM J PATHOL, V123, P195; Hearing VJ, 2000, PIGM CELL RES, V13, P23, DOI 10.1034/j.1600-0749.13.s8.7.x; Hoashi T, 2006, J BIOL CHEM, V281, P21198, DOI 10.1074/jbc.M601643200; KAPUR RP, 1992, J HISTOCHEM CYTOCHEM, V40, P207, DOI 10.1177/40.2.1552165; Kerje S, 2004, GENETICS, V168, P1507, DOI 10.1534/genetics.104.027995; Kim KK, 1996, PIGM CELL RES, V9, P42, DOI 10.1111/j.1600-0749.1996.tb00085.x; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; Kushimoto T, 2001, P NATL ACAD SCI USA, V98, P10698, DOI 10.1073/pnas.191184798; KWON BS, 1987, MOL BIOL MED, V4, P339; Lee ZH, 1996, J INVEST DERMATOL, V106, P605, DOI 10.1111/1523-1747.ep12345163; MARESH GA, 1994, ARCH BIOCHEM BIOPHYS, V311, P95, DOI 10.1006/abbi.1994.1213; MARESH GA, 1994, DNA CELL BIOL, V13, P87, DOI 10.1089/dna.1994.13.87; Marks MS, 2006, PIGM CELL RES, V19, P253, DOI 10.1111/j.1600-0749.2006.00309.x; MARKS MS, 1995, J CELL BIOL, V131, P351, DOI 10.1083/jcb.131.2.351; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Martinez-Esparza MM, 1999, MAMM GENOME, V10, P1168, DOI 10.1007/s003359901184; MAUL GG, 1969, J ULTRA MOL STRUCT R, V26, P163, DOI 10.1016/S0022-5320(69)90042-2; Nichols SE, 2003, J INVEST DERMATOL, V121, P821, DOI 10.1046/j.1523-1747.2003.12474.x; ORLOW SJ, 1995, J INVEST DERMATOL, V105, P3, DOI 10.1111/1523-1747.ep12312291; PILLER V, 1990, J BIOL CHEM, V265, P9264; RADKA SF, 1984, HUM IMMUNOL, V10, P177, DOI 10.1016/0198-8859(84)90038-7; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Reissmann M, 2007, ANIM GENET, V38, P1, DOI 10.1111/j.1365-2052.2006.01553.x; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Rottger S, 1998, J CELL SCI, V111, P45; Santini F, 1998, MOL BIOL CELL, V9, P1177, DOI 10.1091/mbc.9.5.1177; Schonthaler HB, 2005, DEV BIOL, V284, P421, DOI 10.1016/j.ydbio.2005.06.001; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066; Theos AC, 2006, DEV CELL, V10, P343, DOI 10.1016/j.devcel.2006.01.012; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081; THOMSON TM, 1985, J INVEST DERMATOL, V85, P169, DOI 10.1111/1523-1747.ep12276608; THOMSON W, 1989, J AM ACAD DERMATOL, V21, P1280, DOI 10.1016/S0190-9622(89)70344-3; Tsuboi S, 2001, BIOESSAYS, V23, P46, DOI 10.1002/1521-1878(200101)23:1<46::AID-BIES1006>3.3.CO;2-V; Valencia JC, 2006, J CELL SCI, V119, P1080, DOI 10.1242/jcs.02804; Valencia JC, 2007, J BIOL CHEM, V282, P11266, DOI 10.1074/jbc.M608449200; Valencia JC, 2006, PIGM CELL RES, V19, P250, DOI 10.1111/j.1600-0749.2006.00308.x; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; VENNEGOOR C, 1988, AM J PATHOL, V130, P179; Wopereis S, 2006, CLIN CHEM, V52, P574, DOI 10.1373/clinchem.2005.063040; Yasumoto K, 2004, J BIOL CHEM, V279, P28330, DOI 10.1074/jbc.M401269200	59	62	65	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2307	2322		10.1074/jbc.M708007200	http://dx.doi.org/10.1074/jbc.M708007200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17991747	Green Accepted, hybrid			2022-12-25	WOS:000252501000058
J	Lee, MH; El-Shewy, HM; Luttrell, DK; Luttrell, LM				Lee, Mi-Hye; El-Shewy, Hesham M.; Luttrell, Deirdre K.; Luttrell, Louis M.			Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; NUCLEAR EXPORT SIGNAL; REGULATED KINASES; ERK1/2 ACTIVATION; EGF RECEPTOR; BETA-ARRESTIN-2; ENDOCYTOSIS; PATHWAYS; MAPK; PHOSPHORYLATION	Heptahelical G protein-coupled receptors employ several mechanisms to activate the ERK1/2 cascade and control gene transcription. Previous work with the angiotensin AT1a receptor has shown that G(q/11) activation leads to a rapid and transient rise in ERK1/2 activity, whereas beta-arrestin binding supports sustained ERK1/2 activation by scaffolding a Raf center dot MEK center dot ERK complex associated with the internalized receptor. In this study, we compared the role of the two beta-arrestin isoforms in AT1a receptor desensitization, ERK1/2 activation and transcription using selective RNA interference. In HEK293 cells, both the native AT1a receptor and a G protein-coupling deficient DRY/AAY mutant recruited beta-arrestin1 and beta-arrestin2 upon angiotensin binding and internalized with the receptor. In contrast, only beta-arrestin2 supported protein kinase C-independent ERK1/2 activation by both the AT1a and DRY/AAY receptors. Using focused gene expression filter arrays to screen for endogenous transcriptional responses, we found that silencing beta-arrestin1 or beta-arrestin2 individually did not alter the response pattern but that silencing both caused a marked increase in the number of transcripts that were significantly up-regulated in response to AT1a receptor activation. The DRY/AAY receptor failed to elicit any detectable transcriptional response despite its ability to stimulate beta-arrestin2- dependent ERK1/2 activation. These results indicate that the transcriptional response to AT1a receptor activation primarily reflects heterotrimeric G protein activation. Although beta-arrestin1 and beta-arrestin2 are functionally specialized with respect to supporting G protein-independent ERK1/2 activation, their common effect is to dampen the transcriptional response by promoting receptor desensitization.	[Lee, Mi-Hye; El-Shewy, Hesham M.; Luttrell, Deirdre K.; Luttrell, Louis M.] Med Univ S Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, Charleston, SC 29425 USA; [Lee, Mi-Hye; El-Shewy, Hesham M.; Luttrell, Deirdre K.; Luttrell, Louis M.] Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA; [Lee, Mi-Hye; El-Shewy, Hesham M.; Luttrell, Deirdre K.; Luttrell, Louis M.] Med Univ S Carolina, Dept Mol Biol, Charleston, SC 29425 USA; [Lee, Mi-Hye; El-Shewy, Hesham M.; Luttrell, Deirdre K.; Luttrell, Louis M.] Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Luttrell, LM (corresponding author), Med Univ S Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, 96 Jonathan Lucas St, Charleston, SC 29425 USA.	luttrell@musc.edu		Luttrell, Louis/0000-0003-2805-6949	NIDDK NIH HHS [DK55524] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055524, R56DK055524] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Ali MS, 1997, J BIOL CHEM, V272, P23382, DOI 10.1074/jbc.272.37.23382; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Downes GB, 1999, GENOMICS, V62, P544, DOI 10.1006/geno.1999.5992; Elorza A, 2000, MOL PHARMACOL, V57, P778, DOI 10.1124/mol.57.4.778; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Ge L, 2003, J BIOL CHEM, V278, P34418, DOI 10.1074/jbc.M300573200; Gesty-Palmer D, 2005, J BIOL CHEM, V280, P32157, DOI 10.1074/jbc.M507460200; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Heeneman S, 2000, J BIOL CHEM, V275, P15926, DOI 10.1074/jbc.M909616199; Jafri F, 2006, J BIOL CHEM, V281, P19346, DOI 10.1074/jbc.M512643200; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Lin FT, 1999, J BIOL CHEM, V274, P15971, DOI 10.1074/jbc.274.23.15971; LINSEMAN DA, 1995, J BIOL CHEM, V270, P12563, DOI 10.1074/jbc.270.21.12563; Luttrell LM, 2005, J MOL NEUROSCI, V26, P253, DOI 10.1385/JMN:26:2-3:253; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Marrero MB, 1998, AM J PHYSIOL-CELL PH, V275, pC1216, DOI 10.1152/ajpcell.1998.275.5.C1216; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Miller WE, 2001, J BIOL CHEM, V276, P27770, DOI 10.1074/jbc.M102264200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Ogier-Denis E, 2000, J BIOL CHEM, V275, P39090, DOI 10.1074/jbc.M006198200; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pitcher JA, 1999, J BIOL CHEM, V274, P34531, DOI 10.1074/jbc.274.49.34531; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Stoffel RH, 1997, J MEMBRANE BIOL, V157, P1, DOI 10.1007/s002329900210; Terrillon S, 2004, EMBO J, V23, P3950, DOI 10.1038/sj.emboj.7600387; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Wei HJ, 2004, J BIOL CHEM, V279, P48255, DOI 10.1074/jbc.M406205200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Zhai PY, 2005, J CLIN INVEST, V115, P3045, DOI 10.1172/JCI25330; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999	49	52	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2088	2097		10.1074/jbc.M706892200	http://dx.doi.org/10.1074/jbc.M706892200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18006496	hybrid			2022-12-25	WOS:000252501000036
J	Maya-Monteiro, CM; Almeida, PE; D'Avila, H; Martins, AS; Rezende, AP; Castro-Faria-Neto, H; Bozza, PT				Maya-Monteiro, Clarissa M.; Almeida, Patricia E.; D'Avila, Heloisa; Martins, Aline S.; Rezende, Ana Paula; Castro-Faria-Neto, Hugo; Bozza, Patricia T.			Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROPLET-ASSOCIATED PROTEINS; DIFFERENTIATION-RELATED PROTEIN; FATTY-ACID OXIDATION; P70 S6 KINASE; ADIPOCYTE DIFFERENTIATION; SKELETAL-MUSCLE; GENE-EXPRESSION; MTOR; CELL; INSULIN	Leptin is an adipocyte-derived hormone/cytokine that links nutritional status with neuroendocrine and immune functions. Lipid bodies (lipid droplets) are emerging as dynamic organelles with roles in lipid metabolism and inflammation. Here we investigated the roles of leptin in signaling pathways involved in cytoplasmic lipid body biogenesis and leukotriene B-4 synthesis in macrophages. Our results demonstrated that leptin directly activated macrophages and induced the formation of adipose differentiation-related protein-enriched lipid bodies. Newly formed lipid bodies were sites of 5-lipoxygenase localization and correlated with an enhanced capacity of leukotriene B-4 production. We demonstrated that leptin-induced macrophage activation was dependent on phosphatidylinositol 3-kinase (PI3K) activity, since the lipid body formation was inhibited by LY294002 and was absent in the PI3K knock-out mice. Leptin induces phosphorylation of p70(S6K) and 4EBP1 key downstream signaling intermediates of the mammalian target of rapamycin (mTOR) pathway in a rapamycin-sensitive mechanism. The mTOR inhibitor, rapamycin, inhibited leptin-induced lipid body formation, both in vivo and in vitro. In addition, rapamycin inhibited leptin-induced adipose differentiation-related protein accumulation in macrophages and lipid body-dependent leukotriene synthesis, demonstrating a key role for mTOR in lipid body biogenesis and function. Our results establish PI3K/mTOR as an important signaling pathway for leptin-induced cytoplasmic lipid body biogenesis and adipose differentiation-related protein accumulation. Furthermore, we demonstrate a previously unrecognized link between intracellular (mTOR) and systemic (leptin) nutrient sensors in macrophage lipid metabolism. Leptin-induced increased formation of cytoplasmic lipid bodies and enhanced inflammatory mediator production in macrophages may have implications for obesity-related cardiovascular diseases.	[Maya-Monteiro, Clarissa M.; Almeida, Patricia E.; D'Avila, Heloisa; Martins, Aline S.; Rezende, Ana Paula; Castro-Faria-Neto, Hugo; Bozza, Patricia T.] Fundacao Oswaldo Cruz, Lab Imunofarmcol, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz	Maya-Monteiro, CM (corresponding author), Fundacao Oswaldo Cruz, Lab Imunofarmcol, Inst Oswaldo Cruz, Av Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.	clarissa@ioc.fiocruz.br; pbozza@ioc.fiocruz.br	maya-monteiro, clarissa/A-9091-2010; Bozza, Patricia T./AAE-2933-2021; Bozza, Patricia T./AAM-4537-2021	Bozza, Patricia T./0000-0001-8349-9529; Almeida, Patricia Elaine de/0000-0002-9081-8601				Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P443, DOI 10.1161/hq0302.105593; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Beltowski J, 2006, ATHEROSCLEROSIS, V189, P47, DOI 10.1016/j.atherosclerosis.2006.03.003; Bendinelli P, 2005, BIOCHEM BIOPH RES CO, V332, P719, DOI 10.1016/j.bbrc.2005.05.009; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Bozza PT, 2007, PHARMACOL THERAPEUT, V113, P30, DOI 10.1016/j.pharmthera.2006.06.006; Bozza PT, 1997, J EXP MED, V186, P909, DOI 10.1084/jem.186.6.909; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Cho HJ, 2004, BIOCHEM BIOPH RES CO, V321, P942, DOI 10.1016/j.bbrc.2004.07.050; Chung SY, 2005, J LIPID RES, V46, P885, DOI 10.1194/jlr.M400476-JLR200; Cipollone F, 2005, ARTERIOSCL THROM VAS, V25, P1665, DOI 10.1161/01.ATV.0000172632.96987.2d; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; D'Avila H, 2006, J IMMUNOL, V176, P3087, DOI 10.4049/jimmunol.176.5.3087; Davies JD, 2005, J BIOL CHEM, V280, P3911, DOI 10.1074/jbc.M410075200; de Assis EF, 2003, J IMMUNOL, V171, P2090, DOI 10.4049/jimmunol.171.4.2090; DVORAK AM, 1993, INT ARCH ALLERGY IMM, V101, P136, DOI 10.1159/000236511; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gross DN, 2006, MOL ENDOCRINOL, V20, P459, DOI 10.1210/me.2005-0323; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kjerrulf M, 2006, INFLAMM RES, V55, P300, DOI 10.1007/s00011-006-0087-8; Kraiss LW, 2000, AM J PHYSIOL-HEART C, V278, pH1537, DOI 10.1152/ajpheart.2000.278.5.H1537; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Laakso M, 1999, DIABETES, V48, P937, DOI 10.2337/diabetes.48.5.937; Lam QLK, 2007, CELL MOL IMMUNOL, V4, P1; Larigauderie G, 2004, ARTERIOSCL THROM VAS, V24, P504, DOI 10.1161/01.ATV.0000115638.27381.97; Lekmine F, 2004, EXP CELL RES, V295, P173, DOI 10.1016/j.yexcr.2003.12.021; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; Leyva F, 1998, EUR HEART J, V19, P1547, DOI 10.1053/euhj.1998.1045; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Li L, 2005, DIABETES, V54, P2227, DOI 10.2337/diabetes.54.7.2227; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Londos C, 2005, BIOCHIMIE, V87, P45, DOI 10.1016/j.biochi.2004.12.010; Mahoney TS, 2001, P NATL ACAD SCI USA, V98, P10284, DOI 10.1073/pnas.181201398; Mancuso P, 2004, AM J PHYSIOL-LUNG C, V287, pL497, DOI 10.1152/ajplung.00010.2004; Mancuso P, 2002, J IMMUNOL, V168, P4018, DOI 10.4049/jimmunol.168.8.4018; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martin-Romero C, 2001, CELL IMMUNOL, V212, P83, DOI 10.1006/cimm.2001.1851; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mishra R, 2004, AM J PHYSIOL-RENAL, V286, pF913, DOI 10.1152/ajprenal.00323.2003; Motomura W, 2006, BIOCHEM BIOPH RES CO, V340, P1111, DOI 10.1016/j.bbrc.2005.12.121; Nakata M, 1999, DIABETES, V48, P426, DOI 10.2337/diabetes.48.2.426; O'Rourke L, 2002, J BIOL CHEM, V277, P42557, DOI 10.1074/jbc.M202151200; Orci L, 2004, P NATL ACAD SCI USA, V101, P2058, DOI 10.1073/pnas.0308258100; Pacheco P, 2002, J IMMUNOL, V169, P6498, DOI 10.4049/jimmunol.169.11.6498; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Qiu H, 2006, P NATL ACAD SCI USA, V103, P8161, DOI 10.1073/pnas.0602414103; Raso GM, 2002, BRIT J PHARMACOL, V137, P799, DOI 10.1038/sj.bjp.0704903; Reiter AK, 2005, AM J PHYSIOL-ENDOC M, V288, pE980, DOI 10.1152/ajpendo.00333.2004; Ren J, 2004, J ENDOCRINOL, V181, P1, DOI 10.1677/joe.0.1810001; Robenek H, 2005, J BIOL CHEM, V280, P26330, DOI 10.1074/jbc.M413312200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Silva AR, 2002, J IMMUNOL, V168, P4112, DOI 10.4049/jimmunol.168.8.4112; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Wan HC, 2007, FASEB J, V21, P167, DOI 10.1096/fj.06-6711com; Wang SM, 2003, HISTOCHEM CELL BIOL, V120, P285, DOI 10.1007/s00418-003-0575-7; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Weyrich AS, 2007, BLOOD, V109, P1975, DOI 10.1182/blood-2006-08-042192; Winters B, 2000, J APPL PHYSIOL, V89, P2382, DOI 10.1152/jappl.2000.89.6.2382; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; YEH WC, 1995, P NATL ACAD SCI USA, V92, P11086, DOI 10.1073/pnas.92.24.11086; Yu WG, 1998, AM J PATHOL, V152, P759; Yu WG, 2000, BLOOD, V95, P1078, DOI 10.1182/blood.V95.3.1078.003k16_1078_1085; Zhao AZ, 2000, J BIOL CHEM, V275, P11348, DOI 10.1074/jbc.275.15.11348	71	97	102	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2203	2210		10.1074/jbc.M706706200	http://dx.doi.org/10.1074/jbc.M706706200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039669	hybrid, Green Published			2022-12-25	WOS:000252501000048
J	Miller, E; Fiete, D; Blake, NMJ; Beranek, M; Oates, EL; Mi, Y; Roseman, DS; Baenziger, JU				Miller, Erin; Fiete, Dorothy; Blake, Nicquet M. J.; Beranek, Mary; Oates, Edward L.; Mi, Yiling; Roseman, Daniel S.; Baenziger, Jacques U.			A necessary and sufficient determinant for protein-selective glycosylation in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; N-ACETYLGALACTOSAMINE-TRANSFERASE; RENILLA-RENIFORMIS LUCIFERASE; HUMAN CHORIONIC-GONADOTROPIN; CELL-ADHESION MOLECULE; CIRCULATORY HALF-LIFE; BOVINE LUTROPIN; AMINO-ACIDS; MANNOSE PHOSPHORYLATION; GALNAC-TRANSFERASE	A limited number of glycoproteins including luteinizing hormone and carbonic anhydrase-VI(CA6) bearN-linked oligosaccharides that are modified with beta 1,4-linked N-acetylgalactosamine ( GalNAc). The selective addition of GalNAc to these glycoproteins requires that the beta 1,4-N-acetylgalactosaminyl-transferase (beta GT) recognize both the oligosaccharide acceptor and a peptide recognition determinant on the substrate glycoprotein. We report here that two recently cloned beta GTs, beta GT3 and beta GT4, that are able to transfer GalNAc to GlcNAc in beta 1,4-linkage display the necessary glycoprotein specificity in vivo. Both beta GTs transfer GalNAc to N-linked oligosaccharides on the luteinizing hormone alpha subunit and CA6 but not to those on transferrin ( Trf). A single peptide recognition determinant encoded in the carboxyl-terminal 19-amino acid sequence of bovine CA6 mediates transfer of GalNAc to each of its two N-linked oligosaccharides. The addition of this 19-amino acid sequence to the carboxyl terminus of Trf confers full acceptor activity onto Trf for both beta GT3 and beta GT4 in vivo. The complete 19-amino acid sequence is required for optimal GalNAc addition in vivo, indicating that the peptide sequence is both necessary and sufficient for recognition by beta GT3 and beta GT4.	[Miller, Erin; Fiete, Dorothy; Blake, Nicquet M. J.; Beranek, Mary; Oates, Edward L.; Mi, Yiling; Roseman, Daniel S.; Baenziger, Jacques U.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Baenziger, JU (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 4940 Parkview Pl St, St Louis, MO 63110 USA.	Baenziger@wustl.edu	Baenziger, Jacques U/E-9430-2012		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041738] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD058474] Funding Source: Medline; NIDDK NIH HHS [R01-DK41738, R01 DK041738] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAENZIGER JU, 1992, P NATL ACAD SCI USA, V89, P334, DOI 10.1073/pnas.89.1.334; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; BARNES WM, 2003, PCR PRIMER LAB MANUA; CHENG S, 1994, P NATL ACAD SCI USA, V91, P5695, DOI 10.1073/pnas.91.12.5695; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; CHOU PY, 1989, PREDICTION PROTEIN S, P549; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Cuozzo JW, 1998, J BIOL CHEM, V273, P21067, DOI 10.1074/jbc.273.33.21067; DELL A, 1995, J BIOL CHEM, V270, P24116, DOI 10.1074/jbc.270.41.24116; DHARMESH SM, 1993, J BIOL CHEM, V268, P17096; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Fiete D, 2007, J BIOL CHEM, V282, P1873, DOI 10.1074/jbc.M606455200; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Gotoh M, 2004, FEBS LETT, V562, P134, DOI 10.1016/S0014-5793(04)00219-4; GREEN ED, 1985, J BIOL CHEM, V260, P5623; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hooper LV, 1996, FASEB J, V10, P1137, DOI 10.1096/fasebj.10.10.8751716; HOOPER LV, 1995, J BIOL CHEM, V270, P5985, DOI 10.1074/jbc.270.11.5985; Ikehara Y, 2006, GLYCOBIOLOGY, V16, P777, DOI 10.1093/glycob/cwl005; KORNFELD S, 1990, BIOCHEM SOC T, V18, P367, DOI 10.1042/bst0180367; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; Liu JX, 1997, GENE, V203, P141, DOI 10.1016/S0378-1119(97)00505-2; Liu JX, 1999, GENE, V237, P153, DOI 10.1016/S0378-1119(99)00314-5; Lorenz WW, 1996, J BIOLUM CHEMILUM, V11, P31, DOI 10.1002/(SICI)1099-1271(199601)11:1<31::AID-BIO398>3.0.CO;2-M; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Manzella SM, 1996, J BIOL CHEM, V271, P12117, DOI 10.1074/jbc.271.21.12117; Manzella SM, 1997, J BIOL CHEM, V272, P4775, DOI 10.1074/jbc.272.8.4775; Martinez-Pomares L, 1999, J BIOL CHEM, V274, P35211, DOI 10.1074/jbc.274.49.35211; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; MENGELING BJ, 1995, P NATL ACAD SCI USA, V92, P502, DOI 10.1073/pnas.92.2.502; MENGELING BJ, 1991, ANAL BIOCHEM, V199, P286, DOI 10.1016/0003-2697(91)90103-Z; Mi YL, 2002, J CLIN INVEST, V109, P269, DOI 10.1172/JCI13997; Nishikawa A, 1999, J BIOL CHEM, V274, P19309, DOI 10.1074/jbc.274.27.19309; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Sato T, 2003, J BIOL CHEM, V278, P47534, DOI 10.1074/jbc.M308857200; SKELTON TP, 1992, J BIOL CHEM, V267, P12998; SMITH PL, 1988, SCIENCE, V242, P930, DOI 10.1126/science.2460923; SMITH PL, 1992, J BIOL CHEM, V267, P19140; SMITH PL, 1990, J BIOL CHEM, V265, P874; SMITH PL, 1992, P NATL ACAD SCI USA, V89, P329, DOI 10.1073/pnas.89.1.329; SMITH PL, 1990, P NATL ACAD SCI USA, V87, P7275, DOI 10.1073/pnas.87.18.7275; Steet R, 2005, J BIOL CHEM, V280, P33318, DOI 10.1074/jbc.M505994200; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; TORRES BV, 1988, ARCH BIOCHEM BIOPHYS, V262, P1, DOI 10.1016/0003-9861(88)90161-0; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; Wally J, 2006, J BIOL CHEM, V281, P24934, DOI 10.1074/jbc.M604592200; Woodworth A, 2004, J BIOL CHEM, V279, P10413, DOI 10.1074/jbc.M312466200; WOODWORTH A, 2001, GLYCOBIOLOGY, V11; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X	51	21	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1985	1991		10.1074/jbc.M708160200	http://dx.doi.org/10.1074/jbc.M708160200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18048353	hybrid			2022-12-25	WOS:000252501000025
J	Carra, S; Seguin, SJ; Lambert, H; Landry, J				Carra, Serena; Seguin, Samuel J.; Lambert, Herman; Landry, Jacques			HspB8 chaperone activity toward poly(Q)-containing proteins depends on its association with Bag3, a stimulator of macroautophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; ALPHA-B-CRYSTALLIN; MOLECULAR CHAPERONES; MUTANT HUNTINGTIN; UBIQUITIN LIGASE; AUTOPHAGY; POLYGLUTAMINE; DEGRADATION; SUPPRESSION; TOXICITY	Mutations in HspB8, a member of the B group of heat shock proteins (Hsp), have been associated with human neuromuscular disorders. However, the exact function of HspB8 is not yet clear. We previously demonstrated that overexpression of HspB8 in cultured cells prevents the accumulation of aggregation-prone proteins such as the polyglutamine protein Htt43Q. Here we report that HspB8 forms a stable complex with Bag3 in cells and that the formation of this complex is essential for the activity of HspB8. Bag3 overexpression resulted in the accelerated degradation of Htt43Q, whereas Bag3 knockdown prevented HspB8-induced Htt43Q degradation. Additionally, depleting Bag3 caused a reduction in the endogenous levels of LC3-II, a key molecule involved in macroautophagy, whereas overexpressing Bag3 or HspB8 stimulated the formation LC3-II. These results suggested that the HspB8-Bag3 complex might stimulate the degradation of Htt43Q by macroautophagy. This was confirmed by the observation that treatments with macroautophagy inhibitors significantly decreased HspB8- and Bag3-induced degradation of Htt43Q. We conclude that the HspB8 activity is intrinsically dependent on Bag3, a protein that may facilitate the disposal of doomed proteins by stimulating macroautophagy.	[Landry, Jacques] Univ Laval, Ctr Rech Cancerol, Lhotel Dieu Quebec, Quebec City, PQ G1R 2J6, Canada; Univ Laval, Dept Med, Quebec City, PQ G1R 2J6, Canada	Laval University; Laval University	Landry, J (corresponding author), Univ Laval, Ctr Rech Cancerol, Lhotel Dieu Quebec, 9 Rue McMahon, Quebec City, PQ G1R 2J6, Canada.	jacques.landry@med.ulaval.ca	Carra, Serena/O-2835-2015	Carra, Serena/0000-0003-0939-0140				Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Benndorf R, 2004, NAT GENET, V36, P547, DOI 10.1038/ng0604-547; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bonini NM, 2002, P NATL ACAD SCI USA, V99, P16407, DOI 10.1073/pnas.152330499; Carra S, 2005, HUM MOL GENET, V14, P1659, DOI 10.1093/hmg/ddi174; Chowdary TK, 2004, BIOCHEM J, V381, P379, DOI 10.1042/BJ20031958; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Dai Q, 2005, J BIOL CHEM, V280, P38673, DOI 10.1074/jbc.M507986200; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; Lee GJ, 2000, PLANT PHYSIOL, V122, P189, DOI 10.1104/pp.122.1.189; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Pagliuca MG, 2003, FEBS LETT, V541, P11, DOI 10.1016/S0014-5793(03)00274-6; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Perng MD, 2004, MOL BIOL CELL, V15, P2335, DOI 10.1091/mbc.E03-12-0893; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zobel ATC, 2005, CELL STRESS CHAPERON, V10, P157, DOI 10.1379/CSC-102.1; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	50	258	262	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1437	1444		10.1074/jbc.M706304200	http://dx.doi.org/10.1074/jbc.M706304200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18006506	hybrid			2022-12-25	WOS:000252282700027
J	Fisher, LA; Bessho, M; Bessho, T				Fisher, Laura A.; Bessho, Mika; Bessho, Tadayoshi			Processing of a psoralen DNA interstrand cross-link by XPF-ERCC1 complex in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; HOMOLOGOUS RECOMBINATIONAL REPAIR; DOUBLE-STRAND BREAKS; ENDONUCLEASE ERCC1-XPF; MOLECULAR-MECHANISMS; CELLULAR-RESPONSES; MAMMALIAN-CELLS; FANCONI-ANEMIA; REPLICATION; NUCLEASE	The processing of stalled forks caused by DNA interstrand cross-links (ICLs) has been proposed to be an important step in initiating mammalian ICL repair. To investigate a role of the XPF-ERCC1 complex in this process, we designed a model substrate DNA with a single psoralen ICL at a three-way junction (Y-shaped DNA), which mimics a stalled fork structure. We found that the XPF-ERCC1 complex makes an incision 5' to a psoralen lesion on Y-shaped DNA in a damage-dependent manner. Furthermore, the XPF-ERCC1 complex generates an ICL-specific incision on the 3'-side of an ICL. The ICL-specific 3'-incision, along with the 5'-incision, on the cross-linked Y-shaped DNA resulted in the separation of the two cross-linked strands (the unhooking of the ICL) and the induction of a double strand break near the cross-linked site. These results implicate the XPF-ERCC1 complex in initiating ICL repair by unhooking the ICL, which simultaneously induces a double strand break at a stalled fork.	[Fisher, Laura A.; Bessho, Mika; Bessho, Tadayoshi] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Bessho, T (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, 986805 Nebraska Med Ctr, Omaha, NE 68198 USA.	tbessho@unmc.edu			NATIONAL CANCER INSTITUTE [R01CA095291, T32CA009476] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 95291, T32 CA 09476] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adair GR, 2000, EMBO J, V19, P5552, DOI 10.1093/emboj/19.20.5552; Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Bessho T, 2003, J BIOL CHEM, V278, P5250, DOI 10.1074/jbc.M212323200; Bessho T, 1997, MOL CELL BIOL, V17, P6822, DOI 10.1128/MCB.17.12.6822; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Cipak L, 2006, NAT STRUCT MOL BIOL, V13, P729, DOI 10.1038/nsmb1120; de Laat WL, 1998, J BIOL CHEM, V273, P7835, DOI 10.1074/jbc.273.14.7835; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Enzlin JH, 2002, EMBO J, V21, P2045, DOI 10.1093/emboj/21.8.2045; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Guzder SN, 2004, GENE DEV, V18, P2283, DOI 10.1101/gad.1232804; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200; McPherson JP, 2004, SCIENCE, V304, P1822, DOI 10.1126/science.1094557; Mu D, 2000, MOL CELL BIOL, V20, P2446, DOI 10.1128/MCB.20.7.2446-2454.2000; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Niedernhofer LJ, 2001, EMBO J, V20, P6540, DOI 10.1093/emboj/20.22.6540; Noll DM, 2006, CHEM REV, V106, P277, DOI 10.1021/cr040478b; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Scharer OD, 2005, CHEMBIOCHEM, V6, P27, DOI 10.1002/cbic.200400287; Thompson LH, 1996, MUTAT RES-DNA REPAIR, V363, P77, DOI 10.1016/0921-8777(96)00008-0; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159	30	54	57	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1275	1281		10.1074/jbc.M708072200	http://dx.doi.org/10.1074/jbc.M708072200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18006494	hybrid			2022-12-25	WOS:000252282700010
J	Kim, SY; Seo, M; Kim, Y; Lee, YI; Oh, JM; Cho, EA; Kang, JS; Juhnn, YS				Kim, So-Young; Seo, MiRan; Kim, Yeni; Lee, Yun-Il; Oh, Jung-Min; Cho, Eun-Ah; Kang, Jae-Seung; Juhnn, Yong-Sung			Stimulatory heterotrimeric GTP-binding protein inhibits hydrogen peroxide-induced apoptosis by repressing Bak induction in SH-SY5Y human neuroblastoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FENRETINIDE-INDUCED APOPTOSIS; ACTIVATED T-LYMPHOCYTES; NECROSIS-FACTOR-ALPHA; TRANSCRIPTION FACTORS; PROSTAGLANDIN E-2; OXIDATIVE STRESS; NUCLEAR-FACTOR; FAS LIGAND; EXPRESSION	Heterotrimeric stimulatory GTP-binding protein (Gs) stimulates adenylate cyclases to activate the cAMP signaling pathway. Although the cAMP pathway has been reported to be involved in apoptosis, the role of the G(s)-cAMP signaling pathway during reactive oxygen species (ROS)-mediated apoptosis, which is involved in the resistance of cancer cells to chemotherapy and radiation, is not clearly understood. Thus, in this study we aimed to investigate the role of the alpha subunit of G(s) (G alpha(s)) in the ROS-induced apoptosis of cancer cells. The stable expression of constitutively active G alpha(s)(G alpha(s)QL) inhibited the hydrogen peroxide-induced apoptosis of SH-SY5Y human neuroblastoma cells and reduced the hydrogen peroxide-induced increase in Bak and the decrease in Bcl-xL protein expression. Exogenous Bak expression abolished these inhibitory effects of G alpha(s)QL, but Bak small interfering RNA decreased hydrogen peroxide-induced apoptosis. G alpha(s) repressed hydrogen peroxide-induced Bak expression by inhibiting the transcription of Bak mRNA, which resulted from the inhibition of the hydrogen peroxide-induced activation of transcription factors such as AP1, NF-kappa B, and NFAT. Moreover, G alpha(s) also inhibited the hydrogen peroxide-induced binding of AP1, NF-kappa B, and NFAT to the Bak promoter. Furthermore, hydrogen peroxide-induced apoptosis was reduced by treating cells with prostaglandin E-2, which activates G alpha(s), but this was augmented by CCPA, which activates G alpha(i) causing a decrease in cAMP levels. From the results, we conclude that G alpha(s) protects neuroblastoma cells from hydrogen peroxide-induced apoptosis by repressing Bak induction, which is mediated by the inhibition of the hydrogen peroxide-induced activations of AP1, NF-kappa B, and NFAT through cAMP-PKA-CREB signaling system.	[Kim, So-Young; Seo, MiRan; Kim, Yeni; Lee, Yun-Il; Oh, Jung-Min; Cho, Eun-Ah; Juhnn, Yong-Sung] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Canc Res Inst, Seoul 110799, South Korea; [Kang, Jae-Seung] Inha Univ, Coll Med, Dept Microbiol, Inchon 402751, South Korea	Seoul National University (SNU); Inha University	Juhnn, YS (corresponding author), Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Canc Res Inst, 28 Yongon Dong, Seoul 110799, South Korea.	juhnn@snu.ac.kr	Juhnn, Yong-Sung/J-2790-2012; Oh, Jung-Min/ABF-5370-2021; Kang, Jae Seung/J-5363-2012	Oh, Jung-Min/0000-0003-0385-7168; 				Adams JW, 2001, ONCOGENE, V20, P1626, DOI 10.1038/sj.onc.1204275; Ahn YH, 2000, J NEUROSCI RES, V61, P508, DOI 10.1002/1097-4547(20000901)61:5<508::AID-JNR5>3.0.CO;2-V; Ballare E, 1998, J CLIN ENDOCR METAB, V83, P4386, DOI 10.1210/jc.83.12.4386; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BURDON RH, 1990, FREE RADICAL RES COM, V11, P65, DOI 10.3109/10715769009109669; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chow CW, 2000, MOL CELL BIOL, V20, P702, DOI 10.1128/MCB.20.2.702-712.2000; COLLART FR, 1995, RADIAT RES, V142, P188, DOI 10.2307/3579028; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Delgado M, 2001, J IMMUNOL, V166, P1028, DOI 10.4049/jimmunol.166.2.1028; Eliseev RA, 2004, J BIOL CHEM, V279, P46748, DOI 10.1074/jbc.M406217200; Farmer P, 2000, AM J PHYSIOL-LUNG C, V279, pL675, DOI 10.1152/ajplung.2000.279.4.L675; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gorman A, 1997, FEBS LETT, V404, P27, DOI 10.1016/S0014-5793(97)00069-0; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hewson QDC, 2005, APOPTOSIS, V10, P493, DOI 10.1007/s10495-005-1878-z; Holla VR, 2006, J BIOL CHEM, V281, P2676, DOI 10.1074/jbc.M507752200; Hongisto V, 2003, MOL CELL BIOL, V23, P6027, DOI 10.1128/MCB.23.17.6027-6036.2003; Hull MA, 2004, MOL CANCER THER, V3, P1031; HYRIEN O, 1989, NUCLEIC ACIDS RES, V17, P9557, DOI 10.1093/nar/17.23.9557; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jang IS, 2001, EXP MOL MED, V33, P37, DOI 10.1038/emm.2001.8; Jin HO, 2006, J CELL PHYSIOL, V206, P477, DOI 10.1002/jcp.20488; Kamata H, 1996, NEUROSCI LETT, V212, P179, DOI 10.1016/0304-3940(96)12806-8; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lewerenz J, 2003, J NEUROCHEM, V87, P522, DOI 10.1046/j.1471-4159.2003.02019.x; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Li XH, 1996, J NEUROSCI, V16, P5914; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Lovat PE, 2003, CANCER RES, V63, P7310; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Nicco C, 2005, BIOMED PHARMACOTHER, V59, P169, DOI 10.1016/j.biopha.2005.03.009; Parry GCN, 1997, J IMMUNOL, V159, P5450; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pohland T, 2006, ANTI-CANCER DRUG, V17, P471; Radhika V, 2001, ONCOGENE, V20, P1607, DOI 10.1038/sj.onc.1204274; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RAO GN, 1993, NUCLEIC ACIDS RES, V21, P1259, DOI 10.1093/nar/21.5.1259; RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; SATRIANO J, 1994, J CLIN INVEST, V94, P1629, DOI 10.1172/JCI117505; Schoemaker MH, 2002, J HEPATOL, V36, P742, DOI 10.1016/S0168-8278(02)00063-6; Seo MR, 2004, J BIOL CHEM, V279, P17366, DOI 10.1074/jbc.M312442200; Sheng HM, 1998, CANCER RES, V58, P362; Srivastava RK, 1999, J EXP MED, V190, P253, DOI 10.1084/jem.190.2.253; Suzuki Y, 1998, FEBS LETT, V425, P209, DOI 10.1016/S0014-5793(98)00228-2; Vollgraf U, 1999, J NEUROCHEM, V73, P2501, DOI 10.1046/j.1471-4159.1999.0732501.x; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; WU HY, 1994, J BIOL CHEM, V269, P20067; Yano T, 2005, AM J PATHOL, V166, P1333, DOI 10.1016/S0002-9440(10)62352-8; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367	55	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1350	1361		10.1074/jbc.M702344200	http://dx.doi.org/10.1074/jbc.M702344200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17991745	hybrid			2022-12-25	WOS:000252282700018
J	Oltmann-Norden, I; Galuska, SP; Hildebrandt, H; Geyer, R; Gerardy-Schahn, R; Geyer, H; Muhlenhoff, M				Oltmann-Norden, Imke; Galuska, Sebastian P.; Hildebrandt, Herbert; Geyer, Rudolf; Gerardy-Schahn, Rita; Geyer, Hildegard; Muehlenhoff, Martina			Impact of the polysialyltransferases ST8Siall and ST8SiaIV on polysialic acid synthesis during postnatal mouse brain development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; MICE DEFICIENT; EMBRYONIC FORM; MESSENGER-RNA; DENTATE GYRUS; PSA-NCAM; IN-VIVO; II STX; EXPRESSION; ADULT	Polysialic acid (polySia), a post-translational modification of the neural cell adhesion molecule (NCAM), is the key regulator of NCAM-mediated functions and crucial for normal brain development, postnatal growth, and survival. Two polysialyl-transferases, ST8SiaII and ST8SiaIV, mediate polySia biosynthesis. To dissect the impact of each enzyme during postnatal brain development, we monitored the developmental changes in NCAM polysialylation in wild-type, ST8SiaII-, and ST8SiaIV-deficient mice using whole brain lysates obtained at 10 time points from postnatal days 1 to 21 and from adult mice. In wildtype and ST8SiaIV- null brain, polySia biosynthesis kept pace with the rapid increase in brain weight until day 9, and nearly all NCAM was polysialylated. Thereafter, polySia dropped by similar to 70% within 1 week, accompanied by the first occurrence of polySia-free NCAM-140 and NCAM-180. In ST8SiaII-null brain, polySia declined immediately after birth, leading to 60% less polySia at day 9 combined with the untimely appearance of polySia-free NCAM. Polysialyltransferase deficiency did not alter NCAM expression level or isoform pattern. In all three genotypes, NCAM-140 and NCAM- 180 were expressed at constant levels from days 1 to 21 and provided the major polySia acceptors. By contrast, NCAM- 120 first appeared at day 5, followed by a strong up- regulation inverse to the decrease in polySia. Together, we provide a comprehensive quantitative analysis of the developmental changes in polySia level, NCAM polysialylation status, and polysialyltransferase transcript levels and show that the predominant role of ST8SiaII during postnatal brain development is restricted to the first 15 days.	[Oltmann-Norden, Imke; Hildebrandt, Herbert; Gerardy-Schahn, Rita; Muehlenhoff, Martina] Hannover Med Sch, Inst Cellular Chem, D-30625 Hannover, Germany; [Galuska, Sebastian P.; Geyer, Rudolf; Geyer, Hildegard] Univ Giessen, Fac Med, Inst Biochem, D-35392 Giessen, Germany	Hannover Medical School; Justus Liebig University Giessen	Muhlenhoff, M (corresponding author), Hannover Med Sch, Abt Zellulare Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	muehlenhoff.martina@mh-hannover.de	Hildebrandt, Herbert/A-7873-2010	Hildebrandt, Herbert/0000-0002-1044-0881				Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Angata K, 2007, MOL CELL BIOL, V27, P6659, DOI 10.1128/MCB.00205-07; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005.08.016; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A; Ben-Hur T, 1998, J NEUROSCI, V18, P5777, DOI 10.1523/jneurosci.18-15-05777.1998; BENJAMINS JA, 1972, BASIC NEUROCHEMISTRY, P269; BHAT S, 1988, J NEUROCHEM, V50, P1830, DOI 10.1111/j.1471-4159.1988.tb02485.x; BHAT S, 1986, J NEUROSCI, V6, P3348; Charles P, 2000, P NATL ACAD SCI USA, V97, P7585, DOI 10.1073/pnas.100076197; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Durbec P, 2001, MOL NEUROBIOL, V24, P53; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; EDELMAN GM, 1982, P NATL ACAD SCI-BIOL, V79, P7036, DOI 10.1073/pnas.79.22.7036; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Galuska SP, 2008, J BIOL CHEM, V283, P17, DOI 10.1074/jbc.M707024200; Galuska SP, 2006, J BIOL CHEM, V281, P31605, DOI 10.1074/jbc.M606516200; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hayrinen J, 2002, MOL IMMUNOL, V39, P399, DOI 10.1016/S0161-5890(02)00202-X; Hildebrandt H, 1998, J NEUROCHEM, V71, P2339; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; HIRN M, 1983, BRAIN RES, V265, P87, DOI 10.1016/0006-8993(83)91337-9; Inoue S, 2003, METHOD ENZYMOL, V362, P543; Inoue S, 2001, BIOCHIMIE, V83, P605, DOI 10.1016/S0300-9084(01)01307-4; Inoue S, 2001, J BIOL CHEM, V276, P31863, DOI 10.1074/jbc.M103336200; Jakovcevski I, 2007, NEUROSCIENCE, V149, P328, DOI 10.1016/j.neuroscience.2007.07.044; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; Kurosawa N, 1997, J NEUROCHEM, V69, P494; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; MARGOLIS RK, 1983, BIOCHEM BIOPH RES CO, V116, P889, DOI 10.1016/S0006-291X(83)80225-3; Markram K, 2007, NEUROSCIENCE, V144, P788, DOI 10.1016/j.neuroscience.2006.10.024; Maziade M, 2005, MOL PSYCHIATR, V10, P486, DOI 10.1038/sj.mp.4001594; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; Muhlenhoff M, 1996, CURR BIOL, V6, P1188, DOI 10.1016/S0960-9822(02)70687-8; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; Ni Dhuill CM, 1999, J NEUROSCI RES, V55, P99, DOI 10.1002/(SICI)1097-4547(19990101)55:1<99::AID-JNR11>3.0.CO;2-S; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; OUMESMAR BN, 1995, EUR J NEUROSCI, V7, P480, DOI 10.1111/j.1460-9568.1995.tb00344.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips GR, 1997, DEV BRAIN RES, V102, P143, DOI 10.1016/S0165-3806(97)00069-2; ROTHBARD JB, 1982, J BIOL CHEM, V257, P1064; Sato C, 1999, ANAL BIOCHEM, V266, P102, DOI 10.1006/abio.1998.2921; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; SEKI T, 1991, NEUROSCI RES, V12, P503, DOI 10.1016/S0168-0102(09)80003-5; Shen HM, 1997, J NEUROSCI, V17, P5221; Stoenica L, 2006, EUR J NEUROSCI, V23, P2255, DOI 10.1111/j.1460-9568.2006.04771.x; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Tao R, 2007, SCHIZOPHR RES, V90, P108, DOI 10.1016/j.schres.2006.09.029; Theodosis DT, 1999, J NEUROSCI, V19, P10228; THEODOSIS DT, 1991, P NATL ACAD SCI USA, V88, P5494, DOI 10.1073/pnas.88.13.5494; TROTTER J, 1989, J NEUROSCI RES, V22, P369, DOI 10.1002/jnr.490220402; UZMAN LL, 1958, J NEUROCHEM, V3, P170, DOI 10.1111/j.1471-4159.1958.tb12624.x; von der Ohe M, 2002, GLYCOBIOLOGY, V12, P47, DOI 10.1093/glycob/12.1.47; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Wood GK, 1997, MOL BRAIN RES, V51, P69, DOI 10.1016/S0169-328X(97)00209-X; Yamamoto N, 2000, J NEUROSCI, V20, P9145; YANG PF, 1994, J BIOL CHEM, V269, P23039	64	82	84	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1463	1471		10.1074/jbc.M708463200	http://dx.doi.org/10.1074/jbc.M708463200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18045870	hybrid			2022-12-25	WOS:000252282700030
J	Infante, RE; Radhakrishnan, A; Abi-Mosleh, L; Kinch, LN; Wang, ML; Grishin, NV; Goldstein, JL; Brown, MS				Infante, Rodney E.; Radhakrishnan, Arun; Abi-Mosleh, Lina; Kinch, Lisa N.; Wang, Michael L.; Grishin, Nick V.; Goldstein, Joseph L.; Brown, Michael S.			Purified NPC1 protein - II. Localization of sterol binding to a 240-amino acid soluble luminal loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; CLEAVAGE-ACTIVATING PROTEIN; HAMSTER OVARY CELLS; PICK C1 PROTEIN; SENSING DOMAIN; CHOLESTEROL HOMEOSTASIS; C2 DISEASE; ENDOPLASMIC-RETICULUM; DEFICIENT; MEMBRANE	Defects in Niemann-Pick, Type C-1 protein (NPC1) cause cholesterol, sphingolipids, phospholipids, and glycolipids to accumulate in lysosomes of liver, spleen, and brain. In cultured fibroblasts, NPC1 deficiency causes lysosomal retention of lipoprotein-derived cholesterol after uptake by receptor-mediated endocytosis. NPC1 contains 1278 amino acids that form 13 membrane-spanning helices and three large loops that project into the lumen of lysosomes. We showed earlier that NPC1 binds cholesterol and oxysterols. Here we localize the binding site to luminal loop-1, a 240-amino acid domain with 18 cysteines. When produced in cultured cells, luminal loop-1 was secreted as a soluble dimer. This loop bound [H-3] cholesterol (K-d, 130 nM) and [H-3] 25-hydroxycholesterol (25- HC, K-d, 10 nM) with one sterol binding site per dimer. Binding of both sterols was competed by oxysterols (24-, 25-, and 27-HC). Unlabeled cholesterol competed strongly for binding of [H-3] cholesterol, but weakly for [H-3] 25- HC binding. Binding of [ 3H] cholesterol but not [H-3] 25- HC was inhibited by detergents. We also studied NPC2, a soluble protein whose deficiency causes a similar disease phenotype. NPC2 bound cholesterol, but not oxysterols. Epicholesterol and cholesteryl sulfate competed for [H-3] cholesterol binding to NPC2, but not NPC1. Glutamine 79 in luminal loop-1 of NPC-1 is important for sterol binding; a Q79A mutation abolished binding of [H-3] cholesterol and [H-3] 25- HC to full-length NPC1. Nevertheless, the Q79A mutant restored cholesterol transport to NPC1-deficient Chinese hamster ovary cells. Thus, the sterol binding site on luminal loop-1 is not essential for NPC1 function in fibroblasts, but it may function in other cells where NPC1 deficiency produces more complicated lipid abnormalities.	[Infante, Rodney E.; Radhakrishnan, Arun; Abi-Mosleh, Lina; Wang, Michael L.; Goldstein, Joseph L.; Brown, Michael S.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldstein, JL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	joe.goldstein@utsouthwestern.edu; mike.brown@utsouthwestern.edu	Radhakrishnan, Arun/Q-7437-2019; Radhakrishnan, Arun/R-8440-2019; Infante, Rodney/ABG-7756-2020	Radhakrishnan, Arun/0000-0002-7266-7336; Radhakrishnan, Arun/0000-0001-8972-7086; Infante, Rodney/0000-0003-2605-822X; Kinch, Lisa/0000-0003-3041-2615	NHLBI NIH HHS [HL20948] Funding Source: Medline; NIGMS NIH HHS [5T32 GM08014, GM67165] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067165, T32GM008014] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; BRADY RO, 1978, ANNU REV BIOCHEM, V47, P687, DOI 10.1146/annurev.bi.47.070178.003351; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CADIGAN KM, 1988, J BIOL CHEM, V263, P274; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Cheruku SR, 2006, J BIOL CHEM, V281, P31594, DOI 10.1074/jbc.M602765200; Chikh K, 2004, MOL GENET METAB, V83, P220, DOI 10.1016/j.ymgme.2004.06.013; DAHL NK, 1992, J BIOL CHEM, V267, P4889; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Fisher LE, 2003, BIOPHYS J, V85, P3097, DOI 10.1016/S0006-3495(03)74728-6; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Goldstein JL, 2001, SCIENCE, V292, P1310, DOI 10.1126/science.1061815; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Ko DC, 2003, P NATL ACAD SCI USA, V100, P2518, DOI 10.1073/pnas.0530027100; Kolter T, 2006, BBA-BIOMEMBRANES, V1758, P2057, DOI 10.1016/j.bbamem.2006.05.027; Liou HL, 2006, J BIOL CHEM, V281, P36710, DOI 10.1074/jbc.M608743200; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Nohturfft A, 1998, P NATL ACAD SCI USA, V95, P12848, DOI 10.1073/pnas.95.22.12848; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Okamura N, 1999, BBA-MOL CELL BIOL L, V1438, P377, DOI 10.1016/S1388-1981(99)00070-0; Pentchev P. G., 1995, METABOLIC MOL BASES, P2625; Pentchev PG, 2004, BBA-MOL CELL BIOL L, V1685, P3, DOI 10.1016/j.bbalip.2004.08.005; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Scott C, 2004, BBA-MOL CELL BIOL L, V1685, P8, DOI 10.1016/j.bbalip.2004.08.006; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; TINOCO I, 1963, J CHEM PHYS, V38, P1117; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Watari H, 1999, J BIOL CHEM, V274, P21861, DOI 10.1074/jbc.274.31.21861; Xie CL, 2000, J NEUROPATH EXP NEUR, V59, P1106, DOI 10.1093/jnen/59.12.1106; Xu S, 2007, J BIOL CHEM, V282, P23525, DOI 10.1074/jbc.M703848200	42	179	180	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1064	1075		10.1074/jbc.M707944200	http://dx.doi.org/10.1074/jbc.M707944200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17989072	hybrid			2022-12-25	WOS:000252128100046
J	Zaru, R; Mollahan, P; Watts, C				Zaru, Rossana; Mollahan, Pamela; Watts, Colin			3-phosphoinositide-dependent kinase 1 deficiency perturbs toll-like receptor signaling events and actin cytoskeleton dynamics in dendritic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO ROLE; DOCKING SITE; PHOSPHOINOSITIDE 3-KINASE; GLYCOGEN-SYNTHASE; C-EPSILON; PDK1; PHOSPHORYLATION; PHAGOCYTOSIS; MACROPINOCYTOSIS; COMPLEX	The adaptive immune response depends on dendritic cell (DC) activation by microbial products that signal via pattern recognition receptors and activate mitogen-activated protein kinases, NF kappa B and PI3K. The contribution of the AGC kinase family, including protein kinase B, protein kinase C, p90kDa ribosomal S6 kinase, and S6 kinase, has been little investigated because the probable redundancy among their isoforms makes their study difficult. We took advantage of the fact that all these kinases are regulated by the upstream master kinase 3-phosphoinositide-dependent kinase 1 (PDK1). Here we analyze various properties of DC from mice expressing similar to 10% of normal PDK1 (PDK1(fl/-)). DC populations in lymphoid and nonlymphoid tissues appeared normal in PDK1(fl/-) mice, and some in vitro responses to lipopolysaccharide (LPS) such as cytokine production were normal in cultured bone marrow DC. However, LPS-induced expression of class II major histocompatibility complex and CD86 were elevated in PDK1(fl/-) BMDC and PDK1(fl/-) spleen DC produced more interleukin-10 and-12, implying an attenuating role for PDK1. Unexpectedly, PDK1(fl/-) DC had a significantly reduced capacity for LPS-stimulated macropinocytosis and phagocytosis that correlated with a lowered F-actin/G-actin ratio, apparently because of increased actin depolymerization. Several PDK1-regulated kinases, some of which feed into actin regulators, showed reduced activation in PDK1(fl/-) DC. Reintroduction of PDK1 restored S6 kinase activity, increased levels of F-actin, and boosted macropinocytosis thus linking PDK1 and its downstream effectors to the unusual phenotype of PDK1(fl/-) DC.	[Zaru, Rossana; Mollahan, Pamela; Watts, Colin] Univ Dundee, Wellcome Trust Bioctr, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland	University of Dundee	Watts, C (corresponding author), Univ Dundee, Wellcome Trust Bioctr, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland.	c.watts@dundee.ac.uk		Zaru, Rossana/0000-0002-3358-4423; Watts, Colin/0000-0001-6183-2087	Medical Research Council [G0100536] Funding Source: Medline; MRC [G0100536] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aksoy E, 2004, INT J BIOCHEM CELL B, V36, P183, DOI 10.1016/S1357-2725(03)00210-3; Aksoy E, 2002, EUR J IMMUNOL, V32, P3040, DOI 10.1002/1521-4141(200211)32:11<3040::AID-IMMU3040>3.0.CO;2-M; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Balendran A, 2000, FEBS LETT, V484, P217, DOI 10.1016/S0014-5793(00)02162-1; Balendran A, 2000, J BIOL CHEM, V275, P20806, DOI 10.1074/jbc.M000421200; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Burns S, 2004, CELL MOTIL CYTOSKEL, V57, P118, DOI 10.1002/cm.10163; Cantrell D, 2002, SEMIN IMMUNOL, V14, P19, DOI 10.1006/smim.2001.0338; Collins BJ, 2003, EMBO J, V22, P4202, DOI 10.1093/emboj/cdg407; Dormann D, 2004, J CELL SCI, V117, P6497, DOI 10.1242/jcs.01579; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Fairchild PJ, 2000, CURR BIOL, V10, P1515, DOI 10.1016/S0960-9822(00)00824-1; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Ganesan LP, 2004, J BIOL CHEM, V279, P54416, DOI 10.1074/jbc.M408188200; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Hinton HJ, 2004, NAT IMMUNOL, V5, P539, DOI 10.1038/ni1062; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Larsen EC, 2000, J IMMUNOL, V165, P2809, DOI 10.4049/jimmunol.165.5.2809; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Marshall JG, 2001, J CELL BIOL, V153, P1369, DOI 10.1083/jcb.153.7.1369; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; McManus EJ, 2004, EMBO J, V23, P2071, DOI 10.1038/sj.emboj.7600218; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Mora A, 2005, FEBS LETT, V579, P3632, DOI 10.1016/j.febslet.2005.05.040; Mora A, 2005, BIOCHEM J, V385, P639, DOI 10.1042/BJ20041782; Moss CX, 2005, J BIOL CHEM, V280, P18498, DOI 10.1074/jbc.M501241200; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nirula A, 2006, J EXP MED, V203, P1733, DOI 10.1084/jem.20051715; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rodionova E, 2007, BLOOD, V109, P1584, DOI 10.1182/blood-2006-06-028951; Rupper A, 2001, MOL BIOL CELL, V12, P2813, DOI 10.1091/mbc.12.9.2813; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sandu C, 2006, AM J PHYSIOL-GASTR L, V291, pG868, DOI 10.1152/ajpgi.00023.2006; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tan SL, 2003, BIOCHEM J, V376, P545, DOI 10.1042/BJ20031406; Tigges U, 2003, J BIOL CHEM, V278, P23561, DOI 10.1074/jbc.M302302200; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Zaru R, 2007, NAT IMMUNOL, V8, P1227, DOI 10.1038/ni1517	58	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					929	939		10.1074/jbc.M708069200	http://dx.doi.org/10.1074/jbc.M708069200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17991746	hybrid			2022-12-25	WOS:000252128100033
J	Shultzaberger, RK; Chiang, DY; Moses, AM; Eisen, MB				Shultzaberger, Ryan K.; Chiang, Derek Y.; Moses, Alan M.; Eisen, Michael B.			Determining Physical Constraints in Transcriptional Initiation Complexes Using DNA Sequence Analysis	PLOS ONE			English	Article								Eukaryotic gene expression is often under the control of cooperatively acting transcription factors whose binding is limited by structural constraints. By determining these structural constraints, we can understand the "rules'' that define functional cooperativity. Conversely, by understanding the rules of binding, we can infer structural characteristics. We have developed an information theory based method for approximating the physical limitations of cooperative interactions by comparing sequence analysis to microarray expression data. When applied to the coordinated binding of the sulfur amino acid regulatory protein Met4 by Cbf1 and Met31, we were able to create a combinatorial model that can correctly identify Met4 regulated genes. Interestingly, we found that the major determinant of Met4 regulation was the sum of the strength of the Cbf1 and Met31 binding sites and that the energetic costs associated with spacing appeared to be minimal.	[Shultzaberger, Ryan K.; Chiang, Derek Y.; Eisen, Michael B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Moses, Alan M.] Univ Calif Berkeley, Grad Grp Biophys, Berkeley, CA 94720 USA; [Eisen, Michael B.] Ernest Orlando Lawrence Berkeley Natl Lab, Genom Div, Dept Genome Sci, Berkeley, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Eisen, MB (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mbeisen@lbl.gov	Chiang, Derek/L-6452-2019	Eisen, Michael/0000-0002-7528-738X	U.S. Department of Energy [DE-AC02-05CH11231]; NIH [RHG002779A]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002779] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Director, Office of Science, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231 and NIH grant # RHG002779A.	Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Blaiseau PL, 1998, EMBO J, V17, P6327, DOI 10.1093/emboj/17.21.6327; Blaiseau PL, 1997, MOL CELL BIOL, V17, P3640, DOI 10.1128/MCB.17.7.3640; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; Chiang DY, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-16; Chiang DY, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r43; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fauchon M, 2002, MOL CELL, V9, P713, DOI 10.1016/S1097-2765(02)00500-2; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GuhaThakurta D, 2001, BIOINFORMATICS, V17, P608, DOI 10.1093/bioinformatics/17.7.608; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Kent NA, 2004, J BIOL CHEM, V279, P27116, DOI 10.1074/jbc.M403818200; Kuras L, 1997, EMBO J, V16, P2441, DOI 10.1093/emboj/16.9.2441; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Lehman AM, 1998, J BIOL CHEM, V273, P932, DOI 10.1074/jbc.273.2.932; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; NIEDENTHAL RK, 1993, NUCLEIC ACIDS RES, V21, P4726, DOI 10.1093/nar/21.20.4726; RINKEAPPEL J, 1994, NUCLEIC ACIDS RES, V22, P3018, DOI 10.1093/nar/22.15.3018; Schneider TD, 1997, J THEOR BIOL, V189, P427, DOI 10.1006/jtbi.1997.0540; Schneider TD, 1996, METHOD ENZYMOL, V274, P445; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schneider TD, 2001, NUCLEIC ACIDS RES, V29, P4881, DOI 10.1093/nar/29.23.4881; SCHNEIDER TD, 1991, J THEOR BIOL, V148, P125, DOI 10.1016/S0022-5193(05)80467-9; Schneider TD, 2000, NUCLEIC ACIDS RES, V28, P2794, DOI 10.1093/nar/28.14.2794; Shultzaberger RK, 2001, J MOL BIOL, V313, P215, DOI 10.1006/jmbi.2001.5040; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P5275, DOI 10.1093/nar/gkm471; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P771, DOI 10.1093/nar/gkl956; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THOMAS D, 1992, MOL CELL BIOL, V12, P1719, DOI 10.1128/MCB.12.4.1719; Tribus M., 1961, THERMOSTATICS THERMO; Udalova IA, 2002, P NATL ACAD SCI USA, V99, P8167, DOI 10.1073/pnas.102674699; Wieland G, 2001, NUCLEIC ACIDS RES, V29, P1054, DOI 10.1093/nar/29.5.1054	36	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1199	10.1371/journal.pone.0001199	http://dx.doi.org/10.1371/journal.pone.0001199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030333	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459200012
J	Colzato, LS; van den Wildenberg, WPM; Hommel, B				Colzato, Lorenza S.; van den Wildenberg, Wery P. M.; Hommel, Bernhard			Impaired Inhibitory Control in Recreational Cocaine Users	PLOS ONE			English	Article								Chronic use of cocaine is associated with impairment in response inhibition but it is an open question whether and to which degree findings from chronic users generalize to the upcoming type of recreational users. This study compared the ability to inhibit and execute behavioral responses in adult recreational users and in a cocaine-free-matched sample controlled for age, race, gender distribution, level of intelligence, and alcohol consumption. Response inhibition and response execution were measured by a stop-signal paradigm. Results show that users and non users are comparable in terms of response execution but users need significantly more time to inhibit responses to stop-signals than non users. Interestingly, the magnitude of the inhibitory deficit was positively correlated with the individuals lifetime cocaine exposure suggesting that the magnitude of the impairment is proportional to the degree of cocaine consumed.	[Colzato, Lorenza S.; Hommel, Bernhard] Leiden Univ, Inst Psychol Res, Leiden, Netherlands; [Colzato, Lorenza S.; Hommel, Bernhard] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [van den Wildenberg, Wery P. M.] Univ Amsterdam, Amsterdam Ctr Study Adapt Control Brain & Behav A, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam	Colzato, LS (corresponding author), Leiden Univ, Inst Psychol Res, Leiden, Netherlands.	colzato@fsw.leidenuniv.nl	Colzato, Lorenza S/H-6296-2013; Hommel, Bernhard/F-8173-2010	Hommel, Bernhard/0000-0003-4731-5125; Colzato, Lorenza/0000-0003-1735-1280	NWO	NWO(Netherlands Organization for Scientific Research (NWO))	The research of WVDW is supported by NWO (Netherlands Organisation for Scientific Research).	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; ARDILA A, 1991, INT J NEUROSCI, V57, P73, DOI 10.3109/00207459109150348; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Biggins CA, 1997, BIOL PSYCHIAT, V42, P472, DOI 10.1016/S0006-3223(96)00425-8; Bolla K, 2004, J NEUROPSYCH CLIN N, V16, P456, DOI 10.1176/appi.neuropsych.16.4.456; Bolla KI, 1998, J NEUROPSYCH CLIN N, V10, P280, DOI 10.1176/jnp.10.3.280; Colzato LS, 2005, EUR J NEUROSCI, V21, P591, DOI 10.1111/j.1460-9568.2005.03868.x; Colzato LS, 2004, NEUROSCI LETT, V360, P103, DOI 10.1016/j.neulet.2004.01.054; European Monitoring Centre for Drugs and Drug Addiction, 2003, STAT DRUGS PROBL EUR; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; Hershey T, 2004, COGNITIVE BRAIN RES, V20, P438, DOI 10.1016/j.cogbrainres.2004.03.018; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Jovanovski D, 2005, J CLIN EXP NEUROPSYC, V27, P189, DOI 10.1080/13803390490515694; Kubler A, 2005, EUR J NEUROSCI, V21, P1984, DOI 10.1111/j.1460-9568.2005.04027.x; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li CSR, 2006, DRUG ALCOHOL DEPEN, V85, P205, DOI 10.1016/j.drugalcdep.2006.04.008; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Logan Gordon D., 1994, P189; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Monterosso J, 2001, ADDICTION, V96, P1825, DOI 10.1046/j.1360-0443.2001.9612182512.x; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; Raven JC, 1988, MANUAL RAVENS PROGR; Rosenberg DR, 1997, J PSYCHIATR NEUROSCI, V22, P29; SCHACHAR R, 1990, DEV PSYCHOL, V26, P710, DOI 10.1037/0012-1649.26.5.710; Thoma P, 2007, SCHIZOPHR RES, V92, P168, DOI 10.1016/j.schres.2007.02.004; van den Wildenberg WPM, 2006, J COGNITIVE NEUROSCI, V18, P626, DOI 10.1162/jocn.2006.18.4.626; Verdejo-Garcia AJ, 2005, ADDICT BEHAV, V30, P89, DOI 10.1016/j.addbeh.2004.04.015; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Volkow ND, 1999, J PSYCHOPHARMACOL, V13, P337, DOI 10.1177/026988119901300406; von Geusau NA, 2004, PSYCHOPHARMACOLOGY, V175, P331, DOI 10.1007/s00213-004-1832-8	36	113	113	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1143	10.1371/journal.pone.0001143	http://dx.doi.org/10.1371/journal.pone.0001143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17989775	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459000026
J	Omerovic, J; Hammond, DE; Clague, MJ; Prior, IA				Omerovic, J.; Hammond, D. E.; Clague, M. J.; Prior, I. A.			Ras isoform abundance and signalling in human cancer cell lines	ONCOGENE			English	Article						Ras; siRNA; Akt; HGF; EGF	K-RAS; GROWTH-FACTOR; H-RAS; N-RAS; CARCINOMA-CELLS; ERK ACTIVITY; PROLIFERATION; ACTIVATION; PROTEINS; PATHWAY	The ubiquitously expressed major Ras isoforms: H-, K- and N-Ras, are highly conserved, yet exhibit different biological outputs. We have compared the relative efficiencies with which epidermal or hepatocyte growth factor activates Ras isoforms and the requirement for specific isoforms in the activation of downstream pathways. We find that the relative coupling efficiencies to each Ras isoform are conserved between stimuli. Furthermore, in both cases, inhibition of receptor endocytosis led to reduced N- and H- Ras activation, but K- Ras was unaffected. Acute knockdown of each isoform with siRNA allows endogenous Ras isoform function and abundance to be probed. This revealed that there is significant variation in the contribution of individual isoforms to total Ras across a panel of cancer cell lines although typically K >= N >= H. Intriguingly, cancer cell lines where a significant fraction of endogenous Ras is oncogenically mutated showed attenuated activation of canonical Ras effector pathways. We pro. led the contribution of each Ras isoform to the total Ras pool allowing interpretation of the effect of isoform-specific knockdown on signalling outcomes. In contrast to previous studies indicating preferential coupling of isoforms to Raf and PtdIns-3-kinase pathways, we find that endogenous Ras isoforms show no specific coupling to these major Ras pathways.	[Omerovic, J.; Hammond, D. E.; Clague, M. J.; Prior, I. A.] Univ Liverpool, Dept Physiol, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Prior, IA (corresponding author), Univ Liverpool, Dept Physiol, Crown St,POB 147, Liverpool L69 3BX, Merseyside, England.	iprior@liverpool.ac.uk	Clague, Michael J/A-7199-2008; Omerovic, Jasminka/D-4998-2017	Clague, Michael J/0000-0003-3355-9479; Hammond, Dean/0000-0002-6326-8739; Prior, Ian/0000-0002-4055-5161	Cancer Research UK [A6672] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BOS JL, 1989, CANCER RES, V49, P4682; Chen G, 1996, J BIOL CHEM, V271, P28259, DOI 10.1074/jbc.271.45.28259; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; ELHASHIR SM, 2001, NATURE, V411, P494; Fridman M, 2000, J BIOL CHEM, V275, P30363, DOI 10.1074/jbc.M003193200; Giehl K, 2000, ONCOGENE, V19, P2930, DOI 10.1038/sj.onc.1203612; HAIGLER H, 1978, P NATL ACAD SCI USA, V75, P3317, DOI 10.1073/pnas.75.7.3317; Hammond DE, 2003, MOL BIOL CELL, V14, P1346, DOI 10.1091/mbc.E02-09-0578; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Iida M, 1999, LEUKEMIA, V13, P585, DOI 10.1038/sj.leu.2401369; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Mitin NY, 2004, J BIOL CHEM, V279, P22353, DOI 10.1074/jbc.M312867200; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Roy S, 2002, MOL CELL BIOL, V22, P5128, DOI 10.1128/MCB.22.14.5128-5140.2002; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; *SANG, DAT WAS OBT WELLC TR; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Seufferlein T, 1999, GASTROENTEROLOGY, V116, P1441, DOI 10.1016/S0016-5085(99)70509-3; Sharpe CC, 2000, J AM SOC NEPHROL, V11, P1600, DOI 10.1681/ASN.V1191600; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; VIERA AV, 1996, SCIENCE, V274, P2086; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Vos MD, 2003, J BIOL CHEM, V278, P28045, DOI 10.1074/jbc.M300554200; Walsh AB, 2001, J BIOL CHEM, V276, P15609, DOI 10.1074/jbc.M010573200; WITTINGHOFER A, 1995, FEBS LETT, V369, P52, DOI 10.1016/0014-5793(95)00667-X; Wolfman JC, 2000, J BIOL CHEM, V275, P19315, DOI 10.1074/jbc.M000250200; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Yip-Schneider MT, 1999, INT J ONCOL, V15, P271; Yip-Schneider MT, 2001, BIOCHEM BIOPH RES CO, V280, P992, DOI 10.1006/bbrc.2001.4243	34	73	75	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 24	2008	27	19					2754	2762		10.1038/sj.onc.1210925	http://dx.doi.org/10.1038/sj.onc.1210925			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	292IK	17998936	Green Accepted			2022-12-25	WOS:000255259500010
J	Martinez, I; Gardiner, AS; Board, KF; Monzon, FA; Edwards, RP; Khan, SA				Martinez, I.; Gardiner, A. S.; Board, K. F.; Monzon, F. A.; Edwards, R. P.; Khan, S. A.			Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells	ONCOGENE			English	Article						HPVs; microRNA; cervical cancer; oncogene	TUMOR-SUPPRESSOR; GENE-EXPRESSION; GENOMIC INSTABILITY; CANCER; LAMININ-5; P53; E6; PROTEIN; HPV; E7	Human papillomaviruses (HPVs) are involved in the pathogenesis of cancer of the cervix (CaCx). MicroRNA (miRNA) expression analysis using Ambion (Austin, TX, USA) arrays showed that three miRNAs were over-expressed and 24 underexpressed in cervical cell lines containing integrated HPV-16 DNA compared to the normal cervix. Furthermore, nine miRNAs were overexpressed and one underexpressed in integrated HPV-16 cell lines compared to the HPV-negative CaCx cell line C-33A. Based on microarray and/or quantitative realtime PCR and northern blot analyses, microRNA-218 (miR-218) was specifically underexpressed in HPV-positive cell lines, cervical lesions and cancer tissues containing HPV-16 DNA compared to both C-33A and the normal cervix. Expression of the E6 oncogene of high-risk HPV-16, but not that of low-risk HPV-6, reduced miR-218 expression, and conversely, RNA interference of E6/E7 oncogenes in an HPV-16-positive cell line increased miR-218 expression. We also demonstrate that the epithelial cell-specific marker LAMB3 is a target of miR-218. We also show that LAMB3 expression is increased in the presence of the HPV-16 E6 oncogene and this effect is mediated through miR-218. These findings may contribute to a better understanding of the molecular mechanisms involved in cervical carcinogenesis.	[Martinez, I.; Gardiner, A. S.; Board, K. F.; Khan, S. A.] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA; [Monzon, F. A.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; [Monzon, F. A.] Univ Pittsburgh, Sch Med, Ctr Pathol Informat, Pittsburgh, PA 15261 USA; [Edwards, R. P.] Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Khan, SA (corresponding author), Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Room E 1240 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	khan@pitt.edu		Gardiner, Amy S./0000-0002-8179-4919	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F31DE019028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065100] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC016406] Funding Source: Medline; NIDCR NIH HHS [F31 DE019028, F31 DE019028-01A1, DE019028] Funding Source: Medline; NIGMS NIH HHS [5T32GM065100, T32 GM065100] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alazawi W, 2002, CANCER RES, V62, P6959; BAND V, 1993, EMBO J, V12, P1847, DOI 10.1002/j.1460-2075.1993.tb05833.x; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Calaluce R, 2004, NEOPLASIA, V6, P468, DOI 10.1593/neo.03499; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Culp TD, 2006, J VIROL, V80, P8940, DOI 10.1128/JVI.00724-06; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Dallol A, 2002, CANCER RES, V62, P5874; Duensing S, 2000, P NATL ACAD SCI USA, V97, P10002, DOI 10.1073/pnas.170093297; Gardiol D, 1999, ONCOGENE, V18, P5487, DOI 10.1038/sj.onc.1202920; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hebner CM, 2006, REV MED VIROL, V16, P83, DOI 10.1002/rmv.488; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Jiang M, 2002, ONCOGENE, V21, P6041, DOI 10.1038/sj.onc.1205878; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kohlberger P, 2003, GYNECOL ONCOL, V89, P391, DOI 10.1016/S0090-8258(03)00086-6; LECHNER MS, 1992, EMBO J, V11, P3045, DOI 10.1002/j.1460-2075.1992.tb05375.x; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANOS MM, 1994, J INFECT DIS, V170, P1096, DOI 10.1093/infdis/170.5.1096; Martinez I, 2007, EUR J CANCER, V43, P415, DOI 10.1016/j.ejca.2006.09.001; Massimi P, 1996, ONCOGENE, V12, P2325; Meissner JD, 1999, J GEN VIROL, V80, P1725, DOI 10.1099/0022-1317-80-7-1725; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Piboonniyom SO, 2003, CANCER RES, V63, P476; Skyldberg B, 1999, J NATL CANCER I, V91, P1882, DOI 10.1093/jnci/91.21.1882; STANLEY MA, 1989, INT J CANCER, V43, P672, DOI 10.1002/ijc.2910430422; Tang S, 2006, J VIROL, V80, P4249, DOI 10.1128/JVI.80.9.4249-4263.2006; Thomas M, 1999, ONCOGENE, V18, P7690, DOI 10.1038/sj.onc.1202953; Xi YG, 2006, CLIN CANCER RES, V12, P2014, DOI 10.1158/1078-0432.CCR-05-1853; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	33	276	306	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2008	27	18					2575	2582		10.1038/sj.onc.1210919	http://dx.doi.org/10.1038/sj.onc.1210919			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	289LW	17998940	Green Accepted, Bronze			2022-12-25	WOS:000255057000007
J	Schubert, M; Drephal, C; Albrecht, D				Schubert, Mania; Drephal, Christian; Albrecht, Doris			Gender-dependent ATPA-induced changes in long-term potentiation in the rat lateral amygdala	FASEB JOURNAL			English	Article						lateral nucleus of the amygdala; high-frequency stimulation; UBP296; SKF 86002; horizontal brain slice	ACTIVATED PROTEIN-KINASE; KAINATE RECEPTORS; SYNAPTIC-TRANSMISSION; BASOLATERAL AMYGDALA; MAP KINASE; HORIZONTAL SLICES; IN-VITRO; GLUR5; PLASTICITY; NEURONS	There is increasing evidence that kainate receptors contribute to both postsynaptic and presynaptic signaling not only in the hippocampus but also in the amygdala. The present study demonstrates that low concentrations of the specific kainate GLU(K5) receptor agonist, ATPA, depressed baseline activity in the lateral nucleus of the rat amygdala (LA), induced by stimulation of external capsule fibers or by intranuclear stimulation in. horizontal brain slices. ATPA reduced high-frequency-induced long-term potentiation (LTP) in males while it enhanced LTP in females during certain phases of the estrus cycle. In untreated slices from females, LA-LTP differed depending on the phase of the estrus cycle. In addition, we show for the first time that the p38 mitogen-activated protein (MAP) kinase inhibitor, SKF 86002, reduced LA-LTP. In males, the effects of ATPA and SKF 86002 were not additive. To the contrary, in females, the exposure to ATPA in control plus SKF 86002 increases LTP relative to control plus SKF 86002 alone. Thus, we demonstrate that the effectiveness of GLU(K5) stimulation on plasticity changes in the amygdala is gender-dependent and that the MAP kinase pathway might be involved in males.	[Albrecht, Doris] Charite, Inst Neurophysiol, CCM, D-10117 Berlin, Germany; [Schubert, Mania] Univ Auckland, Fac Med & Hlth Sci, Dept Physiol, Auckland 1, New Zealand; [Drephal, Christian] Ev Krankenhaus Bielefeld, Med Klin, Bielefeld, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Auckland	Albrecht, D (corresponding author), Charite, Inst Neurophysiol, CCM, Tucholskystr 2, D-10117 Berlin, Germany.	doris.albrecht@charite.de	Schubert, Manja/AAJ-9575-2021	Schubert, Manja/0000-0003-3592-2470				Aroniadou-Anderjaska V, 2007, AMINO ACIDS, V32, P305, DOI 10.1007/s00726-006-0415-x; Bi RF, 2001, P NATL ACAD SCI USA, V98, P13391, DOI 10.1073/pnas.241507698; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Braga MFM, 2003, J NEUROSCI, V23, P442, DOI 10.1523/JNEUROSCI.23-02-00442.2003; Christensen J, 2005, EPILEPSIA, V46, P956, DOI 10.1111/j.1528-1167.2005.51204.x; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Cui CH, 1999, J NEUROSCI, V19, P8281; Doyere V, 2003, EUR J NEUROSCI, V17, P2703, DOI 10.1046/j.1460-9568.2003.02707.x; Drephal C, 2006, NEUROBIOL LEARN MEM, V85, P272, DOI 10.1016/j.nlm.2005.11.004; FERKING M, 2000, CURR OPIN NEUROBIOL, V10, P342; Fuller G, 2001, MOL BRAIN RES, V89, P126, DOI 10.1016/S0169-328X(01)00071-7; Galanopoulou AS, 2003, NEUROSCI LETT, V342, P201, DOI 10.1016/S0304-3940(03)00282-9; Good M, 1999, EUR J NEUROSCI, V11, P4476, DOI 10.1046/j.1460-9568.1999.00920.x; Gryder DS, 2003, J NEUROSCI, V23, P7069, DOI 10.1523/JNEUROSCI.23-18-07069.2003; Gu Q, 1996, J NEUROSCI, V16, P3620; Heinbockel T, 2000, J NEUROSCI, V20; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; Huettner JE, 2003, PROG NEUROBIOL, V70, P387, DOI 10.1016/S0301-0082(03)00122-9; Kaschel T, 2004, SYNAPSE, V53, P141, DOI 10.1002/syn.20045; Li H, 1998, NEUROPHARMACOLOGY, V37, P1279, DOI 10.1016/S0028-3908(98)00109-9; Li H, 2001, NAT NEUROSCI, V4, P612, DOI 10.1038/88432; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; More JCA, 2004, NEUROPHARMACOLOGY, V47, P46, DOI 10.1016/j.neuropharm.2004.03.005; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Palomero-Gallagher N, 2003, J COMP NEUROL, V459, P468, DOI 10.1002/cne.10638; Paternain AV, 2000, J NEUROSCI, V20, P196, DOI 10.1523/JNEUROSCI.20-01-00196.2000; Pozzo-Miller LD, 1999, J NEUROPHYSIOL, V81, P1404, DOI 10.1152/jn.1999.81.3.1404; Rogawski MA, 2003, ANN NY ACAD SCI, V985, P150; Romeo RD, 2005, NEUROENDOCRINOLOGY, V81, P391, DOI 10.1159/000089557; Schafe GE, 2000, J NEUROSCI, V20, P8177; SCHUBERT M, 2008, IN PRESS NEUROPSYCHO; Smolders I, 2002, NAT NEUROSCI, V5, P796, DOI 10.1038/nn880; Szymczak S, 2006, HIPPOCAMPUS, V16, P453, DOI 10.1002/hipo.20172; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8; von Bohlen und Halbach O, 2002, NEUROSCI RES, V44, P91, DOI 10.1016/S0168-0102(02)00092-5; von Bohlen und Halbach O, 1998, J NEUROSCI METH, V81, P169, DOI 10.1016/S0165-0270(98)00026-0; Warren SG, 1995, BRAIN RES, V703, P26, DOI 10.1016/0006-8993(95)01059-9; WATANABE Y, 1995, NEUROSCI RES, V21, P317, DOI 10.1016/0168-0102(94)00867-F; Woolley CS, 2000, EPILEPSIA, V41, P510, DOI 10.1111/j.1528-1157.2000.tb00203.x	41	2	2	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2008	22	4					1268	1274		10.1096/fj.07-9415com	http://dx.doi.org/10.1096/fj.07-9415com			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	18024837				2022-12-25	WOS:000254581000031
J	Le Saux, CJ; Teeters, K; Miyasato, SK; Hoffmann, PR; Bollt, O; Douet, V; Shohet, RV; Broide, DH; Tam, EK				Le Saux, Claude Jourdan; Teeters, Kelsa; Miyasato, Shelley K.; Hoffmann, Peter R.; Bollt, Oana; Douet, Vanessa; Shohet, Ralph V.; Broide, David H.; Tam, Elizabeth K.			Down-regulation of caveolin-1, an inhibitor of transforming growth factor-beta signaling, in acute allergen-induced airway remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX PROTEINS; BRONCHOALVEOLAR LAVAGE FLUID; HUMAN LUNG FIBROBLASTS; NITRIC-OXIDE SYNTHASE; TGF-BETA; GENE-TRANSCRIPTION; SKIN FIBROBLASTS; MESSENGER-RNA; II RECEPTOR; MOUSE MODEL	Asthma can progress to subepithelial airway fibrosis, mediated in large part by transforming growth factor-beta(TGF-beta). The scaffolding protein caveolin-1 (cav1) can inhibit the activity of TGF-beta, perhaps by forming membrane invaginations that enfold TGF-beta receptors. The study goals were 1) to evaluate how allergen challenge affects lung expression of cav1 and the density of caveolae in vivo 2) to determine whether reduced cav1 expression is mediated by interleukin (IL)-4 and 3) to measure the effects of decreased expression of cav1 on TGF-beta signaling. C57BL/6J, IL-4-deficient mice, and cav1-deficient mice, sensitized by intraperitoneal injections of phosphate-buffered saline or ovalbumin (OVA) at days 0 and 12, received intranasal phosphate-buffered saline or OVA challenges at days 24, 26, and 28. Additionally, another group of C57BL/6J mice received IL-4 by intratracheal instillation for 7 days. We confirmed that the OVA-allergen challenge increased eosinophilia and T-helper type 2-related cytokine levels (IL-4, IL-5, and IL-13) in bronchoalveolar lavage. Allergen challenge reduced lung cav1 mRNA abundance by 40%, cav1 protein by 30%, and the number of lung fibroblast caveolae by 50%. Administration of IL-4 in vivo also substantially decreased cav1 expression. In contrast, the allergen challenge did not decrease cav1 expression in IL-4-deficient mice. The reduced expression of cav1 was associated with activation of TGF-beta signaling that was further enhanced in OVA-sensitized and challenged cav1-deficient mice. This study demonstrates a previously unknown modulation of TGF-beta signaling by IL-4, via cav1, suggesting novel therapeutic targets for controlling the effects of TGF-beta and thereby ameliorating pathological airway remodeling.	[Le Saux, Claude Jourdan; Teeters, Kelsa; Miyasato, Shelley K.; Hoffmann, Peter R.] Univ Hawaii, Dept Cell & Mol Biol, Honolulu, HI 96813 USA; [Bollt, Oana; Shohet, Ralph V.; Tam, Elizabeth K.] Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96813 USA; [Broide, David H.] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA	University of Hawaii System; University of Hawaii System; University of California System; University of California San Diego	Le Saux, CJ (corresponding author), 651 Ilalo St BSB 222, Honolulu, HI 96813 USA.	claude@pbrc.hawaii.edu	Le Saux, Claude/AGF-7659-2022	Le Saux, Claude/0000-0002-6041-2870; Broide, David/0000-0001-8405-9090	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016453, G12RR003061, P20RR016467] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UH1HL073449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070535, R01AI072115, R37AI038425] Funding Source: NIH RePORTER; NCRR NIH HHS [P20RR016467, G12RR0003061, RR16453] Funding Source: Medline; NHLBI NIH HHS [HL073449] Funding Source: Medline; NIAID NIH HHS [R01 AI072115-03, U19 AI070535, R37 AI038425-14, R37 AI038425, U19 AI070535-040001, U19 AI070535-04, R01 AI072115, U19 AI070535-049001] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Batra V, 2004, CLIN EXP ALLERGY, V34, P437, DOI 10.1111/j.1365-2222.2004.01885.x; Bergeron C, 2003, CHEST, V123, p424S, DOI 10.1378/chest.123.3_suppl.424S; Bist A, 2000, BIOCHEMISTRY-US, V39, P1966, DOI 10.1021/bi991721h; Bist A, 1997, P NATL ACAD SCI USA, V94, P10693, DOI 10.1073/pnas.94.20.10693; BORDER WA, 1995, NAT MED, V1, P1000, DOI 10.1038/nm1095-1000; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; Engelman JA, 1999, J BIOL CHEM, V274, P32333, DOI 10.1074/jbc.274.45.32333; Fielding CJ, 1999, BIOCHEMISTRY-US, V38, P2506, DOI 10.1021/bi981012o; Finkelman FD, 2005, J IMMUNOL, V174, P4630, DOI 10.4049/jimmunol.174.8.4630; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; Fujitsu Y, 2003, EXP EYE RES, V76, P107, DOI 10.1016/S0014-4835(02)00248-8; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Gray MJ, 2005, GENE, V353, P98, DOI 10.1016/j.gene.2005.04.004; Hashimoto S, 2001, AM J RESP CRIT CARE, V163, P152, DOI 10.1164/ajrccm.163.1.2005069; Ikeda RK, 2003, AM J RESP CELL MOL, V28, P655, DOI 10.1165/rcmb.4853; Jakubzick C, 2004, AM J PATHOL, V164, P1989, DOI 10.1016/S0002-9440(10)63759-5; Jasmin JF, 2004, CARDIOVASC RES, V63, P747, DOI 10.1016/j.cardiores.2004.05.018; Kathuria H, 2004, J BIOL CHEM, V279, P30028, DOI 10.1074/jbc.M402236200; Kenyon NJ, 2003, THORAX, V58, P772, DOI 10.1136/thorax.58.9.772; Kumar RK, 2002, CLIN EXP ALLERGY, V32, P1104, DOI 10.1046/j.1365-2222.2002.01420.x; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Leigh R, 2004, AM J RESP CRIT CARE, V169, P860, DOI 10.1164/rccm.200305-706OC; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; Llaverias G, 2004, J LIPID RES, V45, P2015, DOI 10.1194/jlr.M400049-JLR200; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Makhluf HA, 1996, J INVEST DERMATOL, V107, P856, DOI 10.1111/1523-1747.ep12331160; McMillan SJ, 2005, J IMMUNOL, V174, P5774, DOI 10.4049/jimmunol.174.9.5774; Minshall EM, 1997, AM J RESP CELL MOL, V17, P326, DOI 10.1165/ajrcmb.17.3.2733; Nakao A, 2002, J ALLERGY CLIN IMMUN, V110, P873, DOI 10.1067/mai.2002.129236; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Ong PY, 1999, MED HYPOTHESES, V53, P19, DOI 10.1054/mehy.1997.0700; Perkins C, 2006, J ALLERGY CLIN IMMUN, V118, P410, DOI 10.1016/j.jaci.2006.06.004; POSTLETHWAITE AE, 1992, J CLIN INVEST, V90, P1479, DOI 10.1172/JCI116015; Razani B, 2001, J BIOL CHEM, V276, P38121; Razani B, 2001, EXP CELL RES, V271, P36, DOI 10.1006/excr.2001.5372; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Redington AE, 1997, AM J RESP CRIT CARE, V156, P642, DOI 10.1164/ajrccm.156.2.9605065; Sagara H, 2002, J ALLERGY CLIN IMMUN, V110, P249, DOI 10.1067/mai.2002.126078; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Shinagawa K, 2003, AM J RESP CRIT CARE, V168, P959, DOI 10.1164/rccm.200210-1188OC; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Song KS, 1997, CELL MOL BIOL, V43, P293; Valles PG, 2007, PEDIATR NEPHROL, V22, P237, DOI 10.1007/s00467-006-0290-4; van der Slot AJ, 2005, BBA-MOL BASIS DIS, V1741, P95, DOI 10.1016/j.bbadis.2004.09.009; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Zhang XL, 2005, J BIOL CHEM, V280, P12239, DOI 10.1074/jbc.M413284200; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	50	50	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5760	5768		10.1074/jbc.M701572200	http://dx.doi.org/10.1074/jbc.M701572200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18056268	hybrid			2022-12-25	WOS:000253426700057
J	Primo, ME; Klinke, S; Sica, MP; Goldbaum, FA; Jakoncic, J; Poskus, E; Ermacora, MR				Primo, Maria E.; Klinke, Sebastian; Sica, Mauricio P.; Goldbaum, Fernando A.; Jakoncic, Jean; Poskus, Edgardo; Ermacora, Mario R.			Structure of the mature ectodomain of the human receptor-type protein-tyrosine phosphatase IA-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEA MODULE; MACROMOLECULAR STRUCTURES; CLEAVAGE; DOMAIN; TRANSMEMBRANE; IA-2-BETA; ALPHA; INHIBITION; REFINEMENT; EXPRESSION	IA-2 (insulinoma-associated protein 2) is a protein-tyrosine phosphatase receptor located in secretory granules of neuroendocrine cells. Initially, it attracted attention due to its involvement in the autoimmune response associated to diabetes. Later it was found that upon exocytosis, the cytoplasmic domain of IA-2 is cleaved and relocated to the nucleus, where it enhances the transcription of the insulin gene. A concerted functioning of the whole receptor is to be expected. However, very little is known about the structure and function of the transmembrane and extracellular domains of IA-2. To address this issue, we solved the x-ray structure of the mature ectodomain of IA-2 (meIA-2) to 1.30 A resolution. The fold of meIA-2 is related to the SEA ( sea urchin sperm protein, enterokinase, agrin)) domains of mucins, suggesting its participation in adhesive contacts to the extracellular matrix and providing clues on how this kind of molecule may associate and form homo- and heterodimers. Moreover, we discovered that meIA-2 is self-proteolyzed in vitro by reactive oxygen species, suggesting the possibility of a new shedding mechanism that might be significant in normal function or pathological processes. Knowledge of meIA-2 structure should facilitate the search of its possible ligands and molecular interactions.	[Primo, Maria E.; Klinke, Sebastian; Sica, Mauricio P.; Goldbaum, Fernando A.; Poskus, Edgardo; Ermacora, Mario R.] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Primo, Maria E.; Poskus, Edgardo] Idehu Conicet UBA, Junin 954, Buenos Aires, DF, Argentina; [Primo, Maria E.; Poskus, Edgardo] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Inmunol, Buenos Aires, DF, Argentina; [Klinke, Sebastian; Goldbaum, Fernando A.] Consejo Nacl Invest Cient & Tecn, IIBBA, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina; [Sica, Mauricio P.; Ermacora, Mario R.] Univ Nacl Quilmes, Dept Ciencia Tecnol, Buenos Aires, DF, Argentina; [Jakoncic, Jean] Brookhaven Natl Lab, Upton, NY 11973 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; United States Department of Energy (DOE); Brookhaven National Laboratory	Ermacora, MR (corresponding author), Consejo Nacl Invest Cient & Tecn, Rivadavia 1917 C1033AAJ,Ciudad Autonoma, RA-1033 Buenos Aires, DF, Argentina.	ermacora@unq.edu.ar	Klinke, Sebastián/N-6174-2018	Klinke, Sebastián/0000-0002-8777-0870; Primo, Maria Evangelina/0000-0002-6873-8867; Ermacora, Mario/0000-0002-1754-4202; Goldbaum, Fernando/0000-0001-6235-3002				Abe J, 2002, J BIOL CHEM, V277, P23391, DOI 10.1074/jbc.M110877200; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; BORK P, 1995, PROTEIN SCI, V4, P1421, DOI 10.1002/pro.5560040716; BRADYKALNAY SM, 1995, CURR OPIN CELL BIOL, V7, P650, DOI 10.1016/0955-0674(95)80106-5; Chin CN, 2005, FEBS LETT, V579, P3855, DOI 10.1016/j.febslet.2005.05.071; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelmann K, 2005, GLYCOBIOLOGY, V15, P1111, DOI 10.1093/glycob/cwi099; ERMACORA MR, 1992, P NATL ACAD SCI USA, V89, P6383, DOI 10.1073/pnas.89.14.6383; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Goldstein BJ, 2005, DIABETES, V54, P311, DOI 10.2337/diabetes.54.2.311; Gross S, 2002, J BIOL CHEM, V277, P48139, DOI 10.1074/jbc.M208228200; Hermel JM, 1999, EUR J NEUROSCI, V11, P2609, DOI 10.1046/j.1460-9568.1999.00677.x; Holm L, 1998, PROTEINS, V33, P88, DOI 10.1002/(SICI)1097-0134(19981001)33:1<88::AID-PROT8>3.0.CO;2-H; Hubbard TJP, 1997, NUCLEIC ACIDS RES, V25, P236, DOI 10.1093/nar/25.1.236; Knoch KP, 2004, NAT CELL BIOL, V6, P207, DOI 10.1038/ncb1099; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kubosaki A, 2006, ENDOCRINOLOGY, V147, P811, DOI 10.1210/en.2005-0638; Kubosaki A, 2005, DIABETES, V54, pS46, DOI 10.2337/diabetes.54.suppl_2.S46; LAN NS, 1996, P NATL ACAD SCI USA, V93, P6367; LASKOWSKI M, 1955, METHOD ENZYMOL, V2, P26, DOI 10.1016/S0076-6879(55)02167-8; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; Maeda T, 2004, J BIOL CHEM, V279, P13174, DOI 10.1074/jbc.M309417200; Magistrelli G, 1996, BIOCHEM BIOPH RES CO, V227, P581, DOI 10.1006/bbrc.1996.1549; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmai-Pallag T, 2005, FEBS J, V272, P2901, DOI 10.1111/j.1742-4658.2005.04711.x; Primo ME, 2006, BBA-PROTEINS PROTEOM, V1764, P174, DOI 10.1016/j.bbapap.2005.11.014; SANTOS J, 2007, BIOPHYS J, V11, P11; Sereikaite J, 2006, PROTEIN J, V25, P369, DOI 10.1007/s10930-006-9014-7; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Solimena M, 1996, EMBO J, V15, P2102, DOI 10.1002/j.1460-2075.1996.tb00564.x; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trajkovski M, 2004, J CELL BIOL, V167, P1063, DOI 10.1083/jcb.200408172; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van der Wijk T, 2004, J BIOL CHEM, V279, P44355, DOI 10.1074/jbc.M407483200; van der Wijk T, 2003, J BIOL CHEM, V278, P13968, DOI 10.1074/jbc.M300632200; Wreschner DH, 2002, PROTEIN SCI, V11, P698, DOI 10.1110/ps.16502	48	18	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4674	4681		10.1074/jbc.M708144200	http://dx.doi.org/10.1074/jbc.M708144200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18048354	hybrid			2022-12-25	WOS:000253426500025
J	Shen, Y; Hirsch, DS; Sasiela, CA; Wu, WJ				Shen, Yi; Hirsch, Dianne S.; Sasiela, Christy A.; Wu, Wen Jin			Cdc42 regulates E-cadherin ubiquitination and degradation through an epidermal growth factor receptor to Src-mediated pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL-ADHESION; EPITHELIAL-MESENCHYMAL TRANSITIONS; BREAST-CANCER CELLS; RHO-GTPASES; DOWN-REGULATION; BETA-CATENIN; C-CBL; RAC1; ENDOCYTOSIS; ACTIVATION	E-cadherins play an essential role in maintaining epithelial polarity by forming Ca2+-dependent adherens junctions between epithelial cells. Here, we report that Ca2+ depletion induces E-cadherin ubiquitination and lysosomal degradation and that Cdc42 plays an important role in regulating this process. We demonstrate that Ca2+ depletion induces activation of Cdc42. This in turn up-regulates epidermal growth factor receptor (EGFR) signaling to mediate Src activation, leading to E-cadherin ubiquitination and lysosomal degradation. Silencing Cdc42 blocks activation of EGFR and Src induced by Ca2+ depletion, resulting in a reduction in E-cadherin degradation. The role of Cdc42 in regulating E-cadherin ubiquitination and degradation is underscored by the fact that constitutively active Cdc42(F28L) increases the activity of EGFR and Src and significantly enhances E-cadherin ubiquitination and lysosomal degradation. Furthermore, we found that GTP-dependent binding of Cdc42 to E-cadherin is critical for Cdc42 to induce the dissolution of adherens junctions. Our data support a model that activation of Cdc42 contributes to mesenchyme-like phenotype by targeting of E-cadherin for lysosomal degradation.	[Shen, Yi; Hirsch, Dianne S.; Sasiela, Christy A.; Wu, Wen Jin] US FDA, CDER, OPS, OBP,Div Monoclonal Antibodies, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA)	Wu, WJ (corresponding author), US FDA, CDER, OPS, OBP,Div Monoclonal Antibodies, Bethesda, MD 20892 USA.	wen.wu@fda.hhs.gov						Akhtar N, 2000, CELL ADHES COMMUN, V7, P465, DOI 10.3109/15419060009040304; Akhtar N, 2001, MOL BIOL CELL, V12, P847, DOI 10.1091/mbc.12.4.847; Al Moustafa AE, 2002, LUNG CANCER, V37, P49, DOI 10.1016/S0169-5002(02)00025-9; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Birchmeier W, 2005, EMBO REP, V6, P413, DOI 10.1038/sj.embor.7400408; Braga V, 2000, NAT CELL BIOL, V2, pE182, DOI 10.1038/35036433; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cary LA, 1996, J CELL SCI, V109, P1787; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Czekay RP, 1997, MOL BIOL CELL, V8, P517, DOI 10.1091/mbc.8.3.517; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Fukata M, 1999, J BIOL CHEM, V274, P26044, DOI 10.1074/jbc.274.37.26044; Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200; GALLOWAY CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3334, DOI 10.1073/pnas.80.11.3334; GRAEVE L, 1989, J CELL BIOL, V109, P2809, DOI 10.1083/jcb.109.6.2809; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hazan RB, 1998, J BIOL CHEM, V273, P9078, DOI 10.1074/jbc.273.15.9078; Hirsch DS, 2006, CANCER RES, V66, P3523, DOI 10.1158/0008-5472.CAN-05-1547; Hirsch DS, 2001, J BIOL CHEM, V276, P875, DOI 10.1074/jbc.M007039200; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Janda E, 2006, ONCOGENE, V25, P7117, DOI 10.1038/sj.onc.1209701; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Le TL, 2002, AM J PHYSIOL-CELL PH, V283, pC489, DOI 10.1152/ajpcell.00566.2001; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Mbalaviele G, 1996, CANCER RES, V56, P4063; Muller T, 2002, EXP CELL RES, V280, P119, DOI 10.1006/excr.2002.5630; Nakagawa M, 2001, J CELL SCI, V114, P1829; Nakaya Y, 2004, DEV CELL, V7, P425, DOI 10.1016/j.devcel.2004.08.003; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; SOUZASCHOREY C, 2005, TRENDS CELL BIOL, V15, P19; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; van Golen KL, 2000, CANCER RES, V60, P5832; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Wu WJ, 1998, J BIOL CHEM, V273, P16655, DOI 10.1074/jbc.273.27.16655; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119	53	99	101	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5127	5137		10.1074/jbc.M703300200	http://dx.doi.org/10.1074/jbc.M703300200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18057010	hybrid			2022-12-25	WOS:000253426500070
J	Han, Q; Robinson, H; Li, JY				Han, Qian; Robinson, Howard; Li, Jianyong			Crystal structure of human kynurenine aminotransferase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMINOADIPATE AMINOTRANSFERASE; 5-PHOSPHATE-TYPE ASPARTATE AMINOTRANSFERASES; ESCHERICHIA-COLI; 3-NITROPROPIONIC ACID; SYNAPTIC-TRANSMISSION; HUNTINGTONS-DISEASE; EXPRESSION; RECEPTOR; PROTEIN; REFINEMENT	Human kynurenine aminotransferase II (hKAT-II) efficiently catalyzes the transamination of knunrenine to kynurenic acid (KYNA). KYNA is the only known endogenous antagonist of N-methyl-D-aspartate (NMDA) receptors and is also an antagonist of 7-nicotinic acetylcholine receptors. Abnormal concentrations of brain KYNA have been implicated in the pathogenesis and development of several neurological and psychiatric diseases in humans. Consequently, enzymes involved in the production of brain KYNA have been considered potential regulatory targets. In this article, we report a 2.16 angstrom crystal structure of hKAT-II and a 1.95 angstrom structure of its complex with kynurenine. The protein architecture of hKAT-II reveals that it belongs to the fold-type I pyridoxal 5-phosphate (PLP)-dependent enzymes. In comparison with all subclasses of fold-type I-PLP-dependent enzymes, we propose that hKAT-II represents a novel subclass in the fold-type I enzymes because of the unique folding of its first 65 N-terminal residues. This study provides a molecular basis for future effort in maintaining physiological concentrations of KYNA through molecular and biochemical regulation of hKAT-II.	[Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Han, Qian; Li, Jianyong] Virginia Tech Univ, Dept Biochem, Blacksburg, VA 24061 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; Virginia Polytechnic Institute & State University	Li, JY (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	lij@vt.edu	Han, Qian/AAS-2134-2020; Han, Qian/J-8696-2014	Han, Qian/0000-0001-6245-5252	NIAID NIH HHS [R01 AI44399] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044399] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alkondon M, 2004, J NEUROSCI, V24, P4635, DOI 10.1523/JNEUROSCI.5631-03.2004; BEAL MF, 1990, J NEUROCHEM, V55, P1327, DOI 10.1111/j.1471-4159.1990.tb03143.x; BIRCH PJ, 1988, EUR J PHARMACOL, V154, P85, DOI 10.1016/0014-2999(88)90367-6; BUCHLI R, 1995, J BIOL CHEM, V270, P29330, DOI 10.1074/jbc.270.49.29330; Chon H, 2005, PROTEINS, V61, P685, DOI 10.1002/prot.20614; Csillik A, 2002, EXP NEUROL, V177, P233, DOI 10.1006/exnr.2002.7973; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Erhardt S, 2001, NEUROSCI LETT, V313, P96, DOI 10.1016/S0304-3940(01)02242-X; Erhardt S, 2007, PHYSIOL BEHAV, V92, P203, DOI 10.1016/j.physbeh.2007.05.025; Goh DLM, 2002, MOL GENET METAB, V76, P172, DOI 10.1016/S1096-7192(02)00037-9; Goto M, 2004, J BIOL CHEM, V279, P16518, DOI 10.1074/jbc.M311575200; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Guidetti P, 2000, NEUROSCI LETT, V283, P233, DOI 10.1016/S0304-3940(00)00956-3; Guidetti P, 1997, J NEUROSCI RES, V50, P457; Guidetti P, 2007, J NEUROCHEM, V102, P103, DOI 10.1111/j.1471-4159.2007.04556.x; Han Q, 2004, EUR J BIOCHEM, V271, P4804, DOI 10.1111/j.1432-1033.2004.04446.x; Han Q, 2002, J BIOL CHEM, V277, P15781, DOI 10.1074/jbc.M201202200; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; JAGER J, 1994, J MOL BIOL, V239, P285, DOI 10.1006/jmbi.1994.1368; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kack H, 1999, J MOL BIOL, V291, P857, DOI 10.1006/jmbi.1999.2997; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEESON PD, 1994, J MED CHEM, V37, P4053, DOI 10.1021/jm00050a001; Luchowski P, 2002, NEUROSCI LETT, V330, P49, DOI 10.1016/S0304-3940(02)00735-8; MALASHKEVICH VN, 1995, J MOL BIOL, V247, P111, DOI 10.1006/jmbi.1994.0126; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCPHALEN CA, 1992, J MOL BIOL, V225, P495, DOI 10.1016/0022-2836(92)90935-D; MEHTA PK, 1993, EUR J BIOCHEM, V214, P549, DOI 10.1111/j.1432-1033.1993.tb17953.x; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; MIYAHARA I, 1994, J BIOCHEM, V116, P1001, DOI 10.1093/oxfordjournals.jbchem.a124620; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OGURA A, 1988, EXP BRAIN RES, V73, P447, DOI 10.1007/BF00406601; OKAMOTO A, 1994, J BIOCHEM, V116, P95, DOI 10.1093/oxfordjournals.jbchem.a124509; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMADA M, 1998, FRONT BIOSCI, V3, P701; PELLICCIARI R, 1994, J MED CHEM, V37, P647, DOI 10.1021/jm00031a015; Pellicciari R, 2006, CHEMMEDCHEM, V1, P528, DOI 10.1002/cmdc.200500095; Pereira EFR, 2002, J NEUROBIOL, V53, P479, DOI 10.1002/neu.10146; PERKINS MN, 1982, BRAIN RES, V247, P184, DOI 10.1016/0006-8993(82)91048-4; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rhee S, 1997, J BIOL CHEM, V272, P17293, DOI 10.1074/jbc.272.28.17293; Rossi F, 2004, J BIOL CHEM, V279, P50214, DOI 10.1074/jbc.M409291200; Sapko MT, 2006, EXP NEUROL, V197, P31, DOI 10.1016/j.expneurol.2005.07.004; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Schwarcz R, 2001, BIOL PSYCHIAT, V50, P521, DOI 10.1016/S0006-3223(01)01078-2; Schwarcz R, 2002, J PHARMACOL EXP THER, V303, P1, DOI 10.1124/jpet.102.034439; SPECIALE C, 1990, NEUROSCI LETT, V116, P198, DOI 10.1016/0304-3940(90)90410-B; Stone TW, 2007, EUR J NEUROSCI, V25, P2656, DOI 10.1111/j.1460-9568.2007.05540.x; Stone TW, 2002, EUR J PHARMACOL, V447, P285, DOI 10.1016/S0014-2999(02)01851-4; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; STONE TW, 1984, NEUROSCI LETT, V52, P335, DOI 10.1016/0304-3940(84)90184-8; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; SWARTZ KJ, 1990, J NEUROSCI, V10, P2965; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; TOBES MC, 1977, J BIOL CHEM, V252, P4591; TURSKI WA, 1989, J NEUROCHEM, V52, P1629, DOI 10.1111/j.1471-4159.1989.tb09218.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Yu P, 2006, GENE, V365, P111, DOI 10.1016/J.gene.2005.09.034; Yu P, 1999, MAMM GENOME, V10, P845, DOI 10.1007/s003359901102; Yu P, 2004, MOL CELL BIOL, V24, P6919, DOI 10.1128/MCB.24.16.6919-6930.2004	66	42	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3567	3573		10.1074/jbc.M708358200	http://dx.doi.org/10.1074/jbc.M708358200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056995	hybrid			2022-12-25	WOS:000253083000062
J	Meng, J; Parroche, P; Golenbock, DT; McKnight, CJ				Meng, Jianmin; Parroche, Peggy; Golenbock, Douglas T.; McKnight, C. James			The differential impact of disulfide bonds and N-linked glycosylation on the stability and function of CD14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LPS BINDING-PROTEIN; QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; LIPOPOLYSACCHARIDE LPS; SIGNAL-TRANSDUCTION; SECRETORY PATHWAY; RECEPTOR 4; ENDOTOXIN; IDENTIFICATION; CELLS	Innate immunity is the first line defense against invading pathogens. During Gram-negative bacterial infection, the Toll-like receptor 4 and MD-2 complex recognize lipopolysaccharide present in the bacterial cell wall. This recognition can be enhanced 100-1000-fold by CD14. However, the beneficial role provided by CD14 becomes detrimental in the context of sepsis and septic shock. An understanding of how CD14 functions will therefore benefit treatments targeted at both immune suppression and immune enhancement. In the present study, we use site-directed mutagenesis to address the role of disulfide bonds and N-linked glycosylation on CD14. A differential impact is observed for the five disulfide bonds on CD14 folding, with the first two (Cys(6)-Cys(17) and Cys(15)-Cys(32)) being indispensable, the third and fourth (Cys(168)-Cys(198) and Cys(222)-Cys(253)) being important, and the last (Cys(287)-Cys(333)) being dispensable. A functional role is observed for the first disulfide bond because the C6A substitution severely reduces the ability of CD14 to confer lipopolysaccharide responsiveness to U373 cells. Two of the four predicted glycosylation sites, asparagines 132 and 263, are actually involved in N-linked glycosylation, resulting in heterogeneity in CD14 molecular weight. Furthermore, glycosylation at Asn(132) plays a role in CD14 trafficking and upstream and/or downstream ligand interactions. When mapped onto the crystal structure of mouse CD14, the first two disulfide bonds and Asn132 are in close proximity to the initial beta strands of the leucine rich repeat domain. Thus, disulfide bonds and N-linked glycosylation in the initial beta sheets of the inner concave surface of CD14 are crucial for structure and function.	[Meng, Jianmin; McKnight, C. James] Boston Univ, Sch Med, Dept Phys & Biophys, Boston, MA 02118 USA; [Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 02118 USA	Boston University; University of Massachusetts System; University of Massachusetts Worcester	McKnight, CJ (corresponding author), 700 Albany St, W407, Worcester, MA 01605 USA.	cjmck@bu.edu		McKnight, Christopher/0000-0002-3237-0896	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054060, R01GM054060] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54060] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Ausubel F. M., 1988, CURRENT PROTOCOLS MO; BALL ED, 1982, P NATL ACAD SCI-BIOL, V79, P5374, DOI 10.1073/pnas.79.17.5374; BAZIL V, 1986, EUR J IMMUNOL, V16, P1583, DOI 10.1002/eji.1830161218; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; Cacan R, 2000, GLYCOBIOLOGY, V10, P645, DOI 10.1093/glycob/10.7.645; Dempski RE, 2002, CURR OPIN CHEM BIOL, V6, P844, DOI 10.1016/S1367-5931(02)00390-3; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; FERRERO E, 1993, P NATL ACAD SCI USA, V90, P2380, DOI 10.1073/pnas.90.6.2380; Fitzgerald KA, 2004, MICROBES INFECT, V6, P1361, DOI 10.1016/j.micinf.2004.08.015; GOLENBOCK DT, 1993, J BIOL CHEM, V268, P22055; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; HAZIOT A, 1988, J IMMUNOL, V141, P547; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2001, PHILOS T ROY SOC B, V356, P147, DOI 10.1098/rstb.2000.0759; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Jiang QQ, 2000, J IMMUNOL, V165, P3541, DOI 10.4049/jimmunol.165.7.3541; JUAN TSC, 1995, J BIOL CHEM, V270, P17237, DOI 10.1074/jbc.270.29.17237; JUAN TSC, 1995, J BIOL CHEM, V270, P5219, DOI 10.1074/jbc.270.10.5219; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE JD, 1992, J EXP MED, V175, P1697, DOI 10.1084/jem.175.6.1697; Leturcq DJ, 1996, J CLIN INVEST, V98, P1533, DOI 10.1172/JCI118945; Liu T, 2005, J PROTEOME RES, V4, P2070, DOI 10.1021/pr0502065; MCGINLEY MD, 1995, J BIOL CHEM, V270, P5213, DOI 10.1074/jbc.270.10.5213; MICHIE HR, 1988, NEW ENGL J MED, V318, P1481, DOI 10.1056/NEJM198806093182301; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; Sambrook J., 1989, MOL CLONING LAB COUR; Schimke J, 1998, P NATL ACAD SCI USA, V95, P13875, DOI 10.1073/pnas.95.23.13875; SETOGUCHI M, 1989, MOL CELL BIOL, V9, P4515, DOI 10.1128/MCB.9.10.4515; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Spiro RG, 2000, J BIOL CHEM, V275, P35657, DOI 10.1074/jbc.R000022200; Stelter F, 1997, EUR J BIOCHEM, V243, P100, DOI 10.1111/j.1432-1033.1997.00100.x; Sugiyama T, 2001, J IMMUNOL, V166, P826, DOI 10.4049/jimmunol.166.2.826; Wang PY, 1998, J BIOL CHEM, V273, P24309, DOI 10.1074/jbc.273.38.24309; Warren Charles E., 1993, Current Opinion in Biotechnology, V4, P596, DOI 10.1016/0958-1669(93)90083-9; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yu B, 1997, J CLIN INVEST, V99, P315, DOI 10.1172/JCI119160	47	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3376	3384		10.1074/jbc.M707640200	http://dx.doi.org/10.1074/jbc.M707640200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18057002	hybrid			2022-12-25	WOS:000253083000042
J	Haanstra, JR; Stewart, M; Luu, VD; van Tuijl, A; Westerhoff, HV; Clayton, C; Bakker, BM				Haanstra, Jurgen R.; Stewart, Mhairi; Luu, Van-Duc; van Tuijl, Arjen; Westerhoff, Hans V.; Clayton, Christine; Bakker, Barbara M.			Control and regulation of gene expression - Quantitative analysis of the expression of phosphoglycerate kinase in bloodstream form Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICED-LEADER RNA; FRUCTOSE BISPHOSPHATE ALDOLASE; POST-TRANSCRIPTIONAL CONTROL; POLYMERASE-II TRANSCRIPTION; GENOME-WIDE ANALYSIS; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; IN-VIVO; METABOLIC-REGULATION; GLYCOLYTIC-ENZYMES	Isoenzymes of phosphoglycerate kinase in Trypanosoma brucei are differentially expressed in its two main life stages. This study addresses how the organism manages to make sufficient amounts of the isoenzyme with the correct localization, which processes (transcription, splicing, and RNA degradation) control the levels of mRNAs, and how the organism regulates the switch in isoform expression. For this, we combined new quantitative measurements of phosphoglycerate kinase mRNA abundance, RNA precursor stability, trans splicing, and ribosome loading with published data and made a kinetic computer model. For the analysis of regulation we extended regulation analysis. Although phosphoglycerate kinase mRNAs are present at surprisingly low concentrations (e. g. 12 molecules per cell), its protein is highly abundant. Substantial control of mRNA and protein levels was exerted by both mRNA synthesis and degradation, whereas splicing and precursor degradation had little control on mRNA and protein concentrations. Yet regulation of mRNA levels does not occur by transcription, but by adjusting mRNA degradation. The contribution of splicing to regulation is negligible, as for all cases where splicing is faster than RNA precursor degradation.	[Haanstra, Jurgen R.; van Tuijl, Arjen; Westerhoff, Hans V.; Bakker, Barbara M.] Vrije Univ Amsterdam, Bioctr, NL-1081 HV Amsterdam, Netherlands; [Stewart, Mhairi; Luu, Van-Duc; Clayton, Christine] Heidelberg Univ, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Westerhoff, Hans V.] Univ Manchester, SCEAS, MIB, Manchester Ctr Integrat Syst Biol, Manchester M1 7ND, Lancs, England	Vrije Universiteit Amsterdam; Ruprecht Karls University Heidelberg; University of Manchester	Bakker, BM (corresponding author), Vrije Univ Amsterdam, Bioctr, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	barbara.bakker@falw.vu.nl	Clayton, Christine/K-7700-2019; Westerhoff, Hans V/I-5762-2012	Westerhoff, Hans V/0000-0002-0443-6114; Bakker, Barbara/0000-0001-6274-3633; Haanstra, Jurgen/0000-0001-9652-0219; Clayton, Christine/0000-0002-6384-0731	BBSRC [BB/D019079/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D019079/1, BB/C008219/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Albert MA, 2005, J BIOL CHEM, V280, P28306, DOI 10.1074/jbc.M502403200; ALEXANDER K, 1991, MOL BIOCHEM PARASIT, V46, P1, DOI 10.1016/0166-6851(91)90193-A; ALEXANDER K, 1993, MOL BIOCHEM PARASIT, V60, P265, DOI 10.1016/0166-6851(93)90137-M; ALLEN TE, 1993, NUCLEIC ACIDS RES, V21, P5431, DOI 10.1093/nar/21.23.5431; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Audibert A, 2002, MOL CELL BIOL, V22, P6706, DOI 10.1128/MCB.22.19.6706-6718.2002; Bakker BM, 1997, J BIOL CHEM, V272, P3207, DOI 10.1074/jbc.272.6.3207; Bakker BM, 1999, P NATL ACAD SCI USA, V96, P10098, DOI 10.1073/pnas.96.18.10098; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Biton M, 2006, MOL BIOCHEM PARASIT, V150, P132, DOI 10.1016/j.molbiopara.2006.07.004; Blattner J, 1998, P NATL ACAD SCI USA, V95, P11596, DOI 10.1073/pnas.95.20.11596; BLATTNER J, 1995, GENE, V162, P153, DOI 10.1016/0378-1119(95)00366-E; Bon M, 2006, FASEB J, V20, P1721, DOI 10.1096/fj.06-6087fje; BONVEN B, 1979, MOL GEN GENET, V170, P225, DOI 10.1007/BF00337800; Bruggeman FJ, 2007, TRENDS MICROBIOL, V15, P45, DOI 10.1016/j.tim.2006.11.003; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; CLAYTON CE, 1988, MOL BIOCHEM PARASIT, V28, P43, DOI 10.1016/0166-6851(88)90178-8; CLAYTON CE, 1987, J CELL BIOL, V105, P2649, DOI 10.1083/jcb.105.6.2649; CLAYTON CE, 1985, EMBO J, V4, P2997, DOI 10.1002/j.1460-2075.1985.tb04035.x; Colasante C, 2007, MOL BIOCHEM PARASIT, V151, P193, DOI 10.1016/j.molbiopara.2006.11.003; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; DELANGE T, 1983, CELL, V34, P891, DOI 10.1016/0092-8674(83)90546-9; Djikeng A, 2003, RNA, V9, P802, DOI 10.1261/rna.5270203; Djikeng A, 1998, GENE, V221, P93, DOI 10.1016/S0378-1119(98)00427-2; DOVEY HF, 1988, P NATL ACAD SCI USA, V85, P2598, DOI 10.1073/pnas.85.8.2598; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; Ersfeld K, 1998, CHROMOSOMA, V107, P237, DOI 10.1007/s004120050302; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Furuya T, 2002, P NATL ACAD SCI USA, V99, P14177, DOI 10.1073/pnas.222454899; GIBSON WC, 1988, J MOL BIOL, V201, P315, DOI 10.1016/0022-2836(88)90140-4; Gornemann J, 2005, MOL CELL, V19, P53, DOI 10.1016/j.molcel.2005.05.007; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Haile S, 2003, RNA, V9, P1491, DOI 10.1261/rna.5940703; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Heinrich R., 1996, REGULATION CELLULAR; Helfert S, 2001, BIOCHEM J, V357, P117, DOI 10.1042/0264-6021:3570117; Hendriks EF, 2003, J BIOL CHEM, V278, P26870, DOI 10.1074/jbc.M302405200; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hornberg JJ, 2005, FEBS J, V272, P244, DOI 10.1111/j.1432-1033.2004.04404.x; Iyer V, 1996, P NATL ACAD SCI USA, V93, P5208, DOI 10.1073/pnas.93.11.5208; Jackson DA, 2000, FASEB J, V14, P242, DOI 10.1096/fasebj.14.2.242; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; KAHN D, 1991, J THEOR BIOL, V153, P255, DOI 10.1016/S0022-5193(05)80426-6; KAPOTAS N, 1993, NUCLEIC ACIDS RES, V21, P4067, DOI 10.1093/nar/21.17.4067; Kessler PS, 2005, J BIOL CHEM, V280, P9030, DOI 10.1074/jbc.M412033200; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; Lacadie SA, 2005, MOL CELL, V19, P65, DOI 10.1016/j.molcel.2005.05.006; Li CH, 2006, RNA, V12, P2171, DOI 10.1261/rna.291506; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Liu L, 2002, J BIOL CHEM, V277, P47348, DOI 10.1074/jbc.M207736200; Mandelboim M, 2003, J BIOL CHEM, V278, P51469, DOI 10.1074/jbc.M308997200; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Martinez-Calvillo S, 2004, EUKARYOT CELL, V3, P506, DOI 10.1128/EC.3.2.506-517.2004; McAndrew M, 1998, EXP PARASITOL, V90, P65, DOI 10.1006/expr.1998.4317; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; MCNALLY KP, 1992, MOL CELL BIOL, V12, P4844, DOI 10.1128/MCB.12.11.4844; Michels PAM, 2000, PARASITOL TODAY, V16, P482, DOI 10.1016/S0169-4758(00)01810-X; MISSET O, 1987, EUR J BIOCHEM, V162, P493, DOI 10.1111/j.1432-1033.1987.tb10667.x; MISSET O, 1986, EUR J BIOCHEM, V157, P441, DOI 10.1111/j.1432-1033.1986.tb09687.x; MOTTRAM JC, 1989, MOL BIOCHEM PARASIT, V37, P115, DOI 10.1016/0166-6851(89)90108-4; PALMITER RD, 1975, CELL, V4, P189, DOI 10.1016/0092-8674(75)90167-1; PARSONS M, 1989, MOL BIOCHEM PARASIT, V33, P215, DOI 10.1016/0166-6851(89)90083-2; PAYS E, 1993, MOL BIOCHEM PARASIT, V61, P107, DOI 10.1016/0166-6851(93)90163-R; PAYS E, 1980, NUCLEIC ACIDS RES, V8, P5965, DOI 10.1093/nar/8.24.5965; Quijada L, 2002, NUCLEIC ACIDS RES, V30, P4414, DOI 10.1093/nar/gkf577; Rossell S, 2005, FEMS YEAST RES, V5, P611, DOI 10.1016/j.femsyr.2004.11.003; Sauro Herbert M., 2003, OMICS A Journal of Integrative Biology, V7, P355, DOI 10.1089/153623103322637670; SAURO HM, 2000, ANIMATING CELLULAR M; Schilling M, 2005, FEBS J, V272, P6400, DOI 10.1111/j.1742-4658.2005.05037.x; Siegel TN, 2005, MOL CELL BIOL, V25, P9586, DOI 10.1128/MCB.25.21.9586-9594.2005; Snoep JL, 2002, EUR J BIOCHEM, V269, P1662, DOI 10.1046/j.1432-1327.2002.02803.x; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Tardiff DF, 2006, MOL CELL, V24, P917, DOI 10.1016/j.molcel.2006.12.002; ter Kuile BH, 2001, FEBS LETT, V500, P169, DOI 10.1016/S0014-5793(01)02613-8; Teusink B, 2000, EUR J BIOCHEM, V267, P5313, DOI 10.1046/j.1432-1327.2000.01527.x; Tu XM, 2005, EUKARYOT CELL, V4, P755, DOI 10.1128/EC.4.4.755-764.2005; ULLU E, 1991, P NATL ACAD SCI USA, V88, P10074, DOI 10.1073/pnas.88.22.10074; ULLU E, 1993, MOL CELL BIOL, V13, P720, DOI 10.1128/MCB.13.1.720; van Deursen FJ, 2001, MOL BIOCHEM PARASIT, V112, P163, DOI 10.1016/S0166-6851(00)00359-5; van Weelden SWH, 2005, J BIOL CHEM, V280, P12451, DOI 10.1074/jbc.M412447200; WALDRON C, 1975, J BACTERIOL, V122, P855, DOI 10.1128/JB.122.3.855-865.1975; Westerhoff H., 1987, THERMODYNAMICS CONTR; WESTERHOFF HV, 1990, NATO ADV SCI I A-LIF, V190, P399; Zhang WW, 2004, MOL MICROBIOL, V54, P1051, DOI 10.1111/j.1365-2958.2004.04327.x; Zomer AWM, 1998, BBA-PROTEIN STRUCT M, V1386, P179, DOI 10.1016/S0167-4838(98)00095-8; ZOMERDIJK JCBM, 1992, NUCLEIC ACIDS RES, V20, P2725, DOI 10.1093/nar/20.11.2725	91	58	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2495	2507		10.1074/jbc.M705782200	http://dx.doi.org/10.1074/jbc.M705782200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	17991737	Green Published, hybrid			2022-12-25	WOS:000252622300006
J	Kamiya, Y; Kamiya, D; Yamamoto, K; Nyfeler, B; Hauri, HP; Kato, K				Kamiya, Yukiko; Kamiya, Daiki; Yamamoto, Kazuo; Nyfeler, Beat; Hauri, Hans-Peter; Kato, Koichi			Molecular basis of sugar recognition by the human L-type lectins ERGIC-53, VIPL, and VIP36	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTAL AFFINITY-CHROMATOGRAPHY; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; TRANSPORT RECEPTOR; BINDING-PROPERTIES; PROTEIN; GLYCOPROTEINS; GLYCANS; GLUCOSYLATION; COMPARTMENT	ERGIC-53, VIPL, and VIP36 are related type 1 membrane proteins of the mammalian early secretory pathway. They are classified as L-type lectins because of their luminal carbohydrate recognition domain, which exhibits homology to leguminous lectins. These L-type lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a Ca2+ -dependent manner, suggesting a role in glycoprotein sorting and trafficking. To understand the function of these lectins, knowledge of their carbohydrate specificity is crucial but only available for VIP36 (Kamiya, Y., Yamaguchi, Y., Takahashi, N., Arata, Y., Kasai, K. I., Ihara, Y., Matsuo, I., Ito, Y., Yamamoto, K., and Kato, K. ( 2005) J. Biol. Chem. 280, 37178-37182). Here we provide a comprehensive and quantitative analysis of sugar recognition of the carbohydrate recognition domains of ERGIC-53 and VIPL in comparison with VIP36 using a pyridylaminated sugar library in conjunction with frontal affinity chromatography. Frontal affinity chromatography revealed selective interaction of VIPL and VIP36 with the deglucosylated trimannose in the D1 branch of high-mannose-type oligosaccharides but with different pH dependence. ERGIC-53 bound high-mannose-type oligosaccharides with low affinity and broad specificity, not discriminating between monoglucosylated and deglucosylated high-mannose-type oligosaccharides. Based on the sugar-binding properties in conjunction with known features of these proteins, we propose a model for the action of the three lectins in glycoprotein guidance and trafficking. Moreover, structure-based mutagenesis revealed that the sugar-binding properties of these L-type lectins can be switched by single amino acid substitutions.	[Kamiya, Yukiko; Kamiya, Daiki; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Yamamoto, Kazuo; Kato, Koichi] CREST, Japan Sci & Technol Corp, Kawaguchi, Saitama 3321102, Japan; [Yamamoto, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Chiba 2278562, Japan; [Nyfeler, Beat; Hauri, Hans-Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Kato, Koichi] Nat Inst Nat Sci, Inst Mol Sci, Aichi 4448787, Japan; [Kato, Koichi] Ocahanomizu Univ, Glycosci Inst, Bunkyo Ku, Tokyo 1128610, Japan; [Kato, Koichi] GLYENCE Co Ltd, Nagoya, Aichi 4740858, Japan	Nagoya City University; Japan Science & Technology Agency (JST); University of Tokyo; University of Basel; National Institutes of Natural Sciences (NINS) - Japan	Kato, K (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	kkato@phar.nagoya-cu.ac.jp		Kato, Koichi/0000-0001-7187-9612; Kamiya, Yukiko/0000-0001-7582-3886				Anelli T, 2007, EMBO J, V26, P4177, DOI 10.1038/sj.emboj.7601844; Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; Appenzeller-Herzog C, 2004, J BIOL CHEM, V279, P12943, DOI 10.1074/jbc.M313245200; Appenzeller-Herzog C, 2005, MOL BIOL CELL, V16, P1258, DOI 10.1091/mbc.E04-08-0708; Arata Y, 2001, J BIOL CHEM, V276, P3068, DOI 10.1074/jbc.M008602200; Fullekrug J, 1999, J CELL SCI, V112, P2813; Hauri HP, 2000, J CELL SCI, V113, P587; Hauri HP, 2000, FEBS LETT, V476, P32, DOI 10.1016/S0014-5793(00)01665-3; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirabayashi J, 2003, METHOD ENZYMOL, V362, P353; Kamiya Y, 2005, J BIOL CHEM, V280, P37178, DOI 10.1074/jbc.M505757200; Kamiya Y, 2006, TRENDS GLYCOSCI GLYC, V18, P231, DOI 10.4052/tigg.18.231; KASAI K, 1986, J CHROMATOGR, V376, P33, DOI 10.1016/S0378-4347(00)80822-1; Kato K, 2007, GLYCOBIOLOGY, V17, P1031, DOI 10.1093/glycob/cwm046; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Neve EPA, 2003, EXP CELL RES, V288, P70, DOI 10.1016/S0014-4827(03)00161-7; Nufer O, 2003, J BIOL CHEM, V278, P15886, DOI 10.1074/jbc.M211199200; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Nyfeler B, 2006, TRAFFIC, V7, P1473, DOI 10.1111/j.1600-0854.2006.00483.x; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Satoh T, 2007, J BIOL CHEM, V282, P28246, DOI 10.1074/jbc.M703064200; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; Spiro RG, 2004, CELL MOL LIFE SCI, V61, P1025, DOI 10.1007/s00018-004-4037-8; Totani K, 2006, J BIOL CHEM, V281, P31502, DOI 10.1074/jbc.M605457200; Velloso LM, 2003, J MOL BIOL, V334, P845, DOI 10.1016/j.jmb.2003.10.031; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Yamaguchi D, 2007, GLYCOBIOLOGY, V17, P1061, DOI 10.1093/glycob/cwm074; Zhang B, 2005, J BIOL CHEM, V280, P25881, DOI 10.1074/jbc.M502160200; Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153	29	105	106	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1857	1861		10.1074/jbc.M709384200	http://dx.doi.org/10.1074/jbc.M709384200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18025080	hybrid			2022-12-25	WOS:000252501000011
J	Klumpp, K; Kalayanov, G; Ma, H; Le Pogam, S; Leveque, V; Jiang, WR; Inocencio, N; De Witte, A; Rajyaguru, S; Tai, E; Chanda, S; Irwin, MR; Sund, C; Winqist, A; Maltseva, T; Eriksson, S; Usova, E; Smith, M; Alker, A; Najera, I; Cammack, N; Martin, JA; Johansson, NG; Smith, DB				Klumpp, Klaus; Kalayanov, Genadiy; Ma, Han; Le Pogam, Sophie; Leveque, Vincent; Jiang, Wen-Rong; Inocencio, Nicole; De Witte, Anniek; Rajyaguru, Sonal; Tai, Ezra; Chanda, Sushmita; Irwin, Michael R.; Sund, Christian; Winqist, Anna; Maltseva, Tatiana; Eriksson, Staffan; Usova, Elena; Smith, Mark; Alker, Andre; Najera, Isabel; Cammack, Nick; Martin, Joseph A.; Johansson, Nils Gunnar; Smith, David B.			2 '-deoxy-4 '-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2 '-alpha-hydroxyl groups	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE; THYMIDINE KINASE; PLUS RIBAVIRIN; SPECIFICITY; EXPRESSION; REPLICON; DESIGN; RIBOSE; DNA	RNA polymerases effectively discriminate against deoxyribo-nucleotides and specifically recognize ribonucleotide substrates most likely through direct hydrogen bonding interaction with the 2 '-alpha-hydroxy moieties of ribonucleosides. Therefore, ribonucleoside analogs as inhibitors of viral RNA polymerases have mostly been designed to retain hydrogen bonding potential at this site for optimal inhibitory potency. Here, two novel nucleoside triphosphate analogs are described, which are efficiently incorporated into nascent RNA by the RNA-dependent RNA polymerase NS5B of hepatitis C virus (HCV), causing chain termination, despite the lack of alpha-hydroxy moieties. 2 '-Deoxy-2 '-beta-fluoro-4 '-azidocytidine (RO-0622) and 2 '-deoxy-2 '-beta-hydroxy-4 '-azidocytidine (RO-9187) were excellent substrates for deoxycytidine kinase and were phosphorylated with efficiencies up to 3-fold higher than deoxycytidine. As compared with previous reports on ribonucleosides, higher levels of triphosphate were formed from RO-9187 in primary human hepatocytes, and both compounds were potent inhibitors of HCV virus replication in the replicon system (IC50 = 171 +/- 12 nM and 24 +/- 3 nM for RO-9187 and RO-0622, respectively; CC50 > 1 mM for both). Both compounds inhibited RNA synthesis by HCV polymerases from either HCV genotypes 1a and 1b or containing S96T or S282T point mutations with similar potencies, suggesting no cross-resistance with either R1479 (4 '-azidocytidine) or 2 '-C-methyl nucleosides. Pharmacokinetic studies with RO-9187 in rats and dogs showed that plasma concentrations exceeding HCV replicon IC50 values 8-150-fold could be achieved by low dose (10 mg/kg) oral administration. Therefore, 2 '-alpha-deoxy-4 '-azido nucleosides are a new class of antiviral nucleosides with promising preclinical properties as potential medicines for the treatment of HCV infection.	[Klumpp, Klaus; Ma, Han; Le Pogam, Sophie; Leveque, Vincent; Jiang, Wen-Rong; Inocencio, Nicole; De Witte, Anniek; Rajyaguru, Sonal; Tai, Ezra; Chanda, Sushmita; Irwin, Michael R.; Smith, Mark; Najera, Isabel; Cammack, Nick; Martin, Joseph A.; Smith, David B.] Roche Palo Alto LLC, Palo Alto, CA 94304 USA; [Eriksson, Staffan; Usova, Elena] Swedish Univ Agr Sci, Ctr Biomed, Dept Anat Physiol & Biochem, S-75123 Uppsala, Sweden; [Kalayanov, Genadiy; Sund, Christian; Winqist, Anna; Maltseva, Tatiana; Johansson, Nils Gunnar] Medivir AB, SE-14144 Huddinge, Sweden; [Alker, Andre] Hoffmann La Roche Ag, CH-4070 Basel, Switzerland	Roche Holding; Swedish University of Agricultural Sciences; Medivir; Roche Holding	Klumpp, K (corresponding author), Roche Palo Alto LLC, 3431 Hillview Ave, Palo Alto, CA 94304 USA.	Klaus.klumpp@roche.com	Irwin, Michael R./H-4870-2013	Irwin, Michael R./0000-0002-1502-8431; Agback, Tatiana/0000-0003-1325-6024				Berger I, 1998, NUCLEIC ACIDS RES, V26, P2473, DOI 10.1093/nar/26.10.2473; BLANDIN M, 1974, BIOCHIM BIOPHYS ACTA, V361, P249, DOI 10.1016/0005-2787(74)90368-2; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Brieba LG, 2000, BIOCHEMISTRY-US, V39, P919, DOI 10.1021/bi992324+; CANONICO PG, 1984, TOXICOL APPL PHARM, V74, P155, DOI 10.1016/0041-008X(84)90138-8; Clark JL, 2005, J MED CHEM, V48, P5504, DOI 10.1021/jm0502788; Dore GJ, 2007, AIDS, V21, P1555, DOI 10.1097/QAD.0b013e328216f2c7; DUARTE MIS, 1989, J SUBMICR CYTOL PATH, V21, P275; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; HERSCHLAG D, 1993, BIOCHEMISTRY-US, V32, P8312, DOI 10.1021/bi00083a035; HILLYARD IW, 1980, RIBAVIRIN BROAD SPEC, P59; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Klumpp K, 2006, J BIOL CHEM, V281, P3793, DOI 10.1074/jbc.M510195200; Koch U, 2007, CURR TOP MED CHEM, V7, P1302; Le Pogam S, 2006, VIROLOGY, V351, P349, DOI 10.1016/j.virol.2006.03.045; LIAW YC, 1992, NUCLEIC ACIDS RES, V20, P459, DOI 10.1093/nar/20.3.459; Ma H, 2007, J BIOL CHEM, V282, P29812, DOI 10.1074/jbc.M705274200; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004; PARDI A, 1981, BIOCHEMISTRY-US, V20, P3986, DOI 10.1021/bi00517a007; Perrone P, 2007, J MED CHEM, V50, P5463, DOI 10.1021/jm070362i; Perrone P, 2007, J MED CHEM, V50, P1840, DOI 10.1021/jm0613370; Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001; Roberts S, 2006, HEPATOLOGY, V44, p692A; Sabini E, 2003, NAT STRUCT BIOL, V10, P513, DOI 10.1038/nsb942; SANTOS RA, 1984, BIOCHEMISTRY-US, V28, P9372; Sheldon J, 2007, EXPERT OPIN INV DRUG, V16, P1171, DOI 10.1517/13543784.16.8.1171; Shim J, 2003, ANTIVIR RES, V58, P243, DOI 10.1016/S0166-3542(03)00007-X; Smith DB, 2007, BIOORG MED CHEM LETT, V17, P2570, DOI 10.1016/j.bmcl.2007.02.004; Sorbera LA, 2006, DRUG FUTURE, V31, P320, DOI 10.1358/dof.2006.031.04.977853; SOUSA R, 1995, EMBO J, V14, P4609, DOI 10.1002/j.1460-2075.1995.tb00140.x; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; STREET IP, 1986, BIOCHEMISTRY-US, V25, P6021, DOI 10.1021/bi00368a028; Stuyver LJ, 2004, ANTIMICROB AGENTS CH, V48, P651, DOI 10.1128/AAC.48.2.651-654.2004; TISDALE M, 1995, ANTIMICROB AGENTS CH, V39, P2454, DOI 10.1128/AAC.39.11.2454; TISDALE M, 1993, ANTIVIR CHEM CHEMOTH, V4, P281, DOI 10.1177/095632029300400504; Tomassini JE, 2005, ANTIMICROB AGENTS CH, V49, P2050, DOI 10.1128/AAC.49.5.2050-2058.2005; UESUGI S, 1981, BIOCHEMISTRY-US, V20, P3056, DOI 10.1021/bi00514a011; Usova EV, 1997, EUR J BIOCHEM, V248, P762, DOI 10.1111/j.1432-1033.1997.t01-2-00762.x; Van Rompay AR, 2001, MOL PHARMACOL, V59, P1181, DOI 10.1124/mol.59.5.1181; Wang JH, 2000, BIOCHEM PHARMACOL, V59, P1583, DOI 10.1016/S0006-2952(00)00285-9; Wang LY, 2000, BIOCHEM J, V351, P469, DOI 10.1042/0264-6021:3510469; Wang QM, 2004, PROTEIN EXPRES PURIF, V35, P304, DOI 10.1016/j.pep.2004.01.017	44	75	91	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2167	2175		10.1074/jbc.M708929200	http://dx.doi.org/10.1074/jbc.M708929200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18003608	hybrid			2022-12-25	WOS:000252501000044
J	Narang, SS; Malone, CL; Deschenes, RJ; Fassler, JS				Narang, Sandhya S.; Malone, Cheryl L.; Deschenes, Robert J.; Fassler, Jan S.			Modulation of yeast Sln1 kinase activity by the Ccw12 cell wall protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MUTANTS; GENOME-WIDE ANALYSIS; INTEGRITY PATHWAY; TURGOR PRESSURE; GENE-EXPRESSION; SUN FAMILY; GLYCEROL; SKN7P; REGULATORS; OSMOSENSOR	The yeast Sln1p sensor kinase is best known as an osmosensor involved in the regulation of the hyperosmolarity glycerol mitogen-activated protein kinase cascade. Down-regulation of Sln1 kinase activity occurs under hypertonic conditions and leads to phosphorylation of the Hog1p mitogen-activated protein kinase and increased osmotic stress-response gene expression. Conditions leading to kinase up-regulation include osmotic imbalance caused by glycerol retention in the glycerol channel mutant, fps1 (Tao, W., Deschenes, R. J., and Fassler, J. S. (1999) J. Biol. Chem. 274, 360-367). The hypothesis that Sln1p kinase activity is responsive to turgor was first suggested by the increased Sln1p kinase activity in mutants lacking Fps1p in which glycerol accumulation leads to water uptake. Also consistent with the turgor hypothesis is the observation that reduced turgor caused by treatment of cells with nystatin, a drug that increases membrane permeability and causes cell shrinkage, reduced Sln1p kinase activity (Tao, W., Deschenes, R. J., and Fassler, J. S. (1999) J. Biol. Chem. 274, 360-367; Reiser, V., Raitt, D. C., and Saito, H. (2003) J. Cell Biol. 161, 1035-1040). The turgor hypothesis is revisited here in the context of the identification and characterization of the cell wall gene, CCW12, as a determinant of Sln1p activity. Results of this analysis suggest that the activity of the plasma membrane localized Sln1p is affected by the presence or absence of specific outer cell wall proteins and that this effect is independent of turgor.	[Narang, Sandhya S.; Malone, Cheryl L.; Fassler, Jan S.] Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; [Deschenes, Robert J.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	University of Iowa; Medical College of Wisconsin	Fassler, JS (corresponding author), Univ Iowa, Dept Biol Sci, 202 BBE, Iowa City, IA 52242 USA.	jan-fassler@uiowa.edu	Deschenes, Robert J/E-4926-2010	Deschenes, Robert J/0000-0001-8325-4257	NIGMS NIH HHS [R01 GM056719-08, GM56719, R01 GM056719] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056719] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal AK, 2003, J BIOL CHEM, V278, P34998, DOI 10.1074/jbc.M306291200; Alberts AS, 1998, J BIOL CHEM, V273, P8616, DOI 10.1074/jbc.273.15.8616; Ausubel F. M., 1988, CURRENT PROTOCOLS MO; BROWN JL, 1993, J BACTERIOL, V175, P6908, DOI 10.1128/jb.175.21.6908-6915.1993; BROWN JL, 1994, EMBO J, V13, P5186, DOI 10.1002/j.1460-2075.1994.tb06849.x; DAVENPORT KR, 1995, J BIOL CHEM, V270, P30157; DEAN N, 1995, P NATL ACAD SCI USA, V92, P1287, DOI 10.1073/pnas.92.5.1287; Fassler JS, 1997, J BIOL CHEM, V272, P13365, DOI 10.1074/jbc.272.20.13365; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hagen I, 2004, MOL MICROBIOL, V52, P1413, DOI 10.1111/j.1365-2958.2004.04064.x; HARDWICK KG, 1992, EMBO J, V11, P4187, DOI 10.1002/j.1460-2075.1992.tb05512.x; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Kapteyn JC, 1997, J BACTERIOL, V179, P6279, DOI 10.1128/JB.179.20.6279-6284.1997; Ketela T, 1999, J BACTERIOL, V181, P3330, DOI 10.1128/JB.181.11.3330-3340.1999; KITAMURA K, 1981, AGR BIOL CHEM TOKYO, V45, P1761, DOI 10.1080/00021369.1981.10864786; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1111/j.1574-6976.2002.tb00613.x; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; Krems B, 1996, CURR GENET, V29, P327, DOI 10.1007/s002940050053; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; Li S, 1998, EMBO J, V17, P6952, DOI 10.1093/emboj/17.23.6952; Li S, 2002, MOL BIOL CELL, V13, P412, DOI 10.1091/mbc.01-09-0434; Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998; Lu JMY, 2003, EUKARYOT CELL, V2, P1304, DOI 10.1128/EC.2.6.1304-1314.2003; LUYTEN K, 1995, EMBO J, V14, P1360, DOI 10.1002/j.1460-2075.1995.tb07122.x; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; Merchan S, 2004, EUKARYOT CELL, V3, P100, DOI 10.1128/EC.3.1.100-107.2004; Miller JH, 1972, EXPT MOL GENETICS, P354; Mouassite M, 2000, YEAST, V16, P905, DOI 10.1002/1097-0061(200007)16:10<905::AID-YEA584>3.0.CO;2-1; Mrsa V, 1999, J BACTERIOL, V181, P3076, DOI 10.1128/JB.181.10.3076-3086.1999; O'Rourke SM, 2002, MOL CELL BIOL, V22, P4739, DOI 10.1128/MCB.22.13.4739-4749.2002; Ostrander DB, 1999, J BACTERIOL, V181, P2527, DOI 10.1128/JB.181.8.2527-2534.1999; OTA IM, 1992, P NATL ACAD SCI USA, V89, P2355, DOI 10.1073/pnas.89.6.2355; PELISSIER P, 1995, CURR GENET, V27, P409, DOI 10.1007/BF00311209; Ragni E, 2007, YEAST, V24, P309, DOI 10.1002/yea.1465; Reiser V, 2003, J CELL BIOL, V161, P1035, DOI 10.1083/jcb.200301099; Reiser V, 2000, NAT CELL BIOL, V2, P620, DOI 10.1038/35023568; Shimoi H, 1998, J BACTERIOL, V180, P3381, DOI 10.1128/JB.180.13.3381-3387.1998; SIKORSKI RS, 1989, GENETICS, V122, P19; Sutherland FCW, 1997, J BACTERIOL, V179, P7790, DOI 10.1128/jb.179.24.7790-7795.1997; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Tao W, 2002, MOL MICROBIOL, V43, P459, DOI 10.1046/j.1365-2958.2002.02757.x; Tao W, 1999, J BIOL CHEM, V274, P360, DOI 10.1074/jbc.274.1.360; Velours G, 2002, FEMS MICROBIOL LETT, V207, P165, DOI 10.1111/j.1574-6968.2002.tb11046.x; Yenush L, 2002, EMBO J, V21, P920, DOI 10.1093/emboj/21.5.920	46	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1962	1973		10.1074/jbc.M706877200	http://dx.doi.org/10.1074/jbc.M706877200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18048366	hybrid, Green Accepted			2022-12-25	WOS:000252501000023
J	Poirier, S; Mayer, G; Benjannet, S; Bergeron, E; Marcinkiewicz, J; Nassoury, N; Mayer, H; Nimpf, J; Prat, A; Seidah, NG				Poirier, Steve; Mayer, Gaetan; Benjannet, Suzanne; Bergeron, Eric; Marcinkiewicz, Jadwiga; Nassoury, Nasha; Mayer, Harald; Nimpf, Johannes; Prat, Annik; Seidah, Nabil G.			The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; SECRETED PCSK9; GROWTH-FACTOR; MICE LACKING; MUTATIONS; GENE; CHOLESTEROL; MUTANTS; PATHWAY; OVEREXPRESSION	The proprotein convertase PCSK9 gene is the third locus implicated in familial hypercholesterolemia, emphasizing its role in cardiovascular diseases. Loss of function mutations and gene disruption of PCSK9 resulted in a higher clearance of plasma low density lipoprotein cholesterol, likely due to a reduced degradation of the liver low density lipoprotein receptor (LDLR). In this study, we show that two of the closest family members to LDLR are also PCSK9 targets. These include the very low density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (ApoER2) implicated in neuronal development and lipid metabolism. Our results show that wild type PCSK9 and more so its natural gain of function mutant D374Y can efficiently degrade the LDLR, VLDLR, and ApoER2 either following cellular co-expression or re-internalization of secreted human PCSK9. Such PCSK9-induced degradation does not require its catalytic activity. Membrane-bound PCSK9 chimeras enhanced the intracellular targeting of PCSK9 to late endosomes/lysosomes and resulted in a much more efficient degradation of the three receptors. We also demonstrate that the activity of PCSK9 and its binding affinity on VLDLR and ApoER2 does not depend on the presence of LDLR. Finally, in situ hybridization show close localization of PCSK9 mRNA expression to that of VLDLR in mouse postnatal day 1 cerebellum. Thus, this study demonstrates a more general effect of PCSK9 on the degradation of the LDLR family that emphasizes its major role in cholesterol and lipid homeostasis as well as brain development.	[Poirier, Steve; Mayer, Gaetan; Benjannet, Suzanne; Bergeron, Eric; Marcinkiewicz, Jadwiga; Nassoury, Nasha; Prat, Annik; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Mayer, Harald; Nimpf, Johannes] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, A-1030 Vienna, Austria	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Seidah, NG (corresponding author), 110 Pine Ave, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Bergeron, Eric/N-9566-2019; Seidah, Nabil/I-3596-2013; Prat, Annik/S-6757-2018	Bergeron, Eric/0000-0003-3398-8628; Seidah, Nabil/0000-0001-6503-9342; Prat, Annik/0000-0002-8007-5277; Nimpf, Johannes/0000-0002-9273-3492				Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 1997, J BIOL CHEM, V272, P26210, DOI 10.1074/jbc.272.42.26210; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; BOURBON M, 2007, ATHEROSCLEROSIS; Brown MS, 2006, SCIENCE, V311, P1721, DOI 10.1126/science.1125884; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Conesa M, 2003, BIOCHEM J, V370, P703, DOI 10.1042/BJ20021301; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Howell BW, 2001, CURR OPIN NEUROBIOL, V11, P74, DOI 10.1016/S0959-4388(00)00176-8; Koch S, 2002, EMBO J, V21, P5996, DOI 10.1093/emboj/cdf599; KRIEGER M, 1983, CELL, V33, P413, DOI 10.1016/0092-8674(83)90423-3; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Marcinkiewicz M, 1999, J COMP NEUROL, V403, P471, DOI 10.1002/(SICI)1096-9861(19990125)403:4<471::AID-CNE4>3.0.CO;2-S; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer H, 2006, MOL CELL BIOL, V26, P19, DOI 10.1128/MCB.26.1.19-27.2006; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Naoumova RP, 2005, ARTERIOSCL THROM VAS, V25, P2654, DOI 10.1161/01.ATV.0000190668.94752.ab; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Nour N, 2005, MOL BIOL CELL, V16, P5215, DOI 10.1091/mbc.E05-06-0504; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Poirier S, 2006, J NEUROCHEM, V98, P838, DOI 10.1111/j.1471-4159.2006.03928.x; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Reiner O, 2002, MOL PSYCHIATR, V7, P12, DOI 10.1038/sj/mp/4000975; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2006, BIOL CHEM, V387, P871, DOI 10.1515/BC.2006.110; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Stolt PC, 2006, CELL SIGNAL, V18, P1560, DOI 10.1016/j.cellsig.2006.03.008; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhao SF, 2007, DEV DYNAM, V236, P2708, DOI 10.1002/dvdy.21283; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	43	324	371	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2363	2372		10.1074/jbc.M708098200	http://dx.doi.org/10.1074/jbc.M708098200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039658	hybrid			2022-12-25	WOS:000252501000063
J	Tucker, NP; D'Autreaux, B; Yousafzai, FK; Fairhurst, SA; Spiro, S; Dixon, R				Tucker, Nicholas P.; D'Autreaux, Benoit; Yousafzai, Faridoon K.; Fairhurst, Shirley A.; Spiro, Stephen; Dixon, Ray			Analysis of the nitric oxide-sensing non-heme iron center in the NorR regulatory protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RALSTONIA-EUTROPHA H16; ELECTRON-PARAMAGNETIC-RESONANCE; FURIOSUS SUPEROXIDE REDUCTASE; SOLUBLE GUANYLATE-CYCLASE; ESCHERICHIA-COLI; TRANSCRIPTION FACTOR; ACTIVE-SITE; CRYSTAL-STRUCTURE; GENE-EXPRESSION; MOLECULAR-BASIS	The NorR regulatory protein senses nitric oxide ( NO) to activate genes required for NO detoxification under anaerobic and microaerobic conditions in Escherichia coli. NorR belongs to the sigma(54)-dependent family of transcriptional activators and contains an N-terminal regulatory GAF (c (G) under bar MP phosphodiesterase, adenylate cyclase, (F) under bar hlA) domain that controls the ATPase activity of the central AAA+ domain to regulate productive interactions with sigma(54). Binding of NO to a non-heme iron center in the GAF domain results in the formation of a mononitrosyl-iron complex and releases intramolecular repression of the AAA+ domain to enable activation of transcription. In this study, we have further characterized NorR spectroscopically and substituted conserved residues in the GAF domain. This analysis, in combination with structural modeling of the GAF domain, has identified five candidate ligands to the non-heme iron and suggests a model in which the metal ion is coordinated in a pseudo-octahedral environment by three aspartate residues, an arginine, and a cysteine.	[Tucker, Nicholas P.; D'Autreaux, Benoit; Yousafzai, Faridoon K.; Fairhurst, Shirley A.; Dixon, Ray] John Innes Ctr Plant Sci Res, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England; [Spiro, Stephen] John Innes Ctr Plant Sci Res, Dept Mol & Cell Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dixon, R (corresponding author), John Innes Ctr Plant Sci Res, Dept Mol Microbiol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	ray.dixon@bbsrc.ac.uk	Spiro, Stephen/B-1838-2009; D'Autreaux, Benoit/M-8520-2018	Spiro, Stephen/0000-0001-5975-9984; Tucker, Nicholas/0000-0002-6331-3704; D'Autreaux, Benoit/0000-0002-1276-3019	BBSRC [BB/D009588/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D009588/1, BBS/E/J/00000016] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		AASA R, 1975, J MAGN RESON, V19, P308, DOI 10.1016/0022-2364(75)90045-1; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; ARCIERO DM, 1985, J BIOL CHEM, V260, P4035; BANCI L, 1982, STRUCT BOND, V52, P37, DOI 10.1007/BFb0111296; Bennett B, 1997, BIOCHEMISTRY-US, V36, P9837, DOI 10.1021/bi970735p; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Bodenmiller DM, 2006, J BACTERIOL, V188, P874, DOI 10.1128/JB.188.3.874-881.2006; Boon EM, 2005, NAT CHEM BIOL, V1, P53, DOI 10.1038/nchembio704; Breece RM, 2005, J BIOL CHEM, V280, P11074, DOI 10.1074/jbc.M412582200; Busch A, 2005, BIOCHEM SOC T, V33, P193, DOI 10.1042/BST0330193; Chauvin AS, 2003, INORG CHEM, V42, P1895, DOI 10.1021/ic020401a; Clay MD, 2003, J BIOL INORG CHEM, V8, P671, DOI 10.1007/s00775-003-0465-4; Clay MD, 2003, P NATL ACAD SCI USA, V100, P3796, DOI 10.1073/pnas.0636858100; Clay MD, 2002, J AM CHEM SOC, V124, P788, DOI 10.1021/ja016889g; Cramm R, 2006, BIOCHEM SOC T, V34, P182, DOI 10.1042/BST0340182; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; D'Autreaux B, 2002, P NATL ACAD SCI USA, V99, P16619, DOI 10.1073/pnas.252591299; D'Autreaux B, 2005, NATURE, V437, P769, DOI 10.1038/nature03953; DAVIS JC, 1981, BIOCHEMISTRY-US, V20, P4062, DOI 10.1021/bi00517a018; Ding HG, 2000, P NATL ACAD SCI USA, V97, P5146, DOI 10.1073/pnas.97.10.5146; ENEMARK JH, 1974, COORDIN CHEM REV, V13, P339, DOI 10.1016/S0010-8545(00)80259-3; Fairlie DP, 1997, INORG CHEM, V36, P1020, DOI 10.1021/ic961138e; Filenko N, 2007, J BACTERIOL, V189, P4410, DOI 10.1128/JB.00080-07; FUJISAWA H, 1968, J BIOL CHEM, V243, P2673; Gardner AM, 2003, J BIOL CHEM, V278, P10081, DOI 10.1074/jbc.M212462200; Gardner AM, 2002, J BIOL CHEM, V277, P8166, DOI 10.1074/jbc.M110470200; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Griep MA, 1997, BIOCHEMISTRY-US, V36, P544, DOI 10.1021/bi9612778; Hausladen A, 2001, P NATL ACAD SCI USA, V98, P10108, DOI 10.1073/pnas.181199698; Hausladen A, 1998, P NATL ACAD SCI USA, V95, P14100, DOI 10.1073/pnas.95.24.14100; Ho YSJ, 2000, EMBO J, V19, P5288, DOI 10.1093/emboj/19.20.5288; Hutchings MI, 2002, J BACTERIOL, V184, P4640, DOI 10.1128/JB.184.16.4640-4643.2002; Iyer LM, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-5; Klink A, 2007, J BACTERIOL, V189, P2743, DOI 10.1128/JB.01865-06; Lee YY, 2006, MICROBIOL-SGM, V152, P1461, DOI 10.1099/mic.0.28796-0; LIN J, 1992, MAR CHEM, V38, P283, DOI 10.1016/0304-4203(92)90038-C; MARTINELLI RA, 1989, BIOCHEMISTRY-US, V28, P2251, DOI 10.1021/bi00431a042; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Moore LJ, 2001, J BIOL CHEM, V276, P45744, DOI 10.1074/jbc.M106569200; Mukhopadhyay P, 2004, P NATL ACAD SCI USA, V101, P745, DOI 10.1073/pnas.0307741100; Nakano MM, 2006, J BACTERIOL, V188, P5878, DOI 10.1128/JB.00486-06; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Outten CE, 2001, BIOCHEMISTRY-US, V40, P10417, DOI 10.1021/bi0155448; Pohlmann A, 2000, MOL MICROBIOL, V38, P626, DOI 10.1046/j.1365-2958.2000.02157.x; Ray P, 2002, NUCLEIC ACIDS RES, V30, P3972, DOI 10.1093/nar/gkf528; Rodionov DA, 2005, PLOS COMPUT BIOL, V1, P415, DOI 10.1371/journal.pcbi.0010055; Shingler V, 1996, MOL MICROBIOL, V19, P409, DOI 10.1046/j.1365-2958.1996.388920.x; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Spiro S, 2007, FEMS MICROBIOL REV, V31, P193, DOI 10.1111/j.1574-6976.2006.00061.x; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; THOMPSEN JC, 1984, ANAL CHEM, V56, P755, DOI 10.1021/ac00268a037; Tucker NP, 2004, J BACTERIOL, V186, P6656, DOI 10.1128/JB.186.19.6656-6660.2004; VASAK M, 1981, BIOCHEMISTRY-US, V20, P6659, DOI 10.1021/bi00526a021; Vicente JB, 2005, J BIOL CHEM, V280, P34599, DOI 10.1074/jbc.M506349200; WERTH MT, 1995, INORG CHEM, V34, P218, DOI 10.1021/ic00105a037; Yikilmaz E, 2002, J AM CHEM SOC, V124, P3482, DOI 10.1021/ja011220v; Zhang X, 2002, MOL MICROBIOL, V45, P895, DOI 10.1046/j.1365-2958.2002.03065.x; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753	60	41	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					908	918		10.1074/jbc.M705850200	http://dx.doi.org/10.1074/jbc.M705850200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18003617	hybrid			2022-12-25	WOS:000252128100031
J	Kanai, R; Sheth, BR; Verstraten, FAJ; Shimojo, S				Kanai, Ryota; Sheth, Bhavin R.; Verstraten, Frans A. J.; Shimojo, Shinsuke			Dynamic Perceptual Changes in Audiovisual Simultaneity	PLOS ONE			English	Article							TEMPORAL-ORDER; COMPLICATION EXPERIMENT; ATTENTION; RECALIBRATION; DISTANCE; CAPTURE; VISION; TIME	Background. The timing at which sensory input reaches the level of conscious perception is an intriguing question still awaiting an answer. It is often assumed that both visual and auditory percepts have a modality specific processing delay and their difference determines perceptual temporal offset. Methodology/Principal Findings. Here, we show that the perception of audiovisual simultaneity can change flexibly and fluctuates over a short period of time while subjects observe a constant stimulus. We investigated the mechanisms underlying the spontaneous alternations in this audiovisual illusion and found that attention plays a crucial role. When attention was distracted from the stimulus, the perceptual transitions disappeared. When attention was directed to a visual event, the perceived timing of an auditory event was attracted towards that event. Conclusions/Significance. This multistable display illustrates how flexible perceived timing can be, and at the same time offers a paradigm to dissociate perceptual from stimulus-driven factors in crossmodal feature binding. Our findings suggest that the perception of crossmodal synchrony depends on perceptual binding of audiovisual stimuli as a common event.	[Kanai, Ryota; Shimojo, Shinsuke] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Sheth, Bhavin R.] Univ Houston, Dept Elect & Comp Engn, Houston, TX USA; [Sheth, Bhavin R.] Univ Houston, Ctr NeuroEngn & Cognit Sci, Houston, TX USA; [Verstraten, Frans A. J.] Univ Utrecht, Helmholtz Inst, Dept Expt Psychol, Utrecht, Netherlands	California Institute of Technology; University of Houston System; University of Houston; University of Houston System; University of Houston; Utrecht University	Kanai, R (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	kanair@gmail.com		Kanai, Ryota/0000-0002-0186-2687	Della Martin Fellowship; JST.ERATO; NWO Pionier	Della Martin Fellowship; JST.ERATO(Japan Science & Technology Agency (JST)); NWO Pionier	This work was supported by Della Martin Fellowship (RK), by JST.ERATO (SS) and by NWO Pionier (FV).	Alais D, 2005, P NATL ACAD SCI USA, V102, P2244, DOI 10.1073/pnas.0407034102; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Burrow NT, 1909, PSYCHOL MONOGR, V11, P1; CAIRNEY PT, 1975, PERCEPTION, V4, P255, DOI 10.1068/p040255; Cinel C, 2002, J EXP PSYCHOL HUMAN, V28, P1243, DOI 10.1037/0096-1523.28.5.1243; Driver J, 2000, CURR BIOL, V10, pR731, DOI 10.1016/S0960-9822(00)00740-5; DUNCAN J, 1989, PERCEPTION, V18, P457, DOI 10.1068/p180457; Dunlap K, 1910, PSYCHOL REV, V17, P157, DOI 10.1037/h0073064; ENGEL GR, 1971, NATURE, V234, P308, DOI 10.1038/234308a0; Farroni T, 2000, VIS COGN, V7, P705, DOI 10.1080/13506280050144399; Fendrich R, 2001, PERCEPT PSYCHOPHYS, V63, P719, DOI 10.3758/BF03194432; Findlay JM, 1999, BEHAV BRAIN SCI, V22, P661, DOI 10.1017/S0140525X99002150; Fraisse P, 1964, PSYCHOL TIME; Fujisaki W, 2005, EXP BRAIN RES, V166, P455, DOI 10.1007/s00221-005-2385-8; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; HIKOSAKA O, 1993, VISION RES, V33, P1219, DOI 10.1016/0042-6989(93)90210-N; Hupe JM, 2003, VISION RES, V43, P531, DOI 10.1016/S0042-6989(02)00593-X; JASKOWSKI P, 1990, PSYCHOL RES-PSYCH FO, V52, P35, DOI 10.1007/BF00867209; Kopinska A, 2004, PERCEPTION, V33, P1049, DOI 10.1068/p5169; Lewald J, 2004, NEUROSCI LETT, V357, P119, DOI 10.1016/j.neulet.2003.12.045; Miyazaki M, 2006, NAT NEUROSCI, V9, P875, DOI 10.1038/nn1712; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; Navarra J, 2005, COGNITIVE BRAIN RES, V25, P499, DOI 10.1016/j.cogbrainres.2005.07.009; Pieron H, 1952, SENSATIONS THEIR FUN; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Pressnitzer D, 2006, CURR BIOL, V16, P1351, DOI 10.1016/j.cub.2006.05.054; RUTSCHMANN JACQUES, 1964, PERCEPT MOT SKILLS, V18, P345; Smith WF, 1933, J EXP PSYCHOL, V16, P239, DOI 10.1037/h0071379; Spence C, 2003, CURR BIOL, V13, pR519, DOI 10.1016/S0960-9822(03)00445-7; Spence C, 2001, J EXP PSYCHOL GEN, V130, P799, DOI 10.1037//0096-3445.130.4.799; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; STONE JV, P BIOL SCI, V268, P31; Sugita Y, 2003, NATURE, V421, P911, DOI 10.1038/421911a; Titchener E. B, 1909, LECT ELEMENTARY PSYC; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; Visser TAW, 2001, PERCEPTION, V30, P135, DOI 10.1068/p3089; Vroomen J, 2004, J EXP PSYCHOL HUMAN, V30, P513, DOI 10.1037/0096-1523.30.3.513; WUNDT WM, 1833, PHILOS STUDIEN; Yeshurun Y, 2003, PSYCHOL SCI, V14, P225, DOI 10.1111/1467-9280.02436; Zampini M, 2005, PERCEPT PSYCHOPHYS, V67, P531, DOI 10.3758/BF03193329; Zampini M, 2003, EXP BRAIN RES, V152, P198, DOI 10.1007/s00221-003-1536-z	41	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1253	10.1371/journal.pone.0001253	http://dx.doi.org/10.1371/journal.pone.0001253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060050	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000207459400002
J	Lighton, JRB; Schilman, PE				Lighton, John R. B.; Schilman, Pablo E.			Oxygen Reperfusion Damage in an Insect	PLOS ONE			English	Article								The deleterious effects of anoxia followed by reperfusion with oxygen in higher animals including mammals are well known. A convenient and genetically well characterized small-animal model that exhibits reproducible, quantifiable oxygen reperfusion damage is currently lacking. Here we describe the dynamics of whole-organism metabolic recovery from anoxia in an insect, Drosophila melanogaster, and report that damage caused by oxygen reperfusion can be quantified in a novel but straightforward way. We monitored CO(2) emission ( an index of mitochondrial activity) and water vapor output ( an index of neuromuscular control of the spiracles, which are valves between the outside air and the insect's tracheal system) during entry into, and recovery from, rapid-onset anoxia exposure with durations ranging from 7.5 to 120 minutes. Anoxia caused a brief peak of CO(2) output followed by knock-out. Mitochondrial respiration ceased and the spiracle constrictor muscles relaxed, but then re-contracted, presumably powered by anaerobic processes. Reperfusion to sustained normoxia caused a bimodal reactivation of mitochondrial respiration, and in the case of the spiracle constrictor muscles, slow inactivation followed by reactivation. After long anoxia durations, both the bimodality of mitochondrial reactivation and the recovery of spiracular control were impaired. Repeated reperfusion followed by episodes of anoxia depressed mitochondrial respiratory flux rates and damaged the integrity of the spiracular control system in a dose-dependent fashion. This is the first time that physiological evidence of oxygen reperfusion damage has been described in an insect or any invertebrate. We suggest that some of the traditional approaches of insect respiratory biology, such as quantifying respiratory water loss, may facilitate using D. melanogaster as a convenient, well-characterized experimental model for studying the underlying biology and mechanisms of ischemia and reperfusion damage and its possible mitigation.	[Lighton, John R. B.] Univ Nevada, Dept Biol Sci, Las Vegas, NV 89154 USA; [Lighton, John R. B.] Sable Syst Int, Las Vegas, NV USA; [Schilman, Pablo E.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of California System; University of California San Diego	Lighton, JRB (corresponding author), Univ Nevada, Dept Biol Sci, Las Vegas, NV 89154 USA.	john.lighton@unlv.edu	Schilman, Pablo/GLR-8952-2022; Lighton, John R B/A-9691-2009	Lighton, John/0000-0002-9264-924X; Schilman, Pablo/0000-0003-1485-1650	Sable Systems International	Sable Systems International	We received funding from Sable Systems International.	Chown SL, 2006, PHYSIOL BIOCHEM ZOOL, V79, P333, DOI 10.1086/499992; Haddad GG, 1997, P NATL ACAD SCI USA, V94, P10809, DOI 10.1073/pnas.94.20.10809; Harrison J, 2006, RESP PHYSIOL NEUROBI, V154, P4, DOI 10.1016/j.resp.2006.02.008; Hermes-Lima M, 2002, COMP BIOCHEM PHYS C, V133, P537, DOI 10.1016/S1532-0456(02)00080-7; Hetz SK, 2005, NATURE, V433, P516, DOI 10.1038/nature03106; Idris AH, 2005, CRIT CARE MED, V33, P2043, DOI 10.1097/01.CCM.0000174104.50799.BD; Joanisse DR, 1996, J EXP BIOL, V199, P1483; Joos B, 1997, PHYSIOL ZOOL, V70, P167, DOI 10.1086/639570; Kestler P., 1985, P137; Krishnan SN, 1997, J INSECT PHYSIOL, V43, P203, DOI 10.1016/S0022-1910(96)00084-4; Krogh A, 1920, PFLUG ARCH GES PHYS, V179, P95, DOI 10.1007/BF01722125; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; Lehmann FA, 2001, SCIENCE, V294, P1926, DOI 10.1126/science.1064821; Lighton JRB, 2007, J THERM BIOL, V32, P134, DOI 10.1016/j.jtherbio.2007.01.009; Lighton JRB, 2005, J EXP BIOL, V208, P4671, DOI 10.1242/jeb.01934; LIGHTON JRB, 1989, PHYSIOL ZOOL, V62, P1232, DOI 10.1086/physzool.62.6.30156211; LIGHTON JRB, 1995, J EXP BIOL, V198, P1613; Lighton JRB, 2004, J EXP BIOL, V207, P4463, DOI 10.1242/jeb.01284; Lighton JRB, 1998, AM ZOOL, V38, P483; Lighton JRB, 1996, J INSECT PHYSIOL, V42, P347, DOI 10.1016/0022-1910(95)00112-3; LIGHTON JRB, 1991, CONCISE ENCY BIOL BI, P201; Liu GW, 2006, PHYSIOL GENOMICS, V25, P134, DOI 10.1152/physiolgenomics.00262.2005; Mellanby K, 1935, BIOL REV CAMB PHILOS, V10, P317, DOI 10.1111/j.1469-185X.1935.tb00487.x; Storey KB., 2004, FUNCTIONAL METABOLIS, DOI [10.1002/047167558X, DOI 10.1002/047167558X]; Wigglesworth V.B., 1983, Advances in Insect Physiology, V17, P85, DOI 10.1016/S0065-2806(08)60217-9; Williams AE, 1998, J EXP BIOL, V201, P2953; Zhou D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000490	27	53	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1267	10.1371/journal.pone.0001267	http://dx.doi.org/10.1371/journal.pone.0001267			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060061	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459400014
J	Ninomiya, Y; Ichinose, S				Ninomiya, Youichirou; Ichinose, Shizuko			Subcellular Distribution of Mitochondrial Ribosomal RNA in the Mouse Oocyte and Zygote	PLOS ONE			English	Article							GERM PLASM; DROSOPHILA EMBRYOS; LOCALIZATION; PROTEINS; POLARITY; CLEAVAGE; SPERM; STAGE; EGGS; ACQUISITION	Mitochondrial ribosomal RNAs (mtrRNAs) have been reported to translocate extra-mitochondrially and localize to the germ cell determinant of oocytes and zygotes in some metazoa except mammals. To address whether the mtrRNAs also localize in the mammals, expression and distribution of mitochondrion-encoded RNAs in the mouse oocytes and zygotes was examined by whole-mount in situ hybridization (ISH). Both 12S and 16S rRNAs were predominantly distributed in the animal hemisphere of the mature oocyte. This distribution pattern was rearranged toward the second polar body in zygotes after fertilization. The amount of mtrRNAs decreased around first cleavage, remained low during second cleavage and increased after third cleavage. Staining intensity of the 12S rRNA was weaker than that of the 16S rRNA throughout the examined stages. Similar distribution dynamics of the 16S rRNA was observed in strontium-activated haploid parthenotes, suggesting the distribution rearrangement does not require a component from sperm. The distribution of 16S rRNAs did not coincide with that of mitochondrion-specific heat shock protein 70, suggesting that the mtrRNA is translocated from mitochondria. The ISH-scanning electron microscopy confirms the extra-mitochondrial mtrRNA in the mouse oocyte. Chloramphenicol (CP) treatment of late pronuclear stage zygotes perturbed first cleavage as judged by the greater than normal disparity in size of blastomeres of 2-cell conceptuses. Two-third of the CP-treated zygotes arrested at either 2-cell or 3-cell stage even after the CP was washed out. These findings indicate that the extra-mitochondrial mtrRNAs are localized in the mouse oocyte and implicated in correct cytoplasmic segregation into blastomeres through cleavages of the zygote.	[Ninomiya, Youichirou] Univ Oxford, Dept Zool, Mammalian Dev Lab, Oxford OX1 3PS, England; [Ichinose, Shizuko] Tokyo Med & Dent Univ, Instrumental Anal Res Ctr, Bunkyo Ku, Tokyo, Japan	University of Oxford; Tokyo Medical & Dental University (TMDU)	Ninomiya, Y (corresponding author), Univ Oxford, Dept Zool, Mammalian Dev Lab, S Parks Rd, Oxford OX1 3PS, England.	yo.ninomy@zoo.ox.ac.uk		Ninomiya, Youichirou/0000-0003-3572-2532	Biotechnology and Biological Sciences Research Council, UK (BBSRC) [43/G17886]; March of Dimes Foundation, USA; Grant-in-Aid for Scientific Research; Japan Society for the Promotion of Science, Japan [19500403]	Biotechnology and Biological Sciences Research Council, UK (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); March of Dimes Foundation, USA(March of Dimes); Grant-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Biotechnology and Biological Sciences Research Council, UK (BBSRC, Grant Reference Number 43/G17886), the March of Dimes Foundation, USA to YN and the Grant-in-Aid for Scientific Research, the Japan Society for the Promotion of Science, Japan (Project Number 19500403) to SI.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Amikura R, 2005, MECH DEVELOP, V122, P1087, DOI 10.1016/j.mod.2005.06.003; Amikura R, 2001, P NATL ACAD SCI USA, V98, P9133, DOI 10.1073/pnas.171286998; Antczak M, 1997, MOL HUM REPROD, V3, P1067, DOI 10.1093/molehr/3.12.1067; Aoki F, 2003, MOL REPROD DEV, V64, P270, DOI 10.1002/mrd.10227; Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; CALARCO PG, 1995, DEV GENET, V16, P36, DOI 10.1002/dvg.1020160108; CASCIO SM, 1981, DEV BIOL, V83, P166, DOI 10.1016/S0012-1606(81)80019-X; Davies TJ, 2002, HUM REPROD, V17, P2368, DOI 10.1093/humrep/17.9.2368; DING D, 1994, DEV BIOL, V163, P503, DOI 10.1006/dbio.1994.1166; DING D, 1993, BIOESSAYS, V15, P651, DOI 10.1002/bies.950151004; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; EVSIKOV SV, 1994, ROUX ARCH DEV BIOL, V203, P199, DOI 10.1007/BF00636335; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Gardner R L, 2003, Reprod Biomed Online, V6, P157; Gardner RL, 2006, HUM REPROD, V21, P492, DOI 10.1093/humrep/dei318; Gardner RL, 2002, HUM REPROD, V17, P3178, DOI 10.1093/humrep/17.12.3178; Gardner RL, 1999, BIOESSAYS, V21, P271, DOI 10.1002/(SICI)1521-1878(199904)21:4<271::AID-BIES2>3.0.CO;2-C; Gardner RL, 2006, REPROD BIOMED ONLINE, V12, P144, DOI 10.1016/S1472-6483(10)60853-X; Gardner RL, 2003, PHILOS T ROY SOC B, V358, P1331, DOI 10.1098/rstb.2003.1322; GREEN JM, 1995, HYBRIDOMA, V14, P347, DOI 10.1089/hyb.1995.14.347; Gur Y, 2006, GENE DEV, V20, P411, DOI 10.1101/gad.367606; HAY B, 1988, DEVELOPMENT, V103, P625; Hiiragi T, 2004, NATURE, V430, P360, DOI 10.1038/nature02595; Hiiragi T, 2006, NATURE, V442, pE3, DOI 10.1038/nature04907; Hiiragi T, 2006, REPROD BIOMED ONLINE, V12, P150, DOI 10.1016/S1472-6483(10)60854-1; Hiiragi T, 2006, INT J DEV BIOL, V50, P581, DOI 10.1387/ijdb.062181th; Ichinose S, 2005, CLIN EXP PHARMACOL P, V32, P561, DOI 10.1111/j.1440-1681.2005.04231.x; Iida T, 1998, P NATL ACAD SCI USA, V95, P11274, DOI 10.1073/pnas.95.19.11274; INGLIS JD, 1993, MAMM GENOME, V4, P401, DOI 10.1007/BF00360595; JOHNSON MH, 1981, BIOL REV, V56, P463, DOI 10.1111/j.1469-185X.1981.tb00356.x; King ML, 1999, BIOESSAYS, V21, P546, DOI 10.1002/(SICI)1521-1878(199907)21:7<546::AID-BIES3>3.0.CO;2-Z; Kloc M, 2001, INT REV CYTOL, V203, P63; Ko MSH, 2000, DEVELOPMENT, V127, P1737; Kobayashi S, 1998, CURR BIOL, V8, P1117, DOI 10.1016/S0960-9822(98)70466-X; KOBAYASHI S, 1989, DEVELOPMENT, V107, P733; KOBAYASHI S, 1995, DEV BIOL, V169, P384, DOI 10.1006/dbio.1995.1153; KOBAYASHI S, 1993, SCIENCE, V260, P1521, DOI 10.1126/science.7684857; LATHAM KE, 1992, DEV BIOL, V149, P457, DOI 10.1016/0012-1606(92)90300-6; Mahowald AP, 2001, INT REV CYTOL, V203, P187; Matova N, 2001, DEV BIOL, V231, P291, DOI 10.1006/dbio.2000.0120; Motosugi N, 2005, GENE DEV, V19, P1081, DOI 10.1101/gad.1304805; Motosugi N, 2006, PLOS BIOL, V4, P799, DOI 10.1371/journal.pbio.0040135; Mowry KL, 1999, FASEB J, V13, P435, DOI 10.1096/fasebj.13.3.435; MULNARD J, 1984, ARCH BIOL, V95, P461; Ninomiya Y, 2005, DEV DYNAM, V233, P837, DOI 10.1002/dvdy.20405; Ogawa M, 1999, ZOOL SCI, V16, P445, DOI 10.2108/zsj.16.445; OKADA M, 1974, DEV BIOL, V37, P43, DOI 10.1016/0012-1606(74)90168-7; Perkins GA, 2000, MICRON, V31, P97, DOI 10.1016/S0968-4328(99)00065-7; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; PIKO L, 1973, J CELL BIOL, V58, P357, DOI 10.1083/jcb.58.2.357; Piotrowska K, 2001, NATURE, V409, P517, DOI 10.1038/35054069; Plusa B, 2002, NAT CELL BIOL, V4, P811, DOI 10.1038/ncb860; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Rand K, 2001, Results Probl Cell Differ, V34, P157; Rasband W., 2006, IMAGEJ; Reunov A, 2004, ZYGOTE, V12, P329, DOI 10.1017/S0967199404002916; Reunov A, 2006, ZYGOTE, V14, P231, DOI 10.1017/S0967199406003789; Rushlow C, 1990, Semin Cell Biol, V1, P137; SCHUPBACH T, 1994, CURR OPIN GENET DEV, V4, P502, DOI 10.1016/0959-437X(94)90064-A; Tokura Takashi, 1993, Journal of Assisted Reproduction and Genetics, V10, P417, DOI 10.1007/BF01228092; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; VANBLERKOM J, 1984, AM J ANAT, V171, P335, DOI 10.1002/aja.1001710309; VANBLERKOM J, 1981, P NATL ACAD SCI-BIOL, V78, P7629; Villegas J, 2002, MOL HUM REPROD, V8, P977, DOI 10.1093/molehr/8.11.977; Vinot S, 2005, DEV BIOL, V282, P307, DOI 10.1016/j.ydbio.2005.03.001; Vinot S, 2004, CURR BIOL, V14, P520, DOI 10.1016/j.cub.2004.02.061; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Zernicka-Goetz M, 1998, DEVELOPMENT, V125, P4803; Zernicka-Goetz M, 2006, CURR OPIN GENET DEV, V16, P406, DOI 10.1016/j.gde.2006.06.011; Zernicka-Goetz MZ, 2005, NAT REV MOL CELL BIO, V6, P919, DOI 10.1038/nrm1782	72	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1241	10.1371/journal.pone.0001241	http://dx.doi.org/10.1371/journal.pone.0001241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043748	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459300022
J	Chan, LY; Cross, HF; She, JK; Cavalli, G; Martins, HFP; Neylon, C				Chan, Lilyan; Cross, Hannah F.; She, Joseph K.; Cavalli, Gabriel; Martins, Hugo F. P.; Neylon, Cameron			Covalent Attachment of Proteins to Solid Supports and Surfaces via Sortase-Mediated Ligation	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; IMMOBILIZATION; MUTANT; CHIP; TUS	Background. There is growing interest in the attachment of proteins to solid supports for the development of supported catalysts, affinity matrices, and micro devices as well as for the development of planar and bead based protein arrays for multiplexed assays of protein concentration, interactions, and activity. A critical requirement for these applications is the generation of a stable linkage between the solid support and the immobilized, but still functional, protein. Methodology. Solid supports including crosslinked polymer beads, beaded agarose, and planar glass surfaces, were modified to present an oligoglycine motif to solution. A range of proteins were ligated to the various surfaces using the Sortase A enzyme of S. aureus. Reactions were carried out in aqueous buffer conditions at room temperature for times between one and twelve hours. Conclusions. The Sortase A transpeptidase of S. aureus provides a general, robust, and gentle approach to the selective covalent immobilization of proteins on three very different solid supports. The proteins remain functional and accessible to solution. Sortase mediated ligation is therefore a straightforward methodology for the preparation of solid supported enzymes and bead based assays, as well as the modification of planar surfaces for microanalytical devices and protein arrays.	[Chan, Lilyan; Cross, Hannah F.; She, Joseph K.; Cavalli, Gabriel; Martins, Hugo F. P.; Neylon, Cameron] Univ Southampton, Sch Chem, Southampton, Hants, England; [Cavalli, Gabriel] Univ Surrey, Sch Biomed & Mol Sci, Guildford GU2 5XH, Surrey, England; [Neylon, Cameron] Rutherford Appleton Lab, Sci & Technol Facil Council, Didcot OX11 0QX, Oxon, England	University of Southampton; University of Surrey; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Neylon, C (corresponding author), Univ Southampton, Sch Chem, Southampton, Hants, England.	C.Neylon@rl.ac.uk	Cavalli, Gabriel/ABE-2401-2020; Cavalli, Gabriel/B-7207-2009	Cavalli, Gabriel/0000-0002-2856-1956; Cavalli, Gabriel/0000-0002-2856-1956; Neylon, Cameron/0000-0002-0068-716X	Research Councils UK through the Basic Technology Programme	Research Councils UK through the Basic Technology Programme	This work was supported in part by Research Councils UK through the Basic Technology Programme.	Camarero JA, 2004, J AM CHEM SOC, V126, P14730, DOI 10.1021/ja0456611; Cazalis CS, 2004, BIOCONJUGATE CHEM, V15, P1005, DOI 10.1021/bc049903y; Cha T, 2005, PROTEOMICS, V5, P416, DOI 10.1002/pmic.200400948; Choi JW, 2002, LAB CHIP, V2, P27, DOI 10.1039/b107540n; Decreau RA, 2007, J ORG CHEM, V72, P2794, DOI 10.1021/jo062349w; Girish A, 2005, BIOORG MED CHEM LETT, V15, P2447, DOI 10.1016/j.bmcl.2005.03.079; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Ichihara T, 2006, J PROTEOME RES, V5, P2144, DOI 10.1021/pr0504889; JEONG WJ, 2005, CONTINUOUS FABRICATI, P3738; KALIA J, BIOCONJUG CHEM; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Neylon C, 2000, BIOCHEMISTRY-US, V39, P11989, DOI 10.1021/bi001174w; Neylon C, 2005, MICROBIOL MOL BIOL R, V69, P501, DOI 10.1128/MMBR.69.3.501-526.2005; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; POPP MW, 2007, NAT CHEM BIOL; PRITZ S, 2007, J ORG CHEM; SCHWENK JM, 2006, MOL CELL PROTEOMICS; Soellner MB, 2003, J AM CHEM SOC, V125, P11790, DOI 10.1021/ja036712h; Sun XL, 2006, BIOCONJUGATE CHEM, V17, P52, DOI 10.1021/bc0502311; Tan LP, 2004, BIOORG MED CHEM LETT, V14, P6067, DOI 10.1016/j.bmcl.2004.09.083; Terrettaz S, 2002, PROTEIN SCI, V11, P1917, DOI 10.1110/ps.0206102; Tomizaki KY, 2005, CHEMBIOCHEM, V6, P783, DOI 10.1002/cbic.200400232; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Watzke A, 2006, ANGEW CHEM INT EDIT, V45, P1408, DOI 10.1002/anie.200502057; Zhang ZL, 2005, MICROELECTRON ENG, V78-79, P556, DOI 10.1016/j.mee.2004.12.071	26	82	92	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1164	10.1371/journal.pone.0001164	http://dx.doi.org/10.1371/journal.pone.0001164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000537	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459100007
J	Tsuruma, R; Ohbayashi, N; Kamitani, S; Ikeda, O; Sato, N; Muromoto, R; Sekine, Y; Oritani, K; Matsuda, T				Tsuruma, R.; Ohbayashi, N.; Kamitani, S.; Ikeda, O.; Sato, N.; Muromoto, R.; Sekine, Y.; Oritani, K.; Matsuda, T.			Physical and functional interactions between STAT3 and KAP1	ONCOGENE			English	Article						IL-6; STAT3; KAP1; transcriptional regulation; phosphorylation	ZINC-FINGER PROTEINS; TRANSCRIPTIONAL ACTIVATION; COREPRESSOR COMPLEX; SIGNAL TRANSDUCERS; PHOSPHORYLATION; ACETYLATION; PATHWAYS; TYROSINE; DOMAIN; FAMILY	Signal transducers and activators of transcription (STATs) mediate cell proliferation, differentiation and survival in immune responses, hematopoiesis, neurogenesis and other biological processes. For example, STAT3 has been reported to be constitutively activated in numerous cancer cells. To clarify the molecular mechanisms underlying the STAT activation, we performed yeast two-hybrid screening and identified KAP1/TIF1b as a novel STAT-binding partner. KAP1 is a universal corepressor protein for the Kruppel-associated box zinc-finger protein superfamily of transcriptional repressors. We found endogenous KAP1 associated with endogenous STAT3 in vivo. Importantly, small-interfering RNA-mediated reduction of KAP1 expression enhanced interleukin (IL)-6-induced STAT3-dependent transcription and gene expression. Furthermore, reduction of KAP1 expression resulted in the marked accumulation of STAT3 phosphorylated on Ser727 in the nucleus, a modi. cation that regulates its transcriptional activation. These results indicate that KAP1 may serve as a transcriptional regulator of the IL-6/STAT3 signaling pathway.	[Tsuruma, R.; Ohbayashi, N.; Kamitani, S.; Ikeda, O.; Sato, N.; Muromoto, R.; Sekine, Y.; Matsuda, T.] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Oritani, K.] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Osaka, Japan	Hokkaido University; Osaka University	Matsuda, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan.	tmatsuda@pharm.hokudai.ac.jp	Muromoto, Ryuta/E-4203-2012; Sekine, Yuichi/S-8813-2019; Matsuda, Tadashi/A-3835-2012	Muromoto, Ryuta/0000-0002-7474-493X; Sekine, Yuichi/0000-0002-2861-603X; Matsuda, Tadashi/0000-0002-3089-3757				Agata Y, 1999, J BIOL CHEM, V274, P16412, DOI 10.1074/jbc.274.23.16412; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Herrmann A, 2004, J CELL SCI, V117, P339, DOI 10.1242/jcs.00833; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Ohbayashi N, 2007, BIOL PHARM BULL, V30, P1860, DOI 10.1248/bpb.30.1860; OShea JJ, 1997, IMMUNITY, V7, P1, DOI 10.1016/S1074-7613(00)80505-1; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Schuringa JJ, 2001, FEBS LETT, V495, P71, DOI 10.1016/S0014-5793(01)02354-7; Sekine Y, 2007, ONCOGENE, V26, P6038, DOI 10.1038/sj.onc.1210426; Sekine Y, 2006, ONCOGENE, V25, P5801, DOI 10.1038/sj.onc.1209578; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; ZHONG Z, 1994, P NATL ACAD SCI USA, V91, P4806, DOI 10.1073/pnas.91.11.4806	22	52	53	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 8	2008	27	21					3054	3059		10.1038/sj.onc.1210952	http://dx.doi.org/10.1038/sj.onc.1210952			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	298IP	18037959	Green Submitted			2022-12-25	WOS:000255681700012
J	Job, V; Carapito, R; Vernet, T; Dessen, A; Zapun, A				Job, Viviana; Carapito, Raphael; Vernet, Thierry; Dessen, Andrea; Zapun, Andre			Common alterations in PBP1a from resistant streptococcus pneumoniae decrease its reactivity toward beta-lactams - Structural insights	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN-BINDING PROTEINS; CRYSTAL-STRUCTURE; CLINICAL ISOLATE; GENES; ANTIBIOTICS; PBP2X; 2X; 1A; SUSCEPTIBILITY; IDENTIFICATION	The development of high level beta-lactam resistance in the pneumococcus requires the expression of an altered form of PBP1a, in addition to modified forms of PBP2b and PBP2x, which are necessary for the appearance of low levels of resistance. Here, we present the crystal structure of a soluble form of PBP1a from the highly resistant Streptococcus pneumoniae strain 5204 (minimal inhibitory concentration of cefotaxime is 12 mg center dot liter(-1)). Mutations T371A, which is adjacent to the catalytic nucleophile Ser(370), and TSQF(574-577) NTGY, which lie in a loop bordering the active site cleft, were investigated by site-directed mutagenesis. The consequences of these substitutions on reaction kinetics with beta-lactams were probed in vitro, and their effect on resistance was measured in vivo. The results are interpreted in the framework of the crystal structure, which displays a narrower, discontinuous active site cavity, compared with that of PBP1a from the beta-lactam susceptible strain R6, as well as a reorientation of the catalytic Ser(370).	[Carapito, Raphael; Vernet, Thierry; Zapun, Andre] Univ Grenoble 1, CNRS,UMR 5075, Inst Biol Struct Jean Pierre Ebel, Lab Ingn Macromol, F-38025 Grenoble, France; [Job, Viviana; Dessen, Andrea] Univ Grenoble 1, CNRS,UMR 5075, Inst Biol Struct Jean Pierre Ebel, Lab Prot Membranaires, F-38025 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Zapun, A (corresponding author), Univ Grenoble 1, CNRS,UMR 5075, Inst Biol Struct Jean Pierre Ebel, Lab Ingn Macromol, 41 Rue Jules Horwitz, F-38025 Grenoble, France.	andre.zapun@ibs.fr	Carapito, Raphael/ABG-5061-2020; Carapito, Raphael/O-5317-2016; Vernet, Thierry/G-1118-2012	Carapito, Raphael/0000-0002-7036-442X; Carapito, Raphael/0000-0002-7036-442X; Zapun, Andre/0000-0001-8953-4399; Dessen, Andrea/0000-0001-6487-4020; Job, Viviana/0000-0001-8421-5292				[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BARCUS VA, 1995, FEMS MICROBIOL LETT, V126, P299, DOI 10.1016/0378-1097(95)00026-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carapito R, 2006, J BIOL CHEM, V281, P1771, DOI 10.1074/jbc.M511506200; Carapito R, 2006, ANAL BIOCHEM, V355, P110, DOI 10.1016/j.ab.2006.04.047; Chesnel L, 2003, J BIOL CHEM, V278, P44448, DOI 10.1074/jbc.M305948200; CLAVERYS JP, 1986, MICROBIOL REV, V50, P133, DOI 10.1128/MMBR.50.2.133-165.1986; Contreras-Martel C, 2006, J MOL BIOL, V355, P684, DOI 10.1016/j.jmb.2005.10.030; Dessen A, 2001, J BIOL CHEM, V276, P45106, DOI 10.1074/jbc.M107608200; Di Guilmi AM, 1998, J BACTERIOL, V180, P5652, DOI 10.1128/JB.180.21.5652-5659.1998; DOWSON CG, 1989, P NATL ACAD SCI USA, V86, P8842, DOI 10.1073/pnas.86.22.8842; DOWSON CG, 1993, MOL MICROBIOL, V9, P635, DOI 10.1111/j.1365-2958.1993.tb01723.x; du Plessis M, 1999, J CLIN MICROBIOL, V37, P628, DOI 10.1128/JCM.37.3.628-632.1999; du Plessis M, 2002, ANTIMICROB AGENTS CH, V46, P2349, DOI 10.1128/AAC.46.8.2349-2357.2002; Graves-Woodward K, 1998, BIOCHEM J, V332, P755, DOI 10.1042/bj3320755; Grebe T, 1996, ANTIMICROB AGENTS CH, V40, P829, DOI 10.1128/AAC.40.4.829; Hakenbeck R, 1999, MOL MICROBIOL, V33, P673, DOI 10.1046/j.1365-2958.1999.01521.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LAIBLE G, 1991, MOL MICROBIOL, V5, P1993, DOI 10.1111/j.1365-2958.1991.tb00821.x; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lu WP, 2001, J BIOL CHEM, V276, P31494, DOI 10.1074/jbc.M102499200; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; MARTIN C, 1992, EMBO J, V11, P3831, DOI 10.1002/j.1460-2075.1992.tb05475.x; MAUGEIN J, 2006, B EPIDEMIOLOGIQUE HE, V1, P6; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Mouz N, 1998, P NATL ACAD SCI USA, V95, P13403, DOI 10.1073/pnas.95.23.13403; Mouz N, 1999, J BIOL CHEM, V274, P19175, DOI 10.1074/jbc.274.27.19175; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Pernot L, 2004, J BIOL CHEM, V279, P16463, DOI 10.1074/jbc.M313492200; Reichmann P, 1996, MICROB DRUG RESIST, V2, P177, DOI 10.1089/mdr.1996.2.177; SIBOLD C, 1994, MOL MICROBIOL, V12, P1013, DOI 10.1111/j.1365-2958.1994.tb01089.x; Smith AM, 1998, ANTIMICROB AGENTS CH, V42, P1329, DOI 10.1128/AAC.42.6.1329; Smith AM, 2003, ANTIMICROB AGENTS CH, V47, P387, DOI 10.1128/AAC.47.1.387-389.2003; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TIPPER DJ, 1965, P NATL ACAD SCI USA, V54, P1133, DOI 10.1073/pnas.54.4.1133	38	37	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4886	4894		10.1074/jbc.M706181200	http://dx.doi.org/10.1074/jbc.M706181200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18055459	Green Published, hybrid			2022-12-25	WOS:000253426500046
J	Langelier, MF; Servent, KM; Rogers, EE; Pascal, JM				Langelier, Marie-France; Servent, Kristin M.; Rogers, Elizabeth E.; Pascal, John M.			A third zinc-binding domain of human poly(ADP-ribose) polymerase-1 coordinates DNA-dependent enzyme activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLTRANSFERASE; CATALYTIC-ACTIVITY; PROTEIN; PARP-1; SIGNAL; ASSOCIATION; CLEAVAGE; FINGERS; DAMAGE; XRCC1	Poly(ADP-ribose) polymerase-1 (PARP-1) is a chromatin-associated enzyme with multiple cellular functions, including DNA repair, transcriptional regulation, and cell signaling. PARP-1 has a modular architecture with six independent domains comprising the 113-kDa polypeptide. Two zinc finger domains at the N terminus of PARP-1 bind to DNA and thereby activate the catalytic domain situated at the C terminus of the enzyme. The tight coupling of DNA binding and catalytic activities is critical to the cellular regulation of PARP-1 function; however, the mechanism for coordinating these activities remains an unsolved problem. Here, we demonstrate using spectroscopic and crystallographic analysis that human PARP-1 has a third zinc-binding domain. Biochemical mutagenesis and deletion analysis indicate that this region mediates interdomain contacts important for DNA-dependent enzyme activation. The crystal structure of the third zinc-binding domain reveals a zinc ribbon fold and suggests conserved residues that could form interdomain contacts. The new zinc-binding domain self-associates in the crystal lattice to form a homodimer with a head-to-tail arrangement. The structure of the homodimer provides a scaffold for assembling the activated state of PARP-1 and suggests a mechanism for coupling the DNA binding and catalytic functions of PARP-1.	[Langelier, Marie-France; Servent, Kristin M.; Rogers, Elizabeth E.; Pascal, John M.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University	Pascal, JM (corresponding author), 233 South 10th St,BLSB 804, Philadelphia, PA 19107 USA.	John.Pascal@mail.jci.tju.edu						ALVAREZGONZALEZ R, 1987, BIOCHEMISTRY-US, V26, P3218, DOI 10.1021/bi00385a042; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; BAUER PI, 1990, BIOCHEM J, V270, P17, DOI 10.1042/bj2700017; Bertini I, 1984, Adv Inorg Biochem, V6, P71; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; BUKI KG, 1995, J BIOL CHEM, V270, P3370, DOI 10.1074/jbc.270.7.3370; BUKI KG, 1988, BIOCHEMISTRY-US, V27, P5990, DOI 10.1021/bi00416a024; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; D'Amours D, 2001, J CELL SCI, V114, P3771; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; GRADWOHL G, 1990, P NATL ACAD SCI USA, V87, P2990, DOI 10.1073/pnas.87.8.2990; GRATZER WB, 1969, NATURE, V222, P426, DOI 10.1038/222426a0; Haince JF, 2005, TRENDS MOL MED, V11, P456, DOI 10.1016/j.molmed.2005.08.003; Huang K, 2004, BIOCHEMISTRY-US, V43, P217, DOI 10.1021/bi0301800; IKEJIMA M, 1990, J BIOL CHEM, V265, P21907; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; KAMESHITA I, 1986, J BIOL CHEM, V261, P3863; Kanai M, 2007, NAT CELL BIOL, V9, P1175, DOI 10.1038/ncb1638; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; KAWAICHI M, 1981, J BIOL CHEM, V256, P9483; Kim JW, 2000, J BIOL CHEM, V275, P8121, DOI 10.1074/jbc.275.11.8121; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Matthews JM, 2000, EUR J BIOCHEM, V267, P1030, DOI 10.1046/j.1432-1327.2000.01095.x; MAY SW, 1978, BIOCHEMISTRY-US, V17, P3333, DOI 10.1021/bi00609a025; MAZEN A, 1989, NUCLEIC ACIDS RES, V17, P4689, DOI 10.1093/nar/17.12.4689; MENDOZAALVAREZ H, 1993, J BIOL CHEM, V268, P22575; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pion E, 2005, BIOCHEMISTRY-US, V44, P14670, DOI 10.1021/bi050755o; Rolli V., 2000, DNA DAMAGE STRESS SI, P35; Ruf A, 1996, P NATL ACAD SCI USA, V93, P7481, DOI 10.1073/pnas.93.15.7481; SASTRY SS, 1989, BIOCHEMISTRY-US, V28, P5670, DOI 10.1021/bi00439a050; SCHREIBER V, 1992, EMBO J, V11, P3263, DOI 10.1002/j.1460-2075.1992.tb05404.x; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THIBODEAU J, 1993, BIOCHIM BIOPHYS ACTA, V1163, P49, DOI 10.1016/0167-4838(93)90277-X; Trucco C, 1996, FEBS LETT, V399, P313, DOI 10.1016/S0014-5793(96)01347-6; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; ZAHRADKA P, 1984, EUR J BIOCHEM, V142, P503, DOI 10.1111/j.1432-1033.1984.tb08314.x; RIKEN STRUCTURAL GEN	52	146	157	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4105	4114		10.1074/jbc.M708558200	http://dx.doi.org/10.1074/jbc.M708558200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18055453	hybrid			2022-12-25	WOS:000253083500046
J	Barthelemy, PA; Raab, H; Appleton, BA; Bond, CJ; Wu, P; Wiesmann, C; Sidhu, SS				Barthelemy, Pierre A.; Raab, Helga; Appleton, Brent A.; Bond, Christopher J.; Wu, Ping; Wiesmann, Christian; Sidhu, Sachdev S.			Comprehensive analysis of the factors contributing to the stability and solubility of autonomous human V-H domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY HUMAN-ANTIBODIES; STAPHYLOCOCCAL PROTEIN-A; LLAMA VHH DOMAIN; SINGLE-DOMAIN; CRYSTAL-STRUCTURE; ANTIGEN-BINDING; ANTI-P185HER2 ANTIBODY; ESCHERICHIA-COLI; VARIABLE DOMAIN; PHAGE DISPLAY	We report a comprehensive analysis of sequence features that allow for the production of autonomous human heavy chain variable (V-H) domains that are stable and soluble in the absence of a light chain partner. Using combinatorial phage- displayed libraries and conventional biophysical methods, we analyzed the entire former light chain interface and the third complementarity determining region (CDR3). Unlike the monomeric variable domains of camelid heavy chain antibodies (VHH domains), in which autonomous behavior depends on interactions between the hydrophobic former light chain interface and CDR3, we find that the stability of many in vitro evolved V-H domains is essentially independent of the CDR3 sequence and instead derives from mutations that increase the hydrophilicity of the former light chain interface by replacing exposed hydrophobic residues with structurally compatible hydrophilic substitutions. The engineered domains can be expressed recombinantly at high yield, are predominantly monomeric at high concentrations, unfold reversibly, and are even more thermostable than typical camelid VHH domains. Many of the stabilizing mutations are rare in natural V-H and VHH domains and thus could not be predicted by studying natural sequences and structures. The results demonstrate that autonomous V-H domains with structural properties beyond the scope of natural frameworks can be derived by using non- natural mutations, which differ from those found in camelid VHH domains. These findings should enable the development of libraries of synthetic V-H domains with CDR3 diversities unconstrained by structural demands.	[Barthelemy, Pierre A.; Appleton, Brent A.; Bond, Christopher J.; Wu, Ping; Wiesmann, Christian; Sidhu, Sachdev S.] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Raab, Helga] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Sidhu, SS (corresponding author), Genentech Inc, Dept Prot Engn, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.	sidhu@gene.com		Wiesmann, Christian/0000-0002-4092-9880; Appleton, Brent/0000-0003-1136-5649				BARBAS CF, 1993, GENE, V137, P57, DOI 10.1016/0378-1119(93)90251-W; Bond CJ, 2005, J MOL BIOL, V348, P699, DOI 10.1016/j.jmb.2005.02.063; Bond CJ, 2003, J MOL BIOL, V332, P643, DOI 10.1016/S0022-2836(03)00967-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; CARTER P, 1992, BIO-TECHNOL, V10, P163, DOI 10.1038/nbt0292-163; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Conrath KE, 2001, J BIOL CHEM, V276, P7346, DOI 10.1074/jbc.M007734200; Cortez-Retamozo V, 2002, INT J CANCER, V98, P456, DOI 10.1002/ijc.10212; DAVIES J, 1994, FEBS LETT, V339, P285, DOI 10.1016/0014-5793(94)80432-X; DAVIES J, 1995, BIO-TECHNOL, V13, P475, DOI 10.1038/nbt0595-475; de Wildt RMT, 2000, NAT BIOTECHNOL, V18, P989, DOI 10.1038/79494; Decanniere K, 1999, STRUCTURE, V7, P361, DOI 10.1016/S0969-2126(99)80049-5; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Desmyter A, 2002, J BIOL CHEM, V277, P23645, DOI 10.1074/jbc.M202327200; Desmyter A, 2001, J BIOL CHEM, V276, P26285, DOI 10.1074/jbc.M102107200; EIGENBROT C, 1993, J MOL BIOL, V229, P969, DOI 10.1006/jmbi.1993.1099; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Fellouse FAS, 2007, MAKING USING ANTIBOD, P157; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2000, MOL IMMUNOL, V37, P579, DOI 10.1016/S0161-5890(00)00081-X; Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Jespers L, 2004, NAT BIOTECHNOL, V22, P1161, DOI 10.1038/nbt1000; Jespers L, 2004, J MOL BIOL, V337, P893, DOI 10.1016/j.jmb.2004.02.013; KABAT EA, 1987, SEQUENCES PROTEINS I, P1; KELLEY RF, 1992, BIOCHEMISTRY-US, V31, P5434, DOI 10.1021/bi00139a003; KELLEY RF, 1993, BIOCHEMISTRY-US, V32, P6828, DOI 10.1021/bi00078a005; KIRKHAM PM, 1992, EMBO J, V11, P603, DOI 10.1002/j.1460-2075.1992.tb05092.x; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; KORTT AA, 1995, J PROTEIN CHEM, V14, P167, DOI 10.1007/BF01980329; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Martin F, 1997, PROTEIN ENG, V10, P607, DOI 10.1093/protein/10.5.607; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meininger DP, 2000, BIOCHEMISTRY-US, V39, P26, DOI 10.1021/bi9920174; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; Nguyen VK, 2000, EMBO J, V19, P921, DOI 10.1093/emboj/19.5.921; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; Potter K N, 1997, Int Rev Immunol, V14, P291, DOI 10.3109/08830189709116521; Potter KN, 1996, J IMMUNOL, V157, P2982; Reiter Y, 1999, J MOL BIOL, V290, P685, DOI 10.1006/jmbi.1999.2923; Riechmann L, 1996, J MOL BIOL, V259, P957, DOI 10.1006/jmbi.1996.0373; RIECHMANN L, 1995, J BIOMOL NMR, V6, P141, DOI 10.1007/BF00211778; Riechmann L, 1999, J IMMUNOL METHODS, V231, P25, DOI 10.1016/S0022-1759(99)00138-6; Rosebrough S F, 1996, Q J Nucl Med, V40, P234; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Sidhu SS, 2004, J MOL BIOL, V338, P299, DOI 10.1016/j.jmb.2004.02.050; Sidhu SS, 2000, J MOL BIOL, V296, P487, DOI 10.1006/jmbi.1999.3465; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spinelli S, 1996, NAT STRUCT BIOL, V3, P752, DOI 10.1038/nsb0996-752; Spinelli S, 2000, BIOCHEMISTRY-US, V39, P1217, DOI 10.1021/bi991830w; Spinelli S, 2004, FEBS LETT, V564, P35, DOI 10.1016/S0014-5793(04)00304-7; Spinelli S, 2001, J MOL BIOL, V311, P123, DOI 10.1006/jmbi.2001.4856; Starovasnik MA, 1999, PROTEIN SCI, V8, P1423, DOI 10.1110/ps.8.7.1423; Stijlemans B, 2004, J BIOL CHEM, V279, P1256, DOI 10.1074/jbc.M307341200; Sundaresan G, 2003, J NUCL MED, V44, P1962; Tanha J, 2002, J IMMUNOL METHODS, V263, P97, DOI 10.1016/S0022-1759(02)00027-3; To R, 2005, J BIOL CHEM, V280, P41395, DOI 10.1074/jbc.M509900200; Tokunaga Eriko, 2006, Int J Clin Oncol, V11, P199, DOI 10.1007/s10147-006-0575-4; Voordijk S, 2000, J MOL BIOL, V300, P963, DOI 10.1006/jmbi.2000.3890; Vranken W, 2002, BIOCHEMISTRY-US, V41, P8570, DOI 10.1021/bi012169a; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; Worn A, 1999, BIOCHEMISTRY-US, V38, P8739, DOI 10.1021/bi9902079; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zuckier LS, 1997, SEMIN NUCL MED, V27, P10, DOI 10.1016/S0001-2998(97)80033-5	74	131	176	6	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3639	3654		10.1074/jbc.M708536200	http://dx.doi.org/10.1074/jbc.M708536200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18045863	hybrid			2022-12-25	WOS:000253083000069
J	Alter-Koltunoff, M; Goren, S; Nousbeck, J; Feng, CG; Sher, A; Ozato, K; Azriel, A; Levi, BZ				Alter-Koltunoff, Michal; Goren, Sigal; Nousbeck, Janna; Feng, Carl G.; Sher, Alan; Ozato, Keiko; Azriel, Aviva; Levi, Ben-Zion			Innate immunity to intraphagosomal pathogens is mediated by interferon regulatory factor 8 (IRF-8) that stimulates the expression of macrophage-specific Nramp1 through antagonizing repression by c-Myc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-BINDING-PROTEIN; INFECTIOUS-DISEASE SUSCEPTIBILITY; INTRACELLULAR IRON TRANSPORT; MYELOID PROGENITOR CELLS; NATURAL-RESISTANCE; GENE-EXPRESSION; INTERLEUKIN-12 EXPRESSION; TRANSCRIPTION FACTOR; LEISHMANIA-DONOVANI; DENDRITIC CELLS	Macrophages are a central arm of innate immune defense against intracellular pathogens. They internalize microbes into phagosomes where the invaders are being killed by oxygen and nitrogen reactive species. Despite this battery of antimicrobial molecules, some are able to thrive within the phagosome thus termed intraphagosomal pathogens among which are Salmonella, Leishmania, and Mycobacteria. In mice, a single dominant gene termed Nramp1/Slc11a1 controls innate resistance to such pathogens. This gene is expressed exclusively in myeloid cells. Previously, we have shown that the restricted expression of Nramp1 is regulated by a myeloid cell-specific transcription factor termed IRF-8/ICSBP. It is demonstrated here that the induction of Nramp1 expression in activated macrophages is accompanied by a promoter shift from a repression state elicited by c-Myc to an activation state elicited by the induction of IRF-8 in activated macrophages. This transition from repression to activation is facilitated by a competitive protein-protein interaction with the transcription factor Miz-1. To show that IRF-8 is directly involved in the elimination of intraphagosomal pathogens through the regulation of Nramp1 gene expression, we bred wild type as well as IRF-8 and Nramp1 null mouse strains and examined macrophages derived from bone marrow and peritoneum. Our results clearly show that the absence of IRF-8 and Nramp1 leads to the same phenotype; defective killing of intraphagosomal Salmonella enterica serovar typhimurium and Mycobacterium bovis. Thus, interplay between repression and activation state of the Nramp1 promoter mediated by IRF-8 provides the molecular basis by which macrophages resist intraphagosomal pathogens at early stage after infection.	[Alter-Koltunoff, Michal; Goren, Sigal; Nousbeck, Janna; Azriel, Aviva; Levi, Ben-Zion] Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel; [Ozato, Keiko] NICHD, Lab Mol Growth Regulat, Bethesda, MD 20892 USA; [Feng, Carl G.; Sher, Alan] NIAID, Immunol Sect, Natl Inst Hlth, Bethesda, MD 20892 USA	Technion Israel Institute of Technology; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Levi, BZ (corresponding author), Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel.	blevi@technion.ac.il		feng, carl/0000-0003-4301-4640	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001044, ZIAAI001044] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alter-Koltunoff M, 2003, J BIOL CHEM, V278, P44025, DOI 10.1074/jbc.M307954200; Atkinson PGP, 1999, IMMUNOLOGY, V96, P656; Barton CH, 1999, J LEUKOCYTE BIOL, V66, P757, DOI 10.1002/jlb.66.5.757; Bayele HK, 2007, BLOOD, V110, P3039, DOI 10.1182/blood-2006-12-063289; Blackwell JM, 2003, IMMUNOL LETT, V85, P197, DOI 10.1016/S0165-2478(02)00231-6; Blackwell JM, 2001, TRENDS MOL MED, V7, P521, DOI 10.1016/S1471-4914(01)02169-4; Bowen H, 2002, J BIOL CHEM, V277, P34997, DOI 10.1074/jbc.M204232200; Cuellar-Mata P, 2002, J BIOL CHEM, V277, P2258, DOI 10.1074/jbc.M105508200; Dahl R, 2003, BLOOD CELL MOL DIS, V31, P229, DOI 10.1016/S1079-9796(03)00152-9; EINAT M, 1985, NATURE, V313, P597, DOI 10.1038/313597a0; Eklund EA, 1999, J IMMUNOL, V163, P6095; Fortier A, 2005, J LEUKOCYTE BIOL, V77, P868, DOI 10.1189/jlb.1004616; Giese NA, 1997, J EXP MED, V186, P1535, DOI 10.1084/jem.186.9.1535; Govoni G, 1999, INFECT IMMUN, V67, P2225, DOI 10.1128/IAI.67.5.2225-2232.1999; Govoni G, 1996, INFECT IMMUN, V64, P2923, DOI 10.1128/IAI.64.8.2923-2929.1996; Gruenheid S, 1997, J EXP MED, V185, P717, DOI 10.1084/jem.185.4.717; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kanno Y, 2005, J INTERF CYTOK RES, V25, P770, DOI 10.1089/jir.2005.25.770; Kim YM, 2000, J IMMUNOL, V165, P3198, DOI 10.4049/jimmunol.165.6.3198; Laricchia-Robbio L, 2005, P NATL ACAD SCI USA, V102, P14368, DOI 10.1073/pnas.0504014102; Levi BZ, 2002, J INTERF CYTOK RES, V22, P153, DOI 10.1089/107999002753452764; Marecki S, 2001, J IMMUNOL, V166, P6829, DOI 10.4049/jimmunol.166.11.6829; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; Ozato K, 2002, BIOTECHNIQUES, V33, pS66; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; SchartonKersten T, 1997, J EXP MED, V186, P1523, DOI 10.1084/jem.186.9.1523; Schneider A, 1997, CURR TOP MICROBIOL, V224, P137; Schroder K, 2007, J LEUKOCYTE BIOL, V81, P1577, DOI 10.1189/jlb.0107036; Searle S, 1999, J MED GENET, V36, P295; Searle S, 1998, J CELL SCI, V111, P2855; Stober CB, 2007, INFECT IMMUN, V75, P5059, DOI 10.1128/IAI.00153-07; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Tamura T, 2003, BLOOD, V102, P4547, DOI 10.1182/blood-2003-01-0291; Tsujimura H, 2004, J IMMUNOL, V172, P6820, DOI 10.4049/jimmunol.172.11.6820; Turcotte K, 2007, J IMMUNOL, V179, P2467, DOI 10.4049/jimmunol.179.4.2467; Via LE, 1998, J CELL SCI, V111, P897; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; White JK, 2005, J LEUKOCYTE BIOL, V77, P311, DOI 10.1189/jlb.0904546; Wyllie S, 2002, MICROBES INFECT, V4, P351, DOI 10.1016/S1286-4579(02)01548-4; Xiong HB, 2005, J BIOL CHEM, V280, P23531, DOI 10.1074/jbc.M414296200; Xiong HB, 2003, J BIOL CHEM, V278, P2271, DOI 10.1074/jbc.M209583200; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200; ZILBERSTEIN D, 1988, BIOCHEM J, V256, P13, DOI 10.1042/bj2560013	51	50	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2724	2733		10.1074/jbc.M707704200	http://dx.doi.org/10.1074/jbc.M707704200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18045875	hybrid			2022-12-25	WOS:000252622300030
J	Gauguin, L; Klaproth, B; Sajid, W; Andersen, AS; McNeil, KA; Forbes, BE; De Meyts, P				Gauguin, Lisbeth; Klaproth, Birgit; Sajid, Waseem; Andersen, Asser S.; McNeil, Kerrie A.; Forbes, Briony E.; De Meyts, Pierre			Structural basis for the lower affinity of the insulin-like growth factors for the insulin receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTO-CROSS-LINKING; FACTOR-I; IGF-II; FUNCTIONAL-CHARACTERISTICS; NEGATIVE COOPERATIVITY; 6-PHOSPHATE RECEPTOR; CRYSTAL-STRUCTURE; FUSION PROTEINS; LIGAND-BINDING; FACTOR (IGF)-I	Insulin and the insulin-like growth factors (IGFs) bind with high affinity to their cognate receptor and with lower affinity to the noncognate receptor. The major structural difference between insulin and the IGFs is that the IGFs are single chain polypeptides containing A-, B-, C-, and D- domains, whereas the insulin molecule contains separate A- and B- chains. The C- domain of IGF-I is critical for high affinity binding to the insulin-like growth factor I receptor, and lack of a C- domain largely explains the low affinity of insulin for the insulin-like growth factor I receptor. It is less clear why the IGFs have lower affinity for the insulin receptor. In this study, 24 insulin analogues and four IGF analogues were expressed and analyzed to explore the role of amino acid differences in the A- and B- domains between insulin and the IGFs in binding affinity for the insulin receptor. Using the information obtained from single substituted analogues, four multiple substituted analogues were produced. A "quadruple insulin" analogue ([Phe(A8), Ser(A10), Thr(B5), Gln(B16)] Ins) showed affinity as IGF-I for the insulin receptor, and a "sextuple insulin" analogue ([Phe(A8), Ser(A10), Thr(A18), Thr(B5), Thr(B14), Gln(B16)] Ins) showed an affinity close to that of IGF-II for the insulin receptor, whereas a "quadruple IGF-I" analogue ([His(4), Tyr(15), Thr(49), Ile(51)] IGF-I) and a "sextuple IGF-II" analogue ([His(7), Ala(16), Tyr(18), Thr(48), Ile(50), Asn58] IGF-II) showed affinities similar to that of insulin for the insulin receptor. The mitogenic potency of these analogues correlated well with the binding properties. Thus, a small number of A- and B- domain substitutions that map to the IGF surface equivalent to the classical binding surface of insulin weaken two hotspots that bind to the insulin receptor site 1.	[Gauguin, Lisbeth; Klaproth, Birgit; Sajid, Waseem; De Meyts, Pierre] Hagedorn Res Inst, Receptor Syst Biol Lab, DK-2820 Gentofte, Denmark; [Andersen, Asser S.] Novo Nordisk AS, Prot Express, DK-2760 Malov, Denmark; [McNeil, Kerrie A.; Forbes, Briony E.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Novo Nordisk; Hagedorn Research Institute; Novo Nordisk; University of Adelaide	Gauguin, L (corresponding author), Hagedorn Res Inst, Receptor Syst Biol Lab, DK-2820 Gentofte, Denmark.	LGau@hagedorn.dk	Forbes, Briony/R-1838-2019	De Meyts, Pierre/0000-0001-6214-0824; Forbes, Briony/0000-0003-4360-9927				Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BAYNE ML, 1989, J BIOL CHEM, V264, P11004; BAYNE ML, 1990, J BIOL CHEM, V265, P15648; BELL GI, 1980, NATURE, V284, P26, DOI 10.1038/284026a0; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; Blundell T L, 1971, Recent Prog Horm Res, V27, P1; CASCIERI MA, 1988, BIOCHEMISTRY-US, V27, P3229, DOI 10.1021/bi00409a016; Chan SJ, 2007, J BIOL CHEM, V282, P13754, DOI 10.1074/jbc.M700724200; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Delaine C, 2007, J BIOL CHEM, V282, P18886, DOI 10.1074/jbc.M700531200; DEMEYTS P, 1978, NATURE, V273, P504; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; DEMEYTS P, 1973, BIOCHEM BIOPH RES CO, V55, P154, DOI 10.1016/S0006-291X(73)80072-5; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Denley A, 2005, MOL ENDOCRINOL, V19, P711, DOI 10.1210/me.2004-0409; Denley A, 2005, CYTOKINE GROWTH F R, V16, P421, DOI 10.1016/j.cytogfr.2005.04.004; DREJER K, 1992, DIABETES METAB REV, V8, P259, DOI 10.1002/dmr.5610080305; Efstratiadis A, 1998, INT J DEV BIOL, V42, P955; FRANCIS GL, 1993, BIOCHEM J, V293, P713, DOI 10.1042/bj2930713; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; HU SQ, 1993, J PROTEIN CHEM, V12, P741, DOI 10.1007/BF01024932; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; HUMBEL RE, 1990, EUR J BIOCHEM, V190, P445, DOI 10.1111/j.1432-1033.1990.tb15595.x; Jansson M, 1998, J BIOL CHEM, V273, P24701, DOI 10.1074/jbc.273.38.24701; Jensen A. M., 2000, THESIS U COPENHAGEN; KING R, 1992, J MOL ENDOCRINOL, V8, P29, DOI 10.1677/jme.0.0080029; Kjeldsen T, 1996, GENE, V170, P107, DOI 10.1016/0378-1119(95)00822-5; Kjeldsen T, 2001, Biotechnol Genet Eng Rev, V18, P89; KRISTENSEN C, 1995, BIOCHEM J, V305, P981, DOI 10.1042/bj3050981; Lawrence MC, 2007, CURR OPIN STRUC BIOL, V17, P699, DOI 10.1016/j.sbi.2007.07.007; Lien S, 2001, BIOTECHNOL BIOENG, V74, P335, DOI 10.1002/bit.1124; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; MILNER SJ, 1995, BIOCHEM J, V308, P865, DOI 10.1042/bj3080865; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; NANJO K, 1986, J CLIN INVEST, V77, P514, DOI 10.1172/JCI112331; PALSGAARD J, 2003, RECEPTOR BINDING PRO; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; RINDERKNECHT E, 1978, FEBS LETT, V89, P283, DOI 10.1016/0014-5793(78)80237-3; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; RYLE AP, 1955, BIOCHEM J, V60, P541, DOI 10.1042/bj0600541; SAKANO KI, 1991, J BIOL CHEM, V266, P20626; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; SCHWARTZ GP, 1985, J PROTEIN CHEM, V4, P185, DOI 10.1007/BF01025264; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; Shooter GK, 1996, J MOL ENDOCRINOL, V17, P237, DOI 10.1677/jme.0.0170237; SUSSENBACH JS, 1992, GROWTH REGULAT, V2, P1; TSUNASAWA S, 1989, J BIOL CHEM, V264, P3832; Walenkamp MJE, 2005, J CLIN ENDOCR METAB, V90, P2855, DOI 10.1210/jc.2004-1254; Wan ZL, 2005, BIOCHEMISTRY-US, V44, P5000, DOI 10.1021/bi047585k; Wan ZL, 2004, BIOCHEMISTRY-US, V43, P16119, DOI 10.1021/bi048223f; Ward CW, 2007, TRENDS BIOCHEM SCI, V32, P129, DOI 10.1016/j.tibs.2007.01.001; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200	56	48	52	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2604	2613		10.1074/jbc.M709220200	http://dx.doi.org/10.1074/jbc.M709220200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18048361	hybrid			2022-12-25	WOS:000252622300017
J	Kleinschmidt, AM; Nassiri, M; Stitt, MS; Wasserloos, K; Watkins, SC; Pitt, BR; Jahroudi, N				Kleinschmidt, Ann M.; Nassiri, Marjan; Stitt, Molly S.; Wasserloos, Karla; Watkins, Simon C.; Pitt, Bruce R.; Jahroudi, Nadia			Sequences in intron 51 of the von Willebrand factor gene target promoter activation to a subset of lung endothelial cells in transgenic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO EXPRESSION; PHENOTYPIC HETEROGENEITY; NUCLEAR ACTIN; TRANSCRIPTION; IDENTIFICATION; REPRESSOR; ELEMENTS; LOCUS; CD34	In vivo analyses of the VWF promoter previously demonstrated that a fragment spanning sequences -487 to +247 targets promoter activation to brain vascular endothelial cells, whereas a longer fragment including 2182 bp of the 5'- flanking sequences, the first exon, and the first intron activated expression in endothelial cells of the heart and muscles as well as the brain of transgenic mice. These results suggested that additional VWF gene sequences were required for expression in other vascular endothelial cells in vivo. We have now identified a region within intron 51 of theVWFgene that is DNase I-hypersensitive (HSS) specifically in nonendothelial cells and interacts with endothelial and nonendothelial specific complexes that contain YY1. We demonstrate that beta-actin is associated with YY1 specifically in the nucleus of nonendothelial cells and is a component of the nuclear protein complexes that interact with the DNase I-hypersensitive region. In vitro transfection analyses demonstrated that HSS sequences containing this YY1-binding site do not significantly affect VWF promoter activity. However, in vivo analyses demonstrated that addition of these sequences to the VWF promoter ( - 487 to + 247) results in promoter activation in lung and brain vascular endothelial cells. These results demonstrate that the HSS sequences in intron 51 of the VWF gene contain cis-acting elements that are necessary for the VWF gene transcription in a subset of lung endothelial cells in vivo.	[Nassiri, Marjan; Jahroudi, Nadia] Univ Alberta, Dept Med Nephrol, Edmonton, AB T6G 2S2, Canada; [Kleinschmidt, Ann M.] Allegheny Coll, Dept Biol, Meadville, PA 16335 USA; [Stitt, Molly S.; Wasserloos, Karla; Pitt, Bruce R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Watkins, Simon C.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	University of Alberta; Allegheny College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jahroudi, N (corresponding author), Univ Alberta, Dept Med Nephrol, 261C-HMRC, Edmonton, AB T6G 2S2, Canada.	nadia.jahroudi@ualberta.ca	Watkins, Simon/ABG-2590-2021; Stitt, Mark/GVT-1242-2022	Watkins, Simon/0000-0003-4092-1552; Stitt, Mark/0000-0002-4900-1763	NHLBI NIH HHS [HL 67729] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067729] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aird WC, 1997, J CELL BIOL, V138, P1117, DOI 10.1083/jcb.138.5.1117; AIRD WC, 1995, P NATL ACAD SCI USA, V92, P4567, DOI 10.1073/pnas.92.10.4567; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Boyes J, 1996, EMBO J, V15, P2496, DOI 10.1002/j.1460-2075.1996.tb00607.x; Duta F, 2006, HISTOCHEM CELL BIOL, V126, P495, DOI 10.1007/s00418-006-0188-z; Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193; Guillot PV, 2000, PHYSIOL GENOMICS, V2, P77, DOI 10.1152/physiolgenomics.2000.2.2.77; Hough C, 2005, BLOOD, V105, P1531, DOI 10.1182/blood-2002-10-3093; HOYT DG, 1995, AM J PHYSIOL-LUNG C, V269, pL171, DOI 10.1152/ajplung.1995.269.2.L171; Jahroudi N, 1996, J BIOL CHEM, V271, P21413, DOI 10.1074/jbc.271.35.21413; JAHROUDI N, 1994, MOL CELL BIOL, V14, P999, DOI 10.1128/MCB.14.2.999; Jahroudi N, 2003, J ALZHEIMERS DIS, V5, P149, DOI 10.3233/JAD-2003-5209; Kajiyama Y, 2006, J BIOL CHEM, V281, P30122, DOI 10.1074/jbc.M603491200; Kappel A, 1999, BLOOD, V93, P4284, DOI 10.1182/blood.V93.12.4284.412k25_4284_4292; Kawanami O, 2000, PATHOL INT, V50, P136, DOI 10.1046/j.1440-1827.2000.01006.x; Kawanami Oichi, 2000, Journal of Nippon Medical School, V67, P118, DOI 10.1272/jnms.67.118; Khandekar M, 2007, DEVELOPMENT, V134, P1703, DOI 10.1242/dev.001297; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; MAUTNER J, 1995, NUCLEIC ACIDS RES, V23, P72, DOI 10.1093/nar/23.1.72; Muller AM, 2002, EXP GERONTOL, V37, P713, DOI 10.1016/S0531-5565(02)00010-4; Peng Y, 2007, ONCOGENE, V26, P7576, DOI 10.1038/sj.onc.1210565; Peng YW, 2002, BLOOD, V99, P2408, DOI 10.1182/blood.V99.7.2408; Peng YW, 2003, J BIOL CHEM, V278, P8385, DOI 10.1074/jbc.M213156200; Prandini MH, 2005, ONCOGENE, V24, P2992, DOI 10.1038/sj.onc.1208483; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Radomska HS, 1998, GENE, V222, P305, DOI 10.1016/S0378-1119(98)00491-0; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; Roque MC, 1996, MOL CELL BIOL, V16, P3138; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHLAEGER TM, 1995, DEVELOPMENT, V121, P1089; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Schwachtgen JL, 1997, ONCOGENE, V15, P3091, DOI 10.1038/sj.onc.1201502; Schwachtgen JL, 1998, BLOOD, V92, P1247, DOI 10.1182/blood.V92.4.1247.416k08_1247_1258; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHRIVASTAVA A, 1994, NUCLEIC ACIDS RES, V22, P5151, DOI 10.1093/nar/22.24.5151; Teichert AM, 2000, AM J PHYSIOL-HEART C, V278, pH1352, DOI 10.1152/ajpheart.2000.278.4.H1352; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; Wang XY, 2004, BLOOD, V104, P1725, DOI 10.1182/blood-2004-01-0082; Wu JI, 2007, SCIENCE, V316, P1710, DOI 10.1126/science.1145014; Yamamoto K, 1998, BLOOD, V92, P2791, DOI 10.1182/blood.V92.8.2791.420k24_2791_2801	42	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2741	2750		10.1074/jbc.M705466200	http://dx.doi.org/10.1074/jbc.M705466200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18048367	hybrid			2022-12-25	WOS:000252622300032
J	Alejandro, EU; Johnson, JD				Alejandro, Emilyn U.; Johnson, James D.			Inhibition of Raf-1 alters multiple downstream pathways to induce pancreatic beta-cell apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; GLUCAGON-LIKE PEPTIDE-1; REGULATED KINASE; INSULIN-RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; SIGNAL-TRANSDUCTION; BCL-2 EXPRESSION; RESPONSE ELEMENT; CA2+ INFLUX; ISLET MASS	The serine threonine kinase Raf-1 plays a protective role in many cell types, but its function in pancreatic beta-cells has not been elucidated. In the present study, we examined whether primary beta-cells possess Raf-1 and tested the hypothesis that Raf-1 is critical for beta-cell survival. Using reverse transcriptase-PCR, Western blot, and immunofluorescence, we identified Raf-1 in human islets, mouse islets, and in the MIN6 beta-cell line. Blocking Raf-1 activity using a specific Raf-1 inhibitor or dominant-negative Raf-1 mutants led to a time-and dose-dependent increase in cell death, assessed by real-time imaging of propidium iodide incorporation, TUNEL, PCR-enhanced DNA laddering, and Caspase-3 cleavage. Although the rapid increase in apoptotic cell death was associated with decreased Erk phosphorylation, studies with two Mek inhibitors suggested that the classical Erk-dependent pathway could explain only part of the cell death observed after inhibition of Raf-1. An alternative Erk-independent pathway downstream of Raf-1 kinase involving the pro-apoptotic protein Bad has recently been characterized in other tissues. Inhibiting Raf-1 in beta-cells led to a striking loss of Bad phosphorylation at serine 112 and an increase in the protein levels of both Bad and Bax. Together, our data strongly suggest that Raf-1 signaling plays an important role regulating beta-cell survival, via both Erk-dependent and Bad-dependent mechanisms. Conversely, acutely inhibiting phosphatidylinositol 3-kinase Akt had more modest effects on beta-cell death. These studies identify Raf-1 as a critical anti-apoptotic kinase in pancreatic beta-cells and contribute to our understanding of survival signaling in this cell type.	[Alejandro, Emilyn U.; Johnson, James D.] Univ British Columbia, Dept Cellular & Physiol Sci, Lab Mol Signaling Diabet, Diabet Res Grp, Vancouver, BC V6T 1Z3, Canada; [Alejandro, Emilyn U.; Johnson, James D.] Univ British Columbia, Dept Surg, Lab Mol Signaling Diabet, Diabet Res Grp, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Johnson, JD (corresponding author), 5358 Life Sci Bldg,2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	jimjohn@interchange.ubc.ca		Alejandro, Emilyn/0000-0002-7941-8439; Johnson, James/0000-0002-7523-9433	NIDDK NIH HHS [F31 DK079346-01, F31DK079346, F31 DK079346] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK079346] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aikin R, 2006, DIABETOLOGIA, V49, P2900, DOI 10.1007/s00125-006-0476-0; APP H, 1991, MOL CELL BIOL, V11, P913, DOI 10.1128/MCB.11.2.913; Augstein P, 1998, MOL MED, V4, P495, DOI 10.1007/BF03401754; Baccarini M, 2005, FEBS LETT, V579, P3271, DOI 10.1016/j.febslet.2005.03.024; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; BLACKSHEAR PJ, 1990, J BIOL CHEM, V265, P12131; Bondeva T, 2002, MOL BIOL CELL, V13, P2323, DOI 10.1091/mbc.E02-01-0019; Briaud I, 2003, DIABETES, V52, P974, DOI 10.2337/diabetes.52.4.974; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; Costes S, 2006, DIABETES, V55, P2220, DOI 10.2337/db05-1618; Dalle S, 2004, J BIOL CHEM, V279, P20345, DOI 10.1074/jbc.M312483200; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Edwards LA, 2006, MOL CANCER THER, V5, P645, DOI 10.1158/1535-7163.MCT-05-0099; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Hindley A, 2002, J CELL SCI, V115, P1575; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; Hugl SR, 1998, J BIOL CHEM, V273, P17771, DOI 10.1074/jbc.273.28.17771; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Jin SH, 2005, J BIOL CHEM, V280, P24698, DOI 10.1074/jbc.M413374200; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Jun T., 1999, SCI STKE, V1999, pPE1; KOIDE H, 1993, P NATL ACAD SCI USA, V90, P8683, DOI 10.1073/pnas.90.18.8683; KOVACINA KS, 1990, J BIOL CHEM, V265, P12115; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Lingohr MK, 2002, DIABETES, V51, P966, DOI 10.2337/diabetes.51.4.966; Longuet C, 2005, ENDOCRINOLOGY, V146, P643, DOI 10.1210/en.2004-0841; Maedler K, 2004, DIABETES, V53, P1706, DOI 10.2337/diabetes.53.7.1706; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matsumoto K, 1999, J BIOL CHEM, V274, P2053, DOI 10.1074/jbc.274.4.2053; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Mohanty S, 2005, EXP CELL RES, V303, P68, DOI 10.1016/j.yexcr.2004.09.011; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pavlovic D, 2000, EUR CYTOKINE NETW, V11, P267; Peruzzi F, 2001, J BIOL CHEM, V276, P25990, DOI 10.1074/jbc.M103188200; Ramachandran S, 2006, AM J TRANSPLANT, V6, P1696, DOI 10.1111/j.1600-6143.2006.01368.x; Salvalaggio PRO, 2002, TRANSPLANTATION, V74, P877, DOI 10.1097/00007890-200209270-00023; Srinivasan S, 2005, DIABETES, V54, P968, DOI 10.2337/diabetes.54.4.968; Stiles BL, 2006, MOL CELL BIOL, V26, P2772, DOI 10.1128/MCB.26.7.2772-2781.2006; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Trumper J, 2005, DIABETOLOGIA, V48, P1534, DOI 10.1007/s00125-005-1820-5; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Wang S, 1998, MOL CELL BIOL, V18, P7487, DOI 10.1128/MCB.18.12.7487; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Xiang H, 2006, MOL CELL BIOL, V26, P8599, DOI 10.1128/MCB.01062-06; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101; Zhang LZ, 2004, SURGERY, V136, P708, DOI 10.1016/j.surg.2003.12.013; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741; Zimmermann S, 1997, ONCOGENE, V15, P1503, DOI 10.1038/sj.onc.1201322	65	43	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2407	2417		10.1074/jbc.M703612200	http://dx.doi.org/10.1074/jbc.M703612200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18006502	Green Accepted, hybrid			2022-12-25	WOS:000252501000067
J	Iijima, R; Kunieda, T; Yamaguchi, S; Kamigaki, H; Fujii-Taira, I; Sekimizu, K; Kubo, T; Natori, S; Homma, KJ				Iijima, Ryoko; Kunieda, Takekazu; Yamaguchi, Shinji; Kamigaki, Hiroko; Fujii-Taira, Ikuko; Sekimizu, Kazuhisa; Kubo, Takeo; Natori, Shunji; Homma, Koichi J.			The extracellular adenosine deaminase growth factor, ADGF/CECR1, plays a role in Xenopus embryogenesis via the adenosine/P1 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAT-EYE SYNDROME; EMBRYONIC-CELL LINE; CENTRAL-NERVOUS-SYSTEM; SARCOPHAGA-PEREGRINA; GASTRULA EMBRYOS; GENE FAMILY; FLESH FLY; EXPRESSION; DROSOPHILA; PURIFICATION	Adenosine deaminase- related growth factors (ADGF), also known as CECR1 in vertebrates, are a novel family of growth factors with sequence similarity to classical cellular adenosine deaminase. Although genes for ADGF/ CECR1 have been identified in both invertebrates as well as vertebrates, their in vivo functions in vertebrates remain unknown. We isolated cDNA clones for two cerc 1s from Xenopus laevis. Both recombinant Xenopus CECR1s exhibited adenosine deaminase and growth factor activity, and the adenosine deaminase activity was found to be indispensable for growth factor activity. The Xenopus cerc 1s are expressed in the somites, pronephros, eyes, cement gland, neural tube, and neural floor plate of the embryos. Knock- down of these two genes using morpholino oligonucleotides caused a reduction in the body size and abnormalities of the body axis in the Xenopus embryos, accompanied by selective changes in the expression of developmental marker genes. Injection of adenosine, agonists for adenosine/P1 receptors, or adenosine deaminase inhibitor into late gastrula archenteron embryos resulted in developmental defects similar to those caused by morpholino oligonucleotide injection. These results show, for the first time, the involvement of CECR1s via the adenosine/P1 receptors in vertebrate embryogenesis via regulation of extracellular adenosine concentrations.	[Yamaguchi, Shinji; Kamigaki, Hiroko; Homma, Koichi J.] Teikyo Univ, Fac Pharmaceut Sci, Kanagawa 2290195, Japan; [Iijima, Ryoko; Yamaguchi, Shinji; Fujii-Taira, Ikuko; Sekimizu, Kazuhisa; Homma, Koichi J.] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Iijima, Ryoko; Kunieda, Takekazu; Kubo, Takeo] Univ Tokyo, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Iijima, Ryoko; Fujii-Taira, Ikuko; Natori, Shunji] RIKEN, Natori Special Lab, Wako, Saitama 3510198, Japan	Teikyo University; University of Tokyo; University of Tokyo; RIKEN	Homma, KJ (corresponding author), Teikyo Univ, Fac Pharmaceut Sci, Kanagawa 2290195, Japan.	homma-kj@umin.ac.jp	KUBO, TAKEO/G-4951-2014; Kunieda, Takekazu/G-4946-2014	Kubo, Takeo/0000-0002-5914-5269; Kunieda, Takekazu/0000-0002-6256-1335				AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Akalal DBG, 2003, MOL BRAIN RES, V117, P228, DOI 10.1016/S0169-328X(03)00287-0; Blackburn MR, 2005, ADV IMMUNOL, V86, P1, DOI 10.1016/S0065-2776(04)86001-2; Carroll TJ, 1996, DEV DYNAM, V206, P131, DOI 10.1002/(SICI)1097-0177(199606)206:2<131::AID-AJA2>3.3.CO;2-I; CHANG Z, 1991, BIOCHEMISTRY-US, V30, P2273, DOI 10.1021/bi00222a033; Chanoine C, 2003, DEV DYNAM, V226, P12, DOI 10.1002/dvdy.10206; Charlab R, 2001, GENE, V267, P13, DOI 10.1016/S0378-1119(01)00393-6; Chen Y, 2003, BIOCHEM BIOPH RES CO, V310, P121, DOI 10.1016/j.bbrc.2003.08.127; Dolezal T, 2005, PLOS BIOL, V3, P1213, DOI 10.1371/journal.pbio.0030201; Dolezal T, 2003, GENETICS, V165, P653; Dosch R, 1997, DEVELOPMENT, V124, P2325; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Footz TK, 2001, GENOME RES, V11, P1053, DOI 10.1101/gr.154901; FREEDOM RM, 1973, AM J DIS CHILD, V126, P16, DOI 10.1001/archpedi.1973.02110190012003; Ghanbari H, 2001, MECH DEVELOP, V101, P271, DOI 10.1016/S0925-4773(00)00572-4; Hatada S, 1997, GENE, V203, P183, DOI 10.1016/S0378-1119(97)00512-X; HEMMATIBRIVANLOU A, 1990, DEVELOPMENT, V110, P325; Homma K, 1996, J BIOL CHEM, V271, P13770, DOI 10.1074/jbc.271.23.13770; Homma KJ, 2001, J BIOL CHEM, V276, P43761, DOI 10.1074/jbc.M105088200; Iwaki-Egawa S, 2001, J RHEUMATOL, V28, P485; Jackson EK, 2004, ANNU REV PHYSIOL, V66, P571, DOI 10.1146/annurev.physiol.66.032102.111604; Klein SL, 2002, DEV DYNAM, V225, P384, DOI 10.1002/dvdy.10174; KOMANO H, 1987, BIOCHEM J, V248, P217, DOI 10.1042/bj2480217; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li S, 2000, GENE, V252, P83, DOI 10.1016/S0378-1119(00)00226-2; LUTTRELL DK, 1994, P NATL ACAD SCI USA, V91, P83, DOI 10.1073/pnas.91.1.83; Maier SA, 2005, J MOL EVOL, V61, P776, DOI 10.1007/s00239-005-0046-y; Maier SA, 2001, GENE, V280, P27, DOI 10.1016/S0378-1119(01)00762-4; Matsushita T, 2000, J BIOL CHEM, V275, P36934, DOI 10.1074/jbc.M003455200; Matsuyama S, 2004, BIOCHEM BIOPH RES CO, V321, P386, DOI 10.1016/j.bbrc.2004.06.161; MITSUHAS.J, 1964, CONTRIB BOYCE THOMPS, V22, P435; Mizuno N, 1999, DIFFERENTIATION, V64, P143, DOI 10.1046/j.1432-0436.1999.6430143.x; MOHUN TJ, 1984, NATURE, V311, P716, DOI 10.1038/311716a0; Montesinos MC, 2004, AM J PATHOL, V164, P1887, DOI 10.1016/S0002-9440(10)63749-2; NEILSEN H, 1997, PROTEIN ENG, V10, P1; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; PAGE B, 1993, INT J ONCOL, V3, P473; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pera EM, 2003, GENE EXPR PATTERNS, V3, P147, DOI 10.1016/S1567-133X(03)00011-5; Pommereit D, 2001, MECH DEVELOP, V102, P255, DOI 10.1016/S0925-4773(01)00305-7; RATECH H, 1981, ENZYME, V26, P74, DOI 10.1159/000459153; Riazi AM, 2005, TRANSGENIC RES, V14, P333, DOI 10.1007/s11248-005-1174-2; Riazi MA, 2000, GENOMICS, V64, P277, DOI 10.1006/geno.1999.6099; Ribeiro JMC, 2001, J EXP BIOL, V204, P2001; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato A, 2000, MECH DEVELOP, V92, P273, DOI 10.1016/S0925-4773(99)00331-7; SCHINZEL A, 1981, HUM GENET, V57, P148; Shiokawa K, 1997, Methods Mol Biol, V62, P247; SIMON LN, 1970, BIOCHEMISTRY-US, V9, P573, DOI 10.1021/bi00805a018; SIVE HL, 1989, CELL, V58, P171, DOI 10.1016/0092-8674(89)90413-3; Skoglund P, 2007, DEV BIOL, V301, P404, DOI 10.1016/j.ydbio.2006.09.005; TAIRA M, 1992, GENE DEV, V6, P356, DOI 10.1101/gad.6.3.356; Tanaka Y, 2006, BIOCHEM BIOPH RES CO, V350, P334, DOI 10.1016/j.bbrc.2006.09.047; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WIGINTON DA, 1981, BIOCHEM J, V195, P389, DOI 10.1042/bj1950389; Zavialov AV, 2005, BIOCHEM J, V391, P51, DOI 10.1042/BJ20050683; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368; Zhou XL, 2004, DEV BIOL, V271, P322, DOI 10.1016/j.ydbio.2004.03.036; Zurovec M, 2002, P NATL ACAD SCI USA, V99, P4403, DOI 10.1073/pnas.062059699	60	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2255	2264		10.1074/jbc.M709279200	http://dx.doi.org/10.1074/jbc.M709279200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18032387	hybrid			2022-12-25	WOS:000252501000053
J	Fedor, MJ				Fedor, Martha J.			Alternative splicing minireview series: Combinatorial control facilitates splicing regulation of gene expression and enhances genome diversity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review									[Fedor, Martha J.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Fedor, Martha J.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Fedor, MJ (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,MB35, La Jolla, CA 92037 USA.	mfedor@scripps.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062277, R01GM046422] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM 046422, R01 GM 062277] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164	6	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1209	1210		10.1074/jbc.R700046200	http://dx.doi.org/10.1074/jbc.R700046200			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024424	hybrid			2022-12-25	WOS:000252282700001
J	Mowbray, AL; Kang, DH; Rhee, SG; Kang, SW; Jo, H				Mowbray, Amy L.; Kang, Dong-Hoon; Rhee, Sue Goo; Kang, Sang Won; Jo, Hanjoong			Laminar shear stress up-regulates peroxiredoxins (PRX) in endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; CAROTID BIFURCATION; SIGNAL-TRANSDUCTION; MONOCYTE ADHESION; WALL SHEAR; EXPRESSION; PROTEIN; FLOW; ATHEROSCLEROSIS; MECHANISMS	Shear stress plays a significant role in endothelial cell biology and atherosclerosis development. Previous work by our group has shown that fluid flow stimulates important functional changes in cells through protein expression regulation. Peroxiredoxins (PRX) are a family of antioxidant enzymes but have yet to be investigated in response to shear stress. Studies have shown that oscillatory shear stress (OS) increases reactive oxygen species (ROS) levels in endothelial cells, whereas laminar shear stress (LS) blocks this response. We hypothesized that PRX are responsible for the anti-oxidative effect of LS. To test this hypothesis, bovine aortic endothelial cells (BAEC) were subjected to LS (15 dyn/cm(2)), OS (+/- 5 dyn/cm(2), 1 Hz), or static conditions for 24 h. Using Western blot and immunofluorescence staining, all six isoforms of PRX were identified in BAEC. When compared with OS and static, exposure to chronic LS up-regulated PRX 1 levels intracellularly. LS also increased expression of PRX 5 relative to static controls, but not OS. PRX exhibited broad subcellular localization, with distribution in the cytoplasm, Golgi, mitochondria, and intermediate filaments. In addition, PRX 1 knock down, using specific small interference RNA, attenuated LS-dependent reactive oxygen species reduction in BAEC. However, PRX 5 depletion did not. Together, these results suggest that PRX 1 is a novel mechanosensitive antioxidant, playing an important role in shear-dependent regulation of endothelial biology and atherosclerosis.	[Kang, Sang Won] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea; [Mowbray, Amy L.; Jo, Hanjoong] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Jo, Hanjoong] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA	Ewha Womans University; University System of Georgia; Georgia Institute of Technology; Emory University	Kang, SW (corresponding author), Ewha Womans Univ, Dept Life Sci, 11-1 Daehyun Dong, Seoul 120750, South Korea.	kangsw@ewha.ac.kr; hanjoong.jo@bme.gatech.edu	Jo, Hanjoong/L-6216-2019	Jo, Hanjoong/0000-0003-1833-372X	NHLBI NIH HHS [HL 71014, HL 75209, HL 70531] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075209, R01HL071014, R01HL070531] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; CARO CG, 1969, NATURE, V223, P1159, DOI 10.1038/2231159a0; Chappell DC, 1998, CIRC RES, V82, P532, DOI 10.1161/01.RES.82.5.532; Chen XL, 2003, J BIOL CHEM, V278, P703, DOI 10.1074/jbc.M203161200; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Davies PF, 2001, ANN NY ACAD SCI, V947, P7; De Keulenaer GW, 1998, CIRC RES, V82, P1094, DOI 10.1161/01.RES.82.10.1094; Finkel T, 1999, J LEUKOCYTE BIOL, V65, P337, DOI 10.1002/jlb.65.3.337; Go YM, 2001, J APPL PHYSIOL, V91, P1574, DOI 10.1152/jappl.2001.91.4.1574; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; Hajra L, 2000, P NATL ACAD SCI USA, V97, P9052, DOI 10.1073/pnas.97.16.9052; Harrison D, 2003, AM J CARDIOL, V91, p7A; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Hwang J, 2003, J BIOL CHEM, V278, P47291, DOI 10.1074/jbc.M305150200; Hwang J, 2003, CIRC RES, V93, P1225, DOI 10.1161/01.RES.0000104087.29395.66; Immenschuh S, 2005, ANTIOXID REDOX SIGN, V7, P768, DOI 10.1089/ars.2005.7.768; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Kinnula VL, 2002, THORAX, V57, P157, DOI 10.1136/thorax.57.2.157; Kinnula VL, 2002, J PATHOL, V196, P316, DOI 10.1002/path.1042; Krapfenbauer K, 2003, BRAIN RES, V967, P152, DOI 10.1016/S0006-8993(02)04243-9; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; McNally JS, 2003, AM J PHYSIOL-HEART C, V285, pH2290, DOI 10.1152/ajpheart.00515.2003; Mueller CFH, 2005, CIRC RES, V97, P637, DOI 10.1161/01.RES.0000183734.21112.b7; Nerem RM, 1998, AM J MED SCI, V316, P169, DOI 10.1097/00000441-199809000-00004; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Sorescu GP, 2004, CIRC RES, V95, P773, DOI 10.1161/01.RES.0000145728.22878.45; Sorescu GP, 2003, J BIOL CHEM, V278, P31128, DOI 10.1074/jbc.M300703200; SUZUKI Y, 1992, BIOCHEM BIOPH RES CO, V184, P1339, DOI 10.1016/S0006-291X(05)80029-4; Sykes MC, 2007, CIRC RES, V100, P152, DOI 10.1161/01.RES.0000258171.08020.72; Takeshita S, 2000, BIOCHEM BIOPH RES CO, V273, P66, DOI 10.1006/bbrc.2000.2898; Terman A, 2007, J PATHOL, V211, P134, DOI 10.1002/path.2094; Topper JN, 1996, P NATL ACAD SCI USA, V93, P10417, DOI 10.1073/pnas.93.19.10417; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Walford GA, 2004, J BIOL CHEM, V279, P4425, DOI 10.1074/jbc.M310582200; WEBER C, 1994, ARTERIOSCLER THROMB, V14, P1665, DOI 10.1161/01.ATV.14.10.1665; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yamawaki H, 2005, J CLIN INVEST, V115, P733, DOI 10.1172/JCI200523001; ZARINS CK, 1983, CIRC RES, V53, P502, DOI 10.1161/01.RES.53.4.502	43	71	72	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1622	1627		10.1074/jbc.M707985200	http://dx.doi.org/10.1074/jbc.M707985200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024958	hybrid			2022-12-25	WOS:000252282700048
J	Dellis, O; Rossi, AM; Dedos, SG; Taylor, CW				Dellis, Olivier; Rossi, Ana M.; Dedos, Skarlatos G.; Taylor, Colin W.			Counting functional inositol 1,4,5-trisphosphate receptors into the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IP3 RECEPTORS; SIGNAL-TRANSDUCTION; ION PERMEATION; CA2+ ENTRY; RELEASE; TRISPHOSPHATE; SELECTIVITY; CHANNELS; TYPE-1; ACID	Inositol 1,4,5-trisphosphate receptors (IP3R) within the endoplasmic reticulum mediate release of Ca2+ from intracellular stores. Different channels usually mediate Ca2+ entry across the plasma membrane. In Blymphocytes and a cell line derived from them (DT40 cells), very few functional IP3R (similar to 2/cell) are invariably expressed in the plasma membrane, where they mediate about half the Ca2+ entry evoked by activation of the B-cell receptor. We show that cells reliably count similar to 2 functional IP3R into the plasma membrane even when their conductance and ability to bind IP3 are massively attenuated. We conclude that very small numbers of functional IP3R can be reliably counted into a specific membrane compartment in the absence of feedback signals from the active protein.	[Dellis, Olivier; Rossi, Ana M.; Dedos, Skarlatos G.; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	cwt1000@cam.ac.uk	Dedos, Skarlatos G./A-5345-2008; Dellis, Olivier/E-8501-2011; Taylor, Colin/G-2447-2010	Dedos, Skarlatos G./0000-0002-0432-338X; Dellis, Olivier/0000-0003-0377-9163; Taylor, Colin/0000-0001-7771-1044	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; FADOOL DA, 1992, NEURON, V9, P907, DOI 10.1016/0896-6273(92)90243-7; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gerasimenko OV, 1996, CELL, V84, P473, DOI 10.1016/S0092-8674(00)81292-1; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Haynes LP, 2004, J BIOL CHEM, V279, P547, DOI 10.1074/jbc.M309617200; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Kasri NN, 2004, EMBO J, V23, P312, DOI 10.1038/sj.emboj.7600037; KHAN AA, 1992, P NATL ACAD SCI USA, V89, P2849, DOI 10.1073/pnas.89.7.2849; Laude AJ, 2005, CELL CALCIUM, V38, P45, DOI 10.1016/j.ceca.2005.04.001; LOIRAND G, 1991, J PHYSIOL-LONDON, V437, P461, DOI 10.1113/jphysiol.1991.sp018606; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Riley AM, 2002, J BIOL CHEM, V277, P40290, DOI 10.1074/jbc.M206925200; Sather WA, 2003, ANNU REV PHYSIOL, V65, P133, DOI 10.1146/annurev.physiol.65.092101.142345; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Taylor CW, 2004, TRENDS BIOCHEM SCI, V29, P210, DOI 10.1016/j.tibs.2004.02.010; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Tovey SC, 2006, NAT PROTOC, V1, P259, DOI 10.1038/nprot.2006.40; VACA L, 1995, AM J PHYSIOL-CELL PH, V269, pC733, DOI 10.1152/ajpcell.1995.269.3.C733; van Rossum DB, 2004, P NATL ACAD SCI USA, V101, P2323, DOI 10.1073/pnas.0308565100; VANKAMPLEN NG, 2001, STOCHASTIC PROCESSES; Wang Y, 2005, BIOPHYS J, V89, P256, DOI 10.1529/biophysj.104.056002; White C, 2006, J BIOL CHEM, V281, P20825, DOI 10.1074/jbc.M602175200; Winding P, 2001, J IMMUNOL METHODS, V249, P1, DOI 10.1016/S0022-1759(00)00333-1; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Xu L, 2006, BIOPHYS J, V90, P443, DOI 10.1529/biophysj.105.072538; Yang J, 2002, P NATL ACAD SCI USA, V99, P7711, DOI 10.1073/pnas.102006299; Yule DI, 1997, J BIOL CHEM, V272, P9093	35	30	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					751	755		10.1074/jbc.M706960200	http://dx.doi.org/10.1074/jbc.M706960200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17999955	hybrid			2022-12-25	WOS:000252128100013
J	Infante, RE; Abi-Mosleh, L; Radhakrishnan, A; Dale, JD; Brown, MS; Goldstein, JL				Infante, Rodney E.; Abi-Mosleh, Lina; Radhakrishnan, Arun; Dale, Jarrod D.; Brown, Michael S.; Goldstein, Joseph L.			Purified NPC1 protein - I. Binding of cholesterol and oxysterols to a 1278-amino acid membrane protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLEAVAGE-ACTIVATING PROTEIN; LOW-DENSITY-LIPOPROTEIN; STEROL-SENSING DOMAIN; PICK C1 PROTEIN; COMPETITIVE INHIBITOR; ENDOPLASMIC-RETICULUM; REGULATED TRANSPORT; HUMAN FIBROBLASTS; SREBPS; REDUCTASE	The Niemann-Pick, Type C1 protein (NPC1) is required for the transport of lipoprotein-derived cholesterol from lysosomes to endoplasmic reticulum. The 1278-amino acid, polytopic membrane protein has not been purified, and its mechanism of action is unknown. Unexpectedly, we encountered NPC1 in a search for a membrane protein that binds 25-hydroxycholesterol (25-HC) and other oxysterols. A 25-HC-binding protein was purified more than 14,000-fold from rabbit liver membranes and identified as NPC1 by mass spectroscopy. We prepared recombinant human NPC1 and confirmed its ability to bind oxysterols, including those with a hydroxyl group on the 24, 25, or 27 positions. Hydroxyl groups on the 7, 19, or 20 positions failed to confer binding. Recombinant human NPC1 also bound [H-3] cholesterol in a reaction inhibited by Nonidet P-40 above its critical micellar concentration. Low concentrations of unlabeled 25-HC abolished binding of [H-3] cholesterol, but the converse was not true, i.e. unlabeled cholesterol, even at high concentrations, did not abolish binding of [H-3]25-HC. NPC1 is not required for the known regulatory actions of oxysterols. Thus, in NPC1-deficient fibroblasts 25-HC blocked the processing of sterol regulatory element-binding proteins and activated acyl-CoA: cholesterol acyltransferase in a normal fashion. The availability of assays to measure NPC1 binding in vitro may further the understanding of ways in which oxysterols regulate intracellular lipid transport.	[Infante, Rodney E.; Abi-Mosleh, Lina; Radhakrishnan, Arun; Dale, Jarrod D.; Brown, Michael S.; Goldstein, Joseph L.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Brown, MS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	mike.brown@utsouthwestern.edu; joe.goldstein@utsouthwestern.edu	Radhakrishnan, Arun/Q-7437-2019; Infante, Rodney/ABG-7756-2020	Radhakrishnan, Arun/0000-0002-7266-7336; Infante, Rodney/0000-0003-2605-822X	NHLBI NIH HHS [HL20948] Funding Source: Medline; NIDDK NIH HHS [DK066141] Funding Source: Medline; NIGMS NIH HHS [5T32 GM08014] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK066141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008014] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1978, J BIOL CHEM, V253, P1121; BROWN MS, 1975, J BIOL CHEM, V250, P4025; Chen Y, 2005, J PROTEOME RES, V4, P998, DOI 10.1021/pr049754t; Cheruku SR, 2006, J BIOL CHEM, V281, P31594, DOI 10.1074/jbc.M602765200; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; DAWSON PA, 1989, J BIOL CHEM, V264, P9046; Fisher LE, 2003, BIOPHYS J, V85, P3097, DOI 10.1016/S0006-3495(03)74728-6; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; KITA T, 1980, J CLIN INVEST, V66, P1094, DOI 10.1172/JCI109938; KOVANEN PT, 1981, P NATL ACAD SCI-BIOL, V78, P1396, DOI 10.1073/pnas.78.3.1396; Liscum L, 2004, BBA-MOL CELL BIOL L, V1685, P22, DOI 10.1016/j.bbalip.2004.08.008; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Nohturfft A, 1998, P NATL ACAD SCI USA, V95, P12848, DOI 10.1073/pnas.95.22.12848; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Ouellette MM, 1999, BIOCHEM BIOPH RES CO, V254, P795, DOI 10.1006/bbrc.1998.0114; Pentchev P. G., 1995, METABOLIC MOL BASES, P2625; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; Pentchev PG, 2004, BBA-MOL CELL BIOL L, V1685, P3, DOI 10.1016/j.bbalip.2004.08.005; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; WILLNOW TE, 1994, J CELL SCI, V107, P719; Wood LD, 2001, ONCOGENE, V20, P278, DOI 10.1038/sj.onc.1204072; Xie CL, 2003, J LIPID RES, V44, P1780, DOI 10.1194/jlr.M300164-JLR200	36	163	165	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1052	1063		10.1074/jbc.M707943200	http://dx.doi.org/10.1074/jbc.M707943200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17989073	hybrid			2022-12-25	WOS:000252128100045
J	Ruettger, A; Schueler, S; Mollenhauer, JA; Wiederanders, B				Ruettger, Anke; Schueler, Susann; Mollenhauer, Juergen A.; Wiederanders, Bernd			Cathepsins B, K, and L are regulated by a defined collagen type II peptide via activation of classical protein kinase C and p38 MAP kinase in articular chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CARTILAGE DEGRADATION; FIBRONECTIN FRAGMENTS; RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; OSTEOARTHRITIC CARTILAGE; TELOPEPTIDE FRAGMENTS; CONNECTIVE TISSUES; BONE DESTRUCTION; ANNEXIN-V	Degradation of the extracellular matrix (ECM) is a prominent feature in osteoarthritis (OA), which is mainly because of the imbalance between anabolic and catabolic processes in chondrocytes resulting in cartilage and bone destruction. Various proteases act in concert to degrade matrix components, e. g. type II collagen, MMPs, ADAMTS, and cathepsins. Protease-generated collagen fragments may foster the destructive process. However, the signaling pathways associated with the action of collagen fragments on chondrocytes have not been clearly defined. The present data demonstrate that the N-terminal telopeptide of collagen type II enhances expression of cathepsins B, K, and L in articular chondrocytes at mRNA, protein, and activity levels, mediated at least in part through extracellular calcium. We also demonstrate that the induction is associated with the activation of protein kinase C and p38 MAP kinase.	[Ruettger, Anke; Schueler, Susann; Wiederanders, Bernd] Univ Jena, Univ Klinikum, Inst Biochem 1, D-07743 Jena, Germany; [Ruettger, Anke; Mollenhauer, Juergen A.] Univ Jena, Univ Klinikum, Orthopaed Res Unit Eisenberg, D-07743 Jena, Germany; [Mollenhauer, Juergen A.] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Mollenhauer, Juergen A.] Univ Tubingen, Nat & Med Sci Inst, D-72770 Reutlingen, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Rush University; Eberhard Karls University of Tubingen	Wiederanders, B (corresponding author), Univ Jena, Univ Klinikum, Inst Biochem 1, D-07743 Jena, Germany.	bwie@mti.uni-jena.de						Afif H, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2151; BAICI A, 1995, ANN RHEUM DIS, V54, P289, DOI 10.1136/ard.54.4.289; Bank RA, 1997, MATRIX BIOL, V16, P233, DOI 10.1016/S0945-053X(97)90012-3; Barilla ML, 2000, SEMIN ARTHRITIS RHEU, V29, P252, DOI 10.1016/S0049-0172(00)80012-8; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Bromme D, 1996, J BIOL CHEM, V271, P2126, DOI 10.1074/jbc.271.4.2126; Camper L, 1998, J BIOL CHEM, V273, P20383, DOI 10.1074/jbc.273.32.20383; Christgau S, 2001, BONE, V29, P209, DOI 10.1016/S8756-3282(01)00504-X; Downs JT, 2001, J IMMUNOL METHODS, V247, P25, DOI 10.1016/S0022-1759(00)00302-1; Drake FH, 1996, J BIOL CHEM, V271, P12511, DOI 10.1074/jbc.271.21.12511; Dreier R, 2001, J CELL SCI, V114, P3813; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Fichter A, 2006, J ORTHOP RES, V24, P63, DOI 10.1002/jor.20001; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Goldring SR, 2004, CLIN ORTHOP RELAT R, pS27, DOI 10.1097/01.blo.0000144854.66565.8f; Hegen M, 2006, J IMMUNOL, V177, P1913, DOI 10.4049/jimmunol.177.3.1913; Hein G, 1997, CLIN RHEUMATOL, V16, P167, DOI 10.1007/BF02247846; HOLLANDER AP, 1994, J CLIN INVEST, V93, P1722, DOI 10.1172/JCI117156; HOMANDBERG GA, 1992, J BIOL CHEM, V267, P3597; Homandberg GA, 2002, OSTEOARTHR CARTILAGE, V10, P938, DOI 10.1053/joca.2002.0854; Homandberg GA, 1997, BIOCHEM J, V321, P751, DOI 10.1042/bj3210751; Hummel KM, 1998, J RHEUMATOL, V25, P1887; Jans R, 2004, ARCH DERMATOL RES, V296, P30, DOI 10.1007/s00403-004-0469-0; Jennings L, 2001, CONNECT TISSUE RES, V42, P71, DOI 10.3109/03008200109014250; Jung M, 2004, PATHOBIOLOGY, V71, P70, DOI 10.1159/000074419; Keyszer G, 1998, ARTHRITIS RHEUM, V41, P1378, DOI 10.1002/1529-0131(199808)41:8<1378::AID-ART6>3.0.CO;2-J; Kim HA, 2006, ARTHRITIS RHEUM-US, V54, P2152, DOI 10.1002/art.21951; Knudson W, 2000, ARTHRITIS RHEUM-US, V43, P1165, DOI 10.1002/1529-0131(200005)43:5<1165::AID-ANR27>3.0.CO;2-H; Konttinen YT, 2002, ARTHRITIS RHEUM, V46, P953, DOI 10.1002/art.10185; KUETTNER KE, 1982, J CELL BIOL, V93, P751, DOI 10.1083/jcb.93.3.751; Kurtis MS, 2001, J ORTHOP RES, V19, P1122, DOI 10.1016/S0736-0266(01)00051-1; Lang A, 2000, J RHEUMATOL, V27, P1970; Le Graverand MPH, 2000, MATRIX BIOL, V19, P431, DOI 10.1016/S0945-053X(00)00093-7; Li ZQ, 2000, BIOCHEMISTRY-US, V39, P529, DOI 10.1021/bi992251u; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Loser R, 2005, J MED CHEM, V48, P7688, DOI 10.1021/jm050686b; Lucic D, 2003, CONNECT TISSUE RES, V44, P225, DOI 10.1080/03008200390248632; MACIEWICZ RA, 1988, BIOCHEM J, V256, P433, DOI 10.1042/bj2560433; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Morko JP, 2004, ANN RHEUM DIS, V63, P649, DOI 10.1136/ard.2002.004671; Mort JS, 2001, ARTHRITIS RES, V3, P337, DOI 10.1186/ar325; Nguyen J, 2006, IMMUNOL LETT, V106, P34, DOI 10.1016/j.imlet.2006.04.003; Pei Y, 2006, OSTEOARTHR CARTILAGE, V14, P749, DOI 10.1016/j.joca.2006.01.017; Rantakokko J, 1996, FEBS LETT, V393, P307, DOI 10.1016/0014-5793(96)00907-6; RIEDE UN, 1977, BEITR PATHOL, V160, P3; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Ruttgers A, 2006, BIOTECHNIQUES, V41, P469, DOI 10.2144/000112259; Sapolsky A, 1976, Compr Ther, V2, P33; Schuler S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-144; Soderholm H, 2001, CELL SIGNAL, V13, P95, DOI 10.1016/S0898-6568(00)00141-8; Stanton LA, 2003, DEV BIOL, V263, P165, DOI 10.1016/S0012-1606(03)00321-X; Stojilkovic SS, 2005, TRENDS ENDOCRIN MET, V16, P81, DOI 10.1016/j.tem.2005.02.002; Tchetina EV, 2007, MATRIX BIOL, V26, P247, DOI 10.1016/j.matbio.2007.01.006; Thibault M, 2002, J ORTHOP RES, V20, P1265, DOI 10.1016/S0736-0266(02)00070-0; Troen BR, 2006, ANN NY ACAD SCI, V1068, P165, DOI 10.1196/annals.1346.018; Uusitalo H, 2000, CALCIFIED TISSUE INT, V67, P382, DOI 10.1007/s002230001152; VELASCO G, 1994, J BIOL CHEM, V269, P27136; Wang HL, 2007, CELL BIOL INT, V31, P1027, DOI 10.1016/j.cellbi.2007.03.017; Wang W, 2006, J BIOL CHEM, V281, P30848, DOI 10.1074/jbc.M605937200; Wei L, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1891; Yasuda T, 2002, ARTHRITIS RHEUM, V46, P138, DOI 10.1002/1529-0131(200201)46:1<138::AID-ART10051>3.0.CO;2-K; Yasuda T, 2006, MATRIX BIOL, V25, P419, DOI 10.1016/j.matbio.2006.06.004; Ze P, 2002, J CELL SCI, V115, P3083; Zwerina J, 2006, ARTHRITIS RHEUM-US, V54, P463, DOI 10.1002/art.21626	65	37	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1043	1051		10.1074/jbc.M704915200	http://dx.doi.org/10.1074/jbc.M704915200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17991740	hybrid			2022-12-25	WOS:000252128100044
J	Boyd, WA; McBride, SJ; Freedman, JH				Boyd, Windy A.; McBride, Sandra J.; Freedman, Jonathan H.			Effects of Genetic Mutations and Chemical Exposures on Caenorhabditis elegans Feeding: Evaluation of a Novel, High-Throughput Screening Assay	PLOS ONE			English	Article							C-ELEGANS; END-POINTS; TOXICITY; CADMIUM; PHARYNX; STARVATION; LONGEVITY; SEROTONIN; BEHAVIOR; MUTANTS	Background. Government agencies have defined a need to reduce, refine or replace current mammalian-based bioassays with testing methods that use alternative species. Invertebrate species, such as Caenorhabditis elegans, provide an attractive option because of their short life cycles, inexpensive maintenance, and high degree of evolutionary conservation with higher eukaryotes. The C. elegans pharynx is a favorable model for studying neuromuscular function, and the effects of chemicals on neuromuscular activity, i.e., feeding. Current feeding methodologies, however, are labor intensive and only semi-quantitative. Methodology/Principal Findings. Here a high-throughput assay is described that uses flow cytometry to measure C. elegans feeding by determining the size and intestinal fluorescence of hundreds of nematodes after exposure to fluorescent-labeled microspheres. This assay was validated by quantifying fluorescence in feeding-defective C. elegans ( eat mutants), and by exposing wild-type nematodes to the neuroactive compounds, serotonin and arecoline. The eat mutations previously determined to cause slow pumping rates exhibited the lowest feeding levels with our assay. Concentration-dependent increases in feeding levels after serotonin exposures were dependent on food availability, while feeding levels decreased in arecoline-exposed nematodes regardless of the presence of food. The effects of the environmental contaminants, cadmium chloride and chlorpyrifos, on wild-type C. elegans feeding were then used to demonstrate an application of the feeding assay. Cadmium exposures above 200 mu M led to a sharp drop in feeding levels. Feeding of chlorpyrifos-exposed nematodes decreased in a concentration-dependent fashion with an EC50 of 2 mu M. Conclusions/Significance. The C. elegans fluorescence microsphere feeding assay is a rapid, reliable method for the assessment of neurotoxic effects of pharmaceutical drugs, industrial chemicals or environmental agents. This assay may also be applicable to large scale genetic or RNAi screens used to identify genes that are necessary for the development or function of the pharynx or other neuromuscular systems.	[Boyd, Windy A.; Freedman, Jonathan H.] NIEHS, Mol Toxicol Lab, Natl Toxicol Program, NIH, Res Triangle Pk, NC 27709 USA; [McBride, Sandra J.; Freedman, Jonathan H.] Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University	Freedman, JH (corresponding author), NIEHS, Mol Toxicol Lab, Natl Toxicol Program, NIH, Res Triangle Pk, NC 27709 USA.	freedma1@niehs.nih.gov		Boyd, Windy/0000-0003-3803-3716; McBride, Sandra/0000-0003-3730-9864	National Toxicology Program; Intramural Research Program of the NIH; NIEHS; NIH National Center for Research Resources (NCRR).; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES102046, ZIAES102046] Funding Source: NIH RePORTER	National Toxicology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH National Center for Research Resources (NCRR).(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported ( in part) by the National Toxicology Program, and by the Intramural Research Program of the NIH, and NIEHS. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	Anderson GL, 2004, ENVIRON TOXICOL CHEM, V23, P1235, DOI 10.1897/03-264; Anderson GL, 2001, ENVIRON TOXICOL CHEM, V20, P833, DOI [10.1897/1551-5028(2001)020&lt;0833:AOSEFT&gt;2.0.CO;2, 10.1002/etc.5620200419]; AVERY L, 1993, GENETICS, V134, P454; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; AVERY L, 1993, GENETICS, V133, P897; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; AVERY L, 1997, C ELEGANS, V2, P679, DOI [10.1101/087969532.33.679, DOI 10.1101/087969532.33.679]; Bargmann CI, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews1005; Barron MG, 1995, REV ENVIRON CONTAM T, V144, P1; Becker RA, 2006, REGUL TOXICOL PHARM, V46, P18, DOI 10.1016/j.yrtph.2006.06.001; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P3049, DOI 10.1897/02-565; BRENNER S, 1974, GENETICS, V77, P71; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Cole RD, 2004, TOXICOL APPL PHARM, V194, P248, DOI 10.1016/j.taap.2003.09.013; Combes D, 2001, INT REV CYTOL, V209, P207; Copeland RA, 2000, ENZYMES PRACTICAL IN, P109; Corsi AK, 2006, ANAL BIOCHEM, V359, P1, DOI 10.1016/j.ab.2006.07.033; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; CROLL NA, 1975, CAN J ZOOL, V53, P894, DOI 10.1139/z75-103; Culetto E, 2000, HUM MOL GENET, V9, P869, DOI 10.1093/hmg/9.6.869; Davis MW, 1995, J NEUROSCI, V15, P8408; Franks DM, 2006, DEV BIOL, V296, P409, DOI 10.1016/j.ydbio.2006.06.008; Furlong EEM, 2001, NAT BIOTECHNOL, V19, P153, DOI 10.1038/84422; Gill MS, 2003, FREE RADICAL BIO MED, V35, P558, DOI 10.1016/S0891-5849(03)00328-9; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Jones D, 1999, J EXP ZOOL, V284, P147, DOI 10.1002/(SICI)1097-010X(19990701)284:2&lt;147::AID-JEZ4&gt;3.0.CO;2-Z; Kaganman I, 2006, NAT METHODS, V3, P662, DOI 10.1038/nmeth0906-662a; KAUFMAN L, 2005, FINDING GROUPS DATA, P126; Khanna N, 1997, ARCH ENVIRON CON TOX, V32, P110, DOI 10.1007/s002449900162; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; KOTSONIS FN, 1977, TOXICOL APPL PHARM, V41, P667, DOI 10.1016/S0041-008X(77)80020-3; Morck C, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-39; NETER J, 1996, APPL LINEAR STAT MOD, P959; Niacaris T, 2003, J EXP BIOL, V206, P223, DOI 10.1242/jeb.00101; Petersen CI, 2004, P NATL ACAD SCI USA, V101, P11773, DOI 10.1073/pnas.0306005101; Pulak Rock, 2006, V351, P275; RAIZEN DM, 1995, GENETICS, V141, P1365; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; RATKOWSKY DA, 1983, NONLINEAR REGRESSION, P75; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Shibata Y, 2000, GENETICS, V154, P635; Thompson G, 2005, J BIOCHEM MOL TOXIC, V19, P87, DOI 10.1002/jbt.20060; Waalkes MP, 2000, J INORG BIOCHEM, V79, P241, DOI 10.1016/S0162-0134(00)00009-X; WILLIAMS PL, 1988, TOXICOL IND HEALTH, V4, P469, DOI 10.1177/074823378800400406; WONG KL, 1982, TOXICOL APPL PHARM, V63, P330, DOI 10.1016/0041-008X(82)90261-7; You YJ, 2006, CELL METAB, V3, P237, DOI 10.1016/j.cmet.2006.02.012	47	51	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1259	10.1371/journal.pone.0001259	http://dx.doi.org/10.1371/journal.pone.0001259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060055	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459400008
J	Smith, TJ; Hill, KK; Foley, BT; Detter, JC; Munk, AC; Bruce, DC; Doggett, NA; Smith, LA; Marks, JD; Xie, G; Brettin, TS				Smith, Theresa J.; Hill, Karen K.; Foley, Brian T.; Detter, John C.; Munk, A. Christine; Bruce, David C.; Doggett, Norman A.; Smith, Leonard A.; Marks, James D.; Xie, Gary; Brettin, Thomas S.			Analysis of the Neurotoxin Complex Genes in Clostridium botulinum A1-A4 and B1 Strains: BoNT/A3, BoNT/Ba4 and BoNT/B1 Clusters Are Located within Plasmids	PLOS ONE			English	Article							GENOME SEQUENCE; INFANT BOTULISM; TOXIN COMPLEX; C-NEUROTOXIN; ORGANIZATION; DATABASE; BINDING; MECHANISMS; DIVERSITY; ALIGNMENT	Background. Clostridium botulinum and related clostridial species express extremely potent neurotoxins known as botulinum neurotoxins (BoNTs) that cause long-lasting, potentially fatal intoxications in humans and other mammals. The amino acid variation within the BoNT is used to categorize the species into seven immunologically distinct BoNT serotypes (A-G) which are further divided into subtypes. The BoNTs are located within two generally conserved gene arrangements known as botulinum progenitor complexes which encode toxin-associated proteins involved in toxin stability and expression. Methodology/Principal Findings. Because serotype A and B strains are responsible for the vast majority of human botulism cases worldwide, the location, arrangement and sequences of genes from eight different toxin complexes representing four different BoNT/A subtypes (BoNT/A1-Ba4) and one BoNT/B1 strain were examined. The bivalent Ba4 strain contained both the BoNT/A4 and BoNT/bvB toxin clusters. The arrangements of the BoNT/A3 and BoNT/A4 subtypes differed from the BoNT/A1 strains and were similar to those of BoNT/A2. However, unlike the BoNT/A2 subtype, the toxin complex genes of BoNT/A3 and BoNT/A4 were found within large plasmids and not within the chromosome. In the Ba4 strain, both BoNT toxin clusters (A4 and bivalent B) were located within the same 270 kb plasmid, separated by 97 kb. Complete genomic sequencing of the BoNT/B1 strain also revealed that its toxin complex genes were located within a 149 kb plasmid and the BoNT/A3 complex is within a 267 kb plasmid. Conclusions/Significance. Despite their size differences and the BoNT genes they contain, the three plasmids containing these toxin cluster genes share significant sequence identity. The presence of partial insertion sequence ( IS) elements, evidence of recombination/gene duplication events, and the discovery of the BoNT/A3, BoNT/Ba4 and BoNT/B1 toxin complex genes within plasmids illustrate the different mechanisms by which these genes move among diverse genetic backgrounds of C. botulinum.	[Hill, Karen K.; Detter, John C.; Munk, A. Christine; Bruce, David C.; Doggett, Norman A.; Xie, Gary; Brettin, Thomas S.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Smith, Theresa J.; Smith, Leonard A.] USA, Med Inst Infect Dis, Integrated Toxicol Div, Ft Detrick, MD USA; [Foley, Brian T.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA; [Marks, James D.] Univ Calif San Francisco, Dept Anesthesia & Pharmaceut Chem, San Francisco, CA 94143 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California San Francisco	Hill, KK (corresponding author), Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA.	Khill@lanl.gov	Foley, Brian T/N-4527-2018	Foley, Brian T/0000-0002-1086-0296; xie, gary/0000-0002-9176-924X	U.S. Department of Energy; NIAID [UO1 AI056493, U01 AI056493]; Intelligence Technology Innovation Center (ITIC); DoD [DAMD17-03-C-0076]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI056493] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intelligence Technology Innovation Center (ITIC); DoD(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this project was provided by the U.S. Department of Energy, and NIAID grant UO1 AI056493. The DOE Joint Genome Institute (JGI) at Los Alamos National Laboratory acknowledges the support of the Intelligence Technology Innovation Center (ITIC) for this research. This work was partially supported by DoD contract DAMD17-03-C-0076 and by NIAID cooperative agreement U01 AI056493.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aoki KR, 2004, CURR MED CHEM, V11, P3085, DOI 10.2174/0929867043363802; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bhandari M, 1997, CURR MICROBIOL, V35, P207, DOI 10.1007/s002849900240; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bruggemann H, 2004, ANAEROBE, V10, P53, DOI 10.1016/j.anaerobe.2003.08.001; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; *CDC, 1998, BOT US 1899 1998 HDB; Collins MD, 1998, J APPL MICROBIOL, V84, P5, DOI 10.1046/j.1365-2672.1997.00313.x; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Dineen SS, 2004, FEMS MICROBIOL LETT, V235, P9, DOI 10.1016/j.femsle.2004.04.002; Dineen SS, 2003, CURR MICROBIOL, V46, P345, DOI 10.1007/s00284-002-3851-1; DODD IB, 1990, NUCLEIC ACIDS RES, V18, P5019, DOI 10.1093/nar/18.17.5019; East AK, 1998, CURR MICROBIOL, V37, P262, DOI 10.1007/s002849900376; East AK, 1996, INT J SYST BACTERIOL, V46, P1105, DOI 10.1099/00207713-46-4-1105; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EDMOND BJ, 1977, TEX MED, V73, P85; Franciosa G, 2006, FEMS MICROBIOL LETT, V261, P88, DOI 10.1111/j.1574-6968.2006.00331.x; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; GIMENEZ DF, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P421; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Han C., 2006, P 2006 INT C BIOINF, P141; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; HAUSER D, 1994, MOL GEN GENET, V243, P631, DOI 10.1007/BF00279572; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Jovita MR, 1998, CURR MICROBIOL, V36, P226, DOI 10.1007/s002849900299; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kubota T, 1998, FEMS MICROBIOL LETT, V158, P215, DOI 10.1016/S0378-1097(97)00525-9; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LAMANNA C, 1947, J BACTERIOL, V54, P575, DOI 10.1128/JB.54.5.575-584.1947; Lee JC, 2005, MICROBIOL-SGM, V151, P3739, DOI 10.1099/mic.0.28421-0; Leighton Gerald, 1923, BOTULISM FOOD PRESER; Lindstrom M, 2006, CLIN MICROBIOL REV, V19, P298, DOI 10.1128/CMR.19.2.298-314.2006; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MACDONALD TE, 2007, APPL ENV MICROBIOL; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Maksymowych AB, 1999, INFECT IMMUN, V67, P4708, DOI 10.1128/IAI.67.9.4708-4712.1999; Marshall KM, 2007, BIOCHEM BIOPH RES CO, V361, P49, DOI 10.1016/j.bbrc.2007.06.166; McHardy AC, 2004, BIOINFORMATICS, V20, P1622, DOI 10.1093/bioinformatics/bth137; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Miyamoto K, 2006, J BACTERIOL, V188, P1585, DOI 10.1128/JB.188.4.1585-1598.2006; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Nakajima H, 1998, MICROBIOL IMMUNOL, V42, P599, DOI 10.1111/j.1348-0421.1998.tb02330.x; NIELSEN H, 1998, P 6 INT C INT SYST M, P122; Popoff MR, 1999, COMPREHENSIVE SOURCE, P202; Raffestin S, 2004, ANAEROBE, V10, P93, DOI 10.1016/j.anaerobe.2004.01.001; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Sakaguchi Y, 2005, P NATL ACAD SCI USA, V102, P17472, DOI 10.1073/pnas.0505503102; Santos-Buelga JA, 1998, CURR MICROBIOL, V37, P312, DOI 10.1007/s002849900384; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; STROM MS, 1984, APPL ENVIRON MICROB, V48, P956, DOI 10.1128/AEM.48.5.956-963.1984; Suzek BE, 2001, BIOINFORMATICS, V17, P1123, DOI 10.1093/bioinformatics/17.12.1123; TAKAHASHI M, 1988, JPN J MED SCI BIOL, V41, P21, DOI 10.7883/yoken1952.41.21; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Webb RP, 2007, VACCINE, V25, P4273, DOI 10.1016/j.vaccine.2007.02.081; ZHOU YT, 1995, INFECT IMMUN, V63, P2087, DOI 10.1128/IAI.63.5.2087-2091.1995	62	126	1289	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1271	10.1371/journal.pone.0001271	http://dx.doi.org/10.1371/journal.pone.0001271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060065	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459400018
J	Bar-Yehuda, D; Korngreen, A				Bar-Yehuda, Dan; Korngreen, Alon			Cellular and Network Contributions to Excitability of Layer 5 Neocortical Pyramidal Neurons in the Rat	PLOS ONE			English	Article								There is a considerable gap between investigating the dynamics of single neurons and the computational aspects of neural networks. A growing number of studies have attempted to overcome this gap using the excitation in brain slices elicited by various chemical manipulations of the bath solution. However, there has been no quantitative study on the effects of these manipulations on the cellular and network factors controlling excitability. Using the whole-cell configuration of the patch-clamp technique we recorded the membrane potential from the soma of layer 5 pyramidal neurons in acute brain slices from the somatosensory cortex of young rats at 22 degrees C and 35 degrees C. Using blockers of synaptic transmission, we show distinct changes in cellular properties following modification of the ionic composition of the artificial cerebrospinal fluid (ACSF). Thus both cellular and network changes may contribute to the observed effects of slice excitation solutions on the physiology of single neurons. Furthermore, our data suggest that the difference in the ionic composition of current standard ACSF from that of CSF measured in vivo cause ACSF to depress network activity in acute brain slices. This may affect outcomes of experiments investigating biophysical and physiological properties of neurons in such preparations. Our results strongly advocate the necessity of redesigning experiments routinely carried out in the quiescent acute brain slice preparation.	[Korngreen, Alon] Bar Ilan Univ, Mina & Everard Fac Life Sci, Ramat Gan, Israel; [Bar-Yehuda, Dan; Korngreen, Alon] Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Korngreen, A (corresponding author), Bar Ilan Univ, Mina & Everard Fac Life Sci, Ramat Gan, Israel.	korngra@mail.biu.ac.il		Korngreen, Alon/0000-0002-2036-6160	German Israeli Foundation [748158.1/2002]	German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development)	This research was supported by the German Israeli Foundation (# 748158.1/2002).	Andrew RD, 1996, J NEUROPHYSIOL, V76, P2707, DOI 10.1152/jn.1996.76.4.2707; Antic SD, 2003, J PHYSIOL-LONDON, V550, P35, DOI 10.1113/jphysiol.2002.033746; Ariav G, 2003, J NEUROSCI, V23, P7750; Arvanov VL, 1997, BRAIN RES, V768, P361, DOI 10.1016/S0006-8993(97)00842-1; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Bischofberger J, 1997, J PHYSIOL-LONDON, V504, P359, DOI 10.1111/j.1469-7793.1997.359be.x; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chen WR, 2002, J NEUROPHYSIOL, V88, P2755, DOI 10.1152/jn.00057.2002; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; De Schutter E, 1999, REV NEUROSCIENCE, V10, P233; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Harsch A, 2000, J NEUROSCI, V20, P6181, DOI 10.1523/JNEUROSCI.20-16-06181.2000; HAUSSER M, 1995, NEURON, V15, P637, DOI 10.1016/0896-6273(95)90152-3; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Ho N, 2000, J NEUROPHYSIOL, V84, P1488, DOI 10.1152/jn.2000.84.3.1488; HVALBY O, 1990, PROG BRAIN RES, V83, P131; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Korngreen A, 2004, J NEUROPHYSIOL, V91, P2400, DOI 10.1152/jn.00115.2004; Korogod SM, 1996, NEUROSCIENCE, V75, P1153, DOI 10.1016/0306-4522(96)00265-5; London M, 2002, NAT NEUROSCI, V5, P332, DOI 10.1038/nn826; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Migliore M, 2002, NAT REV NEUROSCI, V3, P362, DOI 10.1038/nrn810; OVIEDO H, 2002, NAT NEUROSCI, P261; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Reig R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000670; ROBINSON HPC, 1994, TRENDS NEUROSCI, V17, P147, DOI 10.1016/0166-2236(94)90088-4; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Schwindt PC, 1997, J NEUROPHYSIOL, V77, P2466, DOI 10.1152/jn.1997.77.5.2466; SHARP AA, 1993, TRENDS NEUROSCI, V16, P389, DOI 10.1016/0166-2236(93)90004-6; Sickmann T, 2002, BRAIN RES, V929, P166, DOI 10.1016/S0006-8993(01)03386-8; Silberberg G, 2004, J PHYSIOL-LONDON, V556, P19, DOI 10.1113/jphysiol.2004.060962; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; STUART G, 1995, CURR OPIN NEUROBIOL, V5, P389, DOI 10.1016/0959-4388(95)80053-0; Stuart G., 1999, DENDRITES; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Takigawa T, 1999, J PHYSIOL-LONDON, V517, P385, DOI 10.1111/j.1469-7793.1999.0385t.x; Williams SR, 2005, J NEUROSCI, V25, P5894, DOI 10.1523/JNEUROSCI.0502-05.2005; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305; Zhang ZW, 2003, J NEUROSCI, V23, P3373; Zhu JJ, 2000, J PHYSIOL-LONDON, V526, P571, DOI 10.1111/j.1469-7793.2000.00571.x	52	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1209	10.1371/journal.pone.0001209	http://dx.doi.org/10.1371/journal.pone.0001209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030343	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459200022
J	Kumar, S; Chaudhary, K; Foster, JM; Novelli, JF; Zhang, YH; Wang, SL; Spiro, D; Ghedin, E; Carlow, CKS				Kumar, Sanjay; Chaudhary, Kshitiz; Foster, Jeremy M.; Novelli, Jacopo F.; Zhang, Yinhua; Wang, Shiliang; Spiro, David; Ghedin, Elodie; Carlow, Clotilde K. S.			Mining Predicted Essential Genes of Brugia malayi for Nematode Drug Targets	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; ONCHOCERCA-VOLVULUS; LITOMOSOIDES-SIGMODONTIS; RNA INTERFERENCE; CHITIN SYNTHASE; EXPRESSION; FAMILY; RESISTANCE; IVERMECTIN; REGULATOR	We report results from the first genome-wide application of a rational drug target selection methodology to a metazoan pathogen genome, the completed draft sequence of Brugia malayi, a parasitic nematode responsible for human lymphatic filariasis. More than 1.5 billion people worldwide are at risk of contracting lymphatic filariasis and onchocerciasis, a related filarial disease. Drug treatments for filariasis have not changed significantly in over 20 years, and with the risk of resistance rising, there is an urgent need for the development of new anti-filarial drug therapies. The recent publication of the draft genomic sequence for B. malayi enables a genome-wide search for new drug targets. However, there is no functional genomics data in B. malayi to guide the selection of potential drug targets. To circumvent this problem, we have utilized the free-living model nematode Caenorhabditis elegans as a surrogate for B. malayi. Sequence comparisons between the two genomes allow us to map C. elegans orthologs to B. malayi genes. Using these orthology mappings and by incorporating the extensive genomic and functional genomic data, including genome-wide RNAi screens, that already exist for C. elegans, we identify potentially essential genes in B. malayi. Further incorporation of human host genome sequence data and a custom algorithm for prioritization enables us to collect and rank nearly 600 drug target candidates. Previously identified potential drug targets cluster near the top of our prioritized list, lending credibility to our methodology. Over-represented Gene Ontology terms, predicted InterPro domains, and RNAi phenotypes of C. elegans orthologs associated with the potential target pool are identified. By virtue of the selection procedure, the potential B. malayi drug targets highlight components of key processes in nematode biology such as central metabolism, molting and regulation of gene expression.	[Kumar, Sanjay; Chaudhary, Kshitiz; Foster, Jeremy M.; Novelli, Jacopo F.; Zhang, Yinhua; Carlow, Clotilde K. S.] New England Biolabs Inc, Div Parasitol, Ipswich, MA USA; [Wang, Shiliang; Spiro, David; Ghedin, Elodie] Inst Genom Res, Rockville, MD USA; [Ghedin, Elodie] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA USA	New England Biolabs; J. Craig Venter Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carlow, CKS (corresponding author), New England Biolabs Inc, Div Parasitol, Ipswich, MA USA.	carlow@neb.com	Ghedin, Elodie/Y-5654-2019; Kumar, Sanjay/AAO-2593-2021	Ghedin, Elodie/0000-0002-1515-725X; Zhang, Yinhua/0000-0003-0592-9153	New England Biolabs; National Institute for Allergy and Infectious Diseases (NIAID/NIH)	New England Biolabs; National Institute for Allergy and Infectious Diseases (NIAID/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by New England Biolabs. Funding for portions of this work was also provided by a grant from the National Institute for Allergy and Infectious Diseases (NIAID/NIH) awarded to E.G.	AbdelWahab N, 1996, MOL BIOCHEM PARASIT, V76, P187, DOI 10.1016/0166-6851(95)02558-8; Aboobaker AA, 2003, MOL BIOCHEM PARASIT, V129, P41, DOI 10.1016/S0166-6851(03)00092-6; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barnes TM, 1997, J NEUROCHEM, V69, P2251; Behm CA, 2005, TRENDS PARASITOL, V21, P97, DOI 10.1016/j.pt.2004.12.003; Behm CA, 1997, INT J PARASITOL, V27, P215, DOI 10.1016/S0020-7519(96)00151-8; Beverley SM, 2005, EUKARYOT CELL, V4, P1147, DOI 10.1128/EC.4.6.1147-1154.2005; Bieri T, 2007, NUCLEIC ACIDS RES, V35, pD506, DOI 10.1093/nar/gkl818; Bird AF, 1991, STRUCTURE NEMATODES; BLUMENTHAL T, 1995, TRENDS GENET, V11, P132, DOI 10.1016/S0168-9525(00)89026-5; Brooks DR, 2002, PARASITOL INT, V51, P319, DOI 10.1016/S1383-5769(02)00063-6; Burglin TR, 1998, INT J PARASITOL, V28, P395, DOI 10.1016/S0020-7519(97)00208-7; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Craig H, 2007, TRENDS PARASITOL, V23, P248, DOI 10.1016/j.pt.2007.04.003; Denker JA, 2002, NATURE, V417, P667, DOI 10.1038/nature00783; Dent JA, 2000, P NATL ACAD SCI USA, V97, P2674, DOI 10.1073/pnas.97.6.2674; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Filarial Genome Project, 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene, V96, P7, DOI 10.1016/S0035-9203(02)90224-5; Ford L, 2005, J BIOL CHEM, V280, P40845, DOI 10.1074/jbc.M504434200; Foster JM, 2005, TRENDS PARASITOL, V21, P101, DOI 10.1016/j.pt.2004.12.002; Foster JM, 2005, MOL BIOCHEM PARASIT, V142, P126, DOI 10.1016/j.molbiopara.2005.03.011; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Galperin MY, 1999, CURR OPIN BIOTECH, V10, P571, DOI 10.1016/S0958-1669(99)00035-X; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Grossmann S, 2006, LECT NOTES COMPUT SC, V3909, P85; Hao LM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-280; Hao LM, 2006, DEV DYNAM, V235, P1469, DOI 10.1002/dvdy.20721; Harris MT, 2000, MOL BIOCHEM PARASIT, V111, P351, DOI 10.1016/S0166-6851(00)00328-5; Hasan S, 2006, PLOS COMPUT BIOL, V2, P539, DOI 10.1371/journal.pcbi.0020061; Hashmi S, 2001, TRENDS PARASITOL, V17, P387, DOI 10.1016/S1471-4922(01)01986-9; Heid PJ, 2001, DEV BIOL, V236, P165, DOI 10.1006/dbio.2001.0315; Heider U, 2006, INT J MED MICROBIOL, V296, P287, DOI 10.1016/j.ijmm.2005.12.019; Hoerauf Achim, 2006, Expert Rev Anti Infect Ther, V4, P211, DOI 10.1586/14787210.4.2.211; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hristova M, 2005, MOL CELL BIOL, V25, P11059, DOI 10.1128/MCB.25.24.11059-11072.2005; Kleczka B, 2007, J BIOL CHEM, V282, P10498, DOI 10.1074/jbc.M700023200; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Kormish JD, 2005, DEV BIOL, V287, P35, DOI 10.1016/j.ydbio.2005.08.027; Korswagen HC, 2002, GENE DEV, V16, P1291, DOI 10.1101/gad.981802; Kostrouchova M, 2001, P NATL ACAD SCI USA, V98, P7360, DOI 10.1073/pnas.131171898; Kuervers LM, 2003, MOL GENET GENOMICS, V270, P121, DOI 10.1007/s00438-003-0900-9; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LABOUESSE M, 2006, WORMBOOK; Luan CH, 2004, GENOME RES, V14, P2102, DOI 10.1101/gr.2520504; Lustigmana S, 2004, MOL BIOCHEM PARASIT, V138, P165, DOI 10.1016/j.molbiopara.2004.08.003; MacMorris M, 2007, RNA, V13, P511, DOI 10.1261/rna.426707; Maine EM, 2005, CURR BIOL, V15, P1972, DOI 10.1016/j.cub.2005.09.049; Maloof JN, 1999, DEVELOPMENT, V126, P37; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; McCarter JP, 2004, TRENDS PARASITOL, V20, P462, DOI 10.1016/j.pt.2004.07.008; McMahon L, 2001, J CELL SCI, V114, P2265; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Page AP, 2006, INT J PARASITOL, V36, P681, DOI 10.1016/j.ijpara.2006.01.004; Pan F, 2001, J BACTERIOL, V183, P3991, DOI 10.1128/JB.183.13.3991-3998.2001; Pfarr K, 2006, INT J PARASITOL, V36, P661, DOI 10.1016/j.ijpara.2006.01.010; Phelan P, 2005, BBA-BIOMEMBRANES, V1711, P225, DOI 10.1016/j.bbamem.2004.10.004; POWELL JW, 1986, MOL BIOCHEM PARASIT, V18, P171, DOI 10.1016/0166-6851(86)90036-8; QIAO L, 1995, GENETICS, V141, P551; Robertson JG, 2005, BIOCHEMISTRY-US, V44, P5561, DOI 10.1021/bi050247e; Rosamond L, 2000, SCIENCE, V287, P1973, DOI 10.1126/science.287.5460.1973; Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387; Schwab AE, 2005, AM J TROP MED HYG, V73, P234, DOI 10.4269/ajtmh.2005.73.234; SINGH RN, 1978, NEMATOLOGICA, V24, P63, DOI 10.1163/187529278X00074; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Starich T, 2001, CELL COMMUN ADHES, V8, P311, DOI 10.3109/15419060109080744; Starich TA, 1996, J CELL BIOL, V134, P537, DOI 10.1083/jcb.134.2.537; TAYLOR MJ, 1995, INFECT IMMUN, V63, P4417, DOI 10.1128/IAI.63.11.4417-4422.1995; Tsuboi D, 2002, BIOCHEM BIOPH RES CO, V292, P697, DOI 10.1006/bbrc.2002.6717; Vought VE, 2005, GENETICS, V170, P1121, DOI 10.1534/genetics.105.042135; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Whitten SJ, 2007, DEV BIOL, V301, P432, DOI 10.1016/j.ydbio.2006.08.038; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; World Health Organization, 2004, WORLD HLTH REP 2004; Zhang YH, 2005, DEV BIOL, V285, P330, DOI 10.1016/j.ydbio.2005.06.037; Zhang YH, 2004, J BIOL CHEM, V279, P37185, DOI 10.1074/jbc.M405877200; Zugasti O, 2005, GENOME RES, V15, P1402, DOI 10.1101/gr.3935405	78	75	77	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1189	10.1371/journal.pone.0001189	http://dx.doi.org/10.1371/journal.pone.0001189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000556	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000207459100027
J	Al-Azawi, D; Mc Ilroy, M; Kelly, G; Redmond, AM; Bane, FT; Cocchiglia, S; Hill, ADK; Young, LS				Al-Azawi, D.; Mc Ilroy, M.; Kelly, G.; Redmond, A. M.; Bane, F. T.; Cocchiglia, S.; Hill, A. D. K.; Young, L. S.			Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer	ONCOGENE			English	Article						breast cancer; myc; SRC-1; tamoxifen resistance; Ets-2	CREB-BINDING-PROTEIN; ESTROGEN-RECEPTOR; EXPRESSION; PHOSPHORYLATION; ACTIVATION; GROWTH; COACTIVATORS; PATHWAYS; P300; ER81	Associations between p160 coactivator proteins and endocrine resistance have been described. Though thought to primarily interact with steroid receptors, the p160 proteins can also interact with non-nuclear receptor transcription factors including the MAP kinase effector proteins Ets. Here, we observed that in breast cancer cells resistant and insensitive to endocrine treatment, the growth factor EGF induced Ets-2 but not Ets-1 transcriptional regulation of the oncogene myc. Ets-2 regulation of myc was found to be reliant on the p160 proteins SRC-1 and SRC-3. In support of these molecular observations, strong associations were observed between the transcription factor, Ets-2 and its coactivator SRC-1 (P < 0.01) and the target gene myc (P < 0.0001) in a cohort of breast cancer patients with locally advanced disease. Expression of Ets-2, SRC-1 and c-Myc individually all associated with reduced disease-free survival (P < 0.001, P < 0.001 and P = 0.002 respectively). There was no association between SRC-3 and disease-free survival (P = 0.707). SRC-1 can utilize MAP kinase effector transcription factor Ets-2 to regulate the production of the oncogene myc. These signalling mechanisms maybe important in the development of steroid resistant/independent breast cancer.	[Al-Azawi, D.; Mc Ilroy, M.; Redmond, A. M.; Bane, F. T.; Cocchiglia, S.; Hill, A. D. K.; Young, L. S.] Royal Coll Surgeons Ireland, Dept Surg, Dublin 2, Ireland; [Al-Azawi, D.] Univ Coll Dublin, Sch Med & Med Sci, UCD Conway Inst, Dublin 2, Ireland; [Kelly, G.] Univ Coll Dublin, Sch Math Sci Stat & Actuarial Sci, Dublin 2, Ireland	Royal College of Surgeons - Ireland; University College Dublin; University College Dublin	Young, LS (corresponding author), Royal Coll Surgeons Ireland, Dept Surg Res, Lab 3, 4th Floor,York House,RCSI St Stephens Green, Dublin 2, Ireland.	lyoung@rcsi.ie	Hill, Arnold DK/F-8438-2011; McIlroy, Marie/D-6110-2012; Young, Leonie/D-5631-2012	McIlroy, Marie/0000-0002-0827-8096; Young, Leonie/0000-0002-4904-0367				BRONZERT DA, 1985, ENDOCRINOLOGY, V117, P1409, DOI 10.1210/endo-117-4-1409; BRUNNER N, 1993, CANCER RES, V53, P283; Carbone GM, 2004, NUCLEIC ACIDS RES, V32, P4358, DOI 10.1093/nar/gkh744; CHEVALLIER B, 1993, AM J CLIN ONCOL-CANC, V16, P223, DOI 10.1097/00000421-199306000-00006; Cosgrave N, 2006, J MOL ENDOCRINOL, V37, P377, DOI 10.1677/jme.1.02118; Cui YK, 2006, CANCER RES, V66, P5950, DOI 10.1158/0008-5472.CAN-05-3243; DUKE RC, 1994, FASEB J, V8, P237, DOI 10.1096/fasebj.8.2.8119494; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Fowles LF, 1998, MOL CELL BIOL, V18, P5148, DOI 10.1128/MCB.18.9.5148; Galang CK, 1996, J BIOL CHEM, V271, P7992, DOI 10.1074/jbc.271.14.7992; Goel A, 2004, J BIOL CHEM, V279, P14909, DOI 10.1074/jbc.M400036200; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hutcheson IR, 2003, BREAST CANCER RES TR, V81, P81, DOI 10.1023/A:1025484908380; Jayaraman G, 1999, J BIOL CHEM, V274, P17342, DOI 10.1074/jbc.274.24.17342; MCIIROY M, 2006, ENDOCR-RELAT CANCER, V13, P1135; McNeil CM, 2006, J STEROID BIOCHEM, V102, P147, DOI 10.1016/j.jsbmb.2006.09.028; Myers E, 2005, CLIN CANCER RES, V11, P2111, DOI 10.1158/1078-0432.CCR-04-1192; Nicholson RI, 2004, CLIN CANCER RES, V10, p346S, DOI 10.1158/1078-0432.CCR-031206; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Papoutsopoulou S, 2000, MOL CELL BIOL, V20, P7300, DOI 10.1128/MCB.20.19.7300-7310.2000; ROUSSEL MF, 1994, ONCOGENE, V9, P405; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sharrocks AD, 1997, INT J BIOCHEM CELL B, V29, P1371, DOI 10.1016/S1357-2725(97)00086-1; Shepherd T, 2001, J MAMMARY GLAND BIOL, V6, P129, DOI 10.1023/A:1009576801226; Yang BS, 1996, MOL CELL BIOL, V16, P538; Yang C, 1998, MOL CELL BIOL, V18, P2218, DOI 10.1128/MCB.18.4.2218	27	49	49	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 8	2008	27	21					3021	3031		10.1038/sj.onc.1210964	http://dx.doi.org/10.1038/sj.onc.1210964			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	298IP	18059336				2022-12-25	WOS:000255681700009
J	Xi, JH; Bai, F; Gross, J; Townsend, RR; Menko, AS; Andley, UP				Xi, Jing-hua; Bai, Fang; Gross, Julia; Townsend, R. Reid; Menko, A. Sue; Andley, Usha P.			Mechanism of small heat shock protein function in vivo - A knock-in mouse model demonstrates that the R49C mutation in alpha A-crystallin enhances protein insolubility and cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LENS EPITHELIAL-CELLS; AUTOSOMAL-DOMINANT CATARACT; RESONANCE ENERGY-TRANSFER; CHAPERONE-LIKE ACTIVITY; B-CRYSTALLIN; MOLECULAR CHAPERONE; HEREDITARY CATARACT; SIGNALING PATHWAYS; MISSENSE MUTATION; INDUCED APOPTOSIS	alpha A-crystallin (Cryaa/HSPB4) is a small heat shock protein and molecular chaperone that prevents nonspecific aggregation of denaturing proteins. Several point mutations in the alpha A-crystallin gene cause congenital human cataracts by unknown mechanisms. We took a novel approach to investigate the molecular mechanism of cataract formation in vivo by creating gene knock-in mice expressing the arginine 49 to cysteine mutation (R49C) in alpha A-crystallin (alpha A-R49C). This mutation has been linked with autosomal dominant hereditary cataracts in a four-generation Caucasian family. Homologous recombination in embryonic stem cells was performed using a plasmid containing the C to T transition in exon 1 of the cryaa gene. alpha A-R49C heterozygosity led to early cataracts characterized by nuclear opacities. Unexpectedly, alpha A-R49C homozygosity led to small eye phenotype and severe cataracts at birth. Wild type littermates did not show these abnormalities. Lens fiber cells of alpha A-R49C homozygous mice displayed an increase in cell death by apoptosis mediated by a 5-fold decrease in phosphorylated Bad, an anti-apoptotic protein, but an increase in Bcl-2 expression. However, proliferation measured by in vivo bromodeoxyuridine labeling did not decline. The alpha A-R49C heterozygous and homozygous knock-in lenses demonstrated an increase in insoluble alpha A-crystallin and alpha B-crystallin and a surprising increase in expression of cytoplasmic gamma-crystallin, whereas no changes in beta-crystallin were observed. Co-immunoprecipitation analysis showed increased interaction between alpha A-crystallin and lens substrate proteins in the heterozygous knock-in lenses. To our knowledge this is the first knock-in mouse model for a crystallin mutation causing hereditary human cataract and establishes that alpha A-R49C promotes protein insolubility and cell death in vivo.	[Xi, Jing-hua; Bai, Fang; Andley, Usha P.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Gross, Julia; Townsend, R. Reid] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Townsend, R. Reid] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Menko, A. Sue] Thomas Jefferson Univ, Dept Anat Pathol, Dept Cell Biol & Anat, Philadelphia, PA 19107 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Jefferson University	Andley, UP (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, 660 S Euclid Ave,Campus Box 8096, St Louis, MO 63110 USA.	andley@vision.wustl.edu		Andley, Usha/0000-0001-7049-7591; Menko, A. Sue/0000-0002-7514-4696	NEI NIH HHS [EY02687, R01EY05681] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005681, P30EY002687] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alizadeh A, 2002, INVEST OPHTH VIS SCI, V43, P3722; ANDLEY UP, 1986, PHOTOCHEM PHOTOBIOL, V44, P67, DOI 10.1111/j.1751-1097.1986.tb03565.x; Andley UP, 1996, J BIOL CHEM, V271, P31973, DOI 10.1074/jbc.271.50.31973; Andley UP, 1998, J BIOL CHEM, V273, P31252, DOI 10.1074/jbc.273.47.31252; Andley UP, 2004, PHOTOCHEM PHOTOBIOL, V80, P61, DOI 10.1562/2004-02-03-RA-075.1; Andley UP, 2002, J BIOL CHEM, V277, P10178, DOI 10.1074/jbc.M109211200; Andley UP, 2001, FASEB J, V15, P221, DOI 10.1096/fj.00-0296com; Andley Usha P., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000111; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Bai F, 2003, J BIOL CHEM, V278, P36876, DOI 10.1074/jbc.M304010200; Beebe DC, 2000, DEV BIOL, V220, P424, DOI 10.1006/dbio.2000.9638; Beebe DC, 2001, INVEST OPHTH VIS SCI, V42, P727; Bera S, 2002, BIOCHEMISTRY-US, V41, P12421, DOI 10.1021/bi0204140; Bhat SP, 2004, EXP EYE RES, V79, P809, DOI 10.1016/j.exer.2004.08.020; Biswas A, 2006, BIOCHEMISTRY-US, V45, P4569, DOI 10.1021/bi052574s; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Bloss TA, 2003, NATURE, V424, P1066, DOI 10.1038/nature01920; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Cobb BA, 2002, BIOCHEMISTRY-US, V41, P483, DOI 10.1021/bi0112457; Cobb BA, 2000, BIOCHEMISTRY-US, V39, P15791, DOI 10.1021/bi001453j; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Ferreira-Cornwell MC, 2000, EXP CELL RES, V256, P237, DOI 10.1006/excr.2000.4819; FITZGERALD PG, 1987, INVEST OPHTH VIS SCI, V28, P795; Fu L, 2003, INVEST OPHTH VIS SCI, V44, P1155, DOI 10.1167/iovs.02-0950; Gaestel M, 2002, Prog Mol Subcell Biol, V28, P151; Griep AE, 2006, SEMIN CELL DEV BIOL, V17, P686, DOI 10.1016/j.semcdb.2006.10.004; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hsu CD, 2006, INVEST OPHTH VIS SCI, V47, P2036, DOI 10.1167/iovs.05-0524; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; King JB, 2006, ANAL CHEM, V78, P2171, DOI 10.1021/ac051520l; Koteiche HA, 2006, J BIOL CHEM, V281, P14273, DOI 10.1074/jbc.M512938200; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Leong L, 2000, INVEST OPHTH VIS SCI, V41, P3503; Liang JJ, 2006, PROTEIN SCI, V15, P1619, DOI 10.1110/ps.062216006; LIANG JN, 1982, BIOCHEMISTRY-US, V21, P1847, DOI 10.1021/bi00537a022; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Liu BF, 2007, MOL VIS, V13, P854; Liu HQ, 2005, J BIOL CHEM, V280, P25071, DOI 10.1074/jbc.M502490200; Liu YZ, 2006, INVEST OPHTH VIS SCI, V47, P1069, DOI 10.1167/iovs.05-1004; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; Mathew A, 2001, MOL CELL BIOL, V21, P7163, DOI 10.1128/MCB.21.21.7163-7171.2001; Menko AS, 2002, EXP EYE RES, V75, P485, DOI 10.1006/exer.2002.2057; Menko AS, 2002, DEV DYNAM, V224, P321, DOI 10.1002/dvdy.10111; MENKO AS, INVESTIG OPHTHALMOL, V46; Menko KS, 2001, DEV DYNAM, V220, P337, DOI 10.1002/dvdy.1114; Morozov V, 2006, DEVELOPMENT, V133, P813, DOI 10.1242/dev.02262; NAGY A, 1990, DEVELOPMENT, V110, P815; Nollen EAA, 2002, J CELL SCI, V115, P2809; Pande A, 2000, P NATL ACAD SCI USA, V97, P1993, DOI 10.1073/pnas.040554397; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; Pras E, 2000, INVEST OPHTH VIS SCI, V41, P3511; Sandilands A, 2002, EMBO J, V21, P6005, DOI 10.1093/emboj/cdf609; Shroff NP, 2000, BIOCHEMISTRY-US, V39, P1420, DOI 10.1021/bi991656b; Skvorak K, 2006, GENESIS, V44, P345, DOI 10.1002/dvg.20222; Sreelakshmi Y, 2006, MOL VIS, V12, P581; Sun TX, 1997, J BIOL CHEM, V272, P6220, DOI 10.1074/jbc.272.10.6220; Treweek TM, 2005, FEBS J, V272, P711, DOI 10.1111/j.1742-4658.2004.04507.x; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Vanita V, 2006, MOL VIS, V12, P518; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Walker JL, 2002, DEV BIOL, V251, P195, DOI 10.1006/dbio.2002.0823; Wang XH, 2004, INVEST OPHTH VIS SCI, V45, P3608, DOI 10.1167/iovs.04-0423; Wang YQ, 1999, EXP CELL RES, V249, P123, DOI 10.1006/excr.1999.4450; White TW, 2002, SCIENCE, V295, P319, DOI 10.1126/science.1067582; Xi JH, 2003, J CELL SCI, V116, P1073, DOI 10.1242/jcs.00325; Xi JH, 2003, MOL VIS, V9, P410; Xi JH, 2006, FASEB J, V20, P846, DOI 10.1096/fj.05-5532com; Xia CH, 2006, INVEST OPHTH VIS SCI, V47, P3004, DOI 10.1167/iovs.06-0178; Zhou J, 2004, INVEST OPHTH VIS SCI, V45, P2314, DOI 10.1167/iovs.03-1210	74	47	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5801	5814		10.1074/jbc.M708704200	http://dx.doi.org/10.1074/jbc.M708704200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18056999	hybrid			2022-12-25	WOS:000253426700061
J	Ulsamer, A; Ortuno, MJ; Ruiz, S; Susperregui, ARG; Osses, N; Rosa, JL; Ventura, F				Ulsamer, Arnau; Ortuno, M. Jose; Ruiz, Silvia; Susperregui, Antonio R. G.; Osses, Nelson; Rosa, Jose Luis; Ventura, Francesc			BMP-2 induces osterix expression through up-regulation of Dlx5 and its phosphorylation by p38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR OSTERIX; BONE MORPHOGENETIC PROTEINS; PRX1 HOMEOBOX GENE; OSTEOBLAST DIFFERENTIATION; OSTEOCALCIN GENE; SIGNALING PATHWAYS; MESENCHYMAL CELLS; RUNX2; BINDING	Osterix, a zinc-finger transcription factor, is specifically expressed in osteoblasts and osteocytes of all developing bones. Because no bone formation occurs in Osterix null mice, Osterix is thought to be an essential regulator of osteoblast differentiation. We report that bone morphogenetic protein-2 (BMP-2) induces an increase in Osterix expression, which is mediated through a homeodomain sequence located in the proximal region of the Osterix promoter. Our results demonstrate that induction of Dlx5 by BMP-2 mediates Osterix transcriptional activation. First, BMP-2 induction of Dlx5 precedes the induction of Osterix. Second, Dlx5 binds to the BMP-responsive homeodomain sequences both in vitro and in vivo. Third, Dlx5 overexpression and knock-down assays demonstrate its role in activating Osterix expression in response to BMP-2. Furthermore, we show that Dlx5 is a novel substrate for p38 MAPK in vitro and in vivo and that Ser-34 and Ser-217 are the sites phosphorylated by p38. Phosphorylation at Ser-34/217 increases the transactivation potential of Dlx5. Thus, we propose that BMP activates expression of Osterix through the induction of Dlx5 and its further transcriptional activation by p38-mediated phosphorylation.	[Ulsamer, Arnau; Ortuno, M. Jose; Ruiz, Silvia; Susperregui, Antonio R. G.; Rosa, Jose Luis; Ventura, Francesc] Univ Barcelona, LHosp Llobregat, IDIBELL, Dept Ciencias Fisiol 2, E-08907 Barcelona, Spain; [Osses, Nelson] Pontificia Univ Catolica Valparaiso, Fac Ciencias Basicas & Matemat, Inst Quim, Valparaiso 4059, Chile	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Pontificia Universidad Catolica de Valparaiso	Ventura, F (corresponding author), Univ Barcelona, LHosp Llobregat, IDIBELL, Dept Ciencias Fisiol 2, C-Feixa Llarga S-N, E-08907 Barcelona, Spain.	fventura@ub.edu	Ventura, Francesc/ABG-2285-2020; Osses, Nelson/V-9065-2019; Ventura, Francesc/K-9700-2014; Rosa, Jose Luis/K-6685-2014; Ulsamer, A/H-7994-2014	Ventura, Francesc/0000-0001-9673-9405; Osses, Nelson/0000-0003-0974-1051; Ventura, Francesc/0000-0001-9673-9405; Rosa, Jose Luis/0000-0002-6161-5688; Ulsamer, A/0000-0001-7808-1005; Ortuno Romero, Maria Jose/0000-0002-0200-9952				Acampora D, 1999, DEVELOPMENT, V126, P3795; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Celil AB, 2005, J CELL BIOCHEM, V95, P518, DOI 10.1002/jcb.20429; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cowan KJ, 2003, J EXP BIOL, V206, P1107, DOI 10.1242/jeb.00220; Depew MJ, 1999, DEVELOPMENT, V126, P3831; Depew MJ, 2005, J ANAT, V207, P501, DOI 10.1111/j.1469-7580.2005.00487.x; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fan DW, 2007, J CELL PHYSIOL, V211, P577, DOI 10.1002/jcp.21016; Galindo M, 2005, J BIOL CHEM, V280, P20274, DOI 10.1074/jbc.M413665200; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Harris SE, 2003, FRONT BIOSCI, V8, pS1249, DOI 10.2741/1170; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Kim YJ, 2006, GENE, V366, P145, DOI 10.1016/j.gene.2005.08.021; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Kusanagi K, 2000, MOL BIOL CELL, V11, P555, DOI 10.1091/mbc.11.2.555; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Lee JY, 2006, MOL CELLS, V22, P182; Lee MH, 1999, J CELL BIOCHEM, V73, P114, DOI 10.1002/(SICI)1097-4644(19990401)73:1<114::AID-JCB13>3.3.CO;2-D; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Lluis F, 2006, TRENDS CELL BIOL, V16, P36, DOI 10.1016/j.tcb.2005.11.002; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Lu XH, 2006, J BIOL CHEM, V281, P6297, DOI 10.1074/jbc.M507804200; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Milona M, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-43; Mitchell JM, 2006, J DENT RES, V85, P888, DOI 10.1177/154405910608501003; Miyama K, 1999, DEV BIOL, V208, P123, DOI 10.1006/dbio.1998.9197; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Narayanan K, 2004, J BIOL CHEM, V279, P44294, DOI 10.1074/jbc.M403511200; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Norris RA, 2001, J BIOL CHEM, V276, P26829, DOI 10.1074/jbc.M100239200; Noth U, 2003, EXP CELL RES, V291, P201, DOI 10.1016/S0014-4827(03)00386-0; Peterson RE, 2005, DEV DYNAM, V233, P811, DOI 10.1002/dvdy.20412; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; Roca H, 2005, J BIOL CHEM, V280, P30845, DOI 10.1074/jbc.M503942200; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Tsumaki N, 2005, CYTOKINE GROWTH F R, V16, P279, DOI 10.1016/j.cytogfr.2005.04.001; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Villagra A, 2006, J BIOL CHEM, V281, P22695, DOI 10.1074/jbc.M511640200; Vinals F, 2004, EMBO J, V23, P3527, DOI 10.1038/sj.emboj.7600360; Vinals F, 2002, FEBS LETT, V510, P99, DOI 10.1016/S0014-5793(01)03236-7; Wang XY, 2007, ENDOCRINOLOGY, V148, P1629, DOI 10.1210/en.2006-1000; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Young DW, 2005, J CELL BIOCHEM, V94, P720, DOI 10.1002/jcb.20332	54	176	195	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3816	3826		10.1074/jbc.M704724200	http://dx.doi.org/10.1074/jbc.M704724200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18056716	Green Published, hybrid			2022-12-25	WOS:000253083500016
J	Zhao, X; Nicholls, JM; Chen, YG				Zhao, Xingang; Nicholls, John M.; Chen, Ye-Guang			Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATOR INHIBITOR-1 GENE; TGF-BETA; SARS CORONAVIRUS; TRANSCRIPTIONAL ACTIVATION; PULMONARY-FIBROSIS; TUMOR SUPPRESSION; MAMMALIAN-CELLS; EXPRESSION; BINDING; VIRUS	Severe acute respiratory syndrome (SARS) is an acute infectious disease with significant mortality. Atypical clinical feature associated with SARS is pulmonary fibrosis and the associated lung failure. However, the underlying mechanism remains elusive. In this study, we demonstrate that SARS-associated coronavirus (SARS-CoV) nucleocapsid (N) protein potentiates transforming growth factor-beta (TGF-beta)-induced expression of plasminogen activator inhibitor-1 but attenuates Smad3/Smad4-mediated apoptosis of human peripheral lung epithelial HPL1 cells. The promoting effect of N protein on the transcriptional responses of TGF-beta is Smad3-specific. N protein associates with Smad3 and promotes Smad3-p300 complex formation while it interferes with the complex formation between Smad3 and Smad4. These findings provide evidence of a novel mechanism whereby N protein modulates TGF-beta signaling to block apoptosis of SARS-CoV-infected host cells and meanwhile promote tissue fibrosis. Our results reveal a novel mode of Smad3 action in a Smad4-independent manner and may lead to successful strategies for SARS treatment by targeting the TGF-beta signaling molecules.	[Zhao, Xingang; Chen, Ye-Guang] Tsinghua Univ, Dept Biol Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Nicholls, John M.] Univ Hong Kong, Dept Pathol, Hong Kong, Peoples R China	Tsinghua University; University of Hong Kong	Chen, YG (corresponding author), Tsinghua Univ, Dept Biol Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; Nicholls, John Malcolm/C-4375-2009	Nicholls, John Malcolm/0000-0001-7217-7444				BORDER WA, 1994, NEW ENGL J MED, V331, P1286; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; Che XY, 2004, EMERG INFECT DIS, V10, P1947, DOI 10.3201/eid1011.040516; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Cheng PL, 2004, ONCOGENE, V23, P7821, DOI 10.1038/sj.onc.1208066; Choi SH, 2006, J BIOL CHEM, V281, P7468, DOI 10.1074/jbc.M512438200; Datta PK, 2000, J BIOL CHEM, V275, P40014, DOI 10.1074/jbc.C000508200; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ding YQ, 2003, J PATHOL, V200, P282, DOI 10.1002/path.1440; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; He L, 2006, J PATHOL, V210, P288, DOI 10.1002/path.2067; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Hsieh PK, 2005, J VIROL, V79, P13848, DOI 10.1128/JVI.79.22.13848-13855.2005; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Kaminski N, 2000, P NATL ACAD SCI USA, V97, P1778, DOI 10.1073/pnas.97.4.1778; KEETON MR, 1991, J BIOL CHEM, V266, P23048; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Law PTW, 2005, J GEN VIROL, V86, P1921, DOI 10.1099/vir.0.80813-0; Lee DK, 2001, GENE DEV, V15, P455, DOI 10.1101/gad.856201; Lee DK, 2002, J BIOL CHEM, V277, P33766, DOI 10.1074/jbc.M200150200; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Masuda A, 1997, CANCER RES, V57, P4898; Nicholls JM, 2006, PLOS MED, V3, P222, DOI 10.1371/journal.pmed.0030027; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Nishihara A, 1999, J BIOL CHEM, V274, P28716, DOI 10.1074/jbc.274.40.28716; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Prokova V, 2002, J BIOL CHEM, V277, P9342, DOI 10.1074/jbc.M109099200; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Rowland RRR, 2005, J VIROL, V79, P11507, DOI 10.1128/JVI.79.17.11507-11512.2005; Schwarte-Waldhoff I, 1999, ONCOGENE, V18, P3152, DOI 10.1038/sj.onc.1202641; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; Surjit M, 2004, BIOCHEM BIOPH RES CO, V317, P1030, DOI 10.1016/j.bbrc.2004.03.154; Surjit M, 2006, J BIOL CHEM, V281, P10669, DOI 10.1074/jbc.M509233200; Surjit M, 2004, BIOCHEM J, V383, P13, DOI 10.1042/BJ20040984; Tan YJ, 2004, J VIROL, V78, P14043, DOI 10.1128/JVI.78.24.14043-14047.2004; Tan YW, 2006, NUCLEIC ACIDS RES, V34, P4816, DOI 10.1093/nar/gkl650; Timani KA, 2005, VIRUS RES, V114, P23, DOI 10.1016/j.virusres.2005.05.007; Wang Z, 2004, J VIROL, V78, P7523, DOI 10.1128/JVI.78.14.7523-7527.2004; Yan XH, 2006, INT J BIOCHEM CELL B, V38, P1417, DOI 10.1016/j.biocel.2006.02.003; Yanagisawa K, 1998, ONCOGENE, V17, P1743, DOI 10.1038/sj.onc.1202052; Yuan XL, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-66; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06	55	122	127	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3272	3280		10.1074/jbc.M708033200	http://dx.doi.org/10.1074/jbc.M708033200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18055455	Green Published, hybrid			2022-12-25	WOS:000253083000031
J	Christianson, JL; Nicoloro, S; Straubhaar, J; Czech, MP				Christianson, Jennifer L.; Nicoloro, Sarah; Straubhaar, Juerg; Czech, Michael P.			Stearoyl-CoA desaturase 2 is required for peroxisome proliferator-activated receptor gamma expression and adipogenesis in cultured 3T3-L1 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; PROTEIN-KINASE; TRANSLATION INITIATION; MAMMALIAN TARGET; GENE-EXPRESSION; C/EBP-ALPHA; ACID; INSULIN; MICE	Based on recent evidence that fatty acid synthase and endogenously produced fatty acid derivatives are required for adipogenesis in 3T3-L1 adipocytes, we conducted a small interfering RNA-based screen to identify other fatty acid-metabolizing enzymes that may mediate this effect. Of 24 enzymes screened, stearoyl-CoA desaturase 2 (SCD2) was found to be uniquely and absolutely required for adipogenesis. Remarkably, SCD2 also controls the maintenance of adipocyte-specific gene expression in fully differentiated 3T3-L1 adipocytes, including the expression of SCD1. Despite the high sequence similarity between SCD2 and SCD1, silencing of SCD1 did not down-regulate 3T3-L1 cell differentiation or gene expression. SCD2 mRNA expression was also uniquely elevated 44-fold in adipose tissue upon feeding mice a high fat diet, whereas SCD1 showed little response. The inhibition of adipogenesis caused by SCD2 depletion was associated with a decrease in peroxisome proliferator-activated receptor gamma ( PPAR gamma) mRNA and protein, whereas in mature adipocytes loss of SCD2 diminished PPAR gamma protein levels, with little change in mRNA levels. In the latter case, SCD2 depletion did not change the degradation rate of PPAR gamma protein but decreased the metabolic labeling of PPAR gamma protein using [S-35] methionine/cysteine, indicating protein translation was decreased. This requirement of SCD2 for optimal protein synthesis in fully differentiated adipocytes was verified by polysome profile analysis, where a shift in the mRNA to monosomes was apparent in response to SCD2 silencing. These results reveal that SCD2 is required for the induction and maintenance of PPAR gamma protein levels and adipogenesis in 3T3-L1 cells.	[Christianson, Jennifer L.; Nicoloro, Sarah; Straubhaar, Juerg; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St,Suite 100, Worcester, MA 01605 USA.	Michael.Czech@umassmed.edu		Nicoloro, Sarah/0000-0002-8638-4556	NIDDK NIH HHS [DK 60837, DK 32520, DK 30898] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030898, R01DK060837, P30DK032520, R01DK030898] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aktas H, 2004, J NUTR, V134, p2487S, DOI 10.1093/jn/134.9.2487S; Aslan H, 2006, OBES SURG, V16, P1526, DOI 10.1381/096089206778869942; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Bull AW, 2003, CARCINOGENESIS, V24, P1717, DOI 10.1093/carcin/bgg131; Camp HS, 2001, ENDOCRINOLOGY, V142, P3207, DOI 10.1210/en.142.7.3207; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Floyd ZE, 2002, J BIOL CHEM, V277, P4062, DOI 10.1074/jbc.M108473200; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gomez FE, 2003, BIOCHEM BIOPH RES CO, V300, P316; Gustafson B, 2003, BIOCHEM BIOPH RES CO, V308, P933, DOI 10.1016/S0006-291X(03)01518-3; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Kersten S, 2002, EUR J PHARMACOL, V440, P223, DOI 10.1016/S0014-2999(02)01431-0; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Kintscher U, 2005, AM J PHYSIOL-ENDOC M, V288, pE287, DOI 10.1152/ajpendo.00440.2004; Lee MJ, 2007, J BIOL CHEM, V282, P72, DOI 10.1074/jbc.M609518200; Levert KL, 2002, J BIOL CHEM, V277, P16347, DOI 10.1074/jbc.C200113200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Man WC, 2006, J BIOL CHEM, V281, P1251, DOI 10.1074/jbc.M508733200; Mandrup S, 1998, J BIOL CHEM, V273, P23897, DOI 10.1074/jbc.273.37.23897; Meric F, 2002, MOL CANCER THER, V1, P971; Miyazaki M, 2006, J LIPID RES, V47, P700, DOI 10.1194/jlr.C500025-JLR200; Miyazaki M, 2005, P NATL ACAD SCI USA, V102, P12501, DOI 10.1073/pnas.0503132102; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; Neeli I, 2003, BIOCHEM BIOPH RES CO, V309, P755, DOI 10.1016/j.bbrc.2003.08.066; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; ROTMAN EI, 1992, BIOCHEM J, V282, P487, DOI 10.1042/bj2820487; Schmid B, 2005, BIOCHEM BIOPH RES CO, V328, P1073, DOI 10.1016/j.bbrc.2005.01.067; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Stewart WC, 2004, BIOCHEM BIOPH RES CO, V324, P355, DOI 10.1016/j.bbrc.2004.09.053; Taha C, 1999, J BIOL CHEM, V274, P33085, DOI 10.1074/jbc.274.46.33085; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Tang QQ, 2004, BIOCHEM BIOPH RES CO, V319, P235, DOI 10.1016/j.bbrc.2004.04.176; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Tzameli I, 2004, J BIOL CHEM, V279, P36093, DOI 10.1074/jbc.M405346200; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Zhang SB, 2005, BIOCHEM J, V388, P135, DOI 10.1042/BJ20041554	50	56	56	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2906	2916		10.1074/jbc.M705656200	http://dx.doi.org/10.1074/jbc.M705656200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18032385	hybrid			2022-12-25	WOS:000252622300047
J	Chien, YH; Jiang, N; Li, F; Zhang, F; Zhu, C; Leckband, D				Chien, Yuan-Hung; Jiang, Ning; Li, Fang; Zhang, Fang; Zhu, Cheng; Leckband, Deborah			Two stage cadherin kinetics require multiple extracellular domains but not the cytoplasmic region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; LIGAND BINDING-KINETICS; C-CADHERIN; CONFORMATIONAL-CHANGES; LATERAL DIMERIZATION; FUNCTIONAL-ANALYSIS; CONCURRENT BINDING; STRUCTURAL BASIS; CALCIUM-BINDING; I-DOMAIN	Micropipette manipulation measurements quantified the pre-steady state binding kinetics between cell pairs mediated by Xenopus cleavage stage cadherin. The time-dependence of the intercellular binding probability exhibits a fast forming, low probability binding state, which transitions to a slower forming, high probability state. The biphasic kinetics are independent of the cytoplasmic region, but the transition to the high probability state requires the third extracellular domain EC3. Deleting either EC3 or EC3-5, or substituting Trp(2) for Ala reduces the binding curves to a simple, monophasic rise in binding probability to a limiting plateau, as predicted for a single site binding mechanism. The two stage cadherin binding process reported here directly parallels previous biophysical studies, and confirms that the cadherin ectodomain governs the initial intercellular adhesion dynamics.	[Chien, Yuan-Hung] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Jiang, Ning; Zhang, Fang; Zhu, Cheng] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Li, Fang] Univ Illinois, Urbana, IL 61801 USA; [Leckband, Deborah] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University System of Georgia; Georgia Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Zhu, C (corresponding author), 315 Ferst Dr, Atlanta, GA 30332 USA.	cheng.zhu@bme.gatech.edu; Leckband@uiuc.edu	Jiang, Ning/M-5448-2017; Zhu, Cheng/A-5724-2011	Jiang, Ning/0000-0003-1103-5922; 	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044902, R21AI044902, R01AI038282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051338] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR006009] Funding Source: Medline; NIAID NIH HHS [R01 AI044902, R01 AI038282, R01 AI44902, R21 AI044902, R01 AI38282] Funding Source: Medline; NIGMS NIH HHS [R01 GM51338, R01 GM051338] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahrens T, 2002, J BIOL CHEM, V277, P19455, DOI 10.1074/jbc.M200606200; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Bayas MV, 2006, BIOPHYS J, V90, P1385, DOI 10.1529/biophysj.105.069583; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Braga VMM, 2005, CURR OPIN CELL BIOL, V17, P466, DOI 10.1016/j.ceb.2005.08.012; BRIEHER WM, 1994, J CELL BIOL, V126, P519, DOI 10.1083/jcb.126.2.519; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Chesla SE, 2000, J BIOL CHEM, V275, P10235, DOI 10.1074/jbc.275.14.10235; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Dumaswala UJ, 1996, BLOOD, V88, P697, DOI 10.1182/blood.V88.2.697.bloodjournal882697; EVANS E, 1991, BIOPHYS J, V59, P838, DOI 10.1016/S0006-3495(91)82296-2; GOLD ER, 1967, J IMMUNOL, V99, P859; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Harrison OJ, 2005, J CELL SCI, V118, P711, DOI 10.1242/jcs.01665; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; Huang J, 2004, J BIOL CHEM, V279, P44915, DOI 10.1074/jbc.M407039200; Huang J, 2007, J IMMUNOL, V179, P7653, DOI 10.4049/jimmunol.179.11.7653; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kaibuchi K, 1999, CURR OPIN CELL BIOL, V11, P591, DOI 10.1016/S0955-0674(99)00014-9; KAPLANSKI G, 1993, BIOPHYS J, V64, P1922, DOI 10.1016/S0006-3495(93)81563-7; Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624; KOFLER R, 1977, J IMMUNOL METHODS, V16, P201, DOI 10.1016/0022-1759(77)90198-3; Long M, 2001, ANN BIOMED ENG, V29, P935, DOI 10.1114/1.1415529; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; Ozawa M, 2002, J BIOL CHEM, V277, P19600, DOI 10.1074/jbc.M202029200; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Patel SD, 2003, CURR OPIN STRUC BIOL, V13, P690, DOI 10.1016/j.sbi.2003.10.007; Perret E, 2004, P NATL ACAD SCI USA, V101, P16472, DOI 10.1073/pnas.0402085101; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Pierres A, 1996, J IMMUNOL METHODS, V196, P105, DOI 10.1016/0022-1759(96)00103-2; PIERRES A, 1995, J BIOL CHEM, V270, P26586, DOI 10.1074/jbc.270.44.26586; POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x; Prakasam A, 2006, BIOCHEMISTRY-US, V45, P6930, DOI 10.1021/bi060213m; Prakasam AK, 2006, P NATL ACAD SCI USA, V103, P15434, DOI 10.1073/pnas.0606701103; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Sivasankar S, 2001, BIOPHYS J, V80, P1758, DOI 10.1016/S0006-3495(01)76146-2; Sivasankar S, 1999, P NATL ACAD SCI USA, V96, P11820, DOI 10.1073/pnas.96.21.11820; Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x; Tsuiji H, 2007, J BIOL CHEM, V282, P12871, DOI 10.1074/jbc.M611725200; Vorup-Jensen T, 2003, P NATL ACAD SCI USA, V100, P1873, DOI 10.1073/pnas.0237387100; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; WEIDNER KM, 1990, J CELL BIOL, V111, P2097, DOI 10.1083/jcb.111.5.2097; Williams TE, 2000, BIOPHYS J, V79, P1867, DOI 10.1016/S0006-3495(00)76436-8; Williams TE, 2000, BIOPHYS J, V79, P1858, DOI 10.1016/S0006-3495(00)76435-6; Williams TE, 2001, J BIOL CHEM, V276, P13283, DOI 10.1074/jbc.M010427200; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200; Zhong Y, 1999, J CELL BIOL, V144, P351, DOI 10.1083/jcb.144.2.351; Zhu B, 2003, BIOPHYS J, V84, P4033, DOI 10.1016/S0006-3495(03)75129-7; Zhu C, 2000, BIOPHYS J, V79, P1850, DOI 10.1016/S0006-3495(00)76434-4	59	47	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1848	1856		10.1074/jbc.M708044200	http://dx.doi.org/10.1074/jbc.M708044200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17999960	Green Accepted, hybrid			2022-12-25	WOS:000252501000010
J	Hamamoto, S; Marui, J; Matsuoka, K; Higashi, K; Igarashi, K; Nakagawa, T; Kuroda, T; Mori, Y; Murata, Y; Nakanishi, Y; Maeshima, M; Yabe, I; Uozumi, N				Hamamoto, Shin; Marui, Junichiro; Matsuoka, Ken; Higashi, Kyohei; Igarashi, Kazuei; Nakagawa, Tsuyoshi; Kuroda, Teruo; Mori, Yasuo; Murata, Yoshiyuki; Nakanishi, Yoichi; Maeshima, Masayoshi; Yabe, Isamu; Uozumi, Nobuyuki			Characterization of a tobacco TPK-type K+ channel as a novel tonoplast K+ channel using yeast tonoplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL; ION CHANNELS; SACCHAROMYCES-CEREVISIAE; VACUOLAR MEMBRANE; PATCH-CLAMP; ARGININE DECARBOXYLASE; ESCHERICHIA-COLI; CYTOPLASMIC PORE; PLASMA-MEMBRANE; GUARD-CELLS	The tonoplast K+ membrane transport system plays a crucial role in maintaining K+ homeostasis in plant cells. Here, we isolated cDNAs encoding a two-pore K+ channel (NtTPK1) from Nicotiana tabacum cv. SR1 and cultured BY-2 tobacco cells. Two of the four variants of NtTPK1 contained VHG and GHG instead of the GYG signature sequence in the second pore region. All four products were functional when expressed in the Escherichia coli cell membrane, and NtTPK1 was targeted to the tonoplast in tobacco cells. Two of the three promoter sequences isolated from N. tabacum cv. SR1 were active, and expression from these was increased similar to 2-fold by salt stress or high osmotic shock. To determine the properties of NtTPK1, we enlarged mutant yeast cells with inactivated endogenous tonoplast channels and prepared tonoplasts suitable for patch clamp recording allowing the NtTPK1-related channel conductance to be distinguished from the small endogenous currents. NtTPK1 exhibited strong selectivity for K+ over Na+. NtTPK1 activity was sensitive to spermidine and spermine, which were shown to be present in tobacco cells. NtTPK1 was active in the absence of Ca2+, but a cytosolic concentration of 45 mu M Ca2+ resulted in a 2-fold increase in the amplitude of the K+ current. Acidification of the cytosol topH5.5 also markedly increased NtTPK1-mediated K+ currents. These results show that NtTPK1 is a novel tonoplast K+ channel belonging to a different group from the previously characterized vacuolar channels SV, FV, and VK.	[Hamamoto, Shin; Uozumi, Nobuyuki] Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Marui, Junichiro] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 9808579, Japan; [Matsuoka, Ken] Kyushu Univ, Lab Plant Nutr, Fac Agr, Higashi Ku, Fukuoka 8128581, Japan; [Higashi, Kyohei; Igarashi, Kazuei] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba 2608675, Japan; [Nakagawa, Tsuyoshi] Shimane Univ, Dept Mol & Funct Genom, Ctr Integrated Res Sci, Matsue, Shimane 6908504, Japan; [Kuroda, Teruo] Okayama Univ, Sch Med Dent & Pharmaceut Sci, Dept Genome Appl Microbiol, Grad Sch Med, Okayama 7008530, Japan; [Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Div Synth Chem & Biol Chem, Kyoto 6158510, Japan; [Murata, Yoshiyuki] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Nakanishi, Yoichi; Maeshima, Masayoshi] Nagoya Univ, Grad Sch Bioagr Sci, Lab Cell Dynam, Nagoya, Aichi 4648601, Japan; [Yabe, Isamu] Univ Tokyo, Bunkyo Ku, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	Tohoku University; Tohoku University; Kyushu University; Chiba University; Shimane University; Okayama University; Kyoto University; Okayama University; Nagoya University; University of Tokyo	Uozumi, N (corresponding author), Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Aobayama 6-6-07, Sendai, Miyagi 9808579, Japan.	uozumi@biophy.che.tohoku.ac.jp	Matsuoka, Ken/E-3215-2010; Maeshima, Masayoshi/D-3073-2013; Uozumi, Nobuyuki/AAG-3252-2019; KURODA, Teruo/B-2028-2011	Maeshima, Masayoshi/0000-0002-1611-5481; Higashi, Kyohei/0000-0002-2622-4825; Uozumi, Nobuyuki/0000-0003-4268-1126; Matsuoka, Ken/0000-0001-7229-7294				Apse MP, 2007, FEBS LETT, V581, P2247, DOI 10.1016/j.febslet.2007.04.014; Becker D, 2004, P NATL ACAD SCI USA, V101, P15621, DOI 10.1073/pnas.0401502101; BERTL A, 1990, P NATL ACAD SCI USA, V87, P7824, DOI 10.1073/pnas.87.20.7824; Bihler H, 2005, PLANT PHYSIOL, V139, P417, DOI 10.1104/pp.105.065599; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; BUURMAN ET, 1995, J BIOL CHEM, V270, P6678, DOI 10.1074/jbc.270.12.6678; Cona A, 2006, TRENDS PLANT SCI, V11, P80, DOI 10.1016/j.tplants.2005.12.009; Czempinski K, 1997, EMBO J, V16, P2565, DOI 10.1093/emboj/16.10.2565; Czempinski K, 2002, PLANT J, V29, P809, DOI 10.1046/j.1365-313X.2002.01260.x; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; FLORES HE, 1982, SCIENCE, V217, P1259, DOI 10.1126/science.217.4566.1259; FRIEDMAN R, 1986, PLANT PHYSIOL, V82, P1154, DOI 10.1104/pp.82.4.1154; FRITZE K, 1995, PLANT J, V7, P261, DOI 10.1046/j.1365-313X.1995.7020261.x; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; Fujiwara Y, 2006, J GEN PHYSIOL, V127, P401, DOI 10.1085/jgp.200509434; Gambale F, 2006, J MEMBRANE BIOL, V210, P1, DOI [10.1007/s00232-006-0856-x, 10.1007/S00232-006-0856-X]; GELLI A, 1993, PLANT PHYSIOL, V102, P1139, DOI 10.1104/pp.102.4.1139; Gierth M, 2007, FEBS LETT, V581, P2348, DOI 10.1016/j.febslet.2007.03.035; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gobert A, 2007, P NATL ACAD SCI USA, V104, P10726, DOI 10.1073/pnas.0702595104; GOODALL GJ, 1990, METHOD ENZYMOL, V181, P148; GUELMAN R, 2002, BONE, V30, P23; Hagiwara Y, 2003, EMBO J, V22, P344, DOI 10.1093/emboj/cdg033; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; IGARASHI K, 1986, J BACTERIOL, V166, P128, DOI 10.1128/jb.166.1.128-134.1986; JEFFERSON RA, 1987, EMBO J, V6, P3901; Johannes E, 2001, PLANT PHYSIOL, V127, P119, DOI 10.1104/pp.127.1.119; Kaplan B, 2007, FEBS LETT, V581, P2237, DOI 10.1016/j.febslet.2007.02.017; Kim Y, 1999, AM J PHYSIOL-HEART C, V277, pH1669, DOI 10.1152/ajpheart.1999.277.5.H1669; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kumar A, 1996, PLANT J, V9, P147, DOI 10.1046/j.1365-313X.1996.09020147.x; Kurata HT, 2007, J GEN PHYSIOL, V130, P145, DOI 10.1085/jgp.200709742; Kuroda T, 2004, J MEMBRANE BIOL, V198, P177, DOI 10.1007/s00232-004-0671-1; Kuroda T, 1998, J BIOL CHEM, V273, P16897, DOI 10.1074/jbc.273.27.16897; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Latz A, 2007, PLANT J, V52, P449, DOI 10.1111/j.1365-313X.2007.03255.x; Lebaudy A, 2007, FEBS LETT, V581, P2357, DOI 10.1016/j.febslet.2007.03.058; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; LIOUBOV T, 1997, PLANT J, V11, P1059; Liu K, 2000, PLANT PHYSIOL, V124, P1315, DOI 10.1104/pp.124.3.1315; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lubarski I, 2005, J BIOL CHEM, V280, P37717, DOI 10.1074/jbc.M506397200; Lurin C, 2000, BIOCHEM J, V348, P291, DOI 10.1042/0264-6021:3480291; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MAESHIMA M, 1994, PLANT PHYSIOL, V106, P61, DOI 10.1104/pp.106.1.61; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Masgrau C, 1997, PLANT J, V11, P465, DOI 10.1046/j.1365-313X.1997.11030465.x; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; MATSUOKA K, 1991, P NATL ACAD SCI USA, V88, P834, DOI 10.1073/pnas.88.3.834; MCGARVEY P, 1991, BIOTECHNIQUES, V11, P428; MERSEREAU M, 1990, GENE, V90, P149, DOI 10.1016/0378-1119(90)90452-W; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nakanishi Y, 2003, J BIOCHEM, V134, P615, DOI 10.1093/jb/mvg184; Nakanishi Y, 2001, J BIOL CHEM, V276, P7654, DOI 10.1074/jbc.M009743200; Obata T, 2007, PLANT PHYSIOL, V144, P1978, DOI 10.1104/pp.107.101154; Palmer CP, 2001, P NATL ACAD SCI USA, V98, P7801, DOI 10.1073/pnas.141036198; Pandey S, 2007, FEBS LETT, V581, P2325, DOI 10.1016/j.febslet.2007.04.008; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; SLOCUM RD, 1984, ARCH BIOCHEM BIOPHYS, V235, P283, DOI 10.1016/0003-9861(84)90201-7; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Stumpe S, 1997, ARCH MICROBIOL, V167, P126, DOI 10.1007/s002030050425; Suga S, 2001, PLANTA, V212, P294, DOI 10.1007/s004250000396; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TANAKA K, 1990, MOL CELL BIOL, V10, P4303, DOI 10.1128/MCB.10.8.4303; Tena G, 1998, PLANT J, V16, P173, DOI 10.1046/j.1365-313x.1998.00283.x; THIEL G, 1993, P NATL ACAD SCI USA, V90, P11493, DOI 10.1073/pnas.90.24.11493; Uozumi N, 1998, P NATL ACAD SCI USA, V95, P9773, DOI 10.1073/pnas.95.17.9773; UOZUMI N, 2007, AM J PHYSIOL-CELL PH, V104, P34; Voelker C, 2006, PLANT J, V48, P296, DOI 10.1111/j.1365-313X.2006.02868.x; Walker DJ, 1996, P NATL ACAD SCI USA, V93, P10510, DOI 10.1073/pnas.93.19.10510; WARD JM, 1995, PLANT CELL, V7, P833, DOI 10.1105/tpc.7.7.833; WARD JM, 1994, PLANT CELL, V6, P669; Watson MB, 1998, PLANT J, V13, P231, DOI 10.1046/j.1365-313X.1998.00027.x; Yabe I, 1999, J BIOL CHEM, V274, P34903, DOI 10.1074/jbc.274.49.34903; YOSHIHISA T, 1988, J BIOL CHEM, V263, P5158; Yuasa K, 2005, PLANT J, V41, P81, DOI 10.1111/j.1365-313X.2004.02279.x; ZHOU XL, 1995, FEBS LETT, V373, P170, DOI 10.1016/0014-5793(95)01035-D	84	59	69	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1911	1920		10.1074/jbc.M708213200	http://dx.doi.org/10.1074/jbc.M708213200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18029350	hybrid			2022-12-25	WOS:000252501000017
J	Lito, P; Mets, BD; Kleff, S; O'Reilly, S; Maher, VM; McCormick, JJ				Lito, Piro; Mets, Bryan D.; Kleff, Susanne; O'Reilly, Sandra; Maher, Veronica M.; McCormick, J. Justin			Evidence that Sprouty 2 is necessary for sarcoma formation by H-Ras oncogene-transformed human fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; ACTIVATED PROTEIN-KINASE; CELL STRAIN MSU-1.1; MALIGNANT-TRANSFORMATION; DOWN-REGULATION; GENE-EXPRESSION; TYROSINE PHOSPHORYLATION; EPITHELIAL-CELLS; INHIBITOR; PATHWAY	Sprouty 2 (Spry2) acts as an inhibitor of receptor tyrosine kinase signaling in various cellular contexts. Interestingly, Spry2 also prevents the c-Cbl-induced degradation of epidermal growth factor receptor ( EGFR). We compared human fibroblasts malignantly transformed by overexpression of H-Ras(V12) oncogene to their nontransformed parental cells and found that the malignant cells express a high level of Spry2. These cells also exhibited an increase in the level of EGFR compared with their precursor cells. We found that intact EGFR was required if H-Ras-transformed cells were to grow in the absence of exogenous growth factors or form large colonies in agarose. When we decreased expression of Spry2, using a Spry2-specific shRNA, the H-Ras(V12)-transformed fibroblasts could no longer form large colonies in agarose, grow in reduced levels of serum, or form tumors in athymic mice. The level of active H-Ras in these cells remained unaltered. A similar, but less pronounced, effect in tumor formation was observed when Spry2 was down-regulated in human patient-derived fibrosarcoma cell lines. In H-Ras-transformed cells Spry2 sustained the level and the downstream signaling activity of EGFR. In the parental, non-HRas-transformed fibroblasts, expression of Spry2 resulted in the inhibition of H-Ras and ERK activation, suggesting that the positive effect of Spry2 in tumor formation is specific to H-Ras transformation. Co-immunoprecipitation studies with H-Ras-transformed cells revealed that Spry2 and H-Ras interact and that H-Ras interacts with Spry2-binding partners, c-Cbl and CIN85, in a Spry2-dependent manner. These data show that Spry2 plays a critical role in the ability of H-Ras-transformed cells to form tumors in athymic mice.	[Lito, Piro; Mets, Bryan D.; Kleff, Susanne; O'Reilly, Sandra; Maher, Veronica M.; McCormick, J. Justin] Michigan State Univ, Carcinogenesis Lab, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Lito, Piro; Mets, Bryan D.; Kleff, Susanne; O'Reilly, Sandra; Maher, Veronica M.; McCormick, J. Justin] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	McCormick, JJ (corresponding author), Michigan State Univ, Carcinogenesis Lab, Dept Microbiol & Mol Genet, Food Safety & Toxicol Bldg, E Lansing, MI 48824 USA.				NATIONAL CANCER INSTITUTE [R01CA098305] Funding Source: NIH RePORTER; NCI NIH HHS [CA098305] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Bloethner S, 2005, CARCINOGENESIS, V26, P1224, DOI 10.1093/carcin/bgi066; Boley SE, 2000, CANCER RES, V60, P4105; Casanova ML, 2002, CANCER RES, V62, P3402; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Choi H, 2006, J IMMUNOL, V176, P6034, DOI 10.4049/jimmunol.176.10.6034; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; de Alvaro C, 2005, MOL BIOL CELL, V16, P4454, DOI 10.1091/mbc.E05-05-0419; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Fritzsche S, 2006, ENDOCR-RELAT CANCER, V13, P839, DOI 10.1677/erc.1.01190; FRY DG, 1990, ONCOGENE, V5, P1415; Gangarosa LM, 1997, J BIOL CHEM, V272, P18926, DOI 10.1074/jbc.272.30.18926; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Haglund K, 2005, EMBO REP, V6, P635, DOI 10.1038/sj.embor.7400453; Hamilton M, 1998, J BIOL CHEM, V273, P28155, DOI 10.1074/jbc.273.43.28155; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; HURLIN PJ, 1989, P NATL ACAD SCI USA, V86, P187, DOI 10.1073/pnas.86.1.187; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kim HJ, 2007, CURR BIOL, V17, P455, DOI 10.1016/j.cub.2007.01.059; Lee M, 2006, BIOCHEM BIOPH RES CO, V350, P450, DOI 10.1016/j.bbrc.2006.09.067; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Lou Z, 2005, CANCER RES, V65, P1007; Martinez-Lacaci I, 2000, INT J CANCER, V88, P44, DOI 10.1002/1097-0215(20001001)88:1<44::AID-IJC7>3.0.CO;2-8; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; MCCORMICK JJ, 1994, RISK ANAL, V14, P257, DOI 10.1111/j.1539-6924.1994.tb00240.x; Minowada G, 1999, DEVELOPMENT, V126, P4465; MORGAN TL, 1991, EXP CELL RES, V197, P125, DOI 10.1016/0014-4827(91)90489-H; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; O'Reilly S, 1998, RADIAT RES, V150, P577, DOI 10.2307/3579875; Qing J, 1999, ONCOGENE, V18, P335, DOI 10.1038/sj.onc.1202290; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shaw AT, 2007, GENE DEV, V21, P694, DOI 10.1101/gad.1526207; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Sutterluty H, 2007, MOL CANCER RES, V5, P509, DOI 10.1158/1541-7786.MCR-06-0273; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Wang JH, 2006, PROSTATE, V66, P613, DOI 10.1002/pros.20353; WILSON DM, 1990, CANCER RES, V50, P5587; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200	47	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2002	2009		10.1074/jbc.M709046200	http://dx.doi.org/10.1074/jbc.M709046200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18048363	hybrid			2022-12-25	WOS:000252501000027
J	Zhang, Y; Zhou, Y; Schweizer, U; Savaskan, NE; Hua, D; Kipnis, J; Hatfield, DL; Gladyshev, VN				Zhang, Yan; Zhou, You; Schweizer, Ulrich; Savaskan, Nicolai E.; Hua, Deame; Kipnis, Jonathan; Hatfield, Dolph L.; Gladyshev, Vadim N.			Comparative analysis of selenocysteine machinery and selenoproteome gene expression in mouse brain identifies neurons as key functional sites of selenium in mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-PEROXIDASE; TYPE-2 DEIODINASE; TARGET TISSUES; GLIAL-CELLS; RICH DOMAIN; RAT-BRAIN; THIOREDOXIN; MECHANISM; PATTERNS; MICE	Although dietary selenium (Se) deficiency results in phenotypes associated with selenoprotein depletion in various organs, the brain is protected from Se loss. To address the basis for the critical role of Se in brain function, we carried out comparative gene expression analyses for the complete selenoproteome and associated biosynthetic factors. Using the Allen Brain Atlas, we evaluated 159 regions of adult mouse brain and provided experimental analyses of selected selenoproteins. All 24 selenoprotein mRNAs were expressed in the mouse brain. Most strikingly, neurons in olfactory bulb, hippocampus, cerebral cortex, and cerebellar cortex were exceptionally rich in selenoprotein gene expression, in particular in GPx4, SelK, SelM, SelW, and Sep15. Over half of the selenoprotein genes were also expressed in the choroid plexus. A unique expression pattern was observed for one of the highly expressed selenoprotein genes, SelP, which we suggest to provide neurons with Se. Cluster analysis of the expression data linked certain selenoproteins and selenocysteine machinery genes and suggested functional linkages among selenoproteins, such as that between SelM and Sep15. Overall, this study suggests that the main functions of selenium in mammals are confined to certain neurons in the brain.	[Zhang, Yan; Hua, Deame; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Zhou, You] Univ Nebraska, Ctr Biotechnol, Lincoln, NE 68588 USA; [Schweizer, Ulrich] Charite, Neurosci Res Ctr, D-10117 Berlin, Germany; [Savaskan, Nicolai E.] ETH & Univ Zurich, Brain Res Inst, Dept Neuromorphol, CH-8057 Zurich, Switzerland; [Kipnis, Jonathan] Univ Virginia, Dept Neurosci, Charlottesville, VA 22908 USA; [Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Virginia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gladyshev, VN (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	vgladyshev1@unl.edu	Gladyshev, Vadim N/J-6187-2013; Gladyshev, Vadim N/A-9894-2013; Savaskan, Nicolai/D-2923-2018	Schweizer, Ulrich/0000-0003-1380-4780; Savaskan, Nicolai/0000-0003-1348-094X; Gladyshev, Vadim/0000-0002-0372-7016	NATIONAL CANCER INSTITUTE [Z01BC010767, ZIABC010767, Z01BC005317, ZIABC005317] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Baek IJ, 2005, ANAT EMBRYOL, V209, P315, DOI 10.1007/s00429-004-0447-5; BEHNE D, 1988, BIOCHIM BIOPHYS ACTA, V966, P12, DOI 10.1016/0304-4165(88)90123-7; BEHNE D, 1984, J NUTR, V114, P1289, DOI 10.1093/jn/114.7.1289; Brown K M, 2001, Public Health Nutr, V4, P593; Burk RF, 2007, J NEUROSCI, V27, P6207, DOI 10.1523/JNEUROSCI.1153-07.2007; Burk RF, 2005, ANNU REV NUTR, V25, P215, DOI 10.1146/annurev.nutr.24.012003.132120; BURK RF, 1972, J NUTR, V102, P1049, DOI 10.1093/jn/102.8.1049; Ciorba MA, 1999, FEBS LETT, V442, P48, DOI 10.1016/S0014-5793(98)01616-0; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; Fekete C, 2007, ENDOCRINOLOGY, V148, P4865, DOI 10.1210/en.2007-0448; DAMIER P, 1993, NEUROSCIENCE, V52, P1, DOI 10.1016/0306-4522(93)90175-F; Drasch G, 2000, BIOL TRACE ELEM RES, V77, P219, DOI 10.1385/BTER:77:3:219; Dreher I, 1997, J TRACE ELEM MED BIO, V11, P83, DOI 10.1016/S0946-672X(97)80031-4; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Dubois GM, 2006, ENDOCRINOLOGY, V147, P4941, DOI 10.1210/en.2006-0609; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ejima A, 1996, BIOL TRACE ELEM RES, V54, P9, DOI 10.1007/BF02785316; Fekete C, 2007, FRONT NEUROENDOCRIN, V28, P97, DOI 10.1016/j.yfrne.2007.04.002; Ferguson AD, 2006, J BIOL CHEM, V281, P3536, DOI 10.1074/jbc.M511386200; Galton VA, 2005, THYROID, V15, P823, DOI 10.1089/thy.2005.15.823; Galton VA, 2007, ENDOCRINOLOGY, V148, P3080, DOI 10.1210/en.2006-1727; Geoghegan M, 2006, CURR OPIN CRIT CARE, V12, P136, DOI 10.1097/01.ccx.0000216581.80051.d6; GuadanoFerraz A, 1997, P NATL ACAD SCI USA, V94, P10391, DOI 10.1073/pnas.94.19.10391; Hadaszadeh BM, 2006, PHYSIOLOGY, V21, P307, DOI 10.1152/physiol.00021.2006; Hatfield D.L., 2002, SELENIUM ITS MOL BIO, V36, P235, DOI 10.1080/10715760290006394; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hernandez A, 2006, J CLIN INVEST, V116, P476, DOI 10.1172/JCI26240; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; HOCK A, 1975, BRAIN, V98, P49, DOI 10.1093/brain/98.1.49; Hoffmann PR, 2007, NUCLEIC ACIDS RES, V35, P3963, DOI 10.1093/nar/gkm355; Jurado J, 2003, J BIOL CHEM, V278, P45546, DOI 10.1074/jbc.M307866200; Kohrle J, 2000, CELL MOL LIFE SCI, V57, P1853, DOI 10.1007/PL00000667; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Labunskyy VM, 2005, J BIOL CHEM, V280, P37839, DOI 10.1074/jbc.M508685200; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu Z, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-19; MCFARLAND LZ, 1970, POULTRY SCI, V49, P216, DOI 10.3382/ps.0490216; Moustafa ME, 2003, J NUTR, V133, p2494S, DOI 10.1093/jn/133.7.2494S; Nakayama A, 2007, J NUTR, V137, P690, DOI 10.1093/jn/137.3.690; Olson GE, 2007, J BIOL CHEM, V282, P12290, DOI 10.1074/jbc.M611403200; OSTER O, 1988, BIOL TRACE ELEM RES, V15, P23, DOI 10.1007/BF02990125; Peters MM, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-12; Petit N, 2003, HUM MOL GENET, V12, P1045, DOI 10.1093/hmg/ddg115; Rayman MP, 2005, P NUTR SOC, V64, P527, DOI 10.1079/PNS2005467; RENKO K, 2008, IN PERSS BIOCH J; SAIJOH K, 1995, MOL BRAIN RES, V30, P301, DOI 10.1016/0169-328X(94)00007-2; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Savaskan NE, 2002, FASEB J, V16, P112, DOI 10.1096/fj.02-0067fje; Savaskan NE, 2007, FREE RADICAL BIO MED, V43, P191, DOI 10.1016/j.freeradbiomed.2007.03.033; Scharpf M, 2007, J NEURAL TRANSM, V114, P877, DOI 10.1007/s00702-006-0617-0; Schneider MJ, 2006, ENDOCRINOLOGY, V147, P580, DOI 10.1210/en.2005-0739; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Schweizer U, 2005, IUBMB LIFE, V57, P737, DOI 10.1080/15216540500364255; Schweizer U, 2004, BRAIN RES REV, V45, P164, DOI 10.1016/j.brainresrev.2004.03.004; Squires Jeffrey, 2006, Hawaii Med J, V65, P239; Steinert P, 1998, BIOL CHEM, V379, P683, DOI 10.1515/bchm.1998.379.6.683; Sun Y, 2001, J NUTR BIOCHEM, V12, P88, DOI 10.1016/S0955-2863(00)00130-3; TAKIZAWA S, 1994, J NEUROL SCI, V122, P66, DOI 10.1016/0022-510X(94)90053-1; TRAPP GA, 1975, J NEUROCHEM, V24, P593, DOI 10.1111/j.1471-4159.1975.tb07682.x; Trepanier G, 1996, NEUROSCIENCE, V75, P231, DOI 10.1016/0306-4522(96)00222-9; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Zachara BA, 2001, ARCH ENVIRON HEALTH, V56, P461, DOI 10.1080/00039890109604483	63	118	121	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2427	2438		10.1074/jbc.M707951200	http://dx.doi.org/10.1074/jbc.M707951200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18032379	Green Submitted, hybrid			2022-12-25	WOS:000252501000069
J	Zhou, H; Mak, W; Zheng, Y; Dunstan, CR; Seibel, MJ				Zhou, Hong; Mak, Wendy; Zheng, Yu; Dunstan, Colin R.; Seibel, Markus J.			Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; BONE MORPHOGENETIC PROTEIN; INDIAN HEDGEHOG; IN-VITRO; CHONDROCYTE DIFFERENTIATION; BETA-CATENIN; EXPRESSION; GENE; LRP5; GLUCOCORTICOIDS	Lineage commitment of mesenchymal progenitor cells is still poorly understood. Here we demonstrate that Wnt signaling by osteoblasts is essential for mesenchymal progenitor cells to differentiate away from a default adipogenic into an osteoblastic lineage. Dominant adipogenesis and reduced osteoblastogenesis were observed in calvarial cell cultures from transgenic mice characterized by osteoblast-targeted disruption of glucocorticoid signaling. This phenotypic shift in mesenchymal progenitor cell commitment was associated with reciprocal regulation of early adipogenic and osteoblastogenic transcription factors and with a reduction in Wnt7b and Wnt10b mRNA and beta-catenin protein levels in transgenic versus non-transgenic cultures. Transwell co-culture of transgenic mesenchymal progenitor cells with wild type osteoblasts restored commitment to the osteoblast lineage. This effect was blocked by adding sFRP1, a Wnt inhibitor, to the co-culture. Treatment of transgenic cultures with Wnt3a resulted in stimulation of osteoblastogenesis and suppression of adipogenesis. Our findings suggest a novel cellular mechanism in bone cell biology in which osteoblasts exert direct control over the lineage commitment of their mesenchymal progenitor through Wnt signaling. This glucocorticoid-dependent forward control function indicates a central role for osteoblasts in the regulation of early osteoblastogenesis.			Zhou, H (corresponding author), Univ Sydney, ANZAC Res Inst, Bone Res Program, Hosp Rd, Concord, NSW 2139, Australia.	hzhou@med.usyd.edu.au	Ekanayake, Kanchana/P-8817-2016; Dunstan, Colin/G-6214-2013; Research Institute, ANZAC/CAE-9030-2022; Zheng, Yu/B-4381-2012	Dunstan, Colin/0000-0001-7586-4071; Seibel, Markus J/0000-0002-2701-378X; Zheng, Yu/0000-0002-6324-8148; Zhou, Hong/0000-0001-5899-9660				Atanasov AG, 2003, BIOCHEM BIOPH RES CO, V308, P257, DOI 10.1016/S0006-291X(03)01359-7; Bellows CG, 2001, J BONE MINER RES, V16, P1983, DOI 10.1359/jbmr.2001.16.11.1983; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; BERESFORD JN, 1992, J CELL SCI, V102, P341; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Cochrane RL, 2007, GENESIS, V45, P17, DOI 10.1002/dvg.20259; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dovio A, 2004, J CLIN ENDOCR METAB, V89, P4923, DOI 10.1210/jc.2004-0164; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ferrari P, 1996, AM J PHYSIOL-ENDOC M, V270, pE900, DOI 10.1152/ajpendo.1996.270.5.E900; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Jackson A, 2005, BONE, V36, P585, DOI 10.1016/j.bone.2005.01.007; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Kalajzic Z, 2002, BONE, V31, P654, DOI 10.1016/S8756-3282(02)00912-2; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kobayashi H, 2000, BIOCHEM BIOPH RES CO, V273, P630, DOI 10.1006/bbrc.2000.2981; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Kulkarni NH, 2006, J BONE MINER RES, V21, P910, DOI 10.1359/JBMR.060316; Leclerc N, 2004, J MOL ENDOCRINOL, V33, P175, DOI 10.1677/jme.0.0330175; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; MARTIN RB, 1990, CALCIFIED TISSUE INT, V46, P189, DOI 10.1007/BF02555043; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Nuttall ME, 2000, BONE, V27, P177, DOI 10.1016/S8756-3282(00)00317-3; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Shane E, 1997, J CLIN ENDOCR METAB, V82, P1497, DOI 10.1210/jc.82.5.1497; Sher LB, 2006, CALCIFIED TISSUE INT, V79, P118, DOI 10.1007/s00223-005-0297-z; Sher LB, 2004, ENDOCRINOLOGY, V145, P922, DOI 10.1210/en.2003-0655; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Stewart PM, 1999, VITAM HORM, V57, P249; Suda N, 1996, J CELL PHYSIOL, V166, P94, DOI 10.1002/(SICI)1097-4652(199601)166:1<94::AID-JCP11>3.0.CO;2-P; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Wang YH, 2005, J BONE MINER RES, V20, P5, DOI 10.1359/JBMR.041016; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Woitge HW, 2001, ENDOCRINOLOGY, V142, P1341, DOI 10.1210/en.142.3.1341; Young CS, 1998, MOL CELL BIOL, V18, P2474, DOI 10.1128/MCB.18.5.2474	55	109	126	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1936	1945		10.1074/jbc.M702687200	http://dx.doi.org/10.1074/jbc.M702687200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18045882	hybrid			2022-12-25	WOS:000252501000020
J	Lemeshko, VV; Kugler, W				Lemeshko, Victor V.; Kugler, Wilfried			Synergistic inhibition of mitochondrial respiration by anticancer agent erucylphosphohomocholine and cyclosporin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERUCYLPHOSPHOCHOLINE-INDUCED APOPTOSIS; PERMEABILITY TRANSITION PORE; LINES IN-VITRO; CELL-LINES; BENZODIAZEPINE-RECEPTOR; CASPASE ACTIVATION; DOWN-REGULATION; CYTOCHROME-C; GLIOMA-CELLS; INVOLVEMENT	Alkylphosphocholines are a new class of anticancer agents. The mechanisms by which these drugs display their antitumor activities are not known. In this work, we show that erucylphosphohomocholine, a new antineoplastic compound, significantly decreased ATP synthesis in isolated rat liver mitochondria at a concentration of 50 mu M or higher via permeabilization of the inner membrane. At a concentration of 25 mu M, it induced a moderate swelling of mitochondria, a slight decrease of the inner membrane potential, and an increase in state 4 respiration without an essential influence on state 3 respiration or the outer membrane permeability to cytochrome c. We found that cyclosporin A did not prevent mitochondrial swelling induced by 25-100 mu M erucylphosphohomocholine. Moreover, cyclosporin A induced a fast drop of the inner membrane potential in the presence of 25-50 mu M erucylphosphohomocholine that seems to be due to a strong synergistic inhibition of the respiratory activity. The ratio of uncoupled to state 3 respiration rates increased from 1.3 +/- 0.1 with 25 mu M erucylphosphohomocholine and from 1.5 +/- 0.1 with 1 mu M cyclosporin A to 4.5 +/- 0.3 in the presence of both drugs. On the other hand, oligomycin or cyclosporin A protected certain cancer cell lines against erucylphosphohomocholine-induced apoptosis. This protection might be related to a prevention of cellular ATP hydrolysis by permeabilized mitochondria and to the inhibition of the classical permeability transition pore, respectively. Our findings provide new insight into the mechanisms by which these unusual alterations of mitochondria might be involved in anticancer activity of alkylphosphocholines.	Univ Nacl Colombia, Fac Ciencias, Escuela Fis, Medellin 3840, Colombia; [Kugler, Wilfried] Univ Gottingen, ZentrumKinderheilkunde & Jugendmed, D-37075 Gottingen, Germany	Universidad Nacional de Colombia; University of Gottingen	Lemeshko, VV (corresponding author), Univ Nacl Colombia, Fac Ciencias, Escuela Fis, Calle 59A,63-20, Medellin 3840, Colombia.	vvasilie@unal.edu.co						AZZONE GF, 1984, BIOCHEM SOC T, V12, P414, DOI 10.1042/bst0120414; Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X; Di Paola M, 2006, BBA-BIOENERGETICS, V1757, P1330, DOI 10.1016/j.bbabio.2006.03.024; GUNTER TE, 1990, AM J PHYSIOL, V258, P755; Handrick R, 2006, RADIOTHER ONCOL, V80, P199, DOI 10.1016/j.radonc.2006.07.021; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Held-Kuznetsov V, 2005, REV NEUROSCIENCE, V16, pS30; HILGARD P, 1993, CANCER CHEMOTH PHARM, V32, P90, DOI 10.1007/BF00685608; Jendrossek V, 2002, CANCER CHEMOTH PHARM, V50, P71, DOI 10.1007/s00280-002-0440-8; Jendrossek V, 2001, ANTICANCER RES, V21, P3389; Jendrossek V, 1999, INT J ONCOL, V14, P15; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Konstantinov SM, 1998, INT J CANCER, V77, P778, DOI 10.1002/(SICI)1097-0215(19980831)77:5<778::AID-IJC18>3.0.CO;2-Y; Konstantinov SM, 2002, MOL CANCER THER, V1, P877; Kugler W, 2005, APOPTOSIS, V10, P1163, DOI 10.1007/s10495-005-1190-y; Kugler W, 2002, J NEUROCHEM, V82, P1160, DOI 10.1046/j.1471-4159.2002.01034.x; KUGLER W, 2006, 15 ANN M ISR SOC NEU, P56; KUGLER W, 2006, 7 C EUR ASS NEUR ONC, P293; Lemeshko VV, 2006, ARCH BIOCHEM BIOPHYS, V454, P114, DOI 10.1016/j.abb.2006.08.008; LEMESHKO VV, 1982, BIOCHEMISTRY-MOSCOW+, V47, P465; Lemeshko VV, 2005, J BIOL CHEM, V280, P15579, DOI 10.1074/jbc.M414064200; Lemeshko VV, 2002, J BIOL CHEM, V277, P17751, DOI 10.1074/jbc.M201002200; Lemeshko VV, 2001, ARCH BIOCHEM BIOPHYS, V388, P60, DOI 10.1006/abbi.2000.2214; Levin E, 2005, BIOCHEMISTRY-US, V44, P9924, DOI 10.1021/bi050150s; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rubel A, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-6; SCHNEIDER WC, 1950, J BIOL CHEM, V183, P123; Veenman L, 2000, DRUG DEVELOP RES, V50, P355, DOI 10.1002/1098-2299(200007/08)50:3/4<355::AID-DDR18>3.0.CO;2-W	28	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37303	37307		10.1074/jbc.C700134200	http://dx.doi.org/10.1074/jbc.C700134200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17993460	hybrid			2022-12-25	WOS:000251833600004
J	Beste, C; Saft, C; Andrich, J; Muller, T; Gold, R; Falkenstein, M				Beste, Christian; Saft, Carsten; Andrich, Juergen; Mueller, Thomas; Gold, Ralf; Falkenstein, Michael			Time Processing in Huntington's Disease: A Group-Control Study	PLOS ONE			English	Article							ONSET; DYSFUNCTION	Background. "Timing'' processes are mediated via a disturbed neuronal network including the basal ganglia. Brain structures important for "timing'' are also discussed to be critical for the deterioration of movements in Huntington's disease (HD). Changes in "timing processes'' are found in HD, but no study has varied the degree of motor demands in timing functions in parallel in HD. It may be hypothesized that timing functions may be deteriorated to a different extent in motor and non-motor timing, because in motor timing the underlying brain structures may be more demanding than in non-motor timing. Methodology/Principle Findings. We assessed timing in two different experiments: a time-estimation (TE) and a time-discrimination (TD) task. The demand on motor functions is high in the TE-task and low in the TD-task. Furthermore, general motor ability was assessed at different complexity levels. A presymptomatic (pHD), a symptomatic ( HD) and a control group were investigated. We found a decline in timing functions when demands on the motor system were high (TE-task), in HD and even in pHD, compared to controls. In non-motor timing ( TD task) and in the assessment of general motor ability, performance in the pHD-group was comparable to the controls and better than in the symptomatic group. Performance in both timing tasks was related to the duration until the estimated age of onset in pHDs. Conclusions/Significance. The study shows a selective deterioration of time-estimation processes in symptomatic and even presymptomatic Huntington's disease. Time-discrimination processes were not affected in both patient groups. The relation of timing performance to the duration until the estimated age of onset in pHD is of clinical importance.	[Beste, Christian; Saft, Carsten; Andrich, Juergen; Mueller, Thomas; Gold, Ralf] Ruhr Univ Bochum, St Josef Hosp, Huntington Ctr NRW, Dept Neurol, D-4630 Bochum, Germany; [Beste, Christian; Falkenstein, Michael] World Hlth Org WHO Collaborating Ctr Occupat Hlth, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Beste, Christian] Univ Munster, Dept Clin Radiol, Munster, Germany	Ruhr University Bochum; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); World Health Organization; University of Munster	Beste, C (corresponding author), Ruhr Univ Bochum, St Josef Hosp, Huntington Ctr NRW, Dept Neurol, D-4630 Bochum, Germany.	christian.beste@cityweb.de	Falkenstein, Michael/ABA-7497-2020; Müller, Thomas/C-9317-2011	Saft, Carsten/0000-0002-3983-7292	FoRUM, Ruhr University Bochum [AZ-F479-2005]	FoRUM, Ruhr University Bochum	This work was supported by a grant from FoRUM AZ-F479-2005, Ruhr University Bochum.	Aylward EH, 2004, NEUROLOGY, V63, P66, DOI 10.1212/01.WNL.0000132965.14653.D1; Bartenstein P, 1997, BRAIN, V120, P1553, DOI 10.1093/brain/120.9.1553; Beste C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000086; Beste C, 2007, NEUROPSYCHOLOGIA, V45, P2922, DOI 10.1016/j.neuropsychologia.2007.06.004; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Cepeda C, 2007, PROG NEUROBIOL, V81, P253, DOI 10.1016/j.pneurobio.2006.11.001; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Friedrich J, 2020, HUM BRAIN MAPP, V41, P726, DOI 10.1002/hbm.24835; Hinton SC, 2007, J INT NEUROPSYCH SOC, V13, P539, DOI 10.1017/S1355617707070671; Kendall A L, 2000, Prog Brain Res, V127, P381; KREMER, 2002, HUNTINGTONS DIS, P28; Macar Francoise, 2006, Cogn Process, V7, P89, DOI 10.1007/s10339-005-0025-7; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Mitchell IJ, 1999, PROG NEUROBIOL, V59, P691, DOI 10.1016/S0301-0082(99)00019-2; Paulsen JS, 2001, NEUROLOGY, V57, P658, DOI 10.1212/WNL.57.4.658; Paulsen JS, 2004, AM J NEURORADIOL, V25, P1715; RANEN NG, 1995, AM J HUM GENET, V57, P593; Rosas H D, 2004, NeuroRx, V1, P263, DOI 10.1602/neurorx.1.2.263; Saft C, 2006, MOVEMENT DISORD, V21, P1208, DOI 10.1002/mds.20939; Smith MA, 2000, NATURE, V403, P544, DOI 10.1038/35000576; van Vugt JPP, 2004, MOVEMENT DISORD, V19, P285, DOI 10.1002/mds.10718	22	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1263	10.1371/journal.pone.0001263	http://dx.doi.org/10.1371/journal.pone.0001263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060059	Green Submitted, gold, Green Published			2022-12-25	WOS:000207459400012
J	Gwinn, K; Corriveau, RA; Mitsumoto, H; Bednarz, K; Brown, RH; Cudkowicz, M; Gordon, PH; Hardy, J; Kasarskis, EJ; Kaufmann, P; Miller, R; Sorenson, E; Tandan, R; Traynor, BJ; Nash, J; Sherman, A; Mailman, MD; Ostell, J; Bruijn, L; Cwik, V; Rich, SS; Singleton, A; Refolo, L; Andrews, J; Zhang, R; Conwit, R; Keller, MA				Gwinn, Katrina; Corriveau, Roderick A.; Mitsumoto, Hiroshi; Bednarz, Kate; Brown, Robert H., Jr.; Cudkowicz, Merit; Gordon, Paul H.; Hardy, John; Kasarskis, Edward J.; Kaufmann, Petra; Miller, Robert; Sorenson, Eric; Tandan, Rup; Traynor, Bryan J.; Nash, Josefina; Sherman, Alex; Mailman, Matthew D.; Ostell, James; Bruijn, Lucie; Cwik, Valerie; Rich, Stephen S.; Singleton, Andrew; Refolo, Larry; Andrews, Jaime; Zhang, Ran; Conwit, Robin; Keller, Margaret A.		ALS Res Grp	Amyotrophic Lateral Sclerosis: An Emerging Era of Collaborative Gene Discovery	PLOS ONE			English	Article							FAMILIAL ALS; SOD1 GENE; MUTATIONS; DISEASE; COMPLEX; LINKAGE; FORM; LOCALIZATION; PENETRANCE; DIAGNOSIS	Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND). It is currently incurable and treatment is largely limited to supportive care. Family history is associated with an increased risk of ALS, and many Mendelian causes have been discovered. However, most forms of the disease are not obviously familial. Recent advances in human genetics have enabled genome-wide analyses of single nucleotide polymorphisms ( SNPs) that make it possible to study complex genetic contributions to human disease. Genome-wide SNP analyses require a large sample size and thus depend upon collaborative efforts to collect and manage the biological samples and corresponding data. Public availability of biological samples ( such as DNA), phenotypic and genotypic data further enhances research endeavors. Here we discuss a large collaboration among academic investigators, government, and non-government organizations which has created a public repository of human DNA, immortalized cell lines, and clinical data to further gene discovery in ALS. This resource currently maintains samples and associated phenotypic data from 2332 MND subjects and 4692 controls. This resource should facilitate genetic discoveries which we anticipate will ultimately provide a better understanding of the biological mechanisms of neurodegeneration in ALS.	[Gwinn, Katrina; Refolo, Larry; Zhang, Ran; Conwit, Robin] NINDS, NIH, Bethesda, MD 20892 USA; [Corriveau, Roderick A.; Nash, Josefina; Andrews, Jaime; Keller, Margaret A.] Coriell Inst Med Res, Camden, NJ USA; [Mitsumoto, Hiroshi; Bednarz, Kate; Gordon, Paul H.; Kaufmann, Petra] Columbia Univ, Eleanor & Lou Gehrig MDA ALS Res Ctr, New York, NY USA; [Brown, Robert H., Jr.; Cudkowicz, Merit; Sherman, Alex] Massachusetts Gen Hosp, Charlestown, MA USA; [Hardy, John; Singleton, Andrew] NIA, NIH, Bethesda, MD 20892 USA; [Kasarskis, Edward J.] Univ Kentucky, Lexington, KY USA; [Miller, Robert] Calif Pacific Med Ctr, San Francisco, CA USA; [Sorenson, Eric] Mayo Med Ctr, Rochester, MN USA; [Tandan, Rup] Univ Vermont, Burlington, VT USA; [Traynor, Bryan J.] NIMH, NIH, Bethesda, MD 20892 USA; [Mailman, Matthew D.; Ostell, James] NIH, Natl Ctr Bioinformat, Bethesda, MD 20892 USA; [Bruijn, Lucie] ALS Assoc, Calabasas Hills, CA USA; [Cwik, Valerie] Muscular Dystrophy Assoc, Tucson, AZ USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Coriell Institute for Medical Research; Columbia University; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Kentucky; California Pacific Medical Center; Mayo Clinic; University of Vermont; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; University of Virginia	Gwinn, K (corresponding author), NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	GwinnK@ninds.nih.gov	CUDKOWICZ, MERIT/GWM-6585-2022; Hardy, John/C-2451-2009; Singleton, Andrew B/C-3010-2009; Sander-Effron, Samuel/AAX-2231-2020; Traynor, Bryan J/G-5690-2010; Resource Center, NINDS Human Genetics/AGF-2474-2022	CUDKOWICZ, MERIT/0000-0002-7075-1681; Hardy, John/0000-0002-3122-0423; Thakore, Nimish/0000-0003-3418-3362; Bedlack, Richard/0000-0003-4666-7495; Peltier, Amanda/0000-0003-1097-7715; Gordon, Paul/0000-0001-5714-9875; Caress, James/0000-0002-5814-6083; Trivedi, Jaya/0000-0001-6112-2325; Gutmann, Laurie/0000-0003-3926-4209; Carter, Gregory/0000-0001-7617-4750; Rich, Stephen/0000-0003-3872-7793; Gwinn, Katrina/0000-0002-8277-651X	NINDS [N01-NS-2-2349, NOT-03-016, R01 NS049640-01, R01 NS045294-01, R01 NS045087-01, R01 NS048125-01, R01 NS044887-01, R01 NS042759-01]; ALS Association; NIA Intramural Laboratory of Neurogenetics; NIMH Intramural; NIH [RR-00109]; NCBI dbGaP; MRC [G0701075] Funding Source: UKRI; Medical Research Council [G0701075] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042759, R01NS049640, R01NS044887, R01NS045294, R01NS045087, R01NS048125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000933] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ALS Association; NIA Intramural Laboratory of Neurogenetics; NIMH Intramural(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCBI dbGaP; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work described herein was created with funding by NINDS (RAC, JN, JA, MK, Repository, Contract NINDS N01-NS-2-2349, NINDS Supplement Notice NOT-03-016), The ALS Association, NINDS R01 grants (RHB, R01 NS049640-01; MC, R01 NS049640-01; PHG R01 NS045294-01; EK R01 NS045087-01; PK R01 NS048125-01; RM R01 NS044887-01; ES R01 NS042759-01), NIA Intramural Laboratory of Neurogenetics, (JH, AS), NIMH Intramural (BT), NIH RR-00109 ( RT), and NCBI dbGaP ( http://www.ncbi.nlm.nih.gov/sites/entrez?db = gap).	Beskow LM, 2001, JAMA-J AM MED ASSOC, V286, P2315, DOI 10.1001/jama.286.18.2315; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Bowser R, 2006, EXPERT REV MOL DIAGN, V6, P387, DOI 10.1586/14737159.6.3.387; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Conwit RA, 2006, J NEUROL SCI, V251, P1, DOI 10.1016/j.jns.2006.07.009; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Greenway MJ, 2004, NEUROLOGY, V63, P1936, DOI 10.1212/01.WNL.0000144344.39103.F6; Hand CK, 2002, AM J HUM GENET, V70, P251, DOI 10.1086/337945; Hand CK, 2002, MUSCLE NERVE, V25, P135; HANDO S, 2001, NAT GENET, V29, P160; Hentati A, 1998, NEUROGENETICS, V2, P55, DOI 10.1007/s100480050052; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; Kaufmann P, 2006, AMYOTROPH LATERAL SC, V7, P252, DOI 10.1080/07853890601012096; Kovach MJ, 2001, MOL GENET METAB, V74, P458, DOI 10.1006/mgme.2001.3256; Kunst CB, 2004, AM J HUM GENET, V75, P933, DOI 10.1086/426001; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Miller RG, 1999, J NEUROL SCI, V169, P2, DOI 10.1016/S0022-510X(99)00209-9; Mitchell JD, 2000, J NEUROL, V247, P7; Munch C, 2004, NEUROLOGY, V63, P724, DOI 10.1212/01.WNL.0000134608.83927.B1; Murakami T, 2001, J NEUROL SCI, V189, P45, DOI 10.1016/S0022-510X(01)00558-5; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nogales-Gadea G, 2004, J NEUROL SCI, V219, P1, DOI 10.1016/j.jns.2003.10.018; Ostell James, 2005, ACM Queue, V3, P40, DOI 10.1145/1059791.1059806; Palmer LJ, 2005, LANCET, V366, P1223, DOI 10.1016/S0140-6736(05)67485-5; Przedborski S, 2003, J CLIN INVEST, V111, P3, DOI 10.1172/JCI200317522; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Rezania K, 2003, AMYOTROPH LATERAL SC, V4, P162, DOI 10.1080/aml.4.3.162.166; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sapp PC, 2003, AM J HUM GENET, V73, P397, DOI 10.1086/377158; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Varmus Harold, 2003, Nat Genet, V35 Suppl 1, P3, DOI 10.1038/ng1186; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; WILHELMSEN KC, 1994, AM J HUM GENET, V55, P1159; WILHELMSEN KC, 2004, ARCH NEUROL-CHICAGO, V61, P318; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; YATA J, 1975, INT J CANCER, V15, P377, DOI 10.1002/ijc.2910150303	47	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1254	10.1371/journal.pone.0001254	http://dx.doi.org/10.1371/journal.pone.0001254			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060051	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459400003
J	Tejiokem, MC; Gouandjika, I; Beniguel, L; Zanga, MCE; Tene, G; Gody, JC; Njamkepo, E; Kfutwah, A; Penda, I; Bilong, C; Rousset, D; Pouillot, R; Tangy, F; Baril, L				Tejiokem, Mathurin C.; Gouandjika, Ionela; Beniguel, Lydie; Zanga, Marie-Claire Endegue; Tene, Gilbert; Gody, Jean C.; Njamkepo, Elisabeth; Kfutwah, Anfumbom; Penda, Ida; Bilong, Catherine; Rousset, Dominique; Pouillot, Regis; Tangy, Frederic; Baril, Laurence			HIV-Infected Children Living in Central Africa Have Low Persistence of Antibodies to Vaccines Used in the Expanded Program on Immunization	PLOS ONE			English	Article							MEASLES ANTIBODY; HIV-1-INFECTED CHILDREN; ANTIRETROVIRAL THERAPY; POLIO VACCINE; IMMUNODEFICIENCY; INFANTS; MORTALITY; DISEASE; RISK; IMMUNOGENICITY	Background. The Expanded Program on Immunization (EPI) is the most cost-effective measures to control vaccine-preventable diseases. Currently, the EPI schedule is similar for HIV-infected children; the introduction of antiretroviral therapy ( ART) should considerably prolong their life expectancy. Methods and Principal Findings. To evaluate the persistence of antibodies to the EPI vaccines in HIV-infected and HIV-exposed uninfected children who previously received these vaccines in routine clinical practice, we conducted a cross-sectional study of children, aged 18 to 36 months, born to HIV-infected mothers and living in Central Africa. We tested blood samples for antibodies to the combined diphtheria, tetanus, and whole-cell pertussis ( DTwP), the measles and the oral polio (OPV) vaccines. We enrolled 51 HIV-infected children of whom 33 were receiving ART, and 78 HIV-uninfected children born to HIV-infected women. A lower proportion of HIV-infected children than uninfected children had antibodies to the tested antigens with the exception of the OPV types 1 and 2. This difference was substantial for the measles vaccine (20% of the HIV-infected children and 56% of the HIV-exposed uninfected children, p<0.0001). We observed a high risk of low antibody levels for all EPI vaccines, except OPV types 1 and 2, in HIV-infected children with severe immunodeficiency (CD4+ T cells,25%). Conclusions and Significance. Children were examined at a time when their antibody concentrations to EPI vaccines would have still not undergone significant decay. However, we showed that the antibody concentrations were lowered in HIV-infected children. Moreover, antibody concentration after a single dose of the measles vaccine was substantially lower than expected, particularly low in HIV-infected children with low CD4+ T cell counts. This study supports the need for a second dose of the measles vaccine and for a booster dose of the DTwP and OPV vaccines to maintain the antibody concentrations in HIV-infected and HIV-exposed uninfected children.	[Baril, Laurence] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France; [Penda, Ida] Hop Laquintinie, Serv Pediat, Douala, Cameroon; [Tejiokem, Mathurin C.; Pouillot, Regis] Ctr Pasteur Cameroun, Lab Epidemiol & Sante Publ, Yaounde, Cameroon; [Zanga, Marie-Claire Endegue; Kfutwah, Anfumbom; Rousset, Dominique] Ctr Pasteur Cameroun, Virol Lab, Yaounde, Cameroon; [Bilong, Catherine] Ctr Pasteur Cameroun, Lab Anal Med, Yaounde, Cameroon; [Gouandjika, Ionela] Inst Pasteur, Lab Enterovirus, Bangui, Cent Afr Republ; [Beniguel, Lydie] Inst Pasteur, Retrovirus Lab, Bangui, Cent Afr Republ; [Tene, Gilbert] Ctr Mere & Enfant Fdn Chantal Biya, Yaounde, Cameroon; [Njamkepo, Elisabeth] Inst Pasteur, Ctr Natl Reference Bordetella, Paris, France; [Tangy, Frederic] Inst Pasteur, Lab Genom Virale & Vaccinat, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre Pasteur du Cameroun; Centre Pasteur du Cameroun; Centre Pasteur du Cameroun; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Baril, L (corresponding author), Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France.	laurence_baril@yahoo.com	Gouandjika, Ionela/AGR-0778-2022; Pouillot, Regis/E-8103-2010; Rousset, Dominique/S-5400-2019	Gouandjika, Ionela/0000-0002-2498-8725; Pouillot, Regis/0000-0002-6107-5212; Rousset, Dominique/0000-0002-1473-3147; Baril, Laurence/0000-0003-2346-883X; Penda, Calixte Ida/0000-0002-1070-2108	Department of International Affairs (DIA) at the Institut Pasteur ( Paris, France)	Department of International Affairs (DIA) at the Institut Pasteur ( Paris, France)	This study was funded by the Department of International Affairs (DIA) at the Institut Pasteur ( Paris, France). The DIA was informed at regular intervals about the progress of the study. The DIA had no role in study design, data collection and analysis, or preparation of the manuscript.	ALATTAR I, 1995, PEDIATR INFECT DIS J, V14, P149, DOI 10.1097/00006454-199502000-00013; Arpadi SM, 1996, PEDIATRICS, V97, P653; BARBI M, 1992, AIDS, V6, P1465, DOI 10.1097/00002030-199212000-00007; Bautista-Lopez N, 2000, VACCINE, V18, P1393, DOI 10.1016/S0264-410X(99)00396-5; Bekker V, 2006, PEDIATRICS, V118, pE315, DOI 10.1542/peds.2005-2616; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; BRUNELL PA, 1995, J ACQ IMMUN DEF SYND, V10, P540, DOI 10.1097/00042560-199510050-00007; Chiappini E, 2006, AIDS, V20, P207, DOI 10.1097/01.aids.0000200529.64113.3e; Clerici M, 2000, BLOOD, V96, P3866, DOI 10.1182/blood.V96.12.3866.h8003866_3866_3871; Cohen BJ, 2006, J VIROL METHODS, V131, P209, DOI 10.1016/j.jviromet.2005.08.001; deOnis M, 1997, B WORLD HEALTH ORGAN, V75, P11; Dunn DT, 2003, LANCET, V362, P1605, DOI 10.1016/S0140-6736(03)14793-9; Fassinou P, 2004, AIDS, V18, P1905, DOI 10.1097/00002030-200409240-00006; Faye A, 2004, CLIN INFECT DIS, V39, P1692, DOI 10.1086/425739; Gans H, 2001, J INFECT DIS, V184, P817, DOI 10.1086/323346; GARENNE M, 1991, LANCET, V338, P903, DOI 10.1016/0140-6736(91)91771-L; Grais RF, 2007, PLOS MED, V4, P122, DOI 10.1371/journal.pmed.0040016; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Helfand RF, 2005, B WORLD HEALTH ORGAN, V83, P329; Lepage P, 1996, PEDIATR INFECT DIS J, V15, P479, DOI 10.1097/00006454-199606000-00003; LEPAGE P, 1992, AM J DIS CHILD, V146, P550, DOI 10.1001/archpedi.1992.02160170030011; Lindgren-Alves C R, 2001, J Pediatr (Rio J), V77, P496; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Moss WJ, 2007, PLOS MED, V4, P9, DOI 10.1371/journal.pmed.0040024; Moss WJ, 2003, B WORLD HEALTH ORGAN, V81, P61; Naniche D, 2004, J INFECT DIS, V190, P1387, DOI 10.1086/424571; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Pancharoen C, 2004, CURR HIV RES, V2, P293, DOI 10.2174/1570162043351084; RELYVELD E, 1991, VACCINE, V9, P843, DOI 10.1016/0264-410X(91)90224-T; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; RUDY BT, 1994, J PEDIATR-US, V125, P72, DOI 10.1016/S0022-3476(94)70125-3; RYDER RW, 1993, J PEDIATR-US, V122, P697, DOI 10.1016/S0022-3476(06)80007-7; Scott S, 2005, J INFECT DIS, V191, P1854, DOI 10.1086/429963; Setse RW, 2006, J TROP PEDIATRICS, V52, P324, DOI 10.1093/tropej/fmk002; Sutter RW, 2000, NEW ENGL J MED, V343, P767, DOI 10.1056/NEJM200009143431103; Taha T E, 2000, Pediatrics, V106, pE77, DOI 10.1542/peds.106.6.e77; Triki H, 1997, VACCINE, V15, P1123, DOI 10.1016/S0264-410X(97)00001-7; Vigano A, 2007, AIDS, V21, P245, DOI 10.1097/QAD.0b013e328011d7d3; Waibale P, 1999, INT J EPIDEMIOL, V28, P341, DOI 10.1093/ije/28.2.341; *WHO, IMM SERV DEL ACC DIS; *WHO, 1997, MAN VIR INV POL, P44; *WHO UNAIDS, 2006, REP GLOB AIDS EP; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X; World Health Organization, ANT THER HIV INF INF	44	33	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1260	10.1371/journal.pone.0001260	http://dx.doi.org/10.1371/journal.pone.0001260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060056	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459400009
J	Garbuzova-Davis, S; Saporta, S; Haller, E; Kolomey, I; Bennett, SP; Potter, H; Sanberg, PR				Garbuzova-Davis, Svitlana; Saporta, Samuel; Haller, Edward; Kolomey, Irina; Bennett, Steven P.; Potter, Huntington; Sanberg, Paul R.			Evidence of Compromised Blood-Spinal Cord Barrier in Early and Late Symptomatic SOD1 Mice Modeling ALS	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; BRAIN-BARRIER; MOUSE MODEL; CEREBROSPINAL-FLUID; GLUCOSE-TRANSPORTER; DISEASE ONSET; HNT NEURONS; SCLEROSIS; IMMUNE; CELLS	Background. The blood-brain barrier (BBB), blood-spinal cord barrier (BSCB), and blood-cerebrospinal fluid barrier (BCSFB) control cerebral/spinal cord homeostasis by selective transport of molecules and cells from the systemic compartment. In the spinal cord and brain of both ALS patients and animal models, infiltration of T-cell lymphocytes, monocyte-derived macrophages and dendritic cells, and IgG deposits have been observed that may have a critical role in motor neuron damage. Additionally, increased levels of albumin and IgG have been found in the cerebrospinal fluid in ALS patients. These findings suggest altered barrier permeability in ALS. Recently, we showed disruption of the BBB and BSCB in areas of motor neuron degeneration in the brain and spinal cord in G93A SOD1 mice modeling ALS at both early and late stages of disease using electron microscopy. Examination of capillary ultrastructure revealed endothelial cell degeneration, which, along with astrocyte alteration, compromised the BBB and BSCB. However, the effect of these alterations upon barrier function in ALS is still unclear. The aim of this study was to determine the functional competence of the BSCB in G93A mice at different stages of disease. Methodology/Principal Findings. Evans Blue (EB) dye was intravenously injected into ALS mice at early or late stage disease. Vascular leakage and the condition of basement membranes, endothelial cells, and astrocytes were investigated in cervical and lumbar spinal cords using immunohistochemistry. Results showed EB leakage in spinal cord microvessels from all G93A mice, indicating dysfunction in endothelia and basement membranes and confirming our previous ultrastructural findings on BSCB disruption. Additionally, downregulation of Glut-1 and CD146 expressions in the endothelial cells of the BSCB were found which may relate to vascular leakage. Conclusions/Significance. Results suggest that the BSCB is compromised in areas of motor neuron degeneration in ALS mice at both early and late stages of the disease.	[Garbuzova-Davis, Svitlana; Saporta, Samuel; Kolomey, Irina; Sanberg, Paul R.] Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Garbuzova-Davis, Svitlana; Saporta, Samuel; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Neurosurg, Tampa, FL USA; [Garbuzova-Davis, Svitlana; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA; [Garbuzova-Davis, Svitlana; Saporta, Samuel; Haller, Edward; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL USA; [Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Psychiat, Tampa, FL USA; [Bennett, Steven P.; Potter, Huntington] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL USA; [Bennett, Steven P.; Potter, Huntington] Johnnie B Byrds Alzheimer Ctr, Tampa, FL USA; [Bennett, Steven P.; Potter, Huntington] Res Inst, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Garbuzova-Davis, S (corresponding author), Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	sgarbuzo@health.usf.edu	Garbuzova-Davis, Svitlana/Q-3687-2019; Lecuit, Marc/J-4073-2013; Bennett, Steven/GLV-6597-2022; Lecuit, Marc/M-4126-2019	Lecuit, Marc/0000-0002-4491-1063; Lecuit, Marc/0000-0002-4491-1063; Sanberg, Paul/0000-0001-9130-4592; Haller, Edward/0000-0002-8535-2181	USF Internal Awards Program	USF Internal Awards Program	This work was supported by the USF Internal Awards Program.	Alexianu Maria E., 1995, Romanian Journal of Neurology and Psychiatry, V33, P215; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Almer G, 2001, ANN NEUROL, V49, P176, DOI 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.3.CO;2-O; ANNUNZIATA P, 1985, ACTA NEUROL SCAND, V72, P61; APOSTOLSKI S, 1991, ACTA NEUROL SCAND, V83, P96, DOI 10.1111/j.1600-0404.1991.tb04656.x; APPEL SH, 1994, J NEUROL SCI, V124, P14, DOI 10.1016/0022-510X(94)90171-6; Aschner M, 1998, NEUROTOXICOLOGY, V19, P269; AVATA C, 2002, J CLIN NEUROSCI, V9, P113; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Barneoud P, 1997, NEUROREPORT, V8, P2861, DOI 10.1097/00001756-199709080-00012; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; CHIU AY, 1995, MOL CELL NEUROSCI, V6, P349, DOI 10.1006/mcne.1995.1027; Claudio L, 1996, ACTA NEUROPATHOL, V91, P6; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; DERMIETZEL R, 1991, INT REV CYTOL, V127, P57; DONNENFELD H, 1984, J NEUROIMMUNOL, V6, P51, DOI 10.1016/0165-5728(84)90042-0; Dwyer DS, 2002, INT REV NEUROBIOL, V51, P159, DOI 10.1016/S0074-7742(02)51005-9; Engelhardt Britta, 2006, V43, P259, DOI 10.1007/020; Engelhardt JI, 2005, ACTA NEUROL SCAND, V112, P126, DOI 10.1111/j.1600-0404.2005.00445.x; ENGELHARDT JI, 1993, ARCH NEUROL-CHICAGO, V50, P30, DOI 10.1001/archneur.1993.00540010026013; ENGELHARDT JI, 1990, ARCH NEUROL-CHICAGO, V47, P1210, DOI 10.1001/archneur.1990.00530110068019; FARRELL CL, 1991, P NATL ACAD SCI USA, V88, P5779, DOI 10.1073/pnas.88.13.5779; Garbuzova-Davis S, 2001, AMYOTROPH LATERAL SC, V2, P175, DOI 10.1080/14660820152882179; Garbuzova-Davis S, 2002, EXP NEUROL, V174, P169, DOI 10.1006/exnr.2002.7860; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Garbuzova-Davis S, 2007, BRAIN RES, V1157, P126, DOI 10.1016/j.brainres.2007.04.044; Ge SJ, 2006, J NEUROIMMUNOL, V177, P209, DOI 10.1016/j.jneuroim.2006.05.012; GERHART DZ, 1989, J NEUROSCI RES, V22, P464, DOI 10.1002/jnr.490220413; Gordh T, 2006, PAIN, V124, P211, DOI 10.1016/j.pain.2006.05.020; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Hensley K, 2006, ANTIOXID REDOX SIGN, V8, P2075, DOI 10.1089/ars.2006.8.2075; Ince PG, 1996, ACTA NEUROPATHOL, V92, P395, DOI 10.1007/s004010050535; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kirk J, 2003, J PATHOL, V201, P319, DOI 10.1002/path.1434; Kirkinezos IG, 2004, J NEUROCHEM, V88, P821, DOI 10.1046/j.1471-4159.2003.02181.x; KWON EE, 1994, J NEUROPATH EXP NEUR, V53, P625, DOI 10.1097/00005072-199411000-00010; LEONARDI A, 1984, J NEUROL, V231, P75, DOI 10.1007/BF00313720; MEUCCI G, 1993, J NEUROL SCI, V118, P73, DOI 10.1016/0022-510X(93)90248-W; Miller RG, 2000, NEUROLOGY, V54, P53, DOI 10.1212/WNL.54.1.53; Mohamed HA, 2002, J NEUROSCI RES, V69, P110, DOI 10.1002/jnr.10271; MUCKE L, 1993, FASEB J, V7, P1226, DOI 10.1096/fasebj.7.13.8405808; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; OLSSON Y, 1992, PROG BRAIN RES, V91, P197; Ono S, 1998, J NEUROL SCI, V160, P140, DOI 10.1016/S0022-510X(98)00223-8; Pardridge W M, 1991, Semin Cell Biol, V2, P419; Pardridge William M, 2005, NeuroRx, V2, P1, DOI 10.1602/neurorx.2.1.1; Pardridge WM, 1999, J NEUROVIROL, V5, P556, DOI 10.3109/13550289909021285; PARDRIDGE WM, 1988, ANNU REV PHARMACOL, V28, P25; Pirttila T, 2004, ACTA NEUROL SCAND, V109, P337, DOI 10.1111/j.1600-0404.2004.00223.x; Prat A, 2001, GLIA, V36, P145, DOI 10.1002/glia.1104; Rebenko-Moll NM, 2006, CURR OPIN IMMUNOL, V18, P683, DOI 10.1016/j.coi.2006.09.005; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; RUTKA JT, 1988, J NEUROSURG, V69, P155, DOI 10.3171/jns.1988.69.2.0155; SARIA A, 1983, J NEUROSCI METH, V8, P41, DOI 10.1016/0165-0270(83)90050-X; Sasaki S, 2000, NEUROSCI LETT, V291, P44, DOI 10.1016/S0304-3940(00)01370-7; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; STEWART PA, 1994, MICROSC RES TECHNIQ, V27, P516, DOI 10.1002/jemt.1070270606; Strong MJ, 2005, J NEUROPATH EXP NEUR, V64, P649, DOI 10.1097/01.jnen.0000173889.71434.ea; TROOST D, 1990, NEUROPATH APPL NEURO, V16, P401, DOI 10.1111/j.1365-2990.1990.tb01276.x; Vorbrodt AW, 2003, BRAIN RES REV, V42, P221, DOI 10.1016/S0165-0173(03)00177-2; Vos CMP, 2005, NEUROBIOL DIS, V20, P953, DOI 10.1016/j.nbd.2005.06.012; Weydt P, 2003, NEUROREPORT, V14, P1051, DOI 10.1097/01.wnr.0000073685.00308.89; Yenari MA, 2006, STROKE, V37, P1087, DOI 10.1161/01.STR.0000206281.77178.ac	65	174	175	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1205	10.1371/journal.pone.0001205	http://dx.doi.org/10.1371/journal.pone.0001205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030339	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459200018
J	Matsumoto, T; Sasaki, JI; Alsberg, E; Egusa, H; Yatani, H; Sohmura, T				Matsumoto, Takuya; Sasaki, Jun-Ichi; Alsberg, Eben; Egusa, Hiroshi; Yatani, Hirofumi; Sohmura, Taiji			Three-Dimensional Cell and Tissue Patterning in a Strained Fibrin Gel System	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; CONTROLLED-RELEASE; CYCLIC STRAIN; STIFFNESS; ALIGNMENT; DELIVERY; MATRICES	Techniques developed for the in vitro reproduction of three-dimensional (3D) biomimetic tissue will be valuable for investigating changes in cell function in tissues and for fabricating cell/matrix composites for applications in tissue engineering techniques. In this study, we show that the simple application of a continuous strain to a fibrin gel facilitates the development of fibril alignment and bundle-like structures in the fibrin gel in the direction of the applied strain. Myoblasts cultured in this gel also exhibited well-aligned cell patterning in a direction parallel to the direction of the strain. Interestingly, the direction of cell proliferation was identical to that of cell alignment. Finally, the oriented cells formed linear groups that were aligned parallel to the direction of the strain and replicated the native skeletal muscle cell patterning. In addition, vein endothelial cells formed a linear, aligned vessel-like structure in this system. Thus, the system enables the in vitro reproduction of 3D aligned cell sets replicating biological tissue patterns.	[Matsumoto, Takuya; Sasaki, Jun-Ichi; Egusa, Hiroshi; Yatani, Hirofumi; Sohmura, Taiji] Osaka Univ, Dept Oromaxillofacial Regenerat, Suita, Osaka, Japan; [Alsberg, Eben] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	Osaka University; Case Western Reserve University	Matsumoto, T (corresponding author), Osaka Univ, Dept Oromaxillofacial Regenerat, Suita, Osaka, Japan.	tmatsu@dent.osaka-u.ac.jp	Egusa, Hiroshi/AFT-9694-2022	Egusa, Hiroshi/0000-0002-0200-8132; Alsberg, Eben/0000-0002-3487-4625	JSPS [18680039, 19659503]; COE program	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); COE program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grants-in-Aid 18680039 and 19659503 from JSPS and young investigator grant from COE program.	Alsberg E, 2006, TISSUE ENG, V12, P3247, DOI 10.1089/ten.2006.12.3247; Bhang SH, 2007, J BIOMED MATER RES A, V80A, P998, DOI 10.1002/jbm.a.31050; Boontheekul T, 2007, TISSUE ENG, V13, P1431, DOI 10.1089/ten.2006.0356; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chen QH, 2003, J VASC SURG, V37, P660, DOI 10.1067/mva.2003.95; Dubey N, 2001, BIOMATERIALS, V22, P1065, DOI 10.1016/S0142-9612(00)00341-0; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027; FISCHBACH C, 2007, NAT METHODS IN PRESS; Huang YC, 2005, J APPL PHYSIOL, V98, P706, DOI 10.1152/japplphysiol.00273.2004; Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8; Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671; Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392; LEE RC, 1998, Patent No. 5756350; Matsumoto T, 2007, TISSUE ENG, V13, P207, DOI 10.1089/ten.2006.0058; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Neidlinger-Wilke C, 2001, J ORTHOP RES, V19, P286, DOI 10.1016/S0736-0266(00)00029-2; Peretti GM, 2006, TISSUE ENG, V12, P1151, DOI 10.1089/ten.2006.12.1151; Powell CA, 2002, AM J PHYSIOL-CELL PH, V283, pC1557, DOI 10.1152/ajpcell.00595.2001; Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104; Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0; Tan W, 2005, J BIOMED MATER RES A, V72A, P146, DOI 10.1002/jbm.a.30182; Thomas AC, 2004, J CONTROL RELEASE, V100, P357, DOI 10.1016/j.jconrel.2004.09.004; Tranquillo RT, 1996, BIOMATERIALS, V17, P349, DOI 10.1016/0142-9612(96)85573-6; Webb K, 2006, J BIOMECH, V39, P1136, DOI 10.1016/j.jbiomech.2004.08.026; Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011; Zhu XY, 2005, NAT MATER, V4, P403, DOI 10.1038/nmat1365	27	83	83	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1211	10.1371/journal.pone.0001211	http://dx.doi.org/10.1371/journal.pone.0001211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030345	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459200024
J	Das, U; Hariprasad, G; Ethayathulla, AS; Manral, P; Das, TK; Pasha, S; Mann, A; Ganguli, M; Verma, AK; Bhat, R; Chandrayan, SK; Ahmed, S; Sharma, S; Kaur, P; Singh, TP; Srinivasan, A				Das, Utpal; Hariprasad, Gururao; Ethayathulla, Abdul S.; Manral, Pallavi; Das, Taposh K.; Pasha, Santosh; Mann, Anita; Ganguli, Munia; Verma, Amit K.; Bhat, Rajiv; Chandrayan, Sanjeev Kumar; Ahmed, Shubbir; Sharma, Sujata; Kaur, Punit; Singh, Tej P.; Srinivasan, Alagiri			Inhibition of Protein Aggregation: Supramolecular Assemblies of Arginine Hold the Key	PLOS ONE			English	Article								Background. Aggregation of unfolded proteins occurs mainly through the exposed hydrophobic surfaces. Any mechanism of inhibition of this aggregation should explain the prevention of these hydrophobic interactions. Though arginine is prevalently used as an aggregation suppressor, its mechanism of action is not clearly understood. We propose a mechanism based on the hydrophobic interactions of arginine. Methodology. We have analyzed arginine solution for its hydrotropic effect by pyrene solubility and the presence of hydrophobic environment by 1-anilino-8-naphthalene sulfonic acid fluorescence. Mass spectroscopic analyses show that arginine forms molecular clusters in the gas phase and the cluster composition is dependent on the solution conditions. Light scattering studies indicate that arginine exists as clusters in solution. In the presence of arginine, the reverse phase chromatographic elution profile of Alzheimer's amyloid beta 1-42 (A beta(1-42)) peptide is modified. Changes in the hydrodynamic volume of A beta(1-42) in the presence of arginine measured by size exclusion chromatography show that arginine binds to A beta(1-42). Arginine increases the solubility of A beta(1-42) peptide in aqueous medium. It decreases the aggregation of A beta(1-42) as observed by atomic force microscopy. Conclusions. Based on our experimental results we propose that molecular clusters of arginine in aqueous solutions display a hydrophobic surface by the alignment of its three methylene groups. The hydrophobic surfaces present on the proteins interact with the hydrophobic surface presented by the arginine clusters. The masking of hydrophobic surface inhibits protein-protein aggregation. This mechanism is also responsible for the hydrotropic effect of arginine on various compounds. It is also explained why other amino acids fail to inhibit the protein aggregation.	[Das, Utpal; Hariprasad, Gururao; Ethayathulla, Abdul S.; Manral, Pallavi; Sharma, Sujata; Kaur, Punit; Singh, Tej P.; Srinivasan, Alagiri] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Das, Taposh K.] All India Inst Med Sci, Dept Anat, New Delhi 110029, India; [Pasha, Santosh] Univ Delhi, Peptide Chem Lab, Inst Genom & Integrat Biol, Delhi 110007, India; [Mann, Anita; Ganguli, Munia] Univ Delhi, Atom Force Microscopy Lab, Inst Genom & Integrat Biol, Delhi 110007, India; [Verma, Amit K.; Bhat, Rajiv] Jawaharlal Nehru Univ, Sch Biotechnol, Ctr Biotechnol, New Delhi 110067, India; [Chandrayan, Sanjeev Kumar; Ahmed, Shubbir] Inst Microbial Technol, Div Prot Sci & Engn, Chandigarh, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Delhi; Jawaharlal Nehru University, New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Srinivasan, A (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	srini@aiims.ac.in	CHANDRAYAN, SANJEEV/M-1662-2016; Ahmed, Shubbir/AAC-4289-2019; Das, Utpal/E-4692-2013; Mann, Anita/GQP-9814-2022	CHANDRAYAN, SANJEEV/0000-0003-2219-4654; Ahmed, Shubbir/0000-0003-1655-6735; Verma, Amit Kumar/0000-0002-9836-881X	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work has been supported by a research grant to AS from the Department of Biotechnology, Government of India.	Arakawa T, 2003, BIOCHEM BIOPH RES CO, V304, P148, DOI 10.1016/S0006-291X(03)00578-3; Arakawa T, 2007, BIOPHYS CHEM, V127, P1, DOI 10.1016/j.bpc.2006.12.007; Armstrong N, 1999, PROTEIN SCI, V8, P1475, DOI 10.1110/ps.8.7.1475; Arora D, 1996, J BIOTECHNOL, V52, P127, DOI 10.1016/S0168-1656(96)01636-7; Baynes BM, 2005, BIOCHEMISTRY-US, V44, P4919, DOI 10.1021/bi047528r; Baynes BM, 2004, BIOPHYS J, V87, P1631, DOI 10.1529/biophysj.104.042473; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; BREMS DN, 1987, BIOCHEMISTRY-US, V26, P7774, DOI 10.1021/bi00398a036; BUCHNER J, 1991, BIO-TECHNOL, V9, P157, DOI 10.1038/nbt0291-157; Charvat A, 2002, EUR PHYS J D, V20, P573, DOI 10.1140/epjd/e2002-00169-0; [陈启宏 CHEN Qihong], 2006, [华中师范大学学报. 自然科学版, Journal of Central China Normal University. Natural Sciences edition], V40, P42; COLOMBO MF, 1992, SCIENCE, V256, P655, DOI 10.1126/science.1585178; D'Agostino L, 2005, FEBS J, V272, P3777, DOI 10.1111/j.1742-4658.2005.04782.x; D'Agostino L, 2002, EUR J BIOCHEM, V269, P4317, DOI 10.1046/j.1432-1033.2002.03128.x; GOLDBERG ME, 1985, TRENDS BIOCHEM SCI, V10, P388, DOI 10.1016/0968-0004(85)90066-0; Gursky O, 2000, BBA-PROTEIN STRUCT M, V1476, P93, DOI 10.1016/S0167-4838(99)00228-9; Hirai A, 2006, COLLOID POLYM SCI, V284, P520, DOI 10.1007/s00396-005-1423-1; Ho JGS, 2003, PROTEIN SCI, V12, P708, DOI 10.1110/ps.0233703; Hsih MH, 1997, APPL MICROBIOL BIOT, V48, P66, DOI 10.1007/s002530051016; ICHIMURA S, 1977, BIOPOLYMERS, V16, P1449, DOI 10.1002/bip.1977.360160706; Ishibashi MI, 2005, PROTEIN PEPTIDE LETT, V12, P649, DOI 10.2174/0929866054696136; Julian RR, 2001, J AM CHEM SOC, V123, P3577, DOI 10.1021/ja003105a; KARLE IL, 1964, ACTA CRYSTALLOGR, V17, P835, DOI 10.1107/S0365110X64002250; KIRKWOOD JG, 1951, J CHEM PHYS, V19, P774, DOI 10.1063/1.1748352; KOETZLE TF, 1973, ACTA CRYSTALLOGR B, V29, P2571, DOI 10.1107/S0567740873007028; Lartigue A, 2003, J BIOL CHEM, V278, P30213, DOI 10.1074/jbc.M304688200; Lee SH, 2006, PROTEIN SCI, V15, P304, DOI 10.1110/ps.051813506; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Macrae CF, 2006, J APPL CRYSTALLOGR, V39, P453, DOI [10.1107/S002188980600731X, 10.1107/S0021 88980600731X]; MELANDER W, 1977, ARCH BIOCHEM BIOPHYS, V183, P200, DOI 10.1016/0003-9861(77)90434-9; Myung S, 2006, J AM CHEM SOC, V128, P10833, DOI 10.1021/ja0622711; Ory JJ, 1999, BIOPHYS J, V77, P1107, DOI 10.1016/S0006-3495(99)76961-4; Recacha R, 1997, J PEPT RES, V50, P388; Reddy RC, 2005, PROTEIN SCI, V14, P929, DOI 10.1110/ps.041085005; RINAS U, 1990, BIOL CHEM H-S, V371, P49, DOI 10.1515/bchm3.1990.371.1.49; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; SAENGER W, 1972, ACTA CRYSTALL B-STRU, VB 28, P2237, DOI 10.1107/S0567740872005862; Samuel D, 2000, PROTEIN SCI, V9, P344; Samuel D, 1997, BIOCHEM MOL BIOL INT, V41, P235; SCHOBERT B, 1978, BIOCHIM BIOPHYS ACTA, V541, P270, DOI 10.1016/0304-4165(78)90400-2; Schonbrunn E, 2000, P NATL ACAD SCI USA, V97, P6345, DOI 10.1073/pnas.120120397; Shimizu S, 2004, P NATL ACAD SCI USA, V101, P1195, DOI 10.1073/pnas.0305836101; Shiraki K, 2002, J BIOCHEM, V132, P591, DOI 10.1093/oxfordjournals.jbchem.a003261; SRINIVAS V, 1995, LANGMUIR, V11, P2830, DOI 10.1021/la00007a077; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; SUBRAMANIAN E, 1967, ACTA CRYSTALLOGR, V22, P910, DOI 10.1107/S0365110X67001768; SURESH CG, 1983, INT J PEPT PROT RES, V21, P223; TANEJA S, 1994, BIOCHEM J, V303, P147, DOI 10.1042/bj3030147; Timasheff SN, 1998, ADV PROTEIN CHEM, V51, P355; TORII K, 1970, ACTA CRYSTALL B-STRU, VB 26, P1317, DOI 10.1107/S0567740870004065; TORII K, 1971, ACTA CRYSTALL B-STRU, VB 27, P2237, DOI 10.1107/S0567740871005612; TORII K, 1973, ACTA CRYSTALLOGR B, V29, P2799, DOI 10.1107/S0567740873007569; Tsumoto K, 2005, PROTEIN PEPTIDE LETT, V12, P613, DOI 10.2174/0929866054696109; Valente JJ, 2005, BIOPHYS J, V89, P4211, DOI 10.1529/biophysj.105.068551; WRIGHT DA, 1962, ACTA CRYSTALLOGR, V15, P54, DOI 10.1107/S0365110X62000122	56	154	164	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1176	10.1371/journal.pone.0001176	http://dx.doi.org/10.1371/journal.pone.0001176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000547	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459100018
J	Humphries, MJ; Ohm, AM; Schaack, J; Adwan, TS; Reyland, ME				Humphries, M. J.; Ohm, A. M.; Schaack, J.; Adwan, T. S.; Reyland, M. E.			Tyrosine phosphorylation regulates nuclear translocation of PKC delta	ONCOGENE			English	Article						protein kinase C; tyrosine phosphorylation; apoptosis; nuclear localization; salivary gland	PROTEIN-KINASE-C; INDUCED APOPTOSIS; ACINAR-CELLS; ACTIVATION; CONSTRUCTION; SUPPRESSION; ETOPOSIDE; VECTORS	PKC delta is essential for apoptosis, but regulation of the proapoptotic function of this ubiquitous kinase is not well understood. Nuclear translocation of PKC delta is necessary and sufficient to induce apoptosis and is mediated via a C-terminal bipartite nuclear localization sequence. However, PKC delta is found predominantly in the cytoplasm of nonapoptotic cells, and the apoptotic signal that activates its nuclear translocation is not known. We show that in salivary epithelial cells, phosphorylation at specific tyrosine residues in the N-terminal regulatory domain directs PKC delta to the nucleus where it induces apoptosis. Analysis of each tyrosine residue in PKC delta by site-directed mutagenesis identified two residues, Y64 and Y155, as essential for nuclear translocation. Suppression of apoptosis correlated with suppressed nuclear localization of the Y -> F mutant proteins. Moreover, a phosphomimetic PKC delta Y64D/Y155D mutant accumulated in the nucleus in the absence of an apoptotic signal. Forced nuclear accumulation of PKC delta-Y64F and Y155F mutant proteins, by attachment of an SV40 nuclear localization sequence, fully reconstituted their ability to induce apoptosis, indicating that tyrosine phosphorylation per se is not required for apoptosis, but for targeting PKC delta to the nucleus. We propose that phosphorylation/dephosphorylation of PKC delta in the regulatory domain functions as a switch to promote cell survival or cell death.	[Humphries, M. J.; Ohm, A. M.; Schaack, J.; Adwan, T. S.; Reyland, M. E.] Hlth Sci Ctr, Aurora, CO 80045 USA; [Humphries, M. J.; Ohm, A. M.; Adwan, T. S.; Reyland, M. E.] Univ Colorado Denver, Sch Dent, Dept Craniofacial Biol, Program Cell & Dev Biol, Aurora, CO 80045 USA; [Schaack, J.] Univ Colorado Denver, Sch Med, Dept Microbiol, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Reyland, ME (corresponding author), Univ Colorado Denver, Sch Dent, Dept Craniofacial Biol, Program Cell & Dev Biol, 12801 E 17th Ave,Mail Stop 8120,POB 6511, Aurora, CO 80045 USA.	Mary.Reyland@uchsc.edu			NICHD NIH HHS [P01 HD038129, P0I HD038129] Funding Source: Medline; NIDCR NIH HHS [R01 DE015648, R01 DE015648-01, R01 DE015648-05, R01 DE015648-04] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD038129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015648] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Acs P, 2000, CARCINOGENESIS, V21, P887, DOI 10.1093/carcin/21.5.887; Anderson SM, 1999, CELL DEATH DIFFER, V6, P454, DOI 10.1038/sj.cdd.4400507; Blass M, 2002, MOL CELL BIOL, V22, P182, DOI 10.1128/MCB.22.1.182-195.2002; Collazos A, 2006, MOL CELL BIOL, V26, P2247, DOI 10.1128/MCB.26.6.2247-2261.2006; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; GRAHAM FL, 1995, MOL BIOTECHNOL, V3, P207, DOI 10.1007/BF02789331; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Kajimoto T, 2001, MOL CELL BIOL, V21, P1769, DOI 10.1128/MCB.21.5.1769-1783.2001; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Limesand KH, 2003, CELL DEATH DIFFER, V10, P345, DOI 10.1038/sj.cdd.4401153; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Okhrimenko H, 2005, J BIOL CHEM, V280, P23643, DOI 10.1074/jbc.M501374200; Schaack J, 2001, VIROLOGY, V291, P101, DOI 10.1006/viro.2001.1211; Song JS, 1998, ONCOGENE, V16, P3357, DOI 10.1038/sj.onc.1201886; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Sun XG, 2000, J BIOL CHEM, V275, P7470, DOI 10.1074/jbc.275.11.7470; Tatton L, 2003, J BIOL CHEM, V278, P4847, DOI 10.1074/jbc.M209321200; Tolcher AW, 2002, CLIN CANCER RES, V8, P2530; Yoshida K, 2002, J BIOL CHEM, V277, P48372, DOI 10.1074/jbc.M205485200; Yuan ZM, 1998, ONCOGENE, V16, P1643, DOI 10.1038/sj.onc.1201698; Zrachia A, 2002, J BIOL CHEM, V277, P23693, DOI 10.1074/jbc.M111658200	24	45	46	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 8	2008	27	21					3045	3053		10.1038/sj.onc.1210967	http://dx.doi.org/10.1038/sj.onc.1210967			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	298IP	18059334	Green Accepted			2022-12-25	WOS:000255681700011
J	Galie, M; Konstantinidou, G; Peroni, D; Scambi, I; Marchini, C; Lisi, V; Krampera, M; Magnani, P; Merigo, F; Montani, M; Boschi, F; Marzola, P; Orru, R; Farace, P; Sbarbati, A; Amici, A				Galie, M.; Konstantinidou, G.; Peroni, D.; Scambi, I.; Marchini, C.; Lisi, V.; Krampera, M.; Magnani, P.; Merigo, F.; Montani, M.; Boschi, F.; Marzola, P.; Orru, R.; Farace, P.; Sbarbati, A.; Amici, A.			Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice	ONCOGENE			English	Article						mammary carcinoma; reactive stromal cells; mesenchymal stem cells; angiogenesis; molecular signature; HER-2/neu	HUMAN ADIPOSE-TISSUE; ACUTE MYELOID-LEUKEMIA; BREAST-CANCER CELLS; POSTNATAL NEOVASCULARIZATION; STROMAL FIBROBLASTS; ENDOTHELIAL-CELLS; BONE-MARROW; IN-VITRO; ANGIOGENESIS; IDENTIFICATION	Tumor microenvironment in carcinomas recruits mesenchymal cells with an abnormal proangiogenic and invasive phenotype. It is not clear whether mesenchymal tumor cells (MTCs) derive from the activation of mature fibroblasts or from their stem cell precursors. However, stromal cell activation in tumors resembles in several aspects the mesenchymal rearrangement which normally occurs during reparative processes such as wound healing. Mesenchymal stem cells (MSCs) play a crucial role in developmental and reparative processes and have extraordinary proangiogenic potential, on the basis of which they are thought to show great promise for the treatment of ischemic disorders. Here, we show that MTCs have proangiogenic potential and that they share the transcriptional expression of the best-known proangiogenic factors with MSCs. We also found that MTCs and MSCs have the same molecular signature for stemness-related genes, and that when co-implanted with cancer cells in syngeneic animals MSCs determine early tumor appearance, probably by favoring the angiogenic switch. Our data (1) reveal crucial aspects of the proangiogenic phenotype of MTCs, (2) strongly suggest their stem origin and (3) signal the risk of therapeutic use of MSCs in tumor-promoting conditions.	[Galie, M.; Peroni, D.; Scambi, I.; Magnani, P.; Merigo, F.; Boschi, F.; Marzola, P.; Farace, P.; Sbarbati, A.] Univ Verona, Dept Morphol & Biomed Sci, Anat & Histol Sect, I-37134 Verona, Italy; [Konstantinidou, G.; Marchini, C.; Montani, M.; Orru, R.; Amici, A.] Univ Camerino, Genet Immunizat Lab, Dept Mol Cellular & Anim Biol, Camerino, Macerata, Italy; [Lisi, V.; Krampera, M.] Univ Verona, Dept Clin & Expt Med, Haematol Sect, I-37134 Verona, Italy	University of Verona; University of Camerino; University of Verona	Galie, M (corresponding author), Univ Verona, Dept Morphol & Biomed Sci, Anat & Histol Sect, Via Grazie 8, I-37134 Verona, Italy.	mirco@anatomy.univr.it	Konstantinidou, Georgia/O-9192-2016; Farace, Paolo/AAK-4072-2020; KRAMPERA, MAURO/K-5596-2018	Konstantinidou, Georgia/0000-0001-9513-0286; Farace, Paolo/0000-0002-6051-2345; GALIE', Mirco/0000-0002-6441-8313; Peroni, Daniele/0000-0002-0862-266X; Amici, Augusto/0000-0002-4634-1500; KRAMPERA, Mauro/0000-0002-7280-2040; Marchini, Cristina/0000-0001-7692-8428; MARZOLA, Pasquina/0000-0001-6936-8901				Al Sayed AD, 2006, ACTA ONCOL, V45, P188, DOI 10.1080/02841860500513235; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Burns JS, 2005, CANCER RES, V65, P3126, DOI 10.1158/0008-5472.CAN-04-2218; Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Dingli D, 2006, STEM CELLS, V24, P2603, DOI 10.1634/stemcells.2006-0136; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Fiegl H, 2006, CANCER RES, V66, P29, DOI 10.1158/0008-5472.CAN-05-2508; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; Galie M, 2005, CARCINOGENESIS, V26, P1868, DOI 10.1093/carcin/bgi158; Galie M, 2005, NEOPLASIA, V7, P528, DOI 10.1593/neo.04730; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Hayward SW, 2001, CANCER RES, V61, P8135; Hill R, 2005, CELL, V123, P1001, DOI 10.1016/j.cell.2005.09.030; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Hung SC, 2005, CLIN CANCER RES, V11, P7749, DOI 10.1158/1078-0432.CCR-05-0876; Keith WN, 2004, ONCOGENE, V23, P5092, DOI 10.1038/sj.onc.1207762; Knutson KL, 2006, J IMMUNOL, V177, P1526, DOI 10.4049/jimmunol.177.3.1526; Krampera M, 2007, BONE, V40, P382, DOI 10.1016/j.bone.2006.09.006; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; McAlhany SJ, 2003, CANCER RES, V63, P5859; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Petersen OW, 2001, BREAST CANCER RES, V3, P213; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rigotti G, 2007, PLAST RECONSTR SURG, V119, P1409, DOI 10.1097/01.prs.0000256047.47909.71; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wolf D, 2005, JNCI-J NATL CANCER I, V97, P540, DOI 10.1093/jnci/dji088; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	46	95	103	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2008	27	18					2542	2551		10.1038/sj.onc.1210920	http://dx.doi.org/10.1038/sj.onc.1210920			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	289LW	17998939				2022-12-25	WOS:000255057000004
J	Sheerin, NS; Risley, P; Abe, K; Tang, ZY; Wong, WL; Lin, T; Sacks, SH				Sheerin, Neil S.; Risley, Paul; Abe, Katsu; Tang, Ziyong; Wong, Wilson; Lin, Tao; Sacks, Steven H.			Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury	FASEB JOURNAL			English	Article						proteinuria; renal failure; innate immunity	MEMBRANE ATTACK COMPLEX; TUBULOINTERSTITIAL DAMAGE; ADRIAMYCIN NEPHROPATHY; ALTERNATIVE PATHWAY; COMPONENT C3; C5B-9; PROGRESSION; EXPRESSION; DISEASE; RATS	Increased exposure of the tubular epithelium to filtered protein is a proposed mechanism of progressive renal failure associated with glomerular disease, but how this protein overload translates into tubular damage remains unclear. We have examined a model of adriamycin-induced proteinuria to determine the effect of locally synthesized C3, the central proinflammatory protein of the complement cascade. C3(-/-) kidney isografts placed in wild-type C3+/+ mice were protected from proteinuria-associated complement activation, tubular damage, and progressive renal failure despite the presence of abundant circulating C3. The quantity of urinary protein was unaffected by the absence of C3, and thus the influence of C3 was not explained by alteration in the filtered protein load. These results suggest that local synthesis of complement from renal epithelial cells is a critical mediator of tubular damage in proteinuria-associated renal disease. Our results concur with previous findings of increased synthesis of C3 in human tubular epithelium exposed to high concentrations of protein in vitro. Because progressive renal damage in humans associates with proteinuria regardless of cause, our findings have implications for the pathogenesis and treatment of renal failure from many common causes, immunological and nonimmunological.	[Sheerin, Neil S.; Risley, Paul; Tang, Ziyong; Wong, Wilson; Lin, Tao; Sacks, Steven H.] Kings Coll London, Guys Hosp, Dept Nephrol Transplantat, London WC2R 2LS, England; [Sheerin, Neil S.] Newcastle Univ, Sch Med, Sch Clin Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Abe, Katsu] Nagasaki Univ, Sch Med, Dept Internal Med 2, Div Nephrol, Nagasaki 852, Japan; [Tang, Ziyong] Peking Univ, Hosp 3, Dept Nephrol, Beijing 100871, Peoples R China	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Newcastle University - UK; Nagasaki University; Peking University	Sheerin, NS (corresponding author), Newcastle Univ, Sch Med, Sch Clin Med Sci, 4th Fl,William Leech Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	neil.sheerin@ncl.ac.uk	Risley, Paul/E-2489-2013	Sacks, Steven/0000-0001-6361-9095	Medical Research Council [G0000771, G0600892] Funding Source: Medline; MRC [G0000771, G0600892] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abe K, 2004, CLIN EXP IMMUNOL, V136, P60, DOI 10.1111/j.1365-2249.2004.02411.x; Anders HJ, 2002, J CLIN INVEST, V109, P251, DOI 10.1172/JCI14040; ANDREWS PA, 1994, TRANSPLANTATION, V58, P637, DOI 10.1097/00007890-199409150-00023; Braun MC, 2004, J IMMUNOL, V173, P4190, DOI 10.4049/jimmunol.173.6.4190; Brown KM, 2006, NEW ENGL J MED, V354, P2014, DOI 10.1056/NEJMoa052825; CAMUSSI G, 1983, ANN NY ACAD SCI, V420, P321, DOI 10.1111/j.1749-6632.1983.tb22219.x; David S, 1997, NEPHROL DIAL TRANSPL, V12, P51, DOI 10.1093/ndt/12.1.51; De Boer E, 1999, J AM SOC NEPHROL, V10, P2359; Farrar CA, 2006, FASEB J, V20, P217, DOI 10.1096/fj.05-4747com; He C, 2005, J IMMUNOL, V174, P5750, DOI 10.4049/jimmunol.174.9.5750; ICHIDA S, 1994, KIDNEY INT, V46, P89, DOI 10.1038/ki.1994.247; Montinaro V, 2000, KIDNEY INT, V57, P137, DOI 10.1046/j.1523-1755.2000.00812.x; Mosolits S, 1997, NEPHRON, V75, P179, DOI 10.1159/000189529; Nangaku M, 1999, J AM SOC NEPHROL, V10, P2323; Nangaku M, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134928; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Nomura A, 1997, AM J PATHOL, V151, P539; OGRODOWSKI JL, 1991, KIDNEY INT, V40, P1141, DOI 10.1038/ki.1991.326; Pratt JR, 2002, NAT MED, V8, P582, DOI 10.1038/nm0602-582; Rangan GK, 2004, KIDNEY INT, V66, P1838, DOI 10.1111/j.1523-1755.2004.00957.x; Remuzzi G, 1997, KIDNEY INT, V51, P2, DOI 10.1038/ki.1997.2; Ruggenenti P, 1997, LANCET, V349, P1857; SACKS SH, 1993, LANCET, V342, P1273, DOI 10.1016/0140-6736(93)92362-W; Sasaki O, 1997, AM J PATHOL, V151, P1249; Sheerin NS, 2006, J AM SOC NEPHROL, V17, P686, DOI 10.1681/ASN.2004070515; Tang S, 1999, J AM SOC NEPHROL, V10, P69; Tang S, 1999, J IMMUNOL, V162, P4336; Turnberg D, 2006, J IMMUNOL, V177, P4094, DOI 10.4049/jimmunol.177.6.4094; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; Wang Y, 2001, KIDNEY INT, V59, P941, DOI 10.1046/j.1523-1755.2001.00577.x; Welch TR, 1996, KIDNEY INT, V50, P521, DOI 10.1038/ki.1996.344; Welch TR, 2002, CLIN EXP IMMUNOL, V130, P43, DOI 10.1046/j.1365-2249.2002.01957.x; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; Zandi-Nejad K, 2004, KIDNEY INT, V66, pS76, DOI 10.1111/j.1523-1755.2004.09220.x; Zheng ZY, 2005, P NATL ACAD SCI USA, V102, P2502, DOI 10.1073/pnas.0409786102	35	59	65	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2008	22	4					1065	1072		10.1096/fj.07-8719com	http://dx.doi.org/10.1096/fj.07-8719com			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	18039928				2022-12-25	WOS:000254581000012
J	Dammeyer, P; Damdimopoulos, AE; Nordman, T; Jimenez, A; Miranda-Vizuete, A; Arner, ESJ				Dammeyer, Pascal; Damdimopoulos, Anastasios E.; Nordman, Tomas; Jimenez, Alberto; Miranda-Vizuete, Antonio; Arner, Elias S. J.			Induction of cell membrane protrusions by the N-terminal glutaredoxin domain of a rare splice variant of human thioredoxin reductase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN THIOREDOXIN REDUCTASE; EARLY EMBRYONIC LETHALITY; REDOX REGULATION; GLUTATHIONE-REDUCTASE; ACTIVE-SITE; SYSTEM; MECHANISM; TUBULIN; TESTIS; RAT	The human thioredoxin system has a wide range of functions in cells including regulation of cell proliferation and differentiation, immune system modulation, antioxidant defense, redox control of transcription factor activity, and promotion of cancer development. A key component of this enzymatic system is the selenoprotein thioredoxin reductase 1(TrxR1), encoded by the TXNRD1 gene. Transcription of TXNRD1 involves alternative splicing, leading to a number of transcripts also encoding isoforms of TrxR1 that differ from each other at their N-terminal domains. Here we have studied the TXNRD1_v3 isoform containing an atypical N-terminal glutaredoxin (Grx) domain. Expression of the transcript of this isoform was found predominantly in testis but was also detected in ovary, spleen, heart, liver, kidney, and pancreas. By immunohistochemical analysis in human testis with antibodies specific for the Grx domain of TXNRD1_v3, the protein was found to be predominantly expressed in the Leydig cells. Expression of the TXNRD1_v3 transcript was also found in several cancer cell lines (HCC1937, H23, A549, U1810, or H157), and in HeLa cells, it was induced by estradiol or testosterone treatments. Surprisingly, green fluorescent protein fusions with the complete TXNRD1_v3 protein or with only its Grx domain localized to distinct cellular sites in proximity to actin, and furthermore, had a potent capacity to rapidly induce cell membrane protrusions. Analyses of these structures suggested that the Grx domain of TXNRD1_ v3 localizes first in the emerging protrusion and is then followed into the protrusions by actin and subsequently by tubulin. The results presented thus reveal that TXNRD1_ v3 has a unique and distinct expression pattern in human cells and suggest that the protein can guide actin polymerization in relation to cell membrane restructuring.	[Dammeyer, Pascal; Nordman, Tomas; Arner, Elias S. J.] Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden; [Damdimopoulos, Anastasios E.; Jimenez, Alberto; Miranda-Vizuete, Antonio] Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet	Arner, ESJ (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden.	Elias.Arner@ki.se	Miranda-Vizuete, Antonio/D-6927-2012; Jiménez, Alberto/A-6234-2009; Arnér, Elias S.J./J-5832-2012; Arnér, Elias/K-6737-2019; IBIS, REDOX/J-7473-2017	Miranda-Vizuete, Antonio/0000-0002-6856-5396; Jiménez, Alberto/0000-0003-3685-6479; Arnér, Elias S.J./0000-0002-4807-6114; Arnér, Elias/0000-0002-4807-6114; Damdimopoulos, Anastasios/0000-0003-4425-1189				Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Damdimopoulos AE, 2004, J BIOL CHEM, V279, P38721, DOI 10.1074/jbc.M402753200; GAYTAN F, 1994, J REPROD FERTIL, V102, P393, DOI 10.1530/jrf.0.1020393; Gromer S, 2004, MED RES REV, V24, P40, DOI 10.1002/med.10051; Gromer S, 2002, METHOD ENZYMOL, V347, P382; Jimenez A, 2004, J BIOL CHEM, V279, P34971, DOI 10.1074/jbc.M404192200; KHAN IA, 1991, BIOCHIM BIOPHYS ACTA, V1076, P289, DOI 10.1016/0167-4838(91)90280-D; Landino LM, 2004, BIOCHEM BIOPH RES CO, V314, P555, DOI 10.1016/j.bbrc.2003.12.126; Lassing I, 2007, J MOL BIOL, V370, P331, DOI 10.1016/j.jmb.2007.04.056; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; Lee SR, 2000, P NATL ACAD SCI USA, V97, P2521, DOI 10.1073/pnas.050579797; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; LUDUENA RF, 1991, PHARMACOL THERAPEUT, V49, P133, DOI 10.1016/0163-7258(91)90027-J; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; Miranda-Vizuete A, 1999, EUR J BIOCHEM, V261, P405, DOI 10.1046/j.1432-1327.1999.00286.x; Miranda-Vizuete A, 2004, ANTIOXID REDOX SIGN, V6, P25, DOI 10.1089/152308604771978327; Miranda-Vizuete A, 2001, J BIOL CHEM, V276, P31567, DOI 10.1074/jbc.M101760200; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Osborne S A, 2001, BMC Genomics, V2, P10, DOI 10.1186/1471-2164-2-10; PFEIFFER DC, 1991, ANAT REC, V230, P473, DOI 10.1002/ar.1092300406; Rigobello MP, 1998, FREE RADICAL BIO MED, V24, P370, DOI 10.1016/S0891-5849(97)00216-5; Rundlof AK, 2000, BIOCHEM J, V347, P661, DOI 10.1042/0264-6021:3470661; Rundlof AK, 2004, FREE RADICAL BIO MED, V36, P641, DOI 10.1016/j.freeradbiomed.2003.12.004; Rundlof AK, 2004, ANTIOXID REDOX SIGN, V6, P41, DOI 10.1089/152308604771978336; Rundlof AK, 2001, J BIOL CHEM, V276, P30542, DOI 10.1074/jbc.M101452200; Rundlof AK, 2007, DIFFERENTIATION, V75, P123, DOI 10.1111/j.1432-0436.2006.00121.x; Sadek CM, 2003, J BIOL CHEM, V278, P13133, DOI 10.1074/jbc.M300369200; Sadek CM, 2001, GENES CELLS, V6, P1077, DOI 10.1046/j.1365-2443.2001.00484.x; Sandalova T, 2001, P NATL ACAD SCI USA, V98, P9533, DOI 10.1073/pnas.171178698; Su D, 2005, J BIOL CHEM, V280, P26491, DOI 10.1074/jbc.M503638200; Su D, 2004, BIOCHEMISTRY-US, V43, P12177, DOI 10.1021/bi048478t; Sun QA, 2005, BIOCHEMISTRY-US, V44, P14528, DOI 10.1021/bi051321w; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Sun QA, 2001, J BIOL CHEM, V276, P3106, DOI 10.1074/jbc.M004750200; Turanov AA, 2006, J BIOL CHEM, V281, P22953, DOI 10.1074/jbc.M604326200; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Wang J, 2003, P NATL ACAD SCI USA, V100, P5103, DOI 10.1073/pnas.0931345100; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Zhon LW, 1998, J BIOL CHEM, V273, P8581, DOI 10.1074/jbc.273.15.8581; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200	44	37	39	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2814	2821		10.1074/jbc.M708939200	http://dx.doi.org/10.1074/jbc.M708939200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18042542	Green Submitted, hybrid			2022-12-25	WOS:000252622300039
J	Guo, ZH; Jiang, HY; Xu, XR; Duan, WZ; Mattson, MP				Guo, Zhihong; Jiang, Haiyang; Xu, Xiangru; Duan, Wenzhen; Mattson, Mark P.			Leptin-mediated cell survival signaling in hippocampal neurons mediated by JAK STAT3 and mitochondrial stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; AMPA RECEPTOR SUBUNITS; NEUROTROPHIC FACTOR; LIPID-PEROXIDATION; NITRIC-OXIDE; PHOSPHOINOSITIDE 3-KINASE; PEROXYNITRITE PRODUCTION; REPRODUCTIVE FUNCTION; INDUCED APOPTOSIS; OXIDATIVE STRESS	Leptin plays a pivotal role in the regulation of energy homeostasis and metabolism, primarily by acting on neurons in the hypothalamus that control food intake. However, leptin receptors are more widely expressed in the brain suggesting additional, as yet unknown, functions of leptin. Here we show that both embryonic and adult hippocampal neurons express leptin receptors coupled to activation of STAT3 and phosphatidylinositol 3-kinase-Akt signaling pathways. Leptin protects hippocampal neurons against cell death induced by neurotrophic factor withdrawal and excitotoxic and oxidative insults. The neuroprotective effect of leptin is antagonized by the JAK2-STAT3 inhibitor AG-490, STAT3 decoy DNA, and phosphatidylinositol 3-kinase/Akt inhibitors but not by an inhibitor of MAPK. Leptin induces the production of manganese superoxide dismutase and the anti-apoptotic protein Bcl-xL, and stabilizes mitochondrial membrane potential and lessens mitochondrial oxidative stress. Leptin receptor-deficient mice (db/db mice) are more vulnerable to seizure-induced hippocampal damage, and intraventricular administration of leptin protects neurons against seizures. By enhancing mitochondrial resistance to apoptosis and excitotoxicity, our findings suggest that leptin signaling serves a neurotrophic function in the developing and adult hippocampus.	[Guo, Zhihong; Jiang, Haiyang; Xu, Xiangru; Duan, Wenzhen; Mattson, Mark P.] NIA, Neurosci Lab, Baltimore, MD 21224 USA; [Guo, Zhihong; Jiang, Haiyang; Xu, Xiangru; Duan, Wenzhen; Mattson, Mark P.] NIA, Intramural Res Program, Baltimore, MD 21224 USA; [Mattson, Mark P.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University	Mattson, MP (corresponding author), NIA, Neurosci Lab, Baltimore, MD 21224 USA.	mattsonm@grc.nia.nih.gov	Mattson, Mark P/F-6038-2012		Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Attoub S, 2000, FASEB J, V14, P2329, DOI 10.1096/fj.00-0162; Beal MF, 1998, ANN NEUROL, V44, pS110; Boston BA, 1997, SCIENCE, V278, P1641, DOI 10.1126/science.278.5343.1641; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Chan SL, 1999, J NEUROSCI RES, V57, P315, DOI 10.1002/(SICI)1097-4547(19990801)57:3<315::AID-JNR3>3.3.CO;2-R; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Cheng AW, 2003, J BIOL CHEM, V278, P7591, DOI 10.1074/jbc.M207232200; Darnowski JW, 2006, J BIOL CHEM, V281, P17707, DOI 10.1074/jbc.M600088200; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Dicou E, 2001, NEUROREPORT, V12, P3947, DOI 10.1097/00001756-200112210-00019; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Durakoglugil M, 2005, J NEUROCHEM, V95, P396, DOI 10.1111/j.1471-4159.2005.03375.x; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Funahashi H, 2003, INT REV CYTOL, V224, P1, DOI 10.1016/S0074-7696(05)24001-9; Furmaga-Jablonska W, 2003, ANN HUM BIOL, V30, P250, DOI 10.1080/0301446031000064521; Gabriel B, 2003, EXP CELL RES, V289, P195, DOI 10.1016/S0014-4827(03)00255-6; Gillessen T, 2002, BIOMED PHARMACOTHER, V56, P186, DOI 10.1016/S0753-3322(02)00184-1; Glazner GW, 2000, J NEUROSCI, V20, P3641, DOI 10.1523/JNEUROSCI.20-10-03641.2000; Gonzalez-Zulueta M, 1998, J NEUROSCI, V18, P2040; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; Harvey J, 2000, J BIOL CHEM, V275, P4660, DOI 10.1074/jbc.275.7.4660; HEIS FC, 2005, BIOCHEM BIOPH RES CO, V335, P292; Heshka JT, 2001, LIFE SCI, V69, P987, DOI 10.1016/S0024-3205(01)01201-2; Houseknecht KL, 1998, DOMEST ANIM ENDOCRIN, V15, P457, DOI 10.1016/S0739-7240(98)00035-6; Huang XF, 1996, NEUROREPORT, V7, P2635, DOI 10.1097/00001756-199611040-00045; Ishihara K, 2001, BBA-MOL BASIS DIS, V1536, P73, DOI 10.1016/S0925-4439(01)00035-7; Keller JN, 1998, J NEUROSCI, V18, P687; Leong PL, 2003, P NATL ACAD SCI USA, V100, P4138, DOI 10.1073/pnas.0534764100; Li XL, 2002, NEUROSCIENCE, V113, P607, DOI 10.1016/S0306-4522(02)00162-8; Magni P, 2000, REGUL PEPTIDES, V92, P51, DOI 10.1016/S0167-0115(00)00149-X; Mark RJ, 1997, J NEUROSCI, V17, P1046; Matsuoka N, 2002, NEUROSURGERY, V50, P857, DOI 10.1097/00006123-200204000-00032; Mattson MP, 1997, J NEUROSCI RES, V49, P681, DOI 10.1002/(SICI)1097-4547(19970915)49:6<681::AID-JNR3>3.0.CO;2-3; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; Mattson MP, 1998, TRENDS NEUROSCI, V21, P53, DOI 10.1016/S0166-2236(97)01188-0; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Miike S, 1999, J LEUKOCYTE BIOL, V65, P700, DOI 10.1002/jlb.65.5.700; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Najib S, 2002, CELL IMMUNOL, V220, P143, DOI 10.1016/S0008-8749(03)00027-3; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; Nicholls DG, 1999, BIOCHEM SOC SYMP, V66, P55, DOI 10.1042/bss0660055; Orike N, 2001, J CELL BIOL, V154, P995, DOI 10.1083/jcb.200101068; Peterson WM, 2000, J NEUROSCI, V20, P4081; Qiu J, 2001, ENDOCRINOLOGY, V142, P3421, DOI 10.1210/en.142.8.3421; Rothstein JD, 1996, CURR OPIN NEUROBIOL, V6, P679, DOI 10.1016/S0959-4388(96)80103-6; Sanchez-Margalet V, 2003, CLIN EXP IMMUNOL, V133, P11, DOI 10.1046/j.1365-2249.2003.02190.x; Scariano JK, 2003, MECH AGEING DEV, V124, P281, DOI 10.1016/S0047-6374(02)00195-1; Schinder AF, 1996, J NEUROSCI, V16, P6125; Shanley LJ, 2002, NAT NEUROSCI, V5, P299, DOI 10.1038/nn824; Shioda S, 1998, NEUROSCI LETT, V243, P41, DOI 10.1016/S0304-3940(98)00082-2; Sloviter R S, 1996, Neurologia, V11 Suppl 4, P29; Smith GD, 2002, THERIOGENOLOGY, V57, P73, DOI 10.1016/S0093-691X(01)00658-6; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Terui K, 2004, J HEPATOL, V41, P957, DOI 10.1016/j.jhep.2004.08.019; Turkson J, 2005, J BIOL CHEM, V280, P32979, DOI 10.1074/jbc.M502694200; Waelput W., 2002, Current Drug Targets - Inflammation and Allergy, V1, P277, DOI 10.2174/1568010023344634; White RJ, 1996, J NEUROSCI, V16, P5688; ZHAN AZ, 2000, J BIOL CHEM, V275, P11348	60	149	155	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1754	1763		10.1074/jbc.M703753200	http://dx.doi.org/10.1074/jbc.M703753200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17993459	hybrid			2022-12-25	WOS:000252282700062
J	Silversmith, RE; Levin, MD; Schilling, E; Bourret, RB				Silversmith, Ruth E.; Levin, Matthew D.; Schilling, Elmar; Bourret, Robert B.			Kinetic characterization of catalysis by the chemotaxis phosphatase CheZ - Modulation of activity by the phosphorylated CheY substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE REGULATOR CHEY; BACTERIAL CHEMOTAXIS; SIGNALING PROTEINS; BINDING; FLUORESCENT; LOCALIZATION; COMPONENTS; MECHANISM; MUTANTS; DOMAIN	CheZ catalyzes the dephosphorylation of the response regulator CheY in the two-component regulatory system that mediates chemotaxis in Escherichia coli. CheZ is a homodimer with two active sites for dephosphorylation. To gain insight into cellular mechanisms for the precise regulation of intracellular phosphorylated CheY (CheYp) levels, we evaluated the kinetic properties of CheZ. The steady state rate of CheZ-mediated dephosphorylation of CheYp displayed marked sigmoidicity with respect to CheYp concentration and a k(cat) of 4.9 s(-1). In contrast, the gain of function mutant CheZ-I21T with an amino acid substitution far from the active site gave hyperbolic kinetics and required far lower CheYp for half-saturation but had a similar kcat value as the wild type enzyme. Stopped flow fluorescence measurements demonstrated a 6-fold faster CheZ/CheYp association rate for CheZ-I21T (k(assoc) = 3.4 x 107 M-1 s(-1)) relative to wild type CheZ (k(assoc) = 5.6 x 10(6) M-1 s(-1)). Dissociation of the CheZ center dot CheYBeF(3) complex was slow for both wild type CheZ (k(dissoc) = 0.040 s(-1)) and CheZ-I21T (kdissoc = 0.023 s(-1)) and, when taken with the kassoc values, implied K-d values of 7.1 and 0.68 nM, respectively. However, comparison of the kdissoc and kcat values implied that CheZ and CheYp are not at binding equilibrium during catalysis and that once CheYp binds, it is almost always dephosphorylated. The rate constants were collated to formulate a kinetic model for CheZ-mediated dephosphorylation that includes autoregulation by CheYp and allowed prediction of CheZ activities at CheZ and CheYp concentrations likely to be present in cells.	[Silversmith, Ruth E.; Schilling, Elmar; Bourret, Robert B.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Levin, Matthew D.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EJ, England	University of North Carolina; University of North Carolina Chapel Hill; University of Cambridge	Silversmith, RE (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	silversr@med.unc.edu	Bourret, Robert/X-3606-2019	Bourret, Robert/0000-0002-6666-9220	NIGMS NIH HHS [GM 064713, R01 GM050860, R01 GM050860-14, GM 050860] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064713, R01GM050860] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Almogy G, 2001, BIOPHYS J, V81, P3016, DOI 10.1016/S0006-3495(01)75942-5; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Blat Y, 1998, J MOL BIOL, V284, P1191, DOI 10.1006/jmbi.1998.2224; Blat Y, 1996, BIOCHEMISTRY-US, V35, P5679, DOI 10.1021/bi9530447; Boesch KC, 2000, J BACTERIOL, V182, P3544, DOI 10.1128/JB.182.12.3544-3552.2000; Bourret RB, 2002, J BIOL CHEM, V277, P9625, DOI 10.1074/jbc.R100066200; Boxrud PD, 2000, J BIOL CHEM, V275, P14579, DOI 10.1074/jbc.275.19.14579; Cantwell BJ, 2003, J BACTERIOL, V185, P2354, DOI 10.1128/JB.185.7.2354-2361.2003; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Guhaniyogi J, 2006, J MOL BIOL, V359, P624, DOI 10.1016/j.jmb.2006.03.050; Hammarstrom P, 2001, BIOPHYS J, V80, P2867, DOI 10.1016/S0006-3495(01)76253-4; HESS JF, 1991, METHOD ENZYMOL, V200, P188; HUANG CX, 1993, BIOCHIM BIOPHYS ACTA, V1202, P297, DOI 10.1016/0167-4838(93)90019-N; Janin J, 1997, PROTEINS, V28, P153, DOI 10.1002/(SICI)1097-0134(199706)28:2<153::AID-PROT4>3.0.CO;2-G; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Lee SY, 2001, NAT STRUCT BIOL, V8, P52; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; Lipkow K, 2005, J BACTERIOL, V187, P45, DOI 10.1128/JB.187.1.45-53.2005; Lipkow K, 2006, PLOS COMPUT BIOL, V2, P301, DOI 10.1371/journal.pcbi.0020039; Lovdok L, 2007, J BIOTECHNOL, V129, P173, DOI 10.1016/j.jbiotec.2007.01.024; LUKAT GS, 1991, J BIOL CHEM, V266, P8348; LUKAT GS, 1990, BIOCHEMISTRY-US, V29, P5436, DOI 10.1021/bi00475a004; McEvoy MM, 1999, J MOL BIOL, V289, P1423, DOI 10.1006/jmbi.1999.2830; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Rao CV, 2005, PHYS BIOL, V2, P148, DOI 10.1088/1478-3975/2/3/002; RATHLEV T, 1956, ARCH BIOCHEM BIOPHYS, V65, P319, DOI 10.1016/0003-9861(56)90197-7; Sanna MG, 1996, J BIOL CHEM, V271, P7357, DOI 10.1074/jbc.271.13.7357; SANNA MG, 1995, MOL MICROBIOL, V15, P1069, DOI 10.1111/j.1365-2958.1995.tb02282.x; Sanna MG, 1996, J BACTERIOL, V178, P6275, DOI 10.1128/jb.178.21.6275-6280.1996; Scharf BE, 1998, J BACTERIOL, V180, P5123, DOI 10.1128/JB.180.19.5123-5128.1998; Sheridan R. C., 2007, INORG SYN, P23; Silversmith RE, 2005, BIOCHEMISTRY-US, V44, P7768, DOI 10.1021/bi0501636; Silversmith RE, 2003, J BACTERIOL, V185, P1495, DOI 10.1128/JB.185.5.1495-1502.2003; Silversmith RE, 2001, J BIOL CHEM, V276, P18478, DOI 10.1074/jbc.M011418200; Smith JG, 2004, MOL MICROBIOL, V51, P887, DOI 10.1046/j.1365-2958.2003.03882.x; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; STOCK AM, 1993, BIOCHEMISTRY-US, V32, P13375, DOI 10.1021/bi00212a001; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Thompson JR, 2005, BIOCHEMISTRY-US, V44, P5763, DOI 10.1021/bi047944b; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Vaknin A, 2004, P NATL ACAD SCI USA, V101, P17072, DOI 10.1073/pnas.0407812101; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Zhao R, 2002, NAT STRUCT BIOL, V9, P570	45	32	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					756	765		10.1074/jbc.M704400200	http://dx.doi.org/10.1074/jbc.M704400200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17998207	hybrid			2022-12-25	WOS:000252128100014
J	Xi, QR; He, W; Zhang, XHF; Le, HV; Massague, J				Xi, Qiaoran; He, Wei; Zhang, Xiang H. -F.; Le, Hong-Van; Massague, Joan			Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CELL-LINES; PLASMINOGEN-ACTIVATOR INHIBITOR; BREAST-CANCER; LUNG-CANCER; C-MYC; NUCLEOSOME DISRUPTION; MEDIATED REPRESSION; SNON ONCOPROTEIN; BINDING-PROTEINS; GENE-REGULATION	The transcription factors Smad2 and Smad3 mediate a large set of gene responses induced by the cytokine transforming growth factor beta(TGF beta), but the extent to which their function depends on chromatin remodeling remains to be defined. We observed interactions between these two Smads and BRG1, BAF250b, BAF170, and BAF155, which are core components of the SWI/SNF chromatin-remodeling complex. Smad2 and Smad3 have similar affinity for these components in vitro, and their interactions are primarily mediated by BRG1. In vivo, however, BRG1 predominantly interacts with Smad3, and this interaction is enhanced by TGF beta stimulation. Our results suggest that BRG1 is incorporated into transcriptional complexes that are formed by activated Smads in the nucleus, on target promoters. Using BRG1-deficient cell systems, we defined the BRG1 dependence of the TGF beta transcriptional program genome-wide. Most TGF beta gene responses in human epithelial cells are dependent on BRG1 function. Remarkably, BRG1 is not required for the TGF beta-mediated induction of SMAD7 and SNON, which encode key mediators of negative feedback in this pathway. Our results provide a genome-wide scope of the participation of BRG1 in TGF beta action and suggest a widespread yet differential involvement of BRG1 SWI/SNF remodeler in the transcriptional response of many genes to this cytokine.	[Xi, Qiaoran; He, Wei; Zhang, Xiang H. -F.; Le, Hong-Van; Massague, Joan] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Xi, Qiaoran; He, Wei; Zhang, Xiang H. -F.; Le, Hong-Van; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Box 116,1275 York Ave, New York, NY 10021 USA.	j-massague@ski.mskcc.org	Zhang, Xiang/B-1522-2008	Massague, Joan/0000-0001-9324-8408; Zhang, Xiang/0000-0002-5674-8670	NCI NIH HHS [R37 CA034610-26, P30 CA008748, R01 CA034610, R37 CA034610, CA34610] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748, R37CA034610, R01CA034610] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Farrants AKO, 1997, MOL CELL BIOL, V17, P895, DOI 10.1128/MCB.17.2.895; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Flaus A, 2004, CURR OPIN GENET DEV, V14, P165, DOI 10.1016/j.gde.2004.01.007; Fukuoka J, 2004, CLIN CANCER RES, V10, P4314, DOI 10.1158/1078-0432.CCR-03-0489; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hougaard S, 1999, BRIT J CANCER, V79, P1005, DOI 10.1038/sj.bjc.6690161; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; KESKIOJA J, 1988, J BIOL CHEM, V263, P3111; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; KORNBERG RD, 1974, SCIENCE, V184, P865, DOI 10.1126/science.184.4139.865; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Lin F, 2005, HUM MOL GENET, V14, P437, DOI 10.1093/hmg/ddi040; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Merlo GR, 2000, INT J DEV BIOL, V44, P619; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Mudhasani R, 2005, MOL IMMUNOL, V42, P673, DOI 10.1016/j.molimm.2004.09.021; Nagano Y, 2007, J BIOL CHEM, V282, P20492, DOI 10.1074/jbc.M701294200; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Osada H, 2001, CANCER RES, V61, P8331; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0; Reisman DN, 2003, CANCER RES, V63, P560; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; Ross S, 2006, EMBO J, V25, P4490, DOI 10.1038/sj.emboj.7601332; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Simone C, 2006, J CELL PHYSIOL, V207, P309, DOI 10.1002/jcp.20514; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Warner DR, 2003, FEBS LETT, V539, P167, DOI 10.1016/S0014-5793(03)00155-8; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06; Zhu QW, 2005, MOL CELL BIOL, V25, P10731, DOI 10.1128/MCB.25.24.10731-10744.2005	71	81	82	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1146	1155		10.1074/jbc.M707479200	http://dx.doi.org/10.1074/jbc.M707479200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18003620	hybrid, Green Accepted			2022-12-25	WOS:000252128100055
J	Li, HY; Huang, ZW; Gai, JY; Wu, S; Zeng, YR; Li, Q; Wu, RL				Li, Hongying; Huang, Zhongwen; Gai, Junyi; Wu, Song; Zeng, Yanru; Li, Qin; Wu, Rongling			A Conceptual Framework for Mapping Quantitative Trait Loci Regulating Ontogenetic Allometry	PLOS ONE			English	Article								Although ontogenetic changes in body shape and its associated allometry has been studied for over a century, essentially nothing is known about their underlying genetic and developmental mechanisms. One of the reasons for this ignorance is the unavailability of a conceptual framework to formulate the experimental design for data collection and statistical models for data analyses. We developed a framework model for unraveling the genetic machinery for ontogenetic changes of allometry. The model incorporates the mathematical aspects of ontogenetic growth and allometry into a maximum likelihood framework for quantitative trait locus (QTL) mapping. As a quantitative platform, the model allows for the testing of a number of biologically meaningful hypotheses to explore the pleiotropic basis of the QTL that regulate ontogeny and allometry. Simulation studies and real data analysis of a live example in soybean have been performed to investigate the statistical behavior of the model and validate its practical utilization. The statistical model proposed will help to study the genetic architecture of complex phenotypes and, therefore, gain better insights into the mechanistic regulation for developmental patterns and processes in organisms.	[Li, Hongying; Wu, Song; Li, Qin; Wu, Rongling] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [Huang, Zhongwen; Gai, Junyi] Nanjing Agr Univ, Natl Ctr Soybean Improvement, Nanjing, Jiangsu, Peoples R China; [Huang, Zhongwen] Henan Inst Sci & Technol, Dept Agron, Xinxiang, Henan, Peoples R China; [Zeng, Yanru] Zhejiang Forestry Univ, Sch Forestry & Biotechnol, Linan, Zhejiang, Peoples R China	State University System of Florida; University of Florida; Nanjing Agricultural University; Henan Institute of Science & Technology; Zhejiang A&F University	Wu, RL (corresponding author), Univ Florida, Dept Stat, Gainesville, FL 32611 USA.	sri@njau.edu.cn; rwu@stat.ufl.edu	tian, dong/G-5509-2011		Natural Science Foundation of China [30490250, 0540745]; National 973 Program [2002CB111304, 2004CB7206, 2006CB101708]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program(National Basic Research Program of China)	Funding: Natural Science Foundation of China (No. 30490250), the National 973 Program (2002CB111304, 2004CB7206 and 2006CB101708) and NSF grant (No. 0540745)	Banavar JR, 2002, P NATL ACAD SCI USA, V99, P10506, DOI 10.1073/pnas.162216899; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Breuker CJ, 2006, TRENDS ECOL EVOL, V21, P488, DOI 10.1016/j.tree.2006.06.003; Broman KW, 2002, J R STAT SOC B, V64, P641, DOI 10.1111/1467-9868.00354; Calder WA., 1984, SIZE FUNCTION LIFE H; CHURCHILL GA, 1994, GENETICS, V138, P963; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Frankino WA, 2005, SCIENCE, V307, P718, DOI 10.1126/science.1105409; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hou W, 2005, BIOSTATISTICS, V6, P420, DOI 10.1093/biostatistics/kxi019; Jiang CJ, 1997, GENETICA, V101, P47, DOI 10.1023/A:1018394410659; JIANG CJ, 1995, GENETICS, V140, P1111; Jin CF, 2007, J AM STAT ASSOC, V102, P56, DOI 10.1198/016214506000000834; Kao CH, 1999, GENETICS, V152, P1203; KLEIBER MAX, 1932, HILGARDIA, V6, P315; KLINGENBERG CP, 1992, AM NAT, V140, P601, DOI 10.1086/285430; Knott SA, 2000, GENETICS, V156, P899; Korol AB, 2001, GENETICS, V157, P1789; LANDER ES, 1989, GENETICS, V121, P185; Long F, 2006, GENET RES, V87, P207, DOI 10.1017/S0016672306008172; LOUIS TA, 1982, J ROY STAT SOC B MET, V44, P226; Lynch M., 1998, GENETICS ANAL QUANTI; Ma CX, 2003, J MATH BIOL, V47, P313, DOI 10.1007/s00285-003-0212-z; Ma CX, 2002, GENETICS, V161, P1751; Niklas K.J., 1994, PLANT ALLOMETRY SCAL; Niklas KJ, 2006, NEW PHYTOL, V171, P27, DOI 10.1111/j.1469-8137.2006.01760.x; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; Nunez-Anton V, 2000, BIOMETRICS, V56, P699, DOI 10.1111/j.0006-341X.2000.00699.x; Peter R. H, 1983, ECOLOGICAL IMPLICATI; Reis RE, 1998, COPEIA, P177, DOI 10.2307/1447715; Riisgard HU, 1998, ECOL LETT, V1, P71; Rohlf FJ, 1998, SYST BIOL, V47, P147, DOI 10.1080/106351598261094; Rombough P, 2003, NATURE, V424, P268, DOI 10.1038/424268a; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; SHAW RG, 1991, EVOLUTION, V45, P143, DOI 10.1111/j.1558-5646.1991.tb05273.x; Stern DL, 1999, DEVELOPMENT, V126, P1091; Vieira C, 2000, GENETICS, V154, P213; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 2005, J EXP BIOL, V208, P1575, DOI 10.1242/jeb.01589; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; Wu R., 2007, STAT GENETICS QUANTI; Wu R. L., 2006, Journal of Nanjing Forestry University (Natural Sciences Edition), V30, P1; Wu RL, 2006, NAT REV GENET, V7, P229, DOI 10.1038/nrg1804; Wu RL, 2006, GENETICS, V172, P627, DOI 10.1534/genetics.105.045310; Wu RL, 2004, GENETICS, V166, P1541, DOI 10.1534/genetics.166.3.1541; Wu RL, 2002, J THEOR BIOL, V217, P275; Yap JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000554; Yi NJ, 2007, GENETICS, V176, P1865, DOI 10.1534/genetics.107.071365; Yi NJ, 2005, GENETICS, V170, P1333, DOI 10.1534/genetics.104.040386; Zelditch ML, 1998, SYST BIOL, V47, P159, DOI 10.1080/106351598261102; ZELDITCH ML, 1995, J MORPHOL, V223, P341, DOI 10.1002/jmor.1052230309; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zhang WK, 2004, THEOR APPL GENET, V108, P1131, DOI 10.1007/s00122-003-1527-2; Zhao W, 2004, GENETICS, V168, P1751, DOI 10.1534/genetics.104.031484; Zimmerman DL, 2001, TEST-SPAIN, V10, P1, DOI 10.1007/BF02595823	64	18	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1245	10.1371/journal.pone.0001245	http://dx.doi.org/10.1371/journal.pone.0001245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043752	gold, Green Submitted, Green Published			2022-12-25	WOS:000207459300026
J	Niault, T; Hached, K; Sotillo, R; Sorger, PK; Maro, B; Benezra, R; Wassmann, K				Niault, Theodora; Hached, Khaled; Sotillo, Rocio; Sorger, Peter K.; Maro, Bernard; Benezra, Robert; Wassmann, Katja			Changing Mad2 Levels Affects Chromosome Segregation and Spindle Assembly Checkpoint Control in Female Mouse Meiosis I	PLOS ONE			English	Article								The spindle assembly checkpoint (SAC) ensures correct separation of sister chromatids in somatic cells and provokes a cell cycle arrest in metaphase if one chromatid is not correctly attached to the bipolar spindle. Prolonged metaphase arrest due to overexpression of Mad2 has been shown to be deleterious to the ensuing anaphase, leading to the generation of aneuploidies and tumorigenesis. Additionally, some SAC components are essential for correct timing of prometaphase. In meiosis, we and others have shown previously that the Mad2-dependent SAC is functional during the first meiotic division in mouse oocytes. Expression of a dominant-negative form of Mad2 interferes with the SAC in metaphase I, and a knock-down approach using RNA interference accelerates anaphase onset in meiosis I. To prove unambigiously the importance of SAC control for mammalian female meiosis I we analyzed oocyte maturation in Mad2 heterozygote mice, and in oocytes overexpressing a GFP-tagged version of Mad2. In this study we show for the first time that loss of one Mad2 allele, as well as overexpression of Mad2 lead to chromosome missegregation events in meiosis I, and therefore the generation of aneuploid metaphase II oocytes. Furthermore, SAC control is impaired in mad2+/- oocytes, also leading to the generation of aneuploidies in meiosis I.	[Niault, Theodora; Hached, Khaled; Maro, Bernard; Wassmann, Katja] CNRS, UMR Biol Dev 7622, Paris, France; [Niault, Theodora; Hached, Khaled; Maro, Bernard; Wassmann, Katja] Univ Paris 06, Paris, France; [Hached, Khaled; Wassmann, Katja] INSERM, Avenir Team, Cell Div & Associated Checkpoints, Paris, France; [Sotillo, Rocio; Benezra, Robert] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Sorger, Peter K.] MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA; [Sorger, Peter K.] MIT, Biol Engn Div, Cambridge, MA 02139 USA; [Sorger, Peter K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Maro, Bernard] Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, Ramat Aviv, Israel	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Memorial Sloan Kettering Cancer Center; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Tel Aviv University; Sackler Faculty of Medicine	Wassmann, K (corresponding author), CNRS, UMR Biol Dev 7622, Paris, France.	katja.wassmann@snv.jussieu.fr	Maro, Bernard/AAL-2220-2020	Wassmann, Katja/0000-0001-5442-5192; Sotillo, Rocio/0000-0002-0855-7917; Sorger, Peter/0000-0002-3364-1838; Hached, Khaled/0000-0003-1143-6929	CNRS; ARC [3571, 3356, 3883]; FRM; Programme Avenir (Inserm); PNRRE (Inserm);  [UMR7622]	CNRS(Centre National de la Recherche Scientifique (CNRS)); ARC(Australian Research Council); FRM(Fondation pour la Recherche Medicale); Programme Avenir (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); PNRRE (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); 	C. Jessus (UMR7622) provided lab space and funding. This work was supported by the CNRS, an ARC grant to C. Jessus (Nu 3571) and BM (Nu 3356), an ARC and an FRM postdoctoral fellowship to KW, and a Programme Avenir (Inserm), a PNRRE (Inserm), and an ARC grant (Nu 3883) to KW.	Brunet S, 1998, CURR BIOL, V8, P1231, DOI 10.1016/S0960-9822(07)00516-7; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Brunet S, 2003, REPRODUCTION, V126, P443, DOI 10.1530/rep.0.1260443; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Furuta T, 2000, MOL BIOL CELL, V11, P1401, DOI 10.1091/mbc.11.4.1401; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; Gorr IH, 2006, NAT CELL BIOL, V8, P1035, DOI 10.1038/ncb1467; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; He XW, 1997, P NATL ACAD SCI USA, V94, P7965, DOI 10.1073/pnas.94.15.7965; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Hodges CA, 2002, CHROMOSOMA, V111, P165, DOI 10.1007/s00412-002-0195-3; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Irniger S, 2006, CELL CYCLE, V5, P405, DOI 10.4161/cc.5.4.2476; KUBIAK JZ, 1992, J CELL SCI, V102, P457; Kudo NR, 2006, CELL, V126, P135, DOI 10.1016/j.cell.2006.05.033; Ledan E, 2001, DEV BIOL, V232, P400, DOI 10.1006/dbio.2001.0188; Lemaire-Adkins R, 1997, J CELL BIOL, V139, P1611, DOI 10.1083/jcb.139.7.1611; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Stemmann O, 2006, CELL CYCLE, V5, P11, DOI 10.4161/cc.5.1.2296; Steuerwald N, 2001, MOL HUM REPROD, V7, P49, DOI 10.1093/molehr/7.1.49; Terret ME, 2003, CURR BIOL, V13, P1797, DOI 10.1016/j.cub.2003.09.032; Tsurumi C, 2004, J CELL BIOL, V167, P1037, DOI 10.1083/jcb.200405165; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052	30	92	95	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1165	10.1371/journal.pone.0001165	http://dx.doi.org/10.1371/journal.pone.0001165			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043727	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459300001
J	Zhang, KL; Sridhar, VV; Zhu, JH; Kapoor, A; Zhu, JK				Zhang, Kangling; Sridhar, Vaniyambadi V.; Zhu, Jianhua; Kapoor, Avnish; Zhu, Jian-Kang			Distinctive Core Histone Post-Translational Modification Patterns in Arabidopsis thaliana	PLOS ONE			English	Article							DNA METHYLATION; UBIQUITINATION SITES; MASS-SPECTROMETRY; H3; ACETYLATION; CHROMATIN; IDENTIFICATION; VERNALIZATION; LYSINE-9; H2B	Post-translational modifications of histones play crucial roles in the genetic and epigenetic regulation of gene expression from chromatin. Studies in mammals and yeast have found conserved modifications at some residues of histones as well as non-conserved modifications at some other sites. Although plants have been excellent systems to study epigenetic regulation, and histone modifications are known to play critical roles, the histone modification sites and patterns in plants are poorly defined. In the present study we have used mass spectrometry in combination with high performance liquid chromatography (HPLC) separation and phospho-peptide enrichment to identify histone modification sites in the reference plant, Arabidopsis thaliana. We found not only modifications at many sites that are conserved in mammalian and yeast cells, but also modifications at many sites that are unique to plants. These unique modifications include H4 K20 acetylation (in contrast to H4 K20 methylation in non-plant systems), H2B K6, K11, K27 and K32 acetylation, S15 phosphorylation and K143 ubiquitination, and H2A K144 acetylation and S129, S141 and S145 phosphorylation, and H2A. X S138 phosphorylation. In addition, we found that lysine 79 of H3 which is highly conserved and modified by methylation and plays important roles in telomeric silencing in non-plant systems, is not modified in Arabidopsis. These results suggest distinctive histone modification patterns in plants and provide an invaluable foundation for future studies on histone modifications in plants.	[Zhang, Kangling] Loma Linda Univ, Sch Med, Mass Spectrometry Facil, Loma Linda, CA 92350 USA; [Sridhar, Vaniyambadi V.; Zhu, Jianhua; Kapoor, Avnish; Zhu, Jian-Kang] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA	Loma Linda University; University of California System; University of California Riverside	Zhang, KL (corresponding author), Loma Linda Univ, Sch Med, Mass Spectrometry Facil, Loma Linda, CA 92350 USA.	kzhang@llu.edu; jian-kang.zhu@ucr.edu	Zhu, Jian-Kang/F-7658-2011; Zhu, Jianhua/F-7127-2013	Zhu, Jian-Kang/0000-0001-5134-731X; 	NIH [R01GM070795]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070795] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH grant R01GM070795 to JKZ.	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Aihara H, 2004, GENE DEV, V18, P877, DOI 10.1101/gad.1184604; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Beck HC, 2006, MOL CELL PROTEOMICS, V5, P1314, DOI 10.1074/mcp.M600007-MCP200; Bender J, 2004, CURR OPIN PLANT BIOL, V7, P521, DOI 10.1016/j.pbi.2004.07.003; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Fleury D, 2007, PLANT CELL, V19, P417, DOI 10.1105/tpc.106.041319; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; GILBERT N, 2004, MOL CELL, V15, P844; Hatakeyama S, 2005, METHOD ENZYMOL, V399, P277, DOI 10.1016/S0076-6879(05)99019-8; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang GC, 2004, J CELL BIOCHEM, V93, P286, DOI 10.1002/jcb.20146; Johnson L, 2004, NUCLEIC ACIDS RES, V32, P6511, DOI 10.1093/nar/gkh992; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kaiser P, 2005, METHOD ENZYMOL, V399, P266, DOI 10.1016/S0076-6879(05)99018-6; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Liu YX, 2007, PLANT CELL, V19, P433, DOI 10.1105/tpc.106.049221; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MARVIN KW, 1990, J BIOL CHEM, V265, P19839; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Meluh PB, 1999, METHOD ENZYMOL, V304, P414; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; SCHOTTA G, 2006, GENE DEV, V18, P1251; Sridhar VV, 2007, NATURE, V447, P735, DOI 10.1038/nature05864; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; THORNE AW, 1990, EUR J BIOCHEM, V193, P701, DOI 10.1111/j.1432-1033.1990.tb19390.x; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; WATERBORG JH, 1987, ARCH BIOCHEM BIOPHYS, V256, P167, DOI 10.1016/0003-9861(87)90435-8; WATERBORG JH, 1992, BIOCHEMISTRY-US, V31, P6211, DOI 10.1021/bi00142a006; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Zhang KL, 2006, ANAL BIOCHEM, V357, P225, DOI 10.1016/j.ab.2006.07.001; Zhang KL, 2004, PROTEOMICS, V4, P3765, DOI 10.1002/pmic.200400819; Zhang KL, 2004, PROTEOMICS, V4, P1, DOI 10.1002/pmic.200300503; Zhang KL, 2002, ANAL BIOCHEM, V306, P259, DOI 10.1006/abio.2002.5719	51	169	176	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1210	10.1371/journal.pone.0001210	http://dx.doi.org/10.1371/journal.pone.0001210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030344	Green Submitted, gold, Green Published			2022-12-25	WOS:000207459200023
J	Han, X; Saito, H; Miki, Y; Nakanishi, A				Han, X.; Saito, H.; Miki, Y.; Nakanishi, A.			A CRM1-mediated nuclear export signal governs cytoplasmic localization of BRCA2 and is essential for centrosomal localization of BRCA2	ONCOGENE			English	Article						breast cancer; BRCA2; nuclear export; centrosome; leptomycin B; microinjection	SUSCEPTIBILITY GENE BRCA2; CANCER SUSCEPTIBILITY; NUCLEOCYTOPLASMIC TRANSPORT; PHOSPHORYLATION; PROTEIN; GENOME; CRM1	Germ-line mutations of the BRCA2 gene cause inherited susceptibility to breast and ovarian cancers. BRCA2 contains two nuclear localization signals, predominantly localizes in the nucleus and plays significant roles in DNA double-strand break repair. Recently, we reported that BRCA2 localizes to the centrosomes during the S and early M phases of the cell cycle. In this study, for the first time, we identified a functional nuclear export sequence (NES1; (1383)DLSDLTFLEVA(1393)) in BRCA2. The green fluorescent protein (GFP)-NES1 fusion protein was localized in the cytoplasm and could be blocked by the chromosomal region maintenance 1-specific export inhibitor leptomycin B. Mutation of a leucine residue in the NES1 motif to alanine (L1384A) resulted in both cytoplasmic and nuclear localization of the GFP-NES1 fusion protein and a nuclear accumulation of ectopic full-length BRCA2-FLAG. Moreover, treatment of cells with leptomycin B decreased centrosomal localization of BRCA2. Finally, by microinjection of an anti-BRCA2 antibody into the cytoplasm of HeLa S3 cells, we found that depletion of normal BRCA2 proteins in the cytoplasm leads to centrosome amplification and binucleated cells. Our results suggest that disruption of the NES function by genetic changes results in deregulation of BRCA2 export, which ultimately leads to centrosome disorder.	[Han, X.; Miki, Y.] Tokyo Med & Dent Univ, Dept Mol Genet, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan; [Han, X.] Yanbiann Univ, Coll Med, Dept Prevent Med, Yanji, Peoples R China; [Saito, H.; Miki, Y.; Nakanishi, A.] Japanese Fdn Canc Res, Inst Canc, Dept Genet Diag, Tokyo 170, Japan; [Nakanishi, A.] Univ Tokyo, Inst Med Sci, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Yanbian University; Japanese Foundation for Cancer Research; University of Tokyo	Miki, Y (corresponding author), Tokyo Med & Dent Univ, Dept Mol Genet, Med Res Inst, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	miki.mgen@mri.tmd.ac.jp						Bednenko J, 2003, TRAFFIC, V4, P127, DOI 10.1034/j.1600-0854.2003.00109.x; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Nakanishi A, 2007, BIOCHEM BIOPH RES CO, V355, P34, DOI 10.1016/j.bbrc.2007.01.100; Spain BH, 1999, P NATL ACAD SCI USA, V96, P13920, DOI 10.1073/pnas.96.24.13920; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Thompson ME, 2005, J BIOL CHEM, V280, P21854, DOI 10.1074/jbc.M502676200; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Wu KJ, 2005, CANCER RES, V65, P417; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Yano K, 2000, BIOCHEM BIOPH RES CO, V270, P171, DOI 10.1006/bbrc.2000.2392; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	21	32	32	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 8	2008	27	21					2969	2977		10.1038/sj.onc.1210968	http://dx.doi.org/10.1038/sj.onc.1210968			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	298IP	18059333				2022-12-25	WOS:000255681700004
J	Kralova, J; Dvorak, M; Koc, M; Kral, V				Kralova, J.; Dvorak, M.; Koc, M.; Kral, V.			p38 MAPK plays an essential role in apoptosis induced by photoactivation of a novel ethylene glycol porphyrin derivative	ONCOGENE			English	Article						porphyrin; photoactivation; apoptosis; p38 MAPK; caspase; lysosome	CYTOCHROME-C RELEASE; ACTIVATED PROTEIN-KINASE; MITOCHONDRIAL PERMEABILITY TRANSITION; MEDIATED PHOTODYNAMIC THERAPY; SIGNAL-REGULATED KINASE; CARCINOMA A431 CELLS; BID CLEAVAGE; SUBCELLULAR-LOCALIZATION; BCL-2 PHOSPHORYLATION; LYSOSOMAL PHOTODAMAGE	In this study, we provide evidence that photostimulation of various cancer cells preloaded with a new photosensitizing compound, tetrakis-meso-(4-ethyleneglycol- 2,3,5,6-tetra. fluorophenyl) porphyrin (PORF-TEG), results in rapid activation of the cell death machinery. PORF-TEG, although primarily localized in lysosomes, induces mitochondria-driven apoptosis. The induction of apoptosis is accompanied by immediate and sustained activation of p38 mitogen-activated protein kinase (MAPK) and transient activation of c-Jun N-terminal kinase (JNK). Conversely, the inhibition of p38 by PD 169316 or SB202190 and by the p38a dominant-negative mutant as well as the deletion of the p38a gene (MEFs-KO) protected cells from apoptosis, whereas inhibition of JNK did not. Activation of the p38 signaling pathway occurs upstream of caspase activation. In addition, preincubation of cells with scavengers of reactive oxygen species attenuated p38 and caspase activation and increased cell survival, thus connecting reactive oxygen species formation with the activation of the p38 pathway. Later events included degradation of Bcl-2, activation of tBid, and cleavage of Bad and Mcl-1. The data suggest a key role for p38 MAPK in PORF-TEG-photoinduced apoptosis.	[Kralova, J.; Dvorak, M.; Koc, M.] Acad Sci Czech Republic, Inst Mol Genet, Dept Mol Virol, CR-14220 Prague 4, Czech Republic; [Kral, V.] Inst Chem Technol, Dept Analyt Chem, CR-16628 Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of Chemistry & Technology, Prague	Kralova, J (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Dept Mol Virol, Videnska 1083, CR-14220 Prague 4, Czech Republic.	kralova@img.cas.cz	Dvorak, Michal/G-5861-2014; Kral, Vladimir/I-9518-2017; Dvořák, Michal/I-9939-2014; Kralova, Jarmila/G-3834-2014; Koc, Michal/D-1234-2014	Kral, Vladimir/0000-0001-5034-4184; Kralova, Jarmila/0000-0002-4735-8857; Koc, Michal/0000-0003-0928-4196				Ahmad N, 2000, J INVEST DERMATOL, V115, P1041, DOI 10.1046/j.1523-1747.2000.00147.x; Almeida RD, 2004, BBA-REV CANCER, V1704, P59, DOI 10.1016/j.bbcan.2004.05.003; Assefa Z, 1999, J BIOL CHEM, V274, P8788, DOI 10.1074/jbc.274.13.8788; Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; Callsen D, 1999, BIOCHEMISTRY-US, V38, P2279, DOI 10.1021/bi982292a; Condorelli F, 2001, MOL CELL BIOL, V21, P3025, DOI 10.1128/MCB.21.9.3025-3036.2001; De Chiara G, 2006, J BIOL CHEM, V281, P21353, DOI 10.1074/jbc.M511052200; Granville DJ, 1998, FEBS LETT, V437, P5, DOI 10.1016/S0014-5793(98)01193-4; Granville DJ, 1999, BRIT J CANCER, V79, P95, DOI 10.1038/sj.bjc.6690017; He J, 1996, PHOTOCHEM PHOTOBIOL, V64, P845, DOI 10.1111/j.1751-1097.1996.tb01845.x; HENDERSON BW, 1992, PHOTOCHEM PHOTOBIOL, V55, P145, DOI 10.1111/j.1751-1097.1992.tb04222.x; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hishita T, 2001, CANCER RES, V61, P2878; Hsieh YJ, 2003, J CELL PHYSIOL, V194, P363, DOI 10.1002/jcp.10273; Ichinose S, 2006, INT J ONCOL, V29, P349; Ishisaka R, 2001, J BIOCHEM-TOKYO, V129, P35, DOI 10.1093/oxfordjournals.jbchem.a002833; Kagedal K, 2001, BIOCHEM J, V359, P335, DOI 10.1042/0264-6021:3590335; Kessel D, 2000, PHOTOCHEM PHOTOBIOL, V71, P196, DOI 10.1562/0031-8655(2000)071<0196:DOTART>2.0.CO;2; Kessel D, 2002, PHOTOCH PHOTOBIO SCI, V1, P837, DOI 10.1039/b206046a; Kessel D, 1997, PHOTOCHEM PHOTOBIOL, V65, P422, DOI 10.1111/j.1751-1097.1997.tb08581.x; Kim TH, 2000, J BIOL CHEM, V275, P39474, DOI 10.1074/jbc.M003370200; Klotz LO, 1998, CANCER RES, V58, P4297; Kralova J, 2003, J MED CHEM, V46, P2049, DOI 10.1021/jm021060d; Lavie G, 1999, BRIT J CANCER, V79, P423, DOI 10.1038/sj.bjc.6690066; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Matroule JY, 2001, ONCOGENE, V20, P4070, DOI 10.1038/sj.onc.1204546; Oh SH, 2004, TOXICOL APPL PHARM, V194, P221, DOI 10.1016/j.taap.2003.09.011; Oleinick NL, 2002, PHOTOCH PHOTOBIO SCI, V1, P1, DOI 10.1039/b108586g; OLLINGER K, 1995, FREE RADICAL BIO MED, V19, P565, DOI 10.1016/0891-5849(95)00062-3; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Reiners JJ, 2002, CELL DEATH DIFFER, V9, P934, DOI 10.1038/sj.cdd.4401048; Rosini P, 2000, BIOCHEM BIOPH RES CO, V278, P753, DOI 10.1006/bbrc.2000.3871; Saczko J, 2007, FOLIA BIOL-PRAGUE, V53, P7; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P577, DOI 10.1073/pnas.97.2.577; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Tao JS, 1996, J BIOL CHEM, V271, P27107, DOI 10.1074/jbc.271.43.27107; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tong ZM, 2003, J PHOTOCH PHOTOBIO B, V71, P77, DOI 10.1016/j.jphotobiol.2003.08.001; Tong ZM, 2002, CANCER RES, V62, P5528; Usuda J, 2003, J BIOL CHEM, V278, P2021, DOI 10.1074/jbc.M205219200; Van Cruchten S, 2002, ANAT HISTOL EMBRYOL, V31, P214, DOI 10.1046/j.1439-0264.2002.00398.x; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Xue LY, 1999, CELL DEATH DIFFER, V6, P855, DOI 10.1038/sj.cdd.4400558; Yin L, 2005, J CELL BIOCHEM, V94, P433, DOI 10.1002/jcb.20277; Yu WP, 2001, CANCER RES, V61, P6569; Zang Y, 2001, CELL DEATH DIFFER, V8, P477, DOI 10.1038/sj.cdd.4400843; Zhai DY, 2000, FEBS LETT, V472, P293, DOI 10.1016/S0014-5793(00)01471-X; Zhuang SG, 2000, J BIOL CHEM, V275, P25939, DOI 10.1074/jbc.M001185200	48	50	51	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 8	2008	27	21					3010	3020		10.1038/sj.onc.1210960	http://dx.doi.org/10.1038/sj.onc.1210960			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	298IP	18059338				2022-12-25	WOS:000255681700008
J	David, HN; Haelewyn, B; Rouillon, C; Lecoq, M; Chazalviel, L; Apiou, G; Risso, JJ; Lemaire, M; Abraini, JH				David, Helene N.; Haelewyn, Benoit; Rouillon, Christophe; Lecoq, Myriam; Chazalviel, Laurent; Apiou, Gabriela; Risso, Jean-Jacques; Lemaire, Marc; Abraini, Jacques H.			Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia	FASEB JOURNAL			English	Article						oxygen-glucose deprivation; N-methyl-D-aspartate; neurotoxicity; dopamine release; lactate dehydrogenase; neurological outcome	BRAIN BLOOD-FLOW; NITROUS-OXIDE; CARDIOPULMONARY BYPASS; GLUCOSE DEPRIVATION; CHANNEL BLOCKERS; NEURONAL INJURY; NMDA ANTAGONIST; CELL-CULTURE; SHORT-TERM; MEMANTINE	Brain insults are a major cause of acute mortality and chronic morbidity. Given the largely ineffective current therapeutic strategies, the development of new and efficient therapeutic interventions is clearly needed. A series of previous investigations has shown that the noble and anesthetic gas xenon, which has low-affinity antagonistic properties at the N-methyl-D-aspartate (NMDA) receptor, also exhibits potentially neuroprotective properties with no proven adverse side effects. Surprisingly and in contrast with most drugs that are being developed as therapeutic agents, the dose-response neuroprotective effect of xenon has been poorly studied, although this effect could be of major critical importance for its clinical development as a neuroprotectant. Here we show, using ex vivo and in vivo models of excitotoxic insults and transient brain ischemia, that xenon, administered at subanesthetic doses, offers global neuroprotection from reduction of neurotransmitter release induced by ischemia, a critical event known to be involved in excitotoxicity, to reduction of subsequent cell injury and neuronal death. Maximal neuroprotection was obtained with xenon at 50 vol%, a concentration at which xenon further exhibited significant neuroprotective effects in vivo even when administered up to 4 h after intrastriatal NMDA injection and up to at least 2 h after induction of transient brain ischemia.	[Rouillon, Christophe; Lecoq, Myriam; Chazalviel, Laurent; Abraini, Jacques H.] Univ Caen, CNRS, Ctr CYCERON, UMR 6185, F-14074 Caen, France; [David, Helene N.; Haelewyn, Benoit; Abraini, Jacques H.] NNOXe Pharmaceut, Quebec City, PQ, Canada; [Apiou, Gabriela; Lemaire, Marc] Ctr Rech Claude Delorme, Les Loges En Josas, France; [Risso, Jean-Jacques] Inst Med Navale, Serv Sante Armees, Toulon, France	Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie	Abraini, JH (corresponding author), Univ Caen, CNRS, Ctr CYCERON, UMR 6185, BP 5229,Blvd Becquerel, F-14074 Caen, France.	abraini@cyceron.fr						Abraini JH, 2005, ANN NY ACAD SCI, V1053, P289, DOI 10.1196/annals.1344.025; Arrowsmith JE, 1998, STROKE, V29, P2357, DOI 10.1161/01.STR.29.11.2357; Bresink I, 1996, BRIT J PHARMACOL, V119, P195, DOI 10.1111/j.1476-5381.1996.tb15971.x; Colloc'h N, 2007, BIOPHYS J, V92, P217, DOI 10.1529/biophysj.106.093807; CULLEN SC, 1969, ANESTHESIOLOGY, V31, P305, DOI 10.1097/00000542-196910000-00003; David HN, 2006, BIOL PSYCHIAT, V60, P49, DOI 10.1016/j.biopsych.2005.10.007; David HN, 2003, J CEREBR BLOOD F MET, V23, P1168, DOI 10.1097/01.WCB.0000087342.31689.18; Davis SM, 2000, STROKE, V31, P347, DOI 10.1161/01.STR.31.2.347; DESHPANDE SS, 1995, ARCH TOXICOL, V69, P384, DOI 10.1007/s002040050188; Dingley J, 2006, STROKE, V37, P501, DOI 10.1161/01.STR.0000198867.31134.ac; Dinse A, 2005, BRIT J ANAESTH, V94, P479, DOI 10.1093/bja/aei080; Endres M, 2002, ADV EXP MED BIOL, V513, P455; FERRER I, 1995, ACTA NEUROPATHOL, V90, P504; Fisher CM, 1998, NEUROLOGY, V50, P841; Frietsch T, 2001, ANESTHESIOLOGY, V94, P290, DOI 10.1097/00000542-200102000-00019; GEMBA T, 1994, NEUROSCIENCE, V63, P789, DOI 10.1016/0306-4522(94)90523-1; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Goto T, 1998, BRIT J ANAESTH, V80, P255, DOI 10.1093/bja/80.2.255; Goto T, 2000, ANESTHESIOLOGY, V93, P1188, DOI 10.1097/00000542-200011000-00009; Gruss M, 2004, MOL PHARMACOL, V65, P443, DOI 10.1124/mol.65.2.443; HAELEWYN B, 2007, IN PRESS J NEUROSCI; Henninger N, 2006, EXP NEUROL, V201, P316, DOI 10.1016/j.expneurol.2006.04.011; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Homi HM, 2003, ANESTHESIOLOGY, V99, P876, DOI 10.1097/00000542-200310000-00020; Jevtovic-Todorovic V, 1998, NAT MED, V4, P460, DOI 10.1038/nm0498-460; KIM KW, 1995, CLIN EXP PHARMACOL P, V22, P301, DOI 10.1111/j.1440-1681.1995.tb02003.x; Koblin DD, 1998, ANESTH ANALG, V87, P419, DOI 10.1097/00000539-199808000-00035; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Kollmar R, 2007, STROKE, V38, P1585, DOI 10.1161/STROKEAHA.106.475897; Konstas AA, 2006, NEUROCRIT CARE, V4, P168, DOI 10.1385/NCC:4:2:168; Ma D, 2002, BRIT J ANAESTH, V89, P739, DOI 10.1093/bja/aef258; Ma DQ, 2006, J CEREBR BLOOD F MET, V26, P199, DOI 10.1038/sj.jcbfm.9600184; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Ma DQ, 2003, ANESTHESIOLOGY, V98, P690, DOI 10.1097/00000542-200303000-00017; McCarran WJ, 2007, J NEUROSCI, V27, P4220, DOI 10.1523/JNEUROSCI.5542-06.2007; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1989, BRAIN RES, V483, P347, DOI 10.1016/0006-8993(89)90179-0; Nagata A, 2001, ANESTH ANALG, V92, P362, DOI 10.1213/00000539-200102000-00016; Natale G, 2006, ANN NY ACAD SCI, V1074, P650, DOI 10.1196/annals.1369.063; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; OLNEY JW, 1991, SCIENCE, V254, P1515, DOI 10.1126/science.1835799; Palmer GC, 2000, AMINO ACIDS, V19, P151, DOI 10.1007/s007260070043; Parsons CG, 1999, NEUROPHARMACOLOGY, V38, P735, DOI 10.1016/S0028-3908(99)00019-2; Parsons CG, 1998, DRUG NEWS PERSPECT, V11, P523, DOI 10.1358/dnp.1998.11.9.863689; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petzelt C, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-55; Petzelt C, 2003, LIFE SCI, V72, P1909, DOI 10.1016/S0024-3205(02)02439-6; PORTER RHP, 1995, J NEUROCHEM, V64, P614; PRIESTLEY T, 1990, BRAIN RES, V531, P183, DOI 10.1016/0006-8993(90)90772-4; ROGAWSKI MA, 1993, TRENDS PHARMACOL SCI, V14, P325, DOI 10.1016/0165-6147(93)90005-5; Schmidt M, 2001, ANAESTHESIA, V56, P1154, DOI 10.1046/j.1365-2044.2001.02322.x; Sobrado M, 2004, NEUROSCI LETT, V365, P132, DOI 10.1016/j.neulet.2004.04.067; Wilhelm S, 2002, ANESTHESIOLOGY, V96, P1485, DOI 10.1097/00000542-200206000-00031; Yamakura T, 2000, ANESTHESIOLOGY, V93, P1095, DOI 10.1097/00000542-200010000-00034; YAO LP, 1992, STROKE, V23, P69, DOI 10.1161/01.STR.23.1.69; YAO LP, 1992, J NEUROSURG ANESTH, V4, P268, DOI 10.1097/00008506-199210000-00007; Zhou M, 2006, J NEUROSCI, V26, P2956, DOI 10.1523/JNEUROSCI.4299-05.2006	57	92	101	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2008	22	4					1275	1286		10.1096/fj.07-9420com	http://dx.doi.org/10.1096/fj.07-9420com			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	18024836				2022-12-25	WOS:000254581000032
J	Alvarez, VE; Kosec, G; Anna, CS; Turk, V; Cazzulo, JJ; Turk, B				Alvarez, Vanina E.; Kosec, Gregor; Anna, Celso Sant; Turk, Vito; Cazzulo, Juan J.; Turk, Boris			Autophagy is involved in nutritional stress response and differentiation in Trypanosoma cruzi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; MAMMALIAN AUTOPHAGY; MOLECULAR MACHINERY; TARGETING PATHWAY; PROTEINS; CYSTEINE; YEAST; CYTOPLASM; VACUOLE; INHIBITORS	Autophagy is the major mechanism used by eukaryotic cells to degrade and recycle proteins and organelles. Bioinformatics analysis of the genome of the protozoan parasite Trypanosoma cruzi revealed the presence of all components of the Atg8 conjugation system, whereas Atg12, Atg5, and Atg10 as the major components of the Atg12 pathway could not be identified. The two TcATG4 (autophagin) homologs present in the genome were found to correctly process the two ATG8 homologs after the conserved Gly residue. Functional studies revealed that both ATG4 homologues but only one T. cruzi ATG8 homolog (TcATG8.1) complemented yeast deletion strains. During starvation of the parasite, TcAtg8.1, but not TcAtg8.2, was found by immunofluorescence to be located in autophagosome-like vesicles. This confirms its function as an Atg8/LC3 homolog and its potential to be used as an autophagosomal marker. Most importantly, autophagy is involved in differentiation between developmental stages of T. cruzi, a process that is essential for parasite maintenance and survival. These findings suggest that the autophagy pathway could represent a target for a novel chemotherapeutic strategy against Chagas disease.	[Kosec, Gregor; Turk, Vito; Turk, Boris] Univ Ljubljana, Jozef Stefan Inst, SI-1000 Ljubljana, Slovenia; [Alvarez, Vanina E.; Cazzulo, Juan J.] Univ Nacl San Martin, Consejo Nacl Invest Cient & Tecn, IIB INTECH, Buenos Aires, DF, Argentina; [Anna, Celso Sant] Univ Fed Rio de Janeiro, Lab Ultrastrutura Celular Hertha Meyer, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, RJ, Brazil; [Kosec, Gregor; Turk, Vito; Turk, Boris] Univ Ljubljana, Jozef Stefan Inst, Dept Biol Mol Biol & Struct Biol, SL-1000 Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade Federal do Rio de Janeiro; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana	Turk, B (corresponding author), Univ Ljubljana, Jozef Stefan Inst, SI-1000 Ljubljana, Slovenia.	boris.turk@ijs.si		Alvarez, Vanina/0000-0002-9890-6980; Turk, Boris/0000-0002-9007-5764				Abeliovich H, 2000, J CELL BIOL, V151, P1025, DOI 10.1083/jcb.151.5.1025; AMEISEN JC, 1995, CELL DEATH DIFFER, V2, P285; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Besteiro S, 2006, J BIOL CHEM, V281, P11384, DOI 10.1074/jbc.M512307200; Braga MV, 2006, FEMS MICROBIOL LETT, V256, P209, DOI 10.1111/j.1574-6968.2006.00125.x; Cazzulo Juan Jose, 2002, Current Topics in Medicinal Chemistry, V2, P1261, DOI 10.2174/1568026023392995; Chiari E., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P23; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; DECAZZULO BMF, 1994, FEMS MICROBIOL LETT, V124, P81; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; ESTEVES MG, 1989, FEMS MICROBIOL LETT, V59, P31; Figueiredo RCBQ, 2000, J PARASITOL, V86, P1213, DOI 10.1645/0022-3395(2000)086[1213:DOTCEM]2.0.CO;2; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gonzalez J, 1996, J EXP MED, V184, P1909, DOI 10.1084/jem.184.5.1909; Harding TM, 1996, J BIOL CHEM, V271, P17621, DOI 10.1074/jbc.271.30.17621; HARTH G, 1993, MOL BIOCHEM PARASIT, V58, P17, DOI 10.1016/0166-6851(93)90086-D; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Ketelaar T, 2004, FEBS LETT, V567, P302, DOI 10.1016/j.febslet.2004.04.088; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; Kosec G, 2006, MOL BIOCHEM PARASIT, V145, P18, DOI 10.1016/j.molbiopara.2005.09.001; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; MartinezCalvillo S, 1997, GENE, V199, P71, DOI 10.1016/S0378-1119(97)00348-X; Melo RL, 2001, ANAL BIOCHEM, V293, P71, DOI 10.1006/abio.2001.5115; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Parussini F, 2003, MOL BIOCHEM PARASIT, V131, P11, DOI 10.1016/S0166-6851(03)00175-0; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Rigden DJ, 2005, BIOCHEM SOC T, V33, P972, DOI 10.1042/BST20050972; SAMBROOK J, 1989, MOL CLONING, V2, P9; Santa-Rita RM, 2005, J ANTIMICROB CHEMOTH, V55, P780, DOI 10.1093/jac/dki087; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Selzer PM, 1999, P NATL ACAD SCI USA, V96, P11015, DOI 10.1073/pnas.96.20.11015; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sugawara K, 2005, J BIOL CHEM, V280, P40058, DOI 10.1074/jbc.M509158200; SYLVESTER D, 1976, COMP BIOCHEM PHYS B, V55, P443, DOI 10.1016/0305-0491(76)90318-7; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tomas AM, 1997, EUR J BIOCHEM, V244, P596, DOI 10.1111/j.1432-1033.1997.t01-1-00596.x; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Williams RA, 2006, MOL MICROBIOL, V61, P655, DOI 10.1111/j.1365-2958.2006.05274.x; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zingales B, 1997, MEM I OSWALDO CRUZ, V92, P811, DOI 10.1590/S0074-02761997000600016	56	116	122	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3454	3464		10.1074/jbc.M708474200	http://dx.doi.org/10.1074/jbc.M708474200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18039653	hybrid			2022-12-25	WOS:000253083000051
J	Cremades, N; Bueno, M; Neira, JL; Velazquez-Campoy, A; Sancho, J				Cremades, Nunilo; Bueno, Marta; Neira, Jose Luis; Velazquez-Campoy, Adrian; Sancho, Javier			Conformational stability of Helicobacter pylori flavodoxin - Fit to function at pH 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESULFOVIBRIO-DESULFURICANS FLAVODOXIN; STUDYING TRANSLATIONAL DIFFUSION; MOLTEN GLOBULE INTERMEDIATE; NUCLEAR-MAGNETIC-RESONANCE; FOLDING INTERMEDIATE; PROTEIN STABILITY; ALPHA-HELICES; FMN BINDING; APOFLAVODOXIN; ACID	Flavodoxin is an essential protein for Helicobacter pylori, a pathogen living in the very acidic environment of the gastric tract and responsible for several diseases. We report the conformational stability of the protein in neutral and acidic pH. The apoprotein remains native between pH 12 and 5 and adopts a monomeric molten globule conformation at more acidic pH values. The equilibrium unfolding in urea appears two-state for either conformation, but the native one coexists with a hidden equilibrium intermediate of very similar properties. The stability of H. pylori apoflavodoxin is higher than that of the Anabaena homologue throughout the entire pH interval, which may be related to better charge compensation. H. pylori apoflavodoxin is strongly stabilized by its FMN cofactor. A global analysis of apo- and holoflavodoxin equilibrium unfolding, with and without excess FMN, indicates that the cofactor only binds to the native state. Some physical-chemical properties of the protein may represent an adaptation to the acidic environment. Unlike the apoflavodoxin from Anabaena, which becomes highly insoluble at pH 5.0, that from H. pylori remains soluble to at least 40 mu M. This fact, together with the high stability of the apoprotein at this low pH that can arise in the bacteria cytoplasm, seems useful to allow newly synthesized apoflavodoxin molecules to fold and remain soluble to accomplish cofactor binding, which in turn increases the stability. Also, whenever the cytoplasmic pH drops to 5, preexisting flavodoxin molecules will remain folded and soluble and will retain the FMN cofactor, thus remaining functional.	[Cremades, Nunilo; Bueno, Marta; Neira, Jose Luis; Velazquez-Campoy, Adrian; Sancho, Javier] Univ Zaragoza, Fac Ciencias, Biocomp & Complex Syst Phys Inst, E-50009 Zaragoza, Spain; [Cremades, Nunilo; Bueno, Marta; Sancho, Javier] Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain; [Neira, Jose Luis] Univ Miguel Hernandez, Inst Biol Mol & Celular, Alicante 03202, Spain	University of Zaragoza; University of Zaragoza; Universidad Miguel Hernandez de Elche	Sancho, J (corresponding author), Univ Zaragoza, Fac Ciencias, Biocomp & Complex Syst Phys Inst, E-50009 Zaragoza, Spain.	jsancho@unizar.es	Sancho, javier/AAA-1225-2019; Cremades, Nunilo/F-9634-2015; Neira, Jose/ABF-4210-2021; Velazquez-Campoy, Adrian/E-7946-2012; Bueno, Marta/GXM-7181-2022	Sancho, javier/0000-0002-2879-9200; Cremades, Nunilo/0000-0002-9138-6687; Velazquez-Campoy, Adrian/0000-0001-5702-4538; Bueno, Marta/0000-0001-7140-9899; Neira, Jose Luis/0000-0002-4933-0428				Apiyo D, 2002, PROTEIN SCI, V11, P1129, DOI 10.1110/ps.3840102; Apiyo D, 2000, BBA-PROTEIN STRUCT M, V1479, P214, DOI 10.1016/S0167-4838(00)00032-7; BARTIK K, 1994, BIOPHYS J, V66, P1180, DOI 10.1016/S0006-3495(94)80900-2; BLASER MJ, 1992, GASTROENTEROLOGY, V102, P720, DOI 10.1016/0016-5085(92)90126-J; Bollen YJM, 2006, P NATL ACAD SCI USA, V103, P4095, DOI 10.1073/pnas.0509133103; Bollen YJM, 2005, J BIOL CHEM, V280, P7836, DOI 10.1074/jbc.M412871200; BYCHKOVA VE, 1988, FEBS LETT, V238, P231, DOI 10.1016/0014-5793(88)80485-X; Campos LA, 2006, PROTEINS, V63, P581, DOI 10.1002/prot.20855; Campos LA, 2004, J MOL BIOL, V344, P239, DOI 10.1016/j.jmb.2004.08.081; CANTOR CR, 1980, BIOPHYSICAL CHEM 2, P452; CAVANAGH JF, 1996, PROTEIN NMR SPECTROS, P31; Creighton T. E., 1993, PROTEINS STRUCTURES, P141; Cremades N, 2005, BIOPHYS CHEM, V115, P267, DOI 10.1016/j.bpc.2004.12.045; CREMADES N, 2007, BIOCHEMISTRY    1221; Cremades N, 2006, TRENDS BIOCHEM SCI, V31, P494, DOI 10.1016/j.tibs.2006.07.001; Devi VS, 2006, BIOCHEMISTRY-US, V45, P1599, DOI 10.1021/bi052352u; Dubey VK, 2003, BIOCHEMISTRY-US, V42, P12287, DOI 10.1021/bi035047m; EDMONDSON DE, 1971, BIOCHEMISTRY-US, V10, P124; FernandezRecio J, 1997, J MOL BIOL, V267, P184, DOI 10.1006/jmbi.1996.0831; FERRERO R L, 1991, Microbial Ecology in Health and Disease, V4, P121; Freigang J, 2002, PROTEIN SCI, V11, P253, DOI 10.1110/ps.28602; Freire E, 1998, ADV PROTEIN CHEM, V51, P255; Genzor CG, 1996, NAT STRUCT BIOL, V3, P329, DOI 10.1038/nsb0496-329; Genzor CG, 1996, PROTEIN SCI, V5, P1376, DOI 10.1002/pro.5560050716; GOTO Y, 1990, P NATL ACAD SCI USA, V87, P573, DOI 10.1073/pnas.87.2.573; Hammarstrom P, 1999, J BIOL CHEM, V274, P32897, DOI 10.1074/jbc.274.46.32897; HUGHES NJ, 1995, J BACTERIOL, V177, P3953, DOI 10.1128/jb.177.14.3953-3959.1995; Irun MP, 2001, PROTEIN ENG, V14, P173, DOI 10.1093/protein/14.3.173; Lapham J, 1997, J BIOMOL NMR, V10, P255, DOI 10.1023/A:1018310702909; LOEWENTHAL R, 1992, J MOL BIOL, V224, P759, DOI 10.1016/0022-2836(92)90560-7; Lopez-Llano J, 2006, J MOL BIOL, V356, P354, DOI 10.1016/j.jmb.2005.10.086; Lopez-Llano J, 2004, J BIOL CHEM, V279, P47177, DOI 10.1074/jbc.M405792200; Maldonado S, 2002, PROTEIN SCI, V11, P1260, DOI 10.1110/ps.2980102; Maldonado S, 1998, BIOCHEMISTRY-US, V37, P10589, DOI 10.1021/bi980368x; MARSHALL BJ, 1990, GASTROENTEROLOGY, V99, P697, DOI 10.1016/0016-5085(90)90957-3; Martinez-Julvez M, 2007, PROTEINS, V69, P581, DOI 10.1002/prot.21410; MATTHEW JB, 1985, CRC CR REV BIOCH MOL, V18, P91, DOI 10.3109/10409238509085133; Muraidhara BK, 2005, BBA-PROTEINS PROTEOM, V1747, P239, DOI 10.1016/j.bbapap.2004.11.012; Muralidhara BK, 2004, BIOCHEMISTRY-US, V43, P12855, DOI 10.1021/bi048944e; Naseem F, 2004, BBA-PROTEINS PROTEOM, V1699, P191, DOI 10.1016/j.bbapap.2004.02.011; Nuallain BO, 2002, EUR J BIOCHEM, V269, P212, DOI 10.1046/j.0014-2956.2002.02637.x; Pace C N, 1986, Methods Enzymol, V131, P266; Pan H, 1997, PROTEIN SCI, V6, P1985, DOI 10.1002/pro.5560060919; Park SJ, 2004, J BIOCHEM, V135, P337, DOI 10.1093/jb/mvh041; PARSONNET J, 1995, ALIMENT PHARM THERAP, V9, P45; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Price WS, 1997, CONCEPT MAGNETIC RES, V9, P299, DOI 10.1002/(SICI)1099-0534(1997)9:5<299::AID-CMR2>3.3.CO;2-2; Price WS, 1998, CONCEPT MAGNETIC RES, V10, P197, DOI 10.1002/(SICI)1099-0534(1998)10:4<197::AID-CMR1>3.0.CO;2-S; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; PTITSYN OB, 1987, J PROTEIN CHEM, V6, P273; RAO ST, 1992, PROTEIN SCI, V1, P1413, DOI 10.1002/pro.5560011103; Saeki K, 2004, J MOL BIOL, V341, P589, DOI 10.1016/j.jmb.2004.06.010; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; SANCHO J, 1992, BIOCHEMISTRY-US, V31, P2253, DOI 10.1021/bi00123a006; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schaefer M, 1998, ADV PROTEIN CHEM, V51, P1; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Shortle D, 1999, NAT STRUCT BIOL, V6, P203, DOI 10.1038/6640; St Maurice M, 2007, J BACTERIOL, V189, P4764, DOI 10.1128/JB.00287-07; Stingl K, 2002, J BACTERIOL, V184, P3053, DOI 10.1128/JB.184.11.3053-3060.2002; Stingl K, 2002, TRENDS MICROBIOL, V10, P70, DOI 10.1016/S0966-842X(01)02287-9; Sutovsky H, 2004, J BIOL CHEM, V279, P17190, DOI 10.1074/jbc.M311225200; SVENSSON M, 1995, BIOCHEMISTRY-US, V34, P8606, DOI 10.1021/bi00027a010; Van Der Goot Francoise G., 1992, Trends in Cell Biology, V2, P343; Van Mierlo CPM, 1998, PROTEIN SCI, V7, P2331, DOI 10.1002/pro.5560071110; VUILLEUMIER S, 1993, BIOCHEMISTRY-US, V32, P10303, DOI 10.1021/bi00090a005; Wen Y, 2003, INFECT IMMUN, V71, P5921, DOI 10.1128/IAI.71.10.5921-5939.2003; WOTHERSPOON AC, 1993, LANCET, V342, P575, DOI 10.1016/0140-6736(93)91409-F; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; ZORRILLA S, 1998, THESIS U ZARAGOZA ZA	71	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2883	2895		10.1074/jbc.M705677200	http://dx.doi.org/10.1074/jbc.M705677200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	17998211	hybrid			2022-12-25	WOS:000252622300045
J	Xie, MY; Mosig, A; Qi, X; Li, Y; Stadler, PF; Chen, JJL				Xie, Mingyi; Mosig, Axel; Qi, Xiaodong; Li, Yang; Stadler, Peter F.; Chen, Julian J. -L.			Structure and function of the smallest vertebrate telomerase RNA from teleost fish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BODY-SPECIFIC LOCALIZATION; GENOME DUPLICATION; DOMAIN; IDENTIFICATION; PSEUDOKNOT; REVEALS	Telomerase extends chromosome ends by copying a short template sequence within its intrinsic RNA component. Telomerase RNA (TR) from different groups of species varies dramatically in sequence and size. We report here the bioinformatic identification, secondary structure comparison, and functional analysis of the smallest known vertebrate TRs from five teleost fishes. The teleost TRs (312-348 nucleotides) are significantly smaller than the cartilaginous fish TRs (478-559 nucleotides) and tetrapod TRs. This remarkable length reduction of teleost fish TRs correlates positively with the genome size, reflecting an unusual structural plasticity of TR during evolution. The teleost TR consists of a compact three-domain structure, lacking most of the sequences in regions that are variable in other vertebrate TR structures. The medaka and fugu TRs, when assembled with their telomerase reverse transcriptase (TERT) protein counterparts, reconstituted active and processive telomerase enzymes. Titration analysis of individual RNA domains suggests that the efficient assembly of the telomerase complex is influenced more by the telomerase reverse transcriptase (TERT) binding of the CR4-CR5 domain than the pseudoknot domain of TR. The remarkably small teleost fish TR further expands our understanding about the evolutionary divergence of vertebrate TR.	[Xie, Mingyi; Qi, Xiaodong; Li, Yang; Chen, Julian J. -L.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Xie, Mingyi; Qi, Xiaodong; Li, Yang; Chen, Julian J. -L.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Stadler, Peter F.] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04107 Leipzig, Germany; [Mosig, Axel] Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Dept Combinator & Geometry, Shanghai 200031, Peoples R China; [Stadler, Peter F.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04107 Leipzig, Germany; [Stadler, Peter F.] Univ Vienna, Dept Theoret Chem, A-1090 Vienna, Austria; [Stadler, Peter F.] Santa Fe Inst, Santa Fe, NM 87501 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Leipzig University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Leipzig University; University of Vienna; The Santa Fe Institute	Chen, JJL (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.	JLChen@asu.edu	Chen, Julian J.-L./D-6488-2014; Stadler, Peter F. F/L-7857-2015	Chen, Julian J.-L./0000-0002-7253-2722; Stadler, Peter F. F/0000-0002-5016-5191; Mosig, Axel/0000-0001-7266-8323				Backofen R, 2007, J EXP ZOOL PART B, V308B, P1, DOI 10.1002/jezb.21130; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Chen JL, 2004, P NATL ACAD SCI USA, V101, P14683, DOI 10.1073/pnas.0406204101; Chen JL, 2004, TRENDS BIOCHEM SCI, V29, P183, DOI 10.1016/j.tibs.2004.02.003; Chen JL, 2003, GENE DEV, V17, P2747, DOI 10.1101/gad.1140303; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; Chen JL, 2003, EMBO J, V22, P304, DOI 10.1093/emboj/cdg024; Chen JL, 2002, NUCLEIC ACIDS RES, V30, P592, DOI 10.1093/nar/30.2.592; Comolli LR, 2002, P NATL ACAD SCI USA, V99, P16998, DOI 10.1073/pnas.262663599; Eddy SR, 2006, COLD SPRING HARB SYM, V71, P117, DOI 10.1101/sqb.2006.71.003; Ferreira MG, 2004, MOL CELL, V13, P7, DOI 10.1016/S1097-2765(03)00531-8; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Jady BE, 2004, J CELL BIOL, V164, P647, DOI 10.1083/jcb.200310138; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Ly H, 2005, BLOOD, V105, P2332, DOI 10.1182/blood-2004-09-3659; Ly H, 2003, MOL CELL BIOL, V23, P6849, DOI 10.1128/MCB.23.19.6849-6856.2003; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Mitchell JR, 2000, MOL CELL, V6, P361, DOI 10.1016/S1097-2765(00)00036-8; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Mosig A, 2007, LECT N BIOINFORMAT, V4645, P335; Mosig Axel, 2006, Genomics Proteomics & Bioinformatics, V4, P56, DOI 10.1016/S1672-0229(06)60017-X; Nelson JS, 1984, FISHES WORLD; Ren XJ, 2003, NUCLEIC ACIDS RES, V31, P6509, DOI 10.1093/nar/gkg871; Richard P, 2003, EMBO J, V22, P4283, DOI 10.1093/emboj/cdg394; Shefer K, 2007, MOL CELL BIOL, V27, P2130, DOI 10.1128/MCB.01826-06; Tesmer VM, 1999, MOL CELL BIOL, V19, P6207; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Venkatesh B, 2006, SCIENCE, V314, P1892, DOI 10.1126/science.1130708; Vitali P, 2003, NUCLEIC ACIDS RES, V31, P6543, DOI 10.1093/nar/gkg849; Weber MJ, 2006, PLOS GENET, V2, P1984, DOI 10.1371/journal.pgen.0020205; Yap WH, 2005, GENE, V353, P207, DOI 10.1016/j.gene.2005.04.038	37	63	69	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2049	2059		10.1074/jbc.M708032200	http://dx.doi.org/10.1074/jbc.M708032200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039659	hybrid, Green Published			2022-12-25	WOS:000252501000032
J	Burgess, SC; Iizuka, K; Jeoung, NH; Harris, RA; Kashiwaya, Y; Veech, RL; Kitazume, T; Uyeda, K				Burgess, Shawn C.; Iizuka, Katsumi; Jeoung, Nam Ho; Harris, Robert A.; Kashiwaya, Yoshihiro; Veech, Richard L.; Kitazume, Tatsuya; Uyeda, Kosaku			Carbohydrate-response element-binding protein deletion alters substrate utilization producing an energy-deficient liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; TRICARBOXYLIC-ACID CYCLE; TRANSCRIPTION FACTOR; RAT-LIVER; GLUCOSE; MECHANISM; KINASE; PHOSPHORYLATION; PHOSPHATASE; LIPOGENESIS	Livers from mice lacking the carbohydrate-responsive element-binding protein (ChREBP) were compared with wild type (WT) mice to determine the effect of this transcription factor on hepatic energy metabolism. The pyruvate dehydrogenase complex was considerably more active in ChREBP(-/-) mice because of diminished pyruvate dehydrogenase kinase activity. Greater pyruvate dehydrogenase complex activity caused a stimulation of lactate and pyruvate oxidation, and it significantly impaired fatty acid oxidation in perfused livers from ChREBP(-/-) mice. This shift in mitochondrial substrate utilization led to a 3-fold reduction of the free cytosolic [NAD(+)]/[NADH] ratio, a 1.7-fold increase in the free mitochondrial [NAD(+)]/[NADH] ratio, and a 2-fold decrease in the free cytosolic [ATP]/[ADP][P-i] ratio in the ChREBP(-/-) liver compared with control. Hepatic pyruvate carboxylase flux was impaired with ChREBP deletion secondary to decreased fatty acid oxidation, increased pyruvate oxidation, and limited pyruvate availability because of reduced activity of liver pyruvate kinase and malic enzyme, which replenish pyruvate via glycolysis and pyruvate cycling. Overall, the shift from fat utilization to pyruvate and lactate utilization resulted in a decrease in the energy of ATP hydrolysis and a hypo-energetic state in the livers of ChREBP(-/-) mice.	[Iizuka, Katsumi; Kitazume, Tatsuya; Uyeda, Kosaku] Univ Texas SW Med Sch, Dept Biochem, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Burgess, Shawn C.] Univ Texas SW Med Sch, Dept Pharmacol, Dallas, TX 75390 USA; [Uyeda, Kosaku] Dept Vet Affairs Med Ctr, Dallas, TX 75390 USA; [Jeoung, Nam Ho; Harris, Robert A.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Kashiwaya, Yoshihiro; Veech, Richard L.] NIAAA, Lab Met Control, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Indiana University System; Indiana University-Purdue University Indianapolis; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Uyeda, K (corresponding author), Univ Texas SW Med Sch & Vet Affairs, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	kuyeda6400@aol.com	Iizuka, Katsumi/AAB-9135-2019	Iizuka, Katsumi/0000-0002-9837-6238; Jeoung, Nam Ho/0000-0002-7584-3761	NCRR NIH HHS [RR 02584] Funding Source: Medline; NIDDK NIH HHS [DK 063948-04, DK 076169, DK 47844] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076169, R01DK047844, R01DK063948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000111, Z01AA000111] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ASHCROFT SJ, 1968, BIOCHEM J, V107, P599, DOI 10.1042/bj1070599; Bergmeyer H.U., 1985, METHODS ENZYMATIC AN; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; ENGEL PC, 1969, BIOCHEM J, V115, P621, DOI 10.1042/bj1150621; GUYNN RW, 1973, J BIOL CHEM, V248, P6966; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2006, AM J PHYSIOL-ENDOC M, V291, pE358, DOI 10.1152/ajpendo.00027.2006; Jeffrey FMH, 1996, AM J PHYSIOL-ENDOC M, V271, pE788, DOI 10.1152/ajpendo.1996.271.4.E788; Jeoung NH, 2006, ANAL BIOCHEM, V356, P44, DOI 10.1016/j.ab.2006.06.017; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; KRAHENBUHL S, 1991, J BIOL CHEM, V266, P20998; KREBS HA, 1969, PYRIDINE NUCLEOTIDE, P329; Kuriyama H, 2005, CELL METAB, V1, P41, DOI 10.1016/j.cmet.2004.11.004; KWACK H, 1992, CURR TOP CELL REGUL, V33, P185; Lamprecht W, 1974, METHOD ENZYMAT AN, P2101; Liu YQ, 1996, J BIOL CHEM, V271, P8824, DOI 10.1074/jbc.271.15.8824; MALLOY CR, 1990, AM J PHYSIOL, V259, pH987, DOI 10.1152/ajpheart.1990.259.3.H987; MALLOY CR, 1990, BIOCHEMISTRY-US, V29, P6756, DOI 10.1021/bi00481a002; Mochel F, 2005, MOL GENET METAB, V84, P305, DOI 10.1016/j.ymgme.2004.09.007; NISHIMURA M, 1995, J BIOL CHEM, V270, P26341, DOI 10.1074/jbc.270.44.26341; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; RANDLE PJ, 1986, BIOCHEM SOC T, V14, P799, DOI 10.1042/bst0140799; SPRY M, 1971, THESIS OXFORD U OXFO; Veech RL, 2002, IUBMB LIFE, V54, P241, DOI 10.1080/15216540215678; VEECH RL, 1994, ALCOHOL CLIN EXP RES, V18, P1040, DOI 10.1111/j.1530-0277.1994.tb00081.x; VEECH RL, 1979, J BIOL CHEM, V254, P6538; WILLIAMSON JR, 1969, J BIOL CHEM, V244, P4607; Wu PF, 2000, ARCH BIOCHEM BIOPHYS, V381, P1, DOI 10.1006/abbi.2000.1946; Wu PF, 1999, DIABETES, V48, P1593, DOI 10.2337/diabetes.48.8.1593; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298	34	43	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1670	1678		10.1074/jbc.M706540200	http://dx.doi.org/10.1074/jbc.M706540200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18042547	hybrid			2022-12-25	WOS:000252282700054
J	Huang, D; Cai, DT; Chua, RYR; Kemeny, DM; Wong, SH				Huang, Dachuan; Cai, Deyu Tarika; Chua, Rong Yuan Ray; Kemeny, David Michael; Wong, Siew Heng			Nitric-oxide synthase 2 interacts with CD74 and inhibits its cleavage by caspase during dendritic cell development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; NITRIC-OXIDE SYNTHASE; INVARIANT CHAIN; ANTIGEN PRESENTATION; ASPARAGINE ENDOPEPTIDASE; CYSTEINE PROTEASES; S-NITROSATION; IN-VIVO; HLA-DM; EXPRESSION	Dendritic cells (DC) are professional antigen-presenting cells that possess specific and efficient mechanisms to initiate immune responses. Upon encounter with pathogens, immature DC will go through a maturation process that converts them to highly immunogenic mature DC. Despite the fact that nitric oxide (NO) was produced in large amounts in maturing DC, it is still unclear whether NO is the key molecule that initiates and enhances DC maturation and T cell proliferation, respectively. Here, we report that NO donor and overexpression of either nitric-oxide synthase 2 (NOS2) or nitric-oxide synthase 3 (NOS3) alone can induce surface expression of major histocompatibility complex class II (MHC II) and both the essential co-stimulatory molecules CD80 and CD86 in immature DC. Consistently, NO donor-treated immature DC were capable of enhancing T cell proliferation in vitro in the absence of lipolysaccharide. Interestingly, NOS2 interacts with CD74 (the MHC II-associated invariant chain), and the degradation of CD74 by caspases in immature DC was inhibited upon treatment with NO donor. Because the trafficking of MHC II is CD74-dependent, the increase in cell surface localization of MHC II in maturing DC is in part due to the increase in CD74 protein expression in the presence of NOS2 and NO.	[Huang, Dachuan; Cai, Deyu Tarika; Chua, Rong Yuan Ray; Wong, Siew Heng] Natl Univ Singapore, Lab Membrane Trafficking & Immunoregulat, Dept Microbiol, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Kemeny, David Michael; Wong, Siew Heng] Natl Univ Singapore, Immunol Programme, Singapore 117597, Singapore	National University of Singapore; National University of Singapore	Wong, SH (corresponding author), 03-14 Block MD4A,5 Sci Dr 2, Singapore, Singapore.	micwsh@nus.edu.sg		HUANG, DACHUAN/0000-0002-7518-4081				Becker-Herman S, 2005, MOL BIOL CELL, V16, P5061, DOI 10.1091/mbc.E05-04-0327; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bonham CA, 1996, TRANSPLANTATION, V62, P1871, DOI 10.1097/00007890-199612270-00033; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Cao S, 2001, J BIOL CHEM, V276, P14249, DOI 10.1074/jbc.M006258200; Connelly L, 2005, J BIOL CHEM, V280, P10040, DOI 10.1074/jbc.M411991200; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Engering AJ, 1998, INT IMMUNOL, V10, P1713, DOI 10.1093/intimm/10.11.1713; Gomez J, 2004, TISSUE ANTIGENS, V63, P149, DOI 10.1111/j.1399-0039.2004.00159.x; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Houde C, 2003, J BIOL CHEM, V278, P16929, DOI 10.1074/jbc.M301842200; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Kamada S, 1997, CELL DEATH DIFFER, V4, P473, DOI 10.1038/sj.cdd.4400268; Kim SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093/hmg/ddl105; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Maehr R, 2005, J IMMUNOL, V174, P7066, DOI 10.4049/jimmunol.174.11.7066; Maniscalco M, 2007, INFLAMM RES, V56, P58, DOI 10.1007/s00011-006-6111-1; Manoury B, 2003, IMMUNITY, V18, P489, DOI 10.1016/S1074-7613(03)00085-2; Matza D, 2003, TRENDS IMMUNOL, V24, P264, DOI 10.1016/S1471-4906(03)00073-5; Mohr S, 1997, BIOCHEM BIOPH RES CO, V238, P387, DOI 10.1006/bbrc.1997.7304; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Panjwani NN, 2002, J IMMUNOL, V168, P2997, DOI 10.4049/jimmunol.168.6.2997; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; Rossig L, 1999, J BIOL CHEM, V274, P6823, DOI 10.1074/jbc.274.11.6823; Santambrogio L, 2005, NAT IMMUNOL, V6, P1020, DOI 10.1038/ni1250; Serwe M, 1997, INT IMMUNOL, V9, P983, DOI 10.1093/intimm/9.7.983; Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334; Tannenbaum SR, 2006, ACS CHEM BIOL, V1, P615, DOI 10.1021/cb600439h; Vo PA, 2005, J BIOL CHEM, V280, P7236, DOI 10.1074/jbc.M411317200; Wong SH, 2004, P NATL ACAD SCI USA, V101, P17783, DOI 10.1073/pnas.0408229102	31	18	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1713	1722		10.1074/jbc.M705998200	http://dx.doi.org/10.1074/jbc.M705998200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18003616	hybrid			2022-12-25	WOS:000252282700058
J	Yang, KJ; Shin, S; Piao, L; Shin, E; Li, YW; Park, KA; Byun, HS; Won, MH; Hong, JH; Kweon, GR; Hur, GM; Seok, JH; Chun, T; Brazil, DP; Hemmings, BA; Park, J				Yang, Keum-Jin; Shin, Sanghee; Piao, Longzhen; Shin, Eulsoon; Li, Yuwen; Park, Kyeong Ah; Byun, Hee Sun; Won, Minho; Hong, Janghee; Kweon, Gi Ryang; Hur, Gang Min; Seok, Jeong Ho; Chun, Taehoon; Brazil, Derek P.; Hemmings, Brian A.; Park, Jongsun			Regulation of 3-phosphoinositide-dependent protein kinase-1 (PDK1) by src involves tyrosine phosphorylation of PDK1 and Src homology 2 domain binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; HEAT-SHOCK; DOCKING SITE; INSULIN-RECEPTOR; AGC KINASES; SH3 DOMAIN; C-ZETA; ACTIVATION; COMPLEX; HSP90	3-Phosphoinositide-dependent protein kinase-1 (PDK1) appears to play a central regulatory role in many cell signalings between phosphoinositide-3 kinase and various intracellular serine/threonine kinases. In resting cells, PDK1 is known to be constitutively active and is further activated by tyrosine phosphorylation (Tyr(9) and Tyr(373/376)) following the treatment of the cell with insulin or pervanadate. However, little is known about the mechanisms for this additional activation of PDK1. Here, we report that the SH2 domain of Src, Crk, and GAP recognized tyrosine-phosphorylated PDK1 in vitro. Destabilization of PDK1 induced by geldanamycin (a Hsp90 inhibitor) was partially blocked in HEK 293 cells expressing PDK1- Y9F. Co-expression of Hsp90 enhanced PDK1-Src complex formation and led to further increased PDK1 activity toward PKB and SGK. Immunohistochemical analysis with anti- phospho-Tyr9 antibodies showed that the level of Tyr9 phosphorylation was markedly increased in tumor samples compared with normal. Taken together, these data suggest that phosphorylation of PDK1 on Tyr9, distinct from Tyr373/376, is important for PDK1/Src complex formation, leading to PDK1 activation. Furthermore, Tyr9 phosphorylation is critical for the stabilization of both PDK1 and the PDK1/Src complex via Hsp90-mediated protection of PDK1 degradation.	[Yang, Keum-Jin; Shin, Sanghee; Piao, Longzhen; Shin, Eulsoon; Li, Yuwen; Park, Kyeong Ah; Byun, Hee Sun; Won, Minho; Hong, Janghee; Hur, Gang Min; Seok, Jeong Ho; Park, Jongsun] Chungnam Natl Univ, Coll Med, Dept Pharmacol, Daejeon Reg Canc Ctr,Canc Res Inst,Res Inst Med S, Taejon 301131, South Korea; [Kweon, Gi Ryang] Chungnam Natl Univ, Coll Med, Dept Biochem, Taejon 301131, South Korea; [Chun, Taehoon] Korea Univ, Sch Life Sci & Biotechnol, Div Biotechnol, Seoul 136701, South Korea; [Brazil, Derek P.] Univ Coll Dublin, Univ Coll Dublin Conway Inst, Univ Coll Dublin Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Hemmings, Brian A.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Chungnam National University; Chungnam National University; Korea University; University College Dublin; Friedrich Miescher Institute for Biomedical Research	Park, J (corresponding author), Chungnam Natl Univ, Coll Med, Dept Pharmacol, Daejeon Reg Canc Ctr,Canc Res Inst,Res Inst Med S, 6 Munhwa Dong, Taejon 301131, South Korea.	insulin@cnu.ac.kr	Park, Jongsun/E-7465-2010; Hur, Gang-min/ABF-9263-2021; li, yuwen/HGU-6435-2022; Chun, Taehoon/F-2052-2013	Park, Jongsun/0000-0002-4690-1854; Hur, Gang-min/0000-0003-4870-6574; Li, Yuwen/0000-0002-6218-148X; Brazil, Derek/0000-0003-1375-1076; Hong, Jang-Hee/0000-0002-0623-5455; Won, Minho/0000-0002-5873-5216				Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; AMMIRANTE M, 2007, IN PRESS ONCOGENE; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Andjelkovic M, 1999, MOL CELL BIOL, V19, P5061; Azar ZM, 2006, CAN J PHYSIOL PHARM, V84, P777, DOI 10.1139/Y06-024; Balendran A, 2000, J BIOL CHEM, V275, P20806, DOI 10.1074/jbc.M000421200; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; Brouet A, 2001, CIRC RES, V89, P866, DOI 10.1161/hh2201.100319; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; CIOCCA DR, 1992, CANCER RES, V52, P3648; Collins BJ, 2003, EMBO J, V22, P4202, DOI 10.1093/emboj/cdg407; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Donaldson LW, 2002, P NATL ACAD SCI USA, V99, P14053, DOI 10.1073/pnas.212518799; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; ELIAS JM, 1989, AM J CLIN PATHOL, V92, P836; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; FERRARINI M, 1992, INT J CANCER, V51, P613, DOI 10.1002/ijc.2910510418; Filippa N, 2000, MOL CELL BIOL, V20, P5712, DOI 10.1128/MCB.20.15.5712-5721.2000; Fiory F, 2005, MOL CELL BIOL, V25, P10803, DOI 10.1128/MCB.25.24.10803-10814.2005; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Fujita N, 2003, CANCER CHEMOTH PHARM, V52, pS24, DOI 10.1007/s00280-003-0591-2; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; Grillo S, 2000, EUR J BIOCHEM, V267, P6642, DOI 10.1046/j.1432-1327.2000.01759.x; Hinton HJ, 2004, NAT IMMUNOL, V5, P539, DOI 10.1038/ni1062; Kikani CK, 2005, J CELL BIOCHEM, V96, P1157, DOI 10.1002/jcb.20651; Kim DW, 2003, MOL ENDOCRINOL, V17, P1382, DOI 10.1210/me.2002-0402; Kim S, 2001, J BIOL CHEM, V276, P12864, DOI 10.1074/jbc.M001492200; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Komander D, 2003, BIOCHEM J, V375, P255, DOI 10.1042/BJ20031119; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Meares GP, 2004, FEBS LETT, V574, P181, DOI 10.1016/j.febslet.2004.08.026; Mehdi MZ, 2005, ANTIOXID REDOX SIGN, V7, P1014, DOI 10.1089/ars.2005.7.1014; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Neckers L, 1999, INVEST NEW DRUG, V17, P361, DOI 10.1023/A:1006382320697; Neckers L, 1999, DRUG RESIST UPDATE, V2, P165, DOI 10.1054/drup.1999.0082; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Park J, 2001, J BIOL CHEM, V276, P37459, DOI 10.1074/jbc.M105916200; Park KA, 2007, CARCINOGENESIS, V28, P71, DOI 10.1093/carcin/bgl094; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; POSNER BI, 1994, J BIOL CHEM, V269, P4596; Prasad N, 2000, BIOCHEMISTRY-US, V39, P6929, DOI 10.1021/bi000387i; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Roche S, 1996, EMBO J, V15, P4940, DOI 10.1002/j.1460-2075.1996.tb00874.x; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Sato S, 2002, J BIOL CHEM, V277, P39360, DOI 10.1074/jbc.M205141200; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Taniyama Y, 2003, MOL CELL BIOL, V23, P8019, DOI 10.1128/MCB.23.22.8019-8029.2003; Van Slyke P, 2005, MOL CELL BIOL, V25, P3831, DOI 10.1128/MCB.25.9.3831-3841.2005; Wei Q, 2005, J BIOL CHEM, V280, P18081, DOI 10.1074/jbc.M413607200; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Xie ZH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-77; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; YUFU Y, 1992, LEUKEMIA RES, V16, P597, DOI 10.1016/0145-2126(92)90008-U; Yun BG, 2005, CELL SIGNAL, V17, P1477, DOI 10.1016/j.cellsig.2005.03.006; Zeng ZH, 2006, CANCER RES, V66, P3737, DOI 10.1158/0008-5472.CAN-05-1278	67	57	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1480	1491		10.1074/jbc.M706361200	http://dx.doi.org/10.1074/jbc.M706361200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024423	hybrid			2022-12-25	WOS:000252282700032
J	Freel, CD; Richardson, DA; Thomenius, MJ; Gan, EC; Horn, SR; Olson, MR; Kornbluth, S				Freel, Christopher D.; Richardson, D. Ashley; Thomenius, Michael J.; Gan, Eugene C.; Horn, Sarah R.; Olson, Michael R.; Kornbluth, Sally			Mitochondrial localization of reaper to promote inhibitors of apoptosis protein degradation conferred by GH3 domain-lipid interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; CYTOCHROME-C; DROSOPHILA-REAPER; CASPASE ACTIVATION; GRIM; INDUCTION; HID; GENE; BAX; STRESS	Morphological hallmarks of apoptosis result from activation of the caspase family of cysteine proteases, which are opposed by a pro-survival family of inhibitors of apoptosis proteins (IAPs). In Drosophila, disruption of IAP function by Reaper, HID, and Grim (RHG) proteins is sufficient to induce cell death. RHG proteins have been reported to localize to mitochondria, which, in the case of both Reaper and Grim proteins, is mediated by an amphipathic helical domain known as the GH3. Through direct binding, Reaper can bring the Drosophila IAP (DIAP1) to mitochondria, concomitantly promoting IAP auto-ubiquitination and destruction. Whether this localization is sufficient to induce DIAP1 auto-ubiquitination has not been reported. In this study we characterize the interaction between Reaper and the mitochondria using both Xenopus and Drosophila systems. We find that Reaper concentrates on the outer surface of mitochondria in a nonperipheral manner largely mediated by GH3-lipid interactions. Importantly, we show that mitochondrial targeting of DIAP1 alone is not sufficient for degradation and requires Reaper binding. Conversely, Reaper able to bind IAPs, but lacking a mitochondrial targeting GH3 domain (Delta GH3 Reaper), can induce DIAP1 turnover only if DIAP1 is otherwise targeted to membranes. Surprisingly, targeting DIAP1 to the endoplasmic reticulum instead of mitochondria is partially effective in allowing Delta GH3 Reaper to promote DIAP1 degradation, suggesting that co-localization of DIAP and Reaper at a membrane surface is critical for the induction of DIAP degradation. Collectively, these data provide a specific function for the GH3 domain in conferring protein-lipid interactions, demonstrate that both Reaper binding and mitochondrial localization are required for accelerated IAP degradation, and suggest that membrane localization per se contributes to DIAP1 auto-ubiquitination and degradation.	[Freel, Christopher D.; Richardson, D. Ashley; Thomenius, Michael J.; Gan, Eugene C.; Horn, Sarah R.; Olson, Michael R.; Kornbluth, Sally] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Kornbluth, S (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	kornb001@mc.duke.edu			NIGMS NIH HHS [5F32 GM 072165, R01 GM 061919, 5F31GM 073574] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM072165, F31GM073574, R01GM061919] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdelwahid E, 2007, DEV CELL, V12, P793, DOI 10.1016/j.devcel.2007.04.004; Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Chen P, 2004, CELL DEATH DIFFER, V11, P704, DOI 10.1038/sj.cdd.4401406; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Claveria C, 2002, EMBO J, V21, P3327, DOI 10.1093/emboj/cdf354; Claveria C, 1998, EMBO J, V17, P7199, DOI 10.1093/emboj/17.24.7199; Colon-Ramos DA, 2006, NAT STRUCT MOL BIOL, V13, P103, DOI 10.1038/nsmb1052; Colon-Ramos DA, 2003, MOL BIOL CELL, V14, P4162, DOI 10.1091/mbc.E03-03-0139; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dorstyn L, 2002, J CELL BIOL, V156, P1089, DOI 10.1083/jcb.200111107; Dorstyn L, 2004, J CELL BIOL, V167, P405, DOI 10.1083/jcb.200408054; Evans EK, 1997, EMBO J, V16, P7372, DOI 10.1093/emboj/16.24.7372; Goyal G, 2007, DEV CELL, V12, P807, DOI 10.1016/j.devcel.2007.02.002; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Haining WN, 1999, P NATL ACAD SCI USA, V96, P4936, DOI 10.1073/pnas.96.9.4936; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jonas EA, 2004, P NATL ACAD SCI USA, V101, P13590, DOI 10.1073/pnas.0401372101; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kim TH, 2004, MOL BIOL CELL, V15, P3061, DOI 10.1091/mbc.E03-12-0864; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lisi S, 2000, GENETICS, V154, P669; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; McCarthy JV, 1998, J BIOL CHEM, V273, P24009, DOI 10.1074/jbc.273.37.24009; Means J, 2006, CELL DEATH DIFFER, V13, P1222, DOI 10.1038/sj.cdd.4401821; Olson MR, 2003, J BIOL CHEM, V278, P44758, DOI 10.1074/jbc.M308055200; Olson MR, 2003, J BIOL CHEM, V278, P4028, DOI 10.1074/jbc.M209734200; Pedersen P L, 1978, Methods Cell Biol, V20, P411, DOI 10.1016/S0091-679X(08)62030-0; Robey RB, 2005, CELL CYCLE, V4, P654, DOI 10.4161/cc.4.5.1678; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Schwarze SR, 1998, FREE RADICAL BIO MED, V25, P740, DOI 10.1016/S0891-5849(98)00153-1; VAN MEER G, 1989, ANNU REV CELL BIOL, V5, P247, DOI 10.1146/annurev.cellbio.5.1.247; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Varkey J, 1999, J CELL BIOL, V144, P701, DOI 10.1083/jcb.144.4.701; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Wing JP, 2002, NAT CELL BIOL, V4, P451, DOI 10.1038/ncb800; Wing JP, 1998, CELL DEATH DIFFER, V5, P930, DOI 10.1038/sj.cdd.4400423; Yan N, 2006, J BIOL CHEM, V281, P8667, DOI 10.1074/jbc.M513232200; Yokokura T, 2004, J BIOL CHEM, V279, P52603, DOI 10.1074/jbc.M409691200; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Zimmermann KC, 2002, J CELL BIOL, V156, P1077, DOI 10.1083/jcb.20112068	47	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					367	379		10.1074/jbc.M708931200	http://dx.doi.org/10.1074/jbc.M708931200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17998202	hybrid			2022-12-25	WOS:000251940300041
J	Sawalha, RM; Brotherstone, S; Conington, J; Villanueva, B				Sawalha, Rami M.; Brotherstone, Susan; Conington, Joanne; Villanueva, Beatriz			Lambs with Scrapie Susceptible Genotypes Have Higher Postnatal Survival	PLOS ONE			English	Article								Background. Prion protein (PrP) alleles associated with scrapie susceptibility persist in many sheep populations even with high frequencies despite centuries of selection against them. This suggests that scrapie susceptibility alleles have a pleiotropic effect or are associated with fitness or other traits that have been subject to selection. Methodology/Principal Findings. We genotyped all lambs in two scrapie-free Scottish Blackface sheep flocks for polymorphisms at codons 136, 154 and 171 of the PrP gene. We tested potential associations of the PrP genotype with lamb viability at birth and postnatal survival using a complementary log-log link function and a Weibull proportional hazard model, respectively. Here we show there is an association between PrP genotype, as defined by polymorphisms at codons 154 ad 171, and postnatal lamb survival in the absence of scrapie. Sheep carrying the wild-type ARQ allele have higher postnatal survival rates than sheep carrying the more scrapie-resistant alleles (ARR or AHQ). Conclusion. The PrP genotypes associated with higher susceptibility to scrapie are associated with improved postnatal survival in the absence of the disease. This association helps to explain the existence, and in many instances the high frequency, of the ARQ allele in sheep populations.	[Sawalha, Rami M.; Conington, Joanne; Villanueva, Beatriz] Scottish Agr Coll, Edinburgh, Midlothian, Scotland; [Brotherstone, Susan] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland	Scottish Agricultural College; University of Edinburgh	Sawalha, RM (corresponding author), Scottish Agr Coll, Edinburgh, Midlothian, Scotland.	rami.sawalha@sac.uk		Conington, Joanne/0000-0002-2387-3555	DEFRA (Department for Environment, Food and Rural Affairs); SEERAD (Scottish Executive Environment and Rural Affairs Department)	DEFRA (Department for Environment, Food and Rural Affairs)(Department for Environment, Food & Rural Affairs (DEFRA)); SEERAD (Scottish Executive Environment and Rural Affairs Department)	Funding for this project was mainly from DEFRA (Department for Environment, Food and Rural Affairs). SAC also receives funding from SEERAD (Scottish Executive Environment and Rural Affairs Department). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylis M, 2004, J GEN VIROL, V85, P2735, DOI 10.1099/vir.0.79876-0; Baylis M, 2002, J GEN VIROL, V83, P2907, DOI 10.1099/0022-1317-83-11-2907; Binns SH, 2002, PREV VET MED, V52, P287, DOI 10.1016/S0167-5877(01)00255-0; Brandsma JH, 2005, LIVEST PROD SCI, V95, P89, DOI 10.1016/j.livprodsci.2004.12.011; Burkin DJ, 1996, CYTOGENET CELL GENET, V74, P86, DOI 10.1159/000134388; Cagampang FRA, 1999, NEUROSCIENCE, V91, P1201, DOI 10.1016/S0306-4522(99)00092-5; Chase-Topping ME, 2005, J GEN VIROL, V86, P1229, DOI 10.1099/vir.0.80277-0; CLARK AM, 1994, VET REC, V134, P650, DOI 10.1136/vr.134.25.650; Conington J, 1998, ANIM SCI, V67, P299, DOI 10.1017/S1357729800010067; CRAWFORD AM, 1995, GENETICS, V140, P703; De Vries F, 2004, VET REC, V155, P140, DOI 10.1136/vr.155.5.140; DUCROCQ V, 1998, SURVIVAL KIT V3 0 PA, P447; Eales F. A., 1983, Sheep production. Proceedings of the 35th Easter School in Agricultural Science, University of Nottingham, P289; Eglin RD, 2005, VET REC, V156, P433, DOI 10.1136/vr.156.14.433; Gilmour A. R., 2002, ASREML USER GUIDE RE; Hunter N, 1996, ARCH VIROL, V141, P809, DOI 10.1007/BF01718157; Isler BJ, 2006, J ANIM SCI, V84, P783, DOI 10.2527/2006.844783x; Katamine S, 1998, CELL MOL NEUROBIOL, V18, P731, DOI 10.1023/A:1020234321879; Leeman MF, 2002, CRIT REV BIOCHEM MOL, V37, P149, DOI 10.1080/10409230290771483; Maddox JF, 2001, ANIM GENET, V32, P329, DOI 10.1046/j.1365-2052.2001.0730k.x; Man WYN, 2006, ANIM SCI, V82, P607, DOI 10.1079/ASC200673; MATTHEW P, 1994, ANIM GENET, V25, P200, DOI 10.1111/j.1365-2052.1994.tb00121.x; McLean AR, 1999, P ROY SOC B-BIOL SCI, V266, P2531, DOI 10.1098/rspb.1999.0956; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Nicholls N, 2006, VET REC, V158, P732, DOI 10.1136/vr.158.21.732; Nishida N, 1999, LAB INVEST, V79, P689; Sawalha RM, 2007, ANIMAL, V1, P151, DOI 10.1017/S1751731107340056; Sawalha RM, 2007, J ANIM SCI, V85, P632, DOI 10.2527/jas.2006-372; Slate J, 2005, P ROY SOC B-BIOL SCI, V272, P2371, DOI 10.1098/rspb.2005.3259; Vitezica ZG, 2005, ANIM SCI, V81, P325, DOI 10.1079/ASC42110325; Woolhouse MEJ, 2001, TRENDS MICROBIOL, V9, P67, DOI 10.1016/S0966-842X(00)01912-0	31	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2007	2	11							e1236	10.1371/journal.pone.0001236	http://dx.doi.org/10.1371/journal.pone.0001236			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JC	18043743	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459300017
J	Chiuman, W; Li, YF				Chiuman, William; Li, Yingfu			Simple Fluorescent Sensors Engineered with Catalytic DNA 'MgZ' Based on a Non-Classic Allosteric Design	PLOS ONE			English	Article							IN-VITRO SELECTION; RESONANCE ENERGY-TRANSFER; MOLECULAR RECOGNITION; SIGNALING APTAMERS; RATIONAL DESIGN; RNA APTAMERS; RIBOZYMES; DEOXYRIBOZYME; EVOLUTION; ENZYME	Most NAE (nucleic acid enzyme) sensors are composed of an RNA-cleaving catalytic motif and an aptameric receptor. They operate by activating or repressing the catalytic activity of a relevant NAE through the conformational change in the aptamer upon target binding. To transduce a molecular recognition event to a fluorescence signal, a fluorophore-quencher pair is attached to opposite ends of the RNA substrate such that when the NAE cleaves the substrate, an increased level of fluorescence can be generated. However, almost all NAE sensors to date harbor either NAEs that cannot accommodate a fluorophore-quencher pair near the cleavage site or those that can accept such a modification but require divalent transition metal ions for catalysis. Therefore, the signaling magnitude and the versatility of current NAE sensors might not suffice for analytical and biological applications. Here we report an RNA-cleaving DNA enzyme, termed 'MgZ', which depends on Mg2+ for its activity and can accommodate bulky dye moieties next to the cleavage site. MgZ was created by in vitro selection. The selection scheme entailed acidic buffering and ethanol-based reaction stoppage to remove selfish DNAs. Characterization of MgZ revealed a three-way junction structure, a cleavage rate of 1 min(-1), and 26-fold fluorescence enhancement. Two ligand-responsive NAE sensors were rationally designed by linking an aptamer sequence to the substrate of MgZ. In the absence of the target, the aptamer-linked substrate is locked into a conformation that prohibits MgZ from accessing the substrate. In the presence of the target, the aptamer releases the substrate, which induces MgZ-mediated RNA cleavage. The discovery of MgZ and the introduction of the above NAE sensor design strategy should facilitate future efforts in sensor engineering.	[Chiuman, William; Li, Yingfu] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University	Li, YF (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	liying@mcmaster.ca			Canadian Institutes for Health Research [MOP37964]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a research grant from Canadian Institutes for Health Research (grant number MOP37964).	Amontov S, 2006, NUCLEIC ACIDS RES, V34, P5032, DOI 10.1093/nar/gkl613; BREAKER RR, 1995, CHEM BIOL, V2, P655, DOI 10.1016/1074-5521(95)90028-4; BREAKER RR, 1994, P NATL ACAD SCI USA, V91, P6093, DOI 10.1073/pnas.91.13.6093; Chiuman W, 2006, J MOL BIOL, V357, P748, DOI 10.1016/j.jmb.2006.01.036; Chiuman W, 2007, NUCLEIC ACIDS RES, V35, P401, DOI 10.1093/nar/gkl1056; Chiuman W, 2006, CHEM BIOL, V13, P1061, DOI 10.1016/j.chembiol.2006.08.009; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Frauendorf C, 2001, BIOORGAN MED CHEM, V9, P2521, DOI 10.1016/S0968-0896(01)00027-X; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hamaguchi N, 2001, ANAL BIOCHEM, V294, P126, DOI 10.1006/abio.2001.5169; Hartig JS, 2002, NAT BIOTECHNOL, V20, P717, DOI 10.1038/nbt0702-717; HUIZENGA DE, 1995, BIOCHEMISTRY-US, V34, P656, DOI 10.1021/bi00002a033; Jenne A, 1999, ANGEW CHEM INT EDIT, V38, P1300, DOI 10.1002/(SICI)1521-3773(19990503)38:9<1300::AID-ANIE1300>3.0.CO;2-Q; Jhaveri SD, 2000, J AM CHEM SOC, V122, P2469, DOI 10.1021/ja992393b; Koizumi M, 1999, NAT STRUCT BIOL, V6, P1062; Lee JF, 2006, CURR OPIN CHEM BIOL, V10, P282, DOI 10.1016/j.cbpa.2006.03.015; Lee JF, 2004, NUCLEIC ACIDS RES, V32, pD95, DOI 10.1093/nar/gkh094; Levy M, 2002, CHEM BIOL, V9, P417, DOI 10.1016/S1074-5521(02)00123-0; Li J, 2000, NUCLEIC ACIDS RES, V28, P481, DOI 10.1093/nar/28.2.481; Lin CH, 1997, CHEM BIOL, V4, P817, DOI 10.1016/S1074-5521(97)90115-0; Liu JW, 2007, P NATL ACAD SCI USA, V104, P2056, DOI 10.1073/pnas.0607875104; Liu JW, 2003, ANAL CHEM, V75, P6666, DOI 10.1021/AC034924r; Liu ZJ, 2003, J AM CHEM SOC, V125, P7539, DOI 10.1021/ja035208+; Marras SAE, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf121; Mei SHJ, 2003, J AM CHEM SOC, V125, P412, DOI 10.1021/ja0281232; Najafi-Shoushtari SH, 2007, BLOOD CELL MOL DIS, V38, P19, DOI 10.1016/j.bcmd.2006.10.007; Najafi-Shoushtari SH, 2005, RNA, V11, P1514, DOI 10.1261/rna.2840805; Nutiu R, 2003, J AM CHEM SOC, V125, P4771, DOI 10.1021/ja028962o; Peracchi A, 2000, J BIOL CHEM, V275, P11693, DOI 10.1074/jbc.275.16.11693; Piganeau N, 2001, J MOL BIOL, V312, P1177, DOI 10.1006/jmbi.2001.4981; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Robertson MP, 2004, RNA, V10, P114, DOI 10.1261/rna.5900204; Robertson MP, 1999, NAT BIOTECHNOL, V17, P62, DOI 10.1038/5236; Robertson MP, 2001, NAT BIOTECHNOL, V19, P650, DOI 10.1038/90256; Rupcich N, 2006, J AM CHEM SOC, V128, P780, DOI 10.1021/ja053336n; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Shen Y, 2006, CHEMBIOCHEM, V7, P1343, DOI 10.1002/cbic.200600195; Silverman SK, 2005, NUCLEIC ACIDS RES, V33, P6151, DOI 10.1093/nar/gki930; Soukup GA, 2000, J MOL BIOL, V298, P623, DOI 10.1006/jmbi.2000.3704; Soukup GA, 1999, P NATL ACAD SCI USA, V96, P3584, DOI 10.1073/pnas.96.7.3584; Soukup GA, 2001, RNA, V7, P524, DOI 10.1017/S1355838201002175; Srinivasan J, 2004, CHEM BIOL, V11, P499, DOI 10.1016/j.chembiol.2004.03.014; Stojanovic MN, 2004, J AM CHEM SOC, V126, P9266, DOI 10.1021/ja032013t; Stojanovic MN, 2000, NUCLEIC ACIDS RES, V28, P2915, DOI 10.1093/nar/28.15.2915; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Tang J, 1997, CHEM BIOL, V4, P453, DOI 10.1016/S1074-5521(97)90197-6; Thodima V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S6; Thompson Kristin M, 2002, BMC Biotechnol, V2, P21, DOI 10.1186/1472-6750-2-21; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vaish NK, 2002, NAT BIOTECHNOL, V20, P810, DOI 10.1038/nbt719; Vitiello D, 2000, RNA, V6, P628, DOI 10.1017/S1355838200990964; Wang DY, 2002, J MOL BIOL, V318, P33, DOI 10.1016/S0022-2836(02)00046-3; Wang W, 2002, CHEM BIOL, V9, P507, DOI 10.1016/S1074-5521(02)00127-8; Yamazaki S, 2007, CHEM BIOL, V14, P804, DOI 10.1016/j.chembiol.2007.06.003; Yang CJ, 2005, P NATL ACAD SCI USA, V102, P17278, DOI 10.1073/pnas.0508821102; Zivarts M, 2005, NUCLEIC ACIDS RES, V33, P622, DOI 10.1093/nar/gki182	58	39	40	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2007	2	11							e1224	10.1371/journal.pone.0001224	http://dx.doi.org/10.1371/journal.pone.0001224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JB	18030352	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459200031
J	Blanchard, JL; Wholey, WY; Conlon, EM; Pomposiello, PJ				Blanchard, Jeffrey L.; Wholey, Wei-Yun; Conlon, Erin M.; Pomposiello, Pablo J.			Rapid Changes in Gene Expression Dynamics in Response to Superoxide Reveal SoxRS-Dependent and Independent Transcriptional Networks	PLOS ONE			English	Article							ESCHERICHIA-COLI SOXS; SMALL-RNA REGULATOR; DNA-BINDING; HYDROGEN-PEROXIDE; 2FE-2S CLUSTERS; ACTIVATOR SOXS; IRON; PROTEIN; SEQUENCE; INHIBITION	Background. SoxR and SoxS constitute an intracellular signal response system that rapidly detects changes in superoxide levels and modulates gene expression in E. coli. A time series microarray design was used to identify co-regulated SoxRS-dependent and independent genes modulated by superoxide minutes after exposure to stress. Methodology/Principal Findings. soxS mRNA levels surged to near maximal levels within the first few minutes of exposure to paraquat, a superoxide-producing compound, followed by a rise in mRNA levels of known SoxS-regulated genes. Based on a new method for determining the biological significance of clustering results, a total of 138 genic regions, including several transcription factors and putative sRNAs were identified as being regulated through the SoxRS signaling pathway within 10 minutes of paraquat treatment. A statistically significant two-block SoxS motif was identified through analysis of the SoxS-regulated genes. The SoxRS-independent response included members of the OxyR, CysB, IscR, BirA and Fur regulons. Finally, the relative sensitivity to superoxide was measured in 94 strains carrying deletions in individual, superoxide-regulated genes. Conclusions/Significance. By integrating our microarray time series results with other microarray data, E. coli databases and the primary literature, we propose a model of the primary transcriptional response containing 226 protein-coding and sRNA sequences. From the SoxS dependent network the first statistically significant SoxS-related motif was identified.	[Blanchard, Jeffrey L.; Wholey, Wei-Yun; Pomposiello, Pablo J.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Conlon, Erin M.] Univ Massachusetts, Dept Math & Stat, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Blanchard, JL (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.	blanchard@microbio.umass.edu	Blanchard, Jeffrey/AAA-5173-2020	Blanchard, Jeffrey/0000-0002-7310-9678	University of Massachusetts	University of Massachusetts	This research was funded by a University of Massachusetts faculty research starter grant to Jeffrey Blanchard and a University of Massachusetts Commonwealth College Research Grant to Wei-Yun Chen. Wei-Yun Chen was supported by the University of Massachusetts Life Science Fellows Program and a University of Massachusetts Commonwealth College Research Fellowship.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BARBOSA T, 2005, MAR REGULON ESCHERIC; Bennik MHJ, 2000, J BACTERIOL, V182, P3794, DOI 10.1128/JB.182.13.3794-3801.2000; Bockhorst J, 2003, BIOINFORMATICS, V19, P1227, DOI 10.1093/bioinformatics/btg147; Bolstad BM, 2005, STAT BIOL HEALTH, P33; Brumaghim JL, 2003, J BIOL CHEM, V278, P42495, DOI 10.1074/jbc.M306251200; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Chen S, 2004, J BACTERIOL, V186, P6689, DOI 10.1128/JB.186.20.6689-6697.2004; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DENK D, 1987, J GEN MICROBIOL, V133, P515; Ding HG, 1996, J BIOL CHEM, V271, P33173, DOI 10.1074/jbc.271.52.33173; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; FAWCETT WP, 1995, J BACTERIOL, V177, P1742, DOI 10.1128/jb.177.7.1742-1750.1995; FRIDOVICH I, 1984, METHOD ENZYMOL, V105, P59; Gaudu P, 1996, P NATL ACAD SCI USA, V93, P10094, DOI 10.1073/pnas.93.19.10094; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; GREENBERG JT, 1989, J BACTERIOL, V171, P3933, DOI 10.1128/jb.171.7.3933-3939.1989; Griffith KL, 2002, BIOCHEM BIOPH RES CO, V291, P979, DOI 10.1006/bbrc.2002.6559; Grose JH, 2006, P NATL ACAD SCI USA, V103, P7601, DOI 10.1073/pnas.0602494103; HIDALGO E, 1995, J BIOL CHEM, V270, P20908, DOI 10.1074/jbc.270.36.20908; IRIZARRY R, 2003, ANAL GENE EXPRESSION; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jensen ST, 2004, BIOINFORMATICS, V20, P1557, DOI 10.1093/bioinformatics/bth127; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; KREDICH NM, 1996, ESCHERICHIA COLI SAL, P514; Li ZY, 1996, MOL MICROBIOL, V20, P937, DOI 10.1111/j.1365-2958.1996.tb02535.x; LIOCHEV SI, 1994, P NATL ACAD SCI USA, V91, P1328, DOI 10.1073/pnas.91.4.1328; Liu X, 2001, Pac Symp Biocomput, P127; Martin RG, 2000, MOL MICROBIOL, V37, P978, DOI 10.1046/j.1365-2958.2000.02043.x; Martin RG, 2000, MOL MICROBIOL, V35, P623, DOI 10.1046/j.1365-2958.2000.01732.x; Martin RG, 2002, MOL MICROBIOL, V43, P355, DOI 10.1046/j.1365-2958.2002.02748.x; Martin RG, 2002, MOL MICROBIOL, V44, P1611, DOI 10.1046/j.1365-2958.2002.02985.x; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Opdyke JA, 2004, J BACTERIOL, V186, P6698, DOI 10.1128/JB.186.20.6698-6705.2004; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Pomposiello PJ, 2002, ADV MICROB PHYSIOL, V46, P319, DOI 10.1016/S0065-2911(02)46007-9; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Rasmussen AA, 2005, MOL MICROBIOL, V58, P1421, DOI 10.1111/j.1365-2958.2005.04911.x; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Shah IM, 2006, J MOL BIOL, V357, P718, DOI 10.1016/j.jmb.2005.12.088; Shah IM, 2006, MOL MICROBIOL, V60, P199, DOI 10.1111/j.1365-2958.2006.05086.x; Shah IM, 2004, J MOL BIOL, V343, P513, DOI 10.1016/j.jmb.2004.08.057; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405; Varghese S, 2007, MOL MICROBIOL, V64, P822, DOI 10.1111/j.1365-2958.2007.05701.x; Wood TI, 1999, MOL MICROBIOL, V34, P414, DOI 10.1046/j.1365-2958.1999.01598.x; Yeo WS, 2006, MOL MICROBIOL, V61, P206, DOI 10.1111/j.1365-2958.2006.05220.x; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zheng M, 2000, BIOCHEM PHARMACOL, V59, P1, DOI 10.1016/S0006-2952(99)00289-0; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999	60	96	99	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1186	10.1371/journal.pone.0001186	http://dx.doi.org/10.1371/journal.pone.0001186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18000553	Green Published, gold			2022-12-25	WOS:000207459100024
J	Fenton, A; Brockhurst, MA				Fenton, Andy; Brockhurst, Michael A.			Epistatic Interactions Alter Dynamics of Multilocus Gene-for-Gene Coevolution	PLOS ONE			English	Article							ANTAGONISTIC COEVOLUTION; RESISTANCE; EVOLUTION; PLANTS; COST	Fitness costs associated with resistance or virulence genes are thought to play a key role in determining the dynamics of gene-for-gene (GFG) host-parasite coevolution. However, the nature of interactions between fitness effects of multiple resistance or virulence genes (epistasis) has received less attention. To examine effects of the functional form of epistasis on the dynamics of GFG host-parasite coevolution we modified a classic multilocus GFG model framework. We show that the type of epistasis between virulence genes largely determines coevolutionary dynamics, and that coevolutionary fluctuations are more likely with acceleratingly costly (negative) than with linear or deceleratingly costly (positive) epistasis. Our results demonstrate that the specific forms of interaction between multiple resistance or virulence genes are a crucial determinant of host-parasite coevolutionary dynamics.	[Fenton, Andy; Brockhurst, Michael A.] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Brockhurst, MA (corresponding author), Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England.	michael.brockhurst@liv.ac.uk	Brockhurst, Michael A/A-6247-2009; Fenton, Andy/B-5972-2009	Fenton, Andy/0000-0002-7676-917X; Brockhurst, Michael/0000-0003-0362-820X	Royal Society	Royal Society(Royal Society of London)	This work was funded by a research project grant from the Royal Society.	BERGELSON J, 2001, ANN REV GENET, V35; Bohannan BJM, 1999, EVOLUTION, V53, P292, DOI 10.1111/j.1558-5646.1999.tb05355.x; Boots M, 1999, AM NAT, V153, P359, DOI 10.1086/303181; Bowers RG, 2005, J THEOR BIOL, V233, P363, DOI 10.1016/j.jtbi.2004.10.017; Bowers RG, 2001, J THEOR BIOL, V212, P315, DOI 10.1006/jtbi.2001.2378; Buckling A, 2006, P ROY SOC B-BIOL SCI, V273, P45, DOI 10.1098/rspb.2005.3279; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Clay K, 1996, ANNU REV PHYTOPATHOL, V34, P29, DOI 10.1146/annurev.phyto.34.1.29; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; FRANK SA, 1993, EVOL ECOL, V7, P45, DOI 10.1007/BF01237734; Sanjuan R, 2006, P NATL ACAD SCI USA, V103, P14402, DOI 10.1073/pnas.0604543103; Sasaki A, 2000, P ROY SOC B-BIOL SCI, V267, P2183, DOI 10.1098/rspb.2000.1267; Thompson J. N., 2005, INTERSPEC INTERACT; THOMPSON JN, 1992, NATURE, V360, P121, DOI 10.1038/360121a0; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588	15	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1156	10.1371/journal.pone.0001156	http://dx.doi.org/10.1371/journal.pone.0001156			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17989777	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459000038
J	Schug, ZT; da Fonseca, PCA; Bhanumathy, CD; Wagner, L; Zhang, XC; Bailey, B; Morris, EP; Yule, DI; Joseph, SK				Schug, Zachary T.; da Fonseca, Paula C. A.; Bhanumathy, Cunnigaiper D.; Wagner, Larry, II; Zhang, Xianchao; Bailey, Bradley; Morris, Edward P.; Yule, David I.; Joseph, Suresh K.			Molecular characterization of the inositol 1,4,5-trisphosphate receptor pore-forming segment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL RYANODINE RECEPTOR; INWARD RECTIFIER CHANNEL; CENTRAL CORE DISEASE; LIGAND-BINDING SITE; POTASSIUM-CHANNEL; K+ CHANNEL; CA2+ RELEASE; ION PERMEATION; TRISPHOSPHATE RECEPTORS; FUNCTIONAL-PROPERTIES	Specific residues in the putative pore helix, selectivity filter, and S6 transmembrane helix of the inositol 1,4,5-trisphosphate receptor were mutated in order to examine their effects on channel function. Mutation of 5 of 8 highly conserved residues in the pore helix/selectivity filter region inactivated the channel (C2533A, G2541A, G2545A, G2546A, and G2547A). Of the remaining three mutants, C2527A and R2543A were partially active and G2549A behaved like wild type receptor. Mutation of a putative glycine hinge residue in the S6 helix (G2586A) or a putative gating residue at the cytosolic end of S6 helix (F2592A) had minimal effects on function, although channel function was inactivated by G2586P and F2592D mutations. The mutagenesis data are interpreted in the context of a structural homology model of the inositol 1,4,5-trisphosphate receptor.	[Schug, Zachary T.; Bhanumathy, Cunnigaiper D.; Zhang, Xianchao; Bailey, Bradley; Joseph, Suresh K.] Thomas Jefferson Univ, Dept Pathol & Cell Biol, Philadelphia, PA 19107 USA; [da Fonseca, Paula C. A.; Morris, Edward P.] Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England; [Wagner, Larry, II] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	Jefferson University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Rochester	Joseph, SK (corresponding author), Thomas Jefferson Univ, Dept Pathol & Cell Biol, 1020 Locust St JAH 230A, Philadelphia, PA 19107 USA.	suresh.joseph@jefferson.edu		Schug, Zachary/0000-0003-4197-8227; da Fonseca, Paula/0000-0001-8656-5747; Morris, Edward/0000-0003-3544-0041	British Heart Foundation [PG/07/076/23480] Funding Source: Medline; Cancer Research UK Funding Source: Medline; NIAAA NIH HHS [T32 AA 07463] Funding Source: Medline; NIDCR NIH HHS [DE 14765] Funding Source: Medline; NIDDK NIH HHS [DK 54568, DK 34804] Funding Source: Medline; Wellcome Trust Funding Source: Medline	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission)		Avila G, 2003, J GEN PHYSIOL, V121, P277, DOI 10.1085/jgp.200308791; Berridge MJ, 2006, BIOCHEM SOC T, V34, P228, DOI 10.1042/BST0340228; Bhanumathy CD, 2006, J BIOL CHEM, V281, P3722, DOI 10.1074/jbc.M509966200; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Boehning D, 2000, EMBO J, V19, P5450, DOI 10.1093/emboj/19.20.5450; Boehning D, 2001, BIOPHYS J, V81, P117, DOI 10.1016/S0006-3495(01)75685-8; Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; Chatelain FC, 2005, NEURON, V47, P833, DOI 10.1016/j.neuron.2005.08.022; Chen SRW, 2002, BIOPHYS J, V82, P2436, DOI 10.1016/S0006-3495(02)75587-2; Chivers PT, 1996, EMBO J, V15, P2659, DOI 10.1002/j.1460-2075.1996.tb00626.x; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Dart C, 1998, J PHYSIOL-LONDON, V511, P25, DOI 10.1111/j.1469-7793.1998.025bi.x; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Du GG, 2004, BIOCHEM J, V382, P557, DOI 10.1042/BJ20040580; Du GG, 2001, J BIOL CHEM, V276, P31760, DOI 10.1074/jbc.M102751200; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Hurne AM, 2005, J BIOL CHEM, V280, P36994, DOI 10.1074/jbc.M506441200; Iqbalsyah TM, 2006, PROTEIN SCI, V15, P1945, DOI 10.1110/ps.062271506; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Khan MT, 2007, J BIOL CHEM, V282, P32983, DOI 10.1074/jbc.M705183200; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LABOISSIERE MCA, 1995, J BIOL CHEM, V270, P28006; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; MICHIKAWA T, 1994, J BIOL CHEM, V269, P9184; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; Ramos-Franco J, 1999, J GEN PHYSIOL, V114, P243, DOI 10.1085/jgp.114.2.243; Rojas A, 2007, BBA-BIOMEMBRANES, V1768, P39, DOI 10.1016/j.bbamem.2006.06.027; Rosenhouse-Dantsker A, 2006, BIOPHYS J, V91, P2860, DOI 10.1529/biophysj.105.080242; Sackin H, 2005, BIOPHYS J, V88, P2597, DOI 10.1529/biophysj.104.051474; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Seebohm G, 2005, J PHYSIOL-LONDON, V563, P359, DOI 10.1113/jphysiol.2004.080887; Seebohm G, 2006, BIOPHYS J, V90, P2235, DOI 10.1529/biophysj.105.067165; Srikanth S, 2004, BIOPHYS J, V86, P3634, DOI 10.1529/biophysj.104.040121; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Tikhonov DB, 2004, BIOPHYS J, V87, P1526, DOI 10.1529/biophysj.103.037770; TINKER A, 1993, J GEN PHYSIOL, V102, P1107, DOI 10.1085/jgp.102.6.1107; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Wagner LE, 2006, J BIOL CHEM, V281, P17410, DOI 10.1074/jbc.M601340200; Wang RW, 2003, J BIOL CHEM, V278, P51557, DOI 10.1074/jbc.M306788200; Wang Y, 2005, BIOPHYS J, V89, P256, DOI 10.1529/biophysj.104.056002; Welch W, 2004, BIOPHYS J, V87, P2335, DOI 10.1529/biophysj.104.044180; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3	57	111	111	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2939	2948		10.1074/jbc.M706645200	http://dx.doi.org/10.1074/jbc.M706645200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18534977	hybrid			2022-12-25	WOS:000252622300050
